[["Some apocynin analogues have exhibited outstanding inhibition to NADPH oxidase.", {"entities": []}], ["In this study, the key interactions between apocynin analogues and NADPH oxidase were analyzed by the docking method.", {"entities": []}], ["The potential active site was first identified by the SiteID program combining with the key residue CYS378.", {"entities": []}], ["Afterwards, the compounds in the training set were docked into NADPH oxidase (1K4U) under specific docking constraints to discuss the key interactions between ligands and the receptor.", {"entities": []}], ["These key interactions were then validated by the consistence between the docking result and the experimental result of the test set.", {"entities": []}], ["The result reveals that the Pi interaction between apocynin analogues and NADPH oxidase has a direct contribution to inhibition activities, except for H-bond formation and docking score.", {"entities": []}], ["The key interactions might be valuable to discover and screen apocynin analogues as potent inhibitors of NADPH oxidase.", {"entities": []}], ["Antigenic stimulation of the T cell receptor (TCR) initiates a change from a resting state into an activated one, which ultimately results in proliferation and the acquisition of effector functions.", {"entities": []}], ["To accomplish this task, T cells require dramatic changes in metabolism.", {"entities": []}], ["Therefore, we investigated changes of metabolic intermediates indicating for crucial metabolic pathways reflecting the status of T cells.", {"entities": []}], ["Moreover we analyzed possible regulatory molecules required for the initiation of the metabolic changes.", {"entities": []}], ["We found that proliferation inducing conditions result in an increase in key glycolytic metabolites, whereas the citric acid cycle remains unaffected.", {"entities": []}], ["The upregulation of glycolysis led to a strong lactate production, which depends upon AKT/PKB, but not mTOR.", {"entities": [[103, 107, "GENE"]]}], ["The observed upregulation of lactate dehydrogenase results in increased lactate production, which we found to be dependent on IL-2 and to be required for proliferation.", {"entities": []}], ["Additionally we observed upregulation of Glucose-transporter 1 (GLUT1) and glucose uptake upon stimulation, which were surprisingly not influenced by AKT inhibition.", {"entities": []}], ["Our findings suggest that AKT plays a central role in upregulating glycolysis via induction of lactate dehydrogenase expression, but has no impact on glucose uptake of T cells.", {"entities": []}], ["Furthermore, under apoptosis inducing conditions, T cells are not able to upregulate glycolysis and induce lactate production.", {"entities": []}], ["In addition maintaining high glycolytic rates strongly depends on IL-2 production.", {"entities": []}], ["The online version of this article (doi:10.1186/s12860-016-0104-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Judgemental positions are presented on research priorities in regard to the health effects from stationary sources of fossil fuel combustion products.", {"entities": []}], ["Hopefully, they can provide guidance for efforts to ensure that national energy needs are met with minimum environmental and economic burdens on the public.", {"entities": []}], ["The major areas include epidemiological studies, controlled biological studies, mutagenesis and carcinogenesis, trace elements, monitoring and analysis.", {"entities": []}], ["CD86-CD28 interaction has been suggested as the principal costimulatory pathway for the activation and differentiation of na\u00efve T cells in allergic inflammation.", {"entities": []}], ["However, it remains uncertain whether this pathway also has an essential role in the effector phase.", {"entities": []}], ["We sought to determine the contribution of CD86 on dendritic cells in the reactivation of allergen-specific Th2 cells.", {"entities": [[43, 47, "GENE"]]}], ["We investigated the effects of the downregulation of CD86 by short interfering RNAs (siRNAs) on Th2 cytokine production in the effector phase in vitro and on asthma phenotypes in ovalbumin (OVA)-sensitized and -challenged mice.", {"entities": [[158, 164, "DISEASE"], [53, 57, "GENE"]]}], ["Treatment of bone marrow-derived dendritic cells (BMDCs) with CD86 siRNA attenuated LPS-induced upregulation of CD86.", {"entities": [[62, 66, "GENE"], [112, 116, "GENE"], [62, 66, "GENE"], [112, 116, "GENE"]]}], ["CD86 siRNA treatment impaired BMDCs\u2019 ability to activate OVA-specific Th2 cells.", {"entities": [[0, 4, "GENE"]]}], ["Intratracheal administration of CD86 siRNA during OVA challenge downregulated CD86 expression in the airway mucosa.", {"entities": [[32, 36, "GENE"], [78, 82, "GENE"], [32, 36, "GENE"], [78, 82, "GENE"]]}], ["CD86 siRNA treatment ameliorated OVA-induced airway eosinophilia, airway hyperresponsiveness, and the elevations of OVA-specific IgE in the sera and IL-5, IL-13, and CCL17 in the bronchoalveolar lavage fluid, but not the goblet cell hyperplasia.", {"entities": [[52, 64, "DISEASE"], [0, 4, "GENE"], [166, 171, "GENE"]]}], ["These results suggest that local administration of CD86 siRNA during the effector phase ameliorates lines of asthma phenotypes.", {"entities": [[109, 115, "DISEASE"], [51, 55, "GENE"]]}], ["Targeting airway dendritic cells with siRNA suppresses airway inflammation and hyperresponsiveness in an experimental model of allergic asthma.", {"entities": [[127, 142, "DISEASE"], [136, 142, "DISEASE"]]}], ["Pulmonary exposure to nanoparticles (NPs) may affect, in addition to pulmonary toxicity, the cardiovascular system such as procoagulant effects, vascular dysfunction and progression of atherosclerosis.", {"entities": [[185, 200, "DISEASE"], [37, 40, "GENE"]]}], ["However, only few studies have investigated hemostatic effects after pulmonary exposure.", {"entities": []}], ["We used Bmal1 (brain and muscle ARNT-like protein-1) knockout (Bmal1 MWCNTs caused a pronounced inflammatory response in the lung with increased cell counts in the broncho-alveolar lavage and increased secretion of interleukin-1\u03b2 and cytokine-induced neutrophil chemo-attractant (KC), oxidative stress (increased ratio of oxidized versus reduced glutathione and decreased total glutathione) as well as anemic and procoagulant effects as evidenced by a decreased prothrombin time with increased fibrinogen concentrations and coagulation factor (F)VII.", {"entities": []}], ["In contrast, the ZnO NPs seemed to suppress the inflammatory (decreased neutrophils in Bmal1 The Bmal1", {"entities": [[21, 24, "GENE"]]}], ["Male rats were treated with various model compounds or the appropriate vehicle controls.", {"entities": []}], ["Most substances were either well-known hepatotoxicants or showed hepatotoxicity during preclinical testing.", {"entities": []}], ["The aim of the present study was to determine if biological samples from rats treated with various compounds can be classified based on gene expression profiles.", {"entities": []}], ["In addition to gene expression analysis using microarrays, a complete serum chemistry profile and liver and kidney histopathology were performed.", {"entities": []}], ["We analyzed hepatic gene expression profiles using a supervised learning method (support vector machines; SVMs) to generate classification rules and combined this with recursive feature elimination to improve classification performance and to identify a compact subset of probe sets with potential use as biomarkers.", {"entities": []}], ["Two different SVM algorithms were tested, and the models obtained were validated with a compound-based external cross-validation approach.", {"entities": []}], ["Our predictive models were able to discriminate between hepatotoxic and nonhepatotoxic compounds.", {"entities": []}], ["Furthermore, they predicted the correct class of hepatotoxicant in most cases.", {"entities": []}], ["We provide an example showing that a predictive model built on transcript profiles from one rat strain can successfully classify profiles from another rat strain.", {"entities": []}], ["In addition, we demonstrate that the predictive models identify nonresponders and are able to discriminate between gene changes related to pharmacology and toxicity.", {"entities": []}], ["This work confirms the hypothesis that compound classification based on gene expression data is feasible.", {"entities": []}], ["Health professional racial/ethnic bias may impact on clinical decision-making and contribute to subsequent ethnic health inequities.", {"entities": []}], ["However, limited research has been undertaken among medical students.", {"entities": []}], ["This paper presents findings from the Bias and Decision-Making in Medicine (BDMM) study, which sought to examine ethnic bias (M\u0101ori (indigenous peoples) compared with New Zealand European) among medical students and associations with clinical decision-making.", {"entities": []}], ["All final year New Zealand (NZ) medical students in 2014 and 2015 ( n \u2009=\u2009888) were invited to participate in a cross-sectional online study.", {"entities": []}], ["Key components included: two chronic disease vignettes (cardiovascular disease (CVD) and depression) with randomized patient ethnicity (M\u0101ori or NZ European) and questions on patient management; implicit bias measures (an ethnicity preference Implicit Association Test (IAT) and an ethnicity and compliant patient IAT); and, explicit ethnic bias questions.", {"entities": []}], ["Associations between ethnic bias and clinical decision-making responses to vignettes were tested using linear regression.", {"entities": []}], ["Three hundred and\u00a0two students participated (34% response rate).", {"entities": []}], ["Implicit and explicit ethnic bias favoring NZ Europeans was apparent among medical students.", {"entities": []}], ["In the CVD vignette, no significant differences in clinical decision-making by patient ethnicity were observed.", {"entities": []}], ["There were also no differential associations by patient ethnicity between any measures of ethnic bias (implicit or explicit) and patient management responses in the CVD vignette.", {"entities": []}], ["In the depression vignette, some differences in the ranking of recommended treatment options were observed by patient ethnicity and explicit preference for NZ Europeans was associated with increased reporting that NZ European patients would benefit from treatment but not M\u0101ori (slope difference 0.34, 95% CI 0.08, 0.60; p \u2009=\u20090.011), although this was the only significant finding in these analyses.", {"entities": []}], ["NZ medical students demonstrated ethnic bias, although overall this was not associated with clinical decision-making.", {"entities": []}], ["This study both adds to the small body of literature internationally on racial/ethnic bias among medical students and provides relevant and important information for medical education on indigenous health and ethnic health inequities in New Zealand.", {"entities": []}], ["The online version of this article (10.1186/s12909-018-1120-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["High-throughput RNA-sequencing (RNA-seq) technologies provide an unprecedented opportunity to explore the individual transcriptome.", {"entities": []}], ["Unmapped reads are a large and often overlooked output of standard RNA-seq analyses.", {"entities": []}], ["Here, we present Read Origin Protocol (ROP), a tool for discovering the source of all reads originating from complex RNA molecules.", {"entities": []}], ["We apply ROP to samples across 2630 individuals from 54 diverse human tissues.", {"entities": []}], ["Our approach can account for 99.9% of 1 trillion reads of various read length.", {"entities": []}], ["Additionally, we use ROP to investigate the functional mechanisms underlying connections between the immune system, microbiome, and disease.", {"entities": []}], ["ROP is freely available at https://github.com/smangul1/rop/wiki .", {"entities": []}], ["The online version of this article (10.1186/s13059-018-1403-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["With a growing availability of different devices and types of medication, additional evidence is required to assist clinicians in prescribing the optimal medication in relation to chronic obstructive pulmonary disease (COPD) patients\u2019 persistence with long-acting \u03b2 2 -agonists (LABAs).", {"entities": [[180, 217, "DISEASE"]]}], ["To assess the impact of the type of inhaler device (multiple-dose versus single-dose inhalers) on 1-year persistence and switching patterns with LABAs.", {"entities": []}], ["A retrospective observational cohort study was performed comparing a cohort of patients initiating multiple-dose inhalers and a cohort initiating single-dose inhalers.", {"entities": []}], ["The study population consisted of long-acting bronchodilator naive COPD patients, initiating inhalation therapy with mono-LABAs (formoterol, indacaterol or salmeterol).", {"entities": []}], ["Analyses were performed using pharmacy dispensing data from 1994 to 2012, obtained from the IADB.nl database.", {"entities": []}], ["Study outcomes were 1-year persistence and switching patterns.", {"entities": []}], ["Results were adjusted for initial prescriber, initial medication, dosing regimen and relevant comorbidities.", {"entities": []}], ["In all, 575 patients initiating LABAs were included in the final study cohort.", {"entities": []}], ["Among them, 475 (83%) initiated a multiple-dose inhaler and 100 (17%) a single-dose inhaler.", {"entities": []}], ["Further, 269 (47%) initiated formoterol, 9 (2%) indacaterol and 297 (52%) salmeterol.", {"entities": []}], ["There was no significant difference in persistence between users of multiple-dose or single-dose inhalers (hazard ratio: 0.98, 95% confidence interval: 0.76\u20131.26, P =0.99).", {"entities": []}], ["Over 80% re-started or switched medication.", {"entities": []}], ["There seems no impact of inhaler device (multiple-dose versus single-dose inhalers) on COPD patients\u2019 persistence with LABAs.", {"entities": []}], ["Over 80% of patients who initially seemed to discontinue LABAs, re-started their initial medication or switched inhalers or medication within 1 year.", {"entities": []}], ["Antimicrobial resistance is a serious threat to public health, with most antibiotics prescribed in primary care.", {"entities": []}], ["General practitioners (GPs) report defensive antibiotic prescribing to mitigate perceived risk of future hospital admission in children with respiratory tract infections.", {"entities": []}], ["We developed a clinical rule aimed to reduce clinical uncertainty by stratifying risk of future hospital admission.", {"entities": []}], ["8394 children aged between 3 months and 16 years presenting with acute cough (for \u226428 days) and respiratory tract infection were recruited to a prognostic cohort study from 247 general practitioner practices in England.", {"entities": []}], ["Exposure variables included demographic characteristics, parent-reported symptoms, and physical examination signs.", {"entities": []}], ["The outcome was hospital admission for respiratory tract infection within 30 days, collected using a structured, blinded review of medical records.", {"entities": []}], ["8394 (100%) children were included in the analysis, with 78 (0\u00b79%, 95% CI 0\u00b77%\u20131\u00b72%) admitted to hospital: 15 (19%) were admitted on the day of recruitment (day 1), 33 (42%) on days 2\u20137; and 30 (39%) on days 8\u201330.", {"entities": []}], ["Seven characteristics were independently associated (p<0\u00b701) with hospital admission: age <2 years, current asthma, illness duration of 3 days or less, parent-reported moderate or severe vomiting in the previous 24 h, parent-reported severe fever in the previous 24 h or a body temperature of 37\u00b78\u00b0C or more at presentation, clinician-reported intercostal or subcostal recession, and clinician-reported wheeze on auscultation.", {"entities": [[108, 114, "DISEASE"]]}], ["The area under the receiver operating characteristic (AUROC) curve for the coefficient-based clinical rule was 0\u00b782 (95% CI 0\u00b777\u20130\u00b787, bootstrap validated 0\u00b781).", {"entities": []}], ["Assigning one point per characteristic, a points-based clinical rule consisting of short illness, temperature, age, recession, wheeze, asthma, and vomiting (mnemonic STARWAVe; AUROC 0\u00b781, 0\u00b776\u20130\u00b785) distinguished three hospital admission risk strata: very low (0\u00b73%, 0\u00b72\u20130\u00b74%) with 1 point or less, normal (1\u00b75%, 1\u00b70\u20131\u00b79%) with 2 or 3 points, and high (11\u00b78%, 7\u00b73\u201316\u00b72%) with 4 points or more.", {"entities": [[135, 141, "DISEASE"]]}], ["Clinical characteristics can distinguish children at very low, normal, and high risk of future hospital admission for respiratory tract infection and could be used to reduce antibiotic prescriptions in primary care for children at very low risk.", {"entities": []}], ["National Institute for Health Research (NIHR).", {"entities": []}], ["This study focused on respiratory symptoms due to occupational exposures in a contemporary general population cohort.", {"entities": []}], ["Subjects were from the Dutch Monitoring Project on Risk Factors for Chronic Diseases (MORGEN).", {"entities": []}], ["The composition of this population enabled estimation of respiratory risks due to occupation from the recent past for both men and women.", {"entities": []}], ["The study subjects (aged 20\u201359) were all inhabitants of Doetinchem, a small industrial town, and came from a survey of a random sample of 1104 persons conducted in 1993.", {"entities": []}], ["A total of 274 cases with respiratory symptoms (subdivided in asthma and bronchitis symptoms) and 274 controls without symptoms were matched for age and sex.", {"entities": [[62, 68, "DISEASE"], [73, 83, "DISEASE"]]}], ["Relations between industry and occupation and respiratory symptoms were explored and adjusted for smoking habits and social economic status.", {"entities": []}], ["Employment in the 'construction' (OR = 3.38; 95%CI 1.02 \u2013 11.27), 'metal' (OR = 3.17; 95%CI 0.", {"entities": []}], ["98 \u2013 10.28), 'rubber, plastics and synthetics' (OR = 6.52; 95%CI 1.26 \u2013 53.80), and 'printing' industry (OR = 3.96; 95%CI 0.85 \u2013 18.48) were positively associated with chronic bronchitis symptoms.", {"entities": [[176, 186, "DISEASE"]]}], ["In addition, the 'metal' industry was found to be weakly associated with asthma symptoms (OR = 2.59; 95%CI 0.87 \u2013 7.69).", {"entities": [[73, 79, "DISEASE"]]}], ["Duration of employment within these industries was also positively associated with respiratory symptoms.", {"entities": []}], ["Respiratory symptoms in the general population are traceable to employment in particular industries even in a contemporary cohort with relatively young individuals.", {"entities": []}], ["The aim of this study was to evaluate the effects of premedication with oral atenolol or enalapril, in combination with remifentanil under sevoflurane anesthesia, on intraoperative blood loss by achieving adequate deliberate hypotension (DH) during orthognathic surgery.", {"entities": []}], ["Furthermore, we investigated the impact thereof on the amount of nitroglycerin (NTG) administered as an adjuvant agent.", {"entities": []}], ["Seventy-three patients undergoing orthognathic surgery were randomly allocated into one of three groups: an angiotensin converting enzyme inhibitor group (Group A, n=24) with enalapril 10 mg, a \u03b2 blocker group (Group B, n=24) with atenolol 25 mg, or a control group (Group C, n=25) with placebo.", {"entities": []}], ["All patients were premedicated orally 1 h before the induction of anesthesia.", {"entities": []}], ["NTG was the only adjuvant agent used to achieve DH when mean arterial blood pressure (MAP) was not controlled, despite the administration of the maximum remifentanil dose (0.3 \u00b5g kg Seventy-two patients completed the study.", {"entities": []}], ["Blood loss was significantly reduced in Group A, compared to Group C (adjusted p =0.045).", {"entities": []}], ["Over the target range of MAP percentage during DH was significantly higher in Group C than in Groups A and B (adjusted p -values=0.007 and 0.006, respectively).", {"entities": []}], ["The total amount of NTG administered was significantly less in Group A than Group C (adjusted p =0.015).", {"entities": []}], ["Premedication with enalapril (10 mg) combined with remifentanil under sevoflurane anesthesia attenuated blood loss and achieved satisfactory DH during orthognathic surgery.", {"entities": []}], ["Furthermore, the amount of NTG was reduced during the surgery.", {"entities": []}], ["There is suggestive evidence that lower rates of health insurance coverage increases the gaps in quality and access to care among Latinos as compared with non-Latino whites.", {"entities": []}], ["In order to examine these potential disparities, we assessed the effects of insurance coverage and multiple covariates on perceived quality of care.", {"entities": []}], ["To assess the distribution of perceived quality of care received in a national Latino population sample, and the role of insurance in different patient subgroups.", {"entities": []}], ["Telephone interviews conducted between 2007 and 2008 using the Pew Hispanic Center/Robert Wood Johnson Foundation Latino Health Surveys (Waves 1 and 2).", {"entities": []}], ["Randomly selected Latino adults aged \u226518\u00a0years living in the United States.", {"entities": []}], ["Pearson \u03c7 N \u2009=\u20093545).", {"entities": []}], ["Subgroup analyses were conducted among Wave 2 participants reporting chronic conditions ( N \u2009=\u20091067).", {"entities": []}], ["Bivariate and multivariate analyses were conducted to estimate the effects of insurance, demographic variables and consumer characteristics on quality of care.", {"entities": []}], ["Insurance availability had an odds ratio of 1.47 (95% CI, 1.22\u20131.76) net of confounders in predicting perceived quality of care among Latinos.", {"entities": []}], ["The largest gap in rates of excellent/good ratings occurred among the insured with eight or more doctor visits compared to the uninsured (76.2% vs. 54.6%, P \u2009<\u2009.05).", {"entities": []}], ["Future research can gain additional insights by examining the impact of health insurance on processes of care with a refined focus on specific transactions between consumers and providers\u2019 support staff and physicians guided by the principles of patient-centered care.", {"entities": []}], ["There is no clear evidence as to whether the co-location of primary care professionals in the same facility positively influences their way of working and the quality of healthcare as perceived by patients.", {"entities": []}], ["The aim of this study was to identify the relationships between general practitioner (GP) co-location with other GPs and/or other professionals and the GP outcomes and patients\u2019 experiences.", {"entities": []}], ["We wanted to test whether GP co-location is related to a broader range of services provided, the use of clinical governance tools and inter-professional collaboration, and whether the patients of co-located GPs perceive a better quality of care in terms of accessibility, comprehensiveness and continuity of care with their GPs.", {"entities": []}], ["The source of data was the QUALICOPC study (Quality and Costs of Primary Care in Europe), which involved surveys of GPs and their patients in 34 countries, mostly in Europe.", {"entities": []}], ["In order to study the relationships between GP co-location and both GPs\u2019 outcomes and patients\u2019 experience, multilevel linear regression analysis was carried out.", {"entities": []}], ["The GP questionnaire was filled in by 7183 GPs and the patient experience questionnaire by 61,931 patients.", {"entities": []}], ["Being co-located with at least one other professional is the most common situation of the GPs involved in the study.", {"entities": []}], ["Compared with single-handed GP practices, GP co-location are positively associated with the GP outcomes.", {"entities": []}], ["Considering the patients\u2019 perspective, comprehensiveness of care has the strongest negative relationship of GP co-location of all the dimensions of patient experiences analysed.", {"entities": []}], ["The paper highlights that GP mono- and multi-disciplinary co-location is related to positive outcomes at a GP level, such as a broader provision of technical procedures, increased collaboration among different providers and wider coordination with secondary care.", {"entities": []}], ["However, GP co-location, particularly in a multidisciplinary setting, is related to less positive patient experiences, especially in countries with health systems characterised by a weak primary care structure.", {"entities": []}], ["A key function of health systems is implementing interventions to improve health, but coverage of essential health interventions remains low in low-income countries.", {"entities": []}], ["Implementing interventions can be challenging, particularly if it entails complex changes in clinical routines; in collaborative patterns among different healthcare providers and disciplines; in the behaviour of providers, patients or other stakeholders; or in the organisation of care.", {"entities": []}], ["Decision-makers may use a range of strategies to implement health interventions, and these choices should be based on evidence of the strategies' effectiveness.", {"entities": []}], ["To provide an overview of the available evidence from up-to-date systematic reviews about the effects of implementation strategies for health systems in low-income countries.", {"entities": []}], ["Secondary objectives include identifying needs and priorities for future evaluations and systematic reviews on alternative implementation strategies and informing refinements of the framework for implementation strategies presented in the overview.", {"entities": []}], ["We searched Health Systems Evidence in November 2010 and PDQ-Evidence up to December 2016 for systematic reviews.", {"entities": []}], ["We did not apply any date, language or publication status limitations in the searches.", {"entities": []}], ["We included well-conducted systematic reviews of studies that assessed the effects of implementation strategies on professional practice and patient outcomes and that were published after April 2005.", {"entities": []}], ["We excluded reviews with limitations important enough to compromise the reliability of the review findings.", {"entities": []}], ["Two overview authors independently screened reviews, extracted data and assessed the certainty of evidence using GRADE.", {"entities": []}], ["We prepared SUPPORT Summaries for eligible reviews, including key messages, 'Summary of findings' tables (using GRADE to assess the certainty of the evidence) and assessments of the relevance of findings to low-income countries.", {"entities": []}], ["We identified 7272 systematic reviews and included 39 of them in this overview.", {"entities": []}], ["An additional four reviews provided supplementary information.", {"entities": []}], ["Of the 39 reviews, 32 had only minor limitations and 7 had important methodological limitations.", {"entities": []}], ["Most studies in the reviews were from high-income countries.", {"entities": []}], ["There were no studies from low-income countries in eight reviews.", {"entities": []}], ["Implementation strategies addressed in the reviews were grouped into four categories \u2013 strategies targeting: 1. healthcare organisations (e.g.", {"entities": []}], ["strategies to change organisational culture; 1 review); 2. healthcare workers by type of intervention (e.g.", {"entities": []}], ["printed educational materials; 14 reviews); 3. healthcare workers to address a specific problem (e.g.", {"entities": []}], ["unnecessary antibiotic prescription; 9 reviews); 4. healthcare recipients (e.g.", {"entities": []}], ["medication adherence; 15 reviews).", {"entities": []}], ["Overall, we found the following interventions to have desirable effects on at least one outcome with moderate- or high-certainty evidence and no moderate- or high-certainty evidence of undesirable effects.", {"entities": []}], ["Strategies targeted at healthcare workers : educational meetings, nutrition training of health workers, educational outreach, practice facilitation, local opinion leaders, audit and feedback, and tailored interventions.", {"entities": []}], ["Strategies targeted at healthcare workers for specific types of problems : training healthcare workers to be more patient-centred in clinical consultations, use of birth kits, strategies such as clinician education and patient education to reduce antibiotic prescribing in ambulatory care settings, and in-service neonatal emergency care training.", {"entities": []}], ["Strategies targeted at healthcare recipients : mass media interventions to increase uptake of HIV testing; intensive self-management and adherence, intensive disease management programmes to improve health literacy; behavioural interventions and mobile phone text messages for adherence to antiretroviral therapy; a one time incentive to start or continue tuberculosis prophylaxis; default reminders for patients being treated for active tuberculosis; use of sectioned polythene bags for adherence to malaria medication; community-based health education, and reminders and recall strategies to increase vaccination uptake; interventions to increase uptake of cervical screening (invitations, education, counselling, access to health promotion nurse and intensive recruitment); health insurance information and application support.", {"entities": [[356, 368, "DISEASE"], [438, 450, "DISEASE"], [501, 508, "DISEASE"]]}], ["Reliable systematic reviews have evaluated a wide range of strategies for implementing evidence-based interventions in low-income countries.", {"entities": []}], ["Most of the available evidence is focused on strategies targeted at healthcare workers and healthcare recipients and relates to process-based outcomes.", {"entities": []}], ["Evidence of the effects of strategies targeting healthcare organisations is scarce.", {"entities": []}], ["What is the aim of this overview?", {"entities": []}], ["The aim of this Cochrane Overview is to provide a broad summary of what is known about the effects of strategies for implementing interventions to improve health in low-income countries.", {"entities": []}], ["This overview is based on 39 relevant systematic reviews.", {"entities": []}], ["Each of these reviews searched for studies that evaluated the different types of implementation strategies within the scope of the question addressed by the review.", {"entities": []}], ["The reviews included a total of 1332 studies.", {"entities": []}], ["This overview is one of a series of four Cochrane Overviews that evaluate different health system arrangements.", {"entities": []}], ["What was studied in the overview?", {"entities": []}], ["A key function of health systems is implementing interventions to improve health.", {"entities": []}], ["Coverage of essential health interventions remains low in low-income countries.", {"entities": []}], ["Decision-makers may use a range of strategies to implement health interventions, and these choices should be based on evidence of the strategies' effectiveness.", {"entities": []}], ["What are the main results of the overview?", {"entities": []}], ["The following implementation strategies had desirable effects on at least one outcome with moderate- or high-certainty evidence and no moderate- or high-certainty evidence of undesirable effects.", {"entities": []}], ["Strategies targeted at healthcare workers - Educational meetings.", {"entities": []}], ["- Nutrition training of health workers.", {"entities": []}], ["- Educational outreach (vs. no intervention).", {"entities": []}], ["- Practice facilitation.", {"entities": []}], ["- Local opinion leaders.", {"entities": []}], ["- Audit and feedback.", {"entities": []}], ["- Tailored interventions (vs. no intervention).", {"entities": []}], ["Strategies targeted at healthcare workers for specific types of problems - Training healthcare workers to be more patient-centred in clinical consultations.", {"entities": []}], ["- Use of birth kits.", {"entities": []}], ["- Clinician education and patient education to reduce antibiotic prescribing in ambulatory care settings.", {"entities": []}], ["- In-service neonatal emergency care training.", {"entities": []}], ["Strategies targeted at healthcare recipients - Mass media interventions to increase immediate uptake of HIV testing (leaflets and gain-framed videos).", {"entities": []}], ["- Intensive self-management and adherence, intensive disease management to improve health literacy.", {"entities": []}], ["- Behavioural interventions and mobile phone text messages for adherence to antiretroviral therapy.", {"entities": []}], ["- A one-time incentive to start or continue tuberculosis prophylaxis.", {"entities": [[44, 56, "DISEASE"]]}], ["- Default reminders for patients being treated for active tuberculosis.", {"entities": [[58, 70, "DISEASE"]]}], ["- Use of sectioned polythene bags for adherence to malaria medication.", {"entities": [[51, 58, "DISEASE"]]}], ["- Community-based health education, and reminders and recall strategies for vaccination uptake.", {"entities": []}], ["- Providing free insecticide-treated bednets.", {"entities": []}], ["- Interventions to improve uptake of cervical screening (invitations, education, counselling, access to health promotion nurse, and intensive recruitment).", {"entities": []}], ["- Health insurance information and application support.", {"entities": []}], ["The following implementation strategies had low- or very low-certainty evidence (or no studies available) for all the outcomes that were considered.", {"entities": []}], ["Strategies targeted at healthcare organisations - Strategies to improve organisational culture.", {"entities": []}], ["Strategies targeted at healthcare workers - Printed educational materials.", {"entities": []}], ["- Internet-based learning.", {"entities": []}], ["- Interprofessional education.", {"entities": []}], ["- Teaching critical appraisal.", {"entities": []}], ["- Educational outreach (vs. another intervention).", {"entities": []}], ["- Pharmacist-provided services.", {"entities": []}], ["- Safety checklists for use by medical care teams in acute hospital settings.", {"entities": []}], ["- Tailored interventions (vs. non-tailored interventions, and interventions targeted at organisational and individual barriers vs. interventions targeted at individual barriers only).", {"entities": []}], ["- Interventions to encourage the use of systematic reviews in clinical decision-making.", {"entities": []}], ["Strategies targeted at healthcare workers for specific types of problems - Interventions to improve handwashing.", {"entities": []}], ["- Interventions to reduce unnecessary caesarean section rates.", {"entities": []}], ["- Training of traditional birth attendants.", {"entities": []}], ["- Skilled birth attendance.", {"entities": []}], ["- Training of traditional healers about STD and HIV medicine.", {"entities": []}], ["Strategies targeted at healthcare recipients - Providing information/education for promoting HIV testing (multimedia).", {"entities": []}], ["- Providing written medicine information.", {"entities": []}], ["- Single interventions to improve health literacy.", {"entities": []}], ["- Interventions to improve medication adherence.", {"entities": []}], ["- Adherence \u2013 TB (immediate versus deferred incentives; cash vs. non-cash incentive; different levels of cash incentives; incentives vs. other interventions).", {"entities": []}], ["- Adherence \u2013 malarial medication (blister packed tablets and capsules compared to tablets and capsules in paper envelopes; tablets in sectioned polythene bags compared to bottled syrup).", {"entities": []}], ["- Training of healthcare workers, home visits, and monetary incentives to improve immunisation coverage.", {"entities": []}], ["- Risk factor assessment to improve the uptake of cervical cancer screening.", {"entities": [[59, 65, "DISEASE"], [50, 65, "DISEASE"]]}], ["How up to date is this overview?", {"entities": []}], ["The overview authors searched for systematic reviews that had been published up to 17 December 2016.", {"entities": []}], ["Both kynurenic acid and 2-acyl lysophosphatidic acid have been postulated to be the endogenous agonists of GPR35.", {"entities": [[107, 112, "GENE"]]}], ["However, controversy remains whether alternative endogenous agonists exist.", {"entities": []}], ["The molecular targets accounted for many nongenomic actions of thyroid hormones are mostly unknown.", {"entities": []}], ["Here we report the agonist activity of multiple tyrosine metabolites at the GPR35.", {"entities": [[76, 81, "GENE"]]}], ["Tyrosine metabolism intermediates that contain carboxylic acid and/or catechol functional groups were first selected.", {"entities": []}], ["Whole cell dynamic mass redistribution (DMR) assays enabled by label-free optical biosensor were then used to characterize their agonist activity in native HT-29.", {"entities": []}], ["Molecular assays including \u03b2-arrestin translocation, ERK phosphorylation and receptor internalization confirmed that GPR35 functions as a receptor for 5,6-dihydroxyindole-2-carboxylic acid, 3,3\u2032,5\u2032-triiodothyronine, 3,3\u2032,5-triiodothyronine, gentisate, rosmarinate, and 3-nitrotyrosine.", {"entities": [[117, 122, "GENE"]]}], ["These results suggest that multiple tyrosine metabolites are alternative endogenous ligands of GPR35, and GPR35 may represent a druggable target for treating certain diseases associated with abnormality of tyrosine metabolism.", {"entities": [[95, 100, "GENE"], [106, 111, "GENE"], [95, 100, "GENE"], [106, 111, "GENE"]]}], ["What\u2019s Your Cap: Know When to Put a Lid on Drinking (WYC) is a student-led and research-based binge-drinking prevention campaign at the University of Saskatchewan, Canada.", {"entities": []}], ["It was formed to encourage a culture of alcohol moderation on the university campus through peer-to-peer engagement that emphasizes promotional items and activities of interest to students.", {"entities": []}], ["Since its development in 2011, WYC has been guided by a logic model that promotes: 1) perceived and actual student drinking norms on campus; 2) benefits of a student-led initiative; and 3) merits of working with community partners.", {"entities": []}], ["With the release of a clinical guide in Canada for alcohol screening, brief intervention, and referral (SBIR) in 2013, WYC was prompted to consider whether it is a form of population-based SBIR.", {"entities": []}], ["SBIR is commonly undertaken in the substance use field by health care practitioners, and this paper shares the potential for a student-based SBIR modification on a university campus.", {"entities": []}], ["Asthma is a complex human disease that does not have an accurate counterpart in any common model organism.", {"entities": [[0, 6, "DISEASE"]]}], ["Most of our understanding of the immune mechanisms underlying asthma comes from studies in man and mouse.", {"entities": [[62, 68, "DISEASE"]]}], ["However, there are fundamental differences between the spontaneous disease in man and the experimentally induced counterparts in mice.", {"entities": []}], ["We advocate more extensive use of nonhuman primate asthma models to reconcile these differences between man and mouse.", {"entities": [[51, 57, "DISEASE"]]}], ["Asthmatic airways are inflamed and undergo remodelling.", {"entities": []}], ["Inhaled corticosteroids and long-acting \u03b22-agonist combinations are more effective than inhaled corticosteroid monotherapy in controlling disease exacerbations, but their effect on airway remodelling and inflammation remains ill-defined.", {"entities": []}], ["This study evaluates the contribution of inhaled fluticasone and salmeterol, alone or combined, to the reversal of bronchial remodelling and inflammation.", {"entities": []}], ["Severely asthmatic horses (6 horses/group) were treated with fluticasone, salmeterol, fluticasone/salmeterol, or with antigen avoidance for 12 weeks.", {"entities": []}], ["Lung function, central and peripheral airway remodelling, and bronchoalveolar inflammation were assessed.", {"entities": []}], ["Fluticasone/salmeterol and fluticasone monotherapy decreased peripheral airway smooth muscle remodelling after 12 weeks (p\u2009=\u20090.007 and p\u2009=\u20090.02, respectively).", {"entities": []}], ["On average, a 30% decrease was observed with both treatments.", {"entities": []}], ["In central airways, fluticasone/salmeterol reversed extracellular matrix remodelling after 12 weeks, both within the lamina propria (decreased thickness, p\u2009=\u20090.005) and within the smooth muscle layer (p\u2009=\u20090.004).", {"entities": []}], ["Only fluticasone/salmeterol decreased bronchoalveolar neutrophilia (p\u2009=\u20090.03) to the same extent as antigen avoidance already after 8 weeks.", {"entities": []}], ["In conclusion, this study shows that fluticasone/salmeterol combination decreases extracellular matrix remodelling in central airways and intraluminal neutrophilia.", {"entities": []}], ["Fluticasone/salmeterol and fluticasone monotherapy equally reverse peripheral airway smooth muscle remodelling.", {"entities": []}], ["Fundamental to the potential utilisation of heart rate variability (HRV) indices as a prognostic tool is the reproducibility of these measures.", {"entities": []}], ["The purpose of the present study was therefore to investigate the reproducibility of 24-hour derived HRV indices in a clinical paediatric population.", {"entities": []}], ["Eighteen children (10 boys; 12.4 \u00b1 2.8 years) with mild to moderate Cystic Fibrosis (CF; FVC: 83 \u00b1 12% predicted; FEV 1 : 80 \u00b1 9% predicted) and eighteen age- and sex-matched controls (10 boys; 12.5 \u00b1 2.7 years) wore a combined ECG and accelerometer for two consecutive days.", {"entities": [[114, 117, "GENE"]]}], ["Standard time and frequency domain indices of HRV were subsequently derived.", {"entities": []}], ["Reproducibility was assessed by Bland-Altman plots, 95% limits of agreement and intra-class correlation coefficients (ICC).", {"entities": []}], ["In both groups, there was no systematic difference between days, with the variables demonstrating a symmetrical, homoscedastic distribution around the zero line.", {"entities": []}], ["The time domain parameters demonstrated a good to excellent reproducibility irrespective of the population considered (ICC: 0.56 to 0.86).", {"entities": []}], ["In contrast, whilst the frequency domain parameters similarly showed excellent reproducibility in the healthy children (ICC: 0.70 to 0.96), the majority of the frequency domain parameters illustrated a poor to moderate reproducibility in those with CF (ICC: 0.22 to 0.43).", {"entities": []}], ["The exceptions to this trend were the normalised LF and HF components which were associated with a good to excellent reproducibility.", {"entities": []}], ["These findings thereby support the utilisation of time and relative frequency domain HRV indices as a prognostic tool in children with CF.", {"entities": []}], ["Furthermore, the present results highlight the excellent reproducibility of HRV in healthy children, indicating that this may be a useful tool to assess intervention effectiveness in this population.", {"entities": []}], ["The epithelial barrier dysfunction plays a critical role in the pathogenesis of a broad array of immune diseases.", {"entities": []}], ["Alix protein is involved in the endolysosome system.", {"entities": []}], ["This study aims to elucidate the role of Alix in the maintenance of epithelial barrier function.", {"entities": []}], ["The results showed that Alix was detected in T84 cells at both mRNA and protein levels.", {"entities": []}], ["Exposure to Staphylococcal enterotoxin B (SEB) markedly suppressed the expression of Alix in T84 cells, which could be blocked by knocking down the Toll like receptor 2.", {"entities": []}], ["The exposure to SEB did not affect the TER, but markedly increased the permeability of T84 monolayers to OVA; the OVA passing through T84 monolayers still preserved the antigenicity manifesting inducing antigen specific T cells proliferation.", {"entities": []}], ["Alix protein plays a critical role in the maintenance of the barrier function of T84 monolayers.", {"entities": []}], ["Globally, the population aged 60 years and older is projected to reach 22% by 2050.", {"entities": []}], ["In sub-Saharan Africa, this figure is projected to exceed 8%, while in Ghana, the older adult population will reach 12% by 2050.", {"entities": []}], ["The living arrangements and household characteristics are fundamental determinants of the health and well-being of this population, data sources about which are increasingly available.", {"entities": []}], ["The World Health Organization's Study on global AGEing and adult health (SAGE) Wave 1 was conducted in China, Ghana, India, Russian Federation, Mexico, and South Africa between 2007 and 2010.", {"entities": []}], ["SAGE Ghana Wave 1 was implemented in 2007/08 using face-to-face interviews in a nationally representative sample of persons aged 50-plus, along with a smaller cohort aged 18\u201349 years for comparison purposes.", {"entities": []}], ["Household information included a household roster including questions about health insurance coverage for all household members, household and sociodemographic characteristics, status of the dwelling, and economic situation.", {"entities": []}], ["Re-interviews were done in a random 10% of the sample and proxy interviews done where necessary.", {"entities": []}], ["Verbal autopsies were conducted for deaths occurring in older adult household members in the 24 months prior to interview.", {"entities": []}], ["The total household population was 27,270 from 5,178 households.", {"entities": []}], ["The overall household response rate was 86% and household cooperation rate was 98%.", {"entities": []}], ["Thirty-four percent of household members were under 15 years of age while 8.3% were aged 65-plus years.", {"entities": []}], ["Households with more than 11 members were more common in rural areas (57.2%) and in the highest income quintile (30.6%).", {"entities": []}], ["Household members with no formal education formed 24.7% of the sample, with Northern and Upper East regions reaching more than 50%.", {"entities": []}], ["Only 26.8% of the household members had insurance coverage.", {"entities": []}], ["Households with hard floors ranged from 25.7% in Upper West to 97.7% in Ashanti region.", {"entities": []}], ["Overall, 84.9% of the households had access to improved sources of drinking water, with the lowest at 29.6% in the Volta region.", {"entities": []}], ["The overall rate of access to improved sanitation was just 14.9%.", {"entities": []}], ["The findings show significant regional differences, with the three Northern Regions having worse education, income, and sanitation levels, compared to Southern and Central Regions of the country.", {"entities": []}], ["Household characteristics and intra-household dynamics have been shown to influence health and health-seeking behaviors across a number of contexts and countries, and play a fundamental role in the well-being of older Ghanaians.", {"entities": []}], ["SAGE Ghana is part of a multi-country study using standardized questionnaires and tested methodologies to provide household level data required to inform policy on the growing population of older adults in Ghana.", {"entities": []}], ["With the good response rates and measures instituted to assure quality of data, this article demonstrates the high quality data and research methods of SAGE.", {"entities": []}], ["Most patients presenting with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in primary care are prescribed an antibiotic, which may not always be appropriate and may cause harm.", {"entities": [[53, 90, "DISEASE"]]}], ["C-reactive protein (CRP) is an acute-phase biomarker that can be rapidly measured at the point of care and may predict benefit from antibiotic treatment in AECOPD.", {"entities": [[20, 23, "GENE"]]}], ["It is not clear whether the addition of a CRP point-of-care test (POCT) to clinical assessment leads to a reduction in antibiotic consumption without having a negative impact on COPD health status.", {"entities": [[42, 45, "GENE"]]}], ["This is a multicentre, individually randomised controlled trial (RCT) aiming to include 650 participants with a diagnosis of AECOPD in primary care.", {"entities": []}], ["Participants will be randomised to be managed according to usual care (control) or with the addition of a CRP POCT to guide antibiotic prescribing.", {"entities": [[106, 109, "GENE"]]}], ["Antibiotic consumption for AECOPD within 4 weeks post randomisation and COPD health status (total score) measured by the Clinical COPD Questionnaire (CCQ) at 2 weeks post randomisation will be co-primary outcomes.", {"entities": []}], ["Primary analysis (by intention-to-treat) will determine differences in antibiotic consumption for superiority and COPD health status for non-inferiority.", {"entities": []}], ["Secondary outcomes include: COPD health status, CCQ domain scores, use of other COPD treatments (weeks 1, 2 and 4), EQ-5D utility scores (weeks 1, 2 and 4 and month 6), disease-specific, health-related quality of life (HRQoL) at 6 months, all-cause antibiotic consumption (antibiotic use for any condition) during first 4 weeks post randomisation, total antibiotic consumption (number of days during first 4 weeks of antibiotic consumed for AECOPD/any reason), antibiotic prescribing at the index consultation and during following 4 weeks, adverse effects over the first 4 weeks, incidence of pneumonia (weeks 4 and 6 months), health care resource use and cost comparison over the 6 months following randomisation.", {"entities": [[593, 602, "DISEASE"]]}], ["Prevalence and resistance profiles of bacteria will be assessed using throat and sputum samples collected at baseline and 4-week follow-up.", {"entities": []}], ["A health economic evaluation and qualitative process evaluation will be carried out.", {"entities": []}], ["If shown to be effective (i.e.", {"entities": []}], ["leads to a reduction in antibiotic use with no worse COPD health status), the use of the CRP POCT could lead to better outcomes for patients with AECOPD and help reduce selective pressures driving the development of antimicrobial resistance.", {"entities": [[89, 92, "GENE"]]}], ["PACE will be one of the first studies to evaluate the cost-effectiveness of a POCT biomarker to guide clinical decision-making in primary care on patient-reported outcomes, antibiotic prescribing and antibiotic resistance for AECOPD.", {"entities": []}], ["ISRCTN registry, ID: ISRCTN24346473 .", {"entities": []}], ["Registered on 20 August 2014.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-017-2144-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Increased dyspnea, sputum volume, and purulence are subjective symptoms in COPD patients.", {"entities": []}], ["To diagnose COPD exacerbations with chronic respiratory failure (CRF) and to assess the requirement for antibiotic treatment, physicians require more objective criteria.", {"entities": [[44, 63, "DISEASE"]]}], ["We aimed to investigate whether neutrophil-to-lymphocyte ratio (NLR) can be used as an infectious exacerbation marker in COPD patients with CRF.", {"entities": []}], ["This retrospective cross-sectional study was performed in the intensive care outpatient clinic of a tertiary training hospital between 2014 and 2015.", {"entities": []}], ["Patients admitted with CRF due to COPD and who had complete blood count (CBC) results were enrolled.", {"entities": []}], ["CBC results and C-reactive protein (CRP) levels were obtained from the hospital online database.", {"entities": [[36, 39, "GENE"]]}], ["The \u201cmodified exacerbation model (MEM)\u201d was defined as follows: exacerbation A, leukocytes \u226512,000/mm A total of 1,066 COPD patients (430 females, 40.3%), with a mean age of 66\u00b113 years, were included.", {"entities": []}], ["A NLR cutoff value of 3.54 (NLR \u22653.54, n=366, 34%) showed the highest sensitivity and specificity for model A (78%, 69%), model B (63%, 71%), model C (61%, 72%), and model D (58%, 72%).", {"entities": []}], ["Peripheral eosinophilia (PE \u22652%) was present in 48 patients (4.5%).", {"entities": [[11, 23, "DISEASE"]]}], ["The ratio of patients with PE <2% in the NLR \u22653.54 group was significantly higher in the MEM ( P <0.001).", {"entities": []}], ["The NLR presents an attractive option as an exacerbation marker in COPD patients with CRF due to its simplicity and cost-effectiveness.", {"entities": []}], ["In COPD patients with CRF, where the NLR is \u22653.54, PE levels are <2%, and subjective symptoms are present, antibiotic treatment should be considered.", {"entities": []}], ["Small-cell lung cancers (SCLCs) initially respond to chemotherapy, but are often resistant at recurrence.", {"entities": []}], ["The non-steroidal anti-inflammatory drug indomethacin is an inhibitor of multidrug resistance protein 1 (MRP1) function.", {"entities": []}], ["The doxorubicin-resistant MRP1-overexpressing human SCLC cell line GLC 4 -Adr was highly sensitive for indomethacin compared with the parental doxorubicin-sensitive line GLC 4 .", {"entities": []}], ["The purpose of this study was to analyse the relationship between hypersensitivity to indomethacin and MRP1 overexpression.", {"entities": []}], ["The experimental design involved analysis of the effect of MRP1 downregulation on indomethacin-induced cell survival and apoptosis in GLC 4 -Adr and GLC 4 , using siRNA.", {"entities": []}], ["In addition the effect of indomethacin on glutathione levels and mitochondrial membrane potential was investigated.", {"entities": []}], ["Small interfering RNAs directed against MRP1 reduced MRP1 mRNA levels twofold and reduced efflux pump function of MRP1, which was reflected by a 1.8-fold higher accumulation of MRP1 substrate carboxyfluorescein, in si-MRP1 versus si-Luciferase-transfected GLC 4 -Adr cells.", {"entities": []}], ["Multidrug resistance protein 1 downregulation decreased initial high apoptosis levels 2-fold in GLC 4 -Adr after indomethacin treatment for 24\u2009h, and increased cell survival (IC 50 ) from 22.8\u00b12.6 to 30.4\u00b15.1\u2009 \u03bc M following continuous indomethacin exposure.", {"entities": []}], ["Multidrug resistance protein 1 downregulation had no effect on apoptosis in GLC 4 or on glutathione levels in both lines.", {"entities": []}], ["Although indomethacin (20\u2009 \u03bc M ) for 2\u2009h decreased glutathione levels by 31.5% in GLC 4 -Adr, complete depletion of cellular glutathione by L -buthionine (S,R)-sulphoximine only resulted in a small increase in indomethacin-induced apoptosis in GLC 4 -Adr, demonstrating that a reduced cellular glutathione level is not the primary cause of indomethacin-induced apoptosis.", {"entities": []}], ["Indomethacin exposure decreased mitochondrial membrane potential in GLC 4 -Adr cells, suggesting activation of the mitochondrial apoptosis pathway.", {"entities": []}], ["Indomethacin induces apoptosis in a doxorubicin-resistant SCLC cell line through an MRP1-dependent mechanism.", {"entities": []}], ["This may have implications for the treatment of patients with MRP1-overexpressing tumours.", {"entities": []}], ["This work was aimed at evaluating the cardioprotective effects of Castanea sativa Mill.", {"entities": []}], ["(CSM) bark extract characterized in its phenolic composition by HPLC-DAD-MS analysis.", {"entities": []}], ["The study was performed using primary cultures of neonatal rat cardiomyocytes to investigate the antioxidant and cytoprotective effects of CSM bark extract and isolated guinea pig left and right atria, left papillary muscle, and aorta to evaluate its direct effect on cholinergic and adrenergic response.", {"entities": []}], ["In cultured cardiomyocytes the CSM bark extract reduced intracellular reactive oxygen species formation and improved cell viability following oxidative stress in dose-dependent manner.", {"entities": []}], ["Moreover, the extract decreased the contraction induced by noradrenaline (1\u2009 \u03bc M) in guinea pig aortic strips and induced transient negative chronotropic and positive inotropic effects without involvement of cholinergic or adrenergic receptors in the guinea pig atria.", {"entities": []}], ["Our results indicate that CSM bark extract exhibits antioxidant activity and might induce cardioprotective effect.", {"entities": []}], ["Most available quality indicators for hospitals are represented by simple ratios or proportions, and are limited to specific events.", {"entities": []}], ["A generalized method that can be applied to diverse clinical events has not been developed.", {"entities": []}], ["The aim of this study was to develop a simple method of evaluating physicians' prescription patterns for diverse events and their level of awareness of clinical practice guidelines.", {"entities": []}], ["We developed a quantitative method called Prescription pattern Around Clinical Event (PACE), which is applicable to electronic health records (EHRs).", {"entities": []}], ["Three discrete prescription patterns (intervention, maintenance, and discontinuation) were determined based on the prescription change index (PCI), which was calculated by means of the increase or decrease in the prescription rate after a clinical event.", {"entities": []}], ["Hyperkalemia and Clostridium difficile-associated diarrhea (CDAD) were used as example cases.", {"entities": [[50, 58, "DISEASE"]]}], ["We calculated the PCIs of 10 drugs related to hyperkalemia, categorized them into prescription patterns, and then compared the resulting prescription patterns with the known standards for hyperkalemia treatment.", {"entities": []}], ["The hyperkalemia knowledge of physicians was estimated using a questionnaire and compared to the prescription pattern.", {"entities": []}], ["Prescriptions for CDAD were also determined and compared to clinical knowledge.", {"entities": []}], ["Clinical data of 1698, 348, and 1288 patients were collected from EHR data.", {"entities": []}], ["The physicians prescribing behaviors for hyperkalemia and CDAD were concordant with the standard knowledge.", {"entities": []}], ["Prescription patterns were well correlated with individual physicians' knowledge of hyperkalemia (\u03ba\u200a=\u200a0.714).", {"entities": []}], ["Prescribing behaviors according to event severity or clinical condition were plotted as a simple summary graph.", {"entities": []}], ["The algorithm successfully assessed the prescribing patterns from the EHR data.", {"entities": []}], ["The prescription patterns were well correlated with physicians' knowledge.", {"entities": []}], ["We expect that this algorithm will enable quantification of prescribers' adherence to clinical guidelines and be used to facilitate improved prescribing practices.", {"entities": []}], ["To examine the association between exposure to newer antidepressants and risk of gastrointestinal (GI) and other bleeding complications among individuals with major depressive disorder (MDD).", {"entities": [[159, 184, "DISEASE"]]}], ["This study uses an incident user cohort design to compare associations between incidence of vascular/bleeding events and the relative affinity (low, moderate or high) of the antidepressant for the serotonin transporter during an exposure risk period for each patient.", {"entities": []}], ["New England healthcare system electronic medical record database.", {"entities": []}], ["36\u2008389 individuals with a diagnosis of MDD and monotherapy with a selective serotonin reuptake inhibitor, serotonin\u2013norepinephrine reuptake inhibitor or other new-generation antidepressant were identified from among 3.1 million patients in a New England healthcare system.", {"entities": []}], ["Rates of bleeding or other vascular complications, including acute liver failure, acute renal failure, asthma, breast cancer and hip fractures.", {"entities": [[111, 124, "DISEASE"], [103, 109, "DISEASE"], [118, 124, "DISEASE"]]}], ["601 GI bleeds were observed in the 21\u2008462 subjects in the high-affinity group versus 333 among the 14\u2008927 subjects in the lower affinity group (adjusted RR: 1.17, 95% CI 1.02 to 1.34).", {"entities": []}], ["Similarly, 776 strokes were observed in the high-affinity group versus 434 in the lower affinity treatment group (adjusted RR: 1.18, 95% CI 1.06 to 1.32).", {"entities": []}], ["No significant association with risk for a priori negative control outcomes, including acute liver failure, acute renal failure, asthma, breast cancer and hip fractures, was identified.", {"entities": [[137, 150, "DISEASE"], [129, 135, "DISEASE"], [144, 150, "DISEASE"]]}], ["Use of antidepressants with high affinity for the serotonin transporter may confer modestly elevated risk for GI and other bleeding complications.", {"entities": []}], ["While multiple methodologic limitations must be considered, these results suggest that antidepressants with lower serotonin receptor affinity may be preferred in patients at greater risk for such complications.", {"entities": []}], ["Previous reports have suggested that antidepressant use may contribute to dysfunction in platelet aggregation and increased risk for bleeding outcomes.", {"entities": []}], ["The authors hypothesised that antidepressants with higher affinity for the serotonin transporter would exhibit greater risk for these outcomes than those with lesser affinity.", {"entities": []}], ["Use of antidepressants with higher affinity for the serotonin transporter was associated with modest but statistically significant increase in risk for gastrointestinal bleed and stroke.", {"entities": []}], ["Electronic medical record-based pharmacovigilance systems provide an opportunity to examine treatment risk in general clinical populations, in a more systematic fashion than traditional postmarketing surveillance.", {"entities": []}], ["A strength of this report, in addition to cohort size and generalisability, is the restriction to individuals with major depressive disorder, minimising risk for confounding by indication.", {"entities": [[115, 140, "DISEASE"]]}], ["A key limitation is the absence of blood antidepressant levels or data on adherence, which might lead us to underestimate strength of effect.", {"entities": []}], ["Choisya ternata Kunth (Rutaceae) is native to North America where it is popularly known as \u201cMexican orange\u201d.", {"entities": []}], ["In this study, the anti-inflammatory effects of the essential oil (EO) obtained from the leaves of C .", {"entities": []}], ["ternata , one of its minor components (ternanthranin\u2014ISOAN) and its two synthetic analogues (methyl and propyl N -methylanthranilate \u2013 MAN and PAN) were evaluated.", {"entities": []}], ["Mice pretreated with the EO (EO) obtained from C .", {"entities": []}], ["ternata leaves (3\u2013100 mg/kg, p.o.", {"entities": []}], ["), ISOAN, MAN or PAN (1\u201330 mg/kg, p.o.)", {"entities": []}], ["and the reference drugs, morphine (1 mg/kg, p.o.)", {"entities": []}], ["and acetylsalicylic acid (ASA, 100 mg/kg, p.o.", {"entities": []}], ["), were evaluated in inflammation models such as formalin and subcutaneous air pouch models, with measurement of cell migration, exudate volume, protein extravasation, nitric oxide and pro-inflammatory cytokines.", {"entities": []}], ["The EO from C .", {"entities": []}], ["ternata significantly inhibited the time that the animals spent licking the formalin-injected paw in the second phase of the model at their higher doses (30 and 100 mg/kg, respectively).", {"entities": []}], ["An inhibition of the inflammatory reaction induced after subcutaneous carrageenan injection into air pouch was also observed.", {"entities": []}], ["In this model, the EO significantly reduced cell migration, exudate volume, protein extravased, and the increase in levels of inflammatory mediators (nitric oxide, TNF-\u03b1 and IL-1\u03b2).", {"entities": []}], ["ISOAN, MAN and PAN behaved in the same fashion at much smaller doses.", {"entities": []}], ["Also, these molecules were able to show significant effects in the reduction of paw edema (at all tested doses) when the phlogistic agent was carrageenan, bradykinin, 5-HT, PGE2, C48/80 or 12-O-tetradecanoylphorbol-acetate (TPA).", {"entities": []}], ["None of the tested doses had any effect in reducing histamine-induced edema.", {"entities": []}], ["Our results indicate that the EO from C .", {"entities": []}], ["ternata and anthranilate derivatives demonstrates an anti-inflammatory effect.", {"entities": []}], ["Coalitions of supporters of comprehensive tobacco control policy have been crucial in achieving policy success nationally and internationally, but the dynamics of such alliances are not well understood.", {"entities": []}], ["Qualitative semi-structured, narrative interviews with 35 stakeholders involved in developing the European Council Recommendation on smoke-free environments.", {"entities": []}], ["These were thematically analyzed to examine the dynamics of coalition-building, collaboration and leadership in the alliance of organizations which successfully called for the development of comprehensive European Union (EU) smoke-free policy.", {"entities": []}], ["An alliance of tobacco control and public health advocacy organizations, scientific institutions, professional bodies, pharmaceutical companies, and other actors shared the goal of fighting the harms caused by second-hand smoke.", {"entities": []}], ["Alliance members jointly called for comprehensive EU smoke-free policy and the protection of the political debates from tobacco industry interference.", {"entities": []}], ["The alliance\u2019s success was enabled by a core group of national and European actors with long-standing experience in tobacco control, who facilitated consensus-building, mobilized allies and synchronized the actions of policy supporters.", {"entities": []}], ["Representatives of Brussels-based organizations emerged as crucial strategic leaders.", {"entities": []}], ["The insights gained and identification of key enablers of successful tobacco control advocacy highlight the strategic importance of investing into tobacco control at European level.", {"entities": []}], ["Those interested in effective health policy can apply lessons learned from EU smoke-free policy to build effective alliances in tobacco control and other areas of public health.", {"entities": []}], ["Corticotropin-releasing hormone (CRH) plays an important role in the pathophysiology of irritable bowel syndrome (IBS) and regulates the stress response through two CRH receptors (R1 and R2).", {"entities": [[88, 112, "DISEASE"], [104, 112, "DISEASE"], [33, 36, "GENE"], [165, 168, "GENE"], [33, 36, "GENE"], [165, 168, "GENE"]]}], ["Previously, we reported that a CRHR1 gene polymorphism ( rs110402 , rs242924 , and rs7209436 ) and haplotypes were associated with IBS.", {"entities": [[31, 36, "GENE"]]}], ["However, the association between the CRHR2 gene and IBS was not investigated.", {"entities": [[37, 42, "GENE"]]}], ["We tested the hypothesis that genetic polymorphisms and haplotypes of CRHR2 are associated with IBS pathophysiology and negative emotion in IBS patients.", {"entities": [[70, 75, "GENE"]]}], ["A total of 142 IBS patients and 142 healthy controls participated in this study.", {"entities": []}], ["Seven single nucleotide polymorphisms (SNPs) of the CRHR2 gene (r s4722999 , rs3779250 , rs2240403 , rs2267710 , rs2190242 , rs2284217 , and rs2284220 ) were genotyped.", {"entities": [[52, 57, "GENE"]]}], ["Subjects' psychological states were evaluated using the Perceived-Stress Scale, the State-Trait Anxiety Inventory, and the Self-Rating Depression Scale.", {"entities": []}], ["We found that rs4722999 and rs3779250 , located in intronic region, were associated with IBS in terms of genotype frequency ( rs4722999 : P = 0.037; rs3779250 : P = 0.017) and that the distribution of the major allele was significantly different between patients and controls.", {"entities": []}], ["There was a significant group effect (controls vs. IBS), and a CRHR2 genotype effect was observed for three psychological scores, but the interaction was not significant.", {"entities": [[63, 68, "GENE"]]}], ["We found a haplotype of four SNPs ( rs4722999 , rs3779250 , rs2240403 , and rs2267710 ) and two SNPs ( rs2284217 and rs2284220 ) in strong linkage disequilibrium (D\u2032 > 0.90).", {"entities": []}], ["We also found that haplotypes of the CRHR2 gene were significantly different between IBS patients and controls and that they were associated with negative emotion.", {"entities": [[37, 42, "GENE"]]}], ["Our findings support the hypothesis that genetic polymorphisms and haplotypes of CRHR2 are related to IBS.", {"entities": [[81, 86, "GENE"]]}], ["In addition, we found associations between CRHR2 genotypes and haplotypes and negative emotion in IBS patients and controls.", {"entities": [[43, 48, "GENE"]]}], ["Further studies on IBS and the CRH system are warranted.", {"entities": [[31, 34, "GENE"]]}], ["The bronchial pathology of asymptomatic airway hyperreponsiveness (AHR) subjects is not well understood, and the role of atopy in the development of airway remodeling is unclear.", {"entities": [[67, 70, "GENE"]]}], ["The aim of this study was to evaluate whether atopy is associated with airway remodeling in asymptomatic AHR subjects.", {"entities": [[105, 108, "GENE"]]}], ["Five groups, i.e., atopic or non-atopic subjects with asymptomatic AHR, atopic or non-atopic healthy controls, and subjects with mild atopic asthma, were evaluated by bronchoscopic biopsy.", {"entities": [[141, 147, "DISEASE"], [67, 70, "GENE"]]}], ["By electron microscopy, mean reticular basement membrane (RBM) thicknesses were 4.3\u00b11.7 \u00b5m, 3.4\u00b11.8 \u00b5m, 2.5\u00b11.5 \u00b5m, 2.6\u00b11.1 \u00b5m, and 2.3\u00b11.2 \u00b5m in the mild atopic asthma, atopic and non-atopic asymptomatic AHR, atopic and non-atopic control groups, respectively ( p =0.002).", {"entities": [[162, 168, "DISEASE"], [58, 61, "GENE"], [205, 208, "GENE"]]}], ["RBM thicknesses were significantly higher in the mild atopic asthma group and in the atopic asymptomatic AHR group than in the other three groups ( p =0.048).", {"entities": [[61, 67, "DISEASE"], [0, 3, "GENE"], [105, 108, "GENE"]]}], ["No significant difference in RBM thickness was observed between the atopic asymptomatic AHR group and the mild atopic asthma group ( p >0.05), nor between non-atopic asymptomatic AHR group and the two control groups ( p >0.05).", {"entities": [[118, 124, "DISEASE"], [29, 32, "GENE"], [88, 91, "GENE"], [179, 182, "GENE"], [88, 91, "GENE"], [179, 182, "GENE"]]}], ["By light microscopy, subepithelial layer thicknesses between the groups showed the same results.", {"entities": []}], ["These findings suggest that RBM thickening occurs in subjects with atopic asymptomatic AHR, and that atopy plays an important role in airway remodeling.", {"entities": [[28, 31, "GENE"], [87, 90, "GENE"]]}], ["This paper demonstrates a method for estimating the geographical accessibility of public hospitals.", {"entities": []}], ["Cost path analysis was used to determine the minimum travel time and distance to the closest hospital via a road network.", {"entities": []}], ["This analysis was applied to 38,000 census enumeration district centroids in New Zealand allowing geographical access to be linked to local populations.", {"entities": []}], ["Average time and distance statistics have been calculated for local populations by modeling the total travel of a population if everybody visited a hospital once.", {"entities": []}], ["These types of statistics can be generated for different population groups and enable comparisons to be made between regions.", {"entities": []}], ["This study has shown that the northern and southern parts of New Zealand have high average travel times to hospital services.", {"entities": []}], ["Lifetime victimization experiences, including child sexual abuse (CSA), child physical abuse (CPA), adult sexual assault (ASA), and adult physical assault (APA), are associated with health problems.", {"entities": []}], ["To examine relationships between cumulative victimization and physical health among heterosexual and lesbian women and determine whether these relationships differ by sexual identity.", {"entities": []}], ["Large samples of heterosexual (n\u200a=\u200a482) and lesbian women (n\u200a=\u200a394) were interviewed.", {"entities": []}], ["Questions included lifetime victimization experiences and physical health problems.", {"entities": []}], ["Compared to women who reported no childhood victimization, those who reported experiencing both CSA and CPA were 44% more likely to report health problems and women who experienced all four types of victimization (CSA, CPA, APA, ASA) were nearly 240% as likely to report physical health problems.", {"entities": []}], ["Interaction analyses revealed the association between victimization and physical health did not differ by sexual identity.", {"entities": []}], ["Although lesbians were more likely to report all types of victimization, results suggest that victimization conferred increased physical health risks regardless of sexual identity.", {"entities": []}], ["The quality-adjusted life-year (QALY) has become a widely used measure of health outcomes for use in informing decision making in health technology assessment.", {"entities": []}], ["However, there is growing recognition of outcomes beyond health within the health sector and in related sectors such as social care and public health.", {"entities": []}], ["This paper presents the advantages and disadvantages of ten possible approaches covering extending the health-related QALY and using well-being and monetary-based methods, in order to address the problem of using multiple outcome measures to inform resource allocation within and between sectors.", {"entities": []}], ["Population\u2010based estimates of influenza\u2010associated outpatient visits including both pandemic and interpandemic seasons are uncommon.", {"entities": [[30, 39, "DISEASE"]]}], ["Comparisons of such estimates with laboratory\u2010confirmed rates of outpatient influenza are rare.", {"entities": [[76, 85, "DISEASE"]]}], ["To estimate influenza\u2010associated outpatient visits in 6 US integrated healthcare delivery organizations enrolling ~7.7\u00a0million persons.", {"entities": [[12, 21, "DISEASE"]]}], ["Using negative binomial regression methods, we modeled rates of influenza\u2010associated visits with ICD \u20109\u2010 CM \u2010coded pneumonia or acute respiratory outpatient visits during 2001\u201010.", {"entities": [[64, 73, "DISEASE"], [115, 124, "DISEASE"]]}], ["These estimated counts were added to visits coded specifically for influenza to derive estimated rates.", {"entities": [[67, 76, "DISEASE"]]}], ["We compared these rates with those observed in 2 contemporaneous studies recording RT \u2010 PCR \u2010confirmed influenza outpatient visits.", {"entities": [[103, 112, "DISEASE"]]}], ["Outpatient rates estimated with pneumonia visits were 39 (95% confidence interval [ CI ], 30\u201070) and 203 (95% CI , 180\u2010240) per 10\u00a0000 person\u2010years, respectively, for interpandemic and pandemic seasons.", {"entities": [[32, 41, "DISEASE"]]}], ["Corresponding rates estimated with respiratory visits were 185 (95% CI , 161\u2010255) and 542 (95% CI , 441\u2010823) per 10\u00a0000 person\u2010years.", {"entities": []}], ["During the pandemic, children aged 2\u201017\u00a0years had the largest increase in rates (when estimated with pneumonia visits, from 64 [95% CI , 50\u2010121] to 381 [95% CI , 366\u2010481]).", {"entities": [[101, 110, "DISEASE"]]}], ["Rates estimated with pneumonia visits were consistent with rates of RT \u2010 PCR \u2010confirmed influenza visits during 4 of 5 seasons in 1 comparison study.", {"entities": [[88, 97, "DISEASE"], [21, 30, "DISEASE"]]}], ["In another, rates estimated with pneumonia visits during the pandemic for children and adults were consistent in timing, peak, and magnitude.", {"entities": [[33, 42, "DISEASE"]]}], ["Estimated rates of influenza\u2010associated outpatient visits were higher in children than adults during pre\u2010pandemic and pandemic seasons.", {"entities": [[19, 28, "DISEASE"]]}], ["Rates estimated with pneumonia visits plus influenza\u2010coded visits were similar to rates from studies using RT \u2010 PCR \u2010confirmed influenza.", {"entities": [[43, 52, "DISEASE"], [127, 136, "DISEASE"], [21, 30, "DISEASE"]]}], ["The contribution to airflow obstruction by the remodeling of the peripheral airways in chronic obstructive pulmonary disease (COPD) patients has been well documented, but less is known about the role played by the large airways.", {"entities": [[87, 124, "DISEASE"]]}], ["Few studies have investigated the presence of histopathological changes due to remodeling in the large airways of COPD patients.", {"entities": []}], ["The aim of this study was to verify the presence of airway remodeling in the central airways of COPD patients, quantifying the airway smooth muscle (ASM) area and the extracellular matrix (ECM) protein deposition, both in the subepithelial region and in the ASM, and to verify the possible contribution to airflow obstruction by the above mentioned histopathological changes.", {"entities": []}], ["Biopsies of segmental bronchi spurs were performed in COPD patients and control smoker subjects and immunostained for collagen type I, versican, decorin, biglycan, and alpha-smooth muscle actin.", {"entities": []}], ["ECM protein deposition was measured at both subepithelial, and ASM layers.", {"entities": []}], ["The staining for collagen I and versican was greater in the subepithelial layer of COPD patients than in control subjects.", {"entities": []}], ["An inverse correlation was found between collagen I in the subepithelial layer and both forced expiratory volume in 1 second and ratio between forced expiratory volume in 1 second and forced vital capacity.", {"entities": []}], ["A statistically significant increase of the ASM area was observed in the central airways of COPD patients versus controls.", {"entities": []}], ["These findings indicate that airway remodeling also affects the large airways in COPD patients who have greater deposition of ECM proteins in the subepithelial layer and a larger smooth muscle area than control smoker subjects.", {"entities": []}], ["These changes may contribute to chronic airflow obstruction in COPD patients.", {"entities": []}], ["There is wide recognition that pragmatic randomised trials are the best vehicle for economic evaluation.", {"entities": []}], ["This is because trials provide the best chance of ensuring internal validity, not least through the rigorous prospective collection of patient-specific data.", {"entities": []}], ["Furthermore the marginal cost of collecting economic data alongside clinical data is typically modest.", {"entities": []}], ["UK Clinical Research Collaboration (UKCRC) does not require a standard operating procedure (SOP) for economic evaluation as a prerequisite for trial unit registration.", {"entities": []}], ["We judge that such a SOP facilitates the integration of health economics into trials.", {"entities": []}], ["A collaboration between health economists and trialists at Bangor University led to the development of a SOP for economic evaluation alongside pragmatic trials, in addition to the twenty SOPs required by UKCRC for registration, which include randomisation, data management and statistical analysis.", {"entities": []}], ["Our recent telephone survey suggests that no other UKCRC-registered trials unit currently has an economic SOP.", {"entities": []}], ["We argue that UKCRC should require, from all Trials Units undertaking economic evaluation and seeking registration or re-registration, a SOP for economic evaluation as one of their portfolio of supporting SOPs.", {"entities": []}], ["Reversible lysine acetylation plays an important role in the regulation of T cell responses.", {"entities": []}], ["HDAC1 has been shown to control peripheral T helper cells, however the role of HDAC1 in CD8 LckCre -mediated deletion of HDAC1 led to reduced numbers of thymocytes as well as peripheral T cells, and to an increased fraction of CD8 ex vivo PMA/ionomycin stimulation in comparison to wild-type cells.", {"entities": [[0, 5, "GENE"], [79, 84, "GENE"], [121, 126, "GENE"], [0, 5, "GENE"], [79, 84, "GENE"], [121, 126, "GENE"], [0, 5, "GENE"], [79, 84, "GENE"], [121, 126, "GENE"]]}], ["Na\u00efve (CD44 in vivo cytotoxicity was normal in the absence of HDAC1.", {"entities": [[7, 11, "GENE"], [62, 67, "GENE"]]}], ["However, T cell-specific loss of HDAC1 led to a reduced anti-viral CD8 in vivo expansion and activation of CD8", {"entities": [[33, 38, "GENE"]]}], ["Heterogeneity in clinical manifestations and disease progression in Chronic Obstructive Pulmonary Disease (COPD) lead to consequences for patient health risk assessment, stratification and management.", {"entities": []}], ["Implicit with the classical \"spill over\" hypothesis is that COPD heterogeneity is driven by the pulmonary events of the disease.", {"entities": []}], ["Alternatively, we hypothesized that COPD heterogeneities result from the interplay of mechanisms governing three conceptually different phenomena: 1) pulmonary disease, 2) systemic effects of COPD and 3) co-morbidity clustering, each of them with their own dynamics.", {"entities": []}], ["To explore the potential of a systems analysis of COPD heterogeneity focused on skeletal muscle dysfunction and on co-morbidity clustering aiming at generating predictive modeling with impact on patient management.", {"entities": []}], ["To this end, strategies combining deterministic modeling and network medicine analyses of the Biobridge dataset were used to investigate the mechanisms of skeletal muscle dysfunction.", {"entities": []}], ["An independent data driven analysis of co-morbidity clustering examining associated genes and pathways was performed using a large dataset (ICD9-CM data from Medicare, 13 million people).", {"entities": []}], ["Finally, a targeted network analysis using the outcomes of the two approaches (skeletal muscle dysfunction and co-morbidity clustering) explored shared pathways between these phenomena.", {"entities": []}], ["(1) Evidence of abnormal regulation of skeletal muscle bioenergetics and skeletal muscle remodeling showing a significant association with nitroso-redox disequilibrium was observed in COPD; (2) COPD patients presented higher risk for co-morbidity clustering than non-COPD patients increasing with ageing; and, (3) the on-going targeted network analyses suggests shared pathways between skeletal muscle dysfunction and co-morbidity clustering.", {"entities": []}], ["The results indicate the high potential of a systems approach to address COPD heterogeneity.", {"entities": []}], ["Significant knowledge gaps were identified that are relevant to shape strategies aiming at fostering 4P Medicine for patients with COPD.", {"entities": []}], ["Gastroesophageal reflux disease (GERD) is the most common gastrointestinal disease, and the cost of health care and lost productivity due to GERD is extremely high.", {"entities": []}], ["Recently described side effects of long-term acid suppression have increased the interest in nonpharmacologic methods for alleviating GERD symptoms.", {"entities": []}], ["We aimed to examine whether GERD patients follow recommended dietary guidelines, and if adherence is associated with the severity and frequency of reflux symptoms.", {"entities": []}], ["We conducted a population-based cross-sectional study within the Kaiser Permanente Northern California population, comparing 317 GERD patients to 182 asymptomatic population controls.", {"entities": []}], ["All analyses adjusted for smoking and education.", {"entities": []}], ["GERD patients, even those with moderate to severe symptoms or frequent symptoms, were as likely to consume tomato products and large portion meals as GERD-free controls and were even more likely to consume soft drinks and tea [odds ratio (OR)\u2009=\u20092.01 95% confidence interval (CI) 1.12-3.61; OR\u2009=\u20092.63 95% CI 1.24-5.59, respectively] and eat fried foods and high fat diet.", {"entities": []}], ["The only reflux-triggering foods GERD patients were less likely to consume were citrus and alcohol [OR\u2009=\u20090.59; 95% CI: 0.35-0.97 for citrus; OR\u2009=\u20090.41 95% CI 0.19-0.87 for 1\u2009+\u2009drink/day of alcohol].", {"entities": []}], ["The associations were similar when we excluded users of proton pump inhibitors.", {"entities": []}], ["GERD patients consume many putative GERD causing foods as frequently or even more frequently than asymptomatic patients despite reporting symptoms.", {"entities": []}], ["These findings suggest that, if dietary modification is effective in reducing GERD, substantial opportunities for nonpharmacologic interventions exist for many GERD patients.", {"entities": []}], ["Equilibrium binding studies on canine mononuclear and granulocytic cells allow the identification of a single high affinity receptor for the human C-C chemokine RANTES (dissociation constant, 14 +/- 8 pM), that, in contrast to the human RANTES receptor, has no affinity for human macrophage inflammatory protein 1 alpha (hMIP-1 alpha).", {"entities": []}], ["A single intradermal injection of hRANTES in dog resulted in eosinophil- and macrophage-rich inflammatory sites within 4 h. Cell infiltration peaked at 16-24 h after hRANTES injection.", {"entities": []}], ["There was histological evidence of intravascular activation of eosinophils at 4 h, although eosinophils in the vasculature and interstitium contained apparently intact granules.", {"entities": []}], ["Monocytes were the predominant cells adherent to venular endothelium at 16-24 h. Human MIP-1 alpha elicited no response in canine dermis, whereas monocyte chemoattractant protein 1 caused mild perivascular cuffing with monocytes.", {"entities": []}], ["In contrast, human interleukin 8 induced a neutrophilic dermal infiltrate that was maximal by 4 h after challenge.", {"entities": []}], ["This provides the first direct evidence in vivo that RANTES has significant proinflammatory activity and, in addition, could be a mediator in atopic pathologies characterized by eosinophilic and monocytic inflammatory responses.", {"entities": []}], ["Alpha 1 -antitrypsin (AAT) deficiency is characterized by low blood levels of alpha 1 -proteinase inhibitor (alpha 1 -PI) and may lead to emphysema.", {"entities": []}], ["Alpha 1 -PI protects pulmonary tissue from damage caused by the action of proteolytic enzymes.", {"entities": []}], ["Augmentation therapy with Prolastin 1 -Proteinase Inhibitor [Human]) to increase the levels of alpha 1 -PI has been used to treat individuals with AAT deficiency for over 20 years.", {"entities": []}], ["Modifications to the Prolastin manufacturing process, incorporating additional purification and pathogen-reduction steps, have led to the development of an alpha 1 -PI product, designated Prolastin 1 -Proteinase inhibitor [Human]).", {"entities": []}], ["The pharmacokinetic comparability of Prolastin-C to Prolastin was assessed in subjects with AAT deficiency.", {"entities": []}], ["In total, 24 subjects were randomized to receive 60 mg/kg of functionally active Prolastin-C or Prolastin by weekly intravenous infusion for 8 weeks before crossover to the alternate treatment for another 8 weeks.", {"entities": []}], ["Pharmacokinetic plasma samples were drawn over 7 days following last dose in the first treatment period and over 10 days following the last dose in the second period.", {"entities": []}], ["The primary end point for pharmacokinetic comparability was area under the plasma concentration versus time curve over 7 days post dose (AUC 0-7 days ) of alpha 1 -PI determined by potency (functional activity) assay.", {"entities": []}], ["The crossover phase was followed by an 8-week open-label treatment phase with Prolastin-C only.", {"entities": []}], ["Mean AUC 0-7 days was 155.9 versus 152.4 mg*h/mL for Prolastin-C and Prolastin, respectively.", {"entities": []}], ["The geometric least squares mean ratio of AUC 0-7 days for Prolastin-C versus Prolastin had a point estimate of 1.03 and a 90% confidence interval of 0.97-1.09, demonstrating pharmacokinetic equivalence between the 2 products.", {"entities": []}], ["Adverse events were similar for both treatments and occurred at a rate of 0.117 and 0.078 per infusion for Prolastin-C (double-blind treatment phase only) and Prolastin, respectively (p = 0.744).", {"entities": []}], ["There were no treatment-emergent viral infections in any subject for human immunodeficiency virus, hepatitis B or C, or parvovirus B19 during the course of the study.", {"entities": [[99, 108, "DISEASE"]]}], ["Prolastin-C demonstrated pharmacokinetic equivalence and a comparable safety profile to Prolastin.", {"entities": []}], ["ClinicalTrials.gov Identifier: NCT00295061", {"entities": []}], ["Codonopsis , in the family Campanulaceae, is a genus containing 42 species of dicotyledonous herbaceous perennial plants, predominantly found in Central, East and South Asia.", {"entities": []}], ["Several Codonopsis species are widely used in traditional medicine and are considered to have multiple medicinal properties.", {"entities": []}], ["Among the Codonopsis species, Codonopsis pilosula (Franch.)", {"entities": []}], ["and C. lanceolata (Sieb.", {"entities": []}], ["f. ex Trautv.", {"entities": []}], ["are more popular than others according to the findings, especially phytochemical and bioactive studies.", {"entities": []}], ["Phytochemical research shows that Codonopsis species contain mainly polyacetylenes, phenylpropanoids, alkaloids, triterpenoids and polysaccharides, which contribute to multiple bioactivities.", {"entities": []}], ["However, the mechanisms of their bioactivities need to be further elucidated.", {"entities": []}], ["The less popular Codonopsis species remain to be studied and exploited.", {"entities": []}], ["In addition, although a series of methods for the quality evaluation of Codonopsis species have been developed, a feasible and reliable approach to the efficacious and safe use of various Codonopsis species is still needed, with considering botanical origin, chemical constituents and bioactive effects.", {"entities": []}], ["This review aims to provide up-to-date and comprehensive information on the phytochemistry, bioactivity and quality control of medicinal plants in the genus Codonopsis and to highlight current gaps in knowledge, which is useful for the wider development of the Codonopsis genus.", {"entities": []}], ["Hydnora abyssinica (HA) A. Braun is an endemic Sudanese medicinal plant traditionally used as anti-inflammatory and against many infectious diseases.", {"entities": []}], ["However, it proved to be very rich in phenols and tannins, so the present study was undertaken to investigate the immunomodulatory potential of the whole plant ethanolic extract and its isolated compounds.", {"entities": []}], ["Lymphocyte proliferation, chemiluminescence and superoxide reduction assays were used for immunomodulatory evaluation.", {"entities": []}], ["While, MTT (3\u2013(4, 5-dimethylthazol-2-yl)-2, 5-diphenyl tetrazonium bromide) test was performed on 3\u00a0T3 cell line clone in order to evaluate the cytoxicity effect of the extracts and isolated compounds of phenolic derivatives which were carried out by chromotographic techniques.", {"entities": []}], ["Catechin, (1), tyrosol (2) and benzoic acid, 3, 4, dihydroxy-, ethyl ester (3) compounds were isolated from HA ethanolic extract which revealed potent immunosuppressive activity against reactive oxygen species from both polymorph nuclear cells (PMNs) (45\u201390\u00a0% inhibition) and mononuclear cells (MNCs) (30 -65\u00a0% inhibition), T lymphocyte proliferation assay (70\u201393 % inhibition) as well as potent inhibitory effect against superoxide production (42\u201371\u00a0% inhibition) at concentrations of 6.25\u2013100\u00a0\u03bcg/mL.", {"entities": []}], ["Catechin ( 1 ) was found the most potent immunosuppressive agent among all constituents examined.", {"entities": []}], ["These results can support the traditional uses of H. abyssinica extracts as anti-inflammatory and immunosuppressive and further investigations of the mode of action and other pharmacological studies are highly desirable.", {"entities": []}], ["The appropriate time to initiate bisphosphonate treatment after a fragility fracture has not yet been established.", {"entities": []}], ["In this study, we found no significant differences in short-term functional recovery between femoral neck fracture patients who received bisphosphonate treatment at 2 versus 12 weeks after hemiarthroplasty.", {"entities": []}], ["Bisphosphonate is the mainstay therapy for prevention and treatment of osteoporosis.", {"entities": [[71, 83, "DISEASE"]]}], ["The aim of this study was to investigate the effect of bisphosphonate initiation on short-term functional recovery in femoral neck fracture patients at 2 versus 12 weeks after hemiarthroplasty.", {"entities": []}], ["One hundred patients were randomly allocated into two groups in a parallel group designed, randomized, controlled trial.", {"entities": []}], ["Both groups received risedronate 35 mg/week at either 2 or 12 weeks after hemiarthroplasty.", {"entities": []}], ["All patients received calcium and vitamin D supplementation.", {"entities": []}], ["Functional recovery was assessed by de Morton Mobility Index, Barthel Index, EuroQol 5D, visual analog scale, 2-min walk test, and timed get-up-and-go test at 2 weeks, 3 months, and 1 year after surgery.", {"entities": []}], ["At the 3-month follow-up, all functional outcome measures showed significant improvement in both groups.", {"entities": []}], ["There were no statistically significant differences in any of the functional outcomes between groups at both the 3-month and 1-year follow-ups.", {"entities": []}], ["Although patients who received bisphosphonate initiation at week 2 had lower serum calcium level at 3 months and more overall adverse events than patients in the week 12 group, no patients in either group discontinued their prescribed medications.", {"entities": []}], ["While underpowered, the findings of this study suggest that there were no significant differences in short-term functional recovery or significant adverse events between the two bisphosphonate groups.", {"entities": []}], ["Thus, the initiation of bisphosphonate therapy may be considered as early as 2 weeks after femoral neck fracture.", {"entities": []}], ["It is important that low serum calcium and vitamin D status must be corrected with calcium and vitamin D supplementation prior to or at the time of bisphosphonate initiation.", {"entities": []}], ["This study was registered in the database via the Protocol Registration and Results System (PRS) (NCT02148848).", {"entities": []}], ["The online version of this article (doi:10.1007/s11657-017-0321-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study evaluated the antilipogenic and anti-inflammatory effects of Codonopsis lanceolata ( C. lanceolata ) root extract in mice with alcohol-induced fatty liver and elucidated its underlying molecular mechanisms.", {"entities": []}], ["Ethanol was introduced into the liquid diet by mixing it with distilled water at 5% (wt/v), providing 36% of the energy, for nine weeks.", {"entities": []}], ["Among the three different fractions prepared from the C. lanceolata root, the C. lanceolata methanol extract (CME) exhibited the most remarkable attenuation of alcohol-induced fatty liver with respect to various parameters such as hepatic free fatty acid concentration, body weight loss, and hepatic accumulations of triglyceride and cholesterol.", {"entities": []}], ["The hepatic gene and protein expression levels were analysed via RT-PCR and Western blotting, respectively.", {"entities": []}], ["CME feeding significantly restored the ethanol-induced downregulation of the adiponectin receptor (adipoR) 1 and of adipoR2, along with their downstream molecules.", {"entities": [[116, 123, "GENE"]]}], ["Furthermore, the study data showed that CME feeding dramatically reversed ethanol-induced hepatic upregulation of toll-like receptor- (TLR-) mediated signaling cascade molecules.", {"entities": []}], ["These results indicate that the beneficial effects of CME against alcoholic fatty livers of mice appear to be with adenosine- and adiponectin-mediated regulation of hepatic steatosis and TLR-mediated modulation of hepatic proinflammatory responses.", {"entities": []}], ["To assess in clinical practice the frequency and diagnosis associated with the SS-B-positive/SS-A negative autoantibody profile.", {"entities": []}], ["We analyzed a one-year consecutive population of 624 patients referred by clinicians to the immunology laboratory to investigate anti-SS-A and/or anti-SS-B autoantibodies, who were detected using luminex technology.", {"entities": []}], ["Data were analyzed for patients with isolated anti-SS-B autoantibodies.", {"entities": []}], ["The clinical characteristics and diagnosis of connective tissue diseases (CTD) were retrieved according to the international criteria.", {"entities": []}], ["Among 1173 sera positive for anti-SS-A and/or anti-SS-B autoantibodies from 624 patients, we identified 84 patients (13.5%) that had isolated anti-SS-B.", {"entities": []}], ["Among the 75 patients positive for anti-SS-B with known clinical data, 15 were diagnosed with a CTD (20%) including 4 systemic lupus erythematosus (5%), 4 rheumatoid arthritis (5%), 2 idiopathic inflammatory myositis (3%), 1 primary Sj\u00f6gren\u2019s syndrome pSS (1%), 1 systemic sclerosis (1%), 2 undefined CTD (3%), and 1 mixed CTD (1%).", {"entities": [[155, 175, "DISEASE"], [127, 146, "DISEASE"], [243, 251, "DISEASE"], [166, 175, "DISEASE"], [208, 216, "DISEASE"], [118, 146, "DISEASE"]]}], ["Among the 60 other patients, 18 had non-CTD autoimmune diseases and 42 had non-autoimmune diseases.", {"entities": []}], ["Within the CTD population, the presence of isolated anti-SS-B was not significantly associated to characteristic indicating a specific syndrome.", {"entities": [[135, 143, "DISEASE"]]}], ["There was no association between diagnosis of CTD and level of anti-SS-B autoantibodies (p = 0.70).", {"entities": []}], ["Arthralgia was the more frequent sign and encountered in 10 patients (67%), of whom 3 had arthritis.", {"entities": [[90, 99, "DISEASE"]]}], ["The presence of anti-SS-B, without anti-SS-A autoantibodies using luminex technology, was not associated with CTD, especially pSS, in daily clinical practice.", {"entities": []}], ["Our data suggests that the SS-B serological profile is not contributive for the classification criteria of pSS.", {"entities": []}], ["Drosophila imaginal disc growth factor 2 (IDGF2) is a member of chitinase-like protein family (CLPs) able to induce the proliferation of imaginal disc cells in vitro .", {"entities": [[95, 99, "GENE"]]}], ["In this study we characterized physiological concentrations and expression of IDGF2 in vivo as well as its impact on the viability and transcriptional profile of Drosophila cells in vitro .", {"entities": []}], ["We show that IDGF2 is independent of insulin and protects cells from death caused by serum deprivation, toxicity of xenobiotics or high concentrations of extracellular adenosine (Ado) and deoxyadenosine (dAdo).", {"entities": []}], ["Transcriptional profiling suggested that such cytoprotection is connected with the induction of genes involved in energy metabolism, detoxification and innate immunity.", {"entities": []}], ["We also show that IDGF2 is an abundant haemolymph component, which is further induced by injury in larval stages.", {"entities": []}], ["The highest IDGF2 accumulation was found at garland and pericardial nephrocytes supporting its role in organismal defence and detoxification.", {"entities": []}], ["Our findings provide evidence that IDGF2 is an important trophic factor promoting cellular and organismal survival.", {"entities": []}], ["Worldwide, one person dies every 40\u2009seconds by suicide, a potentially preventable tragedy.", {"entities": []}], ["A limiting step in our ability to intervene is the lack of objective, reliable predictors.", {"entities": []}], ["We have previously provided proof of principle for the use of blood gene expression biomarkers to predict future hospitalizations due to suicidality, in male bipolar disorder participants.", {"entities": [[158, 174, "DISEASE"]]}], ["We now generalize the discovery, prioritization, validation, and testing of such markers across major psychiatric disorders (bipolar disorder, major depressive disorder, schizoaffective disorder, and schizophrenia) in male participants, to understand commonalities and differences.", {"entities": [[143, 168, "DISEASE"], [200, 213, "DISEASE"], [125, 141, "DISEASE"], [170, 194, "DISEASE"]]}], ["We used a powerful within-participant discovery approach to identify genes that change in expression between no suicidal ideation and high suicidal ideation states ( n =37 participants out of a cohort of 217 psychiatric participants followed longitudinally).", {"entities": []}], ["We then used a convergent functional genomics (CFG) approach with existing prior evidence in the field to prioritize the candidate biomarkers identified in the discovery step.", {"entities": []}], ["Next, we validated the top biomarkers from the prioritization step for relevance to suicidal behavior, in a demographically matched cohort of suicide completers from the coroner's office ( n =26).", {"entities": []}], ["The biomarkers for suicidal ideation only are enriched for genes involved in neuronal connectivity and schizophrenia, the biomarkers also validated for suicidal behavior are enriched for genes involved in neuronal activity and mood.", {"entities": [[103, 116, "DISEASE"]]}], ["The 76 biomarkers that survived Bonferroni correction after validation for suicidal behavior map to biological pathways involved in immune and inflammatory response, mTOR signaling and growth factor regulation.", {"entities": [[166, 170, "GENE"]]}], ["mTOR signaling is necessary for the effects of the rapid-acting antidepressant agent ketamine, providing a novel biological rationale for its possible use in treating acute suicidality.", {"entities": [[0, 4, "GENE"]]}], ["Similarly, MAOB, a target of antidepressant inhibitors, was one of the increased biomarkers for suicidality.", {"entities": [[11, 15, "GENE"]]}], ["We also identified other potential therapeutic targets or biomarkers for drugs known to mitigate suicidality, such as omega-3 fatty acids, lithium and clozapine.", {"entities": []}], ["Overall, 14% of the top candidate biomarkers also had evidence for involvement in psychological stress response, and 19% for involvement in programmed cell death/cellular suicide (apoptosis).", {"entities": []}], ["It may be that in the face of adversity (stress), death mechanisms are turned on at a cellular (apoptosis) and organismal level.", {"entities": []}], ["Finally, we tested the top increased and decreased biomarkers from the discovery for suicidal ideation (CADM1, CLIP4, DTNA, KIF2C), prioritization with CFG for prior evidence (SAT1, SKA2, SLC4A4), and validation for behavior in suicide completers (IL6, MBP, JUN, KLHDC3) steps in a completely independent test cohort of psychiatric participants for prediction of suicidal ideation ( n =108), and in a future follow-up cohort of psychiatric participants ( n =157) for prediction of psychiatric hospitalizations due to suicidality.", {"entities": [[104, 109, "GENE"], [118, 122, "GENE"], [124, 129, "GENE"], [176, 180, "GENE"], [182, 186, "GENE"], [188, 194, "GENE"], [248, 251, "GENE"], [253, 256, "GENE"], [258, 261, "GENE"], [263, 269, "GENE"]]}], ["The best individual biomarker across psychiatric diagnoses for predicting suicidal ideation was SLC4A4, with a receiver operating characteristic (ROC) area under the curve (AUC) of 72%.", {"entities": [[96, 102, "GENE"]]}], ["For bipolar disorder in particular, SLC4A4 predicted suicidal ideation with an AUC of 93%, and future hospitalizations with an AUC of 70%.", {"entities": [[4, 20, "DISEASE"], [36, 42, "GENE"]]}], ["SLC4A4 is involved in brain extracellular space pH regulation.", {"entities": [[0, 6, "GENE"]]}], ["Brain pH has been implicated in the pathophysiology of acute panic attacks.", {"entities": []}], ["We also describe two new clinical information apps, one for affective state (simplified affective state scale, SASS) and one for suicide risk factors (Convergent Functional Information for Suicide, CFI-S), and how well they predict suicidal ideation across psychiatric diagnoses (AUC of 85% for SASS, AUC of 89% for CFI-S).", {"entities": []}], ["We hypothesized a priori , based on our previous work, that the integration of the top biomarkers and the clinical information into a universal predictive measure (UP-Suicide) would show broad-spectrum predictive ability across psychiatric diagnoses.", {"entities": []}], ["Indeed, the UP-Suicide was able to predict suicidal ideation across psychiatric diagnoses with an AUC of 92%.", {"entities": []}], ["For bipolar disorder, it predicted suicidal ideation with an AUC of 98%, and future hospitalizations with an AUC of 94%.", {"entities": [[4, 20, "DISEASE"]]}], ["Of note, both types of tests we developed (blood biomarkers and clinical information apps) do not require asking the individual assessed if they have thoughts of suicide, as individuals who are truly suicidal often do not share that information with clinicians.", {"entities": []}], ["We propose that the widespread use of such risk prediction tests as part of routine or targeted healthcare assessments will lead to early disease interception followed by preventive lifestyle modifications and proactive treatment.", {"entities": []}], ["Th2 cytokines like interleukin\u20104, \u20105, and \u201013 are regarded as important drivers of the immunopathology underlying allergic rhinitis (AR) and asthma.", {"entities": [[114, 131, "DISEASE"], [123, 131, "DISEASE"], [141, 147, "DISEASE"]]}], ["The present study explores the capacity of pentosan polysulfate sodium (PPS), a semi\u2010synthetic heparin\u2010like macromolecular carbohydrate, to bind Th2 cytokines and exert biological neutralization in vitro, as well as anti\u2010inflammatory actions in vivo.", {"entities": []}], ["The capacity of PPS to bind recombinant Th2 cytokines was tested with surface plasmon resonance (SPR) technology and biological Th2 neutralization was assessed by Th2\u2010dependent proliferation assays.", {"entities": [[97, 100, "GENE"]]}], ["The in vivo anti\u2010inflammatory action of PPS was studied using a validated Guinea\u2010pig model of AR.", {"entities": []}], ["Binding studies revealed a strong and specific binding of PPS to IL\u20104, IL\u20105, and IL\u201013 with IC values suggesting as stronger cytokine binding than for heparin.", {"entities": []}], ["Cytokine binding translated to a biological neutralization as PPS dose dependently inhibited Th2\u2010dependent cell proliferation.", {"entities": []}], ["Topical administration of PPS 30\u2009min prior to nasal allergen challenge of sensitized animals significantly reduced late phase plasma extravasation, luminal influx of eosinophils, neutrophils, and total lavage leukocytes.", {"entities": []}], ["Similar, albeit not statistically secured, effects were found for tissue leukocytes and mucus hyper\u2010secretion.", {"entities": []}], ["The anti\u2010inflammatory effects of PPS compared favorably with established topical nasal steroid treatment.", {"entities": []}], ["This study points out PPS as a potent Th2 cytokine\u2010binding molecule with biological neutralization capacity and broad anti\u2010inflammatory effects in vivo.", {"entities": []}], ["As such PPS fulfills the role as a potential candidate molecule for the treatment of AR and further studies of clinical efficacy seems highly warranted.", {"entities": []}], ["To determine to what extent underlying data published as part of Quality and Outcomes Framework (QOF) can be used to estimate smoking prevalence within practice populations and local areas and to explore the usefulness of these estimates.", {"entities": []}], ["Cross-sectional, observational study of QOF smoking data.", {"entities": []}], ["Smoking prevalence in general practice populations and among patients with chronic conditions was estimated by simple manipulation of QOF indicator data.", {"entities": []}], ["Agreement between estimates from the integrated household survey (IHS) and aggregated QOF-based estimates was calculated.", {"entities": []}], ["The impact of including smoking estimates in negative binomial regression models of counts of premature coronary heart disease (CHD) deaths was assessed.", {"entities": [[113, 126, "DISEASE"], [104, 126, "DISEASE"]]}], ["Primary care in the East Midlands.", {"entities": []}], ["All general practices in the area of study were eligible for inclusion (230).", {"entities": []}], ["14 practices were excluded due to incomplete QOF data for the period of study (2006/2007\u20132012/2013).", {"entities": []}], ["One practice was excluded as it served a restricted practice list.", {"entities": []}], ["Estimates of smoking prevalence in general practice populations and among patients with chronic conditions.", {"entities": []}], ["Median smoking prevalence in the practice populations for 2012/2013 was 19.2% (range 5.8\u201343.0%).", {"entities": []}], ["There was good agreement (mean difference: 0.39%; 95% limits of agreement (\u22123.77, 4.55)) between IHS estimates for local authority districts and aggregated QOF register estimates.", {"entities": []}], ["Smoking prevalence estimates in those with chronic conditions were lower than for the general population (mean difference \u22123.05%), but strongly correlated (R p =0.74, p<0.0001).", {"entities": []}], ["An important positive association between premature CHD mortality and smoking prevalence was shown when smoking prevalence was added to other population and service characteristics.", {"entities": []}], ["Published QOF data allow useful estimation of smoking prevalence within practice populations and in those with chronic conditions; the latter estimates may sometimes be useful in place of the former.", {"entities": []}], ["It may also provide useful estimates of smoking prevalence in local areas by aggregating practice based data.", {"entities": []}], ["Malaria-associated acute lung injury (ALI) is a frequent complication of severe malaria that is often caused by \u201cexcessive\u201d immune responses.", {"entities": [[0, 7, "DISEASE"], [80, 87, "DISEASE"]]}], ["To better understand the mechanism of ALI in malaria infection, here we investigated the roles of galectin (Gal)-1, 3, 8, 9 and the receptors of Gal-9 (Tim-3, CD44, CD137, and PDI) in malaria-induced ALI.", {"entities": [[45, 52, "DISEASE"], [184, 191, "DISEASE"], [159, 163, "GENE"]]}], ["We injected alpha (\u03b1)-lactose into mice-infected with Plasmodium berghei ANKA ( Pb ANKA) to block galectins and found significantly elevated total proteins in bronchoalveolar lavage fluid, higher parasitemia and tissue parasite burden, and increased numbers of CD68 Pb ANKA-infected red blood cells in vitro ; but only IFN-\u03b1 and IFN-\u03b2 were significantly increased after \u03b1-lactose treatment.", {"entities": [[261, 265, "GENE"]]}], ["Our data indicate that Gal-9 interaction with its multiple receptors play an important role in murine malaria-associated ALI.", {"entities": [[102, 109, "DISEASE"]]}], ["Despite an increasing attention and public preference for rural amenities, little evidence is available on the health benefits of a rural environment.", {"entities": []}], ["In this study, we identified physiological and psychological benefits of exposure to a rural environment using multiparametric methods.", {"entities": []}], ["Twelve young male adults participated in a 3-day field experiment (mean \u00b1 standard deviation age, 22.3 \u00b1 1.3 years).", {"entities": []}], ["Sleeping environment, diet program, physical activities, and other factors possibly affecting physiological responses were controlled during experiment period.", {"entities": []}], ["For all participants, salivary cortisol concentration, heart rate variability, and blood pressure were measured at rural and urban field sites.", {"entities": []}], ["Self-evaluation questionnaires were administered to analyze the psychological states in two different environments.", {"entities": []}], ["Volatile compounds in the air were also analyzed to investigate air quality.", {"entities": []}], ["The data were compared between rural and urban environments.", {"entities": []}], ["The data showed that exposure to a rural environment reduced stress hormone secretion and sympathetic nervous activity and increased parasympathetic nervous activity.", {"entities": []}], ["Short-term exposure to a rural environment also improved mood states.", {"entities": []}], ["Our findings indicate that exposure to a rural environment effectively reduced physiological stress and enhanced psychological well-being.", {"entities": []}], ["Chronic inflammatory airway diseases, such as bronchial asthma and chronic obstructive pulmonary disease, are common respiratory disorders worldwide.", {"entities": [[67, 104, "DISEASE"], [56, 62, "DISEASE"]]}], ["Exacerbations of these diseases are frequent and worsen patients\u2019 respiratory condition and overall health.", {"entities": []}], ["However, the mechanisms of exacerbation have not been fully elucidated.", {"entities": []}], ["Recently, it was reported that interleukin (IL)-17A might play an important role in neutrophilic inflammation, which is characteristic of such exacerbations, through increased production of neutrophil chemoattractants.", {"entities": []}], ["Therefore, we hypothesized that IL-17A was involved in the pathogenesis of acute exacerbation, due to viral infection in chronic inflammatory airway diseases.", {"entities": []}], ["In this study, we assessed chemokine production by bronchial epithelial cells and investigated the underlying mechanisms.", {"entities": []}], ["Comprehensive chemokine analysis showed that, compared with poly(I:C) alone, co-stimulation of BEAS-2B cells with IL-17A and poly(I:C) strongly induced production of such neutrophil chemoattractants as CXC chemokine ligand (CXCL)8, growth-related oncogene (GRO), and CXCL1.", {"entities": [[267, 272, "GENE"]]}], ["Co-stimulation synergistically induced CXCL8 and CXCL1 mRNA and protein production by BEAS-2B cells and normal human bronchial epithelial cells.", {"entities": [[49, 54, "GENE"]]}], ["Poly(I:C) induced chemokine expression by BEAS-2B cells mainly via Toll-like receptor 3/TIR-domain-containing adapter-inducing interferon-\u03b2\u2013mediated signals.", {"entities": []}], ["The co-stimulation with IL-17A and poly(I:C) markedly activated the p38 and extracellular-signal-regulated kinase 1/2 pathway, compared with poly(I:C), although there was little change in nuclear factor-\u03baB translocation into the nucleus or the transcriptional activities of nuclear factor-\u03baB and activator protein 1.", {"entities": []}], ["IL-17A promoted stabilization of CXCL8 mRNA in BEAS-2B cells treated with poly(I:C).", {"entities": []}], ["In conclusion, IL-17A appears to be involved in the pathogenesis of chronic inflammatory airway disease exacerbation, due to viral infection by promoting release of neutrophil chemoattractants from bronchial epithelial cells.", {"entities": []}], ["The growing global burden of non communicable diseases (NCDs) is now killing 36 million people each year and needs urgent and comprehensive action.", {"entities": []}], ["This article provides an overview of key critical issues that need to be resolved to ensure that recent political commitments are translated into practical action.", {"entities": []}], ["These include: (i) categorizing and prioritizing NCDs in order to inform donor funding commitments and priorities for intervention; (ii) finding the right balance between the relative importance of treatment and prevention to ensure that responses cover those at risk, and those who are already sick; (iii) defining the appropriate health systems response to address the needs of patients with diseases characterized by long duration and often slow progression; (iv) research needs, in particular translational research in the delivery of care; and (v) sustained funding to support the global NCD response.", {"entities": []}], ["Emergency department discharge instructions are variably understood by patients, and in the setting of emergency department crowding, innovations are needed to counteract shortened interaction times with the physician.", {"entities": []}], ["We evaluated the effect of viewing an online video of diagnosis-specific discharge instructions on patient comprehension and recall of instructions.", {"entities": []}], ["In this prospective, single-center, randomized controlled trial conducted between November 2011 and January 2012, we randomized emergency department patients who were discharged with one of 38 diagnoses to either view (after they left the emergency department) a vetted online video of diagnosis-specific discharge instructions, or to usual care.", {"entities": []}], ["Patients were subsequently contacted by telephone and asked three standardized questions about their discharge instructions; one point was awarded for each correct answer.", {"entities": []}], ["Using an intention-to-treat analysis, differences between groups were assessed using univariate testing, and with logistic regression that accounted for clustering on managing physician.", {"entities": []}], ["A secondary outcome measure was patient satisfaction with the videos, on a 10-point scale.", {"entities": []}], ["Among 133 patients enrolled, mean age was 46.1 (s.d.D.", {"entities": []}], ["21.5) and 55% were female.", {"entities": []}], ["Patients in the video group had 19% higher mean scores (2.5, s.d.", {"entities": []}], ["0.7) than patients in the control group (2.1, s.d.", {"entities": []}], ["0.8) (p=0.002).", {"entities": []}], ["After adjustment for patient age, sex, first language, triage acuity score, and clustering, the odds of achieving a fully correct score (3 out of 3) were 3.5 (95% CI, 1.7 to 7.2) times higher in the video group, compared to the control group.", {"entities": []}], ["Among those who viewed the videos, median rating of the videos was 10 (IQR 8 to 10).", {"entities": []}], ["In this single-center trial, patients who viewed an online video of their discharge instructions scored higher on their understanding of key concepts around their diagnosis and subsequent care.", {"entities": []}], ["Those who viewed the videos found them to be a helpful addition to standard care.", {"entities": []}], ["ClinicalTrials.gov NCT01361932 http://clinicaltrials.gov/ct2/show/NCT01361932?term=nct01361932&rank=1", {"entities": []}], ["There appears to be an obvious gap between a medical and patient adherence perspective.", {"entities": []}], ["Deviating from a medication prescription could be regarded as fairly irrational, but with respect to patients' goals and/or concerns it could be seen as understandable.", {"entities": []}], ["Thus, the aim was to elucidate adherence reasoning in relation to asthma medication.", {"entities": [[66, 72, "DISEASE"]]}], ["This was a qualitative study; data collection and analysis procedures were conducted according to Grounded Theory methodology.", {"entities": []}], ["Eighteen persons, aged 22 with asthma and regular asthma medication treatment, were interviewed.", {"entities": [[31, 37, "DISEASE"], [50, 56, "DISEASE"]]}], ["The emerged theoretical model illustrated that adherence to asthma medication was motivated by three foci, all directed towards a desired outcome in terms of a functional day as desired by the patient .", {"entities": [[60, 66, "DISEASE"]]}], ["A promotive focus was associated with the ambition to achieve a positive asthma outcome by being adherent either to the received prescription or to a self-adjusted dosage.", {"entities": [[73, 79, "DISEASE"]]}], ["A preventive focus was intended to ensure avoidance of a negative asthma outcome either by sticking to the prescription or by preventively overusing the medication.", {"entities": [[66, 72, "DISEASE"]]}], ["A permissive focus was associated with unstructured adherence behaviour in which medication intake was primarily triggered by asthma symptoms.", {"entities": [[126, 132, "DISEASE"]]}], ["As all participants had consciously adopted functioning medication tactics that directed them towards the desired goal of a functional day.", {"entities": []}], ["In an effort to bridge the gap between a patient- and a medical adherence perspective, patients need support in defining their desired functionality and guidance in developing a person-based medication tactic.", {"entities": []}], ["This study investigates the effect of Xiao-Qing-Long-Tang (XQLT) on neurotrophin in an established mouse model of Dermatophagoides pteronyssinus (Der p)-induced acute allergic asthma and in a LA4 cell line model of lung adenoma.", {"entities": [[220, 227, "DISEASE"], [167, 182, "DISEASE"], [215, 227, "DISEASE"], [176, 182, "DISEASE"]]}], ["The effects of XQLT on the regulation of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), airway hyper-responsiveness (AHR) and immunoglobulin E were measured.", {"entities": [[62, 65, "GENE"], [106, 110, "GENE"], [142, 145, "GENE"]]}], ["LA4 cells were stimulated with 100 \u03bcg/ml Der p 24 h and the supernatant was collected for ELISA analysis.", {"entities": []}], ["Der p-stimulated LA4 cells with either XQLT pre-treatment or XQLT co-treatment were used to evaluate the XQLT effect on neurotrophin.", {"entities": []}], ["Balb/c mice were sensitized on days 0 and 7 with a base-tail injection of 50 \u03bcg Dermatophagoides pteronyssinus (Der p) that was emulsified in 50 \u03bcl incomplete Freund\u2019s adjuvant (IFA).", {"entities": []}], ["On day 14, mice received an intra-tracheal challenge of 50 \u03bcl Der p (2 mg/ml).", {"entities": []}], ["XQLT (1g/Kg) was administered orally to mice either on days 2, 4, 6, 8, 10 and 12 as a preventive strategy or on day 15 as a therapeutic strategy.", {"entities": []}], ["XQLT inhibited expression of those NGF, BDNF and thymus-and activation-regulated cytokine (TARC) in LA4 cells that were subjected to a Der p allergen.", {"entities": [[35, 38, "GENE"], [40, 44, "GENE"]]}], ["Both preventive and therapeutic treatments with XQLT in mice reduced AHR.", {"entities": [[69, 72, "GENE"]]}], ["Preventive treatment with XQLT markedly decreased NGF in broncho-alveolar lavage fluids (BALF) and BDNF in serum, whereas therapeutic treatment reduced only serum BDNF level.", {"entities": [[50, 53, "GENE"], [99, 103, "GENE"], [163, 167, "GENE"], [99, 103, "GENE"], [163, 167, "GENE"]]}], ["The reduced NGF levels corresponded to a decrease in AHR by XQLT treatment.", {"entities": [[12, 15, "GENE"], [53, 56, "GENE"]]}], ["Reduced BALF NGF and TARC and serum BDNF levels may have been responsible for decreased eosinophil infiltration into lung tissue.", {"entities": [[13, 16, "GENE"], [36, 40, "GENE"]]}], ["Immunohistochemistry showed that p75NTR and TrkA levels were reduced in the lungs of mice under both XQLT treatment protocols, and this reduction may have been correlated with the prevention of the asthmatic reaction by XQLT.", {"entities": []}], ["XQLT alleviated allergic inflammation including AHR, IgE elevation and eosinophil infiltration in Der p stimulated mice by regulating neurotrophin and reducing TARC.", {"entities": [[48, 51, "GENE"]]}], ["These results revealed the potential pharmacological targets on which the XQLT decotion exerts preventive and therapeutic effects in an allergic asthma mouse model.", {"entities": [[136, 151, "DISEASE"], [145, 151, "DISEASE"]]}], ["To compare the incidence rates of serious cardiovascular events in adult initiators of amphetamines or atomoxetine to rates in non-users.", {"entities": []}], ["This was a retrospective cohort study of new amphetamines (n\u200a=\u200a38,586) or atomoxetine (n\u200a=\u200a20,995) users.", {"entities": []}], ["Each medication user was matched to up to four non-users on age, gender, data source, and state (n\u200a=\u200a238,183).", {"entities": []}], ["The following events were primary outcomes of interest 1) sudden death or ventricular arrhythmia, 2) stroke, 3) myocardial infarction, 4) a composite endpoint of stroke or myocardial infarction.", {"entities": [[112, 133, "DISEASE"], [172, 193, "DISEASE"]]}], ["Cox proportional hazard regression was used to calculate propensity-adjusted hazard ratios for amphetamines versus matched non-users and atomoxetine versus matched non-users, with intracluster dependence within matched sets accounted for using a robust sandwich estimator.", {"entities": []}], ["The propensity-score adjusted hazard ratio for amphetamines use versus non-use was 1.18 (95% CI: 0.55\u20132.54) for sudden death/ventricular arrhythmia, 0.80 (95% CI: 0.44\u20131.47) for stroke, 0.75 (95% CI: 0.42\u20131.35) for myocardial infarction, and 0.78 (95% CI: 0.51\u20131.19) for stroke/myocardial infarction.", {"entities": [[215, 236, "DISEASE"], [278, 299, "DISEASE"]]}], ["The propensity-score adjusted hazard ratio for atomoxetine use versus non-use was 0.41 (95% CI: 0.10\u20131.75) for sudden death/ventricular arrhythmia, 1.30 (95% CI: 0.52\u20133.29) for stroke, 0.56 (95% CI: 0.16\u20132.00) for myocardial infarction, and 0.92 (95% CI: 0.44\u20131.92) for stroke/myocardial infarction.", {"entities": [[214, 235, "DISEASE"], [277, 298, "DISEASE"]]}], ["Initiation of amphetamines or atomoxetine was not associated with an elevated risk of serious cardiovascular events.", {"entities": []}], ["However, some of the confidence intervals do not exclude modest elevated risks, e.g.", {"entities": []}], ["for sudden death/ventricular arrhythmia.", {"entities": []}], ["To determine whether using different intraperitoneal insufflation pressures for transperitoneal laparoscopic urologic surgeries decreases postoperative pain.", {"entities": []}], ["76 patients who underwent transperitoneal laparoscopic upper urinary tract surgery at different insufflation pressures were allocated into the following groups: 10mmHg (group I, n=24), 12mmHg (group II, n=25) and 14mmHg (group III, n=27).", {"entities": []}], ["These patients were compared according to age, gender, body mass index (BMI), type and duration of surgery, intraoperative bleeding volume, postoperative pain score and length of hospital stay.", {"entities": []}], ["A visual analog scale (VAS) was used for postoperative pain.", {"entities": []}], ["Demographic characteristics, mean age, gender, BMI and type of surgeries were statistically similar among the groups.", {"entities": []}], ["The mean operation time was higher in group I than group II and group III but this was not statistically significant (P=0.810).", {"entities": []}], ["The mean intraoperative bleeding volume was significantly higher in group I compared with group II and group III (P=0.030 and P=0.006).", {"entities": []}], ["The mean length of postoperative hospital stays was statistically similar among the groups (P=0.849).", {"entities": []}], ["The mean VAS score at 6h was significantly reduced in group I compared with group III (P=0.011).", {"entities": []}], ["At 12h, the mean VAS score was significantly reduced in group I compared with group II and group III (P=0.009 and P<0.001).", {"entities": []}], ["There was no significant difference in the mean VAS scores at 24h among three groups (P=0.920).", {"entities": []}], ["Lower insufflation pressures are associated with lower postoperative pain scores in the early postoperative period.", {"entities": []}], ["Airway epithelium forms a barrier to the outside world and has a crucial role in susceptibility to viral infections.", {"entities": []}], ["Cyclic adenosine monophosphate (cAMP) is an important second messenger acting via two intracellular signaling molecules: protein kinase A (PKA) and the guanidine nucleotide exchange factor, Epac.", {"entities": []}], ["We sought to investigate effects of increased cAMP level on the disruption of model airway epithelial barrier caused by RSV infection and the molecular mechanisms underlying cAMP actions.", {"entities": []}], ["Human bronchial epithelial cells were infected with RSV-A2 and treated with either cAMP releasing agent, forskolin, or cAMP analogs.", {"entities": []}], ["Structure and functions of the Apical Junctional Complex (AJC) were evaluated by measuring transepithelial electrical resistance and permeability to FITC-dextran, and determining localization of AJC proteins by confocal microscopy.", {"entities": []}], ["Increased intracellular cAMP level significantly attenuated RSV-induced disassembly of AJC.", {"entities": []}], ["These barrier-protective effects of cAMP were due to the activation of PKA signaling and did not involve Epac activity.", {"entities": []}], ["Increased cAMP level reduced RSV-induced reorganization of the actin cytoskeleton, including apical accumulation of an essential actin-binding protein, cortactin, and inhibited expression of the RSV F protein.", {"entities": []}], ["These barrier-protective and antiviral-function of cAMP signaling were evident even when cAMP level was increased after the onset of RSV infection.", {"entities": []}], ["Taken together, our study demonstrates that cAMP/PKA signaling attenuated RSV-induced disruption of structure and functions of the model airway epithelial barrier by mechanisms involving the stabilization of epithelial junctions and inhibition of viral biogenesis.", {"entities": []}], ["Improving our understanding of the mechanisms involved in RSV-induced epithelial dysfunction and viral pathogenesis will help to develop novel anti-viral therapeutic approaches.", {"entities": []}], ["Comments on the article \u201cRegulation of immunity during visceral Leishmania infection\u201d published in Parasites & Vectors 2016, 9:118, and further discussions about the role of antibodies in infections with Leishmania .", {"entities": []}], ["Previous studies have found associations between polymorphisms in T cell immunoglobulin and mucin domain 3 ( TIM-3 ) and increased risks of various cancers.", {"entities": []}], ["However, the association between TIM-3 polymorphisms and breast cancer (BC) remains uncertain.", {"entities": [[57, 70, "DISEASE"], [64, 70, "DISEASE"]]}], ["In this study, a total of 560 BC patients and 583 age, sex, and ethnicity-matched healthy controls from Northwest China were included.", {"entities": []}], ["The polymorphisms were genotyped using Sequenom MassARRAY.", {"entities": []}], ["The expression level of TIM-3 protein was detected by immunohistochemistry.", {"entities": []}], ["We observed rs10053538 had a significantly increased risk of BC, comparing with the wild-type genotype even after Bonferroni correction.", {"entities": []}], ["In addition, the rs4704853 G>A variants were more frequent among BC patients than the controls (GA + AA vs. GG: OR = 1.32, 95% CI = 1.03-1.69, P = 0.026); However, the significance was lost after Bonferroni correction (P = 0.078).", {"entities": []}], ["Furthermore, rs10053538 was associated with lymph node metastasis.", {"entities": []}], ["Age stratification revealed that among patients aged <49 years, those with the rs4704853 GA/AA genotype had a higher risk of BC; But there was no difference when Bonferroni correction was conducted.", {"entities": []}], ["Immunohistochemical analysis showed that the expression of TIM-3 protein in the breast cancer tissues was higher in patients carrying the rs10053538 GT+TT genotype than those with GG genotype (P = 0.012).", {"entities": [[80, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["However, we failed to find any difference between BC patients and controls in any rs1036199 genetic model.", {"entities": []}], ["These findings suggested that rs10053538 in TIM-3 might increase susceptibility to BC and promote the progression of BC in Chinese women.", {"entities": []}], ["The contribution of physical activity on the degree of weight loss following bariatric surgery is unclear.", {"entities": []}], ["To determine impact of exercise on postoperative weight loss.", {"entities": []}], ["Medline search (1988\u20132009) was completed using MeSH terms including bariatric procedures and a spectrum of patient factors with potential relationship to weight loss outcomes.", {"entities": []}], ["Of the 934 screened articles, 14 reported on exercise and weight loss outcomes.", {"entities": []}], ["The most commonly used instruments to measure activity level were the Baecke Physical Activity Questionnaire, the International Physical Activity Questionnaire, and a variety of self-made questionnaires.", {"entities": []}], ["The definition of an active patient varied but generally required a minimum of 30\u00a0min of exercise at least 3\u00a0days per week.", {"entities": []}], ["Thirteen articles reported on exercise and degree of postoperative weight loss ( n \u2009=\u20094,108 patients).", {"entities": []}], ["Eleven articles found a positive association of exercise on postoperative weight loss, and two did not.", {"entities": []}], ["Meta-analysis of three studies revealed a significant increase in 1-year postoperative weight loss (mean difference = 4.2% total body mass index (BMI) loss, 95% confidence interval (CI; 0.26\u20138.11)) for patients who exercise postoperatively.", {"entities": []}], ["Exercise following bariatric surgery appears to be associated with a greater weight loss of over 4% of BMI.", {"entities": []}], ["While a causal relationship cannot be established with observational data, this finding supports the continued efforts to encourage and support patients\u2019 involvement in post-surgery exercise.", {"entities": []}], ["Further research is necessary to determine the recommended activity guidelines for this patient population.", {"entities": []}], ["Adiponectin is an adipose derived hormone that declines in obesity.", {"entities": [[59, 66, "DISEASE"]]}], ["We have previously shown that exogenous administration of adiponectin reduces allergic airways responses in mice.", {"entities": []}], ["T-cadherin (T-cad; Cdh13 ) is a binding protein for the high molecular weight isoforms of adiponectin.", {"entities": [[19, 24, "GENE"]]}], ["To determine whether the beneficial effects of adiponectin on allergic airways responses require T-cad, we sensitized wildtype (WT), T-cadherin deficient (T-cad", {"entities": []}], ["Background and Aims .", {"entities": []}], ["Energy expenditure has been negatively correlated with fat accumulation.", {"entities": []}], ["However, this association is highly variable.", {"entities": []}], ["In the present study we applied a genotype by environment interaction method to examine the presence of Genotype x by Total Daily Energy Expenditure and Genotype x by Daily Energy Expenditure interactions in the expression of different body composition traits.", {"entities": []}], ["Methods and Results .", {"entities": []}], ["A total of 958 subjects from 294 families of The Portuguese Healthy Family Study were included in the analysis.", {"entities": []}], ["TDEE and DEE were assessed using a physical activity recall.", {"entities": []}], ["Body fat percentages were measured with a bioelectrical impedance scale.", {"entities": []}], ["GxTDEE and GxDEE examinations were performed using SOLAR 4.0 software.", {"entities": []}], ["All BC traits were significantly heritable, with heritabilities ranging from 21% to 34%.", {"entities": []}], ["The GxTDEE and GxDEE interaction models fitted the data better than the polygenic model for all traits.", {"entities": []}], ["For all traits, a significant GxTDEE and GxDEE interaction was due to variance heterogeneity among distinct levels of TDEE and DEE.", {"entities": []}], ["For WC, GxTDEE was also significant due to the genetic correlation function.", {"entities": []}], ["Conclusions .", {"entities": []}], ["TDEE and DEE are environmental constraints associated with the expression of individuals' BC genotypes, leading to variability in the phenotypic expression of BC traits.", {"entities": []}], ["Pneumomediastinum is the presence of air in the mediastinum.", {"entities": []}], ["It may occur as spontaneous, traumatic, or iatrogenic pneumomediastinum.", {"entities": []}], ["Although spontaneous pneumomediastinum is usually observed in healthy young men, traumatic pneumomediastinum may be caused by blunt or penetrating trauma to the chest and neck.", {"entities": []}], ["Pneumomediastinum is a clinical condition with potential complications that cause high morbidity and mortality rates.", {"entities": []}], ["Pneumomediastinum also may develop without tracheal or oesophageal injury after spontaneous or blunt chest, neck and facial injuries, and it may be accompanied by pneumothorax.", {"entities": [[163, 175, "DISEASE"]]}], ["We treated two patients who had pneumomediastinum.", {"entities": []}], ["Case 1 was a 20-year-old man who had pain and dyspnoea around the sternum for one hour, as a result of a blow from an elbow during a football match.", {"entities": []}], ["Case 2 was a 23-year-old man who had a two-day history of dyspnoea and chest pain with no history of trauma.", {"entities": []}], ["In both patients, diagnosis of pneumomediastinum was confirmed with thoracic computed tomography scans, and the condition resolved within five days of in-patient observation.", {"entities": []}], ["In conclusion, the diagnosis of pneumomediastinum should be considered for all patients who present to the emergency department with chest pain and dyspnoea.", {"entities": []}], ["Although the BTS-SIGN asthma guideline is one of the most well known and widely respected guidelines in the world, implementation in UK primary care remains patchy.", {"entities": [[22, 28, "DISEASE"]]}], ["Building on extensive earlier descriptive work, we sought to explore the way teamwork and inter-professional relationships impact on the implementation of the BTS-SIGN guideline on asthma in general practice.", {"entities": [[181, 187, "DISEASE"]]}], ["Qualitative comparative case study using nine in-depth interviews and 2 focus groups with general practitioners and practice nurses, involved in delivering asthma care.", {"entities": [[156, 162, "DISEASE"]]}], ["Participants were purposively recruited from practices in a Scottish health board with high and low compliance with the BTS-SIGN asthma guideline.", {"entities": [[129, 135, "DISEASE"]]}], ["There was a marked difference in the way respondents from practices with high compliance and respondents from practices with low compliance spoke about the value of guidelines and the challenges of implementing them.", {"entities": []}], ["On both accounts, the former were more positive than the latter and were able to be more specific about the strategies they used to overcome barriers to implementation.", {"entities": []}], ["We explored the reason for this difference in response and identified practice organisation, centring on delegation of work to nurses, as a factor mediating the practice's level of compliance.", {"entities": []}], ["Effective delegation was underpinned by organisation of asthma work among practice members who have the appropriate level of skills and knowledge, know and understand each others' work and responsibilities, communicate well among themselves and trust each others' skills.", {"entities": [[56, 62, "DISEASE"]]}], ["It was the combination of these factors which made for successful delegation and guideline implementation, not any one factor in isolation.", {"entities": []}], ["In our sample of practices, teamwork and organisation of care within practices appeared to impact on guideline implementation and further larger studies are needed to explore this issue further.", {"entities": []}], ["Isolated interventions such as measures to improve staff's knowledge or increased clinical resource and time, which are currently being considered, are unlikely to be effective unless practices are supported in developing their teams in a way which supports the deployment of these resources.", {"entities": []}], ["Foul-smelling environmental pollution was a major concern following a chemical workplace explosion.", {"entities": []}], ["Malodorous pollution has previously been associated with aggravated physical and psychological health, and in persons affected by a trauma, an incidence-related odour can act as a traumatic reminder.", {"entities": []}], ["Olfaction may even be of significance in the development and persistence of post-traumatic stress symptoms (PTSS).", {"entities": []}], ["The present longitudinal study assessed whether perceived smell related to malodorous environmental pollution in the aftermath of the explosion was a determinant of subjective health complaints (SHC) and PTSS among gainfully employed adults, when the malodorous pollution was present, and after pollution clean-up.", {"entities": []}], ["Questionnaire data from validated instruments were analysed using mixed effects models.", {"entities": []}], ["Individual odour scores were computed, and the participants (n=486) were divided into high and low odour score groups, respectively.", {"entities": []}], ["Participants in the high odour score group (n=233) reported more SHC and PTSS than those in the low odour score group (n=253), before and even after the pollution was eliminated.", {"entities": []}], ["These associations lasted for at least three years after the pollution was removed, and might indicate that prompt clean-up is important to avoid persistent health effects after malodorous chemical spills.", {"entities": []}], ["Garlic and its preparations have been widely recognized as agents for prevention and treatment of cardiovascular and other metabolic diseases, atherosclerosis, hyperlipidemia, thrombosis, hypertension and diabetes.", {"entities": [[188, 200, "DISEASE"], [143, 158, "DISEASE"]]}], ["Effectiveness of garlic in cardiovascular diseases was more encouraging in experimental studies, which prompted several clinical trials.", {"entities": []}], ["Though many clinical trials showed a positive effect of garlic on almost all cardiovascular conditions mentioned above, however a number of negative studies have recently cast doubt on the efficary of garlic specially its cholesterol lowering effect of garlic.", {"entities": []}], ["It is a great challenge for scientists all over the world to make a proper use of garlic and enjoy its maximum beneficial effect as it is the cheapest way to prevent cardiovascular disease.", {"entities": []}], ["This review has attempted to make a bridge the gap between experimental and clinical study and to discuss the possible mechanisms of such therapeutic actions of garlic.", {"entities": []}], ["Antibodies targeting IL-17A or its receptor IL-17RA show unprecedented efficacy in the treatment of autoimmune diseases such as psoriasis.", {"entities": [[128, 137, "DISEASE"]]}], ["These therapies, by neutralizing critical mediators of immunity, may increase susceptibility to infections.", {"entities": []}], ["Here, we compared the effect of antibodies neutralizing IL-17A, IL-17F or TNF\u03b1 on murine host responses to Mycobacterium tuberculosis infection by evaluating lung transcriptomic, microbiological and histological analyses.", {"entities": [[121, 133, "DISEASE"]]}], ["Coinciding with a significant increase of mycobacterial burden and pathological changes following TNF\u03b1 blockade, gene array analyses of infected lungs revealed major changes of inflammatory and immune gene expression signatures 4 weeks post-infection.", {"entities": []}], ["Specifically, gene expression associated with host-pathogen interactions, macrophage recruitment, activation and polarization, host-antimycobacterial activities, immunomodulatory responses, as well as extracellular matrix metallopeptidases, were markedly modulated by TNF\u03b1 blockade.", {"entities": []}], ["IL-17A or IL-17F neutralization elicited only mild changes of few genes without impaired host resistance four weeks after M. tuberculosis infection.", {"entities": [[125, 137, "DISEASE"]]}], ["Further, the absence of both IL-17RA and IL-22 pathways in genetically deficient mice did not profoundly compromise host control of M. tuberculosis over a 6-months period, ruling out potential compensation between these two pathways, while TNF\u03b1-deficient mice succumbed rapidly.", {"entities": [[135, 147, "DISEASE"]]}], ["These data provide experimental confirmation of the low clinical risk of mycobacterial infection under anti-IL-17A therapy, in contrast to anti-TNF\u03b1 treatment.", {"entities": []}], ["In a randomized trial evaluating the effect of installation of ion-exchange water softeners in the households of children with eczema, the researchers found no evidence of improvement in eczema severity as compared to usual care in the study population.", {"entities": []}], ["Epidemiological studies and anecdotal reports suggest a possible link between household use of hard water and atopic eczema.", {"entities": []}], ["We sought to test whether installation of an ion-exchange water softener in the home can improve eczema in children.", {"entities": []}], ["This was an observer-blind randomised trial involving 336 children (aged 6 months to 16 years) with moderate/severe atopic eczema.", {"entities": []}], ["All lived in hard water areas (\u2265200 mg/l calcium carbonate).", {"entities": []}], ["Participants were randomised to either installation of an ion-exchange water softener plus usual eczema care, or usual eczema care alone.", {"entities": []}], ["The primary outcome was change in eczema severity (Six Area Six Sign Atopic Dermatitis Score, SASSAD) at 12 weeks, measured by research nurses who were blinded to treatment allocation.", {"entities": [[69, 86, "DISEASE"], [76, 86, "DISEASE"]]}], ["Analysis was based on the intent-to-treat population.", {"entities": []}], ["Eczema severity improved for both groups during the trial.", {"entities": []}], ["The mean change in SASSAD at 12 weeks was \u22125.0 (20% improvement) for the water softener group and \u22125.7 (22% improvement) for the usual care group (mean difference 0.66, 95% confidence interval \u22121.37 to 2.69, p \u200a=\u200a0.53).", {"entities": []}], ["No between-group differences were noted in the use of topical corticosteroids or calcineurin inhibitors.", {"entities": []}], ["Water softeners provided no additional benefit to usual care in this study population.", {"entities": []}], ["Small but statistically significant differences were found in some secondary outcomes as reported by parents, but it is likely that such improvements were the result of response bias, since participants were aware of their treatment allocation.", {"entities": []}], ["A detailed report for this trial is also available at http://www.hta.ac.uk .", {"entities": []}], ["Current Controlled Trials ISRCTN71423189 Please see later in the article for the Editors' Summary Eczema (sometimes referred to as atopic dermatitis) is a chronic, inflammatory skin condition that affects about 20% of school children in developed countries.", {"entities": [[131, 148, "DISEASE"], [138, 148, "DISEASE"]]}], ["Eczema is often associated with other conditions, such as asthma, hay-fever and food allergy and can cause intractable itching leading to thickened skin, bleeding, secondary infection, sleep loss, poor concentration, and psychological distress.", {"entities": [[80, 92, "DISEASE"], [58, 64, "DISEASE"]]}], ["Current topical treatments for eczema have side effects, for example, topical corticosteroids may cause skin thinning and the long term safety of topical tacrolimus and pimecrolimus has yet to be determined.", {"entities": []}], ["Therefore, there is a lot of interest in exploring the benefits of non-pharmacological treatments that have no apparent side effects.", {"entities": []}], ["Water hardness (\u2265200 mg/l calcium carbonate) has become a recent focus of attention.", {"entities": []}], ["In addition to some epidemiological evidence linking increased water hardness with increased eczema prevalence, there have been widespread anecdotal reports of improvement in the skin of children with eczema when the family has moved from a hard to a soft water area.", {"entities": []}], ["In addition, some patients report how their eczema symptoms have rapidly improved following the installation of a water softener.", {"entities": []}], ["However, to date there have been no relevant published trials evaluating the potential benefit of water softeners for eczema.", {"entities": []}], ["Given the lack of evidence, the high public interest in their potential benefit and the low risk of adverse effects, the researcher conducted a study to assess whether the installation of an ion-exchange water softener reduces the severity of eczema in children with moderate to severe eczema.", {"entities": []}], ["The researchers did a pilot study that showed that it was not possible to blind participants to their treatment allocation using real and \u201cdummy\u201d water softener units because the softened water produced more soap suds.", {"entities": []}], ["So the researchers conducted an observer-blind randomised controlled trial in which they used trained research nurses to conduct an objective assessment of every participant's skin.", {"entities": []}], ["The researchers recruited 336 children who all lived in hard water areas in England.", {"entities": []}], ["Eligible children were aged 6 months to 16 years who had a diagnosis of eczema (in line with the UK working party's diagnostic criteria) and an eczema severity score of 10 or over.", {"entities": []}], ["Participants were randomised to either installation of an ion-exchange water softener plus usual eczema care, or usual eczema care alone.", {"entities": []}], ["Trained research nurses examined each child's skin at baseline and at 6, 12, and 16 weeks to record changes in eczema severity.", {"entities": []}], ["The researchers also analysed any changes in symptoms over the study period such as, sleep loss and itchiness, the amount of topical corticosteroid/calcineurin inhibitors used, the Dermatitis Family Impact questionnaire and the health related Quality of Life (children's version).", {"entities": [[181, 191, "DISEASE"]]}], ["Although both treatment groups improved in disease severity during the course of the trial, the researchers found no difference between the treatment groups in the main outcome\u2014eczema severity.", {"entities": []}], ["Similar finding were found for night movement (scratching) and the use of topical medications (creams/ointments applied to the skin), both of which were blinded to intervention status.", {"entities": []}], ["Nevertheless, parents in the trial did report small health benefits, and just over 50% chose to buy the water softener at the end of the trial because of perceived improvements in the eczema and the wider benefits of water softeners.", {"entities": []}], ["It is unclear how much of this effect can be explained by prior belief in the effectiveness of the water softeners for the treatment of eczema.", {"entities": []}], ["The results of this study suggest that water softeners provide no additional clinical benefit to usual care in children with eczema so the use of ion-exchange water softeners for the treatment of moderate to severe eczema in children should not be recommended.", {"entities": []}], ["However, it is up to each family to decide whether or not the wider benefits of installing a water softener in their home are sufficient to consider buying one.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1000395 .", {"entities": []}], ["The UK's NHS presents information on eczema for patients and families MedlinePlus gives information for patients, families, and caregivers on eczema and other similar conditions The National Eczema Society in the UK provides information and a helpline for eczema patients, families, and caregivers Medinfo provides information for eczema patients Wikipedia has more information about water softening (note that Wikipedia is a free online encyclopedia that anyone can edit; available in several languages)", {"entities": [[9, 12, "GENE"]]}], ["Children's exposure to secondhand smoke (SHS) has been causally linked to a number of childhood morbidities and mortalities.", {"entities": []}], ["Over 50% of UK children whose parents are smokers are regularly exposed to SHS at home.", {"entities": []}], ["No previous review has identified the factors associated with children's SHS exposure in the home.", {"entities": []}], ["To identify by systematic review, the factors which are associated with children's SHS exposure in the home, determined by parent or child reports and/or biochemically validated measures including cotinine, carbon monoxide or home air particulate matter.", {"entities": []}], ["Electronic searches of MEDLINE, EMBASE, PsychINFO, CINAHL and Web of Knowledge to July 2014, and hand searches of reference lists from publications included in the review were conducted.", {"entities": []}], ["Forty one studies were included in the review.", {"entities": []}], ["Parental smoking, low socioeconomic status and being less educated were all frequently and consistently found to be independently associated with children's SHS exposure in the home.", {"entities": []}], ["Children whose parents held more negative attitudes towards SHS were less likely to be exposed.", {"entities": []}], ["Associations were strongest for parental cigarette smoking status; compared to children of non-smokers, those whose mothers or both parents smoked were between two and 13 times more likely to be exposed to SHS.", {"entities": []}], ["Multiple factors are associated with child SHS exposure in the home; the best way to reduce child SHS exposure in the home is for smoking parents to quit.", {"entities": []}], ["If parents are unable or unwilling to stop smoking, they should instigate smoke-free homes.", {"entities": []}], ["Interventions targeted towards the socially disadvantaged parents aiming to change attitudes to smoking in the presence of children and providing practical support to help parents smoke outside the home may be beneficial.", {"entities": []}], ["To construct a prediction model of preference-adjusted health status (SF-6D) for Cushing\u2019s syndrome using a disease-specific health-related quality of life (HRQOL) measure (CushingQoL).", {"entities": [[91, 99, "DISEASE"]]}], ["Data were obtained from the original multicenter, multinational study to validate the CushingQoL questionnaire.", {"entities": []}], ["HRQOL was measured using the CushingQoL and the SF-36 questionnaires.", {"entities": []}], ["SF-6D scores were calculated from responses on the SF-36.", {"entities": []}], ["Sociodemographic and clinical data were also collected.", {"entities": []}], ["Various predictive models were tested and the final one was selected on the basis of four criteria: explanatory power, consistency of estimated coefficients, normality of prediction errors, and parsimony.", {"entities": []}], ["For the mapping analysis, data were available from 116 of the 125 patients included in the original validation study.", {"entities": []}], ["Mean (SD) age was 45.3 (13.1)\u00a0years and the sample was predominantly (83\u00a0%) female.", {"entities": []}], ["Patients had a mean (SD) CushingQoL score of 52.9 (21.9), whereas the SF-6D (derived from SF-36) was skewed towards better health with a mean of 0.71 (median 0.74) on a scale of \u22120.704 to 1.", {"entities": []}], ["Of the various models tested, a model which included the intercept (0.61), CushingQoL overall score, level one in CushingQoL item 2 (always have pain preventing me from leading a normal life), and level one in CushingQoL item 10 (my illness always affects my everyday activities) best met the four criteria for model selection.", {"entities": []}], ["The model had an adjusted R Although the mapping function finally selected appears to be able to accurately map CushingQoL scores onto SF-6D outcomes at the group level, further testing is required to validate the model in independent patient samples.", {"entities": []}], ["The clinical diagnosis of influenza is difficult because it shares nonspecific symptoms with a variety of diseases.", {"entities": [[26, 35, "DISEASE"]]}], ["Emergency departments and clinics were overwhelmed by a surge of anxious patients during the 2009 influenza A virus (H1N1) outbreak.", {"entities": [[98, 107, "DISEASE"]]}], ["Our objective was to identify symptomatic predictors of influenza virus infection for patients with a negative rapid diagnostic test.", {"entities": [[56, 65, "DISEASE"]]}], ["We conducted a retrospective review of 805 patients who presented at Chang Gung Memorial Hospital, from August 1, 2009, to September 30, 2009.", {"entities": []}], ["Respiratory specimens from these patients were subjected to rapid influenza tests and reverse-transcription polymerase chain reactions.", {"entities": [[66, 75, "DISEASE"]]}], ["In total, 36% of 308 children and 23% of 497 adults were positive for 2009 influenza A virus (H1N1) infection by polymerase chain reaction or virus culture.", {"entities": [[75, 84, "DISEASE"]]}], ["For pediatric patients, sore throat and influenza-like illness significantly increased the odds of having 2009 influenza A virus (H1N1) infection, by more than 3-fold (95% confidence interval (CI): 1.9\u20137.3) and 7-fold (95% CI: 4.00\u201314.2), respectively.", {"entities": [[40, 49, "DISEASE"], [111, 120, "DISEASE"]]}], ["For adult patients, cough and constitutional symptoms increased the odds of having 2009 influenza A virus (H1N1) by greater than 5-fold (95% CI: 3.1\u201310.2) and 3-fold (95% CI: 2.1\u20136.7), respectively.", {"entities": [[88, 97, "DISEASE"]]}], ["The negative likelihood ratio of the combination of fever and cough was 0.096 (95% CI: 0.01\u20130.69) for children with negative results of rapid influenza diagnostic tests.", {"entities": [[142, 151, "DISEASE"]]}], ["In influenza epidemic settings, clinicians should be aware that rapid influenza diagnostic tests are relatively insensitive for the diagnosis of influenza virus infection.", {"entities": [[3, 12, "DISEASE"], [70, 79, "DISEASE"], [145, 154, "DISEASE"]]}], ["For patients with negative rapid influenza diagnostic tests, those lacking fever and cough have a low probability of influenza virus infection.", {"entities": [[33, 42, "DISEASE"], [117, 126, "DISEASE"]]}], ["The management strategy should be made individually and depend on the severity of illness.", {"entities": []}], ["Plant protease inhibitors are a structurally highly diverse and ubiquitous class of small proteins, which play various roles in plant development and defense against pests and pathogens.", {"entities": []}], ["Particular isoforms inhibit in vitro proteases and other enzymes that are not their natural substrates, for example proteases that have roles in human diseases.", {"entities": []}], ["Mature potato tubers are a rich source of several protease inhibitor families.", {"entities": []}], ["Different cultivars have different inhibitor profiles.", {"entities": []}], ["With the objective to explore the functional diversity of the natural diversity of potato protease inhibitors, we randomly selected and sequenced 9,600 cDNA clones originated from mature tubers of ten potato cultivars.", {"entities": []}], ["Among these, 120 unique inhibitor cDNA clones were identified by homology searches.", {"entities": []}], ["Eighty-eight inhibitors represented novel sequence variants of known plant protease inhibitor families.", {"entities": []}], ["Most frequent were Kunitz-type inhibitors (KTI), potato protease inhibitors I and II (PIN), pectin methylesterase inhibitors, metallocarboxypeptidase inhibitors and defensins.", {"entities": []}], ["Twenty-three inhibitors were functionally characterized after heterologous expression in the yeast Pichia pastoris .", {"entities": []}], ["The purified recombinant proteins were tested for inhibitory activity on trypsin, eleven pharmacological relevant proteases and the non-proteolytic enzyme 5-lipoxygenase.", {"entities": []}], ["Members of the KTI and PIN families inhibited pig pancreas elastase, \u03b2-Secretase, Cathepsin K, HIV-1 protease and potato 5-lipoxygenase.", {"entities": []}], ["Our results demonstrate in vitro inhibitory diversity of small potato tuber proteins commonly known as protease inhibitors, which might have biotechnological or medical applications.", {"entities": []}], ["The online version of this article (doi:10.1007/s00438-014-0906-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["There are few and debated data regarding possible differences in the clinical presentations of influenza A/H1N1, A/H3N2 and B viruses in children.", {"entities": [[95, 104, "DISEASE"]]}], ["This study evaluates the clinical presentation and socio-economic impact of laboratory-confirmed influenza A/H1N1, A/H3N2 or B infection in children attending an Emergency Room because of influenza-like illness.", {"entities": [[97, 106, "DISEASE"], [188, 197, "DISEASE"]]}], ["Among the 4,726 children involved, 662 had influenza A (143 A/H1N1 and 519 A/H3N2) and 239 influenza B infection detected by means of real-time polymerase chain reaction.", {"entities": [[43, 52, "DISEASE"], [91, 100, "DISEASE"]]}], ["Upon enrolment, systematic recordings were made of the patients' demographic characteristics and medical history using standardised written questionnaires.", {"entities": []}], ["The medical history of the children was re-evaluated 5-7 days after enrolment and until the resolution of their illness by means of interviews and a clinical examination by trained investigators using standardised questionnaires.", {"entities": []}], ["During this evaluation, information was also obtained regarding illnesses and related morbidity among households.", {"entities": []}], ["Children infected with influenza A/H1N1 were significantly younger (mean age, 2.3 yrs) than children infected with influenza A/H3N2 (mean age, 4.7 yrs; p < 0.05)) or with influenza B (mean age, 5.2 yrs; p < 0.05).", {"entities": [[23, 32, "DISEASE"], [115, 124, "DISEASE"], [171, 180, "DISEASE"]]}], ["Adjusted for age and sex, children with influenza A/H3N2 in comparison with those infected by either A/H1N1 or with B influenza virus were more frequently affected by fever (p < 0.05) and lower respiratory tract involvement (p < 0.05), showed a worse clinical outcome (p < 0.05), required greater drug use (p < 0.05), and suffered a worse socio-economic impact (p < 0.05).", {"entities": [[40, 49, "DISEASE"], [118, 127, "DISEASE"]]}], ["Adjusted for age and sex, children with influenza B in comparison with those infected by A/H1N1 influenza virus had significantly higher hospitalization rates (p < 0.05), the households with a disease similar to that of the infected child (p < 0.05) and the need for additional household medical visits (p < 0.05).", {"entities": [[40, 49, "DISEASE"], [96, 105, "DISEASE"]]}], ["Disease due to influenza A/H3N2 viral subtype is significantly more severe than that due to influenza A/H1N1 subtype and influenza B virus, which indicates that the characteristics of the different viral types and subtypes should be adequately considered by health authorities when planning preventive and therapeutic measures.", {"entities": [[15, 24, "DISEASE"], [92, 101, "DISEASE"], [121, 130, "DISEASE"]]}], ["The sensitivity of rapid influenza diagnostic test (RIDT) of children with influenza-like illness (ILI) remains low.", {"entities": [[25, 34, "DISEASE"], [75, 84, "DISEASE"]]}], ["We compare the parameters between pandemic A(H1N1) 2009 influenza with negative RIDT and ILI not H1N1 for improving the low sensitivity of RIDT for children with ILI.", {"entities": [[56, 65, "DISEASE"]]}], ["In a cohort of consecutive laboratory-confirmed H1N1 influenza, we identified 150 H1N1 children with positive RIDT, 152 H1N1 children with negative RIDT, and 75 children with ILI not H1N1.", {"entities": [[53, 62, "DISEASE"]]}], ["Viral load in throat, complete blood count (CBC), and C-reactive protein (CRP) levels between H1N1 children with negative RIDT and children with ILI not H1N1 were assessed.", {"entities": [[74, 77, "GENE"]]}], ["The diagnostic sensitivity of the RIDT was 45\u00b75%.", {"entities": []}], ["An analysis of CBC and CRP levels indicated that H1N1 children with negative RIDT had lower total leukocyte, neutrophil, lymphocyte, and basophil counts, and serum CRP levels ( P < 0\u00b701).", {"entities": [[23, 26, "GENE"], [164, 167, "GENE"], [23, 26, "GENE"], [164, 167, "GENE"]]}], ["Lymphocyte counts less than 1500 cells/mm 10 copies/ml, P < 0\u00b7001); the viral load was negatively correlated to the lymphocyte count ( P < 0\u00b7001).", {"entities": []}], ["A combination of a low lymphocyte count and a low CRP level could, in the early disease phase, provide a useful screening for H1N1 children with false-negative RIDT, potentially facilitating differential diagnoses.", {"entities": [[50, 53, "GENE"]]}], ["In many research areas it is necessary to find differences between treatment groups with several variables.", {"entities": []}], ["For example, studies of microarray data seek to find a significant difference in location parameters from zero or one for ratios thereof for each variable.", {"entities": []}], ["However, in some studies a significant deviation of the difference in locations from zero (or 1 in terms of the ratio) is biologically meaningless.", {"entities": []}], ["A relevant difference or ratio is sought in such cases.", {"entities": []}], ["This article addresses the use of relevance-shifted tests on ratios for a multivariate parallel two-sample group design.", {"entities": []}], ["Two empirical procedures are proposed which embed the relevance-shifted test on ratios.", {"entities": []}], ["As both procedures test a hypothesis for each variable, the resulting multiple testing problem has to be considered.", {"entities": []}], ["Hence, the procedures include a multiplicity correction.", {"entities": []}], ["Both procedures are extensions of available procedures for point null hypotheses achieving exact control of the familywise error rate.", {"entities": []}], ["Whereas the shift of the null hypothesis alone would give straight-forward solutions, the problems that are the reason for the empirical considerations discussed here arise by the fact that the shift is considered in both directions and the whole parameter space in between these two limits has to be accepted as null hypothesis.", {"entities": []}], ["The first algorithm to be discussed uses a permutation algorithm, and is appropriate for designs with a moderately large number of observations.", {"entities": []}], ["However, many experiments have limited sample sizes.", {"entities": []}], ["Then the second procedure might be more appropriate, where multiplicity is corrected according to a concept of data-driven order of hypotheses.", {"entities": []}], ["We investigated prognostic factors (PFs) for 90-day mortality in a large cohort of advanced/metastatic soft tissue sarcoma (STS) patients treated with first-line chemotherapy.", {"entities": [[115, 122, "DISEASE"], [124, 127, "GENE"]]}], ["The PFs were identified by both logistic regression analysis and probability tree analysis in patients captured in the Soft Tissue and Bone Sarcoma Group (STBSG) database (3002 patients).", {"entities": [[140, 147, "DISEASE"]]}], ["Scores derived from the logistic regression analysis and algorithms derived from probability tree analysis were subsequently validated in an independent study cohort from the French Sarcoma Group (FSG) database (404 patients).", {"entities": [[182, 189, "DISEASE"]]}], ["The 90-day mortality rate was 8.6 and 4.5% in both cohorts.", {"entities": []}], ["The logistic regression analysis retained performance status (PS; odds ratio (OR)=3.83 if PS=1, OR=12.00 if PS \u2a7e2), presence of liver metastasis (OR=2.37) and rare site metastasis (OR=2.00) as PFs for early death.", {"entities": []}], ["The CHAID analysis retained PS as a major discriminator followed by histological grade (only for patients with PS \u2a7e2).", {"entities": []}], ["In both models, PS was the most powerful PF for 90-day mortality.", {"entities": []}], ["Performance status has to be taken into account in the design of further clinical trials and is one of the most important parameters to guide patient management.", {"entities": []}], ["For those patients with poor PS, expected benefits from therapy should be weighed up carefully against the anticipated toxicities.", {"entities": []}], ["A gene expression analysis of hypoxic rat retina was undertaken to gain a deeper understanding of the possible molecular mechanisms that underlie hypoxia-induced retinal pathologies and identify possible therapeutic targets.", {"entities": []}], ["Rats were made severely hypoxic (6%\u20137% O 2 ) for 3 h. Some rats were sacrificed at this time, and others were allowed to recover for 24 h under normoxic conditions.", {"entities": []}], ["A focused oligonucleotide microarray of 1,178 genes, qRT\u2013PCR of selected transcripts, and western analysis of hypoxia inducible factor-1\u03b1 (HIF-1\u03b1) were used to compare retinas from the hypoxic and recovery groups to control animals that were not made hypoxic.", {"entities": []}], ["SAM analysis was used to identify statistically significant changes in microarray data, and the bioinformatics programs GoMiner, Gene Set Enrichment Analysis (GSEA), and HiMAP were used to identify significant ontological categories and analyze the N-methyl-D-aspartate (NMDA) receptor interactome.", {"entities": []}], ["HIF-1\u03b1 protein, but not mRNA, was elevated up to 15-fold during hypoxia, beginning at 0.5 h, the shortest duration examined.", {"entities": []}], ["Of the total of 1,178 genes examined by microarray, 119 were significantly upregulated following hypoxia.", {"entities": []}], ["Of these, 86 were still significantly upregulated following recovery.", {"entities": []}], ["However, 24 genes were significantly downregulated following hypoxia, with 12 still significantly downregulated after recovery.", {"entities": []}], ["Of the 1035 genes that did not change with hypoxia, the expression of 36 genes was significantly changed after recovery.", {"entities": []}], ["Ontological analyses showed significant upregulation of a large number of genes in the glutamate receptor family, including 3 of the 5 NMDA subunits.", {"entities": []}], ["qRT\u2013PCR analysis further corroborated these findings.", {"entities": []}], ["Genes known to directly interact specifically with the NR1 subunit of the NMDA receptor were identified using HiMAP databases.", {"entities": []}], ["GSEA analysis revealed that these genes were not affected by either hypoxia or altered after recovery.", {"entities": []}], ["The identification of gene expression alterations as a function of hypoxia and recovery from hypoxia is important to understand the molecular mechanisms underlying retinal dysfunction associated with a variety of diseases.", {"entities": []}], ["Gene changes were identified in hypoxic retina that could be linked to specific networks.", {"entities": []}], ["Retinas recovering from hypoxia also showed distinct patterns of gene expression that were different from both normoxic control retinas and hypoxic retinas, indicating that hypoxia initiates a complex pattern of gene expression.", {"entities": []}], ["Diseases of which hypoxia is a component may exhibit the several changes found here.", {"entities": []}], ["Several potential therapeutic targets have been identified by our approach, including modulation of NMDA receptor expression and signaling, which until now have only been shown to play a role in responding to ischemia.", {"entities": [[209, 217, "DISEASE"]]}], ["Inflammation plays a key role in atherosclerosis.", {"entities": [[33, 48, "DISEASE"]]}], ["The protective role of angiotensin 1\u20137 (Ang\u2010(1\u20137)) in vascular pathologies suggested the therapeutic use of low MW, non\u2010peptide Ang\u2010(1\u20137) mimetics, such as AVE0991.", {"entities": []}], ["The mechanisms underlying the vaso\u2010protective effects of AVE0991, a Mas receptor agonist, remain to be explored.", {"entities": []}], ["We investigated the effects of AVE0991 on the spontaneous atherosclerosis in apolipoprotein E (ApoE)\u2212/\u2212 mice, in the context of vascular inflammation and plaque stability.", {"entities": [[58, 73, "DISEASE"], [95, 99, "GENE"]]}], ["AVE0991 has significant anti\u2010atherosclerotic properties in ApoE\u2212/\u2212 mice and increases plaque stability, by reducing plaque macrophage content, without effects on collagen.", {"entities": []}], ["Using the descending aorta of chow\u2010fed ApoE\u2212/\u2212 mice, before significant atherosclerotic plaque develops, we gained insight to early events in atherosclerosis.", {"entities": [[142, 157, "DISEASE"]]}], ["Interestingly, perivascular adipose tissue (PVAT) and adventitial infiltration with macrophages and T\u2010cells precedes atherosclerotic plaque or the impairment of endothelium\u2010dependent NO bioavailability (a measure of endothelial function).", {"entities": []}], ["AVE0991 inhibited perivascular inflammation, by reducing chemokine expression in PVAT and through direct actions on monocytes/macrophages inhibiting their activation, characterized by production of IL\u20101\u03b2, TNF\u2010\u03b1, CCL2 and CXCL10, and differentiation to M1 phenotype.", {"entities": [[212, 216, "GENE"], [221, 227, "GENE"]]}], ["Pretreatment with AVE0991 inhibited migration of THP\u20101 monocytes towards supernatants of activated adipocytes (SW872).", {"entities": []}], ["Mas receptors were expressed in PVAT and in THP\u20101 cells in vitro , and the anti\u2010inflammatory effects of AVE0991 were partly Mas dependent.", {"entities": []}], ["The selective Mas receptor agonist AVE0991 exhibited anti\u2010atherosclerotic and anti\u2010inflammatory actions, affecting monocyte/macrophage differentiation and recruitment to the perivascular space during early stages of atherosclerosis in ApoE\u2212/\u2212 mice.", {"entities": [[216, 231, "DISEASE"]]}], ["This article is part of a themed section on Targeting Inflammation to Reduce Cardiovascular Disease Risk.", {"entities": []}], ["To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc and http://onlinelibrary.wiley.com/doi/10.1111/bcp.v82.4/issuetoc", {"entities": []}], ["Nasal allergen provocations may be useful in investigating the pathophysiology of allergic rhinitis and effects of treatments.", {"entities": [[82, 99, "DISEASE"], [91, 99, "DISEASE"]]}], ["To use grass pollen nasal allergen challenge ( NAC ) to investigate the effects of allergen immunotherapy in a cross\u2010sectional study.", {"entities": []}], ["We studied nasal and cutaneous responses in untreated subjects with seasonal grass\u2010pollen allergic rhinitis ( n \u00a0=\u00a014) compared with immunotherapy\u2010treated allergics ( n \u00a0=\u00a014), plus a nonatopic control group ( n \u00a0=\u00a014).", {"entities": [[90, 107, "DISEASE"], [99, 107, "DISEASE"]]}], ["Volunteers underwent a standardized NAC with 2000\u00a0biological units of timothy grass allergen (equivalent to 1.3\u00a0\u03bcg major allergen, P hl p5).", {"entities": []}], ["Nasal fluid was collected and analysed by Immuno CAP and multiplex assays.", {"entities": []}], ["Clinical response was assessed by symptom scores and peak nasal inspiratory flow ( PNIF ).", {"entities": []}], ["Cutaneous response was measured by intradermal allergen injection.", {"entities": []}], ["Retrospective seasonal symptom questionnaires were also completed.", {"entities": []}], ["Immunotherapy\u2010treated patients had lower symptom scores ( P \u00a0=\u00a00.04) and higher PNIF ( P \u00a0=\u00a00.02) after challenge than untreated allergics.", {"entities": []}], ["They had reduced early ( P \u00a0=\u00a00.0007) and late ( P \u00a0<\u00a00.0001) skin responses, and lower retrospective seasonal symptom scores ( P \u00a0<\u00a00.0001).", {"entities": []}], ["Compared to untreated allergics, immunotherapy\u2010treated patients had reduced nasal fluid concentrations of IL \u20104, IL \u20109 and eotaxin (all P \u00a0<\u00a00.05, 8\u00a0h level and/or area under the curve comparison), and trends for reduced IL \u201013 ( P \u00a0=\u00a00.07, area under the curve) and early\u2010phase tryptase levels ( P \u00a0=\u00a00.06).", {"entities": []}], ["Nasal allergen challenge is sensitive in the detection of clinical and biological effects of allergen immunotherapy and may be a useful surrogate marker of treatment efficacy in future studies.", {"entities": []}], ["Cancer incidence and mortality in a cohort of 6000 nonsmoking California Seventh-Day Adventists were monitored for a 6-year period, and relationships with long-term cumulative ambient air pollution were observed.", {"entities": [[0, 6, "DISEASE"]]}], ["Total suspended particulates (TSP) and ozone were measured in terms of numbers of hours in excess of several threshold levels corresponding to national standards as well as mean concentration.", {"entities": []}], ["For all malignant neoplasms among females, risk increased with increasing exceedance frequencies of all thresholds of TSP except the lowest one, and those increased risks were highly statistically significant.", {"entities": []}], ["For respiratory cancers, increased risk was associated with only one threshold of ozone, and this result was of borderline significance.", {"entities": []}], ["Respiratory disease symptoms were assessed in 1977 and again in 1987 using the National Heart, Lung and Blood Institute respiratory symptoms questionnaire on a subcohort of 3914 individuals.", {"entities": []}], ["Multivariate analyses which adjusted for past and passive smoking and occupational exposures indicated statistically significantly (p less than 0.05) elevated relative risks ranging up to 1.7 for incidence of asthma, definite symptoms of airway obstructive disease, and chronic bronchitis with TSP in excess of all thresholds except the lowest one but not for any thresholds of ozone.", {"entities": [[209, 215, "DISEASE"], [278, 288, "DISEASE"]]}], ["A trend association (p = 0.056) was noted between the threshold of 10 pphm ozone and incidence of asthma.", {"entities": [[98, 104, "DISEASE"]]}], ["These results are presented within the context of standards setting for these constituents of air pollution.", {"entities": []}], ["Nephrotic syndrome represents a condition in pediatric nephrology typified by a relapsing and remitting course, proteinuria and the presence of edema.", {"entities": [[0, 18, "DISEASE"], [112, 123, "DISEASE"], [10, 18, "DISEASE"]]}], ["The PROMIS measures have previously been studied and validated in cross-sectional studies of children with nephrotic syndrome.", {"entities": [[107, 125, "DISEASE"], [117, 125, "DISEASE"]]}], ["This study was designed to longitudinally validate the PROMIS measures in pediatric nephrotic syndrome.", {"entities": [[84, 102, "DISEASE"], [94, 102, "DISEASE"]]}], ["One hundred twenty seven children with nephrotic syndrome between the ages of 8 and 17\u00a0years participated in this prospective cohort study.", {"entities": [[39, 57, "DISEASE"], [49, 57, "DISEASE"]]}], ["Patients completed a baseline assessment while their nephrotic syndrome was active, a follow-up assessment at the time of their first complete proteinuria remission or study month 3 if no remission occurred, and a final assessment at study month 12.", {"entities": [[53, 71, "DISEASE"], [143, 154, "DISEASE"], [63, 71, "DISEASE"]]}], ["Participants completed six PROMIS measures (Mobility, Fatigue, Pain Interference, Depressive Symptoms, Anxiety, and Peer Relationships), the PedsQL version 4.0, and two global assessment of change items.", {"entities": []}], ["Disease status was classified at each assessment: nephrotic syndrome active in 100% at baseline, 33% at month 3, and 46% at month 12.", {"entities": [[50, 68, "DISEASE"], [60, 68, "DISEASE"]]}], ["The PROMIS domains of Mobility, Fatigue, Pain Interference, Depressive Symptoms, and Anxiety each showed a significant overall improvement over time ( p \u00a0<\u00a00.001).", {"entities": []}], ["When the PROMIS measures were compared to the patients\u2019 global assessment of change, the domains of Mobility, Fatigue, Pain Interference, and Anxiety consistently changed in an expected fashion.", {"entities": []}], ["With the exception of Pain Interference, change in PROMIS domain scores did not correlate with changes in disease activity.", {"entities": []}], ["PROMIS domain scores were moderately correlated with analogous PedsQL domain scores.", {"entities": []}], ["This study demonstrates that the PROMIS Mobility, Fatigue, Pain Interference, and Anxiety domains are sensitive to self-reported changes in disease and overall health status over time in children with nephrotic syndrome.", {"entities": [[201, 219, "DISEASE"], [211, 219, "DISEASE"]]}], ["The lack of significant anchoring to clinically defined nephrotic syndrome disease active and remission status may highlight an opportunity to improve the measurement of HRQOL in children with nephrotic syndrome through the development of a nephrotic syndrome disease-specific HRQOL measure.", {"entities": [[56, 74, "DISEASE"], [193, 211, "DISEASE"], [241, 259, "DISEASE"], [66, 74, "DISEASE"], [203, 211, "DISEASE"], [251, 259, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12955-017-0737-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["B7-H3, a new member of the B7 superfamily, acts as both a T cell costimulator and coinhibitor.", {"entities": []}], ["Recent studies identified B7-H3 plays a critical role in the development of asthma.", {"entities": [[76, 82, "DISEASE"]]}], ["But the definitive mechanism is not clear.", {"entities": []}], ["In this study, we further report that B7-H3 participates in the development of OVA-induced asthma in a murine model.", {"entities": [[91, 97, "DISEASE"]]}], ["And study its mechanism through the vitro and vivo experiment.", {"entities": []}], ["Exogenous administration of B7-H3 strongly amplified the inflammatory response and augmented proinflammatory cytokines in vitro and vivo .", {"entities": []}], ["These B7-H3\u2013associated proinflammatory effects were not dependent on TLR2 signaling, as airway inflammation, eosinophils infiltration and cytokins (IL-4, IL-5, IL-13 and IFN-gamma) augment were still amplified in TLR2-deficient mice after administrated recombinant mouse B7-H3.", {"entities": [[69, 73, "GENE"], [213, 217, "GENE"]]}], ["These results indicated an important role for B7-H3 in the development of Th1 and Th2 cells in a murine model of asthma and its proinflammatory effects are not dependent on TLR2 signaling.", {"entities": [[113, 119, "DISEASE"], [173, 177, "GENE"]]}], ["Multiple sclerosis (MS) is less prevalent among Indians when compared to white populations.", {"entities": []}], ["Genetic susceptibility remaining the same it is possible that environmental associations may have a role in determining disease prevalence.", {"entities": []}], ["To determine whether childhood infections, vaccination status, past infection with Helicobacter pylori ( H .", {"entities": []}], ["pylori ), diet, socioeconomic and educational status were associated with MS. 139 patients and 278 matched control subjects were selected.", {"entities": []}], ["A validated environmental exposure questionnaire was administered.", {"entities": []}], ["Estimation of serum H .", {"entities": []}], ["pylori IgG antibody was done by ELISA.", {"entities": []}], ["Patients and controls were genotyped for HLA-DRB1*15:01.", {"entities": []}], ["In our cohort a significant association was seen with measles ( p <0.007), vegetarian diet ( p < 0.001, higher educational status ( p <0.0001) and urban living ( p <0.0001).", {"entities": [[54, 61, "DISEASE"]]}], ["An inverse relationship was seen with H .", {"entities": []}], ["Pylori infection and MS ( p <0.001).", {"entities": []}], ["Measles infection (OR 6.479, CI 1.21- 34.668, p < 0.029) and high educational status (OR 3.088, CI 1.212- 7.872, p < 0.018) were significant risk factors associated with MS. H .", {"entities": [[0, 7, "DISEASE"]]}], ["pylori infection was inversely related to MS (OR 0.", {"entities": []}], ["319, CI 0.144- 0.706, p <0.005).", {"entities": []}], ["Environmental influences may be important in determining MS prevalence.", {"entities": []}], ["Birt-Hogg-Dub\u00e9 (BHD) syndrome is an autosomal dominant condition characterized by dermatologic lesions, pulmonary manifestations, and renal tumors.", {"entities": [[21, 29, "DISEASE"]]}], ["The syndrome arises from germline mutations in the folliculin (FLCN) gene .", {"entities": [[4, 12, "DISEASE"], [63, 67, "GENE"]]}], ["We present findings from the single largest family BHD cohort described to date.", {"entities": []}], ["Primary objectives were to characterize cystic lung changes on computed tomography (CT) chest scanning and identify features that stratify patients at higher risk of pneumothorax.", {"entities": [[166, 178, "DISEASE"]]}], ["Secondary objectives entailed description of the following: type and natural history of BHD-associated pneumothorax, pulmonary function characteristics, and relationship between cystic lung changes and pulmonary function.", {"entities": [[103, 115, "DISEASE"]]}], ["The study was a retrospective chart review for a case series of a single family.", {"entities": []}], ["Over 70 family members of a proband with documented BHD were identified, 68 of which consented to genetic testing.", {"entities": []}], ["All those with confirmed BHD were offered a clinical assessment by the Medical Genetics and Pulmonary services which included a history, physical exam, complete pulmonary function tests, and computed tomography (CT) scan of the chest and abdomen.", {"entities": []}], ["Thirty-six individuals had a heterozygous mutation in the FLCN gene (c.59delT).", {"entities": [[58, 62, "GENE"]]}], ["Of these, 100\u00a0% (28/28) had pulmonary cysts, 41\u00a0% (13/32) had spontaneous pneumothoraces, 26\u00a0% (8/31) had kidney cysts, 3\u00a0% (1/31) had renal tumors, and 53\u00a0% (18/34) had dermatologic manifestations.", {"entities": []}], ["Recurrent pneumothoraces were common (40\u00a0%).", {"entities": []}], ["Cyst size (OR 3.23, 95\u00a0% CI 1.35\u20137.73) and extent of lower lung zone disease (OR 6.43, 95\u00a0% CI 1.41\u201329.2) were the only findings associated with pneumothorax.", {"entities": [[145, 157, "DISEASE"]]}], ["The size or extent of cystic disease did not correlate with lung function results.", {"entities": []}], ["This is the largest single family cohort of patients with BHD syndrome documented to date.", {"entities": [[62, 70, "DISEASE"]]}], ["We found that all individuals had pulmonary cysts, pneumothoraces were common, and cyst size and lower lobe predominant disease were associated with pneumothorax.", {"entities": [[149, 161, "DISEASE"]]}], ["Lung function was generally preserved and not affected by a high cyst burden.", {"entities": []}], ["Pulmonary involvement is a common complication of vasculitides, especially small vessel vasculitides.", {"entities": []}], ["This review provides an overview of vasculitic manifestations of the lung as well as of other organs involved in vasculitides.", {"entities": []}], ["Furthermore, it provides the diagnostic procedures required to asses a patient with vasculitic lung involvement and gives an overview of current treatment strategies.", {"entities": []}], ["The objective of this review was to summarize findings on aquatic exercise and balneotherapy and to assess the quality of systematic reviews based on randomized controlled trials.", {"entities": []}], ["Studies were eligible if they were systematic reviews based on randomized clinical trials (with or without a meta-analysis) that included at least 1 treatment group that received aquatic exercise or balneotherapy.", {"entities": []}], ["We searched the following databases: Cochrane Database Systematic Review, MEDLINE, CINAHL, Web of Science, JDream II, and Ichushi-Web for articles published from the year 1990 to August 17, 2008.", {"entities": []}], ["We found evidence that aquatic exercise had small but statistically significant effects on pain relief and related outcome measures of locomotor diseases (eg, arthritis, rheumatoid diseases, and low back pain).", {"entities": [[159, 168, "DISEASE"]]}], ["However, long-term effectiveness was unclear.", {"entities": []}], ["Because evidence was lacking due to the poor methodological quality of balneotherapy studies, we were unable to make any conclusions on the effects of intervention.", {"entities": []}], ["There were frequent flaws regarding the description of excluded RCTs and the assessment of publication bias in several trials.", {"entities": []}], ["Two of the present authors independently assessed the quality of articles using the AMSTAR checklist.", {"entities": []}], ["Aquatic exercise had a small but statistically significant short-term effect on locomotor diseases.", {"entities": []}], ["However, the effectiveness of balneotherapy in curing disease or improving health remains unclear.", {"entities": []}], ["Preconception care may be an efficacious tool to reduce risk factors for adverse pregnancy outcomes that are associated with lifestyles and health status before pregnancy.", {"entities": []}], ["We conducted a web-based cohort study in Italian women planning a pregnancy to assess whether a tailored web intervention may change knowledge and behaviours associated with risks for adverse pregnancy outcomes.", {"entities": []}], ["The study was entirely conducted on the web on a cohort of Italian women of childbearing age.", {"entities": []}], ["Data collected at baseline on health status, lifestyles and knowledge of risk factors for adverse pregnancy outcomes were used for generating a tailored document including recommendations for folic acid supplementation, obesity and underweight, smoking, alcohol consumption, vaccinations, chronic and genetic diseases, exposure to medications.", {"entities": [[220, 227, "DISEASE"]]}], ["Prevalence of risk factors and knowledge was assessed 6\u00a0months after the intervention.", {"entities": []}], ["Logistic regression models were used to explore the factors associated with risk factors after the intervention.", {"entities": []}], ["Of the 508 enrolled women, 282 (55.5%) completed the study after 6\u00a0months since the delivery of tailored recommendations.", {"entities": []}], ["At baseline, 48% of the participants took folic acid supplementation (95% CI 43.2; 51.9) and 69% consumed alcohol (95% CI 64.7; 72.9).", {"entities": []}], ["At the follow up 71% of the participants had a preconception visit with a physician.", {"entities": []}], ["Moreover we observed a decrease of alcohol consumption (\u221246.5% 95% CI \u221253.28; \u221238.75) and of the proportion of women not taking folic acid supplementation (\u221223.4% 95% CI \u221231.0; 15.36).", {"entities": []}], ["We observed an improvement in knowledge of the information about the preconception behaviours to prevent adverse pregnancy outcomes (20.9% 95% CI 14.6%; 27.1%).", {"entities": []}], ["Having a preconception visit during follow up was significally associated to an increase in folic acid supplementation (OR 2.53 95% CI 1.40; 4.60).", {"entities": []}], ["Our results suggest that a tailored web intervention may improve general preconception health in women planning a pregnancy.", {"entities": []}], ["A web preconception intervention may be integrated with classic preconception care by health professionals.", {"entities": []}], ["Clinical trials should be conducted to confirm these findings.", {"entities": []}], ["It is estimated that pollen allergies affect approximately 40% of allergic individuals.", {"entities": []}], ["In general, tree pollen allergies are mainly elicited by allergenic trees belonging to the orders Fagales, Lamiales, Proteales, and Pinales.", {"entities": []}], ["Over 25\u00a0years ago, the gene encoding the major birch pollen allergen Bet v 1 was the first such gene to be cloned and its product characterized.", {"entities": []}], ["Since that time, 53 tree pollen allergens have been identified and acknowledged by the WHO / IUIS allergen nomenclature subcommittee.", {"entities": []}], ["Molecule\u2010based profiling of allergic sensitization has helped to elucidate the immunological connections of allergen cross\u2010reactivity, whereas advances in biochemistry have revealed structural and functional aspects of allergenic proteins.", {"entities": []}], ["In this review, we provide a comprehensive overview of the present knowledge of the molecular aspects of tree pollen allergens.", {"entities": []}], ["We analyze the geographic distribution of allergenic trees, discuss factors pivotal for allergic sensitization, and describe the role of tree pollen panallergens.", {"entities": []}], ["Novel allergenic tree species as well as tree pollen allergens are continually being identified, making research in this field highly competitive and instrumental for clinical applications.", {"entities": []}], ["Advancements in mobile phone technology offer huge potential for enhancing the timely delivery of health behavior change interventions.", {"entities": []}], ["The development of smartphone-based health interventions (apps) is a rapidly growing field of research, yet there have been few longitudinal examinations of how people experience and use these apps within their day-to-day routines, particularly within the context of a hybrid Web- and app-based intervention.", {"entities": []}], ["This study used an in-depth mixed-methods design to examine individual variation in (1) impact on self-reported goal engagement (ie, motivation, self-efficacy, awareness, effort, achievement) of access to a weight management app (POWeR Tracker) when provided alongside a Web-based weight management intervention (POWeR) and (2) usage and views of POWeR Tracker.", {"entities": [[225, 228, "GENE"]]}], ["Thirteen adults were provided access to POWeR and were monitored over a 4-week period.", {"entities": []}], ["Access to POWeR Tracker was provided in 2 alternate weeks (ie, weeks 1 and 3 or weeks 2 and 4).", {"entities": []}], ["Participants\u2019 goal engagement was measured daily via self-report.", {"entities": []}], ["Mixed effects models were used to examine change in goal engagement between the weeks when POWeR Tracker was and was not available and whether the extent of change in goal engagement varied between individual participants.", {"entities": []}], ["Usage of POWeR and POWeR Tracker was automatically recorded for each participant.", {"entities": []}], ["Telephone interviews were conducted and analyzed using inductive thematic analysis to further explore participants\u2019 experiences using POWeR and POWeR Tracker.", {"entities": []}], ["Access to POWeR Tracker was associated with a significant increase in participants\u2019 awareness of their eating (\u03b2 1 =0.31, P =.04) and physical activity goals (\u03b2 1 =0.28, P =.03).", {"entities": []}], ["The level of increase varied between individual participants.", {"entities": []}], ["Usage data showed that participants used the POWeR website for similar amounts of time during the weeks when POWeR Tracker was (mean 29 minutes, SD 31 minutes) and was not available (mean 27 minutes, SD 33 minutes).", {"entities": []}], ["POWeR Tracker was mostly accessed in short bursts (mean 3 minutes, SD 2 minutes) during convenient moments or moments when participants deemed the intervention content most relevant.", {"entities": []}], ["The qualitative data indicated that nearly all participants agreed that it was more convenient to access information on-the-go via their mobiles compared to a computer.", {"entities": []}], ["However, participants varied in their views and usage of the Web- versus app-based components and the informational versus tracking tools provided by POWeR Tracker.", {"entities": []}], ["This study provides evidence that smartphones have the potential to improve individuals\u2019 engagement with their health-related goals when used as a supplement to an existing online intervention.", {"entities": []}], ["The perceived convenience of mobile access to information does not appear to deter use of Web-based interventions or strengthen the impact of app access on goal engagement.", {"entities": [[142, 145, "GENE"]]}], ["A mixed-methods design enabled exploration of individual variation in daily usage of the app-based tools.", {"entities": []}], ["The activation of antigen receptors triggers two important signalling pathways originating from phosphatidylinositol(4,5)-bisphosphate [PtdIns(4,5) P 2 ].", {"entities": []}], ["The first is phospholipase C\u03b3 (PLC\u03b3)-mediated hydrolysis of PtdIns(4,5) P 2 , resulting in the activation of Ras, protein kinase C and Ca P 2 to yield phosphatidylinositol(3,4,5)-trisphosphate, activating signalling pathways that overlap with PLC\u03b3 or are PI3K-specific.", {"entities": []}], ["Pathways that are PI3K-specific include Akt-mediated inactivation of Foxo transcription factors and transcription-independent regulation of glucose uptake and metabolism.", {"entities": []}], ["The p110\u03b4 isoform of PI3K is the main source of PI3K activity following antigen recognition by B cells, T cells and mast cells.", {"entities": []}], ["Here, we review the roles of p110\u03b4 in regulating antigen-dependent responses in these cell types.", {"entities": []}], ["The performance of laboratory tests to diagnose pulmonary tuberculosis is dependent on the quality of the sputum sample tested.", {"entities": [[58, 70, "DISEASE"], [48, 70, "DISEASE"]]}], ["The relative merits of sputum collection methods to improve tuberculosis diagnosis are poorly characterised.", {"entities": [[60, 72, "DISEASE"]]}], ["We therefore aimed to investigate the effects of sputum collection methods on tuberculosis diagnosis.", {"entities": [[78, 90, "DISEASE"]]}], ["We did a systematic review and meta-analysis to investigate whether non-invasive sputum collection methods in people aged at least 12 years improve the diagnostic performance of laboratory testing for pulmonary tuberculosis.", {"entities": [[211, 223, "DISEASE"], [201, 223, "DISEASE"]]}], ["We searched PubMed, Google Scholar, ProQuest, Web of Science, CINAHL, and Embase up to April 14, 2017, to identify relevant experimental, case-control, or cohort studies.", {"entities": []}], ["We analysed data by pairwise meta-analyses with a random-effects model and by network meta-analysis.", {"entities": []}], ["All diagnostic performance data were calculated at the sputum-sample level, except where authors only reported data at the individual patient-level.", {"entities": []}], ["Heterogeneity was assessed, with potential causes identified by logistic meta-regression.", {"entities": []}], ["We identified 23 eligible studies published between 1959 and 2017, involving 8967 participants who provided 19\u2008252 sputum samples.", {"entities": []}], ["Brief, on-demand spot sputum collection was the main reference standard.", {"entities": []}], ["Pooled sputum collection increased tuberculosis diagnosis by microscopy (odds ratio [OR] 1\u00b76, 95% CI 1\u00b73\u20131\u00b79, p<0\u00b70001) or culture (1\u00b77, 1\u00b72\u20132\u00b74, p=0\u00b701).", {"entities": [[35, 47, "DISEASE"]]}], ["Providing instructions to the patient before sputum collection, during observed collection, or together with physiotherapy assistance increased diagnostic performance by microscopy (OR 1\u00b76, 95% CI 1\u00b73\u20132\u00b70, p<0\u00b70001).", {"entities": []}], ["Collecting early morning sputum did not significantly increase diagnostic performance of microscopy (OR 1\u00b75, 95% CI 0\u00b79\u20132\u00b76, p=0\u00b72) or culture (1\u00b74, 0\u00b79\u20132\u00b74, p=0\u00b72).", {"entities": []}], ["Network meta-analysis confirmed these findings, and revealed that both pooled and instructed spot sputum collections were similarly effective techniques for increasing the diagnostic performance of microscopy.", {"entities": []}], ["Tuberculosis diagnoses were substantially increased by either pooled collection or by providing instruction on how to produce a sputum sample taken at any time of the day.", {"entities": [[0, 12, "DISEASE"]]}], ["Both interventions had a similar effect to that reported for the introduction of new, expensive laboratory tests, and therefore warrant further exploration in the drive to end the global tuberculosis epidemic.", {"entities": [[187, 199, "DISEASE"]]}], ["Wellcome Trust, Joint Global Health Trials consortium, Innovation For Health and Development, and Bill & Melinda Gates Foundation.", {"entities": []}], ["Systemic lupus erythematosus (SLE) is a multi-system, complex disease in which the environment interacts with inherited genes to produce broad phenotypes with inter-individual variability.", {"entities": [[9, 28, "DISEASE"]]}], ["Of 46 single nucleotide polymorphisms (SNPs) shown to confer genetic risk for SLE in recent genome-wide association studies, 30 lie within noncoding regions of the human genome.", {"entities": []}], ["We therefore sought to identify and describe the functional elements (aside from genes) located within these regions of interest.", {"entities": []}], ["We used chromatin immunoprecipitation followed by sequencing to identify epigenetic marks associated with enhancer function in adult neutrophils to determine whether enhancer-associated histone marks were enriched within the linkage disequilibrium (LD) blocks encompassing the 46 SNPs of interest.", {"entities": []}], ["We also interrogated available data in Roadmap Epigenomics for CD4 All three cell types demonstrated enrichment of enhancer-associated histone marks compared with genomic background within LD blocks encoded by SLE-associated SNPs.", {"entities": [[63, 66, "GENE"]]}], ["In addition, within the promoter regions of these LD blocks, all three cell types demonstrated enrichment for transcription factor binding sites above genomic background.", {"entities": []}], ["In CD19 Much of the genetic risk for SLE lies within or near genomic regions of disease-relevant cells that are enriched for epigenetic marks associated with enhancer function.", {"entities": [[3, 7, "GENE"]]}], ["Elucidating the specific roles of these noncoding elements within these cell-type-specific genomes will be crucial to our understanding of SLE pathogenesis.", {"entities": []}], ["The online version of this article (doi:10.1186/s13075-016-1169-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In general, published studies analyse healthcare utilisation, rather than foregone care, among different population groups.", {"entities": []}], ["The assessment of forgone care as an aspect of healthcare system performance is important because it indicates the gap between perceived need and actual utilisation of healthcare services.", {"entities": []}], ["This study focused on a specific vulnerable group, middle-aged and elderly people with chronic diseases, and evaluated the prevalence of foregone care and associated factors among this population in China.", {"entities": []}], ["Data were obtained from a nationally representative household survey of middle-aged and elderly individuals (\u226545 years), the China Health and Retirement Longitudinal Study, which was conducted by the National School of Development of Peking University in 2013.", {"entities": []}], ["Descriptive statistics were used to analyse sample characteristics and the prevalence of foregone care.", {"entities": []}], ["Andersen\u2019s healthcare utilisation and binary logistic models were used to evaluate the determinants of foregone care among middle-aged and elderly individuals with chronic diseases.", {"entities": []}], ["The prevalence of foregone outpatient and inpatient care among middle-aged and elderly people was 10.21% and 6.84%, respectively, whereas the prevalence of foregone care for physical examinations was relatively high (57.88%).", {"entities": []}], ["Predisposing factors, including age, marital status, employment, education and family size, significantly affected foregone care in this population.", {"entities": []}], ["Regarding enabling factors, individuals in the highest income group reported less foregone inpatient care or physical examinations compared with those in the lowest income group.", {"entities": []}], ["Social healthcare insurance could significantly reduce foregone care in outpatient and inpatient situations; however, these schemes (except for urban employee medical insurance) did not appear to have a significant impact on foregone care involving physical examinations.", {"entities": []}], ["In China, policy-makers may need to further adjust healthcare policies, such as health insurance schemes, and improve the hierarchical medical system, to promote reduction in foregone care and effective utilisation of health services.", {"entities": []}], ["For the detection of allergen-specific IgE in sera, solid-phase IgE-binding assays like the CAP test are commonly used.", {"entities": []}], ["Although such immunochemical methods are very sensitive, they frequently produce false positives.", {"entities": []}], ["Degranulation of the human IgE receptor (Fc\u03b5RI)-transfected rat mast cell (RBL) lines seems to be a possible indicator for human IgE, but spontaneous mediator release from these cells in the presence of human sera is not negligible.", {"entities": []}], ["The nuclear factor of activated T-cells (NFAT)-responsive luciferase reporter gene was stably transfected into human Fc\u03b5RI-expressing RBL-SX38 cells.", {"entities": []}], ["One established clone (RS-ATL8) was sensitized with 1 : 100 dilution of sera from patients with egg white allergy and then stimulated with purified or a crude extract of egg white allergen.", {"entities": []}], ["Sensitization with 15 pg/ml IgE was sufficient to detect IgE crosslinking\u2013induced luciferase expression (EXiLE) by anti-IgE stimulation.", {"entities": []}], ["Allergen-specific EXiLE was elicited by as little as 1 fg/ml of egg white protein without cytotoxicity.", {"entities": []}], ["There was a good correlation between results with EXiLE and oral food challenge tests on patients with egg allergy ( P = 0.001687, Fisher's exact test).", {"entities": [[103, 114, "DISEASE"]]}], ["The measured values of EXiLE and the CAP test also correlated well ( R = 0.9127, Spearman's test).", {"entities": []}], ["The EXiLE test using RS-ATL8 cells is a promising in vitro IgE test to evaluate the biological activity of the binding between IgE and allergens.", {"entities": []}], ["This study aimed to record the use, and knowledge that residents from S\u00e3o Francisco community (Paraiba, Brazil) have regarding the Cactaceae.", {"entities": []}], ["Semi-structured interviews were carried out with 118 informants; 50 men and 68 women.", {"entities": []}], ["The cacti cited in this study were organised into use categories and use values were calculated.", {"entities": []}], ["Differences in the values applied to species and use categories by men and women were compared via a G test (Williams).", {"entities": []}], ["The nine species identified were: Cereus jamacaru DC., Melocactus bahiensis (Brtitton & Rose) Luetzelb., Nopalea cochenillifera (L.) Salm-Dyck., Opuntia ficus indica (L.) Mill, Opuntia stricta (Haw.)", {"entities": []}], ["Haw., Pilosocereus gounellei (F.A.C.", {"entities": []}], ["Weber) Byles & Rowley, Pilosocereus pachycladus F. Ritter, Tacinga inamoena (K. Schum) N.P.", {"entities": []}], ["Taylor & Stuppy, Tacinga palmadora (Britton & Rose) N.P.", {"entities": []}], ["Taylor & Stuppy.", {"entities": []}], ["In total, 1,129 use citations were recorded, divided into 11 categories.", {"entities": []}], ["The use value categories with the highest scores were forage (0.42), food (0.30) and construction (building) (0.25).", {"entities": []}], ["P. pachycladus showed the greatest use value, versatility and number of plant parts used.", {"entities": []}], ["The survey showed that the Cactaceae is extremely important for several uses and categories attributed to different species.", {"entities": []}], ["Apart from contributing to the ethnobotanical knowledge of the Cactaceae, another important focus of this study was to reinforce the necessity for further studies that record the traditional knowledge about this plant family, which has been lost in younger generations.", {"entities": []}], ["Population-based estimates of asthma and allergic rhinitis in sub-Saharan African adults are lacking.", {"entities": [[41, 58, "DISEASE"], [50, 58, "DISEASE"], [30, 36, "DISEASE"]]}], ["We assessed the prevalence and determinants of asthma and allergic rhinitis in urban adult Cameroonians.", {"entities": [[58, 75, "DISEASE"], [67, 75, "DISEASE"], [47, 53, "DISEASE"]]}], ["A community-based survey was conducted from December 2013 to April 2014 among adults aged 19 years and above (N = 2,304, 57.3% women), selected through multilevel stratified random sampling across all districts of Yaounde (Capital city).", {"entities": []}], ["Internationally validated questionnaires were used to investigate the presence of allergic diseases.", {"entities": []}], ["Logistic regressions were employed to investigate the determinants of allergic conditions.", {"entities": []}], ["Prevalence rates were 2.7% (95% CI: 2.1-3.4) for asthma-ever, 6.9% (5.9-7.9) for lifetime wheezing, 2.9% (92.2-3.6) for current wheezing and 11.4% (10.1-12.7) for self-reported lifetime allergic rhinitis; while 240 (10.4%) participants reported current symptoms of allergic rhinitis, and 125 (5.4%) had allergic rhino-conjunctivitis.", {"entities": [[186, 203, "DISEASE"], [265, 282, "DISEASE"], [195, 203, "DISEASE"], [274, 282, "DISEASE"], [318, 332, "DISEASE"], [49, 55, "DISEASE"]]}], ["The prevalence of current asthma medication use and self-reported asthma attack was 0.8 (0.4-1.2) and 1 (0.6-1.4) respectively.", {"entities": [[26, 32, "DISEASE"], [66, 72, "DISEASE"]]}], ["Multivariable adjusted determinants of current wheezing were signs of atopic eczema [2.91 (1.09-7.74)] and signs of allergic rhinitis [3.24 (1.83-5.71)].", {"entities": [[116, 133, "DISEASE"], [125, 133, "DISEASE"]]}], ["Age group 31-40 years [0.27(0.09-0.78), p = 0.016] was an independent protective factor for wheezing.", {"entities": []}], ["Determinants of current rhinitis symptoms were active smoking [2.20 (1.37-3.54), p<0.001], signs of atopic eczema [2.84 (1.48-5.46)] and current wheezing [3.02 (1.70-5.39)].", {"entities": [[24, 32, "DISEASE"]]}], ["Prevalence rates for asthma and allergic rhinitis among adults in this population were at the lower tails of those reported in other regions of the world.", {"entities": [[32, 49, "DISEASE"], [41, 49, "DISEASE"], [21, 27, "DISEASE"]]}], ["Beside the classical interrelation between allergic diseases found in this study, active smoking was an independent determinant of allergic rhinitis symptoms.", {"entities": [[131, 148, "DISEASE"], [140, 148, "DISEASE"]]}], ["Nationwide surveys are needed to investigate regional variations.", {"entities": []}], ["Recent studies have demonstrated marked international variations in the prevalence of asthma, but less is known about ethnic variations in asthma epidemiology within individual countries and in particular the impact of migration on risk of developing asthma.", {"entities": [[86, 92, "DISEASE"], [139, 145, "DISEASE"], [251, 257, "DISEASE"]]}], ["Recent within country comparisons have however revealed that despite originating from areas of the world with a low risk for developing asthma, South Asian and Afro-Caribbean people in the UK are significantly (3\u00d7 and 2\u00d7 respectively) more likely to be admitted to hospital for asthma related problems than Whites.", {"entities": [[136, 142, "DISEASE"], [278, 284, "DISEASE"]]}], ["Using data from the Fourth National Study of Morbidity Statistics in General Practice, a one-percent broadly representative prospective cohort study of consultations in general practice, we investigated ethnic variations in incident asthma consultations (defined as new or first consultations), and compared consultation rates between those born inside and outside the UK (migrant status).", {"entities": [[233, 239, "DISEASE"]]}], ["Logistic regression models were used to examine the combined effects of ethnicity and migration on asthma incident consultations.", {"entities": [[99, 105, "DISEASE"]]}], ["Results showed significantly lower new/first asthma consultation rates for Whites than for each of the ethnic minority groups studied (mean age-adjusted consultation rates per 1000 patient-years: Whites 26.4 (95%CI 26.4, 26.4); South Asians 30.4 (95%CI 30.3, 30.5); Afro-Caribbeans 35.1 (95%CI 34.9, 35.3); and Others 27.8 (27.7, 28.0).", {"entities": [[45, 51, "DISEASE"]]}], ["Within each of these ethnic groups, those born outside of the UK showed consistently lower rates of incident asthma consultations.", {"entities": [[109, 115, "DISEASE"]]}], ["Modelling the combined effects of ethnic and migrant status revealed that UK-born South Asians and Afro-Caribbeans experienced comparable risks for incident GP consultations for asthma to UK-born Whites.", {"entities": [[178, 184, "DISEASE"]]}], ["Non-UK born Whites however experienced reduced risks (adjusted OR 0.82, 95%CI 0.69, 0.97) whilst non-UK born South Asians experienced increased risks (adjusted OR 1.33, 95%CI 1.04, 1.70) compared to UK-born Whites.", {"entities": []}], ["These findings strongly suggest that ethnicity and migration have significant and independent effects on asthma incidence.", {"entities": [[105, 111, "DISEASE"]]}], ["The known poorer asthma outcomes in UK South Asians and Afro-Caribbeans may in part be explained by the offspring of migrants experiencing an increased risk of developing asthma when compared to UK-born Whites.", {"entities": [[17, 23, "DISEASE"], [171, 177, "DISEASE"]]}], ["This is the first study to find heterogeneity for incident asthma consultations in Whites by migrant status.", {"entities": [[59, 65, "DISEASE"]]}], ["Prostaglandins E2 (PGE2) has been shown to enhance IgE production by B cells in vitro .", {"entities": []}], ["The physiological and pathological relevance of this phenomenon and the underlying molecular mechanism, however, remain to be elucidated.", {"entities": []}], ["B cells from wild type and EP2-deficient mice were compared in culture for their responses to PGE2 in terms of IgE class switching and production.", {"entities": []}], ["Ovalbumin (OVA)-induced asthma models were used to evaluate the impact of EP2-deficiency on IgE responses and the development of asthma.", {"entities": [[24, 30, "DISEASE"], [129, 135, "DISEASE"]]}], ["PGE2 promoted IgE class switching, generation of IgE in vitro data, EP2-deficient mice showed a markedly suppressed IgE antibody response and developed less pronounced airway inflammation in the OVA-induced asthma model.", {"entities": [[207, 213, "DISEASE"]]}], ["Mechanistic studies demonstrated that PGE2, in an EP2-depedent manner, enhanced STAT6 activation induced by IL-4, thereby promoting the expression of IgE germline and post switch transcripts and the transcription of activation-induced cytidine deaminase (AID).", {"entities": [[80, 85, "GENE"]]}], ["Collectively, these data support an important regulatory role of the PGE2-EP2-STAT6 signaling pathway in IgE response and allergic diseases.", {"entities": []}], ["Cyanate is formed mostly during nonenzymatic urea biodegradation.", {"entities": []}], ["Its active form isocyanate reacts with protein \u2013NH 2 and \u2013SH groups, which changes their structure and function.", {"entities": []}], ["The present studies aimed to investigate the effect of cyanate on activity of the enzymes, which possess \u2013SH groups in the active centers and are implicated in anaerobic cysteine transformation and cyanide detoxification, as well as on glutathione level and peroxidative processes in different brain structures of the rat: cortex, striatum, hippocampus, and substantia nigra.", {"entities": []}], ["In addition, we examined whether a concomitant treatment with lipoate, a dithiol that may act as a target of S-carbamoylation, can prevent these changes.", {"entities": []}], ["Cyanate-inhibited sulfurtransferase activities and lowered sulfide level, which was accompanied by a decrease in glutathione concentration and elevation of reactive oxygen species level in almost all rat brain structures.", {"entities": []}], ["Lipoate administered in combination with cyanate was able to prevent the above-mentioned negative cyanate-induced changes in a majority of the examined brain structures.", {"entities": []}], ["These observations can be promising for chronic renal failure patients since lipoate can play a double role in these patients contributing to efficient antioxidant defense and protection against cyanate and cyanide toxicity.", {"entities": []}], ["Helicobacter pylori colonizes half of the world\u2019s population as the dominant member of the gastric microbiota resulting in a lifelong chronic infection.", {"entities": []}], ["Host responses toward the bacterium can result in asymptomatic, pathogenic or even favorable health outcomes; however, mechanisms underlying the dual role of H .", {"entities": []}], ["pylori as a commensal versus pathogenic organism are not well characterized.", {"entities": []}], ["Recent evidence suggests mononuclear phagocytes are largely involved in shaping dominant immunity during infection mediating the balance between host tolerance and succumbing to overt disease.", {"entities": []}], ["We combined computational modeling, bioinformatics and experimental validation in order to investigate interactions between macrophages and intracellular H .", {"entities": []}], ["Global transcriptomic analysis on bone marrow-derived macrophages (BMDM) in a gentamycin protection assay at six time points unveiled the presence of three sequential host response waves: an early transient regulatory gene module followed by sustained and late effector responses.", {"entities": []}], ["Kinetic behaviors of pattern recognition receptors (PRRs) are linked to differential expression of spatiotemporal response waves and function to induce effector immunity through extracellular and intracellular detection of H .", {"entities": []}], ["We report that bacterial interaction with the host intracellular environment caused significant suppression of regulatory NLRC3 and NLRX1 in a pattern inverse to early regulatory responses.", {"entities": [[122, 127, "GENE"], [132, 137, "GENE"]]}], ["To further delineate complex immune responses and pathway crosstalk between effector and regulatory PRRs, we built a computational model calibrated using time-series RNAseq data.", {"entities": []}], ["Our validated computational hypotheses are that: 1) NLRX1 expression regulates bacterial burden in macrophages; and 2) early host response cytokines down-regulate NLRX1 expression through a negative feedback circuit.", {"entities": [[52, 57, "GENE"], [163, 168, "GENE"], [52, 57, "GENE"], [163, 168, "GENE"]]}], ["This paper applies modeling approaches to characterize the regulatory role of NLRX1 in mechanisms of host tolerance employed by macrophages to respond to and/or to co-exist with intracellular H .", {"entities": [[78, 83, "GENE"]]}], ["To investigate how attitudes and beliefs about exercise relate to physical activity behavior in older adults with knee pain attributable to osteoarthritis (OA).", {"entities": [[140, 154, "DISEASE"]]}], ["We conducted secondary data analyses of a randomized controlled trial of exercise interventions (ISRCTN: 93634563).", {"entities": []}], ["Participants were adults \u226545 years old with knee pain attributable to OA (n\u2009=\u2009514).", {"entities": []}], ["Crude and adjusted cross\u2010sectional and longitudinal associations between baseline Self\u2010Efficacy for Exercise (SEE), Positive Outcome Expectations for Exercise (POEE), Negative Outcome Expectations for Exercise scores, and physical activity level, at baseline, 3 months, and 6 months (measured by self\u2010report using the Physical Activity Scale for the Elderly [PASE]), and important increases in physical activity level (from baseline to 6\u2010month followup) were investigated using multiple linear and logistic regression.", {"entities": []}], ["Cross\u2010sectional associations were found between SEE and PASE scores (\u03b2\u2009=\u20094.14 [95% confidence interval (95% CI) 0.26, 8.03]) and POEE and PASE scores (\u03b2\u2009=\u200916.71 [95% CI 1.87, 31.55]), adjusted for sociodemographic and clinical covariates.", {"entities": []}], ["Longitudinal associations were found between baseline SEE and PASE scores at 3 months (\u03b2\u2009=\u20094.95 [95% CI 1.02, 8.87]) and 6 months \u03b2\u2009=\u20093.71 (0.26, 7.16), and baseline POEE and PASE at 3 months (\u03b2\u2009=\u200934.55 [95% CI 20.13, 48.97]) and 6 months (\u03b2\u2009=\u200925.74 [95% CI 11.99, 39.49]), adjusted for baseline PASE score and intervention arm.", {"entities": []}], ["However, no significant associations with important increases in physical activity level were found.", {"entities": []}], ["Greater exercise self\u2010efficacy and more positive exercise outcome expectations were associated with higher current and future physical activity levels.", {"entities": []}], ["These may be targets for interventions aimed at increasing physical activity.", {"entities": []}], ["Prioritising scarce resources for investment in innovation by publically funded health systems is unavoidable.", {"entities": []}], ["Many healthcare systems wish to foster transparency and accountability in the decisions they make by incorporating the public in decision-making processes.", {"entities": []}], ["This paper presents a unique conceptual approach exploring the public\u2019s preferences for health service innovations by viewing healthcare innovations as \u2018bundles\u2019 of characteristics.", {"entities": []}], ["This decompositional approach allows policy-makers to compare numerous competing health service innovations without repeatedly administering surveys for specific innovation choices.", {"entities": []}], ["A Discrete Choice Experiment (DCE) was used to elicit preferences.", {"entities": []}], ["Individuals chose from presented innovation options that they believe the UK National Health Service (NHS) should invest the most in.", {"entities": [[102, 105, "GENE"]]}], ["Innovations differed according to: (i) target population; (ii) target age; (iii) implementation time; (iv) uncertainty associated with their likely effects; (v) potential health benefits; and, (vi) cost to a taxpayer.", {"entities": []}], ["This approach fosters multidimensional decision-making, rather than imposing a single decision criterion (e.g., cost, target age) in prioritisation.", {"entities": []}], ["Choice data was then analysed using scale-adjusted Latent Class models to investigate variability in preferences and scale and valuations amongst respondents.", {"entities": []}], ["Three latent classes with considerable heterogeneity in the preferences were present.", {"entities": []}], ["Each latent class is composed of two consumer subgroups varying in the level of certainty in their choices.", {"entities": []}], ["All groups preferred scientifically proven innovations, those with potential health benefits that cost less.", {"entities": []}], ["There were, however, some important differences in their preferences for innovation investment choices: Class-1 (54%) prefers innovations benefitting adults and young people and does not prefer innovations targeting people with \u2018drug addiction\u2019 and \u2018obesity\u2019.", {"entities": [[250, 257, "DISEASE"]]}], ["Class- 2 (34%) prefers innovations targeting \u2018cancer\u2019 patients only and has negative preferences for innovations targeting elderly, and Class-3 (12%) prefers spending on elderly and cancer patients the most.", {"entities": [[46, 52, "DISEASE"], [182, 188, "DISEASE"]]}], ["DCE can help policy-makers incorporate public preferences for health service innovation investment choices into decision making.", {"entities": []}], ["The findings provide useful information on the public\u2019s valuation and acceptability of potential health service innovations.", {"entities": []}], ["Such information can be used to guide innovation prioritisation decisions by comparing competing innovation options.", {"entities": []}], ["The approach in this paper makes, these often implicit and opaque decisions, more transparent and explicit.", {"entities": []}], ["The endoplasmic reticulum (ER) is an essential organelle that contributes to several key cellular functions, including lipogenesis, gluconeogenesis, calcium storage, and organelle biogenesis.", {"entities": []}], ["The ER also serves as the major site for protein folding and trafficking, especially in specialized secretory cells.", {"entities": []}], ["Accumulation of misfolded proteins and failure of ER adaptive capacity activates the unfolded protein response (UPR) which has been implicated in several chronic diseases, including cancer.", {"entities": [[182, 188, "DISEASE"]]}], ["A number of recent studies have implicated UPR in prostate cancer (PCa) and greatly expanded our understanding of this key stress signaling pathway and its regulation in PCa.", {"entities": [[59, 65, "DISEASE"], [50, 65, "DISEASE"]]}], ["Here we summarize these developments and discuss their potential therapeutic implications.", {"entities": []}], ["First trimester pregnancy is defined as twelve weeks after the last menstrual period.", {"entities": []}], ["Ultrasonography has revolutionized validation and management of first trimester pregnancies.", {"entities": []}], ["The aim was to analyze ultrasonographic findings of first trimester pregnancies in University of Uyo teaching hospital (UUTH), Uyo, Nigeria.", {"entities": []}], ["The departmental ultrasonographic records of pregnant women who were referred to Radiology department of UUTH, Uyo, Nigeria.", {"entities": []}], ["For ultrasound scans were retrospectively reviewed.", {"entities": []}], ["The period under consideration was from 8 26.4% (n-645) of the 2438 pregnant women who underwent obstetric ultrasonography had first trimester ultrasonography during the studied period.", {"entities": []}], ["The peak frequency was seen in the 20-29 age range with 52.2% (n-337) and followed by 30-39 age range with 41.7% (n-269).", {"entities": []}], ["The commonest first trimester ultrasound findings was viable pregnancy with 42.5% (n-274), followed by incomplete miscarriage with 34.3% (n-221).", {"entities": []}], ["The least finding was trophoblastic pregnancies 0.3% (n-2).", {"entities": []}], ["The earliest age at which normal viable pregnancy was diagnosed in this study was 5weeks 5days from the last menstrual period.", {"entities": []}], ["Only 2.19% (n-6) of the normal viable pregnancies were multiple pregnancies and they were all twins.", {"entities": []}], ["The highest number of referrals to Radiology Department for first trimester ultrasonography was from accident and emergency unit with 34.42% (n-222) while antenatal clinic referral was only 16.12% (n-104).", {"entities": []}], ["The commonest first trimester\u2019s obstetric ultrasonographic findings in Uyo, Nigeria are viable pregnancies and are predominantly single gestation.", {"entities": []}], ["The earliest age of ultasonographic pregnancy detection in Uyo is 5week 5days and peak maternal age is second and third decades.", {"entities": []}], ["Locally advanced non\u2010small\u2010cell lung cancer (NSCLC) is a common disease with a low overall survival even with aggressive treatments.", {"entities": [[32, 43, "DISEASE"], [37, 43, "DISEASE"]]}], ["Standard imaging (CT and PET/CT) provide no information about normal lung function.", {"entities": []}], ["We therefore, sought to pilot HeMRI in patients with non\u2010small\u2010cell lung cancer before and after definitive radiotherapy (RT).", {"entities": [[68, 79, "DISEASE"], [73, 79, "DISEASE"]]}], ["Five patients with NSCLC receiving RT were enrolled on a prospective IRB approved study.", {"entities": []}], ["Patients underwent CT, FDG\u2010PET and HeMRI before and (within 10 days) following RT.", {"entities": []}], ["All images (CT, FDG\u2010PET and HeMRI) were co\u2010registered.", {"entities": []}], ["The CT and PET GTVs were contoured, as well as the ventilation defects on HeMRI caused by the tumor.", {"entities": []}], ["Patients also underwent pulmonary function tests (PFTs).", {"entities": []}], ["Correlations between the images and PFTs were evaluated by linear regression.", {"entities": []}], ["CT and FDG\u2010PET tumor volumes were highly correlated ( r 2 = 0.91 before treatment and 0.99 following RT).", {"entities": []}], ["There was less correlation between HeMRI and CT or PET ( r 2 = 0.67 (CT) and 0.38 (PET)) prior to treatment and 0.27 following RT).", {"entities": []}], ["However, HeMRI volumes correlated very well with FEV1, both prior to and following RT.", {"entities": []}], ["( r 2 = 0.89 and 0.83, respectively).", {"entities": []}], ["3 Helium MRI scanning is feasible in NSCLC before and after treatment.", {"entities": []}], ["HeMRI provides important functional information in addition to CT and CT/PET scanning.", {"entities": []}], ["PACS number: 87.55.D\u2010", {"entities": []}], ["The low body mass index (BMI) phenotype of less than 18.5 has been linked to medical and psychological morbidity as well as increased mortality risk.", {"entities": []}], ["Although genetic factors have been shown to influence BMI across the entire BMI, the contribution of genetic factors to the low BMI phenotype is unclear.", {"entities": []}], ["We hypothesized genetic factors would contribute to risk of a low BMI phenotype.", {"entities": []}], ["To test this hypothesis, we conducted a genealogy data analysis using height and weight measurements from driver's license data from the Utah Population Data Base.", {"entities": []}], ["The Genealogical Index of Familiality (GIF) test and relative risk in relatives were used to examine evidence for excess relatedness among individuals with the low BMI phenotype.", {"entities": []}], ["The overall GIF test for excess relatedness in the low BMI phenotype showed a significant excess over expected (GIF 4.47 for all cases versus 4.10 for controls, overall empirical p-value<0.001).", {"entities": []}], ["The significant excess relatedness was still observed when close relationships were ignored, supporting a specific genetic contribution rather than only a family environmental effect.", {"entities": []}], ["This study supports a specific genetic contribution in the risk for the low BMI phenotype.", {"entities": []}], ["Better understanding of the genetic contribution to low BMI holds promise for weight regulation and potentially for novel strategies in the treatment of leanness and obesity.", {"entities": [[166, 173, "DISEASE"]]}], ["Background: Air pollution epidemiologic studies, often conducted in large metropolitan areas because of proximity to regulatory monitors, are limited in their ability to examine potential associations between air pollution exposures and health effects in rural locations.", {"entities": []}], ["Methods: Using a time-stratified case-crossover framework, we examined associations between asthma emergency department (ED) visits in North Carolina (2006\u20132008), collected by a surveillance system, and short-term ozone (O 3 ) exposures using predicted concentrations from the Community Multiscale Air Quality (CMAQ) model.", {"entities": [[92, 98, "DISEASE"]]}], ["We estimated associations by county groupings based on four urbanicity classifications (representative of county size and urban proximity) and county health.", {"entities": []}], ["Results: O 3 was associated with asthma ED visits in all-year and warm season (April\u2013October) analyses [odds ratio (OR) = 1.019; 95% CI: 0.998, 1.040; OR = 1.020; 95% CI: 0.997, 1.044, respectively, for a 20-ppb increase in lag 0\u20132 days O 3 ].", {"entities": [[33, 39, "DISEASE"]]}], ["The association was strongest in Less Urbanized counties, with no evidence of a positive association in Rural counties.", {"entities": []}], ["Associations were similar when adjusted for fine particulate matter in copollutant models.", {"entities": []}], ["Associations were stronger for children (5\u201317 years of age) compared with other age groups, and for individuals living in counties identified with poorer health status compared with counties that had the highest health rankings, although estimated associations for these subgroups had larger uncertainty.", {"entities": []}], ["Conclusions: Associations between short-term O 3 exposures and asthma ED visits differed by overall county health and urbanicity, with stronger associations in Less Urbanized counties, and no positive association in Rural counties.", {"entities": [[63, 69, "DISEASE"]]}], ["Results also suggest that children are at increased risk of O 3 -related respiratory effects.", {"entities": []}], ["Citation: Sacks JD, Rappold AG, Davis JA Jr, Richardson DB, Waller AE, Luben TJ.", {"entities": []}], ["Influence of urbanicity and county characteristics on the association between ozone and asthma emergency department visits in North Carolina.", {"entities": [[88, 94, "DISEASE"]]}], ["Environ Health Perspect 122:506\u2013512;\u2002 http://dx.doi.org/10.1289/ehp.1306940", {"entities": []}], ["The occurrence of numerous cases of interstitial lung disease in children (chILD) every spring in Korea starting in 2006 raised suspicion about a causal relationship with the use of humidifier disinfectants (HDs).", {"entities": [[36, 61, "DISEASE"], [49, 61, "DISEASE"]]}], ["The aim of this study was to evaluate the association between HD use and the risk of chILD.", {"entities": []}], ["This retrospective, 1\u22363 matched case-control study consisted of 16 cases of chILD that had developed between 2010 and 2011.", {"entities": []}], ["The three groups of parallel controls (patients with acute lobar pneumonia, asthma, and healthy children) were matched by age, gender, and index date.", {"entities": [[65, 74, "DISEASE"], [76, 82, "DISEASE"]]}], ["Indoor/outdoor environmental risk factors, including HD use, were investigated by asking the guardians to complete a questionnaire.", {"entities": []}], ["The median age of the affected children (43.8% male) was 26 months (18.25\u201336.25).", {"entities": []}], ["The chILD group did not differ significantly from the control groups with respect to socio-demographic and clinical variables.", {"entities": []}], ["Indoor and outdoor environmental factors were not associated with a risk of chILD.", {"entities": []}], ["However, the previous use of HDs (OR; 2.73.", {"entities": []}], ["95% CI; 1.41\u20135.90, P \u200a=\u200a0.00) were independently associated with an increased risk.", {"entities": []}], ["This study showed that HDs, which are widely used in South Korea in the winter season, independently increased the risk of chILD in spring.", {"entities": []}], ["Therefore, continuous monitoring and, if needed, changes in policy are essential to prevent and control pediatric diseases caused by toxic chemicals.", {"entities": []}], ["The purpose of this study was to investigate autonomic nervous system dysfunction by measuring pupil sizes in pediatric patients with allergic rhinitis.", {"entities": [[134, 151, "DISEASE"], [143, 151, "DISEASE"]]}], ["The study group consisted of 60 children (28 girls and 32 boys) who were age and gender matched with the control group, which also consisted of 60 children (26 girls and 34 boys).", {"entities": []}], ["The diagnosis of allergic rhinitis was based on the history, physical examination and skin prick test performed by an allergologist.", {"entities": [[17, 34, "DISEASE"], [26, 34, "DISEASE"]]}], ["Pupil diameter measurements were performed using the pupillometer incorporated in the N\u0130DEK OPD-Scan.", {"entities": []}], ["In the allergic rhinitis group, mean photopic and mesopic pupil diameters were 3.52 \u00b1 0.07 and 5.98 \u00b1 0.21, respectively, while in the control group, corresponding measurements were 4.03 \u00b1 0.18 and 6.55 \u00b1 0.16.", {"entities": [[7, 24, "DISEASE"], [16, 24, "DISEASE"]]}], ["There was a significant difference for photopic and mesopic pupil diameter between the groups (p < 0.001).", {"entities": []}], ["This study showed that the pupil size in response to a light stimulus in children with allergic rhinitis was smaller than that of the control group and may indicate parasympathetic hyperactivity and sympathetic hypoactivity.", {"entities": [[87, 104, "DISEASE"], [96, 104, "DISEASE"]]}], ["A variety of different approaches to the synthesis of qualitative data are advocated in the literature.", {"entities": []}], ["The aim of this paper is to describe the application of a pragmatic method of qualitative evidence synthesis and the lessons learned from adopting this \"best fit\" framework synthesis approach.", {"entities": []}], ["An evaluation of framework synthesis as an approach to the qualitative systematic review of evidence exploring the views of adults to the taking of potential agents within the context of the primary prevention of colorectal cancer.", {"entities": [[213, 230, "DISEASE"], [224, 230, "DISEASE"]]}], ["Twenty papers from North America, Australia, the UK and Europe met the criteria for inclusion.", {"entities": []}], ["Fourteen themes were identified a priori from a related, existing conceptual model identified in the literature, which were then used to code the extracted data.", {"entities": []}], ["Further analysis resulted in the generation of a more sophisticated model with additional themes.", {"entities": []}], ["The synthesis required a combination of secondary framework and thematic analysis approaches and was conducted within a health technology assessment timeframe.", {"entities": []}], ["The novel and pragmatic \"best fit\" approach to framework synthesis developed and described here was found to be fit for purpose.", {"entities": []}], ["Future research should seek to test further this approach to qualitative data synthesis.", {"entities": []}], ["Chemotaxis, a directional cell migration guided by extracellular chemoattractant gradients, plays an essential role in the recruitment of neutrophils to sites of inflammation.", {"entities": []}], ["Chemotaxis is mediated by the G protein-coupled receptor (GPCR) signaling pathway.", {"entities": []}], ["Extracellular stimuli trigger activation of the PLC/PKC/PKD signaling axis, which controls several signaling pathways.", {"entities": []}], ["Here, we concentrate on the novel functions of PLC/PKC/PKD signaling in GPCR-mediated chemotaxis of neutrophils.", {"entities": []}], ["Despite the limited genetic heterogeneity of Spanish populations, substantial evidences support that historical African influences have not affected them uniformly.", {"entities": []}], ["Accounting for such population differences might be essential to reduce spurious results in association studies of genetic factors with disease.", {"entities": []}], ["Using ancestry informative markers (AIMs), we aimed to measure the African influences in Spanish populations and to explore whether these might introduce statistical bias in population-based association studies.", {"entities": []}], ["We genotyped 93 AIMs in Spanish (from the Canary Islands and the Iberian Peninsula) and Northwest Africans, and conducted population and individual-based clustering analyses along with reference data from the HapMap, HGDP-CEPH, and other sources.", {"entities": []}], ["We found significant differences for the Northwest African influence among Spanish populations from as low as \u22485% in Spanish from the Iberian Peninsula to as much as \u224817% in Canary Islanders, whereas the sub-Saharan African influence was negligible.", {"entities": []}], ["Strikingly, the Northwest African ancestry showed a wide inter-individual variation in Canary Islanders ranging from 0% to 96%, reflecting the violent way the Islands were conquered and colonized by the Spanish in the XV century.", {"entities": []}], ["As a consequence, a comparison of allele frequencies between Spanish samples from the Iberian Peninsula and the Canary Islands evidenced an excess of markers with significant differences.", {"entities": []}], ["However, the inflation of p -values for the differences was adequately controlled by correcting for genetic ancestry estimates derived from a reduced number of AIMs.", {"entities": []}], ["Although the African influences estimated might be biased due to marker ascertainment, these results confirm that Northwest African genetic footprints are recognizable nowadays in the Spanish populations, particularly in Canary Islanders, and that the uneven African influences existing in these populations might increase the risk for false positives in association studies.", {"entities": []}], ["Adjusting for population stratification assessed with a few dozen AIMs would be sufficient to control this effect.", {"entities": []}], ["In vivo detection and quantification of inflammation is a major goal in molecular imaging.", {"entities": []}], ["Furthermore, cell-specific detection of inflammation would be a tremendous advantage in the characterization of many diseases.", {"entities": []}], ["Here, we show how this goal can be achieved through the synergistic combination of nanotechnology and nuclear imaging.", {"entities": []}], ["One of the most remarkable features of this hybrid approach is the possibility to tailor the pharmacokinetics of the nanomaterial-incorporated biomolecule and radionuclide.", {"entities": []}], ["A good example of this approach is the covalent binding of a large amount of a neutrophil-specific, hydrophobic peptide on the surface of in vivo detection of acute inflammation with very high in vivo labelling efficiency, i.e.", {"entities": []}], ["a large percentage of labelled neutrophils.", {"entities": []}], ["Furthermore, we demonstrate that the tracer is neutrophil-specific and yields images of neutrophil recruitment of unprecedented quality.", {"entities": []}], ["Finally, the nano-radiotracer was successfully detected in chronic inflammation in atherosclerosis-prone ApoE", {"entities": [[83, 98, "DISEASE"], [105, 109, "GENE"]]}], ["Effective treatment of Mycobacterium tuberculosis ( Mtb ) infection requires at least 6\u00a0months of daily therapy with multiple orally administered antibiotics.", {"entities": [[37, 49, "DISEASE"]]}], ["Although this drug regimen is administered annually to millions worldwide, the impact of such intensive antimicrobial treatment on the host microbiome has never been formally investigated.", {"entities": []}], ["Here, we characterized the longitudinal outcome of conventional isoniazid-rifampin-pyrazinamide (HRZ) TB drug administration on the diversity and composition of the intestinal microbiota in Mtb -infected mice by means of 16S rRNA sequencing.", {"entities": []}], ["We also investigated the effects of each of the individual antibiotics alone and in different combinations.", {"entities": []}], ["While inducing only a transient decrease in microbial diversity, HRZ treatment triggered a marked, immediate and reproducible alteration in community structure that persisted for the entire course of therapy and for at least 3\u00a0months following its cessation.", {"entities": []}], ["Members of order Clostridiales were among the taxa that decreased in relative frequencies during treatment and family Porphyromonadaceae significantly increased post treatment.", {"entities": []}], ["Experiments comparing monotherapy and different combination therapies identified rifampin as the major driver of the observed alterations induced by the HRZ cocktail but also revealed unexpected effects of isoniazid and pyrazinamide in certain drug pairings.", {"entities": []}], ["This report provides the first detailed analysis of the longitudinal changes in the intestinal microbiota due to anti-tuberculosis therapy.", {"entities": [[118, 130, "DISEASE"]]}], ["Importantly, many of the affected taxa have been previously shown in other systems to be associated with modifications in immunologic function.", {"entities": []}], ["Together, our findings reveal that the antibiotics used in conventional TB treatment induce a distinct and long lasting dysbiosis.", {"entities": []}], ["In addition, they establish a murine model for studying the potential impact of this dysbiosis on host resistance and physiology.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-017-0286-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["With great interest we read the article by Kelly et al.", {"entities": []}], ["on the measurement of physical activity (PA) and sedentary behavior (SB) (Kelly P et al.", {"entities": []}], ["Int J Behav Nutr Phys Act 13:(1) 32, 2016).", {"entities": []}], ["We appreciate the invitation of the authors to provide feedback on their ideas and we take this opportunity to contribute to the discussion.", {"entities": []}], ["Our main proposition is that this field can learn much from the field of quality of life research and the methodology developed for validating quality of life questionnaires.", {"entities": []}], ["In 2014, the International Study of Asthma and Allergies in Childhood (ISAAC) reported that the highest prevalence of symptoms of severe asthma was found in the low- and middle-income countries (LMICs), including Nigeria.", {"entities": [[36, 42, "DISEASE"], [137, 143, "DISEASE"]]}], ["While exposure to biomass fuel use may be an important risk factor in the development of asthma, its association with asthma symptoms severity has not been well-established.", {"entities": [[89, 95, "DISEASE"], [118, 124, "DISEASE"]]}], ["The aim of this study is to extend the spectrum of environmental risk factors that may be contributing towards increasing asthma morbidity, especially asthma symptoms severity in rural schoolchildren in Nigeria and to examine possible asthma underdiagnosis among this population.", {"entities": [[122, 128, "DISEASE"], [151, 157, "DISEASE"], [235, 241, "DISEASE"]]}], ["Authors conducted a cross-sectional survey in three rural communities in Nigeria.", {"entities": []}], ["Asthma symptoms were defined according to the ISAAC criteria.", {"entities": [[0, 6, "DISEASE"]]}], ["Information on the types of household fuel used for cooking was used to determine household cooking fuel status.", {"entities": []}], ["Asthma symptoms severity was defined based on frequencies of wheeze, day- and night-time symptoms, and speech limitations.", {"entities": [[0, 6, "DISEASE"]]}], ["Logistic regression analyses were used to explore associations.", {"entities": []}], ["A total of 1,690 Nigerian schoolchildren participated in the study.", {"entities": []}], ["Overall, 37 (2.2%) had diagnosed asthma and 413 (24.4%) had possible asthma (asthma-related symptoms but not diagnosed asthma).", {"entities": [[33, 39, "DISEASE"], [69, 75, "DISEASE"], [77, 83, "DISEASE"], [119, 125, "DISEASE"]]}], ["Children from biomass fuel households had higher proportion of possible asthma (27.7 vs. 22.2%; p \u2009<\u20090.05) and symptoms of severe asthma (18.2 vs. 7.6%; p \u2009=\u20090.048).", {"entities": [[72, 78, "DISEASE"], [130, 136, "DISEASE"]]}], ["In adjusted analyses, biomass fuel use was associated with increased odds of severe symptoms of asthma [odds ratios (OR)\u2009=\u20092.37; 95% CI: 1.16\u20134.84], but not with possible asthma (OR\u2009=\u20091.22; 95% CI: 0.95\u20131.56).", {"entities": [[96, 102, "DISEASE"], [171, 177, "DISEASE"]]}], ["In rural Nigerian children with asthma symptoms, the use of biomass fuel for cooking is associated with an increased risk of severe asthma symptoms.", {"entities": [[32, 38, "DISEASE"], [132, 138, "DISEASE"]]}], ["There is additional evidence that rural children might be underdiagnosed for asthma.", {"entities": [[77, 83, "DISEASE"]]}], ["In elderly asthmatics, underdiagnosis is one of the important features.", {"entities": []}], ["The main reason for underdiagnosis is thought to be a low frequency in complaining of symptoms due to the reduction of intellectual recognition and physical activity.", {"entities": []}], ["Among the various symptoms, wheezing is the principal due in diagnosing bronchial asthma, and decreased complaints for wheezing are also noted in elderly asthmatics.", {"entities": [[82, 88, "DISEASE"]]}], ["The objective of this study is to determine if less complaints of wheezing in elderly asthmatic is due to a decrease in the development of wheezing.", {"entities": []}], ["61 young (20\u201339 years old), 68 middle-aged (40\u201359 years old) and 65 elderly (older than 60 years old) stable asthmatic subjects were studied (each group shall be called, hereafter, Young Group, Middle-aged Group and Old Group, respectively).", {"entities": []}], ["During the methacholine induced airway narrowing, lung auscultation and questionnaire survey about presence and perception of wheezing were conducted in 194 asthmatics.", {"entities": []}], ["One hundred and sixty-nine patients (87%) developed wheezing during the methacholine induced airway obstruction.", {"entities": []}], ["The frequency of wheezing during the methacholine challenge was found to be comparable among the groups.", {"entities": []}], ["The methacholine concentration, % fall in FEV1, and FEV1 levels of the initial detection of wheezing were not different among the groups.", {"entities": []}], ["Among the patients who developed wheezing, 47 patients (77%), 42 patients (61.8%) and 26 patients (40%) complained of wheezing in Young, Middle and Old Group, respectively.", {"entities": []}], ["In conclusion, the decreased perception of wheezing is a main factor for the low frequency of complaints of wheezing in elderly asthmatics.", {"entities": []}], ["Treatment of depression, the most prevalent and costly mental disorder, needs to be improved.", {"entities": []}], ["Non-concordance with clinical guidelines and non-adherence can limit the efficacy of pharmacological treatment of depression.", {"entities": []}], ["Through pharmaceutical care, pharmacists can improve patients' compliance and wellbeing.", {"entities": []}], ["The aim of this study is to evaluate the effectiveness and cost-effectiveness of a community pharmacist intervention developed to improve adherence and outcomes of primary care patients with depression.", {"entities": []}], ["A randomized controlled trial, with 6-month follow-up, comparing patients receiving a pharmaceutical care support programme in primary care with patients receiving usual care.", {"entities": []}], ["The total sample comprises 194 patients (aged between 18 and 75) diagnosed with depressive disorder in a primary care health centre in the province of Barcelona (Spain).", {"entities": []}], ["Subjects will be asked for written informed consent in order to participate in the study.", {"entities": []}], ["Diagnosis will be confirmed using the SCID-I.", {"entities": []}], ["The intervention consists of an educational programme focused on improving knowledge about medication, making patients aware of the importance of compliance, reducing stigma, reassuring patients about side-effects and stressing the importance of carrying out general practitioners' advice.", {"entities": []}], ["Measurements will take place at baseline, and after 3 and 6 months.", {"entities": []}], ["Main outcome measure is compliance with antidepressants.", {"entities": []}], ["Secondary outcomes include; clinical severity of depression (PHQ-9), anxiety (STAI-S), health-related quality of life (EuroQol-5D), satisfaction with the treatment received, side-effects, chronic physical conditions and socio-demographics.", {"entities": []}], ["The use of healthcare and social care services will be assessed with an adapted version of the Client Service Receipt Inventory (CSRI).", {"entities": []}], ["This trial will provide valuable information for health professionals and policy makers on the effectiveness and cost-effectiveness of a pharmaceutical intervention programme in the context of primary care.", {"entities": []}], ["NCT00794196", {"entities": []}], ["Tobacco smoke is the principal risk factor for chronic obstructive pulmonary disease (COPD), though the mechanisms of its toxicity are still unclear.", {"entities": [[47, 84, "DISEASE"]]}], ["The ABC transporters multidrug resistance-associated protein 1 (MRP1) and P-glycoprotein (P-gp/MDR1) extrude a wide variety of toxic substances across cellular membranes and are highly expressed in bronchial epithelium.", {"entities": []}], ["Their impaired function may contribute to COPD development by diminished detoxification of noxious compounds in cigarette smoke.", {"entities": []}], ["We examined whether triple knock-out (TKO) mice lacking the genes for Mrp1 and Mdr1a/1b are more susceptible to develop COPD features than their wild-type (WT) littermates.", {"entities": []}], ["TKO and WT mice (six per group) were exposed to 2 cigarettes twice daily by nose-only exposure or room air for 6 months.", {"entities": []}], ["Inflammatory infiltrates were analyzed in lung sections, cytokines and chemokines in whole lung homogenates, emphysema by mean linear intercept.", {"entities": []}], ["Multiple linear regression analysis with an interaction term was used to establish the statistical significances of differences.", {"entities": []}], ["TKO mice had lower levels of interleukin (IL)-7, KC (mouse IL-8), IL-12p70, IL-17, TNF-alpha, G-CSF, GM-CSF and MIP-1-alpha than WT mice independent of smoke exposure ( P < 0.05).", {"entities": []}], ["IL-1-alpha, IL-6, IL-8, IL-13, IL-17, TNF-alpha, G-CSF, GM-CSF and MCP-1 increased after smoke exposure in both groups, but the increase in IL-8 was lower in TKO than WT mice ( P < 0.05) with a same trend for G-CSF ( P < 0.10).", {"entities": []}], ["Smoke-induced increase in pulmonary inflammatory cells in WT mice was almost absent in TKO mice.", {"entities": []}], ["The mean linear intercept was not different between groups.", {"entities": []}], ["Mrp1/Mdr1a/1b knock-out mice have a reduced inflammatory response to cigarette smoke.", {"entities": []}], ["In addition, the expression levels of several cytokines and chemokines were also lower in lungs of Mrp1/Mdr1a/1b knock-out mice independent of smoke exposure.", {"entities": []}], ["Further studies are required to determine whether dysfunction of MRP1 and/or P-gp contribute to the pathogenesis of COPD.", {"entities": []}], ["Nuocytes are essential in innate type-2 immunity and contribute to the exacerbation of asthma responses.", {"entities": [[87, 93, "DISEASE"]]}], ["Here we show that nuocytes arise in the bone marrow and differentiate from common lymphoid progenitors, which makes them distinct new members of the lymphoid lineage.", {"entities": []}], ["Nuocytes required interleukin 7 (IL-7), IL-33 and Notch signalling for development in vitro .", {"entities": []}], ["Double negative 1 (DN1) and DN2 pro-T-cell progenitors maintained nuocyte potential in vitro , although the thymus was not essential for nuocyte development.", {"entities": []}], ["Notably, the transcription factor Ror\u03b1 was critical for nuocyte development and their role in parasitic worm expulsion.", {"entities": []}], ["To identify childhood respiratory tract-related illness presentation rates and service utilisation in primary care by interrogating free text and coded data from electronic medical records.", {"entities": []}], ["Retrospective cohort study.", {"entities": []}], ["Data interrogation used a natural language processing software inference algorithm.", {"entities": []}], ["36 primary care practices in New Zealand.", {"entities": []}], ["Data analysed from January 2008 to December 2013.", {"entities": []}], ["The records from 77\u2009582 children enrolled were reviewed over a 6-year period to estimate the presentation of childhood respiratory illness and service utilisation.", {"entities": []}], ["This cohort represents 268\u2009919 person-years of data and over 650\u2009000 unique consultations.", {"entities": []}], ["Childhood respiratory illness presentation rate to primary care practice, with description of seasonal and yearly variation.", {"entities": []}], ["Respiratory conditions constituted 46% of all child-general practitioner consultations with a stable year-on-year pattern of seasonal peaks.", {"entities": []}], ["Upper respiratory tract infection was the most common respiratory category accounting for 21.0% of all childhood consultations, followed by otitis media (12.2%), wheeze-related illness (9.7%), throat infection (7.4%) and lower respiratory tract infection (4.4%).", {"entities": [[140, 152, "DISEASE"]]}], ["Almost 70% of children presented to their general practitioner with at least one respiratory condition in their first year of life; this reduced to approximately 25% for children aged 10\u201317.", {"entities": []}], ["This is the first study to assess the primary care incidence and service utilisation of childhood respiratory illness in a large primary care cohort by interrogating electronic medical record free text.", {"entities": []}], ["The study identified the very high primary care workload related to childhood respiratory illness, especially during the first 2\u2009years of life.", {"entities": []}], ["These data can enable more effective planning of health service delivery.", {"entities": []}], ["The findings and methodology have relevance to many countries, and the use of primary care \u2018big data\u2019 in this way can be applied to other health conditions.", {"entities": []}], ["The small GTPase Rho and one of its targets, Rho-associated kinase (ROCK), participate in a variety of actin-based cellular processes including smooth muscle contraction, cell migration, and stress fiber formation.", {"entities": []}], ["The ROCK protein consists of an N-terminal kinase domain, a central coiled-coil domain containing a Rho binding site, and a C-terminal pleckstrin homology domain.", {"entities": []}], ["Here we present the crystal structure of a large section of the central coiled-coil domain of human ROCK I (amino acids 535\u2013700).", {"entities": []}], ["The structure forms a parallel \u03b1-helical coiled-coil dimer that is structurally similar to tropomyosin, an actin filament binding protein.", {"entities": []}], ["There is an unusual discontinuity in the coiled-coil; three charged residues (E613, R617 and D620) are positioned at what is normally the hydrophobic core of coiled-coil packing.", {"entities": []}], ["We speculate that this conserved irregularity could function as a hinge that allows ROCK to adopt its autoinhibited conformation.", {"entities": []}], ["Ethnic differences in the prevalence of asthma among children in the UK are under-researched.", {"entities": [[40, 46, "DISEASE"]]}], ["We aimed to determine the ethnic differences in the prevalence of asthma and atopic asthma in children from the main UK ethnic groups, and whether differences are associated with differential distributions in social and psychosocial risk factors.", {"entities": [[66, 72, "DISEASE"], [84, 90, "DISEASE"]]}], ["6,643 pupils aged 11-13 years, 80% ethnic minorities.", {"entities": []}], ["Outcomes were asthma/wheeze with (atopic) and without hay fever/eczema.", {"entities": [[14, 20, "DISEASE"]]}], ["Risk factors examined were family history of asthma, length of residence in the UK, socioeconomic disadvantage, tobacco exposure, psychological well-being, and body mass index (BMI).", {"entities": [[45, 51, "DISEASE"]]}], ["There was a pattern of lower prevalence of asthma in Black African boys and girls, and Indian and Bangladeshi girls compared to White UK.", {"entities": [[43, 49, "DISEASE"]]}], ["The overall prevalence was higher in Mixed Black Caribbean/White boys, with more atopic asthma in Black Caribbean boys and Mixed Black Caribbean/White boys due to more hayfever.", {"entities": [[88, 94, "DISEASE"]]}], ["Poor psychological well-being and family history of asthma were associated with an increased risk of asthma within each ethnic group.", {"entities": [[52, 58, "DISEASE"], [101, 107, "DISEASE"]]}], ["UK residence for \u2264 5 years was protective for Black Caribbeans and Black Africans.", {"entities": []}], ["Increased BMI was associated with an increased reporting of asthma for Black Africans.", {"entities": [[60, 66, "DISEASE"]]}], ["Adjustments for all variables did not remove the excess asthma reported by Black Caribbean boys (atopic) or Mixed Black Caribbean/White boys.", {"entities": [[56, 62, "DISEASE"]]}], ["The protective effect of being born abroad accounted for ethnic differences in some groups, signalling a role for socio-environmental factors in patterning ethnic differences in asthma in adolescence.", {"entities": [[178, 184, "DISEASE"]]}], ["Prostaglandin (PG) D 2 is an early-phase mediator in inflammation, but its action and the roles of the 2 D-type prostanoid receptors (DPs) DP 1 and DP 2 (also called chemoattractant receptor\u2013homologous molecule expressed on T H 2 cells) in regulating macrophages have not been elucidated to date.", {"entities": []}], ["We investigated the role of PGD 2 receptors on primary human macrophages, as well as primary murine lung macrophages, and their ability to influence neutrophil action in vitro and in vivo .", {"entities": [[28, 31, "GENE"]]}], ["In vitro studies, including migration, Ca In vivo pulmonary inflammation was assessed in male BALB/c mice.", {"entities": []}], ["Activation of DP 1 , DP 2 , or both receptors on human macrophages induced strong intracellular Ca 2 receptor resulted in aggravated airway neutrophilia, tissue myeloperoxidase activity, cytokine contents, and decreased lung compliance.", {"entities": []}], ["Selective depletion of alveolar macrophages abolished the PGD 2 -enhanced inflammatory response.", {"entities": [[58, 61, "GENE"]]}], ["Activation of PGD 2 receptors on human macrophages enhanced the migratory capacity and prolonged the survival of neutrophils in vitro .", {"entities": [[14, 17, "GENE"]]}], ["In human lung tissue specimens both DP 1 and DP 2 receptors were located on alveolar macrophages along with hematopoietic PGD synthase, the rate-limiting enzyme of PGD 2 synthesis.", {"entities": [[122, 125, "GENE"], [164, 167, "GENE"], [122, 125, "GENE"], [164, 167, "GENE"]]}], ["For the first time, our results show that PGD 2 markedly augments disease activity through its ability to enhance the proinflammatory actions of macrophages and subsequent neutrophil activation.", {"entities": [[42, 45, "GENE"]]}], ["Early-onset pulmonary emphysema is uncommon and its pathogenesis is poorly defined.", {"entities": [[12, 31, "DISEASE"]]}], ["A 30-year-old man was admitted to our intensive care unit with severe respiratory failure.", {"entities": [[70, 89, "DISEASE"]]}], ["Besides smoking heavily since the 14 years of age, he had habitually inhaled organic solvents, such as toluene, in his adolescence.", {"entities": []}], ["High-resolution computed tomography showed evident pulmonary emphysema throughout the lung fields.", {"entities": [[51, 70, "DISEASE"]]}], ["Based on the findings of right heart catheterization, he was diagnosed with an acute exacerbation of chronic obstructive pulmonary disease complicated with pulmonary hypertension.", {"entities": [[166, 178, "DISEASE"], [101, 138, "DISEASE"], [156, 178, "DISEASE"]]}], ["Heavy smoking from a young age and exposure to toluene were the suspected causes of the patient's severe pulmonary emphysema.", {"entities": [[105, 124, "DISEASE"]]}], ["Patients with chronic heart failure (CHF) experience a number of debilitating symptoms, which impact on activities of daily living and result in poor quality of life.", {"entities": []}], ["Prospective memory, which is defined as memory to carry out future intentions, has not been investigated in this group.", {"entities": []}], ["However, emerging evidence suggests CHF patients have difficulties with cognitive processes related to prospective memory.", {"entities": []}], ["Self-care, which partly relies on prospective memory, is essential in symptom management and preventing acute clinical deterioration.", {"entities": []}], ["This study aims to measure prospective memory in CHF patients, and examine the relationship between prospective memory and CHF self-care.", {"entities": []}], ["A comprehensive neuropsychological assessment will be conducted to assess a range of cognitive functions and psychopathology.", {"entities": []}], ["The primary focus will be an assessment of prospective memory using a well-established behavioral measure; Virtual Week.", {"entities": []}], ["Thirty CHF patients attending a nurse-led management program will be recruited from three hospital sites in Melbourne, Australia and their self-care behaviors will be assessed using the Self-care Chronic Heart Failure Index (SCHFI), a validated self-report tool.", {"entities": []}], ["An additional 30 healthy controls, matched on age, gender, and IQ will be recruited from the general community.", {"entities": []}], ["This is a group comparison study that will provide an evaluation of the prospective memory abilities of CHF patients.", {"entities": []}], ["The findings of this research will provide insight into whether prospective memory may be hindering patients\u2019 ability to perform adequate self-care.", {"entities": []}], ["There is a growing body of evidence attesting to links between early life exposure to stress and childhood asthma.", {"entities": [[107, 113, "DISEASE"]]}], ["However, available evidence is largely based on small, genetically high risk samples.", {"entities": []}], ["The aim of this study was to explore the associations between the course of maternal depressive symptoms across early childhood and childhood asthma in a nationally representative longitudinal cohort study of Australian children.", {"entities": [[142, 148, "DISEASE"]]}], ["Participants were 4164 children and their biological mothers from the Longitudinal Study of Australian Children.", {"entities": []}], ["Latent class analysis identified three trajectories of maternal depressive symptoms across four biennial waves from the first postnatal year to when children were 6\u20137 years: minimal symptoms (74.6%), sub-clinical symptoms (20.8%), and persistent and increasing high symptoms (4.6%).", {"entities": []}], ["Logistic regression analyses revealed that childhood asthma at age 6\u20137 years was associated with persistent and increasing high depressive symptoms after accounting for known risk factors including smoking during pregnancy and maternal history of asthma (adjusted OR 2.36, 95% CI 1.61\u20133.45), p.001).", {"entities": [[53, 59, "DISEASE"], [247, 253, "DISEASE"]]}], ["Our findings from a nationally representative sample of Australian children provide empirical support for a relationship between maternal depressive symptoms across the early childhood period and childhood asthma.", {"entities": [[206, 212, "DISEASE"]]}], ["The burden of disease from childhood asthma may be reduced by strengthening efforts to promote maternal mental health in the early years of parenting.", {"entities": [[37, 43, "DISEASE"]]}], ["French Guiana is a South American French territory, where HIV prevalence consistently exceeds 1% in the adult population.", {"entities": []}], ["In the only correctional facility, HIV prevalence fluctuates at around 4%.", {"entities": []}], ["After describing the population of HIV-positive inmates, we aimed to evaluate mortality after release from the correctional facility, and to identify its predictive factors.", {"entities": []}], ["Outside North American settings, data on treatment outcome and vital status of HIV-positive former inmates are scarce.", {"entities": []}], ["There were no data in French Guiana.", {"entities": []}], ["Filling this gap represents a basis for potential improvements.", {"entities": []}], ["All HIV-infected adults released from an incarceration of 30 days or more, between 2007 and 2013, were enrolled in a retrospective cohort study.", {"entities": []}], ["Mortality was described over time, one to seven years following release, using Kaplan-Meier estimates.", {"entities": []}], ["Factors associated with mortality were identified through a non-parametric survival regression model.", {"entities": []}], ["147 former inmates were included.", {"entities": []}], ["The male to female ratio was 4.4.", {"entities": []}], ["The median age was 37.3 years.", {"entities": []}], ["The majority were migrants, 25.8% were homeless, 70.1% suffered from substance abuse, with 34.0% of crack-cocaine users.", {"entities": [[69, 84, "DISEASE"]]}], ["On admission, 78.1% had an early HIV-stage infection (CDC-stage A), with a median CD4 count of 397.5/mm3, 34.0% had one comorbidity, mainly hypertension.", {"entities": [[140, 152, "DISEASE"], [82, 85, "GENE"]]}], ["Upon release, 50.3% were on ART.", {"entities": []}], ["Reasons for not being treated were not fulfilling the criteria for 74.6%, and refusing for 15.1%.", {"entities": []}], ["Before release, 84.5% of the patients on ART had a viral load\u2264200cp/ml.", {"entities": []}], ["After release, 8.2% of the cohort had died, with a crude incidence of 33.8/1000 person-years.", {"entities": []}], ["All recorded deaths were males, with an incidence of 42.2/1000 person-years.", {"entities": []}], ["Comparing with the age-specific mortality rates for males in French Guiana, the standardized mortality ratio was 14.8.", {"entities": []}], ["In multivariate analysis, factors associated with death were age and CD4 count before release.", {"entities": [[69, 72, "GENE"]]}], ["Despite access to ART while incarcerated, with good virological outcome, the post-release mortality was very high for males, almost 15 times what is observed in the general male population living in French Guiana, after age standardization.", {"entities": []}], ["Access to ART in correctional facilities may be a necessary, but not sufficient condition to protect male inmates from death after release.", {"entities": []}], ["Psoriasis is a chronic inflammatory immune-mediated disorder associated and often coexisting with many other immune-related clinical conditions including those affecting the gastrointestinal tract.", {"entities": [[0, 9, "DISEASE"]]}], ["Data obtained from the reviewed literature suggest an association between psoriasis and pathologies of the oral cavity, both psoriasis-specific lesions, as well as non-specific, such as geographic tongue or fissured tongue.", {"entities": [[207, 222, "DISEASE"], [74, 83, "DISEASE"], [125, 134, "DISEASE"]]}], ["These findings show the importance of thorough examination of oral mucosa in psoriatic patients.", {"entities": []}], ["Inflammatory bowel diseases (IBD) are also linked with psoriasis.", {"entities": [[55, 64, "DISEASE"]]}], ["Crohn\u2019s disease and ulcerative colitis share a common genetic background, inflammatory pathways and have an evident iatrogenic anti-TNF treatment link, necessitating dermatological or gastroenterological care in patients with IBD or psoriasis, respectively, as well as treatment adjusted to manifestations.", {"entities": [[233, 242, "DISEASE"], [20, 38, "DISEASE"]]}], ["The presence of celiac disease-specific antibodies in psoriatic patients and their correlation with the severity of the disease show the association between these disorders.", {"entities": [[16, 30, "DISEASE"]]}], ["The linking pathogenesis comprises vitamin D deficiency, immune pathway, genetic background and increase in the intestinal permeability, which suggests a potential benefit from gluten-free diet among psoriatic patients.", {"entities": []}], ["The link between psoriasis and non-alcoholic fatty liver disease implies screening patients for components of metabolic syndrome and lifestyle changes necessity.", {"entities": [[45, 64, "DISEASE"], [51, 64, "DISEASE"], [17, 26, "DISEASE"], [120, 128, "DISEASE"]]}], ["Some studies indicate increased prevalence of cancer in patients with psoriasis, probably due to negative influence of skin lesion impact on lifestyle rather than the role of psoriasis in carcinogenesis.", {"entities": [[70, 79, "DISEASE"], [175, 184, "DISEASE"], [46, 52, "DISEASE"]]}], ["However, there are no sufficient data to exclude such an oncogenic hit, which is yet to be confirmed.", {"entities": []}], ["Therefore, all psoriasis-associated comorbidities establish the importance of a multidisciplinary approach in the treatment of these patients.", {"entities": [[15, 24, "DISEASE"]]}], ["Asthma is one of the commonest chronic diseases in the UK.", {"entities": [[0, 6, "DISEASE"]]}], ["Acute exacerbations of asthma are unpredictable, disruptive and frightening.", {"entities": [[23, 29, "DISEASE"]]}], ["They cause considerable morbidity and account for a large component of the health service costs of asthma.", {"entities": [[99, 105, "DISEASE"]]}], ["The widespread use of an asthma self-management plan, designed to encourage disease monitoring and timely intervention, can reduce exacerbations and is, therefore, recommended for all patients with asthma.", {"entities": [[25, 31, "DISEASE"], [198, 204, "DISEASE"]]}], ["Unfortunately, the majority of patients are not provided with such a plan.", {"entities": []}], ["There are a variety of reasons for this but uncertainty about what to include in the plan when asthma control is deteriorating, but before the need for orally administered corticosteroids, is a contributing factor.", {"entities": [[95, 101, "DISEASE"]]}], ["The aim of this trial is to determine whether an asthma self-management plan, which includes a temporary quadrupling of the dose of inhaled corticosteroid when asthma control starts to deteriorate, reduces asthma exacerbations requiring orally administered corticosteroids or unscheduled health care consultation for asthma.", {"entities": [[49, 55, "DISEASE"], [160, 166, "DISEASE"], [206, 212, "DISEASE"], [317, 323, "DISEASE"]]}], ["A multicentre, pragmatic, randomised trial in adults aged over 16\u00a0years with a clinical diagnosis of asthma, treated with a licensed dose of inhaled corticosteroid and at least one exacerbation in the previous 12\u00a0months requiring treatment with systemic corticosteroids.", {"entities": [[101, 107, "DISEASE"]]}], ["Participants will be randomised to either a self-management plan, which includes a temporary (maximum of 14\u00a0days) fourfold increase in inhaled corticosteroid or the same plan without an increase in inhaled corticosteroid.", {"entities": []}], ["Participants will be followed up at 6 and 12\u00a0months and will attend the clinic for an additional visit if their asthma control deteriorates.", {"entities": [[112, 118, "DISEASE"]]}], ["The primary outcome is time to first asthma exacerbation, defined as the need for systemic corticosteroids and/or unscheduled health care consultation for asthma.", {"entities": [[37, 43, "DISEASE"], [155, 161, "DISEASE"]]}], ["The estimated sample size is 1800 participants.", {"entities": []}], ["The FAST trial is an independent study that has been prioritised and commissioned by the National Institute for Health Research (NIHR) in the United Kingdom.", {"entities": []}], ["It will provide high-quality evidence to inform clinical decision-making on the role of an asthma self-management plan, which includes a temporary fourfold increase of inhaled corticosteroid, when asthma control starts to deteriorate.", {"entities": [[91, 97, "DISEASE"], [197, 203, "DISEASE"]]}], ["The first participant was randomised on 17th May 2013 and recruitment will close on 31 January 2016 with the last patient last visit taking place in January 2017.", {"entities": []}], ["ISRCTN: 15441965 , registered on 25 April 2013.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-016-1608-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cockroach exposure is a major risk factor for the development of asthma.", {"entities": [[65, 71, "DISEASE"]]}], ["Inhalation of fecal remnants (frass) is the likely sensitizing agent; however isolated frass has not been tested for its ability to induce experimental asthma in mice.", {"entities": [[152, 158, "DISEASE"]]}], ["Mice (Balb/c or C57Bl/6) were sensitized and challenged with GC frass or GC frass devoid of proteases and measurements of airway inflammation and hyperresponsiveness were performed (interleukin (IL)-5, -13, and interferon gamma (IFN\u03b3) levels in bronchoalveolar lavage fluid, serum IgE levels, airway hyperresponsiveness, cellular infiltration, and mucin production).", {"entities": [[61, 63, "GENE"], [73, 75, "GENE"], [61, 63, "GENE"], [73, 75, "GENE"]]}], ["Sensitization and challenge of Balb/c mice with GC frass resulted in increased airway inflammation and hyperresponsiveness.", {"entities": [[48, 50, "GENE"]]}], ["C57Bl/6 mice were not susceptible to this model of sensitization; however they were sensitized to GC frass using a more aggressive sensitization and challenge protocol.", {"entities": [[98, 100, "GENE"]]}], ["In mice that were sensitized by inhalation, the active serine proteases in GC frass played a role in airway hyperresponsiveness as these mice had less airway hyperresponsiveness to acetylcholine and less mucin production.", {"entities": [[75, 77, "GENE"]]}], ["Proteases did not play a role in mediating the allergic inflammation in mice sensitized via intraperitoneal injection.", {"entities": []}], ["While both strains of mice were able to induce experimental asthma following GC frass sensitization and challenge, the active serine proteases in GC frass only play a role in airway hyperresponsiveness in Balb/c mice that were susceptible to sensitization via inhalation.", {"entities": [[60, 66, "DISEASE"], [77, 79, "GENE"], [146, 148, "GENE"], [77, 79, "GENE"], [146, 148, "GENE"]]}], ["The differences in the method of sensitization suggest genetic differences between strains of mice.", {"entities": []}], ["Type 1 diabetes is an autoimmune disease characterised by selective destruction of pancreatic beta cells by the immune system.", {"entities": []}], ["The transcription factor nuclear factor-kappa B (NF-\u03baB) regulates innate and adaptive immune responses.", {"entities": []}], ["Using gene targeting and in vitro analysis of pancreatic islets and immune cells, NF-\u03baB activation has been implicated in type 1 diabetes development.", {"entities": []}], ["Here we use a non-obese diabetic (NOD) mouse model that expresses a luciferase reporter of transcriptionally active NF-\u03baB to determine its activation in vivo during development of diabetes.", {"entities": []}], ["Increased luciferase activity was readily detected upon treatment with Toll-like receptor ligands in vitro and in vivo , indicating activation of NF-\u03baB.", {"entities": []}], ["However, activated NF-\u03baB was detectable at low levels above background in unmanipulated NOD mice, but did not vary with age, despite the progression of inflammatory infiltration in islets over time.", {"entities": []}], ["NF-\u03baB was highly activated in an accelerated model of type 1 diabetes that requires CD4", {"entities": [[84, 87, "GENE"]]}], ["The objective of this study was to evaluate cancer mortality in pulp and paper industry workers exposed to chlorinated organic compounds.", {"entities": [[44, 50, "DISEASE"]]}], ["We assembled a multinational cohort of workers employed between 1920 and 1996 in 11 countries.", {"entities": []}], ["Exposure to both volatile and nonvolatile organochlorine compounds was estimated at the department level using an exposure matrix.", {"entities": []}], ["We conducted a standardized mortality ratio (SMR) analysis based on age and calendar-period\u2013specific national mortality rates and a Poisson regression analysis.", {"entities": []}], ["The study population consisted of 60,468 workers.", {"entities": []}], ["Workers exposed to volatile organochlorines experienced a deficit of all-cause [SMR = 0.91; 95% confidence interval (CI), 0.89\u20130.93] and all-cancer (SMR = 0.93; 95% CI, 0.89\u20130.97) mortality, with no evidence of increased risks for any cancer of a priori interest.", {"entities": [[141, 147, "DISEASE"], [235, 241, "DISEASE"]]}], ["There was a weak, but statistically significant, trend of increasing risk of all-cancer mortality with increasing weighted cumulative exposure.", {"entities": [[81, 87, "DISEASE"]]}], ["A similar deficit in all-cause (SMR = 0.94; 95% CI, 0.91\u20130.96) and all-cancer (SMR = 0.94; 95% CI, 0.89\u20131.00) mortality was observed in those exposed to non-volatile organochlorines.", {"entities": [[71, 77, "DISEASE"]]}], ["No excess risk was observed in cancers of a priori interest, although mortality from Hodgkin disease was elevated (SMR = 1.76; 95% CI, 1.02\u20132.82).", {"entities": []}], ["In this study we found little evidence that exposure to organochlorines at the levels experienced in the pulp and paper industry is associated with an increased risk of cancer, apart from a weak but significant association between all-cancer mortality and weighted cumulative volatile organochlorine exposure.", {"entities": [[169, 175, "DISEASE"], [235, 241, "DISEASE"]]}], ["Accumulating evidence has shown the importance of Stat6-mediated signaling in allergic diseases.", {"entities": []}], ["In this study, we show a novel regulatory mechanism of Stat6-mediated signaling in mast cells.", {"entities": []}], ["When Stat6 is activated by interleukin (IL)-4 and translocated to the nucleus, Stat6 is cleaved by a nucleus-associated protease in mast cells.", {"entities": [[5, 10, "GENE"], [79, 84, "GENE"], [5, 10, "GENE"], [79, 84, "GENE"]]}], ["The cleaved 65-kD Stat6 lacks the COOH-terminal transactivation domain and functions as a dominant-negative molecule to Stat6-mediated transcription.", {"entities": [[18, 23, "GENE"], [120, 125, "GENE"]]}], ["The retrovirus-mediated expression of cleavage-resistant Stat6 mutants prolongs the nuclear accumulation of Stat6 upon IL-4 stimulation and enhances IL-4\u2013induced gene expression and growth inhibition in mast cells.", {"entities": [[57, 62, "GENE"], [108, 113, "GENE"], [57, 62, "GENE"], [108, 113, "GENE"]]}], ["These results indicate that the proteolytic processing of Stat6 functions as a lineage-specific negative regulator of Stat6-dependent signaling in mast cells, and thus suggest that it may account for the limited role of Stat6 in IL-4 signaling in mast cells.", {"entities": [[58, 63, "GENE"], [118, 123, "GENE"], [220, 225, "GENE"], [58, 63, "GENE"], [118, 123, "GENE"], [220, 225, "GENE"]]}], ["Antithyroid drugs as thionamides are largely used in the treatment of the thyrotoxicosis.", {"entities": [[74, 88, "DISEASE"]]}], ["Side effects were reported in less than 10% of the cases, especially hematological, hepatic or skin allergies.", {"entities": []}], ["One of the most severe manifestations is agranulocytosis, probably based on an immune mechanism that is exacerbated by the presence of the thyroid autoimmune disease itself.", {"entities": [[41, 56, "DISEASE"]]}], ["If the presence of the severe leucopenia is actually an epiphenomenon of a preexisting hematological disturbance as multiple myeloma is debated.", {"entities": [[125, 132, "DISEASE"], [116, 132, "DISEASE"]]}], ["The myeloma may also be correlated with an autoimmune predisposition.", {"entities": [[4, 11, "DISEASE"]]}], ["We present the case of a 56 years old female patient diagnosed with Graves\u2019 disease, who developed agranulocytosis after 8 months of therapy with thiamazole.", {"entities": [[99, 114, "DISEASE"]]}], ["Two months after antithyroid drug\u2019s withdrawal, the granulocytes number increased and she received therapy with radioiodine.", {"entities": []}], ["Two years later she came back for diffuse bone pain that turned out to be caused by a multiple myeloma, confirmed by bone marrow biopsy.", {"entities": [[95, 102, "DISEASE"], [86, 102, "DISEASE"]]}], ["It might be a connection between the severe form of leucopenia that the patient developed and the medullar malignancy.", {"entities": []}], ["An increasing number of animal and human studies are indicating that inflammation is associated with behavioral disorders including aggression.", {"entities": []}], ["This study investigates the association between chronic physical aggression during childhood and plasma cytokine levels in early adulthood.", {"entities": []}], ["Two longitudinal studies were used to select males on a chronic physical aggression trajectory from childhood to adolescence (n\u200a=\u200a7) and a control group from the same background (n\u200a=\u200a25).", {"entities": []}], ["Physical aggression was assessed yearly by teachers from childhood to adolescence and plasma levels of 10 inflammatory cytokines were assessed at age 26 and 28 years.", {"entities": []}], ["Compared to the control group, males on a chronic physical aggression trajectory from childhood to adolescence had consistently lower plasma levels of five cytokines: lower pro-inflammatory interleukins IL-1\u03b1 ( T (28.7)\u200a=\u200a3.48, P\u200a=\u200a 0.002) and IL-6 ( T (26.9)\u200a=\u200a3.76, P\u200a=\u200a 0.001), lower anti-inflammatory interleukin IL-4 ( T (27.1)\u200a=\u200a4.91, P\u200a=\u200a 0.00004) and IL-10 ( T (29.8)\u200a=\u200a2.84, P\u200a=\u200a 0.008) and lower chemokine IL-8 ( T (26)\u200a=\u200a3.69, P\u200a=\u200a 0.001).", {"entities": []}], ["The plasma levels of four cytokines accurately predicted aggressive and control group membership for all subjects.", {"entities": []}], ["Physical aggression of boys during childhood is a strong predictor of reduced plasma levels of cytokines in early adulthood.", {"entities": []}], ["The causal and physiological relations underlying this association should be further investigated since animal data suggest that some cytokines such as IL-6 and IL-1\u03b2 play a causal role in aggression.", {"entities": []}], ["Lymphoid neogenesis is traditionally viewed as a pre\u2010programmed process that promotes the formation of lymphoid organs during development.", {"entities": []}], ["Here, the spatial organization of T and B cells in lymph nodes and spleen into discrete structures regulates antigen\u2010specific responses and adaptive immunity following immune challenge.", {"entities": []}], ["However, lymphoid neogenesis is also triggered by chronic or persistent inflammation.", {"entities": []}], ["Here, ectopic (or tertiary) lymphoid organs frequently develop in inflamed tissues as a response to infection, auto\u2010immunity, transplantation, cancer or environmental irritants.", {"entities": [[143, 149, "DISEASE"]]}], ["Although these structures affect local immune responses, the contribution of these lymphoid aggregates to the underlining pathology are highly context dependent and can elicit either protective or deleterious outcomes.", {"entities": []}], ["Here we review the cellular and molecular mechanisms responsible for ectopic lymphoid neogenesis and consider the relevance of these structures in human disease.", {"entities": []}], ["IgG4-related disease is a novel disease entity characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells.", {"entities": []}], ["Typical renal pathology is tubulointerstitial nephritis with storiform fibrosis, although the co-existence of various glomerular lesions has been described.", {"entities": [[46, 55, "DISEASE"]]}], ["Here, we present the first report of a case of IgG4-related kidney disease and membranoproliferative glomerulonephritis showing the discrepancy in IgG subclasses between the kidney interstitium and glomeruli.", {"entities": [[101, 119, "DISEASE"], [60, 74, "DISEASE"], [79, 119, "DISEASE"]]}], ["A 70-year-old Japanese woman was diagnosed with membranoproliferative glomerulonephritis and focal tubulointerstitial nephritis with IgG4-positive plasma cells.", {"entities": [[70, 88, "DISEASE"], [48, 88, "DISEASE"], [118, 127, "DISEASE"]]}], ["Immunofluorescence studies revealed predominant deposition of IgG3 and IgG2, but not IgG4 in the glomeruli.", {"entities": []}], ["We administered oral prednisolone at 30\u00a0mg/day, and the abnormalities in urine and blood tests gradually resolved.", {"entities": []}], ["In this case, different patterns of IgG subclasses detected in the glomeruli and interstitial plasma cells suggest overlapping immunologic abnormalities.", {"entities": []}], ["The favorable clinical course in our patient suggests that steroid therapy is promising in cases of IgG4-related kidney disease accompanied by glomerulonephritis.", {"entities": [[143, 161, "DISEASE"], [113, 127, "DISEASE"]]}], ["Thymoquinone is an active ingredient isolated from Nigella sativa (Black Seed).", {"entities": []}], ["This study aimed to evaluate the in vitro and in vivo anti-leukemic effects of thymoquinone on WEHI-3 cells.", {"entities": []}], ["The cytotoxic effect of thymoquinone was assessed using an MTT assay, while the inhibitory effect of thymoquinone on murine WEHI-3 cell growth was due to the induction of apoptosis, as evidenced by chromatin condensation dye, Hoechst 33342 and acridine orange/propidium iodide fluorescent staining.", {"entities": []}], ["In addition, Annexin V staining for early apoptosis was performed using flowcytometric analysis.", {"entities": []}], ["Apoptosis was found to be associated with the cell cycle arrest at the S phase.", {"entities": []}], ["Expression of Bax, Bcl2 and HSP 70 proteins were observed by western blotting.", {"entities": [[14, 17, "GENE"], [19, 23, "GENE"]]}], ["The effects of thymoquinone on BALB/c mice injected with WEHI-3 cells were indicated by the decrease in the body, spleen and liver weights of the animal, as compared to the control.", {"entities": []}], ["Thymoquinone promoted natural killer cell activities.", {"entities": []}], ["This compound showed high toxicity against WEHI-3 cell line which was confirmed by an increase of the early apoptosis, followed by up-regulation of the anti-apoptotic protein, Bcl2, and down-regulation of the apoptotic protein, Bax.", {"entities": [[176, 180, "GENE"], [228, 231, "GENE"]]}], ["On the other hand, high reduction of the spleen and liver weight, and significant histopathology study of spleen and liver confirmed that thymoquinone inhibited WEHI-3 growth in the BALB/c mice.", {"entities": []}], ["Results from this study highlight the potential of thymoquinone to be developed as an anti-leukemic agent.", {"entities": []}], ["Orai1 is the key subunit of the Ca ORAI1 (lenti- ORAI1 ) into the nostrils of OVA-sensitized mice before the challenges, and analyzed its effect on allergic responses, as compared with the unsensitized mice and untreated AR mice.", {"entities": [[0, 5, "GENE"], [35, 40, "GENE"], [49, 54, "GENE"], [0, 5, "GENE"], [35, 40, "GENE"], [49, 54, "GENE"], [0, 5, "GENE"], [35, 40, "GENE"], [49, 54, "GENE"]]}], ["Administration of lenti- ORAI1 into the nasal cavity successfully infected cells in the epithelial layer of the nasal mucosa, and significantly decreased the frequencies of sneezing and nasal rubbing of the mice.", {"entities": [[25, 30, "GENE"]]}], ["Protein levels of leukotriene C4, OVA-specific IgE, and IL-4 in the nasal lavage fluid and serum and eosinophil cation protein in the serum were also significantly reduced by lenti- ORAI1 , as were the mRNA levels of these factors in the nasal mucosa and spleen.", {"entities": [[182, 187, "GENE"]]}], ["These data suggested that administration of lenti- ORAI1 into the nasal cavity effectively decreased Orai1 expression in the nasal mucosa, alleviated AR symptoms, and partially inhibited the hyperresponsiveness of the local and systemic immune cells including T cells, B cells, mast cells and eosinophils that are involved in the pathogenesis of AR.", {"entities": [[51, 56, "GENE"], [101, 106, "GENE"], [51, 56, "GENE"], [101, 106, "GENE"]]}], ["H9N2 subtype avian influenza viruses (AIVs) have been isolated from various species of wild birds and domestic poultry in the world, and occasionally transmitted to humans.", {"entities": [[19, 28, "DISEASE"], [13, 28, "DISEASE"]]}], ["Although H9N2 AIVs are seldom isolated from ostriches, seven such strains were isolated from sick ostriches in China between 2013 and 2014.", {"entities": []}], ["Sequence analysis showed several amino acid changes relating to viral adaptation in mammals were identified.", {"entities": []}], ["The phylogenetic analyses indicated that these isolates were quadruple reassortant viruses, which are different from the early ostrich isolates from South Africa or Israel.", {"entities": []}], ["Most of the ostrich virus carried a human-type receptor-binding property.", {"entities": []}], ["The chicken experiments showed the ostrich strains displayed low pathogenicity, while they could cause mild to severe symptoms in chicken.", {"entities": []}], ["Theses strains could efficiently transmit among chickens, and one strain showed higher transmissibility.", {"entities": []}], ["The virus could not kill mice, and merely replicated in the lung of mice.", {"entities": []}], ["The ostrich strains could not efficiently transmit between guinea pigs in the direct contact model.", {"entities": []}], ["These results suggested we should pay attention to the interface between ostrich and other domestic fowl, and keep an eye on this population when monitoring of influenza virus.", {"entities": [[160, 169, "DISEASE"]]}], ["A milieu of cytokines and signaling molecules are involved in the induction of UV-induced immune suppression and thus the etiology of non-melanoma skin cancer (NMSC).", {"entities": [[147, 158, "DISEASE"], [138, 146, "DISEASE"], [152, 158, "DISEASE"]]}], ["Targeting the UV-induced immunosuppression pathway, and using a large population based study of NMSC, we have investigated the risk associated with functional variants in 10 genes ( IL10 , IL4 , IL4R , TNF , TNFR2 , HTR2A , HRH2 , IL12B , PTGS2 , and HAL ).", {"entities": [[182, 186, "GENE"], [189, 192, "GENE"], [195, 199, "GENE"], [202, 205, "GENE"], [216, 221, "GENE"], [224, 228, "GENE"], [231, 236, "GENE"], [239, 244, "GENE"], [251, 254, "GENE"]]}], ["The most prominent single genetic effect was observed for IL10 .", {"entities": [[58, 62, "GENE"]]}], ["There was increasing risk for both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) with increasing number of variant IL10 haplotypes (BCC: p trend \u200a=\u200a0.0048; SCC: p trend \u200a=\u200a0.031).", {"entities": [[46, 55, "DISEASE"], [80, 89, "DISEASE"], [35, 55, "DISEASE"], [66, 89, "DISEASE"], [130, 134, "GENE"]]}], ["Having two IL10 GC haplotypes was associated with increased odds ratios of BCC and SCC (OR BCC \u200a=\u200a1.5, 95% CI 1.1\u20131.9; OR SCC \u200a=\u200a1.4, 95% CI 1.0\u20131.9), and these associations were largely confined to women (OR BCC \u200a=\u200a2.2, 95% CI 1.4\u20133.4; SCC: OR SCC \u200a=\u200a1.8, 95% CI 1.1\u20133.0).", {"entities": [[11, 15, "GENE"], [16, 18, "GENE"]]}], ["To examine how combinations of these variants contribute to risk of BCC and SCC, we used multifactor dimensionality reduction (MDR) and classification and regression trees (CART).", {"entities": []}], ["Results from both of these methods found that in men, a combination of skin type, burns, IL10 , IL4R , and possibly TNFR2 were important in both BCC and SCC.", {"entities": [[89, 93, "GENE"], [96, 100, "GENE"]]}], ["In women, skin type, burns, and IL10 were the most critical risk factors in SCC, with risk of BCC involving these same factors plus genetic variants in HTR2A , IL12B and IL4R .", {"entities": [[32, 36, "GENE"], [152, 157, "GENE"], [160, 165, "GENE"], [170, 174, "GENE"]]}], ["These data suggest differential genetic susceptibility to UV-induced immune suppression and skin cancer risk by gender.", {"entities": [[92, 103, "DISEASE"], [97, 103, "DISEASE"]]}], ["To find evidence, either corroborating or refuting, for many persisting beliefs regarding the feasibility of carrying out surgical randomised controlled trials with a placebo arm, with emphasis on the challenges related to recruitment, funding, anaesthesia or blinding.", {"entities": []}], ["Systematic review.", {"entities": []}], ["The analysis involved studies published between 1959 and 2014 that were identified during an earlier systematic review of benefits and harms of placebo-controlled surgical trials published in 2014.", {"entities": []}], ["63 trials were included in the review.", {"entities": []}], ["The main problem reported in many trials was a very slow recruitment rate, mainly due to the difficulty in finding eligible patients.", {"entities": []}], ["Existing placebo trials were funded equally often from commercial and non-commercial sources.", {"entities": []}], ["General anaesthesia or sedation was used in 41% of studies.", {"entities": []}], ["Among the reviewed trials, 81% were double-blinded, and 19% were single-blinded.", {"entities": []}], ["Across the reviewed trials, 96% (range 50\u2013100%) of randomised patients completed the study.", {"entities": []}], ["The withdrawal rate during the study was similar in the surgical and in the placebo groups.", {"entities": []}], ["This review demonstrated that placebo-controlled surgical trials are feasible, at least for procedures with a lower level of invasiveness, but also that recruitment is difficult.", {"entities": []}], ["Many of the presumed challenges to undertaking such trials, for example, funding, anaesthesia or blinding of patients and assessors, were not reported as obstacles to completion in any of the reviewed trials.", {"entities": []}], ["We tested the hypothesis that objectively measured physical function predicts mortality among cancer survivors.", {"entities": [[94, 100, "DISEASE"]]}], ["We assessed objectively measured physical function including the short physical performance battery (SPPB) and fast walk speed in older adult cancer survivors.", {"entities": [[142, 148, "DISEASE"]]}], ["Among 413 cancer survivors, 315 (76%) died during a median follow-up of 11.0 years.", {"entities": [[10, 16, "DISEASE"]]}], ["In multivariable-adjusted analyses, each 1-unit increase in the SPPB score and 0.1\u2009m\u2009s P <0.001, and HR: 0.88 (95% CI: 0.82\u20130.96); P =0.003, respectively).", {"entities": [[101, 103, "GENE"]]}], ["Objectively measured physical function may predict mortality among cancer survivors.", {"entities": [[67, 73, "DISEASE"]]}], ["Fibromyalgia (FM) is characterized by chronic pain.", {"entities": []}], ["Impaired growth hormone responses and reduced serum insulin-like growth factor 1 (IGF-1) are common in FM.", {"entities": []}], ["The aim was to examine changes in serum IGF-1, cerebrospinal fluid (CSF), neuropeptides, and cytokines during aerobic exercise in FM patients.", {"entities": []}], ["In total, 49 patients (median age, 52 years) with FM were included in the study.", {"entities": []}], ["They were randomized to either the moderate- to high-intensity Nordic Walking (NW) program ( n = 26) or the supervised low-intensity walking (LIW) program ( n = 23).", {"entities": []}], ["Patients participated in blood tests before and after 15 weeks of aerobic exercise.", {"entities": []}], ["Changes in serum levels of free IGF-1, pain rating on a 0- to 100-mm scale, pain threshold, and 6-minute walk test (6MWT) were examined.", {"entities": []}], ["CSF, neuropeptides, matrix metalloproteinase 3 (MMP-3), and inflammatory cytokines were determined.", {"entities": []}], ["Nonparametric tests were used for group comparisons and correlation analyses.", {"entities": []}], ["Serum free IGF-1 levels did not change during 15 weeks of exercise between the two groups, although the 6MWT significantly improved in the NW group ( p = 0.033) when compared with LIW.", {"entities": []}], ["Pain did not significantly change in any of the groups, but tended to decrease ( p = 0.052) over time in the total group.", {"entities": []}], ["A tendency toward a correlation was noted between baseline IGF-1 and a decrease of pain in response to exercise ( r = 0.278; p = 0.059).", {"entities": []}], ["When adjusted for age, this tendency disappeared.", {"entities": []}], ["The change in serum free IGF-1 correlated positively with an alteration in CSF substance P (SP) levels ( r p = 0.072), neuropeptide Y (NPY) ( r = 0.802; p = 0.001), and pain threshold ( r = 0.276; p = 0.058).", {"entities": [[135, 138, "GENE"]]}], ["Differing CSF SP levels correlated positively to a change in pain threshold ( r p = 0.023), whereas the shift in CSF MMP-3 inversely correlated with an altered pain threshold ( r p = 0.034).", {"entities": []}], ["The baseline level of serum free IGF-1 did not change during high or low intensity of aerobic exercise.", {"entities": []}], ["Changes in IGF-1 correlated positively with a variation in CSF SP, NPY, and pain threshold.", {"entities": [[67, 70, "GENE"]]}], ["These data indicate a beneficial role of IGF-1 during exercise in FM.", {"entities": []}], ["Trial registration : ClinicalTrials.gov NCT00643006 .", {"entities": []}], ["Only the carotid chemoreceptors stimulate breathing during hypoxia in Man.", {"entities": []}], ["They are also ideally located to warn if the brain's oxygen supply falls, or if hypercapnia occurs.", {"entities": []}], ["Since their discovery ~80 years ago stimulation, ablation, and recording experiments still leave 3 substantial difficulties in establishing how important the carotid chemoreceptors are in controlling breathing during exercise in Man: (i) they are in the wrong location to measure metabolic rate (but are ideally located to measure any mismatch), (ii) they receive no known signal during exercise linking them with metabolic rate and no overt mismatch signals occur and (iii) their denervation in Man fails to prevent breathing matching metabolic rate in exercise.", {"entities": []}], ["New research is needed to enable recording from carotid chemoreceptors in Man to establish whether there is any factor that rises with metabolic rate and greatly increases carotid chemoreceptor activity during exercise.", {"entities": []}], ["Available evidence so far in Man indicates that carotid chemoreceptors are either one of two mechanisms that explain breathing matching metabolic rate or have no importance.", {"entities": []}], ["We still lack key experimental evidence to distinguish between these two possibilities.", {"entities": []}], ["Background Hyaluronan (HA) is a major component of the extracellular matrix (ECM) with increased synthesis during tissue repair.", {"entities": []}], ["Tumour necrosis factor-stimulated gene-6 (TSG-6) is known to catalyze the covalent transfer of heavy chains (HC1 and HC2) from inter-\u03b1-inhibitor (I\u03b1I) onto HA, and resultant HC\u2022HA complexes have been implicated in physiological and pathological processes related to remodelling and inflammation.", {"entities": []}], ["Objective The aims of this study were to determine the expression of HA, TSG-6 and the I\u03b1I polypeptides in unscarred skin, normal scars and keloid scars.", {"entities": []}], ["Methods Formalin-fixed paraffin-embedded sections of unscarred skin, normal scars and keloid scars were prepared from patient samples collected during scar revision surgery.", {"entities": []}], ["Haematoxylin and eosin, as well as immunofluorescent staining for HA, TSG-6 and the three polypeptide chains of I\u03b1I (i.e.", {"entities": []}], ["HC1, HC2 and bikunin) were performed.", {"entities": []}], ["Results All skin types stained positive for TSG-6, HC1, HC2 and bikunin, associated with keratinocytes, fibroblasts and skin appendages all in close proximity to HA.", {"entities": []}], ["Keloid lesions showed altered HA organization patterns compared with unscarred skin and normal scars.", {"entities": []}], ["TSG-6 staining was significantly more intense in the epidermis compared with the dermis of all sample types.", {"entities": []}], ["There was a significant reduction in TSG-6 levels within keloid lesions compared with the dermis of unscarred skin ( P = 0.017).", {"entities": []}], ["Conclusion TSG-6 is expressed in unscarred skin, where its close association with HA and I\u03b1I could give rise to TSG-6-mediated HC\u2022HA formation within this tissue.", {"entities": []}], ["A reduction in the beneficial effects of TSG-6, caused by diminished protein levels in keloid lesions, could contribute to this abnormal scarring process.", {"entities": []}], ["Respiratory syncytial virus (RSV) has been reported to infect human mesenchymal stem cells (MSCs) but the consequences are poorly understood.", {"entities": []}], ["MSCs are present in nearly every organ including the nasal mucosa and the lung and play a role in regulating immune responses and mediating tissue repair.", {"entities": []}], ["We sought to determine whether RSV infection of MSCs enhances their immune regulatory functions and contributes to RSV-associated lung disease.", {"entities": [[130, 142, "DISEASE"]]}], ["RSV was shown to replicate in human MSCs by fluorescence microscopy, plaque assay, and expression of RSV transcripts.", {"entities": []}], ["RSV-infected MSCs showed differentially altered expression of cytokines and chemokines such as IL-1\u03b2, IL6, IL-8 and SDF-1 compared to epithelial cells.", {"entities": [[102, 105, "GENE"]]}], ["Notably, RSV-infected MSCs exhibited significantly increased expression of IFN-\u03b2 (~100-fold) and indoleamine-2,3-dioxygenase (IDO) (~70-fold) than in mock-infected MSCs.", {"entities": []}], ["IDO was identified in cytosolic protein of infected cells by Western blots and enzymatic activity was detected by tryptophan catabolism assay.", {"entities": []}], ["Treatment of PBMCs with culture supernatants from RSV-infected MSCs reduced their proliferation in a dose dependent manner.", {"entities": []}], ["This effect on PBMC activation was reversed by treatment of MSCs with the IDO inhibitors 1-methyltryptophan and vitamin K 3 during RSV infection, a result we confirmed by CRISPR/Cas9-mediated knockout of IDO in MSCs.", {"entities": []}], ["Neutralizing IFN-\u03b2 prevented IDO expression and activity.", {"entities": []}], ["Treatment of MSCs with an endosomal TLR inhibitor, as well as a specific inhibitor of the TLR3/dsRNA complex, prevented IFN-\u03b2 and IDO expression.", {"entities": []}], ["Together, these results suggest that RSV infection of MSCs alters their immune regulatory function by upregulating IFN-\u03b2 and IDO, affecting immune cell proliferation, which may account for the lack of protective RSV immunity and for chronicity of RSV-associated lung diseases such as asthma and COPD.", {"entities": [[284, 290, "DISEASE"]]}], ["The differential diagnosis of intestinal obstruction includes mechanical obstruction, obstruction secondary to systemic disease, and idiopathic intestinal pseudo-obstruction.", {"entities": [[30, 52, "DISEASE"], [144, 173, "DISEASE"]]}], ["The causes of these are extensive; however, the majority of cases involve a mechanical cause.", {"entities": []}], ["Superior mesenteric artery syndrome (SMAS) is a rare and controversial form of mechanical obstruction with just over 300 well-defined cases described in the literature.", {"entities": [[0, 35, "DISEASE"], [27, 35, "DISEASE"]]}], ["The diagnosis is often difficult to establish, even after surgery.", {"entities": []}], ["In addition, this syndrome sometimes may be managed conservatively, leaving a definitive diagnosis unproven.", {"entities": [[18, 26, "DISEASE"]]}], ["We describe herein 2 patients with SMAS successfully treated with laparoscopic duodenojejunostomy.", {"entities": []}], ["Two cases of SMAS occurred in young men ages 23 and 34.", {"entities": []}], ["The workup included a consultation with a gastroenterologist, an upper gastrointestinal (GI) endoscopy, upper GI series with small bowel follow-through, computed tomography scan, ultrasound of the abdomen, and abdominal aortogram.", {"entities": []}], ["This diagnosis was established after consultation with the surgeon and the gastroenterologist in each case.", {"entities": []}], ["Laparoscopic duodenojejunostomy was performed in each case, and both patients have had complete resolution of their preoperative symptoms.", {"entities": []}], ["A laparoscopic approach to the management of superior mesenteric artery syndrome is a reasonable and successful way of treating these patients.", {"entities": [[45, 80, "DISEASE"], [72, 80, "DISEASE"]]}], ["The recent introduction of mobile phones into the rural Bandarban district of Bangladesh provided a resource to improve case detection and treatment of patients with malaria.", {"entities": [[166, 173, "DISEASE"]]}], ["During studies to define the epidemiology of malaria in villages in south-eastern Bangladesh, an area with hypoendemic malaria, the project recorded 986 mobile phone calls from families because of illness suspected to be malaria between June 2010 and June 2012.", {"entities": [[45, 52, "DISEASE"], [119, 126, "DISEASE"], [221, 228, "DISEASE"]]}], ["Based on phone calls, field workers visited the homes with ill persons, and collected blood samples for malaria on 1,046 people.", {"entities": [[104, 111, "DISEASE"]]}], ["265 (25%) of the patients tested were positive for malaria.", {"entities": [[51, 58, "DISEASE"]]}], ["Of the 509 symptomatic malaria cases diagnosed during this study period, 265 (52%) were detected because of an initial mobile phone call.", {"entities": [[23, 30, "DISEASE"]]}], ["Mobile phone technology was found to be an efficient and effective method for rapidly detecting and treating patients with malaria in this remote area.", {"entities": [[123, 130, "DISEASE"]]}], ["This technology, when combined with local knowledge and field support, may be applicable to other hard-to-reach areas to improve malaria control.", {"entities": [[129, 136, "DISEASE"]]}], ["Primary influenza pneumonia has a high mortality rate during pandemics, not only in immunocompromised individuals and patients with underlying comorbid conditions, but also in young healthy adults.", {"entities": [[8, 17, "DISEASE"], [18, 27, "DISEASE"]]}], ["Clinicians should maintain a high index of suspicion for this diagnosis in patients presenting with influenza-like symptoms that progress quickly (2 to 5 days) to respiratory distress and extensive pulmonary involvement.", {"entities": [[100, 109, "DISEASE"]]}], ["The sensitivity of rapid diagnostic techniques in identifying infections with the pandemic 2009 H1N1v influenza strain is currently suboptimal.", {"entities": [[102, 111, "DISEASE"]]}], ["The most reliable real-time reverse transcriptase-polymerase chain reaction molecular testing is available in limited clinical settings.", {"entities": []}], ["Despite 6 months of pandemic circulation, most novel H1N1v pandemic strains remain susceptible to oseltamivir.", {"entities": []}], ["Ensuring an appropriate oxygenation and ventilation strategy, as well as prompt initiation of antiviral therapy, is essential in management.", {"entities": []}], ["Exposure to endotoxin, a component of gram-negative bacterial cell walls, is widespread in many industrial settings and in the ambient environment.", {"entities": []}], ["Heavy-exposure environments include livestock farms, cotton textile facilities, and saw mills.", {"entities": []}], ["Concentrations are highly variable in non-occupational indoor and outdoor environments.", {"entities": []}], ["Endotoxin is a potent inflammagen with recognized health effects, including fever, shaking chills, septic shock, toxic pneumonitis, and respiratory symptoms.", {"entities": [[113, 130, "DISEASE"]]}], ["Somewhat paradoxically, given the putative role of inflammation in carcinogenesis, various lines of evidence suggest that endotoxin may prevent cancer initiation or limit tumor growth.", {"entities": [[144, 150, "DISEASE"]]}], ["The hypothesis that components of bacteria may retard cancer progression dates back to William B. Coley\u2019s therapeutic experiments (\u201cbacterial vaccine\u201d) in the 1890s.", {"entities": [[54, 60, "DISEASE"]]}], ["In this article, we review epidemiologic, clinical trial, and experimental studies pertinent to the hypothesis that endotoxin prevents cancer.", {"entities": [[135, 141, "DISEASE"]]}], ["Since the 1970s, epidemiologic studies of cotton textile and other endotoxin-exposed occupational groups have consistently demonstrated reduced lung cancer risks.", {"entities": [[144, 155, "DISEASE"], [149, 155, "DISEASE"]]}], ["Experimental animal toxicology research and some limited therapeutic trials in cancer patients offer additional support for an anticarcinogenic potential.", {"entities": [[79, 85, "DISEASE"]]}], ["The underlying biological mechanisms of anticarcinogenesis are not entirely understood but are thought to involve the recruitment and activation of immune cells and proinflammatory mediators (e.g., tumor necrosis factor \u03b1 and interleukin-1 and -6).", {"entities": []}], ["In view of the current state of knowledge, it would be premature to recommend endotoxin as a cancer-chemopreventive agent.", {"entities": [[93, 99, "DISEASE"]]}], ["Nonetheless, further epidemiologic and experimental investigations that can clarify further dose\u2013effect and exposure\u2013timing relations could have substantial public health and basic biomedical benefits.", {"entities": []}], ["Asthma is characterized by airway remodeling.", {"entities": [[0, 6, "DISEASE"]]}], ["Follistatin-like protein 1 (FSTL1) is an extracellular glycoprotein.", {"entities": [[28, 33, "GENE"]]}], ["Recent studies suggest that FSTL1 may participate in the pathogenesis of asthma.", {"entities": [[73, 79, "DISEASE"], [28, 33, "GENE"]]}], ["To analyze the association between FSTL1 and some parameters and inspect the role of FSTL1 in asthma.", {"entities": [[94, 100, "DISEASE"], [35, 40, "GENE"], [85, 90, "GENE"], [35, 40, "GENE"], [85, 90, "GENE"]]}], ["We examined FSTL1 levels in 32 asthmatics and 25 controls.", {"entities": [[12, 17, "GENE"]]}], ["All subjects enrolled had routine blood tests, spirometry, and impulse oscillometry performed.", {"entities": []}], ["Additionally, 15 of the 32 asthmatics underwent fibre optic bronchoscopy.", {"entities": []}], ["Spearman rank analysis was performed to detect the correlation between FSTL1 and other parameters.", {"entities": [[71, 76, "GENE"]]}], ["Plasma FSTL1 levels were higher in asthmatics (130.762\u2009\u00b1\u200946.029\u2009ng/mL) than in controls (95.408\u2009\u00b1\u200933.938\u2009ng/mL) ( p = 0.009).", {"entities": [[7, 12, "GENE"]]}], ["Plasma FSTL1 levels were associated with fibrosis levels around the airways (rs = 0.529, p = 0.043) and \u03b1 -smooth muscle actin ( \u03b1 -SMA) (rs = 0.554, p = 0.032).", {"entities": [[7, 12, "GENE"]]}], ["FSTL1 levels in bronchoalveolar lavage fluid were associated with collagen I (rs = 0.536, p = 0.040), \u03b1 -SMA (rs = 0.561, p = 0.029), fibrosis levels (rs = 0.779, p = 0.001), and the thickness of the airway reticular basement membrane (RBM) (rs = 0.660, p = 0.007).", {"entities": [[0, 5, "GENE"], [236, 239, "GENE"]]}], ["FSTL1 levels in asthmatics were linked with increased smooth muscle mass and thickened RBM.", {"entities": [[0, 5, "GENE"], [87, 90, "GENE"]]}], ["FSTL1 may contribute to airway remodeling in asthmatics.", {"entities": [[0, 5, "GENE"]]}], ["Infectious diseases such as pneumonia take the lives of millions of children in low- and middle-income countries every year.", {"entities": [[28, 37, "DISEASE"]]}], ["Many of these deaths could be prevented with the availability of robust and low-cost diagnostic tools using integrated sensor technology.", {"entities": []}], ["Pulse oximetry in particular, offers a unique non-invasive and specific test for an increase in the severity of many infectious diseases such as pneumonia.", {"entities": [[145, 154, "DISEASE"]]}], ["If pulse oximetry could be delivered on widely available mobile phones, it could become a compelling solution to global health challenges.", {"entities": []}], ["Many lives could be saved if this technology was disseminated effectively in the affected regions of the world to rescue patients from the fatal consequences of these infectious diseases.", {"entities": []}], ["We describe the implementation of such an oximeter that interfaces a conventional clinical oximeter finger sensor with a smartphone through the headset jack audio interface, and present a simulator-based systematic verification system to be used for automated validation of the sensor interface on different smartphones and media players.", {"entities": []}], ["An excellent agreement was found between the simulator and the audio oximeter for both oxygen saturation and heart rate over a wide range of optical transmission levels on 4th and 5th generations of the iPod Touch\u2122 and iPhone\u2122 devices.", {"entities": []}], ["Dyskeratosis congenita is a rare genodermatosis, characterized by a triad of reticular skin pigmentation, nail dystrophy and leukoplakia of mucous membranes.", {"entities": [[0, 22, "DISEASE"]]}], ["It is also associated with a variety of non-cutaneous abnormalities such as bone marrow failure, malignancy and pulmonary complications.", {"entities": []}], ["Among its wide range of clinical manifestations, fatal pneumothorax has rarely been reported.", {"entities": [[55, 67, "DISEASE"]]}], ["We report the case of a 31-year-old Lebanese woman with dyskeratosis congenita who succumbed to devastating bilateral pneumothoraces.", {"entities": [[56, 78, "DISEASE"]]}], ["Careful surveillance of patients with dyskeratosis congenita is required as incipient respiratory failure due to pneumothorax may be successfully treated if detected at an early stage.", {"entities": [[86, 105, "DISEASE"], [38, 60, "DISEASE"], [113, 125, "DISEASE"]]}], ["Affymetrix Axiom single nucleotide polymorphism (SNP) arrays provide a cost-effective, high-density, and high-throughput genotyping solution for population-optimized analyses.", {"entities": []}], ["However, no public software is available for the integrated genomic analysis of hybridization intensities and genotypes for this new-generation population-optimized genotyping platform.", {"entities": []}], ["A set of statistical methods was developed for an integrated analysis of allele frequency (AF), allelic imbalance (AI), loss of heterozygosity (LOH), long contiguous stretch of homozygosity (LCSH), and copy number variation or alteration (CNV/CNA) on the basis of SNP probe hybridization intensities and genotypes.", {"entities": []}], ["This study analyzed 3,236 samples that were genotyped using different SNP platforms.", {"entities": []}], ["The proposed AF adjustment method considerably increased the accuracy of AF estimation.", {"entities": []}], ["The proposed quick circular binary segmentation algorithm for segmenting copy number reduced the computation time of the original segmentation method by 30\u201367\u00a0%.", {"entities": []}], ["The proposed CNV/CNA detection, which integrates AI and LOH/LCSH detection, had a promising true positive rate and well-controlled false positive rate in simulation studies.", {"entities": []}], ["Moreover, our real-time quantitative polymerase chain reaction experiments successfully validated the CNVs/CNAs that were identified in the Axiom data analyses using the proposed methods; some of the validated CNVs/CNAs were not detected in the Affymetrix Array 6.0 data analysis using the Affymetrix Genotyping Console.", {"entities": []}], ["All the analysis functions are packaged into the ALICE (AF/LOH/LCSH/AI/CNV/CNA Enterprise) software.", {"entities": []}], ["ALICE and the used genomic reference databases, which can be downloaded from http://hcyang.stat.sinica.edu.tw/software/ALICE.html , are useful resources for analyzing genomic data from the Axiom and other SNP arrays.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-016-2478-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["With the goal of reducing exposure to secondhand smoke, the state of Minnesota (MN), enacted a smoke-free law (i.e., Freedom to Breathe Act) in all workplaces, restaurants, and bars in 2007.", {"entities": []}], ["This retrospective cohort study analyzes emergency department (ED) visits in Olmsted County, MN, for chronic obstructive pulmonary disease (COPD) and asthma over a five-year period to assess changes after enactment of the smoke-free law.", {"entities": [[101, 138, "DISEASE"], [150, 156, "DISEASE"]]}], ["We calculated the rates of ED visits in Olmsted County, MN, with a primary diagnosis of COPD and asthma in the five-year period from January 1, 2005 to December 31, 2009.", {"entities": [[97, 103, "DISEASE"]]}], ["Analyses were performed using segmented Poisson regression to assess whether ED visit rates declined following enactment of the smoke free law after adjusting for potential underlying temporal trends in ED visit rates during this time period.", {"entities": []}], ["Using segmented Poisson regression analyses, a significant reduction was detected in asthma-related ED visits (RR 0.814, p\u2009<\u20090.001) but not for COPD-related ED visits following the enactment of the smoke-free law.", {"entities": [[85, 91, "DISEASE"]]}], ["The reduction in asthma related ED visits was observed in both adults (RR 0.840, p\u2009=\u20090.015) and children (RR 0.751, p\u2009=\u20090.015).", {"entities": [[17, 23, "DISEASE"]]}], ["In Olmsted County, MN, asthma-related ED visits declined significantly after enactment of a smoke-free law.", {"entities": [[23, 29, "DISEASE"]]}], ["These results add to the body of literature supporting community health benefits of smoke-free policies in public environments and their potential to reduce health care costs.", {"entities": []}], ["Hyperglycaemia is very common during exacerbations of asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[65, 102, "DISEASE"], [54, 60, "DISEASE"]]}], ["However, its clinical significance is not clear.", {"entities": []}], ["The objective of the present study was to assess whether exacerbation-associated hyperglycaemia affects long-term mortality in these patients.", {"entities": []}], ["A prospective, observational cohort study.", {"entities": []}], ["A single hospital in eastern Finland.", {"entities": []}], ["153 consecutive patients who were hospitalised due to mild to moderate obstructive lung disease exacerbation (110 with asthma and 43 with COPD) and who survived at least 30\u2005days.", {"entities": [[71, 95, "DISEASE"], [119, 125, "DISEASE"], [83, 95, "DISEASE"]]}], ["Plasma glucose levels were recorded seven times during the first day on the ward.", {"entities": []}], ["Several possible confounders were also recorded.", {"entities": []}], ["The median follow-up time was 6\u2005years and 2\u2005months.", {"entities": []}], ["During the follow-up, 57 (37%) of the patients died.", {"entities": []}], ["Previously diagnosed diabetes was strongly associated with elevated mortality (adjusted HR (aHR) 3.03 (1.28 to 7.18).", {"entities": [[88, 90, "GENE"], [92, 95, "GENE"]]}], ["The highest fasting glucose value (aHR 1.10 (1.01 to 1.20) per 1\u2005mmol/L) and the highest postprandial glucose value ((aHR 1.07 (1.00 to 1.16)) were also associated with late mortality.", {"entities": [[35, 38, "GENE"], [118, 121, "GENE"], [35, 38, "GENE"], [118, 121, "GENE"]]}], ["However, the associations between highest glucose values and mortality vanished when the diagnosis of diabetes was included in the same model.", {"entities": []}], ["Within the patients without diabetes, neither fasting (aHR 0.92 (0.42 to 2.02)) nor postprandial ((aHR 1.04 (0.50 to 2.12)) hyperglycaemia was associated with late mortality.", {"entities": [[55, 58, "GENE"], [99, 102, "GENE"], [55, 58, "GENE"], [99, 102, "GENE"]]}], ["There were no statistically significant differences in the underlying causes of death between the patients with and without diabetes.", {"entities": []}], ["A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality.", {"entities": [[68, 92, "DISEASE"], [80, 92, "DISEASE"]]}], ["Associations between interleukin-13 (IL-13) polymorphisms and asthma risk remained controversial and ambiguous.", {"entities": [[62, 68, "DISEASE"]]}], ["Therefore, we performed a meta-analysis to assess the associations between IL-13 polymorphisms and asthma susceptibility.", {"entities": [[99, 105, "DISEASE"]]}], ["Pubmed, EMBASE, Chinese National Knowledge Infrastructure (CNKI) and Wangfang databases were searched.", {"entities": []}], ["Odds ratios (ORs) with 95% confidence intervals (CIs) were used to calculate the strength of association in the random-effects model.", {"entities": []}], ["Thirty-four studies were included in this meta-analysis.", {"entities": []}], ["The results indicated that IL13 -1112C/T polymorphism was significantly associated with asthma risk (OR\u200a=\u200a1.20, 95% CI 1.08\u20131.34, P \u200a=\u200a0.0009) in a dominant genetic model.", {"entities": [[88, 94, "DISEASE"], [27, 31, "GENE"]]}], ["When stratifying for race, IL13 -1112C/T polymorphism exhibited increased asthma risk in Caucasians (OR\u200a=\u200a1.30, 95% CI 1.09\u20131.55, P\u200a=\u200a 0.003), while no significant association was found in Asians and African Americans.", {"entities": [[74, 80, "DISEASE"], [27, 31, "GENE"]]}], ["In the subgroup analysis based on atopic status, significant association was observed in atopic patients (OR\u200a=\u200a1.25, 95% CI 1.07\u20131.45, P\u200a=\u200a 0.004) but not in the non-atopic patients.", {"entities": []}], ["In addition, a significant association between IL13 +2044A/G polymorphism and asthma risk was observed (OR\u200a=\u200a1.18, 95% CI 1.08\u20131.28, P \u200a=\u200a0.0002).", {"entities": [[78, 84, "DISEASE"], [47, 51, "GENE"]]}], ["In the subgroup analysis by ethnicity, there were significant associations between IL13 +2044A/G polymorphism and asthma risk in Asians (OR\u200a=\u200a1.19, 95% CI 1.04\u20131.36, P\u200a=\u200a 0.01) and Caucasians (OR\u200a=\u200a1.22, 95% CI 1.06\u20131.40, P\u200a=\u200a 0.005) but not in African Americans.", {"entities": [[114, 120, "DISEASE"], [83, 87, "GENE"]]}], ["In the subgroup analysis stratified by atopic status, a marginal significant association was found in atopic patients (OR\u200a=\u200a1.12, 95% CI 1.00\u20131.26, P\u200a=\u200a 0.05).", {"entities": []}], ["This meta-analysis suggested that the IL13 -1112C/T and +2044A/G polymorphisms were risk factors for asthma.", {"entities": [[101, 107, "DISEASE"], [38, 42, "GENE"]]}], ["The involvement of complement activation products in promoting tumor growth has not yet been recognized.", {"entities": []}], ["Here we show that generation of complement C5a in the tumor microenvironment enhanced tumor growth by suppressing the anti-tumor CD8", {"entities": []}], ["Serine proteases promote inflammation and tissue remodeling by activating proteinase-activated receptors, urokinase, metalloproteinases and angiotensin.", {"entities": []}], ["In the present study, 4-(2-Aminoethyl) benzenesulfonyl fluoride (AEBSF) a serine protease inhibitor was evaluated for prophylactic and therapeutic treatment in mouse model of airway allergy.", {"entities": []}], ["BALB/c mice were sensitized by i.p route and challenged with ovalbumin.", {"entities": []}], ["They were treated i.n.", {"entities": []}], ["with 2, 10 and 50 \u00b5g of AEBSF, one hour before or after challenge and euthanized to collect BALF (bronchoalveolar lavage fluid), blood and lungs.", {"entities": []}], ["Proteolytic activity, total cell/eosinophil/neutrophil count eosinophil peroxidase activity (EPO), IL-4, IL-5, IL-10, IL-13, cysteinyl leukotrienes and 8-isoprostane were determined in BALF and immunoglobulins were measured in serum.", {"entities": [[93, 96, "GENE"]]}], ["H&E and PAS stained lung sections were examined for cellular infiltration and airway inflammation.", {"entities": []}], ["Mice exposed to ovalbumin and treated with PBS showed increased cellular infiltration in lungs and higher serum IgE, IgG1 and IgG2a levels as compared to sham mice.", {"entities": []}], ["Treatment with AEBSF reduced total cells/eosinophil/neutrophil infiltration.", {"entities": []}], ["Both prophylactic and therapeutic AEBSF treatment of 10 or 50 \u00b5g reduced serum IgE and IgG1 significantly (p<0.05) than control.", {"entities": []}], ["AEBSF treatment reduced the proteolytic activity in BALF.", {"entities": []}], ["IL-4 IL-5 and IL-13 levels decreased significantly (p<0.05) after AEBSF treatment while IL-10 levels increased significantly (p<0.05) in BALF.", {"entities": []}], ["Airway inflammation and goblet cell hyperplasia reduced as demonstrated by lung histopathology, EPO activity and cysteinyl leukotrienes in BALF after treatment.", {"entities": [[96, 99, "GENE"]]}], ["AEBSF treatment also suppressed oxidative stress in terms of 8-isoprostane in BALF.", {"entities": []}], ["Among the treatment doses, 10 or 50 \u00b5g of AEBSF were most effective in reducing the inflammatory parameters.", {"entities": []}], ["Prophylactic and therapeutic treatment with serine protease inhibitor attenuates the airway inflammation in mouse model of airway allergy and have potential for adjunct therapy.", {"entities": []}], ["We examined the association of impaired lung function and respiratory symptoms with measures of health status and health-related quality of life (HRQOL) among US adults.", {"entities": []}], ["The sample included 5139 participants aged 40\u201379\u00a0years in the National Health and Nutrition Examination Survey 2007\u20132010 who underwent spirometric testing and responded to questions about respiratory symptoms, health status, and number of physically unhealthy, mentally unhealthy, or activity limitation days in the prior 30\u00a0days.", {"entities": []}], ["Among these adults, 7.2% had restrictive impairment (FEV 1 /FVC\u2009\u2265\u200970%; FVC\u2009<\u200980% of predicted), 10.9% had mild obstruction (FEV 1 /FVC\u2009<\u200970%; FEV 1 \u2009\u2265\u200980% predicted), and 9.0% had moderate\u2013severe obstruction (FEV 1 /FVC\u2009<\u200970%; FEV 1 \u2009<\u200980% predicted).", {"entities": [[53, 56, "GENE"], [124, 127, "GENE"], [142, 145, "GENE"], [209, 212, "GENE"], [227, 230, "GENE"], [53, 56, "GENE"], [124, 127, "GENE"], [142, 145, "GENE"], [209, 212, "GENE"], [227, 230, "GENE"], [53, 56, "GENE"], [124, 127, "GENE"], [142, 145, "GENE"], [209, 212, "GENE"], [227, 230, "GENE"], [53, 56, "GENE"], [124, 127, "GENE"], [142, 145, "GENE"], [209, 212, "GENE"], [227, 230, "GENE"], [53, 56, "GENE"], [124, 127, "GENE"], [142, 145, "GENE"], [209, 212, "GENE"], [227, 230, "GENE"]]}], ["Individuals with restrictive impairment or moderate\u2013severe obstruction were more likely to report fair/poor health compared to those with normal lung function (prevalence ratio (PR) =1.5 [95% CI: 1.2-1.9] and 1.5 [1.3-1.8]), after controlling for sociodemographics, non-respiratory chronic diseases, body mass index, smoking, and respiratory symptoms.", {"entities": []}], ["Frequent mental distress (FMD; \u226514 mentally unhealthy days), frequent physical distress (FPD; \u226514 physically unhealthy days), and frequent activity limitation (FAL; \u226514 activity limitation days) did not differ by lung function status.", {"entities": []}], ["Adults who reported any respiratory symptoms (frequent cough, frequent phlegm, or past year wheeze) were more likely to report fair/poor health (PR\u2009=\u20091.5 [1.3-1.7]), FPD (PR\u2009=\u20091.6 [1.4-1.9]), FMD (PR\u2009=\u20091.8 [1.4-2.2]), and FAL (PR\u2009=\u20091.4 [1.1-1.9]) than those with no symptoms.", {"entities": []}], ["These results suggest the importance of chronic respiratory symptoms as potential risk factors for poor HRQOL and suggest improved symptom treatment and prevention efforts would likely improve HRQOL.", {"entities": []}], ["The first report of systematic miRNA profiling in cells of the hematopoietic system suggests that, in addition to regulating commitment to particular cellular lineages, miRNAs might have a general role in cell differentiation and cell identity.", {"entities": []}], ["MicroRNAs (miRNAs) are a class of recently discovered noncoding RNA genes that post-transcriptionally regulate gene expression.", {"entities": []}], ["It is becoming clear that miRNAs play an important role in the regulation of gene expression during development.", {"entities": []}], ["However, in mammals, expression data are principally based on whole tissue analysis and are still very incomplete.", {"entities": []}], ["We used oligonucleotide arrays to analyze miRNA expression in the murine hematopoietic system.", {"entities": []}], ["Complementary oligonucleotides capable of hybridizing to 181 miRNAs were immobilized on a membrane and probed with radiolabeled RNA derived from low molecular weight fractions of total RNA from several different hematopoietic and neuronal cells.", {"entities": []}], ["This method allowed us to analyze cell type-specific patterns of miRNA expression and to identify miRNAs that might be important for cell lineage specification and/or cell effector functions.", {"entities": []}], ["This is the first report of systematic miRNA gene profiling in cells of the hematopoietic system.", {"entities": []}], ["As expected, miRNA expression patterns were very different between hematopoietic and non-hematopoietic cells, with further subtle differences observed within the hematopoietic group.", {"entities": []}], ["Interestingly, the most pronounced similarities were observed among fully differentiated effector cells (Th1 and Th2 lymphocytes and mast cells) and precursors at comparable stages of differentiation (double negative thymocytes and pro-B cells), suggesting that in addition to regulating the process of commitment to particular cellular lineages, miRNAs might have an important general role in the mechanism of cell differentiation and maintenance of cell identity.", {"entities": []}], ["Transcranial Doppler evaluates cerebral hemodynamics in patients with brain injury and is a useful technical tool in diagnosing cerebral circulatory arrest, usually present in the brain-dead patient.", {"entities": []}], ["This Latin American Consensus was formed by a group of 26 physicians experienced in the use of transcranial Doppler in the context of brain death.", {"entities": []}], ["The purpose of this agreement was to make recommendations regarding the indications, technique, and interpretation of the study of transcranial ultrasonography in patients with a clinical diagnosis of brain death or in the patient whose clinical diagnosis presents difficulties; a working group was formed to enable further knowledge and to strengthen ties between Latin American physicians working on the same topic.", {"entities": []}], ["A review of the literature, concepts, and experiences were exchanged in two meetings and via the Internet.", {"entities": []}], ["Questions about pathophysiology, equipment, techniques, findings, common problems, and the interpretation of transcranial Doppler in the context of brain death were answered.", {"entities": []}], ["The basic consensus statements are the following: cerebral circulatory arrest is the final stage in the evolution of progressive intracranial hypertension, which is visualized with transcranial Doppler as a \"pattern of cerebral circulatory arrest\".", {"entities": [[142, 154, "DISEASE"], [129, 154, "DISEASE"]]}], ["The following are accepted as the standard of cerebral circulatory arrest: reverberant pattern, systolic spikes, and absence of previously demonstrated flow.", {"entities": []}], ["Ultrasonography should be used - in acceptable hemodynamic conditions - in the anterior circulation bilaterally (middle cerebral artery) and in the posterior (basilar artery) territory.", {"entities": []}], ["If no ultrasonographic images are found in any or all of these vessels, their proximal arteries are acceptable to be studied to look for a a pattern of cerebral circulatory arrest.", {"entities": []}], ["The knowledge that the environment in which we live, grow and play, can have negative or positive impacts on our health and development is not new.", {"entities": []}], ["However the recognition that adverse environments can significantly and specifically affect the growth and development of a child from early intrauterine life through to adolescence, as well as impact their health later in adulthood, is relatively recent and has not fully reached health care providers involved in paediatric care.", {"entities": []}], ["Over the past 15 years, world declarations and statements on children's rights, sustainable development, chemical safety and most recently climate change, have succeeded in cultivating a global focus on children's health and their right to a healthy environment.", {"entities": []}], ["Many international calls for research in the area, have also been able to identify patterns of environmental diseases in children, assess children's exposures to many environmental toxicants, identify developmental periods of vulnerability, and quantify the cost benefits to public health systems and beyond, of addressing environmentally related diseases in children.", {"entities": []}], ["Transferring this information to front-line health care providers and increasing their awareness about the global burden of disease attributed to the environment and children's especial vulnerability to environmental threats is the salient aim of this commentary.", {"entities": []}], ["The Prevention and Incidence of Asthma and Mite Allergy (PIAMA) study is a birth cohort study that investigates the influence of allergen exposure on the development of allergy and asthma in the first several years of life.", {"entities": [[32, 38, "DISEASE"], [181, 187, "DISEASE"]]}], ["The objectives of this study were to investigate the relationship between a family history of allergy and/or asthma and exposure of newborn children to mite and pet allergen and to study the influence of different home and occupant characteristics on mite allergen exposure.", {"entities": [[109, 115, "DISEASE"]]}], ["Dust was sampled from the child's mattress and the parental mattress at 3 months after birth of the index child and analyzed for mite and pet allergens.", {"entities": []}], ["Subjects were divided in groups according to history of asthma and allergy in their parents, and allergen exposure was studied in the different groups.", {"entities": [[56, 62, "DISEASE"]]}], ["Cat allergen exposure was significantly lower on parental mattresses in families with allergic mothers, but dog allergen exposure was not different.", {"entities": []}], ["Mite allergen exposure was lower on parental mattresses in families with allergic mothers.", {"entities": []}], ["Use of mite allergen-impermeable mattress covers reduced mite allergen exposure.", {"entities": []}], ["Some other characteristics such as age of home and mattress were also found to influence mite allergen exposure.", {"entities": []}], ["Parental mattresses in homes of allergic mothers had lower cat and mite (but not dog) allergen loadings than mattresses in homes of nonallergic parents.", {"entities": []}], ["Paternal (as opposed to maternal) allergy seemed to have little influence.", {"entities": []}], ["This study aims to describe the types of intrafamilial violence perpetrated against children according to living conditions, family factors, and child characteristics, and to identify the association between types of intrafamilial violence and asthma symptoms in atopic and non-atopic children.", {"entities": [[244, 250, "DISEASE"]]}], ["A cross-sectional study was carried out with 1,370 caregivers as part of the Social Changes, Asthma and Allergy in Latin America (SCAALA) study, conducted in 2006 in Brazil.", {"entities": [[93, 99, "DISEASE"]]}], ["The study population was selected by random sampling.", {"entities": []}], ["The main outcome measures were atopic and non-atopic asthma.", {"entities": [[53, 59, "DISEASE"]]}], ["We investigate the association between intrafamilial violence and asthma symptoms in atopic and non-atopic children.", {"entities": [[66, 72, "DISEASE"]]}], ["A backward multivariate logistic polytomous regression was performed to verify the main association.", {"entities": []}], ["Nonviolent discipline (NVD) and maltreatment nonviolent discipline (MNVD) were positively associated with non-atopic asthma symptoms (NVD: odds ratio (OR)\u00a0=\u00a01.95/95% confidence interval (CI)\u00a0=\u00a01.17\u20133.25; MNVD: OR\u00a0=\u00a01.95/95% CI\u00a0=\u00a01.19\u20133.20).", {"entities": [[117, 123, "DISEASE"]]}], ["However, for the most severe intrafamilial violence, this association was not found after control of potential confounders.", {"entities": []}], ["This study demonstrates the effect of types of intrafamilial violence on non-atopic asthma.", {"entities": [[84, 90, "DISEASE"]]}], ["Intrafamilial violence against children represents one more component in the determination of non-atopic asthma in Latin America.", {"entities": [[105, 111, "DISEASE"]]}], ["Methotrexate has immunosuppressive effects and is administered for refractory chronic urticaria.", {"entities": [[86, 95, "DISEASE"]]}], ["We present a case of Pneumocystis jirovecii pneumonia in a patient with refractory chronic urticaria managed by low-dose weekly methotrexate treatment (total cumulative dose 195mg).", {"entities": [[91, 100, "DISEASE"], [44, 53, "DISEASE"]]}], ["Our study highlights the importance of providing prompt diagnosis and treatment of Pneumocystis jirovecii pneumonia in patients with chronic urticaria under methotrexate therapy.", {"entities": [[141, 150, "DISEASE"], [106, 115, "DISEASE"]]}], ["Natural Killer (NK) cells are active against Aspergillus fumigatus, which in turn is able to impair the host defense.", {"entities": []}], ["Unfortunately, little is known on the mutual interaction of NK cells and A. fumigatus .", {"entities": []}], ["We coincubated human NK cells with A. fumigatus hyphae and assessed the gene expression and protein concentration of selected molecules.", {"entities": []}], ["We found that A. fumigatus up-regulates the gene expression of pro-inflammatory molecules in NK cells, but inhibited the release of these molecules resulting in intracellular accumulation and limited extracellular availability.", {"entities": []}], ["A. fumigatus down-regulatedmRNA levels of perforin in NK cells, but increased its intra- and extracellular protein concentration.", {"entities": []}], ["The gene expression of stress related molecules of A. fumigatus such as heat shock protein hsp90 was up-regulated by human NK cells.", {"entities": []}], ["Our data characterize for the first time the immunosuppressive effect of A. fumigatus on NK cells and may help to develop new therapeutic antifungal strategies.", {"entities": []}], ["Obesity is a global epidemic affecting chronic inflammatory diseases.", {"entities": [[0, 7, "DISEASE"]]}], ["Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease that can occur as an extraintestinal manifestation of inflammatory bowel disease (IBD).", {"entities": [[130, 156, "DISEASE"], [8, 30, "DISEASE"], [62, 75, "DISEASE"], [19, 30, "DISEASE"]]}], ["Previously we reported that patients with PSC who are obese have a higher risk of advanced liver disease.", {"entities": [[91, 104, "DISEASE"]]}], ["Currently it is unknown how obesity accelerates or worsens PSC.", {"entities": [[28, 35, "DISEASE"]]}], ["We evaluated the progression of PSC in an antigen-driven cholangitis mouse model of diet-induced obesity.", {"entities": [[97, 104, "DISEASE"], [57, 68, "DISEASE"]]}], ["Obesity was induced in our murine model of immune-mediated cholangitis (OVAbil).", {"entities": [[0, 7, "DISEASE"], [59, 70, "DISEASE"]]}], ["OVAbil mice were fed standard chow or high-fat/sucrose diet for twelve weeks followed by induction of biliary inflammation by OVA-specific T cell transfer.", {"entities": []}], ["Histopathological damage in portal tracts was scored and serum collected.", {"entities": []}], ["Neutralizing antibodies against IL-15 were administered daily until study termination.", {"entities": []}], ["Obese mice developed exacerbated liver inflammation and damage.", {"entities": []}], ["Immune cell phenotyping in liver revealed greater numbers of neutrophils and CD8+ T cells in obese mice.", {"entities": []}], ["Higher levels of cytokines and chemokines were found in obese mice with cholangitis.", {"entities": [[72, 83, "DISEASE"]]}], ["Immuno-neutralizing antibodies against IL-15 greatly attenuated cholangitis in obese mice.", {"entities": [[64, 75, "DISEASE"]]}], ["Obesity exacerbated experimental PSC in part by overproduction of IL-15.", {"entities": [[0, 7, "DISEASE"]]}], ["Timely targeting of IL-15 may slow the progression of PSC.", {"entities": []}], ["Critical transitions are sudden, often irreversible, changes that can occur in a large variety of complex systems; signals that warn of critical transitions are therefore highly desirable.", {"entities": []}], ["We propose a new method for early warning signals that integrates multiple sources of information and data about the system through the framework of a generalized model.", {"entities": []}], ["We demonstrate our proposed approach through several examples, including a previously published fisheries model.", {"entities": []}], ["We regard our method as complementary to existing early warning signals, taking an approach of intermediate complexity between model-free approaches and fully parameterized simulations.", {"entities": []}], ["One potential advantage of our approach is that, under appropriate conditions, it may reduce the amount of time series data required for a robust early warning signal.", {"entities": []}], ["Fisheries, coral reefs, productive farmland, planetary climate, neural activity in the brain, and financial markets are all complex systems that can be susceptible to sudden changes leading to drastic re-organization or collapse.", {"entities": []}], ["A variety of signals based on analysis of time-series data have been proposed that would provide warning of these so-called critical transitions.", {"entities": []}], ["We propose a new method for calculating early warning signals that is complementary to existing approaches.", {"entities": []}], ["The key step is to incorporate other available information about the system through the framework of a so-called generalized model.", {"entities": []}], ["Our new approach may help to anticipate future catastrophic regime shifts in nature and society, allowing humankind to avert or to mitigate the consequences of the impending change.", {"entities": []}], ["Objective To establish mortality from pandemic A/H1N1 2009 influenza up to 8 November 2009.", {"entities": [[59, 68, "DISEASE"]]}], ["Design Investigation of all reported deaths related to pandemic A/H1N1 in England.", {"entities": []}], ["Setting Mandatory reporting systems established in acute hospitals and primary care.", {"entities": []}], ["Participants Physicians responsible for the patient.", {"entities": []}], ["Main outcome measures Numbers of deaths from influenza combined with mid-range estimates of numbers of cases of influenza to calculate age specific case fatality rates.", {"entities": [[45, 54, "DISEASE"], [112, 121, "DISEASE"]]}], ["Underlying conditions, time course of illness, and antiviral treatment.", {"entities": []}], ["Results With the official mid-range estimate for incidence of pandemic A/H1N1, the overall estimated case fatality rate was 26 (range 11-66) per 100\u2009000.", {"entities": []}], ["It was lowest for children aged 5-14 (11 (range 3-36) per 100\u2009000) and highest for those aged \u226565 (980 (range 300-3200) per 100\u2009000).", {"entities": []}], ["In the 138 people in whom the confirmed cause of death was pandemic A/H1N1, the median age was 39 (interquartile range 17-57).", {"entities": []}], ["Two thirds of patients who died (92, 67%) would now be eligible for the first phase of vaccination in England.", {"entities": []}], ["Fifty (36%) had no, or only mild, pre-existing illness.", {"entities": []}], ["Most patients (108, 78%) had been prescribed antiviral drugs, but of these, 82 (76%) did not receive them within the first 48 hours of illness.", {"entities": []}], ["Conclusions Viewed statistically, mortality in this pandemic compares favourably with 20th century influenza pandemics.", {"entities": [[99, 108, "DISEASE"]]}], ["A lower population impact than previous pandemics, however, is not a justification for public health inaction.", {"entities": []}], ["Our data support the priority vaccination of high risk groups.", {"entities": []}], ["We observed delayed antiviral use in most fatal cases, which suggests an opportunity to reduce deaths by making timely antiviral treatment available, although the lack of a control group limits the ability to extrapolate from this observation.", {"entities": []}], ["Given that a substantial minority of deaths occur in previously healthy people, there is a case for extending the vaccination programme and for continuing to make early antiviral treatment widely available.", {"entities": []}], ["There are limited studies directly comparing correlation and agreement between peak expiratory flow rate (PEFR) and forced expiratory volume in 1 second (FEV 1 ) for severity classification of COPD.", {"entities": [[154, 157, "GENE"]]}], ["However, clarifying the role of PEFR as a surrogate of COPD severity classification instead of FEV 1 is essential in situations and areas where spirometry is not routinely available.", {"entities": [[95, 98, "GENE"]]}], ["To evaluate the agreement between FEV 1 and PEFR using Global initiative for chronic Obstructive Lung Disease (GOLD) severity classification criteria.", {"entities": [[34, 37, "GENE"]]}], ["This cross-sectional study included stable COPD patients.", {"entities": []}], ["Both absolute values and % predicted FEV 1 and % predicted PEFR were obtained from the same patients at a single visit.", {"entities": [[37, 40, "GENE"]]}], ["The severity of COPD was classified according to GOLD criteria.", {"entities": []}], ["Pearson\u2019s correlation coefficient was used to examine the relationship between FEV 1 and PEFR.", {"entities": [[79, 82, "GENE"]]}], ["The agreement of % predicted FEV 1 and % predicted PEFR in assigning severity categories was calculated using Kappa statistic, and identification of the limits of agreement was by Bland\u2013Altman analysis.", {"entities": [[29, 32, "GENE"]]}], ["Statistical significance was set at P -value <0.05.", {"entities": []}], ["Three hundred stable COPD patients were enrolled; 195 (65.0%) male, mean age 70.4\u00b19.4 years, and mean % predicted FEV 1 51.4\u00b120.1.", {"entities": [[114, 117, "GENE"]]}], ["Both correlations between the % predicted FEV 1 and PEFR as well as the absolute values were strongly significant ( r =0.76, P <0.001 and r =0.87, P <0.001, respectively).", {"entities": [[42, 45, "GENE"]]}], ["However, severity categories of airflow limitation based on % predicted FEV 1 or PEFR intervals were concordant in only 179 patients (59.7%).", {"entities": [[72, 75, "GENE"]]}], ["The Kappa statistic for agreement was 0.41 (95% confidence interval, 0.34\u20130.48), suggesting unsatisfied agreement.", {"entities": []}], ["The calculated limits of agreement were wide (+27.1% to \u221228.9%).", {"entities": []}], ["Although the correlation between FEV 1 and PEFR measurements were strongly significant, the agreement between the two tests was unsatisfied and may influence inappropriate clinical decision making in diagnosis, severity classification, and management of COPD.", {"entities": [[33, 36, "GENE"]]}], ["Interleukin 13 (IL13) is a T-helper type 2 (Th2) cytokine associated with inflammation and pathology in allergic diseases such as bronchial asthma.", {"entities": [[140, 146, "DISEASE"], [16, 20, "GENE"]]}], ["We have shown that treatment with lebrikizumab, an anti-IL13 monoclonal antibody, significantly improves prebronchodilator forced expiratory volume in 1 s (FEV 1 ) in a subset of subjects with uncontrolled asthma.", {"entities": [[206, 212, "DISEASE"], [156, 159, "GENE"]]}], ["To evaluate efficacy and safety of lebrikizumab in subjects with mild asthma who underwent bronchial allergen challenge.", {"entities": [[70, 76, "DISEASE"]]}], ["Twenty-nine subjects were randomized 1: 1\u20135 mg/kg lebrikizumab ( n = 13) or placebo ( n = 16) administered subcutaneously every 4 weeks over 12 weeks, a total of four doses.", {"entities": []}], ["Primary efficacy outcome was late asthmatic response (LAR) at Week 13, defined as area under the curve of FEV 1 measured 2\u20138 h following inhaled allergen challenge.", {"entities": [[106, 109, "GENE"]]}], ["Serum biomarkers were measured to verify IL13 pathway inhibition and identify patients with an increased response to lebrikizumab.", {"entities": [[41, 45, "GENE"]]}], ["At Week 13, the LAR in lebrikizumab subjects was reduced by 48% compared with placebo subjects, although this was not statistically significant (95% confidence interval, \u221219%, 90%).", {"entities": []}], ["Exploratory analysis indicated that lebrikizumab-treated subjects with elevated baseline levels of peripheral blood eosinophils, serum IgE, or periostin exhibited a greater reduction in LAR compared with subjects with lower baseline levels of these biomarkers.", {"entities": []}], ["Lebrikizumab exerted systemic effects on markers of Th2 inflammation, reducing serum immunoglobulin E (IgE), chemokine ligands 13 and 17 by approximately 25% ( P < 0.01).", {"entities": []}], ["Lebrikizumab was well tolerated.", {"entities": []}], ["Lebrikizumab reduced the LAR in subjects with mild asthma.", {"entities": [[51, 57, "DISEASE"]]}], ["Clinical trial number NCT00781443.", {"entities": []}], ["We investigated whether children affected by tension-type headache and migraine without aura, compared with a healthy control group that was matched by age, culturally and socioeconomically display a diverse intellectual functioning and have a separate \u201ccognitive profile\u201d.", {"entities": [[71, 92, "DISEASE"], [71, 79, "DISEASE"]]}], ["A cross-sectional study was conducted from January 2006 to November 2008 at \u201cSapienza University\u201d in Rome.", {"entities": []}], ["A total of 134 children were diagnosed as being affected by either migraine without aura (93) or tension-type headache (41).", {"entities": [[67, 88, "DISEASE"], [67, 75, "DISEASE"]]}], ["On the basis of our exclusion/inclusion criteria, we enrolled 82 of these 134 children, 63 of whom were affected by migraine without aura and 19 by tension-type headache.", {"entities": [[116, 137, "DISEASE"], [116, 124, "DISEASE"]]}], ["On entry, cognitive functions were assessed in both the affected subjects and the control group by the Wechsler Intelligence Scale for Children-revised.", {"entities": []}], ["Significant differences were found between the headache and control groups in the mean total intelligence quotient and verbal intelligence quotient scores ( p \u00a0<\u00a00.001).", {"entities": []}], ["Significant negative correlations were found between the total intelligence quotient, verbal intelligence quotient, performance intelligence quotient and the frequency of attacks ( r \u00a0=\u00a0\u22120.55 and p \u00a0<\u00a00.001, r \u00a0=\u00a0\u22120.61 and p \u00a0<\u00a00.001, r \u00a0=\u00a0\u22120.29 and p \u00a0<\u00a00.01, respectively), as well as between the total intelligence quotient score and the age at headache onset ( r \u00a0=\u00a00.234, p \u00a0<\u00a00.05).", {"entities": []}], ["Our results suggest that the cognitive profile of children affected by headache should be assessed at the first child neurology outpatient observation.", {"entities": []}], ["From a therapeutic point of view, although within a normal range, the abilities most likely to be less brilliant in such children are verbal skills.", {"entities": []}], ["Conventional asthma and COPD treatments include the use of bronchodilators, mainly \u03b22-adrenergic agonists, muscarinic receptor antagonists and corticosteroids or leukotriene antagonists as anti-inflammatory agents.", {"entities": [[13, 19, "DISEASE"]]}], ["These active drugs are administered either separately or given as a fixed-dose combination medication into a single inhaler.", {"entities": []}], ["ASM-024, a homopiperazinium compound, derived from the structural modification of diphenylmethylpiperazinium (DMPP), has been developed to offer an alternative mechanism of action that could provide symptomatic control through combined anti-inflammatory and bronchodilator properties in a single entity.", {"entities": []}], ["A dose-dependent inhibition of cellular inflammation in bronchoalveolar lavage fluid was observed in ovalbumin-sensitized mice, subsequently treated for 3 days by nose-only exposure with aerosolized ASM-024 at doses up to 3.8 mg/kg (ED 50 \u200a=\u200a0.03 mg/kg).", {"entities": []}], ["The methacholine ED 250 values indicated that airway hyperresponsivenness (AHR) to methacholine decreased following ASM-024 administration by inhalation at a dose of 1.5 mg/kg, with a value of 0.145\u00b10.032 mg/kg for ASM 024-treated group as compared to 0.088\u00b10.023 mg/kg for untreated mice.", {"entities": [[75, 78, "GENE"]]}], ["In in vitro isometric studies, ASM-024 elicited dose-dependent relaxation of isolated mouse tracheal, human, and dog bronchial preparations contracted with methacholine and guinea pig tracheas contracted with histamine.", {"entities": []}], ["ASM-024 showed also a dose and time dependant protective effect on methacholine-induced contraction.", {"entities": []}], ["Overall, with its combined anti-inflammatory, bronchodilating and bronchoprotective properties, ASM-024 may represent a new class of drugs with a novel pharmacological approach that could prove useful for the chronic maintenance treatment of asthma and, possibly, COPD.", {"entities": [[242, 248, "DISEASE"]]}], ["Microsomal triglyceride transfer protein (MTP), an endoplasmic reticulum lipid transfer protein critical for apolipoprotein B (apoB) secretion, regulates CD1d antigen presentation.", {"entities": [[127, 131, "GENE"], [154, 158, "GENE"]]}], ["We identified MTP variant 1 (MTPv1), a novel splice variant of mouse MTP, by polymerase chain reaction and Northern analysis in non\u2013apoB-secreting tissues, including thymocytes and antigen-presenting cells (APCs).", {"entities": [[207, 211, "GENE"]]}], ["Edman degradation of MTPv1 isolated from transfected cells revealed three unique residues; however, recombinant MTP and MTPv1 had an equivalent protein disulfide isomerase association, subcellular localization, triglyceride transfer, phospholipid transfer, response to inhibitors, and ability to support apoB secretion.", {"entities": [[304, 308, "GENE"]]}], ["MTP and MTPv1 efficiently transferred phosphatidylethanolamine to CD1d in vitro.", {"entities": [[66, 70, "GENE"]]}], ["NKT cells fail to develop in fetal thymic organ culture (FTOC) treated with MTP antagonists.", {"entities": []}], ["MTP-inhibited FTOCs produced negligible numbers of CD1d tetramer\u2013positive cells and exhibited marked defects in IL-4 production upon stimulation with anti-CD3 or \u03b1-galactosylceramide\u2013pulsed APCs.", {"entities": [[51, 55, "GENE"], [190, 194, "GENE"]]}], ["CD1d expression on CD4", {"entities": [[0, 4, "GENE"], [19, 22, "GENE"]]}], ["We describe a lethal respiratory outbreak among wild chimpanzees in Uganda in 2013 for which molecular and epidemiologic analyses implicate human rhinovirus C as the cause.", {"entities": []}], ["Postmortem samples from an infant chimpanzee yielded near-complete genome sequences throughout the respiratory tract; other pathogens were absent.", {"entities": []}], ["Epidemiologic modeling estimated the basic reproductive number ( R 0 ) for the epidemic as 1.83, consistent with the common cold in humans.", {"entities": [[117, 128, "DISEASE"]]}], ["Genotyping of 41 chimpanzees and examination of 24 published chimpanzee genomes from subspecies across Africa showed universal homozygosity for the cadherin-related family member 3 CDHR3 -Y 529 allele, which increases risk for rhinovirus C infection and asthma in human children.", {"entities": [[254, 260, "DISEASE"], [181, 186, "GENE"]]}], ["These results indicate that chimpanzees exhibit a species-wide genetic susceptibility to rhinovirus C and that this virus, heretofore considered a uniquely human pathogen, can cross primate species barriers and threatens wild apes.", {"entities": []}], ["We advocate engineering interventions and prevention strategies for rhinovirus infections for both humans and wild apes.", {"entities": []}], ["Amidst diverging discourses describing chronic non-communicable disease (NCD) and healthcare access, the hermeneutical tradition within sociology, particularly as exemplified in the work of Jurgen Habermas, provides a starting point for exploring and interpreting the experiences of chronic illness and healthcare access.", {"entities": []}], ["In this study, we aimed to understand how women living with NCDs experience their illness and access healthcare in an urban and rural context.", {"entities": []}], ["This study was a mixed-methods comparative case study of the healthcare access experiences of women with NCDs in an urban and rural area in South Africa.", {"entities": []}], ["The core of the study methodology was a comparative qualitative case study, with quantitative methods serving to contextualise the findings.", {"entities": []}], ["The cross-sectional survey describes a low resource population with a high prevalence of NCDs.", {"entities": []}], ["Slightly over half the respondents in urban Soweto (50.7%) reported having at least one NCD.", {"entities": []}], ["Only around a third (33.3%) of these participants reported accessing formal healthcare services in the past 6 months.", {"entities": []}], ["Similar trends were found in the review of research carried out in rural Agincourt.", {"entities": []}], ["The qualitative case study in Soweto is characterised by a preoccupation with how medicine from the clinic interacts with the body.", {"entities": []}], ["The Agincourt qualitative case study highlights the importance of church membership, particularly of African Christian Churches, as the strongest factor motivating against the open use of traditional medicine.", {"entities": []}], ["A consideration of the findings suggests five broad themes for further research: 1) processes of constructing body narratives; 2) encounters with purposive\u2013rational systems; 3) encounters with traditional medicine; 4) encounters with contemporary informal medicine; and 5) religion and healthcare.", {"entities": []}], ["These five themes constitute the beginning of a comprehensive schema of the lifeworld/healthworld.", {"entities": []}], ["IL-19 is expressed in esophageal squamous cell carcinoma (SCC), but its biological effect on esophageal cancer remains unclear.", {"entities": [[93, 110, "DISEASE"], [47, 56, "DISEASE"], [33, 56, "DISEASE"], [104, 110, "DISEASE"]]}], ["We determined the correlation between IL-19 expression levels and clinicopathological variables and explored the effects of IL-19 on the esophageal SCC in vivo and in vitro.", {"entities": []}], ["We determined the expression levels of esophageal SCC tissues from 60 patients using immunohistochemistry.", {"entities": []}], ["We examined the effects of IL-19 on intracellular signaling, cytokines production as well as proliferation, colonization, and migration in the human esophageal SCC cell line CE81T.", {"entities": []}], ["Monoclonal antibodies (mAbs) against IL-19 (1BB1) and its receptor IL-20R1 (51D) were used to antagonize the effects of IL-19.", {"entities": []}], ["We injected SCID mice with CE81T cells and then treated them with anti-IL-19 mAb or control IgG every 3 days and determined tumor growth for 32 days.", {"entities": []}], ["Of the 60 esophageal SCC patients, 36 patients (60%) were IL-19 strongly stained, which was associated with advanced tumor stage.", {"entities": []}], ["CE81T cells expressed IL-19 and its receptors.", {"entities": []}], ["IL-19 induced phosphorylation of STAT3, P38, JNK, ERK1/2, Akt, and NF-\u03baB in CE81T cells.", {"entities": [[33, 38, "GENE"]]}], ["IL-19 promoted the proliferation, colonization, and migration of CE81T cells, which were antagonized by 1BB1 and 51D.", {"entities": []}], ["IL-19 also induced expression of the transcripts of TGF-\u03b2, cyclin B1, CXCR4, and MMP-1 in CE81T cells.", {"entities": [[70, 75, "GENE"]]}], ["In CE81T tumor-bearing mice, 1BB1 reduced tumor growth and downregulated TGF-\u03b2, cyclin B1, MMP-1, and CXCR4 expression in tumors.", {"entities": [[102, 107, "GENE"]]}], ["IL-19 affects the pathogenesis of esophageal cancer.", {"entities": [[34, 51, "DISEASE"], [45, 51, "DISEASE"]]}], ["IL-19 mAb (1BB1) is potentially a potent drug for esophageal cancer therapy.", {"entities": [[50, 67, "DISEASE"], [61, 67, "DISEASE"]]}], ["It is becoming increasingly clear that vitamin D has a broad range of actions in the human body.", {"entities": []}], ["Besides its well-known effects on calcium/phosphate homeostasis, vitamin D influences muscle function, cardiovascular homeostasis, nervous function, and the immune response.", {"entities": []}], ["Vitamin D deficiency/insufficiency has been associated with muscle weakness and a high incidence of various chronic diseases such as cardiovascular disease, cancer, multiple sclerosis, and type 1 and 2 diabetes.", {"entities": [[165, 183, "DISEASE"], [157, 163, "DISEASE"]]}], ["Most importantly, low vitamin D status has been found to be an independent predictor of all-cause mortality.", {"entities": []}], ["Several recent randomized controlled trials support the assumption that vitamin D can improve muscle strength, glucose homeostasis, and cardiovascular risk markers.", {"entities": []}], ["In addition, vitamin D may reduce cancer incidence and elevated blood pressure.", {"entities": [[34, 40, "DISEASE"]]}], ["Since the prevalence of vitamin D deficiency/insufficiency is high throughout the world, there is a need to improve vitamin D status in the general adult population.", {"entities": []}], ["However, the currently recommended daily vitamin D intake of 5-15 \u00b5g is too low to achieve an adequate vitamin D status in individuals with only modest skin synthesis.", {"entities": []}], ["Thus, there is a need to recommend a vitamin D intake that is effective for achieving adequate circulating 25-hydroxyvitamin D concentrations (>75 nmol/L).", {"entities": []}], ["Mitochondria contain their own DNA (MtDNA) that is very sensitive to oxidative stress and as a consequence could be damaged in quantity.", {"entities": []}], ["Oxidative stress is largely recognized to play a key role in the pathogenesis of asthma and COPD and might have a role in the new intermediate phenotype ACOS (asthma-COPD overlap syndrome).", {"entities": [[179, 187, "DISEASE"], [81, 87, "DISEASE"], [159, 165, "DISEASE"]]}], ["The aim of this study was to investigate MtDNA alterations, as an expression of mitochondrial dysfunction, in ACOS and to verify whether they might help in the identification of this new phenotype and in its differentiation from asthma and COPD.", {"entities": [[229, 235, "DISEASE"]]}], ["Ten (10) ACOS according to Spanish guidelines, 13 ACOS according to GINA guidelines, 13 COPD, 14 asthmatic patients and ten normal subjects were enrolled.", {"entities": []}], ["They further underwent a blood, induced sputum and exhaled nitric oxide collection.", {"entities": []}], ["Content of MtDNA and nuclear DNA (nDNA) were measured in the blood cells of patients by Real Time PCR.", {"entities": []}], ["ACOS patients showed an increase of MtDNA/nDNA ratio.", {"entities": []}], ["Dividing ACOS according to guidelines, those from the Spanish showed a higher value of MtDNA/nDNA compared to those from GINA/GOLD (92.69\u2009\u00b1\u20097.31 vs 80.68\u2009\u00b1\u20094.16).", {"entities": []}], ["Spanish ACOS presented MtDNA/nDNA ratio closer to COPD than asthma.", {"entities": [[60, 66, "DISEASE"]]}], ["MtDNA was higher in asthmatic, COPD, GINA and Spanish ACOS patients compared to healthy subjects (73.30\u2009\u00b1\u20094.47\u2013137.0\u2009\u00b1\u200919.45\u201380.68\u2009\u00b1\u20094.16\u201392.69\u2009\u00b1\u20097.31 vs 65.97\u2009\u00b1\u200920.56).", {"entities": []}], ["We found an increase of MtDNA/nDNA ratio in ACOS subjects that led us to conclude that there is presence of mitochondrial dysfunction in this disease, that makes it closer to COPD than to asthma.", {"entities": [[188, 194, "DISEASE"]]}], ["Although the MtDNA/nDNA ratio results are a useful marker for differential diagnosis from asthma, COPD and ACOS, further studies are needed to confirm the potentiality of MtDNA/nDNA ratio and to a better characterization of ACOS.", {"entities": [[90, 96, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12890-016-0192-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Functional deterioration in cystic fibrosis (CF) may be reflected by increasing bronchial obstruction and, as recently shown, by ventilation inhomogeneities.", {"entities": [[28, 43, "DISEASE"]]}], ["This study investigated which physiological factors (airway obstruction, ventilation inhomogeneities, pulmonary hyperinflation, development of trapped gas) best express the decline in lung function, and what role specific CFTR genotypes and different types of bronchial infection may have upon this process.", {"entities": [[222, 226, "GENE"]]}], ["Serial annual lung function tests, performed in 152 children (77 males; 75 females) with CF (age range: 6\u201318 y) provided data pertaining to functional residual capacity (FRC pleth , FRC MBNW ), volume of trapped gas (V TG ), effective specific airway resistance (sR eff ), lung clearance index (LCI), and forced expiratory indices (FVC, FEV 1 , FEF 50 ).", {"entities": [[219, 221, "GENE"], [337, 340, "GENE"]]}], ["All lung function parameters showed progression with age.", {"entities": []}], ["Pulmonary hyperinflation (FRC pleth > 2SDS) was already present in 39% of patients at age 6\u20138 yrs, increasing to 67% at age 18 yrs.", {"entities": []}], ["The proportion of patients with V TG > 2SDS increased from 15% to 54% during this period.", {"entities": [[34, 36, "GENE"]]}], ["Children with severe pulmonary hyperinflation and trapped gas at age 6\u20138 yrs showed the most pronounced disease progression over time.", {"entities": []}], ["Age related tracking of lung function parameters commences early in life, and is significantly influenced by specific CFTR genotypes.", {"entities": [[118, 122, "GENE"]]}], ["The group with chronic P. aeruginosa infection demonstrated most rapid progression in all lung function parameters, whilst those with chronic S. aureus infection had the slowest rate of progression.", {"entities": []}], ["LCI, measured as an index of ventilation inhomogeneities was the most sensitive discriminator between the 3 types of infection examined ( p < 0.0001).", {"entities": []}], ["The relationships between lung function indices, CFTR genotypes and infective organisms observed in this study suggest that measurement of other lung function parameters, in addition to spirometry alone, may provide important information about disease progression in CF.", {"entities": [[49, 53, "GENE"]]}], ["The COhort of BRonchial obstruction and Asthma (COBRA) is a longitudinal cohort that involves 12 French academic institutions.", {"entities": [[40, 46, "DISEASE"]]}], ["DNA, serum samples and clinical data are collected at entry and every 6\u2005months thereafter.", {"entities": []}], ["Of 1080 patients with asthma recruited between 2007 and 2015, 401 had mild/moderate and 613 had severe asthma.", {"entities": [[22, 28, "DISEASE"], [103, 109, "DISEASE"]]}], ["In cross-sectional analyses, compared with patients with milder disease, patients with severe asthma had more symptoms, exacerbations, hospitalisations and visits to the emergency department during the preceding 12\u2005months, higher numbers of blood eosinophils, and more comorbidities.", {"entities": [[94, 100, "DISEASE"]]}], ["More than 60% of patients with severe asthma were therapy-uncontrolled at entry, and 152 of them were being treated with omalizumab.", {"entities": [[38, 44, "DISEASE"]]}], ["In addition, patients with asthma who had the highest eosinophilia levels (>300/mm Longitudinal analyses performed in 427 patients with asthma with at least three differential blood cell counts demonstrated that both eosinophil numbers and eosinophil increase over time were associated with the number of exacerbations occurring until the next visit and with Juniper score.", {"entities": [[54, 66, "DISEASE"], [27, 33, "DISEASE"], [136, 142, "DISEASE"]]}], ["Studies with the COBRA cohort will help to improve knowledge concerning the risk and biological factors associated with asthma severity and to better understand their influence on the disease trajectory.", {"entities": [[120, 126, "DISEASE"]]}], ["The COBRA cohort will be a useful tool to characterise asthma phenotypes and to identify associated biomarkers http://ow.ly/10HX30d71vG", {"entities": [[55, 61, "DISEASE"]]}], ["Thymic stromal lymphopoietin (TSLP) has recently been suggested in several epithelial cancers, either pro-tumor or anti-tumor.", {"entities": [[30, 34, "GENE"]]}], ["However, the role of TSLP in colon cancer remains unknown.", {"entities": [[29, 41, "DISEASE"], [35, 41, "DISEASE"], [21, 25, "GENE"]]}], ["We here found significantly decreased TSLP levels in tumor tissues compared with tumor-surrounding tissues of patients with colon cancer and TSLP levels negatively correlated with the clinical staging score of colon cancer.", {"entities": [[124, 136, "DISEASE"], [210, 222, "DISEASE"], [130, 136, "DISEASE"], [216, 222, "DISEASE"], [38, 42, "GENE"], [141, 145, "GENE"], [38, 42, "GENE"], [141, 145, "GENE"]]}], ["TSLPR, the receptor of TSLP, was expressed in all three colon cancer cell lines investigated and colon tumor tissues.", {"entities": [[56, 68, "DISEASE"], [62, 68, "DISEASE"], [23, 27, "GENE"]]}], ["The addition of TSLP significantly enhanced apoptosis of colon cancer cells in a TSLPR-dependent manner.", {"entities": [[57, 69, "DISEASE"], [63, 69, "DISEASE"], [16, 20, "GENE"]]}], ["Interestingly, TSLP selectively induced the apoptosis of colon cancer cells, but not normal colonic epithelial cells.", {"entities": [[57, 69, "DISEASE"], [63, 69, "DISEASE"], [15, 19, "GENE"]]}], ["Furthermore, we demonstrated that TSLP induced JNK and p38 activation and initiated apoptosis mainly through the extrinsic pathway, as caspase-8 inhibitor significantly reversed the apoptosis-promoting effect of TSLP.", {"entities": [[34, 38, "GENE"], [212, 216, "GENE"], [34, 38, "GENE"], [212, 216, "GENE"]]}], ["Finally, using a xenograft mouse model, we demonstrated that peritumoral administration of TSLP greatly reduced tumor growth accompanied with extensive tumor apoptotic response, which was abolished by tumor cell-specific knockdown of TSLPR.", {"entities": [[91, 95, "GENE"]]}], ["Collectively, our study reveals a novel anti-tumor effect of TSLP via direct promotion of the apoptosis of colon cancer cells, and suggests that TSLP could be of value in treating colon cancer.", {"entities": [[107, 119, "DISEASE"], [180, 192, "DISEASE"], [113, 119, "DISEASE"], [186, 192, "DISEASE"], [61, 65, "GENE"], [145, 149, "GENE"], [61, 65, "GENE"], [145, 149, "GENE"]]}], ["Vitamin D deficiency (VDD) has been hypothesized not only to be common but also to represent a potentially modifiable risk factor for greater illness severity and clinical outcome during critical illness.", {"entities": []}], ["The objective of this systematic review was to determine the frequency of VDD in pediatric critical illness and its association with clinical outcomes.", {"entities": []}], ["MEDLINE, Embase, and CENTRAL were searched through December 12, 2016, with no date or language restrictions.", {"entities": []}], ["The primary objective was to estimate the prevalence of VDD in the pediatric intensive care unit (PICU) and compare vitamin D status with healthy control populations.", {"entities": []}], ["Secondary objectives were to evaluate whether VDD is associated with mortality, increased illness severity, PICU interventions, and patient clinical course.", {"entities": []}], ["Random effects meta-analysis was used to calculate pooled VDD event rate, compare levels with those of control subjects, and evaluate for associations between VDD and clinical outcome.", {"entities": []}], ["Among 2700 citations, 17 studies meeting study eligibility were identified.", {"entities": []}], ["The studies reported a total of 2783 critically ill children and had a median sample size of 120 (range 12\u2013511).", {"entities": []}], ["The majority of studies used a 25-hydroxyvitamin D [25(OH)D] level less than 50\u00a0nmol/L to define VDD, and the pooled VDD prevalence was 54.8 (95% CI 45.4\u201363.9).", {"entities": []}], ["Average 25(OH)D levels were significantly lower in PICU patients than in healthy control subjects (pooled difference \u221217.3\u00a0nmol/L, 95% CI \u221214.0 to \u221220.6).", {"entities": []}], ["In a meta-analysis calculation, we found that VDD was associated with increased mortality (OR 1.62, 95% CI 1.11\u20132.36), illness severity, and need for PICU interventions.", {"entities": []}], ["Approximately 50% of critically ill children have VDD at the time of PICU admission, defined as a blood total 25(OH)D concentration under 50\u00a0nmol/L.", {"entities": []}], ["VDD was further determined to be associated with greater illness severity, multiple organ dysfunction, and mortality in the PICU setting.", {"entities": []}], ["Clinical trials are required to determine if optimization of vitamin D status improves patient outcome.", {"entities": []}], ["PROSPERO, CRD42016026617 .", {"entities": []}], ["Registered on 11 January 2016.", {"entities": []}], ["The online version of this article (doi:10.1186/s13054-017-1875-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Current guidelines recommend inhaled pharmacologic therapy as the preferred route of administration for treating COPD.", {"entities": []}], ["Bronchodilators (\u03b2 2 -agonists and antimuscarinics) are the mainstay of pharmacologic therapy in patients with COPD, with long-acting agents recommended for patients with moderate to severe symptoms or those who are at a higher risk for COPD exacerbations.", {"entities": []}], ["Dry powder inhalers and pressurized metered dose inhalers are the most commonly used drug delivery devices, but they may be inadequate in various clinical scenarios (eg, the elderly, the cognitively impaired, and hospitalized patients).", {"entities": []}], ["As more drugs become available in solution formulations, patients with COPD and their caregivers are becoming increasingly satisfied with nebulized drug delivery, which provides benefits similar to drugs delivered by handheld inhalers in both symptom relief and improved quality of life.", {"entities": []}], ["This article reviews recent innovations in nebulized drug delivery and the important role of nebulized therapy in the treatment of COPD.", {"entities": []}], ["Most of the studies on air pollution focus on emissions from fossil fuel burning in urban centers.", {"entities": []}], ["However, approximately half of the world's population is exposed to\u00a0air pollution\u00a0caused by biomass burning emissions.", {"entities": []}], ["In the Brazilian Amazon population, over 10 million people are directly exposed to high levels of pollutants resulting from deforestation and agricultural fires.", {"entities": []}], ["This work is the first study to present an integrated view of the effects of inhalable particles present in emissions of biomass burning.", {"entities": []}], ["Exposing human lung cells to particulate matter smaller than 10 \u00b5m (PM 10 ), significantly increased the level of reactive oxygen species (ROS), inflammatory cytokines, autophagy, and DNA damage.", {"entities": []}], ["Continued PM 10 exposure activated apoptosis and necrosis.", {"entities": []}], ["Interestingly, retene, a polycyclic aromatic hydrocarbon present in PM 10 , is a potential compound for the effects of PM 10 , causing DNA damage and cell death.", {"entities": []}], ["The PM 10 concentrations observed during Amazon biomass burning were sufficient to induce severe adverse effects in human lung cells.", {"entities": []}], ["Our study provides new data that will help elucidate the mechanism of PM 10 -mediated lung cancer development.", {"entities": [[86, 97, "DISEASE"], [91, 97, "DISEASE"]]}], ["In addition, the results of this study support the establishment of new guidelines for human health protection in regions strongly impacted by biomass burning.", {"entities": []}], ["Atopic dermatitis is a prevalent health problem in the world.", {"entities": [[7, 17, "DISEASE"]]}], ["Allergic sensitization is an important risk factor, but the roles of other factors, inherent in tropic region, are unknown.", {"entities": []}], ["A cohort study was designed in a tropical city to investigate molecular and environmental risk factors for eczema, considering as particular features perennial exposure to mites, poor living conditions and others tropical characteristics.", {"entities": []}], ["433 patients were included at baseline and biological samples were collected during 24 months of follow-up.", {"entities": []}], ["Clinical information was collected using questionnaires (SCORAD, DLQI and a subjective scale) during each clinical assessment.", {"entities": []}], ["The prevalence of atopic eczema was 93%, with similar frequency between children and adults; parents history of eczema and polysensitization to mites, dogs, cats, cockroaches and birds, were risk factors for severe and persistent eczema and allergic comorbidities.", {"entities": []}], ["Food sensitization was present in 16% of patients but food-induced allergies were scarce.", {"entities": []}], ["Psychiatric, dental and ocular disorders were the most frequent non-allergic comorbidities.", {"entities": []}], ["selection bias.", {"entities": []}], ["We presented a tropical cohort of patients with eczema and we identified some risk factors for severe and persistent dermatitis.", {"entities": [[117, 127, "DISEASE"]]}], ["Some patterns of sensitization were associated with severe eczema and respiratory symptoms, and the natural history of \"atopic march\" is different to that described in some industrialized countries.", {"entities": []}], ["The collection of biological samples will contribute to the understanding of the gene/environment interactions leading to allergy inception and evolution.", {"entities": []}], ["Neutrophils are increased in the airways and in induced sputum of severe asthma patients.", {"entities": [[73, 79, "DISEASE"]]}], ["We determined the expression of activation markers from circulating neutrophils in severe asthma, and their supressibility by corticosteroids.", {"entities": [[90, 96, "DISEASE"]]}], ["We compared blood neutrophils from mild, moderate-to-severe and severe steroid-dependent asthma, and non-asthmatics (n = 10 each).", {"entities": [[89, 95, "DISEASE"]]}], ["We examined the effect of adding or increasing oral prednisolone (30 mg/day;1 week).", {"entities": []}], ["Flow cytometric expression of CD35 and CD11b, but not of CD62L or CD18, was increased in severe asthma.", {"entities": [[96, 102, "DISEASE"]]}], ["F-met-leu-phe increased CD11b, CD35 and CD18 and decreased CD62L expression in all groups, with a greater CD35 increase in severe asthma.", {"entities": [[130, 136, "DISEASE"]]}], ["In severe steroid-dependent asthma, an increase in prednisolone dose had no effect on neutrophil markers particularly CD62L, but reduced CD11b and CD62L on eosinophils.", {"entities": [[28, 34, "DISEASE"]]}], ["Phorbol myristate acetate-stimulated oxidative burst and IL-8 release by IL-1\u03b2, lipopolysaccharide and GM-CSF in whole blood from mild but not severe asthmatics were inhibited after prednisolone.", {"entities": []}], ["There were no differences in myeloperoxidase or neutrophil elastase release from purified neutrophils.", {"entities": []}], ["Because blood neutrophils in severe asthma are activated and are not inhibited by oral corticosteroids, they may be important in the pathogenesis of severe asthma.", {"entities": [[36, 42, "DISEASE"], [156, 162, "DISEASE"]]}], ["The prevalence of diabetes mellitus is rapidly rising in SSA.", {"entities": [[18, 35, "DISEASE"]]}], ["Interventions are needed to support the decentralization of services to improve and expand access to care.", {"entities": []}], ["We describe a clinical mentorship and quality improvement program that connected nurse mentors with nurse mentees to support the decentralization of type 2 diabetes care in rural Rwanda.", {"entities": []}], ["This is a descriptive study.", {"entities": []}], ["Routinely collected data from patients with type 2 diabetes cared for at rural health center NCD clinics between January 1, 2013 and December 31, 2015, were extracted from EMR system.", {"entities": []}], ["Data collected as part of the clinical mentorship program were extracted from an electronic database.", {"entities": []}], ["Summary statistics are reported.", {"entities": []}], ["The patient population reflects the rural settings, with low rates of traditional NCD risk factors: 5.6% of patients were current smokers, 11.0% were current consumers of alcohol, and 11.9% were obese.", {"entities": []}], ["Of 263 observed nurse mentee-patient encounters, mentor and mentee agreed on diagnosis 94.4% of the time.", {"entities": []}], ["Similarly, agreement levels were high for medication, laboratory exam, and follow-up plans, at 86.3%, 87.1%, and 92.4%, respectively.", {"entities": []}], ["Nurses that receive mentorship can adhere to a type 2 diabetes treatment protocol in rural Rwanda primary health care settings.", {"entities": []}], ["To determine whether optic nerve head (ONH) astrocytes, a key cellular component of glaucomatous neuropathy, exhibit differential gene expression in primary cultures of astrocytes from normal African American (AA) donors compared to astrocytes from normal Caucasian American (CA) donors.", {"entities": [[97, 107, "DISEASE"]]}], ["We used oligonucleotide Affymetrix microarray (HG U133A & HG U133A 2.0 chips) to compare gene expression levels in cultured ONH astrocytes from twelve CA and twelve AA normal age matched donor eyes.", {"entities": []}], ["Chips were normalized with Robust Microarray Analysis (RMA) in R using Bioconductor.", {"entities": []}], ["Significant differential gene expression levels were detected using mixed effects modeling and Statistical Analysis of Microarray (SAM).", {"entities": []}], ["Functional analysis and Gene Ontology were used to classify differentially expressed genes.", {"entities": []}], ["Differential gene expression was validated by quantitative real time RT-PCR.", {"entities": []}], ["Protein levels were detected by Western blots and ELISA.", {"entities": []}], ["Cell adhesion and migration assays tested physiological responses.", {"entities": []}], ["Glutathione (GSH) assay detected levels of intracellular GSH.", {"entities": []}], ["Multiple analyses selected 87 genes differentially expressed between normal AA and CA (P<0.01).", {"entities": []}], ["The most relevant genes expressed in AA were categorized by function, including: signal transduction, response to stress, ECM genes, migration and cell adhesion.", {"entities": []}], ["These data show that normal astrocytes from AA and CA normal donors display distinct expression profiles that impact astrocyte functions in the ONH.", {"entities": []}], ["Our data suggests that differences in gene expression in ONH astrocytes may be specific to the development and/or progression of glaucoma in AA.", {"entities": [[129, 137, "DISEASE"]]}], ["Pneumonia is considered the major cause of mortality among children with acute respiratory disease in low-income countries but may be over-diagnosed at the cost of under-diagnosing asthma.", {"entities": [[0, 9, "DISEASE"], [181, 187, "DISEASE"]]}], ["We report the magnitude of asthma and pneumonia among \u201cunder-fives\u201d with cough and difficulty breathing, based on stringent clinical criteria.", {"entities": [[38, 47, "DISEASE"], [27, 33, "DISEASE"]]}], ["We also describe the treatment for children with acute respiratory symptoms in Mulago Hospital.", {"entities": []}], ["We enrolled 614 children aged 2\u201359 months with cough and difficulty breathing.", {"entities": []}], ["Interviews, physical examination, blood and radiological investigations were done.", {"entities": []}], ["We defined asthma according to Global Initiative for Asthma guidelines.", {"entities": [[11, 17, "DISEASE"], [53, 59, "DISEASE"]]}], ["Pneumonia was defined according to World Health Organization guidelines, which were modified by including fever and white cell count, C-reactive protein, blood culture and chest x-ray.", {"entities": [[0, 9, "DISEASE"]]}], ["Children with asthma or bronchiolitis were collectively referred to as \u201casthma syndrome\u201d due to challenges of differentiating the two conditions in young children.", {"entities": [[79, 87, "DISEASE"], [14, 20, "DISEASE"], [72, 78, "DISEASE"], [24, 37, "DISEASE"]]}], ["Three pediatricians reviewed each participant\u2019s case report post hoc and made a diagnosis according to the study criteria.", {"entities": []}], ["Of the 614 children, 41.2% (95% CI: 37.3\u201345.2) had asthma syndrome, 27.2% (95% CI: 23.7\u201330.9) had bacterial pneumonia, 26.5% (95% CI: 23.1\u201330.2) had viral pneumonia, while 5.1% (95% CI: 3.5\u20137.1) had other diagnoses including tuberculosis.", {"entities": [[108, 117, "DISEASE"], [155, 164, "DISEASE"], [225, 237, "DISEASE"], [58, 66, "DISEASE"], [98, 117, "DISEASE"], [51, 57, "DISEASE"], [149, 164, "DISEASE"]]}], ["Only 9.5% of the children with asthma syndrome had been previously diagnosed as asthma.", {"entities": [[38, 46, "DISEASE"], [31, 37, "DISEASE"], [80, 86, "DISEASE"]]}], ["Of the 253 children with asthma syndrome, 95.3% (95% CI: 91.9\u201397.5) had a prescription for antibiotics, 87.7% (95% CI: 83.1\u201391.5) for bronchodilators and 43.1% (95% CI: 36.9\u201349.4) for steroids.", {"entities": [[32, 40, "DISEASE"], [25, 31, "DISEASE"]]}], ["Although reports indicate that acute respiratory symptoms in children are predominantly due to pneumonia, asthma syndrome contributes a significant proportion.", {"entities": [[95, 104, "DISEASE"], [113, 121, "DISEASE"], [106, 112, "DISEASE"]]}], ["Antibiotics are used irrationally due to misdiagnosis of asthma as pneumonia.", {"entities": [[67, 76, "DISEASE"], [57, 63, "DISEASE"]]}], ["There is need for better diagnostic tools for childhood asthma and pneumonia in Uganda.", {"entities": [[67, 76, "DISEASE"], [56, 62, "DISEASE"]]}], ["DC derived-exosomes are nanomeric vesicles harboring functional MHC/peptide complexes capable of promoting T cell immune responses and tumor rejection.", {"entities": []}], ["Here we report the feasability and safety of the first Phase I clinical trial using autologous exosomes pulsed with MAGE 3 peptides for the immunization of stage III/IV melanoma patients.", {"entities": [[169, 177, "DISEASE"]]}], ["Secondary endpoints were the monitoring of T cell responses and the clinical outcome.", {"entities": []}], ["Exosomes were purified from day 7 autologous monocyte derived-DC cultures.", {"entities": []}], ["Fifteen patients fullfilling the inclusion criteria (stage IIIB and IV, HLA-A1 The GMP process allowed to harvest about 5 \u00d7 10 The first exosome Phase I trial highlighted the feasibility of large scale exosome production and the safety of exosome administration.", {"entities": []}], ["Well-being is now accepted as one of four cross-cutting measures in gauging progress for Healthy People 2020.", {"entities": []}], ["This shift to population indicators of well-being redresses notions of health that have focused on absence of illness (negative health) as a primary or sufficient indicator of positive functioning.", {"entities": []}], ["The purpose of this study was to estimate mental, social, and physical well-being in three US states using new measures piloted on the 2010 Behavioral Risk Factor Surveillance Survey System (BRFSS).", {"entities": []}], ["Baseline estimates were provided for states overall, and within states for demographic subgroups, those with chronic health conditions or disabilities, and those with behavioral risk factors.", {"entities": []}], ["Ten validated questions designed to assess mental (e.g., satisfaction with life, satisfaction with life domains, happiness), physical (e.g., satisfaction with energy level), and social dimensions (e.g., frequency of social support) of well-being were selected with state input for inclusion on BRFSS.", {"entities": []}], ["18,622 individuals responded to the BRFSS surveys administered by New Hampshire (N\u2009=\u20093,139), Oregon (N\u2009=\u20092,289), and Washington (N\u2009=\u200913,194).", {"entities": []}], ["Multivariate adjusted proportions of positive responses to well-being items were examined.", {"entities": []}], ["After adjustment for confounders, about 67% of adults in these states had high levels of well-being, including >80% reporting experiencing happiness.", {"entities": []}], ["Most adults were satisfied with their work, neighborhood, and education, but significant differences were seen in subgroups.", {"entities": []}], ["Well-being differed by demographic characteristics such as marital status, health behaviors, chronic conditions, and disability status, with those who reported a disability and smokers consistently experiencing the worst well-being.", {"entities": []}], ["Well-being is accepted as one of four cross-cutting measures in gauging progress for Healthy People 2020.", {"entities": []}], ["Well-being differs by important sociodemographic factors and health conditions (e.g., age, employment, smoking, disability status).", {"entities": []}], ["These findings provide baseline estimates for the three states to use in gauging improvements in well-being and can serve as a model for other state-level or national surveillance systems.", {"entities": []}], ["These findings also assist states in identifying vulnerable subgroups who may benefit from potential interventions such as those in the National Prevention Strategy that focus on enhancing well-being where such disparities exist.", {"entities": []}], ["This letter considers the main challenges that people with rare diseases and their families face: delay in diagnosis, lack of appropriate support and information, and impaired access to treatment.", {"entities": []}], ["The differences in medical experience between a patient with a rare disease and one with a common one are made through the use of a real-life example: the diagnosis of leiomyosarcoma received by my mother.", {"entities": [[168, 182, "DISEASE"]]}], ["I highlight how patients with rare disease are often misdiagnoses and how their symptoms are often overlooked.", {"entities": []}], ["I also highlight the isolation patients with rare diseases and their families experience due to the lack of knowledge about their condition, the struggle to access treatment and the small amount of information and evidence based medicine for managing rare conditions.", {"entities": []}], ["This article was the winning entry in the Findacure essay contest \u2018The Student Voice\u2019.", {"entities": []}], ["More information about Findacure can be found at http://www.findacure.org.uk .", {"entities": []}], ["Retnla (Resistin-like molecule alpha/FIZZ1) is induced during Th2 cytokine immune responses.", {"entities": []}], ["However, the role of Retnla in Th2-type immunity is unknown.", {"entities": []}], ["Here, using Retnla Schistosoma mansoni is dependent on IL-4 and IL-13 and associated with marked increases in Retnla expression.", {"entities": []}], ["We found that both primary and secondary pulmonary granuloma formation were exacerbated in the absence of Retlna.", {"entities": []}], ["The number of granuloma-associated eosinophils and serum IgE titers were also enhanced.", {"entities": []}], ["Moreover, when chronically infected with S. mansoni cercariae, Retnla Nippostrongylus brasiliensis had intensified lung pathology to migrating larvae, reduced fecundity, and accelerated expulsion of adult worms from the intestine, suggesting Th2 immunity was enhanced.", {"entities": []}], ["When their immune responses were compared, helminth infected Retnla Retnla is a member of a family of cysteine-rich secreted proteins, referred to as \u2018resistin-like molecules\u2019 or \u2018found in inflammatory zone\u2019 that increase in expression during allergic reactions and following infection with a variety of metazoan parasites.", {"entities": []}], ["Retnla was originally hypothesized to function as an effector molecule during helminth-induced Th2-type immune responses.", {"entities": []}], ["Studies conducted here with Retnla-deficient mice, however, suggest that Retnla primarily functions as a regulatory molecule during helminth infection.", {"entities": []}], ["Using three helminth model systems affecting three different organ systems, we show that Retlna is induced by IL-4 and IL-13 as a mechanism to suppress Th2-type immunity.", {"entities": []}], ["Retnla deficiency increased inflammation in the lung following i.v.", {"entities": []}], ["challenge with Schistosoma mansoni eggs.", {"entities": []}], ["Retnla deficiency also accelerated the development of liver fibrosis following S. mansoni infection.", {"entities": []}], ["This finding was particularly surprising since Retnla was previously shown to activate collagen-producing fibroblasts that induce fibrosis.", {"entities": []}], ["Thus, Retnla may represent a novel target for the treatment of fibrotic diseases.", {"entities": []}], ["Finally, resistance to the intestinal nematode parasite Nippostrongylus brasiliensis was significantly increased in the absence of Retnla.", {"entities": []}], ["When viewed together, the combined results from all three models establish a critical role for the Th2-inducible gene Retnla (Fizz1/Relm-alpha) in the suppression of helminth-induced Th2-type immunity.", {"entities": []}], ["The influenza virus is a human pathogen that causes epidemics every year, as well as potential pandemic outbreaks, as occurred in 2009.", {"entities": [[4, 13, "DISEASE"]]}], ["Vaccination has proven to be sufficient in the prevention and containment of viral spreading.", {"entities": []}], ["In addition to the current egg-based vaccines, new and promising vaccine platforms, such as cell culture-derived vaccines that include virus-like particles (VLPs), have been developed.", {"entities": []}], ["VLPs have been shown to be both safe and immunogenic against influenza infections.", {"entities": [[61, 70, "DISEASE"]]}], ["Although antibody persistence has been studied in traditional egg-based influenza vaccines, studies on antibody response durations induced by VLP influenza vaccines in humans are scarce.", {"entities": [[72, 81, "DISEASE"], [146, 155, "DISEASE"]]}], ["Here, we show that subjects vaccinated with an insect cell-derived VLP vaccine, in the midst of the 2009 H1N1 influenza pandemic outbreak in Mexico City, showed antibody persistence up to 24 months post-vaccination.", {"entities": [[110, 119, "DISEASE"]]}], ["Additionally, we found that subjects that reported being revaccinated with a subsequent inactivated influenza virus vaccine showed higher antibody titres to the pandemic influenza virus than those who were not revaccinated.", {"entities": [[100, 109, "DISEASE"], [170, 179, "DISEASE"]]}], ["These findings provide insights into the duration of the antibody responses elicited by an insect cell-derived pandemic influenza VLP vaccine and the possible effects of subsequent influenza vaccination on antibody persistence induced by this VLP vaccine in humans.", {"entities": [[120, 129, "DISEASE"], [181, 190, "DISEASE"]]}], ["The cellular prion protein (PrP", {"entities": []}], ["Families of overweight and obese children require support to make sustainable lifestyle changes to improve their child\u2019s diet and activity behaviours and in turn weight status.", {"entities": []}], ["The aim of this pre-post intervention pilot study was to evaluate the feasibility of an individualised home-based intervention for treatment seeking overweight/obese 4\u201312\u00a0year olds and their caregivers.", {"entities": []}], ["Baseline measures were used to develop a family-specific intervention to improve the quality of the home environment.", {"entities": []}], ["The intervention was delivered as individualised written recommendations and resources plus phone call and home visit support.", {"entities": []}], ["Baseline measures were repeated approximately 6\u00a0months later.", {"entities": []}], ["Complete data for 24 children was available.", {"entities": []}], ["Parents reported that 43\u00a0% of intervention recommendations were implemented \u2018very much\u2019.", {"entities": []}], ["Some descriptive changes were observed in the home environment, most commonly including fruit and vegetables in their child\u2019s lunchbox, not providing food treats, and restricting children\u2019s access to chips/savoury snack biscuits.", {"entities": []}], ["At the group level, minimal change was detected in children\u2019s diet and activity behaviours or weight status (all p\u00a0>\u00a00.05).", {"entities": []}], ["The study findings did not support intervention feasibility in its current form.", {"entities": []}], ["Future interventions should target the family food and activity environment, but also utilise an approach to address the complex social circumstances which limit parent\u2019s ability to prioritise healthy family lifestyle behaviours.", {"entities": []}], ["Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR) 3/12/2014.", {"entities": []}], ["http://www.ANZCTR.org.au .", {"entities": []}], ["ACTRN12614001264673", {"entities": []}], ["In inflammation, inducible nitric oxide synthase (iNOS) produces nitric oxide (NO), which modulates inflammatory processes.", {"entities": []}], ["We investigated the effects of Janus kinase (JAK) inhibitors, AG-490 and WHI-P154, on iNOS expression and NO production in J774 murine macrophages stimulated with interferon-\u03b3 (IFN-\u03b3).", {"entities": []}], ["JAK inhibitors AG-490 and WHI-P154 decreased IFN-\u03b3-induced nuclear levels of signal transducer and activator of transcription 1\u03b1 (STAT1\u03b1).", {"entities": []}], ["JAK inhibitors AG-490 and WHI-P154 decreased also iNOS protein and mRNA expression and NO production in a concentration-dependent manner.", {"entities": []}], ["Neither of the JAK inhibitors affected the decay of iNOS mRNA when determined by actinomycin D assay.", {"entities": []}], ["Our results suggest that the inhibition of JAK-STAT1-pathway by AG-490 or WHI-P154 leads to the attenuation of iNOS expression and NO production in IFN-\u03b3-stimulated macrophages.", {"entities": []}], ["People who undergo weight loss surgery require a comprehensive treatment program to achieve successful outcomes.", {"entities": []}], ["eHealth solutions, such as secure online portals, create new opportunities for improved health care delivery and care, but depend on the organizational delivery systems and on the health care professionals providing it.", {"entities": []}], ["So far, these have received limited attention and the overall adoption of eHealth solutions remains low.", {"entities": []}], ["In this study, a secure eHealth portal was implemented in a bariatric surgery clinic and offered to their patients.", {"entities": []}], ["During the study period of 6 months, 60 patients and 5 health care professionals had access.", {"entities": []}], ["The portal included patient information, self-management tools, and communication features for online dialog with peers and health care providers at the bariatric surgery clinic.", {"entities": []}], ["The aim of this study was to characterize and assess the impact of an eHealth portal on health care professionals\u2019 interaction with patients in bariatric surgery.", {"entities": []}], ["This qualitative case study involved a field study consisting of contextual interviews at the clinic involving observing and speaking with personnel in their actual work environment.", {"entities": []}], ["Semi-structured in-depth interviews were conducted with health care professionals who interacted with patients through the portal.", {"entities": []}], ["Analysis of the collected material was done inductively using thematic analysis.", {"entities": []}], ["The analysis revealed two main dimensions of using an eHealth portal in bariatric surgery: the transparency it represents and the responsibility that follows by providing it.", {"entities": []}], ["The professionals reported the eHealth portal as (1) a source of information, (2) a gateway to approach and facilitate the patients, (3) a medium for irrevocable postings, (4) a channel that exposes responsibility and competence, and (5) a tool in the clinic.", {"entities": []}], ["By providing an eHealth portal to patients in a bariatric surgery program, health care professionals can observe patients\u2019 writings and revelations thereby capturing patient challenges and acting and implementing measures.", {"entities": []}], ["Interacting with patients through the portal can prevent dropouts and deterioration of patients\u2019 health.", {"entities": []}], ["However, professionals report on organizational challenges and personal constraints related to communicating with patients in writing online.", {"entities": []}], ["Further development of guidelines and education of health care professionals about how to handle, prioritize, communicate, and facilitate patients online is required in addition to increased attention to the organizational infrastructures and incentives for enabling such solutions in health care.", {"entities": []}], ["In cell culture, extracellular guanosine increases extracellular adenosine by attenuating the disposition of extracellular adenosine ( American Journal of Physiology \u2013 Cell Physiology 304: C406\u2013C421, 2013).", {"entities": []}], ["The goal of this investigation was to determine whether this \u201cguanosine\u2013adenosine mechanism\u201d is operative in an intact organ.", {"entities": []}], ["Twenty\u2010seven isolated, perfused mouse kidneys were subjected to metabolic poisons (iodoacetate plus 2,4\u2010dinitrophenol) to cause energy depletion and thereby stimulate renal adenosine production.", {"entities": []}], ["Adenosine levels in the renal venous perfusate increased from a baseline of 36 \u00b1 8 to 499 \u00b1 96, 258 \u00b1 50, and 71 \u00b1 13 nmol/L at 15, 30, and 60 min, respectively, after administering metabolic poisons (% of basal; 1366 \u00b1 229, 715 \u00b1 128, and 206 \u00b1 33, respectively).", {"entities": []}], ["Changes in renal venous levels of guanosine closely mirrored the time course of changes in adenosine: baseline of 15 \u00b1 2 to 157 \u00b1 13, 121 \u00b1 8, and 50 \u00b1 5 nmol/L at 15, 30, and 60 min, respectively (% of basal; 1132 \u00b1 104, 871 \u00b1 59, and 400 \u00b1 51, respectively).", {"entities": []}], ["Freeze\u2010clamp experiments in 12 kidneys confirmed that metabolic poisons increased kidney tissue levels of adenosine and guanosine.", {"entities": []}], ["In eight additional kidneys, we examined the ability of guanosine to reduce the renal clearance of exogenous adenosine; and these experiments revealed that guanosine significantly decreased the renal extraction of adenosine.", {"entities": []}], ["Because guanosine is metabolized by purine nucleoside phosphorylase (PNPase), in another set of 16 kidneys we examined the effects of 8\u2010aminoguanine (PNPase inhibitor) on renal venous levels of adenosine and inosine (adenosine metabolite).", {"entities": []}], ["Kidneys treated with 8\u2010aminoguanine showed a more robust increase in both adenosine and inosine in response to metabolic poisons.", {"entities": []}], ["We conclude that in the intact kidney, guanosine regulates adenosine levels.", {"entities": []}], ["In cell culture, extracellular guanosine increases extracellular adenosine by attenuating the disposition of extracellular adenosine ( American Journal of Physiology \u2013 Cell Physiology 304: C406\u2013C421, 2013).", {"entities": []}], ["The goal of this study was to determine whether the \u201cguanosine\u2013adenosine mechanism\u201d is operative in an intact organ.", {"entities": []}], ["In isolated, perfused mouse kidneys, inhibition of energy production induced changes in renal venous levels of guanosine that closely mirrored the time course of changes in adenosine, and freeze\u2010clamp experiments confirmed that metabolic poisons similarly increased kidney tissue levels of adenosine and guanosine.", {"entities": []}], ["Moreover, exogenous guanosine significantly decreased the renal extraction of exogenous adenosine, and inhibition of purine nucleoside phosphorylase (metabolizes guanosine) augmented the effects of energy depletion on renal levels of both guanosine and adenosine.", {"entities": []}], ["We conclude that in the intact kidney, guanosine regulates adenosine levels.", {"entities": []}], ["BACKGROUND: Damp conditions indoors favour the growth of microorganisms, and these contain several agents that may cause inflammation when inhaled.", {"entities": []}], ["Moulds contain a polyglucose in their cell wall, defined as (1-->3)-beta-D-glucan, exhibiting effects on inflammatory cells.", {"entities": []}], ["AIM: The aim of the present study was to evaluate whether an inhalation challenge to purified (1-->3)-beta-D-glucan (grifolan) in humans could induce effects on inflammatory markers in blood, and to evaluate whether the reactions were related to the home exposure to (1-->3)-beta-D-glucan.", {"entities": []}], ["METHODS: Seventeen subjects in homes with high levels of airborne (1-->3)-beta-D-glucan (G-high) and 18 subjects in homes with low levels of (1-->3)-beta-D-glucan (G-low) underwent two randomised, double-blind inhalation challenges, one to (1-->3)-beta-D-glucan suspended in saline and one to saline alone.", {"entities": []}], ["A blood sample was taken before and after the challenges, and differential cell count, granulocyte enzymes in serum and the secretion of cytokines from peripheral blood mononuclear cells (PBMC) were measured.", {"entities": []}], ["RESULTS: Inhalation challenge with (1-->3)-beta-D-glucan induced a decrease in the secretion of tumour necrosis factor alpha from endotoxin-stimulated PBMC in the G-high group as well as in the G-low group.", {"entities": []}], ["In the G-high group, the inhalation of (1-->3)-beta-D-glucan induced an increase in blood lymphocytes that was significantly different from the saline-induced effect.", {"entities": []}], ["CONCLUSIONS: The results suggest that an inhalation challenge to (1-->3)-beta-D-glucan has an effect on inflammatory cells and this effect may be related to a chronic exposure to moulds at home.", {"entities": []}], ["Genetic and disease-related factors give rise to a wide spectrum of glucocorticoid (GC) sensitivity in rheumatoid arthritis (RA).", {"entities": [[103, 123, "DISEASE"], [114, 123, "DISEASE"], [84, 86, "GENE"]]}], ["In clinical practice, GC treatment is not adapted to these differences in GC sensitivity.", {"entities": [[22, 24, "GENE"], [74, 76, "GENE"], [22, 24, "GENE"], [74, 76, "GENE"]]}], ["In vitro assessment of GC sensitivity before the start of therapy could allow more individualized GC therapy.", {"entities": [[23, 25, "GENE"], [98, 100, "GENE"], [23, 25, "GENE"], [98, 100, "GENE"]]}], ["The aim of the study was to investigate the association between in vitro and in vivo GC sensitivity in RA.", {"entities": [[85, 87, "GENE"]]}], ["Thirty-eight early and 37 established RA patients were prospectively studied.", {"entities": []}], ["In vitro GC sensitivity was assessed with dexamethasone-induced effects on interleukin-2 (IL-2) and glucocorticoid-induced leucine zipper (GILZ) messenger RNA expression in peripheral blood mononuclear cells (PBMCs).", {"entities": [[9, 11, "GENE"]]}], ["A whole-cell dexamethasone-binding assay was used to measure number and affinity (1/K D ) of glucocorticoid receptors (GRs).", {"entities": []}], ["In vivo GC sensitivity was determined by measuring the disease activity score (DAS) and health assessment questionnaire disability index (HAQ-DI) score before and after 2 weeks of standardized GC treatment.", {"entities": [[8, 10, "GENE"], [193, 195, "GENE"], [8, 10, "GENE"], [193, 195, "GENE"]]}], ["GR number was positively correlated with improvement in DAS.", {"entities": []}], ["IL-2-EC 50 and GILZ-EC 50 values both had weak near-significant correlations with clinical improvement in DAS in intramuscularly treated patients only.", {"entities": []}], ["HAQ responders had lower GILZ-EC 50 values and higher GR number and K D .", {"entities": []}], ["Baseline cellular in vitro glucocorticoid sensitivity is modestly associated with in vivo improvement in DAS and HAQ-DI score after GC bridging therapy in RA.", {"entities": [[132, 134, "GENE"]]}], ["Further studies are needed to evaluate whether in vitro GC sensitivity may support the development of tailor-made GC therapy in RA.", {"entities": [[56, 58, "GENE"], [114, 116, "GENE"], [56, 58, "GENE"], [114, 116, "GENE"]]}], ["This study compared results from Internet and written questionnaires about respiratory symptoms in order to find out if both forms of the survey yielded the same answers.", {"entities": []}], ["One thousand seventy-one students, ages 13 to 17, were asked to complete either an Internet or a written questionnaire.", {"entities": []}], ["The demographic characteristics of the participants equalled those of the general Dutch adolescent population.", {"entities": []}], ["Participants were randomly assigned to fill out an electronic or written questionnaire.", {"entities": []}], ["In addition to eight items from the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire, two items on doctor visits (medical attention) regarding asthma or allergic disease during the past 12 months were included.", {"entities": [[59, 65, "DISEASE"], [173, 179, "DISEASE"]]}], ["The participation rate was 87%.", {"entities": []}], ["The Internet version of the questionnaire showed fewer missing answers than the written version, but this was not statistically significant.", {"entities": []}], ["The respiratory items did not show statistically significant score differences between the Internet and written modes of administration, and there was no visible trend for higher respectively lower scores by either mode of questionnaire administration.", {"entities": []}], ["From these results, we conclude that respiratory questionnaires may be provided to adolescents electronically rather than on paper, since both approaches yielded equal results.", {"entities": []}], ["To generalize these findings, we recommend repeated studies in other settings.", {"entities": []}], ["Respiratory and emotional responses to blood-acidifying inhalation of CO 2 are markers of some human anxiety disorders, and can be enhanced by repeatedly cross-fostering (RCF) mouse pups from their biological mother to unrelated lactating females.", {"entities": []}], ["Yet, these dynamics remain poorly understood.", {"entities": []}], ["We show RCF-associated intergenerational transmission of CO 2 sensitivity in normally-reared mice descending from RCF-exposed females, and describe the accompanying alterations in brain DNA methylation patterns.", {"entities": []}], ["These epigenetic signatures were compared to DNA methylation profiles of monozygotic twins discordant for emotional reactivity to a CO 2 challenge.", {"entities": []}], ["Altered methylation was consistently associated with repeated elements and transcriptional regulatory regions among RCF-exposed animals, their normally-reared offspring, and humans with CO 2 hypersensitivity.", {"entities": []}], ["In both species, regions bearing differential methylation were associated with neurodevelopment, circulation, and response to pH acidification processes, and notably included the ASIC2 gene.", {"entities": []}], ["Our data show that CO 2 hypersensitivity is associated with specific methylation clusters and genes that subserve chemoreception and anxiety.", {"entities": []}], ["The methylation status of genes implicated in acid-sensing functions can inform etiological and therapeutic research in this field.", {"entities": []}], ["Primary health care in industrialized countries faces major challenges due to demographic changes, an increasing prevalence of chronic diseases and a shortage of primary care physicians.", {"entities": []}], ["One approach to counteract these developments might be to reduce primary care physicians\u2019 workload supported by the use of health information technology (HIT) and non-physician practice staff.", {"entities": []}], ["In 2009, the U.S. Commonwealth Fund (CWF) conducted an international survey of primary care physicians which the present secondary descriptive analysis is based on.", {"entities": []}], ["The aim of this analysis was twofold: First, to explore to what extend German primary care physicians already get support by HIT and non-physician practice staff, and second, to show possible future perspectives.", {"entities": []}], ["The CWF questionnaire was sent to a representative random sample of 1,500 primary care physicians all over Germany.", {"entities": []}], ["The data was descriptively analyzed.", {"entities": []}], ["Group comparisons regarding differences in gender and age groups were made by means of Chi Square Tests for categorical variables.", {"entities": []}], ["An alpha-level of p < 0.05 was used for statistical significance.", {"entities": []}], ["Altogether 715 primary care physicians answered the questionnaire (response rate 49%).", {"entities": []}], ["Seventy percent of the physicians use electronic medical records.", {"entities": []}], ["Technical features such as electronic ordering and access to laboratory parameters are mainly used.", {"entities": []}], ["However, the majority does not routinely use technical functions for drug prescribing, reminder-systems for guideline-based interventions or recall of patients.", {"entities": []}], ["Six percent of surveyed physicians are able to transfer prescriptions electronically to a pharmacy, 1% use email communication with patients regularly.", {"entities": []}], ["Seventy-two percent of primary care physicians get support by non-physician practice staff in patient care, mostly in administrative tasks or routine preventive services.", {"entities": []}], ["One fourth of physicians is supported in telephone calls to the patient or in patient education and counseling.", {"entities": []}], ["Within this sample the majority of primary care physicians get support by HIT and non-physician practice staff in their daily work.", {"entities": []}], ["However, the potential has not yet been fully used.", {"entities": []}], ["Supportive technical functions like electronic alarm functions for medication or electronic prescribing should be improved technically and more adapted to physicians\u2019 needs.", {"entities": []}], ["To warrant pro-active health care, recall and reminder systems should get refined to encourage their use.", {"entities": []}], ["Adequately qualified non-physician practice staff could play a more active role in patient care.", {"entities": []}], ["Reimbursement should not only be linked to doctors\u2019, but also to non-physician practice staff services.", {"entities": []}], ["Endothelial dysfunction is a complication of both obesity and obstructive sleep apnea syndrome (OSAS), the latter being highly prevalent among obese children.", {"entities": [[50, 57, "DISEASE"], [86, 94, "DISEASE"]]}], ["It is unknown whether obesity causes endothelial dysfunction in children in the absence of OSAS.", {"entities": [[22, 29, "DISEASE"]]}], ["This study examines endothelial function in obese and non-obese children without OSAS.", {"entities": []}], ["Pre-pubertal non-hypertensive children were recruited.", {"entities": []}], ["Endothelial function was assessed in a morning fasted state, using a modified hyperemic test involving cuff-induced occlusion of the radial and ulnar arteries.", {"entities": []}], ["The absence of OSAS was confirmed by overnight polysomnography.", {"entities": []}], ["Anthropometry was also performed.", {"entities": []}], ["55 obese children (mean age 8.6 \u00b1 1.4 years, mean BMI z-score: 2.3 \u00b1 0.3) were compared to 50 non-obese children (mean age 8.0 \u00b1 1.6 years, mean BMI z-score 0.3 \u00b1 0.9).", {"entities": []}], ["Significant delays to peak capillary reperfusion after occlusion release occurred in obese compared to non-obese children (45.3 \u00b1 21.9 sec vs .", {"entities": []}], ["31.5 \u00b1 14.1 sec, p < 0.01), but no differences in the magnitude of hyperemia emerged.", {"entities": []}], ["Time to peak reperfusion and percentage of body fat were positively correlated (r = 0.365, p < 0.01).", {"entities": []}], ["Our findings confirm that endothelial dysfunction occurs early in life in obese children, even in the absence of OSAS.", {"entities": []}], ["Thus, mechanisms underlying endothelial dysfunction in pediatric obesity are operational in the absence of sleep-disordered breathing.", {"entities": [[65, 72, "DISEASE"]]}], ["Little is known about health outcomes related to electronic cigarette (EC) use, despite its growing popularity.", {"entities": []}], ["The aim of this study is to investigate the association between EC use and asthma.", {"entities": [[75, 81, "DISEASE"]]}], ["The study design is a cross-sectional study.", {"entities": []}], ["A total of 35,904 high school students were included as the final study population.", {"entities": []}], ["The presence of asthma was based on a student\u2019s self-reported doctor diagnosis of asthma in the past 12 months.", {"entities": [[16, 22, "DISEASE"], [82, 88, "DISEASE"]]}], ["Prevalence rates of asthmatics in \u2018current EC users\u2019 (n = 2,513), \u2018former EC users\u2019 (n = 2,078), and \u2018never EC users\u2019 (n = 31,313), were 3.9% (n = 98), 2.2% (n = 46) and 1.7% (n = 530), respectively.", {"entities": []}], ["Comparing \u2018current EC\u2019 users with \u2018never EC\u2019 users, the unadjusted OR for asthma was 2.36 (95% CI: 1.89\u20132.94).", {"entities": [[74, 80, "DISEASE"]]}], ["In order to control for the effect of conventional cigarette (CC) smoking, after stratifying the subjects by the three CC smoking categories (never CC, former CC, and current CC), within the \u2018never CC\u2019 category, the unadjusted OR for asthma for \u2018current EC\u2019 users was 3.41 (95% CI: 1.79\u20136.49), and the adjusted OR was 2.74 (95% CI: 1.30\u20135.78).", {"entities": [[234, 240, "DISEASE"]]}], ["Severe asthma was reflected by the number of days absent from school due to asthma symptoms; current EC users had the highest adjusted OR for severe asthma compared to \u2018never EC\u2019 users.", {"entities": [[7, 13, "DISEASE"], [76, 82, "DISEASE"], [149, 155, "DISEASE"]]}], ["When compared to a reference population of high school students in South Korea, EC users have an increased association with asthma and are more likely to have had days absent from school due to severe asthma symptoms.", {"entities": [[124, 130, "DISEASE"], [201, 207, "DISEASE"]]}], ["In conclusion, the results indicate that EC use may be a risk factor for asthma.", {"entities": [[73, 79, "DISEASE"]]}], ["The results may be useful in developing a scientific basis for the evaluation of a potential health hazard by EC.", {"entities": []}], ["The 2\u2009\u00d7\u20092 factorial design is widely used for assessing the existence of interaction and the extent of generalizability of two factors where each factor had only two levels.", {"entities": []}], ["Accordingly, research problems associated with the main effects and interaction effects can be analyzed with the selected linear contrasts.", {"entities": []}], ["To correct for the potential heterogeneity of variance structure, the Welch-Satterthwaite test is commonly used as an alternative to the t test for detecting the substantive significance of a linear combination of mean effects.", {"entities": []}], ["This study concerns the optimal allocation of group sizes for the Welch-Satterthwaite test in order to minimize the total cost while maintaining adequate power.", {"entities": []}], ["The existing method suggests that the optimal ratio of sample sizes is proportional to the ratio of the population standard deviations divided by the square root of the ratio of the unit sampling costs.", {"entities": []}], ["Instead, a systematic approach using optimization technique and screening search is presented to find the optimal solution.", {"entities": []}], ["Numerical assessments revealed that the current allocation scheme generally does not give the optimal solution.", {"entities": []}], ["Alternatively, the suggested approaches to power and sample size calculations give accurate and superior results under various treatment and cost configurations.", {"entities": []}], ["The proposed approach improves upon the current method in both its methodological soundness and overall performance.", {"entities": []}], ["Supplementary algorithms are also developed to aid the usefulness and implementation of the recommended technique in planning 2\u2009\u00d7\u20092 factorial designs.", {"entities": []}], ["The online version of this article (doi:10.1186/s12874-016-0214-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Formaldehyde (FA), a ubiquitous environmental pollutant, has long been suspected of having male reproductive toxicity.", {"entities": []}], ["However, FA male reproductive toxicity was inconclusive due to dearth of human studies.", {"entities": []}], ["Therefore, we sought to investigate whether occupational exposure to FA affects semen quality.", {"entities": []}], ["Semen quality including five conventional parameters and seven kinematics parameters were compared between 114 male workers occupationally exposed to FA and 76 referents.", {"entities": []}], ["FA exposure index (FEI) was measured and calculated.", {"entities": []}], ["Our results showed that sperm progressive motility, total sperm motility, VCL, VSL and VAP were statistically significant decreased in FA exposure workers compared with the referents.", {"entities": [[74, 77, "GENE"]]}], ["Moreover, FEI was significantly negative associated with sperm progressive motility (\u03b2\u2009=\u2009\u22120.19, P \u2009=\u20090.01) and total sperm motility (\u03b2\u2009=\u2009\u22120.23, P\u2009=\u20090.004).", {"entities": []}], ["In addition, a significant elevated risk of abnormal sperm progressive motility were observed in both low- (OR\u2009=\u20092.58; 95%\u2009CI: 1.11\u20135.97) and high-FA-exposed group (OR\u2009=\u20093.41; 95%\u2009CI: 1.45\u20137.92) respectively.", {"entities": []}], ["Furthermore, a significant increased risk was also estimated for abnormal total sperm motility in both low- (OR\u2009=\u20093.21; 95%\u2009CI: 1.24\u20138.28) and high-FA-exposed group (OR\u2009=\u20094.84; 95%\u2009CI: 1.83\u201312.81) respectively.", {"entities": []}], ["In conclusion, our study revealed the adverse effects of FA occupation exposure on semen quality, especially on sperm motion parameters.", {"entities": []}], ["The burden of obstructive sleep apnea among commercial drivers in Nigeria is not known.", {"entities": []}], ["To assess the prevalence of high risk of obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS) among intra-city commercial drivers.", {"entities": []}], ["A descriptive cross-sectional study in three major motor parks in Lagos metropolis.", {"entities": []}], ["Demographic, anthropometric and historical data was obtained.", {"entities": []}], ["The risk of OSA and EDS was assessed using the STOP BANG questionnaire and the Epworth Sleepiness Scale, respectively.", {"entities": []}], ["The relationship between the OSA risk, EDS risk and past road traffic accident (RTA) was explored using the Pearson's chi square.", {"entities": []}], ["Independent determinants of OSA risk, EDS risk and past RTA, respectively, were assessed by multiple logistic regression models.", {"entities": []}], ["Five hundred male commercial drivers (mean age (years) \u00b1SD = 42.36 \u00b1 11.17 and mean BMI (kg/m P < 0.001).", {"entities": []}], ["Sixty-one (12.2%) drivers had a past history of RTA but there was no significant relationship between a past RTA and either OSA risk (X P = 0.15) or EDS risk (X P = 0.1), respectively.", {"entities": []}], ["Abdominal adiposity, regular alcohol use and EDS were independent determinants of OSA risk while the use of cannabis and OSA risk were independent determinants of EDS.", {"entities": []}], ["No independent risk factor for past RTA was identified.", {"entities": []}], ["A significant proportion of commercial drivers in Lagos metropolis are at high risk of OSA and EDS.", {"entities": []}], ["Melioidosis, a lethal tropical infection that is endemic in southeast Asia and northern Australia, is caused by the saprophytic Gram-negative bacterium Burkholderia pseudomallei .", {"entities": [[0, 11, "DISEASE"]]}], ["Overall mortality approaches 40% yet little is known about mechanisms of host defense.", {"entities": []}], ["Toll-like receptors (TLRs) are host transmembrane receptors that recognize conserved pathogen molecular patterns and induce an inflammatory response.", {"entities": []}], ["The lipopolysaccharide (LPS) of Gram-negative bacteria is a potent inducer of the host innate immune system.", {"entities": []}], ["TLR4, in association with MD-2, is the archetype receptor for LPS although B. pseudomallei LPS has been previously identified as a TLR2 agonist.", {"entities": [[0, 4, "GENE"], [131, 135, "GENE"]]}], ["We examined TLR signaling induced by B. pseudomallei , B. pseudomallei LPS, and B. pseudomallei lipid A using gain-of-function transfection assays of NF-\u03baB activation and studies of TLR-deficient macrophages.", {"entities": []}], ["In HEK293 cells transfected with murine or human TLRs, CD14, and MD-2, heat-killed B. pseudomallei activated TLR2 (in combination with TLR1 or TLR6) and TLR4.", {"entities": [[55, 59, "GENE"], [109, 113, "GENE"], [135, 139, "GENE"], [143, 147, "GENE"], [153, 157, "GENE"]]}], ["B. pseudomallei LPS and lipid A activated TLR4 and this TLR4-mediated signaling required MD-2.", {"entities": [[42, 46, "GENE"], [56, 60, "GENE"]]}], ["In TLR2 B. pseudomallei augmented TNF-\u03b1 and MIP-2 production whereas in TLR4 B. pseudomallei LPS or lipid A was entirely dependent on TLR4 but was increased in the absence of TLR2.", {"entities": [[3, 7, "GENE"], [175, 179, "GENE"], [72, 76, "GENE"], [134, 138, "GENE"], [72, 76, "GENE"], [134, 138, "GENE"], [3, 7, "GENE"], [175, 179, "GENE"]]}], ["TLR adaptor molecule MyD88 strongly regulated TNF-\u03b1 production in response to heat-killed B. pseudomallei .", {"entities": [[21, 26, "GENE"]]}], ["B. pseudomallei activates TLR2 and TLR4.", {"entities": [[26, 30, "GENE"], [35, 39, "GENE"]]}], ["In the presence of MD-2, B. pseudomallei LPS and lipid A are TLR4 ligands.", {"entities": [[61, 65, "GENE"]]}], ["Although the macrophage cytokine response to B. pseudomallei LPS or lipid A is completely dependent on TLR4, in TLR2 B. pseudomallei, B. pseudomallei LPS or lipid A, cytokine production is augmented.", {"entities": [[103, 107, "GENE"], [112, 116, "GENE"]]}], ["Other MyD88-dependent signaling pathways may also be important in the host response to B. pseudomallei infection.", {"entities": []}], ["These findings provide new insights into critical mechanisms of host defense in melioidosis.", {"entities": [[80, 91, "DISEASE"]]}], ["The therapeutic efficacy of allergen specific immunotherapy (SIT) on allergic diseases is to be improved.", {"entities": []}], ["Probiotics can regulate immune response.", {"entities": []}], ["This study aims to promote the effect of SIT on allergic rhinitis (AR) by co-administration with Clostridium butyricum (Cb).", {"entities": [[48, 65, "DISEASE"], [57, 65, "DISEASE"]]}], ["In this study, patients with AR sensitized to mite allergens were enrolled to this study, and treated with SIT or/and Cb.", {"entities": []}], ["The therapeutic efficacy was evaluated by the total nasal symptom scores (NSS), medication scores, serum specific IgE levels and T helper (Th)2 cytokine levels.", {"entities": []}], ["The improvement of immune regulation in the AR patients was assessed by immunologic approaches.", {"entities": []}], ["The results showed that treating AR patients with SIT alone markedly reduced NSS and medication scores; but did not alter the serum specific IgE, Th2 cytokines and skin prick test (SPT) index.", {"entities": []}], ["The clinical symptoms on AR in SIT group relapsed one month after stopping SIT.", {"entities": []}], ["Co-administration of Cb significantly enhanced the efficacy of SIT on AR as shown by suppression of NSS, medication scores, serum specific IgE, Th2 cytokines and SPT index; the regulatory B cell frequency was also markedly increased.", {"entities": []}], ["Such an effect on AR was maintained throughout the observation period even after stopping the treatment.", {"entities": []}], ["Butyrate blocked the activation of histone deacetylase-1, the downstream activities of epsilon chain promoter activation, and the IgE production in the antigen specific B cells.", {"entities": []}], ["On the other hand, butyrate induced the IL-10 expression in B cells with a premise of the B cell receptor activation by specific antigens.", {"entities": []}], ["In conclusion, administration with Cb can markedly enhance the efficacy of SIT on AR.", {"entities": []}], ["Although environmental policy decisions are often based in part on both risk assessment information and environmental justice concerns, formalized approaches for addressing inequality or inequity when estimating the health benefits of pollution control have been lacking.", {"entities": []}], ["Inequality indicators that fulfill basic axioms and agree with relevant definitions and concepts in health benefits analysis and environmental justice analysis can allow for quantitative examination of efficiency-equality tradeoffs in pollution control policies.", {"entities": []}], ["To develop appropriate inequality indicators for health benefits analysis, we provide relevant definitions from the fields of risk assessment and environmental justice and consider the implications.", {"entities": []}], ["We evaluate axioms proposed in past studies of inequality indicators and develop additional axioms relevant to this context.", {"entities": []}], ["We survey the literature on previous applications of inequality indicators and evaluate five candidate indicators in reference to our proposed axioms.", {"entities": []}], ["We present an illustrative pollution control example to determine whether our selected indicators provide interpretable information.", {"entities": []}], ["We conclude that an inequality indicator for health benefits analysis should not decrease when risk is transferred from a low-risk to high-risk person, and that it should decrease when risk is transferred from a high-risk to low-risk person (Pigou-Dalton transfer principle), and that it should be able to have total inequality divided into its constituent parts (subgroup decomposability).", {"entities": []}], ["We additionally propose that an ideal indicator should avoid value judgments about the relative importance of transfers at different percentiles of the risk distribution, incorporate health risk with evidence about differential susceptibility, include baseline distributions of risk, use appropriate geographic resolution and scope, and consider multiple competing policy alternatives.", {"entities": []}], ["Given these criteria, we select the Atkinson index as the single indicator most appropriate for health benefits analysis, with other indicators useful for sensitivity analysis.", {"entities": []}], ["Our illustrative pollution control example demonstrates how these indices can help a policy maker determine control strategies that are dominated from an efficiency and equality standpoint, those that are dominated for some but not all societal viewpoints on inequality averseness, and those that are on the optimal efficiency-equality frontier, allowing for more informed pollution control policies.", {"entities": []}], ["Natural products of animals, plants and microbes are potential source of important chemical compounds, with diverse applications including therapeutics.", {"entities": []}], ["Endophytic bacteria that are especially associated with medicinal plants presents a reservoir of therapeutic compounds.", {"entities": []}], ["Fagonia indica has been recently investigated by numerous researchers because of its striking therapeutic potential especially in cancer.", {"entities": [[130, 136, "DISEASE"]]}], ["It is also reported that endophytes play a vital role in the biosynthesis of various metabolites; therefore we believe that endophytes associated with F. indica are of crucial importance in this regard.", {"entities": []}], ["The present study aims successful isolation, molecular identification of endophytic bacteria and their screening for bioactive metabolites quantification and in vitro pharmacological activities.", {"entities": []}], ["16S rRNA gene sequencing was used for the identification of isolated endophytic bacteria.", {"entities": []}], ["Methanolic extracts were evaluated for total phenolic contents (TPC), total flavonoids contents (TFC), DPPH free radical scavenging activity, reducing power and total anti-oxidant assays were performed.", {"entities": []}], ["And also screened for antibacterial and antifungal activities by disc diffusion method and their MIC were calculated by broth dilution method using microplate reader.", {"entities": []}], ["Further, standard protocols were followed for antileishmanial activity and protein kinase inhibition.", {"entities": []}], ["Analysis and statistics were performed using SPSS, Table curve and Origin 8.5 for graphs.", {"entities": []}], ["Bacterial strains belonging to various genera ( Bacillus , Enterobacter , Pantoea , Erwinia and Stenotrophomonas) were isolated and identified.", {"entities": []}], ["Total phenolic contents and total flavonoids contents varies among all the bacterial extracts respectively in which Bacillus subtilis showed high phenolic contents 243\u00a0\u00b5g/mg of gallic acid equivalents (GAE) and Stenotrophomonas maltophilia showed high flavonoids contents 15.9\u00a0\u00b5g/mg quercitin equivalents (QA), total antioxidant capacity (TAC) 37.6\u00a0\u00b5g/mg of extract, reducing power (RP) 206\u00a0\u00b5g/mg of extract and 2, 2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging activity with 98.7\u00a0\u03bcg/mL IC 50 value.", {"entities": []}], ["Although all the extracts tested were active to inhibit growth of selected pathogenic microbes (bacteria and fungi), but significant antibacterial activity was observed against Klebsiella pneumonia and B. subtilis.", {"entities": [[188, 197, "DISEASE"]]}], ["An Enterobacter cloaca was active against Leishmania tropica with IC 50 value of 1.4\u00a0\u00b5g/mg extracts.", {"entities": []}], ["B. subtilis and Bacillus tequilensis correspondingly exhibit significant protein kinase inhibition of 47\u00a0\u00b1\u00a00.72 and 42\u00a0\u00b1\u00a01.21\u00a0mm bald zones, indicating anti-infective and antitumor potential.", {"entities": []}], ["Our findings revealed that crude extracts of selected endophytic bacteria from F. indica possess excellent biological activities indicating their potential as an important source of antibiotics (antifungal, antibacterial) compounds.", {"entities": []}], ["The pharmacological management of early pregnancy loss reduced substantially the need for dilation and curettage.", {"entities": []}], ["However, prognostic markers of successful outcome were not established.", {"entities": []}], ["Thus the major purpose of this study was to determine the sensitivity and specificity of the uterine artery pulsatility (PI) and resistance (RI) indices to detect early pregnancy loss patients requiring dilation and curettage after unsuccessful management.", {"entities": []}], ["A cohort prospective observational study was undertaken to include women with early pregnancy loss, \u2264 12\u00a0weeks of gestation, managed with mifepristone (200\u00a0mg) and misoprostol (1600\u00a0\u03bcg) followed by PI and RI evaluation of both uterine arteries 2\u00a0weeks after.", {"entities": []}], ["At this time, in 173/315 patients, incomplete miscarriage was diagnosed.", {"entities": []}], ["Among them, 32 underwent uterine dilatation and curettage at 8\u00a0weeks of follow-up.", {"entities": []}], ["The cut-off points for the uterine artery PI and RI, leading to the maximum values of sensitivity (69.5%, CI 95% : 61.5%-76.5% and 75.0%, CI 95% : 57.9%-86.8%, respectively) and specificity (75.0%, CI 95% : 57.9%-86.8% and 65.6%, CI 95% : 48.3%-79.6%, respectively), for the discrimination between the women who needed curettage from those who resolved spontaneously were 2.8 and 1, respectively.", {"entities": []}], ["The potential usefulness of uterine artery Doppler evaluation to predict the need for uterine curettage in patients submitted to medical treatment for early pregnancy loss was demonstrated.", {"entities": []}], ["\u2022 DNA vaccine targeting affected humoral and cellular immunity.", {"entities": []}], ["\u2022 Elevated Th1 immunity did not correlate with superior protection from sensitization.", {"entities": []}], ["\u2022 Plasmid vaccination boosted Treg numbers within re-stimulated splenocyte cultures.", {"entities": []}], ["DNA vaccine targeting affected humoral and cellular immunity.", {"entities": []}], ["Elevated Th1 immunity did not correlate with superior protection from sensitization.", {"entities": []}], ["Plasmid vaccination boosted Treg numbers within re-stimulated splenocyte cultures.", {"entities": []}], ["Gene vaccines offer attractive rationales for prophylactic as well as therapeutic treatments of type I allergies.", {"entities": []}], ["DNA and mRNA vaccines have been shown to prevent from allergic sensitization and to counterbalance established allergic immune reactions.", {"entities": []}], ["Recent advances in gene vaccine manipulation offer additional opportunities for modulation of T helper cell profiles by specific targeting of cellular compartments.", {"entities": []}], ["DNA vaccines encoding the major birch pollen allergen Bet v 1.0101 were equipped with different leader sequences to shuttle the antigen to lysosomes (LIMP-II), to trigger cellular secretion (hTPA), or to induce proteasomal degradation via forced ubiquitination (ubi).", {"entities": []}], ["Mice were pre-vaccinated with these constructs and the protective efficacy was tested by subcutaneous Th2-promoting challenges, followed by allergen inhalation.", {"entities": []}], ["IgG antibody subclass distribution and allergen-specific IgE as well as cytokine profiles from re-stimulated splenocytes and from BALFs were assessed.", {"entities": []}], ["The cellular composition of BALFs, and lung resistance and compliance were determined.", {"entities": []}], ["Immunization with all targeting variants protected from allergic sensitization, i.e.", {"entities": []}], ["IgE induction, airway hyperresponsiveness, lung inflammation, and systemic and local Th2 cytokine expression.", {"entities": []}], ["Surprisingly, protection did not clearly correlate with the induction of a systemic Th1 cytokine profile, but rather with proliferating CD4+ CD25+ FoxP3+ T regulatory cells in splenocyte cultures.", {"entities": []}], ["Targeting the allergen to proteasomal or lysosomal degradation severely down-regulated antibody induction after vaccination, while T cell responses remained unaffected.", {"entities": []}], ["Although secretion of antigen promoted the highest numbers of Th1 cells, this vaccine type was the least efficient in suppressing the establishment of an allergic immune response.", {"entities": []}], ["This comparative analysis highlights the modulatory effect of antigen targeting on the resulting immune response, with a special emphasis on prophylactic anti-allergy DNA vaccination.", {"entities": []}], ["Targeting the antigen to proteasomal or lysosomal degradation reduces the availability of native allergen, thereby rendering the vaccine hypoallergenic without compromising efficacy, an important feature for a therapeutic setting.", {"entities": []}], ["Typically, gene expression biomarkers are being discovered in course of high-throughput experiments, for example, RNAseq or microarray profiling.", {"entities": []}], ["Analytic pipelines that extract so-called signatures suffer from the \"Dimensionality curse\": the number of genes expressed exceeds the number of patients we can enroll in the study and use to train the discriminator algorithm.", {"entities": []}], ["Hence, problems with the reproducibility of gene signatures are more common than not; when the algorithm is executed using a different training set, the resulting diagnostic signature may turn out to be completely different.", {"entities": []}], ["In this paper we propose an alternative novel approach which takes into account quantifiable expression levels of all genes assayed.", {"entities": []}], ["In our analysis, the cumulative gene expression pattern of an individual patient is represented as a point in the multidimensional space formed by all gene expression profiles assayed in given system, where the clusters of \"normal samples\" and \"affected samples\" and defined.", {"entities": []}], ["The degree of separation of the given sample from the space occupied by \"normal samples\" reflects the drift of the sample away from homeostasis in the course of development of the pathophysiological process that underly the disease.", {"entities": []}], ["The outlined approach was validated using the publicly available glioma dataset deposited in Rembrandt and associated with survival data.", {"entities": []}], ["Additionally, the applicability of the distance analysis to the classification of non-malignant sampled was tested using psoriatic lesions and non-lesional matched controls as a model.", {"entities": []}], ["Keywords: biomarkers; clustering; human diseases; RNA", {"entities": []}], ["Understanding of genetic diversity and linkage disequilibrium (LD) decay in diverse maize germplasm is fundamentally important for maize improvement.", {"entities": []}], ["A total of 287 tropical and 160 temperate inbred lines were genotyped with 1943 single nucleotide polymorphism (SNP) markers of high quality and compared for genetic diversity and LD decay using the SNPs and their haplotypes developed from genic and intergenic regions.", {"entities": []}], ["Intronic SNPs revealed a substantial higher variation than exonic SNPs.", {"entities": []}], ["The big window size haplotypes (3-SNP slide-window covering 2160 kb on average) revealed much higher genetic diversity than the 10 kb-window and gene-window haplotypes.", {"entities": []}], ["The polymorphic information content values revealed by the haplotypes (0.436\u20130.566) were generally much higher than individual SNPs (0.247\u20130.259).", {"entities": []}], ["Cluster analysis classified the 447 maize lines into two major groups, corresponding to temperate and tropical types.", {"entities": []}], ["The level of genetic diversity and subpopulation structure were associated with the germplasm origin and post-domestication selection.", {"entities": []}], ["Compared to temperate lines, the tropical lines had a much higher level of genetic diversity with no significant subpopulation structure identified.", {"entities": []}], ["Significant variation in LD decay distance (2\u2013100 kb) was found across the genome, chromosomal regions and germplasm groups.", {"entities": []}], ["The average of LD decay distance (10\u2013100 kb) in the temperate germplasm was two to ten times larger than that in the tropical germplasm (5\u201310 kb).", {"entities": []}], ["In conclusion, tropical maize not only host high genetic diversity that can be exploited for future plant breeding, but also show rapid LD decay that provides more opportunity for selection.", {"entities": []}], ["Many patients and healthcare professionals believe that work\u2010related psychosocial stress, such as job strain, can make asthma worse, but this is not corroborated by empirical evidence.", {"entities": [[119, 125, "DISEASE"]]}], ["We investigated the associations between job strain and the incidence of severe asthma exacerbations in working\u2010age European men and women.", {"entities": [[80, 86, "DISEASE"]]}], ["We analysed individual\u2010level data, collected between 1985 and 2010, from 102 175 working\u2010age men and women in 11 prospective E uropean studies.", {"entities": []}], ["Job strain (a combination of high demands and low control at work) was self\u2010reported at baseline.", {"entities": []}], ["Incident severe asthma exacerbations were ascertained from national hospitalization and death registries.", {"entities": [[16, 22, "DISEASE"]]}], ["Associations between job strain and asthma exacerbations were modelled using C ox regression and the study\u2010specific findings combined using random\u2010effects meta\u2010analyses.", {"entities": [[36, 42, "DISEASE"]]}], ["During a median follow\u2010up of 10\u00a0years, 1 109 individuals experienced a severe asthma exacerbation (430 with asthma as the primary diagnostic code).", {"entities": [[78, 84, "DISEASE"], [108, 114, "DISEASE"]]}], ["In the age\u2010 and sex\u2010adjusted analyses, job strain was associated with an increased risk of severe asthma exacerbations defined using the primary diagnostic code (hazard ratio, HR : 1.27, 95% confidence interval, CI : 1.00, 1.61).", {"entities": [[98, 104, "DISEASE"], [176, 178, "GENE"]]}], ["This association attenuated towards the null after adjustment for potential confounders ( HR : 1.22, 95% CI : 0.96, 1.55).", {"entities": [[90, 92, "GENE"]]}], ["No association was observed in the analyses with asthma defined using any diagnostic code ( HR : 1.01, 95% CI : 0.86, 1.19) .", {"entities": [[49, 55, "DISEASE"], [92, 94, "GENE"]]}], ["Our findings suggest that job strain is probably not an important risk factor for severe asthma exacerbations leading to hospitalization or death.", {"entities": [[89, 95, "DISEASE"]]}], ["Prevention of IgE-binding to cellular IgE-receptors by anti-IgE (Omalizumab) is clinically effective in allergic asthma, but limited by IgE threshold-levels.", {"entities": [[104, 119, "DISEASE"], [113, 119, "DISEASE"]]}], ["To overcome this limitation, we developed a single-use IgE immunoadsorber column (IgEnio).", {"entities": []}], ["IgEnio is based on a recombinant, IgE-specific antibody fragment and can be used for the specific extracorporeal desorption of IgE.", {"entities": []}], ["To study safety and efficacy of IgEnio regarding the selective depletion of IgE in a randomized, open-label, controlled pilot trial in patients with allergic asthma and to investigate if IgEnio can bind IgE-Omalizumab immune complexes.", {"entities": [[149, 164, "DISEASE"], [158, 164, "DISEASE"]]}], ["Fifteen subjects were enrolled and randomly assigned to the treatment group (n\u00a0=\u00a010) or to the control group (n\u00a0=\u00a05).", {"entities": []}], ["Immunoadsorption was done by veno-venous approach, processing the twofold calculated plasma volume during each treatment.", {"entities": []}], ["A minimum average IgE-depletion of 50% after the last cycle in the intention-to-treat population was defined as primary endpoint.", {"entities": []}], ["Safety of the treatment was studied as secondary endpoint.", {"entities": []}], ["In addition, possible changes in allergen-specific sensitivity were investigated, as well as clinical effects by peak flow measurement and symptom-recording.", {"entities": []}], ["The depletion of IgE-Omalizumab immune complexes was studied in vitro .", {"entities": []}], ["The study was registered at clinicaltrials.gov ( NCT02096237 ) and conducted from December 2013 to July 2014.", {"entities": []}], ["IgE immunoadsorption with IgEnio selectively depleted 86.2% (\u00b1\u00a05.1% SD) of IgE until the end of the last cycle (p\u00a0<\u00a00.0001).", {"entities": []}], ["Removal of pollen allergen-specific IgE was associated with a reduction of allergen-specific basophil-sensitivity and prevented increases of allergen-specific skin-sensitivity and clinical symptoms during pollen seasons.", {"entities": []}], ["IgEnio also depleted IgE-Omalizumab immune complexes in vitro .", {"entities": []}], ["The therapy under investigation was safe and well-tolerated.", {"entities": []}], ["During a total of 81 aphereses, 2 severe adverse events (SAE) were recorded, one of which, an episode of acute dyspnea, possibly was related to the treatment and resolved after administration of antihistamines and corticosteroids.", {"entities": []}], ["This pilot study indicates that IgE immunoadsorption with IgEnio may be used to treat patients with pollen-induced allergic asthma.", {"entities": [[115, 130, "DISEASE"], [124, 130, "DISEASE"]]}], ["Furthermore, the treatment could render allergic patients with highly elevated IgE-levels eligible for the administration of Omalizumab and facilitate the desorption of IgE-Omalizumab complexes.", {"entities": []}], ["This study was funded by Fresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.", {"entities": []}], ["Image 1 \u2022 An IgE-specific immunoadsorber, IgEnio, was developed.", {"entities": []}], ["\u2022 IgEnio selectively depleted IgE from subjects with allergic asthma.", {"entities": [[53, 68, "DISEASE"], [62, 68, "DISEASE"]]}], ["\u2022 IgEnio treatment was safe and well tolerated.", {"entities": []}], ["\u2022 IgE-depletion prevented increase of pollen-induced symptoms.", {"entities": []}], ["\u2022 In treated subjects, decreased skin- and basophil-reactivities were recorded.", {"entities": []}], ["An IgE-specific immunoadsorber, IgEnio, was developed.", {"entities": []}], ["IgEnio selectively depleted IgE from subjects with allergic asthma.", {"entities": [[51, 66, "DISEASE"], [60, 66, "DISEASE"]]}], ["IgEnio treatment was safe and well tolerated.", {"entities": []}], ["IgE-depletion prevented increase of pollen-induced symptoms.", {"entities": []}], ["In treated subjects, decreased skin- and basophil-reactivities were recorded.", {"entities": []}], ["IgE-associated allergy affects more than 25% of the population.", {"entities": []}], ["Symptoms of allergy are caused by activation of inflammatory cells by IgE-allergen immune complexes.", {"entities": []}], ["We developed an immunoadsorber, IgEnio, for the selective, effective and safe depletion of IgE from patients suffering from allergic asthma by immunoadsorption.", {"entities": [[124, 139, "DISEASE"], [133, 139, "DISEASE"]]}], ["IgE immunoadsorption with IgEnio may be useful for the treatment of allergen-induced asthma and perhaps other manifestations of IgE-associated allergies.", {"entities": [[85, 91, "DISEASE"]]}], ["Science press officers can play an integral role in helping promote expectations and hype about biomedical research.", {"entities": []}], ["Using this as a starting point, this article draws on interviews with 10 UK-based science press officers, which explored how they view their role as science reporters and as generators of expectations.", {"entities": []}], ["Using Goodwin\u2019s notion of \u2018professional vision\u2019, we argue that science press officers have a specific professional vision that shapes how they produce biomedical press releases, engage in promotion of biomedical research and make sense of hype.", {"entities": []}], ["We discuss how these insights can contribute to the sociology of expectations, as well as inform responsible science communication.", {"entities": []}], ["Patient-reported outcome measures (PROMs) are intended to reflect outcomes relevant to patients.", {"entities": []}], ["They are increasingly used for healthcare quality improvement.", {"entities": []}], ["To produce valid measures, patients should be involved in the development process but it is unclear whether this usually includes people with low literacy skills or learning disabilities.", {"entities": []}], ["This potential exclusion raises concerns about whether these groups will be able to use these measures and participate in quality improvement practices.", {"entities": []}], ["Taking PROMs for chronic obstructive pulmonary disease (COPD) as an exemplar condition, our review determined the inclusion of people with low literacy skills and learning disabilities in research developing, validating, and using 12 PROMs for COPD patients.", {"entities": [[17, 54, "DISEASE"]]}], ["The studies included in our review were based on those identified in two existing systematic reviews and our update of this search.", {"entities": []}], ["People with low literacy skills and/or learning disabilities were excluded from the development of PROMs in two ways: explicitly through the participant eligibility criteria and, more commonly, implicitly through recruitment or administration methods that would require high-level reading and cognitive abilities.", {"entities": []}], ["None of the studies mentioned efforts to include people with low literacy skills or learning disabilities.", {"entities": []}], ["Our findings suggest that people with low literacy skills or learning disabilities are left out of the development of PROMs.", {"entities": []}], ["Given that implicit exclusion was most common, researchers and those who administer PROMs may not even be aware of this problem.", {"entities": []}], ["Without effort to improve inclusion, unequal quality improvement practices may become embedded in the health system.", {"entities": []}], ["Chronic lung diseases, such as cystic fibrosis (CF), asthma, and chronic obstructive pulmonary disease (COPD) are incurable and represent a very high social burden.", {"entities": [[65, 102, "DISEASE"], [31, 46, "DISEASE"], [53, 59, "DISEASE"]]}], ["Stem cell-based treatment may represent a hope for the cure of these diseases.", {"entities": []}], ["In this paper, we revise the overall knowledge about the plasticity and engraftment of exogenous marrow-derived stem cells into the lung, as well as their usefulness in lung repair and therapy of chronic lung diseases.", {"entities": []}], ["The lung is easily accessible and the pathophysiology of these diseases is characterized by injury, inflammation, and eventually by remodeling of the airways.", {"entities": []}], ["Bone marrow-derived stem cells, including hematopoietic stem/progenitor cells (HSPCs) and mesenchymal stromal (stem) cells (MSCs), encompass a wide array of cell subsets with different capacities of engraftment and injured tissue regenerating potential.", {"entities": []}], ["Proof-of-principle that marrow cells administered locally may engraft and give rise to specialized epithelial cells has been given, but the efficiency of this conversion is too limited to give a therapeutic effect.", {"entities": []}], ["Besides the identification of plasticity mechanisms, the characterization/isolation of the stem cell subpopulations represents a major challenge to improving the efficacy of transplantation protocols used in regenerative medicine for lung diseases.", {"entities": []}], ["Objectives: The purpose of this study is to explore the gains and losses, from the trainees\u2019 perspective, that occur when replacing process-oriented basic medical training with competency-based training and to explore whether competency-based training can justify a reduction in clinical training.", {"entities": []}], ["We performed a national cross-sectional survey of attitudes of Danish doctors who had completed either the old process-oriented 18-month training period (n=671) or the new competency-based 12-month training period (n=547).", {"entities": []}], ["A total of 1218 doctors were included and 792 of them completed an online survey, yielding a response rate of 65%.", {"entities": []}], ["Trainees of the old process-oriented programme (53%) felt more ready to continue medical training than the doctors (84%) who followed the new and shorter competency-based programme.", {"entities": []}], ["The differences was statistically significant (t (790) = 11.16; p<0.0001).", {"entities": []}], ["The latter group did not feel the competency-based programme improved the learning environment.", {"entities": []}], ["Some trainees reported that learning objectives seem to optimize their learning within defined learning frames.", {"entities": []}], ["They valued a curriculum that should not only contain learning objectives but that should also ensure relevant learning opportunities, providing sufficient time for learning and useful feedback.", {"entities": []}], ["It is unlikely that a competency-based curriculum can justify a significant reduction in the time spent on clinical training.", {"entities": []}], ["The learning approaches and the amount of time that we dedicate to training are important.", {"entities": []}], ["Implementation of a new curriculum requires a substantial effort.", {"entities": []}], ["To investigate the presence of airway obstruction by determining the FEV 1 /FVC and FEV 1 /slow vital capacity (SVC) ratios.", {"entities": [[69, 72, "GENE"], [84, 87, "GENE"], [69, 72, "GENE"], [84, 87, "GENE"]]}], ["This was a quantitative, retrospective cross-sectional study.", {"entities": []}], ["The sample comprised 1,084 individuals who underwent spirometry and plethysmography in a central hospital in Lisbon, Portugal.", {"entities": []}], ["The study sample was stratified into six groups, by pulmonary function.", {"entities": []}], ["The analysis of the FEV 1 /FVC ratio revealed the presence of airway obstruction in 476 individuals (43.9%), compared with 566 individuals (52.2%) for the analysis of the FEV 1 /SVC ratio.", {"entities": [[20, 23, "GENE"], [171, 174, "GENE"], [20, 23, "GENE"], [171, 174, "GENE"]]}], ["In the airway obstruction, airway obstruction plus lung hyperinflation, and mixed pattern groups, the difference between SVC and FVC (SVC \u2212 FVC) was statistically superior to that in the normal pulmonary function, reduced FEF, and restrictive lung disease groups.", {"entities": [[243, 255, "DISEASE"]]}], ["The SVC \u2212 FVC parameter showed a significant negative correlation with FEV 1 (in % of the predicted value) only in the airway obstruction plus lung hyperinflation group.", {"entities": [[71, 74, "GENE"]]}], ["The FEV 1 /SVC ratio detected the presence of airway obstruction in more individuals than did the FEV 1 /FVC ratio; that is, the FEV 1 /SVC ratio is more reliable than is the FEV 1 /FVC ratio in the detection of obstructive pulmonary disease.", {"entities": [[4, 7, "GENE"], [98, 101, "GENE"], [129, 132, "GENE"], [175, 178, "GENE"], [4, 7, "GENE"], [98, 101, "GENE"], [129, 132, "GENE"], [175, 178, "GENE"], [4, 7, "GENE"], [98, 101, "GENE"], [129, 132, "GENE"], [175, 178, "GENE"], [4, 7, "GENE"], [98, 101, "GENE"], [129, 132, "GENE"], [175, 178, "GENE"]]}], ["Davallia mariesii Moore (Drynaria rhizome extract (DRE)) is widely known for its efficacy in treating inflammation, arteriosclerosis, and bone injuries.", {"entities": [[116, 132, "DISEASE"]]}], ["This study evaluated whether treatment with DRE inhibited Fc \u025b RI-mediated allergic responses in the RBL-2H3 mast cells and investigated the early- and late-phase mechanisms by which DRE exerts its antiallergic effects.", {"entities": []}], ["IgE anti-DNP/DNP-HSA-sensitized RBL-2H3 mast cells were tested for cytotoxicity to DRE, followed by the assessment of \u03b2 -hexosaminidase release.", {"entities": []}], ["We measured the amounts of inflammatory mediators (e.g., histamine, PGD 2 , TNF- \u03b1 , IL-4, and IL-6) and examined the expression of genes involved in arachidonate and Fc \u03b5 RI signaling pathways.", {"entities": [[68, 71, "GENE"]]}], ["In addition, we confirmed the antiallergic effects of DRE on passive cutaneous anaphylaxis (PCA) in mice.", {"entities": []}], ["DRE inhibited RBL-2H3 mast cell degranulation and production of allergic mediators in them.", {"entities": []}], ["In early allergic responses, DRE reduced expression of Fc \u03b5 RI signaling-related genes (e.g., Syk, Lyn, and Fyn) and extracellular signal-regulated kinase phosphorylation in mast cells.", {"entities": [[94, 97, "GENE"], [99, 102, "GENE"], [108, 111, "GENE"]]}], ["In late allergic responses, DRE reduced PGD 2 release and COX-2 expression and cPLA 2 phosphorylation in Fc \u025b RI-mediated mast cells.", {"entities": [[40, 43, "GENE"]]}], ["Lastly, 250\u2013500 mg/kg DRE significantly attenuated the IgE-induced PCA reaction in mice.", {"entities": []}], ["These findings provide novel information on the molecular mechanisms underlying the antiallergic effects of DRE in Fc \u025b RI-mediated allergic responses.", {"entities": []}], ["The aims of this study were to record behavioral problems in children with epilepsy (CWE), compare the prevalence with that reported among healthy children without epilepsy, and investigate the risk factors.", {"entities": []}], ["A child behavioral questionnaire for parents comprising 15 items was administered to the main caregiver of 108 CWE and 108 controls matched for age in Kilifi, Kenya.", {"entities": []}], ["CWE had a higher mean score for reported behavioral problems than controls (6.9 vs 4.9, t \u00a0=\u00a04.7, P \u00a0<\u00a00.001).", {"entities": []}], ["CWE with active epilepsy also recorded more behavioral problems than those with inactive epilepsy (8.2 vs 6.2, t \u00a0=\u00a0\u2212\u00a02.9, P \u00a0=\u00a00.005).", {"entities": []}], ["A significantly greater proportion of CWE (49% vs 26% of controls) were reported to have behavioral problems.", {"entities": []}], ["Active epilepsy, cognitive impairment, and focal seizures were the most significant independent covariates of behavioral problems.", {"entities": []}], ["Behavioral problems in African CWE are common and need to be taken into consideration in planning comprehensive clinical services in this region.", {"entities": []}], ["\u25ba Behavioral problems in children with epilepsy were studied.", {"entities": []}], ["\u25ba Behavioral problems were reported in 49% of children with epilepsy and in 26% of the controls.", {"entities": []}], ["\u25ba Active epilepsy type, cognitive impairment, and focal seizures predicted behavioral problems.", {"entities": []}], ["\u25ba Behavioral problems are common in children with epilepsy and need to be considered in planning clinical services.", {"entities": []}], ["Transient receptor potential vanilloid 1 (TRPV1), which has been identified as a molecular target for the activation of sensory neurons by various painful stimuli, was reported to regulate the signaling and activation of CD4", {"entities": [[42, 47, "GENE"], [221, 224, "GENE"]]}], ["Microbial exposures have been suggested to confer protection from allergic disorders and reduced exposures to gastrointestinal microbiota have been proposed as an explanation for the increase in asthma prevalence.", {"entities": [[195, 201, "DISEASE"]]}], ["Since the general prevalence of Helicobacter pylori has been decreasing, we hypothesized that H. pylori serostatus would be inversely related to the presence of asthma.", {"entities": [[161, 167, "DISEASE"]]}], ["Adults were recruited to participate in the New York University (NYU)/Bellevue Asthma Registry in New York City.", {"entities": [[79, 85, "DISEASE"]]}], ["Adult asthma cases (N\u200a=\u200a318) and controls (N\u200a=\u200a208) were identified and serum IgG antibodies to H. pylori whole cell antigens or the immunodominant CagA antigen were measured.", {"entities": [[6, 12, "DISEASE"]]}], ["As expected, the asthma cases and controls differed with respect to atopy and lung function.", {"entities": [[17, 23, "DISEASE"]]}], ["Seropositivity to H. pylori or CagA antigen was present in 47.1% of the total case and control study population.", {"entities": []}], ["Asthma was inversely associated with CagA seropositivity (OR\u200a=\u200a0.57, 95% CI\u200a=\u200a0.36\u20130.89).", {"entities": [[0, 6, "DISEASE"]]}], ["Median age of onset of asthma (doctor's diagnosis) was older (21 years) among individuals with CagA + strains than among H. pylori- individuals (11 years) ( p \u200a=\u200a0.006).", {"entities": [[23, 29, "DISEASE"]]}], ["These data are consistent with the hypothesis that colonization with CagA+ H. pylori strains is inversely associated with asthma and is associated with an older age of asthma onset in an urban population.", {"entities": [[122, 128, "DISEASE"], [168, 174, "DISEASE"]]}], ["The data suggest H. pylori as a marker for protection.", {"entities": []}], ["ClinicalTrials.gov NCT00212537", {"entities": []}], ["Uderhardt et al.", {"entities": []}], ["show that eosinophils accumulate in freshly formed thrombi, where they provide a procoagulant surface that is rich in oxidized phospholipids and allows assembly and activation of plasmatic coagulation factors.", {"entities": []}], ["This mechanism stabilizes the thrombus and enables hemostasis but also contributes to thrombotic disease.", {"entities": []}], ["Blood coagulation is essential for physiological hemostasis but simultaneously contributes to thrombotic disease.", {"entities": []}], ["However, molecular and cellular events controlling initiation and propagation of coagulation are still incompletely understood.", {"entities": []}], ["In this study, we demonstrate an unexpected role of eosinophils during plasmatic coagulation, hemostasis, and thrombosis.", {"entities": []}], ["Using a large-scale epidemiological approach, we identified eosinophil cationic protein as an independent and predictive risk factor for thrombotic events in humans.", {"entities": []}], ["Concurrent experiments showed that eosinophils contributed to intravascular thrombosis by exhibiting a strong endogenous thrombin-generation capacity that relied on the enzymatic generation and active provision of a procoagulant phospholipid surface enriched in 12/15-lipoxygenase\u2013derived hydroxyeicosatetraenoic acid\u2013phosphatidylethanolamines.", {"entities": []}], ["Our findings reveal a previously unrecognized role of eosinophils and enzymatic lipid oxidation as regulatory elements that facilitate both hemostasis and thrombosis in response to vascular injury, thus identifying promising new targets for the treatment of thrombotic disease.", {"entities": []}], ["Total hip replacement (THR) is successful in treating hip arthritis.", {"entities": [[58, 67, "DISEASE"]]}], ["Prosthetic survivorship may depend on the medications taken by the patient; particularly, the role of benzodiazepines and related drugs (Z-drugs) with THR revision has been poorly investigated.", {"entities": []}], ["Our objective was to compare THR short-term survivorship according to level of exposure to benzodiazepine and Z-drugs.", {"entities": []}], ["All French patients aged 40 years or older, having undergone primary THR from January 1, 2009, through December 31, 2012, for arthritis according to French national health insurance databases were included in the cohort.", {"entities": [[126, 135, "DISEASE"]]}], ["Outcome of interest was THR revision, including any surgical procedure in which the implant or any component was changed or removed.", {"entities": []}], ["Follow-up started the day the primary THR was performed.", {"entities": []}], ["Observations were right-censored on December 31, 2014, if neither revision nor death had yet occurred.", {"entities": []}], ["Exposure of interest was the cumulative defined daily doses per day (cDDD/day) of benzodiazepines and Z-drugs dispensed within 6 months before or after inclusion.", {"entities": []}], ["We defined four exposure groups; cDDD/d = 0: unexposed; <0.08: low exposure;] 0.08\u20130.38]: medium exposure; >0.38: high exposure.", {"entities": []}], ["THR survivorship was assessed according to level of exposure to benzodiazepines and Z-drugs in univariate and multivariate Cox models adjusted for patient, THR and implanting center characteristics.", {"entities": []}], ["The study cohort comprised 246,940 individuals: mean age at baseline, 69.9 years; women, 57.9%; unexposed: 51.7%; low exposure: 16.7%; medium exposure: 15.9%; and high exposure: 15.7%.", {"entities": []}], ["During the median 45-month follow-up, 9043 individuals underwent prosthetic revision.", {"entities": []}], ["Adjusted hazard ratios in low, medium and high exposed groups were 1.18 (95%CI, 1.12\u20131.26; P<0.001), 1.32 (95%CI, 1.24\u20131.40; P<0.001) and 1.37 (95%CI, 1.29\u20131.45; P<0.001), respectively, compared to unexposed.", {"entities": []}], ["Exposure to benzodiazepines and Z-drugs is associated with an increased risk of THR revision, with a dose-response relationship.", {"entities": []}], ["Cautious prescribing might be needed as well as careful history examination and assessment of risk for patients with a hip prosthesis.", {"entities": []}], ["Inequalities in the use of new medications may contribute to health disparities.", {"entities": []}], ["We analyzed socioeconomic gradients in the use of tiotropium for chronic obstructive pulmonary disease (COPD).", {"entities": [[65, 102, "DISEASE"]]}], ["In a cohort of adults with COPD aged \u226555 years identified through population-based sampling, we elicited questionnaire responses on demographics, socioeconomic status (SES; lower SES defined as high school education or less or annual household income <US $20,000), and medication use and other clinical variables.", {"entities": []}], ["In a subset we obtained pulmonary function testing.", {"entities": []}], ["We used multiple logistic regression analysis to estimate the associations between SES and tiotropium use in COPD, adjusting for disease severity measured by a COPD Severity Score.", {"entities": []}], ["Of 427 subjects, 44 (10.3%) reported using tiotropium in 2006.", {"entities": []}], ["Adjusting for COPD severity, lower SES was associated with reduced odds of tiotropium use (OR 0.3; 95% CI 0.1\u20130.7; p = 0.005).", {"entities": []}], ["Among the subset with lung function data (n = 95), after including COPD Global Obstructive Lung Disease (GOLD) Stage \u22652 in the model, lower SES remained associated with reduced odds of tiotropium use (OR 0.03; 95% CI < 0.001\u20130.7; p = 0.03).", {"entities": []}], ["Including forced expiratory volume in one second in the model as a continuous variable instead of GOLD Stage \u22652 yielded similar results for lower SES (OR 0.1; 95% CI < 0.001\u20130.5; p = 0.02).", {"entities": []}], ["There was a strong SES gradient in tiotropium use such that there was less use with lower SES.", {"entities": []}], ["To the extent that this is an efficacious medication for COPD, this gradient represents a potential source of health disparities.", {"entities": []}], ["Spirometry is an important test for the diagnosis of respiratory diseases, yet it is underused especially in older adults.", {"entities": []}], ["Several predictors of good-quality spirometry in this age group have been reported, based mainly on in/outpatients of geriatric and/or respiratory units.", {"entities": []}], ["This study aims to assess predictors of poor-quality spirometry in community-dwelling older adults from two primary care cohorts in Russia and Belgium.", {"entities": []}], ["Spirograms from two population-based cohort studies in Russia (CRYSTAL) and Belgium (BELFRAIL) were assessed in accordance with the American Thoracic Society/European Respiratory Society (ATS/ERS) acceptability and repeatability criteria and grouped into good and poor quality.", {"entities": []}], ["Multivariable analysis assessed the association of poor-quality spirometry with socio-demographics, functional dependency, physical and mental functioning and co-morbidities.", {"entities": []}], ["In all, 43.3% of the 522 BELFRAIL participants (84.71\u00b13.67 years old) and 57.7% of the 605 CRYSTAL participants (75.11\u00b15.97 years old) achieved all ATS/ERS acceptability and repeatability criteria.", {"entities": []}], ["In both cohorts, those with poor-quality spirometry had lower cognitive function (mini-mental state examination (MMSE) \u2a7d24).", {"entities": []}], ["After adjustment in multivariable analysis, MMSE \u2a7d24 had an odds ratio for poor-quality spirometry of 1.33 (95% CI=0.78\u20132.28) in the BELFRAIL and 1.30 (95% CI=0.88\u20131.91) in the CRYSTAL cohort.", {"entities": []}], ["In community-dwelling older adults, including those over 80 years old, impaired cognition measured by the MMSE may not be an independent predictor of poor-quality spirometry.", {"entities": []}], ["Further research is needed in this area, and spirometry should be used more often in older adults in primary care.", {"entities": []}], ["Currently, the analyses of most genome-wide association studies (GWAS) have been performed on a single phenotype.", {"entities": []}], ["There is increasing evidence showing that pleiotropy is a widespread phenomenon in complex diseases.", {"entities": []}], ["Therefore, using only one single phenotype may lose statistical power to identify the underlying genetic mechanism.", {"entities": []}], ["There is an increasing need to develop and apply powerful statistical tests to detect association between multiple phenotypes and a genetic variant.", {"entities": []}], ["In this paper, we develop an Adaptive Fisher\u2019s Combination (AFC) method for joint analysis of multiple phenotypes in association studies.", {"entities": []}], ["The AFC method combines p-values obtained in standard univariate GWAS by using the optimal number of p-values which is determined by the data.", {"entities": []}], ["We perform extensive simulations to evaluate the performance of the AFC method and compare the power of our method with the powers of TATES, Tippett\u2019s method, Fisher\u2019s combination test, MANOVA, MultiPhen, and SUMSCORE.", {"entities": []}], ["Our simulation studies show that the proposed method has correct type I error rates and is either the most powerful test or comparable with the most powerful test.", {"entities": []}], ["Finally, we illustrate our proposed methodology by analyzing whole-genome genotyping data from a lung function study.", {"entities": []}], ["Research on the effects of dietary nutrients on respiratory health in human populations have not investigated curcumin, a potent anti-oxidant and anti-inflammatory compound present principally in turmeric used in large amounts in Asian curry meals.", {"entities": []}], ["To examine the association of curry intake with pulmonary function among smokers and non-smokers.", {"entities": []}], ["The frequency of curry intake, respiratory risk factors and spirometry were measured in a population-based study of 2,478 Chinese older adults aged 55 and above in the Singapore Longitudinal Ageing Studies.", {"entities": []}], ["Curry intake (at least once monthly) was significantly associated with better FEV 1 (b\u200a=\u200a0.045\u00b10.018, p\u200a=\u200a0.011) and FEV 1 /FVC (b\u200a=\u200a1.14\u00b10.52, p\u200a=\u200a0.029) in multivariate analyses that controlled simultaneously for gender, age, height, height-squared, smoking, occupational exposure and asthma/COPD history and other dietary or supplementary intakes.", {"entities": [[287, 293, "DISEASE"], [78, 81, "GENE"], [117, 120, "GENE"], [78, 81, "GENE"], [117, 120, "GENE"]]}], ["Increasing levels of curry intake (\u2018never or rarely\u2019, \u2018occasional\u2019, \u2018often\u2019, \u2018very often\u2019) were associated with higher mean adjusted FEV 1 (p for linear trend\u200a=\u200a0.001) and FEV 1 /FVC% (p for linear trend\u200a=\u200a0.048).", {"entities": [[133, 136, "GENE"], [172, 175, "GENE"], [133, 136, "GENE"], [172, 175, "GENE"]]}], ["Significant effect modifications were observed for FEV 1 (curry* smoking interaction, p\u200a=\u200a0.028) and FEV 1 /FVC% (curry*smoking interaction, p\u200a=\u200a0.05).", {"entities": [[51, 54, "GENE"], [101, 104, "GENE"], [51, 54, "GENE"], [101, 104, "GENE"]]}], ["There were significantly larger differences in FEV 1 and FEV 1 /FVC% between curry intake and non-curry intake especially among current and past smokers.", {"entities": [[47, 50, "GENE"], [57, 60, "GENE"], [47, 50, "GENE"], [57, 60, "GENE"]]}], ["The mean adjusted FEV 1 associated with curry intake was 9.2% higher among current smokers, 10.3% higher among past smokers, and 1.5% higher among non-smokers.", {"entities": [[18, 21, "GENE"]]}], ["The possible role of curcumins in protecting the pulmonary function of smokers should be investigated in further clinical studies.", {"entities": []}], ["The resolution of inflammation is an integral and natural part of the physiological response to tissue injury, infection and allergens or other noxious stimuli.", {"entities": []}], ["Resolution is now recognised as an active process with highly regulated cellular and biochemical events.", {"entities": []}], ["Recent discoveries have highlighted that innate inflammatory cells have bimodal effector functions during the inflammatory response, including active roles during the resolution process.", {"entities": []}], ["Several mediators displaying potent pro-resolving actions have recently been uncovered.", {"entities": []}], ["Lipoxin A 4 , the lead member of this new class of pro-resolving mediators, has anti-inflammatory actions on type 2 innate lymphoid cells and pro-resolving actions through natural killer cells in asthma immunobiology.", {"entities": [[196, 202, "DISEASE"]]}], ["Eosinophils are also able to control crucial aspects of resolution through the generation of pro-resolving mediators.", {"entities": []}], ["Uncontrolled asthma has been associated with a defect in thegeneration of specialised pro-resolving mediators, including lipoxin A 4 and protectin D1.", {"entities": [[13, 19, "DISEASE"]]}], ["Thus, bioactive stable analogue mimetics of these mediators that can harness endogenous resolution mechanisms for inflammation may offer new therapeutic strategies for asthma and airway inflammation associated diseases.", {"entities": [[168, 174, "DISEASE"]]}], ["The chemokine receptor 1 CXCR-1 (or IL8R-alpha) is a specific receptor for the interleukin 8 (IL-8), which is chemoattractant for neutrophils and has an important role in the inflammatory response.", {"entities": []}], ["The polymorphism rs2234671 at position Ex2+860G > C of the CXCR1 gene causes a conservative amino acid substitution (S276T).", {"entities": [[59, 64, "GENE"]]}], ["This single nucleotide polymorphism (SNP) seemed to be functional as it was associated with decreased lung cancer risk.", {"entities": [[102, 113, "DISEASE"], [107, 113, "DISEASE"]]}], ["Previous studies of our group found association of haplotypes in the IL8 and in the CXCR2 genes with the multifactorial disease chronic periodontitis.", {"entities": [[136, 149, "DISEASE"], [69, 72, "GENE"], [84, 89, "GENE"]]}], ["In this study we investigated the polymorphism rs2234671 in 395 Brazilian subjects with and without chronic periodontitis.", {"entities": [[108, 121, "DISEASE"]]}], ["Similar distribution of the allelic and genotypic frequencies were observed between the groups (p > 0.05).", {"entities": []}], ["The polymorphism rs2234671 in the CXCR1 gene was not associated with the susceptibility to chronic periodontitis in the studied Brazilian population.", {"entities": [[99, 112, "DISEASE"], [34, 39, "GENE"]]}], ["Pulmonary emphysema is characterized by irreversible airflow obstruction, inflammation, oxidative stress imbalance and lung remodeling, resulting in reduced lung function and a lower quality of life.", {"entities": []}], ["Flavonoids are plant compounds with potential anti-inflammatory and antioxidant effects that have been used in folk medicine.", {"entities": []}], ["Our aim was to determine whether treatment with sakuranetin, a flavonoid extracted from the aerial parts of Baccharis retusa, interferes with the development of lung emphysema.", {"entities": []}], ["Intranasal saline or elastase was administered to mice; the animals were then treated with sakuranetin or vehicle 2\u00a0h later and again on days 7, 14 and 28.", {"entities": []}], ["We evaluated lung function and the inflammatory profile in bronchoalveolar lavage fluid (BALF).", {"entities": []}], ["The lungs were removed to evaluate alveolar enlargement, extracellular matrix fibers and the expression of MMP-9, MMP-12, TIMP-1, 8-iso-PGF-2\u03b1 and p65-NF-\u03baB in the fixed tissues as well as to evaluate cytokine levels and p65-NF-\u03baB protein expression.", {"entities": []}], ["In the elastase-treated animals, sakuranetin treatment reduced the alveolar enlargement, collagen and elastic fiber deposition and the number of MMP-9- and MMP-12-positive cells but increased TIMP-1 expression.", {"entities": []}], ["In addition, sakuranetin treatment decreased the inflammation and the levels of TNF-\u03b1, IL-1\u03b2 and M-CSF in the BALF as well as the levels of NF-\u03baB and 8-iso-PGF-2\u03b1 in the lungs of the elastase-treated animals.", {"entities": []}], ["However, this treatment did not affect the changes in lung function.", {"entities": []}], ["These data emphasize the importance of oxidative stress and metalloproteinase imbalance in the development of emphysema and suggest that sakuranetin is a potent candidate that should be further investigated as an emphysema treatment.", {"entities": []}], ["This compound may be useful for counteracting lung remodeling and oxidative stress and thus attenuating the development of emphysema.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0233-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In this report we test the hypothesis that long-term virus-induced alterations in CYP occur from changes initiated by the virus that may not be related to the immune response.", {"entities": []}], ["Enzyme activity, protein expression and mRNA of CYP3A2, a correlate of human CYP3A4, and CYP2C11, responsive to inflammatory mediators, were assessed 0.25, 1, 4, and 14 days after administration of several different recombinant adenoviruses at a dose of 5.7 \u00d7 10 p \u2264 0.01).", {"entities": [[77, 83, "GENE"]]}], ["Helper-dependent adenovirus, with all viral genes removed, suppressed CYP3A2 (43%) and CYP2C11 (55%) within six hours.", {"entities": []}], ["CYP3A2 remained significantly suppressed (47%, 14 days, p \u2264 0.01) while CYP2C11 returned to baseline at this time.", {"entities": []}], ["CYP3A2 and 2C11 were reduced by 45 and 42% respectively 6 hours after treatment with PEGylated adenovirus, which has a low immunological profile ( p \u2264 0.05).", {"entities": []}], ["CYP3A2 remained suppressed (34%, p \u2264 0.05) for 14 days while CYP2C11 recovered.", {"entities": []}], ["Inactivated virus suppressed CYP3A2 activity by 25\u201350% for 14 days ( p \u2264 0.05).", {"entities": []}], ["CYP2C11 was affected similar manner but recovered by day 14.", {"entities": []}], ["Microarray and in vitro studies suggest that changes in cellular signaling pathways initiated early in virus infection contribute to changes in CYP.", {"entities": []}], ["Oral corticosteroids and inhaled bronchodilators with or without antibiotics represent standard treatment of COPD exacerbations of moderate severity.", {"entities": []}], ["Frequent courses of oral steroids may be a safety issue.", {"entities": []}], ["We wanted to evaluate in an out-patient setting whether a 2-week course of inhaled budesonide/formoterol would be equally effective for treatment of acute COPD exacerbations as standard therapy in patients judged by the investigator not to require hospitalisation.", {"entities": []}], ["This was a double-blind, randomised, non-inferiority, parallel-group, multicentre study comparing two treatment strategies; two weeks' treatment with inhaled budesonide/formoterol (320/9 \u03bcg, qid) was compared with prednisolone (30 mg once daily) plus inhaled formoterol (9 \u03bcg bid) in patients with acute exacerbations of COPD attending a primary health care centre.", {"entities": []}], ["Inclusion criteria were progressive dyspnoea for less than one week, FEV 1 30\u201360% of predicted normal after acute treatment with a single dose of oral corticosteroid plus nebulised salbutamol/ipratropium bromide and no requirement for subsequent immediate hospitalisation, i.e the clinical status after the acute treatment allowed for sending the patient home.", {"entities": [[69, 72, "GENE"]]}], ["A total of 109 patients (mean age 67 years, 33 pack-years, mean FEV 1 45% of predicted) were randomized to two weeks' double-blind treatment with budesonide/formoterol or prednisolone plus formoterol and subsequent open-label budesonide/formoterol (320/9 \u03bcg bid) for another 12 weeks.", {"entities": [[64, 67, "GENE"]]}], ["Change in FEV 1 was the primary efficacy variable.", {"entities": [[10, 13, "GENE"]]}], ["Non-inferiority was predefined.", {"entities": []}], ["Non-inferiority of budesonide/formoterol was proven because the lower limit of FEV 1 -change (97.5% CI) was above 90% of the efficacy of the alternative treatment.", {"entities": [[79, 82, "GENE"]]}], ["Symptoms, quality of life, treatment failures, need for reliever medication (and exacerbations during follow-up) did not differ between the groups.", {"entities": []}], ["No safety concerns were identified.", {"entities": []}], ["High dose budesonide/formoterol was as effective as prednisolone plus formoterol for the ambulatory treatment of acute exacerbations in non-hospitalized COPD patients.", {"entities": []}], ["An early increase in budesonide/formoterol dose may therefore be tried before oral corticosteroids are used.", {"entities": []}], ["NCT00259779", {"entities": []}], ["To demonstrate the calcium antagonistic property of ethanol extract of Bacopa monniera in guinea-pig trachea.", {"entities": []}], ["The dose response curves of CaCl 2 (1 \u00d7 10 Bacopa monniera (100, 500 and 700 \u03bcg/ml) or nifedipine (1 \u00d7 10 P < 0.05 was considered statistically significant.", {"entities": []}], ["The plant extract (500 and 700 \u03bcg/ml) significantly ( P < 0.05) depressed and shifted the calcium concentration-response curves (1 \u00d7 10 Bacopa monniera extract exhibited calcium channel blocking activity in guinea-pig tracheal smooth muscles that may rationalize its relaxant action on guinea-pig trachea and its traditional use in respiratory disorders.", {"entities": []}], ["The aim of the study was to develop quality indicators that can be used for quality assessment of registries of occupational diseases in relation to preventive policy on a national level.", {"entities": []}], ["The research questions were: 1.", {"entities": []}], ["Which indicators determine the quality of national registries of occupational diseases with respect to their ability to provide appropriate information for preventive policy?", {"entities": []}], ["What are the criteria that can distinguish low quality from high quality?", {"entities": []}], ["First, we performed a literature search to assess which output of registries can be considered appropriate for preventive policy and to develop a set of preliminary indicators and criteria.", {"entities": []}], ["Second, final indicators and criteria were assessed and their content validity was tested in a Delphi study, for which experts from the 25 EU Member States were invited.", {"entities": []}], ["The literature search revealed two different types of information output to be appropriate for preventive policy: monitor and alert information.", {"entities": []}], ["For the evaluation of the quality of the monitor and alert function we developed ten indicators and criteria.", {"entities": []}], ["Sixteen of the twenty-five experts responded in the first round of the Delphi study, and eleven in the second round.", {"entities": []}], ["Based on their comments, we assessed the final nine indicators: the completeness of the notification form, coverage of registration, guidelines or criteria for notification, education and training of reporting physicians, completeness of registration, statistical methods used, investigation of special cases, presentation of monitor information, and presentation of alert information.", {"entities": []}], ["Except for the indicator \"coverage of registration\" for the alert function, all the indicators met the preset requirements of content validity.", {"entities": []}], ["We have developed quality indicators and criteria to evaluate registries for occupational diseases on the ability to provide appropriate information for preventive policy on a national level.", {"entities": []}], ["Together, these indicators form a tool which can be used for quality improvement of registries of occupational diseases.", {"entities": []}], ["Microglial cells act as the sentinel of the central nervous system .They are involved in neuroprotection but are highly implicated in neurodegeneration of the aging brain.", {"entities": []}], ["When over-activated, microglia release pro-inflammatory factors, such as nitric oxide (NO) and cytokines, which are critical in eliciting neuroinflammatory responses associated with neurodegenerative diseases.", {"entities": []}], ["This study examined whether bromelain, the pineapple-derived extract, may exert an anti-inflammatory effect in primary microglia and may be neuroprotective by regulating microglial activation.", {"entities": []}], ["Following the isolation of neonatal rat primary microglial cells, the activation profile of microglia was investigated by studying the effects of bromelain (5, 10, 20, and 30 \u00b5g/ml) on the levels of NO, inducible nitric oxide synthase (iNOS), and nuclear factor kappa B (NF-\u03baB) in microglia treated with lipopolysaccharide (LPS) (1 \u00b5g/ml).", {"entities": []}], ["Data were analyzed using Student's t-test.", {"entities": []}], ["P values less than 0.05 were considered to be statistically significant, compared with the LPS-treated group without bromelain.", {"entities": []}], ["Results showed that pretreatment of rat primary microglia with bromelain, decreased the production of NO induced by LPS (1 \u00b5g/ml) treatment in a dose-dependent manner.", {"entities": []}], ["Bromelain (30 \u00b5g/ml) also significantly reduced the expression of iNOS at mRNA level and NF-\u03baB at protein level.", {"entities": []}], ["Moreover, the study of mitochondrial activity in microglia indicated that bromelain had no cytotoxicity at any of the applied doses, suggesting that the anti-inflammatory effects of bromelain are not due to cell death.", {"entities": []}], ["Bromelain can be of potential use as an agent for alleviation of symptoms in neurodegenerative diseases.", {"entities": []}], ["Little is known about the dynamics or magnitude of antibody response in patients with influenza A (H1N1) pdm09-associated pneumonia.", {"entities": [[86, 95, "DISEASE"], [122, 131, "DISEASE"]]}], ["We described and compared the antibody response to influenza A (H1N1) pdm09 in patients with and without pneumonia.", {"entities": [[51, 60, "DISEASE"], [105, 114, "DISEASE"]]}], ["We collected serum samples and determined antibody titers by the hemagglutination inhibition (HI) and microneutralization (mNT) assays from patients with RT-PCR confirmed influenza A (H1N1) pdm09 virus at baseline, 1, 2 and 6 months after onset of illness.", {"entities": [[171, 180, "DISEASE"], [123, 126, "GENE"]]}], ["Fifty-nine patients were enrolled, 45 (76.3%) were between 15 and 60 years of age, 49 (83.1%) were hospitalized and 25 (42.4%) had complications with pneumonia.", {"entities": [[150, 159, "DISEASE"]]}], ["Ninety-four percent of patients had HI titers \u2265 1: 40 and 90% had mNT titers \u2265 1: 160 at 2 months after illness.", {"entities": [[66, 69, "GENE"]]}], ["Geometric mean titers (GMT) of HI and mNT increased significantly ( p <0.001) between baseline and months 1 or 2, then declined significantly ( p <0.001) at month 6 by the HI assay, but dropped to an insignificant level ( p =0.24) by the mNT assay.", {"entities": [[38, 41, "GENE"], [238, 241, "GENE"], [38, 41, "GENE"], [238, 241, "GENE"]]}], ["The mNT-GMT was at least twice as high as corresponding HI antibodies over a 6 month period.", {"entities": []}], ["The GMT of HI and mNT in those with pneumonia (1 mo) peaked earlier than that of those without pneumonia (2 mo).", {"entities": [[36, 45, "DISEASE"], [95, 104, "DISEASE"], [18, 21, "GENE"]]}], ["When adjusted by age and gender, those with pneumonia had a higher HI-GMT than those without pneumonia at 1 month (264 vs. 117, p =0.007), 2 months (212 vs. 159, p =0.013), and 6 months (160 vs. 82, p =0.018).", {"entities": [[44, 53, "DISEASE"], [93, 102, "DISEASE"]]}], ["The patients recovered from influenza A (H1N1) pdm09-associated pneumonia, clearly developed an earlier and more robust antibody response until 6 months after onset of illness.", {"entities": [[28, 37, "DISEASE"], [64, 73, "DISEASE"]]}], ["The results in our study are useful to determine an appropriate donor and timing to obtain convalescent plasma for adjunctive treatment of seriously ill patients with pandemic H1N1 influenza.", {"entities": [[181, 190, "DISEASE"]]}], ["Variation in the 10 toll-like receptor (TLR) genes has been significantly associated with allergic rhinitis (AR) in several candidate gene studies and three large genome-wide association studies.", {"entities": [[90, 107, "DISEASE"], [99, 107, "DISEASE"]]}], ["These have all investigated common variants, but no investigations for rare variants (MAF\u2009\u2264\u20091%) have been made in AR.", {"entities": [[86, 89, "GENE"]]}], ["The present study aims to describe the genetic variation of the promoter and coding sequences of the 10 TLR genes in 288 AR patients.", {"entities": []}], ["Sanger sequencing and Ion Torrent next-generation sequencing was used to identify polymorphisms in a Swedish AR population and these were subsequently compared and evaluated using 1000Genomes and Exome Aggregation Consortium (ExAC) data.", {"entities": []}], ["The overall level of genetic variation was clearly different among the 10 TLR genes.", {"entities": []}], ["The TLR10 - TLR1 - TLR6 locus was the most variable, while the TLR7 - TLR8 locus was consistently showing a much lower level of variation.", {"entities": [[4, 9, "GENE"], [12, 16, "GENE"], [19, 23, "GENE"], [63, 67, "GENE"], [70, 74, "GENE"]]}], ["The AR patients had a total of 37 promoter polymorphisms with 14 rare (MAF\u2009\u2264\u20091%) and 14 AR-specific polymorphisms.", {"entities": [[71, 74, "GENE"]]}], ["These numbers were highly similar when comparing the AR and the European part of the 1000Genomes populations, with the exception of TLR10 where a significant ( P \u2009=\u20090.00009) accumulation of polymorphisms were identified.", {"entities": [[132, 137, "GENE"]]}], ["The coding sequences had a total of 119 polymorphisms, 68 were rare and 43 were not present in the European part of the 1000Genomes population.", {"entities": []}], ["Comparing the numbers of rare and AR-specific SNPs in the patients with the European part of the 1000Genomes population it was seen that the numbers were quite similar both for individual genes and for the sum of all 10 genes.", {"entities": []}], ["However, TLR1 , TLR5 , TLR7 and TLR9 showed a significant excess of rare variants in the AR population when compared to the non-Finnish European part of ExAC.", {"entities": [[9, 13, "GENE"], [16, 20, "GENE"], [23, 27, "GENE"], [32, 36, "GENE"]]}], ["In particular the TLR1 S324* nonsense mutation was clearly overrepresented in the AR population.", {"entities": [[18, 22, "GENE"]]}], ["Most TLR genes showed a similar level of variation between AR patients and public databases, but a significant excess of rare variants in AR patients were detected in TLR1 , TLR5 , TLR7 , TLR9 and TLR10 .", {"entities": [[167, 171, "GENE"], [174, 178, "GENE"], [181, 185, "GENE"], [188, 192, "GENE"], [197, 202, "GENE"]]}], ["This further emphasizes the frequently reproduced TLR10 - TLR1 - TLR6 locus as being involved in the pathogenesis of allergic rhinitis.", {"entities": [[117, 134, "DISEASE"], [126, 134, "DISEASE"], [50, 55, "GENE"], [58, 62, "GENE"], [65, 69, "GENE"]]}], ["The online version of this article (doi:10.1186/s12881-017-0379-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Bronchial epithelial cells are the first barrier of defense against respiratory pathogens.", {"entities": []}], ["Dust particles as extracellular stimuli are associated with inflammatory reactions after inhalation.", {"entities": []}], ["It has been reported that dust particles induce intracellular Ca 10 dust particles and subsequent mediated intracellular Ca 10 -induced Ca 10 -mediated Ca 3 -PLC blockers, and TRPM2 inhibitors.", {"entities": [[176, 181, "GENE"]]}], ["Our results show that blockades of PLC or TRPM2 reduced both of PM 10 -mediated Ca", {"entities": [[42, 47, "GENE"]]}], ["Innate lymphoid cells (ILCs) are part of a heterogeneous family of innate immune cells with newly identified roles in mediating immunity, tissue homeostasis and pathologic inflammation.", {"entities": []}], ["Here, we review recent studies delineating the roles of ILCs in the pathogenesis of multiple inflammatory skin disorders and their unique effector functions.", {"entities": []}], ["Finally, we address how these studies have informed our understanding of the regulation of ILCs and the therapeutic potential of targeting these cells in the context of skin inflammation.", {"entities": []}], ["The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health convened a Working Group on the Microbiome in Cardiovascular, Pulmonary and Hematologic Health and Diseases from June 25, 2014, to June 26, 2014.", {"entities": []}], ["The Working Group\u2019s central goal was to define what major microbiome research areas warranted additional study in the context of heart, lung, and blood (HLB) diseases.", {"entities": []}], ["The Working Group identified studies of the human virome a key priority.", {"entities": []}], ["Chronic sinusitis is a major cause of morbidity today.", {"entities": [[8, 17, "DISEASE"]]}], ["Regional variations in the incidence of this disease have been reported.", {"entities": []}], ["The aim of this study was to evaluate the incidence of fungal infection as the causative agent of chronic sinusitis among Iranian patients.", {"entities": [[106, 115, "DISEASE"]]}], ["A cross sectional hospital based study was designed; the patients underwent paranasal sinus washing and maxillary sinus biopsy.", {"entities": []}], ["All specimens were studied by light microscopy.", {"entities": []}], ["Fungal culturing was employed to confirm diagnosis.", {"entities": []}], ["The patients underwent Computed Tomography for sinus evaluation.", {"entities": []}], ["Of 162 participants, 12 samples from patients showed fungal elements, 2 of them Aspergillus fulvous (1.2%), 9 of them Alternaria species (5.56%) and 1 of them Psilomysis (0.6%).", {"entities": []}], ["All patients presented radiologic evidence of sinusitis, ranging from mucosal thickening to total opacity.", {"entities": [[46, 55, "DISEASE"]]}], ["In conclusion, results obtained showed a low prevalence of fungal sinusitis among Iranian patients with chronic sinusitis.", {"entities": [[66, 75, "DISEASE"], [112, 121, "DISEASE"]]}], ["Findings also showed that Alternaria is the most causative agent.", {"entities": []}], ["The assessment of airway inflammation for the diagnosis of asthma or COPD is still uncommon in pneumology-specialized general practices.", {"entities": [[59, 65, "DISEASE"]]}], ["In this respect, the measurement of exhaled nitric oxide (NO), as a fast and simple methodology, is increasingly used.", {"entities": []}], ["The indirect assessment of airway inflammation, however, does have its limits and therefore there will always be a need for methods enabling a direct evaluation of airway inflammatory cell composition.", {"entities": []}], ["Sampling of spontaneous sputum is a well-known, simple, economic and non-invasive method to derive a qualitative cytology of airway cells and here we aimed to assess today's value of spontaneous sputum cytology in clinical practice.", {"entities": []}], ["Three pneumologists provided final diagnoses in 481 patients having sputum cytology and we retrospectively determined posterior versus prior probabilities of inflammatory airway disorders.", {"entities": []}], ["Moreover, in a prospective part comprising 108 patients, pneumologists rated their confidence in a given diagnosis before and after knowing sputum cytology and rated its impact on the diagnostic process on an analogue scale.", {"entities": []}], ["Among the 481 patients, 45% were diagnosed as having asthma and/or airway hyperresponsiveness.", {"entities": [[53, 59, "DISEASE"]]}], ["If patients showed sputum eosinophilia, the prevalence of this diagnosis was elevated to 73% (n = 109, p < 0.001).", {"entities": [[26, 38, "DISEASE"]]}], ["The diagnosis of COPD increased from 40 to 66% in patients with neutrophilia (n = 29, p < 0.01).", {"entities": []}], ["Thirty-three of the 108 patients were excluded from the prospective part (26 insufficient samples, 7 incomplete questionnaires).", {"entities": []}], ["In 48/75 cases the confidence into a diagnosis was raised after knowing sputum cytology, and in 15/75 cases the diagnosis was changed as cytology provided new clues.", {"entities": []}], ["Our data suggest that spontaneous sputum cytology is capable of assisting in the diagnosis of inflammatory airway diseases in the outpatient setting.", {"entities": []}], ["Despite the limitations by the semiquantitative assessment and lower sputum quality, the supportive power and the low economic effort needed can justify the use of this method, particularly if the diagnosis in question is thought to have an allergic background.", {"entities": []}], ["We conducted a survey in 2008 to measure the prevalence of lifestyle-related diseases and risk factors in Philippine adults.", {"entities": []}], ["Stratified multistage sampling was used to cover the entire Philippine population of adults aged 20 years or older.", {"entities": []}], ["Using health questionnaires, anthropometric measurements, and blood examinations, the prevalences of atherosclerosis-related risk factors and diseases were determined.", {"entities": [[101, 116, "DISEASE"]]}], ["Survey results were compared with those obtained in 2003.", {"entities": []}], ["Out of 7700 eligible subjects, 64% to 93.7% responded to different survey items.", {"entities": []}], ["Age-adjusted hypertension prevalence was 24.6% at a single visit and 20.6% when corrected for true prevalence.", {"entities": [[13, 25, "DISEASE"]]}], ["The prevalence of diabetes was 3.9% on the basis of fasting blood glucose (FBG), 5.2% by FBG and history, and 6.0% when 2-hour post-load plasma glucose level was determined.", {"entities": []}], ["The prevalence of dyslipidemia was 72.0% and the prevalence of smoking was 31%.", {"entities": []}], ["The prevalence of obesity was 4.9% by body mass index (BMI), and 10.2% and 65.6% by waist-hip ratio (WHR) in men and women, respectively.", {"entities": [[18, 25, "DISEASE"]]}], ["The prevalences of coronary, cerebrovascular, and peripheral arterial diseases were 1.1%, 0.9%, and 1.0%, respectively.", {"entities": []}], ["The prevalences of risk factors for atherosclerosis were higher in 2008 than in 2003, although the increase in diabetes was not significant and smoking decreased.", {"entities": [[36, 51, "DISEASE"]]}], ["These findings indicate a need for active collaborative intervention by all government agencies and medical societies in the Philippines.", {"entities": []}], ["We assessed whether any household dust reduction intervention has the effect of increasing or decreasing the development or severity of atopic disease.", {"entities": []}], ["Electronic searches on household intervention and atopic disease were conducted in January 2007 in EMBASE, MEDLINE, and the Cochrane Central Register of Controlled Trials.", {"entities": []}], ["No date or language restriction was placed on the literature search.", {"entities": []}], ["We included randomized controlled trials comparing asthma outcomes in a household intervention group with either placebo intervention or no intervention.", {"entities": [[51, 57, "DISEASE"]]}], ["Fourteen studies met the inclusion criteria.", {"entities": []}], ["Eight recruited antenatally and measured development of atopic disease.", {"entities": []}], ["Six recruited known atopic individuals and measured disease status change.", {"entities": []}], ["Meta-analyses on the prevention studies found that the interventions made no difference to the onset of wheeze but made a significant reduction in physician-diagnosed asthma.", {"entities": [[167, 173, "DISEASE"]]}], ["Meta-analysis of lung function outcomes indicated no improvement due to the interventions but found a reduction in symptom days.", {"entities": []}], ["Qualitatively, health care was used less in those receiving interventions.", {"entities": []}], ["However, in one study that compared intervention, placebo, and control arms, the reduction in heath care use was similar in the placebo and intervention arms.", {"entities": []}], ["This review suggests that there is not sufficient evidence to suggest implementing hygiene measures in an attempt to improve outcomes in existing atopic disease, but interventions from birth in those at high risk of atopy are useful in preventing diagnosed asthma but not parental-reported wheeze.", {"entities": [[257, 263, "DISEASE"]]}], ["The link between histologic acute chorioamnionitis and infection is well established in preterm deliveries, but less well-studied in term pregnancies, where infection is much less common.", {"entities": [[34, 50, "DISEASE"]]}], ["We conducted a secondary analysis among 195 low-risk women with term pregnancies enrolled in a randomized trial.", {"entities": []}], ["Histologic and microbiologic evaluation of placentas included anaerobic and aerobic cultures (including mycoplasma/ureaplasma species) as well as PCR.", {"entities": []}], ["Infection was defined as \u22651,000 cfu of a single known pathogen or a \u22652 log difference in counts for a known pathogen versus other organisms in a mixed culture.", {"entities": []}], ["Placental membranes were scored and categorized as: no chorioamnionitis, Grade 1 (subchorionitis and patchy acute chorioamnionitis), or Grade 2 (severe, confluent chorioamnionitis).", {"entities": [[55, 71, "DISEASE"], [114, 130, "DISEASE"], [163, 179, "DISEASE"]]}], ["Grade 1 or grade 2 histologic chorioamnionitis was present in 34% of placentas (67/195), but infection was present in only 4% (8/195).", {"entities": [[30, 46, "DISEASE"]]}], ["Histologic chorioamnionitis was strongly associated with intrapartum fever >38\u00b0C [69% (25/36) fever, 26% (42/159) afebrile, P <.0001].", {"entities": [[11, 27, "DISEASE"]]}], ["Fever occurred in 18% (n\u200a=\u200a36) of women.", {"entities": []}], ["Most febrile women [92% (33/36)] had received epidural for pain relief, though the association with fever was present with and without epidural.", {"entities": []}], ["The association remained significant in a logistic regression controlling for potential confounders (OR\u200a=\u200a5.8, 95% CI\u200a=\u200a2.2,15.0).", {"entities": []}], ["Histologic chorioamnionitis was also associated with elevated serum levels of interleukin-8 (median\u200a=\u200a1.3 pg/mL no histologic chorioamnionitis, 1.5 pg/mL Grade 1, 2.1 pg/mL Grade 2, P\u200a=\u200a0.05) and interleukin-6 (median levels\u200a=\u200a2.2 pg/mL no chorioamnionitis, 5.3 pg/mL Grade 1, 24.5 pg/mL Grade 2, P\u200a=\u200a0.02) at admission for delivery as well as higher admission WBC counts (mean\u200a=\u200a12,000cells/mm P \u200a=\u200a0.0005).", {"entities": [[11, 27, "DISEASE"], [126, 142, "DISEASE"], [240, 256, "DISEASE"]]}], ["Our results suggest histologic chorioamnionitis at term most often results from a noninfectious inflammatory process.", {"entities": [[31, 47, "DISEASE"]]}], ["It was strongly associated with fever, most of which was related to epidural used for pain relief.", {"entities": []}], ["A more \u2018activated\u2019 maternal immune system at admission was also associated with histologic chorioamnionitis.", {"entities": [[91, 107, "DISEASE"]]}], ["Nutrition support practitioners are currently dealing with shortages of parenteral nutrition micronutrients, including multivitamins (MVI), selenium and zinc.", {"entities": []}], ["A recent survey from the American Society of Enteral and Parenteral Nutrition (ASPEN) indicates that this shortage is having a profound effect on clinical practice.", {"entities": []}], ["A majority of respondents reported taking some aggressive measures to ration existing supplies.", {"entities": []}], ["Most premature infants and many infants with congenital anomalies are dependent on parenteral nutrition for the first weeks of life to meet nutritional needs.", {"entities": []}], ["Because of fragile health and poor reserves, they are uniquely susceptible to this problem.", {"entities": []}], ["It should be understood that shortages and rationing have been associated with adverse outcomes, such as lactic acidosis and Wernicke encephalopathy from thiamine deficiency or pulmonary and skeletal development concerns related to inadequate stores of Vitamin A and D. In this review, we will discuss the current parenteral shortages and the possible impact on a population of very low birth weight infants.", {"entities": [[105, 120, "DISEASE"]]}], ["This review will also present a case study of a neonate who was impacted by these current shortages.", {"entities": []}], ["Primary care physicians are caring for increasing numbers of persons with comorbid chronic illness.", {"entities": []}], ["Longitudinal information on health outcomes associated with specific chronic conditions may be particularly relevant in caring for these populations.", {"entities": []}], ["Our objective was to assess the effect of certain comorbid conditions on physical well being over time in a population of persons with chronic medical conditions; and to compare these effects to that of hypertension alone.", {"entities": [[203, 215, "DISEASE"]]}], ["We conducted a secondary analysis of 4-year longitudinal data from the Medical Outcomes Study.", {"entities": []}], ["A heterogeneous population of 1574 patients with either hypertension alone (referent) or one or more of the following conditions: diabetes, coronary artery disease, congestive heart failure, respiratory illness, musculoskeletal conditions and/or depression were recruited from primary and specialty (endocrinology, cardiology or mental health) practices within HMO and fee-for-service settings in three U.S. cities.", {"entities": [[165, 189, "DISEASE"], [56, 68, "DISEASE"]]}], ["We measured categorical change (worse vs. same/better) in the SF-36 Specific diagnoses of CHF, diabetes and/or chronic respiratory disease; or 4 or more chronic conditions, were predictive of a clinically significant decline in PCS.", {"entities": []}], ["Clinical recognition of these specific chronic conditions or 4 or more of a list of chronic conditions may provide an opportunity for proactive clinical decision making to maximize physical functioning in these populations.", {"entities": []}], ["Sepsis is a serious issue in the geriatric population due to its association with high mortality rates in the elderly.", {"entities": []}], ["The increase in mortality in the elderly correlates with inflammation.", {"entities": []}], ["We have previously demonstrated that the inflammatory response is exacerbated in a rodent endotoxemia model of sepsis in aged rats compared with young rats.", {"entities": []}], ["However, the molecular mediators associated with this hyperinflammatory response in aged rats have not been completely determined.", {"entities": []}], ["Sphingosine kinase-1 (Sphk-1), an enzyme present in neutrophils and macrophages, regulates proinflammatory responses associated with endotoxemia and sepsis.", {"entities": []}], ["To determine whether Sphk-1 is a molecular mediator associated with the observed hyperinflammatory response in aging, Sphk-1 mRNA expression was examined in hepatic tissues of young and aged rats subjected to endotoxemia.", {"entities": []}], ["A significant increase in Sphk-1 mRNA was observed in endotoxemic aged rats compared with young rats.", {"entities": []}], ["This increase was correlated with a significant increase in TNF-\u03b1 mRNA levels in the liver.", {"entities": []}], ["CD14 is a receptor component for lipopolysaccharide (LPS) and therefore, CD14 mRNA expression in hepatic tissues of endotoxemic young and aged rats was examined.", {"entities": [[0, 4, "GENE"], [73, 77, "GENE"], [0, 4, "GENE"], [73, 77, "GENE"]]}], ["Of note, CD14 mRNA was significantly upregulated in endotoxemic aged rats.", {"entities": [[9, 13, "GENE"]]}], ["Sphk-1 mRNA expression was significantly elevated in LPS-treated Kupffer cells and this increase correlated with an increase in CD14 mRNA expression.", {"entities": [[128, 132, "GENE"]]}], ["Results of the present study indicated that increased Sphk-1 expression in the liver in response to endotoxemia mediates the hyperinflammatory state observed in aged animals.", {"entities": []}], ["Electronic cigarettes (e-cigarettes) are generally recognized as a safer alternative to combusted tobacco products, but there are conflicting claims about the degree to which these products warrant concern for the health of the vapers (e-cigarette users).", {"entities": []}], ["This paper reviews available data on chemistry of aerosols and liquids of electronic cigarettes and compares modeled exposure of vapers with occupational safety standards.", {"entities": []}], ["Both peer-reviewed and \u201cgrey\u201d literature were accessed and more than 9,000 observations of highly variable quality were extracted.", {"entities": []}], ["Comparisons to the most universally recognized workplace exposure standards, Threshold Limit Values (TLVs), were conducted under \u201cworst case\u201d assumptions about both chemical content of aerosol and liquids as well as behavior of vapers.", {"entities": []}], ["There was no evidence of potential for exposures of e-cigarette users to contaminants that are associated with risk to health at a level that would warrant attention if it were an involuntary workplace exposures.", {"entities": []}], ["The vast majority of predicted exposures are\u2009<\u2009<1% of TLV.", {"entities": []}], ["Predicted exposures to acrolein and formaldehyde are typically <5% TLV.", {"entities": []}], ["Considering exposure to the aerosol as a mixture of contaminants did not indicate that exceeding half of TLV for mixtures was plausible.", {"entities": []}], ["Only exposures to the declared major ingredients -- propylene glycol and glycerin -- warrant attention because of precautionary nature of TLVs for exposures to hydrocarbons with no established toxicity.", {"entities": []}], ["Current state of knowledge about chemistry of liquids and aerosols associated with electronic cigarettes indicates that there is no evidence that vaping produces inhalable exposures to contaminants of the aerosol that would warrant health concerns by the standards that are used to ensure safety of workplaces.", {"entities": []}], ["However, the aerosol generated during vaping as a whole (contaminants plus declared ingredients ) creates personal exposures that would justify surveillance of health among exposed persons in conjunction with investigation of means to keep any adverse health effects as low as reasonably achievable.", {"entities": []}], ["Exposures of bystanders are likely to be orders of magnitude less, and thus pose no apparent concern.", {"entities": []}], ["During the last decade, oral bisphosphonates (BP) became the most widely prescribed pharmacologic class for post-menopausal osteoporosis.", {"entities": [[124, 136, "DISEASE"]]}], ["However, many surveys revealed the important issue of poor persistence with those drugs resulting in a failure of treatment to reduce fracture risk sufficiently.", {"entities": []}], ["Using a published Markov model, this study analyses the economic impact of non-persistence with bisphosphonates in the context of the introduction of generics in France.", {"entities": []}], ["Direct costs of vertebral, hip and wrist fracture were assessed and included in an existing 10-year Markov model developed to analyse consequences of non-persistence.", {"entities": []}], ["Three alternatives of comparison were set: no treatment, real-world persistence, and ideal persistence.", {"entities": []}], ["Simulated patients' characteristics matched those from a French observational study and the real-world adherence alternative employed persistence data from published database analysis.", {"entities": []}], ["The risk of fracture of menopausal women and the risk reduction associated with the drugs were based on results reported in clinical trials.", {"entities": []}], ["Incremental cost-effectiveness ratios (ICERs) were calculated first between real-world adherence and no treatment alternatives, and second between ideal and real-world persistence alternatives.", {"entities": []}], ["The cost of non-persistence was defined as the difference between total cost of ideal and real-world persistence alternatives.", {"entities": []}], ["Within fractured women population, mean costs of 10-year management of fracture were significantly different between the three alternatives with \u20ac7,239 (\u00b1 \u20ac4,783), \u20ac6,711 (\u00b1 \u20ac4,410) and \u20ac6,134 (\u00b1 \u20ac3,945) in the no-treatment, the real-world and ideal persistence alternatives, respectively (p < 0.0001).", {"entities": []}], ["Cost-effectiveness ratio for real-world treatment persistence compared with no-treatment alternative was found dominant and as well, alternative of ideal persistence dominated the former.", {"entities": []}], ["Each ten percentage point of persistence gain amounted to \u20ac58 per patient, and extrapolation resulted in a global annual cost of non-persistence of over \u20ac30 million to the French health care system, with a substantial transfer from hospital to pharmacy budgets.", {"entities": []}], ["Within term, improving persistence with oral bisphosphonates should be economically dominant on levels currently known in real-world.", {"entities": []}], ["Given this potential savings, ambitious adherence-enhancing interventions should be considered in osteoporotic patients.", {"entities": []}], ["Medication non-adherence is a major public health problem in Ghana.", {"entities": []}], ["Locus of control (LoC) may influence adherence to medication.", {"entities": []}], ["In this study we examine the association between locus orientation and adherence to hypertensive medication among adult patients.", {"entities": []}], ["We also take into account the role of medication side effects.", {"entities": []}], ["We conducted a hospital-based cross-sectional study involving two tertiary hospitals in southern and northern Ghana.", {"entities": []}], ["Data were collected from 400 hypertensive patients using a structured questionnaire.", {"entities": []}], ["We gathered information on patient\u2019s sociodemographic characteristics, health LoC, side effects of anti-hypertensive medication and adherence to anti-hypertensive medication.", {"entities": []}], ["Participants exhibited features of mixed LoC (both internal and external) usually referred to as bi-local expectancy.", {"entities": []}], ["However, orientation was skewed towards external LoC.", {"entities": []}], ["Females were marginally more likely than males to have an internal LoC.", {"entities": []}], ["Education was associated with a greater likelihood of internal LoC.", {"entities": []}], ["While most patients (93.3%) poorly adhered to antihypertensive medications, logistic regression model revealed that non-adherence was significantly associated with low internal LoC, medication side effects and the combined effect of medication side effects and external LoC.", {"entities": []}], ["Medication non-adherence, experiences of medication side effects and LoC are associated.", {"entities": []}], ["Multifaceted intervention programmes highlighting personality characteristics like LoC may improve anti-hypertensive medication adherence.", {"entities": []}], ["The endocannabinoid system is a component of the neuroprotective mechanisms that an organism displays after traumatic brain injury (TBI).", {"entities": []}], ["A diurnal variation in several components of this system has been reported.", {"entities": []}], ["This variation may influence the recovery and survival rate after TBI.", {"entities": []}], ["We have previously reported that the recovery and survival rate of rats is higher if TBI occurs at 1:00 than at 13:00.", {"entities": []}], ["This could be explained by a diurnal variation of the endocannabinoid system.", {"entities": []}], ["Here, we describe the effects of anandamide administration in rats prior to the induction of TBI at two different times of the day: 1:00 and 13:00.", {"entities": []}], ["We found that anandamide reduced the neurological damage at both times.", {"entities": []}], ["Nevertheless, its effects on bleeding, survival, food intake, and body weight were dependent on the time of TBI.", {"entities": []}], ["In addition, we analyzed the diurnal variation of the expression of the cannabinoid receptors CB1R and CB2R in the cerebral cortex of both control rats and rats subjected to TBI.", {"entities": []}], ["We found that CB1R protein was expressed more during the day, whereas its mRNA level was higher during the night.", {"entities": []}], ["We did not find a diurnal variation for the CB2R.", {"entities": []}], ["In addition, we also found that TBI increased CB1R and CB2R in the contralateral hemisphere and disrupted the CB1R diurnal cycle.", {"entities": []}], ["The diagnosis of ventilator-associated pneumonia (VAP) remains time-consuming and costly, the clinical tools lack specificity and a bedside test to exclude infection in suspected patients is unavailable.", {"entities": [[39, 48, "DISEASE"]]}], ["Breath contains hundreds to thousands of volatile organic compounds (VOCs) that result from host and microbial metabolism as well as the environment.", {"entities": []}], ["The present study aims to use breath VOC analysis to develop a model that can discriminate between patients who have positive cultures and who have negative cultures with a high sensitivity.", {"entities": []}], ["The Molecular Analysis of Exhaled Breath as Diagnostic Test for Ventilator-Associated Pneumonia (BreathDx) study is a multicentre observational study.", {"entities": [[86, 95, "DISEASE"]]}], ["Breath and bronchial lavage samples will be collected from 100 and 53 intubated and ventilated patients suspected of VAP.", {"entities": []}], ["Breath will be analysed using Thermal Desorption \u2013 Gas Chromatography \u2013 Mass Spectrometry (TD-GC-MS).", {"entities": []}], ["The primary endpoint is the accuracy of cross-validated prediction for positive respiratory cultures in patients that are suspected of VAP, with a sensitivity of at least 99% (high negative predictive value).", {"entities": []}], ["To our knowledge, BreathDx is the first study powered to investigate whether molecular analysis of breath can be used to classify suspected VAP patients with and without positive microbiological cultures with 99% sensitivity.", {"entities": []}], ["UKCRN ID number 19086, registered May 2015; as well as registration at www.trialregister.nl under the acronym \u2018BreathDx\u2019 with trial ID number NTR 6114 (retrospectively registered on 28 October 2016).", {"entities": []}], ["The role of lung mast cells in exercise-induced asthma (EIA) is controversial.", {"entities": [[48, 54, "DISEASE"]]}], ["To investigate whether the skin mast cell releasability is increased after exercise in EIA, 49 young atopic men with or without asthma took part in a free-running test for 6 min and were given skin prick tests using morphine, a mast cell secretagogue, before and after the exercise.", {"entities": [[128, 134, "DISEASE"]]}], ["The mean diameters of the wheal induced by morphine in patients with EIA were not significantly different from those in patients without EIA before exercise, although the baseline lung function was significantly lower and the airway hyperresponsiveness, the peripheral blood eosinophil count, and the size of the wheal in response to Dermatophagoides pteronyssinus were significantly higher in patients with EIA.", {"entities": []}], ["However, the differences of the morphine-induced wheal diameter between patients with EIA and those without EIA became significant at 120 min after exercise ( p <0.05), while the responses to histamine were not significantly different.", {"entities": []}], ["These results suggest that exercise increases the releasability of skin mast cells in EIA patients whose asthma/allergy are relatively severe.", {"entities": [[105, 111, "DISEASE"]]}], ["Tocilizumab (TCZ) and tumour necrosis factor inhibitors (TNFi) are recommended for the treatment of rheumatoid arthritis (RA) in patients with inadequate response (IR) to prior disease-modifying antirheumatic drugs (DMARDs).", {"entities": [[100, 120, "DISEASE"], [111, 120, "DISEASE"]]}], ["This retrospective analysis assessed the efficacy of TCZ and TNFi, alone or in combination with DMARDs, in 1603 patients with IR to previous treatment with either DMARDs (DMARD-IR) and/or TNFi (TNFi-IR), initiating treatment with TCZ or a TNFi, managed in routine clinical practice.", {"entities": []}], ["Patients were grouped according to treatment history and treatment initiated: DMARD-IR patients initiating treatment with TCZ + DMARD (DMARD-IR TCZ) or TNFi + DMARD (DMARD-IR TNFi), DMARD-IR and/or TNFi-IR patients initiating treatment with TCZ monotherapy (TCZ mono) or TNFi monotherapy (TNFi mono), and TNFi-IR patients initiating treatment with TCZ + DMARD (TNFi-IR TCZ) or TNFi + DMARD (TNFi-IR TNFi).", {"entities": []}], ["Patients initiating treatment with TCZ generally had more severe disease and longer disease duration compared with the corresponding TNFi group.", {"entities": []}], ["Significantly more patients achieved remission (DAS28 ESR <2.6) in the TCZ groups compared with corresponding TNFi groups (DMARD-IR, TCZ 44.0\u00a0% vs. TNFi 29.6\u00a0%; monotherapy, TCZ 37.2\u00a0% vs. TNFi 30.2\u00a0%; TNF-IR, TCZ 41.3\u00a0% vs. TNFi 19.2\u00a0%; p \u2009<\u20090.001 for all comparisons).", {"entities": []}], ["More patients achieved moderate\u2013good responses (EULAR criteria) in the TCZ treatment groups (79\u201385\u00a0%) compared with TNFi treatment groups (65\u201381\u00a0%).", {"entities": []}], ["Patient-reported outcomes showed greater improvements in TCZ compared with TNFi groups.", {"entities": []}], ["In patients with inadequate response to DMARDs and/or TNFi treated in routine clinical practice, TCZ in combination with DMARDs or as monotherapy resulted in significantly more patients achieving remission and more marked improvements in patient-reported outcomes compared with TNF inhibitors.", {"entities": [[278, 281, "GENE"]]}], ["Previous research using the National Health and Nutrition Examination Surveys (NHANES) data documented a significant downward trend in secondhand smoke (SHS) exposure between 1988 and 2002.", {"entities": []}], ["The objective of this study was to assess whether the downward trend in exposure continued from 2001 through 2006.", {"entities": []}], ["We analyzed data from the 2001-2006 NHANES to estimate exposure of nonsmokers to SHS.", {"entities": []}], ["Geometric means of serum cotinine levels for all nonsmokers were computed.", {"entities": []}], ["Overall serum cotinine levels (95% Confidence Intervals) in 2001-2002, 2003-2004, and 2005-2006 were 0.06 ng/mL (0.05-0.07), 0.07 ng/mL (0.06-0.09), and 0.05 ng/mL (0.05-0.06), respectively.", {"entities": []}], ["Subgroup analysis by age, gender, and race/ethnicity groups showed similar trends in cotinine levels.", {"entities": []}], ["Children, males, and non-Hispanic Blacks had higher cotinine levels than adults, females, and non-Hispanic Whites and Mexican Americans, respectively.", {"entities": []}], ["Insignificant P values from the Wald test indicate that serum cotinine levels did not differ over time.", {"entities": []}], ["The long-term trend of declining exposure to SHS among nonsmokers appears to have leveled off.", {"entities": []}], ["However, disparities noted in previous research persist today, with the young, non-Hispanic Blacks, and males experiencing higher levels of exposure.", {"entities": []}], ["This study was conducted to evaluate the association between hemorrhoid and risk of incident peripheral artery occlusive disease (PAOD).", {"entities": [[61, 71, "DISEASE"]]}], ["Using the Taiwanese Longitudinal Health Insurance Database 2000, we compared the incident PAOD risk between the hemorrhoid and the non-hemorrhoid cohorts.", {"entities": [[112, 122, "DISEASE"], [135, 145, "DISEASE"]]}], ["Both of these cohorts were followed up from the index date until the date of PAOD diagnosis, withdrawal from the National Health Insurance program, or the end of 2011.", {"entities": []}], ["The mean follow-up period was 6.82 (standard deviation [SD], 3.22) and 6.70 (SD, 3.23) years in the hemorrhoid and non-hemorrhoid cohorts, respectively.", {"entities": [[100, 110, "DISEASE"], [119, 129, "DISEASE"]]}], ["The plot of the Kaplan\u2013Meier analysis showed that, by the end of the 12-year follow-up period, the cumulative incidence of PAOD was significantly higher for the hemorrhoid cohort than for the non-hemorrhoid cohort (log-rank test: P \u00a0<\u00a00.001).", {"entities": [[161, 171, "DISEASE"], [196, 206, "DISEASE"]]}], ["A significantly increased PAOD risk in patients with hemorrhoids was found in this nationwide cohort study.", {"entities": []}], ["\u2022 This study is a nationwide population-based cohort study.", {"entities": []}], ["\u2022 This study aimed to evaluate the association between hemorrhoid and risk of PAOD.", {"entities": [[55, 65, "DISEASE"]]}], ["\u2022 Increased risk of PAOD in patients with hemorrhoids was found in this study.", {"entities": []}], ["This study is a nationwide population-based cohort study.", {"entities": []}], ["This study aimed to evaluate the association between hemorrhoid and risk of PAOD.", {"entities": [[53, 63, "DISEASE"]]}], ["Increased risk of PAOD in patients with hemorrhoids was found in this study.", {"entities": []}], ["Catecholamine infusion elicits an increase in clotting factors and this increase has been attributed to stimulation of \u03b2 2 -adrenorecptors (\u03b22AR).", {"entities": []}], ["Accordingly, we tested the hypothesis that inhalation of a short-acting selective \u03b22AR agonist can induce a procoagulant state in healthy individuals.", {"entities": []}], ["We recruited 23 healthy volunteers (nine females; mean age: 26\u00b10.8 years; body mass index: 24.7\u00b10.5 kg/m Saline inhalation had no effect on the procoagulant, anticoagulant and fibrinolytic profiles of the six healthy volunteer in the study's saline arm.", {"entities": []}], ["Salbutamol inhalation caused (a) a significant increase in the activity or levels of the procoagulant factors; FVIII increased by 11\u00b13% (p = 0.04), von Willebrand factor increased by 7\u00b11% (p = 0.03), and (b) a significant decrease in the activated partial prothrombin time from 27.4\u00b10.4 seconds to 25.5 \u00b10.5 seconds (p<0.001) in the 17 volunteers in the study's \u03b22AR arm.", {"entities": []}], ["D-dimer and prothrombin fragments F1+2 were elevated by 200 \u00b190% and 505.0 \u00b1300.0%, respectively.", {"entities": []}], ["In addition, the activity of the anticoagulant protein C pathway (demonstrated by the protein C Global assay) decreased from 1.0\u00b10.08 to 0.82\u00b10.06 (p<0.001).", {"entities": []}], ["Although plasma levels of tissue plasminogen activator decreased, all other indices of the fibrinolytic system did not change following salbutamol inhalation.", {"entities": []}], ["We found that a single inhalation of salbutamol, a short-acting \u03b22AR agonist, activates the clotting system without affecting the fibrinolytic system.", {"entities": []}], ["This induction of a procoagulant state in healthy subjects warrants further investigation in patients treated with these agents.", {"entities": []}], ["This study was designed to test the hypothesis that fetal exposure to corticosteroids in the antenatal period is an independent risk factor for the development of asthma in early childhood with little or no effect in later childhood.", {"entities": [[163, 169, "DISEASE"]]}], ["A population-based cohort study of all pregnant women who resided in Nova Scotia, Canada, and gave birth to a singleton fetus between 1989 and 1998 was undertaken.", {"entities": []}], ["After a priori specified exclusions, 80,448 infants were available for analysis.", {"entities": []}], ["Using linked health care utilization records, incident asthma cases developed after 36 months of age were identified.", {"entities": [[55, 61, "DISEASE"]]}], ["Extended Cox proportional hazards models were used to estimate hazard ratios while controlling for confounders.", {"entities": []}], ["Exposure to corticosteroids during pregnancy was associated with a risk of asthma in childhood between 3\u20135 years of age: adjusted hazard ratio of 1.19 (95% confidence interval: 1.03, 1.39), with no association noted after 5 years of age: adjusted hazard ratio for 5\u20137 years was 1.06 (95% confidence interval: 0.86, 1.30) and for 8 or greater years was 0.74 (95% confidence interval: 0.54, 1.03).", {"entities": [[75, 81, "DISEASE"]]}], ["Antenatal steroid therapy appears to be an independent risk factor for the development of asthma between 3 and 5 years of age.", {"entities": [[90, 96, "DISEASE"]]}], ["Many simple, affordable and effective disease control measures have had limited impact due to poor access especially by the poorer populations (urban and rural) and inadequate community participation.", {"entities": []}], ["A proven strategy to address the problem of access to health interventions is the Community Directed Interventions (CDI) approach, which has been used successfully in rural areas.", {"entities": []}], ["This study was carried out to assess resources for the use of a CDI strategy in delivering health interventions in poorly-served urban communities in Ibadan, Nigeria.", {"entities": []}], ["A formative study was carried out in eight urban poor communities in the Ibadan metropolis in the Oyo State.", {"entities": []}], ["Qualitative methods comprising 12 focus group discussions (FGDs) with community members and 73 key informant interviews (KIIs) with community leaders, programme managers, community-based organisations (CBOs), non-government organisations (NGOs) and other stakeholders at federal, state and local government levels were used to collect data to determine prevalent diseases and healthcare delivery services, as well as to explore the potential resources for a CDI strategy.", {"entities": []}], ["All interviews were audio recorded.", {"entities": []}], ["Content analysis was used to analyse the data.", {"entities": []}], ["Malaria, upper respiratory tract infection, diarrhoea and measles were found to be prevalent in children, while hypertension and diabetes topped the list of diseases among adults.", {"entities": [[112, 124, "DISEASE"], [58, 65, "DISEASE"], [0, 7, "DISEASE"]]}], ["Healthcare was financed mainly by out-of-pocket expenses.", {"entities": []}], ["Cost and location were identified as hindrances to utilisation of health facilities; informal cooperatives ( esusu ) were available to support those who could not pay for care.", {"entities": []}], ["Immunisation, nutrition, reproductive health, tuberculosis (TB) and leprosy, environmental health, malaria and HIV/AIDs control programmes were the ongoing interventions.", {"entities": [[68, 75, "DISEASE"], [46, 58, "DISEASE"], [99, 106, "DISEASE"]]}], ["Delivery strategies included house-to-house, home-based treatment, health education and campaigns.", {"entities": []}], ["Community participation in the planning, implementation and monitoring of development projects was reported as common practice.", {"entities": []}], ["The resources available for these activities and which constitute potential resources for the CDI process include community volunteers, CBOs and NGOs.", {"entities": []}], ["Others are landlords; professional, women and youth associations; social clubs, religious organisations and the available health facilities.", {"entities": []}], ["This study\u2019s findings support the feasibility of using the CDI process in delivering health interventions in urban poor communities and show that potential resources for the strategy abound in the communities.", {"entities": []}], ["This study was designed to determine the rate and pattern of vitreo-retinal diseases at a tertiary eye care center in South-eastern Nigeria.", {"entities": []}], ["The outpatient register at the Eye Clinic of the University of Nigeria Teaching Hospital, Enugu, was retrospectively examined to identify all new patients registered between January 2004 and December 2008.", {"entities": []}], ["A chart review of subjects with vitreo-retinal disease was conducted to record relevant demographic and clinical data including the needs for vitreo-retinal care.", {"entities": [[39, 54, "DISEASE"]]}], ["Descriptive and analytical statistics were performed.", {"entities": []}], ["A P -value <0.001 (one degree of freedom) was considered statistically significant.", {"entities": []}], ["Of the 8,239 new patients reported during the period, 326 subjects (males- 59.3%; females- 40.7%; sex ratio = 1.1:1) aged 49.3 \u00b1 16.8 years (range 3-82 years) had vitreo-retinal disease.", {"entities": [[170, 185, "DISEASE"]]}], ["The rate of vitreo-retinal disease was 3.9%.", {"entities": [[19, 34, "DISEASE"]]}], ["The rate was higher in subjects above 40 years old ( P < 0.001), but did not differ between sexes ( P = 0.469).", {"entities": []}], ["Diabetic retinopathy (24.9%), hypertensive retinopathy (13.3%), and age-related macular degeneration (10.7%) were the leading vitreo-retinal diseases.", {"entities": [[30, 54, "DISEASE"], [80, 100, "DISEASE"]]}], ["Blindness from vitreo-retinal disease was bilateral in 6.1% of subjects and unilateral in 17.5% of subjects.", {"entities": [[22, 37, "DISEASE"]]}], ["The common co-morbidities were ocular conditions such as refractive error (19.8%), cataract (14.2%), and glaucoma (10.4%); and systemic conditions such as diabetes mellitus (14.6%) and hypertension (13.2%).", {"entities": [[185, 197, "DISEASE"], [83, 91, "DISEASE"], [105, 113, "DISEASE"], [57, 73, "DISEASE"], [155, 172, "DISEASE"]]}], ["The rate of vitreo-retinal diseases among new ophthalmic outpatients at UNTH, Enugu, is 3.9%.", {"entities": []}], ["Retinal vascular disorders and age-related maculopathy are the leading retinal diseases.", {"entities": []}], ["At UNTH, resource needs for vitreo-retinal care are urgent including retinal photography/angiography, laser photocoagulation, intra-vitreal pharmacotherapy, and vitreo-retinal surgery.", {"entities": []}], ["Parasite-specific IgE levels correlate with human resistance to reinfection with Schistosoma spp .", {"entities": []}], ["after chemotherapy.", {"entities": []}], ["Although the role of eosinophils in schistosomiasis has been the focus of a great deal of important research, the involvement of other Fc\u03b5 receptor-bearing cells, such as mast cells and basophils, has not been investigated in relation to human immunity to schistosomes.", {"entities": [[36, 51, "DISEASE"]]}], ["Chemotherapy with praziquantel (PZQ) kills schistosomes living in an in vivo blood environment rich in IgE, eosinophils and basophils.", {"entities": []}], ["This releases parasite Ags that have the potential to cross-link cell-bound IgE.", {"entities": []}], ["However, systemic hypersensitivity reactions are not induced by treatment.", {"entities": []}], ["Here, we describe the effects of schistosomiasis, and its treatment, on human basophil function by following changes in total cellular histamine and in vitro histamine-release induced by schistosome Ags or anti-IgE, in blood samples from infected Ugandan fishermen, who are continuously exposed to S. mansoni infection, before and 1-day and 21-days after PZQ treatment.", {"entities": [[33, 48, "DISEASE"]]}], ["There was a significant increase in the total cellular histamine in blood samples at 1-day post-treatment, followed by a very significant further increase by 21-days post-treatment.", {"entities": []}], ["In vitro histamine-release induced by S. mansoni egg (SEA) or worm (SWA) Ags or anti-IgE antibody, was significantly reduced 1-day post-treatment.", {"entities": []}], ["The degree of this reduction correlated with pre-treatment infection intensity.", {"entities": []}], ["Twenty-1-days post-treatment, SEA-induced histamine-release was still significantly lower than at pretreatment.", {"entities": []}], ["Histamine-release was not correlated to plasma concentrations of total or parasite-specific IgE, nor to specific IgG4 plasma concentrations.", {"entities": []}], ["The biology of human blood basophils is modulated by S. mansoni infection and praziquantel treatment.", {"entities": []}], ["Infection intensity-dependent suppression of basophil histamine-release, histamine-dependent resistance to infection, and similarities with allergen desensitisation are discussed as possible explanations of these observations.", {"entities": []}], ["The increase and persistence of inflammation in community-acquired pneumonia (CAP) patients can lead to higher mortality.", {"entities": [[67, 76, "DISEASE"]]}], ["Biomarkers capable of measuring this inadequate inflammatory response are likely candidates to be related with a bad outcome.", {"entities": []}], ["We investigated the association between concentrations of several inflammatory markers and mortality of CAP patients.", {"entities": []}], ["This was a prospective study of hospitalised CAP patients in a Spanish university hospital.", {"entities": []}], ["Blood tests upon admittance and in the early-stage evolution (72\u2013120 hours) were carried out, where C-reactive protein, procalcitonin, proadrenomedullin, copeptin, white blood cell, Lymphocyte Count Percentage (LCP), Neutrophil Count Percentage (NCP) and Neutrophil/Lymphocyte Ratio (NLR) were measured.", {"entities": []}], ["The outcome variable was mortality at 30 and 90 days.", {"entities": []}], ["Statistical analysis included logistic regression, ROC analysis and area-under-curve test.", {"entities": []}], ["154 hospitalised CAP patients were included.", {"entities": []}], ["Patients who died during follow-up had higher levels of procalcitonin, copeptin, proadrenomedullin, lower levels of LCP, and higher of NCP and NLR.", {"entities": []}], ["Remarkably, multivariate analysis showed a relationship between NCP and mortality, regardless of age, severity of CAP and comorbidities.", {"entities": []}], ["AUC analysis showed that NLR and NCP at admittance and during early-stage evolution achieved a good diagnostic power.", {"entities": []}], ["ROC test for NCP and NLR were similar to those of the novel serum biomarkers analysed.", {"entities": []}], ["NLR and NCP, are promising candidate predictors of mortality for hospitalised CAP patients, and both are cheaper, easier to perform, and at least as reliable as the new serum biomarkers.", {"entities": []}], ["Future implementation of new biomarkers would require comparison not only with classic inflammatory parameters like White Blood Cell count but also with NLR and NCP.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) has traditionally been considered an inexorably progressive disease, associated with a constant increase of symptoms that occur as the forced expiratory volume in 1 second (FEV 1 ) worsens, only intermittently interrupted by exacerbations.", {"entities": [[218, 221, "GENE"]]}], ["However, this paradigm has been challenged in recent decades by the available evidence.", {"entities": []}], ["Recent studies have pointed out that COPD-related symptoms are not consistently perceived by patients in the same way, showing not only seasonal variation, but also changes in symptom perception during a week or even within a single day.", {"entities": []}], ["According to the available data, patients experience the biggest increase in respiratory symptoms during the first hours of the early morning, followed by the nighttime.", {"entities": []}], ["This variation over time is of considerable importance, since it impacts on daily life activities and health-related quality of life, as measured by a recently developed ad hoc questionnaire.", {"entities": []}], ["Additionally, recent clinical trials have suggested that the use of rapid-onset long-acting bronchodilators may have an impact on morning symptoms, despite their current use as maintenance treatment for a determined period.", {"entities": []}], ["Although this hypothesis is to be validated in future long-term clinical trials comparing fast-onset versus slow-onset inhaled drugs in COPD, it may bring forward a new concept of long-term bronchodilator therapy.", {"entities": []}], ["At the present time, the two available long-acting, fast-onset bronchodilators used in the treatment of COPD are formoterol and the recently marketed indacaterol.", {"entities": []}], ["Newer drugs have also been shown to have a rapid onset of action in preclinical studies.", {"entities": []}], ["Health care professionals caring for COPD patients should consider this variation in the perception of symptoms during their clinical interview as a potential new target in the long-term treatment plan.", {"entities": []}], ["We use a large cohort of immune competent adults to analyze the influence of MBL2 genetic variants on sepsis susceptibility and survival.", {"entities": [[77, 81, "GENE"]]}], ["We find no significant associations with the 4 main functional single nucleotide polymorphisms in MBL2 , or any combination of genotypes.", {"entities": [[98, 102, "GENE"]]}], ["Background.", {"entities": []}], ["Sepsis is an increasingly common condition, which continues to be associated with unacceptably high mortality.", {"entities": []}], ["A large number of association studies have investigated susceptibility to, or mortality from, sepsis for variants in the functionally important immune-related gene MBL2 .", {"entities": [[164, 168, "GENE"]]}], ["These studies have largely been underpowered and contradictory.", {"entities": []}], ["We genotyped and analyzed 4 important MBL2 single nucleotide polymorphisms (SNPs; rs5030737, rs1800450, rs1800451, and rs7096206) in 1839 European community-acquired pneumonia (CAP) and peritonitis sepsis cases, and 477 controls from the United Kingdom.", {"entities": [[166, 175, "DISEASE"], [186, 197, "DISEASE"], [38, 42, "GENE"]]}], ["We analyzed the following predefined subgroups and outcomes: 28-day and 6 month mortality from sepsis due to CAP or peritonitis combined, 28-day mortality from CAP sepsis, peritonitis sepsis, pneumococcal sepsis or sepsis in younger patients, and susceptibility to CAP sepsis or pneumococcal sepsis in the United Kingdom.", {"entities": [[116, 127, "DISEASE"], [172, 183, "DISEASE"]]}], ["There were no significant associations (all P -values were greater than .05 after correction for multiple testing) between MBL2 genotypes and any of our predefined analyses.", {"entities": [[123, 127, "GENE"]]}], ["Conclusions.", {"entities": []}], ["In this large, well-defined cohort of immune competent adult patients, no associations between MBL2 genotype and sepsis susceptibility or outcome were identified.", {"entities": [[95, 99, "GENE"]]}], ["The impact of attention-deficit/hyperactivity disorder (ADHD) on health-related quality of life (HRQoL) is reported to be similar to that of other mental health and physical disorders.", {"entities": []}], ["In this cross-sectional study, we hypothesized that children with ADHD and children with type 1 diabetes mellitus (T1DM) would have significantly worse HRQoL compared with healthy children, and that better clinical status in ADHD and T1DM would be associated with better HRQoL.", {"entities": [[89, 113, "DISEASE"], [96, 113, "DISEASE"]]}], ["Children were recruited from three outpatient services in Scotland.", {"entities": []}], ["Responses to two frequently used validated HRQoL instruments, the Paediatric Quality of Life Inventory (PedsQL) and Child Health and Illness Profile-child edition (CHIP-CE), were obtained from parents/carers and children (6\u201316\u00a0years) with/without ADHD or T1DM.", {"entities": []}], ["Child and parent/carer-completed HRQoL measurements were evaluated for 213 children with ADHD, 58 children with T1DM and 117 healthy children (control group).", {"entities": []}], ["Significantly lower self and parent/carer ratings were observed across most PedsQL ( P \u00a0<\u00a00.001) and CHIP-CE ( P \u00a0<\u00a00.05) domains (indicating reduced HRQoL) for the ADHD group compared with the T1DM and control groups.", {"entities": []}], ["Parent/carer and child ratings were significantly correlated for both measures of HRQoL (PedsQL total score: P \u00a0<\u00a00.001; CHIP-CE all domains: P \u00a0<\u00a00.001), but only with low-to-moderate strength.", {"entities": []}], ["Correlation between ADHD severity and HRQoL was significant with both PedsQL and CHIP-CE for all parent/carer ( P \u00a0<\u00a00.01) and most child ( P \u00a0<\u00a00.05) ratings; more ADHD symptoms were associated with poorer HRQoL.", {"entities": []}], ["These data demonstrate that ADHD has a significant impact on HRQoL (as observed in both parent/carer and child ratings), which seems to be greater than that for children with T1DM.", {"entities": []}], ["Asthma is the most common chronic childhood illness, with rapidly increasing prevalence in low-income countries.", {"entities": [[0, 6, "DISEASE"]]}], ["Among young children, asthma is often under-diagnosed.", {"entities": [[22, 28, "DISEASE"]]}], ["We investigated the factors associated with asthma among under-fives presenting with acute respiratory symptoms at Mulago hospital, Uganda.", {"entities": [[44, 50, "DISEASE"]]}], ["A hospital-based cross sectional study of 614 children with cough and/or difficult breathing, and fast breathing, was conducted between August 2011 and June 2012.", {"entities": []}], ["A questionnaire focusing on clinical history of the child was administered to the caretakers.", {"entities": []}], ["A physical examination and, laboratory and radiological investigations were done.", {"entities": []}], ["Asthma was defined according to GINA (Global Initiative for Asthma) guidelines which were modified by excluding the symptom of \u201cchest tightness\u201d, spirometry/peak expiratory flow measurements and by adding chest x-ray findings to distinguish asthma from pneumonia.", {"entities": [[253, 262, "DISEASE"], [0, 6, "DISEASE"], [60, 66, "DISEASE"], [241, 247, "DISEASE"]]}], ["A panel of three paediatricians reviewed the participants\u2019 case reports and, guided by the study definitions, made a diagnosis of asthma or other.", {"entities": [[130, 136, "DISEASE"]]}], ["Multivariable logistic regression analysis was done to determine factors independently associated with asthma.", {"entities": [[103, 109, "DISEASE"]]}], ["Of the 614 children, 128 (20.8%) had asthma, 125 (20.4%) bronchiolitis, 167 (27.2%) bacterial pneumonia only, 163 (26.5%) viral pneumonia while 31 (5.1%) had other diagnoses including pulmonary tuberculosis.", {"entities": [[94, 103, "DISEASE"], [128, 137, "DISEASE"], [194, 206, "DISEASE"], [84, 103, "DISEASE"], [37, 43, "DISEASE"], [184, 206, "DISEASE"], [122, 137, "DISEASE"], [57, 70, "DISEASE"]]}], ["The majority (71.1%) of children with asthma were aged\u2009\u2265\u200912\u00a0months.", {"entities": [[38, 44, "DISEASE"]]}], ["Factors associated with asthma included maternal asthma (AOR\u00a02.4, 95% CI 1.2, 4.6), a history of allergy in the patient (AOR 2.6, 95% CI 1.2, 5.4,), use of gas for cooking (AOR\u00a03.8, 95% CI 1.2, 13.3), prematurity (AOR 9.3, 95% CI 1.2, 83.3) and high level of education of caretaker (AOR\u00a09.1, 95% CI 1.1, 72.8).", {"entities": [[24, 30, "DISEASE"], [49, 55, "DISEASE"]]}], ["Maternal asthma, a history of allergy in the patient, use of gas for cooking, prematurity and high level of education of caretaker were significantly associated with asthma.", {"entities": [[9, 15, "DISEASE"], [166, 172, "DISEASE"]]}], ["There is need for studies to explore the role of the above factors in development and exacerbation of childhood asthma to provide information that can be used to design strategies for asthma prevention and control.", {"entities": [[112, 118, "DISEASE"], [184, 190, "DISEASE"]]}], ["Changes in gene regulation have long been thought to play an important role in evolution and speciation, especially in primates.", {"entities": []}], ["Over the past decade, comparative genomic studies have revealed extensive inter-species differences in gene expression levels, yet we know much less about the extent to which regulatory mechanisms differ between species.", {"entities": []}], ["To begin addressing this gap, we perform a comparative epigenetic study in primate lymphoblastoid cell lines, to query the contribution of RNA polymerase II and four histone modifications, H3K4me1, H3K4me3, H3K27ac, and H3K27me3, to inter-species variation in gene expression levels.", {"entities": []}], ["We find that inter-species differences in mark enrichment near transcription start sites are significantly more often associated with inter-species differences in the corresponding gene expression level than expected by chance alone.", {"entities": []}], ["Interestingly, we also find that first-order interactions among the five marks, as well as chromatin states, do not markedly contribute to the degree of association between the marks and inter-species variation in gene expression levels, suggesting that the marginal effects of the five marks dominate this contribution.", {"entities": []}], ["Our observations suggest that epigenetic modifications are substantially associated with changes in gene expression levels among primates and may represent important molecular mechanisms in primate evolution.", {"entities": []}], ["The online version of this article (doi:10.1186/s13059-014-0547-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Excessive daytime sleepiness ( EDS ), a common symptom among patients with sleep\u2010disordered breathing, is closely associated with the development of cardiovascular diseases, but its long\u2010term prognostic value is not completely understood.", {"entities": []}], ["The aim of this study was to investigate whether EDS would be an independent prognostic factor after myocardial infarction.", {"entities": [[101, 122, "DISEASE"]]}], ["We prospectively recruited 112 post\u2013myocardial infarction patients.", {"entities": [[36, 57, "DISEASE"]]}], ["The Epworth Sleepiness Scale was completed before polysomnography, and EDS was defined as a score \u226511.", {"entities": []}], ["After exclusion of 8 patients who accepted treatment with continuous positive airway pressure, 104 patients were followed up for 48\u00a0months.", {"entities": []}], ["The primary composite end point was major adverse cardiac events.", {"entities": []}], ["Patients with EDS had higher rates of major adverse cardiac events (48.4% versus 27.4%, \u03c7 P =0.022) and reinfarction (29.0% versus 5.5%, \u03c7 P =0.0002) compared with those without EDS .", {"entities": []}], ["In the Cox proportional hazards model, patients with EDS had 2.15 times (95% confidence interval, 1.08\u20134.18; P =0.030) higher crude risk of major adverse cardiac events, with prognostic significance persisting after adjusting for age, diabetes mellitus, depression, left ventricular ejection fraction, apnea\u2013hypopnea index, and nocturnal nadir oxygen saturation (hazard ratio: 2.13, 95% confidence interval, 1.04\u20134.26, P =0.039).", {"entities": [[235, 252, "DISEASE"]]}], ["Furthermore, among participants with moderate to severe sleep\u2010disordered breathing, the presence of EDS was associated with higher risk of major adverse cardiac events than those without EDS , after adjusting for age and nadir oxygen saturation (hazard ratio: 3.17, 95% confidence interval, 1.22\u20137.76, P =0.019).", {"entities": []}], ["EDS may be an independent prognostic factor of adverse outcome in post\u2013myocardial infarction patients with moderate to severe sleep\u2010disordered breathing.", {"entities": [[71, 92, "DISEASE"]]}], ["Evaluation of EDS may shed new light on risk stratification and identify treatment responders for this patient population.", {"entities": []}], ["Physical inactivity is a major public health problem.", {"entities": []}], ["The It\u2019s LiFe!", {"entities": []}], ["monitoring and feedback tool embedded in the Self-Management Support Program (SSP) is an attempt to stimulate physical activity in people with chronic obstructive pulmonary disease or type 2 diabetes treated in primary care.", {"entities": [[143, 180, "DISEASE"]]}], ["Our aim was to evaluate whether the SSP combined with the use of the monitoring and feedback tool leads to more physical activity compared to usual care and to evaluate the additional effect of using this tool on top of the SSP.", {"entities": []}], ["This was a three-armed cluster randomised controlled trial.", {"entities": []}], ["Twenty four family practices were randomly assigned to one of three groups in which participants received the tool + SSP (group 1), the SSP (group 2), or care as usual (group 3).", {"entities": []}], ["The primary outcome measure was minutes of physical activity per day.", {"entities": []}], ["The secondary outcomes were general and exercise self-efficacy and quality of life.", {"entities": []}], ["Outcomes were measured at baseline after the intervention (4-6 months), and 3 months thereafter.", {"entities": []}], ["The group that received the entire intervention (tool + SSP) showed more physical activity directly after the intervention than Group 3 (mean difference 11.73, 95% CI 6.21-17.25; P <.001), and Group 2 (mean difference 7.86, 95% CI 2.18-13.54; P =.003).", {"entities": []}], ["Three months after the intervention, this effect was still present and significant (compared to Group 3: mean difference 10.59, 95% CI 4.94-16.25; P <.001; compared to Group 2: mean difference 9.41, 95% CI 3.70-15.11; P <.001).", {"entities": []}], ["There was no significant difference in effect between Groups 2 and 3 on both time points.", {"entities": []}], ["There was no interaction effect for disease type.", {"entities": []}], ["The combination of counseling with the tool proved an effective way to stimulate physical activity.", {"entities": []}], ["Counseling without the tool was not effective.", {"entities": []}], ["Future research about the cost-effectiveness and application under more tailored conditions and in other target groups is recommended.", {"entities": []}], ["ClinicalTrials.gov: NCT01867970, https://clinicaltrials.gov/ct2/show/NCT01867970 (archived by WebCite at http://www.webcitation.org/6a2qR5BSr).", {"entities": []}], ["Coronary artery disease (CAD) is a common, complex, and progressive disorder characterized by the accumulation of lipids and fibrous elements in the arteries.", {"entities": []}], ["It is one of the leading causes of death in industrialized nations.", {"entities": []}], ["Oxidative modification of low-density lipoprotein (LDL) in the arterial wall plays an important role in the initiation and progression of atherosclerosis.", {"entities": [[138, 153, "DISEASE"]]}], ["Paraoxonase1 ( PON1 ) is involved in lipid metabolism and is believed to protect LDL oxidation.", {"entities": [[15, 19, "GENE"]]}], ["In our study, we aimed to clarify the relationship between PON1 gene L55M polymorphism and the extent and severity of CAD.", {"entities": [[59, 63, "GENE"]]}], ["In total, 114 patients (54 males, mean age: 56.7\u00b112.0 years; 60 females, mean age: 55.7\u00b113.2 years) with stable angina or angina equivalent symptoms were enrolled in this prospective study.", {"entities": []}], ["Cardiological evaluation was performed with electrocardiogram and transthoracic echocardiogram.", {"entities": []}], ["The presence of hypertension, dyslipidemia, diabetes, and smoking status were ascertained.", {"entities": [[16, 28, "DISEASE"]]}], ["The patients were grouped according to their Gensini scores and gender.", {"entities": []}], ["Genetic analysis of the PON1 gene L55M polymorphism was performed by polymerase chain reaction-restriction fragment length polymorphism.", {"entities": [[24, 28, "GENE"]]}], ["We determined that the LL genotype was more prevalent in patients with Gensini score higher than or equal to 20 (p=0.026) and that this correlated with severe atherosclerotic coronary artery lesions in both gender groups, reaching a statistical significance in the female subjects (p=0.038).", {"entities": []}], ["It was thought that the PON1 gene L55M polymorphism plays a significant role in CAD progression, especially in females.", {"entities": [[24, 28, "GENE"]]}], ["Physicians, nurses and hospital pharmacists were surveyed to assess attitudes of hospital-based pediatric caregivers regarding the dosing of medicine to children.", {"entities": []}], ["Our objectives were to gauge how current resources are utilized to guide the management of pediatric pharmacotherapy, assess drugs and drug classes where guidance is most critical and examine the prevalence and practice of dose adjustment in pediatric patients.", {"entities": []}], ["Questionnaire categories included demographics, pharmacotherapy resources, dosing adjustment and modification, and valuation of additional tools to provide improved pharmacotherapy guidance.", {"entities": []}], ["The questionnaire was developed in collaboration with representative nurse, pharmacist and physician team members using the SurveyMonkey.com site and survey tool.", {"entities": []}], ["The survey link was distributed to caregivers via email.", {"entities": []}], ["The questionnaire results of 303 respondents were collected into MS Excel and imported into SAS for data summarization.", {"entities": []}], ["A total of 313 responses were obtained.", {"entities": []}], ["Physician and nurse practitioner groups comprised the majority of the responses.", {"entities": []}], ["Approximately 80% of the responders considered dosing adjustment important in pediatric pharmacotherapy.", {"entities": []}], ["While there was general satisfaction with available resources, nearly 75% responded in support of access to predictive tools that facilitate individualized patient pharmacotherapy.", {"entities": []}], ["The majority of respondents (> 65%) indicated that dosing outside standard practice occurs in 1-20% of their patients, while still a substantial number of respondents (a range of 8 to 20% reflecting the resident and fellow categories) estimated between 20 and 50% of their patients required adjustments outside the standard practice.", {"entities": []}], ["Differences in prescribing habits based on caregiver role, specialty and location were small and likely require further exploration.", {"entities": []}], ["Existing resources are generally viewed as helpful but inadequate to guide recommendations for individual patients.", {"entities": []}], ["Decision support systems connected to hospital-based electronic medical records offer the promise of informative and individualized pharmacotherapy guidance.", {"entities": []}], ["Various allergens are implicated in the pathogenesis of allergic diseases in different regions.", {"entities": []}], ["This study attempted to identify the most common allergens among patients with allergies based on the results of skin prick tests in different parts of Iran.", {"entities": []}], ["Relevant studies conducted from 2000 to 2016 were identified from the MEDLINE database.", {"entities": []}], ["Six common groups of allergen types, including animal, cockroach, food, fungus, house dust mite, and pollen were considered.", {"entities": []}], ["Subgroup analysis was performed to determine the prevalence of each type of allergen.", {"entities": []}], ["The Egger test was used to assess publication bias.", {"entities": []}], ["We included 44 studies in this meta-analysis.", {"entities": []}], ["The overall prevalence of positive skin test results for at least one allergen was estimated to be 59% in patients with allergies in various parts of Iran.", {"entities": []}], ["The number of patients was 11,646 (56% male and 44% female), with a mean age of 17.46\u00b111.12 years.", {"entities": []}], ["The most common allergen sources were pollen (47.0%), mites (35.2%), and food (15.3%).", {"entities": []}], ["The prevalence of sensitization to food and cockroach allergens among children was greater than among adults.", {"entities": []}], ["Pollen is the most common allergen sensitization in cities of Iran with a warm and dry climate; however, sensitization to house dust mites is predominant in northern and southern coastal areas of Iran.", {"entities": []}], ["As more inhaled corticosteroid (ICS) devices become available, there may be pressure for health-care providers to switch patients with asthma to cheaper inhaler devices.", {"entities": [[135, 141, "DISEASE"]]}], ["Our objective was to evaluate impact on asthma control of inhaler device switching without an accompanying consultation in general practice.", {"entities": [[40, 46, "DISEASE"]]}], ["This 2-year retrospective matched cohort study used the UK General Practice Research Database to identify practices where ICS devices were changed without a consultation for \u22655 patients within 3 months.", {"entities": []}], ["Patients 6\u201365 years of age from these practices whose ICS device was switched were individually matched with patients using the same ICS device who were not switched.", {"entities": []}], ["Asthma control over 12 months after the switch was assessed using a composite measure including short-acting \u03b2-agonist and oral corticosteroid use, hospitalizations, and subsequent changes to therapy.", {"entities": [[0, 6, "DISEASE"]]}], ["A total of 824 patients from 55 practices had a device switch and could be matched.", {"entities": []}], ["Over half (53%) of device switches were from dry powder to metered-dose inhalers.", {"entities": []}], ["Fewer patients in switched than matched cohort experienced successful treatment based on the composite measure (20% vs. 34%) and more experienced unsuccessful treatment (51% vs. 38%).", {"entities": []}], ["After adjusting for possible baseline confounding factors, the odds ratio for treatment success in the switched cohort compared with controls was 0.29 (95% confidence interval [CI], 0.19 to 0.44; p < 0.001) and for unsuccessful treatment was 1.92 (95% CI, 1.47 to 2.56; p < 0.001).", {"entities": []}], ["Switching ICS devices without a consultation was associated with worsened asthma control and is therefore inadvisable.", {"entities": [[74, 80, "DISEASE"]]}], ["Background: Multiple sclerosis (MS) risk is determined by both genes and environment.", {"entities": []}], ["One of the most striking features of MS is its geographic distribution, particularly the pattern of high MS frequency in areas with low sunlight exposure, the main inducer of vitamin D synthesis.", {"entities": []}], ["Recent epidemiologic, experimental, and clinical evidence support an effect for low environmental supplies of vitamin D in mediating an increased susceptibility to MS.", {"entities": []}], ["Objectives: We 1 ) examined the association of serum 25-hydroxy-vitaminD [25(OH)D] concentrations and MS status and 2 ) assessed the genetic contribution to serum 25(OH)D concentrations and tested for its association with genetic variants in 2 candidate genes [vitamin D receptor and 1-\u03b1-hydroxylase ( CYP27B1 )].", {"entities": [[302, 309, "GENE"]]}], ["Design: We used a twin study approach, comprising adult pairs identified from the longitudinal population-based Canadian Collaborative Project on Genetic Susceptibility to MS. Monozygotic (MZ; n = 40) and dizygotic (DZ; n = 59) pairs, both concordant and discordant for MS, were studied.", {"entities": []}], ["End-of-winter serum 25(OH)D concentrations were measured by radioimmunoassay, and genotypes were assessed by single nucleotide polymorphism (SNP) assay.", {"entities": []}], ["Results: Serum concentrations of 25(OH)D were highly correlated in MS-concordant pairs ( r = 0.83, P < 0.001), but they were not significantly associated with having the disease ( P = 0.4) when analyzed by logistic regression.", {"entities": []}], ["Intraclass correlation for 25(OH)D concentration was significantly greater in MZ pairs (MZ, r : 0.71 > DZ r : 0.32, P = 0.006).", {"entities": []}], ["Significant associations of 2 CYP27B1 SNP variants and 25(OH)D concentrations were observed.", {"entities": [[30, 37, "GENE"]]}], ["Conclusion: The findings indicate important genetic influences on regulation of seasonal circulating 25(OH)D concentrations in MS twins.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death throughout the world and is largely associated with cigarette smoking.", {"entities": []}], ["Despite the appreciation of the central role of smoking in the development of COPD, only a relatively small number of smokers (15%\u201320%) develop COPD.", {"entities": []}], ["Recent studies depicting familial aggregation suggest that some subjects may have a genetic predisposition to developing COPD.", {"entities": []}], ["In this respect, a number of single nucleotide polymorphisms have been reported in association with different COPD features (subphenotypes), although much of this data remains controversial.", {"entities": []}], ["Classical genetic studies (including twin and family studies) assume an \u201cequal-environment\u201d scenario, but as gene-environment interactions occur in COPD, this assumption needs revision.", {"entities": []}], ["Thus, new integrated models are needed to examine the major environmental factors associated with COPD which include smoking as well as air pollution, and respiratory infections, and not only genetic predisposition.", {"entities": []}], ["Revisiting this area, may help answer the question of what has more bearing in the pathogenesis of COPD\u2014the environment or the genomic sequence of the affected subjects.", {"entities": []}], ["It is anticipated that an improved understanding of this interaction will both enable improved identification of individuals susceptible to developing this disease, as well as improved future treatments for this disease.", {"entities": []}], ["Lung cancer is the most frequently fatal cancer, with poor survival once the disease is advanced.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"], [41, 47, "DISEASE"]]}], ["Annual low dose computed tomography has shown a survival benefit in screening individuals at high risk for lung cancer.", {"entities": [[107, 118, "DISEASE"], [112, 118, "DISEASE"]]}], ["Based on the available evidence, the European Society of Radiology and the European Respiratory Society recommend lung cancer screening in comprehensive, quality-assured, longitudinal programmes within a clinical trial or in routine clinical practice at certified multidisciplinary medical centres.", {"entities": [[114, 125, "DISEASE"], [119, 125, "DISEASE"]]}], ["Minimum requirements include: standardised operating procedures for low dose image acquisition, computer-assisted nodule evaluation, and positive screening results and their management; inclusion/exclusion criteria; expectation management; and smoking cessation programmes.", {"entities": []}], ["Further refinements are recommended to increase quality, outcome and cost-effectiveness of lung cancer screening: inclusion of risk models, reduction of effective radiation dose, computer-assisted volumetric measurements and assessment of comorbidities (chronic obstructive pulmonary disease and vascular calcification).", {"entities": [[91, 102, "DISEASE"], [254, 291, "DISEASE"], [96, 102, "DISEASE"]]}], ["All these requirements should be adjusted to the regional infrastructure and healthcare system, in order to exactly define eligibility using a risk model, nodule management and quality assurance plan.", {"entities": []}], ["The establishment of a central registry, including biobank and image bank, and preferably on a European level, is strongly encouraged.", {"entities": []}], ["The ESR/ERS provide new recommendations for lung cancer screening in this white paper http://ow.ly/KbUck", {"entities": [[44, 55, "DISEASE"], [49, 55, "DISEASE"]]}], ["An association between body weight in childhood and subsequent lung function and asthma has been suggested, but few longitudinal studies exist.", {"entities": [[81, 87, "DISEASE"]]}], ["Our aim was to explore whether weight-related anthropometric measurements through childhood were associated with lung function in late childhood.", {"entities": []}], ["From an original nested case-control study, a cohort study was conducted, where lung function was measured in 463 children aged 12.8\u00a0years, and anthropometry was measured at several ages from birth through 12.8\u00a0years of age.", {"entities": []}], ["Associations between anthropometrics and lung function were analysed using multiple linear and fractional polynomial regression analysis.", {"entities": []}], ["Birthweight and body mass index (BMI; kg/m 1 %) at 12.8\u00a0years of age.", {"entities": []}], ["BMI, waist circumference, waist-to-height ratio and skinfolds at 12.8\u00a0years of age and the change in BMI from early to late childhood were positively associated with FVC % and FEV 1 % and negatively associated with FEV 1 /FVC and forced expiratory flow at 25\u201375% of FVC/FVC.", {"entities": [[176, 179, "GENE"], [215, 218, "GENE"], [176, 179, "GENE"], [215, 218, "GENE"]]}], ["Interaction analyses showed that positive associations between anthropometrics other than BMI and lung function were mainly found in girls.", {"entities": []}], ["Inverse U-shaped associations were found between BMI at the ages of 10.8/11.8 (girls/boys) and 12.8\u00a0years (both genders) and FVC % and FEV 1 % at 12.8\u00a0years of age.", {"entities": [[135, 138, "GENE"]]}], ["Weight-related anthropometrics through childhood may influence lung function in late childhood.", {"entities": []}], ["These findings may be physiological or associated with air flow limitation.", {"entities": []}], ["Inverse U-shaped associations suggest a differential impact on lung function in normal-weight and overweight children.", {"entities": []}], ["This study was observational without any health care intervention for the participants.", {"entities": []}], ["Therefore, no trial registration number is available.", {"entities": []}], ["The online version of this article (doi: 10.1186/s12890-017-0567-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The prevalence of asthma and allergy has recently risen among children.", {"entities": [[18, 24, "DISEASE"]]}], ["This increase in prevalence might be related to various factors, particularly diet.", {"entities": []}], ["The aim of this study is to assess the prevalence and association of asthma and allergic sensitization with dietary factors in the French Six Cities Study.", {"entities": [[69, 75, "DISEASE"]]}], ["Cross-sectional studies were performed among 7432 schoolchildren aged 9\u201311 years in Bordeaux, Clermont-Ferrand, Cr\u00e9teil, Marseille, Reims, and Strasbourg.", {"entities": []}], ["Parental questionnaires, based on the International Study on Asthma and Allergies in Childhood (ISAAC), were used to collect information on allergic diseases and potential exposure factors including a food frequency questionnaire to evaluate dietary habits.", {"entities": [[61, 67, "DISEASE"]]}], ["Skin prick testing to common allergens for allergic sensitization and bronchial hyper-responsiveness (BHR) testing to exercise were performed.", {"entities": []}], ["Confounders control was performed with multiple logistic regressions.", {"entities": []}], ["Asthma symptoms, asthma and allergic sensitization were more prevalent in boys than in girls and were more prevalent in the South than in the North of France.", {"entities": [[0, 6, "DISEASE"], [17, 23, "DISEASE"]]}], ["After adjustment for confounders, fruit juice intake was associated with a low prevalence of lifetime asthma (ORa [95 % CI]; 0.73 [0.56\u20130.97]), butter intake was positively associated with atopic wheeze (1.48 [1.07\u20132.05]) and having lunch at the canteen 1\u20132 times/week compared to never or occasionally was associated with a lower prevalence of past year wheeze (0.71 [0.52\u20130.96]), lifetime asthma (0.76 [0.60\u20130.96]) and allergic sensitization (0.80 [0.67\u20130.95]).", {"entities": [[102, 108, "DISEASE"], [391, 397, "DISEASE"]]}], ["Meat intake was inversely related to past year wheeze among atopic children (0.68 [0.50\u20130.98]) while fast food consumption and butter intake were associated with an increase prevalence of asthma (2.39 [1.47\u20133.93] and 1.51 [1.17\u20132.00] respectively).", {"entities": [[188, 194, "DISEASE"]]}], ["Fish intake was associated with a lower prevalence of asthma among non-atopic children (0.61 [0.43\u20130.87].", {"entities": [[54, 60, "DISEASE"]]}], ["None of the dietary factors was associated with BHR.", {"entities": []}], ["Diet is associated with wheeze, asthma and allergic sensitization but not with BHR in children.", {"entities": [[32, 38, "DISEASE"]]}], ["These results provide further evidence that adherence to a healthy diet including fruits, meat and fish seems to have a protective effect on asthma and allergy in childhood.", {"entities": [[141, 147, "DISEASE"]]}], ["However, prospective and experimental studies are needed to provide causal evidence concerning the effect of diet on asthma and atopy.", {"entities": [[117, 123, "DISEASE"]]}], ["Hydrosol soft drinks in Persian nutrition culture are produced as side products of the essential oil industry to be used as safe remedies for treatment of some ailments.", {"entities": []}], ["This study investigated hydrosols for women\u2019s hormonal health conditions.", {"entities": []}], ["Detailed information was gathered by questionnaires.", {"entities": []}], ["Chemical constituents of these mono- or poly-herbal hydrosols were identified after liquid/liquid extraction and gas chromatography\u2013mass spectrometry.", {"entities": []}], ["Hierarchical cluster and K-means analysis (SPSS software) were used to find their relevance.", {"entities": []}], ["A literature survey was also performed.", {"entities": []}], ["In most cases, thymol, carvacrol, and carvone were the major constituents except for dill, white horehound, willow, Moderr, and yarrow hydrosols, whose their major components were dill ether, menthol, phenethyl alcohol, linalool, or camphor.", {"entities": []}], ["Based on clustering methods, some similarities could be found in their constituents with some exceptions.", {"entities": []}], ["None of them have been studied scientifically before.", {"entities": []}], ["These investigations may lead to the development of some functional drinks or even new lead components.", {"entities": []}], ["Bronchodilators such as long-acting muscarinic antagonists (LAMAs) and long-acting \u03b2 2 -agonists (LABAs) are central to the pharmacological management of COPD.", {"entities": []}], ["Dual bronchodilation with umeclidinium/vilanterol (UMEC/VI; 62.5/25 \u03bcg) is a novel LAMA/LABA combination approved for maintenance treatment for patients with COPD.", {"entities": []}], ["The objective of this study was to assess the cost-effectiveness of maintenance treatment with UMEC/VI compared with tiotropium (TIO) 18 \u03bcg, open dual LAMA + LABA treatment, or no long-acting bronchodilator treatment in patients with moderate to very severe COPD.", {"entities": []}], ["A Markov model was developed to estimate the costs and outcomes associated with UMEC/VI treatment in patients with moderate to very severe COPD (GSK study number: HO-13-13411).", {"entities": []}], ["Clinical efficacy, costs, utilities, and mortality obtained from the published literature were used as the model inputs.", {"entities": []}], ["Costs are presented in US dollars based on 2015 prices.", {"entities": []}], ["The model outputs are total costs, drug costs, other medical costs, number of COPD exacerbations, and quality-adjusted life-years (QALYs).", {"entities": []}], ["Costs and outcomes were discounted at a 3% annual rate.", {"entities": []}], ["Incremental cost-effectiveness ratios were calculated.", {"entities": []}], ["One-way and probabilistic sensitivity analyses were conducted to assess the effects of changing parameters on the uncertainty of the results.", {"entities": []}], ["UMEC/VI treatment for moderate to very severe COPD was associated with lower lifetime medical costs ($82,344) compared with TIO ($88,822), open dual LAMA + LABA treatment ($114,442), and no long-acting bronchodilator ($86,751).", {"entities": []}], ["Fewer exacerbations were predicted to occur with UMEC/VI treatment compared with no long-acting bronchodilator treatment.", {"entities": []}], ["UMEC/VI provided an 0.11 and 0.25 increase in QALYs compared with TIO and no long-acting bronchodilator treatment, and as such, dominated these cost-effectiveness analyses.", {"entities": []}], ["Sensitivity analyses confirmed that the results were robust.", {"entities": []}], ["The results from this model suggest that UMEC/VI treatment would be dominant compared with TIO and no long-acting bronchodilator treatment, and less costly than open dual LAMA + LABA treatment in patients with moderate to very severe COPD.", {"entities": []}], ["Recruitment to randomized controlled trials is known to be challenging.", {"entities": []}], ["It is important to understand and identify predictors of good or poor accrual to a clinical trial so that appropriate strategies can be put in place to overcome these problems and facilitate successful trial completion.", {"entities": []}], ["We have developed a survey tool to establish the recruitment experience of clinical teams regarding facilitators and barriers to recruitment in a clinical trial and describe herein the method of developing the questionnaire.", {"entities": []}], ["A literature search was conducted to identify studies that have explored facilitators and barriers to recruitment, and a list of potential factors affecting recruitment to a clinical trial was generated.", {"entities": []}], ["These factors were categorized in terms relating to the (i) trial, (ii) site, (iii) patient, (iv) clinical team, (v) information and consent and (vi) study team.", {"entities": []}], ["A list was provided for responders to grade these factors as weak, intermediate or strong facilitators or barriers to recruitment.", {"entities": []}], ["A web-based survey questionnaire was developed.", {"entities": []}], ["This survey was designed to establish the recruitment experience of clinical teams with regard to the perceived facilitators and barriers to recruitment, to identify strategies applied to overcome these problems, and to obtain suggestions for change in the organization of future trials.", {"entities": []}], ["The survey tool can be used to assess the recruitment experience of clinical teams in a single/multicenter trial in any clinical setting or speciality involving adults or children either in an ongoing trial or at trial completion.", {"entities": []}], ["The questionnaire is short, easy to administer and to complete, with an estimated completion time of 11 minutes.", {"entities": []}], ["We have presented a robust methodology for developing this survey tool that provides an evidence-based list of potential factors that can affect recruitment to a clinical trial.", {"entities": []}], ["We recommend that all clinical trialists should consider using this tool with appropriate trial-specific adaptations to monitor and improve recruitment performance in an ongoing trial or conduct the survey at trial completion to gather information on facilitators and barriers to recruitment that can form the basis of interventions and strategies to improve recruitment to future clinical trials.", {"entities": []}], ["Background: Environmental health effects vary considerably with regard to their severity, type of disease, and duration.", {"entities": []}], ["Integrated measures of population health, such as environmental burden of disease (EBD), are useful for setting priorities in environmental health policies and research.", {"entities": []}], ["This review is a summary of the full Environmental Burden of Disease in European countries (EBoDE) project report.", {"entities": []}], ["Objectives: The EBoDE project was set up to provide assessments for nine environmental risk factors relevant in selected European countries (Belgium, Finland, France, Germany, Italy, and the Netherlands).", {"entities": []}], ["Methods: Disability-adjusted life years (DALYs) were estimated for benzene, dioxins, secondhand smoke, formaldehyde, lead, traffic noise, ozone, particulate matter (PM 2.5 ), and radon, using primarily World Health Organization data on burden of disease, (inter)national exposure data, and epidemiological or toxicological risk estimates.", {"entities": []}], ["Results are presented here without discounting or age-weighting.", {"entities": []}], ["Results: About 3\u20137% of the annual burden of disease in the participating countries is associated with the included environmental risk factors.", {"entities": []}], ["Airborne particulate matter (diameter \u2264 2.5 \u03bcm; PM 2.5 ) is the leading risk factor associated with 6,000\u201310,000 DALYs/year and 1 million people.", {"entities": []}], ["Secondhand smoke, traffic noise (including road, rail, and air traffic noise), and radon had overlapping estimate ranges (600\u20131,200 DALYs/million people).", {"entities": []}], ["Some of the EBD estimates, especially for dioxins and formaldehyde, contain substantial uncertainties that could be only partly quantified.", {"entities": []}], ["However, overall ranking of the estimates seems relatively robust.", {"entities": []}], ["Conclusions: With current methods and data, environmental burden of disease estimates support meaningful policy evaluation and resource allocation, including identification of susceptible groups and targets for efficient exposure reduction.", {"entities": []}], ["International exposure monitoring standards would enhance data quality and improve comparability.", {"entities": []}], ["Citation: H\u00e4nninen O, Knol AB, Jantunen M, Lim TA, Conrad A, Rappolder M, Carrer P, Fanetti AC, Kim R, Buekers J, Torfs R, Iavarone I, Classen T, Hornberg C, Mekel OC, EBoDE Working Group.", {"entities": []}], ["Environmental burden of disease in Europe: assessing nine risk factors in six countries.", {"entities": []}], ["Environ Health Perspect 122:439\u2013446;\u2002 http://dx.doi.org/10.1289/ehp.1206154", {"entities": []}], ["Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are common causes of respiratory infections in children.", {"entities": []}], ["Diseases caused by hMPV are generally considered to be less severe than those caused by RSV; the underlying mechanisms, however, remain unknown.", {"entities": []}], ["In the present study, the expressions of TLRs in airway epithelial cells and lungs of BALB/c mice infected by hMPV or RSV were measured in an attempt to explore the differences in the airway inflammation caused by the two viruses.", {"entities": []}], ["Our results demonstrate that both hMPV and RSV infection upregulated the expressions of TLRs and inflammatory cytokines.", {"entities": []}], ["Specifically, the TLR3 expression was revealed to be elevated in vitro and in mouse lungs.", {"entities": [[18, 22, "GENE"]]}], ["IFN-\u03b1 produced by A549 cells after RSV or hMPV infection remained undistinguishable, whereas production of TNF-\u03b1 was significantly higher after RSV infection than hMPV infection either in the presence or absence of Poly I:C. This study provides a clue that more severe clinical syndrome of RSV infection may be due to the greater magnitude of induction of airway inflammation by RSV involving TLR3 activation and production of TNF-\u03b1.", {"entities": [[278, 286, "DISEASE"], [393, 397, "GENE"]]}], ["Everolimus is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of advanced renal cell carcinoma, pancreatic neuroendocrine tumors, subependymal giant cell astrocytoma associated with tuberous sclerosis complex, renal angiomyolipoma and tuberous sclerosis complex, and, in combination with exemestane, for hormone receptor-positive HER2-negative advanced breast cancer after failure of treatment with letrozole or anastrozole.", {"entities": [[244, 258, "DISEASE"], [113, 122, "DISEASE"], [381, 394, "DISEASE"], [182, 193, "DISEASE"], [210, 228, "DISEASE"], [263, 281, "DISEASE"], [102, 122, "DISEASE"], [158, 193, "DISEASE"], [388, 394, "DISEASE"], [47, 51, "GENE"]]}], ["Results from the phase III BOLERO-2 trial demonstrated that everolimus in combination with exemestane provided significant clinical benefit to patients with advanced hormone receptor-positive breast cancer.", {"entities": [[192, 205, "DISEASE"], [199, 205, "DISEASE"]]}], ["Although everolimus is generally well tolerated, as with most therapies administered in an advanced cancer setting, drug-related adverse events (AEs) inevitably occur.", {"entities": [[100, 106, "DISEASE"]]}], ["Most common AEs observed in the everolimus studies include stomatitis, rash, infection, noninfectious pneumonitis, and hyperglycemia.", {"entities": [[59, 69, "DISEASE"], [119, 132, "DISEASE"]]}], ["Clinical awareness and early identification of such AEs by oncology nurses are essential to dosing (interruptions, reduction, and treatment discontinuation); quality of life; and, ultimately, patient outcomes.", {"entities": []}], ["Because everolimus has already been shown to significantly improve clinical efficacy in patients with advanced breast cancer, a proactive approach to the practical management of AEs associated with this mTOR inhibitor as well as other most common AEs observed in this patient population has been reviewed and outlined here.", {"entities": [[111, 124, "DISEASE"], [118, 124, "DISEASE"], [203, 207, "GENE"]]}], ["Physical activity helps diabetic older adults who have physical impairments or comorbid conditions to control their disease.", {"entities": []}], ["To enable state planners to select physical activity programs for these adults, we calculated synthetic state-specific estimates of inactive older adults with diabetes, categorized by defined health status groups.", {"entities": []}], ["Using data from the 2000 through 2009 National Health Interview Survey (NHIS) and the Behavioral Risk Factor Surveillance System (BRFSS), we calculated synthetic state-specific estimates of inactive adults with diabetes who were aged 50 years or older for 5 mutually exclusive health status groups: 1) homebound, 2) frail (functional difficulty in walking one-fourth mile, climbing 10 steps, standing for 2 hours, and stooping, bending, and kneeling), 3) functionally impaired (difficulty in 1 to 3 of these functions), 4) having 1 or more comorbid conditions (with no functional impairments), and 5) healthy (no impairments or comorbid conditions).", {"entities": []}], ["We combined NHIS regional proportions for the health status groups of inactive, older diabetic adults with BRFSS data of older diabetic adults to estimate state-specific proportions and totals.", {"entities": []}], ["State-specific estimates of health status groups among all older adults ranged from 2.2% to 3.0% for homebound, 5.8% to 8.8% for frail, 20.1% to 26.1% for impaired, 34.9% to 43.7% for having comorbid conditions, and 4.0% to 6.9% for healthy; the remainder were older active diabetic adults.", {"entities": []}], ["Except for the homebound, the percentages in these health status groups varied significantly by region and state.", {"entities": []}], ["These state-specific estimates correspond to existing physical activity programs to match certain health status characteristics of groups and may be useful to program planners to meet the needs of inactive, older diabetic adults.", {"entities": []}], ["Depression is common mental health problem and leading contributor to the global burden of disease.", {"entities": []}], ["The attitudes and beliefs of the public and of health professionals influence social acceptance and affect the esteem and help-seeking of people experiencing mental health problems.", {"entities": []}], ["The attitudes of clinicians are particularly relevant to their role in accurately recognising and providing appropriate support and management of depression.", {"entities": []}], ["This study examines the characteristics of the revised depression attitude questionnaire (R-DAQ) with doctors working in healthcare settings in Lahore, Pakistan.", {"entities": []}], ["A cross-sectional survey was conducted in 2015 using the revised depression attitude questionnaire (R-DAQ).", {"entities": []}], ["A convenience sample of 700 medical practitioners based in six hospitals in Lahore was approached to participate in the survey.", {"entities": []}], ["The R-DAQ structure was examined using Parallel Analysis from polychoric correlations.", {"entities": []}], ["Unweighted least squares analysis (ULSA) was used for factor extraction.", {"entities": []}], ["Model fit was estimated using goodness-of-fit indices and the root mean square of standardized residuals (RMSR), and internal consistency reliability for the overall scale and subscales was assessed using reliability estimates based on Mislevy and Bock (BILOG 3 Item analysis and test scoring with binary logistic models.", {"entities": []}], ["Mooresville: Scientific Software, 601 (86%) of the doctors approached consented to participate in the study.", {"entities": []}], ["Exploratory factor analysis of R-DAQ scale responses demonstrated the same 3-factor structure as in the UK development study, though analyses indicated removal of 7 of the 22 items because of weak loading or poor model fit.", {"entities": []}], ["The 3 factor solution accounted for 49.8% of the common variance.", {"entities": []}], ["Scale reliability and internal consistency were adequate: total scale standardised alpha was 0.694; subscale reliability for professional confidence was 0.732, therapeutic optimism/pessimism was 0.638, and generalist perspective was 0.769.", {"entities": []}], ["The R-DAQ was developed with a predominantly UK-based sample of health professionals.", {"entities": []}], ["This study indicates that this scale functions adequately and provides a valid measure of depression attitudes for medical practitioners in Pakistan, with the same factor structure as in the scale development sample.", {"entities": []}], ["However, optimal scale function necessitated removal of several items, with a 15-item scale enabling the most parsimonious factor solution for this population.", {"entities": []}], ["With recent advances in the manufacture and application of nickel oxide nanoparticles (NiONPs), concerns about their adverse effects on the respiratory system are increasing.", {"entities": []}], ["However, the underlying cellular and molecular mechanisms of NiONP-induced pulmonary toxicity remain unclear.", {"entities": []}], ["In this study, we focused on the impacts of NiONPs on pulmonary inflammation and investigated whether the NLRP3 inflammasome is involved in NiONP-induced pulmonary inflammation and injury.", {"entities": [[106, 111, "GENE"]]}], ["NiONP suspensions were administered by single intratracheal instillation to rats, and inflammatory responses were evaluated at 3 days, 7 days, or 28 days after treatment.", {"entities": []}], ["NiONP exposure resulted in sustained pulmonary inflammation accompanied by inflammatory cell infiltration, alveolar proteinosis, and cytokine secretion.", {"entities": []}], ["Expression of Nlrp3 was markedly upregulated by the NiONPs, which was accompanied by overexpression of the active form of caspase-1 (p20) and interleukin (IL)-1\u03b2 secretion in vivo.", {"entities": [[14, 19, "GENE"]]}], ["NiONP-induced IL-1\u03b2 secretion was partially prevented by co-treatment with a caspase-1 inhibitor in macrophages.", {"entities": []}], ["Moreover, siRNA-mediated Nlrp3 knockdown completely attenuated NiONP-induced cytokine release and caspase-1 activity in macrophages in vitro.", {"entities": [[25, 30, "GENE"]]}], ["In addition, NiONP-induced NLRP3 inflammasome activation requires particle uptake and reactive oxygen species production.", {"entities": [[27, 32, "GENE"]]}], ["Collectively, our findings suggest that the NLRP3 inflammasome participates in NiONP-induced pulmonary inflammation and offer new strategies to combat the pulmonary toxicity induced by NiONPs.", {"entities": [[44, 49, "GENE"]]}], ["Bronchiectasis is characterized by abnormal, permanent and irreversible dilatation of the bronchi, usually responsible for daily symptoms and frequent respiratory complications.", {"entities": [[0, 14, "DISEASE"]]}], ["Many causes have been identified, but only limited data are available concerning the association between bronchiectasis and renal transplantation.", {"entities": [[105, 119, "DISEASE"]]}], ["We conducted a retrospective multicenter study of cases of bronchiectasis diagnosed after renal transplantation in 14 renal transplantation departments (French SPIESSER group).", {"entities": [[59, 73, "DISEASE"]]}], ["Demographic, clinical, laboratory and CT scan data were collected.", {"entities": []}], ["Forty-six patients were included (mean age 58.2\u00a0years, 52.2\u00a0% men).", {"entities": []}], ["Autosomal dominant polycystic kidney disease (32.6\u00a0%) was the main underlying renal disease.", {"entities": [[30, 44, "DISEASE"], [19, 44, "DISEASE"]]}], ["Chronic cough and sputum (50.0\u00a0%) were the major symptoms leading to chest CT scan.", {"entities": []}], ["Mean duration of symptoms before diagnosis was 1.5\u00a0years [0\u201312.1\u00a0years].", {"entities": []}], ["Microorganisms were identified in 22 patients, predominantly Haemophilus influenzae .", {"entities": []}], ["Hypogammaglobulinemia was observed in 46.9\u00a0% patients.", {"entities": []}], ["Bronchiectasis was usually extensive (84.8\u00a0%).", {"entities": [[0, 14, "DISEASE"]]}], ["The total bronchiectasis score was 7.4\u2009\u00b1\u20095.5 with a significant gradient from apex to bases.", {"entities": [[10, 24, "DISEASE"]]}], ["Many patients remained symptomatic (43.5\u00a0%) and/or presented recurrent respiratory tract infections (37.0\u00a0%) during follow-up.", {"entities": []}], ["Six deaths (13\u00a0%) occurred during follow-up, but none were attributable to bronchiectasis.", {"entities": [[75, 89, "DISEASE"]]}], ["These results highlight that the diagnosis of bronchiectasis should be considered in patients with de novo respiratory symptoms after renal transplantation.", {"entities": [[46, 60, "DISEASE"]]}], ["Further studies are needed to more clearly understand the mechanisms underlying bronchiectasis in this setting.", {"entities": [[80, 94, "DISEASE"]]}], ["This paper reviews the role of toxicological studies in understanding the health effects of environmental exposures to mixtures.", {"entities": []}], ["The approach taken is to review mixtures that have received the greatest emphasis from toxicology; major mixtures research programs; the toxicologist's view of mixtures and approaches to their study; and the complementary roles of toxicological, clinical, and epidemiological studies.", {"entities": []}], ["Studies of tobacco smoke, engine exhaust, combustion products, and air pollutants comprise most of the past research on mixtures.", {"entities": []}], ["Because of their great experimental control over subjects, exposures, and endpoints, toxicologists tend to consider a wider range of toxic interactions among mixture components and sequential exposures than is practical for human studies.", {"entities": []}], ["The three fundamental experimental approaches used by toxicologists are integrative (studying the mixture as a whole), dissective (dissecting a mixture to determine causative constituents), and synthetic (studying interactions between agents in simple combinations).", {"entities": []}], ["Toxicology provides information on potential hazards, mechanisms by which mixture constituents interact to cause effects, and exposure dose-effect relationships; but extrapolation from laboratory data to quantitative human health risks is problematic.", {"entities": []}], ["Toxicological, clinical, and epidemiological approaches are complementary but are seldom coordinated.", {"entities": []}], ["Fostering synergistic interactions among the disciplines in studying the risks from mixtures could be advantageous.", {"entities": []}], ["Human adenoviruses are known to persist in T-lymphocytes of tonsils, adenoids and intestinal tract.", {"entities": []}], ["The oncogenic potential of different adenovirus types has been widely studied in rodents, in which adenovirus inoculation can induce multiple tumors such as undifferentiated sarcomas, adenocarcinomas and neuroectodermal tumors.", {"entities": []}], ["However, the oncogenic potential of this virus has never been proven in human subjects.", {"entities": []}], ["Using a highly sensitive broad-spectrum qRT-PCR, we have screened a set of different human sarcomas including leiomyosarcoma, liposarcoma and gastro intestinal stroma tumors.", {"entities": [[110, 124, "DISEASE"], [126, 137, "DISEASE"]]}], ["Primers binding the viral oncogene E1A and the capsid-coding gene Hexon were used to detect the presence of adenovirus DNA in tumor samples.", {"entities": []}], ["We found that 18% of the tested leiomyosarcomas and 35% of the liposarcomas were positive for the presence of adenovirus DNA, being species C types the most frequently detected adenoviruses.", {"entities": []}], ["However, only in one sample of the gastro intestinal stroma tumors the virus DNA could be detected.", {"entities": []}], ["The occurrence of adenovirus in the tumor sections was confirmed by subsequent fluorescence in-situ-hybridization analysis and co-staining with the transcription factor Bcl11b gives evidence for the presence of the virus in infiltrating T-lymphocytes within the tumors.", {"entities": [[169, 175, "GENE"]]}], ["Together these data underline, for the first time, the persistence of adenovirus in T-lymphocytes infiltrated in muscular and fatty tissue tumor samples.", {"entities": []}], ["If an impaired immune system leads to the viral persistence and reactivation of the virus is involved in additional diseases needs further investigation.", {"entities": []}], ["The harmful effects from inhalation of coal dust are well-documented.", {"entities": []}], ["The prevalence of lung disease varies by mining region and may, in part, be related to regional differences in the bioavailable iron content of the coal.", {"entities": [[18, 30, "DISEASE"]]}], ["Pyrite (FeS 2 ), a common inorganic component in coal, has been shown to spontaneously form reactive oxygen species (ROS) (i.e., hydrogen peroxide and hydroxyl radicals) and degrade nucleic acids.", {"entities": [[8, 11, "GENE"]]}], ["This raises the question regarding the potential for similar reactivity from coal that contains pyrite.", {"entities": []}], ["Experiments were performed to specifically evaluate the role of pyrite in coal dust reactivity.", {"entities": []}], ["Coal samples containing various amounts of FeS 2 were compared for differences in their generation of ROS and degradation of RNA.", {"entities": [[43, 46, "GENE"]]}], ["Coals that contain iron also show the presence of FeS 2 , generate ROS and degrade RNA.", {"entities": [[50, 53, "GENE"]]}], ["Coal samples that do not contain pyrite do not produce ROS nor degrade RNA.", {"entities": []}], ["The concentration of generated ROS and degradation rate of RNA both increase with greater FeS 2 content in the coals.", {"entities": [[90, 93, "GENE"]]}], ["The prevalence of coal workers' pneumoconiosis can be correlated to the amount of FeS 2 in the coals.", {"entities": [[32, 46, "DISEASE"], [82, 85, "GENE"]]}], ["Considering the harmful effects of generation of ROS by inhaled particles, the results presented here show a possible mechanism whereby coal samples may contribute to CWP.", {"entities": []}], ["This suggests that the toxicity of coal may be explained, in part, by the presence of FeS 2 .", {"entities": [[86, 89, "GENE"]]}], ["This study investigated the risk of ischaemic bowel syndrome (IBS) in androgen deprivation therapy (ADT) users to explore the long-term outcomes of patients with prostate cancer (PC) receiving ADT treatment.", {"entities": [[52, 60, "DISEASE"], [171, 177, "DISEASE"], [162, 177, "DISEASE"], [179, 181, "GENE"]]}], ["We performed a population-based retrospective cohort study.", {"entities": []}], ["All the clinical information of the study participants were acquired from the Longitudinal Health Insurance Database for Catastrophic Illness Patients in Taiwan.", {"entities": []}], ["We extracted data for all the patients newly diagnosed with prostate malignancy (ICD-9-CM 185 or C61 in ICD-10-CM) from 2000 to 2008.", {"entities": []}], ["The patients were then divided into two groups: 7160 male ADT cohort receiving ADT and 7160 male non-ADT comparison group frequency matched by age and index year of ADT treatment of the ADT group.", {"entities": []}], ["Cox proportional hazard regression was used to estimate the adjusted HR and 95% CIs of the IBS risk.", {"entities": [[69, 71, "GENE"]]}], ["No significant difference was noted in the overall incidence rate for IBS between the ADT and non-ADT cohorts (0.86 and 0.89 per 1000 person\u2013year, respectively, p=0.89).", {"entities": []}], ["Even after adjusting for potential risk factors, a 1.06-fold risk of IBS (95% CI 0.62 to 1.82, p=0.82) was observed in the ADT cohort relative to the non-ADT cohorts.", {"entities": []}], ["Moreover, we stratified the ADT cohort by time point of ADT treatment after PC diagnosis.", {"entities": [[76, 78, "GENE"]]}], ["Different IBS incidence rates were observed among the early ADT, late-ADT and non-ADT users at 0.77, 1.23 and 0.89 per 1000 person-years, respectively; nonetheless, the difference was not statistically significant.", {"entities": []}], ["Moreover, no difference was found between the ADT treatment types and IBS risk, including sole orchiectomy, sole luteinising-hormone-releasing hormone and both.", {"entities": []}], ["Results showed that ADT treatment in patients with PC is not an independent factor for IBS incidence.", {"entities": [[51, 53, "GENE"]]}], ["Large sample sizes for patients with IBS with patients with PC who had received ADT treatment are needed for further study.", {"entities": [[60, 62, "GENE"]]}], ["Peripheral blood monocytes (PBMo) originate from the bone marrow, circulate in the blood and emigrate into various organs where they differentiate into tissue resident cellular phenotypes of the mononuclear phagocyte system, including macrophages (M\u03d5) and dendritic cells (DC).", {"entities": []}], ["Like in other organs, this emigration and differentiation process is essential to replenish the mononuclear phagocyte pool in the lung under both inflammatory and non-inflammatory steady-state conditions.", {"entities": []}], ["While many studies have addressed inflammation-driven monocyte trafficking to the lung, the emigration and pulmonary differentiation of PBMo under non-inflammatory conditions is much less understood.", {"entities": []}], ["In order to assess the transcriptional profile of circulating and lung resident mononuclear phagocyte phenotypes, PBMo, lung M\u03d5 and lung DC from na\u00efve mice were flow-sorted to high purity, and their gene expression was compared by DNA microarrays on a genome-wide scale.", {"entities": []}], ["Differential regulation of selected genes was validated by quantitative PCR and on protein level by flow cytometry.", {"entities": []}], ["Differentially-expressed genes related to cell traffic were selected and grouped into the clusters (i) matrix metallopeptidases, (ii) chemokines/chemokine receptors, and (iii) integrins.", {"entities": []}], ["Expression profiles of clustered genes were further assessed at the mRNA and protein levels in subsets of circulating PBMo (GR1- vs GR1+) and lung resident macrophages (alveolar vs interstitial M\u03d5).", {"entities": []}], ["Our data identify differentially activated genetic programs in circulating monocytes and their lung descendents.", {"entities": []}], ["Lung DC activate an extremely diverse set of gene families but largely preserve a mobile cell profile with high expression levels of integrin and chemokine/chemokine receptors.", {"entities": []}], ["In contrast, interstitial and even more pronounced alveolar M\u03d5, stepwise downregulate gene expression of these traffic relevant communication molecules, but strongly upregulate a distinct set of matrix metallopetidases potentially involved in tissue invasion and remodeling.", {"entities": []}], ["Our data provide new insight in the changes of the genetic profiles of PBMo and their lung descendents, namely DC and M\u03d5 under non-inflammatory, steady-state conditions.", {"entities": []}], ["These findings will help to better understand the complex relations within the mononuclear phagocyte pool of the lung.", {"entities": []}], ["Extended Spectrum Beta- Lactamase producing organisms causing urinary tract infections (ESBL-UTI) are increasing in incidence and pose a major burden to health care.", {"entities": []}], ["While ESBL producing Klebsiella species seem to account for most nosocomial outbreaks, ESBL-producing E. coli have been isolated from both hospitalized and non-hospitalized patients.", {"entities": []}], ["Although 95-100% ESBL organisms are still considered sensitive to meropenem, rapid emergence of carbapenem resistance has been documented in many countries.", {"entities": []}], ["The objective of this study was to evaluate urinary tract infections caused by ESBL producers and the antibiotic susceptibility patterns in Sri Lanka.", {"entities": []}], ["Patients with confirmed ESBL-UTI admitted to Professorial Medical Unit, Colombo North Teaching Hospital from January \u2013 June 2015 were recruited to the study.", {"entities": []}], ["Their urine culture and antibiotic susceptibility reports were evaluated after obtaining informed written consent.", {"entities": []}], ["Of 61 culture positive ESBL-UTIs, E. coli caused 53 (86.8%), followed by Klebsiella in 8 (13.1%).30 (49.1%) had a history of hospitalization within the past three months and included 6/8(75%) of K lebsiella UTI and 24/53(45.2%) of E.coli UTI.", {"entities": []}], ["Antibiotic susceptibility of ESBL organisms were; Meropenem 58 (95%), Imipenem 45 (73.7%), Amikacin 37 (60.6%) and Nitrofurantoin 28(45.9%).", {"entities": []}], ["In 3(4.9%), E.coli were resistant to Meropenem.", {"entities": []}], ["These three patients had received multiple antibiotics including meropenem in the recent past for recurrent UTI.", {"entities": []}], ["We observed a higher percentage of E. coli over Klebsiella as ESBL producing organisms suggesting most ESBL-UTIs to be community acquired, Carbapenems seem to remain as the first line therapy for majority of ESBL-UTIs in the local setting.", {"entities": []}], ["However 4.9% prevalence of meropenem resistance is alarming compared to other countries.", {"entities": []}], ["Although prior antibiotic utilization and hospitalization may contribute to emergence of ESBL producing Klebsiella and E.coli in Sri Lanka, high prevalence of community acquired ESBL- E. coli needs further investigations to identify potential causes .", {"entities": []}], ["Being a third world country with a free health care system, observed alarming rate of carbapenem resistance is likely to add a significant burden to health budget.", {"entities": []}], ["We feel that treatment of infections in general needs a careful approach adhering to recommended antibiotic guidelines in order to prevent emergence of multi drug resistant organisms.", {"entities": []}], ["It has previously been demonstrated that the presence of fetal bovine serum is necessary for TGF-\u03b23 (transforming growth factor beta 3)-dependent elimination of low-dose hyper-radiosensitivity (HRS) in cells by 1 h of low-dose-rate \u03b3-irradiation (0.2\u20130.3 Gy/h).", {"entities": []}], ["The purpose of the present study was to identify the serum constituent involved.", {"entities": []}], ["Two human HRS-positive (T-47D, T98G) cell lines were used.", {"entities": []}], ["The effects of different pretreatments on HRS were investigated using the colony assay.", {"entities": []}], ["Total inducible nitric oxide synthase (iNOS) levels were measured using a cell-based ELISA assay.", {"entities": []}], ["The serum factor was identified as interleukin-13 (IL-13).", {"entities": []}], ["In order for low dose-rate irradiation to eliminate HRS through the TGF-\u03b23-dependent mechanism, the cells must be exposed to IL-13 first.", {"entities": []}], ["Inhibiting receptor IL-13R\u03b12 showed that this receptor is involved in the response.", {"entities": []}], ["Adding IL-13 to serum-free medium restored the properties of full medium but not when an inhibitor of proprotein convertase activity was added together with IL-13.", {"entities": []}], ["The presence of IL-13 resulted in upregulation of total iNOS protein levels.", {"entities": []}], ["Thus, this study indicates that IL-13 interacts with the cells though receptor IL-13R\u03b12 and induces upregulation of iNOS and activation of one or more furin-like proprotein convertases.", {"entities": []}], ["DNA methylation plays an important role in regulating cell growth and disease development.", {"entities": []}], ["Methylation profiles are examined by bisulfite conversion; however, the lack of markers for bisulfite conversion efficiency and appropriate internal control genes remains a major challenge.", {"entities": []}], ["To address these issues, we utilized two bioinformatics approaches, coefficients of variances and resampling tests, to identify probes showing stable methylation levels from several independent microarray datasets.", {"entities": []}], ["Mass spectrometry validated the consistently high methylation levels of the five probes ( N4BP2 , EGFL8 , CTRB1 , TSPAN3 , and ZNF690 ) in 13 human tissue types from 24 cell lines.", {"entities": [[90, 95, "GENE"], [98, 103, "GENE"], [106, 111, "GENE"], [114, 120, "GENE"]]}], ["Linear associations between detected methylation levels and methyl concentrations of DNA samples were further demonstrated in three genes ( N4BP2 , EGFL8 , and CTRB1 ).", {"entities": [[140, 145, "GENE"], [148, 153, "GENE"], [160, 165, "GENE"]]}], ["To summarize, we identified five genes which may serve as internal controls for methylation studies by analyzing large-scale microarray data, and three of them can be used as markers for evaluating the efficiency of bisulfite conversion.", {"entities": []}], ["Serum testosterone (T) levels in men decline with age.", {"entities": []}], ["Low T levels are associated with sarcopenia and frailty in men aged > 80 years.", {"entities": []}], ["T levels have not previously been directly associated with disability in older men.", {"entities": []}], ["We explored associations between T levels, frailty and disability in a cohort of octogenarian men.", {"entities": []}], ["Data from all men from Life and Living in Advanced Age Cohort Study in New Zealand, a longitudinal cohort study in community-dwelling older adults.", {"entities": []}], ["Community-dwelling ( > 80 years) adult men excluding those receiving T treatment or with prostatic carcinoma.", {"entities": [[99, 108, "DISEASE"]]}], ["Associations between baseline total testosterone (TT) and calculated free testosterone (fT), frailty (Fried scale) and disability (Nottingham Extended Activities of Daily Living scale (NEADL)) (baseline and 24\u2009months) were examined using multivariate regression and Wald\u2019s \u03c7 Participants: 243 men, mean (SD) age 83.7 (2.0) years.", {"entities": []}], ["Mean (SD) TT=17.6 (6.8) nmol/L and fT=225.3 (85.4) pmol/L.", {"entities": []}], ["On multivariate analyses, lower TT levels were associated with frailty: \u03b2=0.41, p=0.017, coefficient of determination (R In men over 80 years, we confirm an association between T levels and baseline frailty scores.", {"entities": []}], ["The new finding of association between T levels and disability is potentially relevant to debates on T supplementation in older men, though, as associations were not present at 24 months, further work is needed.", {"entities": []}], ["Inhaled nanoparticles can deposit in the deep lung where they interact with pulmonary cells.", {"entities": []}], ["Despite numerous studies on pulmonary nanotoxicity, detailed molecular mechanisms of specific nanomaterial-induced lung injury have yet to be identified.", {"entities": []}], ["Using whole-body dynamic inhalation model, we studied the interactions between aluminum oxide nanoparticles (Al 2 O 3 NPs) and the pulmonary system in vivo.", {"entities": [[118, 121, "GENE"]]}], ["We found that seven-day-exposure to Al 2 O 3 NPs resulted in emphysema and small airway remodeling in murine lungs, accompanied by enhanced inflammation and apoptosis.", {"entities": [[45, 48, "GENE"]]}], ["Al 2 O 3 NPs exposure led to suppression of PTPN6 and phosphorylation of STAT3, culminating in increased expression of the apoptotic marker PDCD4.", {"entities": [[9, 12, "GENE"], [44, 49, "GENE"], [73, 78, "GENE"], [140, 145, "GENE"]]}], ["Rescue of PTPN6 expression or application of a STAT3 inhibitor, effectively protected murine lungs from inflammation and apoptosis, as well as, in part, from the induction of chronic obstructive pulmonary disease (COPD)-like effects.", {"entities": [[175, 212, "DISEASE"], [10, 15, "GENE"], [47, 52, "GENE"]]}], ["In summary, our studies show that inhibition of PTPN6 plays a critical role in Al 2 O 3 NPs-induced COPD-like lesions.", {"entities": [[48, 53, "GENE"]]}], ["The online version of this article (10.1186/s12989-017-0234-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["TCTP has been implicated in a plethora of important cellular processes related to cell growth, cell cycle progression, malignant transformation and inhibition of apoptosis.", {"entities": []}], ["In addition to these intracellular functions, TCTP has extracellular functions and plays an important role in immune cells.", {"entities": []}], ["TCTP expression was previously shown to be deregulated in prostate cancer, but its function in prostate cancer cells is largely unknown.", {"entities": [[67, 73, "DISEASE"], [104, 110, "DISEASE"], [58, 73, "DISEASE"], [95, 110, "DISEASE"]]}], ["Here we show that TCTP expression is regulated by androgens in LNCaP prostate cancer cells in vitro as well as human prostate cancer xenografts in vivo .", {"entities": [[78, 84, "DISEASE"], [126, 132, "DISEASE"], [69, 84, "DISEASE"], [117, 132, "DISEASE"]]}], ["Knockdown of TCTP reduced colony formation and increased apoptosis in LNCaP cells, implicating it as an important factor for prostate cancer cell growth.", {"entities": [[134, 140, "DISEASE"], [125, 140, "DISEASE"]]}], ["Global gene expression profiling in TCTP knockdown LNCaP cells showed that several interferon regulated genes are regulated by TCTP, suggesting that it may have a role in regulating immune function in prostate cancer.", {"entities": [[210, 216, "DISEASE"], [201, 216, "DISEASE"]]}], ["In addition, recombinant TCTP treatment increased colony formation in LNCaP cells suggesting that secreted TCTP may function as a proliferative factor in prostate cancer.", {"entities": [[163, 169, "DISEASE"], [154, 169, "DISEASE"]]}], ["These results suggest that TCTP may have a role in prostate cancer development.", {"entities": [[60, 66, "DISEASE"], [51, 66, "DISEASE"]]}], ["This Whole Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession AMXX00000000 (SMACv1.0, unscaffolded genome assembly).", {"entities": []}], ["The version described in this paper is the first version (AMXX01000000).", {"entities": []}], ["The scaffolded assembly (SMACv1.1) has been deposited at DDBJ/EMBL/GenBank under the accession AOUJ00000000, and is also the first version (AOUJ01000000).", {"entities": []}], ["Strong biological interest in traits such as the acquisition and utilization of speech, cognitive abilities, and longevity catalyzed the utilization of two next-generation sequencing platforms to provide the first-draft de novo genome assembly for the large, new world parrot Ara macao (Scarlet Macaw).", {"entities": []}], ["Despite the challenges associated with genome assembly for an outbred avian species, including 951,507 high-quality putative single nucleotide polymorphisms, the final genome assembly (>1.035 Gb) includes more than 997 Mb of unambiguous sequence data (excluding N\u2019s).", {"entities": [[219, 221, "GENE"]]}], ["Cytogenetic analyses including ZooFISH revealed complex rearrangements associated with two scarlet macaw macrochromosomes (AMA6, AMA7), which supports the hypothesis that translocations, fusions, and intragenomic rearrangements are key factors associated with karyotype evolution among parrots.", {"entities": []}], ["In silico annotation of the scarlet macaw genome provided robust evidence for 14,405 nuclear gene annotation models, their predicted transcripts and proteins, and a complete mitochondrial genome.", {"entities": []}], ["Comparative analyses involving the scarlet macaw, chicken, and zebra finch genomes revealed high levels of nucleotide-based conservation as well as evidence for overall genome stability among the three highly divergent species.", {"entities": []}], ["Application of a new whole-genome analysis of divergence involving all three species yielded prioritized candidate genes and noncoding regions for parrot traits of interest (i.e., speech, intelligence, longevity) which were independently supported by the results of previous human GWAS studies.", {"entities": []}], ["We also observed evidence for genes and noncoding loci that displayed extreme conservation across the three avian lineages, thereby reflecting their likely biological and developmental importance among birds.", {"entities": []}], ["Nonadherence to psychopharmacological treatments poses a significant challenge to treatment success in individuals with serious mental illness, with upwards of 60% of people not taking their psychiatric medications as prescribed.", {"entities": []}], ["Nonadherence is associated with adverse outcomes, including exacerbation of psychiatric symptoms, impaired functioning, increased hospitalizations and emergency room use, and increased health care costs.", {"entities": []}], ["Whereas interventions using psychoeducation or cognitive approaches, such as motivational interviewing, have largely proven ineffective in improving adherence, approaches employing behavioral tailoring that incorporate medication taking into the daily routine and/or use environmental supports have shown promise.", {"entities": []}], ["Recently, adherence-enhancing behavioral tailoring interventions that utilize novel technologies, such as electronic monitors and mobile phones, have been developed.", {"entities": []}], ["Although interventions utilizing these platforms have the potential for widespread dissemination to a broad range of individuals, most require further empirical testing.", {"entities": []}], ["This paper reviews selected behavioral tailoring strategies that aim to improve medication adherence and other functional outcomes among individuals with serious mental illness.", {"entities": []}], ["In this paper we report on the collection of fine (PM 1 ) and ultrafine (PM 0.1 ), or nanoparticulate, carbonaceous materials using thermophoretic precipitation onto silicon monoxide/formvar-coated 3 mm grids which were examined in the transmission electron microscope (TEM).", {"entities": []}], ["We characterize and compare diesel particulate matter (DPM), tire particulate matter (TPM), wood burning particulate matter, and other soot (or black carbons (BC)) along with carbon nanotube and related fullerene nanoparticle aggregates in the outdoor air, as well as carbon nanotube aggregates in the indoor air; and with reference to specific gas combustion sources.", {"entities": []}], ["These TEM investigations include detailed microstructural and microdiffraction observations and comparisons as they relate to the aggregate morphologies as well as their component (primary) nanoparticles.", {"entities": []}], ["We have also conducted both clinical surveys regarding asthma incidence and the use of gas cooking stoves as well as random surveys by zip code throughout the city of El Paso.", {"entities": [[55, 61, "DISEASE"]]}], ["In addition, we report on short term (2 day) and longer term (2 week) in vitro assays for black carbon and a commercial multiwall carbon nanotube aggregate sample using a murine macrophage cell line, which demonstrate significant cytotoxicity; comparable to a chrysotile asbestos nanoparticulate reference.", {"entities": []}], ["The multi-wall carbon nanotube aggregate material is identical to those collected in the indoor and outdoor air, and may serve as a surrogate.", {"entities": []}], ["Taken together with the plethora of toxic responses reported for DPM, these findings prompt concerns for airborne carbonaceous nanoparticulates in general.", {"entities": []}], ["The implications of these preliminary findings and their potential health effects, as well as directions for related studies addressing these complex issues, will also be examined.", {"entities": []}], ["A higher prevalence of respiratory symptoms and an associated increase in health care utilization among children with parents who smoke is to be expected.", {"entities": []}], ["From previous studies however, it appears that parents who smoke may underutilize health services for their children, especially with respect to respiratory care.", {"entities": []}], ["This study explores the validity and generalizability of the previous assumption.", {"entities": []}], ["Data were obtained from a Dutch birth-cohort study; the Prevention and Incidence of Asthma and Mite Allergy (PIAMA) project.", {"entities": []}], ["Information regarding parental smoking, the child's respiratory symptoms and health care use and potential confounders were obtained by postal questionnaires.", {"entities": []}], ["Multivariate logistic models were used to relate parental smoking to the child's respiratory symptoms and health care use.", {"entities": []}], ["The study comprised 3,564, 4-year old children.", {"entities": []}], ["In the crude analysis, respiratory symptoms were more frequent among children with a parent who smoked, while health care utilization for respiratory symptoms was not significantly different between children with or without a parent who smoked.", {"entities": []}], ["In the multivariate analyses, maternal smoking had a larger impact on the child's respiratory symptoms and health care use as compared to paternal smoking.", {"entities": []}], ["Maternal smoking was positively associated with mild respiratory symptoms of the child, adjusted odds ratio [AOR] 1.50 (1.19\u20131.91), but not with severe respiratory symptoms AOR 1.03 (0.75\u20131.40).", {"entities": []}], ["Among children with mild respiratory symptoms, children with a mother who smoked were less likely to be taken to the general practitioner (GP) for respiratory symptoms, than children with mothers who did not smoke, AOR 0.58 (0.33\u20131.01).", {"entities": []}], ["This finding was less pronounced among children with severe respiratory symptoms AOR 0.86 (0.49\u20131.52).", {"entities": []}], ["Neither GP visits for non-respiratory symptoms nor specialized care for respiratory disease were significantly associated with parental smoking.", {"entities": []}], ["Mothers who smoke appear to underutilize health care for their children with mild respiratory symptoms.", {"entities": []}], ["Health care workers should be informed about this phenomenon.", {"entities": []}], ["Inquiring after the respiratory health of the children during regular visits to healthy baby clinics may help to track potential underutilization of care.", {"entities": []}], ["There is heterogeneity in intrapartum antibiotic use and implementation of policy varies widely.", {"entities": []}], ["Global strategies to enhance the prevention of group B streptococcal disease that may include maternal vaccination are needed.", {"entities": []}], ["Intrapartum antibiotic chemoprophylaxis (IAP) prevents most early-onset group B streptococcal (GBS) disease.", {"entities": []}], ["However, there is no description of how IAP is used around the world.", {"entities": []}], ["This article is the sixth in a series estimating the burden of GBS disease.", {"entities": []}], ["Here we aimed to review GBS screening policies and IAP implementation worldwide.", {"entities": []}], ["We identified data through (1) systematic literature reviews (PubMed/Medline, Embase, Literature in the Health Sciences in Latin America and the Caribbean [LILACS], World Health Organization library database [WHOLIS], and Scopus) and unpublished data from professional societies and (2) an online survey and searches of policies from medical societies and professionals.", {"entities": []}], ["We included data on whether an IAP policy was in use, and if so whether it was based on microbiological or clinical risk factors and how these were applied, as well as the estimated coverage (percentage of women receiving IAP where indicated).", {"entities": []}], ["We received policy information from 95 of 195 (49%) countries.", {"entities": []}], ["Of these, 60 of 95 (63%) had an IAP policy; 35 of 60 (58%) used microbiological screening, 25 of 60 (42%) used clinical risk factors.", {"entities": []}], ["Two of 15 (13%) low-income, 4 of 16 (25%) lower-middle\u2013income, 14 of 20 (70%) upper-middle\u2013income, and 40 of 44 (91%) high-income countries had any IAP policy.", {"entities": []}], ["The remaining 35 of 95 (37%) had no national policy (25/33 from low-income and lower-middle\u2013income countries).", {"entities": []}], ["Coverage varied considerably; for microbiological screening, median coverage was 80% (range, 20%\u201395%); for clinical risk factor\u2013based screening, coverage was 29% (range, 10%\u201350%).", {"entities": []}], ["Although there were differences in the microbiological screening methods employed, the individual clinical risk factors used were similar.", {"entities": []}], ["There is considerable heterogeneity in IAP screening policies and coverage worldwide.", {"entities": []}], ["Alternative global strategies, such as maternal vaccination, are needed to enhance the scope of global prevention of GBS disease.", {"entities": []}], ["The allocation of limited available healthcare resources demands an agreed rational allocation principle and the consequent priority setting.", {"entities": []}], ["We assessed the association between economic evaluations of healthcare interventions published in Spain (1983-2008) and the disease burden in the population.", {"entities": []}], ["Electronic databases (e.g., PubMed/MEDLINE, SCOPUS, ISI Web of Knowledge, CRD, IME, IBECS) and reports from health technology assessment agencies were systematically reviewed.", {"entities": []}], ["For each article, multiple variables were recorded such as: year and journal of publication, type of study, health intervention targetted, perspective of analysis, type of costs and sources of information, first author's affiliation, explicit recommendations aimed at decision-making, and the main disease cause to which the intervention was addressed.", {"entities": []}], ["The following disease burden measures were calculated: years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life years (DALYs), and mortality by cause.", {"entities": []}], ["Correlation and linear regression models were fitted.", {"entities": []}], ["Four hundred and seventy-seven economic evaluations were identified.", {"entities": []}], ["Cardiovascular diseases (15.7%), infectious diseases (15.3%), malignant neoplasms (13.2%), and neuropsychiatric diseases (9.6%) were the conditions most commonly addressed.", {"entities": []}], ["Accidents and injuries, congenital anomalies, oral conditions, nutritional deficiencies and other neoplasms were the categories with a lowest number of studies (0.6% for each of them).", {"entities": []}], ["For the main disease categories (n = 20), a correlation was seen with: mortality 0.67 (p = 0.001), DALYs 0.63 (p = 0.003), YLLs 0.54 (p = 0.014), and YLDs 0.51 (p = 0.018).", {"entities": []}], ["By disease sub-categories (n = 51), the correlations were generally low and non statistically significant.", {"entities": []}], ["Examining discrepancies between economic evaluations in particular diseases and the overall burden of disease helps shed light on whether there are potentially over- and under-investigated areas.", {"entities": []}], ["The approach taken could help policy-makers understand whether resources for economic evaluation are being allocated by using summary measures of population health.", {"entities": []}], ["Within a population, the differences of pharmacogenomic variant frequencies may produce diversities in drug efficacy, safety, and the risk associated with adverse drug reactions.", {"entities": []}], ["With the development of pharmacogenomics, widespread genetic research on drug metabolism has been conducted on major populations, but less is known about minorities.", {"entities": []}], ["In this study, we recruited 100 unrelated, healthy Mongol adults from Xinjiang and genotyped 85 VIP variants from the PharmGKB database.", {"entities": [[96, 99, "GENE"]]}], ["We compared our data with eleven populations listed in 1000 genomes project and HapMap database.", {"entities": []}], ["We used \u03c7 Our results demonstrated that different polymorphic allele frequencies exist between different nationalities,and indicated Mongol is most similar to Chinese populations, followed by JPT.", {"entities": []}], ["This information on the Mongol population complements the existing pharmacogenomic data and provides a theoretical basis for screening and therapy in the different ethnic groups within Xinjiang.", {"entities": []}], ["Complementary therapists spend considerable time with their patients, especially in the first consultation.", {"entities": []}], ["The communication between patients and their therapists is important for raising consciousness and activation of the patient\u2019s self-healing power.", {"entities": []}], ["Thus, the aims in this study were to delineate what complementary therapists regard as essential in patient consultations, their view of the healing process, and how the therapists understand the placebo effect and its position in the healing process.", {"entities": []}], ["Semi-structured individual interviews ( n \u00a0=\u00a04), focus group interview ( n \u00a0=\u00a01) and participant observation were conducted among four different complementary therapists in a Norwegian community.", {"entities": []}], ["The text data was transcribed verbatim and the analysis of the material was conducted according to conventional and direct content analysis.", {"entities": []}], ["Some codes were predefined and others were defined during the analysis.", {"entities": []}], ["The pilot study showed that the implemented methods seems feasible and fit well with the aims of this study.", {"entities": []}], ["Complementary therapists (chiropractor, naprapath (musculoskeletal therapist), acupuncturist and acupuncturist/homeopath) representing four different complementary modalities participated.", {"entities": []}], ["A combination of the conversation and examination during the first consultation formed the basis for the therapist\u2019s choice of treatment.", {"entities": []}], ["A successful consultation was characterized by a fruitful relationship between the therapist and the patient.", {"entities": []}], ["Moreover, the therapist needs to be humble and show the patient respect.", {"entities": []}], ["Patients\u2019 positive beliefs and expectations about the treatment play a significant role in the healing process.", {"entities": []}], ["The more hope the therapist can bring about, the more easily the patient can start believing that it is possible to get well.", {"entities": []}], ["This was a pilot study.", {"entities": []}], ["Therefore the findings should be appreciated as limited and preliminary.", {"entities": []}], ["Therapists\u2019 and patients\u2019 mutual understanding and treatment goals were essential for a successful consultation.", {"entities": []}], ["The therapists emphasized their professional skills and therapeutic competence as important when building fruitful relationships with their patients.", {"entities": []}], ["Exerting authority and making the patient feel confident were essential factors for a successful healing process.", {"entities": []}], ["The complementary therapists understood the placebo effect as the patient\u2019s self-healing power, resulting from establishing trust and belief in the treatment process.", {"entities": []}], ["The online version of this article (doi:10.1186/s12906-017-1770-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In recent years, the pleiotropic roles of vitamin D have been highlighted in various diseases.", {"entities": []}], ["However, the association between serum vitamin D and COPD is not well studied.", {"entities": []}], ["This updated systematic review and meta-analysis aimed to assess the relationship between vitamin D and the risk, severity, and exacerbation of COPD.", {"entities": []}], ["A systematic literature search was conducted in PubMed, Medline, EMBASE, Chinese National Knowledge Infrastructure, Wanfang, and Weipu databases.", {"entities": []}], ["The pooled risk estimates were standardized mean difference (SMD) with 95% confidence interval (CI) for vitamin D levels and odds ratio (OR) with 95% CI for vitamin D deficiency.", {"entities": []}], ["Meta-regression and subgroup analyses were performed on latitude, body mass index, and assay method.", {"entities": []}], ["A total of 21 studies, including 4,818 COPD patients and 7,175 controls, were included.", {"entities": []}], ["Meta-analysis showed that lower serum vitamin D levels were found in COPD patients than in controls (SMD: \u22120.69, 95% CI: \u22121.00, \u22120.38, P <0.001), especially in severe COPD (SMD: \u22120.87, 95% CI: \u22121.51, \u22120.22, P =0.001) and COPD exacerbation (SMD: \u22120.43, 95% CI: \u22120.70, \u22120.15, P =0.002).", {"entities": []}], ["Vitamin D deficiency was associated with increased risk of COPD (OR: 1.77, 95% CI: 1.18, 2.64, P =0.006) and with COPD severity (OR: 2.83, 95% CI: 2.00, 4.00, P <0.001) but not with COPD exacerbation (OR: 1.17, 95% CI: 0.86, 1.59, P =0.326).", {"entities": []}], ["Assay methods had significant influence on the heterogeneity of vitamin D deficiency and COPD risk.", {"entities": []}], ["Serum vitamin D levels were inversely associated with COPD risk, severity, and exacerbation.", {"entities": []}], ["Vitamin D deficiency is associated with increased risk of COPD and severe COPD but not with COPD exacerbation.", {"entities": []}], ["It is worth considering assay methods in the heterogeneity sources analysis of association between vitamin D deficiency and COPD.", {"entities": []}], ["United Kingdom (UK) national guidelines recommend that all pregnant women who smoke should be advised to quit at every available opportunity, and brief cessation advice is an efficient and cost-effective means to increase quit rates.", {"entities": []}], ["The Quality and Outcomes Framework (QOF) implemented in 2004 requires general practitioners to document their delivery of smoking cessation advice in patient records.", {"entities": []}], ["However, no specific targets have been set in QOF for the recording of this advice in pregnant women.", {"entities": []}], ["We used a large electronic primary care database from the UK to quantify the pregnancies in which women who smoked were recorded to have been given smoking cessation advice, and the associated maternal characteristics.", {"entities": []}], ["Using The Health Improvement Network database we calculated annual proportions of pregnant smokers between 2000 and 2009 with cessation advice documented in their medical records during pregnancy.", {"entities": []}], ["Logistic regression was used to assess variation in the recording of cessation advice with maternal characteristics.", {"entities": []}], ["Among 45,296 pregnancies in women who smoked, recorded cessation advice increased from 7% in 2000 to 37% in 2004 when the QOF was introduced and reduced slightly to 30% in 2009.", {"entities": []}], ["Pregnant smokers from the youngest age group (15\u201319) were 21% more likely to have a record of cessation advice compared to pregnant smokers aged 25\u201329 (OR 1.21, 95% CI 1.10-1.35) and pregnant smokers from the most deprived group were 38% more likely to have a record for cessation advice compared to pregnant smokers from the least deprived group (OR 1.38, 95% CI 1.14-1.68).", {"entities": []}], ["Pregnant smokers with asthma were twice as likely to have documentation of cessation advice in their primary care records compared to pregnant smokers without asthma (OR 1.97, 95% CI 1.80-2.16).", {"entities": [[22, 28, "DISEASE"], [159, 165, "DISEASE"]]}], ["Presence of comorbidities such as diabetes, hypertension and mental illness also increased the likelihood of having smoking cessation advice recorded.", {"entities": [[44, 56, "DISEASE"]]}], ["No marked variations were observed in the recording of cessation advice with body mass index.", {"entities": []}], ["Recorded delivery of smoking cessation advice for pregnant smokers in primary care has increased with some fluctuation over the years, especially after the implementation of the QOF, and varies with maternal characteristics.", {"entities": []}], ["The prevalence of human and canine allergic diseases is commonly perceived to be increasing.", {"entities": []}], ["Suggested predisposing factors in people and dogs include increased allergen load, increased exposure to pollutants, reduced family size, reduced microbial load and less exposure to infection at a young age, increasingly urbanised environment, and changes in dietary habits.", {"entities": []}], ["Genetic make\u2010up may provide a template for phenotypic predisposition which is strongly influenced by our diet and environment leading to constant regulation of gene expression.", {"entities": []}], ["One way in which diet can alter gene expression is via its effects on the gut flora or microbiota, the collection of microbes residing in the gastrointestinal tract.", {"entities": []}], ["The resident microbiota is important in maintaining structural and functional integrity of the gut and in immune system regulation.", {"entities": []}], ["It is an important driver of host immunity, helps protect against invading enteropathogens, and provides nutritional benefits to the host.", {"entities": []}], ["Disruption of the microbiota (dysbiosis) may lead to severe health problems, both in the gastrointestinal tract and extra\u2010intestinal organ systems.", {"entities": []}], ["The precise mechanisms by which the intestinal microbiota exerts its effects are only beginning to be unravelled but research is demonstrating close links between gut microflora and many factors involved in the pathogenesis of atopic dermatitis ( AD ).", {"entities": [[227, 244, "DISEASE"], [234, 244, "DISEASE"]]}], ["AD and indeed any other \u2018skin disease\u2019, may be seen as a possible manifestation of a more systemic problem involving gut dysbiosis and increased intestinal permeability, which may occur even in the absence of gastrointestinal signs.", {"entities": [[25, 37, "DISEASE"]]}], ["Manipulation of the canine intestinal microbiota as a method for modifying atopy, may be attempted in many ways including avoidance of certain foods, supplementation with probiotics and prebiotics, optimising nutrient intake, minimising stress, antimicrobial therapy, correction and prevention of low stomach acid, and faecal microbiota transplantation ( FMT ).", {"entities": []}], ["Up-regulation of cyclooxygenase (COX)-2 and its metabolite prostaglandin E 2 (PGE 2 ) are frequently implicated in lung inflammation.", {"entities": []}], ["Extracellular nucleotides, such as ATP have been shown to act via activation of P2 purinoceptors, leading to COX-2 expression in various inflammatory diseases, such as lung inflammation.", {"entities": []}], ["However, the mechanisms underlying ATP-induced COX-2 expression and PGE 2 release remain unclear.", {"entities": []}], ["Here, we showed that ATP\u03b3S induced COX-2 expression in A549 cells revealed by western blot and real-time PCR.", {"entities": []}], ["Pretreatment with the inhibitors of P2 receptor (PPADS and suramin), PKC (G\u00f66983, G\u00f66976, Ro318220, and Rottlerin), ROS (Edaravone), NADPH oxidase [diphenyleneiodonium chloride (DPI) and apocynin], Jak2 (AG490), and STAT3 [cucurbitacin E (CBE)] and transfection with siRNAs of PKC\u03b1, PKC\u03b9, PKC\u03bc, p47 , Jak2, STAT3, and cPLA 2 markedly reduced ATP\u03b3S-induced COX-2 expression and PGE 2 production.", {"entities": [[198, 202, "GENE"], [301, 305, "GENE"], [216, 221, "GENE"], [307, 312, "GENE"], [198, 202, "GENE"], [301, 305, "GENE"], [216, 221, "GENE"], [307, 312, "GENE"]]}], ["In addition, pretreatment with the inhibitors of P2 receptor attenuated PKCs translocation from the cytosol to the membrane in response to ATP\u03b3S.", {"entities": []}], ["Moreover, ATP\u03b3S-induced ROS generation and p47 translocation was also reduced by pretreatment with the inhibitors of P2 receptor, PKC, and NADPH oxidase.", {"entities": []}], ["On the other hand, ATP\u03b3S stimulated Jak2 and STAT3 activation which were inhibited by pretreatment with PPADS, suramin, G\u00f66983, G\u00f66976, Ro318220, GF109203X, Rottlerin, Edaravone, DPI, and apocynin in A549 cells.", {"entities": [[36, 40, "GENE"], [45, 50, "GENE"]]}], ["Taken together, these results showed that ATP\u03b3S induced COX-2 expression and PGE 2 production via a P2 receptor/PKC/NADPH oxidase/ROS/Jak2/STAT3/cPLA 2 signaling pathway in A549 cells.", {"entities": []}], ["Increased understanding of signal transduction mechanisms underlying COX-2 gene regulation will create opportunities for the development of anti-inflammation therapeutic strategies.", {"entities": []}], ["Recent studies demonstrated an adverse effect of chronic exposure to air pollution (AP) on metabolic syndrome and its components.", {"entities": [[101, 109, "DISEASE"]]}], ["In a population-based study, we investigated the association between exposure to ambient AP and serum glucose (SG), among subjects with normal glucose, impaired fasting glucose (IFG), and diabetes mellitus (DM).", {"entities": [[188, 205, "DISEASE"]]}], ["We included 1,063,887 SG tests performed in 131,882 subjects (years 2001\u20132012).", {"entities": []}], ["Exposure data included daily levels of SO 2 , NO 2 and other pollutants of industrial, traffic, and nonanthropogenic sources.", {"entities": []}], ["Demographical, clinical, and medications purchase data were assessed.", {"entities": []}], ["Log-transformed SG levels were analyzed by linear mixed models adjusted for seasonal variables and personal characteristics.", {"entities": []}], ["SG increases (%increase [95% CI]), among subjects with normal glucose, IFG, and DM, respectively, were associated with 6.36\u200appb increase of NO 2 measured 24 to 72\u200ahours before the test (0.40% [0.31%; 0.50%], 0.56% [0.40%; 0.71%], and 1.08% [0.86%; 1.29%]); and with 1.17\u200appb increase of SO 2 measured 24\u200ahours before the test (0.29% [0.22%; 0.36%], 0.20% [0.10%; 0.31%], and 0.33% [0.14%; 0.52%]).", {"entities": []}], ["Among DM population, weakest association was observed among patients treated with Metformin (0.56% increase in SG [0.18%; 0.95%]).", {"entities": []}], ["In conclusion, NO 2 and SO 2 exposure is associated with small but significantly increased levels of SG.", {"entities": []}], ["Although DM patients were found to be more susceptible to the AP induced SG variations, Metformin treatment seem to have a protective effect.", {"entities": []}], ["Given the chronic lifetime exposure to AP and the broad coverage of the population, even small associations such as those found in our study can be associated with detrimental health effects and may have profound public health implications.", {"entities": []}], ["Despite the growing importance of stroke in developing countries, little is known of stroke burden in survivors.", {"entities": []}], ["The authors investigated the prevalence of self-reported stroke, stroke-related disability, dependence and care-giver strain in Latin America (LA), China and India.", {"entities": []}], ["Cross-sectional surveys were conducted on individuals aged 65+ (n=15\u2008022) living in specified catchment areas.", {"entities": []}], ["Self-reported stroke diagnosis, disability, care needs and care giver burden were assessed using a standardised protocol.", {"entities": []}], ["For those reporting stroke, the correlates of disability, dependence and care-giver burden were estimated at each site using Poisson or linear regression, and combined meta-analytically.", {"entities": []}], ["The prevalence of self-reported stroke ranged between 6% and 9% across most LA sites and urban China, but was much lower in urban India (1.9%), and in rural sites in India (1.1%), China (1.6%) and Peru (2.7%).", {"entities": []}], ["The proportion of stroke survivors needing care varied between 20% and 39% in LA sites but was higher in rural China (44%), urban China (54%) and rural India (73%).", {"entities": []}], ["Comorbid dementia and depression were the main correlates of disability and dependence.", {"entities": [[9, 17, "DISEASE"]]}], ["The prevalence of stroke in urban LA and Chinese sites is nearly as high as in industrialised countries.", {"entities": []}], ["High levels of disability and dependence in the other mainly rural and less-developed sites suggest underascertainment of less severe cases as one likely explanation for the lower prevalence in those settings.", {"entities": []}], ["As the health transition proceeds, a further increase in numbers of older stroke survivors is to be anticipated.", {"entities": []}], ["In addition to prevention, stroke rehabilitation and long-term care needs should be addressed.", {"entities": []}], ["The translocator protein (18 kDa) (TSPO) is highly expressed on the bronchial and bronchiole epithelium, submucosal glands in intrapulmonary bronchi, pneumocytes and alveolar macrophages in human lung.", {"entities": [[35, 39, "GENE"]]}], ["This study aimed to perform positron emission tomography (PET) imaging of lung inflammation with [ An acute lung injury model was prepared by intratracheal administration of lipopolysaccharide (LPS) to rat.", {"entities": []}], ["Uptake of radioactivity in the rat lungs was measured with small-animal PET after injection of [ The uptake of [ From this study we conclude that PET with [", {"entities": []}], ["Background: Perfluoroalkyl chemicals (PFCs) are a family of commonly used industrial chemicals whose persistence and ubiquity in human blood samples has led to concern about possible toxicity.", {"entities": []}], ["Several animal studies and one recent human study have suggested a link between exposure to PFCs and asthma, although few epidemiologic studies have been conducted.", {"entities": [[101, 107, "DISEASE"]]}], ["Objectives: We investigated children\u2019s PFC serum concentrations and their associations with asthma-related outcomes.", {"entities": [[92, 98, "DISEASE"]]}], ["Methods: We evaluated the association between serum concentrations of eight PFCs, including perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), perfluorononanoic acid (PFNA), and perfluorohexane sulfonic acid (PFHxS), with self-reported lifetime asthma, recent wheezing, and current asthma using data from participants 12\u201319 years of age from the 1999\u20132000 and 2003\u20132008 National Health and Nutrition Examination Surveys.", {"entities": [[263, 269, "DISEASE"], [300, 306, "DISEASE"]]}], ["Results: In multivariable-adjusted models, PFOA was associated with higher odds of ever having received a diagnosis of asthma [odds ratio (OR) = 1.18; 95% CI: 1.01, 1.39 for a doubling in PFOA], whereas for PFOS there were inverse relationships with both asthma and wheezing (OR = 0.88; 95% CI: 0.74, 1.04, and OR = 0.83; 95% CI: 0.67, 1.02, respectively).", {"entities": [[119, 125, "DISEASE"], [255, 261, "DISEASE"]]}], ["The associations were attenuated after accounting for sampling weights.", {"entities": []}], ["No associations were seen between the other PFCs and any outcome.", {"entities": []}], ["Conclusions: This cross-sectional study provides some evidence for associations between exposure to PFCs and asthma-related outcomes in children.", {"entities": [[109, 115, "DISEASE"]]}], ["The evidence is inconsistent, however, and prospective studies are needed.", {"entities": []}], ["Citation: Humblet O, Diaz-Ramirez LG, Balmes JR, Pinney SM, Hiatt RA.", {"entities": []}], ["Perfluoroalkyl chemicals and asthma among children 12\u201319 years of age: NHANES (1999\u20132008).", {"entities": [[29, 35, "DISEASE"]]}], ["Environ Health Perspect 122:1129\u20131133;\u2002 http://dx.doi.org/10.1289/ehp.1306606", {"entities": []}], ["Recent scholarship points to a protective association between green space and birth outcomes as well a positive relationship between blue space and wellbeing.", {"entities": []}], ["We add to this body of literature by exploring the relationship between expectant mothers\u2019 exposure to green and blue spaces and adverse birth outcomes in New York City.", {"entities": []}], ["The Normalized Difference Vegetation Index (NDVI), the NYC Street Tree Census, and access to major green spaces served as measures of greenness, while proximity to waterfront areas represented access to blue space.", {"entities": []}], ["Associations between these factors and adverse birth outcomes, including preterm birth, term birthweight, term low birthweight, and small for gestational age, were evaluated via mixed-effects linear and logistic regression models.", {"entities": []}], ["The analyses were conducted separately for women living in deprived neighborhoods to test for differential effects on mothers in these areas.", {"entities": []}], ["The results indicate that women in deprived neighborhoods suffer from higher rates adverse birth outcomes and lower levels of residential greenness.", {"entities": []}], ["In adjusted models, a significant inverse association between nearby street trees and the odds of preterm birth was found for all women.", {"entities": []}], ["However, we did not identify a consistent significant relationship between adverse birth outcomes and NDVI, access to major green spaces, or waterfront access when individual covariates were taken into account.", {"entities": []}], ["The success of highly active antiretroviral therapy (HAART) has determined a dramatic decline in AIDS- and immunodeficiency-related causes of death in the HIV-infected population.", {"entities": []}], ["As life-expectancy increases, such individuals have become gradually exposed not only to the effects of aging itself, but also to the influence of environmental risk factors, which are known to act in the general population.", {"entities": []}], ["These features can lead to obesity, diabetes mellitus and ultimately cardiovascular diseases (CVD).", {"entities": [[27, 34, "DISEASE"], [36, 53, "DISEASE"]]}], ["Metabolic complications and abnormal fat distribution were frequently observed after a few years of antiretroviral therapy and, as the array of antiretroviral drugs became broader, long term metabolic alterations are becoming far more common worldwide.", {"entities": []}], ["Nevertheless, the risk of not being on HAART is overwhelmingly greater than the metabolic adverse events in terms of morbidity and mortality events.", {"entities": []}], ["HIV/HAART-induced metabolic unbalances overlap in some extent the components of Metabolic Syndrome (MetS) and its high rates in the HIV population place infected individuals in an elevated CVD risk category.", {"entities": []}], ["MetS can explain at least in part the emergence of CVD as the major morbidity and mortality conditions in the HIV population.", {"entities": []}], ["In this review we convey information on the underlying aspects of MetS during HIV infection, highlighting some physiopathological and epidemiological features of this comorbidity along with the role played by HIV itself and the synergy action of some antiretroviral drugs.", {"entities": []}], ["Considerations on MetS management in the HIV population are also depicted.", {"entities": []}], ["Smoking is associated with a mixed inflammatory infiltrate in the airways.", {"entities": []}], ["We evaluated whether airway inflammation in smokers is related to lung function parameters and inflammatory markers in exhaled breath.", {"entities": []}], ["Thirty-seven smokers undergoing lung resection for primary lung cancer were assessed pre-operatively by lung function testing including single-breath-nitrogen washout test (sb-N2-test), measurement of fractional exhaled nitric oxide (FeNO) and pH/8-isoprostane in exhaled breath condensate (EBC).", {"entities": [[59, 70, "DISEASE"], [64, 70, "DISEASE"]]}], ["Lung tissue sections containing cancer-free large (LA) and small airways (SA) were stained for inflammatory cells.", {"entities": [[32, 38, "DISEASE"]]}], ["Mucosal (MC T ) respectively connective tissue mast cells (MC TC ) and interleukin-17A (IL-17A) expression by mast cells was analysed using a double-staining protocol.", {"entities": []}], ["The median number of neutrophils, macrophages and mast cells infiltrating the lamina propria and adventitia of SA was higher than in LA.", {"entities": []}], ["Both MCTC and MC T were higher in the lamina propria of SA compared to LA (MC TC : 49 vs. 27.4 cells/mm T : 162.5 vs. 35.4 cells/mm TC of LA.", {"entities": []}], ["Significant correlations were found for the slope of phase III % pred.", {"entities": []}], ["of the sb-N2-test (r s = -0.39), for the FEV 1 % pred.", {"entities": [[41, 44, "GENE"]]}], ["(r s = 0.37) and for FEV 1 /FVC ratio (r s =0.38) with MC T in SA (P<0.05 for all instances).", {"entities": [[21, 24, "GENE"]]}], ["8-isoprostane concentration correlated with the mast cells in the SA (r s =0.44), there was no correlation for pH or FeNO with cellular distribution in SA.", {"entities": []}], ["Neutrophils, macrophages and mast cells are more prominent in the SA indicating that these cells are involved in the development of small airway dysfunction in smokers.", {"entities": []}], ["Among these cell types, the best correlation was found for mast cells with lung function parameters and inflammatory markers in exhaled breath.", {"entities": []}], ["Furthermore, the observed predominant expression of IL-17A in mast cells warrants further investigation to elucidate their role in smoking-induced lung injury, despite the lack of correlation with lung function and exhaled breath parameters.", {"entities": []}], ["Background.", {"entities": []}], ["The live attenuated influenza vaccine (LAIV) is the preferred vaccine for children, but the mechanisms behind protective immune responses are unclear, and the duration of immunity remains to be elucidated.", {"entities": [[20, 29, "DISEASE"]]}], ["This study reports on the longevity of B-cell and T-cell responses elicited by the LAIV.", {"entities": []}], ["Thirty-eight children (3\u201317 years old) were administered seasonal LAIV.", {"entities": []}], ["Blood samples were collected before vaccination with sequential sampling up to 1 year after vaccination.", {"entities": []}], ["Humoral responses were evaluated by a hemagglutination inhibition assay, and memory B-cell responses were evaluated by an enzyme-linked immunosorbent spot assay (ELISpot).", {"entities": []}], ["T-cell responses were evaluated by interferon \u03b3 (IFN-\u03b3) ELISpot analysis, and intracellular cytokine staining of CD4 Results.", {"entities": [[113, 116, "GENE"]]}], ["LAIV induced significant increases in B-cell and T-cell responses, which were sustained at least 1 year after vaccination.", {"entities": []}], ["Strain variations were observed, in which the B strain elicited stronger responses.", {"entities": []}], ["IFN-\u03b3\u2013expressing T cell counts increased significantly, and remained higher than prevaccination levels 1 year later.", {"entities": []}], ["Expression of T-helper type 1 intracellular cytokines (interleukin 2, IFN-\u03b3, and tumor necrosis factor \u03b1) increased after 1 dose and were boosted after the second dose.", {"entities": []}], ["Hemagglutination inhibition titers were sustained for 1 year.", {"entities": []}], ["Vaccine-induced memory B cell counts were significantly increased, and the response persisted for one year.", {"entities": []}], ["Conclusions.", {"entities": []}], ["LAIV elicited B-cell and T-cell responses that persisted for at least 1 year in children.", {"entities": []}], ["This is a novel finding that will aid future vaccine policy.", {"entities": []}], ["A systematic review and meta-analysis to investigate the impact of electronic nicotine delivery systems (ENDS) and/or electronic non-nicotine delivery systems (ENNDS) versus no smoking cessation aid, or alternative smoking cessation aids, in cigarette smokers on long-term tobacco use.", {"entities": []}], ["Searches of MEDLINE, EMBASE, PsycInfo, CINAHL, CENTRAL and Web of Science up to December 2015.", {"entities": []}], ["Randomised controlled trials (RCTs) and prospective cohort studies.", {"entities": []}], ["Three pairs of reviewers independently screened potentially eligible articles, extracted data from included studies on populations, interventions and outcomes and assessed their risk of bias.", {"entities": []}], ["We used the Grading of Recommendations Assessment, Development and Evaluation approach to rate overall certainty of the evidence by outcome.", {"entities": []}], ["Three randomised trials including 1007 participants and nine cohorts including 13\u2005115 participants proved eligible.", {"entities": []}], ["Results provided by only two RCTs suggest a possible increase in tobacco smoking cessation with ENDS in comparison with ENNDS (RR 2.03, 95% CI 0.94 to 4.38; p=0.07; I There is very limited evidence regarding the impact of ENDS or ENNDS on tobacco smoking cessation, reduction or adverse effects: data from RCTs are of low certainty and observational studies of very low certainty.", {"entities": []}], ["The limitations of the cohort studies led us to a rating of very low-certainty evidence from which no credible inferences can be drawn.", {"entities": []}], ["Lack of usefulness with regard to address the question of e-cigarettes' efficacy on smoking reduction and cessation was largely due to poor reporting.", {"entities": []}], ["This review underlines the need to conduct well-designed trials measuring biochemically validated outcomes and adverse effects.", {"entities": []}], ["Irritable bowel syndrome (IBS) is one of the most common disorders diagnosed by gastroenterologists and a common cause of general practice visits.", {"entities": [[0, 24, "DISEASE"], [16, 24, "DISEASE"]]}], ["Although this disease is not life threatening, patients with IBS seem to be seriously affected in their everyday life.", {"entities": []}], ["The study was designed to explore the pattern of IBS in clinical practice and the impact on the quality of life.", {"entities": []}], ["This is a case control descriptive study.", {"entities": []}], ["117 individuals were included in this study.", {"entities": []}], ["Rome II criteria were used for the diagnosis of IBS.", {"entities": []}], ["Impact of IBS on patient's quality of life was determined by irritable bowel syndrome quality of life (IBS-QOL) questionnaire.", {"entities": [[61, 85, "DISEASE"], [77, 85, "DISEASE"]]}], ["Prevalence of IBS among the study sample was 34.2%.", {"entities": []}], ["10% were IBS-Diarrhea, 37.5% were IBS-Constipation and 52.5% were alternators.", {"entities": []}], ["There is statistical insignificant relationship between IBS (+) and age while it was a significant relation regarding gender (more common among women 80%).", {"entities": []}], ["There is statistical significance relationship between IBS (+) on one hand and marital status and occupational status on the other hand.", {"entities": []}], ["Patients with IBS had statistically significant lower scores for all IBS- QOL domains compared with the control group.", {"entities": []}], ["IBS is a prevalent disorder that affects females more than males and it has significant impacts on work, lifestyle and social well-being.", {"entities": []}], ["Even though the pathogenicity and invasiveness of pneumococcus largely depend on capsular types, the impact of serotypes on post-viral pneumococcal pneumonia is unknown.", {"entities": [[148, 157, "DISEASE"]]}], ["This study was performed to evaluate the impact of capsular serotypes on the development of pneumococcal pneumonia after preceding respiratory viral infections.", {"entities": [[105, 114, "DISEASE"]]}], ["Patients with a diagnosis of pneumococcal pneumonia were identified.", {"entities": [[42, 51, "DISEASE"]]}], ["Pneumonia patients were divided into two groups (post-viral pneumococcal pneumonia versus primary pneumococcal pneumonia), and then their pneumococcal serotypes were compared.", {"entities": [[0, 9, "DISEASE"], [73, 82, "DISEASE"], [111, 120, "DISEASE"]]}], ["Nine hundred and nineteen patients with pneumococcal pneumonia were identified during the study period, including 327 (35.6%) cases with post-viral pneumococcal pneumonia and 592 (64.4%) cases with primary pneumococcal pneumonia.", {"entities": [[53, 62, "DISEASE"], [161, 170, "DISEASE"], [219, 228, "DISEASE"]]}], ["Overall, serotypes 3 and 19A were the most prevalent, followed by serotypes 19F, 6A, and 11A/11E.", {"entities": []}], ["Although relatively uncommon (33 cases, 3.6%), infrequently colonizing invasive serotypes (4, 5, 7F/7A, 8, 9V/9A, 12F, and 18C) were significantly associated with preceding respiratory viral infections (69.7%, P <0.01).", {"entities": []}], ["Multivariate analysis revealed several statistically significant risk factors for post-viral pneumococcal pneumonia: immunodeficiency (OR 1.66; 95% CI, 1.10\u20132.53), chronic lung diseases (OR 1.43; 95% CI, 1.09\u20131.93) and ICI serotypes (OR 4.66; 95% CI, 2.07\u201310.47).", {"entities": [[106, 115, "DISEASE"]]}], ["Infrequently colonizing invasive serotypes would be more likely to cause pneumococcal pneumonia after preceding respiratory viral illness, particularly in patients with immunodeficiency or chronic lung diseases.", {"entities": [[86, 95, "DISEASE"]]}], ["Patients' preferences and expectations should be taken into account in treatment decision making in the last phase of life.", {"entities": []}], ["Shared decision making ( SDM ) is regarded as a way to give the patient a central role in decision making.", {"entities": []}], ["Little is known about how SDM is used in clinical practice in advanced cancer care.", {"entities": [[71, 77, "DISEASE"]]}], ["To examine whether and how the steps of SDM can be recognized in decision making about second\u2010 and third\u2010line chemotherapy.", {"entities": []}], ["Fourteen advanced cancer patients were followed over time using face\u2010to\u2010face in\u2010depth interviews and observations of the patients' out\u2010clinic visits.", {"entities": [[18, 24, "DISEASE"]]}], ["Interviews and outpatient clinic visits in which treatment options were discussed or decisions made were transcribed verbatim and analysed using open coding.", {"entities": []}], ["Patients were satisfied with the decision\u2010making process, but the steps of SDM were barely seen in daily practice.", {"entities": []}], ["The creation of awareness about available treatment options by physicians was limited and not discussed in an equal way.", {"entities": []}], ["Patients' wishes and concerns were not explicitly assessed, which led to different expectations about improved survival from subsequent lines of chemotherapy.", {"entities": []}], ["To reach SDM in daily practice, physicians should create awareness of all treatment options, including forgoing treatment, and communicate the risk of benefit and harm.", {"entities": []}], ["Open and honest communication is needed in which patients' expectations and concerns are discussed.", {"entities": []}], ["Through this, the difficult process of decision making in the last phase of life can be facilitated and the focus on the best care for the specific patient is strengthened.", {"entities": []}], ["Motivation: We investigate and quantify the generalizability of the white blood cell (WBC) transcriptome to the general, multiorgan transcriptome.", {"entities": []}], ["We use data from the NCBI's Gene Expression Omnibus (GEO) public repository to define two datasets for comparison, WBC and OO (Other Organ) sets.", {"entities": []}], ["Results: Comprehensive pair-wise correlation and expression level profiles are calculated for both datasets (with sizes of 81 and 1463, respectively).", {"entities": []}], ["We have used mapping and ranking across the Gene Ontology (GO) categories to quantify similarity between the two sets.", {"entities": []}], ["GO mappings of the most correlated and highly expressed genes from the two datasets tightly match, with the notable exceptions of components of the ribosome, cell adhesion and immune response.", {"entities": []}], ["That is, 10 877 or 48.8% of all measured genes do not change >10% of rank range between WBC and OO; only 878 (3.9%) change rank >50%.", {"entities": []}], ["Two trans -tissue gene lists are defined, the most changing and the least changing genes in expression rank.", {"entities": []}], ["We also provide a general, quantitative measure of the probability of expression rank and correlation profile in the OO system given the expression rank and correlation profile in the WBC dataset.", {"entities": []}], ["Contact: vvaltchinov@partners.org Supplementary information: Supplementary data are available at Bioinformatics online.", {"entities": []}], ["Atopic dermatitis (AD) is a multifactorial inflammatory skin disease resulting from interactions between genetic susceptibility and environmental factors.", {"entities": [[56, 68, "DISEASE"], [7, 17, "DISEASE"]]}], ["The pathogenesis of AD is poorly understood, and the treatment of recalcitrant AD is still challenging.", {"entities": []}], ["There is accumulating evidence for new gene polymorphisms related to the epidermal barrier function and innate and adaptive immunity in patients with AD.", {"entities": []}], ["Newly-found T cells and dendritic cell subsets, cytokines, chemokines and signaling pathways have extended our understanding of the molecular pathomechanism underlying AD.", {"entities": []}], ["Genetic changes caused by environmental factors have been shown to contribute to the pathogenesis of AD.", {"entities": []}], ["We herein present a review of the genetics, epigenetics, barrier dysfunction and immunological abnormalities in AD with a focus on updated molecular biology.", {"entities": []}], ["Treatment options for malignant mesothelioma are limited, and the results with conventional therapies have been rather disappointing to this date.", {"entities": [[22, 44, "DISEASE"]]}], ["Chemotherapy is the only evidence-based treatment for mesothelioma patients in good clinical condition, with an increase in median survival of only 2 months.", {"entities": []}], ["Therefore, there is urgent need for a different approach to battle this malignancy.", {"entities": []}], ["As chronic inflammation precedes mesothelioma, the immune system plays a key role in the initiation of this type of tumour.", {"entities": []}], ["Also, many immunological cell types can be found within the tumour at different stages of the disease.", {"entities": []}], ["However, mesothelioma cells can evade the surveillance capacity of the immune system.", {"entities": []}], ["They build a protective tumour microenvironment to harness themselves against the immune system's attacks, in which they even abuse immune cells to act against the antitumour immune response.", {"entities": []}], ["In our opinion, modulating the immune system simultaneously with the targeting of mesothelioma tumour cells might prove to be a superior treatment.", {"entities": []}], ["However, this strategy is challenging since the tumour microenvironment possesses numerous forms of defence strategies.", {"entities": []}], ["In this paper, we will discuss the interplay between immunological cells that can either inhibit or stimulate tumour growth and the challenges associated with immunotherapy.", {"entities": []}], ["We will provide possible strategies and discuss opportunities to overcome these problems.", {"entities": []}], ["To compare physical activity (PA) in children with juvenile idiopathic arthritis (JIA) with controls and to analyse the effect of disease specific factors on PA in children with JIA treated according to current treatment regimes.", {"entities": [[71, 80, "DISEASE"]]}], ["PA was measured with a 7-day activity diary and expressed as physical activity level (PAL).", {"entities": []}], ["Moderate to vigorous physical activity (MVPA) (hours/day) and sedentary time (hours/day) was determined.", {"entities": []}], ["In children with JIA, medication, the number of swollen and/or painful joints, disease activity, functional ability, pain and well-being was determined.", {"entities": []}], ["Multivariate regression analysis was performed to analyze differences in PA between JIA and controls, adjusted for influences of age, gender, season, Body Mass Index (BMI) and to analyze predictors of PA in JIA patients.", {"entities": []}], ["Seventy-six children with JIA (26 boys and 50 girls, mean\u2009\u00b1\u2009SD age 10.0\u2009\u00b1\u20091.4\u00a0years) and 131 controls (49 boys and 82 girls, mean\u2009\u00b1\u2009SD age 10.4\u2009\u00b1\u20091.2\u00a0years) participated in this study.", {"entities": []}], ["Children with JIA had a significantly lower PAL (0.10, p \u2009=\u20090.01) corrected for age, BMI, gender and season.", {"entities": []}], ["They spent less time in MVPA (0.41\u00a0h/day, p \u2009=\u20090.06) and had a significantly higher mean time spent in sedentary activities (0.59\u00a0h/day, p 0.02) compared to controls.", {"entities": []}], ["The activity level of children with JIA was related to age, gender, season, feeling of well-being and pain.", {"entities": []}], ["Children with JIA have a lower PAL, spent less time in MVPA and spent more time on sedentary activities compared to controls despite current medical treatment and PA encouragement.", {"entities": []}], ["Data of the children with JIA are from the Rheumates@work study ISRCTN92733069 .", {"entities": []}], ["In the present investigation, the effect of Curcuma longa (Cl) and Ocimum sanctum (Os) on myocardial apoptosis and cardiac function was studied in an ischemia and reperfusion (I-R) model of myocardial injury.", {"entities": [[150, 158, "DISEASE"]]}], ["Wistar albino rats were divided into four groups and orally fed saline once daily (sham, control IR) or Cl (100 mg/kg; Cl-IR) or Os (75 mg/kg; Os-IR) respectively for 1 month.", {"entities": []}], ["On the 31 Chronic treatment with Cl significantly reduced TUNEL positivity (p < 0.05), Bax protein (p < 0.001) and upregulated Bcl-2 (p < 0.001) expression in comparison to control IR group.", {"entities": [[87, 90, "GENE"]]}], ["In addition, Cl demonstrated mitigating effects on several myocardial injury induced hemodynamic {(+)LVdP/dt, (-) LVdP/dt & LVEDP} and histopathological perturbations.", {"entities": []}], ["Chronic Os treatment resulted in modest modulation of the hemodynamic alterations (MAP, LVEDP) but failed to demonstrate any significant antiapoptotic effects and prevent the histopathological alterations as compared to control IR group.", {"entities": []}], ["In the present study, significant cardioprotection and functional recovery demonstrated by Cl may be attributed to its anti-apoptotic property.", {"entities": []}], ["In contrast to Os, Cl may attenuate cell death due to apoptosis and prevent the impairment of cardiac performance.", {"entities": []}], ["Background .", {"entities": []}], ["Cognitive deterioration may impair COPD patient's ability to perform tasks like driving vehicles.", {"entities": []}], ["We investigated: (a) whether subclinical neuropsychological deficits occur in stable COPD patients with mild hypoxemia (PaO 2 > 55\u2009mmHg), and (b) whether these deficits affect their driving performance.", {"entities": []}], ["We recruited 35 stable COPD patients and 10 normal subjects matched for age, IQ, and level of education.", {"entities": []}], ["All subjects underwent an attention/alertness battery of tests for assessing driving performance based on the Vienna Test System.", {"entities": []}], ["Pulmonary function tests, arterial blood gases, and dyspnea severity were also recorded.", {"entities": []}], ["COPD patients performed significantly worse than normal subjects on tests suitable for evaluating driving ability.", {"entities": []}], ["Therefore, many (22/35) COPD patients were classified as having inadequate driving ability (failure at least in one of the tests), whereas most (8/10) healthy individuals were classified as safe drivers ( P = 0.029).", {"entities": []}], ["PaO 2 and FEV1 were correlated with almost all neuropsychological tests.", {"entities": []}], ["Conclusions .", {"entities": []}], ["COPD patients should be warned of the potential danger and risk they face when they drive any kind of vehicle, even when they do not exhibit overt symptoms related to driving inability.", {"entities": []}], ["This is due to the fact that stable COPD patients may manifest impaired information processing operations.", {"entities": []}], ["Although the relationship between allergic inflammation and lung carcinogenesis is not clearly defined, several reports suggest an increased incidence of lung cancer in patients with asthma.", {"entities": [[154, 165, "DISEASE"], [183, 189, "DISEASE"], [159, 165, "DISEASE"]]}], ["We aimed at determining the functional impact of allergic inflammation on chemical carcinogenesis in the lungs of mice.", {"entities": []}], ["Balb/c mice received single-dose urethane (1 g/kg at day 0) and two-stage ovalbumin during tumor initiation (sensitization: days -14 and 0; challenge: daily at days 6-12), tumor progression (sensitization: days 70 and 84; challenge: daily at days 90-96), or chronically (sensitization: days -14 and 0; challenge: daily at days 6-12 and thrice weekly thereafter).", {"entities": []}], ["In addition, interleukin (IL)-5 deficient and wild-type C57BL/6 mice received ten weekly urethane injections.", {"entities": []}], ["All mice were sacrificed after four months.", {"entities": []}], ["Primary end-points were number, size, and histology of lung tumors.", {"entities": []}], ["Secondary end-points were inflammatory cells and mediators in the airspace compartment.", {"entities": []}], ["Ovalbumin provoked acute allergic inflammation and chronic remodeling of murine airways, evident by airspace eosinophilia, IL-5 up-regulation, and airspace enlargement.", {"entities": [[109, 121, "DISEASE"]]}], ["Urethane resulted in formation of atypical alveolar hyperplasias, adenomas, and adenocarcinomas in mouse lungs.", {"entities": []}], ["Ovalbumin-induced allergic inflammation during tumor initiation, progression, or continuously did not impact the number, size, or histologic distribution of urethane-induced pulmonary neoplastic lesions.", {"entities": []}], ["In addition, genetic deficiency in IL-5 had no effect on urethane-induced lung tumorigenesis.", {"entities": []}], ["Allergic inflammation does not impact chemical-induced carcinogenesis of the airways.", {"entities": []}], ["These findings suggest that not all types of airway inflammation influence lung carcinogenesis and cast doubt on the idea of a mechanistic link between asthma and lung cancer.", {"entities": [[163, 174, "DISEASE"], [152, 158, "DISEASE"], [168, 174, "DISEASE"]]}], ["The host response to mycobacterial infection depends on host and pathogen genetic factors.", {"entities": []}], ["Recent studies in human populations suggest a strain specific genetic control of tuberculosis.", {"entities": [[81, 93, "DISEASE"]]}], ["To test for mycobacterial-strain specific genetic control of susceptibility to infection under highly controlled experimental conditions, we performed a comparative genetic analysis using the A/J- and C57BL/6J-derived recombinant congenic (RC) mouse panel infected with the Russia and Pasteur strains of Mycobacterium bovis Bacille Calmette Gu\u00e9rin (BCG).", {"entities": []}], ["Bacillary counts in the lung and spleen at weeks 1 and 6 post infection were used as a measure of susceptibility.", {"entities": []}], ["By performing genome-wide linkage analyses of loci that impact on tissue-specific bacillary burden, we were able to show the importance of correcting for strain background effects in the RC panel.", {"entities": []}], ["When linkage analysis was adjusted on strain background, we detected a single locus on chromosome 11 that impacted on pulmonary counts of BCG Russia but not Pasteur.", {"entities": []}], ["The same locus also controlled the splenic counts of BCG Russia but not Pasteur.", {"entities": []}], ["By contrast, a locus on chromosome 1 which was indistinguishable from Nramp1 impacted on splenic bacillary counts of both BCG Russia and Pasteur.", {"entities": []}], ["Additionally, dependent upon BCG strain, tissue and time post infection, we detected 9 distinct loci associated with bacillary counts.", {"entities": []}], ["Hence, the ensemble of genetic loci impacting on BCG infection revealed a highly dynamic picture of genetic control that reflected both the course of infection and the infecting strain.", {"entities": []}], ["This high degree of adaptation of host genetics to strain-specific pathogenesis is expected to provide a suitable framework for the selection of specific host-mycobacteria combinations during co-evolution of mycobacteria with humans.", {"entities": []}], ["Susceptibility to mycobacterial infection results from a complex interaction between host and bacterial genetic factors.", {"entities": []}], ["To examine the effect of host and pathogen genetic variability on the control of mycobacterial infection, we infected a panel of genetically related recombinant congenic (RC) mouse strains with two closely related strains of Mycobacterium bovis BCG.", {"entities": []}], ["Bacterial counts of BCG Russia and BCG Pasteur were determined in the lung and spleen at 1 and 6 weeks following infection and used for genetic analysis.", {"entities": []}], ["A novel analytical approach was developed to perform genome-wide linkage analyses using the RC strains.", {"entities": []}], ["Comparative linkage analysis using this model identified a strong genetic effect on chromosome 1 controlling counts of BCG Pasteur at 1 week and of BCG Russia at 1 week and 6 weeks in the spleen.", {"entities": []}], ["A locus impacting on late BCG Russia counts in the lung and spleen was identified on chromosome 11.", {"entities": []}], ["Nine additional loci were shown to control bacterial counts in a tissue-, time-, and BCG strain-specific manner.", {"entities": []}], ["Our findings suggest that the host genetic control of mycobacterial infection is highly dynamic and adapted to the stage of pathogenesis and to the infecting strain.", {"entities": []}], ["Such a high degree of genetic plasticity in the host-pathogen interplay is expected to favour evolutionary co-adaptation in mycobacterial disease.", {"entities": []}], ["With the increasing prevalence of chronic noncommunicable diseases, patient education is becoming important to strengthen disease prevention and control.", {"entities": []}], ["We aimed to systematically determine the extent to which registered, ongoing randomized controlled trials (RCTs) evaluated an educational intervention focus on patient-important outcomes (i.e., outcomes measuring patient health status and quality of life).", {"entities": []}], ["On May 6, 2009, we searched for all ongoing RCTs registered in the World Health Organization International Clinical Trials Registry platform.", {"entities": []}], ["We used a standardized data extraction form to collect data and determined whether the outcomes assessed were 1) patient-important outcomes such as clinical events, functional status, pain, or quality of life or 2) surrogate outcomes, such as biological outcome, treatment adherence, or patient knowledge.", {"entities": []}], ["We selected 268 of the 642 potentially eligible studies and assessed a random sample of 150.", {"entities": []}], ["Patient-important outcomes represented 54% (178 of 333) of all primary outcomes and 46% (286 of 623) of all secondary outcomes.", {"entities": []}], ["Overall, 69% of trials (104 of 150) used at least one patient-important outcome as a primary outcome and 66% (99 of 150) as a secondary outcome.", {"entities": []}], ["Finally, for 31% of trials (46 of 150), primary outcomes were only surrogate outcomes.", {"entities": []}], ["The results varied by medical area.", {"entities": []}], ["In neuropsychiatric disorders, patient important outcomes represented 84% (51 of 61) of primary outcomes, as compared with 54% (32 of 59) in malignant neoplasm and 18% (4 of 22) in diabetes mellitus trials.", {"entities": [[181, 198, "DISEASE"]]}], ["In addition, only 35% assessed the long-term impact of interventions (i.e., >6 months).", {"entities": []}], ["There is a need to improve the relevance of outcomes and to assess the long term impact of educational interventions in RCTs.", {"entities": []}], ["Low-producing MBL2 genotypes may have increased risk for MRSA co-infection.", {"entities": [[14, 18, "GENE"]]}], ["We compared the prevalence of 8 polymorphisms in the tumor necrosis factor and mannose-binding lectin genes among 105 children and young adults with fatal influenza with US population estimates and determined in subanalyses whether these polymorphisms were associated with sudden death and bacterial co-infection among persons with fatal influenza.", {"entities": [[155, 164, "DISEASE"], [338, 347, "DISEASE"]]}], ["No differences were observed in genotype prevalence or minor allele frequencies between persons with fatal influenza and the reference sample.", {"entities": [[107, 116, "DISEASE"]]}], ["Fatal cases with low-producing MBL2 genotypes had a 7-fold increased risk for invasive methicillin-resistant Staphylococcus aureus (MRSA) co-infection compared with fatal cases with high- and intermediate-producing MBL2 genotypes (odds ratio 7.1, 95% confidence interval 1.6\u201332.1).", {"entities": [[31, 35, "GENE"], [215, 219, "GENE"], [31, 35, "GENE"], [215, 219, "GENE"]]}], ["Limited analysis of 2 genes important to the innate immune response found no association between genetic variants and fatal influenza infection.", {"entities": [[124, 133, "DISEASE"]]}], ["Among children and young adults who died of influenza, low-producing MBL2 genotypes may have increased risk for MRSA co-infection.", {"entities": [[44, 53, "DISEASE"], [69, 73, "GENE"]]}], ["Only a few studies have investigated non-malignant respiratory effects of glass microfibers and these have provided inconsistent results.", {"entities": []}], ["Our objective was to assess the effects of exposure to glass microfibers on respiratory and skin symptoms, asthma and lung function.", {"entities": [[107, 113, "DISEASE"]]}], ["A cross-sectional study of 102 workers from a microfiber factory (response rate 100%) and 76 office workers (73%) from four factories in Thailand was conducted.", {"entities": []}], ["They answered a questionnaire on respiratory health, occupational exposures, and lifestyle factors, and performed spirometry.", {"entities": []}], ["Measurements of respirable dust were available from 2004 and 2005.", {"entities": []}], ["Workers exposed to glass microfibers experienced increased risk of cough (adjusted OR 2.04), wheezing (adjOR 2.20), breathlessness (adjOR 4.46), nasal (adjOR 2.13) and skin symptoms (adjOR 3.89) and ever asthma (adjOR 3.51), the risks of breathlessness (95%CI 1.68\u201311.86) and skin symptoms (1.70\u20138.90) remaining statistically significant after adjustment for confounders.", {"entities": [[204, 210, "DISEASE"]]}], ["There was an exposure-response relation between the risk of breathlessness and skin symptoms and increasing level of microfiber exposure.", {"entities": []}], ["Workers exposed to sensitizing chemicals, including phenol-formaldehyde resin, experienced increased risk of cough (3.43, 1.20\u20139.87) and nasal symptoms (3.07, 1.05\u20139.00).", {"entities": []}], ["This study provides evidence that exposure to glass microfibers increases the risk of respiratory and skin symptoms, and has an exposure-response relation with breathlessness and skin symptoms.", {"entities": []}], ["Exposure to sensitizing chemicals increased the risk of cough and nasal symptoms.", {"entities": []}], ["The results suggest that occupational exposure to glass microfibers is related to non-malignant adverse health effects, and that implementing exposure control measures in these industries could protect the health of employees.", {"entities": []}], ["The Acne Priority Setting Partnership (PSP) was set up to identify and rank treatment uncertainties by bringing together people with acne, and professionals providing care within and beyond the National Health Service (NHS).", {"entities": [[4, 8, "DISEASE"], [133, 137, "DISEASE"], [219, 222, "GENE"]]}], ["The UK with international participation.", {"entities": []}], ["Teenagers and adults with acne, parents, partners, nurses, clinicians, pharmacists, private practitioners.", {"entities": [[26, 30, "DISEASE"]]}], ["Treatment uncertainties were collected via separate online harvesting surveys, embedded within the PSP website, for patients and professionals.", {"entities": []}], ["A wide variety of approaches were used to promote the surveys to stakeholder groups with a particular emphasis on teenagers and young adults.", {"entities": []}], ["Survey submissions were collated using keywords and verified as uncertainties by appraising existing evidence.", {"entities": []}], ["The 30 most popular themes were ranked via weighted scores from an online vote.", {"entities": []}], ["At a priority setting workshop, patients and professionals discussed the 18 highest-scoring questions from the vote, and reached consensus on the top 10.", {"entities": []}], ["In the harvesting survey, 2310 people, including 652 professionals and 1456 patients (58% aged 24 y or younger), made submissions containing at least one research question.", {"entities": []}], ["After checking for relevance and rephrasing, a total of 6255 questions were collated into themes.", {"entities": []}], ["Valid votes ranking the 30 most common themes were obtained from 2807 participants.", {"entities": []}], ["The top 10 uncertainties prioritised at the workshop were largely focused on management strategies, optimum use of common prescription medications and the role of non-drug based interventions.", {"entities": []}], ["More female than male patients took part in the harvesting surveys and vote.", {"entities": []}], ["A wider range of uncertainties were provided by patients compared to professionals.", {"entities": []}], ["Engaging teenagers and young adults in priority setting is achievable using a variety of promotional methods.", {"entities": []}], ["The top 10 uncertainties reveal an extensive knowledge gap about widely used interventions and the relative merits of drug versus non-drug based treatments in acne management.", {"entities": [[159, 163, "DISEASE"]]}], ["Guidelines for management of chronic obstructive pulmonary disease (COPD) primarily focus on the prevention of weight loss, while overweight and obesity are highly prevalent in patients with milder stages of COPD.", {"entities": [[29, 66, "DISEASE"], [145, 152, "DISEASE"]]}], ["This cross-sectional study examines the association of overweight and obesity with the prevalence of comorbid disorders and prescribed medication for obstructive airway disease, in patients with mild to moderate COPD.", {"entities": [[70, 77, "DISEASE"]]}], ["Data were used from electronic health records of 380 Dutch general practices in 2014.", {"entities": []}], ["In total, we identified 4938 patients with mild or moderate COPD based on spirometry data, and a recorded body mass index (BMI) of \u226521\u2009kg/m Doctors should pay more attention to weight management in patients with mild chronic lung disease, say researchers in the Netherlands.", {"entities": [[225, 237, "DISEASE"]]}], ["While guidelines for treating chronic obstructive pulmonary disease (COPD) focus primarily on preventing weight-loss in severe COPD, around 65 per cent of patients with mild COPD are overweight or obese.", {"entities": [[30, 67, "DISEASE"]]}], ["Excessive weight exacerbates symptoms and triggers co-morbidities, and so can impact heavily on COPD healthcare provision.", {"entities": []}], ["Lisa Verberne and co-workers at the Netherlands Institute for Health Services Research analyzed data from 315 Dutch general practices in 2014, identifying 3404 patients were classified as overweight or obese and 1534 as normal weight.", {"entities": []}], ["So in total 4938 patients were identified.", {"entities": []}], ["The team compared this cohort with COPD patients of normal weight, and found they were at higher risk of diabetes, osteoarthritis and hypertension.", {"entities": [[134, 146, "DISEASE"], [115, 129, "DISEASE"]]}], ["Obese patients were also at risk of heart failure and were prescribed more medication for COPD.", {"entities": []}], ["Rheumatoid arthritis (RA) is an autoimmune disease characterised by the destruction of articular cartilage and bone damage.", {"entities": [[11, 20, "DISEASE"]]}], ["The chronic treatment of RA patients causes a higher susceptibility to infectious diseases such as tuberculosis (TB); one-third of the world\u2019s population is latently infected (LTBI) with Mycobacterium tuberculosis (Mtb).", {"entities": [[99, 111, "DISEASE"], [201, 213, "DISEASE"]]}], ["The tuberculin skin test is used to identify individuals LTBI, but many studies have shown that this test is not suitable for RA patients.", {"entities": []}], ["The goal of this work was to test the specific cellular immune responses to the Mtb malate synthase (GlcB) and heat shock protein X (HspX) antigens of RA patients and to correlate those responses with LTBI status.", {"entities": []}], ["The T-helper (Th)1, Th17 and Treg-specific immune responses to the GlcB and HspX Mtb antigens were analysed in RA patients candidates for tumour necrosis factor-\u03b1 blocker treatment.", {"entities": []}], ["Our results demonstrated that LTBI RA patients had Th1-specific immune responses to GlcB and HspX.", {"entities": []}], ["Patients were followed up over two years and 14.3% developed active TB.", {"entities": []}], ["After the development of active TB, RA patients had increased numbers of Th17 and Treg cells, similar to TB patients.", {"entities": []}], ["These results demonstrate that a GlcB and HspX antigen assay can be used as a diagnostic test to identify LTBI RA patients.", {"entities": []}], ["New therapeutic approaches are sorely needed for acute lung injury.", {"entities": []}], ["Neutrophil recruitment is a pathological hallmark of this syndrome, and is mainly regulated by CXC chemokine receptor 2 and its ligand CXC ligand 1.", {"entities": [[58, 66, "DISEASE"]]}], ["Rossaint and colleagues have described a new mechanism for regulation of this axis by 12/15-lipoxygenase products.", {"entities": []}], ["This work opens the door for new therapeutic approaches and highlights the crucial interplay between lipid mediators and chemokines, a time-honored but often-ignored concept.", {"entities": []}], ["Vanadium pentoxide (V 2 O 5 ) exposure is a cause of occupational bronchitis and airway fibrosis.", {"entities": [[66, 76, "DISEASE"]]}], ["Respiratory syncytial virus (RSV) is a ubiquitous pathogen that causes airway inflammation.", {"entities": []}], ["It is unknown whether individuals with pre-existing respiratory viral infection are susceptible to V 2 O 5 -induced bronchitis.", {"entities": [[116, 126, "DISEASE"]]}], ["We hypothesized that respiratory viral infection will exacerbate vanadium-induced lung fibrosis.", {"entities": []}], ["In this study we investigated the effect of RSV pre- or post-exposure to V 2 O 5 in male AKR mice.", {"entities": []}], ["Mice were pre-exposed by intranasal aspiration to RSV or media vehicle prior to intranasal aspiration of V 2 O 5 or saline vehicle at day 1 or day 7.", {"entities": []}], ["A parallel group of mice were treated first with V 2 O 5 or saline vehicle at day 1 and day 7 then post-exposed to RSV or media vehicle at day 8.", {"entities": []}], ["V 2 O 5 -induced airway inflammation and fibrosis were decreased by RSV pre- or post-exposure.", {"entities": []}], ["Real time quantitative RT-PCR showed that V 2 O 5 significantly increased lung mRNAs encoding pro-fibrogenic growth factors (TGF-\u03b21, CTGF, PDGF-C) and collagen (Col1A2), but also increased mRNAs encoding anti-fibrogenic type I interferons (IFN-\u03b1, -\u03b2) and IFN-inducible chemokines (CXCL9 and CXCL10).", {"entities": [[133, 137, "GENE"], [161, 167, "GENE"], [281, 286, "GENE"], [291, 297, "GENE"]]}], ["RSV pre- or post-exposure caused a significantly reduced mRNAs of pro-fibrogenic growth factors and collagen, yet reduced RNA levels of anti-fibrogenic interferons and CXC chemokines.", {"entities": []}], ["Collectively these data suggest that RSV infection reduces the severity of V 2 O 5 -induced fibrosis by suppressing growth factors and collagen genes.", {"entities": []}], ["However, RSV suppression of V 2 O 5 -induced IFNs and IFN-inducible chemokines suggests that viral infection also suppresses the innate immune response that normally serves to resolve V 2 O 5 -induced fibrosis.", {"entities": []}], ["During April 2009\u2013June 2010, thirty-seven (0.5%) of 6,740 pandemic (H1N1) 2009 viruses submitted to a US surveillance system were oseltamivir resistant.", {"entities": []}], ["Most patients with oseltamivir-resistant infections were severely immunocompromised (76%) and had received oseltamivir before specimen collection (89%).", {"entities": []}], ["No evidence was found for community circulation of resistant viruses; only 4 (unlinked) patients had no oseltamivir exposure.", {"entities": []}], ["Lung clearance index (LCI) is a measure of abnormal ventilation distribution derived from the multiple breath inert gas washout (MBW) technique.", {"entities": []}], ["We aimed to determine the clinical utility of LCI in non-CF bronchiectasis, and to assess two novel MBW parameters that distinguish between increases in LCI due to specific ventilation inequality (LCI vent ) and increased respiratory dead space (LCI ds ).", {"entities": [[60, 74, "DISEASE"]]}], ["Forty-three patients with non-CF bronchiectasis and 18 healthy control subjects underwent MBW using the sulphur hexafluoride wash-in technique, and data from 40 adults with CF were re-analysed.", {"entities": [[33, 47, "DISEASE"]]}], ["LCI vent and LCI ds were calculated using a theoretical two-compartment lung model, and represent the proportional increase in LCI above its ideal value due to specific ventilation inequality and increased respiratory dead space, respectively.", {"entities": []}], ["LCI was significantly raised in patients with non-CF bronchiectasis compared to healthy controls (9.99 versus 7.28, p\u2009<\u20090.01), and discriminated well between these two groups (area under receiver operating curve\u2009=\u20090.90, versus 0.83 for forced expiratory volume in one second [% predicted]).", {"entities": [[53, 67, "DISEASE"]]}], ["LCI, LCI vent and LCI ds were repeatable (intraclass correlation coefficient\u2009>\u20090.75), and correlated significantly with measures of spirometric airflow obstruction.", {"entities": []}], ["LCI is repeatable, discriminatory, and is associated with spirometric airflow obstruction in patients with non-CF bronchiectasis.", {"entities": [[114, 128, "DISEASE"]]}], ["LCI vent and LCI ds are a practical and repeatable alternative to phase III slope analysis and may allow a further level of mechanistic information to be extracted from the MBW test in patients with severe ventilation heterogeneity.", {"entities": []}], ["Hyperventilation has been linked to emotional distress in adults.", {"entities": []}], ["This study investigates end-tidal carbon dioxide (ETCO 2 ), respiratory rate (RR), and heart rate variability (HRV) in adolescent girls with emotional disorders and healthy controls.", {"entities": []}], ["ETCO 2 , RR, HRV, and ratings of emotional symptom severity were collected in adolescent female psychiatric patients with emotional disorders ( n \u2009=\u200963) and healthy controls ( n \u2009=\u200962).", {"entities": []}], ["ETCO 2 and RR differed significantly between patients and controls.", {"entities": []}], ["ETCO 2 , HR, and HRV were significant independent predictors of group status, that is, clinical or healthy, while RR was not.", {"entities": [[9, 11, "GENE"]]}], ["ETCO 2 and RR were significantly related to emotional symptom severity and to HRV in the total group.", {"entities": []}], ["ETCO 2 and RR were not affected by use of selective serotonin reuptake inhibitors.", {"entities": []}], ["It is concluded that emotional dysregulation is related to hyperventilation in adolescent girls.", {"entities": []}], ["Respiratory-based treatments may be relevant to investigate in future research.", {"entities": []}], ["There is increasing evidence that prevention programmes for type 2 diabetes mellitus (T2DM) and obesity need to consider individual and regional risk factors.", {"entities": [[96, 103, "DISEASE"], [67, 84, "DISEASE"], [60, 84, "DISEASE"]]}], ["Our objective is to assess the independent association of area level deprivation with T2DM and obesity controlling for individual risk factors in a large study covering the whole of Germany.", {"entities": [[95, 102, "DISEASE"]]}], ["We combined data from two consecutive waves of the national health interview survey \u2018GEDA\u2019 conducted by the Robert Koch Institute in 2009 and 2010.", {"entities": []}], ["Data collection was based on computer-assisted telephone interviews.", {"entities": []}], ["After exclusion of participants <30 years of age and those with missing responses, we included n\u200a=\u200a33,690 participants in our analyses.", {"entities": []}], ["The outcome variables were the 12-month prevalence of known T2DM and the prevalence of obesity (BMI \u226530 kg/m Of all men and women living in the most deprived areas, 8.6% had T2DM and 16.9% were obese (least deprived areas: 5.8% for T2DM and 13.7% for obesity).", {"entities": [[87, 94, "DISEASE"], [251, 258, "DISEASE"]]}], ["For women, higher area level deprivation and lower educational level were both independently associated with higher T2DM and obesity prevalence [highest area level deprivation: OR 1.28 (95% CI: 1.05\u20131.55) for T2DM and OR 1.28 (95% CI: 1.10\u20131.49) for obesity].", {"entities": [[125, 132, "DISEASE"], [250, 257, "DISEASE"]]}], ["For men, a similar association was only found for obesity [OR 1.20 (95% CI: 1.02\u20131.41)], but not for T2DM.", {"entities": [[50, 57, "DISEASE"]]}], ["Area level deprivation is an independent, important determinant of T2DM and obesity prevalence in Germany.", {"entities": [[76, 83, "DISEASE"]]}], ["Identifying and targeting specific area-based risk factors should be considered an essential public health issue relevant to increasing the effectiveness of diabetes and obesity prevention.", {"entities": [[170, 177, "DISEASE"]]}], ["Potential functional allele T/C single nucleotide polymorphism (SNP) of Interleukin 10 (IL-10) promoter -819 (rs1800871) has been implicated in gastric cancer risk.", {"entities": [[152, 158, "DISEASE"]]}], ["We aimed to explore the role of T/C SNP of IL-10 -819 in the susceptibility to gastric cancer through a systematic review and meta-analysis.", {"entities": [[87, 93, "DISEASE"]]}], ["Each initially included article was scored for quality appraisal.", {"entities": []}], ["Desirable data were extracted and registered into databases.", {"entities": []}], ["11 studies were ultimately eligible for the meta-analysis of IL-10 -819 T/C SNP.", {"entities": []}], ["We adopted the most probably appropriate genetic model (recessive model).", {"entities": []}], ["Potential sources of heterogeneity were sought out via subgroup and sensitivity analyses, and publication biases were estimated.", {"entities": []}], ["IL-10 -819 TT genotype is associated with the overall reduced gastric cancer risk among Asians and even apparently observed among high quality subgroup Asians.", {"entities": [[70, 76, "DISEASE"]]}], ["IL-10-819 TT genotype is not statistically associated with the overall reduced gastric cancer susceptibility in persons with H. pylori infection compared with controls without H. pylori infection.", {"entities": [[87, 93, "DISEASE"]]}], ["IL-10 -819 TT genotype is reversely associated with diffuse-subtype risk but not in intestinal-subtype risk.", {"entities": []}], ["IL-10 -819 TT genotype is not reversely associated with non-cardia or cardia subtype gastric cancer susceptibility.", {"entities": [[93, 99, "DISEASE"]]}], ["IL-10 -819 TT genotype seems to be more protective from gastric cancer in Asians.", {"entities": [[64, 70, "DISEASE"]]}], ["Whether IL-10 -819 TT genotype may be protective from gastric cancer susceptibility in persons infected with H. pylori or in diffuse-subtype cancer needs further exploring in the future well-designed high quality studies among different ethnicity populations.", {"entities": [[62, 68, "DISEASE"], [141, 147, "DISEASE"]]}], ["Direct sequencing should be more used in the future.", {"entities": []}], ["Although pregnancy is considered as a physiological state, most pregnant women in developed countries receive multiple medications to prevent maternal or neonatal complications, with antibiotics among the most frequently prescribed.", {"entities": []}], ["During pregnancy, antibiotics are often prescribed in the context of preterm labor, intrapartum fever, prevention of neonatal Group B Streptococcus fever, and cesarean section.", {"entities": []}], ["Outside this period, they are commonly prescribed in the community setting for respiratory, urinary, and ear, nose and throat infection symptoms.", {"entities": []}], ["Whereas some of the current indications have insightful reasons to justify their use, potential risks related to overuse and misuse may surpass the benefits.", {"entities": []}], ["Of note, the recent 2014 World Health Assembly expressed serious concern regarding antibiotic resistance due to antibiotic overuse and misuse and urged immediate action to combat antibiotic resistance on a global scale.", {"entities": []}], ["Most studies in the obstetrics field have focused on the benefits of antibiotics for short-term maternal and neonatal complications, but with very little (if any) interest in long-term consequences.", {"entities": []}], ["The aim of this study was to assess the association of lung function with serum fatty-acid binding protein 4 (FABP4) in apparently healthy Korean adults.", {"entities": [[110, 115, "GENE"]]}], ["In 495 participants in a health screening program, Force Exploratory Volume (FEV) 1 and Forced Vital Capacity (FVC) were assessed with standard spirometry.", {"entities": [[77, 80, "GENE"]]}], ["Subjects with obstructive ( n \u2009=\u200919) and restrictive ( n \u2009=\u200945) lung function were excluded from the analysis.", {"entities": []}], ["Serum FABP4 level was measured by enzyme-linked immunosorbent assay and transformed into Ln(FABP4).", {"entities": [[6, 11, "GENE"], [92, 97, "GENE"], [6, 11, "GENE"], [92, 97, "GENE"]]}], ["431 subjects with normal ventilator function (72.4\u00a0% men, mean age 41\u00a0years) were included in the final analysis.", {"entities": []}], ["Mean Ln(FABP4) significantly decreased in subjects from 1 p \u2009=\u20090.008).", {"entities": [[8, 13, "GENE"]]}], ["Ln(FABP4) did not show significant differences across the quartile groups of FEV1.", {"entities": [[3, 8, "GENE"]]}], ["The odds ratio (OR) of being in the lowest quartile of FVC was 2.704 in subject with 3 Increased FABP4 level showed increased risk for reduced lung function in subjects with normal ventilatory function.", {"entities": [[97, 102, "GENE"]]}], ["The online version of this article (doi:10.1186/s12890-016-0190-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["1,25-Dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ] has recently been found to be involved in the development of autoimmune diseases.", {"entities": []}], ["This study was to investigate the expression and potential role of 1,25(OH) 2 D 3 in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.", {"entities": []}], ["Blood samples were obtained from VKH patients and healthy individuals.", {"entities": []}], ["Serum 1,25(OH) 2 D 3 levels were measured using ELISA.", {"entities": []}], ["Peripheral blood mononuclear cells (PBMCs) or cluster of differentiation (CD) 4 2 D 3 in the presence of anti-CD3 and anti-CD28 for the measurement of cell proliferation and cytokines.", {"entities": []}], ["The cell proliferation was detected using the Cell Counting Kit.", {"entities": []}], ["The levels of interleukin (IL)-17 and interferon (IFN)-\u03b3 levels in the supernatants of PBMCs or CD4 1,25(OH) 2 D 3 was significantly decreased in the serum of active VKH patients as compared with inactive VKH patients and controls.", {"entities": [[96, 99, "GENE"]]}], ["It significantly inhibited PBMCs proliferation and CD4 These findings suggest that decreased expression of 1,25(OH) 2 D 3 may be involved in the development of VKH disease.", {"entities": [[51, 54, "GENE"]]}], ["1,25(OH) 2 D 3 may be potentially used in the treatment of this disease.", {"entities": []}], ["B-Cell Activating Factor (BAFF) is a cytokine regulating antibody production.", {"entities": []}], ["Polymorphisms in the gene encoding BAFF were associated with the antibody response to Ascaris but not to mite allergens.", {"entities": []}], ["In the present study we evaluated the relationship between BAFF and specific antibodies against Ascaris and mites in 448 controls and 448 asthmatics.", {"entities": []}], ["Soluble BAFF was measured by ELISA and BAFF mRNA by qPCR.", {"entities": []}], ["Surface expression of BAFF and its receptor (BAFF-R) was analyzed by flow cytometry.", {"entities": []}], ["Individuals with specific IgE levels to Ascaris >75th percentile had lower levels of soluble BAFF; those with specific IgG levels to Ascari s >75th percentile had reduced BAFF mRNA.", {"entities": []}], ["Total IgE and specific IgE to mites were not related to BAFF levels.", {"entities": []}], ["There were no differences in soluble BAFF or mRNA levels between asthmatics and controls.", {"entities": []}], ["There was an inverse relationship between the cell-surface expression of BAFF-R on CD19 These findings suggest that differences in BAFF levels are related to the strength of the antibody response to Ascaris .", {"entities": [[83, 87, "GENE"]]}], ["Severe status asthmaticus (SA) in children may require intubation and mechanical ventilation with a subsequent increased risk of death.", {"entities": [[7, 25, "DISEASE"]]}], ["In the patient with SA and refractory hypercapnoeic respiratory failure, use of extracorporeal life support (ECLS) has been anecdotally reported for carbon dioxide removal and respiratory support.", {"entities": [[52, 71, "DISEASE"]]}], ["We aimed to review the experience of a single paediatric centre with the use of ECLS in children with severe refractory SA, and to compare this with international experience from the Extracorporeal Life Support Organization (ELSO) registry.", {"entities": []}], ["All paediatric patients (aged from 1 to 17 years) with primary International Classification of Diseases (ICD)-9 diagnoses of SA receiving ECLS for respiratory failure from both the Children's Healthcare of Atlanta at Egleston (Children's at Egleston) database and the ELSO registry were reviewed.", {"entities": [[147, 166, "DISEASE"]]}], ["Thirteen children received ECLS for refractory SA at the Children's at Egleston from 1986 to 2007.", {"entities": []}], ["The median age of the children was 10 years (range 1 to 16 years).", {"entities": []}], ["Patients generally received aggressive use of medical and anaesthetic therapies for SA before cannulation with a median partial pressure of arterial carbon dioxide (PaCO 2 ) of 130 mmHg (range 102 to 186 mmHg) and serum pH 6.89 (range 6.75 to 7.03).", {"entities": []}], ["The median time of ECLS support was 95 hours (range 42 to 395 hours).", {"entities": []}], ["All 13 children survived without neurological sequelae.", {"entities": []}], ["An ELSO registry review found 64 children with SA receiving ECLS during the same time period (51 excluding the Children's at Egleston cohort).", {"entities": []}], ["Median age, pre-ECLS PaCO 2 and pH were not different in non-Children's ELSO patients.", {"entities": []}], ["Overall survival was 60 of 64 (94%) children, including all 13 from the Children's at Egleston cohort.", {"entities": []}], ["Survival was not significantly associated with age, pre-ECLS PaCO 2 , pH, cardiac arrest, mode of cannulation or time on ECLS.", {"entities": []}], ["Significant neurological complications were noted in 3 of 64 (4%) patients; patients with neurological complications were not significantly more likely to die ( P = 0.67).", {"entities": []}], ["Single centre and ELSO registry experience provide results of a cohort of children with refractory SA managed with ECLS support.", {"entities": []}], ["Further study is necessary to determine if use of ECLS in this setting produces better outcomes than careful mechanical ventilation and medical therapy alone.", {"entities": []}], ["The type I interferon (IFN) system is a first line of defense against viral infections.", {"entities": []}], ["Viruses have developed various mechanisms to counteract this response.", {"entities": []}], ["So far, the interferon antagonistic activity of influenza A viruses was mainly observed on the level of IFN\u03b2 gene induction via action of the viral non-structural protein 1 (NS1).", {"entities": [[48, 57, "DISEASE"]]}], ["Here we present data indicating that influenza A viruses not only suppress IFN\u03b2 gene induction but also inhibit type I IFN signaling through a mechanism involving induction of the suppressor of cytokine signaling-3 (SOCS-3) protein.", {"entities": [[37, 46, "DISEASE"]]}], ["Our study was based on the observation that in cells that were infected with influenza A virus and subsequently stimulated with IFN\u03b1/\u03b2, phosphorylation of the signal transducer and activator of transcription protein 1 (STAT1) was strongly reduced.", {"entities": [[77, 86, "DISEASE"], [219, 224, "GENE"]]}], ["This impaired STAT1 activation was not due to the action of viral proteins but rather appeared to be induced by accumulation of viral 5\u2032 triphosphate RNA in the cell.", {"entities": [[14, 19, "GENE"]]}], ["SOCS proteins are potent endogenous inhibitors of Janus kinase (JAK)/STAT signaling.", {"entities": []}], ["Closer examination revealed that SOCS-3 but not SOCS-1 mRNA levels increase in an RNA- and nuclear factor kappa B (NF-\u03baB)-dependent but type I IFN-independent manner early in the viral replication cycle.", {"entities": [[48, 54, "GENE"]]}], ["This direct viral induction of SOCS-3 mRNA and protein expression appears to be relevant for suppression of the antiviral response since in SOCS-3 deficient cells a sustained phosphorylation of STAT1 correlated with elevated expression of type I IFN-dependent genes.", {"entities": [[194, 199, "GENE"]]}], ["As a consequence, progeny virus titers were reduced in SOCS-3 deficient cells or in cells were SOCS-3 expression was knocked-down by siRNA.", {"entities": []}], ["These data provide the first evidence that influenza A viruses suppress type I IFN signaling on the level of JAK/STAT activation.", {"entities": [[43, 52, "DISEASE"]]}], ["The inhibitory effect is at least in part due to the induction of SOCS-3 gene expression, which results in an impaired antiviral response.", {"entities": []}], ["The type I interferon (IFN) system is one of the most powerful innate defenses against viral pathogens.", {"entities": []}], ["Most RNA viruses are sensitive to the action of type I IFN.", {"entities": []}], ["Therefore, these pathogens have evolved strategies to evade this response.", {"entities": []}], ["For example, influenza viruses express a viral protein, the non-structural protein 1 (NS1), that suppresses production of IFN\u03b2 by lowering cellular sensitivity to viral nucleic acid as a pathogen pattern.", {"entities": [[13, 22, "DISEASE"]]}], ["Here we present data indicating that influenza A viruses are not only capable of suppressing production of the IFN\u03b2 gene but also inhibit action of this antiviral cytokine on cells.", {"entities": [[37, 46, "DISEASE"]]}], ["This occurs by viral induction of a cellular protein, the suppressor of cytokine signaling (SOCS)-3, a potent endogenous inhibitor of IFN signaling.", {"entities": []}], ["This is a novel mechanism by which influenza viruses inhibit the antiviral response of the host and paves the path to efficient virus replication.", {"entities": [[35, 44, "DISEASE"]]}], ["This may be especially relevant for influenza viruses that induce high cytokine responses (cytokine burst), such as highly pathogenic avian influenza viruses of the H5N1 subtype.", {"entities": [[36, 45, "DISEASE"], [140, 149, "DISEASE"], [134, 149, "DISEASE"]]}], ["Induction of SOCS-3 expression would allow efficient replication despite high IFN and cytokine levels.", {"entities": []}], ["Infections with filamentous fungi are common to all animals, but attention is rising especially due to the increasing incidence and high mortality rates observed in immunocompromised human individuals.", {"entities": []}], ["Here, Aspergillus fumigatus and other members of its genus are the leading causative agents.", {"entities": []}], ["Attributes like their saprophytic life-style in various ecological niches coupled with nutritional flexibility and a broad host range have fostered the hypothesis that environmental predators could have been the actual target for some of their virulence determinants.", {"entities": []}], ["In this mini review, we have merged the recent findings focused on the potential dual-use of fungal defense strategies against innate immune cells and soil amoebae as natural phagocytes.", {"entities": []}], ["Well-established virulence attributes like the melanized surface of fungal conidia or their capacity to produce toxic secondary metabolites have also been found to be protective against the model amoeba Dictyostelium discoideum .", {"entities": []}], ["Some of the recent advances during interaction studies with human cells have further promoted the adaptation of other amoeba infection models, including the wide-spread generalist Acanthamoeba castellanii , or less prominent representatives like Vermamoeba vermiformis .", {"entities": []}], ["We further highlight prospects and limits of these natural phagocyte models with regard to the infection biology of filamentous fungi and in comparison to the phagocytes of the innate immune system.", {"entities": []}], ["Ethnic minority groups usually have a more unfavourable disease risk profile than the host population.", {"entities": []}], ["In Europe, ethnic inequalities in health have been observed in relatively small studies, with limited possibilities to explore underlying causes.", {"entities": []}], ["The aim of the Healthy Life in an Urban Setting (HELIUS) study is to investigate the causes of (the unequal burden of) diseases across ethnic groups, focusing on three disease categories: cardiovascular diseases, mental health and infectious diseases.", {"entities": []}], ["The HELIUS study is a prospective cohort study among six large ethnic groups living in Amsterdam, the Netherlands.", {"entities": []}], ["Between 2011 and 2015, a total 24\u2009789 participants (aged 18\u201370 years) were included at baseline.", {"entities": []}], ["Similar-sized samples of individuals of Dutch, African Surinamese, South-Asian Surinamese, Ghanaian, Turkish and Moroccan origin were included.", {"entities": []}], ["Participants filled in an extensive questionnaire and underwent a physical examination that included the collection of biological samples (biobank).", {"entities": []}], ["Data on physical, behavioural, psychosocial and biological risk factors, and also ethnicity-specific characteristics (eg, culture, migration history, ethnic identity, socioeconomic factors and discrimination) were collected, as were measures of health outcomes (cardiovascular, mental health and infections).", {"entities": []}], ["The first results have confirmed large inequalities in health between ethnic groups, such as diabetes and depressive symptoms, and also early markers of disease such as arterial wave reflection and chronic kidney disease, which can only just partially be explained by inequalities in traditional risk factors, such as obesity and socioeconomic status.", {"entities": [[206, 220, "DISEASE"], [318, 325, "DISEASE"]]}], ["In addition, the first results provided important clues for targeting prevention and healthcare.", {"entities": []}], ["HELIUS will be used for further research on the underlying causes of ethnic differences in health.", {"entities": []}], ["Follow-up data will be obtained by repeated measurements and by linkages with existing registries (eg, hospital data, pharmacy data and insurance data).", {"entities": []}], ["Brain-Derived Neurotrophic Factor (BDNF) has attracted increasing interest as potential biomarker to support the diagnosis or monitor the efficacy of therapies in brain disorders.", {"entities": [[35, 39, "GENE"]]}], ["Circulating BDNF can be measured in serum, plasma or whole blood.", {"entities": [[12, 16, "GENE"]]}], ["However, the use of BDNF as biomarker is limited by the poor reproducibility of results, likely due to the variety of methods used for sample collection and BDNF analysis.", {"entities": [[20, 24, "GENE"], [157, 161, "GENE"], [20, 24, "GENE"], [157, 161, "GENE"]]}], ["To overcome these limitations, using sera from 40 healthy adults, we compared the performance of five ELISA kits (Aviscera-Bioscience, Biosensis, Millipore-ChemiKine", {"entities": []}], ["Climate change represents a significant and growing threat to population health.", {"entities": []}], ["Rural areas face unique challenges, such as high rates of vulnerable populations; economic uncertainty due to their reliance on industries that are vulnerable to climate change; less resilient infrastructure; and lower levels of access to community and emergency services than urban areas.", {"entities": []}], ["This article fills a gap in public health practice by developing climate and health environmental public health indicators for a local public health department in a rural area.", {"entities": []}], ["We adapted the National Environmental Public Health Tracking Network's framework for climate and health indicators to a seven-county health department in Western Kentucky.", {"entities": []}], ["Using a three-step review process, we identified primary climate-related environmental public health hazards for the region (extreme heat, drought, and flooding) and a suite of related exposure, health outcome, population vulnerability, and environmental vulnerability indicators.", {"entities": []}], ["Indicators that performed more poorly at the county level than at the state and national level were defined as \u201chigh vulnerability.\u201d Six to eight high vulnerability indicators were identified for each county.", {"entities": []}], ["The local health department plans to use the results to enhance three key areas of existing services: epidemiology, public health preparedness, and community health assessment.", {"entities": []}], ["Patients admitted to a 30 bedded acute geriatric medical ward in 1993 were followed up to discharge.", {"entities": []}], ["The admission rate on weekend days was half that for weekdays.", {"entities": []}], ["Six percent of ward discharges occurred at weekends, over half being due to death.", {"entities": []}], ["Respiratory, cardiovascular and central nervous systems disorders were the commonest reasons for admission (56%) and death (73%).", {"entities": []}], ["Greater emphasis should be placed on discharging patients at weekends.", {"entities": []}], ["Individuals <2\u00a0years and \u226550\u00a0years of age, as well as those with other specific risk factors, are especially vulnerable to invasive pneumococcal disease (IPD).", {"entities": []}], ["Conjugate vaccines have been developed against encapsulated bacteria such as Streptococcus pneumoniae to provide improved immune responses.", {"entities": []}], ["The 7-valent pneumococcal conjugate vaccine (PCV7) has significantly reduced the burden of vaccine-type pneumococcal diseases in children, including invasive disease and pneumonia and acute otitis media.", {"entities": [[190, 202, "DISEASE"], [170, 179, "DISEASE"]]}], ["There have also been significant declines in antimicrobial resistance in 7-valent vaccine serotypes and carriage of S. pneumoniae in the post-PCV7 era.", {"entities": []}], ["Two to three\u00a0years after the introduction of PCV13, there is emerging, global evidence of a reduced burden of pneumococcal diseases in children, including declines in IPD (UK and Germany) and nasopharyngeal carriage of PCV13 serotypes (Portugal and France).", {"entities": []}], ["The functional immunogenicity of PCV13 in individuals \u226550\u00a0years of age has been demonstrated in clinical trials in comparison with the 23-valent pneumococcal polysaccharide vaccine and for children and adults 6 to 49\u00a0years of age.", {"entities": []}], ["Between 2011 and 2013, PCV13 received market authorisation by the European Medicines Agency (EMA) for these additional age groups and is now available in Europe for the prevention of pneumococcal disease in all age groups.", {"entities": []}], ["Mild hypoxia is common after stroke and associated with poor long-term outcome.", {"entities": []}], ["Oxygen supplementation could prevent hypoxia and improve recovery.", {"entities": []}], ["A previous study of routine oxygen supplementation showed no significant benefit at 7 and 12 months.", {"entities": []}], ["This pilot study reports the effects of routine oxygen supplementation for 72 hours on oxygen saturation and neurological outcomes at 1 week after a stroke.", {"entities": []}], ["Patients with a clinical diagnosis of acute stroke were recruited within 24 h of hospital admission between October 2004 and April 2008.", {"entities": []}], ["Participants were randomized to oxygen via nasal cannulae (72 h) or control (room air, oxygen given only if clinically indicated).", {"entities": []}], ["Clinical outcomes were assessed by research team members at 1 week.", {"entities": []}], ["Baseline data for oxygen (n\u200a=\u200a148) and control (n\u200a=\u200a141) did not differ between groups.", {"entities": []}], ["The median (interquartile range) National Institutes of Health Stroke Scale (NIHSS) score for the groups at baseline was 6 (7) and 5 (7) respectively.", {"entities": []}], ["The median Nocturnal Oxygen Saturation during treatment was 1.4% (0.3) higher in the oxygen than in the control group (p<0.001) during the intervention.", {"entities": []}], ["At 1 week, the median NIHSS score had reduced by 2 (3) in the oxygen and by 1 (2) in the control group.", {"entities": []}], ["31% of participants in the oxygen group and 14% in the control group had an improvement of \u22654 NIHSS points at 1 week doubling the odds of improvement in the oxygen group (OR: 2.9).", {"entities": []}], ["Our data show that routine oxygen supplementation started within 24 hours of hospital admission with acute stroke led to a small, but statistically significant, improvement in neurological recovery at 1 week.", {"entities": []}], ["However, the difference in NIHSS improvement may be due to baseline imbalance in stroke severity between the two groups and needs to be confirmed in a larger study and linked to longer-term clinical outcome.", {"entities": []}], ["Controlled-Trials.com ISRCTN12362720 ; European Clinical Trials Database 2004-001866-41", {"entities": []}], ["Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract illness in infants, young children and the elderly.", {"entities": []}], ["However, there is no licensed vaccine available against RSV infection.", {"entities": []}], ["In this study, we generated virus-like particle (VLP) vaccine and investigated the vaccine efficacy in a mouse model.", {"entities": []}], ["For VLP vaccines, tandem gene (1\u2013780 bp) for V1 VLPs and tandem repeat gene (repeated 450\u2013780 bp) for V5 VLPs were constructed in pFastBac", {"entities": []}], ["Studies on ultra-endurance suggest that during the races, athletes typically experience three vitality states (i.e., preservation, loss, and revival) at the phenomenological level.", {"entities": []}], ["Nevertheless, how these states contribute to the management and outcome of performance remains unclear.", {"entities": []}], ["The aim of this study was to determine whether and how the vitality states experienced by runners and their evolution during a trail race can be used to distinguish finishers from withdrawers.", {"entities": []}], ["From an enactive and phenomenological framework, we processed enactive interviews and blog posts of race narratives.", {"entities": []}], ["We distinguished units of meaning, which were grouped into sequences of experience; each sequence was then categorized as one of the three vitality states: state of vitality preservation (SVP), state of vitality loss (SVL) or state of vitality revival (SVR).", {"entities": []}], ["We analyzed the distribution of these vitality states and their temporal organization at the beginning, in the second and third quarters, and at the end of the races, and we qualitatively characterized runners\u2019 adaptations to SVL.", {"entities": []}], ["Results showed that finishers completed the race in SVP, with overall significantly more sequences in SVP and significantly fewer sequences in SVL than withdrawers.", {"entities": []}], ["SVR did not discriminate finishers from withdrawers.", {"entities": []}], ["The temporal organization of the vitality states showed a significant difference in the emergence of SVP from the second quarter of the race, as well as a significant difference in the emergence of SVL from the third quarter of the race.", {"entities": []}], ["The analysis of adaptations to SVL confirmed that finishers were more capable of exiting SVL by enacting a preservation world when they felt physical or psychological alerts, whereas withdrawers remained in SVL.", {"entities": []}], ["Our results showed that finishers and withdrawers did not enact the same phenomenological worlds in the race situation, especially in the organization of vitality adaptations and their relationships to difficulties; the cumulative effect of the succession of experienced vitality states differed, as well.", {"entities": []}], ["To assess the respiratory symptoms and pulmonary function of carpenters from the city of Mashhad (northeast Iran).", {"entities": []}], ["The frequency of respiratory symptoms was retrospectively estimated in a sample of 66 carpenters in the city of Mashhad in northeast Iran using a questionnaire including questions on work\u2010related respiratory symptoms in the past year, allergy, type of irritant chemicals that induce respiratory symptoms, smoking habits, and working periods as a carpenter.", {"entities": []}], ["PFT values were also measured in all participants, and the age and smoking habits matched those of a sample of men from the general population as a control group.", {"entities": []}], ["Thirty\u2010five carpenters (53%) reported work\u2010related respiratory symptoms.", {"entities": []}], ["Cough (34.4%) and sputum (33.3%) were the most common symptoms, and only 15.15% of carpenters reported wheezing during work.", {"entities": []}], ["All respiratory symptoms were higher in carpenters than in controls, which was statistically significant for cough and sputum (p<0.001 in both cases).", {"entities": []}], ["Most allergic symptoms were also significantly greater among the carpenters than in the control group (p<0.05 for both itchy eyes and sneezing).", {"entities": []}], ["Most respiratory and allergic symptoms in the carpenters increased during work compared to rest period which was statistically significant only for cough (p<0.05).", {"entities": []}], ["PFT values were significantly lower in the carpenters than in control subjects (p<0.05 to p<0.001).", {"entities": []}], ["Carpentry work was associated with a high frequency of respiratory symptoms, particularly after exposure to irritating chemicals during work.", {"entities": []}], ["PFT values were also significantly reduced among carpenters compared to controls.", {"entities": []}], ["Self-reported medical history information is included in many studies.", {"entities": []}], ["However, data on the validity of Web-based questionnaires assessing medical history are scarce.", {"entities": []}], ["If proven to be valid, Web-based questionnaires may provide researchers with an efficient means to collect data on this parameter in large populations.", {"entities": []}], ["The aim of this study was to assess the validity of a Web-based questionnaire on chronic medical conditions, allergies, and blood pressure readings against obstetric records and data from general practitioners.", {"entities": []}], ["Self-reported questionnaire data were compared with obstetric records for 519 pregnant women participating in the Dutch PRegnancy and Infant DEvelopment (PRIDE) Study from July 2011 through November 2012.", {"entities": []}], ["These women completed Web-based questionnaires around their first prenatal care visit and in gestational weeks 17 and 34.", {"entities": []}], ["We calculated kappa statistics (\u03ba) and the observed proportions of positive and negative agreement between the baseline questionnaire and obstetric records for chronic conditions and allergies.", {"entities": []}], ["In case of inconsistencies between these 2 data sources, medical records from the woman\u2019s general practitioner were consulted as the reference standard.", {"entities": []}], ["For systolic and diastolic blood pressure, intraclass correlation coefficients (ICCs) were calculated for multiple data points.", {"entities": []}], ["Agreement between the baseline questionnaire and the obstetric record was substantial (\u03ba=.61) for any chronic condition and moderate for any allergy (\u03ba=.51).", {"entities": []}], ["For specific conditions, we found high observed proportions of negative agreement (range 0.88-1.00) and on average moderate observed proportions of positive agreement with a wide range (range 0.19-0.90).", {"entities": []}], ["Using the reference standard, the sensitivity of the Web-based questionnaire for chronic conditions and allergies was comparable to or even better than the sensitivity of the obstetric records, in particular for migraine (0.90 vs 0.40, P =.02), asthma (0.86 vs 0.61, P =.04), inhalation allergies (0.92 vs 0.74, P =.003), hay fever (0.90 vs 0.64, P =.001), and allergies to animals (0.89 vs 0.53, P =.01).", {"entities": [[212, 220, "DISEASE"], [245, 251, "DISEASE"]]}], ["However, some overreporting of allergies was observed in the questionnaire and for some nonsomatic conditions sensitivity of both measurement instruments was low.", {"entities": []}], ["The ICCs for blood pressure readings ranged between 0.72 and 0.92 with very small mean differences between the 2 methods of data collection.", {"entities": []}], ["Web-based questionnaires can be used to validly collect data on many chronic disorders, allergies, and blood pressure readings among pregnant women.", {"entities": []}], ["Combining novel mouse reporters and single-cell transcriptomic analyses, Wu et al.", {"entities": []}], ["uncover differential activation thresholds for the transcripts that direct antibody class switching to IgE versus IgG1 in response to IL-4 and explain how cell-intrinsic transcriptional heterogeneity governs CSR.", {"entities": []}], ["Noncoding transcripts originating upstream of the immunoglobulin constant region (I transcripts) are required to direct activation-induced deaminase to initiate class switching in B cells.", {"entities": []}], ["Differential regulation of I\u03b5 and I\u03b31 transcription in response to interleukin 4 (IL-4), hence class switching to IgE and IgG1, is not fully understood.", {"entities": []}], ["In this study, we combine novel mouse reporters and single-cell RNA sequencing to reveal the heterogeneity in IL-4\u2013induced I transcription.", {"entities": []}], ["We identify an early population of cells expressing I\u03b5 but not I\u03b31 and demonstrate that early I\u03b5 transcription leads to switching to IgE and occurs at lower activation levels than I\u03b31.", {"entities": []}], ["Our results reveal how probabilistic transcription with a lower activation threshold for I\u03b5 directs the early choice of IgE versus IgG1, a key physiological response against parasitic infestations and a mediator of allergy and asthma.", {"entities": [[227, 233, "DISEASE"]]}], ["The interest in equestrian sports has increased substantially during the last decades, resulting in increased number of horse facilities around urban areas.", {"entities": []}], ["In Sweden, new guidelines for safe distance have been decided based on the size of the horse facility (e.g., number of horses) and local conditions, such as topography and meteorology.", {"entities": []}], ["There is therefore an increasing need to estimate dispersion of horse allergens to be used, for example, in the planning processes for new residential areas in the vicinity of horse facilities.", {"entities": []}], ["The aim of this study was to develop a method for calculating short- and long-term emissions and dispersion of horse allergen and odor around horse facilities.", {"entities": []}], ["First, a method was developed to estimate horse allergen and odor emissions at hourly resolution based on field measurements.", {"entities": []}], ["Secondly, these emission factors were used to calculate concentrations of horse allergen and odor by using 3-D dispersion modeling.", {"entities": []}], ["Results from these calculations showed that horse allergens spread up to about 200 m, after which concentration levels were very low (<2 U/m", {"entities": []}], ["Obesity has become a global health challenge as its prevalence has increased globally in recent decades.", {"entities": [[0, 7, "DISEASE"]]}], ["Studies in high-income countries have shown that obesity is more prevalent among the poor.", {"entities": [[49, 56, "DISEASE"]]}], ["In contrast, obesity is more prevalent among the rich in low- and middle-income countries, hence requiring different focal points to design public health policies in the latter contexts.", {"entities": [[13, 20, "DISEASE"]]}], ["We examined socioeconomic inequalities in abdominal obesity in Purworejo District, Central Java, Indonesia and identified factors contributing to the inequalities.", {"entities": [[52, 59, "DISEASE"]]}], ["We utilised data from the WHO-INDEPTH Study on global AGEing and adult health (WHO-INDEPTH SAGE) conducted in the Purworejo Health and Demographic Surveillance System (HDSS) in Purworejo District, Indonesia in 2010.", {"entities": []}], ["The study included 14,235 individuals aged 50\u00a0years and older.", {"entities": []}], ["Inequalities in abdominal obesity across wealth groups were assessed separately for men and women using concentration indexes.", {"entities": [[26, 33, "DISEASE"]]}], ["Decomposition analysis was conducted to assess the determinants of socioeconomic inequalities in abdominal obesity.", {"entities": [[107, 114, "DISEASE"]]}], ["Abdominal obesity was five-fold more prevalent among women than in men (30% vs. 6.1%; p \u2009<\u20090.001).", {"entities": [[10, 17, "DISEASE"]]}], ["The concentration index\u00a0(CI) analysis showed that socioeconomic inequalities in abdominal obesity were less prominent among women (CI\u2009=\u20090.26, SE\u2009=\u20090.02, p \u2009<\u20090.001) compared to men (CI\u2009=\u20090.49, SE\u2009=\u20090.04, p \u2009<\u20090.001).", {"entities": [[90, 97, "DISEASE"]]}], ["Decomposition analysis showed that physical labour was the major determinant of socioeconomic inequalities in abdominal obesity among men, explaining 47% of the inequalities, followed by poor socioeconomic status (31%), \u2264\u20096\u00a0years of education (15%) and current smoking (11%).", {"entities": [[120, 127, "DISEASE"]]}], ["The three major determinants of socioeconomic inequalities in abdominal obesity among women were poor socio-economic status (48%), physical labour (17%) and no formal education (16%).", {"entities": [[72, 79, "DISEASE"]]}], ["Abdominal obesity was more prevalent among older women in a rural Indonesian setting.", {"entities": [[10, 17, "DISEASE"]]}], ["Socioeconomic inequality in abdominal obesity exists and concentrates more among the rich population in both sexes.", {"entities": [[38, 45, "DISEASE"]]}], ["The inequality gap is less prominent among women, indicating a trend towards obesity being more common in poor women.", {"entities": [[77, 84, "DISEASE"]]}], ["Policies to address social determinants of health need to be developed to address the socioeconomic inequality gaps in obesity, with particular focus on addressing the existing burden of obesity among the better-off population group, while preventing the imminent burden of obesity among the worst-off group, particularly among women.", {"entities": [[119, 126, "DISEASE"], [187, 194, "DISEASE"], [274, 281, "DISEASE"]]}], ["The most appropiate management for bronchial asthma is the control of airway inflammation.", {"entities": [[45, 51, "DISEASE"]]}], ["Corticosteroids are the most effective anti-inflammatory drugs available, but they have a number of side effects; most of these are dose-dependent.", {"entities": []}], ["In children, asthma control should be accomplished with low steroid doses possibly given by inhalation.", {"entities": [[13, 19, "DISEASE"]]}], ["In a double-bind placebo-controlled crossover study a group of children with mild to moderate asthma received NED 16 mg/day or BDP 400 \u03bcg/day.", {"entities": [[94, 100, "DISEASE"]]}], ["Values for FEV 1 , PEF, symptoms use ofbronchodilators overlapped, whereas bronchial hyper-responsiveness assessed by histamine bronchoprovocation challenge was better with BDP than NED.", {"entities": [[11, 14, "GENE"]]}], ["In another case, one boy with high bronchial hyper-reactivity assessed by provocation test with hypertonic solution, experienced a significant improvement only after 2 weeks of therapy with Deflazacort (2 mg/Kg/day) followed by 4 months on combined treatment with NED (16 mg/day) and BDP (300 \u03bc/day).", {"entities": []}], ["Authors conclude that NED could have a steroidsparing effect over long-term use.", {"entities": []}], ["To explore and document the experiences of those receiving support from a lay health trainer, in order to inform the optimisation and evaluation of such interventions.", {"entities": []}], ["Longitudinal qualitative study with up to four serial interviews conducted over 12 months.", {"entities": []}], ["Interviews were transcribed and analysed using the constant comparative approach associated with grounded theory.", {"entities": []}], ["13 health trainers, 5 managers and 26 clients.", {"entities": []}], ["Three health trainer services targeting disadvantaged communities in northern England.", {"entities": []}], ["The final dataset comprised 116 interviews (88 with clients and 28 with staff).", {"entities": []}], ["Discussions with health trainers and managers revealed a high degree of heterogeneity between the local services in terms of their primary aims and activities.", {"entities": []}], ["However, these were found to converge over time.", {"entities": []}], ["There was agreement that health trainer interventions are generally \u2018person-centred\u2019 in terms of being tailored to the needs of individual clients.", {"entities": []}], ["This led to a range of self-reported outcomes, including behaviour changes, physical health improvements and increased social activity.", {"entities": []}], ["Factors impacting on the maintenance of lifestyle changes included the cost and timing of health-promoting activities, ill-health or low mood.", {"entities": []}], ["Participants perceived a need for ongoing access to low cost facilities to ensure that any lifestyle changes can be maintained in the longer term.", {"entities": []}], ["Health trainers may be successful in terms of supporting people from socio-economically disadvantaged communities to make positive lifestyle changes, as well as achieving other health-related outcomes.", {"entities": []}], ["This is not a \u2018one-size-fits-all\u2019 approach; commissioners and providers should select the intervention models that best meet the needs of their local populations.", {"entities": []}], ["By delivering holistic interventions that address multiple lifestyle risks and incorporate relapse prevention strategies, health trainers could potentially have a significant impact on health inequalities.", {"entities": []}], ["However, rigorous, formal outcome and economic evaluation of the range of health trainer delivery models is needed.", {"entities": []}], ["There are limited data on air quality parameters, including airborne particulate matter (PM) in residential green buildings, which are increasing in prevalence.", {"entities": []}], ["Exposure to PM is associated with cardiovascular and pulmonary diseases, and since Americans spend almost 90% of their time indoors, residential exposures may substantially contribute to overall airborne PM exposure.", {"entities": []}], ["Our objectives were to: (1) measure various PM fractions longitudinally in apartments in multi-family green buildings with natural (Building E) and mechanical (Building L) ventilation; (2) compare indoor and outdoor PM mass concentrations and their ratios (I/O) in these buildings, taking into account the effects of occupant behavior; and (3) evaluate the effect of green building designs and operations on indoor PM.", {"entities": []}], ["We evaluated effects of ventilation, occupant behaviors, and overall building design on PM mass concentrations and I/O.", {"entities": []}], ["Median PM TOTAL was higher in Building E (56 \u00b5g/m", {"entities": []}], ["The disease burden of children with laboratory-confirmed influenza in China has not been well described.", {"entities": [[57, 66, "DISEASE"]]}], ["The aim of this study was to understand the epidemiology and socio-economic burden of influenza in children younger than 5 years in outpatient and emergency department settings.", {"entities": [[86, 95, "DISEASE"]]}], ["A prospective study of laboratory-confirmed influenza among children presenting to the outpatient settings in Soochow University Affiliated Children's Hospital with symptoms of influenza-like illness (ILI) was performed from March 2011 to February 2012.", {"entities": [[44, 53, "DISEASE"], [177, 186, "DISEASE"]]}], ["Throat swabs were collected for detection of influenza virus by reverse transcription polymerase chain reaction assay.", {"entities": [[45, 54, "DISEASE"]]}], ["Data were collected using a researcher administered questionnaire, concerning demographics, clinical characteristics, direct and indirect costs, day care absence, parental work loss and similar respiratory illness development in the family.", {"entities": []}], ["Among a total of 6,901 children who sought care at internal outpatient settings, 1,726 (25%) fulfilled the criteria of ILI and 1,537 were enrolled.", {"entities": []}], ["Influenza was documented in 365 (24%) of enrolled 1,537 ILI cases.", {"entities": [[0, 9, "DISEASE"]]}], ["Among positive patients, 52 (14%) were type A and 313 (86%) were type B.", {"entities": []}], ["About 52% of influenza outpatients had over-the-counter medications before physician visit and 41% visited hospitals two or more times.", {"entities": [[13, 22, "DISEASE"]]}], ["Children who attended daycare missed an average of 1.9 days.", {"entities": []}], ["For each child with influenza-confirmed disease, the parents missed a mean of 1.8 work days.", {"entities": [[20, 29, "DISEASE"]]}], ["Similar respiratory symptoms were reported in 43% of family contacts of influenza positive children after onset of the child's illness.", {"entities": [[72, 81, "DISEASE"]]}], ["The mean direct and indirect costs per episode of influenza were $123.4 for outpatient clinics and $134.6 for emergency departments, and $125.9 for influenza A and $127.5 for influenza B.", {"entities": [[50, 59, "DISEASE"], [148, 157, "DISEASE"], [175, 184, "DISEASE"]]}], ["Influenza is a common cause of influenza-like illness among children and has substantial socio-economic impact on children and their families regarding healthcare seeking and day care/work absence.", {"entities": [[0, 9, "DISEASE"], [31, 40, "DISEASE"]]}], ["The direct and indirect costs of childhood influenza impose a heavy financial burden on families.", {"entities": [[43, 52, "DISEASE"]]}], ["Prevention measures such as influenza vaccine could reduce the occurrence of influenza in children and the economic burden on families.", {"entities": [[28, 37, "DISEASE"], [77, 86, "DISEASE"]]}], ["Due to the ubiquity of mobile phones in low and middle income countries, we aimed to examine the feasibility of SMS education among diabetic patients in Egypt, and assess the impact of educational text messages, compared to traditional paper-based methods, on glycemic control and self-management behaviors.", {"entities": [[112, 115, "GENE"]]}], ["We conducted a 12-week randomized controlled trial at Misr University for Science & Technology hospital in Cairo-Egypt.", {"entities": []}], ["Known as MUST diabetes awareness program, patients were included if they had diabetes, owned a mobile phone, and could read SMS messages or lived with someone that could read for them.", {"entities": [[124, 127, "GENE"]]}], ["Intervention patients received daily messages and weekly reminders addressing various diabetes care categories.", {"entities": []}], ["We expected greater improvement in their glycemic control compared to controls who only received paper-based educational material.", {"entities": []}], ["The primary outcome was the change in HbA1c, measured by the difference between endpoint and baseline values and by the number of patients who experienced at least 1% reduction from baseline to endpoint.", {"entities": []}], ["Key secondary outcomes included blood glucose levels, body weight, treatment and medication adherence, self-efficacy, and diabetes knowledge.", {"entities": []}], ["Data were analyzed using ANCOVA, chi-square, and t-tests.", {"entities": []}], ["Thirty four intervention and 39 control patients completed the study.", {"entities": []}], ["Over 12\u00a0weeks, 3880 messages were sent.", {"entities": []}], ["Each intervention patient received 84 educational and 12 reminder messages plus one welcome message.", {"entities": []}], ["Our primary outcome did not differ significantly (\u0394 0.290; 95% CI -0.402 to 0.983; p \u2009=\u20090.406) between groups after 3\u00a0months, demonstrating a mean drop of \u22120.69% and \u22121.05% in the control and intervention group respectively.", {"entities": []}], ["However, 16 intervention patients achieved the targeted 1% drop versus only 6 controls, suggesting clear association between study group and 1% HbA1c reductions (chi-square\u2009=\u20098.655; df\u2009=\u20091; p \u2009=\u20090.003).", {"entities": []}], ["Secondary outcomes seemed in favor of intervention patients at endpoint, with considerable improvements in treatment and medication adherence, self-efficacy, and knowledge scores.", {"entities": []}], ["Participants also indicated full satisfaction with the program.", {"entities": []}], ["SMS education is a feasible and acceptable method for improving glycemic control and self-management behaviors among Egyptian diabetics.", {"entities": [[0, 3, "GENE"]]}], ["However, whether it is more effective than traditional paper-based methods needs further investigation.", {"entities": []}], ["ClinicalTrials.gov NCT02868320 .", {"entities": []}], ["Registered 9 August 2016.", {"entities": []}], ["Retrospectively registered.", {"entities": []}], ["The online version of this article (10.1186/s12889-017-4973-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cannabis is the most commonly used illegal drug and its therapeutic aspects have a growing interest.", {"entities": []}], ["Short-term psychotic reactions have been described but not clearly with synthetic oral THC, especially in occasional users.", {"entities": []}], ["We report two cases of healthy subjects who were occasional but regular cannabis users without psychiatric history who developed transient psychotic symptoms (depersonalization, paranoid feelings and derealisation) following oral administration of cannabis.", {"entities": []}], ["In contrast to most other case reports where circumstances and blood concentrations are unknown, the two cases reported here happened under experimental conditions with all subjects negative for cannabis, opiates, amphetamines, cocaine, benzodiazepines and alcohol, and therefore the ingested dose, the time-events of effects on behavior and performance as well as the cannabinoid blood levels were documented.", {"entities": []}], ["While the oral route of administration achieves only limited blood concentrations, significant psychotic reactions may occur.", {"entities": []}], ["Commercial sheep raised for mutton grow faster than traditional Chinese sheep breeds.", {"entities": []}], ["Here, we aimed to evaluate genetic selection among three different types of sheep breed: two well-known commercial mutton breeds and one indigenous Chinese breed.", {"entities": []}], ["We first combined locus-specific branch lengths and d i statistical methods to detect candidate regions targeted by selection in the three different populations.", {"entities": []}], ["The results showed that the genetic distances reached at least medium divergence for each pairwise combination.", {"entities": []}], ["We found these two methods were highly correlated, and identified many growth-related candidate genes undergoing artificial selection.", {"entities": []}], ["For production traits, APOBR and FTO are associated with body mass index.", {"entities": [[33, 36, "GENE"]]}], ["For meat traits, ALDOA , STK32B and FAM190A are related to marbling.", {"entities": [[17, 22, "GENE"], [25, 31, "GENE"], [36, 43, "GENE"]]}], ["For reproduction traits, CCNB2 and SLC8A3 affect oocyte development.", {"entities": [[25, 30, "GENE"], [35, 41, "GENE"]]}], ["We also found two well-known genes, GHR (which affects meat production and quality) and EDAR (associated with hair thickness) were associated with German mutton merino sheep.", {"entities": [[36, 39, "GENE"], [88, 92, "GENE"]]}], ["Furthermore, four genes ( POL , RPL7 , MSL1 and SHISA9 ) were associated with pre-weaning gain in our previous genome-wide association study.", {"entities": [[32, 36, "GENE"], [39, 43, "GENE"]]}], ["Our results indicated that combine locus-specific branch lengths and d i statistical approaches can reduce the searching ranges for specific selection.", {"entities": []}], ["And we got many credible candidate genes which not only confirm the results of previous reports, but also provide a suite of novel candidate genes in defined breeds to guide hybridization breeding.", {"entities": []}], ["Regular physical activity is recommended for all people with chronic obstructive pulmonary disease (COPD), but the dose of physical activity required to gain mortality benefit in this population is not yet known.", {"entities": [[61, 98, "DISEASE"]]}], ["This aim of this study was to examine the associations of total and type-specific physical activity with mortality risk in people with COPD.", {"entities": []}], ["People with COPD aged \u226540\u00a0years were identified from the 1997 Health Survey for England and the 1998 and 2003 Scottish Health Survey cohorts.", {"entities": []}], ["Self-reported total physical activity, moderate-vigorous intensity physical activity (MVPA), walking, domestic physical activity, and sport/exercise were assessed at baseline.", {"entities": []}], ["Cox proportional hazards models were used to examine the associations between physical activity and mortality risk.", {"entities": []}], ["Two thousand three hundred ninety-eight participants with COPD were included in the analysis and followed up for a mean 8.5 (SD 3.9) years.", {"entities": []}], ["For both total physical activity and MVPA, we observed dose-response associations with all-cause and cardiovascular disease (CVD) mortality risk, and with respiratory mortality risk to a lesser extent.", {"entities": []}], ["Compared to those who reported no physical activity, participants who met the physical activity guidelines demonstrated the greatest reductions in all-cause (HR 0.56, 95% CI 0.45\u20130.69), CVD (HR 0.48, 95% CI 0.32\u20130.71) and respiratory mortality risk (HR 0.40, 95% CI 0.24\u20130.67).", {"entities": [[158, 160, "GENE"], [191, 193, "GENE"], [250, 252, "GENE"], [158, 160, "GENE"], [191, 193, "GENE"], [250, 252, "GENE"], [158, 160, "GENE"], [191, 193, "GENE"], [250, 252, "GENE"]]}], ["Participants who reported a level of physical activity of at least half the dosage recommended by the guidelines also had a reduced risk of all-cause (HR 0.75, 95% CI 0.56\u20131.00) and CVD mortality (HR 0.48, 95% CI 0.26\u20130.88).", {"entities": [[151, 153, "GENE"], [197, 199, "GENE"], [151, 153, "GENE"], [197, 199, "GENE"]]}], ["Dose-response associations with mortality risk were demonstrated for walking and sport/exercise, but not domestic physical activity.", {"entities": []}], ["We found a dose-response association between physical activity and all-cause and CVD mortality risk in people with COPD, with protective effects appearing at levels considerably lower than the general physical activity recommendations.", {"entities": []}], ["People with COPD may benefit from engagement in low levels of physical activity, particularly walking and structured exercise.", {"entities": []}], ["The online version of this article (10.1186/s12889-018-5167-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To explore the influence of comorbidities on clinical outcomes and disease activity in rheumatoid arthritis (RA).", {"entities": [[87, 107, "DISEASE"], [98, 107, "DISEASE"]]}], ["In patients included in the cross-sectional observational multicenter international study COMORA, demographics, disease characteristics and comorbidities (hypertension, diabetes, hyperlipidemia, renal failure, ischemic heart disease, stroke, cancer, gastro-intestinal ulcers, hepatitis, depression, chronic pulmonary disease, obesity) were collected.", {"entities": [[155, 167, "DISEASE"], [210, 232, "DISEASE"], [219, 232, "DISEASE"], [326, 333, "DISEASE"], [276, 285, "DISEASE"], [242, 248, "DISEASE"]]}], ["Multivariable linear regression models explored the relationship between each comorbidity and disease activity measures: 28-swollen joint count (SJC), 28-tender joint count (TJC), erythrocyte sedimentation rate (ESR), patient\u2019s and physician\u2019s global assessment (PtGA, PhGA), patient reported fatigue and 28-Disease Activity Score (DAS28).", {"entities": []}], ["Results are expressed as mean difference (MD) adjusted for the main confounders (age, gender, disease characteristics and treatment).", {"entities": []}], ["A total of 3,920 patients were included: age (mean \u00b1SD) 56.27 \u00b113.03 yrs, female 81.65%, disease duration median 7.08 yrs (IQR 2.97\u201313.27), DAS28 (mean \u00b1SD) 3.74 \u00b1 1.55.", {"entities": []}], ["Patients with diabetes had more swollen and tender joints and worse PtGA and PhGA (MD +1.06, +0.93, +0.53 and +0.54, respectively).", {"entities": []}], ["Patients with hyperlipidemia had a lower number of swollen and tender joints, lower ESR and better PtGA and PhGA (MD -0.77, -0.56, -3.56, -0.31 and -0.35, respectively).", {"entities": []}], ["Patients with history of ischemic heart disease and obese patients had more tender joints (MD +1.27 and +1.07) and higher ESR levels (MD +5.64 and +5.20).", {"entities": [[25, 47, "DISEASE"], [34, 47, "DISEASE"]]}], ["DAS28 is influenced exclusively by cardiovascular comorbidities, in particular diabetes, hyperlipidemia, ischemic heart disease and obesity.", {"entities": [[105, 127, "DISEASE"], [114, 127, "DISEASE"], [132, 139, "DISEASE"]]}], ["Cardiovascular comorbidities relate more than others with disease activity in RA.", {"entities": []}], ["Diabetes and hyperlipidemia in particular seem associated with higher and lower disease activity respectively influencing almost all considered outcomes, suggesting a special importance of this pattern of comorbidities in disease activity assessment and clinical management.", {"entities": []}], ["Microparticles are released from the endothelium under normal homeostatic conditions and have been shown elevated in disease states, most notably those characterised by endothelial dysfunction.", {"entities": []}], ["The endothelium is sensitive to oxidative stress/status and vascular cell adhesion molecule-1 (VCAM-1) expression is upregulated upon activated endothelium, furthermore the presence of VCAM-1 on microparticles is known.", {"entities": []}], ["S100A12, a calcium binding protein part of the S100 family, is shown to be present on circulating leukocytes and is thought a sensitive marker to local inflammatory process, which may be driven by oxidative stress.", {"entities": [[0, 7, "GENE"]]}], ["Eight healthy males were subjected to breathing hypoxic air (15% O 2 , approximately equivalent to 3000 metres altitude) for 80 minutes in a temperature controlled laboratory and venous blood samples were processed immediately for VCAM-1 microparticles (VCAM-1 MP) and S100A12 association with leukocytes by flow cytometry.", {"entities": [[269, 276, "GENE"]]}], ["A pre-hypoxic blood sample was used for comparison.", {"entities": []}], ["Both VCAM-1 MP and S100A12 association with neutrophils were significantly elevated post hypoxic breathing later declining to levels observed in the pre-test samples.", {"entities": [[19, 26, "GENE"]]}], ["A similar trend was observed in both cases and a correlation may exist between these two markers in response to hypoxia.", {"entities": []}], ["These data offer evidence using novel markers of endothelial and circulating blood responses to hypoxia.", {"entities": []}], ["To assess the level of caregiver knowledge about respiratory signs and symptoms of acute respiratory infection (ARI) as well as their ability to detect the early warning signs and need for medical assistance in children referred to an emergency service.", {"entities": []}], ["This is a prospective, cross-sectional study.", {"entities": []}], ["A standardized questionnaire with questions on the perception of the severity of ARI signs and symptoms was applied to caregivers of pediatric patients assisted in the emergency room of a university hospital from August 2011 to May 2012.", {"entities": []}], ["Chi-square and Student\u2019s t-tests were used to determine which variables contributed with caregivers\u2019 recognition of severity of acute respiratory diseases.", {"entities": []}], ["499 caregivers were interviewed.", {"entities": []}], ["The most cited causes of ARI were flu syndrome (78.6%), common cold (73.9%), pharyngitis (64.1%), and pneumonia (54.5%).", {"entities": [[102, 111, "DISEASE"], [38, 46, "DISEASE"], [56, 67, "DISEASE"], [77, 88, "DISEASE"]]}], ["Fever (34.1%) and cough (15.8%) were major reasons for referral to hospital.", {"entities": []}], ["The most cited signs of severity recognized by caregivers were fever (99.6%), dyspnea (91.4%), wheezing (86.4%), adynamia (80.2%), coughing (79.8%), and tachypnea (78.6%).", {"entities": []}], ["Children\u2019s history of respiratory diseases (p=0.002), caregiver\u2019s age (p=0.010) and marital status (p=0.014) were significantly associated with tachypnea, the most severe ARI symptom.", {"entities": []}], ["Although caregivers of children can recognize ARI most important signs and symptoms, they are unable to judge severity, which may delay medical care and early treatment.", {"entities": []}], ["Early presumptions opined that autism spectrum disorder (ASD) was related to the rearing of these children by emotionally-distant mothers.", {"entities": [[31, 55, "DISEASE"]]}], ["Advances in the 1960s and 1970s clearly demonstrated the biologic basis of autism with a high heritability.", {"entities": []}], ["Recent advances have demonstrated that specific etiologic factors in autism spectrum disorders can be identified in 30%\u201340% of cases.", {"entities": []}], ["Based on early reports newer, emerging genomic technologies are likely to increase this diagnostic yield to over 50%.", {"entities": []}], ["To date these investigations have focused on etiologic factors that are largely mono-factorial.", {"entities": []}], ["The currently undiagnosed causes of ASDs will likely be found to have causes that are more complex.", {"entities": []}], ["Epigenetic, multiple interacting loci, and four dimensional causes (with timing as a variable) are likely to be associated with the currently unidentifiable cases.", {"entities": []}], ["Today, the \u201cWhy\u201d is more important than ever.", {"entities": []}], ["Understanding the causes of ASDs help inform families of important issues such as recurrence risk, prognosis, natural history, and predicting associated co-morbid medical conditions.", {"entities": []}], ["In the current era of emerging efforts in \u201cpersonalized medicine\u201d, identifying an etiology will be critical in identifying endo-phenotypic groups and individual variations that will allow for tailored treatment for persons with ASD.", {"entities": []}], ["Rheumatoid arthritis (RA) is a complex polygenic inflammatory disease associated with accelerated atherosclerosis and increased risk of cardiovascular (CV) disease.", {"entities": [[98, 113, "DISEASE"], [11, 20, "DISEASE"]]}], ["Previous genome-wide association studies have described SMAD3 rs17228212 polymorphism as an important signal associated with CV events.", {"entities": [[56, 61, "GENE"]]}], ["The aim of the present study was to evaluate for the first time the relationship between this gene polymorphism and the susceptibility to CV manifestations and its potential association with the presence of subclinical atherosclerosis assessed by the evaluation of carotid intima-media thickness (cIMT) in patients with RA.", {"entities": [[219, 234, "DISEASE"]]}], ["One thousand eight hundred and ninety-seven patients fulfilling classification criteria for RA were genotyped for SMAD3 rs17228212 gene polymorphism through TaqMan genotyping assay.", {"entities": [[114, 119, "GENE"]]}], ["Also, subclinical atherosclerosis determined by the assessment of cIMT was analyzed in a subgroup of these patients by carotid ultrasonography.", {"entities": [[18, 33, "DISEASE"]]}], ["No statistically significant differences were observed when allele frequencies of RA patients with or without CV events were compared.", {"entities": []}], ["Nevertheless, when RA patients were stratified according to anti-cyclic citrullinated peptide (anti-CCP) status, we found that in RA patients who were negative for anti-CCP antibodies, the presence of C allele of SMAD3 rs17228212 polymorphism conferred a protective effect against the risk of cerebrovascular accident (CVA) after adjustment for demographic and classic CV risk factors (HR [95%CI]=0.36 [0.14\u20130.94], p =0.038) in a Cox regression model.", {"entities": [[293, 317, "DISEASE"], [213, 218, "GENE"], [386, 388, "GENE"]]}], ["Additionally, correlation between the presence of C allele of SMAD3 rs17228212 polymorphism and lower values of cIMT was found after adjustment for demographic and classic CV risk factors ( p-value =0.0094) in the anti-CCP negative RA patients.", {"entities": [[62, 67, "GENE"]]}], ["Our results revealed that SMAD3 rs17228212 gene variant is associated with lower risk of CVA and less severe subclinical atherosclerosis in RA patients negative for anti-CCP antibodies.", {"entities": [[121, 136, "DISEASE"], [26, 31, "GENE"]]}], ["These findings may have importance to establish predictive models of CV disease in RA patients according to anti-CCP status.", {"entities": []}], ["Triclosan (TCS), an antimicrobial chemical with potential endocrine-disrupting properties, may pose a risk to early embryonic development and cellular homeostasis during adulthood.", {"entities": []}], ["Here, we show that TCS induces toxicity in both the nematode C. elegans and human mesenchymal stem cells (hMSCs) by disrupting the SKN-1/Nrf2-mediated oxidative stress response.", {"entities": []}], ["Specifically, TCS exposure affected C. elegans survival and hMSC proliferation in a dose-dependent manner.", {"entities": []}], ["Cellular analysis showed that TCS inhibited the nuclear localization of SKN-1/Nrf2 and the expression of its target genes, which were associated with oxidative stress response.", {"entities": []}], ["Notably, TCS-induced toxicity was significantly reduced by either antioxidant treatment or constitutive SKN-1/Nrf2 activation.", {"entities": []}], ["As Nrf2 is strongly associated with aging and chemoresistance, these findings will provide a novel approach to the identification of therapeutic targets and disease treatment.", {"entities": []}], ["The implementation of a bachelor degree in \u201cInterprofessional Health Care\u201d at the University of Heidelberg, Germany has fostered the need to evaluate the impact of this innovative programme.", {"entities": []}], ["The Readiness for Interprofessional Learning Scale (RIPLS) was developed by Parsell and Bligh (1999) to assess student\u2019s attitudes towards interprofessional education.", {"entities": []}], ["The RIPLS consists of 19 items and four subscales were identified by McFadyen ( J Interprof Care 19: 595\u2013603, 2005): \u201cteamwork and collaboration\u201d, \u201cnegative professional identity\u201d, \u201cpositive professional identity\u201d and \u201croles and responsibilities\u201d.", {"entities": []}], ["The RIPLS has been translated into a number of languages and used in a variety of different educational settings.", {"entities": []}], ["A German version of the RIPLS was not available.", {"entities": []}], ["Aim of the study was the translation of the RIPLS into German and testing of internal consistency.", {"entities": []}], ["The RIPLS was translated to German according to international guidelines and its psychometric properties were assessed in two online surveys with two different samples a) health care graduates and b) health care students.", {"entities": []}], ["Descriptive analysis (mean, SD, corrected item-total correlation) of the Readiness for Interprofessional Learning Scale \u2013 German (RIPLS-D) was performed for item characteristics and Cronbach\u2019s Alpha was calculated for internal consistency of overall and subscales of the RIPLS-D. Each sample consisted of 76 datasets.", {"entities": []}], ["Reliability for the RIPLS-D overall scale was 0.83 in both samples.", {"entities": []}], ["The subscales displayed internal consistency between 0.42 and 0.88.", {"entities": []}], ["Corrected item-total correlation showed low values in two subscales in the sample of graduates.", {"entities": []}], ["While the overall RIPLS-D scale is reliable, several subscales showed low values and should be used with caution to measure readiness for interprofessional learning in the German health care context.", {"entities": []}], ["Internal consistency of the instrument does not seem to be given in health care professionals at different stages of their professional career.", {"entities": []}], ["In particular the sub-scale \u201croles and responsibilities\u201d was problematic.", {"entities": []}], ["For these reasons, the RIPLS-D cannot be recommended for use to assess this concept.", {"entities": []}], ["Natural killer cells (NK) secrete eosinophilotactic cytokines, however, whether they contribute to eosinophil chemotaxis by secreting IL-8 is not known.", {"entities": []}], ["We investigated the ability of CD56+CD3-ve (NK cells) to induce chemotaxis of peripheral blood eosinophils from allergic rhinitis (AR) patients, through IL-8 secretion, and the effects of IL-15, the NK cell proactivating cytokine, and calcitriol: 1 \u03b1 , 25-dihydroxy Vitamin D 3 (vitamin D 3 ), the immunomodulator agent, in this scenario.", {"entities": [[112, 129, "DISEASE"], [121, 129, "DISEASE"]]}], ["Herein, it is shown that supernatants from unstimulated NK cells exhibited chemotactic activity against eosinophil.", {"entities": []}], ["This effect was significantly augmented by IL-15 (1\u2009ng/mL) treatment, resulting in an increase in the chemotactic index of approximately 3 folds and was abrogated by neutralizing antibody (Ab) to IL-8 in a dose-dependent fashion.", {"entities": []}], ["The amount of IL-8 secreted by NK cells was increased by IL-15 treatment from levels of 88.64 \u00b1 21.5 to 178.9 \u00b1 23.6\u2009Pg/mL and was significantly reduced by 10 3 to levels of 59.2 \u00b1 16.3\u2009Pg/mL.", {"entities": []}], ["Our results indicate a novel inflammatory crosstalk between NK cells and eosinophils via IL-15/IL-8 axis that can be modulated by vitamin D 3 .", {"entities": []}], ["In 2013, physicians at the Honolulu Queen\u2019s Medical Center (QMC) noticed that seven liver disease patients reported the use of OxyELITE Pro (OEP), a widely consumed dietary supplement (DS).", {"entities": [[84, 97, "DISEASE"]]}], ["Assuming a temporal association between OEP use and disease, they argued that OEP was the cause of this mysterious cluster.", {"entities": []}], ["Subsequent reexamination, however, has revealed that this QMC cohort is heterogeneous and not a cluster with a single agent causing a single disease.", {"entities": []}], ["It is heterogeneous because patients used multiple DS\u2019s and drugs and because patients appeared to have suffered from multiple liver diseases: liver cirrhosis, liver failure by acetaminophen, hepatotoxicity by non-steroidal antiinflammatory drugs (NSAIDs), resolving acute viral hepatitis by hepatitis B virus (HBV), herpes simplex virus (HSV), and varicella zoster virus (VZV), and suspected hepatitis E virus (HEV).", {"entities": [[317, 331, "DISEASE"], [292, 303, "DISEASE"], [143, 158, "DISEASE"], [279, 288, "DISEASE"], [292, 301, "DISEASE"], [393, 402, "DISEASE"], [273, 288, "DISEASE"]]}], ["Failing to exclude these confounders and to consider more viable diagnoses, the QMC physicians may have missed specific treatment options in some of their patients.", {"entities": []}], ["The QMC physicians unjustifiably upgraded their Roussel Uclaf Causality Assessment Method (RUCAM) causality scores so that all patients would appear to be \u201cprobable\u201d for OEP.", {"entities": []}], ["However, subsequent RUCAM reassessments by our group demonstrated a lack of causality for OEP in the evaluated QMC cases.", {"entities": []}], ["The QMC\u2019s questionable approaches explain the extraordinary accumulation of suspected OEP cases at the QMC in Hawaii as single place, whereas similar cohorts were not published by any larger US liver center, substantiating that the problem is with the QMC.", {"entities": []}], ["In this review article, we present and discuss new case data and critically evaluate upcoming developments of problematic regulatory assessments by the US Centers for Disease Control and Prevention (CDC), the Hawaii Department of Health (HDOH), and the Food and Drug Administration (FDA), as based on invalid QMC conclusions, clarifying now also basic facts and facilitating constructive discussions.", {"entities": []}], ["Perioperative hypertension is commonly encountered in patients that undergo surgery.", {"entities": [[14, 26, "DISEASE"]]}], ["While attempts have been made to standardize the method to characterize the intraoperative hemodynamics, these methods still vary widely.", {"entities": []}], ["In addition, there is a lack of consensus concerning treatment thresholds and appropriate therapeutic targets, making absolute recommendations about treatment difficult.", {"entities": []}], ["Nevertheless, perioperative hypertension requires careful management.", {"entities": [[28, 40, "DISEASE"]]}], ["When treatment is necessary, therapy should be individualized for the patient.", {"entities": []}], ["This paper reviews the pharmacologic agents and strategies commonly used in the management of perioperative hypertension.", {"entities": [[108, 120, "DISEASE"]]}], ["Emerging T\u2010helper type 2 (Th 2 ) cytokine\u2010based asthma therapies, such as tralokinumab, lebrikizumab (anti\u2010interleukin (IL)\u201013), and mepolizumab (anti\u2010IL\u20105), have shown differences in their blood eosinophil (EOS) response.", {"entities": [[48, 54, "DISEASE"]]}], ["To better understand these effects, we developed a mathematical model of EOS dynamics.", {"entities": []}], ["For the anti\u2010IL\u201013 therapies, lebrikizumab and tralokinumab, the model predicted an increase of 30% and 10% in total and activated EOS in the blood, respectively, and a decrease in the total and activated EOS in the airways.", {"entities": []}], ["The model predicted a rapid decrease in total and activated EOS levels in blood and airways for the anti\u2010IL\u20105 therapy mepolizumab.", {"entities": []}], ["All model\u2010based predictions were consistent with published clinical observations.", {"entities": []}], ["The modeling approach provided insights into EOS response after treatment with Th 2 \u2010targeted therapies, and supports the hypothesis that an increase in blood EOS after anti\u2010IL\u201013 therapy is part of the pharmacological action of these therapies.", {"entities": []}], ["Providers wish to help patients with prescription costs but often lack drug cost information.", {"entities": []}], ["We examined whether giving providers formulary and drug cost information was associated with changes in their diabetes patients\u2019 drug costs and use.", {"entities": []}], ["We conducted a longitudinal non-randomized evaluation of the web-based Prescribing Guide ( www.PrescribingGuide.com ), a free resource available to Hawaii\u2019s providers since 2006, which summarizes the formularies and copayments of six health plans for drugs to treat 16 common health conditions.", {"entities": []}], ["All adult primary care physicians in Hawaii were offered the Prescribing Guide, and providers who enrolled received a link to the website and regular hardcopy updates.", {"entities": []}], ["We analyzed prescription claims from a large health plan in Hawaii for 5,883 members with diabetes from 2007 (baseline) to 2009 (follow-up).", {"entities": []}], ["Patients were linked to 299 \u201cmain prescribing\u201d providers, who on average, accounted for >88\u00a0% of patients\u2019 prescriptions and drug costs.", {"entities": []}], ["We compared changes in drug costs and use for \u201cstudy\u201d patients whose main provider enrolled to receive the Prescribing Guide, versus \u201ccontrol\u201d patients whose main provider did not enroll to receive the Prescribing Guide.", {"entities": []}], ["In multivariate analyses controlling for provider specialty and clustering of patients by providers, both patient groups experienced similar increases in number of prescriptions (+3.2 vs. +2.7 increase, p \u2009=\u20090.24), and days supply of medications (+141 vs. +129 increase, p \u2009=\u20090.40) averaged across all drugs.", {"entities": []}], ["Total and out-of-pocket drug costs also increased for both control and study patients.", {"entities": []}], ["However, control patients showed higher increases in yearly total drug costs of $208 per patient (+$792 vs. +$584 increase, p \u2009=\u20090.02) and in 30-day supply costs (+$9.40 vs. +$6.08 increase, p \u2009=\u20090.03).", {"entities": []}], ["Both groups experienced similar changes in yearly out-of-pocket costs (+$41 vs\u2009+\u2009$31 increase, p \u2009=\u20090.36) and per 30-day supply (\u2212$0.23 vs. \u2212$0.19 decrease, p \u2009=\u20090.996).", {"entities": []}], ["Giving formulary and drug cost information to providers was associated with lower increases in total drug costs but not with lower out-of-pocket costs or greater medication use.", {"entities": []}], ["Insurers and health information technology businesses should continue to increase providers\u2019 access to formulary and drug cost information at the point of care.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-016-1752-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The histones in the core of nucleosomes may be subject to covalent post-transcriptional modifications.", {"entities": []}], ["These modifications are thought to correlate with and possibly affect various genomic functions, including transcription.", {"entities": []}], ["Each modification may alone or in combination with other modifications influence or be influenced by transcription.", {"entities": []}], ["We aimed to identify correlations between single modifications or combinations of modifications at specific nucleosome sized gene regions with transcription activity based on global histone modification and transcription data of human CD4+ T cells and three other human cell lines.", {"entities": []}], ["Transcription activity was defined in a binary fashion as either on or off.", {"entities": []}], ["The analysis was done using the Classification and Regression Tree (CART) data mining protocol, and the Multifactorial Dimensionality Reduction (MDR) method was performed to confirm the CART results.", {"entities": []}], ["These powerful methods have not previously been used for analysis of histone modification data.", {"entities": []}], ["We showed that analysis of the single histone modification H2BK5ac at only four gene regions correctly predicted transcription activity status of over 75% of genes in CD4+ T-cells.", {"entities": []}], ["The H2BK5ac modification status also had high power for prediction of gene transcription activity in the three other cell lines studied.", {"entities": []}], ["The informative gene regions with the H2BK5ac modification were all positioned proximal to transcription initiation sites.", {"entities": []}], ["The CART and MDR methods were appropriate tools for the analysis performed.", {"entities": []}], ["In the study, we also developed a non-arbitrary protocol for binary classification of genes as transcriptionally active or inactive.", {"entities": []}], ["The importance of H2BK5ac modification with regards to transcription control has not previously been emphasized.", {"entities": []}], ["Analysis of this single modification at only four nucleosome sized gene regions, all of which are at or proximal to transcription initiation, has high power for prediction of gene transcription activity.", {"entities": []}], ["The online version of this article (doi:10.1186/s12859-016-1418-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To determine the presence of staphylococcal superantigen-specific IgE antibodies and degree of IgE-mediated sensitization, as well as whether or not those are associated with the severity of asthma in adult patients.", {"entities": [[191, 197, "DISEASE"]]}], ["This was a cross-sectional study involving outpatients with asthma under treatment at a tertiary care university hospital in the city of Rio de Janeiro, Brazil.", {"entities": [[60, 66, "DISEASE"]]}], ["Consecutive patients were divided into two groups according to the severity of asthma based on the Global Initiative for Asthma criteria: mild asthma (MA), comprising patients with mild intermittent or persistent asthma; and moderate or severe asthma (MSA).", {"entities": [[79, 85, "DISEASE"], [121, 127, "DISEASE"], [143, 149, "DISEASE"], [213, 219, "DISEASE"], [244, 250, "DISEASE"]]}], ["We determined the serum levels of staphylococcal toxin-specific IgE antibodies, comparing the results and performing a statistical analysis.", {"entities": []}], ["The study included 142 patients: 72 in the MA group (median age = 46 years; 59 females) and 70 in the MSA group (median age = 56 years; 60 females).", {"entities": []}], ["In the sample as a whole, 62 patients (43.7%) presented positive results for staphylococcal toxin-specific IgE antibodies: staphylococcal enterotoxin A (SEA), in 29 (20.4%); SEB, in 35 (24.6%); SEC, in 33 (23.2%); and toxic shock syndrome toxin (TSST), in 45 (31.7%).", {"entities": [[230, 238, "DISEASE"], [218, 238, "DISEASE"]]}], ["The mean serum levels of IgE antibodies to SEA, SEB, SEC, and TSST were 0.96 U/L, 1.09 U/L, 1.21 U/L, and 1.18 U/L, respectively.", {"entities": []}], ["There were no statistically significant differences between the two groups in terms of the qualitative or quantitative results.", {"entities": []}], ["Serum IgE antibodies to SEA, SEB, SEC, and TSST were detected in 43.7% of the patients in our sample.", {"entities": []}], ["However, neither the qualitative nor quantitative results showed a statistically significant association with the clinical severity of asthma.", {"entities": [[135, 141, "DISEASE"]]}], ["Lung cancer remains one of the most prominent public health challenges, accounting for the highest incidence and mortality among all human cancers.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"]]}], ["While pulmonary invasive mucinous adenocarcinoma (PIMA) is one of the most aggressive types of non-small cell lung cancer, transcriptional drivers of PIMA remain poorly understood.", {"entities": [[25, 48, "DISEASE"], [34, 48, "DISEASE"], [110, 121, "DISEASE"], [115, 121, "DISEASE"]]}], ["In the present study, we found that Forkhead box M1 transcription factor (FOXM1) is highly expressed in human PIMAs and associated with increased extracellular mucin deposition and the loss of NKX2.1.", {"entities": [[74, 79, "GENE"]]}], ["To examine consequences of FOXM1 expression in tumor cells in vivo , we employed an inducible, transgenic mouse model to express an activated FOXM1 transcript in urethane-induced benign lung adenomas.", {"entities": [[27, 32, "GENE"], [142, 147, "GENE"], [27, 32, "GENE"], [142, 147, "GENE"]]}], ["FOXM1 accelerated tumor growth, induced progression from benign adenomas to invasive, metastatic adenocarcinomas, and induced SOX2, a marker of poorly differentiated tumor cells.", {"entities": [[0, 5, "GENE"], [126, 130, "GENE"]]}], ["Adenocarcinomas in FOXM1 transgenic mice expressed increased MUC5B and MUC5AC, and reduced NKX2.1, which are characteristics of mucinous adenocarcinomas.", {"entities": [[19, 24, "GENE"], [61, 66, "GENE"]]}], ["Expression of FOXM1 in Kras AGR2 gene promoter via the -257/-247 bp region.", {"entities": [[14, 19, "GENE"], [28, 32, "GENE"]]}], ["Finally, using orthotopic xenografts we demonstrated that inhibition of either FOXM1 or AGR2 in human PIMAs inhibited mucinous characteristics, and reduced tumor growth and invasion.", {"entities": [[79, 84, "GENE"], [88, 92, "GENE"]]}], ["Altogether, FOXM1 is necessary and sufficient to induce mucinous phenotypes in lung tumor cells in vivo .", {"entities": [[12, 17, "GENE"]]}], ["Lung cancer is the leading cause of cancer-related deaths in men and women in the United States.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"], [36, 42, "DISEASE"]]}], ["It has a high rate of mortality due to late detection and aggressive metastasis.", {"entities": []}], ["While multiple genes were implicated in the development of lung cancer, the molecular mechanisms that trigger the progression of benign lung adenomas to aggressive adenocarcinomas are still unclear.", {"entities": [[59, 70, "DISEASE"], [64, 70, "DISEASE"]]}], ["FOXM1 is a transcription factor, which is induced in lung cancers and is correlated with poor prognosis.", {"entities": [[0, 5, "GENE"]]}], ["In the present study, we used genetically-altered mice to express an activated form of FOXM1 protein in pre-existing benign lung adenomas.", {"entities": [[87, 92, "GENE"]]}], ["FOXM1 induced progression of lung adenomas into invasive, metastatic adenocarcinomas with a mucinous phenotype.", {"entities": [[0, 5, "GENE"]]}], ["In an orthotopic xenograft model of human mucinous lung adenocarcinoma, inhibition of FOXM1 suppressed mucinous characteristics and reduced the tumor invasion and metastasis.", {"entities": [[56, 70, "DISEASE"], [51, 70, "DISEASE"], [86, 91, "GENE"]]}], ["FOXM1 directly activated the AGR2 gene, a key regulator of mucinous phenotype in lung cancer cells.", {"entities": [[81, 92, "DISEASE"], [86, 92, "DISEASE"], [0, 5, "GENE"], [29, 33, "GENE"]]}], ["We have demonstrated that FOXM1 is sufficient to drive progression of adenomas to adenocarcinomas and is nessesary to maintain a mucinous phenotype.", {"entities": [[26, 31, "GENE"]]}], ["Therapeutic targeting of FOXM1 can be beneficial for treatment of PIMA patients.", {"entities": [[25, 30, "GENE"]]}], ["The zinc-dependent metalloproteases with His-Glu-x-x-His (HExxH) active site motif, zincins, are a broad group of proteins involved in many metabolic and regulatory functions, and found in all forms of life.", {"entities": []}], ["Human genome contains more than 100 genes encoding proteins with known zincin-like domains.", {"entities": []}], ["A survey of all proteins containing the HExxH motif shows that approximately 52% of HExxH occurrences fall within known protein structural domains (as defined in the Pfam database).", {"entities": []}], ["Domain families with majority of members possessing a conserved HExxH motif include, not surprisingly, many known and putative metalloproteases.", {"entities": []}], ["Furthermore, several HExxH-containing protein domains thus identified can be confidently predicted to be putative peptidases of zincin fold.", {"entities": []}], ["Thus, we predict zincin-like fold for eight uncharacterised Pfam families.", {"entities": []}], ["Besides the domains with the HExxH motif strictly conserved, and those with sporadic occurrences, intermediate families are identified that contain some members with a conserved HExxH motif, but also many homologues with substitutions at the conserved positions.", {"entities": []}], ["Such substitutions can be evolutionarily conserved and non-random, yet functional roles of these inactive zincins are not known.", {"entities": []}], ["The CLCAs are a novel zincin-like protease family with many cases of substituted active sites.", {"entities": []}], ["We show that this allegedly metazoan family has a number of bacterial and archaeal members.", {"entities": []}], ["An extremely patchy phylogenetic distribution of CLCAs in prokaryotes and their conserved protein domain composition strongly suggests an evolutionary scenario of horizontal gene transfer (HGT) from multicellular eukaryotes to bacteria, providing an example of eukaryote-derived xenologues in bacterial genomes.", {"entities": []}], ["Additionally, in a protein family identified here as closely homologous to CLCA, the CLCA_X (CLCA-like) family, a number of proteins is found in phages and plasmids, supporting the HGT scenario.", {"entities": []}], ["Giardia is the most frequently identified intestinal parasite in North America.", {"entities": []}], ["Although information on geographical distribution of giardiasis is critical in identifying communities at high risk, little has been done in this area.", {"entities": [[53, 63, "DISEASE"]]}], ["Therefore, the objective of this study was to investigate the geographical and temporal distribution of human giardiasis in Ontario in order to identify possible high risk areas and seasons.", {"entities": [[110, 120, "DISEASE"]]}], ["Two spatial scales of analyses and two disease measures were used with a view to identifying the best of each in assessing geographical patterns of giardiasis in Ontario.", {"entities": [[148, 158, "DISEASE"]]}], ["Global Moran's I and Moran Local Indicators of Spatial Associations were used to test for evidence of global and local spatial clustering, respectively.", {"entities": []}], ["There were seasonal patterns with summer peaks and a significant (P < 0.001) decreasing temporal trend.", {"entities": []}], ["Significant (P < 0.05) global spatial clustering of high rates was observed at the Census Sub-division spatial scale but not at the Census Division scale.", {"entities": []}], ["The Census Sub-division scale was a better scale of analyses but required spatial empirical Bayesian smoothing of the rates.", {"entities": []}], ["A number of areas with significant local clustering of giardiasis rates were identified.", {"entities": [[55, 65, "DISEASE"]]}], ["The study identified spatial and temporal patterns in giardiasis distribution.", {"entities": [[54, 64, "DISEASE"]]}], ["This information is important in guiding decisions on disease control strategies.", {"entities": []}], ["The study also showed that there is benefit in performing spatial analyses at more than one spatial scale to assess geographical patterns in disease distribution and that smoothing of disease rates for mapping in small areas enhances visualization of spatial patterns.", {"entities": []}], ["COPD is a long-term condition associated with considerable disability with a clinical course characterized by episodes of worsening respiratory signs and symptoms associated with exacerbations.", {"entities": []}], ["Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal conditions in the general population and has emerged as a comorbidity of COPD.", {"entities": []}], ["GERD may be diagnosed by both symptomatic approaches (including both typical and atypical symptoms) and objective measurements.", {"entities": []}], ["Based on a mix of diagnostic approaches, the prevalence of GERD in COPD ranges from 17% to 78%.", {"entities": []}], ["Although GERD is usually confined to the lower esophagus in some individuals, it may be associated with pulmonary microaspiration of gastric contents.", {"entities": []}], ["Possible mechanisms that may contribute to GERD in COPD originate from gastroesophageal dysfunction, including altered pressure in the lower esophageal sphincter (which normally protect against GERD) and changes in esophageal motility.", {"entities": []}], ["Proposed respiratory contributions to the development of GERD include respiratory medications that may alter esophageal sphincter tone and changes in respiratory mechanics, with increased lung hyperinflation compromising the antireflux barrier.", {"entities": []}], ["Although the specific cause and effect relationship between GERD and COPD has not been fully elucidated, GERD may influence lung disease severity and has been identified as a significant predictor of acute exacerbations of COPD.", {"entities": [[124, 136, "DISEASE"]]}], ["Further clinical effects could include a poorer health-related quality of life and an increased cost in health care, although these factors require further clarification.", {"entities": []}], ["There are both medical and surgical options available for the treatment of GERD in COPD and while extensive studies in this population have not been undertaken, this comorbidity may be amenable to treatment.", {"entities": []}], ["Curcumin, a naturally occurring polyphenolic compound, is known to possess diverse pharmacological properties.", {"entities": []}], ["There is a scarcity of literature documenting the exact mechanism by which curcumin modulates its biological effects.", {"entities": []}], ["In the present study, we have used yeast as a model organism to dissect the mechanism underlying the action of curcumin.", {"entities": []}], ["We found that the yeast mutants of histone proteins and chromatin modifying enzymes were sensitive to curcumin and further supplementation of iron resulted in reversal of the changes induced by curcumin.", {"entities": []}], ["Additionally, treatment of curcumin caused the iron starvation induced expression of FET3, FRE1 genes.", {"entities": []}], ["We also demonstrated that curcumin induces degradation of Sml1p, a ribonucleotide reductase inhibitor involved in regulating dNTPs production.", {"entities": []}], ["The degradation of Sml1p was mediated through proteasome and vacuole dependent protein degradation pathways.", {"entities": []}], ["Furthermore, curcumin exerts biological effect by altering global proteome profile without affecting chromatin architecture.", {"entities": []}], ["These findings suggest that the medicinal properties of curcumin are largely contributed by its cumulative effect of iron starvation and epigenetic modifications.", {"entities": []}], ["Pangi Valley is the interior most tribal area in Himachal Pradesh of Northwest Himalaya.", {"entities": []}], ["An ethnobotanical investigation is attempted to highlight the traditional knowledge of medicinal plants being used by the tribes of Pangi Valley.", {"entities": []}], ["Various localities visited in the valley 2-3 times in a year and ethnobotanical information was collected through interviews with elderly people, women, shepherds, and local vaids during May 2009 to September 2013.", {"entities": []}], ["This paper documented 67 plant species from 59 genera and 36 families along with their botanical name, local name, family name, habit, medicinal parts used, and traditional usage, including the use of 35 plants with new ethnomedicinal and other use from the study area for the first time.", {"entities": []}], ["Wild plants represent an important part of their medicinal, dietary, handicraft, fuel wood, veterinary, and fodder components.", {"entities": []}], ["These tribal inhabitants and migrants depend on the wild plant resources for food, medicines, fuel, fibre, timber, and household articles for their livelihood security.", {"entities": []}], ["The present study documents and contributes significant ethnobotanical information from the remote high altitude and difficult region of the world, which remains cut off from rest of the world for 6-7 months due to heavy snowfall.", {"entities": []}], ["The risks of the morbidity of the asbestos-related lung cancer was estimated in the general population of Poles as the result of increased exposure to asbestos fibers during the removal of asbestos-cement products and the possibility of the valuation of the social costs related to this risk.", {"entities": [[51, 62, "DISEASE"], [56, 62, "DISEASE"]]}], ["The prediction of the new incidences was made using linear regression model.", {"entities": []}], ["The forecast shows that to the end of 2030 about 3,500 new cases of lung cancer can be expected as a result of occupational exposure to asbestos in the past which makes together with paraoccupational exposure about 14.000 new cases.", {"entities": [[68, 79, "DISEASE"], [73, 79, "DISEASE"]]}], ["The forecast shows the increasing number of asbestos-related lung cancer in Poland and indicates the priority areas where preventive action should be implemented.", {"entities": [[61, 72, "DISEASE"], [66, 72, "DISEASE"]]}], ["A large increase in nitric oxide fraction (FeNO) after radiotherapy (RT) for lung cancer may predict RT-induced lung toxicity.", {"entities": [[77, 88, "DISEASE"], [82, 88, "DISEASE"]]}], ["In this study, we assessed the relationships between FeNO variations and respiratory symptoms, CT scan changes or dose volume histogram (DVH) parameters after RT.", {"entities": []}], ["We measured FeNO before RT, 4, 5, 6, 10\u2009weeks, 4 and 7.5\u2009months after RT in 65 lung cancer patients.", {"entities": [[79, 90, "DISEASE"], [84, 90, "DISEASE"]]}], ["Eleven lung cancer patients (17%) complained of significant respiratory symptoms and 21 (31%) had radiation pneumonitis images in >1/3 of the irradiated lung after RT.", {"entities": [[7, 18, "DISEASE"], [12, 18, "DISEASE"]]}], ["Thirteen patients (20%) showed increases in FeNO >10\u2009ppb.", {"entities": []}], ["The sensitivity and specificity of a >10\u2009ppb FeNO increase for the diagnosis of RT-associated respiratory symptoms were 18% and 83%, respectively.", {"entities": []}], ["There was no correlation between DVH parameters or CT scan changes after RT and FeNO variations.", {"entities": []}], ["Three patients (5%) showed intriguingly strong (2 or 3-fold, up to 55\u2009ppb) and sustained increases in FeNO at 4 and 5\u2009weeks, followed by significant respiratory symptoms and/or radiation-pneumonitis images.", {"entities": []}], ["Serial FeNO measurements during RT had a low ability to identify lung cancer patients who developed symptoms or images of radiation pneumonitis.", {"entities": [[65, 76, "DISEASE"], [70, 76, "DISEASE"]]}], ["However, three patients presented with a particular pattern which deserves to be investigated.", {"entities": []}], ["\u2018Finding the missing millions\u2019 with chronic obstructive pulmonary disease became part of the Department of Health strategy for England in 2010.", {"entities": [[36, 73, "DISEASE"]]}], ["Targeted case-finding within primary care is one potential pro-active strategy, but currently little is known about the views of healthcare professionals on this approach.", {"entities": []}], ["In this study, 36 healthcare professionals (12 GPs, 14 nurses, and 10 practice managers) from 34 UK practices participated in semi-structured telephone interviews about targeted case-finding.", {"entities": []}], ["Interviews followed an interview guide, were audio-recorded, transcribed verbatim, coded and analysed using \u2018Framework Approach\u2019.", {"entities": []}], ["Most of those interviewed practiced opportunistic case-finding.", {"entities": []}], ["The main perceived barriers to wider case-finding programmes were the resource implications associated with running such programmes and identifying more chronic obstructive pulmonary disease patients.", {"entities": [[153, 190, "DISEASE"]]}], ["Financial incentives, support from specialist clinicians, and comprehensive guidance were viewed as facilitators.", {"entities": []}], ["While targeted case-finding is conceptually accepted by primary care staff, scepticism surrounding (1) the value of identifying those with mild disease and (2) the availability of effective targeted case-finding methods, may lead some to favour an opportunistic approach.", {"entities": []}], ["Key concerns were a lack of unequivocal evidence for the relative benefits vs. disadvantages of diagnosing patients earlier, and resource constraints in an already over-burdened system.", {"entities": []}], ["Barriers to practical implementation of case-finding studies may be addressed with financial, human and educational resources, such as additional staff to undertake searches and perform spirometry tests, and practical and educational support from specialist teams.", {"entities": []}], ["Additional staff and resources would facilitate targeted searches for patients showing symptoms of early-stage chronic lung disease.", {"entities": [[119, 131, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) costs the UK economy billions of pounds each year, yet disparate symptoms mean patients aren\u2019t always diagnosed in the early, treatable stages of the disease.", {"entities": [[0, 37, "DISEASE"]]}], ["Recent guidelines suggest introducing \u2018targeted case-finding\u2019, where symptomatic patients with known risk factors are identified and approached for testing by doctors.", {"entities": []}], ["Rachael Summers and colleagues at the University of Southampton analyzed the opinions of healthcare professionals on implementing targeted case-finding in primary care.", {"entities": []}], ["While most of the 36 professionals interviewed agreed that diagnosing COPD earlier had clear benefits, concerns were raised regarding negative patient responses and increased stress for patients, alongside the added strain on already stretched resources.", {"entities": []}], ["Employing independent staff and enhancing resources may facilitate such a program.", {"entities": []}], ["The function of the nuclear receptor (NR) in breast cancer progression has been investigated for decades.", {"entities": [[45, 58, "DISEASE"], [52, 58, "DISEASE"]]}], ["The majority of the nuclear receptors have well characterized natural ligands, but a few of them are orphan receptors for which no ligand has been identified.", {"entities": []}], ["ROR\u03b1, one member of the retinoid orphan nuclear receptor (ROR) subfamily of orphan receptors, regulates various cellular and pathological activities.", {"entities": []}], ["ROR\u03b1 is commonly down-regulated and/or hypoactivated in breast cancer compared to normal mammary tissue.", {"entities": [[56, 69, "DISEASE"], [63, 69, "DISEASE"]]}], ["Expression of ROR\u03b1 suppresses malignant phenotypes in breast cancer cells, in vitro and in vivo .", {"entities": [[54, 67, "DISEASE"], [61, 67, "DISEASE"]]}], ["Activity of ROR\u03b1 can be categorized into the canonical and non-canonical nuclear receptor pathways, which in turn regulate various breast cancer cellular function, including cell proliferation, apoptosis and invasion.", {"entities": [[131, 144, "DISEASE"], [138, 144, "DISEASE"]]}], ["This information suggests that ROR\u03b1 is a potent tumor suppressor and a potential therapeutic target for breast cancer.", {"entities": [[104, 117, "DISEASE"], [111, 117, "DISEASE"]]}], ["Flavonoids, from Scutellaria baicalensis (Chinese skullcap) and Acacia catechu (black catechu), have been shown to exert a variety of therapeutic effects, including anti-inflammatory, antiviral, antibacterial, and anticancer activities.", {"entities": []}], ["Flavocoxid is a mixed extract containing baicalin and catechin and it acts as a dual balanced inhibitor of cyclooxygenase-1 (COX-1) and COX-2 peroxidase enzyme activities with a significant inhibition of 5-lipoxygenase (5-LOX) enzyme activity in vitro .", {"entities": []}], ["Flavocoxid downregulates gene or protein expression of several inflammatory markers and exerts also strong antioxidant activity in several experimental models.", {"entities": []}], ["Controlled clinical trials and a postmarketing study have clearly shown that flavocoxid is as effective as naproxen in managing the signs and symptoms of osteoarthritis of the knee and it has better upper gastrointestinal, renal, and respiratory safety profile than naproxen.", {"entities": [[154, 168, "DISEASE"]]}], ["Flavocoxid may therefore provide a potential therapeutic approach to the treatment of chronic inflammatory conditions.", {"entities": []}], ["When a randomised trial is subject to deviations from randomised treatment, analysis according to intention-to-treat does not estimate two important quantities: relative treatment efficacy and effectiveness in a setting different from that in the trial.", {"entities": []}], ["Even in trials of a predominantly pragmatic nature, there may be numerous reasons to consider the extent, and impact on analysis, of such deviations from protocol.", {"entities": []}], ["Simple methods such as per-protocol or as-treated analyses, which exclude or censor patients on the basis of their adherence, usually introduce selection and confounding biases.", {"entities": []}], ["However, there exist appropriate causal estimation methods which seek to overcome these inherent biases, but these methods remain relatively unfamiliar and are rarely implemented in trials.", {"entities": []}], ["This paper demonstrates when it may be of interest to look beyond intention-to-treat analysis for answers to alternative causal research questions through illustrative case studies.", {"entities": []}], ["We seek to guide trialists on how to handle treatment changes in the design, conduct and planning the analysis of a trial; these changes may be planned or unplanned, and may or may not be permitted in the protocol.", {"entities": []}], ["We highlight issues that must be considered at the trial planning stage relating to: the definition of nonadherence and the causal research question of interest, trial design, data collection, monitoring, statistical analysis and sample size.", {"entities": []}], ["During trial planning, trialists should define their causal research questions of interest, anticipate the likely extent of treatment changes and use these to inform trial design, including the extent of data collection and data monitoring.", {"entities": []}], ["A series of concise recommendations is presented to guide trialists when considering undertaking causal analyses.", {"entities": []}], ["We have cloned a novel mouse CC chemokine cDNA from the lung during an allergic inflammatory reaction.", {"entities": []}], ["The protein encoded by this cDNA is chemotactic for eosinophils, monocytes, and lymphocytes in vitro and in vivo.", {"entities": []}], ["Based on its similarities in sequence and function with other CC chemokines, we have named it mouse monocyte chemotactic protein-5 (mMCP- 5).", {"entities": []}], ["Under noninflammatory conditions, expression of mMCP-5 in the lymph nodes and thymus is constitutive and is generally restricted to stromal cells.", {"entities": []}], ["Neutralization of mMCP-5 protein with specific antibodies during an allergic inflammatory reaction in vivo resulted in a reduction in the number of eosinophils that accumulated in the lung.", {"entities": []}], ["Moreover, mMCP- 5 mRNA expression in vivo is regulated differently from that of other major CC chemokines in the lung during the allergic reaction, including Eotaxin.", {"entities": []}], ["The presence of lymphocytes is essential for expression of mMCP-5 by alveolar macrophages and smooth muscle cells in the lung, and the induction of mMCP-5 RNA occurs earlier than that of the eosinophil chemokine Eotaxin during allergic inflammation.", {"entities": []}], ["In contrast to Eotaxin, mRNA for mMCP-5 can be produced by mast cells.", {"entities": []}], ["From these results, we postulate that mMCP-5 plays a pivotal role during the early stages of allergic lung inflammation.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a chronic and progressive disease that affects an estimated 10% of the world\u2019s population over the age of 40 years.", {"entities": []}], ["Worldwide, COPD ranks in the top ten for causes of disability and death.", {"entities": []}], ["Given the significant impact of this disease, it is important to note that acute exacerbations of COPD (AECOPD) are by far the most costly and devastating aspect of disease management.", {"entities": []}], ["Systemic steroids have long been a standard for the treatment of AECOPD; however, the optimal strategy for dosing and administration of these medications continues to be debated.", {"entities": []}], ["To review the use of corticosteroids in the treatment of acute exacerbations of COPD.", {"entities": []}], ["Literature was identified through PubMed Medline (1950\u2013February 2014) and Embase (1950\u2013February 2014) utilizing the search terms corticosteroids, COPD, chronic bronchitis, emphysema, and exacerbation.", {"entities": [[160, 170, "DISEASE"]]}], ["All reference citations from identified publications were reviewed for possible inclusion.", {"entities": []}], ["All identified randomized, placebo-controlled trials, meta-analyses, and systematic reviews evaluating the efficacy of systemic corticosteroids in the treatment of AECOPD were reviewed and summarized.", {"entities": []}], ["The administration of corticosteroids in the treatment of AECOPD was assessed.", {"entities": []}], ["In comparison to placebo, systemic corticosteroids improve airflow, decrease the rate of treatment failure and risk of relapse, and may improve symptoms and decrease the length of hospital stay.", {"entities": []}], ["Therefore, corticosteroids are recommended by all major guidelines in the treatment of AECOPD.", {"entities": []}], ["Existing literature suggests that low-dose oral corticosteroids are as efficacious as high-dose, intravenous corticosteroid regimens, while minimizing adverse effects.", {"entities": []}], ["Recent data suggest that shorter durations of corticosteroid therapy are as efficacious as the traditional treatment durations currently recommended by guidelines.", {"entities": []}], ["Systemic corticosteroids are efficacious in the treatment of AECOPD and considered a standard of care for patients experiencing an AECOPD.", {"entities": []}], ["Therefore, systemic corticosteroids should be administered to all patients experiencing AECOPD severe enough to seek emergent medical care.", {"entities": []}], ["The lowest effective dose and shortest duration of therapy should be considered.", {"entities": []}], ["Lanphear and colleagues argue that the existing requirements in the US for toxicity testing and regulation of pesticides and industrial chemicals are inadequate to safeguard children Toxicity testing of pesticides and industrial chemicals is a crucial step", {"entities": []}], ["Gout is a prevalent inflammatory arthritis affecting 1\u20132% of adults characterized by activation of innate immune cells by monosodium urate (MSU) crystals resulting in the secretion of interleukin-1\u03b2 (IL-1\u03b2).", {"entities": [[33, 42, "DISEASE"], [0, 4, "DISEASE"]]}], ["Since neutrophils play a major role in gout we sought to determine whether their activation may involve the formation of proinflammatory neutrophil extracellular traps (NETs) in relation to autophagy and IL-1\u03b2.", {"entities": [[39, 43, "DISEASE"]]}], ["Synovial fluid neutrophils from six patients with gout crisis and peripheral blood neutrophils from six patients with acute gout and six control subjects were isolated.", {"entities": [[50, 54, "DISEASE"], [124, 128, "DISEASE"]]}], ["MSU crystals, as well as synovial fluid or serum obtained from patients with acute gout, were used for the treatment of control neutrophils.", {"entities": [[83, 87, "DISEASE"]]}], ["NET formation was assessed using immunofluorescence microscopy.", {"entities": []}], ["MSU crystals or synovial fluid or serum from patients induced NET formation in control neutrophils.", {"entities": []}], ["Importantly, NET production was observed in neutrophils isolated from synovial fluid or peripheral blood from patients with acute gout.", {"entities": [[130, 134, "DISEASE"]]}], ["NETs contained the alarmin high mobility group box 1 (HMGB1) supporting their pro-inflammatory potential.", {"entities": [[54, 59, "GENE"]]}], ["Inhibition of phosphatidylinositol 3-kinase signaling or phagolysosomal fusion prevented NET formation, implicating autophagy in this process.", {"entities": []}], ["NET formation was driven at least in part by IL-1\u03b2 as demonstrated by experiments involving IL-1\u03b2 and its inhibitor anakinra.", {"entities": []}], ["These findings document for the first time that activation of neutrophils in gout is associated with the formation of proinflammatory NETs and links this process to both autophagy and IL-1\u03b2.", {"entities": [[77, 81, "DISEASE"]]}], ["Modulation of the autophagic machinery may represent an additional therapeutic study in crystalline arthritides.", {"entities": []}], ["Vitamin D is associated with lung health in epidemiologic studies, but mechanisms mediating observed associations are poorly understood.", {"entities": []}], ["This study explores mechanisms for an effect of vitamin D in lung through an in vivo gene expression study, an expression quantitative trait loci (eQTL) analysis in lung tissue, and a population-based cohort study of sequence variants.", {"entities": []}], ["Microarray analysis investigated the association of gene expression in small airway epithelial cells with serum 25(OH)D in adult non-smokers.", {"entities": []}], ["Sequence variants in candidate genes identified by the microarray were investigated in a lung tissue eQTL database, and also in relation to cross-sectional pulmonary function in the Health, Aging, and Body Composition (Health ABC) study, stratified by race, with replication in the Framingham Heart Study (FHS).", {"entities": []}], ["13 candidate genes had significant differences in expression by serum 25(OH)D (nominal p\u2009<\u20090.05), and a genome-wide significant eQTL association was detected for SGPP2.", {"entities": [[162, 167, "GENE"]]}], ["In Health ABC, SGPP2 SNPs were associated with FEV 1 in both European- and African-Americans, and the gene-level association was replicated in European-American FHS participants.", {"entities": [[15, 20, "GENE"], [47, 50, "GENE"]]}], ["SNPs in 5 additional candidate genes ( DAPK1, FSTL1, KAL1, KCNS3, and RSAD2 ) were associated with FEV 1 in Health ABC participants.", {"entities": [[39, 44, "GENE"], [46, 51, "GENE"], [53, 57, "GENE"], [59, 64, "GENE"], [70, 75, "GENE"], [99, 102, "GENE"]]}], ["SGPP2, a sphingosine-1-phosphate phosphatase, is a novel vitamin D-responsive gene associated with lung function.", {"entities": [[0, 5, "GENE"]]}], ["The identified associations will need to be followed up in further studies.", {"entities": []}], ["The innate immune response is essential for combating infectious disease.", {"entities": []}], ["Macrophages and other cells respond to infection by releasing cytokines such as interleukin-1\u03b2 (IL-1\u03b2), which in turn activate a well-described myeloid differentiation factor 88 (MYD88) -mediated, nuclear factor-\u03baB (NF-\u03baB) -dependent transcriptional pathway that results in inflammatory cell activation and recruitment", {"entities": [[179, 184, "GENE"]]}], ["Toxocara canis and T. cati are parasites of dogs and cats, respectively, that infect humans and cause human toxocariasis.", {"entities": [[108, 120, "DISEASE"]]}], ["Infection may cause asthma-like symptoms but is often asymptomatic and is associated with a marked eosinophilia.", {"entities": [[99, 111, "DISEASE"], [20, 26, "DISEASE"]]}], ["Previous epidemiological studies indicate that T. canis infection may be associated with the development of atopy and asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["To investigate possible associations between Toxocara spp.", {"entities": []}], ["seropositivity and atopy and childhood wheezing in a population of children living in non-affluent areas of a large Latin American city.", {"entities": []}], ["The study was conducted in the city of Salvador, Brazil.", {"entities": []}], ["Data on wheezing symptoms were collected by questionnaire, and atopy was measured by the presence of aeroallergen-specific IgE (sIgE).", {"entities": []}], ["Skin prick test (SPT), total IgE and peripheral eosinophilia were measured.", {"entities": [[48, 60, "DISEASE"]]}], ["Toxocara seropositivity was determined by the presence of anti- Toxocara IgG antibodies, and intestinal helminth infections were determined by stool microscopy.", {"entities": []}], ["Children aged 4 to 11 years were studied, of whom 47% were seropositive for anti- Toxocara IgG; eosinophilia >4% occurred in 74.2% and >10% in 25.4%; 59.6% had elevated levels of total IgE; 36.8% had sIgE\u22650.70 kU/L and 30.4% had SPT for at least one aeroallergen; 22.4% had current wheezing symptoms.", {"entities": [[96, 108, "DISEASE"]]}], ["Anti- Toxocara IgG was positively associated with elevated eosinophils counts, total IgE and the presence of specific IgE to aeroallergens but was inversely associated with skin prick test reactivity.", {"entities": []}], ["The prevalence of Toxocara seropositivity was high in the studied population of children living in conditions of poverty in urban Brazil.", {"entities": []}], ["Toxocara infection, although associated with total IgE, sIgE and eosinophilia, may prevent the development of skin hypersensitivity to aeroallergens, possibly through increased polyclonal IgE and the induction of a modified Th2 immune reaction.", {"entities": [[65, 77, "DISEASE"]]}], ["Toxocara canis and T. cati are roundworms found in dogs and cats, respectively, that can also infect humans and cause several clinical features, including asthma-like symptoms.", {"entities": [[155, 161, "DISEASE"]]}], ["Human infections with T. canis have been associated with an increased prevalence of atopy and asthma.", {"entities": [[94, 100, "DISEASE"]]}], ["In the present study, we investigated the associations between Toxocara seropositivity with eosinophilia, total IgE, specific IgE and skin prick test reactivity to aeroallergens, as well as atopic and non-atopic wheezing.", {"entities": [[92, 104, "DISEASE"]]}], ["Toxocara seropositivity was associated with elevated eosinophil counts and total and aeroallergen-specific IgE but was also associated with a decreased prevalence of skin prick test.", {"entities": []}], ["Toxocara seropositivity was not associated with atopic wheezing.", {"entities": []}], ["In conclusion, our data show that human toxocariasis, although associated with eosinophilia and raised levels of total and allergen-specific IgE, may play a role in the modulation of allergic effector responses in the skin.", {"entities": [[40, 52, "DISEASE"], [79, 91, "DISEASE"]]}], ["Several components of air pollution have been linked to asthma.", {"entities": [[56, 62, "DISEASE"]]}], ["In addition to the well-studied critera air pollutants, such as nitrogen dioxide, sulfur dioxide, and ozone, diesel exhaust and diesel exhaust particles (DEPs) also appear to play a role in respiratory and allergic diseases.", {"entities": []}], ["Diesel exhaust is composed of vapors, gases, and fine particles emitted by diesel-fueled compression-ignition engines.", {"entities": []}], ["DEPs can act as nonspecific airway irritants at relatively high levels.", {"entities": []}], ["At lower levels, DEPs promote release of specific cytokines, chemokines, immunoglobulins, and oxidants in the upper and lower airway.", {"entities": []}], ["Release of these mediators of the allergic and inflammatory response initiates a cascade that can culminate in airway inflammation, mucus secretion, serum leakage into the airways, and bronchial smooth muscle contraction.", {"entities": []}], ["DEPs also may promote expression of the T(subscript)H(/subscript)2 immunologic response phenotype that has been associated with asthma and allergic disease.", {"entities": [[128, 134, "DISEASE"]]}], ["DEPs appear to have greater immunologic effects in the presence of environmental allergens than they do alone.", {"entities": []}], ["This immunologic evidence may help explain the epidemiologic studies indicating that children living along major trucking thoroughfares are at increased risk for asthmatic and allergic symptoms and are more likely to have objective evidence of respiratory dysfunction.", {"entities": []}], ["Mycobacterium immunogenum is an emerging pathogen of the immune-mediated lung disease hypersensitivity pneumonitis (HP) reported in machinists occupationally exposed to contaminated metal working fluid (MWF).", {"entities": [[73, 85, "DISEASE"], [116, 118, "GENE"]]}], ["However, the mechanism of its interaction with the host lung is unclear.", {"entities": []}], ["Considering that alveolar macrophages play a central role in host defense in the exposed lung, understanding their interaction with the pathogen could provide initial insights into the underlying immunopathogenesis events and mechanisms.", {"entities": []}], ["In the current study, M. immunogenum 700506, a predominant genotype isolated from HP-linked fluids, was shown to multiply intracellularly, induce proinflammatory mediators (TNF-\u03b1, IL-1\u03b1, IL-1\u03b2, IL-6, GM-CSF, NO) and cause cytotoxicity/cell death in the cultured murine alveolar macrophage cell line MH-S in a dose- and time-dependent manner.", {"entities": []}], ["The responses were detected as early as 3h post-infection.", {"entities": []}], ["Comparison of this and four additional genotypes of M. immunogenum (MJY-3, MJY-4, MJY-12, MJY-14) using an effective dose-time combination (100 MOI for 24h) showed these macrophage responses in the following order (albeit with some variations for individual response indicators).", {"entities": []}], ["Inflammatory: MJY-3 \u2265 700506 > MJY-4 \u2265 MJY-14 \u2265 MJY-12; Cytotoxic: 700506 \u2265 MJY-3 > MJY-4 \u2265 MJY-12 \u2265 MJY-14.", {"entities": []}], ["In general, 700506 and MJY-3 showed a more aggressive response than other genotypes.", {"entities": []}], ["Chemical blocking of either p38 or JNK inhibited the induction of proinflammatory mediators (cytokines, NO) by 700506.", {"entities": []}], ["However, the cellular responses showed a somewhat opposite effect.", {"entities": []}], ["This is the first report on M .", {"entities": []}], ["immunogenum interactions with alveolar macrophages and on the identification of JNK- and p38- mediated signaling and its role in mediating the proinflammatory responses during these interactions.", {"entities": []}], ["Spirometry is a cost-effective diagnostic tool for evaluation of lung function and for case-finding in a resource-limited setting.", {"entities": []}], ["The acceptance of this test depends on the awareness of its indications and the ability to interpret the results.", {"entities": []}], ["No studies have assessed the knowledge of spirometry among Nigerian doctors.", {"entities": []}], ["The aim of this study was to evaluate the current knowledge, awareness and practice of spirometry among hospital-based Nigerian doctors.", {"entities": []}], ["We carried out a cross-sectional survey among 321 doctors working in Nigerian hospitals between March 2008 and June 2008.", {"entities": []}], ["Information on knowledge, awareness, practice of and barriers to spirometry were obtained using a pre-tested, self-administered structured questionnaire and the data were then analysed.", {"entities": []}], ["Of the 321 doctors that participated, 108 (33.6%) reported that they have good knowledge of spirometry.", {"entities": []}], ["One hundred and ninety-five (60.7%) were aware of the importance of spirometry in aiding the diagnosis of respiratory diseases; 213(66.4%) were aware of the importance of spirometry in determining the severity of diseases.", {"entities": []}], ["Medical school was the most common source of knowledge on spirometry (64.5%).", {"entities": []}], ["Eighty-one (25.2%) doctors reported having a spirometer in their hospitals.", {"entities": []}], ["Doctors having access to a spirometer used it more frequently for aiding the diagnosis of COPD (40.7% vs.27.5%) and for monitoring of asthma (18.5% vs.11.3%) than those without access to a spirometer.", {"entities": [[134, 140, "DISEASE"]]}], ["The doctors working in University Teaching Hospitals and Federal Medical Centres (FMC) (22.4% vs. 4.5%) and those having access to a spirometer (40.7 vs.11.3%) were very confident of interpreting spirometry results compared to those working in District and General Hospitals and without access to a spirometer.", {"entities": []}], ["Irrespective of access to a spirometer or the type of hospital they were employed in, doctors reported that unavailability of a spirometer was the greatest barrier to its use (62.5%) followed by lack of awareness about its usefulness (17.2%).", {"entities": []}], ["The knowledge and practice of spirometry were poor among hospital-based Nigerian doctors because of unavailability of spirometers in most hospitals.", {"entities": []}], ["These findings have implications for further evaluation, planning and management of patient care in respiratory disease.", {"entities": []}], ["Spirometers should be made available in all hospitals, and the knowledge of spirometry should be improved among doctors.", {"entities": []}], ["In 2003, an internet-based monitoring system of influenza-like illness (ILI), the Great Influenza Survey (GIS), was initiated in Belgium.", {"entities": [[48, 57, "DISEASE"], [88, 97, "DISEASE"]]}], ["For the Flemish part of Belgium, we investigate the representativeness of the GIS population and assess the validity of the survey in terms of ILI incidence during eight influenza seasons (from 2003 through 2011).", {"entities": [[170, 179, "DISEASE"]]}], ["The validity is investigated by comparing estimated ILI incidences from the GIS with recorded incidences from two other monitoring systems, ( i ) the Belgian Sentinel Network and ( ii ) the Google Flu Trends, and by performing a risk factor analysis to investigate whether the risks on acquiring ILI in the GIS population are comparable with results in the literature.", {"entities": []}], ["A random walk model of first order is used to estimate ILI incidence trends based on the GIS.", {"entities": []}], ["Good to excellent correspondence is observed between the estimated ILI trends in the GIS and the recorded trends in the Sentinel Network and the Google Flu Trends.", {"entities": []}], ["The results of the risk factor analysis are in line with the literature.", {"entities": []}], ["In conclusion, the GIS is a useful additional surveillance network for ILI monitoring in Flanders.", {"entities": []}], ["The advantages are the speed at which information is available and the fact that data is gathered directly in the community at an individual level.", {"entities": []}], ["Primary ciliary dyskinesia is characterized by chronic upper and lower respiratory infections which are caused by the grossly impaired ciliary transport.", {"entities": [[0, 26, "DISEASE"]]}], ["Since the cilia and neutrophils both utilize microtubular system for their movement, it has been speculated that neutrophil motility such as chemotaxis might be impaired in patients with primary ciliary dyskinesia.", {"entities": [[187, 213, "DISEASE"]]}], ["Neutrophils were purified from whole blood from 16 patients with primary ciliary dyskinesia and from 15 healthy controls.", {"entities": [[65, 91, "DISEASE"]]}], ["Chemotactic responses of neutrophils to leukotriene B(4) (LTB(4)), complement 5a (C5a), and formylmethionylleucylphenylalanine (fMLP) were examined using the under agarose method.", {"entities": [[58, 61, "GENE"]]}], ["The chemotactic differentials in response to LTB4, C5a, and fMLP in neutrophils from the patient group were significantly lower than the corresponding values in neutrophils from the control group (p<0.05 for all comparisons).", {"entities": []}], ["The difference in chemotactic index between the two groups was statistically significant for LTB4 and fMLP (p<0.05 for both comparisons), but not for C5a (p=0.20).", {"entities": []}], ["Neutrophils from patients with primary ciliary dyskinesia showed a decreased chemotactic response as compared with those from normal subjects.", {"entities": [[31, 57, "DISEASE"]]}], ["It is concluded that the increased frequency of respiratory tract infection in patients with primary ciliary dyskinesia is possibly due to the defective directional migration of neutrophils, as well as to the defective mucociliary clearance of the airways.", {"entities": [[93, 119, "DISEASE"]]}], ["People with dementia are susceptible to adverse drug reactions (ADRs).", {"entities": [[12, 20, "DISEASE"]]}], ["However, they are not always closely monitored for potential problems relating to their medicines: structured nurse-led ADR Profiles have the potential to address this care gap.", {"entities": []}], ["We aimed to assess the number and nature of clinical problems identified and addressed and changes in prescribing following introduction of nurse-led medicines\u2019 monitoring.", {"entities": []}], ["Pragmatic cohort stepped-wedge cluster Randomised Controlled Trial (RCT) of structured nurse-led medicines\u2019 monitoring versus usual care.", {"entities": []}], ["Five UK private sector care homes 41 service users, taking at least one antipsychotic, antidepressant or anti-epileptic medicine.", {"entities": []}], ["Nurses completed the West Wales ADR (WWADR) Profile for Mental Health Medicines with each participant according to trial step.", {"entities": []}], ["Problems addressed and changes in medicines prescribed.", {"entities": []}], ["Information was collected from participants\u2019 notes before randomisation and after each of five monthly trial steps.", {"entities": []}], ["The impact of the Profile on problems found, actions taken and reduction in mental health medicines was explored in multivariate analyses, accounting for data collection step and site.", {"entities": []}], ["Five of 10 sites and 43 of 49 service users approached participated.", {"entities": []}], ["Profile administration increased the number of problems addressed from a mean of 6.02 [SD 2.92] to 9.86 [4.48], effect size 3.84, 95% CI 2.57\u20134.11, P <0.001.", {"entities": []}], ["For example, pain was more likely to be treated (adjusted Odds Ratio [aOR] 3.84, 1.78\u20138.30), and more patients attended dentists and opticians (aOR 52.76 [11.80\u2013235.90] and 5.12 [1.45\u201318.03] respectively).", {"entities": []}], ["Profile use was associated with reduction in mental health medicines (aOR 4.45, 1.15\u201317.22).", {"entities": []}], ["The WWADR Profile for Mental Health Medicines can improve the quality and safety of care, and warrants further investigation as a strategy to mitigate the known adverse effects of prescribed medicines.", {"entities": []}], ["ISRCTN 48133332", {"entities": []}], ["Combinations of drugs with distinct and complementary mechanisms of action may offer improved efficacy in the treatment of chronic obstructive pulmonary disease (COPD).", {"entities": [[123, 160, "DISEASE"]]}], ["In two 12-week, double-blind, parallel-group studies, patients with COPD were randomized 1:1:1 to once-daily umeclidinium (UMEC; 62.5 \u03bcg and 125 \u03bcg) \u2028or placebo (PBO), added to twice-daily fluticasone propionate/salmeterol (FP/SAL; 250/50 \u03bcg).", {"entities": []}], ["In both studies, the primary efficacy measure was trough forced expiratory volume in 1 second (FEV 1 ) at Day 85.", {"entities": [[95, 98, "GENE"]]}], ["Secondary endpoints were weighted-mean (WM) FEV 1 over 0\u20136 hours post-dose (Day 84) and rescue albuterol use.", {"entities": [[44, 47, "GENE"]]}], ["Health-related quality of life outcomes (St. George's Respiratory Questionnaire [SGRQ] and COPD assessment test [CAT]) were also examined.", {"entities": []}], ["Safety was assessed throughout.", {"entities": []}], ["Both UMEC+FP/SAL doses provided statistically significant improvements in trough FEV 1 (Day 85: 0.127\u20130.148 L) versus PBO+FP/SAL.", {"entities": [[81, 84, "GENE"]]}], ["Similarly, both UMEC+FP/SAL doses provided statistically-significant improvements in 0\u20136 hours post-dose WM FEV 1 versus PBO+FP/SAL (Day 84: 0.144\u20130.165 L).", {"entities": [[108, 111, "GENE"]]}], ["Rescue use over Weeks 1\u201312 decreased with UMEC+FP/SAL in both studies versus PBO+FP/SAL (Study 1, 0.3 puffs/day [both doses]; Study 2, 0.5 puffs/day [UMEC 125+FP/SAL]).", {"entities": []}], ["Decreases from baseline in CAT score were generally larger for both doses of UMEC+FP/SAL versus PBO+FP/SAL (except for Day 84 Study 2).", {"entities": []}], ["In Study 1, no differences in SGRQ score were observed between UMEC+FP/SAL and PBO+FP/SAL; however, in Study 2, statistically significant improvements were observed with UMEC 62.5+FP/SAL (Day 28) and UMEC 125+FP/SAL (Days 28 and 84) versus PBO+FP/SAL.", {"entities": []}], ["The incidence of on-treatment adverse events across all treatment groups was 37\u201341% in Study 1 and 36\u201338% in Study 2.", {"entities": []}], ["Overall, these data indicate that the combination of UMEC+FP/SAL can provide additional benefits over FP/SAL alone in patients with COPD.", {"entities": []}], ["Pulmonary surfactant protein A (SP-A), a heterooligomer of SP-A1 and SP-A2, is an important regulator of innate immunity of the lung.", {"entities": []}], ["Nonsynonymous single nucleotide variants of SP-A have been linked to respiratory diseases, but the expressed repertoire of SP-A protein in human airway has not been investigated.", {"entities": []}], ["Here, we used parallel trypsin and Glu-C digestion, followed by LC\u2013MS/MS, to obtain sequence coverage of common SP-A variants and isoform-determining peptides.", {"entities": []}], ["We further developed a SDS-PAGE-based, multiple reaction monitoring (GeLC-MRM) assay for enrichment and targeted quantitation of total SP-A, the SP-A2 isoform, and the Gln223 and Lys223 variants of SP-A, from as little as one milliliter of bronchoalveolar lavage fluid.", {"entities": []}], ["This assay identified individuals with the three genotypes at the 223 position of SP-A2: homozygous major (Gln223/Gln223), homozygous minor (Lys223/Lys223), or heterozygous (Gln223/Lys223).", {"entities": []}], ["More generally, our studies demonstrate the challenges inherent in distinguishing highly homologous, copurifying protein isoforms by MS and show the applicability of MRM mass spectrometry for identification and quantitation of nonsynonymous single nucleotide variants and other proteoforms in airway lining fluid.", {"entities": []}], ["Folate-sensitive fragile sites (FSFS) are a rare cytogenetically visible subset of dynamic mutations.", {"entities": []}], ["Of the eight molecularly characterized FSFS, four are associated with intellectual disability (ID).", {"entities": [[70, 93, "DISEASE"]]}], ["Cytogenetic expression results from CGG tri-nucleotide-repeat expansion mutation associated with local CpG hypermethylation and transcriptional silencing.", {"entities": []}], ["The best studied is the FRAXA site in the FMR1 gene, where large expansions cause fragile X syndrome, the most common inherited ID syndrome.", {"entities": [[92, 100, "DISEASE"], [131, 139, "DISEASE"], [42, 46, "GENE"]]}], ["Here we studied three families with FRA2A expression at 2q11 associated with a wide spectrum of neurodevelopmental phenotypes.", {"entities": []}], ["We identified a polymorphic CGG repeat in a conserved, brain-active alternative promoter of the AFF3 gene, an autosomal homolog of the X-linked AFF2 / FMR2 gene: Expansion of the AFF2 CGG repeat causes FRAXE ID.", {"entities": [[96, 100, "GENE"], [144, 148, "GENE"], [179, 183, "GENE"], [144, 148, "GENE"], [179, 183, "GENE"]]}], ["We found that FRA2A-expressing individuals have mosaic expansions of the AFF3 CGG repeat in the range of several hundred repeat units.", {"entities": [[73, 77, "GENE"]]}], ["Moreover, bisulfite sequencing and pyrosequencing both suggest AFF3 promoter hypermethylation.", {"entities": [[63, 67, "GENE"]]}], ["cSNP-analysis demonstrates monoallelic expression of the AFF3 gene in FRA2A carriers thus predicting that FRA2A expression results in functional haploinsufficiency for AFF3 at least in a subset of tissues.", {"entities": [[57, 61, "GENE"], [168, 172, "GENE"], [57, 61, "GENE"], [168, 172, "GENE"]]}], ["By whole-mount in situ hybridization the mouse AFF3 ortholog shows strong regional expression in the developing brain, somites and limb buds in 9.5\u201312.5dpc mouse embryos.", {"entities": [[47, 51, "GENE"]]}], ["Our data suggest that there may be an association between FRA2A and a delay in the acquisition of motor and language skills in the families studied here.", {"entities": []}], ["However, additional cases are required to firmly establish a causal relationship.", {"entities": []}], ["Some human genetic diseases are caused by dynamic mutations, or expansions of a short repeated sequence in the genome that can be unstably passed on from generation to generation.", {"entities": []}], ["A subset of these dynamic mutations known as fragile sites can be seen as a break or gap on the chromosome when cells are cultured under specific conditions.", {"entities": []}], ["To date eight folate-sensitive fragile sites (FSFS) have been characterized, and all are due to CGG-repeat expansions within the 5\u2032 UTR or promoter region of the respective gene.", {"entities": []}], ["When the repeat expands in size, it becomes hypermethylated and the adjacent gene or genes are transcriptionally silenced.", {"entities": []}], ["For at least four of the eight known fragile sites this silencing of the associated gene(s) lead to intellectual disability syndromes such as fragile X.", {"entities": [[100, 123, "DISEASE"]]}], ["In this work we describe molecular characterization of an autosomal FSFS called FRA2A on chromosome 2.", {"entities": []}], ["As the molecular cause of FRA2A, we identify an expansion of a CGG repeat which subsequently results in silencing of the neighbouring gene AFF3 .", {"entities": [[139, 143, "GENE"]]}], ["This gene is one of the four autosomal paralogss of the AFF2/FMR2 gene which, when mutated, is the cause of the FRAXE syndrome.", {"entities": [[118, 126, "DISEASE"]]}], ["We find that FRA2A expression is associated with highly variable developmental anomalies in the three FRA2A families studied.", {"entities": []}], ["Population-based studies for olfactory dysfunction are lacking.", {"entities": []}], ["The aim of this study is to evaluate the prevalence of subjective olfactory dysfunction and its risk factors in the Korean general population.", {"entities": []}], ["The data were obtained from the 2009 Korea National Health and Nutrition Examination Survey (KNHANES), which was a cross-sectional survey of non-institutionalized population all around the country (n\u200a=\u200a10,533).", {"entities": []}], ["All interviewees underwent medical interviews, physical examinations, endoscopic examination and blood/urine tests.", {"entities": []}], ["Whether sense of smell has been normal or abnormal during the last 3 months was asked.", {"entities": []}], ["Complete olfaction data were obtained from 7,306 participants and the participants were divided into normosmic and hyposmic group.", {"entities": []}], ["Multivariate logistic regression analyses were performed to identify its risk factors.", {"entities": []}], ["The weighted prevalence of subjective olfactory dysfunction was 4.5%.", {"entities": []}], ["Its increased prevalence was significantly associated with the increasing age for both men and women.", {"entities": []}], ["In the multivariate analyses, low income (adjusted odds ratio [OR]\u200a=\u200a1.43, 95% Confidence Interval [CI]\u200a=\u200a1.01\u20132.03), habitual exposure to air pollutants (adjusted OR\u200a=\u200a2.18, CI\u200a=\u200a1.33\u20133.55), a history of hepatitis B (adjusted OR\u200a=\u200a3.10, CI\u200a=\u200a1.25\u20137.68), rhinitis (adjusted OR\u200a=\u200a1.78, CI\u200a=\u200a1.26\u20132.51) and chronic sinusitis (adjusted OR\u200a=\u200a14.55, CI\u200a=\u200a10.06\u201321.05) were risk factors of olfactory dysfunction.", {"entities": [[255, 263, "DISEASE"], [313, 322, "DISEASE"], [205, 214, "DISEASE"]]}], ["Our population-based study showed that olfactory dysfunction was quite prevalent and several risk factors were associated with impaired sense of smell.", {"entities": []}], ["Given its prevalence, further researches for its prevention and management are required.", {"entities": []}], ["Ephedra is among Palestinian medicinal plants that are traditionally used in folkloric medicine for treating many diseases.", {"entities": []}], ["Ephedra is known to have antibacterial and antioxidant effects.", {"entities": []}], ["The goal of this study is to evaluate the antioxidant activity of different extracts from the Ephedra alata plant growing wild in Palestine, and to analyze their phenolic and flavonoid constituents by HPLC/PDA and HPLC/MS.", {"entities": []}], ["Samples of the Ephedra alata plant grown wild in Palestine were extracted with three different solvents namely, 100% water, 80% ethanol, and 100% ethanol.", {"entities": []}], ["The extracts were analyzed for their total phenolic content (TPC), total flavonoid content (TFC), antioxidant activity (AA), as well as phenolic and flavonoids content by HPLC/PDA/MS.", {"entities": []}], ["The results revealed that the polarity of the extraction solvent affects the TPC, TFC, and AA of extracts.", {"entities": []}], ["It was found that both TPC and AA are highest for plant extracted with 80% ethanol, followed by 100% ethanol, and finally with 100% water.", {"entities": []}], ["TFC however was highest in the following order: 100% ethanol > 80% ethanol > water.", {"entities": []}], ["Pearson correlation indicated that there is a significant correlation between AA and TPC, but there is no correlation between AA and TFC.", {"entities": []}], ["Simultaneous HPLC-PDA and UHPLC-MS analysis of the ethanolic plant extracts revealed the presence of Luteolin-7-O-glucuronide flavone, Myricetin 3-rhamnoside and some other major polyphenolic compounds that share myricetin skeleton.", {"entities": []}], ["Ephedra alata extract is rich in potent falvonoid glycosidic compounds as revealed by their similar overlaid UV-Vis spectra and UHPLC-MS results.", {"entities": []}], ["On the basis of these findings, it is concluded that Ephedra alata constitutes a natural source of potent antioxidants that may prevent many diseases and could be potentially used in food, cosmetics, and pharmaceutical products.", {"entities": []}], ["Quorum sensing controls the virulence determinants in most proteobacteria.", {"entities": []}], ["In this work, the hexane, chloroform and methanol extracts of an Ayurveda spice, namely clove ( Syzygium aromaticum) , shown anti-quorum sensing activity.", {"entities": []}], ["Hexane and methanol extracts of clove inhibited the response of C. violaceum CV026 to exogenously supplied N \u2010hexanoylhomoserine lactone, in turn preventing violacein production.", {"entities": []}], ["Chloroform and methanol extracts of clove significantly reduced bioluminescence production by E. coli [pSB1075] grown in the presence of N -(3-oxododecanoyl)- l -homoserine lactone.", {"entities": []}], ["We demonstrated that clove extract inhibited quorum sensing-regulated phenotypes in Pseudomonas aeruginosa PA01, including expression of lecA::lux (by hexane extract), swarming (maximum inhibition by methanol extract), pyocyanin (maximum inhibition by hexane extract).", {"entities": []}], ["This study shows that the presence of natural compounds that exhibit anti-quorum sensing activity in the clove extracts may be useful as the lead of anti-infective drugs.", {"entities": []}], ["Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends.", {"entities": []}], ["The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015.", {"entities": []}], ["These results informed an in-depth investigation of observed and expected mortality patterns based on sociodemographic measures.", {"entities": []}], ["We estimated all-cause mortality by age, sex, geography, and year using an improved analytical approach originally developed for GBD 2013 and GBD 2010.", {"entities": []}], ["Improvements included refinements to the estimation of child and adult mortality and corresponding uncertainty, parameter selection for under-5 mortality synthesis by spatiotemporal Gaussian process regression, and sibling history data processing.", {"entities": []}], ["We also expanded the database of vital registration, survey, and census data to 14\u2008294 geography\u2013year datapoints.", {"entities": []}], ["For GBD 2015, eight causes, including Ebola virus disease, were added to the previous GBD cause list for mortality.", {"entities": []}], ["We used six modelling approaches to assess cause-specific mortality, with the Cause of Death Ensemble Model (CODEm) generating estimates for most causes.", {"entities": []}], ["We used a series of novel analyses to systematically quantify the drivers of trends in mortality across geographies.", {"entities": []}], ["First, we assessed observed and expected levels and trends of cause-specific mortality as they relate to the Socio-demographic Index (SDI), a summary indicator derived from measures of income per capita, educational attainment, and fertility.", {"entities": []}], ["Second, we examined factors affecting total mortality patterns through a series of counterfactual scenarios, testing the magnitude by which population growth, population age structures, and epidemiological changes contributed to shifts in mortality.", {"entities": []}], ["Finally, we attributed changes in life expectancy to changes in cause of death.", {"entities": []}], ["We documented each step of the GBD 2015 estimation processes, as well as data sources, in accordance with Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER).", {"entities": []}], ["Globally, life expectancy from birth increased from 61\u00b77 years (95% uncertainty interval 61\u00b74\u201361\u00b79) in 1980 to 71\u00b78 years (71\u00b75\u201372\u00b72) in 2015.", {"entities": []}], ["Several countries in sub-Saharan Africa had very large gains in life expectancy from 2005 to 2015, rebounding from an era of exceedingly high loss of life due to HIV/AIDS.", {"entities": []}], ["At the same time, many geographies saw life expectancy stagnate or decline, particularly for men and in countries with rising mortality from war or interpersonal violence.", {"entities": []}], ["From 2005 to 2015, male life expectancy in Syria dropped by 11\u00b73 years (3\u00b77\u201317\u00b74), to 62\u00b76 years (56\u00b75\u201370\u00b72).", {"entities": []}], ["Total deaths increased by 4\u00b71% (2\u00b76\u20135\u00b76) from 2005 to 2015, rising to 55\u00b78 million (54\u00b79 million to 56\u00b76 million) in 2015, but age-standardised death rates fell by 17\u00b70% (15\u00b78\u201318\u00b71) during this time, underscoring changes in population growth and shifts in global age structures.", {"entities": []}], ["The result was similar for non-communicable diseases (NCDs), with total deaths from these causes increasing by 14\u00b71% (12\u00b76\u201316\u00b70) to 39\u00b78 million (39\u00b72 million to 40\u00b75 million) in 2015, whereas age-standardised rates decreased by 13\u00b71% (11\u00b79\u201314\u00b73).", {"entities": []}], ["Globally, this mortality pattern emerged for several NCDs, including several types of cancer, ischaemic heart disease, cirrhosis, and Alzheimer's disease and other dementias.", {"entities": [[104, 117, "DISEASE"], [86, 92, "DISEASE"]]}], ["By contrast, both total deaths and age-standardised death rates due to communicable, maternal, neonatal, and nutritional conditions significantly declined from 2005 to 2015, gains largely attributable to decreases in mortality rates due to HIV/AIDS (42\u00b71%, 39\u00b71\u201344\u00b76), malaria (43\u00b71%, 34\u00b77\u201351\u00b78), neonatal preterm birth complications (29\u00b78%, 24\u00b78\u201334\u00b79), and maternal disorders (29\u00b71%, 19\u00b73\u201337\u00b71).", {"entities": [[269, 276, "DISEASE"]]}], ["Progress was slower for several causes, such as lower respiratory infections and nutritional deficiencies, whereas deaths increased for others, including dengue and drug use disorders.", {"entities": []}], ["Age-standardised death rates due to injuries significantly declined from 2005 to 2015, yet interpersonal violence and war claimed increasingly more lives in some regions, particularly in the Middle East.", {"entities": []}], ["In 2015, rotaviral enteritis (rotavirus) was the leading cause of under-5 deaths due to diarrhoea (146\u2008000 deaths, 118\u2008000\u2013183\u2008000) and pneumococcal pneumonia was the leading cause of under-5 deaths due to lower respiratory infections (393\u2008000 deaths, 228\u2008000\u2013532\u2008000), although pathogen-specific mortality varied by region.", {"entities": [[149, 158, "DISEASE"]]}], ["Globally, the effects of population growth, ageing, and changes in age-standardised death rates substantially differed by cause.", {"entities": []}], ["Our analyses on the expected associations between cause-specific mortality and SDI show the regular shifts in cause of death composition and population age structure with rising SDI.", {"entities": []}], ["Country patterns of premature mortality (measured as years of life lost [YLLs]) and how they differ from the level expected on the basis of SDI alone revealed distinct but highly heterogeneous patterns by region and country or territory.", {"entities": []}], ["Ischaemic heart disease, stroke, and diabetes were among the leading causes of YLLs in most regions, but in many cases, intraregional results sharply diverged for ratios of observed and expected YLLs based on SDI.", {"entities": [[10, 23, "DISEASE"]]}], ["Communicable, maternal, neonatal, and nutritional diseases caused the most YLLs throughout sub-Saharan Africa, with observed YLLs far exceeding expected YLLs for countries in which malaria or HIV/AIDS remained the leading causes of early death.", {"entities": [[181, 188, "DISEASE"]]}], ["At the global scale, age-specific mortality has steadily improved over the past 35 years; this pattern of general progress continued in the past decade.", {"entities": []}], ["Progress has been faster in most countries than expected on the basis of development measured by the SDI.", {"entities": []}], ["Against this background of progress, some countries have seen falls in life expectancy, and age-standardised death rates for some causes are increasing.", {"entities": []}], ["Despite progress in reducing age-standardised death rates, population growth and ageing mean that the number of deaths from most non-communicable causes are increasing in most countries, putting increased demands on health systems.", {"entities": []}], ["Bill & Melinda Gates Foundation.", {"entities": []}], ["Human microbial communities are characterized by their taxonomic, metagenomic, and metabolic diversity, which varies by distinct body sites and influences human physiology.", {"entities": []}], ["However, when and how microbial communities within each body niche acquire unique taxonomical and functional signatures in early life remains underexplored.", {"entities": []}], ["We thus sought to assess the taxonomic composition and potential metabolic function of the neonatal and early infant microbiota across multiple body sites, and assess the impact of mode of delivery and its potential confounders or modifiers.", {"entities": []}], ["A cohort of pregnant women in their early 3 n =81) were prospectively enrolled for longitudinal sampling through 6 weeks post-delivery, and a second matched cross-sectional cohort ( n =81) was additionally recruited for sampling once at delivery.", {"entities": []}], ["Samples were collected for each maternal-infant dyad across multiple body sites, including stool, oral gingiva, nares, skin and vagina.", {"entities": []}], ["16S rRNA gene sequencing analysis and whole genome shotgun sequencing was performed to interrogate the composition and function of the neonatal and maternal microbiota.", {"entities": []}], ["We found that the neonatal microbiota and its associated functional pathways were relatively homogenous across all body sites at delivery, with the notable exception of neonatal meconium.", {"entities": []}], ["However, by 6 weeks, the infant microbiota structure and function had significantly expanded and diversified, with body site serving as the primary determinant of the bacterial community composition and its functional capacity.", {"entities": []}], ["Although minor variations in the neonatal (immediately at birth) microbiota community structure were associated with Cesarean delivery in some body sites (oral, nares, and skin; R p >0.05) and there was no observable difference in community function regardless of delivery mode.", {"entities": []}], ["By 6 weeks of age, the infant microbiota structure and function had expanded and diversified with demonstrable body site specificity ( p <0.001, R p =0.057, R", {"entities": []}], ["Surveys have generally found that individuals more likely to use complementary and alternative medicine are female, live in the western United States, are likely to have a health complaint, and have a higher socioeconomic status than do nonusers.", {"entities": []}], ["What is not known is the extent to which those who use complementary and alternative medicine also engage in positive health behaviors, such as smoking cessation or increased physical activity and/or exhibit fewer health risk factors such as obesity.", {"entities": [[242, 249, "DISEASE"]]}], ["This has been identified as a key research question in a recent Institute of Medicine report.", {"entities": []}], ["In the present study we sought to determine whether the use of complementary and alternative medicine is associated with health behaviors or risk factors known to impact on health status.", {"entities": []}], ["The current study is a cross-sectional regression analysis using data from the 2002 National Health Interview Survey.", {"entities": []}], ["Data were collected in-person from 31,044 adults throughout the 50 states and the District of Columbia.", {"entities": []}], ["After controlling for a range of other factors, we found that engaging in leisure-time physical activity, having consumed alcohol in one's life but not being a current heavy drinker, and being a former smoker are independently associated with the use of CAM.", {"entities": []}], ["Obese individuals are slightly less likely to use CAM than individuals with a healthy body-mass index.", {"entities": []}], ["No significant associations were observed between receipt of an influenza vaccine and CAM use.", {"entities": [[64, 73, "DISEASE"]]}], ["Those engaging in positive health behaviors and exhibiting fewer health risk factors are more likely to use CAM than those who forgo positive health behaviors or exhibit more health risk factors.", {"entities": []}], ["The fact that users of CAM tend to pursue generally healthy lifestyles suggests that they may be open to additional recommendations toward optimizing their health.", {"entities": []}], ["Exosomes are small extracellular nanovesicles of endocytic origin that mediate different signals between cells, by surface interactions and by shuttling functional RNA from one cell to another.", {"entities": []}], ["Exosomes are released by many cells including mast cells, dendritic cells, macrophages, epithelial cells and tumour cells.", {"entities": []}], ["Exosomes differ compared to their donor cells, not only in size, but also in their RNA, protein and lipid composition.", {"entities": []}], ["In this study, we show that exosomes, released by mouse mast cells exposed to oxidative stress, differ in their mRNA content.", {"entities": []}], ["Also, we show that these exosomes can influence the response of other cells to oxidative stress by providing recipient cells with a resistance against oxidative stress, observed as an attenuated loss of cell viability.", {"entities": []}], ["Furthermore, Affymetrix microarray analysis revealed that the exosomal mRNA content not only differs between exosomes and donor cells, but also between exosomes derived from cells grown under different conditions; oxidative stress and normal conditions.", {"entities": []}], ["Finally, we also show that exposure to UV-light affects the biological functions associated with exosomes released under oxidative stress.", {"entities": []}], ["These results argue that the exosomal shuttle of RNA is involved in cell-to-cell communication, by influencing the response of recipient cells to an external stress stimulus.", {"entities": []}], ["The use of consumer-grade wearables for purposes beyond fitness tracking has not been comprehensively explored.", {"entities": []}], ["We generated and analyzed multidimensional data from 233 normal volunteers, integrating wearable data, lifestyle questionnaires, cardiac imaging, sphingolipid profiling, and multiple clinical-grade cardiovascular and metabolic disease markers.", {"entities": []}], ["We show that subjects can be stratified into distinct clusters based on daily activity patterns and that these clusters are marked by distinct demographic and behavioral patterns.", {"entities": []}], ["While resting heart rates (RHRs) performed better than step counts in being associated with cardiovascular and metabolic disease markers, step counts identified relationships between physical activity and cardiac remodeling, suggesting that wearable data may play a role in reducing overdiagnosis of cardiac hypertrophy or dilatation in active individuals.", {"entities": []}], ["Wearable-derived activity levels can be used to identify known and novel activity-modulated sphingolipids that are in turn associated with insulin sensitivity.", {"entities": []}], ["Our findings demonstrate the potential for wearables in biomedical research and personalized health.", {"entities": []}], ["Little is known about how data from wearable sensors can be used apart from fitness tracking.", {"entities": []}], ["We comprehensively studied 233 normal volunteers, integrating data from wearable sensors with lifestyle questionnaires, cardiac imaging, sphingolipid profiling, and clinical measurements of various heart and metabolic disease markers.", {"entities": []}], ["Apart from showing that wearable sensors can be used to identify groups of volunteers with distinct behavioral and demographic characteristics, we showed that resting heart rate (RHR) from wearables performed better than step counts in predicting heart and metabolic disease risk markers.", {"entities": []}], ["Notably, we further demonstrated that wearable data could be used in 2 areas of biomedical research.", {"entities": []}], ["In the field of cardiac imaging, we showed that activity data from wearables can be used to determine how the size of heart is influenced by physical activity.", {"entities": []}], ["Wearable data could also identify active individuals that are more likely than others to have enlarged hearts and potentially be misdiagnosed with heart disease.", {"entities": [[147, 160, "DISEASE"]]}], ["In the field of lipidomics, we showed that wearable data can be used to identify species of sphingolipids that are affected by how active a person is.", {"entities": []}], ["Some of these compounds are known to be associated with obesity, diabetes, and heart disease.", {"entities": [[79, 92, "DISEASE"], [56, 63, "DISEASE"]]}], ["The risks and benefits of feeding preterm formula (PF) versus donor human milk (DHM) in preterm infants are uncertain, and studies evaluating the efficacy of DHM to the morbidities and growth of preterm infants in the neonatal intensive care unit are confused by the need for milk fortification.", {"entities": []}], ["We aimed to determine and compare the outcome of short-term morbidities in neonatal intensive care unit and growth between premature infants fed exclusively DHM only until a volume of 130\u200amL/kg/d of enteral feeding was achieved and infants fed with a PF mix after birth.", {"entities": []}], ["The data of 132 infants with low birth weight of <1500\u200ag and gestational age of less than 32 weeks were considered.", {"entities": []}], ["Ninety infants were analyzed, of which 86 were discharged alive.", {"entities": []}], ["The DHM group (n\u200a=\u200a36) was made up of infants who were fed exclusively with DHM, whereas the PF group (n\u200a=\u200a54) consisted of infants who were fed with a combination of PF and either DHM or human milk, until a volume of 130\u200amL/kg/d of enteral feeding was achieved.", {"entities": []}], ["Once feeding in the DHM group progressed to volumes greater than 130\u200amL/kg/d, infants were fed fortified DHM and PF alternately.", {"entities": []}], ["One infant (2.8%) in the DHM group had late-onset sepsis or necrotizing enterocolitis compared with 21 (38.9%) in the PF group (adjusted odds ratio 0.05, 95% confidence interval 0.01\u20130.41); 13 (36.1%) infants in the DHM group had bronchopulmonary dysplasia compared with 38 (70.4%) in the PF group (odds ratio 0.18, 95% confidence interval 0.05\u20130.41).", {"entities": []}], ["Although the DHM group demonstrated a comparatively lower rate of weight gain, head circumference increment, and height increment from birth to the age at which an enteral feeding volume of 130\u200amL/kg/d was achieved, there were no significant differences in these values at 36 weeks\u2019 postmenstrual age between both groups.", {"entities": []}], ["Alcohol consumption in western pregnant women is not uncommon and could be a risk factor for childhood atopic disease.", {"entities": []}], ["However, reported alcohol intake may be unreliable, and associations are likely to be confounded.", {"entities": []}], ["We aimed to study the relation between prenatal alcohol exposure and atopic phenotypes in a large population-based birth cohort with the use of a Mendelian randomization approach to minimize bias and confounding.", {"entities": []}], ["In white mothers and children in the Avon Longitudinal Study of Parents and Children (ALSPAC) we first analyzed associations between reported maternal alcohol consumption during pregnancy and atopic outcomes in the offspring measured at 7 years of age (asthma, wheezing, hay fever, eczema, atopy, and total IgE).", {"entities": [[253, 259, "DISEASE"]]}], ["We then analyzed the relation of maternal alcohol dehydrogenase (ADH)1B genotype (rs1229984) with these outcomes (the A\u00a0allele is associated with faster metabolism and reduced alcohol consumption and, among drinkers, would be expected to reduce fetal exposure to ethanol).", {"entities": []}], ["After controlling for confounders, reported maternal drinking in late pregnancy was negatively associated with childhood asthma and hay fever (adjusted odds ratio [OR] per category increase in intake: 0.91 [95% CI, 0.82-1.01] and 0.87 [95% CI, 0.78-0.98], respectively).", {"entities": [[121, 127, "DISEASE"]]}], ["However, maternal ADH1B genotype was not associated with asthma comparing carriers of A\u00a0allele with persons homozygous for G allele (OR, 0.98 [95% CI, 0.66-1.47]) or hay fever (OR, 1.11 [95% CI, 0.71-1.72]), nor with any other atopic outcome.", {"entities": [[57, 63, "DISEASE"], [18, 23, "GENE"]]}], ["We have found no evidence to suggest that prenatal alcohol exposure increases the risk of asthma or atopy in childhood.", {"entities": [[90, 96, "DISEASE"]]}], ["The Otitis Media-6 questionnaire (OM-6) is the most frequently used instrument to measure health related quality of life in children with otitis media.", {"entities": [[4, 16, "DISEASE"], [138, 150, "DISEASE"]]}], ["The main objectives of this study are 1) to translate and cross-culturally adapt the OM-6 into Danish, and 2) to assess important psychometric properties including structural validity and interpretability of the OM-6 in a Danish population of children suffering from otitis media.", {"entities": [[267, 279, "DISEASE"]]}], ["The OM-6 was translated and cross-culturally adapted according to international guidelines.", {"entities": []}], ["A longitudinal validation study enrolled 491 children and their families, and the measurement properties of the OM-6 were evaluated using the Cosmin taxonomy.", {"entities": []}], ["The properties assessed were construct and structural validity (confirmatory factor analysis) including internal consistency, reproducibility (test-retest reliability and smallest detectable change), responsiveness and interpretability.", {"entities": []}], ["A total of 435 children were eligible to participate in the study.", {"entities": []}], ["Analyses of structural validity and internal consistency indicated that parent appraisal of hearing and speech problems may be problematic.", {"entities": []}], ["Both scales showed similarly good test-retest reliability and construct validity, were able to discriminate between diagnostic subgroups and responsive to change.", {"entities": []}], ["Cut-off values of 16.7 and 30.0 were found to represent minimal important change for the patients.", {"entities": []}], ["The Danish version of the OM-6 is a reliable, valid, responsive and interpretable questionnaire to measure quality of life in children with otitis media.", {"entities": [[140, 152, "DISEASE"]]}], ["This study sheds light on possible weaknesses of the instrument that needs to be acknowledged in the utilization of the instrument.", {"entities": []}], ["However, despite these issues our results support the continuing use of OM-6 as a 1-factor functional health scale with a separate global health rating.", {"entities": []}], ["Furthermore, indications of values representing minimal important change as perceived by the respondent are presented.", {"entities": []}], ["Physical activity decreases deaths from cardiovascular disease and other causes; however, it is unclear whether physical activity is associated with cancer incidence and death in Asian populations.", {"entities": [[149, 155, "DISEASE"]]}], ["Data from 59 636 Koreans aged 30 to 93 years were collected using a questionnaire and medical examination at the Severance Hospital Health Promotion Center between 1994 and 2004.", {"entities": []}], ["Study participants were followed for a mean duration of 10.3 years.", {"entities": []}], ["In the exercising group, the multivariate Cox proportional hazards model showed a lower risk of cancer death (hazard ratio [HR] = 0.72, 95% CI = 0.62\u20130.85) in men but not in women.", {"entities": [[96, 102, "DISEASE"], [124, 126, "GENE"]]}], ["Those who exercised, as compared with those who did not, had lower risks of all-cause death (men: HR = 0.68, 95% CI = 0.60\u20130.76; women: HR = 0.65, 95% CI = 0.53\u20130.79) and noncancer death (men: 0.63, 0.53\u20130.75; women: 0.52, 0.39\u20130.69).", {"entities": [[98, 100, "GENE"], [136, 138, "GENE"], [98, 100, "GENE"], [136, 138, "GENE"]]}], ["Physical activity was inversely associated with risk of noncancer death among men and women.", {"entities": []}], ["Physical activity was associated with lower risks of cancer death and noncancer death.", {"entities": [[53, 59, "DISEASE"]]}], ["Previous studies suggest that maternal characteristics may be associated with neonatal outcomes.", {"entities": []}], ["However, the influence of maternal characteristics on birth weight (BW) has not been adequately determined in Korean populations.", {"entities": []}], ["We investigated associations between maternal characteristics and BW in a sample of 813 Korean women living in the Seoul metropolitan area, Korea recruited using data from the prospective hospital-based COhort for Childhood Origin of Asthma and allergic diseases (COCOA) between 2007 and 2011.", {"entities": []}], ["The mean maternal age at delivery was 32.3 \u00b1 3.5 yr and prepregnancy maternal body mass index (BMI) was 20.7 \u00b1 2.5 kg/m P < 0.05).", {"entities": []}], ["Presence of allergic symptoms in the mother was not associated with BW.", {"entities": []}], ["In conclusion, prepregnancy maternal BMI, gestational age at delivery, a maternal history of allergic disease, and nulliparity may be associated with BW, respectively.", {"entities": []}], ["Over the past decade, a steady increase in the incidence of HPRT-related hyperuricemia (HRH) has been observed in Saudi Arabia.", {"entities": [[73, 86, "DISEASE"]]}], ["We examined all the nine exons of HPRT gene for mutations in ten biochemically confirmed hyperuricemia patients, including one female and three normal controls.", {"entities": [[89, 102, "DISEASE"]]}], ["In all, we identified 13 novel mutations in Saudi Arabian HPRT-related hyperuricemia patients manifesting different levels of uric acid.", {"entities": [[71, 84, "DISEASE"]]}], ["The Lys103Met alteration was highly recurrent and was observed in 50% of the cases, while Ala160Thr and Lys158Asn substitutions were found in two patients.", {"entities": []}], ["Moreover, in 70% of the patients \u22652 mutations were detected concurrently in the HPRT gene.", {"entities": []}], ["Interestingly, one of the patients that harbored Lys103Met substitution along with two frameshift mutations at codons 85 and 160 resulting in shortened protein demonstrated unusually high serum uric acid level of 738\u2009 \u03bc mol/L.", {"entities": []}], ["Two of the seven point mutations that resulted in amino acid change (Lys103Met and Val160Gly) were predicted to be damaging by SIFT and Polyphen and were further analyzed for their protein stability and function by molecular dynamics simulation.", {"entities": []}], ["The identified novel mutations in the HPRT gene may prove useful in the prenatal diagnosis and genetic counseling.", {"entities": []}], ["Food allergies are one of the first manifestations of allergic disease and have been shown to significantly impact on general health perception, parental emotional distress and family activities.", {"entities": []}], ["It is estimated that in the Western world, almost one in ten children have an IgE-mediated allergy.", {"entities": []}], ["Cow\u2019s milk and egg allergy are common childhood allergies.", {"entities": [[15, 26, "DISEASE"]]}], ["Until recently, children with food allergy were advised to avoid all dietary exposure to the allergen to which they were sensitive, in the thought that consumption would exacerbate their allergy.", {"entities": [[30, 42, "DISEASE"]]}], ["However, recent publications indicate that up to 70% of children with egg allergy can tolerate egg baked in a cake or muffin without apparent reaction.", {"entities": [[70, 81, "DISEASE"]]}], ["Likewise, up to 75% of children can tolerate baked goods containing cow\u2019s milk, and these children demonstrate IgE and IgG4 profiles indicative of tolerance development.", {"entities": []}], ["This article will review the current literature regarding the use of heated food allergens as immunotherapy for children with cow\u2019s milk and egg allergy.", {"entities": [[141, 152, "DISEASE"]]}], ["Asthma is a serious health problem causing significant mortality and morbidity globally.", {"entities": [[0, 6, "DISEASE"]]}], ["Persistent airway inflammation, airway hyperresponsiveness, increased immunoglobulin E (IgE) levels and mucus hypersecretion are key characteristics of the condition.", {"entities": []}], ["Asthma is mediated via a dominant T-helper 2 (Th2) immune response, causing enhanced expression of Th2 cytokines.", {"entities": [[0, 6, "DISEASE"]]}], ["These cytokines are responsible for the various pathological changes associated with allergic asthma.", {"entities": [[85, 100, "DISEASE"], [94, 100, "DISEASE"]]}], ["To investigate the anti-asthmatic potential of afzelin, as well as the underlying mechanisms involved, its anti-asthmatic potential were investigated in a murine model of asthma.", {"entities": [[171, 177, "DISEASE"]]}], ["In the present study, BALB/c mice were systemically sensitized using ovalbumin (OVA) followed by aerosol allergen challenges.", {"entities": []}], ["The effect of afzelin on airway hyperresponsiveness, eosinophilic infiltration, Th2 cytokine and OVA-specific IgE production in a mouse model of asthma were investigated.", {"entities": [[145, 151, "DISEASE"]]}], ["It was found that afzelin-treated groups suppressed eosinophil infiltration, allergic airway inflammation, airway hyperresponsiveness, OVA-specific IgE and Th2 cytokine secretion.", {"entities": []}], ["The results of the present study suggested that the therapeutic mechanism by which afzelin effectively treats asthma is based on reduction of Th2 cytokine via inhibition of GATA-binding protein 3 transcription factor, which is the master regulator of Th2 cytokine differentiation and production.", {"entities": [[110, 116, "DISEASE"]]}], ["The goal of this study was to examine changes in the expression of transcripts and proteins associated with drusen in Age-related Macular Degeneration (AMD) after exposing human retinal pigment epithelium (hRPE) cells to chronic oxidative stress.", {"entities": []}], ["Primary adult human RPE cells were isolated from cadaveric donor eyes.", {"entities": [[20, 23, "GENE"]]}], ["The subpopulation of RPE stem cells (RPESCs) was activated, expanded, and then differentiated into RPE progeny.", {"entities": [[21, 24, "GENE"], [99, 102, "GENE"], [21, 24, "GENE"], [99, 102, "GENE"]]}], ["Confluent cultures of RPESC-derived hRPE and ARPE-19 cells were exposed to a regimen of tert-butylhydroperoxide (TBHP) for 1-5 days.", {"entities": []}], ["After treatment, gene expression was measured by quantitative PCR (qPCR), protein expression was assessed by immunocytochemistry and transepithelial resistance and cell toxicity were measured.", {"entities": []}], ["hRPE cells exposed to a regimen of TBHP for 5 days upregulate expression of several molecules identified in drusen, including molecular chaperones and pro-angiogenic factors.", {"entities": []}], ["5-day TBHP treatment was significantly more effective than 1-day treatment at eliciting these effects.", {"entities": []}], ["The extent of hRPE response to 5-day treatment varied significantly between individual donors, nevertheless, 6 transcripts were reliably significantly upregulated.", {"entities": []}], ["ARPE-19 cells treated with the same 5-day stress regime did not show the same pattern of response and did not upregulate this group of transcripts.", {"entities": []}], ["RPESC-derived hRPE cells change significantly when exposed to repeated oxidative stress conditions, upregulating expression of several drusen-related proteins and transcripts.", {"entities": []}], ["This is consistent with the hypothesis that hRPE cells are competent to be a source of proteins found in drusen deposits.", {"entities": []}], ["Our results suggest that donor-specific genetic and environmental factors influence the RPE stress response.", {"entities": [[88, 91, "GENE"]]}], ["ARPE-19 cells appear to be less representative of AMD-like changes than RPESC-derived hRPE.", {"entities": []}], ["This adult stem cell-based system using chronic TBHP treatment of hRPE represents a novel in vitro model useful for the study of drusen formation and dry AMD pathophysiology.", {"entities": []}], ["Asymmetric dimethylarginine (ADMA) is considered an independent mortality and cardiovascular risk factor in chronic kidney disease (CKD) patients, and contributes to the development of renal fibrosis.", {"entities": [[116, 130, "DISEASE"]]}], ["Quercetin (QC), a natural component of foods, protects against renal injury.", {"entities": []}], ["Here, we explored the possible mechanisms that are responsible for ADMA-induced renal fibrosis and the protective effect of QC.", {"entities": []}], ["We found that ADMA treatment activated the endoplasmic reticulum (ER) stress sensor proteins phosphorylated protein kinase RNA-activated-like ER kinase (PERK) and inositol requiring-1\u03b1 (IRE1), which correspondingly induced C/EBP homologous protein (CHOP) expression and phosphorylated c-Jun N -terminal kinase (JNK) phosphorylation in glomerular endothelial cells (GEnCs).", {"entities": []}], ["Following this, ADMA promoted ER stress-induced apoptosis and resulted in transforming growth factor \u03b2 (TGF-\u03b2) expression in GEnCs.", {"entities": []}], ["SP600125, an inhibitor of JNK, and CHOP siRNA protected against ADMA-induced cell apoptosis and TGF-\u03b2 expression.", {"entities": []}], ["QC prevented ADMA-induced PERK and IRE1 apoptotic ER stress pathway activation.", {"entities": []}], ["Also, ADMA-induced GEnCs apoptosis and TGF-\u03b2 expression was reduced by QC.", {"entities": []}], ["Overexpression of CHOP blocked QC-mediated protection from apoptosis in ER stressed cells.", {"entities": []}], ["Overall, these observations indicate that ADMA may induce GEnCs apoptosis and TGF-\u03b2 expression by targeting the PERK-CHOP and IRE1-JNK pathway.", {"entities": []}], ["In addition, drugs such as QC targeting ER stress may hold great promise for the development of novel therapies against ADMA-induced renal fibrosis.", {"entities": []}], ["Immediate access to the equipment required for difficult airway management (DAM) is vital.", {"entities": []}], ["However, in Japan, data are scarce regarding the availability of DAM resources in prehospital settings.", {"entities": []}], ["The purpose of this study was to determine whether Japanese helicopter emergency medical services (HEMS) are adequately equipped to comply with the DAM algorithms of Japanese and American professional anesthesiology societies.", {"entities": []}], ["This nationwide cross-sectional study was conducted in May 2015.", {"entities": []}], ["Base hospitals of HEMS were mailed a questionnaire about their airway management equipment and back-up personnel.", {"entities": []}], ["Outcome measures were (1) call for help, (2) supraglottic airway device (SGA) insertion, (3) verification of tube placement using capnometry, and (4) the establishment of surgical airways, all of which have been endorsed in various airway management guidelines.", {"entities": []}], ["The criteria defining feasibility were the availability of (1) more than one physician, (2) SGA, (3) capnometry, and (4) a surgical airway device in the prehospital setting.", {"entities": []}], ["Of the 45 HEMS base hospitals questioned, 42 (93.3\u00a0%) returned completed questionnaires.", {"entities": []}], ["A surgical airway was practicable by all HEMS.", {"entities": []}], ["However, in the prehospital setting, back-up assistance was available in 14.3\u00a0%, SGA in 16.7\u00a0%, and capnometry in 66.7\u00a0%.", {"entities": []}], ["No HEMS was capable of all four steps.", {"entities": []}], ["In Japan, compliance with standard airway management algorithms in prehospital settings remains difficult because of the limited availability of alternative ventilation equipment and back-up personnel.", {"entities": []}], ["Prehospital health care providers need to consider the risks and benefits of performing endotracheal intubation in environments not conducive to the success of this procedure.", {"entities": []}], ["The online version of this article (doi:10.1007/s00540-015-2124-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The need to reduce carbon emissions and fuel poverty has led to increased building envelope air tightness, intended to reduce uncontrolled ventilation heat losses.", {"entities": []}], ["Ventilation strategies in dwellings still allow the use of trickle ventilators in window frames for background ventilation.", {"entities": []}], ["The extent to which this results in \u201chealthy\u201d Indoor Air Quality (IAQ) in recently constructed dwellings was a concern of regulators in Scotland.", {"entities": []}], ["This paper describes research to explore this.", {"entities": []}], ["First a review of literature was conducted, then data on occupant interactions with ventilation provisions (windows, doors, trickle vents) gathered through an interview-based survey of 200 recently constructed dwellings, and measurements made on a sample of 40 of these.", {"entities": []}], ["The main measured parameter discussed here is CO 2 concentration.", {"entities": []}], ["It was concluded after the literature review that 1000 ppm absolute was a reasonable threshold to use for \u201cadequate\u201d ventilation.", {"entities": []}], ["The occupant survey found that there was very little occupant interaction with the trickle ventilators e.g., in bedrooms 63% were always closed, 28% always open, and in only 9% of cases occupants intervened to make occasional adjustments.", {"entities": []}], ["In the measured dwellings average bedroom CO 2 levels of 1520 ppm during occupied (night time) hours were observed.", {"entities": []}], ["Where windows were open the average bedroom CO 2 levels were 972 ppm.", {"entities": []}], ["With windows closed, the combination of \u201ctrickle ventilators open plus doors open\u201d gave an average of 1021 ppm.", {"entities": []}], ["\u201cTrickle ventilators open\u201d gave an average of 1571 ppm.", {"entities": []}], ["All other combinations gave averages of 1550 to 2000 ppm.", {"entities": []}], ["Ventilation rates and air change rates were estimated from measured CO 2 levels, for all dwellings calculated ventilation rate was less than 8 L/s/p, in 42% of cases calculated air change rate was less than 0.5 ach.", {"entities": []}], ["It was concluded that trickle ventilation as installed and used is ineffective in meeting desired ventilation rates, evidenced by high CO 2 levels reported across the sampled dwellings.", {"entities": []}], ["Potential implications of the results are discussed.", {"entities": []}], ["Hypertension is the major risk factor for stroke, and genetic factors contribute to its development.", {"entities": [[0, 12, "DISEASE"]]}], ["Inflammation has been hypothesized to be the key link between blood pressure elevation and stroke.", {"entities": []}], ["We performed an analysis of the association between inflammatory mediator gene polymorphisms and the incidence of stroke in patients with essential hypertension (EH).", {"entities": [[148, 160, "DISEASE"], [138, 160, "DISEASE"]]}], ["The study group consisted of 625 individuals (296 patients with noncomplicated EH, 71 hypertensive patients with ischemic stroke, and 258 control subjects).", {"entities": []}], ["Both patients and controls were ethnic Tatars originating from the Republic of Bashkortostan (Russian Federation).", {"entities": []}], ["The analysis has shown that the risk of ischemic stroke was associated with the CXCR2 rs1126579 polymorphism.", {"entities": [[80, 85, "GENE"]]}], ["Our results indicate that among patients with EH, the heterozygous genotype carriers had a higher risk of stroke (OR = 1.72, 95% CI 1.01-2.92), whereas the CXCR2 *C/C genotype was protective against stroke (OR = 0.32, 95% CI 0.12-0.83).", {"entities": [[156, 161, "GENE"]]}], ["As shown by the gene-gene interaction analysis, the CXCR2 rs1126579 polymorphism was also present in all genotype/allele combinations associated with the risk of stroke.", {"entities": [[52, 57, "GENE"]]}], ["Genetic patterns associated with stroke also included polymorphisms in the CCL2, CCL18, CX3CR1, CCR5 , and CXCL8 (IL8) genes, although no association between these loci and stroke was detected by individual analysis.", {"entities": [[75, 79, "GENE"], [81, 86, "GENE"], [88, 94, "GENE"], [96, 100, "GENE"], [114, 117, "GENE"]]}], ["Australian Aboriginal children are more likely than non-Aboriginal children to have developmental vulnerability at school entry that tracks through to poorer literacy and numeracy outcomes and multiple social and health disadvantages in later life.", {"entities": []}], ["Empirical evidence identifying the key drivers of positive early childhood development in Aboriginal children, and supportive features of local communities and early childhood service provision, are lacking.", {"entities": []}], ["The study population will be identified via linkage of Australian Early Development Census data to perinatal and birth registration data sets.", {"entities": []}], ["It will include an almost complete population of children who started their first year of full-time school in New South Wales (NSW), Australia, in 2009 and 2012.", {"entities": []}], ["Early childhood health and development trajectories for these children will be constructed via linkage to a range of administrative data sets relating to birth outcomes, congenital conditions, hospital admissions, emergency department presentations, receipt of ambulatory mental healthcare services, use of general practitioner services, contact with child protection and out-of-home care services, receipt of income assistance and fact of death.", {"entities": []}], ["Using multilevel modelling techniques, we will quantify the contributions of individual-level and area-level factors to variation in early childhood development outcomes in Aboriginal and non-Aboriginal children.", {"entities": []}], ["Additionally, we will evaluate the impact of two government programmes that aim to address early childhood disadvantage, the NSW Aboriginal Maternal and Infant Health Service and the Brighter Futures Program.", {"entities": []}], ["These evaluations will use propensity score matching methods and multilevel modelling.", {"entities": []}], ["Ethical approval has been obtained for this study.", {"entities": []}], ["Dissemination mechanisms include engagement of stakeholders (including representatives from Aboriginal community controlled organisations, policy agencies, service providers) through a reference group, and writing of summary reports for policy and community audiences in parallel with scientific papers.", {"entities": []}], ["Air pollution constitutes a significant stimulus of asthma exacerbations; however, the impacts of exposure to major air pollutants on asthma-related hospital admissions and emergency room visits (ERVs) have not been fully determined.", {"entities": [[52, 58, "DISEASE"], [134, 140, "DISEASE"]]}], ["We sought to quantify the associations between short-term exposure to air pollutants [ozone (O 3 ), carbon monoxide (CO), nitrogen dioxide (NO 2 ), sulfur dioxide (SO 2 ), and particulate matter \u226410\u03bcm (PM 10 ) and PM 2.5 ] and the asthma-related emergency room visits (ERV) and hospitalizations.", {"entities": [[231, 237, "DISEASE"]]}], ["Systematic computerized searches without language limitation were performed.", {"entities": []}], ["Pooled relative risks (RRs) and 95% confidence intervals (95%CIs) were estimated using the random-effect models.", {"entities": []}], ["Sensitivity analyses and subgroup analyses were also performed.", {"entities": []}], ["After screening of 246 studies, 87 were included in our analyses.", {"entities": []}], ["Air pollutants were associated with significantly increased risks of asthma ERVs and hospitalizations [O 3 : RR(95%CI), 1.009 (1.006, 1.011); I 2 : RR(95%CI), 1.018 (1.014, 1.022); I 2 : RR(95%CI), 1.011 (1.007, 1.015); I 10 : RR(95%CI), 1.010 (1.008, 1.013); I 2.5 : RR(95%CI), 1.023 (1.015, 1.031); I Short-term exposures to air pollutants account for increased risks of asthma-related ERVs and hospitalizations that constitute a considerable healthcare utilization and socioeconomic burden.", {"entities": [[69, 75, "DISEASE"], [373, 379, "DISEASE"]]}], ["Many factors act simultaneously in childhood to influence health status, life chances and well being, including pre-birth influences, the environmental pollutants of early life, health status but also the social influences of family and school.", {"entities": []}], ["A cohort study is needed to disentangle these influences and explore attribution.", {"entities": []}], ["Elfe will be a nationally representative cohort of 20 000 children followed from birth to adulthood using a multidisciplinary approach.", {"entities": []}], ["The cohort will be based on the INSEE Permanent Demographic Panel (EDP) established using census data and civil records.", {"entities": []}], ["The sample size has been defined in order to match the representativeness criteria and to obtain some prevalence estimation, but also to address the research area of low exposure/rare effects.", {"entities": []}], ["The cohort will be based on repeated surveys by face to face or phone interview (at birth and each year) as well as medical interview (at 2 years) and examination (at 6 years).", {"entities": []}], ["Furthermore, biological samples will be taken at birth to evaluate the foetal exposition to toxic substances, environmental sensors will be placed in the child's homes.", {"entities": []}], ["Pilot studies have been initiated in 2007 (500 children) with an overall acceptance rate of 55% and are currently under progress, the 2-year survey being carried out in October this year.", {"entities": []}], ["The longitudinal study will provide a unique source of data to analyse the development of children in their environment, to study the various factors interacting throughout the life course up to adulthood and to determine the impact of childhood experience on the individual's physical, psychological, social and professional development.", {"entities": []}], ["Airway inflammation is accompanied by infiltration of inflammatory cells and an abnormal response of airway smooth muscle.", {"entities": []}], ["These cells secrete chemokines and express the cell surface chemokine receptors that play an important role in the migration and degranulation of inflammatory cells.", {"entities": []}], ["Omalizumab is a monoclonal antibody directed against immunoglobulin E, and its blocking of IgE signaling not only reduces inflammatory cell infiltration mediated by the Th2 immune response but also inhibits other immune responses.", {"entities": []}], ["The chemokine CCL15 is influenced by omalizumab, and the source of CCL15 has been reported to be airway smooth muscle cells and basophils.", {"entities": [[14, 19, "GENE"], [67, 72, "GENE"], [14, 19, "GENE"], [67, 72, "GENE"]]}], ["CCL15 binds to its receptor CCR1, which has been reported to be expressed by various inflammatory cells and also by airway smooth muscle cells.", {"entities": [[0, 5, "GENE"], [28, 32, "GENE"]]}], ["Therefore, CCL15/CCR1 signaling could be a target for the treatment of asthma.", {"entities": [[71, 77, "DISEASE"]]}], ["We review the role of CCL15 in the pathogenesis of asthma and also discuss the influence of IgE-mediated immunomodulation via CCL15 and its receptor CCR1.", {"entities": [[51, 57, "DISEASE"], [22, 27, "GENE"], [126, 131, "GENE"], [22, 27, "GENE"], [126, 131, "GENE"], [149, 153, "GENE"]]}], ["In contrast to some other neurodegenerative diseases, little is known about ventilatory dysfunction in Parkinson\u2019s disease (PD).", {"entities": []}], ["To assess the spectrum of ventilation disorders in PD, we searched for and reviewed studies of dyspnea, lung volumes, respiratory muscle function, sleep breathing disorders and the response to hypoxemia in PD.", {"entities": []}], ["Among the studies, we identified some limitations: (i) small study populations (mainly composed of patients with advanced PD), (ii) the absence of long-term follow-up and (iii) the absence of functional evaluations under \u201coff-drug\u201d conditions.", {"entities": []}], ["Although there are many reports of abnormal spirometry data in PD (mainly related to impairment of the inspiratory muscles), little is known about hypoventilation in PD.", {"entities": []}], ["We conclude that ventilatory dysfunction in PD has been poorly studied and little is known about its frequency and clinical relevance.", {"entities": []}], ["Hence, there is a need to characterize the different phenotypes of ventilation disorders in PD, study their relationships with disease progression and assess their prognostic value.", {"entities": []}], ["GSK2190915 is a high affinity 5-lipoxygenase-activating protein inhibitor being developed for the treatment of asthma.", {"entities": [[111, 117, "DISEASE"]]}], ["The objective of this study was to evaluate GSK2190915 efficacy, dose\u2013response and safety in subjects with persistent asthma treated with short-acting beta2-agonists (SABAs) only.", {"entities": [[118, 124, "DISEASE"]]}], ["Eight-week multicentre, randomised, double-blind, double-dummy, stratified (by age and smoking status), parallel-group, placebo-controlled study in subjects aged \u226512\u00a0years with a forced expiratory volume in 1\u00a0second (FEV 1 ) of 50\u201385% predicted.", {"entities": [[217, 220, "GENE"]]}], ["Subjects (n\u2009=\u2009700) were randomised to receive once-daily (QD) oral GSK2190915 (10\u2013300\u00a0mg), twice-daily inhaled fluticasone propionate 100\u00a0\u03bcg, oral montelukast 10\u00a0mg QD or placebo.", {"entities": []}], ["The primary endpoint was mean change from baseline (randomisation) in trough (morning pre-dose and pre-rescue bronchodilator) FEV 1 at the end of the 8-week treatment period.", {"entities": [[126, 129, "GENE"]]}], ["Secondary endpoints included morning and evening peak expiratory flow, symptom-free days and nights, rescue-free days and nights, day and night-time symptom scores, day and night-time rescue medication use, withdrawals due to lack of efficacy, Asthma Control Questionnaire and Asthma Quality of Life Questionnaire scores.", {"entities": [[244, 250, "DISEASE"], [277, 283, "DISEASE"]]}], ["For the primary endpoint, there was no statistically significant difference between any dose of GSK2190915 QD and placebo.", {"entities": []}], ["However, repeated measures sensitivity analysis demonstrated nominal statistical significance for GSK2190915 30\u00a0mg QD compared with placebo (mean difference: 0.115\u00a0L [95% confidence interval: 0.00, 0.23], p\u2009=\u20090.044); no nominally statistically significant differences were observed with any of the other doses.", {"entities": []}], ["For the secondary endpoints, decreases were observed in day-time symptom scores and day-time SABA use for GSK2190915 30\u00a0mg QD versus placebo (p\u2009\u2264\u20090.05).", {"entities": []}], ["No dose\u2013response relationship was observed for the primary and secondary endpoints across the GSK2190915 dose range studied; the 10\u00a0mg dose appeared to be sub-optimal.", {"entities": []}], ["GSK2190915 was associated with a dose-dependent reduction in urinary leukotriene E 4 .", {"entities": []}], ["The profile and incidence of adverse events were similar between treatment groups.", {"entities": []}], ["Efficacy was demonstrated for GSK2190915 30\u00a0mg compared with placebo in day-time symptom scores and day-time SABA use.", {"entities": []}], ["No additional improvement on efficacy endpoints was gained by administration of GSK2190915 doses greater than 30\u00a0mg. GSK2190915 was well-tolerated.", {"entities": []}], ["These results may support further studies with GSK2190915 30\u00a0mg. Clinicaltrials.gov: NCT01147744 .", {"entities": []}], ["Protein-protein, cell signaling, metabolic, and transcriptional interaction networks are useful for identifying connections between lists of experimentally identified genes/proteins.", {"entities": []}], ["However, besides physical or co-expression interactions there are many ways in which pairs of genes, or their protein products, can be associated.", {"entities": []}], ["By systematically incorporating knowledge on shared properties of genes from diverse sources to build functional association networks (FANs), researchers may be able to identify additional functional interactions between groups of genes that are not readily apparent.", {"entities": []}], ["Genes2FANs is a web based tool and a database that utilizes 14 carefully constructed FANs and a large-scale protein-protein interaction (PPI) network to build subnetworks that connect lists of human and mouse genes.", {"entities": []}], ["The FANs are created from mammalian gene set libraries where mouse genes are converted to their human orthologs.", {"entities": []}], ["The tool takes as input a list of human or mouse Entrez gene symbols to produce a subnetwork and a ranked list of intermediate genes that are used to connect the query input list.", {"entities": []}], ["In addition, users can enter any PubMed search term and then the system automatically converts the returned results to gene lists using GeneRIF.", {"entities": []}], ["This gene list is then used as input to generate a subnetwork from the user\u2019s PubMed query.", {"entities": []}], ["As a case study, we applied Genes2FANs to connect disease genes from 90 well-studied disorders.", {"entities": []}], ["We find an inverse correlation between the counts of links connecting disease genes through PPI and links connecting diseases genes through FANs, separating diseases into two categories.", {"entities": []}], ["Genes2FANs is a useful tool for interpreting the relationships between gene/protein lists in the context of their various functions and networks.", {"entities": []}], ["Combining functional association interactions with physical PPIs can be useful for revealing new biology and help form hypotheses for further experimentation.", {"entities": []}], ["Our finding that disease genes in many cancers are mostly connected through PPIs whereas other complex diseases, such as autism and type-2 diabetes, are mostly connected through FANs without PPIs, can guide better strategies for disease gene discovery.", {"entities": []}], ["Genes2FANs is available at: http://actin.pharm.mssm.edu/genes2FANs .", {"entities": []}], ["Short chain fatty acids (SCFAs) are produced in the gut by bacterial fermentation of poorly digested carbohydrates.", {"entities": []}], ["A key mediator of their actions is the G protein-coupled free fatty acid 2 (FFA2) receptor, and this has been suggested as a therapeutic target for the treatment of both metabolic and inflammatory diseases.", {"entities": []}], ["However, a lack of understanding of the molecular determinants dictating how ligands bind to this receptor has hindered development.", {"entities": []}], ["We have developed a novel radiolabeled FFA2 antagonist to probe ligand binding to FFA2, and in combination with mutagenesis and molecular modeling studies, we define how agonist and antagonist ligands interact with the receptor.", {"entities": []}], ["Although both agonist and antagonist ligands contain negatively charged carboxylates that interact with two key positively charged arginine residues in transmembrane domains V and VII of FFA2, there are clear differences in how these interactions occur.", {"entities": []}], ["Specifically, although agonists require interaction with both arginine residues to bind the receptor, antagonists require an interaction with only one of the two.", {"entities": []}], ["Moreover, different chemical series of antagonist interact preferentially with different arginine residues.", {"entities": []}], ["A homology model capable of rationalizing these observations was developed and provides a tool that will be invaluable for identifying improved FFA2 agonists and antagonists to further define function and therapeutic opportunities of this receptor.", {"entities": []}], ["Human respiratory syncytial virus (RSV) is an important community and nosocomial pathogen in developed countries but data regarding the importance of RSV in developing countries are relatively scarce.", {"entities": []}], ["During a 1-year surveillance study in 2010, we took serial samples from children admitted to the Emergency Unit of the Respiratory Ward of Children's Hospital 1 in Ho Chi Minh City, Vietnam.", {"entities": []}], ["RSV was detected within 72\u00a0hours of admission to the ward in 26% (376/1439; RSV A: n \u00a0=\u00a0320; RSV B: n \u00a0=\u00a054; and RSV A and B: n \u00a0=\u00a02).", {"entities": []}], ["Among those negative in the first 72\u00a0hours after admission, 6\u00b76% (25/377) acquired nosocomial RSV infection during hospitalization (RSV A: n \u00a0=\u00a022; and RSV B: n \u00a0=\u00a03).", {"entities": []}], ["Children with nosocomial RSV infection were younger ( P \u00a0=\u00a00\u00b7001) and had a longer duration of hospitalization ( P \u00a0<\u00a00\u00b7001).", {"entities": []}], ["The rate of incomplete recovery among children with nosocomial RSV infection was significantly higher than among those without ( P \u00a0<\u00a00\u00b7001).", {"entities": []}], ["Phylogenetic analysis of partial G gene sequences obtained from 79% (316/401) of positive specimens revealed the co-circulation of multiple genotypes with RSV A NA1 being predominant (A NA1: n \u00a0=\u00a0275; A GA5: n \u00a0=\u00a05; B BA3: n \u00a0=\u00a03; B BA9: n \u00a0=\u00a026; and B BA10: n \u00a0=\u00a07).", {"entities": []}], ["The RSV A GA5 and RSV B BA3 genotypes have not been reported from Vietnam, previously.", {"entities": []}], ["Besides emphasizing the importance of RSV as a cause of respiratory infection leading to hospitalization in young children and as a nosocomial pathogen, data from this study extend our knowledge on the genetic diversity of RSV circulating in Vietnam.", {"entities": []}], ["Chronic airway inflammation and airway remodeling are the major pathophysiological characteristics of chronic obstructive pulmonary disease (COPD).", {"entities": [[102, 139, "DISEASE"]]}], ["Resveratrol and genistein have been previously demonstrated to have anti-inflammatory and antioxidative properties.", {"entities": []}], ["The present study aimed to measure the inhibitory effects of resveratrol and genistein on tumor necrosis factor (TNF)-\u03b1 and matrix metalloproteinase (MMP)-9 concentration in patients with COPD.", {"entities": [[113, 116, "GENE"]]}], ["Lymphocytes were isolated from the blood of 34 patients with COPD and 30 healthy subjects, then randomly divided into the following four treatment groups: Control, dexamethasone (0.5 \u00b5 mol/l), resveratrol (12.5 \u00b5 mol/l) and genistein (25 \u00b5 mol/l) groups.", {"entities": []}], ["After 1 h of treatment, 100 \u00b5 l lymphocytes were collected for nuclear factor (NF)-\u03baB immunocytochemical staining.", {"entities": []}], ["After 48 h treatment, the supernatant of the lymphocytes was collected for analysis of TNF-\u03b1 and MMP-9 concentration levels.", {"entities": []}], ["The percentage of lymphocytes with positive nuclear NF-\u03baB expression was analyzed by immunocytochemical staining.", {"entities": []}], ["The concentration levels of TNF-\u03b1 and MMP-9 were measured using radioimmunoassay and enzyme-linked immunosorbent assay, respectively.", {"entities": []}], ["The present study demonstrated that the percentage of NF-\u03baB-positive cells, and the levels of TNF-\u03b1 and MMP-9 in lymphocytes from patients with COPD patients were significantly higher compared with healthy subjects.", {"entities": []}], ["Additionally, there were positive correlations between the percentage of NF-\u03baB-positive cells, and the concentration levels of TNF-\u03b1 and MMP-9 in patients with COPD.", {"entities": []}], ["All three factors were significantly reduced in lymphocytes treated with resveratrol and genistein, and the inhibitory effects of resveratrol on NF-\u03baB, TNF-\u03b1 and MMP-9 were more potent than the effects of genistein.", {"entities": []}], ["In conclusion, resveratrol and genistein may inhibit the NF-\u03baB, TNF-\u03b1 and MMP-9-associated pathways in patients with COPD.", {"entities": []}], ["It is suggested that resveratrol and genistein may be potential drugs candidates for use in the treatment of COPD.", {"entities": []}], ["The positive effects of early developmental intervention (EDI) on early child development have been reported in numerous controlled trials in a variety of countries.", {"entities": []}], ["An important aspect to determining the efficacy of EDI is the degree to which dosage is linked to outcomes.", {"entities": []}], ["However, few studies of EDI have conducted such analyses.", {"entities": []}], ["This observational cohort study examined the association between treatment dose and children\u2019s development when EDI was implemented in three low and low-middle income countries as well as demographic and child health factors associated with treatment dose.", {"entities": []}], ["Infants (78 males, 67 females) born in rural communities in India, Pakistan, and Zambia received a parent-implemented EDI delivered through biweekly home visits by trainers during the first 36\u00a0months of life.", {"entities": []}], ["Outcome was measured at age 36\u00a0months with the Mental (MDI) and Psychomotor (PDI) Development Indices of the Bayley Scales of Infant Development-II.", {"entities": []}], ["Treatment dose was measured by number of home visits completed and parent-reported implementation of assigned developmental stimulation activities between visits.", {"entities": []}], ["Sociodemographic, prenatal, perinatal, and child health variables were measures as correlates.", {"entities": []}], ["Average home visits dose exceeded 91% and mothers engaged the children in activities on average 62.5% of days.", {"entities": []}], ["Higher home visits dose was significantly associated with higher MDI (mean for dose quintiles 1\u20132 combined\u2009=\u200997.8, quintiles 3\u20135 combined\u2009=\u2009103.4, p \u2009=\u20090.0017).", {"entities": []}], ["Higher treatment dose was also generally associated with greater mean PDI, but the relationships were non-linear.", {"entities": []}], ["Location, sociodemographic, and child health variables were associated with treatment dose.", {"entities": []}], ["Receiving a higher dose of EDI during the first 36\u00a0months of life is generally associated with better developmental outcomes.", {"entities": []}], ["The higher benefit appears when receiving \u226591% of biweekly home visits and program activities on \u226567% of days over 3\u00a0years.", {"entities": []}], ["It is important to ensure that EDI is implemented with a sufficiently high dose to achieve desired effect.", {"entities": []}], ["To this end groups at risk for receiving lower dose can be identified and may require special attention to ensure adequate effect.", {"entities": []}], ["The AMPK-Sirt1 pathway is an important regulator of energy metabolism and therefore a potential target for prevention and therapy of metabolic diseases.", {"entities": []}], ["We recently demonstrated leucine and its metabolite \u03b2-hydroxy-\u03b2-methylbutyrate (HMB) to synergize with low-dose resveratrol (200 nM) to activate sirtuin signaling and stimulate energy metabolism.", {"entities": []}], ["Here we show that leucine exerts a direct effect on Sirt1 kinetics, reducing its Km for NAD", {"entities": [[52, 57, "GENE"]]}], ["The interaction between IgE and allergen is a key event at the initiation of an allergic response, and its characteristics have substantial effects on the clinical manifestation.", {"entities": []}], ["Despite this, the molecular details of the interaction between human IgE and the major birch allergen Bet v 1, one of the most potent tree allergens, still remain poorly investigated.", {"entities": []}], ["To isolate Bet v 1-specific human monoclonal IgE and characterize their interaction with the allergen.", {"entities": []}], ["Recombinant human IgE were isolated from a combinatorial antibody fragment library and their interaction with Bet v 1 assessed using various immunological assays.", {"entities": []}], ["The structure of one such IgE in the single-chain fragment variable format was determined using X-ray crystallography.", {"entities": []}], ["We present four novel Bet v 1-specific IgE, for one of which we solve the structure, all with their genetic origin in the IGHV5 germline gene, and demonstrate that they target two non-overlapping epitopes on the surface of Bet v 1, thereby fulfilling the basic criteria for Fc\u03b5RI cross-linkage.", {"entities": []}], ["We further define these epitopes and for one epitope pinpoint single amino acid residues important for the interaction with human IgE.", {"entities": []}], ["This provides a potential explanation, at the molecular level, for the differences in recognition of isoforms of Bet v 1 and other allergens in the PR-10 protein family displayed by IgE targeting this epitope.", {"entities": []}], ["Finally, we present the first high-resolution structure of a human allergen-specific IgE fragment in the single-chain fragment variable (scFv) format.", {"entities": []}], ["We here display the usefulness of allergen-specific human monoclonal IgE as a tool in studies of the crucial molecular interaction taking place at the initiation of an allergic response.", {"entities": []}], ["Such studies may aid us in development of better diagnostic tools and guide us in the development of new therapeutic compounds.", {"entities": []}], ["This 1998 workshop was convened to address the health risks of exposure to environmental tobacco smoke (ETS) in the workplace.", {"entities": []}], ["It was paired with a 1997 workshop on issues related to ETS exposure in work environments ((italic)1(/italic)).", {"entities": []}], ["In the 1998 workshop, a multidisciplinary group of participants was charged with reviewing evidence on the quantitative risks to health posed by ETS and to discuss development of risk assessment methodology for the future.", {"entities": []}], ["The overall charges for the present workshop were to consider various health outcomes and make recommendations regarding those health outcomes to be included in assessment of health risk resulting from ETS in the workplace; to consider available studies addressing these health outcomes and to evaluate the validity of data for estimating risk from occupational ETS exposure; to review and evaluate mathematical models useful for estimating the risk due to ETS exposure; to examine dose-response models and to characterize the models regarding validity and uncertainty in estimating health risk attributable to ETS exposure in the workplace.", {"entities": []}], ["The low\u2010affinity IgE receptor Fc\u03f5RII (CD23) is part of the regulatory system controlling IgE synthesis in human B cells and exists in membrane and soluble forms.", {"entities": []}], ["Binding of IgE to CD23 has been described to have stabilizing effects and to prevent cleavage of CD23.", {"entities": []}], ["Previous experiments using anti\u2010CD23 antibodies reduced IgE synthesis but were difficult to interpret as the antibody Fc part might also mediate feedback mechanisms.", {"entities": []}], ["The purpose of this study was to investigate the regulatory role of CD23, by using designed ankyrin repeat proteins (DARPins) that specifically recognize CD23.", {"entities": []}], ["Anti\u2010CD23 DARPins were isolated by ribosome display and were produced as monovalent and bivalent constructs.", {"entities": []}], ["Affinities to CD23 were measured by surface plasmon resonance.", {"entities": []}], ["IgE synthesis and up\u2010regulation of CD23 in human peripheral B cells were induced by IL\u20104 and anti\u2010CD40 antibody.", {"entities": []}], ["We assessed CD23 expression and its stabilization by FACS and used an ELISA for detecting soluble CD23.", {"entities": []}], ["IgE synthesis was measured by ELISA and real\u2010time PCR.", {"entities": []}], ["Surface plasmon resonance revealed affinities of the DARPins to CD23 in the pico\u2010molar range.", {"entities": []}], ["Anti\u2010CD23 DARPins strongly inhibited binding of IgE to CD23 and share thus a similar binding epitope as IgE.", {"entities": []}], ["The DARPins stabilized membrane CD23 and reduced IgE synthesis in an isotype specific manner.", {"entities": []}], ["Furthermore, the anti\u2010CD23 DARPins decreased IgE transcript through inhibition of mature C\u03f5 RNA synthesis suggesting a posttranscriptional control mechanism.", {"entities": []}], ["This study demonstrates that targeting CD23 alone is sufficient to inhibit IgE synthesis and suggests that a negative signaling occurs directly through the CD23 molecule.", {"entities": []}], ["Pulmonary hypertension (PH) contributes to the mortality of patients with lung and heart diseases.", {"entities": [[10, 22, "DISEASE"], [0, 22, "DISEASE"]]}], ["However, the underlying mechanism has not been completely elucidated.", {"entities": []}], ["Accumulating evidence suggests that inflammatory response may be involved in the pathogenesis of PH.", {"entities": []}], ["Macrophage migration inhibitory factor (MIF) is a critical upstream inflammatory mediator which promotes a broad range of pathophysiological processes.", {"entities": [[40, 43, "GENE"]]}], ["The aim of the study was to investigate the role of MIF in the pulmonary vascular remodeling of hypoxia-induced PH.", {"entities": [[52, 55, "GENE"]]}], ["We found that MIF mRNA and protein expression was increased in the lung tissues from hypoxic pulmonary hypertensive rats.", {"entities": [[14, 17, "GENE"]]}], ["Intensive immunoreactivity for MIF was observed in smooth muscle cells of large pulmonary arteries (PAs), endothelial cells of small PAs, and inflammatory cells of hypoxic lungs.", {"entities": [[31, 34, "GENE"]]}], ["MIF participated in the hypoxia-induced PASMCs proliferation, and it could directly stimulate proliferation of these cells.", {"entities": [[0, 3, "GENE"]]}], ["MIF-induced enhanced growth of PASMCs was attenuated by MEK and JNK inhibitor.", {"entities": []}], ["Besides, MIF antagonist ISO-1 suppressed the ERK1/2 and JNK phosphorylation induced by MIF.", {"entities": [[9, 12, "GENE"], [87, 90, "GENE"], [9, 12, "GENE"], [87, 90, "GENE"]]}], ["In conclusion, the current finding suggested that MIF may act on the proliferation of PASMCs through the activation of the ERK1/2 and JNK pathways, which contributes to hypoxic pulmonary hypertension.", {"entities": [[187, 199, "DISEASE"], [177, 199, "DISEASE"], [50, 53, "GENE"]]}], ["Prostacyclin, or PGI 2 , is an end product derived from the sequential metabolism of arachidonic acid via cyclooxygenase and PGI synthase (PGIS).", {"entities": []}], ["The receptor for PGI 2 , IP, can be found on a variety of cell types and signaling through this receptor exhibits broad physiological effects.", {"entities": []}], ["Historically, PGI 2 has been understood to play a role in cardiovascular health, specifically having powerful vasodilatory effects via relaxation of smooth muscle and inhibiting of platelet aggregation.", {"entities": []}], ["For these reasons, PGI 2 has a long history of use for the treatment of pulmonary arterial hypertension (PAH).", {"entities": [[91, 103, "DISEASE"]]}], ["Only recently, its importance as an immunomodulatory agent has been investigated.", {"entities": []}], ["PGI 2 regulates both the innate and adaptive immune systems and its effects are, for the most part, thought to be anti-inflammatory or immunosuppressive in nature, which may have implications for its further clinical use.", {"entities": []}], ["The overall aim of this project is to help develop knowledge about primary care delivery models likely to improve the accessibility, quality and efficiency of care.", {"entities": []}], ["Operationally, this objective will be achieved through supporting and evaluating 8 primary care team pilot sites that rely on an expanded nursing role within a more intensive team-based, interdisciplinary setting.", {"entities": []}], ["The first research component is aimed at supporting the development and implementation of the pilot projects, and is divided into 2 parts.", {"entities": []}], ["The first part is a logical analysis based on interpreting available scientific data to understand the causal processes by which the objectives of the intervention being studied may be achieved.", {"entities": []}], ["The second part is a developmental evaluation to support teams in the field in a participatory manner and thereby learn from experience.", {"entities": []}], ["Operationally, the developmental evaluation phase mainly involves semistructured interviews.", {"entities": []}], ["The second component of the project design focuses on evaluating pilot project results and assessing their costs.", {"entities": []}], ["This component is in turn made up of 2 parts.", {"entities": []}], ["Part 1 is a pre-and-post survey of patients receiving the intervention care to analyse their care experience.", {"entities": []}], ["In part 2, each patient enrolled in part 1 (around 4000 patients) will be matched with 2 patients followed within a traditional primary care model, so that a comparative analysis of the accessibility, quality and efficiency of the intervention can be performed.", {"entities": []}], ["The cohorts formed in this way will be followed longitudinally for 4\u2005years.", {"entities": []}], ["The project, as well as all consent forms and research tools, have been accepted by 2 health sciences research ethics committees.", {"entities": []}], ["The procedures used will conform to best practices regarding the anonymity of patients.", {"entities": []}], ["The purpose of this study was to assess the effect of personal variables on the fit of the respirators used by firefighters and workers in highly polluted environments.", {"entities": []}], ["However, resistance from many plants managers was met to conduct the study on their workers.", {"entities": []}], ["Therefore, we were forced to limit the study on firefighters who were found very cooperative.", {"entities": []}], ["Forty volunteer firefighters from different departments participated in the study.", {"entities": []}], ["They were subjected to a daily leak rate measurement using a Control Negative Pressure (CNP) fit tester for five consecutive days.", {"entities": [[88, 91, "GENE"]]}], ["Two types of respirators were used for each volunteer: the Drager type and the MSA.", {"entities": []}], ["At the end of the study, the association between face shape and presence of beard with the respirator leak rates was investigated.", {"entities": []}], ["A significant difference in the leak rate was detected between the two types of respirators used, with the Drager respirator having higher leak rates.", {"entities": []}], ["The presence of a beard increased dramatically the leak rate whatever the face shape was.", {"entities": []}], ["The oval shape was the best fitting to the respirators, followed by the rounded and finally the rectangular face.", {"entities": []}], ["The study recommends that personal variables like face shape must be taken into consideration and fit testing must be carried out periodically, to specify the respirator that best fits each firefighter.", {"entities": []}], ["Having beard must be absolutely prohibited, since it can be life threatening in environmental dangerous conditions such those encountered during extinguishing fires and overhaul situations.", {"entities": []}], ["The microRNA (miR)183 cluster, which is comprised of miRs-183, -96 and -182, is also a miR family with sequence homology.", {"entities": []}], ["Despite the strong similarity in the sequences of these miRs, minute differences in their seed sequences result in both overlapping and distinct messenger RNA targets, which are often within the same pathway.", {"entities": []}], ["These miRs have tightly synchronized expression during development and are required for maturation of sensory organs.", {"entities": []}], ["In comparison to their defined role in normal development, the miR-183 family is frequently highly expressed in a variety of non-sensory diseases, including cancer, neurological and auto-immune disorders.", {"entities": [[157, 163, "DISEASE"], [63, 70, "GENE"]]}], ["Here, we discuss the conservation of the miR-183 cluster and the functional role of this miR family in normal development and diseases.", {"entities": [[41, 48, "GENE"]]}], ["We also describe the regulation of vital cellular pathways by coordinated expression of these miR siblings.", {"entities": []}], ["This comprehensive review sheds light on the likely reasons why the genomic organization and seeming redundancy of the miR-183 family cluster was conserved through 600 million years of evolution.", {"entities": [[119, 126, "GENE"]]}], ["There is a link between joint and gut inflammation of unknown etiology in arthritis.", {"entities": [[74, 83, "DISEASE"]]}], ["Existing research indicates that regular consumption of high-fructose corn syrup sweetened (HFCS) soft drinks, but not diet soft drinks, may be associated with increased risk of seropositive rheumatoid arthritis (RA) in women, independent of other dietary and lifestyle factors.", {"entities": [[191, 211, "DISEASE"], [202, 211, "DISEASE"]]}], ["One unexplored hypothesis for this association is that fructose malabsorption, due to regular consumption of excess free fructose (EFF) and HFCS, contributes to fructose reactivity in the gastrointestinal tract and intestinal in situ formation of enFruAGEs, which once absorbed, travel beyond the intestinal boundaries to other tissues and promote inflammation.", {"entities": []}], ["In separate studies, the accumulation of advanced glycation end-products has been associated with joint inflammation in RA.", {"entities": []}], ["Objective of this study was to assess the association between EFF beverages intake and non-age, non-wear and tear-associated arthritis in US young adults.", {"entities": [[125, 134, "DISEASE"]]}], ["In this cross sectional study of 1209 adults aged 20\u201330y, (Nutrition and Health Examination Surveys 2003\u20132006) exposure variables were high EFF beverages, including HFCS sweetened soft drinks, and any combination of HFCS sweetened soft drinks, fruit drinks (FD) and apple juice, referred to as tEFF.", {"entities": []}], ["Analyses of diet soda and diet FD were included for comparison.", {"entities": []}], ["The outcome was self-reported arthritis.", {"entities": [[30, 39, "DISEASE"]]}], ["Rao Scott \u04b2 Young adults consuming any combination of high EFF beverages (tEFF) \u2a7e5 times/week (but not diet soda) were three times as likely to have arthritis as non/low consumers (odds ratios=3.01; p \u2a7d0.021; 95% confidence intervals=1.20\u20137.59), independent of all covariates, including physical activity, other dietary factors, blood glucose and smoking.", {"entities": [[149, 158, "DISEASE"]]}], ["EFF beverage intake is significantly associated with arthritis in US adults aged 20\u201330 years, possibly due to the intestinal in situ formation of enFruAGEs.", {"entities": [[53, 62, "DISEASE"]]}], ["The study aimed to determine whether exposure to a volcanic eruption was associated with increased prevalence of physical and/or mental symptoms.", {"entities": []}], ["Cohort, with non-exposed control group.", {"entities": []}], ["Natural disasters like volcanic eruptions constitute a major public-health threat.", {"entities": []}], ["The Icelandic volcano Eyjafjallaj\u00f6kull exposed residents in southern Iceland to continuous ash fall for more than 5\u2005weeks in spring 2010.", {"entities": []}], ["This study was conducted during November 2010\u2013March 2011, 6\u20139\u2005months after the Eyjafjallaj\u00f6kull eruption.", {"entities": []}], ["Adult (18\u201380\u2005years of age) eruption-exposed South Icelanders (N=1148) and a control population of residents of Skagafj\u00f6r\u00f0ur, North Iceland (N=510).", {"entities": []}], ["The participation rate was 72%.", {"entities": []}], ["Physical symptoms in the previous year (chronic), in the previous month (recent), General Health Questionnaire (GHQ-12) measured psychological morbidity.", {"entities": []}], ["The likelihood of having symptoms during the last month was higher in the exposed population, such as; tightness in the chest (OR 2.5; 95% CI 1.1 to 5.8), cough (OR 2.6; 95% CI 1.7 to 3.9), phlegm (OR 2.1; 95% CI 1.3 to 3.2), eye irritation (OR 2.9; 95% CI 2.0 to 4.1) and psychological morbidity symptoms (OR 1.3; 95% CI 1.0 to 1.7).", {"entities": []}], ["Respiratory symptoms during the last 12\u2005months were also more common in the exposed population; cough (OR 2.2; 95% CI 1.6 to 2.9), dyspnoea (OR 1.6; 95% CI 1.1 to 2.3), although the prevalence of underlying asthma and heart disease was similar.", {"entities": [[218, 231, "DISEASE"], [207, 213, "DISEASE"]]}], ["Twice as many in the exposed population had two or more symptoms from nose, eyes or upper-respiratory tract (24% vs 13%, p<0.001); these individuals were also more likely to experience psychological morbidity (OR 4.7; 95% CI 3.4 to 6.5) compared with individuals with no symptoms.", {"entities": []}], ["Most symptoms exhibited a dose\u2013response pattern within the exposed population, corresponding to low, medium and high exposure to the eruption.", {"entities": []}], ["6\u20139\u2005months after the Eyjafjallaj\u00f6kull eruption, residents living in the exposed area, particularly those closest to the volcano, had markedly increased prevalence of various physical symptoms.", {"entities": []}], ["A portion of the exposed population reported multiple symptoms and may be at risk for long-term physical and psychological morbidity.", {"entities": []}], ["Studies of long-term consequences are therefore warranted.", {"entities": []}], ["Human controlled-exposure studies have assessed the impact of ambient fine particulate matter on cardiac autonomic function measured by heart rate variability (HRV), but whether these effects are modified by concomitant ozone exposure remains unknown.", {"entities": []}], ["In this study we assessed the impact of O 3 and particulate matter exposure on HRV in humans.", {"entities": []}], ["In a crossover design, 50 subjects (19\u201348 years of age) were randomized to 2-hr controlled exposures to filtered air (FA), concentrated ambient particles (CAPs), O 3 , or combined CAPs and ozone (CAPs + O 3 ).", {"entities": [[155, 159, "GENE"], [180, 184, "GENE"], [196, 200, "GENE"], [155, 159, "GENE"], [180, 184, "GENE"], [196, 200, "GENE"], [155, 159, "GENE"], [180, 184, "GENE"], [196, 200, "GENE"]]}], ["The primary end point was change in HRV between the start and end of exposure.", {"entities": []}], ["Secondary analyses included blood pressure (BP) responses, and effect modification by asthmatic status.", {"entities": []}], ["Achieved mean CAPs and O 3 exposure concentrations were 121.6 \u00b1 48.0 \u03bcg/m 3 .", {"entities": [[14, 18, "GENE"]]}], ["This heterogeneity was statistically significant for the low-frequency component of HRV ( p = 0.02) and approached significance for the high-frequency component and time-domain measures of HRV.", {"entities": []}], ["Exposure to CAPs + O 3 increased diastolic BP by 2.0 mmHg (SE, 1.2; p = 0.02).", {"entities": [[12, 16, "GENE"]]}], ["No other statistically significant changes in BP were observed.", {"entities": []}], ["Asthmatic status did not modify these effects.", {"entities": []}], ["The potentiation by O 3 of CAPs effects on diastolic BP and possibly HRV is of small magnitude in young adults.", {"entities": [[27, 31, "GENE"]]}], ["Further studies are needed to assess potential effects in more vulnerable populations.", {"entities": []}], ["Methods based on real-time polymerase chain reaction (PCR) can speed up the diagnosis of invasive aspergillosis but are limited by a lack of standardization.", {"entities": [[98, 111, "DISEASE"], [89, 111, "DISEASE"]]}], ["We evaluated the commercially available MycAssay\u2122 Aspergillus test for the diagnosis of invasive aspergillosis in patients without hematological cancer.", {"entities": [[97, 110, "DISEASE"], [88, 110, "DISEASE"], [145, 151, "DISEASE"]]}], ["We prospectively collected 322 lower respiratory tract samples (November 2009\u2013January 2011) from 175 patients with lower respiratory tract infection and the following predisposing conditions: solid cancer (16.8%), cirrhosis (16.8%), corticosteroid therapy (71.7%), HIV infection (15.6%), chronic obstructive pulmonary disease (COPD, 52.6%), solid organ transplantation (kidney [1.2%], heart [3%], liver [4.6%]), or none (3.5%).", {"entities": [[288, 325, "DISEASE"], [198, 204, "DISEASE"]]}], ["Specimens were obtained when clinically indicated and analyzed in the microbiology laboratory.", {"entities": []}], ["Aspergillus DNA was extracted and amplified by means of MycXtra\u00ae and MycAssay\u2122 Aspergillus.", {"entities": []}], ["Aspergillus spp.", {"entities": []}], ["was isolated from 65 samples (31 patients).", {"entities": []}], ["According to the European Organization for Research and Treatment of Cancer and Bulpa's criteria (for patients with COPD), 15 had probable invasive aspergillosis.", {"entities": [[148, 161, "DISEASE"], [139, 161, "DISEASE"], [69, 75, "DISEASE"]]}], ["MycAssay\u2122 Aspergillus results were negative (n\u200a=\u200a254), positive (n\u200a=\u200a54), or indeterminate (n\u200a=\u200a14).", {"entities": []}], ["The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic odds ratio of the MycAssay\u2122 (first sample/any sample) were 86.7/93, 87.6/82.4, 34.1/34.1, 92.2/100, and 48/68.75.", {"entities": []}], ["The differences between the proportion of samples with positive PCR determinations (63%) and the proportion of samples with Aspergillus spp.", {"entities": []}], ["isolation (75%) did not reach statistical significance ( P \u200a=\u200a0.112).", {"entities": []}], ["The median time from sample culture to visualization of fungal growth was 3 days, compared with \u223c4 hours for MycAssay\u2122 Aspergillus PCR.", {"entities": []}], ["MycAssay\u2122 Aspergillus showed high sensitivity for the diagnosis of invasive aspergillosis in patients without hematological cancer.", {"entities": [[76, 89, "DISEASE"], [67, 89, "DISEASE"], [124, 130, "DISEASE"]]}], ["Sensitivity increased when multiple samples were used.", {"entities": []}], ["Compared with fungal culture, PCR significantly reduced the time to diagnosis.", {"entities": []}], ["The development of healthy food portion sizes among families is deemed critical to childhood weight management; yet little is known about the interacting factors influencing parents\u2019 portion control behaviours.", {"entities": []}], ["This study aimed to use two synergistic theoretical models of behaviour: the COM-B model (Capability, Opportunity, Motivation \u2013 Behaviour) and Theoretical Domains Framework (TDF) to identify a broad spectrum of theoretically derived influences on parents\u2019 portion control behaviours including examination of affective and habitual influences often excluded from prevailing theories of behaviour change.", {"entities": []}], ["Six focus groups exploring family weight management comprised of one with caseworkers ( n \u00a0=\u00a04), four with parents of overweight children ( n \u00a0=\u00a014) and one with parents of healthy weight children ( n \u00a0=\u00a08).", {"entities": []}], ["A thematic analysis was performed across the dataset where the TDF/COM-B were used as coding frameworks.", {"entities": []}], ["To achieve the target behaviour, the behavioural analysis revealed the need for eliciting change in all three COM-B domains and nine associated TDF domains.", {"entities": []}], ["Findings suggest parents\u2019 internal processes such as their emotional responses, habits and beliefs, along with social influences from partners and grandparents, and environmental influences relating to items such as household objects, interact to influence portion size behaviours within the home environment.", {"entities": []}], ["This is the first study underpinned by COM-B/TDF frameworks applied to childhood weight management and provides new targets for intervention development and the opportunity for future research to explore the mediating and moderating effects of these variables on one another.", {"entities": []}], ["The aim of the present study was to explore the roles of OX40/OX40 ligand (OX40L) signaling and OX40", {"entities": []}], ["Differences among species in the anatomic sites of particle retention could influence responses to inhaled particles.", {"entities": []}], ["In this study, we used morphometric techniques to examine the influence of exposure concentration on particle retention in histologic sections from rats and humans.", {"entities": []}], ["The rats had been exposed for 24 months to diesel exhaust at 0.35, 3.5, or 7.0 mg soot/m(3).", {"entities": []}], ["The human subjects were nonsmokers who did not work as miners, nonsmoking coal miners who worked under the current standard of 2 mg dust/m(3) for 10-20 years (mean = 14 years), and nonsmoking coal miners who worked under the former standard of < 10 mg dust/m(3) for 33-50 years (mean = 40 years).", {"entities": []}], ["The distribution of retained particles within the lung compartments was markedly different between species.", {"entities": []}], ["In all three groups of rats, 82-85% of the retained particulate material was located in the alveolar and alveolar duct lumens, primarily in macrophages.", {"entities": []}], ["In humans, 57, 68, and 91% of the retained particulate material was located in the interstitium of the lung in the non-miners, coal miners under the current standard, and coal miners under the former standard, respectively.", {"entities": []}], ["These results show that chronically inhaled diesel soot is retained predominantly in the airspaces of rats over a wide range of exposures, whereas in humans, chronically inhaled particulate material is retained primarily in the interstitium.", {"entities": []}], ["In humans, the percentage of particles in the interstitium is increased with increased dose (exposure concentration, years of exposure, and/or lung burden).", {"entities": []}], ["This difference in distribution may bring different lung cells into contact with the retained particles or particle-containing macrophages in rats and humans and may account for differences in species response to inhaled particles.", {"entities": []}], ["Epilepsy is a complex neurological disorder and a significant health problem.", {"entities": []}], ["The pathogenesis of epilepsy remains obscure in a significant number of patients and the current treatment options are not adequate in about a third of individuals which were known as refractory epilepsies (RE).", {"entities": []}], ["Network medicine provides an effective approach for studying the molecular mechanisms underlying complex diseases.", {"entities": []}], ["Here we integrated 1876 disease-gene associations of RE and located those genes to human protein-protein interaction (PPI) network to obtain 42 significant RE-associated disease modules.", {"entities": []}], ["The functional analysis of these disease modules showed novel molecular pathological mechanisms of RE, such as the novel enriched pathways (e.g., \u201cpresynaptic nicotinic acetylcholine receptors\u201d, \u201csignaling by insulin receptor\u201d).", {"entities": []}], ["Further analysis on the relationships between current drug targets and the RE-related disease genes showed the rational mechanisms of most antiepileptic drugs.", {"entities": []}], ["In addition, we detected ten potential novel drug targets (e.g., KCNA1, KCNA4-6, KCNC3, KCND2, KCNMA1, CAMK2G, CACNB4 and GRM1) located in three RE related disease modules, which might provide novel insights into the new drug discovery for RE therapy.", {"entities": [[65, 70, "GENE"], [81, 86, "GENE"], [88, 93, "GENE"], [95, 101, "GENE"], [103, 109, "GENE"], [111, 117, "GENE"], [122, 126, "GENE"]]}], ["There are many age-associated changes in the respiratory and pulmonary immune system.", {"entities": []}], ["These changes include decreases in the volume of the thoracic cavity, reduced lung volumes, and alterations in the muscles that aid respiration.", {"entities": []}], ["Muscle function on a cellular level in the aging population is less efficient.", {"entities": []}], ["The elderly population has less pulmonary reserve, and cough strength is decreased in the elderly population due to anatomic changes and muscle atrophy.", {"entities": []}], ["Clearance of particles from the lung through the mucociliary elevator is decreased and associated with ciliary dysfunction.", {"entities": []}], ["Many complex changes in immunity with aging contribute to increased susceptibility to infections including a less robust immune response from both the innate and adaptive immune systems.", {"entities": []}], ["Considering all of these age-related changes to the lungs, pulmonary disease has significant consequences for the aging population.", {"entities": []}], ["Chronic lower respiratory tract disease is the third leading cause of death in people aged 65 years and older.", {"entities": [[8, 39, "DISEASE"]]}], ["With a large and growing aging population, it is critical to understand how the body changes with age and how this impacts the entire respiratory system.", {"entities": []}], ["Understanding the aging process in the lung is necessary in order to provide optimal care to our aging population.", {"entities": []}], ["This review focuses on the nonpathologic aging process in the lung, including structural changes, changes in muscle function, and pulmonary immunologic function, with special consideration of obstructive lung disease in the elderly.", {"entities": [[192, 216, "DISEASE"], [204, 216, "DISEASE"]]}], ["Physical activity (PA) protects against most noncommunicable diseases and has been associated with decreased risk of allergic phenotype, which is increasing worldwide.", {"entities": []}], ["However, the association is not always present; furthermore it is not clear whether it is strongest for asthma, rhinitis, symptoms of these, or atopic sensitization; which sex is most affected; or whether it can be explained by either avoidance of sport or exacerbation of symptoms by exercise.", {"entities": [[112, 120, "DISEASE"], [104, 110, "DISEASE"]]}], ["Interventions are thus difficult to target.", {"entities": []}], ["PA was measured by one-week accelerometry in 1137 Germans (mean age 15.6 years, 47% boys) from the GINIplus and LISAplus birth cohorts, and modeled as a correlate of allergic symptoms, sensitization, or reported doctor-diagnosed asthma or rhinitis.", {"entities": [[239, 247, "DISEASE"], [229, 235, "DISEASE"]]}], ["8.3% of children had asthma, of the remainder 7.9% had rhinitis, and of the remainder 32% were sensitized to aero-allergens (atopic).", {"entities": [[55, 63, "DISEASE"], [21, 27, "DISEASE"]]}], ["52% were lung-healthy controls.", {"entities": []}], ["Lung-healthy boys and girls averaged 46.4 min and 37.8 min moderate-to-vigorous PA per day, of which 14.6 and 11.4 min was vigorous.", {"entities": []}], ["PA in allergic girls was not altered, but boys with asthma got 13% less moderate and 29% less vigorous PA, and those with rhinitis with 13% less moderate PA, than lung-healthy boys.", {"entities": [[122, 130, "DISEASE"], [52, 58, "DISEASE"]]}], ["Both sexes participated comparably in sport (70 to 84%).", {"entities": []}], ["Adolescents with wheezing (up to 68%, in asthma) and/or nose/eye symptoms (up to 88%, in rhinitis) were no less active.", {"entities": [[89, 97, "DISEASE"], [41, 47, "DISEASE"]]}], ["We found that asthma and rhinitis, but not atopy, were independently associated with low PA in boys, but not in girls.", {"entities": [[25, 33, "DISEASE"], [14, 20, "DISEASE"]]}], ["These results indicate that allergic boys remain a high-risk group for physical inactivity even if they participate comparably in sport.", {"entities": []}], ["Research into the link between PA and allergy should consider population-specific and sex-specific effects, and clinicians, parents, and designers of PA interventions should specifically address PA in allergic boys to ensure full participation.", {"entities": []}], ["A prospective study to investigate the pattern of pro- and anti-inflammatory cytokine responses in neonates with surgical necrotizing enterocolitis (NEC) and identify those cytokines being the most promising for future research.", {"entities": []}], ["A panel of 11 different cytokines were measured in 9 infants with proven NEC and compared with 18 age-matched healthy neonates.", {"entities": []}], ["The serum concentrations of the interleukins (IL)-6, IL-8, and IL-10 were significantly (32\u2013fold to 56-fold) higher in NEC infants compared with controls.", {"entities": []}], ["In contrast, IL-5, IFN gamma, IL-4 and IL-2 showed slightly (1.4-fold to 5.9-fold) lower levels in the NEC samples.", {"entities": []}], ["However, these cytokines showed a very low absolute concentration in infants with NEC and in controls.", {"entities": []}], ["The sum of the serum concentrations of IL-6, IL-8 and IL-10 was able to clearly separate infants with NEC from control samples.", {"entities": []}], ["IL-1 beta and TNF-alpha showed no statistically different levels.", {"entities": []}], ["The serum levels of TNF-beta and IL-12p70 were below the detection limit in more than 50% of all samples per group.", {"entities": []}], ["In spite of strong local inflammation only three out of eleven cytokines (IL-6, IL-8, and IL-10) showed strongly increased serum levels indicating an important role of them in the pathogenesis of NEC.", {"entities": []}], ["At least two of these three cytokines were elevated in every single NEC patient.", {"entities": []}], ["Thus, longitudinal monitoring of combined IL-8, IL-6, and IL-10 levels could reveal their potency in being clinical relevant markers in NEC.", {"entities": []}], ["Exposure to soybean allergens has been linked to asthma outbreaks.", {"entities": [[49, 55, "DISEASE"]]}], ["Exposure to diesel exhaust particles (DEP) has been associated with an increase in the risk of asthma and asthma exacerbation; however, in both cases the underlying mechanisms remain poorly understood, as does the possible interaction between the two entities.", {"entities": [[95, 101, "DISEASE"], [106, 112, "DISEASE"]]}], ["To investigate how the combination of soybean allergens and DEP can affect the induction or exacerbation of asthma in a murine model.", {"entities": [[108, 114, "DISEASE"]]}], ["BALB/c mice received intranasal instillations of saline, 3 or 5 mg protein/ml soybean hull extract (SHE), or a combination of one of these three solutions with DEP.", {"entities": []}], ["Airway hyperresponsiveness (AHR), pulmonary inflammation in bronchoalveolar lavage, total serum immunoglobulin E and histological studies were assessed.", {"entities": [[28, 31, "GENE"]]}], ["A 5 mg protein/ml SHE solution was able by itself to enhance AHR (p = 0.0033), increase eosinophilic inflammation (p = 0.0003), increase levels of IL-4, IL-5, IL-13, IL-17A, IL-17F and CCL20, and reduce levels of IFN-\u03b3.", {"entities": [[61, 64, "GENE"], [185, 190, "GENE"]]}], ["The combination of 5 mg protein/ml SHE with DEP also produced an increase in AHR and eosinophilic inflammation, but presented a slightly different cytokine profile with higher levels of Th17-related cytokines.", {"entities": [[77, 80, "GENE"]]}], ["However, while the 3 mg protein/ml SHE solution did not induce asthma, co-exposure with DEP resulted in a markedly enhanced AHR (p = 0.002) and eosinophilic inflammation (p = 0.004), with increased levels of IL-5, IL-17F and CCL20 and decreased levels of IFN-\u03b3.", {"entities": [[63, 69, "DISEASE"], [124, 127, "GENE"], [225, 230, "GENE"]]}], ["The combination of soybean allergens and DEP is capable of triggering an asthmatic response through a Th17-related mechanism when the soybean allergen concentration is too low to promote a response by itself.", {"entities": []}], ["DEP monitoring may be a useful addition to allergen monitoring in order to prevent new asthma outbreaks.", {"entities": [[87, 93, "DISEASE"]]}], ["To evaluate the activity of recombinant adenovirus encoding human vasohibin-1 (Ad-Vasohibin-1) on mouse corneal neovasularization induced by alkali burn.", {"entities": []}], ["For the treatment group, 50 mice each received subconjunctival injection (5 \u03bcl) of 10 Vegf ), VEGF receptor 1 and 2 ( Vegfr1 , Vegfr2 ), and vasohibin-1 ( Vash1 ) were analyzed and compared by real time quantitative reverse-transcription polymerase chain reaction.", {"entities": [[155, 160, "GENE"]]}], ["The percentage of neovascularized area within the cornea was significantly reduced in mice treated with Ad-Vasohibin-1 compared to mice treated with AdNull at every time point after alkali-induced injury (7.11%\u00b13.91% and 15.48%\u00b11.79% of corneal area in the treatment and control groups, respectively, on day 3; 31.64%\u00b14.71% and 43.93%\u00b16.15% on day 6, and 45.02%\u00b19.98% and 66.24%\u00b17.17% on day 9, all p<0.001).", {"entities": []}], ["Human vasohibin-1 protein was detected at the injection sites on day 3 after corneal burn and was highly expressed in the central subepithelial stroma and co-localized with neovascularized vessels within the alkali-treated cornea on day 6.", {"entities": []}], ["On day 9, the peripheral cornea exhibited a similar staining pattern as the central cornea, but a more intense vasohibin-1 immunostaining signal was detected in the deep stroma.", {"entities": []}], ["Some of the vasohibin-1 stain signal diffused into the frontal and deep stroma of the central cornea and was not co-localized with new vessels.", {"entities": []}], ["By contrast, in mice injected with AdNull or normal corneas, no vasohibin-1 stain signal was detected within the corneas.", {"entities": []}], ["Vasohibin-1 protein expression within treated corneas was also further confirmed by western blotting on day 5.", {"entities": []}], ["Expression appeared to peak by day 8 and was maintained at high levels until day 14.", {"entities": []}], ["However, Vasohibin-1 protein was not detected in the corneas of normal mice or mice treated with AdNull.", {"entities": []}], ["Real-time quantitative reverse-transcription polymerase chain reaction analysis showed that expression of Vegfr2 and endogenous Vash1 mRNA were significantly decreased in the treatment versus control group ( t 1 =\u20132.161, p 1 =0.047; t 2 =\u20132.236, p 2 =0.041).", {"entities": [[128, 133, "GENE"]]}], ["In contrast, there were no significant differences in Vegf and Vegfr1 mRNA expression levels between the treatment and control groups (p>0.05 for both).", {"entities": []}], ["Subconjunctival injection of Ad-Vasohibin-1 significantly reduces corneal neovascularization in alkali-treated mouse corneas.", {"entities": [[66, 92, "DISEASE"]]}], ["This effect of anti-neovascularization may be related to the downregulation of Vegfr2 expression.", {"entities": []}], ["Severe alpha1-antitrypsin (AAT) deficiency is a strong risk factor for COPD.", {"entities": []}], ["But the impact of gene variants resulting in mild or intermediate AAT deficiency on the longitudinal course of respiratory health remains controversial.", {"entities": []}], ["There is indication from experimental studies that pro-inflammatory agents like cigarette smoke can interact with these variants and thus increase the risk of adverse respiratory health effects.", {"entities": []}], ["Therefore, we tested the effect of the presence of a protease inhibitor (Pi) S or Z allele (PiMS and PiMZ) on the change in lung function in different inflammation-exposed subgroups of a large, population-based cohort study.", {"entities": []}], ["The SAPALDIA population includes over 4600 subjects from whom SERPINA1 genotypes for S and Z alleles, spirometry and respiratory symptoms at baseline and after 11 years follow-up, as well as proxies for inflammatory conditions, such as detailed smoking history, obesity and high sensitivity C-reactive protein (hs-CRP), were available.", {"entities": [[262, 269, "DISEASE"], [62, 70, "GENE"]]}], ["All analyses were performed by applying multivariate regression models.", {"entities": []}], ["There was no overall unfavourable effect of PiMS or PiMZ genotype on lung function change.", {"entities": []}], ["We found indication that PiZ heterozygosity interacted with inflammatory stimuli leading to an accelerated decline in measures in use as indices for assessing mild airway obstruction.", {"entities": []}], ["Obese individuals with genotype PiMM had an average annual decline in the forced mid expiratory flow ( \u0394 FEF25-75%) of 58.4 ml whereas in obese individuals with PiMZ it amounted to 92.2 ml (p\u200a=\u200a0.03).", {"entities": []}], ["Corresponding numbers for persistent smokers differed even more strongly (66.8 ml (PiMM) vs. 108.2 ml (PiMZ), p\u200a=\u200a0.005).", {"entities": []}], ["Equivalent, but less strong associations were observed for the change in the FEV1/FVC ratio.", {"entities": []}], ["We suggest that, in addition to the well established impact of the rare PiZZ genotype, one Z allele may be sufficient to accelerate lung function decline in population subgroups characterized by elevated levels of low grade inflammation.", {"entities": []}], ["Pollen grains from Populus tomentosa , a widely cultivated tree in northern area of China, are considered to be an important aeroallergen causing severe allergic diseases.", {"entities": []}], ["To gain insight into their allergenic components, mature Populus tomentosa pollen proteins were analyzed by two-dimensional gel electrophoresis (2-DE) and matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF/TOF MS).", {"entities": []}], ["A total of 412 spots from mature pollen were resolved on pH 4\u20137 immobilized pH gradient (IPG) strips and 159 distinct proteins were identified from 242 spots analyzed.", {"entities": []}], ["The identified proteins were categorized based on their functional role in the pollen, which included proteins involved in energy regulation, protein fate, protein synthesis and processing, metabolism, defense/stress responses, development and other functional categories.", {"entities": []}], ["Moreover, among the identified proteins, 27 proteins were identified as putative allergens using the Structural Database of Allergenic Proteins (SDAP) tool and Allergen Online.", {"entities": []}], ["The expression patterns of these putative allergen genes indicate that several of these genes are highly expressed in pollen.", {"entities": []}], ["The identified putative allergens have the potential to improve specific diagnosis and can be used to develop vaccines for immunotherapy against poplar pollen allergy.", {"entities": []}], ["Indacaterol is a novel once-daily ultra long-acting \u03b2 2 -agonist for the treatment of chronic obstructive pulmonary disease.", {"entities": [[86, 123, "DISEASE"]]}], ["It is known that \u03b2 2 -agonists, like other adrenergic compounds, can prolong the QT-interval.", {"entities": []}], ["This thorough QT/QTc study (as per ICH E14 guideline) evaluated the effect of indacaterol on the QT interval in healthy subjects.", {"entities": []}], ["In this randomized, double-blind, parallel-group, placebo- and positive-controlled (open-label moxifloxacin) study, non-smoking healthy subjects (18-55 years, body mass index: 18.5-32.0 kg/m In total, 404 subjects were randomized to receive indacaterol (150 [n = 108], 300 [n = 108], 600 \u03bcg [n = 54]), placebo (n = 107), or placebo/moxifloxacin (n = 27); 388 subjects completed the study.", {"entities": []}], ["Maximal time-matched mean (90% confidence intervals) treatment differences from placebo in QTcF change from baseline on Day 14 were 2.66 (0.55, 4.77), 2.98 (1.02, 4.93) and 3.34 (0.86, 5.82) ms for indacaterol 150 \u03bcg, 300 \u03bcg and 600 \u03bcg, respectively.", {"entities": []}], ["Study sensitivity was confirmed with moxifloxacin demonstrating a significant maximal time-matched QTcF prolongation of 13.90 (10.58, 17.22) ms compared to placebo.", {"entities": []}], ["All indacaterol doses were well tolerated.", {"entities": []}], ["Indacaterol, at doses up to 600 \u03bcg once daily (2-4 times the therapeutic dose) does not have any clinically relevant effect on the QT interval.", {"entities": []}], ["ClinicalTrials.gov: NCT01263808", {"entities": []}], ["Mechanical ventilation with a tidal volume (V T ) of 6 mL/kg/predicted body weight (PBW), to maintain plateau pressure (P plat ) lower than 30 cmH 2 O, does not completely avoid the risk of ventilator induced lung injury (VILI).", {"entities": []}], ["The aim of this study was to evaluate safety and feasibility of a ventilation strategy consisting of very low V T combined with extracorporeal carbon dioxide removal (ECCO 2 R).", {"entities": []}], ["In fifteen patients with moderate ARDS, V T was reduced from baseline to 4 mL/kg PBW while PEEP was increased to target a plateau pressure \u2013 (P plat ) between 23 and 25 cmH 2 O. Low-flow ECCO 2 R was initiated when respiratory acidosis developed (pH\u2009<\u20097.25, PaCO 2 \u2009>\u200960 mmHg).", {"entities": []}], ["Ventilation parameters (V T , respiratory rate, PEEP), respiratory compliance (C RS ), driving pressure (DeltaP\u2009=\u2009V T /C RS ), arterial blood gases, and ECCO 2 R system operational characteristics were collected during the period of ultra-protective ventilation.", {"entities": []}], ["Patients were weaned from ECCO 2 R when PaO 2 /FiO 2 was higher than 200 and could tolerate conventional ventilation settings.", {"entities": []}], ["Complications, mortality at day 28, need for prone positioning and extracorporeal membrane oxygenation, and data on weaning from both MV and ECCO 2 R were also collected.", {"entities": []}], ["During the 2 h run in phase, V T reduction from baseline (6.2 mL/kg PBW) to approximately 4 mL/kg PBW caused respiratory acidosis (pH\u2009<\u20097.25) in all fifteen patients.", {"entities": []}], ["At steady state, ECCO 2 R with an average blood flow of 435 mL/min and sweep gas flow of 10 L/min was effective at correcting pH and PaCO 2 to within 10 % of baseline values.", {"entities": []}], ["PEEP values tended to increase at V T of 4 mL/kg from 12.2 to 14.5 cmH 2 O, but this change was not statistically significant.", {"entities": []}], ["Driving pressure was significantly reduced during the first two days compared to baseline (from 13.9 to 11.6 cmH 2 O; p\u2009<\u20090.05) and there were no significant differences in the values of respiratory system compliance.", {"entities": []}], ["Rescue therapies for life threatening hypoxemia such as prone position and ECMO were necessary in four and two patients, respectively.", {"entities": []}], ["Only two study-related adverse events were observed (intravascular hemolysis and femoral catheter kinking).", {"entities": []}], ["The low-flow ECCO 2 R system safely facilitates a low volume, low pressure ultra-protective mechanical ventilation strategy in patients with moderate ARDS.", {"entities": []}], ["The relationship between asthma and traffic-related pollutants has received considerable attention.", {"entities": [[25, 31, "DISEASE"]]}], ["The use of individual-level exposure measures, such as residence location or proximity to emission sources, may avoid ecological biases.", {"entities": []}], ["This study focused on the pediatric Medicaid population in Detroit, MI, a high-risk population for asthma-related events.", {"entities": [[99, 105, "DISEASE"]]}], ["A population-based matched case-control analysis was used to investigate associations between acute asthma outcomes and proximity of residence to major roads, including freeways.", {"entities": [[100, 106, "DISEASE"]]}], ["Asthma cases were identified as all children who made at least one asthma claim, including inpatient and emergency department visits, during the three-year study period, 2004-06.", {"entities": [[0, 6, "DISEASE"], [67, 73, "DISEASE"]]}], ["Individually matched controls were randomly selected from the rest of the Medicaid population on the basis of non-respiratory related illness.", {"entities": []}], ["We used conditional logistic regression with distance as both categorical and continuous variables, and examined non-linear relationships with distance using polynomial splines.", {"entities": []}], ["The conditional logistic regression models were then extended by considering multiple asthma states (based on the frequency of acute asthma outcomes) using polychotomous conditional logistic regression.", {"entities": [[86, 92, "DISEASE"], [133, 139, "DISEASE"]]}], ["Asthma events were associated with proximity to primary roads with an odds ratio of 0.97 (95% CI: 0.94, 0.99) for a 1 km increase in distance using conditional logistic regression, implying that asthma events are less likely as the distance between the residence and a primary road increases.", {"entities": [[0, 6, "DISEASE"], [195, 201, "DISEASE"]]}], ["Similar relationships and effect sizes were found using polychotomous conditional logistic regression.", {"entities": []}], ["Another plausible exposure metric, a reduced form response surface model that represents atmospheric dispersion of pollutants from roads, was not associated under that exposure model.", {"entities": []}], ["There is moderately strong evidence of elevated risk of asthma close to major roads based on the results obtained in this population-based matched case-control study.", {"entities": [[56, 62, "DISEASE"]]}], ["Using biochemical, epifluorescence and electron microscopic techniques in a U937 model system, we investigated the effect of anti-allergic drugs di-sodium cromoglycate and sodium nedocromil on the trafficking and release of the anti-inflammatory protein Annexin-A1 (Anx-A1) when this was triggered by glucocorticoid (GC) treatment.", {"entities": [[317, 319, "GENE"]]}], ["GCs alone produced a rapid (within 5\u00a0min) concentration-dependent activation of PKC\u03b1/\u03b2 (Protein Kinase C; EC 2.7.11.13) and phosphorylation of Anx-A1 on Ser 2 generation.", {"entities": []}], ["When administered alone, cromoglycate or nedocromil had little effect on this pathway however, in the presence of a fixed sub-maximal concentration of GCs, increasing amounts of the cromoglycate-like drugs caused a striking concentration-dependent enhancement of Anx-A1 and PKC\u03b1/\u03b2 phosphorylation, membrane recruitment and Anx-A1 release from cells resulting in greatly enhanced inhibition of TxB 2 generation.", {"entities": []}], ["GCs also stimulated phosphatase accumulation at the plasma membrane of U937 cells.", {"entities": []}], ["Both cromoglycate and nedocromil inhibited this enzymatic activity as well as that of a highly purified PP2A phosphatase preparation.", {"entities": []}], ["We conclude that stimulation by the cromoglycate-like drugs of intracellular Anx-A1 trafficking and release (hence inhibition of eicosanoid release) is secondary to inhibition of a phosphatase PP2A (phosphoprotein phosphatase; EC 3.1.3.16), which probably forms part of a control loop to limit Anx-A1 release.", {"entities": []}], ["These experiments provide a basis for a novel mechanism of action for the cromolyns, a group of drugs that have long puzzled investigators.", {"entities": []}], ["Whereas the topic of the \u2018cultural sensitivity\u2019 of healthcare systems has been addressed extensively in the US and the UK, literature on the subject in most European countries, specifically looking at the situation of Roma, is still scarce.", {"entities": []}], ["Drawing on qualitative research conducted mainly in the city of Barcelona under the communicative approach with Roma subjects who have stable socioeconomic positions and higher cultural capitals (end-users, professionals of the healthcare system, and key informants of a regional policy oriented to the improvement of Roma living conditions), the present study aims to fill this gap.", {"entities": []}], ["We explore the barriers that the Roma face in accessing the healthcare system, reflecting on how these barriers are accentuated by the existing anti-Roma prejudices and institutional arrangements that do not account for minority cultures.", {"entities": []}], ["Our results point out a series of obstacles at two levels, in the interaction with healthcare professionals, and in relation to existing institutional arrangements, which prevent Roma families from having equal access to the healthcare system.", {"entities": []}], ["Education stands up as a mechanism to contest anti-Roma sentiments among healthcare professionals.", {"entities": []}], ["Despite shame being recognised as a powerful force in the clinical encounter, it is underacknowledged, under-researched and undertheorised in the contexts of health and medicine.", {"entities": []}], ["In this paper we make two claims.", {"entities": []}], ["The first is that emotional or affective states, in particular shame, can have a significant impact on health, illness and health-related behaviours.", {"entities": []}], ["We outline four possible processes through which this might occur: (1) acute shame avoidance behaviour; (2) chronic shame health-related behaviours; (3) stigma and social status threat and (4) biological mechanisms.", {"entities": []}], ["Second, we postulate that shame's influence is so insidious, pervasive and pernicious, and so critical to clinical and political discourse around health, that it is imperative that its vital role in health, health-related behaviours and illness be recognised and assimilated into medical, social and political consciousness and practice.", {"entities": []}], ["In essence, we argue that its impact is sufficiently powerful for it to be considered an affective determinant of health, and provide three justifications for this.", {"entities": []}], ["We conclude with a proposal for a research agenda that aims to extend the state of knowledge of health-related shame.", {"entities": []}], ["Group 2 innate lymphoid cells (ILC2s) are involved in human diseases, such as allergy, atopic dermatitis and nasal polyposis, but their function in human cancer remains unclear.", {"entities": [[87, 104, "DISEASE"], [154, 160, "DISEASE"], [94, 104, "DISEASE"]]}], ["Here we show that, in acute promyelocytic leukaemia (APL), ILC2s are increased and hyper-activated through the interaction of CRTH2 and NKp30 with elevated tumour-derived PGD2 and B7H6, respectively.", {"entities": []}], ["ILC2s, in turn, activate monocytic myeloid-derived suppressor cells (M-MDSCs) via IL-13 secretion.", {"entities": []}], ["Upon treating APL with all-trans retinoic acid and achieving complete remission, the levels of PGD2, NKp30, ILC2s, IL-13 and M-MDSCs are restored.", {"entities": []}], ["Similarly, disruption of this tumour immunosuppressive axis by specifically blocking PGD2, IL-13 and NKp30 partially restores ILC2 and M-MDSC levels and results in increased survival.", {"entities": []}], ["Thus, using APL as a model, we uncover a tolerogenic pathway that may represent a relevant immunosuppressive, therapeutic targetable, mechanism operating in various human tumour types, as supported by our observations in prostate cancer.", {"entities": [[230, 236, "DISEASE"], [221, 236, "DISEASE"]]}], ["Group 2 innate lymphoid cells (ILC2s) modulate inflammatory and allergic responses, but their function in cancer immunity is still unclear.", {"entities": [[106, 112, "DISEASE"]]}], ["Here the authors show that, in acute promyelocytic leukaemia, tumour-activated ILC2s secrete IL-13 to induce myeloid-derived suppressor cells and support tumour growth.", {"entities": []}], ["BET proteins have been shown to regulate gene expression including inflammatory genes.", {"entities": []}], ["In order to investigate the role of the BET proteins in immunoglobulin production we treated the human B-cell line CLNH11.4 and primary human B cells and ozone-exposed mice with BET inhibitors (JQ1 or IBET151).", {"entities": []}], ["Both proliferation and IgG production were reduced by JQ1 in a concentration-dependent manner.", {"entities": []}], ["JQ1 significantly reduced immunoglobulin gene transcription.", {"entities": []}], ["In vivo treatment of ozone-exposed mice with the BET inhibitor IBET151 similarly inhibited ozone-induced immunoglobulin production.", {"entities": []}], ["JQ1 did not reduce the protein levels of Brd4 or Oct2 per se but reduced the ability of Brd4 and Oct2 to co-immunoprecipitate and of Oct2 to bind to immunoglobulin gene promoters.", {"entities": [[41, 45, "GENE"], [88, 92, "GENE"], [41, 45, "GENE"], [88, 92, "GENE"]]}], ["Our results indicate that BET proteins including Brd4 play a crucial role regulation B-cell-specific gene expression and immunoglobulin production.", {"entities": [[49, 53, "GENE"]]}], ["Interleukin-26 (IL-26) is one of the cytokines secreted by Th17 cells whose role in human tumors remains unknown.", {"entities": []}], ["Here, we investigated the expression and potential role of IL-26 in human gastric cancer (GC).", {"entities": [[82, 88, "DISEASE"], [90, 92, "GENE"]]}], ["The expression of IL-26 and related molecules such as IL-20R1, STAT1 and STAT3 was examined by real-time PCR and immunohistochemisty.", {"entities": [[63, 68, "GENE"], [73, 78, "GENE"]]}], ["The effects of IL-26 on cell proliferation and cisplatin-induced apoptosis were analyzed by BrdU cooperation assay and PI-Annexin V co-staining, respectively.", {"entities": []}], ["Lentiviral mediated siRNA was used to explore its mechanism of action, and IL-26 related signaling was analyzed by western blotting.", {"entities": []}], ["Human GC tissues showed increased levels of IL-26 and its related molecules and activation of STAT3 signaling, whereas STAT1 activation did not differ significantly between GC and normal gastric tissues.", {"entities": [[6, 8, "GENE"], [173, 175, "GENE"], [94, 99, "GENE"], [119, 124, "GENE"], [6, 8, "GENE"], [173, 175, "GENE"]]}], ["Moreover, IL-26 was primarily produced by Th17 and NK cells.", {"entities": []}], ["IL-26 promoted the proliferation and survival of MKN45 and SGC-7901 gastric cancer cells in a dose-dependent manner.", {"entities": [[76, 82, "DISEASE"]]}], ["Furthermore, IL-20R2 and IL-10R1, which are two essential receptors for IL-26 signaling, were expressed in both cell lines.", {"entities": []}], ["IL-26 activated STAT1 and STAT3 signaling; however, the upregulation of the expression of Bcl-2, Bcl-xl and c-myc indicated that the effect of IL-26 is mediated by STAT3 activation.", {"entities": [[16, 21, "GENE"], [26, 31, "GENE"], [164, 169, "GENE"], [26, 31, "GENE"], [164, 169, "GENE"]]}], ["Knockdown of STAT1 and STAT3 expression suggested that the proliferative and anti-apoptotic effects of IL-26 are mediated by the modulation of STAT1/STAT3 activation.", {"entities": [[13, 18, "GENE"], [143, 148, "GENE"], [23, 28, "GENE"], [149, 154, "GENE"]]}], ["In summary, elevated levels of IL-26 in human GC promote proliferation and survival by modulating STAT1/STAT3 signaling.", {"entities": [[46, 48, "GENE"]]}], ["Long-lasting impairment of the immune system is believed to be the underlying reason for delayed deaths after surviving sepsis.", {"entities": []}], ["We tested the hypothesis of persisting changes to the immune system in survivors of sepsis for the first time.", {"entities": []}], ["In our prospective, cross-sectional pilot study, eight former patients who survived catecholamine-dependent sepsis and eight control individuals matched for age, sex, diabetes and renal insufficiency were enrolled.", {"entities": []}], ["Each participant completed a questionnaire concerning morbidities, medications and infection history.", {"entities": []}], ["Peripheral blood was collected for determination of i) immune cell subsets (CD4 After surviving sepsis, former patients presented with increased numbers of clinical apparent infections, including those typically associated with an impaired immune system.", {"entities": [[76, 79, "GENE"]]}], ["Standard inflammatory markers indicated a low-level inflammatory situation in former sepsis patients.", {"entities": []}], ["CD8 Cytokine secretion as a reaction to different activators of the immune system seemed to be comprehensively impaired in survivors of sepsis.", {"entities": []}], ["Among others, this could be based on trends in the downregulation of distinct cell surface receptors.", {"entities": []}], ["Based on our results, the conduct of larger validation studies seems feasible, aiming to characterize alterations and to find potential therapeutic targets to engage.", {"entities": []}], ["A common genetic variant, rs4939827, located in SMAD7 , was identified by two recent genome-wide association (GWA) studies to be strongly associated with the risk of colorectal cancer (CRC).", {"entities": [[166, 183, "DISEASE"], [177, 183, "DISEASE"], [48, 53, "GENE"]]}], ["However, the following replication studies yielded conflicting results.", {"entities": []}], ["We conducted a case-control study of 641 cases and 1037 controls in a Chinese population and then performed a meta-analysis, integrating our and published data of 34313 cases and 33251 controls, to clarify the relationship between rs4939827 and CRC risk.", {"entities": []}], ["In our case-control study, the dominant model was significant associated with increased CRC risk [Odds Ratio (OR)\u200a=\u200a1.46; 95% confidence interval (95% CI), 1.19\u20131.80].", {"entities": []}], ["The following meta-analysis further confirmed this significant association for all genetic models but with significant between-study heterogeneity (all P for heterogeneity <0.1).", {"entities": []}], ["By stratified analysis, we revealed that ethnicity, sample size, and tumor sites might constitute the source of heterogeneity.", {"entities": []}], ["The cumulative analysis suggested that evident tendency to significant association was seen with adding study samples over time; whilst, sensitive analysis showed results before and after removal of each study were similar, indicating the highly stability of the current results.", {"entities": []}], ["Results from our case-control study and the meta-analysis collectively confirmed the significant association of the variant rs4939827 with increased risk of colorectal cancer.", {"entities": [[157, 174, "DISEASE"], [168, 174, "DISEASE"]]}], ["Nevertheless, fine-mapping of the susceptibility loci defined by rs4939287 should be imposed to reveal causal variant.", {"entities": []}], ["Nasopharyngeal swabs were taken from volunteers attending a general medical practice and a general hospital in Lancaster, UK, and at Lancaster University, in the winter of 2014\u20132015.", {"entities": []}], ["51 swabs were selected based on high RNA yield and allocated to deep sequencing pools as follows: patients with chronic obstructive pulmonary disease; asthmatics; adults with no respiratory symptoms; adults with feverish respiratory symptoms; adults with respiratory symptoms and presence of antibodies against influenza C; paediatric patients with respiratory symptoms (2 pools); adults with influenza C infection (2 pools), giving a total of 9 pools.", {"entities": [[311, 320, "DISEASE"], [393, 402, "DISEASE"], [112, 149, "DISEASE"]]}], ["Illumina sequencing was performed, with data yields per pool in the range of 345.6 megabases to 14 gigabases after removal of reads aligning to the human genome.", {"entities": []}], ["The data were deposited in the Sequence Read Archive at NCBI, and constitute a resource for study of the viral, bacterial and fungal metagenome of the human nasopharynx in healthy and diseased states and comparison with other metagenomic studies on the human respiratory tract.", {"entities": []}], ["With the increasing use of recombinant \u03b1 and \u03b2 interferon therapy for the treatment of various disorders, cases of interferon-associated sarcoidosis have been reported in the literature.", {"entities": [[137, 148, "DISEASE"]]}], ["The majority of these have been cases of interferon-\u03b1-induced sarcoidosis.", {"entities": [[62, 73, "DISEASE"]]}], ["We present the first case, to the best of our knowledge, of interferon-induced pulmonary sarcoidosis in a patient whose multiple sclerosis was treated with interferon-\u03b2.", {"entities": [[120, 138, "DISEASE"], [89, 100, "DISEASE"], [79, 100, "DISEASE"]]}], ["We present the case of a 30-year-old Caucasian woman who presented with unusually persistent bilateral areas of lung consolidation on serial radiographs.", {"entities": []}], ["Pulmonary sarcoidosis was diagnosed on transbronchial lung biopsy five months after the initiation of treatment with interferon-\u03b2 for multiple sclerosis.", {"entities": [[134, 152, "DISEASE"], [10, 21, "DISEASE"], [0, 21, "DISEASE"]]}], ["Sarcoidosis should be considered in the differential diagnosis of a patient who develops clinical or radiological pulmonary disease while undergoing interferon therapy.", {"entities": [[0, 11, "DISEASE"]]}], ["It is important to note that interferon-induced sarcoidosis, though usually seen in cases with interferon-\u03b1, can occur with interferon-\u03b2.", {"entities": [[48, 59, "DISEASE"]]}], ["Neurologists managing patients with multiple sclerosis should be aware of this association between interferon-\u03b2 and sarcoidosis and promptly refer patients developing respiratory symptoms for further investigation.", {"entities": [[36, 54, "DISEASE"], [116, 127, "DISEASE"]]}], ["Inflammation of the middle ear (otitis media) is very common and can lead to serious complications if not resolved.", {"entities": [[32, 44, "DISEASE"]]}], ["Genetic studies suggest an inherited component, but few of the genes that contribute to this condition are known.", {"entities": []}], ["Mouse mutants have contributed significantly to the identification of genes predisposing to otitis media The dearisch mouse mutant is an ENU-induced mutant detected by its impaired Preyer reflex (ear flick in response to sound).", {"entities": [[92, 104, "DISEASE"]]}], ["Auditory brainstem responses revealed raised thresholds from as early as three weeks old.", {"entities": []}], ["Pedigree analysis suggested a dominant but partially penetrant mode of inheritance.", {"entities": []}], ["The middle ear of dearisch mutants shows a thickened mucosa and cellular effusion suggesting chronic otitis media with effusion with superimposed acute infection.", {"entities": [[101, 113, "DISEASE"]]}], ["The inner ear, including the sensory hair cells, appears normal.", {"entities": []}], ["Due to the low penetrance of the phenotype, normal backcross mapping of the mutation was not possible.", {"entities": []}], ["Exome sequencing was therefore employed to identify a non-conservative tyrosine to cysteine (Y71C) missense mutation in the Islet1 gene, Isl1 .", {"entities": [[137, 141, "GENE"]]}], ["Isl1 is expressed in the normal middle ear mucosa.", {"entities": [[0, 4, "GENE"]]}], ["The findings suggest the Isl1 mutation is likely to predispose carriers to otitis media.", {"entities": [[75, 87, "DISEASE"], [25, 29, "GENE"]]}], ["Dearisch, Isl1 , represents the first point mutation in the mouse Isl1 gene and suggests a previously unrecognized role for this gene.", {"entities": [[10, 14, "GENE"], [66, 70, "GENE"], [10, 14, "GENE"], [66, 70, "GENE"]]}], ["It is also the first recorded exome sequencing of the C3HeB/FeJ background relevant to many ENU-induced mutants.", {"entities": []}], ["Most importantly, the power of exome resequencing to identify ENU-induced mutations without a mapped gene locus is illustrated.", {"entities": []}], ["A chronic illness, such as Juvenile Idiopathic Arthritis (JIA), has an impact on the whole family, especially on parents caring for the ill child.", {"entities": [[47, 56, "DISEASE"]]}], ["Therefore the aim of this study is to evaluate parental Health Related Quality of Life (HRQOL) and parental perceptions of child vulnerability (PPCV) and associated variables in parents of a child with JIA.", {"entities": []}], ["Parents of all JIA patients (0\u201318 years) in Amsterdam, the Netherlands, were eligible.", {"entities": []}], ["HRQOL was measured using the TNO-AZL Questionnaire (TAAQOL) and PPCV using the Child Vulnerability Scale (CVS).", {"entities": []}], ["The HRQOL of parents of a child with JIA was compared to a norm population, and differences between parents of a child with JIA and active arthritis versus parents of a child with JIA without active arthritis were analyzed (ANOVA).", {"entities": [[139, 148, "DISEASE"], [199, 208, "DISEASE"]]}], ["For PPCV, parents of a child with JIA were compared to a norm population, including healthy and chronically ill children (Chi 155 parents (87.5% mothers) completed online questionnaires.", {"entities": []}], ["JIA parents showed worse HRQOL than parents of healthy children on one out of twelve domains: fine motor HRQOL (p\u2009<\u2009.001).", {"entities": []}], ["Parents of children with active arthritis showed worse HRQOL regarding daily activities (p\u2009<\u2009.05), cognitive functioning (p\u2009<\u2009.01) and depressive emotions (p\u2009<\u2009.05) compared to parents of children without active arthritis.", {"entities": [[32, 41, "DISEASE"], [212, 221, "DISEASE"]]}], ["Parents of children with JIA perceived their child as more vulnerable than parents of a healthy child (p\u2009<\u2009.001) and parents of a chronically ill child (p\u2009<\u2009.001).", {"entities": []}], ["Parents of children with active arthritis reported higher levels of PPCV (p\u2009<\u2009.05) than parents of children without active arthritis.", {"entities": [[32, 41, "DISEASE"], [123, 132, "DISEASE"]]}], ["A higher degree of functional disability (p\u2009<\u2009.01) and shorter disease duration (p\u2009<\u2009.05) were associated with higher levels of PPCV.", {"entities": []}], ["The HRQOL of JIA parents was comparable to the HRQOL of parents of a healthy child.", {"entities": []}], ["JIA parents of a child with active arthritis showed worse HRQOL than parents of a child without active arthritis.", {"entities": [[35, 44, "DISEASE"], [103, 112, "DISEASE"]]}], ["Parents perceived their child with JIA as vulnerable.", {"entities": []}], ["In humans and mice, CD8\u03b1 Polyinosinic:polycytidylic acid (poly IC), a double-stranded RNA, is an effective adjuvant in vivo.", {"entities": []}], ["IFN-\u03bbs (also termed IL-28/29) are potent immunomodulatory and antiviral cytokines.", {"entities": []}], ["We demonstrate that poly IC injection in vivo induces large amounts of IFN-\u03bb, which depended on hematopoietic cells and the presence of TLR3 (Toll-like receptor 3), IRF3 (IFN regulatory factor 3), IRF7, IFN-I receptor, Fms-related tyrosine kinase 3 ligand (FL), and IRF8 but not on MyD88 (myeloid differentiation factor 88), Rig-like helicases, or lymphocytes.", {"entities": [[136, 140, "GENE"], [165, 169, "GENE"], [197, 201, "GENE"], [266, 270, "GENE"], [282, 287, "GENE"]]}], ["Upon poly IC injection in vivo, the IFN-\u03bb production by splenocytes segregated with cells phenotypically resembling CD8\u03b1", {"entities": []}], ["Embryo implantation is essential for a successful pregnancy, and leads to the decidualization of endometrial stromal cells (ESCs) in the secretory phase of the menstrual cycle.", {"entities": []}], ["It has previously been demonstrated that decidual stromal cells (DSCs) co-express interleukin (IL)-25/IL-17RB and that IL-25 further promotes the proliferation of DSCs via activating c-Jun n-terminal kinase and protein kinase B signals, therefore the present study primarily focused on the role of IL-25 in the process of decidualization in vitro .", {"entities": []}], ["It was demonstrated that the expression of IL-25/IL-17RB in ESCs was decreased compared with DSCs.", {"entities": []}], ["In addition, following decidualization, the expression levels of IL-25/IL-17RB in ESCs were significantly elevated.", {"entities": []}], ["Recombinant human (rh) IL-25 promoted the decidualization of ESCs in the presence of 8-bromoadenosine 3\u2032,5\u2032-cyclic monophosphate sodium salt and 6\u03b1-methyl17\u03b1-acetoxyprogesterone, which was partially inhibited by anti-human IL-25 neutralizing antibody (anti-IL-25) or anti-IL-17RB.", {"entities": []}], ["In addition, decidual natural killer (dNK) cells not only secreted IL-25, however also further accelerated the decidualization in vitro .", {"entities": []}], ["Therefore, these findings indicated that ESCs differentiate into DSCs in the presence of ovarian hormones, resulting in the upregulation of IL-25/IL-17RB expression in ESCs.", {"entities": []}], ["Furthermore, IL-25 secreted by ESCs and dNK cells further facilitates the decidualization of ESCs, which may form a positive feedback mechanism at the maternal-fetal interface and thus contribute to the establishment and maintenance of normal pregnancy.", {"entities": []}], ["\u03b2-catenin has been shown to be regulated by inducible nitric oxide synthase (NOS) in endothelial cells.", {"entities": []}], ["We investigated here whether \u03b2-catenin interacts with and regulates endothelial NOS (eNOS) and whether eNOS activation promotes \u03b2-catenin signalling.", {"entities": []}], ["We identified \u03b2-catenin as a novel eNOS binding protein in human umbilical vein endothelial cells (HUVECs) by mass spectroscopy and western blot analyses of \u03b2-catenin and eNOS immunoprecipitates.", {"entities": []}], ["This was confirmed by in situ proximity ligation assay.", {"entities": []}], ["eNOS activity, assessed by cGMP production and eNOS phosphorylation (Ser1177), was enhanced in \u03b2-catenin These data reveal bidirectional cross-talk and regulation between the NO-cGMP and \u03b2-catenin signalling pathways.", {"entities": []}], ["Fibrotic remodeling is a process common to chronic lung diseases such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, acute respiratory distress syndrome and asthma.", {"entities": [[73, 110, "DISEASE"], [166, 174, "DISEASE"], [119, 137, "DISEASE"], [179, 185, "DISEASE"]]}], ["Based on preclinical studies phosphodiesterase 4 (PDE4) inhibitors may exhibit beneficial anti-inflammatory and anti-remodeling properties for the treatment of these respiratory disorders.", {"entities": []}], ["Effects of PDE4 inhibitors on changes in the lung metabolome in models of pulmonary fibrotic remodeling have not yet been explored.", {"entities": []}], ["This work studies the effects of the PDE4 inhibitor roflumilast on changes in the lung metabolome in the common murine model of bleomycin-induced lung fibrosis by nuclear magnetic resonance (NMR) metabolic profiling of intact lung tissue.", {"entities": []}], ["Metabolic profiling reveals strong differences between fibrotic and non-fibrotic tissue.", {"entities": []}], ["These differences include increases in proline, glycine, lactate, taurine, phosphocholine and total glutathione and decreases in global fatty acids.", {"entities": []}], ["In parallel, there was a loss in plasma BH4.", {"entities": []}], ["This profile suggests that bleomycin produces alterations in the oxidative equilibrium, a strong inflammatory response and activation of the collagen synthesis among others.", {"entities": []}], ["Roflumilast prevented most of these metabolic effects associated to pulmonary fibrosis suggesting a favorable anti-fibrotic profile.", {"entities": [[68, 86, "DISEASE"]]}], ["Background: Arsenic is a significant global environmental health problem.", {"entities": []}], ["Exposure to arsenic in early life has been shown to increase the rate of respiratory infections during infancy, reduce childhood lung function, and increase the rates of bronchiectasis in early adulthood.", {"entities": [[170, 184, "DISEASE"]]}], ["Objective: We aimed to determine if early life exposure to arsenic exacerbates the response to early life influenza infection in mice.", {"entities": [[106, 115, "DISEASE"]]}], ["Methods: C57BL/6 mice were exposed to arsenic in utero and throughout postnatal life.", {"entities": []}], ["At 1 week of age, a subgroup of mice were infected with influenza A.", {"entities": [[56, 65, "DISEASE"]]}], ["We then assessed the acute and long-term effects of arsenic exposure on viral clearance, inflammation, lung structure, and lung function.", {"entities": []}], ["Results: Early life arsenic exposure reduced the clearance of and exacerbated the inflammatory response to influenza A, and resulted in acute and long-term changes in lung mechanics and airway structure.", {"entities": [[107, 116, "DISEASE"]]}], ["Conclusions: Increased susceptibility to respiratory infections combined with exaggerated inflammatory responses throughout early life may contribute to the development of bronchiectasis in arsenic-exposed populations.", {"entities": [[172, 186, "DISEASE"]]}], ["Citation: Ramsey KA, Foong RE, Sly PD, Larcombe AN, Zosky GR.", {"entities": []}], ["Early life arsenic exposure and acute and long-term responses to influenza A infection in mice.", {"entities": [[65, 74, "DISEASE"]]}], ["Environ Health Perspect 121:1187\u20131193;\u2002 http://dx.doi.org/10.1289/ehp.1306748", {"entities": []}], ["The pediatric small vessel vasculitides reviewed in this article are Henoch\u2013Sch\u00f6nlein purpura (HSP) and the anti-neutrophil cytoplasmic antibody-associated vasculitides (AAV).", {"entities": [[86, 93, "DISEASE"]]}], ["The new classification criteria for HSP and Wegener\u2019s granulomatosis are now validated and will facilitate the conduct of future epidemiological studies and clinical trials.", {"entities": []}], ["The clinical manifestations of small vessel vasculitis in children are described, and current therapies discussed.", {"entities": [[44, 54, "DISEASE"]]}], ["There is a lack of good clinical trial data on which to base therapy for HSP.", {"entities": []}], ["Similarly, data based on randomized controlled trials (RCTs) for pediatric AAV are lacking, although children with AAV are for the first time now included in a RCT of mycophenolate mofetil versus cyclophosphamide.", {"entities": []}], ["Significant challenges remain in the field of pediatric small vessel vasculitis, including the development of validated disease outcome measures and biomarkers to be used in clinical trials.", {"entities": [[69, 79, "DISEASE"]]}], ["Lastly, long-term outcome data are lacking in survivors of pediatric small vessel vasculitis.", {"entities": [[82, 92, "DISEASE"]]}], ["Restaurant workers are at risk from exposure to toxic compounds from burning of fuel and fumes from cooking.", {"entities": []}], ["However, the literature is almost silent on the issue.", {"entities": []}], ["What discussion that can be found in the literature focuses on the potential effects from biomass smoke exposure in the home kitchen, and does not address the problem as occurring in the workplace, particularly in restaurants.", {"entities": []}], ["This was a cross-sectional survey of 224 worker from 142 food restaurants in the Tha Pho sub-district of Phitsanulok, a province in Thailand.", {"entities": []}], ["The standard questionnaire from the British Medical Research Council was used to collect data on chronic respiratory symptoms, including cough, phlegm, dyspnea, severe dyspnea, stuffy nose in the participating workers.", {"entities": []}], ["Data on their health symptoms experienced in the past 30\u00a0days was also asked.", {"entities": []}], ["A constructed questionnaire was used to collect exposure data, including type of job, time in the kitchen, the frequency of frying food, tears while cooking (TWC), the type of restaurant, fuel used for cooking, the size and location of the kitchen, and the exhaust system and ventilation.", {"entities": []}], ["The prevalence of the symptoms was compared with those obtained from 395 controls, who were neighbors of the participants who do not work in a restaurant.", {"entities": []}], ["In comparison to the control group, the restaurant workers had twice or more the prevalence on most of the chronic health symptoms.", {"entities": []}], ["Men had a higher risk for \u201cdyspnea\u201d, \u201cstuffy nose\u201d and \u201cwheeze\u201d while women had higher risk of \u201ccough\u201d.", {"entities": []}], ["A Rate Ratio (RR) of susceptibility was established, which ranged from 1.4 up to 9.9.", {"entities": []}], ["The minimum RR was for women with \u201csevere dyspnea\u201d (RR of 1.4, 95%CI 0.8, 2.5) while the men showed the maximum RR of 9.9 (95%CI 4.5\u201322.0) for \u201cwheeze\u201d.", {"entities": []}], ["Possible risk factors identified were job description, job period, size of restaurant, kitchen location, type of cooking oil, hours of stay in the kitchen area, number of fry dishes prepared, frequency of occurrence of TWC, and additional cooking at home.", {"entities": []}], ["Working for 6\u201310 year increased the risk of \u201ccough\u201d with an Odd Ratio (OR) of 3.19 ( P \u2009<\u20090.01) while working for more than 10\u00a0years increased the risk of \u201ccough\u201d (OR\u2009=\u20093.27, P \u2009<\u20090.01), \u201cphlegm\u201d (OR\u2009=\u20093.87, P \u2009=\u20090.01) and \u201cwheeze\u201d (OR\u2009=\u20092.38, P \u2009=\u20090.05).", {"entities": []}], ["Working as a chef had a higher risk of \u201ccough\u201d by 2.33 ( P \u2009=\u20090.01) as comparing to other jobs.", {"entities": []}], ["Workers in a relatively large restaurant using 4 or more stoves had increased risk of \u201cwheeze\u201d with OR of 3.81 ( P \u2009<\u20090.01) and \u201cstuffy nose\u201d with OR of 3.56 ( P \u2009<\u20090.01).", {"entities": []}], ["Using vegetable oil increased the risk of \u201cstuffy nose\u201d by 2.94 ( P \u2009<\u20090.01).", {"entities": []}], ["Every 10\u00a0h of stay in the kitchen area was associated with a minimal increase in the risk of \u201ccough\u201d, \u201cwheeze\u201d and \u201csymptoms in the past 30\u00a0days\u201d by 1.15 ( P \u2009=\u20090.02), 1.16 ( P \u2009=\u20090.01) and 1.16 ( P \u2009=\u20090.02), respectively.", {"entities": []}], ["Restaurant workers are at risk of respiratory symptoms caused by exposure to toxic compounds from cooking fumes.", {"entities": []}], ["Job description, job period, size of restaurant, kitchen location, type of cooking oil, hours of stay in the kitchen area, number of fry dishes prepared, frequency of occurrence of TWC, and additional cooking at home were the predictive factors.", {"entities": []}], ["Workplace Health and Safety protection of restaurant worker is urgently needed and the issue should receive more public attention.", {"entities": []}], ["Asthma morbidity and mortality are disproportionately high in urban centers, and minority children are especially vulnerable.", {"entities": [[0, 6, "DISEASE"]]}], ["Factors that contribute to this dilemma include inadequate preventive medical care for asthma management, inadequate asthma knowledge and management skills among children and their families, psychosocial factors, and environmental exposure to allergens or irritants.", {"entities": [[87, 93, "DISEASE"], [117, 123, "DISEASE"]]}], ["Living in substandard housing often constitutes excess exposure to indoor allergens and pollutants.", {"entities": []}], ["Allergens associated with dust mites (DM) and cockroaches (CR) are probably important in both onset and worsening of asthma symptoms for children who are chronically exposed to these agents.", {"entities": [[117, 123, "DISEASE"]]}], ["Young children spend a great deal of time on or near the floor where these allergens are concentrated in dust.", {"entities": []}], ["Of children (2 to 10 years of age) living in metropolitan Washington, DC, 60% were found to be sensitive to CR and 72% were allergic to DM.", {"entities": []}], ["Exposure to tobacco smoke contributes to onset of asthma earlier in life and is a risk factor for asthma morbidity.", {"entities": [[50, 56, "DISEASE"], [98, 104, "DISEASE"]]}], ["Since disparity of asthma mortality and morbidity among minority children in urban centers is closely linked to socioeconomic status and poverty, measures to reduce exposure to environmental allergens and irritants and to eliminate barriers to access to health care are likely to have a major positive impact.", {"entities": [[19, 25, "DISEASE"]]}], ["Interventions for children in urban centers must focus on prevention of asthma symptoms and promotion of wellness.", {"entities": [[72, 78, "DISEASE"]]}], ["Childhood asthma is a significant public health problem in the United States and evidence is accumulating regarding the contribution from traffic and ambient air pollution.", {"entities": [[10, 16, "DISEASE"]]}], ["This study is a companion piece of a related Buffalo asthma study in adults recently published in the July 2004 issue of American Journal of Public Health .", {"entities": [[53, 59, "DISEASE"]]}], ["This study focuses on children under 18 years of age diagnosed with asthma during a three-year period (2000\u20132002).", {"entities": [[68, 74, "DISEASE"]]}], ["In order to determine the effects of particulate air pollution on public health, we conducted an ecologic study of childhood asthma and point-source respirable particulate air pollution in patients diagnosed with asthma ( n = 6,425).", {"entities": [[125, 131, "DISEASE"], [213, 219, "DISEASE"]]}], ["Patients diagnosed with gastroenteritis (n = 5,132) were used as controls.", {"entities": [[24, 39, "DISEASE"]]}], ["Although the results of this study show spatial patterns similar to the ones observed in the adult study, a multiple-comparison test shows that EPA-designated focus sites located in Buffalo's east side are statistically ( p < 0.008) more linked to childhood asthma than sites located elsewhere.", {"entities": [[258, 264, "DISEASE"]]}], ["Findings of this study can be useful in geographic targeting and in the design of optimal and preventive measures.", {"entities": []}], ["The Visual Simplified Respiratory Questionnaire (VSRQ) was designed to assess health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[134, 171, "DISEASE"]]}], ["It contains eight items: dyspnea, anxiety, depressed mood, sleep, energy, daily activities, social activities and sexual life.", {"entities": []}], ["Psychometric properties were assessed during a clinical trial that evaluated the impact of tiotropium on HRQoL of COPD patients.", {"entities": []}], ["These included the determination of structure, internal consistency reliability, concurrent validity with the St George\u2019s Respiratory Questionnaire (SGRQ), test \u2013 retest reliability, clinical validity and responsiveness to change over two weeks.", {"entities": []}], ["Minimal important difference (MID) was calculated; cumulative response curves (CRC) were based on the dyspnea item.", {"entities": []}], ["Psychometric analyses showed that VSRQ structure was unidimensional.", {"entities": []}], ["The questionnaire demonstrated good internal consistency reliability (Cronbach\u2019s alpha = 0.84), good concurrent validity with SGRQ (Spearman = \u22120.70) and clinical validity, good test-retest reproducibility (ICC = 0.77), and satisfactory responsiveness (standardized response mean = 0.57; Guyatt\u2019s statistic = 0.63).", {"entities": []}], ["MID was 3.4; CRC median value of the \u2018minimally improved\u2019 patients was 3.5.", {"entities": []}], ["In conclusion, VSRQ brevity and satisfactory psychometric properties make it a good candidate for large studies to assess HRQoL in COPD patients.", {"entities": []}], ["Further validation is needed to extend its use in clinical practice.", {"entities": []}], ["Vitamin D is a micronutrient important for bone growth and immune function.", {"entities": []}], ["Deficiency can lead to rickets and has been linked to various infections, including respiratory infections.", {"entities": [[23, 30, "DISEASE"]]}], ["The evidence on the effects of supplementation on infections in children has not been assessed systematically.", {"entities": []}], ["To evaluate the role of vitamin D supplementation in preventing pneumonia, tuberculosis (TB), diarrhoea, and malaria in children under five years of age.", {"entities": [[64, 73, "DISEASE"], [75, 87, "DISEASE"], [109, 116, "DISEASE"]]}], ["This includes high-, middle-, and low-income countries.", {"entities": []}], ["We searched the Cochrane Infectious Diseases Group Specialized Register, the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Library, MEDLINE, EMBASE, LILACS, the WHO International Clinical Trials Registry Platform (ICTRP; http://www.who.int/ictrp/en/ ), ClinicalTrials.gov and the ISRCTN registry ( http://www.isrctn.com/ ) up to 16 June 2016.", {"entities": []}], ["We included randomized controlled trials (RCTs) that evaluated preventive supplementation of vitamin D (versus placebo or no intervention) in children under five years of age.", {"entities": []}], ["Two review authors independently screened the titles and abstracts, extracted the data, and assessed the risk of bias of included trials.", {"entities": []}], ["Four trials met the inclusion criteria, with a total of 3198 children under five years of age, and were conducted in Afghanistan, Spain, and the USA.", {"entities": []}], ["Prevalence of vitamin D deficiency varied widely in these populations (range: 73.1% in Afghanistan, 10 to 12% in USA, and 6.2% in Spain).", {"entities": []}], ["The included trials evaluated mortality (two trials), pneumonia incidence (two trials), diarrhoea incidence (two trials), hospitalization (two trials), and mean serum vitamin D concentrations (four trials).", {"entities": [[54, 63, "DISEASE"]]}], ["We do not know whether vitamin D supplementation impacts on all-cause mortality because this outcome was underpowered due to few events (risk ratio (RR) 1.43, 95% confidence interval (CI) 0.54 to 3.74; one trial, 3046 participants, low quality evidence ).", {"entities": []}], ["For pneumonia, episodes of 'radiologically confirmed' first or only episode of pneumonia were little different in the supplemented and unsupplemented group (Rate Ratio: 1.06, 95% confidence interval (CI) 0.89 to 1.26; two trials, 3134 participants, moderate quality evidence ), and similarly for children with confirmed or unconfirmed pneumonia (RR 0.95, 95% CI 0.87 to 1.04; one trial, 3046 participants).", {"entities": [[4, 13, "DISEASE"], [79, 88, "DISEASE"], [335, 344, "DISEASE"]]}], ["In these two trials there were no obvious differences between supplemented and unsupplemented children regarding episodes of diarrhoea.", {"entities": []}], ["In the single large trial from Afghanistan, the trial authors reported that vitamin D supplementation was associated with an increase in repeat episodes of pneumonia confirmed by chest radiograph (RR 1.69, 95% CI 1.28 to 2.21; one trial, 3046 participants), but not reflected in the outcome of confirmed or unconfirmed pneumonia (RR 1.06, 95% CI 1.00 to 1.13; one trial, 3046 participants).", {"entities": [[156, 165, "DISEASE"], [319, 328, "DISEASE"]]}], ["For hospital admission measured in one small trial, there was no difference detected (RR 0.86, 95% CI 0.20 to 3.62; one trial, 88 participants; very low quality evidence ).", {"entities": []}], ["The mean serum vitamin D concentrations were higher in supplemented compared to unsupplemented children at the end of supplementation (MD 7.72 ng/mL, 95% CI 0.50 to 14.93; four trials, 266 participants, low quality evidence ).", {"entities": []}], ["These results were driven primarily by two smaller trials with large magnitudes of effect.", {"entities": []}], ["In the other two bigger trials, serum vitamin D concentrations were elevated in the intervention group for most of the trial duration but not at the end of supplementation.", {"entities": []}], ["This may be due to time elapsed at measurement from the last dose, incomplete compliance, or increased need of vitamin D with infant age.", {"entities": []}], ["We did not find any trial that reported on the incidence of TB, malaria or febrile illness, duration of pneumonia, duration of diarrhoea, severity of infection, and cause-specific mortality (due to TB, diarrhoea, or malaria).", {"entities": [[104, 113, "DISEASE"], [64, 71, "DISEASE"], [216, 223, "DISEASE"]]}], ["Evidence from one large trial did not demonstrate benefit of vitamin D supplementation on the incidence of pneumonia or diarrhoea in children under five years.", {"entities": [[107, 116, "DISEASE"]]}], ["To our knowledge, trials that evaluated supplementation for preventing other infections, including TB and malaria, have not been performed.", {"entities": [[106, 113, "DISEASE"]]}], ["Background Vitamin D is a micronutrient important for bone growth and immune function.", {"entities": []}], ["Deficiency can lead to rickets and has been linked to various infections, including respiratory infections.", {"entities": [[23, 30, "DISEASE"]]}], ["Several studies have reported an association between vitamin D deficiency and infections among children, and is thought to be related to the role of vitamin D in the immune system.", {"entities": []}], ["In this systematic review, Cochrane researchers examined the role of vitamin D supplementation in prevention of infections in children under five years of age.", {"entities": []}], ["The researchers studied the infections of pneumonia, tuberculosis (TB), diarrhoea, and malaria in this review.", {"entities": [[42, 51, "DISEASE"], [53, 65, "DISEASE"], [87, 94, "DISEASE"]]}], ["Study characteristics The review authors examined the available evidence up to 17 June 2016, and included four trials with a total of 3198 children under five years of age.", {"entities": []}], ["The included trials were conducted in Afghanistan, Spain and the USA.", {"entities": []}], ["Key findings The review did not detect an effect of vitamin D supplementation on death ( low quality evidence ); the occurrence of the first or only episode of pneumonia; or on children with pneumonia, irrespective of whether this had been confirmed by hospital tests ( moderate quality evidence ).", {"entities": [[160, 169, "DISEASE"], [191, 200, "DISEASE"]]}], ["Limited evidence showed that there was no obvious difference in the first or repeat episodes of diarrhoea between supplemented and unsupplemented children.", {"entities": []}], ["We do not know about whether Vitamin D influences hospital admissions as there was only one small study measuring this ( very low quality evidence ).", {"entities": []}], ["The mean serum vitamin D concentrations were higher in the supplemented versus unsupplemented children at the end of supplementation period ( low quality evidence ).", {"entities": []}], ["One large trial from Afghanistan showed an increase in repeat episodes of confirmed pneumonia but not on confirmed and unconfirmed pneumonia.", {"entities": [[84, 93, "DISEASE"], [131, 140, "DISEASE"]]}], ["None of the included trials reported on TB or malaria as outcomes.", {"entities": [[46, 53, "DISEASE"]]}], ["Conclusions One large trial has not demonstrated an effect of vitamin D on death or respiratory infections in children under five years of age.", {"entities": []}], ["We did not find trials evaluating Vitamin D supplementation to prevent other infections such as TB and malaria.", {"entities": [[103, 110, "DISEASE"]]}], ["Interleukin (IL)-10 exerts potent anti-inflammatory effects by suppression of both T-help (Th) 1 and Th2 cells.", {"entities": []}], ["Previous studies have reported that IL-10 can ameliorate various inflammatory disorders.", {"entities": []}], ["The present study was performed to examine whether IL-10 plasmid DNA could suppress development of atopic dermatitis (AD)-like skin lesions in NC/Nga mice, as an initial step towards the development of an appliance for use in dogs with AD.", {"entities": [[99, 116, "DISEASE"], [106, 116, "DISEASE"]]}], ["Intradermal injection of IL-10 plasmid DNA markedly inhibited the development of AD-like skin lesions, as evidenced by a marked decrease in skin symptoms and reduced inflammation within the skin lesions.", {"entities": []}], ["Efficacy was confirmed by significant decreases in eosinophil ratio and serum IgE concentration, and a reduction in the number of Staphylococcus aureus recovered from the ear.", {"entities": []}], ["Moreover, relative mRNA expression levels of IL-4 and interferon-\u03b3 in the skin lesions of mice injected with IL-10 plasmid DNA were also decreased compared with those of control mice.", {"entities": []}], ["Of note, higher serum IL-10 levels in mice injected with IL-10 plasmid DNA were maintained compared with those in control mice.", {"entities": []}], ["Taken together, the results indicate that IL-10 plasmid DNA can suppress the development of AD-like skin lesions by suppressing both Th1 and Th2 cell responses.", {"entities": []}], ["Beneficial effects of IL-10 plasmid DNA may be expected in dogs with AD.", {"entities": []}], ["Respiratory activity is an essential vital sign of life that can indicate changes in typical breathing patterns and irregular body functions such as asthma and panic attacks.", {"entities": [[149, 155, "DISEASE"]]}], ["Many times, there is a need to monitor breathing activity while performing day-to-day functions such as standing, bending, trunk stretching or during yoga exercises.", {"entities": []}], ["A single IMU (inertial measurement unit) can be used in measuring respiratory motion; however, breathing motion data may be influenced by a body trunk movement that occurs while recording respiratory activity.", {"entities": []}], ["This research employs a pair of wireless, wearable IMU sensors custom-made by the Department of Electrical Engineering at San Diego State University.", {"entities": []}], ["After appropriate sensor placement for data collection, this research applies principles of robotics, using the Denavit-Hartenberg convention, to extract relative angular motion between the two sensors.", {"entities": []}], ["One of the obtained relative joint angles in the \u201cSagittal\u201d plane predominantly yields respiratory activity.", {"entities": []}], ["An improvised version of the proposed method and wearable, wireless sensors can be suitable to extract respiratory information while performing sports or exercises, as they do not restrict body motion or the choice of location to gather data.", {"entities": []}], ["The introduction of the Ghana national health insurance scheme (NHIS) has led to progressive and significant increase in utilization of health services.", {"entities": []}], ["However, the financial burden of caring for children with non-communicable diseases (NCDs) under the dispensation of the NHIS, especially during hospitalization, is less researched.", {"entities": []}], ["This paper therefore sought to assess the financial burden parents/caregivers face in caring for children hospitalized with NCDs in Ghana, in the era of the Ghana NHIS.", {"entities": []}], ["We conducted a cross-sectional survey of 225 parents or caregivers of children with NCDS hospitalized in three hospitals.", {"entities": []}], ["Convenience sampling was used to select those whose children were discharged from hospital after hospitalization.", {"entities": []}], ["Descriptive statistics such as frequencies and chi-square and logistic regression were used in data analysis.", {"entities": []}], ["The main outcome variable was financial burden of care, proxied by cost of hospitalization.", {"entities": []}], ["The independent variable included socio-economic and other indicators such as age, sex, income levels and financial difficulties faced by parents/caregivers.", {"entities": []}], ["The study found that over 30\u00a0% of parents/caregivers spend more than Gh\u00a250 (25$) as cost of treatment of children hospitalized with NCDs; and over 40\u00a0% of parents/caregivers also face financial difficulties in providing health care to their wards.", {"entities": []}], ["It was also found that even though many children hospitalized with NCDs have been covered by the NHIS, and that the NHIS indeed, provides significant financial relief to parents in the care of children with NCDs, children who are insured still pay out-of-pocket for health care, in spite of their insurance status.", {"entities": []}], ["It was also found that there is less support from relatives and friends in the care of children hospitalized with NCDs, thus exacerbating parents/caregivers financial burden of caring for the children.", {"entities": []}], ["Even though health insurance has proven to be of significant relief to the financial burden of caring for children with NCDs, parents/caregivers still face significant financial burden in the care of their wards.", {"entities": []}], ["Stakeholders in health care delivery should therefore ensure that all children with NCDs including those excluded from the NHIS should be covered by NHIS.", {"entities": []}], ["A special effort focusing on identifying children with NCDs within the lower income groups, especially from rural areas, in order to exempt them from any form of payment for their health care is recommended.", {"entities": []}], ["Exposure assessment is an integral part of health risk characterization.", {"entities": []}], ["Exposure assessments typically address three critical aspects of exposure: the number of people exposed to the environmental toxicant, at specific concentrations, for the time period of interest; the resulting dose; and the relative contribution of important sources and pathways to exposure/dose.", {"entities": []}], ["Because historically both \"point-of-contact\" measurements and information about dose and related pharmacokinetic processes have been lacking, exposure assessments have had to rely on construction of \"scenarios\" to estimate exposure and dose.", {"entities": []}], ["This could change, however, as advances in development of biologic markers of exposure and dose make it possible to measure and interpret toxicant concentrations in accessible human tissues.", {"entities": []}], ["The increasing availability of \"biomarkers,\" coupled with improvements in pharmacokinetic understanding, present opportunities to estimate (\"reconstruct\") exposure from measurements of dose and knowledge of intake and uptake parameters.", {"entities": []}], ["Human tissue monitoring, however, is not a substitute for more traditional methods of measuring exposure, but rather a complementary approach.", {"entities": []}], ["A combination of exposure measurements and dose measurements provides the most credible scientific basis for exposure assessment.", {"entities": []}], ["The alveolar recruitment maneuver (RM) has been reported to improve oxygenation in acute respiratory distress syndrome (ARDS) and may be related to reduced extravascular lung water (EVLW) in animals.", {"entities": [[110, 118, "DISEASE"]]}], ["This study was designed to investigate the effects of RM on EVLW in patients with ARDS.", {"entities": []}], ["An open label, prospective, randomized controlled trial including patients with ARDS was conducted in hospitals in North Taiwan between 2010 and 2016.", {"entities": []}], ["The patients were divided into 2 groups (with and without RM).", {"entities": []}], ["The primary endpoint was the comparison of the EVLW index between the 2 groups.", {"entities": []}], ["Twenty-four patients with ARDS on mechanical ventilator support were randomized to receive ventilator treatment with RM (RM group, n\u200a=\u200a12) or without RM (non-RM group, n\u200a=\u200a12).", {"entities": []}], ["Baseline demographic characteristics were similar between the 2 groups.", {"entities": []}], ["After recruitment, the day 3 extravascular lung water index (EVLWI) (25.3\u200a\u00b1\u200a9.3 vs 15.5\u200a\u00b1\u200a7.3\u200amL/kg, P \u200a=\u200a.008) and the arterial oxygen tension/fractional inspired oxygen ratio (PaO 2 /FiO 2 ) (132.3\u200a\u00b1\u200a43.5 vs 185.6\u200a\u00b1\u200a38.8\u200amL/kg, P \u200a=\u200a.003) both improved over that of day 1.", {"entities": []}], ["However, both EVLWI and PaO 2 /FiO 2 did not significantly change from day 1 to 3 in the non-RM group.", {"entities": []}], ["RM is a feasible method for improving oxygenation and the EVLW index in patients with ARDS, as well as for decreasing ventilator days and intensive care unit stay duration.", {"entities": []}], ["A fast-track intervention with a short pre operative optimization period and short post operative hospitalization has a potential for reduced convalescence and thereby a reduced need for postoperative rehabilitation.", {"entities": []}], ["The purpose of this study was to describe patient-related outcomes, the need for additional rehabilitation after a fast-track total hip arthroplasty (THA), and the association between generic and disease specific outcomes.", {"entities": []}], ["The study consisted of 196 consecutive patients of which none received additional rehabilitation beyond an instructional exercise plan at discharge, which was adjusted at one in-patient visit.", {"entities": []}], ["The patients filled in 3 questionnaires to measure health-related quality-of-life (HRQOL) and hip specific function (EQ-5 D, SF36, and Harris Hip Score (HHS)) at 2 time points pre - and 2 time points post operatively.", {"entities": []}], ["The observed results were compared to normative population data for EQ-5 D, SF36, and HHS.", {"entities": []}], ["3-months post operatively patients had reached a HRQOL level of 0.84 (SD, 0.14), which was similar to the population norm ( P = 0.33), whereas they exceeded the population norm at 12 months post operatively ( P < 0.01).", {"entities": []}], ["For SF36, physical function (PF) was 67.8 (SD, 19.1) 3 months postoperatively, which was lower than the population norm ( P < 0.01).", {"entities": []}], ["PF was similar to population norm 12-months postoperatively ( P = 0.35).", {"entities": []}], ["For HHS, patients never reached the population norm within 12 months postoperatively.", {"entities": []}], ["Generic and disease specific outcomes were strongly associated.", {"entities": []}], ["If HRQOL is considered the primary outcome after THA, the need for additional post operative rehabilitation for all THA patients following a fast-track intervention is questionable.", {"entities": []}], ["However, a pre- or early post operative physical intervention seems relevant if the PF of the population norm should be reached at 3 months.", {"entities": []}], ["If disease specific outcome is considered the primary outcome after fast-track THA, clear goals for the rehabilitation must be established before patient selection, intervention type and timing of intervention can be made.", {"entities": []}], ["This retrospective cohort study compared the risks of exacerbations and COPD-related healthcare costs between patients with chronic obstructive pulmonary disease (COPD) initiating tiotropium (TIO) alone and patients initiating triple therapy with fluticasone-salmeterol combination (FSC) added to TIO.", {"entities": [[124, 161, "DISEASE"]]}], ["Managed-care enrollees who had an index event of \u2265 1 pharmacy claim for TIO during the study period (January 1, 2003-April 30, 2008) and met other eligibility criteria were categorized into one of two cohorts depending on their medication use.", {"entities": []}], ["Patients in the TIO+FSC cohort had combination therapy with TIO and FSC, defined as having an FSC claim on the same date as the TIO claim.", {"entities": []}], ["Patients in the TIO cohort had no such FSC use.", {"entities": []}], ["The risks of COPD exacerbations and healthcare costs were compared between cohorts during 1 year of follow-up.", {"entities": []}], ["The sample comprised 3333 patients ( n = 852 TIO+FSC cohort, n = 2481 TIO cohort).", {"entities": []}], ["Triple therapy with FSC added to TIO compared with TIO monotherapy was associated with significant reductions in the adjusted risks of moderate exacerbation (hazard ratio 0.772; 95% confidence interval [CI] 0.641, 0.930) and any exacerbation (hazard ratio 0.763; 95% CI 0.646, 0.949) and a nonsignificant reduction in COPD-related adjusted monthly medical costs.", {"entities": []}], ["Triple therapy with FSC added to TIO compared with TIO monotherapy was associated with significant reductions in the adjusted risks of moderate exacerbation and any exacerbation over a follow-up period of up to 1 year.", {"entities": []}], ["These improvements were gained with triple therapy at roughly equal cost of that of TIO alone.", {"entities": []}], ["Dental disease and treatment experience can negatively affect the oral health related quality of life (OHRQL) of preschool aged children and their caregivers.", {"entities": []}], ["Currently no valid and reliable instrument is available to measure these negative influences in very young children.", {"entities": []}], ["The objective of this research was to develop the Early Childhood Oral Health Impact Scale (ECOHIS) to measure the OHRQL of preschool children and their families.", {"entities": []}], ["Twenty-two health professionals evaluated a pool of 45 items that assess the impact of oral health problems on 6-14-year-old children and their families.", {"entities": []}], ["The health professionals identified 36 items as relevant to preschool children.", {"entities": []}], ["Thirty parents rated the importance of these 36 items to preschool children; 13 (9 child and 4 family) items were considered important.", {"entities": []}], ["The 13-item ECOHIS was administered to 295 parents of 5-year-old children to assess construct validity and internal consistency reliability (using Cronbach's alpha).", {"entities": []}], ["Test-retest reliability was evaluated among another sample of parents (N = 46) using the intraclass correlation coefficient (ICC).", {"entities": []}], ["ECOHIS scores on the child and parent sections indicating worse quality of life were significantly associated with fair or poor parental ratings of their child's general and oral health, and the presence of dental disease in the child.", {"entities": []}], ["Cronbach's alphas for the child and family sections were 0.91 and 0.95 respectively, and the ICC for test-retest reliability was 0.84.", {"entities": []}], ["The ECOHIS performed well in assessing OHRQL among children and their families.", {"entities": []}], ["Studies in other populations are needed to further establish the instrument's technical properties.", {"entities": []}], ["Events of the past decade have stimulated development of new drug formulations and delivery devices that have improved the efficiency, ease of use, and environmental impact of inhaled drug therapy.", {"entities": []}], ["Recent heritability analyses have indicated that genome-wide association studies (GWAS) have the potential to improve genetic risk prediction for complex diseases based on polygenic risk score (PRS), a simple modelling technique that can be implemented using summary-level data from the discovery samples.", {"entities": []}], ["We herein propose modifications to improve the performance of PRS.", {"entities": []}], ["We introduce threshold-dependent winner\u2019s-curse adjustments for marginal association coefficients that are used to weight the single-nucleotide polymorphisms (SNPs) in PRS.", {"entities": []}], ["Further, as a way to incorporate external functional/annotation knowledge that could identify subsets of SNPs highly enriched for associations, we propose variable thresholds for SNPs selection.", {"entities": []}], ["We applied our methods to GWAS summary-level data of 14 complex diseases.", {"entities": []}], ["Across all diseases, a simple winner\u2019s curse correction uniformly led to enhancement of performance of the models, whereas incorporation of functional SNPs was beneficial only for selected diseases.", {"entities": []}], ["Compared to the standard PRS algorithm, the proposed methods in combination led to notable gain in efficiency (25\u201350% increase in the prediction R P = 0.0017) and incorporating functional annotation data further improved R P = 2\u00d710 Large GWAS have identified tens or even hundreds of common SNPs significantly associated with individual complex diseases; however, these SNPs typically explain a small proportion of phenotypic variance.", {"entities": []}], ["Recently, heritability analyses based on GWAS data suggest that common SNPs have the potential to explain substantially larger fraction of phenotypic variance and to improve the genetic risk prediction.", {"entities": []}], ["Because of the polygenic nature, improving genetic risk prediction for complex diseases typically requires substantially increasing the sample size in the discovery set.", {"entities": []}], ["Thus, it is crucial to develop more efficient algorithms using existing GWAS summary data.", {"entities": []}], ["In this article, we extend the polygenic risk score (PRS) method by adjusting the marginal effect size of SNPs for winner\u2019s curse and by incorporating external functional annotation data.", {"entities": []}], ["Theoretical analysis and simulation studies show that the performance improvement depends on the genetic architecture of the trait, sample size of the discovery sample set and the degree of enrichment of association for SNPs annotated as \u201chigh-prior\u201d and the linkage disequilibrium patterns of these SNPs.", {"entities": []}], ["We applied our method to the summary data of 14 GWAS.", {"entities": []}], ["Our method achieved 25\u201350% gain in efficiency (measured in the prediction R", {"entities": []}], ["The Nod-like receptor, Nlrp3, has been linked to inflammatory diseases and adjuvant-mediated immune responses.", {"entities": [[23, 28, "GENE"]]}], ["A wide array of structurally diverse agents does not interact directly with Nlrp3, but is thought to activate the Nlrp3 inflammasome by inducing a common upstream signal, such as lysosome rupture.", {"entities": [[76, 81, "GENE"], [114, 119, "GENE"], [76, 81, "GENE"], [114, 119, "GENE"]]}], ["To test the connection between lysosome integrity and Nlrp3 signaling, we analyzed inflammasome activation following stimulation of murine macrophages with lysosome-destabilizing agents and pyroptosis inducers.", {"entities": [[54, 59, "GENE"]]}], ["Here we provide evidence that lysosomal rupture and the corresponding release of lysosomal hydrolases is an early event in macrophages exposed to the lysosome-destabilizing adjuvants LLOMe and alum.", {"entities": []}], ["Lysosome rupture preceded cell death induction mediated by these agents and was associated with the degradation of low-molecular weight proteins, including the inflammasome component caspase-1.", {"entities": []}], ["Proteolysis of caspase-1 was controlled by specific cathepsins, but was independent of autocatalytic processes and Nlrp3 signaling.", {"entities": [[115, 120, "GENE"]]}], ["Consistent with these findings, lysosome-disrupting agents triggered only minimal caspase-1 activation and failed to cause caspase-1-dependent cell death (pyroptosis), generally associated with Nlrp3 signaling.", {"entities": [[194, 199, "GENE"]]}], ["In contrast, lysosome rupture was a late event in macrophages exposed to prototypical pyroptosis inducers.", {"entities": []}], ["These agents triggered extensive Nlrp3 signaling prior to lysosome rupture with only minimal impact on the cellular proteome.", {"entities": [[33, 38, "GENE"]]}], ["Taken together, our findings suggest that lysosome impairment triggers a cascade of events culminating in cell death but is not crucial for Nlrp3 signaling.", {"entities": [[140, 145, "GENE"]]}], ["The significant differences observed between lysosome-disrupting agents and pyroptosis inducers might explain the distinct immunologic responses associated with these compounds.", {"entities": []}], ["Pulmonary cachexia is common in advanced chronic obstructive pulmonary disease (COPD), culminating in exercise intolerance and a poor prognosis.", {"entities": [[41, 78, "DISEASE"]]}], ["Ghrelin is a novel growth hormone (GH)-releasing peptide with GH-independent effects.", {"entities": []}], ["The efficacy and safety of adding ghrelin to pulmonary rehabilitation (PR) in cachectic COPD patients were investigated.", {"entities": []}], ["In a multicenter, randomized, double-blind, placebo-controlled trial, 33 cachectic COPD patients were randomly assigned PR with intravenous ghrelin (2 \u00b5g/kg) or placebo twice daily for 3 weeks in hospital.", {"entities": []}], ["The primary outcomes were changes in 6-min walk distance (6-MWD) and the St. George Respiratory Questionnaire (SGRQ) score.", {"entities": []}], ["Secondary outcomes included changes in the Medical Research Council (MRC) scale, and respiratory muscle strength.", {"entities": []}], ["At pre-treatment, serum GH levels were increased from baseline levels by a single dose of ghrelin (mean change, +46.5 ng/ml; between-group p<0.0001), the effect of which continued during the 3-week treatment.", {"entities": []}], ["In the ghrelin group, the mean change from pre-treatment in 6-MWD was improved at Week 3 (+40 m, within-group p\u200a=\u200a0.033) and was maintained at Week 7 (+47 m, within-group p\u200a=\u200a0.017), although the difference between ghrelin and placebo was not significant.", {"entities": []}], ["At Week 7, the mean changes in SGRQ symptoms (between-group p\u200a=\u200a0.026), in MRC (between-group p\u200a=\u200a0.030), and in maximal expiratory pressure (MEP; between-group p\u200a=\u200a0.015) were better in the ghrelin group than in the placebo group.", {"entities": []}], ["Additionally, repeated-measures analysis of variance (ANOVA) indicated significant time course effects of ghrelin versus placebo in SGRQ symptoms (p\u200a=\u200a0.049) and MEP (p\u200a=\u200a0.021).", {"entities": []}], ["Ghrelin treatment was well tolerated.", {"entities": []}], ["In cachectic COPD patients, with the safety profile, ghrelin administration provided improvements in symptoms and respiratory strength, despite the lack of a significant between-group difference in 6-MWD.", {"entities": []}], ["UMIN Clinical Trial Registry C000000061", {"entities": []}], ["Influenza virus is one of the most prevalent and ancient infections in humans.", {"entities": [[0, 9, "DISEASE"]]}], ["About a fifth of world\u2019s population is infected by influenza virus annually, leading to high morbidity and mortality, particularly in infants, the elderly and the immunocompromised.", {"entities": [[51, 60, "DISEASE"]]}], ["In the US alone, influenza outbreaks lead to roughly 30,000 deaths each year.", {"entities": [[17, 26, "DISEASE"]]}], ["Current vaccines and anti-influenza drugs are of limited use due to high mutation rate of the virus and side effects.", {"entities": [[26, 35, "DISEASE"]]}], ["In recent years, RNA interference, triggered by synthetic short interfering RNA (siRNA), has rapidly evolved as a potent antiviral regimen.", {"entities": []}], ["Properly designed siRNAs have been shown to function as potent inhibitors of influenza virus replication.", {"entities": [[77, 86, "DISEASE"]]}], ["The siRNAs outperform traditional small molecule antivirals in a number of areas, such as ease of design, modest cost, and fast turnaround.", {"entities": []}], ["Although specificity and tissue delivery remain major bottlenecks in the clinical applications of RNAi in general, intranasal application of siRNA against respiratory viruses including, but not limited to influenza virus, has experienced significant success and optimism, which is reviewed here.", {"entities": [[205, 214, "DISEASE"]]}], ["The United States is experiencing an epidemic of chronic disease.", {"entities": []}], ["As the US population ages, health care providers and policy makers urgently need decision models that provide systematic, credible prediction regarding the prevention and treatment of chronic diseases to improve population health management and medical decision-making.", {"entities": []}], ["Agent-based modeling is a promising systems science approach that can model complex interactions and processes related to chronic health conditions, such as adaptive behaviors, feedback loops, and contextual effects.", {"entities": []}], ["This article introduces agent-based modeling by providing a narrative review of agent-based models of chronic disease and identifying the characteristics of various chronic health conditions that must be taken into account to build effective clinical- and policy-relevant models.", {"entities": []}], ["We also identify barriers to adopting agent-based models to study chronic diseases.", {"entities": []}], ["Finally, we discuss future research directions of agent-based modeling applied to problems related to specific chronic health conditions.", {"entities": []}], ["Pulmonary coagulopathy is a hallmark of lung injury following inhalation trauma.", {"entities": []}], ["Locally applied heparin attenuates lung injury in animal models of smoke inhalation.", {"entities": []}], ["Whether local treatment with heparin benefits patients with inhalation trauma is uncertain.", {"entities": []}], ["The present trial aims at comparing a strategy using frequent nebulizations of heparin with standard care in intubated and ventilated burn patients with bronchoscopically confirmed inhalation trauma.", {"entities": []}], ["The Randomized Controlled Trial Investigating the Efficacy and Safety of Nebulized HEParin versus Placebo in BURN Patients with Inhalation Trauma (HEPBURN) is an international multi-center, double-blind, placebo-controlled, two-arm study.", {"entities": []}], ["One hundred and sixteen intubated and ventilated burn patients with confirmed inhalation trauma are randomized to nebulizations of heparin (the nebulized heparin strategy) or nebulizations of normal saline (the control strategy) every four hours for 14\u00a0days or until extubation, whichever comes first.", {"entities": []}], ["The primary endpoint is the number of ventilator-free days, defined as days alive and breathing without assistance during the first 28\u00a0days, if the period of unassisted breathing lasts for at least 24 consecutive hours.", {"entities": []}], ["As far as the authors know, HEPBURN is the first randomized, placebo-controlled trial, powered to investigate whether local treatment with heparin shortens duration of ventilation of intubated and ventilated burn patients with inhalation trauma.", {"entities": []}], ["NCT01773083 ( http://www.clinicaltrials.gov ), registered on 16 January 2013.", {"entities": []}], ["Recruiting.", {"entities": []}], ["Randomisation commenced on 1 January 2014.", {"entities": []}], ["Physical inactivity among children is an increasing problem that adversely affects children\u2019s health.", {"entities": []}], ["A better understanding of factors which affect physical activity (PA) will help create effective interventions aimed at raising the activity levels of children.", {"entities": []}], ["This cross-sectional study examined the associations of PA with individual (biological, social, behavioral, psychological) and environmental (East vs. West Germany, rural vs. urban regions) characteristics in children.", {"entities": []}], ["Information on PA and potential correlates was collected from 1843 girls and 1997 boys using questionnaires during the 10-year follow-up of two prospective birth cohort studies (GINIplus and LISAplus).", {"entities": []}], ["Study regions represent urban and rural sites as well as East and West of Germany.", {"entities": []}], ["Logistic regression modeling was applied to examine cross-sectional associations between individual as well as environmental factors and PA levels.", {"entities": []}], ["Five of fourteen variables were significantly associated with PA.", {"entities": []}], ["Among children aged 10, girls tended to be less active than boys, especially with respect to vigorous PA (OR\u2009=\u20090.72 for summer).", {"entities": []}], ["Children who were not a member of a sports club showed a substantially reduced amount of PA in winter (OR\u2009=\u20090.15).", {"entities": []}], ["Rural environments promote moderate PA, particularly in winter (OR\u2009=\u20091.88), whereas an increased time outdoors primarily promotes moderate PA in summer (OR\u2009=\u200912.41).", {"entities": []}], ["Children with abnormal emotional symptoms exhibited reduced physical activity, particularly in winter (OR\u2009=\u20090.60).", {"entities": []}], ["BMI, puberty, parental BMI, parental education, household income, siblings, TV/PC consumption, and method of arriving school, were not associated with PA.", {"entities": []}], ["When considering correlates of PA from several domains simultaneously, only few factors (sex, sports club membership, physical environment, time outdoors, and emotional symptoms) appear to be relevant.", {"entities": []}], ["Although the causality needs to be ascertained in longitudinal studies, variables which cannot be modified should be used to identify risk groups while modifiable variables, such as sports club activities, may be addressed in intervention programs.", {"entities": []}], ["Cancer cachexia is a major cause of morbidity and mortality with no widely approved treatment.", {"entities": [[0, 6, "DISEASE"]]}], ["The ACT\u2010ONE trial is a randomized, double\u2010blind, parallel group, placebo\u2010controlled, phase II multicentre trial in patients (25\u201080\u2009years) with stages III or IV colorectal cancer or non\u2010small cell lung cancer\u2010related cachexia that tested two doses of espindolol (a novel non\u2010selective \u03b2 blocker with central 5\u2010HT1a and partial \u03b22 receptor agonist effects).", {"entities": [[196, 207, "DISEASE"], [160, 177, "DISEASE"], [171, 177, "DISEASE"], [201, 207, "DISEASE"]]}], ["The primary endpoint was the difference in the rate of weight change over 16\u2009weeks (linear mixed\u2010effect model for repeated measures) between high\u2010dose espindolol and placebo.", {"entities": []}], ["Eighty\u2010seven patients were randomized centrally in blocks in a ratio 3:2:1 [42 high dose, 10\u2009mg twice daily (bd):31 placebo:14 low dose, 2.5\u2009mg bd].", {"entities": []}], ["High\u2010dose espindolol produced a statistically and clinically significant weight gain (+0.54\u2009kg/4\u2009weeks, 95% CI 0.38\u20130.70) compared with a weight loss on placebo (\u22120.21\u2009kg/4\u2009weeks, 95% CI \u20100.37\u20130.05); P \u2009<\u20090.0001.", {"entities": []}], ["High\u2010dose espindolol produced a statistically significant increase in lean body mass, whilst changes in fat mass were neutral.", {"entities": []}], ["Hand grip strength significantly (high dose \u22121.15\u2009\u00b1\u20090.7\u2009kg, placebo \u22123.51\u2009\u00b1\u20090.8\u2009kg change per 4\u2009weeks; P \u2009=\u20090.0134), stair climbing power, and 6\u2010min walk test non\u2010significantly were all directionally in favour of high\u2010dose espindolol.", {"entities": []}], ["There were no clinically significant differences in safety signals or survival between treatment groups, although a numerical excess of dyspnoea was seen with high\u2010dose espindolol (19.1%) compared with placebo (3.2%).", {"entities": []}], ["This positive trial showed that espindolol 10\u2009mg bd significantly reversed weight loss, improved fat free mass, and maintained fat mass in advanced colorectal cancer and non\u2010small cell lung cancer\u2010related cachexia.", {"entities": [[185, 196, "DISEASE"], [148, 165, "DISEASE"], [159, 165, "DISEASE"], [190, 196, "DISEASE"]]}], ["This was associated with a significant improvement in handgrip strength, supporting the further investigation of 10\u2009mg bd espindolol for the treatment of cancer cachexia.", {"entities": [[154, 160, "DISEASE"]]}], ["Although not powered to look at dose response, most treatment effects for low dose lay between high dose and placebo, suggesting that there may be a dose response in the effects of espindolol.", {"entities": []}], ["Obesity is associated with low-grade inflammation, increased ROS production and DNA damage.", {"entities": [[0, 7, "DISEASE"]]}], ["Supplementation with antioxidants might ameliorate DNA damage and support epigenetic regulation of DNA repair.", {"entities": []}], ["C57BL/6J male mice were fed a high-fat (HFD) or a control diet (CD) with and without vitamin E supplementation (4.5 mg/kg body weight (b.w.))", {"entities": []}], ["for four months.", {"entities": []}], ["DNA damage, DNA promoter methylation and gene expression of Dnmt1 and a DNA repair gene ( MLH1 ) were assayed in liver and colon.", {"entities": [[60, 65, "GENE"], [90, 94, "GENE"]]}], ["The HFD resulted in organ specific changes in DNA damage, the epigenetically important Dnmt1 gene, and the DNA repair gene MLH1 .", {"entities": [[87, 92, "GENE"], [123, 127, "GENE"]]}], ["Vitamin E reduced DNA damage and showed organ-specific effects on MLH1 and Dnmt1 gene expression and methylation.", {"entities": [[66, 70, "GENE"], [75, 80, "GENE"]]}], ["These results suggest that interventions with antioxidants and epigenetic active food ingredients should be developed as an effective prevention for obesity\u2014and oxidative stress\u2014induced health risks.", {"entities": [[149, 156, "DISEASE"]]}], ["For decades, the discussion on children\u2019s competence to consent to medical issues has concentrated around normative concerns, with little progress in clinical practices.", {"entities": []}], ["Decision-making competence is an important condition in the informed consent model.", {"entities": []}], ["In pediatrics, clinicians need to strike a proper balance in order to both protect children\u2019s interests when they are not fully able to do so themselves and to respect their autonomy when they are.", {"entities": []}], ["Children\u2019s competence to consent, however, is currently not assessed in a standardized way.", {"entities": []}], ["Moreover, the correlation between competence to give informed consent and age in children has never been systematically investigated, nor do we know which factors exactly contribute to children\u2019s competence.", {"entities": []}], ["This article aims at identifying these gaps in knowledge and suggests options for dealing with the obstacles in empirical research in order to advance policies and practices regarding children\u2019s medical decision-making competence.", {"entities": []}], ["Understanding children\u2019s competency is hampered by the law.", {"entities": []}], ["Legislative regulations concerning competency are established on a strong presumption that persons older than a certain age are competent, whereas younger persons are not.", {"entities": []}], ["Furthermore, a number of contextual factors are believed to be of influence on a child\u2019s decision-making competence: the developmental stage of children, the influence of parents and peers, the quality of information provision, life experience, the type of medical decision, and so on.", {"entities": []}], ["Ostensibly, these diverse and extensive barriers hinder any form of advancement in this conflicted area.", {"entities": []}], ["Addressing these obstacles encourages the discussion on children\u2019s competency, in which the most prominent question concerns the lack of a clear operationalization of children\u2019s competence to consent.", {"entities": []}], ["Empirical data are needed to substantiate the discussion.", {"entities": []}], ["The empirical approach offers an opportunity to give direction to the debate.", {"entities": []}], ["Recommendations for future research include: studying a standardized assessment instrument covering all four relevant dimensions of competence (understanding, reasoning, appreciation, expressing a choice), including a study population of children covering the full age range of 7 to 18\u00a0years, improving information provision, and assessing relevant contextual data.", {"entities": []}], ["This study described the differences between elderly men and women living in Lebanese long-term care nursing homes on socio-economic, health and nutritional status.", {"entities": []}], ["This study used a cross-sectional design.", {"entities": []}], ["Field researchers obtained data from 221 residents; 148 (67%) women and 73 (33%) men, living in 36 nursing homes.", {"entities": []}], ["Data on health conditions; nutritional, psychological, and functional status; socio-demographic characteristics, as well as social relations were collected.", {"entities": []}], ["The analysis used both chi-square and t-test tests.", {"entities": []}], ["The majority of elderly had low socio-economic and poor health status.", {"entities": []}], ["In comparison to men, women were significantly less educated, had lower occupational status, had no partner, relied financially on their children and relatives, and enjoyed better social relations and health behaviours.", {"entities": []}], ["Furthermore, the prevalence of both; malnutrition, and at risk of malnutrition, were at 3.2% and 27.6% respectively.", {"entities": []}], ["There was no statistically significant difference between women and men on Mini Nutritional Assessment, Activities of Daily Living, Geriatric Depression Scale, Body Mass Index, and chronic diseases.", {"entities": []}], ["While women reported \u201cgood\u201d health status compared to men, they continued to have higher prevalence of diseases and chronic pain.", {"entities": []}], ["This study explored the socio-demographic, health, and nutritional status of elderly residing in Lebanese nursing homes and compared these characteristics across gender.", {"entities": []}], ["The results indicated the need of health support and institutional interventions for elderly women residents.", {"entities": []}], ["While immunization is one of the most effective and successful public health interventions, there are still up to 30,000 deaths in major developed economies each year due to vaccine-preventable diseases, almost all in adults.", {"entities": []}], ["In the UK, despite comparatively high vaccination rates among \u226765 s (73%) and, to a lesser extent, at-risk \u226465 s (52%) in 2013/2014, over 10,000 excess deaths were reported the previous influenza season.", {"entities": [[186, 195, "DISEASE"]]}], ["Adult tetanus vaccines are not routinely recommended in the UK, but may be overly administered.", {"entities": [[6, 13, "DISEASE"]]}], ["Social influences and risk-perceptions of diseases and vaccines are known to affect vaccine uptake.", {"entities": []}], ["We aimed to explore the socio-psychological factors that drive adult vaccination in the UK, specifically influenza and tetanus, and to evaluate whether these factors are comparable between vaccines.", {"entities": [[105, 114, "DISEASE"], [119, 126, "DISEASE"]]}], ["20 in-depth, face-to-face interviews were conducted with members of the UK public who represented a range of socio-demographic characteristics associated with vaccination uptake.", {"entities": []}], ["We employed qualitative interviewing approaches to reach a comprehensive understanding of the factors influencing adult vaccination decisions.", {"entities": []}], ["Thematic analysis was used to analyze the data.", {"entities": []}], ["Participants were classified according to their vaccination status as regular, intermittent and non-vaccinators for influenza, and preventative, injury-led, mixed (both preventative and injury-led) and as non-vaccinators for tetanus.", {"entities": [[116, 125, "DISEASE"], [225, 232, "DISEASE"]]}], ["We present our finding around five overarching themes: 1) perceived health and health behaviors; 2) knowledge; 3) vaccination influences; 4) disease appraisal; and 5) vaccination appraisal.", {"entities": []}], ["The uptake of influenza and tetanus vaccines was largely driven by participants' risk perception of these diseases.", {"entities": [[14, 23, "DISEASE"], [28, 35, "DISEASE"]]}], ["The tetanus vaccine is perceived as safe and sufficiently tested, whereas the changing composition of the influenza vaccine is a cause of uncertainty and distrust.", {"entities": [[106, 115, "DISEASE"], [4, 11, "DISEASE"]]}], ["To maximize the public health impact of adult vaccines, policy should be better translated into high vaccination rates through evidence-based implementation approaches.", {"entities": []}], ["After validation of the widely used health-related quality of life (HRQOL) generic measure, the Short Form 36 version 2 (SF-36v2), we investigated the HRQOL and associated factors of frontline railway workers in China.", {"entities": []}], ["Ground workers, conductors, and train drivers were selected from Ankang Precinct by using a stratified cluster sampling technique.", {"entities": []}], ["A total of 784 frontline railway workers participated in the survey.", {"entities": []}], ["The reliability and validity of SF-36v2 was satisfactory.", {"entities": []}], ["The physical component summary (PCS) scores of three subgroups attained the average range for the USA general population, whereas the mental component summary (MCS) scores were well below the range.", {"entities": []}], ["Most domains scored below the norm, except for the physical functioning (PF) domain.", {"entities": []}], ["Among three subgroups, train drivers reported significantly lower scores on MCS and six health domains (excluding PF and bodily pain (BP)).", {"entities": []}], ["After controlled confounders, conductors had significantly higher PCS and MCS scores than ground workers.", {"entities": []}], ["There is heterogeneity on risk factors among three subgroups, but having long or irregular working schedules was negatively associated with HRQOL in all subgroups.", {"entities": []}], ["SF-36v2 is a reliable and valid HRQOL measurement in railway workers in China.", {"entities": []}], ["The frontline railway workers\u2019 physical health was comparative to American norms, whilst mental health was relatively worse.", {"entities": []}], ["Long or irregular working schedules were the most important factors.", {"entities": []}], ["Australian Aboriginal and Torres Strait Islander peoples (Indigenous Australians) smoke at much higher rates than non-Indigenous people and smoking is an important contributor to increased disease, hospital admissions and deaths in Indigenous Australian populations.", {"entities": []}], ["Smoking cessation programs in Australia have not had the same impact on Indigenous smokers as on non-Indigenous smokers.", {"entities": []}], ["This paper describes the outcome of a study that aimed to test the efficacy of a locally-tailored, intensive, multidimensional smoking cessation program.", {"entities": []}], ["A randomised controlled trial of Aboriginal researcher delivered tailored smoking cessation counselling during face-to-face visits, aiming for weekly for the first four weeks, monthly to six months and two monthly to 12 months.", {"entities": []}], ["The control (\u201cusual care\u201d) group received routine care relating to smoking cessation at their local primary health care service.", {"entities": []}], ["Data collection occurred at enrolment, six and 12 months.", {"entities": []}], ["The primary outcome was self-reported smoking cessation with urinary cotinine confirmation at final follow-up (median 13 (interquartile range 12\u201315) months after enrolment).", {"entities": []}], ["Participants in the intervention (n\u2009=\u200955) and usual care (n\u2009=\u2009108) groups were similar in baseline characteristics, except the intervention group was slightly older.", {"entities": []}], ["At final follow-up the smoking cessation rate for participants assigned to the intervention group (n\u2009=\u20096; 11%), while not statistically significant, was double that of usual care (n\u2009=\u20095; 5%; p\u2009=\u20090.131).", {"entities": []}], ["A meta-analysis of these findings and a similarly underpowered but comparable study of pregnant Indigenous Australian women showed that Indigenous Australian participants assigned to the intervention groups were 2.4 times (95% CI, 1.01-5.5) as likely to quit as participants assigned to usual care.", {"entities": []}], ["Culturally appropriate, multi-dimensional Indigenous quit smoking programs can be successfully implemented in remote primary health care.", {"entities": []}], ["Intensive one-on-one interventions with substantial involvement from Aboriginal and Torres Strait Islander workers are likely to be effective in these settings.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry ( ACTRN12608000604303 ).", {"entities": []}], ["MendelianRandomization is a software package for the R open-source software environment that performs Mendelian randomization analyses using summarized data.", {"entities": []}], ["The core functionality is to implement the inverse-variance weighted, MR-Egger and weighted median methods for multiple genetic variants.", {"entities": []}], ["Several options are available to the user, such as the use of robust regression, fixed- or random-effects models and the penalization of weights for genetic variants with heterogeneous causal estimates.", {"entities": []}], ["Extensions to these methods, such as allowing for variants to be correlated, can be chosen if appropriate.", {"entities": []}], ["Graphical commands allow summarized data to be displayed in an interactive graph, or the plotting of causal estimates from multiple methods, for comparison.", {"entities": []}], ["Although the main method of data entry is directly by the user, there is also an option for allowing summarized data to be incorporated from the PhenoScanner database of genotype\u2014phenotype associations.", {"entities": []}], ["We hope to develop this feature in future versions of the package.", {"entities": []}], ["The R software environment is available for download from [ https://www.r-project.org/ ].", {"entities": []}], ["The MendelianRandomization package can be downloaded from the Comprehensive R Archive Network (CRAN) within R, or directly from [ https://cran.r -project.org/web/packages/MendelianRandomization/].", {"entities": []}], ["Both R and the MendelianRandomization package are released under GNU General Public Licenses (GPL-2|GPL-3).", {"entities": []}], ["Background: The findings of prior studies of air pollution effects on adverse birth outcomes are difficult to synthesize because of differences in study design.", {"entities": []}], ["Objectives: The International Collaboration on Air Pollution and Pregnancy Outcomes was formed to understand how differences in research methods contribute to variations in findings.", {"entities": []}], ["We initiated a feasibility study to a ) assess the ability of geographically diverse research groups to analyze their data sets using a common protocol and b ) perform location-specific analyses of air pollution effects on birth weight using a standardized statistical approach.", {"entities": []}], ["Methods: Fourteen research groups from nine countries participated.", {"entities": []}], ["We developed a protocol to estimate odds ratios (ORs) for the association between particulate matter \u2264 10 \u03bcm in aerodynamic diameter (PM 10 ) and low birth weight (LBW) among term births, adjusted first for socioeconomic status (SES) and second for additional location-specific variables.", {"entities": []}], ["Results: Among locations with data for the PM 10 analysis, ORs estimating the relative risk of term LBW associated with a 10-\u03bcg/m 10 concentration during pregnancy, adjusted for SES, ranged from 0.63 [95% confidence interval (CI), 0.30\u20131.35] for the Netherlands to 1.15 (95% CI, 0.61\u20132.18) for Vancouver, with six research groups reporting statistically significant adverse associations.", {"entities": []}], ["We found evidence of statistically significant heterogeneity in estimated effects among locations.", {"entities": []}], ["Conclusions: Variability in PM 10 \u2013LBW relationships among study locations remained despite use of a common statistical approach.", {"entities": []}], ["A more detailed meta-analysis and use of more complex protocols for future analysis may uncover reasons for heterogeneity across locations.", {"entities": []}], ["However, our findings confirm the potential for a diverse group of researchers to analyze their data in a standardized way to improve understanding of air pollution effects on birth outcomes.", {"entities": []}], ["In March 2013, three fatal human cases of infection with influenza A virus (H7N9) were reported in China.", {"entities": [[57, 66, "DISEASE"]]}], ["Since then, human cases have been accumulating.", {"entities": []}], ["Given the public health importance of this virus, we performed a pathogenicity study of the H7N9 virus in the cynomolgus macaque model, focusing on clinical aspects of disease, radiographic, histological, and gene expression profile changes in the upper and lower respiratory tracts, and changes in systemic cytokine and chemokine profiles during infection.", {"entities": []}], ["Cynomolgus macaques developed transient, mild to severe disease with radiographic evidence of pulmonary infiltration.", {"entities": []}], ["Virus replicated in the upper as well as lower respiratory tract, with sustained replication in the upper respiratory tract until the end of the experiment at 6\u00a0days after inoculation.", {"entities": []}], ["Virus shedding occurred mainly via the throat.", {"entities": []}], ["Histopathological changes in the lungs were similar to those observed in humans, albeit less severe, with diffuse alveolar damage, infiltration of polymorphonuclear cells, formation of hyaline membranes, pneumocyte hyperplasia, and fibroproliferative changes.", {"entities": []}], ["Analysis of gene expression profiles in lung lesions identified pathways involved in tissue damage during H7N9 infection as well as leads for development of therapeutics targeting host responses rather than virus replication.", {"entities": []}], ["Overall, H7N9 infection was not as severe in cynomolgus macaques as in humans, supporting the possible role of underlying medical complications in disease severity as discussed for human H7N9 infection (H. N. Gao et al., N. Engl.", {"entities": []}], ["368:2277\u20132285, 2013, doi:10.1056/NEJMoa1305584).", {"entities": []}], ["Influenza A virus H7N9 emerged early in 2013, and human cases have continued to emerge since then.", {"entities": [[0, 9, "DISEASE"]]}], ["Although H7N9 virus-induced disease in humans is often very severe and even lethal, the majority of reported H7N9 cases occurred in older people and people with underlying medical conditions.", {"entities": []}], ["To better understand the pathogenicity of this virus, healthy cynomolgus macaques were inoculated with influenza A virus H7N9.", {"entities": [[103, 112, "DISEASE"]]}], ["Cynomolgus macaques were used as a model because the receptor distribution for H7N9 virus in macaques was recently shown to be more similar to that in humans than that of other frequently used animal models.", {"entities": []}], ["From comparison with previous studies, we conclude that the emerging H7N9 influenza virus was more pathogenic in cynomolgus macaques than seasonal influenza A viruses and most isolates of the pandemic H1N1 virus but less pathogenic than the 1918 Spanish influenza virus or highly pathogenic avian influenza (HPAI) H5N1 virus.", {"entities": [[74, 83, "DISEASE"], [147, 156, "DISEASE"], [254, 263, "DISEASE"], [297, 306, "DISEASE"], [291, 306, "DISEASE"]]}], ["This article aims to review the current prevalence rate of latex allergy among healthcare workers, susceptible patients, and the general public, and to investigate why latex is still a ubiquitous occupational health hazard.", {"entities": []}], ["Scientific publications on PubMed, particularly those published within the last five years, and current regulations from agencies such as Food and Drug Administration (FDA) were reviewed.", {"entities": []}], ["Consumer and commercial products that may contain latex were also surveyed.", {"entities": []}], ["Approximately 12 million tons of natural rubber latex is produced annually and is widely used to manufacture millions of consumer and commercial products.", {"entities": []}], ["Only limited number of latex-derived products have been approved and regulated by government agencies, such as FDA, whereas the majority of finished products do not label whether they contain latex.", {"entities": []}], ["Owing to millions of unidentifiable products containing latex and many routes for exposure to latex, preventing contact with latex allergens and reducing the prevalence of latex allergy are more difficult than expected.", {"entities": []}], ["Reported data suggest that the average prevalence of latex allergy worldwide remains 9.7%, 7.2%, and 4.3% among healthcare workers, susceptible patients, and general population, respectively.", {"entities": []}], ["Latex-derived products are ubiquitous, and latex allergy remains a highly prevalent health risk in many occupations and to the general population.", {"entities": []}], ["Developing alternative materials and increasing the ability to identify and label latex-derived products will be practicable approaches to effectively control the health risks associated with latex.", {"entities": []}], ["Acute inflammation, an integral part of host defence and immunity, is a highly conserved cellular response to pathogens and other harmful stimuli.", {"entities": []}], ["An inflammatory stimulation triggers transcriptional activation of selective pro-inflammatory genes that carry out specific functions such as anti-microbial activity or tissue healing.", {"entities": []}], ["Based on the nature of inflammatory stimuli, an extensive exploitation of selective transcriptional activations of pro-inflammatory genes is performed by the host to ensure a defined inflammatory response.", {"entities": []}], ["Inflammatory signal transductions are initiated by the recognition of inflammatory stimuli by transmembrane receptors, followed by the transmission of the signals to the nucleus for differential gene activations.", {"entities": []}], ["The differential transcriptional activation of pro-inflammatory genes is precisely controlled by the selective binding of transcription factors to the promoters of these genes.", {"entities": []}], ["Among a number of transcription factors identified to date, NF-\u03baB still remains the most prominent and studied factor for its diverse range of selective transcriptional activities.", {"entities": []}], ["Differential transcriptional activities of NF-\u03baB are dictated by post-translational modifications, specificities in dimer formation, and variability in activation kinetics.", {"entities": []}], ["Apart from the differential functions of transcription factors, the transcriptional activation of selective pro-inflammatory genes is also governed by chromatin structures, epigenetic markers, and other regulators as the field is continuously expanding.", {"entities": []}], ["The aim of the present study was to investigate the association of glutathione S-transferase GSTT1 and GSTM1 genotypes with pseudoexfoliative glaucoma (PEXG) in a group of Pakistani patients.", {"entities": [[142, 150, "DISEASE"], [93, 98, "GENE"], [103, 108, "GENE"]]}], ["Multiplex polymerase chain reaction was used to study the GSTT1 and GSTM1 polymorphisms in 165 PEXG patients and 162 unaffected controls.", {"entities": [[58, 63, "GENE"], [68, 73, "GENE"]]}], ["In the current study we describe a significant gender-specific association of GSTT1 and GSTM1 null genotypes with PEXG.", {"entities": [[78, 83, "GENE"], [88, 93, "GENE"]]}], ["The three null genotype combinations (i.e., T1M0, T0M1, and T0M0) were found at significantly higher frequencies in the PEXG patients as compared to the controls (\u03c7 The results suggest that there is a significant involvement of the GSTT1 and GSTM1 polymorphisms in female Pakistani patients having PEXG, which suggests a possible gender-specific impairment of detoxification in this group.", {"entities": [[232, 237, "GENE"], [242, 247, "GENE"]]}], ["There is no simple and practical way to monitor sleep patterns in patients in acute care units.", {"entities": []}], ["We designed this study to assess sleep patterns, energy expenditure and circadian rhythms of patients\u2019 skin temperature in the coronary care unit (CCU) utilizing a new portable device.", {"entities": []}], ["The SenseWear Armband (SWA) was used to record sleep duration, distribution over 24 hr, energy expenditure and the circadian rhythms of skin temperature in 46 patients with acute coronary syndrome (ACS) for the first 24 hr in the CCU and upon transfer to the ward.", {"entities": [[188, 196, "DISEASE"], [84, 86, "GENE"], [220, 222, "GENE"], [84, 86, "GENE"], [220, 222, "GENE"]]}], ["An advanced analysis was used to extract and compare data associated with the above variables in the two settings.", {"entities": []}], ["Patients in the CCU had a reduced night\u2019s sleep duration (5.6\u00b12.2 hr) with more frequent and significantly shorter night sessions (p=0.015) than patients in the ward.", {"entities": [[66, 68, "GENE"]]}], ["Energy expenditure and METs (metabolic equivalents of a task) were significantly lower in the CCU than in the ward.", {"entities": []}], ["However, the midline-estimating statistic of rhythm (MESOR) and acrophase for skin temperature did not exhibit any significant difference between the two settings.", {"entities": []}], ["Patients with ACS have sleep fragmentation and shorter nocturnal sleep duration in the CCU compared to the ward.", {"entities": []}], ["On the other hand, there was no difference in the circadian rhythms of skin temperature between patients in the CCU and the general wards.", {"entities": []}], ["Engagement of P2X 7 on mouse dendritic cells, presumably by ATP released in response to contact allergen, is needed for IL-1\u03b2 production and the sensitization phase of contact hypersensitivity.", {"entities": []}], ["Sensitization to contact allergens requires activation of the innate immune system by endogenous danger signals.", {"entities": []}], ["However, the mechanisms through which contact allergens activate innate signaling pathways are incompletely understood.", {"entities": []}], ["In this study, we demonstrate that mice lacking the adenosine triphosphate (ATP) receptor P2X 7 are resistant to contact hypersensitivity (CHS).", {"entities": []}], ["P2X 7 -deficient dendritic cells fail to induce sensitization to contact allergens and do not release IL-1\u03b2 in response to lipopolysaccharide (LPS) and ATP.", {"entities": []}], ["These defects are restored by pretreatment with LPS and alum in an NLRP3- and ASC-dependent manner.", {"entities": []}], ["Whereas pretreatment of wild-type mice with P2X 7 antagonists, the ATP-degrading enzyme apyrase or IL-1 receptor antagonist, prevents CHS, IL-1\u03b2 injection restores CHS in P2X 7 -deficient mice.", {"entities": []}], ["Thus, P2X 7 is a crucial receptor for extracellular ATP released in skin in response to contact allergens.", {"entities": []}], ["The lack of P2X 7 triggering prevents IL-1\u03b2 release, which is an essential step in the sensitization process.", {"entities": []}], ["Interference with P2X 7 signaling may be a promising strategy for the prevention of allergic contact dermatitis.", {"entities": [[93, 111, "DISEASE"], [84, 111, "DISEASE"], [101, 111, "DISEASE"]]}], ["COPD is the fourth leading cause of death worldwide, with particularly high rates in the People\u2019s Republic of China, even among never smokers.", {"entities": []}], ["Large population-based cohort studies should allow for reliable assessment of the determinants of diseases, which is dependent on the quality of disease diagnoses.", {"entities": []}], ["We assessed the validity of COPD diagnoses collected through electronic health records in the People\u2019s Republic of China.", {"entities": []}], ["The CKB study recruited 0.5 million adults aged 30\u201379 years from ten diverse regions in the People\u2019s Republic of China during the period 2004\u20132008.", {"entities": [[4, 7, "GENE"]]}], ["During 7 years of follow-up, 11,800 COPD cases were identified by linkage with mortality registries and the national health insurance system.", {"entities": []}], ["We randomly selected ~10% of the reported COPD cases and then undertook an independent adjudication of retrieved hospital medical records in 1,069 cases.", {"entities": []}], ["Overall, these 1,069 cases were accrued over a 9-year period (2004\u20132013) involving 153 hospitals across ten regions.", {"entities": []}], ["A diagnosis of COPD was confirmed in 911 (85%) cases, corresponding to a positive predictive value of 85% (95% confidence interval [CI]: 83%\u201387%), even though spirometry testing was not widely used (14%) in routine hospital care.", {"entities": []}], ["The positive predictive value for COPD did not vary significantly by hospital ranking or calendar period, but was higher in men than women (89% vs 79%), at age \u226570 years than in younger people (88%, 95% CI: 85%\u201391%), and when the cases were reported from both death registry and health insurance systems (97%, 95% CI: 94%\u2013100%).", {"entities": []}], ["Among the remaining cases, 87 (8.1%) had other respiratory diseases (chiefly pneumonia and asthma; n=85) and 71 (6.6%) cases showed no evidence of any respiratory disease on their clinical records.", {"entities": [[77, 86, "DISEASE"], [91, 97, "DISEASE"]]}], ["In the People\u2019s Republic of China, COPD diagnoses obtained from electronic health records are of good quality and suitable for large population-based studies and do not warrant systematic adjudication of all the reported cases.", {"entities": []}], ["Wireless esophageal pH monitoring system is an important approach for diagnosis of gastroesophageal reflux disease (GERD), the aim of this study is to test the tolerability and utility of the first wireless esophageal pH monitoring system made in China, and evaluate whether it is feasible for clinical application to diagnose GERD.", {"entities": [[83, 114, "DISEASE"]]}], ["Thirty patients from Department of Gastroenterology of The First Affiliated Hospital of Chongqing Medical University who were suspected GERD underwent JSPH-1 pH capsule.", {"entities": []}], ["The capsule was placed 5\u2009cm proximal to the squamocolumnar junction (SCJ) by endoscopic determination, the data was recorded consecutively for 48\u2009hours.", {"entities": []}], ["Then all pH data was downloaded to a computer for analysis.", {"entities": []}], ["The discomforts reported by patients were recorded.", {"entities": []}], ["30 patients were placed JSPH-1 pH capsule successfully and completed 24-hour data recording, 29 patients completed 48-hour data recording.", {"entities": []}], ["One patient complained of chest pain and required endoscopic removal.", {"entities": []}], ["No complications and interference of daily activities were reported during data monitoring or follow-up period.", {"entities": []}], ["48-hour pH monitoring detected 15 patients of abnormal acid exposure, on day1 detected 9 patients, the difference had statistical significance ( P <0.01).", {"entities": []}], ["Positive symptom index (SI) was identified in 3 patients with normal pH data in both 24-hours.", {"entities": []}], ["In total, 48-hour monitoring increased diagnosis of GERD in 9 patients.", {"entities": []}], ["48-hour esophageal pH monitoring with JSPH-1 wireless pH monitoring system is safe, well tolerated and effective.", {"entities": []}], ["It can be feasible for clinical application to diagnose GERD.", {"entities": []}], ["Skin, as the outermost organ in the human body, continuously confronts the external environment and serves as a primary defense system.", {"entities": []}], ["The protective functions of skin include UV-protection, anti-oxidant and antimicrobial functions.", {"entities": []}], ["In addition to these protections, skin also acts as a sensory organ and the primary regulator of body temperature.", {"entities": []}], ["Within these important functions, the epidermal permeability barrier, which controls the transcutaneous movement of water and other electrolytes, is probably the most important.", {"entities": []}], ["This permeability barrier resides in the stratum corneum, a resilient layer composed of corneocytes and stratum corneum intercellular lipids.", {"entities": []}], ["Since the first realization of the structural and biochemical diversities involved in the stratum corneum, a tremendous amount of work has been performed to elucidate its roles and functions in the skin, and in humans in general.", {"entities": []}], ["The perturbation of the epidermal permeability barrier, previously speculated to be just a symptom involved in skin diseases, is currently considered to be a primary pathophysiologic factor for many skin diseases.", {"entities": []}], ["In addition, much of the evidence provides support for the idea that various protective functions in the skin are closely related or even co-regulated.", {"entities": []}], ["In this review, the recent achievements of skin researchers focusing on the functions of the epidermal permeability barrier and their importance in skin disease, such as atopic dermatitis and psoriasis, are introduced.", {"entities": [[192, 201, "DISEASE"], [170, 187, "DISEASE"], [148, 160, "DISEASE"], [177, 187, "DISEASE"]]}], ["The aim of present study was to compare the efficacy and safety of fixed combination of brimonidine and timolol with individual components used as monotherapy in patients of primary open angle glaucoma.", {"entities": [[174, 201, "DISEASE"], [193, 201, "DISEASE"]]}], ["Patients were randomly assigned to receive brimonidine or timolol or brimonidine-timolol fixed combination, with 30 patients in each group.", {"entities": []}], ["The mean reduction in intraocular pressure in brimonidine, timolol, and brimonidine-timolol group were 4.29 \u00b1 1.97 mm Hg, 4.34 \u00b1 1.21 mm Hg, and 5.54 \u00b1 1.87 mm Hg respectively at 2 weeks and 4.86 \u00b1 1.16 mm Hg, 5.42 \u00b1 1.50 mm Hg, and 7.36 \u00b1 2.58 mm Hg respectively at 6 weeks.", {"entities": []}], ["When values of mean reduction in intraocular pressure were compared between brimonidine-timolol fixed combination with brimonidine and timolol, it was found to be statistically significant ( P < 0.05) at 2 weeks and highly significant (0.001) at 6 weeks.", {"entities": []}], ["The overall frequency of adverse effects was similar in all three groups.", {"entities": []}], ["Studies that evaluate the mechanisms for increased airway responsiveness are very sparse, although there are reports of exercise-induced bronchospasm.", {"entities": []}], ["Therefore, we have evaluated the tracheal reactivity and the rate of lipid peroxidation after different intensities of swimming exercise in rats.", {"entities": []}], ["Thus, male Wistar rats (age 8 weeks; 250\u2013300\u2005g) underwent a forced swimming exercise for 1\u2005h whilst carrying attached loads of 3, 4, 5, 6 and 8% of their body weight (groups G3, G4, G5, G6 and G8, respectively; n =5 each).", {"entities": []}], ["Immediately after the test, the trachea of each rat was removed and suspended in an organ bath to evaluate contractile and relaxant responses.", {"entities": []}], ["The rate of lipid peroxidation was estimated by measuring malondialdehyde levels.", {"entities": []}], ["According to a one-way ANOVA, all trained groups showed a significant decrease in the relaxation induced by aminophylline (10 max values of G5, G6, G8 groups were reduced by 94.2, 88.0 and 77.0%, respectively.", {"entities": [[126, 129, "GENE"]]}], ["Additionally, all trained groups showed a significant increase in contraction induced by carbachol (10", {"entities": []}], ["Cinnamon bark is one of the most popular herbal ingredients in traditional oriental medicine and possesses diverse pharmacological activities including anti-bacterial, anti-viral, and anti-cancer properties.", {"entities": [[189, 195, "DISEASE"]]}], ["The goal of this study is to investigate the in vivo and in vitro inhibitory effect of cinnamon water extract (CWE) on lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-\u03b1 and its underlying intracellular mechanisms.", {"entities": [[175, 178, "GENE"]]}], ["CWE was orally administrated to mice for 6 days prior to intraperitoneal injection of LPS.", {"entities": []}], ["Serum levels of TNF-\u03b1 and interleukin (IL)-6 were determined 1 hour after LPS stimulation.", {"entities": []}], ["Peritoneal macrophages from thioglycollate-injected mice were isolated and assayed for viability, cytokine expression and signaling molecules upon LPS stimulation.", {"entities": []}], ["CWE was further fractioned according to molecular size, and the levels of total polyphenols and biological activities of each fraction were measured.", {"entities": []}], ["The oral administration of CWE to mice significantly decreased the serum levels of TNF-\u03b1 and IL-6.", {"entities": []}], ["CWE treatment in vitro decreased the mRNA expression of TNF-\u03b1.", {"entities": []}], ["CWE blocked the LPS-induced degradation of I\u03baB\u03b1 as well as the activation of JNK, p38 and ERK1/2.", {"entities": []}], ["Furthermore, size-based fractionation of CWE showed that the observed inhibitory effect of CWE in vitro occurred in the fraction containing the highest level of total polyphenols.", {"entities": []}], ["Treatment with CWE decreased LPS-induced TNF-\u03b1 in serum.", {"entities": []}], ["In vitro inhibition of TNF-\u03b1 gene by CWE may occur via the modulation of I\u03baB\u03b1 degradation and JNK, p38, and ERK1/2 activation.", {"entities": []}], ["Our results also indicate that the observed anti-inflammatory action of CWE may originate from the presence of polyphenols.", {"entities": []}], ["A growing number of Local Authorities (LAs) have introduced integrated wellness services as part of efforts to deliver cost effective, preventive services that address the social determinants of health.", {"entities": []}], ["This study examined which elements of an integrated wellness service in the north east of England were effective in improving health and wellbeing (HWB).", {"entities": []}], ["The study used a mixed-methods approach.", {"entities": []}], ["In-depth semi-structured interviews (IVs) were conducted with integrated wellness service users ( n \u2009=\u200925) and focus groups (FGs) with group based service users ( n \u2009=\u200914) and non-service users ( n \u2009=\u200923) to gather the views of stakeholders.", {"entities": []}], ["Findings are presented here alongside analysis of routine monitoring data.", {"entities": []}], ["The different data were compared to examine what each data source revealed about the effectiveness of the service.", {"entities": []}], ["Findings suggest that integrated wellness services work by addressing the social determinants of health and respond to multiple complex health and social concerns rather than single issues.", {"entities": []}], ["The paper identifies examples of \u2018active ingredients\u2019 at the heart of the programme, such as sustained relationships, peer support and confidence building, as well as the activities through which changes take place, such as sports and leisure opportunities which in turn encourage social interaction.", {"entities": []}], ["Wider wellbeing outcomes, including reduced social isolation and increased self-efficacy are also reported.", {"entities": []}], ["Practical and motivational support helped build community capacity by encouraging community groups to access funding, helped navigate bureaucratic systems, and promoted understanding of marginalised communities.", {"entities": []}], ["Fully integrated wellness services could support progression opportunities through volunteering and mentoring.", {"entities": []}], ["An integrated wellness service that offers a holistic approach was valued by service users and allowed them to address complex issues simultaneously.", {"entities": []}], ["Few of the reported health gains were captured in routine data.", {"entities": []}], ["Quantitative and qualitative data each offered a partial view of how effectively services were working.", {"entities": []}], ["Previous estimates for the prevalence of musculoskeletal conditions (MSK) and chronic pain in Australia have been based on self-report.", {"entities": []}], ["We aimed to determine the prevalence and distribution of arthritis, chronic back pain, gout, osteoporosis, spondyloarthropathies and rheumatoid arthritis and current consultations for chronic pain among adults attending Australian general practice, and describe their distribution according to sociodemographic characteristics and presence of co-morbidities.", {"entities": [[133, 153, "DISEASE"], [93, 105, "DISEASE"], [57, 66, "DISEASE"], [144, 153, "DISEASE"], [87, 91, "DISEASE"]]}], ["We investigated 1,501,267 active adult patients (57.6% females; 22.5% \u226565y) evaluated between 2013 and 2016 and included in the MedicineInsight database (a National Prescribing Service MedicineWise program), a large general practice data program that extracts longitudinal de-identified electronic medical record data from \u2018active\u2019 patients in over 550 practices.", {"entities": []}], ["Three main groups of outcomes were investigated: 1) \u201cprevalence\u201d of arthritis, chronic back pain, gout, osteoporosis, spondyloarthropathies, and/or rheumatoid arthritis between 2000 and 2016; 2) \u201ccurrent\u201d diagnosis/encounter for the same conditions occurring between 2013 and 2016, and; 3) \u201ccurrent\u201d consultations for chronic pain of any type occurring between 2013 and 2016.", {"entities": [[148, 168, "DISEASE"], [104, 116, "DISEASE"], [68, 77, "DISEASE"], [159, 168, "DISEASE"], [98, 102, "DISEASE"]]}], ["The combined \u201cprevalence\u201d of the investigated MSK (diagnosis between 2000 and 2016) among adults attending Australian general practice was 16.8% (95%CI 15.9;17.7) with 21.3% (95%CI 20.2;22.4) of the sample consulting for chronic pain between 2013 and 2016.", {"entities": []}], ["The investigated MSK with the highest \u201cprevalence\u201d were arthritis (9.5%) and chronic back pain (6.7%).", {"entities": [[56, 65, "DISEASE"]]}], ["Patients with some of these MSK attended general practices more frequently than those without these conditions (median 2.0 and 1.0 contacts/year, respectively).", {"entities": []}], ["The \u201cprevalence\u201d of the investigated MSK and \u201ccurrent\u201d consultations for chronic pain increased with age, especially in women, but chronic pain remained stable at 22% for males aged >\u200940\u00a0years.", {"entities": []}], ["The investigated MSK and chronic pain were more frequent among those in lower socioeconomic groups, veterans, Aboriginal and Torrent Strait Islanders, current and ex-smokers, and patients with chronic obstructive pulmonary disease or heart failure.", {"entities": [[193, 230, "DISEASE"]]}], ["The investigated MSK are more frequent among lower socioeconomic groups and the elderly.", {"entities": []}], ["Based on information collected from adults attending Australian general practices, MedicineInsight provided similar estimates to those obtained from population-based studies, with the advantage of being based on medical diagnosis and including a national sample.", {"entities": []}], ["The online version of this article (10.1186/s12891-018-1941-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Although safe doses of radiation have been determined, concerns about the harmful effects of low-dose radiation persist.", {"entities": []}], ["In particular, to date, few studies have investigated the correlation between low-dose radiation and disease development.", {"entities": []}], ["Asthma is a common chronic inflammatory airway disease that is recognized as a major public health problem.", {"entities": [[0, 6, "DISEASE"]]}], ["In this study, we evaluated the effects of low-dose-rate chronic irradiation on allergic asthma in a murine model.", {"entities": [[80, 95, "DISEASE"], [89, 95, "DISEASE"]]}], ["Mice were sensitized and airway-challenged with ovalbumin (OVA) and were exposed to continuous low-dose-rate irradiation (0.554 or 1.818 mGy/h) for 24 days after initial sensitization.", {"entities": []}], ["The effects of chronic radiation on proinflammatory cytokines and the activity of matrix metalloproteinase-9 (MMP-9) were investigated.", {"entities": []}], ["Exposure to low-dose-rate chronic irradiation significantly decreased the number of inflammatory cells, methylcholine responsiveness (PenH value), and the levels of OVA-specific immunoglobulin E, interleukin (IL)-4, and IL-5.", {"entities": []}], ["Furthermore, airway inflammation and the mucus production in lung tissue were attenuated and elevated MMP-9 expression and activity induced by OVA challenge were significantly suppressed.", {"entities": []}], ["These results indicate that low-dose-rate chronic irradiation suppresses allergic asthma induced by OVA challenge and does not exert any adverse effects on asthma development.", {"entities": [[73, 88, "DISEASE"], [82, 88, "DISEASE"], [156, 162, "DISEASE"]]}], ["Our findings can potentially provide toxicological guidance for the safe use of radiation and relieve the general anxiety about exposure to low-dose radiation.", {"entities": []}], ["Worldwide there is increasing interest in the manipulation of human gut microbiota by the use of probiotic supplements to modify or prevent a range of communicable and non-communicable diseases.", {"entities": []}], ["Probiotic interventions administered during pregnancy and breastfeeding offer a unique opportunity to influence a range of important maternal and infant outcomes.", {"entities": []}], ["The aim of the Probiotics in Pregnancy Study (PiP Study) is to assess if supplementation by the probiotic Lactobacillus rhamnosus HN001 administered to women from early pregnancy and while breastfeeding can reduce the rates of infant eczema and atopic sensitisation at 1\u00a0year, and maternal gestational diabetes mellitus, bacterial vaginosis and Group B Streptococcal vaginal colonisation before birth, and depression and anxiety postpartum.", {"entities": [[290, 310, "DISEASE"], [321, 340, "DISEASE"], [302, 319, "DISEASE"]]}], ["The PiP Study is a two-centre, randomised, double-blind placebo-controlled trial in Wellington and Auckland, New Zealand.", {"entities": []}], ["Four hundred pregnant women expecting infants at high risk of allergic disease will be enrolled in the study at 14\u201316 weeks gestation and randomised to receive either Lactobacillus rhamnosus HN001 (6\u2009\u00d7\u200910 Primary infant outcomes are the development and severity of eczema and atopic sensitisation in the first year of life.", {"entities": []}], ["Secondary outcomes are diagnosis of maternal gestational diabetes mellitus, presence of bacterial vaginosis and vaginal carriage of Group B Streptococcus (at 35\u201337 weeks gestation).", {"entities": [[45, 65, "DISEASE"], [88, 107, "DISEASE"], [57, 74, "DISEASE"]]}], ["Other outcome measures include maternal weight gain, maternal postpartum depression and anxiety, infant birth weight, preterm birth, and rate of caesarean sections.", {"entities": []}], ["A range of samples including maternal and infant faecal samples, maternal blood samples, cord blood and infant cord tissue samples, breast milk, infant skin swabs and infant buccal swabs will be collected for the investigation of the mechanisms of probiotic action.", {"entities": []}], ["The study will investigate if mother-only supplementation with Lactobacillus rhamnosus HN001 in pregnancy and while breastfeeding can reduce rates of eczema and atopic sensitisation in infants by 1\u00a0year, and reduce maternal rates of gestational diabetes mellitus, bacterial vaginosis, vaginal carriage of Group B Streptococcus before birth and maternal depression and anxiety postpartum.", {"entities": [[233, 253, "DISEASE"], [264, 283, "DISEASE"], [245, 262, "DISEASE"]]}], ["Australian New Zealand Clinical Trials Registration: ACTRN12612000196842.", {"entities": []}], ["Date Registered: 15/02/12.", {"entities": []}], ["The online version of this article (doi:10.1186/s12884-016-0923-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Neuromuscular blockade, induced by neuromuscular blocking agents, has allowed prescribed immobility, improved surgical exposure, optimal airway management conditions, and facilitated mechanical ventilation.", {"entities": []}], ["However, termination of the effects of neuromuscular blocking agents has, until now, remained limited.", {"entities": []}], ["A novel cyclodextrin encapsulation process offers improved termination of the paralytic effects of aminosteroidal non-depolarizing neuromuscular blocking agents.", {"entities": []}], ["Sugammadex sodium is the first in a new class of drug called selective relaxant binding agents.", {"entities": []}], ["Currently, in clinical trials, sugammadex, a modified gamma cyclodextrin, has shown consistent and rapid termination of neuromuscular blockade with few side effects.", {"entities": []}], ["The pharmacology of cyclodextrins in general and sugammadex in particular, together with the results of current clinical research are reviewed.", {"entities": []}], ["The ability of sugammadex to terminate the action of neuromuscular blocking agents by direct encapsulation is compared to the indirect competitive antagonism of their effects by cholinesterase inhibitors.", {"entities": []}], ["Also discussed are the clinical implications that extend beyond fast, effective reversal, including numerous potential perioperative benefits.", {"entities": []}], ["Membrane proteins are crucial in transport, signaling, bioenergetics, catalysis, and as drug targets.", {"entities": []}], ["Here, we show that membrane proteins have dramatically fewer detectable orthologs than water-soluble proteins, less than half in most species analyzed.", {"entities": []}], ["This sparse distribution could reflect rapid divergence or gene loss.", {"entities": []}], ["We find that both mechanisms operate.", {"entities": []}], ["First, membrane proteins evolve faster than water-soluble proteins, particularly in their exterior-facing portions.", {"entities": []}], ["Second, we demonstrate that predicted ancestral membrane proteins are preferentially lost compared with water-soluble proteins in closely related species of archaea and bacteria.", {"entities": []}], ["These patterns are consistent across the whole tree of life, and in each of the three domains of archaea, bacteria, and eukaryotes.", {"entities": []}], ["Our findings point to a fundamental evolutionary principle: membrane proteins evolve faster due to stronger adaptive selection in changing environments, whereas cytosolic proteins are under more stringent purifying selection in the homeostatic interior of the cell.", {"entities": []}], ["This effect should be strongest in prokaryotes, weaker in unicellular eukaryotes (with intracellular membranes), and weakest in multicellular eukaryotes (with extracellular homeostasis).", {"entities": []}], ["We demonstrate that this is indeed the case.", {"entities": []}], ["Similarly, we show that extracellular water-soluble proteins exhibit an even stronger pattern of low homology than membrane proteins.", {"entities": []}], ["These striking differences in conservation of membrane proteins versus water-soluble proteins have important implications for evolution and medicine.", {"entities": []}], ["The 1000 Genomes Project, an international collaboration, is sequencing the whole genome of approximately 2,000 individuals from different worldwide populations.", {"entities": []}], ["The central goal of this project is to describe most of the genetic variation that occurs at a population frequency greater than 1%.", {"entities": []}], ["The results of this project will allow scientists to identify genetic variation at an unprecedented degree of resolution and will also help improve the imputation methods for determining unobserved genetic variants that are not represented on current genotyping arrays.", {"entities": []}], ["By identifying novel or rare functional genetic variants, researchers will be able to pinpoint disease-causing genes in genomic regions initially identified by association studies.", {"entities": []}], ["This level of detailed sequence information will also improve our knowledge of the evolutionary processes and the genomic patterns that have shaped the human species as we know it today.", {"entities": []}], ["The new data will also lay the foundation for future clinical applications, such as prediction of disease susceptibility and drug response.", {"entities": []}], ["However, the forthcoming availability of whole genome sequences at affordable prices will raise ethical concerns and pose potential threats to individual privacy.", {"entities": []}], ["Nevertheless, we believe that these potential risks are outweighed by the benefits in terms of diagnosis and research, so long as rigorous safeguards are kept in place through legislation that prevents discrimination on the basis of the results of genetic testing.", {"entities": []}], ["Links between environmental chemicals and human health have emerged over the last few decades, but the effects from polyaromatic hydrocarbons were less studied, compared to other commonly known environmental chemicals such as heavy metals, phthalates, arsenic, phenols, pesticides, etc.", {"entities": []}], ["Therefore, the aim of the study was to examine the relationships of urinary polyaromatic hydrocarbons and adult respiratory health conditions using a large human sample in a national and population-based setting in recent years.", {"entities": []}], ["Data were retrieved from United States National Health and Nutrition Examination Surveys, 2011\u20132012 including demographics, self-reported health conditions, and urinary polyaromatic hydrocarbons.", {"entities": []}], ["Statistical analyses including chi-square test, t test, and survey-weighted logistic regression modeling were performed.", {"entities": []}], ["Of 5560 American adults aged 20\u201380, urinary 2-hydroxyfluorene and 3-hydroxyfluorene were positively associated with emphysema (OR, 1.60, 95\u00a0% CI 1.26 to 2.03, P \u00a0=\u00a00.001 and OR, 1.42, 95\u00a0% CI 1.15 to 1.77, P \u00a0=\u00a00.003, respectively) and chronic bronchitis (OR, 1.42, 95\u00a0% CI 1.04 to 1.94, P \u00a0=\u00a00.031 and OR, 1.40, 95\u00a0% CI 1.03 to 1.91, P \u00a0=\u00a00.036, respectively), while 2-hydroxynaphthalene (2-naphthol) was likely to be borderline associated with emphysema and chronic bronchitis.", {"entities": [[244, 254, "DISEASE"], [468, 478, "DISEASE"]]}], ["Conversely, urinary 1-hydroxyphenanthrene, 3-hydroxyphenanthrene, 1-hydroxypyrene, and 4-hydroxyphenanthrene were inversely associated with asthma and infections.", {"entities": [[140, 146, "DISEASE"]]}], ["Urinary polyaromatic hydrocarbons are associated with adult respiratory health conditions, although the causality cannot be established.", {"entities": []}], ["For future research, studies using large human sample across regions to longitudinally monitor would be suggested.", {"entities": []}], ["For practice and policy-making, regulation on minimizing polyaromatic hydrocarbons exposure to protect respiratory health might need to be considered in future health and environmental policies and intervention programs.", {"entities": []}], ["The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol showed increased effectiveness regarding lung function and health-related quality of life in patients with chronic obstructive pulmonary disease (COPD) compared with the use of its mono-components.", {"entities": [[189, 226, "DISEASE"]]}], ["Yet, while effectiveness and safety have been shown, the health economic implication of this treatment is still unknown.", {"entities": []}], ["The aim of this study was to assess the cost\u2013utility and budget impact of tiotropium\u2013olodaterol FDC in patients with moderate to very severe COPD in the Netherlands.", {"entities": []}], ["A cost\u2013utility study was performed, using an individual-level Markov model.", {"entities": []}], ["To populate the model, individual patient-level data (age, height, sex, COPD duration, baseline forced expiratory volume in 1 second) were obtained from the tiotropium\u2013olodaterol TOnado trial.", {"entities": []}], ["In the model, forced expiratory volume in 1 second and patient-level data were extrapolated to utility and survival, and treatment with tiotropium\u2013olodaterol FDC was compared with tiotropium.", {"entities": []}], ["Cost\u2013utility analysis was performed from the Dutch health care payer\u2019s perspective using a 15-year time horizon in the base-case analysis.", {"entities": []}], ["The standard Dutch discount rates were applied (costs: 4.0%; effects: 1.5%).", {"entities": []}], ["Both univariate and probabilistic sensitivity analyses were performed.", {"entities": []}], ["Budget impact was annually assessed over a 5-year time horizon, taking into account different levels of medication adherence.", {"entities": []}], ["As a result of cost increases, combined with quality-adjusted life-year (QALY) gains, results showed that tiotropium\u2013olodaterol FDC had an incremental cost-effectiveness ratio of \u20ac7,004/QALY.", {"entities": []}], ["Without discounting, the incremental cost-effectiveness ratio was \u20ac5,981/QALY.", {"entities": []}], ["Results were robust in univariate and probabilistic sensitivity analyses.", {"entities": []}], ["Budget impact was estimated at \u20ac4.3 million over 5 years assuming 100% medication adherence.", {"entities": []}], ["Scenarios with 40%, 60%, and 80% adherence resulted in lower 5-year incremental cost increases of \u20ac1.7, \u20ac2.6, and \u20ac3.4 million, respectively.", {"entities": []}], ["Tiotropium\u2013olodaterol FDC can be considered a cost-effective treatment under current Dutch cost-effectiveness thresholds.", {"entities": []}], ["General practitioners (GPs) in Australia play a central role in the delivery of mental health care.", {"entities": []}], ["This article describes the PULSAR (Principles Unite Local Services Assisting Recovery) Primary Care protocol, a novel mixed methods evaluation of a training intervention for GPs in recovery-oriented practice.", {"entities": []}], ["The aim of the intervention is to optimize personal recovery in patients consulting study GPs for mental health issues.", {"entities": []}], ["The intervention mixed methods design involves a stepped-wedge cluster randomized controlled trial testing the outcomes of training in recovery-oriented practice, together with an embedded qualitative study to identify the contextual enablers and challenges to implementing recovery-oriented practice.", {"entities": []}], ["The project is conducted in Victoria, Australia between 2013 and 2017.", {"entities": []}], ["Eighteen general practices and community health centers are randomly allocated to one of two steps (nine months apart) to start an intervention comprising GP training in the delivery of recovery-oriented practice.", {"entities": []}], ["Data collection consists of cross-sectional surveys collected from patients of participating GPs at baseline, and again at the end of Steps 1 and 2.", {"entities": []}], ["The primary outcome is improvement in personal recovery using responses to the Questionnaire about the Process of Recovery.", {"entities": []}], ["Secondary outcomes are improvements in patient-rated measures of personal recovery and wellbeing, and of the recovery-oriented practice they have received, using the INSPIRE questionnaire, the Warwick-Edinburgh Mental Well-being Scale, and the Kessler Psychological Distress Scale.", {"entities": []}], ["Participant data will be analyzed in the group that the cluster was assigned to at each study time point.", {"entities": []}], ["Another per-protocol dataset will contain all data time-stamped according to the date of intervention received at each cluster site.", {"entities": []}], ["Qualitative interviews with GPs and patients at three and nine months post-training will investigate experiences and challenges related to implementing recovery-oriented practice in primary care.", {"entities": []}], ["Recovery-oriented practice is gaining increasing prominence in mental health service delivery and the outcomes of such an approach within the primary care sector for the first time will be evaluated in this project.", {"entities": []}], ["If findings are positive, the intervention has the potential to extend recovery-oriented practice to GPs throughout the community.", {"entities": []}], ["Australian and New Zealand Clinical Trial Registry ( ACTRN12614001312639 ).", {"entities": []}], ["Registered: 8 August 2014.", {"entities": []}], ["We conducted a mail survey of practicing pediatricians in Georgia to assess their knowledge, attitudes, and behaviors regarding recording patients' environmental histories.", {"entities": []}], ["Of 477 eligible pediatricians, 266 (55.8%) responded.", {"entities": []}], ["Fewer than one in five reported having received training in environmental history-taking.", {"entities": []}], ["Pediatricians reported that they strongly believe in the importance of environmental exposures in children's health, and 53.5% of respondents reported experience with a patient who was seriously affected by an environmental exposure.", {"entities": []}], ["Pediatricians agreed moderately strongly that environmental history-taking is useful in identifying potentially hazardous exposures and in helping prevent these exposures.", {"entities": []}], ["Respondents reported low self-efficacy regarding environmental history-taking, discussing environmental exposures with parents, and finding diagnosis and treatment resources related to environmental exposures.", {"entities": []}], ["The probability of self-reported history-taking varied with the specific exposure, with environmental tobacco smoke and pets most frequently queried and asbestos, mercury, formaldehyde, and radon rarely queried.", {"entities": []}], ["The pediatricians' preferred information resources include the American Academy of Pediatrics, newsletters, and patient education materials.", {"entities": []}], ["Pediatricians are highly interested in pediatric environmental health but report low self-efficacy in taking and following up on environmental histories.", {"entities": []}], ["There is considerable opportunity for training in environmental history-taking and for increasing the frequency with which such histories are taken.", {"entities": []}], ["Renal replacement therapy (RRT) is a fully established treatment for critically ill patients with acute kidney injury (AKI) but there are no scientifically established criteria when to initiate it.", {"entities": []}], ["Our objectives were to describe the epidemiology of critically ill patients with AKI receiving RRT and to evaluate the relationship between biochemical, physiological and comorbid factors at time of RRT and ICU mortality.", {"entities": []}], ["Retrospective analysis of demographic and physiologic data of 1,847 patients who received RRT for AKI in 22 ICUs in UK and Germany between 1989 - 1999.", {"entities": []}], ["54.1% of RRT patients died in ICU.", {"entities": []}], ["ICU survivors were younger, had a lower APACHE II score and fewer failed organ systems on admission to ICU compared to non-survivors.", {"entities": []}], ["Multivariate analysis showed that at time of initiation of RRT, independent risk factors for ICU mortality were mechanical ventilation [odds ratio (OR) 6.03], neurological failure (OR 2.48), liver failure (OR 2.44), gastrointestinal failure (OR 2.04), pre-existing chronic illnesses (OR 1.74), haematological failure (OR 1.74), respiratory failure (OR 1.62), oligoanuria (OR 1.6), age (OR 1.03), serum urea (OR 1.004) and cardiovascular failure (OR 1.3).", {"entities": [[328, 347, "DISEASE"]]}], ["A higher pH at initiation of RRT was independently associated with a better outcome.", {"entities": []}], ["Failure to correct acidosis and development of more organ failure within 48 hours after initiation of RRT were also associated with an increased risk of dying in ICU.", {"entities": []}], ["Oligoanuria, acidosis and concomitant dysfunction of other organs at time of RRT were associated with poor survival.", {"entities": []}], ["In contrast, serum creatinine and urea levels only had a weak correlation with outcome after RRT.", {"entities": []}], ["To evaluate the risk of severe cutaneous adverse drug reactions (SCAR) after exposure to multi-indication antiepileptic drugs for in Korean elderly patients.", {"entities": []}], ["We used a nationwide database from the Korean Health Insurance Review and Assessment Service claims constructed for the monitoring of drug utilization among the entire Korean elderly population from January 2005 to June 2006.", {"entities": []}], ["We identified cases of SCARs among inpatients aged \u226565 years and those newly diagnosed with erythema multiforme according to the International Classification of Diseases, 10th revision code (L51).", {"entities": [[92, 111, "DISEASE"]]}], ["Each case was matched to four controls for gender, age, and the first hospitalization date as the index date.", {"entities": []}], ["The use of carbamazepine, gabapentin, lamotrigine, topiramate, phenobarbital, phenytoin, and valproate during a 60-day period before the index date was compared.", {"entities": []}], ["A conditional logistic regression analysis was performed to calculate the odds ratios (OR) and 95% confidence intervals (CI) of SCARs for antiepileptic drug.", {"entities": []}], ["We identified 286 cases of SCAR and 1,144 matched controls.", {"entities": []}], ["Among the 25 patients who were prescribed antiepileptic drugs within 60 days of the index date.", {"entities": []}], ["There were 11 cases (3.8%) of severe ocular manifestations, and most elderly patients were first-time or short-term users of antiepileptic drugs.", {"entities": []}], ["Among the 10 cases of carbamazepine use, only 2 cases were prescribed carbamazepine for seizure.", {"entities": []}], ["All antiepileptic drugs were associated with an increased SCAR risk (adjusted OR\u200a=\u200a3.42, 95% CI: 1.75\u20136.63).", {"entities": []}], ["The SCAR risk was highest in patients treated with carbamazepine (adjusted OR\u200a=\u200a10.39, 95% CI: 2.64\u201340.86, for multi-indication; adjusted OR\u200a=\u200a6.84, 95% CI: 1.55\u201330.10, for neuropathic pain).", {"entities": []}], ["Carbamazepine use was associated with a nearly 10-fold increase in severe cutaneous drug reactions in Korean elderly patients.", {"entities": []}], ["This association was consistently high with SCAR patients who received carbamazepine for neuropathic pain.", {"entities": []}], ["Recent reports have shown that statin (HMG-CoA reductase inhibitors) may have the potential to inhibit inflammatory arthritis.", {"entities": [[116, 125, "DISEASE"]]}], ["More recently, the idea that chondrocyte aging is closely associated with the progression of cartilage degeneration has been promulgated.", {"entities": []}], ["Here, we demonstrate the potential of statin as protective agents against chondrocyte aging and degeneration of articular cartilage during the progression of osteoarthritis (OA), both in vitro and in vivo.", {"entities": [[158, 172, "DISEASE"]]}], ["The OA-related catabolic factor, IL-1\u03b2 induced marked downregulation of cellular activity, expression of a senescent biomarker, specific senescence-associated \u03b2-galactosidase activity and shortening of the cellular lifespan in chondrocytes.", {"entities": []}], ["In contrast, treatment with statin inhibited the IL-1\u03b2-induced production of cartilage matrix degrading enzymes (metalloprotease-1 and -13) and cellular senescence in of chondrocytes in vitro.", {"entities": []}], ["In addition, this statin accelerated the production of cartilage matrix proteoglycan in chondrocytes.", {"entities": []}], ["The in vivo study was performed on the STR/OrtCrlj mouse, an experimental model which spontaneously develops an osteoarthritic process.", {"entities": []}], ["In this mouse model, treatment with statin significantly reduced the degeneration of articular cartilage, while the control knee joints showed progressive cartilage degeneration over time.", {"entities": []}], ["These findings suggest that statin may have the potential to prevent the catabolic stress-induced chondrocyte disability and aging observed in articular cartilage.", {"entities": []}], ["Our results indicate that statin are potential therapeutic agents for protection of articular cartilage against the progression of OA.", {"entities": []}], ["Parasites from the family Anisakidae are widely distributed in marine fish populations worldwide and mainly nematodes of the three genera Anisakis, Pseudoterranova and Contracaecum have attracted attention due to their pathogenicity in humans.", {"entities": []}], ["Their life cycles include invertebrates and fish as intermediate or transport hosts and mammals or birds as final hosts.", {"entities": []}], ["Human consumption of raw or underprocessed seafood containing third stage larvae of anisakid parasites may elicit a gastrointestinal disease (anisakidosis) and allergic responses.", {"entities": []}], ["Excretory and secretory (ES) compounds produced by the parasites are assumed to be key players in clinical manifestation of the disease in humans, but the molecules are likely to play a general biological role in invertebrates and lower vertebrates as well.", {"entities": []}], ["ES products have several functions during infection, e.g.", {"entities": []}], ["penetration of host tissues and evasion of host immune responses, but are at the same time known to elicit immune responses (including antibody production) both in fish and mammals.", {"entities": []}], ["ES proteins from anisakid nematodes, in particular Anisakis simplex , are currently applied for diagnostic purposes but recent evidence suggests that they also may have a therapeutic potential in immune-related diseases.", {"entities": []}], ["Although expression of inducible NO synthase (iNOS) in the lungs of asthmatics and associated nitrosative damage are established, iNOS failed as a therapeutic target for blocking airway hyperresponsiveness (AHR) and inflammation in asthmatics.", {"entities": [[207, 210, "GENE"]]}], ["This dichotomy calls for better strategies with which the enzyme is adequately targeted.", {"entities": []}], ["Here, we confirm iNOS expression in the asthmatic lung with concomitant protein nitration and poly(ADP-ribose) polymerase (PARP) activation.", {"entities": []}], ["We show, for the first time, that iNOS is highly expressed in peripheral blood mononuclear cells (PBMCs) of asthmatics with uncontrolled disease, which did not correspond to protein nitration.", {"entities": []}], ["Selective iNOS inhibition with L-NIL protected against AHR upon acute, but not chronic, exposure to ovalbumin or house dust mite (HDM) in mice.", {"entities": [[55, 58, "GENE"]]}], ["Supplementation of NO by nitrite administration significantly blocked AHR in chronically HDM-exposed mice that were treated with L-NIL.", {"entities": [[70, 73, "GENE"]]}], ["Protection against chronic HDM exposure-induced AHR by olaparib-mediated PARP inhibition may be associated with the partial but not the complete blockade of iNOS expression.", {"entities": [[48, 51, "GENE"]]}], ["Indeed, L-NIL administration prevented olaparib-mediated protection against AHR in chronically HDM-exposed mice.", {"entities": [[76, 79, "GENE"]]}], ["Our study suggests that the amount of iNOS and NO are critical determinants in the modulation of AHR by selective iNOS inhibitors and renews the potential of iNOS as a therapeutic target for asthma.", {"entities": [[191, 197, "DISEASE"], [97, 100, "GENE"]]}], ["Allergic diseases mediated by T helper type (Th) 2 cell immune responses are rising dramatically in most developed countries.", {"entities": []}], ["Exaggerated Th2 cell reactivity could result, for example, from diminished exposure to Th1 cell\u2013inducing microbial infections.", {"entities": []}], ["Epidemiological studies, however, indicate that Th2 cell\u2013stimulating helminth parasites may also counteract allergies, possibly by generating regulatory T cells which suppress both Th1 and Th2 arms of immunity.", {"entities": []}], ["We therefore tested the ability of the Th2 cell\u2013inducing gastrointestinal nematode Heligmosomoides polygyrus to influence experimentally induced airway allergy to ovalbumin and the house dust mite allergen Der p 1.", {"entities": []}], ["Inflammatory cell infiltrates in the lung were suppressed in infected mice compared with uninfected controls.", {"entities": []}], ["Suppression was reversed in mice treated with antibodies to CD25.", {"entities": []}], ["Most notably, suppression was transferable with mesenteric lymph node cells (MLNC) from infected animals to uninfected sensitized mice, demonstrating that the effector phase was targeted.", {"entities": []}], ["MLNC from infected animals contained elevated numbers of CD4 \u03b2 expression, and produced strong interleukin (IL)-10 responses to parasite antigen.", {"entities": [[57, 60, "GENE"]]}], ["However, MLNC from IL-10\u2013deficient animals transferred suppression to sensitized hosts, indicating that IL-10 is not the primary modulator of the allergic response.", {"entities": []}], ["Suppression was associated with CD4", {"entities": [[32, 35, "GENE"]]}], ["Developed countries are suffering from an epidemic rise in immunologic disorders, such as allergy-related diseases and certain autoimmunities.", {"entities": []}], ["Several studies have demonstrated a negative association between helminth infections and inflammatory diseases (eg, allergy), providing a strong case for the involvement of helminth infections in this respect.", {"entities": []}], ["However, some studies point in the opposite direction.", {"entities": []}], ["The discrepancy may be explained by differences in frequency, dose, time, and type of helminth.", {"entities": []}], ["In this review, new studies are discussed that may support the concept that chronic helminth infections in particular\u2014but not acute infections\u2014are associated with the expression of regulatory networks necessary for downmodulating allergic immune responses to harmless antigens.", {"entities": []}], ["Furthermore, different components of regulatory networks are highlighted, such as the role of regulatory T and B cells, modulation of dendritic cells, early innate signals from structural cells (eg, epithelial cells), and their individual contributions to protection against allergic diseases.", {"entities": []}], ["It is of great interest to define and characterize specific helminth molecules that have profound immunomodulatory capacities as targets for therapeutic application in the treatment or prophylaxis of allergic manifestations.", {"entities": []}], ["Nurses played a critical role in performing triage during the Iran-Iraq War.", {"entities": []}], ["However, their experiences in triage have not been discussed.", {"entities": []}], ["Therefore, the current study aimed to investigate the triage experiences of civilian nurses during the Iran-Iraq War.", {"entities": []}], ["Oral history method and in-depth interviews were used to collect data to gain the nurses' experiences in triage.", {"entities": []}], ["Four themes were extracted from the data, which were the development of triage, challenging environment to perform triage, development of mobile triage teams, and challenges of triage chemical victims for nurses.", {"entities": []}], ["Triage is an important skill for nurses to manage critical situations such as disasters and wars.", {"entities": [[92, 96, "GENE"]]}], ["Nurses have to be competent in performing triage.", {"entities": []}], ["Involvement in critical situations helps the nurses learn and gain more experience on how to manage unexpected events.", {"entities": []}], ["Many clinicians have concerns about the safety of atopic dermatitis (AD) treatments, particularly in children requiring long-term daily maintenance therapy.", {"entities": [[50, 67, "DISEASE"], [57, 67, "DISEASE"]]}], ["Topical corticosteroids (TCS) have been widely used for >5 decades.", {"entities": []}], ["Long-term TCS monotherapy has been associated with adverse cutaneous effects including atrophy, rebound flares, and increased percutaneous absorption with potential for adverse systemic effects.", {"entities": []}], ["Topical calcineurin inhibitors (TCIs), tacrolimus and pimecrolimus, available for 1\u20132 decades, are not associated with atrophy or increased percutaneous absorption after prolonged use and have much lower potential for systemic effects.", {"entities": []}], ["However, since 2006 TCIs have carried a controversial Boxed Warning based on a theoretical risk of malignancy (eg, skin and lymphoma) that has limited TCI use for standard-of-care maintenance therapy.", {"entities": [[124, 132, "DISEASE"]]}], ["A comparative systematic search of PubMed was done for long-term (\u226512\u00a0week) clinical trials of TCS or TCI treatment in patients <12\u00a0years with AD.", {"entities": []}], ["Citations were reviewed for inclusion based on MeSH terms, abstracts, and relevant article text.", {"entities": []}], ["Studies were excluded if they did not encompass subjects <12\u00a0years, or were <12\u00a0weeks\u2019 duration, retrospective, meta-analyses, or limited to anecdotal case reports.", {"entities": []}], ["Of 27 trials meeting criteria, 21 included 5825 pediatric patients treated with TCIs, and 6 included 1999 patients treated with TCS.", {"entities": []}], ["TCS studies were limited to low- to mid-potency products, and all but one study lacked a vehicle control.", {"entities": []}], ["Eight TCI studies were vehicle-controlled, and safety data were well reported, with \u22645\u00a0% of patients reporting discontinuation due to adverse effects (DAEs).", {"entities": []}], ["Cutaneous and systemic adverse events (AEs) were similar in TCI and vehicle groups, with no reports of lymphoma.", {"entities": [[103, 111, "DISEASE"]]}], ["Safety data in TCS trials were less well reported.", {"entities": []}], ["DAE incidence was addressed in just 2 trials, and systemic and cutaneous AEs were mostly unreported.", {"entities": []}], ["Data supporting long-term use of TCIs are robust, documenting safety and efficacy, while data supporting long-term TCS use are limited to low- to mid-potency products.", {"entities": []}], ["Our review identifies a lack of information on the safety of commonly prescribed, long-term monotherapy with mid- to high-potency TCS in pediatric AD, and supports standard-of-care maintenance therapy with TCIs and intermittent use of low- to mid-potency TCS for flares.", {"entities": []}], ["Ethnic differences in the birth prevalence of congenital heart defects (CHDs) have been reported; however, studies of the contemporary UK population are lacking.", {"entities": []}], ["We investigated ethnic variations in incidence of serious CHDs requiring cardiac intervention before 1\u2005year of age.", {"entities": []}], ["All infants who had a cardiac intervention in England and Wales between 1 January 2005 and 31 December 2010 were identified in the national congenital heart disease surgical audit and matched with paediatric intensive care admission records to create linked individual child records.", {"entities": [[151, 164, "DISEASE"]]}], ["Agreement in reporting of ethnic group by each audit was evaluated.", {"entities": []}], ["For infants born 1 January 2006 to 31 December 2009, we calculated incidence rate ratios (IRRs) for CHDs by ethnicity and investigated age at intervention, antenatal diagnosis and area deprivation.", {"entities": []}], ["We identified 5350 infants (2940 (55.0%) boys).", {"entities": []}], ["Overall CHD incidence was significantly higher in Asian and Black ethnic groups compared with the White reference population (incidence rate ratios (IRR) (95% CIs): Asian 1.5 (1.4 to 1.7); Black 1.4 (1.3 to 1.6)); incidence of specific CHDs varied by ethnicity.", {"entities": []}], ["No significant differences in age at intervention or antenatal diagnosis rates were identified but affected children from non-White ethnic groups were more likely to be living in deprived areas than White children.", {"entities": []}], ["Significant ethnic variations exist in the incidence of CHDs, including for specific defects with high infant mortality.", {"entities": []}], ["It is essential that healthcare provision mitigates ethnic disparity, including through timely identification of CHDs at screening, supporting parental choice and effective interventions.", {"entities": []}], ["Future research should explore the factors underlying ethnic variation and impact on longer-term outcomes.", {"entities": []}], ["Increasing evidence suggests that crosstalk between airway epithelial cells (AEC) and adjacent dendritic cells (DC) tightly regulates airway mucosal DC function in steady state.", {"entities": []}], ["AEC are known to express multiple immmuno-modulatory factors, though detailed information on how this influences human DC function remains incomplete.", {"entities": []}], ["We recently demonstrated using an in vitro coculture model that AEC alter differentiation of monocytes into DC in a manner that inhibits expression of potentially damaging Th2 effector function.", {"entities": []}], ["In the current study, we have extended these findings to examine other aspects of DC function.", {"entities": []}], ["Using micro-array technology we show that multiple genes important for immune surveillance are significantly over expressed in purified AEC-conditioned DC, compared to control DC.", {"entities": []}], ["These findings were confirmed by quantitative real time PCR or flow cytometry in an independent sample set.", {"entities": []}], ["In particular, AEC-conditioned DC showed selective upregulation of chemokines that recruit Th1 cells, but minimal change in chemokines linked to Th2 cell recruitment.", {"entities": []}], ["AEC-conditioned DC were also characterized by enhanced expression of complement family genes ( C1QB, C2, CD59 and SERPING1 ), Fc\u03b3 receptor genes ( FCGR1A , FCGR2A , FCGR2B and FCGR2C ), signaling lymphocytic activation molecule family member 1 (SLAM), programmed death ligands 1 and 2, CD54 and CD200R1, relative to control DC.", {"entities": [[95, 99, "GENE"], [101, 103, "GENE"], [105, 109, "GENE"], [114, 122, "GENE"], [147, 153, "GENE"], [156, 162, "GENE"], [165, 171, "GENE"], [176, 182, "GENE"], [295, 302, "GENE"]]}], ["These findings suggest that AEC conditioning facilitates the capacity of DC to react to danger signals, to enhance leukocyte recruitment, especially of Th1 effector cells, and to interact with other immune cell populations while minimizing the risks of excessive inflammation leading to tissue damage.", {"entities": []}], ["The purpose of the present study was to investigate activation of inflammatory markers in human macrophages derived from the U937 cell line after exposure to particulate matter (PM) collected on dairy farms in California and to identify the most potent components of the PM.", {"entities": []}], ["PM from different dairies were collected and tested to induce an inflammatory response determined by the expression of various pro-inflammatory genes, such as Interleukin (IL)-8, in U937 derived macrophages.", {"entities": []}], ["Gel shift and luciferase reporter assays were performed to examine the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-\u03baB) and Toll-like-receptor 4 (TLR4).", {"entities": [[182, 186, "GENE"]]}], ["Macrophage exposure to PM derived from dairy farms significantly activated expression of pro-inflammatory genes, including IL-8, cyclooxygenase 2 and Tumor necrosis factor-alpha, which are hallmarks of inflammation.", {"entities": []}], ["Acute phase proteins, such as serum amyloid A and IL-6, were also significantly upregulated in macrophages treated with PM from dairies.", {"entities": []}], ["Coarse PM fractions demonstrated more pro-inflammatory activity on an equal-dose basis than fine PM.", {"entities": []}], ["Urban PM collected from the same region as the dairy farms was associated with a lower concentration of endotoxin and produced significantly less IL-8 expression compared to PM collected on the dairy farms.", {"entities": []}], ["The present study provides evidence that the endotoxin components of the particles collected on dairies play a major role in mediating an inflammatory response through activation of TLR4 and NF-\u03baB signaling.", {"entities": [[182, 186, "GENE"]]}], ["Genome-wide association studies (GWAS) have become a common approach to identifying single nucleotide polymorphisms (SNPs) associated with complex diseases.", {"entities": []}], ["As complex diseases are caused by the joint effects of multiple genes, while the effect of individual gene or SNP is modest, a method considering the joint effects of multiple SNPs can be more powerful than testing individual SNPs.", {"entities": []}], ["The multi-SNP analysis aims to test association based on a SNP set, usually defined based on biological knowledge such as gene or pathway, which may contain only a portion of SNPs with effects on the disease.", {"entities": []}], ["Therefore, a challenge for the multi-SNP analysis is how to effectively select a subset of SNPs with promising association signals from the SNP set.", {"entities": []}], ["We developed the Optimal P-value Threshold Pedigree Disequilibrium Test (OPTPDT).", {"entities": []}], ["The OPTPDT uses general nuclear families.", {"entities": []}], ["A variable p-value threshold algorithm is used to determine an optimal p-value threshold for selecting a subset of SNPs.", {"entities": []}], ["A permutation procedure is used to assess the significance of the test.", {"entities": []}], ["We used simulations to verify that the OPTPDT has correct type I error rates.", {"entities": []}], ["Our power studies showed that the OPTPDT can be more powerful than the set-based test in PLINK, the multi-SNP FBAT test, and the p-value based test GATES.", {"entities": []}], ["We applied the OPTPDT to a family-based autism GWAS dataset for gene-based association analysis and identified MACROD2-AS1 with genome-wide significance ( p -value= 2.5\u2009\u00d7\u200910 Our simulation results suggested that the OPTPDT is a valid and powerful test.", {"entities": []}], ["The OPTPDT will be helpful for gene-based or pathway association analysis.", {"entities": []}], ["The method is ideal for the secondary analysis of existing GWAS datasets, which may identify a set of SNPs with joint effects on the disease.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-015-1620-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Little is known about gender differences in plasma biomarker levels in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[85, 122, "DISEASE"]]}], ["There are differences in serum biomarker levels between women and men with COPD.", {"entities": []}], ["Explore gender differences in plasma biomarker levels in patients with COPD and smokers without COPD.", {"entities": []}], ["We measured plasma levels of IL-6, IL-8, IL-16, MCP-1, MMP-9, PARC and VEGF in 80 smokers without COPD (40 males, 40 females) and 152 stable COPD patients (76 males, 76 females) with similar airflow obstruction.", {"entities": []}], ["We determined anthropometrics, smoking history, lung function, exercise tolerance, body composition, BODE index, co-morbidities and quality of life.", {"entities": []}], ["We then explored associations between plasma biomarkers levels and the clinical characteristics of the patients and also with the clinical and physiological variables known to predict outcome in COPD.", {"entities": []}], ["The plasma biomarkers level explored were similar in men and women without COPD.", {"entities": []}], ["In contrast, in patients with COPD the median value in pg/mL of IL-6 (6.26 vs 8.0, p\u200a=\u200a0.03), IL-16 (390 vs 321, p\u200a=\u200a0.009) and VEGF (50 vs 87, p\u200a=\u200a0.02) differed between women and men.", {"entities": []}], ["Adjusted for smoking history, gender was independently associated with IL-16, PARC and VEGF levels.", {"entities": []}], ["There were also gender differences in the associations between IL-6, IL-16 and VEGF and physiologic variables that predict outcomes.", {"entities": []}], ["In stable COPD patients with similar airflow obstruction, there are gender differences in plasma biomarker levels and in the association between biomarker levels and important clinical or physiological variables.", {"entities": []}], ["Further studies should confirm our findings.", {"entities": []}], ["The present study was undertaken to explore the effect of piperine in obesity-induced dyslipidemia.", {"entities": [[70, 77, "DISEASE"]]}], ["Male Sprague Dawley rats were fed high-fat diet (HFD) for the first eight weeks, to develop obesity-induced dyslipidemia.", {"entities": [[92, 99, "DISEASE"]]}], ["Later on piperine (40 mg / kg) and sibutramine (5 mg / kg) were administered for three weeks along with the continuation of HFD to two separate groups, which served as the test and standard groups, respectively.", {"entities": []}], ["Body weight, food intake, serum triglyceride, total cholesterol, LDL, VLDL, and HDL were measured at the end of the fourth, eighth (before treatment), and eleventh (after treatment) week, while the fat mass was measured at the end of the eleventh week in the normal, HFD-control, test, and standard groups.", {"entities": []}], ["Supplementing piperine with HFD significantly reduced not only body weight, triglyceride, total cholesterol, LDL, VLDL, and fat mass, but also increased the HDL levels, with no change in food intake.", {"entities": []}], ["The above results suggest that piperine possesses potential fat reducing and lipid lowering effects, without any change in food appetite, at a small dose of 40 mg / kg.", {"entities": []}], ["The mechanism of action for such an activity needs to be determined.", {"entities": []}], ["However, looking to structural similarity with the presently known Melanocortin-4 (MC-4) agonists, involvement of MC-4 receptors in its activity can be guessed.", {"entities": []}], ["The purpose of the study was to assess the prevalence of pulmonary embolism (PE) and other lung diseases among pregnant women with suspected PE and to calculate the radiation exposure to patient and fetus in this population.", {"entities": [[57, 75, "DISEASE"]]}], ["As a secondary aim, we evaluated the negative predictive value of a normal ventilation/perfusion single photon emission computed tomography (V/P SPECT) examination in pregnancy.", {"entities": []}], ["We studied all 127 pregnant women who had suspected PE and had undergone V/P SPECT at our institution in the course of a 5-year period.", {"entities": []}], ["Radiation exposure to patient and fetus and the negative predictive value of a normal V/P SPECT examination were also measured.", {"entities": []}], ["V/P SPECT identified PE in 11 women (9\u00a0%).", {"entities": []}], ["Moreover, in 15 women (12\u00a0%) the examination revealed pneumonia (in 2 cases in addition to PE) and in 1 woman signs of airway obstruction were revealed.", {"entities": [[54, 63, "DISEASE"]]}], ["Among the 116/127 women (91\u00a0%) where PE was ruled out by V/P SPECT, none was diagnosed subsequently with PE or deep venous thrombosis (DVT) during the same pregnancy or puerperal period.", {"entities": []}], ["For P SPECT, the calculated fetal absorbed dose was\u2009<\u20090.6 mGy,and the calculated breast absorbed dose 0.6 mGy.", {"entities": []}], ["For V SPECT, the calculated fetal absorbed dose was\u2009<\u20090.014 mGy and the breast absorbed dose 0.25 mGy.", {"entities": []}], ["The prevalence of PE was low (9\u00a0%) among pregnant women with suspected disease.", {"entities": []}], ["Pneumonia was diagnosed in 12\u00a0% of patients.", {"entities": [[0, 9, "DISEASE"]]}], ["The negative predictive value of V/P SPECT was high, and the radiation exposure from V/P SPECT was low both for fetus and patient.", {"entities": []}], ["Allergy places a considerable cost burden on society.", {"entities": []}], ["Specific immunoglobulin E (spIgE) testing may improve the management of allergy patients.", {"entities": []}], ["There is therefore a reason to quantify the economic consequences of the use of spIgE testing in the diagnosis of allergic conditions.", {"entities": []}], ["The expected costs of spIgE testing versus no-testing were calculated using a clinical decision model based on a prospective clinical trial performed in primary care.", {"entities": []}], ["The expected costs per patient over 2 years decreased from 802 euros in the \"no-test strategy\" to 560 euros in the spIgE \"test strategy\".", {"entities": []}], ["Cost savings persisted even after assumptions about the prevalence of allergy and the prices of medications were changed.", {"entities": []}], ["The \"test strategy\" increased the percentage of patients correctly diagnosed from 54 to 87%.", {"entities": []}], ["spIgE testing of children with respiratory and/or skin problems in primary care in Italy reduces overall costs to society.", {"entities": []}], ["These cost savings mostly result from a reduction in the use of medications, particularly corticosteroids.", {"entities": []}], ["The study indicates that spIgE testing of all children with respiratory and/or skin symptoms would be a cost-effective strategy.", {"entities": []}], ["Previous work has shown patients commonly misuse adrenaline autoinjectors ( AAI ).", {"entities": []}], ["It is unclear whether this is due to inadequate training, or poor device design.", {"entities": []}], ["We undertook a prospective randomized controlled trial to evaluate ability to administer adrenaline using different AAI devices.", {"entities": []}], ["We allocated mothers of food\u2010allergic children prescribed an AAI for the first time to Anapen or EpiPen using a computer\u2010generated randomization list, with optimal training according to manufacturer's instructions.", {"entities": []}], ["After one year, participants were randomly allocated a new device (EpiPen, Anapen, new EpiPen, JEXT or Auvi\u2010Q), without device\u2010specific training.", {"entities": []}], ["We assessed ability to deliver adrenaline using their AAI in a simulated anaphylaxis scenario six weeks and one year after initial training, and following device switch.", {"entities": []}], ["Primary outcome was successful adrenaline administration at six weeks, assessed by an independent expert.", {"entities": []}], ["Secondary outcomes were success at one year, success after switching device, and adverse events.", {"entities": []}], ["We randomized 158 participants.", {"entities": []}], ["At six weeks, 30 of 71 (42%) participants allocated to Anapen and 31 of 73 (43%) participants allocated to EpiPen were successful \u2013 RR 1.00 (95% CI 0.68\u20131.46).", {"entities": []}], ["Success rates at one year were also similar, but digital injection was more common at one year with EpiPen (8/59, 14%) than Anapen (0/51, 0%, P \u00a0=\u00a00.007).", {"entities": []}], ["When switched to a new device without specific training, success rates were higher with Auvi\u2010Q (26/28, 93%) than other devices (39/80, 49%; P \u00a0<\u00a00.001).", {"entities": []}], ["AAI device design is a major determinant of successful adrenaline administration.", {"entities": []}], ["Success rates were low with several devices, but were high using the audio\u2010prompt device Auvi\u2010Q.", {"entities": []}], ["We demonstrate that high mobility group box 1 protein (HMGB1) directs Th17 skewing by regulating dendritic cell (DC) function.", {"entities": [[55, 60, "GENE"]]}], ["First, our in vitro studies reveal that recombinant HMGB1 (rHMGB1) activates myeloid DCs to produce IL-23 in vitro , and rHMGB1-activated DCs prime na\u00efve lymphocytes to produce the Th17 cytokine IL-17A.", {"entities": [[52, 57, "GENE"]]}], ["Second, we demonstrate that anti-HMGB1 neutralizing antibody attenuates HMGB1 expression, neutrophilic inflammation, airway hyperresponsiveness, and Th17-related cytokine secretion in vivo by using a murine model of neutrophilic asthma induced by ovalbumin (OVA) plus lipopolysaccharide (LPS).", {"entities": [[229, 235, "DISEASE"], [33, 38, "GENE"], [72, 77, "GENE"]]}], ["Furthermore, anti-HMGB1 neutralizing antibody decreases the number of Th17 cells in lung cells and suppresses the production of IL-23 by lung CD11C", {"entities": []}], ["Social inequalities in health exist globally and are a major public health concern.", {"entities": []}], ["This study focus on a systematic investigation into the associations between health indicators, living conditions and parental educational level as indicator of the social status of 6-year-old children living in West and East Germany in the decade after re-unification.", {"entities": []}], ["Explanations of observed associations between parental education and health indicators were examined.", {"entities": []}], ["All boys and girls entering elementary school and living in predefined areas of East and West Germany were invited to participate in a series of cross-sectional surveys conducted between 1991 and 2000.", {"entities": []}], ["Data of 28,888 German children with information on parental education were included in the analysis.", {"entities": []}], ["Information about educational level of the parents, individual living conditions, symptoms and diagnoses of infectious diseases and allergies were taken from questionnaire.", {"entities": []}], ["At the day of investigation, atopic eczema was diagnosed by dermatologists, blood was taken for the determination of allergen-specific immuno-globulin E, height and weight was measured and lung function tests were done in subgroups.", {"entities": []}], ["Regression analysis was applied to investigate the associations between the health indicators and parental educational level as well as the child's living conditions.", {"entities": []}], ["Gender, urban/rural residency and year of survey were used to control for confounding.", {"entities": []}], ["Average response was 83% in East Germany and 71% in West Germany.", {"entities": []}], ["Strong associations between health indicators and parental education were observed.", {"entities": []}], ["Higher educated parents reported more diagnoses and symptoms than less educated.", {"entities": []}], ["Children of higher educated parents were also more often sensitized against grass pollen or house dust mites, but had higher birth weights, lower airway resistance and were less overweight at the age of six.", {"entities": []}], ["Furthermore, most of the health indicators were significantly associated with one or more living conditions such as living as a single child, unfavourable indoor air, damp housing condition, maternal smoking during pregnancy or living near a busy road.", {"entities": []}], ["The total lung capacity and the prevalence of an atopic eczema at the day of investigation were the only health indicators those did not show associations with any of the predictor variables.", {"entities": []}], ["Despite large differences in living conditions and evidence that some poor health outcomes were directly associated with poor living conditions, only few indicators demonstrated poorer health in social disadvantaged children.", {"entities": []}], ["These were in both parts of Germany increased levels of overweight, higher airway resistance and, in East Germany only, reduced height in children with lower educated parents compared to those of higher education.", {"entities": []}], ["In both East and West Germany, higher prevalence of airway symptoms was associated with a damp housing condition, and lower birth weight, reduced height and increased airway resistance at the age of six were associated with maternal smoking during pregnancy.", {"entities": []}], ["The latter explained to a large extent the difference in birth weight and airway resistance between the educational groups.", {"entities": []}], ["Epilepsy is a serious and common neurological disorder.", {"entities": []}], ["Expression quantitative loci (eQTL) analysis is a vital aid for the identification and interpretation of disease-risk loci.", {"entities": []}], ["Many eQTLs operate in a tissue- and condition-specific manner.", {"entities": []}], ["We have performed the first genome-wide cis-eQTL analysis of human hippocampal tissue to include not only normal ( n \u2009=\u200922) but also epileptic ( n \u2009=\u200922) samples.", {"entities": []}], ["We demonstrate that disease-associated variants from an epilepsy GWAS meta-analysis and a febrile seizures (FS) GWAS are significantly more enriched with epilepsy-eQTLs than with normal hippocampal eQTLs from two larger independent published studies.", {"entities": []}], ["In contrast, GWAS meta-analyses of two other brain diseases associated with hippocampal pathology (Alzheimer\u2019s disease and schizophrenia) are more enriched with normal hippocampal eQTLs than with epilepsy-eQTLs.", {"entities": [[123, 136, "DISEASE"]]}], ["These observations suggest that an eQTL analysis that includes disease-affected brain tissue is advantageous for detecting additional risk SNPs for the afflicting and closely related disorders, but not for distinct diseases affecting the same brain regions.", {"entities": []}], ["We also show that epilepsy eQTLs are enriched within epilepsy-causing genes: an epilepsy cis-gene is significantly more likely to be a causal gene for a Mendelian epilepsy syndrome than to be a causal gene for another Mendelian disorder.", {"entities": [[163, 180, "DISEASE"], [172, 180, "DISEASE"]]}], ["Epilepsy cis-genes, compared to normal hippocampal cis-genes, are more enriched within epilepsy-causing genes.", {"entities": []}], ["Hence, we utilize the epilepsy eQTL data for the functional interpretation of epilepsy disease-risk variants and, thereby, highlight novel potential causal genes for sporadic epilepsy.", {"entities": []}], ["In conclusion, an epilepsy-eQTL analysis is superior to normal hippocampal tissue eQTL analyses for identifying the variants and genes underlying epilepsy.", {"entities": []}], ["Measuring genome-wide changes in transcript abundance in circulating peripheral whole blood is a useful way to study disease pathobiology and may help elucidate the molecular mechanisms of disease, or discovery of useful disease biomarkers.", {"entities": []}], ["The sensitivity and interpretability of analyses carried out in this complex tissue, however, are significantly affected by its dynamic cellular heterogeneity.", {"entities": []}], ["It is therefore desirable to quantify this heterogeneity, either to account for it or to better model interactions that may be present between the abundance of certain transcripts, specific cell types and the indication under study.", {"entities": []}], ["Accurate enumeration of the many component cell types that make up peripheral whole blood can further complicate the sample collection process, however, and result in additional costs.", {"entities": []}], ["Many approaches have been developed to infer the composition of a sample from high-dimensional transcriptomic and, more recently, epigenetic data.", {"entities": []}], ["These approaches rely on the availability of isolated expression profiles for the cell types to be enumerated.", {"entities": []}], ["These profiles are platform-specific, suitable datasets are rare, and generating them is expensive.", {"entities": []}], ["No such dataset exists on the Affymetrix Gene ST platform.", {"entities": []}], ["We present \u2018Enumerateblood\u2019, a freely-available and open source R package that exposes a multi-response Gaussian model capable of accurately predicting the composition of peripheral whole blood samples from Affymetrix Gene ST expression profiles, outperforming other current methods when applied to Gene ST data.", {"entities": []}], ["\u2018Enumerateblood\u2019 significantly improves our ability to study disease pathobiology from whole blood gene expression assayed on the popular Affymetrix Gene ST platform by allowing a more complete study of the various components of this complex tissue without the need for additional data collection.", {"entities": []}], ["Future use of the model may allow for novel insights to be generated from the ~400 Affymetrix Gene ST blood gene expression datasets currently available on the Gene Expression Omnibus (GEO) website.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-016-3460-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Macrophages are major cell types of the immune system, and they comprise both tissue-resident populations and circulating monocyte-derived subsets.", {"entities": []}], ["Here, we discuss microglia, the resident macrophage within the central nervous system (CNS), and CNS-infiltrating macrophages.", {"entities": []}], ["Under steady state, microglia play important roles in the regulation of CNS homeostasis through the removal of damaged or unnecessary neurons and synapses.", {"entities": []}], ["In the face of inflammatory or pathological insults, microglia and CNS-infiltrating macrophages not only constitute the first line of defense against pathogens by regulating components of innate immunity, but they also regulate the adaptive arms of immune responses.", {"entities": []}], ["Dysregulation of these responses contributes to many CNS disorders.", {"entities": []}], ["In this overview, we summarize the current knowledge regarding the highly diverse and complex function of microglia and macrophages during CNS autoimmunity\u2014multiple sclerosis and cancer\u2014malignant glioma.", {"entities": [[186, 202, "DISEASE"], [156, 174, "DISEASE"], [179, 185, "DISEASE"]]}], ["We emphasize how the crosstalk between natural killer (NK) cells or glioma cells or glioma stem cells and CNS macrophages impacts on the pathological processes.", {"entities": []}], ["Given the essential role of CNS microglia and macrophages in the regulation of all types of CNS disorders, agents targeting these subsets are currently applied in preclinical and clinical trials.", {"entities": []}], ["We believe that a better understanding of the biology of these macrophage subsets offers new exciting paths for therapeutic intervention.", {"entities": []}], ["Acupuncture is an effective yet complex therapy, integrating syndrome differentiation, selection of appropriate acupoints and skillful needling techniques.", {"entities": [[61, 69, "DISEASE"]]}], ["Clinicians carefully tailor acupuncture treatment to each patient.", {"entities": []}], ["However, most clinical trials of acupuncture have been based on a standardized formula of points for every patient without properly accounting for individualdifferences and, as a result, have not been reflective of the true efficacy of clinical practice.", {"entities": []}], ["To determine the efficacy of meridian-based syndrome differentiation and Sa-am acupuncture, we have designed a simple pragmatic trial providing individualized treatments while working within a general framework.", {"entities": [[44, 52, "DISEASE"]]}], ["The study is designed to be a parallel, patient- and assessor-blind, randomized controlled trial (RCT).", {"entities": []}], ["A total of250 patients with knee osteoarthritis (OA) will be recruited from two independent hospitals, Semyung University Oriental Medicine Hospital in Chung-ju and Dongguk University Oriental Hospital in Ilsan, South Korea.", {"entities": [[33, 47, "DISEASE"]]}], ["Patients will be randomly allocated into four treatment groups: 1. individualized, meridian-based syndrome differentiation and Sa-am acupuncture treatment;2. standard acupuncture treatment;3. sham acupuncture treatment; and 4. no acupuncture treatment.", {"entities": [[98, 106, "DISEASE"]]}], ["Patients in groups 1 to 3 will be treated by certified oriental medicine doctors twice a week for 6\u2009weeks.", {"entities": []}], ["The primary outcome measure will be the self-reported total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score change.", {"entities": [[102, 116, "DISEASE"]]}], ["The trial will also include secondary outcome measures.", {"entities": []}], ["This trial is designed to determine the efficacy of individualized acupuncture treatment in patients with knee OA by comparing the differences between individualized, standard, sham and no acupuncture treatments.", {"entities": []}], ["The results of this trial may validate the efficacy of individualized acupuncture therapy, encouraging its widespread use.", {"entities": []}], ["ClinicalTrials.gov: NCT01569230", {"entities": []}], ["In 2011, more than half of the patients with stroke in Australian hospitals were not assessed for the need for rehabilitation.", {"entities": []}], ["Further, there were no recommended criteria to guide rehabilitation assessment decisions.", {"entities": []}], ["Subsequently, a decision-making tool called the Assessment for Rehabilitation Tool (ART) was developed.", {"entities": []}], ["The ART was designed to assist Australian hospital clinicians to identify the rehabilitation needs of patients with stroke using evidence-based criteria.", {"entities": []}], ["The ART was released and made freely available for use in 2012.", {"entities": []}], ["This study evaluated the effectiveness of an education-only intervention (1 onsite education session and distribution of the ART) and a multifaceted intervention (2 or more onsite education sessions, distribution of the ART, audit and feedback, barrier identification, site-specific strategy development, promotion of interdisciplinary teamwork, opinion leaders and reminders) for improving assessments of rehabilitation needs after stroke.", {"entities": []}], ["Ten hospitals in 2 states of Australia were randomly assigned to an education-only or a multifaceted intervention.", {"entities": []}], ["Medical records were audited by assessors blinded to group allocation before and after the implementation period.", {"entities": []}], ["Difference in the proportion of patients assessed for rehabilitation before and after the intervention was analysed using mixed-effects logistic regression analysis, with time period as the dependent variable, an interaction between intervention type and time included to test for differences between the interventions, and hospital included as the random effect to account for patient clustering.", {"entities": []}], ["Data from 586 patients (284 pre-intervention; 302 post-intervention; age 76\u00a0years, 59\u00a0% male) showed that the multifaceted intervention was not more effective than education-only in improving the proportion of patients whose rehabilitation needs were assessed (reference category education-only; odds ratio 1.29, 95\u00a0% confidence interval 0.63\u20132.67, p \u2009=\u20090.483).", {"entities": []}], ["Post-intervention, the odds of a patient\u2019s rehabilitation needs being assessed was 3.69 times greater than pre-intervention (95\u00a0% confidence interval 2.57\u20135.30, p \u2009<\u20090.001).", {"entities": []}], ["Evidence-based criteria were not consistently used when patients were deemed to have no rehabilitation needs.", {"entities": []}], ["A multifaceted intervention was not more effective than education-only in improving the assessment of rehabilitation needs of patients with stroke.", {"entities": []}], ["Further interventions are required to ensure that all patients are assessed for the need for rehabilitation using evidence-based criteria.", {"entities": []}], ["ANZCTR (Australian New Zealand Clinical Trials Registry), ACTRN12616000340437 The online version of this article (doi:10.1186/s13012-016-0487-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Patients' experiences are often treated as health care quality indicators.", {"entities": []}], ["Our aim was to identify the range of experiences of health care delivery that matter to patients and to produce a conceptual map to facilitate consideration of why they matter.", {"entities": []}], ["Broad-based review and critical interpretive synthesis of research literature on patients' perspectives of health care delivery.", {"entities": []}], ["We recorded experiences reported by a diverse range of patients on \u2018concept cards\u2019, considered why they were important, and explored various ways of organizing them, including internationally recognized health care quality frameworks.", {"entities": []}], ["We developed a conceptual map that we refined with feedback from stakeholders.", {"entities": []}], ["Patients identify many health care experiences as important.", {"entities": []}], ["Existing health care quality frameworks do not cover them all.", {"entities": []}], ["Our conceptual map presents a rich array of experiences, including health care relationships (beyond communication) and their implications for people's valued capabilities (e.g.", {"entities": []}], ["to feel respected, contribute to their care, experience reciprocity).", {"entities": []}], ["It is organized to reflect our synthesis argument, which links health care delivery to what people are enabled (or not) to feel, be and do.", {"entities": []}], ["The map highlights the broad implications of the social dynamics of health care delivery.", {"entities": []}], ["Experiences are labelled from a patient's perspective, rendering the importance of responsiveness to individuals axiomatic.", {"entities": []}], ["Our conceptual map identifies and helps explain the importance of diverse experiences of health care delivery.", {"entities": []}], ["It challenges and helps policy-makers, service providers and researchers to attend to the range of experiences that matter, and to take seriously the need for responsiveness to individuals.", {"entities": []}], ["Macrolide antibiotics are known to have various anti-inflammatory effects in addition to their antimicrobial activity, but the mechanisms are still unclear.", {"entities": []}], ["The effect of azithromycin on inflammatory molecules in the lipopolysaccharide-induced rat conjunctivitis model was investigated.", {"entities": [[91, 105, "DISEASE"]]}], ["Twenty-four Wistar rats were divided into two groups receiving topical ocular azithromycin (15 mg/g) or vehicle.", {"entities": []}], ["In total, six doses (25 \u00b5l) were administered as one dose twice a day for three days before subconjunctival lipopolysaccharide injection (3 mg/ml).", {"entities": []}], ["Before the rats were euthanized, mucus secretion, conjunctival and palpebral edema and redness were evaluated.", {"entities": []}], ["Real-time polymerase chain reaction was used to determine gene expression for interleukin-6, cyclooxygenase-2, tumor necrosis factor-\u03b1, matrix metalloproteinase (MMP)-2, and MMP-9.", {"entities": []}], ["Interleukin-6 was determined with enzyme-linked immunosorbent assay, nuclear factor-kappa B with western blot, and MMP-2 activity with gelatin zymogram.", {"entities": []}], ["Four eyes per group were processed for histology and subsequent periodic acid-Schiff staining and CD68 for immunofluorescence.", {"entities": [[98, 102, "GENE"]]}], ["The Student t test or the Wilcoxon test for independent samples was applied (SPSS v.15.0).", {"entities": []}], ["Azithromycin-treated animals showed a significant reduction in all clinical signs (p<0.05) compared to controls.", {"entities": []}], ["Interleukin-6 (p<0.05), nuclear factor-kappa B protein expression (p<0.01), and MMP-2 activity (p<0.05) in conjunctival homogenates were significantly reduced compared with the control animals.", {"entities": []}], ["MMP-2 gene expression showed a tendency to decrease in the azithromycin group (p=0.063).", {"entities": []}], ["Mucus secretion by goblet cells and the macrophage count in conjunctival tissue were also decreased in the azithromycin group (p<0.05).", {"entities": []}], ["These results suggest that azithromycin administration ameliorates induced inflammation effects in a rat model of acute conjunctivitis.", {"entities": [[114, 134, "DISEASE"], [120, 134, "DISEASE"]]}], ["To design, develop and prototype clinical dashboards to integrate high-frequency health and wellness data streams using interactive and real-time data visualisation and analytics modalities.", {"entities": []}], ["We developed a clinical dashboard development framework called electronic healthcare data visualization (EHDViz) toolkit for generating web-based, real-time clinical dashboards for visualising heterogeneous biomedical, healthcare and wellness data.", {"entities": []}], ["The EHDViz is an extensible toolkit that uses R packages for data management, normalisation and producing high-quality visualisations over the web using R/Shiny web server architecture.", {"entities": []}], ["We have developed use cases to illustrate utility of EHDViz in different scenarios of clinical and wellness setting as a visualisation aid for improving healthcare delivery.", {"entities": []}], ["Using EHDViz, we prototyped clinical dashboards to demonstrate the contextual versatility of EHDViz toolkit.", {"entities": []}], ["An outpatient cohort was used to visualise population health management tasks ( n =14\u2005221), and an inpatient cohort was used to visualise real-time acuity risk in a clinical unit ( n =445), and a quantified-self example using wellness data from a fitness activity monitor worn by a single individual was also discussed ( n-of-1 ).", {"entities": []}], ["The back-end system retrieves relevant data from data source, populates the main panel of the application and integrates user-defined data features in real-time and renders output using modern web browsers.", {"entities": []}], ["The visualisation elements can be customised using health features, disease names, procedure names or medical codes to populate the visualisations.", {"entities": []}], ["The source code of EHDViz and various prototypes developed using EHDViz are available in the public domain at http://ehdviz.dudleylab.org .", {"entities": []}], ["Collaborative data visualisations, wellness trend predictions, risk estimation, proactive acuity status monitoring and knowledge of complex disease indicators are essential components of implementing data-driven precision medicine.", {"entities": []}], ["As an open-source visualisation framework capable of integrating health assessment, EHDViz aims to be a valuable toolkit for rapid design, development and implementation of scalable clinical data visualisation dashboards.", {"entities": []}], ["Androgen deprivation therapy (ADT) is an effective palliation treatment in men with advanced prostate cancer (PC).", {"entities": [[102, 108, "DISEASE"], [93, 108, "DISEASE"], [110, 112, "GENE"]]}], ["However, ADT has well documented side effects that could alter the patient\u2019s health-related quality of life (HRQoL).", {"entities": []}], ["The current study aims to test whether a genetic stratification could provide better knowledge for optimising ADT options to minimize HRQoL effects.", {"entities": []}], ["A cohort of 206 PC survivors (75 treated with and 131 without ADT) was recruited with written consent to collect patient characteristics, clinical data and HRQoL data related to PC management.", {"entities": [[16, 18, "GENE"], [178, 180, "GENE"], [16, 18, "GENE"], [178, 180, "GENE"]]}], ["The primary outcomes were the percentage scores under each HRQoL subscale assessed using the European Organisation for Research and Treatment of Cancer Quality of Life questionnaires (QLQ-C30 and PR25) and the Depression Anxiety Stress Scales developed by the University of Melbourne, Australia.", {"entities": [[145, 151, "DISEASE"]]}], ["Genotyping of these men was carried out for the aldo-keto reductase family 1, member C3 ( AKR1C3 ) rs12529 single nucleotide polymorphism (SNP).", {"entities": [[85, 87, "GENE"], [90, 96, "GENE"]]}], ["Analysis of HRQoL scores were carried out against ADT duration and in association with the AKR1C3 rs12529 SNP using the generalised linear model.", {"entities": [[91, 97, "GENE"]]}], ["P-values <0\u2009\u00b7\u200905 were considered significant, and were further tested for restriction with Bonferroni correction.", {"entities": []}], ["Increase in hormone treatment-related effects were recorded with long-term ADT compared to no ADT.", {"entities": []}], ["The C and G allele frequencies of the AKR1C3 rs12529 SNP were 53\u00b74 % and 46\u00b76 % respectively.", {"entities": [[38, 44, "GENE"]]}], ["Hormone treatment-related symptoms showed an increase with ADT when associated with the AKR1C3 rs12529 G allele.", {"entities": [[88, 94, "GENE"]]}], ["Meanwhile, decreasing trends on cancer-specific symptoms and increased sexual interest were recorded with no ADT when associated with the AKR1C3 rs12529 G allele and reverse trends with the C allele.", {"entities": [[32, 38, "DISEASE"], [138, 144, "GENE"]]}], ["As higher incidence of cancer-specific symptoms relate to cancer retention it is possible that associated with the C allele there could be higher incidence of unresolved cancers under no ADT options.", {"entities": [[23, 29, "DISEASE"], [58, 64, "DISEASE"]]}], ["If these findings can be reproduced in larger homogeneous cohorts, a genetic stratification based on the AKR1C3 rs12529 SNP, can minimize ADT-related HRQoL effects in PC patients.", {"entities": [[105, 111, "GENE"], [167, 169, "GENE"]]}], ["Our data additionally show that with this stratification it could also be possible to identify men needing ADT for better oncological advantage.", {"entities": []}], ["The online version of this article (doi:10.1186/s12894-016-0164-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Previous studies have shown that formaldehyde (FA) could cause immunotoxicity by changing the number of T lymphocytes and that cytokines play a pivotal role in the regulation of T lymphocytes.", {"entities": []}], ["However, the previously used cytokine detection methods are difficult to use in the measurement of several cytokines in a small amount of sample for one test.", {"entities": []}], ["Therefore, the cytometric bead array (CBA) technique was used.", {"entities": []}], ["CBA showed better analytical efficiency and sensitivity than the previous methods.", {"entities": []}], ["C57BL/6 mice were exposed to the control (normal saline), low FA concentration (0.5 mg/kg), and high FA concentration (2 mg/kg) for 1 week or 1 month.", {"entities": []}], ["The contents of cytokines, including Th1-related cytokines (IL-2, IFN-\u03b3, and tumor necrosis factor), Th2-related cytokines (IL-4, IL-6, and IL-10), and Th17-related cytokines (IL-17A), were measured by using the BD FACS Canto II Flow Cytometer and analyzed by FCAP Array Software.", {"entities": []}], ["Th1/Th2/Th17-related cytokines showed a slightly decreasing trend after low FA exposure.", {"entities": []}], ["Conversely, a significantly increasing trend was found after high FA exposure.", {"entities": []}], ["Th1/Th2/Th17-related cytokines all serve important functions in the immune reactions in mice after FA exposure.", {"entities": []}], ["The CB 2 receptor is the peripheral receptor for cannabinoids.", {"entities": []}], ["It is mainly expressed in immune tissues, highlighting the possibility that the endocannabinoid system has an immunomodulatory role.", {"entities": []}], ["In this respect, the CB 2 receptor was shown to modulate immune cell functions, both in cellulo and in animal models of inflammatory diseases.", {"entities": []}], ["In this regard, numerous studies have reported that mice lacking the CB 2 receptor have an exacerbated inflammatory phenotype.", {"entities": []}], ["This suggests that therapeutic strategies aiming at modulating CB 2 signaling could be promising for the treatment of various inflammatory conditions.", {"entities": []}], ["Herein, we review the pharmacology of the CB 2 receptor, its expression pattern, and the signaling pathways induced by its activation.", {"entities": []}], ["We next examine the regulation of immune cell functions by the CB 2 receptor and the evidence obtained from primary human cells, immortalized cell lines, and animal models of inflammation.", {"entities": []}], ["Finally, we discuss the possible therapies targeting the CB 2 receptor and the questions that remain to be addressed to determine whether this receptor could be a potential target to treat inflammatory disease.", {"entities": []}], ["The associations between leptin, interleukin (IL)-6, and hip radiographic osteoarthritis (OA) have not been reported, and their roles in obesity-related hip OA are unclear.", {"entities": [[137, 144, "DISEASE"], [74, 88, "DISEASE"]]}], ["The aim of this study was to describe the associations between leptin, IL-6, and hip radiographic osteoarthritis (ROA) in older adults.", {"entities": [[98, 112, "DISEASE"]]}], ["A cross-sectional sample of 193 randomly selected subjects (mean age, 63 years; range, 52 to 78 years; 48% female subjects) were studied.", {"entities": []}], ["Hip ROA, including joint-space narrowing (JSN) and osteophytes, was determined by anteroposterior radiograph.", {"entities": []}], ["Serum levels of leptin and interleukin (IL)-6 were measured with radioimmunoassay.", {"entities": []}], ["Fat mass was measured with dual-energy x-ray absorptiometry (DXA).", {"entities": []}], ["Body mass index (BMI) and waist-to-hip ratio (WHR) were calculated.", {"entities": []}], ["In multivariable analysis, hip JSN was associated with serum levels of leptin in the whole sample (\u03b2 = 0.046 per \u03bcg/L, P = 0.024 for superior; \u03b2 = 0.068 per \u03bcg/L, P = 0.004 for axial compartment) and IL-6 only in females (\u03b2 = 0.241 per pg/ml, P = 0.002 for superior; \u03b2 = 0.239 per pg/ml, P = 0.001 for axial compartment).", {"entities": []}], ["The positive associations between body-composition measures (BMI, WHR, percentage total fat mass, and percentage trunk fat mass) and hip JSN in women became nonsignificant after adjustment for leptin but not for IL-6.", {"entities": []}], ["No significant associations were found between leptin, IL-6, and the presence or severity of osteophytes.", {"entities": []}], ["This study suggests that metabolic and inflammatory mechanisms may play a role in the etiology of hip OA and that the associations between body composition and hip JSN are mediated by leptin, particularly in women.", {"entities": []}], ["Cigarette smoke exposure is the most common risk factor for emphysema, which is one of the major pathologies of COPD.", {"entities": []}], ["Protein arginine methyltransferase 6 (PRMT6) is a nuclear enzyme that specially catalyzes dimethylation of R2 in histone H3 (H3R2me2a).", {"entities": [[38, 43, "GENE"]]}], ["H3R2me2a prevents trimethylation of H3K4 (H3K4me3), which is located in the transcription start sites of genes in mammalian genomes.", {"entities": []}], ["We attempted to determine the expression of PRMT6 in human samples, and investigate whether the upregulation of PRMT6 expression can attenuate the development of cigarette smoke extract (CSE)-induced emphysema.", {"entities": [[44, 49, "GENE"], [112, 117, "GENE"], [44, 49, "GENE"], [112, 117, "GENE"]]}], ["Further experiments were performed to elucidate the molecular mechanisms involved.", {"entities": []}], ["Human lung tissues were obtained from patients undergoing pneumonectomy for benign pulmonary lesions.", {"entities": []}], ["BALB/c mice were treated with lentiviral vectors intratracheally and injected with CSE three times.", {"entities": []}], ["The protein expression of PRMT6, H3R2me2a, and H3K4me3 in human and mouse samples, as well as B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), and endothelial nitric oxide synthase (eNOS) in mice were detected in lung homogenates by Western blotting.", {"entities": [[101, 109, "DISEASE"], [26, 31, "GENE"], [149, 152, "GENE"]]}], ["The mRNA expression of cyclooxygenase-2, interleukin-6, Bcl-2, Bax, and eNOS in mice was measured by quantitative real-time polymerase chain reaction.", {"entities": [[63, 66, "GENE"]]}], ["The expression of PRMT6 was significantly downregulated in the pulmonary parenchyma in smokers with COPD as well as in mice treated with CSE.", {"entities": [[18, 23, "GENE"]]}], ["Overexpression of PRMT6 was detected in the CSE + Lenti-PRMT6 group of mice, which reversed the expression of H3R2me2a and H3K4me3.", {"entities": [[18, 23, "GENE"], [56, 61, "GENE"]]}], ["Inflammation, apoptosis, and oxidative stress levels were severe in the CSE-treated emphysema mice compared with the control group, which was inhibited by the overexpression of PRMT6.", {"entities": [[177, 182, "GENE"]]}], ["The overexpression of PRMT6 might inhibit inflammation, apoptosis, and oxidative stress in CSE-induced emphysema mediated by H3R2me2a.", {"entities": [[22, 27, "GENE"]]}], ["The synthesis of leukotrienes in human blood neutrophils chiefly relies on the activity of two enzymes, phospholipase A2 and 5-lipoxygenase (5- LO).", {"entities": []}], ["In turn, the activation of the 5-LO requires the participation of a recently characterized membrane-bound protein, the 5-LO-activating protein (FLAP).", {"entities": []}], ["In this study, we have investigated conditions under which FLAP expression in neutrophils may be modulated.", {"entities": []}], ["Of several cytokines tested, only granulocyte/macrophage colony-stimulating factor (GM-CSF) (and to a lesser extent tumor necrosis factor alpha) significantly increased expression of FLAP.", {"entities": []}], ["GM-CSF increased FLAP mRNA steady-state levels in a time- and dose-dependent manner.", {"entities": []}], ["The stimulatory effect of GM-CSF on FLAP mRNA was inhibited by prior treatment of the cells with the transcription inhibitor, actinomycin D, and pretreatment of the cells with the protein synthesis inhibitor, cycloheximide, failed to prevent the increase in FLAP mRNA induced by GM-CSF.", {"entities": []}], ["The accumulation of newly synthesized FLAP, as determined by immunoprecipitation after incorporation of 35S-labeled amino acids, was also increased after incubation of neutrophils with GM-CSF.", {"entities": []}], ["In addition, the total level of FLAP protein was increased in GM-CSF- treated neutrophils, as determined by two-dimensional gel electrophoresis, followed by Western blot.", {"entities": []}], ["GM-CSF did not alter the stability of the FLAP protein, indicating that the effect of GM-CSF on FLAP accumulation was the consequence of increased de novo synthesis as opposed to decreased degradation of FLAP.", {"entities": []}], ["Finally, incubation of neutrophils with the synthetic glucocorticoid dexamethasone directly stimulated the upregulation of FLAP mRNA and protein, and enhanced the effect of GM-CSF.", {"entities": []}], ["Taken together, these data demonstrate that FLAP expression may be upmodulated after appropriate stimulation of neutrophils.", {"entities": []}], ["The increase in FLAP expression induced by GM-CSF in inflammatory conditions could confer upon neutrophils a prolonged capacity to synthesize leukotrienes.", {"entities": []}], ["Non-enveloped viruses must deliver their viral genome across a cell membrane without the advantage of membrane fusion.", {"entities": []}], ["The mechanisms used to achieve this remain poorly understood.", {"entities": []}], ["Human rhinovirus, a frequent cause of the common cold, is a non-enveloped virus of the picornavirus family, which includes other significant pathogens such as poliovirus and foot-and-mouth disease virus.", {"entities": [[183, 196, "DISEASE"], [42, 53, "DISEASE"]]}], ["During picornavirus cell entry, the small myristoylated capsid protein VP4 is released from the virus, interacts with the cell membrane and is implicated in the delivery of the viral RNA genome into the cytoplasm to initiate replication.", {"entities": []}], ["In this study, we have produced recombinant C-terminal histidine-tagged human rhinovirus VP4 and shown it can induce membrane permeability in liposome model membranes.", {"entities": []}], ["Dextran size-exclusion studies, chemical crosslinking and electron microscopy demonstrated that VP4 forms a multimeric membrane pore, with a channel size consistent with transfer of the single-stranded RNA genome.", {"entities": []}], ["The membrane permeability induced by recombinant VP4 was influenced by pH and was comparable to permeability induced by infectious virions.", {"entities": []}], ["These findings present a molecular mechanism for the involvement of VP4 in cell entry and provide a model system which will facilitate exploration of VP4 as a novel antiviral target for the picornavirus family.", {"entities": []}], ["Human rhinovirus (HRV) is a non-enveloped virus of the picornavirus family and is responsible for respiratory infections (common colds) costing billions of dollars ($) annually.", {"entities": []}], ["There remains no vaccine or licensed drug to prevent or reduce infection.", {"entities": []}], ["Related members of the picornavirus family include significant pathogens such as poliovirus, enterovirus 71 and foot-and-mouth disease virus, for which improved control measures are also required.", {"entities": [[121, 134, "DISEASE"]]}], ["A fundamental step in virus infection is the delivery of the viral genetic material through the barrier of the cellular membrane.", {"entities": []}], ["Viruses such as HIV and influenza are enveloped in an outer membrane which can fuse with the host cell membrane to allow the viral genome to penetrate into the cytoplasm.", {"entities": [[24, 33, "DISEASE"]]}], ["However, non-enveloped viruses such as picornaviruses lack a membrane and the mechanisms for penetration of the membrane by these viruses remain poorly understood.", {"entities": []}], ["The capsid protein VP4 has previously been implicated in the delivery of the picornavirus genome.", {"entities": []}], ["In this study we demonstrate that HRV VP4 interacts with membranes to make them permeable by the formation of multimeric, size-selective membrane pores with properties consistent with the transport of viral genome through the membrane.", {"entities": []}], ["This function of VP4 provides a novel antiviral target for this family of viruses.", {"entities": []}], ["A rich microbial environment in infancy protects against asthma We identified 5,054 16S rRNA bacterial sequences from 43 subjects, detecting >70% of species present.", {"entities": [[57, 63, "DISEASE"]]}], ["The bronchial tree was not sterile, and contained a mean of 2,000 bacterial genomes per cm Haemophilus spp., were much more frequent in bronchi of adult asthmatics or patients with COPD than controls.", {"entities": []}], ["We found similar highly significant increases in Proteobacteria in asthmatic children.", {"entities": []}], ["Conversely, Bacteroidetes, particularly Prevotella spp., were more frequent in controls than adult or child asthmatics or COPD patients.", {"entities": []}], ["The results show the bronchial tree to contain a characteristic microbiota, and suggest that this microbiota is disturbed in asthmatic airways.", {"entities": []}], ["Babies born before 28 weeks\u2019 gestation have lower plasma thyroid hormone concentrations than more mature infants.", {"entities": []}], ["This may contribute to their risk of poor developmental outcome.", {"entities": []}], ["Previous studies have suggested that thyroxine supplementation for extremely preterm neonates may be beneficial.", {"entities": []}], ["The aim of this study was to investigate the effect of administration of supplemental thyroxine to very premature babies on brain size and somatic growth at 36 weeks\u2019 corrected gestational age (CGA).", {"entities": [[194, 197, "GENE"]]}], ["In this explanatory multicentre double blind randomised placebo controlled trial, 153 infants born below 28 weeks\u2019 gestation were randomised to levothyroxine (LT4) supplementation or placebo until 32 weeks\u2019 CGA.", {"entities": [[207, 210, "GENE"]]}], ["The primary outcome was brain size assessed by the width of the subarachnoid space measured by cranial ultrasound at 36 weeks\u2019 CGA.", {"entities": [[127, 130, "GENE"]]}], ["Lower leg length was measured by knemometry.", {"entities": []}], ["Babies in the LT4-supplemented and placebo groups had similar baseline characteristics.", {"entities": []}], ["There were no significant differences between infants given LT4 ( n =78) or placebo ( n =75) for width of the subarachnoid space, head circumference at 36 weeks\u2019 CGA, body weight at 36 weeks\u2019 CGA or mortality.", {"entities": [[162, 165, "GENE"], [192, 195, "GENE"], [162, 165, "GENE"], [192, 195, "GENE"]]}], ["Infants who received LT4 had significantly shorter leg lengths at 36 weeks\u2019 CGA although adjusted analysis for baseline length did not find a statistical difference.", {"entities": [[76, 79, "GENE"]]}], ["There was a significant correlation between low FT4 and wider subarachnoid space.", {"entities": []}], ["No unexpected serious adverse events were noted and incidence of adverse events did not differ between the two groups.", {"entities": []}], ["This is the only randomised controlled trial of thyroxine supplementation targeting extremely premature infants.", {"entities": []}], ["Supplementing all babies below 28 weeks\u2019 gestation with LT4 had no apparent effect on brain size.", {"entities": []}], ["These results do not support routine supplementation with LT4 for all babies born below 28 weeks\u2019 gestation.", {"entities": []}], ["Current Controlled Trials ISRCTN89493983 EUDRACT number: 2005-003-09939", {"entities": []}], ["Severe injury remains a leading cause of death and morbidity in patients under 40, with the number of annual trauma-related deaths approaching 160,000 in the United States.", {"entities": []}], ["Patients who survive the initial trauma and post-traumatic resuscitation are at risk for immune dysregulation, which contributes to late mortality and accounts for approximately 20% of deaths after traumatic injury.", {"entities": []}], ["This post-traumatic immunosuppressed state has been attributed to over-expression of anti-inflammatory mediators in an effort to restore host homeostasis.", {"entities": []}], ["We measured a panel of monocyte markers and cytokines in 50 severely injured trauma patients for 3 days following admission.", {"entities": []}], ["We made the novel observation that the subpopulation of monocytes expressing high levels of CD14 and CD16 was expanded in the majority of patients.", {"entities": [[92, 96, "GENE"]]}], ["These cells also expressed CD163 consistent with differentiation into alternatively activated macrophages with potential regulatory or wound-healing activity.", {"entities": [[27, 32, "GENE"]]}], ["We examined factors in trauma plasma that may contribute to the generation and activation of these cells.", {"entities": []}], ["The percentage of CD14", {"entities": [[18, 22, "GENE"]]}], ["To describe hospital admission and emergency visit rates and potential risk factors of prolonged hospitalisation and death among children in Hanoi.", {"entities": []}], ["A retrospective study reviewed 212\u2009216 hospitalisation records of children (aged 0\u201317) who attended the Vietnam National Children's Hospital in Hanoi between 2007 and 2014.", {"entities": []}], ["Four indicators were analysed and reported: (1) rate of emergency hospital visits, (2) rate of hospitalisation, (3) length of hospital stay and (4) number of deaths.", {"entities": []}], ["The risk of prolonged hospitalisation was investigated using Cox proportion hazard, and the risk of death was investigated through logistic regressions.", {"entities": []}], ["During 2007\u20132014, the average annual rate of emergency visits was 2.2 per 1000 children and the rate of hospital admissions was 13.8 per 1000 children.", {"entities": []}], ["The annual rates for infants increased significantly by 3.9 per 1000 children during 2012\u20132014 for emergency visits and 25.1 per 1000 children during 2009\u20132014 for hospital admissions.", {"entities": []}], ["Digestive diseases (32.0%) and injuries (30.2%) were common causes of emergency visits, whereas respiratory diseases (37.7%) and bacterial and parasitic infections (19.8%) accounted for most hospital admissions.", {"entities": []}], ["Patients with mental and behavioural disorders remained in the hospital the longest (median=12 days).", {"entities": []}], ["Morbidities related to the perinatal period dominated mortality causes (32.5% of deaths among those admitted to the hospital.", {"entities": []}], ["Among the respiratory diseases, pneumonia was the leading cause of both prolonged hospitalisation and death.", {"entities": [[32, 41, "DISEASE"]]}], ["Preventable health problems, such as common bacterial infections and respiratory diseases, were the primary causes of hospital admissions in Vietnam.", {"entities": []}], ["Health systems increasingly try to make their services more responsive to users' expectations.", {"entities": []}], ["In the context of the World Health Report 2000, WHO developed the concept of health system responsiveness as a performance parameter.", {"entities": []}], ["Responsiveness relates to the system's ability to respond to service users' legitimate expectations of non-medical aspects.", {"entities": []}], ["We used this concept in an effort to evaluate the performance of mental health care in a catchment area in Germany.", {"entities": []}], ["In accordance with the method WHO used for its responsiveness survey, responsiveness for inpatient and outpatient mental health care was evaluated by a standardised questionnaire.", {"entities": []}], ["Responsiveness was assessed in the following domains: attention, dignity , clear communication , autonomy, confidentiality, basic amenities, choice of health care provider, continuity , and access to social support .", {"entities": []}], ["Users with complex mental health care needs (i.e., requiring social and medical services or inpatient care) were recruited consecutively within the mental health services provided in the catchment area of the Hanover Medical School.", {"entities": []}], ["221 persons were recruited in outpatient care and 91 in inpatient care.", {"entities": []}], ["Inpatient service users reported poor responsiveness (22%) more often than outpatients did (15%); however this was significant only for the domains dignity and communication .", {"entities": []}], ["The best performing domains were confidentiality and dignity ; the worst performing were choice , autonomy and basic amenities (only inpatient care).", {"entities": []}], ["Autonomy was rated as the most important domain, followed by attention and communication .", {"entities": []}], ["Responsiveness within outpatient care was rated worse by people who had less money and were less well educated.", {"entities": []}], ["Inpatient responsiveness was rated better by those with a higher level of education and also by those who were not so well educated.", {"entities": []}], ["23% of participants reported having been discriminated against in mental health care during the past 6 months.", {"entities": []}], ["The results are similar to prior responsiveness surveys with regard to the overall better performance of outpatient care.", {"entities": []}], ["Where results differ, this can best be explained by certain characteristics that are applicable to mental health care and also by the users with complex needs.", {"entities": []}], ["The expectations of attention and autonomy , including participation in the treatment process, are not met satisfactorily in inpatient and outpatient care.", {"entities": []}], ["Responsiveness as a health system performance parameter provides a refined picture of inpatient and outpatient mental health care.", {"entities": []}], ["Reforms to the services provided should be orientated around domains that are high in importance, but low in performance.", {"entities": []}], ["Measuring responsiveness could provide well-grounded guidance for further development of mental health care systems towards becoming better patient-orientated and providing patients with more respect.", {"entities": []}], ["Although height (H) has been considered the principal anthropometric variable governing lung function, the age-dependent differences in its influences on determining spirometric parameters (SPs) have not been conclusively investigated.", {"entities": []}], ["Moreover, there has been no study centered on age-dependent effects of other anthropometric variables, including body weight (BW) and body fat mass (BFM) on SPs.", {"entities": []}], ["In addition, the age-dependent influences of these anthropometric variables are anticipated to differ quantitatively between male and female participants.", {"entities": []}], ["A total of 16,919 nonsmoking healthy Japanese adults (men: 6,116, women: 10,803) were partitioned into six groups stratified by gender and age at intervals of 20-years: young-, middle-, and advanced-age groups of either gender.", {"entities": []}], ["Using a model in which a SP was described by a logarithmic additive function of age, H, BW, and BFM, we determined the partial regression coefficients of the respective anthropometric variables to predict the reference means of SPs, including FVC, FEV 1 , FEV 1 /FVC, PEF, FEF 50 , and FEF 75 , in the six groups.", {"entities": [[248, 251, "GENE"], [256, 259, "GENE"], [248, 251, "GENE"], [256, 259, "GENE"]]}], ["Although the impact of H on FVC and FEV 1 was relatively homogeneous irrespective of gender and age, its homogeneity faded for flow parameters, particularly in the female middle- and advanced-age groups, indicating that the age-dependent contribution of H to SPs was enhanced more in women.", {"entities": [[36, 39, "GENE"]]}], ["The impact of BW on SPs differed depending on age, and this effect was also more conspicuous for female participants.", {"entities": []}], ["H and BW generally exerted positive effects on SPs, whereas BFM had negative effects.", {"entities": []}], ["Opposite effects of BW and BFM were observed in the female middle-age group in particular.", {"entities": []}], ["The effects of anthropometric variables on spirometric parameters are highly age-dependent, particularly in women, leading to the conclusion that the assumption of age-independent, constant partial regression coefficients of anthropometric variables while predicting the reference mean of a certain spirometric parameter may result in substantial errors.", {"entities": []}], ["Matrix metalloproteinases are zinc-containing enzymes capable of degrading all components of the extracellular matrix.", {"entities": []}], ["Owing to their role in human disease, matrix metalloproteinase have been the subject of extensive study.", {"entities": []}], ["A bioinorganic approach was recently used to identify novel inhibitors based on a maltol zinc-binding group, but accompanying molecular-docking studies failed to explain why one of these inhibitors, AM-6, had approximately 2500-fold selectivity for MMP-3 over MMP-2.", {"entities": []}], ["A number of studies have suggested that the matrix-metalloproteinase active site is highly flexible, leading some to speculate that differences in active-site flexibility may explain inhibitor selectivity.", {"entities": []}], ["To extend the bioinorganic approach in a way that accounts for MMP-2 and MMP-3 dynamics, we here investigate the predicted binding modes and energies of AM-6 docked into multiple structures extracted from matrix-metalloproteinase molecular dynamics simulations.", {"entities": []}], ["Our findings suggest that accounting for protein dynamics is essential for the accurate prediction of binding affinity and selectivity.", {"entities": []}], ["Additionally, AM-6 and other similar inhibitors likely select for and stabilize only a subpopulation of all matrix-metalloproteinase conformations sampled by the apo protein.", {"entities": []}], ["Consequently, when attempting to predict ligand affinity and selectivity using an ensemble of protein structures, it may be wise to disregard protein conformations that cannot accommodate the ligand.", {"entities": []}], ["The anti-allergic potential of egg white protein hydrolysates (from ovalbumin, lysozyme and ovomucoid) was evaluated as their ability to hinder cytokine and IgE production by Th2-skewed human peripheral blood mononuclear cells (PBMCs), as well as the release of pro-inflammatory factors and generation of reactive oxygen species from Th1-stimulated peripheral blood leukocytes (PBLs).", {"entities": []}], ["The binding to IgE of egg allergic patients was determined and the peptides present in the hydrolysates were identified.", {"entities": []}], ["The hydrolysates with alcalase down-regulated the production of Th2-biased cytokines and the secretion of IgE to the culture media of Th2-skewed PBMCs, and they significantly neutralized oxidative stress in PBLs.", {"entities": []}], ["The hydrolysates of ovalbumin and ovomucoid with pepsin helped to re-establish the Th1/Th2 balance in Th2-biased PBMCs, while they also inhibited the release of pro-inflammatory mediators and reduced oxidative stress in PBLs treated with inflammatory stimuli.", {"entities": []}], ["The hydrolysates with alcalase, in addition to equilibrating Th2 differentiation, exhibited a low IgE-binding.", {"entities": []}], ["Therefore, they would elicit mild allergic reactions while retaining T cell-stimulating abilities, which might correlate with an anti-allergic benefit.", {"entities": []}], ["Prenatal exposure to excess endogenous glucocorticoid (GC) has been linked to attention-deficit/hyperactivity disorder (ADHD).", {"entities": [[55, 57, "GENE"]]}], ["We investigated whether prenatal exposure to exogenous GC is associated with ADHD.", {"entities": [[55, 57, "GENE"]]}], ["Nationwide cohort study.", {"entities": []}], ["A cohort of 875\u2009996 singletons born alive between 1996 and 2009 in Denmark.", {"entities": []}], ["Data were obtained from national registries.", {"entities": []}], ["We identified children exposed prenatally to GCs, children unexposed prenatally and born to maternal former users, and children unexposed and born to maternal never users.", {"entities": []}], ["We compared ADHD risk in children prenatally exposed to GCs and in children of former GC users with risk in unexposed children of never users.", {"entities": [[86, 88, "GENE"]]}], ["We computed cumulative incidence at 10 years of age and adjusted HRs (aHRs).", {"entities": []}], ["In addition, we compared exposed children with unexposed siblings in a sibling design.", {"entities": []}], ["We identified 875\u2009996 children, among whom 5319 were prenatally exposed to systemic GCs and 36\u2009780 to local/inhaled GCs.", {"entities": []}], ["Cumulative incidences of ADHD at 10 years of age were 2.65% in prenatally exposed children and 2.03% in unexposed children of never users.", {"entities": []}], ["At the general population level, prenatal exposure was associated with ADHD compared with unexposed, with aHR of 1.43(95% CI 1.24 to 1.65) for systemic exposure and 1.23 (95% CI 1.15 to 1.31) for local/inhaled exposure.", {"entities": [[106, 109, "GENE"]]}], ["However, our former user analysis (aHR of 1.25 (95% CI 1.20 to 1.29)) and sibling design (aHR of 1.03 (95% CI 0.87 to 1.20)) indicated that these findings were due to confounding.", {"entities": [[35, 38, "GENE"], [90, 93, "GENE"], [35, 38, "GENE"], [90, 93, "GENE"]]}], ["This study provides no evidence of a causal association between prenatal exposure to GCs and risk of ADHD.", {"entities": []}], ["Mannose receptor (MR) is a member of the C-type lectin receptor family involved in pathogen molecular-pattern recognition and thought to be critical in shaping host immune response.", {"entities": []}], ["The aim of this study was to investigate potential associations of genetic variants in the MRC1 gene with sarcoidosis.", {"entities": [[106, 117, "DISEASE"], [91, 95, "GENE"]]}], ["Nine single nucleotide polymorphisms (SNPs), encompassing the MRC1 gene, were genotyped in a total of 605 Japanese consisting of 181 sarcoidosis patients and 424 healthy controls.", {"entities": [[133, 144, "DISEASE"], [62, 66, "GENE"]]}], ["Suggestive evidence of association between rs691005 SNP and risk of sarcoidosis was observed independent of sex and age in a recessive model ( P = 0.001).", {"entities": [[68, 79, "DISEASE"]]}], ["These results suggest that MRC1 is an important candidate gene for sarcoidosis.", {"entities": [[67, 78, "DISEASE"], [27, 31, "GENE"]]}], ["This is the first study to imply that genetic variants in MRC1 , a major member of the C-type lectin, contribute to the development of sarcoidosis.", {"entities": [[135, 146, "DISEASE"], [58, 62, "GENE"]]}], ["To develop and optimize a rapid dynamic hyperpolarized Spiral k\u2010space trajectories were designed with the number of interleaves N int \u2009=\u20091, 2, 4, and 8 corresponding to voxel sizes of 8\u2009mm, 5\u2009mm, 4\u2009mm, and 2.5\u2009mm, respectively, for field of view\u2009=\u200915\u2009cm.", {"entities": []}], ["DXeV images were acquired from a gas\u2010flow phantom to investigate the ability of N int \u2009=\u20091, 2, 4, and 8 to capture signal\u2010time curves.", {"entities": []}], ["A finite element model was constructed to investigate gas\u2010flow dynamics corroborating the experimental signal\u2010time curves.", {"entities": []}], ["DXeV images were also carried out in six subjects (three healthy and three chronic obstructive pulmonary disease subjects).", {"entities": [[75, 112, "DISEASE"]]}], ["DXeV images and numerical modelling of signal\u2010time curves permitted the quantification of temporal and spatial resolutions for different numbers of spiral interleaves.", {"entities": []}], ["The two\u2010interleaved spiral ( N int \u2009=\u20092) was found to be the most time\u2010efficient to obtain DXeV images and signal\u2010time curves of whole lungs with a temporal resolution of 624 ms for 13 slices.", {"entities": []}], ["Signal\u2010time curves were well matched in three healthy volunteers.", {"entities": []}], ["The Spearman's correlations of chronic obstructive pulmonary disease subjects were statistically different from three healthy subjects ( P \u2009<\u20090.05).", {"entities": [[31, 68, "DISEASE"]]}], ["The N int \u2009=\u20092 spiral demonstrates the successful acquisition of DXeV images and signal\u2010time curves in healthy subjects and chronic obstructive pulmonary disease patients.", {"entities": [[124, 161, "DISEASE"]]}], ["Magn Reson Med 79:2597\u20132606, 2018.", {"entities": []}], ["\u00a9 2017 The Authors Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine.", {"entities": []}], ["This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and lung inflammation resulting in a progressive decline in lung function whose principle cause is cigarette smoke.", {"entities": []}], ["MAP3K19 is a novel kinase expressed predominantly by alveolar and interstitial macrophages and bronchial epithelial cells in the lung.", {"entities": []}], ["We found that MAP3K19 mRNA was overexpressed in a limited sampling of lung tissue from COPD patients, and a closer examination found it to be overexpressed in bronchoalveolar macrophages from COPD patients, as well as the bronchial epithelium and inflammatory cells in the lamina propria.", {"entities": []}], ["We further found MAP3K19 to be induced in various cell lines upon environmental stress, such as cigarette smoke, oxidative and osmotic stress.", {"entities": []}], ["Exogenous expression of MAP3K19 in cells caused an upregulation of transcriptionally active NF-\u03baB, and secretion of the chemokines CXCL-8, CCL-20 and CCL-7.", {"entities": []}], ["Inhibition of MAP3K19 activity by siRNA or small molecular weight inhibitors caused a decrease in cigarette smoke-induced inflammation in various murine models, which included a decrease in pulmonary neutrophilia and KC levels.", {"entities": []}], ["In a chronic cigarette smoke model, inhibition of MAP3K19 significantly attenuated emphysematous changes in airway parenchyma.", {"entities": []}], ["Finally, in a viral exacerbation model, mice exposed to cigarette smoke and influenza A virus showed a decrease in pulmonary neutrophilia, pro-inflammatory cytokines and viral load upon inhibition of MAP3K19.", {"entities": [[76, 85, "DISEASE"]]}], ["Collectively, these results suggest that inhibition of MAP3K19 may represent a novel strategy to target COPD that promises to have a potential therapeutic benefit for patients.", {"entities": []}], ["The aim of this study was to explore whether matched or mismatched strains of influenza vaccines (IVs) are beneficial at reducing the risk of acute myocardial infarction (AMI) in elderly persons.", {"entities": [[78, 87, "DISEASE"], [148, 169, "DISEASE"], [142, 169, "DISEASE"]]}], ["Data were obtained from the Longitudinal Health Database 2005 (LHID 2005) which is maintained by the National Health Insurance Research Institute in Taiwan.", {"entities": []}], ["The analytical data included individuals who were vaccinated with mismatched vaccines during the October 2007 to December 2007 season and individuals vaccinated with matched strains during the October 2008 to December 2008 season.", {"entities": []}], ["All participants were 65 years of age and older.", {"entities": []}], ["In this analysis, individuals were considered to be exposed if their records showed that they were vaccinated against influenza, and they were considered to be nonexposed if they were not vaccinated during these seasons.", {"entities": [[118, 127, "DISEASE"]]}], ["A Cox hazard model was used to estimate AMI hazard ratio.", {"entities": []}], ["This study enrolled 93,051 exposed and 109,007 unexposed individuals.", {"entities": []}], ["The AMI hazards ratios (HRs) for the men and women exposed to mismatched vaccine (in 2007) were 0.990 (95% confidence interval [CI], 0.745\u20131.316) and 1.102 (95% CI: 0.803\u20131.513), respectively.", {"entities": []}], ["Men exposed to matched vaccines (in 2008) had significant HRs (HR: 0.681; 95% CI: 0.509\u20130.912) while the HRs in the women were barely significant (HR: 0.737; 95% CI: 0.527\u20131.029).", {"entities": [[63, 65, "GENE"], [147, 149, "GENE"], [63, 65, "GENE"], [147, 149, "GENE"]]}], ["AMI risk could be particularly reduced in men if the IV matches well with the circulating strains in elderly people 65 years of age and older.", {"entities": []}], ["Worms may protect against allergy.", {"entities": []}], ["Early-life worm exposure may be critical, but this has not been fully investigated.", {"entities": []}], ["To investigate whether worms in pregnancy and in early childhood are associated with childhood eczema incidence.", {"entities": []}], ["The Entebbe Mother and Baby Study, an anthelminthic treatment trial, enrolled pregnant women between 2003 and 2005 in Uganda.", {"entities": []}], ["Mothers were investigated for worms during pregnancy and children annually.", {"entities": []}], ["Eczema was doctor-diagnosed from birth to age five years.", {"entities": []}], ["A planned observational analysis was conducted within the trial cohort to investigate associations between worms and eczema.", {"entities": []}], ["Data for 2345 live-born children were analysed.", {"entities": []}], ["Hookworm was the most prevalent maternal worm (45%).", {"entities": []}], ["Childhood worms were less prevalent.", {"entities": []}], ["Eczema incidence was 4.68/100 person-years.", {"entities": []}], ["Maternal hookworm was associated with reduced eczema incidence [adjusted hazard ratio (95% confidence interval), p-value: 0.71(0.51\u20130.99), 0.04] and modified effects of known risk factors for eczema: Dermatophagoides-specific IgE in children was positively associated with eczema incidence if the mother had no hookworm [2.72(1.11\u20136.63), 0.03], but not if the mother had hookworm [0.41(0.10\u20131.69), 0.22], interaction p-value\u00a0=\u00a00.03.", {"entities": []}], ["Similar interactions were seen for maternal history of eczema {[2.87(1.31\u20136.27, 0.008) vs. [0.73(0.23\u20132.30), 0.60], interaction p-value\u00a0=\u00a00.05}, female gender {[1.82(1.22\u20132.73), 0.004 vs. [0.96(0.60\u20131.53), 0.87], interaction p-value\u00a0=\u00a00.04} and allergen-specific IgE.", {"entities": []}], ["Childhood Trichuris trichiura and hookworm were inversely associated with eczema.", {"entities": []}], ["Maternal hookworm modifies effects of known risk factors for eczema.", {"entities": []}], ["Mechanisms by which early-life worm exposures influence allergy need investigation.", {"entities": []}], ["Worms or worm products, and intervention during pregnancy have potential for primary prevention of allergy.", {"entities": []}], ["Studies have shown that inflammation promoted atherosclerotic progression; however, it remains unclear whether inflammation promoted atherosclerotic progression properties by altering cholesterol metabolism in human macrophages.", {"entities": []}], ["In the present study, we evaluated a potential mechanism of inflammation on atherogenic effects.", {"entities": []}], ["We evaluated the ability of TNFa to affect Reverse cholesterol transport (RCT) and cholesterol uptake and its mechanism(s) of action in human macrophages.", {"entities": []}], ["We initially determined the potential effects of TNFa on cholesterol efflux in the human macrophages.", {"entities": []}], ["We also determined alterations in mRNA and protein levels of ABCA1, ABCG1, LXRa, CD-36, SR-A in human macrophages using quantitative real-time polymerase chain reaction (PCR) and Western immunoblot analyses.", {"entities": [[61, 66, "GENE"], [68, 73, "GENE"]]}], ["The cholesterol efflux rate and protein expression of ABCA1, ABCG1, LXRa, CD-36, SR-A were quantified in human macrophages under PKC-\u03b8 inhibition using PKC-\u03b8 siRNA.", {"entities": [[54, 59, "GENE"], [61, 66, "GENE"]]}], ["Our results showed that TNFa inhibited the rate of cholesterol efflux and down-regulation the expression levels of ABCA1, ABCG1 and LXRa and up-regulation the expression levels of CD-36, SR-A in human macrophages; PKC-\u03b8 inhibition by PKC-\u03b8 siRNA attenuated the effect of TNFa on ABCA1, ABCG1, LXRa, SR-A, CD-36 expression.", {"entities": [[115, 120, "GENE"], [279, 284, "GENE"], [122, 127, "GENE"], [286, 291, "GENE"], [115, 120, "GENE"], [279, 284, "GENE"], [122, 127, "GENE"], [286, 291, "GENE"]]}], ["Our results suggest TNFa alter cholesterol metabolism in human macrophages through the inhibition of Reverse cholesterol transport and enhancing cholesterol uptake via PKC-\u03b8-dependent pathway, implicating a potential mechanism of inflammation on atherogenic effects.", {"entities": []}], ["The extent to which evolutionary changes have impacted the phenotypic relationships among human diseases remains unclear.", {"entities": []}], ["In this work, we report that phenotypically similar diseases are connected by the evolutionary constraints on human disease genes.", {"entities": []}], ["Human disease groups can be classified into slowly or rapidly evolving classes, where the diseases in the slowly evolving class are enriched with morphological phenotypes and those in the rapidly evolving class are enriched with physiological phenotypes.", {"entities": []}], ["Our findings establish a clear evolutionary connection between disease classes and disease phenotypes for the first time.", {"entities": []}], ["Furthermore, the high comorbidity found between diseases connected by similar evolutionary constraints enables us to improve the predictability of the relative risk of human diseases.", {"entities": []}], ["We find the evolutionary constraints on disease genes are a new layer of molecular connection in the network-based exploration of human diseases.", {"entities": []}], ["Effective transitions to home care have been identified as among the factors leading to reducing hospital readmissions within 30 days of discharge and improvements on various other quality measures.", {"entities": []}], ["Innovative applications of published evidence-based models and best practices designed to improve care transitions have been implemented in various settings across the country in an effort to enhance quality performance.", {"entities": []}], ["For this article, The Joint Commission collected a series of case examples to examine how evidence-based innovations in care transitions are reducing readmissions and improving other quality outcomes.", {"entities": []}], ["The organizations providing the case examples were interviewed and asked to provide performance data demonstrating quality improvement, as well as information about their care processes and data-gathering techniques.", {"entities": []}], ["Their innovative approaches are reducing hospital readmissions; improving patient safety, satisfaction, and engagement; and contributing to other positive outcomes.", {"entities": []}], ["Despite strong evidence linking infections to the pathogenesis of bronchopulmonary dysplasia (BPD), limitations of bacterial culture methods have precluded systematic studies of airway organisms relative to disease outcomes.", {"entities": []}], ["Application of molecular bacterial identification strategies may provide new insight into the role of bacterial acquisition in the airways of preterm infants at risk for BPD.", {"entities": []}], ["Serial (within 72 hours, 7, 14, and 21 days of life) tracheal aspirate samples were collected from 10 preterm infants with gestational age \u226434 weeks at birth, and birth weight of 500\u20131250 g who required mechanical ventilation for at least 21 days.", {"entities": []}], ["Samples were analyzed by quantitative real time PCR assays for total bacterial load and by pyrosequencing for bacterial identification.", {"entities": []}], ["Subjects were diagnosed with mild (1), moderate (3), or severe (5) BPD.", {"entities": []}], ["One patient died prior to determination of disease severity.", {"entities": []}], ["107,487 sequences were analyzed, with mean of 3,359 (range 1,724\u20134,915) per sample.", {"entities": []}], ["2 of 10 samples collected <72 hours of life contained adequate bacterial DNA for successful sequence analysis, one of which was from a subject exposed to chorioamnionitis.", {"entities": [[154, 170, "DISEASE"]]}], ["All other samples exhibited bacterial loads >70copies/reaction.", {"entities": []}], ["72 organisms were observed in total.", {"entities": []}], ["Seven organisms represented the dominant organism (>50% of total sequences) in 31/32 samples with positive sequences.", {"entities": []}], ["A dominant organism represented>90% of total sequences in 13 samples.", {"entities": []}], ["Staphylococcus , Ureaplasmaparvum , and Ureaplasmaurealyticum were the most frequently identified dominant organisms, but Pseudomonas , Enterococcus , and Escherichia were also identified.", {"entities": []}], ["Early bacterial colonization with diverse species occursafter the first 3 days of life in the airways of intubated preterm infants, and can be characterized by bacterial load and marked species diversity.", {"entities": []}], ["Molecular identification of bacteria in the lower airways of preterm infants has the potential to yield further insight into the pathogenesis of BPD.", {"entities": []}], ["We investigated the association between seasonal influenza vaccination in South Korea and socioeconomic status (SES) as well as other potential related factors.", {"entities": [[49, 58, "DISEASE"]]}], ["The study was based on data obtained in the Korea National Health and Nutrition Examination Survey from 2010 to 2011.", {"entities": []}], ["Education level and household income were used as indicators for SES.", {"entities": []}], ["Univariate and multiple logistic regression analyses were used to evaluate SES and other demographic variables as related factors for influenza vaccination, the primary outcome.", {"entities": [[134, 143, "DISEASE"]]}], ["Higher household income was positively associated with higher vaccine uptake in the younger (19\u201349 years) group [adjusted odds ratio (aOR) 1.55, 95% confidence interval (CI) 1.08\u20132.23], whereas the low-income and low-education group had increased vaccination coverage than the middle-income and middle-education group in the older (\u2265 50 years) group (aOR 1.36, 95% CI 1.09\u20131.69).", {"entities": []}], ["Current smokers tend to be unvaccinated in all age groups.", {"entities": []}], ["Among individuals aged \u2265 50, older age, mild to moderate alcohol consumption, regular exercise, and having co-morbidities were positively associated with vaccination, while those who self-reported their health status as good were less likely to be vaccinated.", {"entities": []}], ["The relationship between SES and seasonal influenza vaccination coverage differed between the age groups throughout the adult South Korean population.", {"entities": [[42, 51, "DISEASE"]]}], ["Public health policies need to address these inequalities.", {"entities": []}], ["Obstructive lung diseases of different etiologies present with progressive peripheral airway involvement.", {"entities": []}], ["The peripheral airways, known as the silent lung zone, are not adequately evaluated with conventional function tests.", {"entities": []}], ["The principle of gas washout has been used to detect pulmonary ventilation inhomogeneity and to estimate the location of the underlying disease process.", {"entities": []}], ["Volumetric capnography (VC) analyzes the pattern of CO 2 elimination as a function of expired volume.", {"entities": []}], ["To measure normalized phase 3 slopes with VC in patients with non-cystic fibrosis bronchiectasis (NCB) and in bronchitic patients with chronic obstructive pulmonary disease (COPD) in order to compare the slopes obtained for the groups.", {"entities": [[135, 172, "DISEASE"], [82, 96, "DISEASE"], [66, 81, "DISEASE"]]}], ["NCB and severe COPD were enrolled sequentially from an outpatient clinic (Hospital of the State University of Campinas).", {"entities": []}], ["A control group was established for the NCB group, paired by sex and age.", {"entities": []}], ["All subjects performed spirometry, VC, and the 6-Minute Walk Test (6MWT).", {"entities": []}], ["Two comparisons were made: NCB group versus its control group, and NCB group versus COPD group.", {"entities": []}], ["The project was approved by the ethical committee of the institution.", {"entities": []}], ["Statistical tests used were Wilcoxon or Student\u2019s t -test; P <0.05 was considered to be a statistically significant difference.", {"entities": []}], ["Concerning the NCB group (N=20) versus the control group (N=20), significant differences were found in body mass index and in several functional variables (spirometric, VC, 6MWT) with worse results observed in the NCB group.", {"entities": []}], ["In the comparison between the COPD group (N=20) versus the NCB group, although patients with COPD had worse spirometric and 6MWT values, the capnographic variables mean phase 2 slope (Slp2), mean phase 3 slope normalized by the mean expiratory volume, or mean phase 3 slope normalized by the end-tidal CO 2 concentration were similar.", {"entities": []}], ["These findings may indicate that the gas elimination curves are not sensitive enough to monitor the severity of structural abnormalities.", {"entities": []}], ["The role of normalized phase 3 slope may be worth exploring as a more sensitive index of small airway disease, even though it may not be equally sensitive in discriminating the severity of the alterations.", {"entities": []}], ["Dual-energy CT has remained underutilized over the past decade probably due to a cumbersome workflow issue and current technical limitations.", {"entities": []}], ["Clinical radiologists should be made aware of the potential clinical benefits of dual-energy CT over single-energy CT. To accomplish this aim, the basic principle, current acquisition methods with advantages and disadvantages, and various material-specific imaging methods as clinical applications of dual-energy CT should be addressed in detail.", {"entities": []}], ["Current dual-energy CT acquisition methods include dual tubes with or without beam filtration, rapid voltage switching, dual-layer detector, split filter technique, and sequential scanning.", {"entities": []}], ["Dual-energy material-specific imaging methods include virtual monoenergetic or monochromatic imaging, effective atomic number map, virtual non-contrast or unenhanced imaging, virtual non-calcium imaging, iodine map, inhaled xenon map, uric acid imaging, automatic bone removal, and lung vessels analysis.", {"entities": []}], ["In this review, we focus on dual-energy CT imaging including related issues of radiation exposure to patients, scanning and post-processing options, and potential clinical benefits mainly to improve the understanding of clinical radiologists and thus, expand the clinical use of dual-energy CT; in addition, we briefly describe the current technical limitations of dual-energy CT and the current developments of photon-counting detector.", {"entities": []}], ["Women in contact with the prison system have high health needs.", {"entities": []}], ["Short periods in prison and serial incarcerations are common.", {"entities": []}], ["Examination of their experiences of health care both in prison and in the community may assist in better supporting their wellbeing and, ultimately, decrease their risk of returning to prison.", {"entities": []}], ["We interviewed women in prisons in Sydney, Australia, using pre-release and post-release interviews.", {"entities": []}], ["We undertook thematic analysis of the combined interviews, considering them as continuing narratives of their healthcare experiences.", {"entities": []}], ["We further reviewed the findings using the theoretical lens of candidacy to generate additional insights on healthcare access.", {"entities": []}], ["Sixty-nine interviews were conducted with 40 women pre-release and 29 of these post-release.", {"entities": []}], ["Most had histories of substance misuse.", {"entities": []}], ["Women saw prison as an opportunity to address neglected health problems, but long waiting lists impeded healthcare delivery.", {"entities": []}], ["Both in prison and in the community, the dual stigmas of substance misuse and being a prisoner could lead to provider judgements that their claims to care were not legitimate.", {"entities": []}], ["They feared they would be blocked from care even if seriously ill. Family support, self-efficacy, assertiveness, overcoming substance misuse, compliance with health system rules and transitional care programs increased their personal capacity to access health care.", {"entities": []}], ["For women in transition between prison and community, healthcare access could be experienced as \u2018medical homelessness\u2019 in which women felt caught in a perpetual state of waiting and exclusion during cycles of prison- and community-based care.", {"entities": []}], ["Their healthcare experiences were characterized by ineffectual attempts to access care, transient relationships with healthcare providers, disrupted medical management and a fear that stigma would prevent candidacy to health care even in the event of serious illness.", {"entities": []}], ["Consideration of the vulnerabilities and likely points of exclusion for women in contact with the criminal justice system will assist in increasing healthcare access for this marginalised population.", {"entities": []}], ["The purpose of the study is to evaluate whether primary care electronic medical records (EMRs) from patients with severe asthma can be used to identify allergic bronchopulmonary aspergillosis (ABPA) cases.", {"entities": [[178, 191, "DISEASE"], [121, 127, "DISEASE"], [152, 191, "DISEASE"]]}], ["This cross\u2010sectional feasibility study was conducted in adults with active and severe asthma registered with the Clinical Practice Research Datalink.", {"entities": [[86, 92, "DISEASE"]]}], ["A set of keywords flagged terms potentially indicative of ABPA in free\u2010text comments of patients' EMRs to produce a grid on the basis of keywords' hit or miss.", {"entities": []}], ["The grid was examined for occurrence and concurrence of keywords to discern patterns of concurrence potentially indicative of an underlying diagnosis of ABPA.", {"entities": []}], ["The analyses included 3\u00a0653\u00a0169 free\u2010text items from 21\u00a0054 patients.", {"entities": []}], ["In total, 52 patients (0.25%) had at least one mention of \u2018ABPA\u2019 in their medical record; 67% of these patients also had a mention of \u2018aspergillus/aspergillosis\u2019, 54% of \u2018bronchiectasis\u2019, 42% of \u2018itraconazole\u2019 and 62% of \u2018IgE\u2019.", {"entities": [[147, 160, "DISEASE"], [171, 185, "DISEASE"]]}], ["The term \u2018aspergillus/aspergillosis\u2019 occurred with a proportion of 1.84% ( N \u00a0=\u00a0387); 9% of these patients also had a mention of \u2018ABPA\u2019, and the remaining 91% were potential additional cases of ABPA.", {"entities": [[22, 35, "DISEASE"]]}], ["From the observed concurrence of keywords, we were able to devise a potential algorithm to identify cases with varying degrees of specificity.", {"entities": []}], ["This study suggests that analysis of free text within asthmatic patients' EMRs may be used to identify potential cases of ABPA.", {"entities": []}], ["This could be an efficient approach to identify rare conditions and to quantify their potential burden.", {"entities": []}], ["\u00a9 2017 The Authors.", {"entities": []}], ["Pharmacoepidemiology & Drug Safety Published by John Wiley & Sons Ltd.", {"entities": []}], ["Mammals contain 28 genes encoding Transient Receptor Potential (TRP) proteins.", {"entities": []}], ["The proteins assemble into cationic channels, often with calcium permeability.", {"entities": []}], ["Important roles in physiology and disease have emerged and so there is interest in whether the channels might be suitable therapeutic drug targets.", {"entities": []}], ["Here we review selected members of three subfamilies of mammalian TRP channel (TRPC5, TRPM2 and TRPA1) that show relevance to sensing of adversity by cells and biological systems.", {"entities": [[79, 84, "GENE"], [86, 91, "GENE"], [96, 101, "GENE"]]}], ["Summarized are the cellular and tissue distributions, general properties, endogenous modulators, protein partners, cellular and tissue functions, therapeutic potential, and pharmacology.", {"entities": []}], ["TRPC5 is stimulated by receptor agonists and other factors that include lipids and metal ions; it heteromultimerises with other TRPC proteins and is involved in cell movement and anxiety control.", {"entities": [[0, 5, "GENE"]]}], ["TRPM2 is activated by hydrogen peroxide; it is implicated in stress-related inflammatory, vascular and neurodegenerative conditions.", {"entities": [[0, 5, "GENE"]]}], ["TRPA1 is stimulated by a wide range of irritants including mustard oil and nicotine but also, controversially, noxious cold and mechanical pressure; it is implicated in pain and inflammatory responses, including in the airways.", {"entities": [[0, 5, "GENE"]]}], ["The channels have in common that they show polymodal stimulation, have activities that are enhanced by redox factors, are permeable to calcium, and are facilitated by elevations of intracellular calcium.", {"entities": []}], ["Developing inhibitors of the channels could lead to new agents for a variety of conditions: for example, suppressing unwanted tissue remodeling, inflammation, pain and anxiety, and addressing problems relating to asthma and stroke.", {"entities": [[213, 219, "DISEASE"]]}], ["An important prerequisite for the Chronic Care Model is to be able to identify, in a valid, simple and inexpensive way, the population with a chronic condition that needs proactive and planned care.", {"entities": []}], ["We investigated if a set of administrative data could be used to identify patients with Chronic Obstructive Pulmonary Disease in a Danish population.", {"entities": []}], ["Seven general practices were asked to identify patients with known Chronic Obstructive Pulmonary Disease in their practices.", {"entities": []}], ["For the 266 patients (population A), we used administrative data on hospital admissions for lung-related diagnoses, redeemed prescriptions for lung-diseases drugs and lung- function tests combined to develop an algorithm that identified the highest proportion of patients with Chronic Obstructive Pulmonary Disease with the fewest criteria involved.", {"entities": []}], ["We tested nine different algorithms combining two to four criteria.", {"entities": []}], ["The simplest algorithm with highest positive predictive value identified 532 patients (population B); with possible diagnosis of Chronic Obstructive Pulmonary Disease in five general practices.", {"entities": []}], ["The doctors were asked to confirm the diagnosis.", {"entities": []}], ["The same algorithm identified 2,895 patients whom were asked to confirm their diagnosis (population C).", {"entities": []}], ["In population A the chosen algorithm had a positive predictive value of 72.2\u2009% and three criteria: a) discharged patients with a chronic lung-disease diagnosis at least once during the preceding 5\u2009years; or b) redeemed prescription of lung-medication at least twice during the preceding 12\u2009months; or c) at least two spirometries performed at different dates during the preceding 12\u2009months.", {"entities": []}], ["In population B the positive predictive value was 65.0\u2009% [60.8;69.1\u2009%] and the sensitivity 44.8\u2009% [41.3;48.4\u2009%)] when the \u201cuncertain\u201d were added to where doctors agreed with the diagnosis.", {"entities": []}], ["For the 1,984 respondents in population C, the positive predictive value was 72.9\u2009% [70.8;74.8\u2009%] and the sensitivity 29.7\u2009% [28.4;31.0\u2009%].", {"entities": []}], ["An algorithm based on administrative data has been developed and validated with sufficient positive predictive value to be used as a tool for identifying patients with Chronic Obstructive Pulmonary Disease.", {"entities": []}], ["Some of the identified patients had other chronic lung-diseases (asthma).", {"entities": [[65, 71, "DISEASE"]]}], ["The algorithm should mostly be regarded as a tool for identifying chronic lung-disease and further development of the algorithm is needed.", {"entities": []}], ["www.clinicaltrials.gov (NCT01228708)", {"entities": []}], ["Although outdoor particulate matter (PM) has been linked to mortality and asthma morbidity, the impact of indoor PM on asthma has not been well established.", {"entities": [[74, 80, "DISEASE"], [119, 125, "DISEASE"]]}], ["This study was designed to investigate the effect of in-home PM on asthma morbidity.", {"entities": [[67, 73, "DISEASE"]]}], ["For a cohort of 150 asthmatic children (2\u20136 years of age) from Baltimore, Maryland, a technician deployed environmental monitoring equipment in the children\u2019s bedrooms for 3-day intervals at baseline and at 3 and 6 months.", {"entities": []}], ["Caregivers completed questionnaires and daily diaries during air sampling.", {"entities": []}], ["Longitudinal data analyses included regression models with generalized estimating equations.", {"entities": []}], ["Children were primarily African Americans (91%) from lower socioeconomic backgrounds and spent most of their time in the home.", {"entities": []}], ["Mean (\u00b1 SD) indoor PM 2.5\u201310 (PM with aerodynamic diameter 2.5\u201310 \u03bcm) and PM 2.5 (aerodynamic diameter < 2.5 \u03bcm) concentrations were 17.4 \u00b1 21.0 and 40.3 \u00b1 35.4 \u03bcg/m 2.5\u201310 and PM 2.5 were associated with increased incidences of asthma symptoms: 6% [95% confidence interval (CI), 1 to 12%] and 3% (95% CI, \u20131 to 7%), respectively; symptoms causing children to slow down: 8% (95% CI, 2 to 14%) and 4% (95% CI, 0 to 9%), respectively; nocturnal symptoms: 8% (95% CI, 1 to 14%) and 6% (95% CI, 1 to 10%), respectively; wheezing that limited speech: 11% (95% CI, 3 to 19%) and 7% (95% CI, 0 to 14%), respectively; and use of rescue medication: 6% (95% CI, 1 to 10%) and 4% (95% CI, 1 to 8%), respectively.", {"entities": [[229, 235, "DISEASE"]]}], ["Increases of 10 \u03bcg/m 2.5 were associated with 7% (95% CI, 2 to 11%) and 26% (95% CI, 1 to 52%) increases in exercise-related symptoms, respectively.", {"entities": []}], ["Among preschool asthmatic children in Baltimore, increases in in-home PM 2.5\u201310 and PM 2.5 were associated with respiratory symptoms and rescue medication use.", {"entities": []}], ["Increases in in-home and ambient PM 2.5 were associated with exercise-related symptoms.", {"entities": []}], ["Although reducing PM outdoors may decrease asthma morbidity, reducing PM indoors, especially in homes of inner-city children, may lead to improved asthma health.", {"entities": [[43, 49, "DISEASE"], [147, 153, "DISEASE"]]}], ["Air pollution in Beijing, especially PM 2.5, has received increasing attention in the past years.", {"entities": []}], ["Despite Beijing being one of the most polluted cities in the world, there has still been a lack of quantitative research regarding the health impact of PM 2.5 on the impact of diseases in Beijing.", {"entities": []}], ["In this study, we aimed to characterize temporal pattern of PM 2.5 and its potential association with human influenza in Beijing.", {"entities": [[108, 117, "DISEASE"]]}], ["Based on the data collected on hourly ambient PM 2.5 from year 2008 to 2013 and on monthly human influenza cases from 2008 and 2011, we investigated temporal patterns of PM 2.5 over the five-year period and utilized the wavelet approach to exploring the potential association between PM 2.5 and influenza.", {"entities": [[97, 106, "DISEASE"], [295, 304, "DISEASE"]]}], ["Our results found that ambient PM 2.5 pollution was severe in Beijing with PM 2.5 concentrations being significantly higher than the standards of the World Health Organization, the US EPA, and the Chinese EPA in the majority of days during the study period.", {"entities": []}], ["Furthermore, PM 2.5 concentrations in the winter heating seasons were higher than those in non-heating seasons despite high variations.", {"entities": []}], ["We also found significant association between ambient PM 2.5 peak and human influenza case increase with a delayed effect (e.g.", {"entities": [[76, 85, "DISEASE"]]}], ["delayed effect of PM 2.5 on influenza).", {"entities": [[28, 37, "DISEASE"]]}], ["Ambient PM 2.5 concentrations were significantly associated with human influenza cases in Beijing, which have important implications for public health and environmental actions.", {"entities": [[71, 80, "DISEASE"]]}], ["CXCL12 (stromal cell-derived factor-1, SDF-1) is a potent chemokine for homing of CXCR4", {"entities": [[0, 6, "GENE"], [82, 87, "GENE"]]}], ["Background .", {"entities": []}], ["Management of individual triggers is suboptimal in practice.", {"entities": []}], ["In this project, we investigated the impact of symptom perception interventions on asthma trigger identification and self-reported asthma quality of life.", {"entities": [[83, 89, "DISEASE"], [131, 137, "DISEASE"]]}], ["Children with asthma ( n = 227) participated in three asthma education sessions and then were randomized first to one of three home monitoring conditions (symptom monitoring and peak flow training with feedback, peak flow training without feedback, or no peak flow training) and then subsequently to one of three resistive load discrimination training conditions (signal detection training with feedback, signal detection training without feedback, or no training).", {"entities": [[14, 20, "DISEASE"], [54, 60, "DISEASE"]]}], ["Triggers were reported at enrollment, following home monitoring, and following discrimination training; quality of life was measured after home monitoring and after resistive load testing.", {"entities": []}], ["Symptom perception interventions resulted in increases in reported triggers, which increased reliably as a function of home monitoring, and increased further in participants who completed discrimination training with feedback.", {"entities": []}], ["Increases in the number of reported asthma triggers were associated with decreases in quality of life.", {"entities": [[36, 42, "DISEASE"]]}], ["Discussion .", {"entities": []}], ["Patients may benefit from strategies that make trigger-symptom contingencies clear.", {"entities": []}], ["Complementary strategies are needed to address changes in the perceived burden of asthma which comes from awareness of new asthma triggers.", {"entities": [[82, 88, "DISEASE"], [123, 129, "DISEASE"]]}], ["Over the past decade, a rapidly expanding body of literature has demonstrated the existence of disparities in health and health care.", {"entities": []}], ["While consensus has not emerged regarding the causes of disparities, they are generally thought to be related to sociocultural, behavioral, economic, environmental, biologic, or societal factors.", {"entities": []}], ["To effectively address disparities, several authorities have suggested the need for greater information technology research and investments.", {"entities": []}], ["eHealth researchers may be able to make significant contributions in this area through research and its applications.", {"entities": []}], ["This paper begins with a historical overview of health disparities in the United States and Europe.", {"entities": []}], ["It then discusses the role that the Internet, and access to the Internet, may play in the genesis of health disparities.", {"entities": []}], ["Finally, this paper closes with a discussion of the potential benefits of eHealth applications and the possible contributions of the field to overcoming disparities in health and health care.", {"entities": []}], ["Multimorbidity is one of the most important and challenging aspects in public health.", {"entities": []}], ["Multimorbid people are associated with more hospital admissions, a large number of drug prescriptions and higher risks of mortality.", {"entities": []}], ["As there is evidence that multimorbidity varies with age and socioeconomic disparity, the main objective aimed at determining age-specific prevalence rates as well as exploring educational differences relating to multimorbidity in Germany.", {"entities": []}], ["This cross-sectional analysis is based on the national telephone health interview survey \u201cGerman Health Update\u201d (GEDA2012) conducted between March 2012 and March 2013 with nearly 20,000 adults.", {"entities": []}], ["GEDA2012 provides information on 17 self-reported health conditions along with sociodemographic characteristics.", {"entities": []}], ["Multimorbidity was defined as the occurrence of two or more chronic conditions in one individual at the same time.", {"entities": []}], ["Descriptive statistical analysis was used to examine multimorbidity according to age and education, which was defined by the International Standard Classification of Education (ISCED 1997).", {"entities": []}], ["Overall, 39.6% (95% confidence interval (CI) 38.7%\u201340.6%) of the 19,294 participants were multimorbid and the proportion of adults with multimorbidity increased substantially with age: nearly half (49.2%, 95% CI 46.9%\u201351.5%) of the adults aged 50\u201359\u00a0years had already two or more chronic health conditions.", {"entities": []}], ["Prevalence rates of multimorbidity differed considerably between the levels of education.", {"entities": []}], ["Low-level educated adults aged 40\u201349\u00a0years were more likely to be multimorbid with a prevalence rate of 47.4% (95% CI 44.2%\u201350.5%) matching those of highly educated men and women aged about ten years older.", {"entities": []}], ["Our findings demonstrate that both, age and education are associated with a higher risk of being multimorbid in Germany.", {"entities": []}], ["Hence, special emphasis in the development of new approaches in national public health and prevention programs on multimorbidity should be given to low-level educated people aged <65\u00a0years.", {"entities": []}], ["The online version of this article (10.1186/s12889-017-4833-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Non-protective work practices followed by farm workers during spraying of pesticides lead to occupational exposure among them.", {"entities": []}], ["This study is designed to explore the respiratory health and hematological profile of agricultural workers occupationally exposed to OP pesticides.", {"entities": []}], ["A cross sectional study was undertaken among 166 pesticide sprayers working in mango orchards of Lucknow district in North India compared with 77 controls to assess the respiratory illness, lung functions, cholinesterase levels and hematological profile.", {"entities": []}], ["A questionnaire based survey and clinical examination for respiratory health were conducted among study subjects.", {"entities": []}], ["Lung function test was conducted among study subjects by using spirometer.", {"entities": []}], ["Cholinesterase level as biomarker of OP pesticides and hematological profile of study subjects were investigated in the laboratory by following the standard protocols.", {"entities": []}], ["Overall respiratory morbidity observed among exposed subjects was 36.75%.", {"entities": []}], ["Symptoms for respiratory illness like dry cough, productive cough, wheezing, irritation of throat and blood stained sputum were found to be significantly more (p<0.05) among pesticide sprayers than controls.", {"entities": []}], ["Lung function parameters viz.", {"entities": []}], ["PEFR, FEV 1 , %PEFR predicted, %FEV 1 predicted and FEV 1 /FVC were found to be significantly decreased (p<0.05) among pesticide sprayers as compared to controls.", {"entities": [[6, 9, "GENE"], [32, 35, "GENE"], [52, 55, "GENE"], [6, 9, "GENE"], [32, 35, "GENE"], [52, 55, "GENE"], [6, 9, "GENE"], [32, 35, "GENE"], [52, 55, "GENE"]]}], ["Exposure wise distribution of respiratory illness and lung functions among pesticide sprayers show that the exposure duration significantly elevates (p<0.05) the respiratory problems and significantly decreases (p<0.001) lung functions among pesticide sprayers.", {"entities": []}], ["Activities of acetylcholinesterase and butyrylcholinesterase were found to be significantly depleted (p<0.001) among pesticide sprayers as compared to controls which show the exposure of OP pesticides among them.", {"entities": []}], ["The hematological profile viz.", {"entities": []}], ["RBC, WBC, monocytes, neutrophils, MCV, MCH, MCHC and platelet count were significantly altered (p<0.001) in pesticide sprayers than controls.", {"entities": []}], ["This study shows that the unsafe occupational exposure of OP pesticides causes respiratory illness, decreased lung functions and hematological alterations among pesticide sprayers.", {"entities": []}], ["Medication errors are an important cause of morbidity and mortality in primary care.", {"entities": []}], ["The aims of this study are to determine the effectiveness, cost effectiveness and acceptability of a pharmacist-led information-technology-based complex intervention compared with simple feedback in reducing proportions of patients at risk from potentially hazardous prescribing and medicines management in general (family) practice.", {"entities": []}], ["Research subject group : \"At-risk\" patients registered with computerised general practices in two geographical regions in England.", {"entities": []}], ["Design : Parallel group pragmatic cluster randomised trial.", {"entities": []}], ["Interventions : Practices will be randomised to either: (i) Computer-generated feedback; or (ii) Pharmacist-led intervention comprising of computer-generated feedback, educational outreach and dedicated support.", {"entities": []}], ["Primary outcome measures : The proportion of patients in each practice at six and 12 months post intervention: - with a computer-recorded history of peptic ulcer being prescribed non-selective non-steroidal anti-inflammatory drugs - with a computer-recorded diagnosis of asthma being prescribed beta-blockers - aged 75 years and older receiving long-term prescriptions for angiotensin converting enzyme inhibitors or loop diuretics without a recorded assessment of renal function and electrolytes in the preceding 15 months.", {"entities": [[149, 161, "DISEASE"], [271, 277, "DISEASE"]]}], ["Secondary outcome measures ; These relate to a number of other examples of potentially hazardous prescribing and medicines management.", {"entities": []}], ["Economic analysis : An economic evaluation will be done of the cost per error avoided, from the perspective of the UK National Health Service (NHS), comparing the pharmacist-led intervention with simple feedback.", {"entities": [[143, 146, "GENE"]]}], ["Qualitative analysis : A qualitative study will be conducted to explore the views and experiences of health care professionals and NHS managers concerning the interventions, and investigate possible reasons why the interventions prove effective, or conversely prove ineffective.", {"entities": [[131, 134, "GENE"]]}], ["Sample size : 34 practices in each of the two treatment arms would provide at least 80% power (two-tailed alpha of 0.05) to demonstrate a 50% reduction in error rates for each of the three primary outcome measures in the pharmacist-led intervention arm compared with a 11% reduction in the simple feedback arm.", {"entities": []}], ["At the time of submission of this article, 72 general practices have been recruited (36 in each arm of the trial) and the interventions have been delivered.", {"entities": []}], ["Analysis has not yet been undertaken.", {"entities": []}], ["Current controlled trials ISRCTN21785299", {"entities": []}], ["Epithelia function as barriers against environmental insults and express the transcription factor aryl hydrocarbon receptor (AhR).", {"entities": [[125, 128, "GENE"]]}], ["However, AhR function in these tissues is unknown.", {"entities": [[9, 12, "GENE"]]}], ["Here we show that AhR regulates multiciliogenesis in both murine airway epithelia and in Xenopus laevis epidermis.", {"entities": [[18, 21, "GENE"]]}], ["In air-exposed airway epithelia, induction of factors required for multiciliogenesis, including cyclin O (Ccno) and Multicilin (Mcidas), is AhR dependent, and air exposure induces AhR binding to the Ccno promoter.", {"entities": [[106, 110, "GENE"], [199, 203, "GENE"], [140, 143, "GENE"], [180, 183, "GENE"], [140, 143, "GENE"], [180, 183, "GENE"], [106, 110, "GENE"], [199, 203, "GENE"]]}], ["Submersion and hypoxic conditions impede AhR-dependent Ccno induction.", {"entities": [[55, 59, "GENE"]]}], ["This is mediated by the persistence of Notch signalling, as Notch blockade renders multiciliogenesis and Ccno induction by AhR independent from air exposure.", {"entities": [[105, 109, "GENE"], [123, 126, "GENE"]]}], ["In contrast to Ccno induction, air exposure does not induce the canonical AhR target cytochrome P450 1a1 ( Cyp1a1 ).", {"entities": [[15, 19, "GENE"], [74, 77, "GENE"], [107, 113, "GENE"]]}], ["Inversely, exposure to AhR ligands induces Cyp1a1 but not Ccno and impeded ciliogenesis.", {"entities": [[23, 26, "GENE"], [43, 49, "GENE"], [58, 62, "GENE"]]}], ["These data indicate that AhR involvement in detoxification of environmental pollutants may impede its physiological role, resulting in respiratory pathology.", {"entities": [[25, 28, "GENE"]]}], ["Epithelia are barriers against environmental insults and express the transcription factor aryl hydrocarbon receptor (AhR).", {"entities": [[117, 120, "GENE"]]}], ["Here the authors show that AhR regulates multiciliogenesis via cyclin O and Multicilin in a Notch-dependent manner and that this is blocked by toxic ligands.", {"entities": [[27, 30, "GENE"]]}], ["Genetic variants within the endothelin-1 gene ( EDN1 ) have been associated with several cardiovascular diseases and may act as genetic prognostic markers.", {"entities": [[48, 52, "GENE"]]}], ["Here, we explored the overall relevance of EDN1 polymorphisms for long-term survival in patients undergoing on-pump cardiac surgery.", {"entities": [[43, 47, "GENE"]]}], ["A prospectively collected cohort of 455 Caucasian patients who underwent cardiac surgery with cardiopulmonary bypass was followed up for 5 years.", {"entities": []}], ["The obtained genotypes and inferred haplotypes were analyzed for their associations with the five-year mortality rate (primary endpoint).", {"entities": []}], ["The EDN1 T-1370G and K198N genotype distributions did not deviate from Hardy\u2013Weinberg equilibrium and the major allele frequencies were 83% and 77%, respectively.", {"entities": [[4, 8, "GENE"]]}], ["The cardiovascular risk factors were equally distributed in terms of the different genotypes and haplotypes associated with the two polymorphisms.", {"entities": []}], ["The five-year mortality rate did not differ among the different EDN1 T-1370G and K198N genotypes and haplotypes.", {"entities": [[64, 68, "GENE"]]}], ["Haplotype analysis revealed that carriers of the G-T (compound EDN1 T-1370G G/K198N T) haplotype had a higher cardiac index than did non-carriers (p = 0.0008); however, this difference did not reach significance after adjusting for multiple testing.", {"entities": [[63, 67, "GENE"]]}], ["The results indicate that common variations in EDN1 do not act as prognostic markers for long-term survival in patients undergoing on-pump cardiac surgery.", {"entities": [[47, 51, "GENE"]]}], ["In primary care and epidemiological studies of chronic rhinosinusitis (CRS), symptom-based diagnosis is common, yet limited, because endoscopic and radiological signs are not considered.", {"entities": []}], ["To evaluate the correlation between symptoms and objective findings of CRS to improve its symptom-based diagnosis for primary care and epidemiological studies by using data from a large-scale nationwide epidemiological study, the Korean National Health and Nutrition Examination Survey (KNHANES).", {"entities": []}], ["Cross-sectional study.", {"entities": []}], ["Data from 2008 to 2012 KNHANES.", {"entities": []}], ["29\u2005225 Adults aged >19\u2005years.", {"entities": []}], ["Questionnaires targeted two major (nasal blockage and anterior/posterior nasal drip) and two minor (facial pain/pressure and reduction or loss of smell) symptoms.", {"entities": []}], ["Nasal polyps or mucopurulent discharge from the middle meatus was defined as positive endoscopic findings for diagnosing CRS.", {"entities": []}], ["Of the four symptoms, reduction or loss of smell was the symptom most significantly related to positive endoscopic findings in multivariable analysis (OR=1.936 (95% CI 1.604 to 2.337)).", {"entities": []}], ["The combinations of symptoms showed higher ORs than individual symptoms and combinations of reduction or loss of smell with other symptoms were statistically more reliable for positive endoscopic findings than other combinations.", {"entities": []}], ["Our results show that reduction or loss of smell was the symptom most significantly related to positive nasal endoscopic findings.", {"entities": []}], ["Therefore, symptom-based diagnosis of CRS can be improved by considering reduction or loss of smell as an important symptom for positive endoscopic findings of CRS.", {"entities": []}], ["The physics of tightly packed structures of a wire and other threadlike materials confined in cavities has been explored in recent years in connection with crumpled systems and a number of topics ranging from applications to DNA packing in viral capsids and surgical interventions with catheter to analogies with the electron gas at finite temperature and with theories of two-dimensional quantum gravity.", {"entities": []}], ["When a long piece of wire is injected into two-dimensional cavities, it bends and originates in the jammed limit a series of closed structures that we call loops.", {"entities": []}], ["In this work we study the extraction of a crumpled tightly packed wire from a circular cavity aiming to remove loops individually.", {"entities": []}], ["The size of each removed loop, the maximum value of the force needed to unpack each loop, and the total length of the extracted wire were measured and related to an exponential growth and a mean field model consistent with the literature of crumpled wires.", {"entities": []}], ["Scaling laws for this process are reported and the relationship between the processes of packing and unpacking of wire is commented upon.", {"entities": []}], ["Cooking fumes contain aldehydes, alkanoic acids, polycyclic aromatic hydrocarbons, and heterocyclic compounds.", {"entities": []}], ["The inhalation of cooking fumes entails a risk of deleterious health effects.", {"entities": []}], ["The aim of this study was to see if the inhalation of cooking fumes alters the expression of inflammatory reactions in the bronchial mucosa and its subsequent systemic inflammatory response in blood biomarkers.", {"entities": []}], ["Twenty-four healthy volunteers stayed in a model kitchen on two different occasions for 2 or 4h.", {"entities": []}], ["On the first occasion, there was only exposure to normal air, and on the second, there was exposure to controlled levels of cooking fumes.", {"entities": []}], ["On each occasion, samples of blood, exhaled air, and exhaled breath condensate (EBC) were taken three times in 24h and inflammatory markers were measured from all samples.", {"entities": []}], ["There was an increase in the concentration of the d -dimer in blood from 0.27 to 0.28mg ml P- value = 0.004).", {"entities": []}], ["There was also a trend of an increase in interleukin (IL)-6 in blood, ethane in exhaled air, and IL-1\u03b2 in EBC after exposure to cooking fumes.", {"entities": []}], ["In a sub-analysis of 12 subjects, there was also an increase in the levels of ethane\u2014from 2.83 parts per billion (ppb) on the morning before exposure to cooking fumes to 3.53 ppb on the morning after exposure ( P = 0.013)\u2014and IL-1\u03b2\u2014from 1.04 on the morning before exposure to cooking fumes to 1.39 pg ml P = 0.024).", {"entities": []}], ["In our experimental setting, we were able to unveil only small changes in the levels of inflammatory markers in exhaled air and in blood after short-term exposure to moderate concentrations of cooking fumes.", {"entities": []}], ["Pollen is one of the primary causes of allergic rhinoconjunctivitis in urban centers.", {"entities": []}], ["In the present study, the concentrations of 39 different pollens in the Santiago de Chile metropolitan area over the period 2009\u20132013 are characterized.", {"entities": []}], ["The pollen was monitored daily using Burkard volumetric equipment.", {"entities": []}], ["The contribution of each type of pollen and the corresponding time trends are evaluated.", {"entities": []}], ["The concentrations of the pollens are compared with the established threshold levels for the protection of human health.", {"entities": []}], ["The results show that the total amount of pollen grains originating from trees, grasses, weeds and indeterminate sources throughout the period of the study was 258,496 grains m-3, with an annual average of 51,699 \u00b1 3,906 grains m-3 year-1.", {"entities": []}], ["The primary source of pollen is Platanus orientalis, which produces 61.8% of the analyzed pollen.", {"entities": []}], ["Grass pollen is the third primary component of the analyzed pollen, with a contribution of 5.82%.", {"entities": []}], ["Among the weeds, the presence of Urticacea (3.74%) is remarkable.", {"entities": []}], ["The pollination pattern of the trees is monophasic, and the grasses have a biphasic pattern.", {"entities": []}], ["The trends indicate that the total pollen and tree pollen do not present a time trend that is statistically significant throughout the period of the study, whereas the grass pollen and weed pollen concentrations in the environment present a statistically significant decreasing trend.", {"entities": []}], ["The cause of this decrease is unclear.", {"entities": []}], ["The pollen load has doubled over the past decade.", {"entities": []}], ["When the observed concentrations of the pollens were compared with the corresponding threshold levels, the results indicated that over the period of the study, the pollen concentrations were at moderate, high and very high levels for an average of 293 days per year.", {"entities": []}], ["Systematic counts of the pollen grains are an essential method for diagnosing and treating patients with pollinosis and for developing forestation and urban planning strategies.", {"entities": []}], ["One of the most referenced theoretical frameworks to measure Health Related Quality of Life (HRQoL) is the Wilson and Cleary framework.", {"entities": []}], ["With some adaptions this framework has been validated in the adult population, but has not been tested in pediatric populations.", {"entities": []}], ["Our goal was to empirically investigate it in children.", {"entities": []}], ["The contributory factors to Health Related Quality of Life that we included were symptom status (presence of chronic disease or hospitalizations), functional status (developmental status), developmental aspects of the individual (social-emotional) behavior, and characteristics of the social environment (socioeconomic status and area of education).", {"entities": []}], ["Structural equation modeling was used to assess the measurement structure of the model in 214 German children (3\u20135 years old) participating in a follow-up study that investigates pediatric health outcomes.", {"entities": []}], ["Model fit was \u03c72\u200a=\u200a5.5; df\u200a=\u200a6; p\u200a=\u200a0.48; SRMR \u200a=\u200a0.01.", {"entities": []}], ["The variance explained of Health Related Quality of Life was 15%.", {"entities": []}], ["Health Related Quality of Life was affected by the area education (i.e.", {"entities": []}], ["where kindergartens were located) and development status.", {"entities": []}], ["Developmental status was affected by the area of education, socioeconomic status and individual behavior.", {"entities": []}], ["Symptoms did not affect the model.", {"entities": []}], ["The goodness of fit and the overall variance explained were good.", {"entities": []}], ["However, the results between children' and adults' tests differed and denote a conceptual gap between adult and children measures.", {"entities": []}], ["Indeed, there is a lot of variety in pediatric Health Related Quality of Life measures, which represents a lack of a common definition of pediatric Health Related Quality of Life.", {"entities": []}], ["We recommend that researchers invest time in the development of pediatric Health Related Quality of Life theory and theory based evaluations.", {"entities": []}], ["Mucolytics can improve disease outcome in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).", {"entities": [[79, 116, "DISEASE"]]}], ["The objectives of this study were to investigate the effects of erdosteine (ER), a mucolytic agent with antioxidant activity, on systemic inflammation, symptoms, recurrence of exacerbation, and time to first exacerbation postdischarge in hospitalized patients with AECOPD.", {"entities": []}], ["Patients admitted to hospital with AECOPD were randomized to receive either ER 900 mg daily (n=20) or a matching control (n=20).", {"entities": []}], ["Treatment was continued for 10 days until discharge.", {"entities": []}], ["Patients also received standard treatment with steroids, nebulized bronchodilators, and antibiotics as appropriate.", {"entities": []}], ["Serum C-reactive protein levels, lung function, and breathlessness\u2013cough\u2013sputum scale were measured on hospital admission and thereafter at days 10 and 30 posttreatment.", {"entities": []}], ["Recurrence of AECOPD-requiring antibiotics and/or oral steroids and time to first exacerbation in the 2 months (days 30 and 60) postdischarge were also assessed.", {"entities": []}], ["Mean serum C-reactive protein levels were lower in both groups at days 10 and 30, compared with those on admission, with significantly lower levels in the ER group at day 10.", {"entities": []}], ["Improvements in symptom score and forced expiratory volume in 1 second were greater in the ER than the control group, which reached statistical significance on day 10.", {"entities": []}], ["ER was associated with a 39% lower risk of exacerbations and a significant delay in time to first exacerbation (log-rank test P =0.009 and 0.075 at days 30 and 60, respectively) compared with controls.", {"entities": []}], ["Results confirm that the addition of ER (900 mg/d) to standard treatment improves outcomes in patients with AECOPD.", {"entities": []}], ["ER significantly reduced airway inflammation, improved the symptoms of AECOPD, and prolonged time to first exacerbation.", {"entities": []}], ["The authors suggest ER could be most beneficial in patients with recurring, prolonged, and/or severe exacerbations of COPD.", {"entities": []}], ["Clinically significant psychological distress in pregnancy is common, with epidemiological research suggesting that between 15 and 25\u00a0% of pregnant women experience elevated symptoms of stress, anxiety, and depression.", {"entities": []}], ["Untreated psychological distress in pregnancy is associated with poor obstetrical outcomes, changes in maternal physiology, elevated incidence of child physical and psychological disorders, and is predictive of maternal postpartum mood disorders.", {"entities": []}], ["Despite the wide-ranging impact of antenatal psychological distress on mothers and their children, there is a gap in our knowledge about the most effective treatments that are available for psychological distress experienced in pregnancy.", {"entities": []}], ["Additionally, no trials have focused on potential physiological changes that may occur as a result of receiving mindfulness training in pregnancy.", {"entities": []}], ["The proposed trial will determine the effectiveness of an 8-week modified Mindfulness-based Cognitive Therapy (MBCT) intervention delivered during pregnancy.", {"entities": []}], ["A randomized controlled trial (RCT) design with repeated measures will be used to evaluate the effectiveness of MBCT to treat psychological distress in pregnancy.", {"entities": []}], ["A sample of 60 consenting pregnant women aged 18\u00a0years and above will be enrolled and randomized to the experimental (MBCT) or control (treatment as usual) condition.", {"entities": []}], ["Primary (e.g., symptoms of stress, depression, and anxiety), secondary (cortisol, blood pressure (BP), heart rate variability (HRV), and sleep) and other outcome data (e.g., psychological diagnoses) will be collected via a combination of laboratory visits and at-home assessments from both groups at baseline (T 1 ), immediately following the intervention (T 2 ), and at 3\u00a0months postpartum (T 3 ).", {"entities": []}], ["Descriptive statistics will be used to describe sample characteristics.", {"entities": []}], ["Data will be analyzed using an intention-to-treat approach.", {"entities": []}], ["Hierarchical linear models will be used to test intervention effects on primary and secondary outcomes.", {"entities": []}], ["The trial is expected to improve knowledge about evidence-based treatments for psychological distress experienced in pregnancy and to evaluate the potential impact of mindfulness-based interventions on maternal physiology.", {"entities": []}], ["ClinicalTrials.gov: NCT02214732 , registered on 7 August 2014.", {"entities": []}], ["Protocol Version 2.0., 5 September 2016.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-016-1601-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In the latter part of a large hospital case-control study of the relationship of type of cigarette smoked to risk of various smoking-associated diseases, patients answered questions on the smoking habits of their first spouse and on the extent of passive smoke exposure at home, at work, during travel and during leisure.", {"entities": []}], ["In an extension of this study an attempt was made to obtain smoking habit data directly from the spouses of all lifelong non-smoking lung cancer cases and of two lifelong non-smoking matched controls for each case.", {"entities": [[133, 144, "DISEASE"], [138, 144, "DISEASE"]]}], ["The attempt was made regardless of whether the patients had answered passive smoking questions in hospital or not.", {"entities": []}], ["Amongst lifelong non-smokers, passive smoking was not associated with any significant increase in risk of lung cancer, chronic bronchitis, ischaemic heart disease or stroke in any analysis.", {"entities": [[106, 117, "DISEASE"], [149, 162, "DISEASE"], [111, 117, "DISEASE"], [127, 137, "DISEASE"]]}], ["Limitations of past studies on passive smoking are discussed and the need for further research underlined.", {"entities": []}], ["From all the available evidence, it appears that any effect of passive smoke on risk of any of the major diseases that have been associated with active smoking is at most small, and may not exist at all.", {"entities": []}], ["The mechanism by which fibrogenic particulates induce inflammation that can progress to lung fibrosis is uncertain.", {"entities": []}], ["The alveolar macrophage (AM) has been implicated in the inflammatory process because of its function and reported release of inflammatory mediators when isolated from fibrotic patients.", {"entities": []}], ["It has been recently shown that fibrogenic, but not nonfibrogenic, particulates are highly potent in inducing apoptosis of human AM.", {"entities": []}], ["In this study, we tested the hypothesis that fibrogenic particulates could shift the phenotypic ratio of human AM to a more inflammatory condition.", {"entities": []}], ["The macrophage phenotypes were characterized by flow cytometry targeting the RFD1 and RFD7 epitopes.", {"entities": []}], ["Results demonstrated that chrysotile and crocidolite asbestos, as well as crystalline silica, but not titanium dioxide or wollastonite, increased the RFD1+ phenotype (inducer or immune activator macrophages) and decreased the RFD1+ RFD7+ phenotype (suppressor macrophages).", {"entities": []}], ["These results provide a mechanistic explanation that may link apoptosis (namely, suppressor macrophages) to a shift in the ratio of macrophage phenotypes that could initiate lung inflammation.", {"entities": []}], ["Patient safety may be enhanced by using reports from front-line staff of near misses and unsafe conditions to identify latent safety events.", {"entities": []}], ["We describe paediatric emergency department (ED) near-miss events and unsafe conditions from hospital reporting systems in a 1-year observational study from hospitals participating in the Pediatric Emergency Care Applied Research Network (PECARN).", {"entities": []}], ["This is a secondary analysis of 1\u2005year of incident reports (IRs) from 18 EDs in 2007\u20132008.", {"entities": []}], ["Using a prior taxonomy and established method, this analysis is of all reports classified as near-miss (events not reaching the patient) or unsafe condition.", {"entities": []}], ["Classification included type, severity, contributing factors and personnel involved.", {"entities": []}], ["In-depth review of 20% of IRs was performed.", {"entities": []}], ["487 reports (16.8% of eligible IRs) are included.", {"entities": []}], ["Most common were medication-related, followed by laboratory-related, radiology-related and process-related IRs.", {"entities": []}], ["Human factors issues were related to 87% and equipment issues to 11%.", {"entities": []}], ["Human factor issues related to non-compliance with procedures accounted for 66.4%, including 5.95% with no or incorrect ID.", {"entities": []}], ["Handoff issues were important in 11.5%.", {"entities": []}], ["Medication and process-related issues are important causes of near miss and unsafe conditions in the network.", {"entities": []}], ["Human factors issues were highly reported and non-compliance with established procedures was very common, and calculation issues, communications (ie, handoffs) and clinical judgment were also important.", {"entities": []}], ["This work should enable us to help improve systems within the environment of the ED to enhance patient safety in the future.", {"entities": []}], ["Little is known about how the proportions of dependency states have changed between generational cohorts of older people.", {"entities": []}], ["We aimed to estimate years lived in different dependency states at age 65 years in 1991 and 2011, and new projections of future demand for care.", {"entities": []}], ["In this population-based study, we compared two Cognitive Function and Ageing Studies (CFAS I and CFAS II) of older people (aged \u226565 years) who were permanently registered with a general practice in three defined geographical areas (Cambridgeshire, Newcastle, and Nottingham; UK).", {"entities": []}], ["These studies were done two decades apart (1991 and 2011).", {"entities": []}], ["General practices provided lists of individuals to be contacted and were asked to exclude those who had died or might die over the next month.", {"entities": []}], ["Baseline interviews were done in the community and care homes.", {"entities": []}], ["Participants were stratified by age, and interviews occurred only after written informed consent was obtained.", {"entities": []}], ["Information collected included basic sociodemographics, cognitive status, urinary incontinence, and self-reported ability to do activities of daily living.", {"entities": []}], ["CFAS I was assigned as the 1991 cohort and CFAS II as the 2011 cohort, and both studies provided prevalence estimates of dependency in four states: high dependency (24-h care), medium dependency (daily care), low dependency (less than daily), and independent.", {"entities": []}], ["Years in each dependency state were calculated by Sullivan's method.", {"entities": []}], ["To project future demands for social care, the proportions in each dependency state (by age group and sex) were applied to the 2014 England population projections.", {"entities": []}], ["Between 1991 and 2011, there were significant increases in years lived from age 65 years with low dependency (1\u00b77 years [95% CI 1\u00b70\u20132\u00b74] for men and 2\u00b74 years [1\u00b78\u20133\u00b71] for women) and increases with high dependency (0\u00b79 years [0\u00b72\u20131\u00b77] for men and 1\u00b73 years [0\u00b75\u20132\u00b71] for women).", {"entities": []}], ["The majority of men's extra years of life were spent independent (36\u00b73%) or with low dependency (36\u00b73%) whereas for women the majority were spent with low dependency (58\u00b70%), and only 4\u00b78% were independent.", {"entities": []}], ["There were substantial reductions in the proportions with medium and high dependency who lived in care homes, although, if these dependency and care home proportions remain constant in the future, further population ageing will require an extra 71\u2008215 care home places by 2025.", {"entities": []}], ["On average older men now spend 2\u00b74 years and women 3\u00b70 years with substantial care needs, and most will live in the community.", {"entities": []}], ["These findings have considerable implications for families of older people who provide the majority of unpaid care, but the findings also provide valuable new information for governments and care providers planning the resources and funding required for the care of their future ageing populations.", {"entities": []}], ["Medical Research Council (G9901400) and (G06010220), with support from the National Institute for Health Research Comprehensive Local research networks in West Anglia and Trent, UK, and Neurodegenerative Disease Research Network in Newcastle, UK.", {"entities": []}], ["Primary pulmonary choriocarcinoma (PPC) is extremely rare, especially in males.", {"entities": [[18, 33, "DISEASE"]]}], ["It is characterized by a poor response to therapy and shortened survival times.", {"entities": []}], ["Here, we report a successful diagnosis and modified treatment for PPC in a male and a review of the literature.", {"entities": []}], ["This case report describes a 67-year-old male who was discovered to have a left pulmonary mass.", {"entities": []}], ["The patient underwent a pulmonary lobectomy.", {"entities": []}], ["Pathological examination showed a poorly biphasic differential tumor.", {"entities": []}], ["Immunostaining displayed that beta-human chorionic gonadotropin (\u03b2-HCG), CD10, and GATA3 were positive, and the increase of postoperative serum \u03b2-HCG secretion was also confirmed.", {"entities": [[83, 88, "GENE"]]}], ["Systemic and genital screening was performed, but other abnormal findings were not observed.", {"entities": []}], ["The diagnosis of PPC was confirmed.", {"entities": []}], ["Then, the patient received 4 cycles of modified chemotherapy according the condition of his body.", {"entities": []}], ["The patient has been alive for >13 months without recurrence, and the level of serum \u03b2-HCG has already decreased to normal.", {"entities": []}], ["In addition to reporting this case, we have also summarized the similar previously published cases.", {"entities": []}], ["Currently, there is no standard treatment for PPC.", {"entities": []}], ["A rapid and correct diagnosis is necessary.", {"entities": []}], ["Surgery and modified chemotherapy, based on the physical condition of the patient, may currently be the best therapy for PPC.", {"entities": []}], ["The aim of our study was to determine whether some bacterial components as well as some proinflammatory cytokines can affect surface mast cell levels.", {"entities": []}], ["By the use of flow cytometry technique, we documented that freshly isolated mature rat peritoneal mast cells do express surface TLR2 and TLR4 protein, but not CD14 molecules, and respond to stimulation with TLR2 and TLR4 ligands by cysteinyl leukotriene generation.", {"entities": [[128, 132, "GENE"], [207, 211, "GENE"], [137, 141, "GENE"], [216, 220, "GENE"], [159, 163, "GENE"], [128, 132, "GENE"], [207, 211, "GENE"], [137, 141, "GENE"], [216, 220, "GENE"]]}], ["The level of TLR2 protein is modulated by PGN and CCL5 treatment, but not by LPS, LAM, TNF, or IL-6.", {"entities": [[13, 17, "GENE"], [50, 54, "GENE"], [87, 90, "GENE"]]}], ["Surface mast cell TLR4 expression is affected by LPS, LAM, IL-6, and CCL5.", {"entities": [[18, 22, "GENE"], [69, 73, "GENE"]]}], ["Considering that TLR-mediated activation conditions not only engaged these cells in antibacterial defense and development of inflammation but also might influence allergic processes, our observations that surface TLR2 and TLR4 expression can be regulated both bacterial components and proinflammatory cytokines seem to be very intriguing and importance.", {"entities": [[213, 217, "GENE"], [222, 226, "GENE"]]}], ["The Canadian Healthy Infant Longitudinal Development birth cohort was designed to elucidate interactions between environment and genetics underlying development of asthma and allergy.", {"entities": [[164, 170, "DISEASE"]]}], ["Over 3600 pregnant mothers were recruited from the general population in four provinces with diverse environments.", {"entities": []}], ["The child is followed to age 5 years, with prospective characterization of diverse exposures during this critical period.", {"entities": []}], ["Key exposure domains include indoor and outdoor air pollutants, inhalation, ingestion and dermal uptake of chemicals, mold, dampness, biological allergens, pets and pests, housing structure, and living behavior, together with infections, nutrition, psychosocial environment, and medications.", {"entities": []}], ["Assessments of early life exposures are focused on those linked to inflammatory responses driven by the acquired and innate immune systems.", {"entities": []}], ["Mothers complete extensive environmental questionnaires including time-activity behavior at recruitment and when the child is 3, 6, 12, 24, 30, 36, 48, and 60 months old.", {"entities": []}], ["House dust collected during a thorough home assessment at 3\u20134 months, and biological specimens obtained for multiple exposure-related measurements, are archived for analyses.", {"entities": []}], ["Geo-locations of homes and daycares and land-use regression for estimating traffic-related air pollution complement time-activity-behavior data to provide comprehensive individual exposure profiles.", {"entities": []}], ["Several analytical frameworks are proposed to address the many interacting exposure variables and potential issues of co-linearity in this complex data set.", {"entities": []}], ["The evidence that iron deficiency increases lead child exposure is based primarily on animal data and limited human studies, and some of this evidence is contradictory.", {"entities": []}], ["No studies of iron status and blood lead levels in children have accounted for environmental lead contamination and, therefore, the source of their exposure.", {"entities": []}], ["Thus, no studies have directly determined whether iron deficiency modifies the relationship of environmental lead and blood lead.", {"entities": []}], ["In this study, we compared blood lead levels of iron-deficient and iron-replete children living in low, medium, or highly contaminated environments.", {"entities": []}], ["Measurements of lead in paint, soil, dust, and blood, age of housing, and iron status were collected from 319 children ages 1-5.", {"entities": []}], ["We developed two lead exposure factors to summarize the correlated exposure variables: Factor 1 summarized all environmental measures, and Factor 2 was weighted for lead loading of house dust.", {"entities": []}], ["The geometric mean blood lead level was 4.9 microg/dL; 14% exceeded 10 microg/dL.", {"entities": []}], ["Many of the children were iron deficient (24% with ferritin < 12 ng/dL).", {"entities": []}], ["Seventeen percent of soil leads exceeded 500 microg/g, and 23% and 63% of interior and exterior paint samples exceeded 5,000 microg/g.", {"entities": []}], ["The unadjusted geometric mean blood lead level for iron-deficient children was higher by 1 microg/dL; this difference was greater (1.8 microg/dL) after excluding Asians.", {"entities": []}], ["Blood lead levels were higher for iron-deficient children for each tertile of exposure as estimated by Factors 1 and 2 for non-Asian children.", {"entities": []}], ["Elevated blood lead among iron-deficient children persisted after adjusting for potential confounders by multivariate regression; the largest difference in blood lead levels between iron-deficient and -replete children, approximately 3 microg/dL, was among those living in the most contaminated environments.", {"entities": []}], ["Asian children had a paradoxical association of sufficient iron status and higher blood lead level, which warrants further investigation.", {"entities": []}], ["Improving iron status, along with reducing exposures, may help reduce blood lead levels among most children, especially those living in the most contaminated environments.", {"entities": []}], ["Background: The exposome encompasses all life-course environmental exposures from the prenatal period onward that influence health.", {"entities": []}], ["MicroRNAs (miRNAs) are interesting entities within this concept as markers and causation of disease.", {"entities": []}], ["MicroRNAs are short oligonucleotide sequences that can interact with several mRNA targets.", {"entities": []}], ["Objectives: We reviewed the current state of the field on the potential of using miRNAs as biomarkers for environmental exposure.", {"entities": []}], ["We investigated miRNA signatures in response to all types of environmental exposure to which a human can be exposed, including cigarette smoke, air pollution, nanoparticles, and diverse chemicals; and we examined the health conditions for which the identified miRNAs have been reported (i.e., cardiovascular disease, cancer, and diabetes).", {"entities": [[317, 323, "DISEASE"]]}], ["Methods: We searched the PubMed and ScienceDirect databases to identify relevant studies.", {"entities": []}], ["Results: For all exposures incorporated in this review, 27 miRNAs were differentially expressed in at least two independent studies.", {"entities": []}], ["miRNAs that had expression alterations associated with smoking observed in multiple studies are miR-21, miR-34b, miR-125b, miR-146a, miR-223, and miR-340; and those miRNAs that were observed in multiple air pollution studies are miR-9, miR-10b, miR-21, miR-128, miR-143, miR-155, miR-222, miR-223, and miR-338.", {"entities": [[96, 102, "GENE"], [245, 251, "GENE"], [104, 111, "GENE"], [113, 121, "GENE"], [123, 131, "GENE"], [133, 140, "GENE"], [289, 296, "GENE"], [146, 153, "GENE"], [229, 234, "GENE"], [236, 243, "GENE"], [96, 102, "GENE"], [245, 251, "GENE"], [253, 260, "GENE"], [262, 269, "GENE"], [271, 278, "GENE"], [280, 287, "GENE"], [133, 140, "GENE"], [289, 296, "GENE"]]}], ["We found little overlap among in vitro , in vivo , and human studies between miRNAs and exposure.", {"entities": []}], ["Here, we report on disease associations for those miRNAs identified in multiple studies on exposure.", {"entities": []}], ["Conclusions: miRNA changes may be sensitive indicators of the effects of acute and chronic environmental exposure.", {"entities": []}], ["Therefore, miRNAs are valuable novel biomarkers for exposure.", {"entities": []}], ["Further studies should elucidate the role of the mediation effect of miRNA between exposures and effect through all stages of life to provide a more accurate assessment of the consequences of miRNA changes.", {"entities": []}], ["Citation: Vrijens K, Bollati V, Nawrot TS.", {"entities": []}], ["MicroRNAs as potential signatures of environmental exposure or effect: a systematic review.", {"entities": []}], ["Environ Health Perspect 123:399\u2013411;\u2002 http://dx.doi.org/10.1289/ehp.1408459", {"entities": []}], ["Physicians often select clinical management strategies not strongly supported by evidence or guidelines.", {"entities": []}], ["Our objective was to examine the likelihood of selecting, and rationale for pursuing, clinical management strategies with more or less guideline support among physicians using clinical vignettes of eight common medical admissions.", {"entities": []}], ["We conducted a cross-sectional survey using clinical vignettes of attending physicians and housestaff at one internal medicine program in New York City.", {"entities": []}], ["Each clinical vignette included a brief clinical scenario and a varying number of clinical management strategies: diagnostic tests, consultations, and treatments, some of which had strong evidence or guideline support (Level 1 strategies) while others had limited evidence or guideline support (Level 3 strategies).", {"entities": []}], ["Likelihood of selecting a given management strategy was assessed using Likert scales and multiple response options were used to indicate rationale(s) for selections.", {"entities": []}], ["Our sample included 79 physicians; 68 (86%) were younger than 40\u00a0years of age, 34 (43%) were female.", {"entities": []}], ["There were 31 attending physicians (39%) and 48 housestaff (61%) and 39 (49%) had or planned to have primarily primary care internal medicine clinical responsibilities.", {"entities": []}], ["Overall, physicians were more likely to select Level 1 strategies \u201calways\u201d or \u201cmost of the time\u201d when compared with Level 3 strategies (82% vs. 43%; p\u2009<\u20090.001), with wide variation across the eight medical admissions.", {"entities": []}], ["There were no differences between attending and housestaff physician likelihood of selecting Level 3 strategies (47% vs. 45%, p\u2009=\u20090.36).", {"entities": []}], ["Supportive evidence and local practice patterns were the two most common rationales behind selections; supportive evidence was cited as the most common rationale for selecting Level 1 when compared with Level 3 strategies (63% versus 30%; p\u2009<\u20090.001), whereas ruling out other severe conditions was cited most often for Level 3 strategies.", {"entities": []}], ["For eight common medical admissions, physicians selected more than 80% of management strategies with strong evidence or guideline support, but also selected more than 40% of strategies for which there was limited evidence or guideline support.", {"entities": []}], ["The promotion of evidence-based care, including the avoidance of care that is not strongly supported by evidence or guidelines, may require better evidence dissemination and educational outreach to physicians.", {"entities": []}], ["Background .", {"entities": []}], ["Tumor necrosis factor-alpha (TNF- \u03b1 ) gene polymorphisms have been implicated in the manifestation of atherosclerosis.", {"entities": [[102, 117, "DISEASE"]]}], ["Controversy exists regarding the link between the cytokine's variant genotype and CHD among different ethnic groups.", {"entities": []}], ["There have been fewer studies on the TNF- \u03b1 gene \u22121031T>C and \u2212863C>A polymorphisms in relation to CHD.", {"entities": []}], ["Therefore, the current study was designed to investigate the association of the TNF- \u03b1 gene \u22121031T>C and \u2212863C>A polymorphisms with CHD in a Pakistani population.", {"entities": []}], ["Patients with CHD ( n = 310) and healthy individuals ( n = 310) were enrolled in this study.", {"entities": []}], ["Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).", {"entities": []}], ["A significant difference was observed in the \u2212863C>A polymorphism between patients with CHD and control subjects ( P < 0.0001).", {"entities": []}], ["CHD risk was positively associated with the variant allele \u2212863A ( P < 0.0001) in the study subjects.", {"entities": []}], ["There was no significant link between the \u22121031T>C polymorphism and CHD risk in the study population.", {"entities": []}], ["Haplotypes A-T and A-C of the TNF-alpha gene loci at \u2212863 and \u22121031 showed higher frequency in the patient group compared with controls ( P < 0.05).", {"entities": []}], ["Conclusion .", {"entities": []}], ["The TNF- \u03b1 \u2009\u2009\u2212863C>A gene polymorphism was associated with the pathogenesis of CHD while the \u22121031T>C polymorphism did not show any link with the disease in a Pakistani population.", {"entities": []}], ["Rationale (hypothesis): IgG4-related disease (IgG4-RD) is a pathological entity recently recognized by the medical world that can affect any organ or system.", {"entities": []}], ["However, there is insufficient data about this disease in medical literature.", {"entities": []}], ["Aim (objective): A more extensive clarification of the IgG4 molecule, the diversified aspects of IgG4-related disease, and the response of this disease to treatment, will provide a crucial understanding of the immune system and other diseases now known to be associated with IgG4.", {"entities": []}], ["Methods and results: The MEDLINE online medical database was used, and, after a comprehensive review of medical articles regarding IgG4-RD, published after 2003, using the search words \u201cIgG4- related disease\u201d and \u201cIgG4 molecule\u201d, we have described the clinical, pathological and therapeutic features of IgG4-RD, as well as the presence of the IgG4 molecule in the evolution, diagnosis and management of this syndrome.", {"entities": [[408, 416, "DISEASE"]]}], ["We characterized the potential disease mechanisms and discussed early observations related to treatment.", {"entities": []}], ["Discussion: Given the response to immunosuppressive therapy, it is hypothesized that IgG4-related disease is most likely an autoimmune disease.", {"entities": []}], ["Therefore, IgG4-related disease is a fibro-inflammatory condition that can affect any organ and can lead to the formation of pseudotumoral lesions requiring differential diagnosis with various malignancies.", {"entities": []}], ["Positive diagnostic criteria are histopathological and require at least two features out of the following three: dense limphoplasmocitary infiltrate, storiform fibrosis, obliterative phlebitis.", {"entities": [[183, 192, "DISEASE"]]}], ["To investigate the feasibility, the ease of implementation, and the extent to which community health workers with little experience of data collection could be trained and successfully supervised to collect data using mobile phones in a large baseline survey A web-based system was developed to allow electronic surveys or questionnaires to be designed on a word processor, sent to, and conducted on standard entry level mobile phones.", {"entities": []}], ["The web-based interface permitted comprehensive daily real-time supervision of CHW performance, with no data loss.", {"entities": []}], ["The system permitted the early detection of data fabrication in combination with real-time quality control and data collector supervision.", {"entities": []}], ["The benefits of mobile technology, combined with the improvement that mobile phones offer over PDA's in terms of data loss and uploading difficulties, make mobile phones a feasible method of data collection that needs to be further explored.", {"entities": []}], ["A birch pollen emission model is described and its main features are discussed.", {"entities": []}], ["The development of the model is based on a double-threshold temperature sum model that describes the propagation of the flowering season and naturally links to the thermal time models to predict the onset and duration of flowering.", {"entities": []}], ["For the flowering season, the emission model considers ambient humidity and precipitation rate, both of which suppress the pollen release, as well as wind speed and turbulence intensity, which promote it.", {"entities": []}], ["These dependencies are qualitatively evaluated using the aerobiological observations.", {"entities": []}], ["Reflecting the probabilistic character of the flowering of an individual tree in a population, the model introduces relaxation functions at the start and end of the season.", {"entities": []}], ["The physical basis of the suggested birch pollen emission model is compared with another comprehensive emission module reported in literature.", {"entities": []}], ["The emission model has been implemented in the SILAM dispersion modelling system, the results of which are evaluated in a companion paper.", {"entities": []}], ["Dichloro-bis(aminophosphine) complexes of palladium with the general formula of [(P{(NC 5 H 10 ) 3- n (C 6 H 11 ) n }) 2 Pd(Cl) 2 ] (where n = 0-2), belong to a new family of easy accessible, very cheap, and air stable, but highly active and universally applicable C-C cross-coupling catalysts with an excellent functional group tolerance.", {"entities": []}], ["Dichloro{bis[1,1',1''-(phosphinetriyl)tripiperidine]}palladium [(P(NC 5 H 10 ) 3 ) 2 Pd(Cl) 2 ] ( 1 ), the least stable complex within this series towards protons; e.g.", {"entities": []}], ["in the form of water, allows an eased nanoparticle formation and hence, proved to be the most active Heck catalyst within this series at 100 \u00b0C and is a very rare example of an effective and versatile catalyst system that efficiently operates under mild reaction conditions.", {"entities": []}], ["Rapid and complete catalyst degradation under work-up conditions into phosphonates, piperidinium salts and other, palladium-containing decomposition products assure an easy separation of the coupling products from catalyst and ligands.", {"entities": []}], ["The facile, cheap, and rapid synthesis of 1,1',1\"-(phosphinetriyl)tripiperidine and 1 respectively, the simple and convenient use as well as its excellent catalytic performance in the Heck reaction at 100 \u00b0C make 1 to one of the most attractive and greenest Heck catalysts available.", {"entities": []}], ["We provide here the visualized protocols for the ligand and catalyst syntheses as well as the reaction protocol for Heck reactions performed at 10 mmol scale at 100 \u00b0C and show that this catalyst is suitable for its use in organic syntheses.", {"entities": []}], ["Diethylcarbamazine (DEC) is an antifilarial drug with potent anti-inflammatory properties as a result of its interference with the metabolism of arachidonic acid.", {"entities": []}], ["The aim of the present study was to evaluate the anti-inflammatory activity of DEC in a mouse model of acute inflammation (carrageenan-induced pleurisy).", {"entities": [[143, 151, "DISEASE"]]}], ["The injection of carrageenan into the pleural cavity induced the accumulation of fluid containing a large number of polymorphonuclear cells (PMNs) as well as infiltration of PMNs in lung tissues and increased production of nitrite and tumor necrosis factor- \u03b1 and increased expression of interleukin-1 \u03b2 , cyclooxygenase (COX-2), and inducible nitric oxide synthase.", {"entities": []}], ["Carrageenan also induced the expression of nuclear factor- \u03ba B.", {"entities": []}], ["The oral administration of DEC (50\u2009mg/Kg) three days prior to the carrageenan challenge led to a significant reduction in all inflammation markers.", {"entities": []}], ["The present findings demonstrate that DEC is a potential drug for the treatment of acute lung inflammation.", {"entities": []}], ["The hygiene hypothesis implies that microbial agents including probiotic bacteria may modulate foetal/neonatal immune programming and hence offer effective strategies for primary allergy prevention; however their mechanisms of action are poorly understood.", {"entities": []}], ["We investigated whether oral administration of Lactobacillus paracasei NCC 2461 to mothers during gestation/lactation can protect against airway inflammation in offspring in a mouse model of birch pollen allergy, and examined the immune mechanisms involved.", {"entities": []}], ["BALB/c mice were treated daily with L. paracasei in drinking water or drinking water alone in the last week of gestation and during lactation.", {"entities": []}], ["Their offspring were sensitized with recombinant Bet v 1, followed by aerosol challenge with birch pollen extract.", {"entities": []}], ["Maternal exposure to L. paracasei prevented the development of airway inflammation in offspring, as demonstrated by attenuation of eosinophil influx in the lungs; reduction of IL-5 levels in bronchoalveolar lavage, and in lung and mediastinal lymph node cell cultures; and reduced peribronchial inflammatory infiltrate and mucus hypersecretion.", {"entities": []}], ["While allergen-specific IgE and IgG antibody levels remained unchanged by the treatment, IL-4 and IL-5 production in spleen cell cultures were significantly reduced upon allergen stimulation in offspring of L. paracasei treated mice.", {"entities": []}], ["Offspring of L. paracasei supplemented mothers had significantly reduced Bet v 1-specific as well as Concanavalin A-induced responses in spleen and mesenteric lymph node cell cultures, suggesting the modulation of both antigen-specific and mitogen-induced immune responses in offspring.", {"entities": []}], ["These effects were associated with increased Foxp3 mRNA expression in the lungs and increased TGF-beta in serum.", {"entities": [[45, 50, "GENE"]]}], ["Our data show that in a mouse model of birch pollen allergy, perinatal administration of L. paracasei NCC 2461 to pregnant/lactating mothers protects against the development of airway inflammation in offspring by activating regulatory pathways, likely through TLR2/4 signalling.", {"entities": []}], ["Nosocomial pneumonia accounts for the vast majority of healthcare-associated infections (HAI).", {"entities": [[11, 20, "DISEASE"]]}], ["Although numerous medical devices have been discussed as potential vehicles for microorganisms, very little is known about the role played by oxygen humidifiers as potential sources of nosocomial pathogens.", {"entities": []}], ["The purpose of this research was to evaluate the safety of the reuse of humidifiers by analysing the rate of microbial contamination in reusable and disposable oxygen humidifiers used during therapy, and then discuss their potential role in the transmission of respiratory pathogens.", {"entities": []}], ["Water samples from reusable and disposable oxygen humidifiers were collected from different wards of the University Hospital of Messina, Italy, where nosocomial pneumonia has a higher incidence rate due to the \"critical\" clinical conditions of inpatients.", {"entities": [[161, 170, "DISEASE"]]}], ["In particular, we monitored the Internal Medicine and Pulmonology wards for the medical area; the General Surgery and Thoracic and Cardiovascular Surgery wards for the surgical area and the Intensive Care Unit and Neonatal Intensive Care Unit for the emergency area.", {"entities": []}], ["The samples were always collected after a period of 5 days from initial use for both types of humidifiers.", {"entities": []}], ["Samples were processed using standard bacteriological techniques and microbial colonies were identified using manual and automated methods.", {"entities": []}], ["High rates of microbial contamination were observed in samples from reusable oxygen humidifiers employed in medical (83%), surgical (77%) and emergency (50%) areas.", {"entities": []}], ["The most relevant pathogens were Pseudomonas aeruginosa, amongst the Gram-negative bacteria, and Staphylococcus aureus, amongst the Gram-positive bacteria.", {"entities": []}], ["Other pathogens were detected in lower percentage.", {"entities": []}], ["The disposable oxygen humidifier samples showed no contamination.", {"entities": []}], ["This research presents evidence of the high rate and type of microbial contamination of reusable humidifiers employed for oxygen therapy.", {"entities": []}], ["These devices may thus be involved in the transmission of potential pathogens.", {"entities": []}], ["It could be important, for the prevention of nosocomial pneumonia, to replace them with singleuse humidifiers for which the absence of microbial contamination has been confirmed.", {"entities": [[56, 65, "DISEASE"]]}], ["Addressing the problem of preventable drug related morbidity (PDRM) in primary care is a challenge for health care systems internationally.", {"entities": []}], ["The increasing implementation of clinical information systems in the UK and internationally provide new opportunities to systematically identify patients at risk of PDRM for targeted medication review.", {"entities": []}], ["The objectives of this study were (1) to develop a set of explicit medication assessment criteria to identify patients with sub-optimally effective or high-risk medication use from electronic medical records and (2) to identify medication use topics that are perceived by UK primary care clinicians to be priorities for quality and safety improvement initiatives.", {"entities": []}], ["For objective (1), a 2-round consensus process based on the RAND/UCLA Appropriateness Method (RAM) was conducted, in which candidate criteria were identified from the literature and scored by a panel of 10 experts for 'appropriateness' and 'necessity'.", {"entities": []}], ["A set of final criteria was generated from candidates accepted at each level.", {"entities": []}], ["For objective (2), thematically related final criteria were clustered into 'topics', from which a panel of 26 UK primary care clinicians identified priorities for quality improvement in a 2-round Delphi exercise.", {"entities": []}], ["(1) The RAM process yielded a final set of 176 medication assessment criteria organised under the domains 'quality' and 'safety', each classified as targeting 'appropriate/necessary to do' (quality) or 'inappropriate/necessary to avoid' (safety) medication use.", {"entities": []}], ["Fifty-two final 'quality' assessment criteria target patients with unmet indications, sub-optimal selection or intensity of beneficial drug treatments.", {"entities": []}], ["A total of 124 'safety' assessment criteria target patients with unmet needs for risk-mitigating agents, high-risk drug selection, excessive dose or duration, inconsistent monitoring or dosing instructions.", {"entities": []}], ["(2) The UK Delphi panel identified 11 (23%) of 47 scored topics as 'high priority' for quality improvement initiatives in primary care.", {"entities": []}], ["The developed criteria set complements existing medication assessment instruments in that it is not limited to the elderly, can be implemented in electronic data sets and focuses on drug groups and conditions implicated in common and/or severe PDRM in primary care.", {"entities": []}], ["Identified priorities for quality and safety improvement can guide the selection of targets for initiatives to address the PDRM problem in primary care.", {"entities": []}], ["The polymeric mucin component of the intestinal mucus barrier changes during nematode infection to provide not only physical protection but also to directly affect pathogenic nematodes and aid expulsion.", {"entities": []}], ["Despite this, the direct interaction of the nematodes with the mucins and the mucus barrier has not previously been addressed.", {"entities": []}], ["We used the well-established Trichuris muris nematode model to investigate the effect on mucins of the complex mixture of immunogenic proteins secreted by the nematode called excretory/secretory products (ESPs).", {"entities": []}], ["Different regimes of T. muris infection were used to simulate chronic (low dose) or acute (high dose) infection.", {"entities": []}], ["Mucus/mucins isolated from mice and from the human intestinal cell line, LS174T, were treated with ESPs.", {"entities": []}], ["We demonstrate that serine protease(s) secreted by the nematode have the ability to change the properties of the mucus barrier, making it more porous by degrading the mucin component of the mucus gel.", {"entities": []}], ["Specifically, the serine protease(s) acted on the N-terminal polymerising domain of the major intestinal mucin Muc2, resulting in depolymerisation of Muc2 polymers.", {"entities": [[111, 115, "GENE"], [150, 154, "GENE"], [111, 115, "GENE"], [150, 154, "GENE"]]}], ["Importantly, the respiratory/gastric mucin Muc5ac, which is induced in the intestine and is critical for worm expulsion, was protected from the depolymerising effect exerted by ESPs.", {"entities": []}], ["Furthermore, serine protease inhibitors (Serpins) which may protect the mucins, in particular Muc2, from depolymerisation, were highly expressed in mice resistant to chronic infection.", {"entities": [[94, 98, "GENE"]]}], ["Thus, we demonstrate that nematodes secrete serine protease(s) to degrade mucins within the mucus barrier, which may modify the niche of the parasite to prevent clearance from the host or facilitate efficient mating and egg laying from the posterior end of the parasite that is in intimate contact with the mucus barrier.", {"entities": []}], ["However, during a T H 2-mediated worm expulsion response, serpins, Muc5ac and increased levels of Muc2 protect the barrier from degradation by the nematode secreted protease(s).", {"entities": [[98, 102, "GENE"]]}], ["Gastrointestinal parasitic worm infections cause significant morbidity, affecting up to a third of the world's populationand their domestic pets and livestock.", {"entities": []}], ["Mucus, the gel-like material that blankets the surface of the intestine, forms a protective barrier that is an important part of our innate immune system.", {"entities": []}], ["The whipworm Trichuris is closely associated with the intestinal mucus barrier.", {"entities": []}], ["The major structural component of this barrier, large glycoproteins known as mucins play a significant role in the expulsion of these worms in a mouse model.", {"entities": []}], ["Using mice that get longterm chronic infections and others able to expel the worms from the intestine, we uncover a novel role for products secreted by the worms.", {"entities": []}], ["Enzymes secreted by whipworms can disrupt the mucin network that gives mucus its viscous properties.", {"entities": []}], ["Moreover, we unravel that worm products are unable to degrade forms of mucins present in the mucus barrier during worm expulsion, suggesting that these enzymes may be released by the worm as part of its regime to improve its niche and survival in the host.", {"entities": []}], ["However, the host is capable of producing mucins and other protective molecules that protect the mucus barrier from degradation and are detrimental to the viability of the worm.", {"entities": []}], ["The heritability of most common, multifactorial diseases is rather modest and known genetic effects account for a small part of it.", {"entities": []}], ["The remaining portion of disease aetiology has been conventionally ascribed to environmental effects, with an unknown part being stochastic.", {"entities": []}], ["This review focuses on recent studies highlighting stochastic events of potentially great importance in human disease\u2014the accumulation of post-zygotic structural aberrations with age in phenotypically normal humans.", {"entities": []}], ["These findings are in agreement with a substantial mutational load predicted to occur during lifetime within the human soma.", {"entities": []}], ["A major consequence of these results is that the genetic profile of a single tissue collected at one time point should be used with caution as a faithful portrait of other tissues from the same subject or the same tissue throughout life.", {"entities": []}], ["Thus, the design of studies in human genetics interrogating a single sample per subject or applying lymphoblastoid cell lines may come into question.", {"entities": []}], ["Sporadic disorders are common in medicine.", {"entities": []}], ["We wish to stress the non-heritable genetic variation as a potentially important factor behind the development of sporadic diseases.", {"entities": []}], ["Moreover, associations between post-zygotic mutations, clonal cell expansions and their relation to cancer predisposition are central in this context.", {"entities": [[100, 106, "DISEASE"]]}], ["Post-zygotic mutations are amenable to robust examination and are likely to explain a sizable part of non-heritable disease causality, which has routinely been thought of as synonymous with environmental factors.", {"entities": []}], ["In view of the widespread accumulation of genetic aberrations with age and strong predictions of disease risk from such analyses, studies of post-zygotic mutations may be a fruitful approach for delineation of variants that are causative for common human disorders.", {"entities": []}], ["Modern lifestyles, such as shift work, nocturnal social activities, and jet lag, disturb the circadian rhythm.", {"entities": []}], ["The interaction between mammals and the co-evolved intestinal microbiota modulates host physiopathological processes.", {"entities": []}], ["Radiotherapy is a cornerstone of modern management of malignancies; however, it was previously unknown whether circadian rhythm disorder impairs prognosis after radiotherapy.", {"entities": []}], ["To investigate the effect of circadian rhythm on radiotherapy, C57BL/6 mice were housed in different dark/light cycles, and their intestinal bacterial compositions were compared using high throughput sequencing.", {"entities": []}], ["The survival rate, body weight, and food intake of mice in diverse cohorts were measured following irradiation exposure.", {"entities": []}], ["Finally, the enteric bacterial composition of irradiated mice that experienced different dark/light cycles was assessed using 16S RNA sequencing.", {"entities": []}], ["Intriguingly, mice housed in aberrant light cycles harbored a reduction of observed intestinal bacterial species and shifts of gut bacterial composition compared with those of the mice kept under 12 h dark/12 h light cycles, resulting in a decrease of host radioresistance.", {"entities": []}], ["Moreover, the alteration of enteric bacterial composition of mice in different groups was dissimilar.", {"entities": []}], ["Our findings provide novel insights into the effects of biological clocks on the gut bacterial composition, and underpin that the circadian rhythm influences the prognosis of patients after radiotherapy in a preclinical setting.", {"entities": []}], ["Antibiotic and oral corticosteroid prescribing rate in patients suffering from acute exacerbations of chronic obstructive pulmonary disease (COPD) or asthma in general practice are only sparsely described.", {"entities": [[102, 139, "DISEASE"], [150, 156, "DISEASE"]]}], ["Our aim was to identify predictors for such prescribing when results from CRP testing, spirometry, and pulse oximetry are available.", {"entities": [[74, 77, "GENE"]]}], ["Patients aged 40\u00a0years or more diagnosed with asthma, COPD or both, the previous five years from seven general practice offices in Norway, were invited to a baseline examination and asked to visit their GPs during exacerbations the following 12\u00a0months.", {"entities": [[46, 52, "DISEASE"]]}], ["At all visits, symptoms, chest findings, and results from spirometry, pulse oximetry and CRP testing were registered.", {"entities": [[89, 92, "GENE"]]}], ["Out of the 376 who took part in baseline examination, 95 patients with an exacerbation were included in the analysis.", {"entities": []}], ["Based on the diagnosis made by GPs, 46 patients (48.4%) were only registered with asthma, and 49 (51.6%) with COPD (or both diagnosis).", {"entities": [[82, 88, "DISEASE"]]}], ["11 patients had taken antibiotics and 16 had taken systemic corticosteroids prior to their visit to their GPs.", {"entities": []}], ["After excluding those already treated, antibiotics were prescribed in 34.9% and systemic corticosteroids in 42.5% of patients diagnosed with COPD compared to 14.6% and 30.8% respectively in patients only diagnosed with asthma ( P \u2009=\u20090.02, P \u2009=\u20090.2).", {"entities": [[219, 225, "DISEASE"]]}], ["In the COPD group, antibiotic prescribing was not significantly associated with purulence or other respiratory symptoms, but increased phlegm was a significant predictor of antibiotic prescribing in the whole sample ( P \u2009=\u20090.04).", {"entities": []}], ["Prolonged expiration, wheezes and diminished breath sounds also predicted the prescribing of both antibiotics and systemic corticosteroids in the whole sample with P values\u2009<\u20090.01.", {"entities": []}], ["The prescribing rate of antibiotics and systemic corticosteroids also increased with increasing CRP value ( P \u2009=\u20090.001 and P \u2009=\u20090.01, respectively) and with decreasing oxygen saturation ( P \u2009=\u20090.01 and P \u2009=\u20090.003, respectively).", {"entities": [[96, 99, "GENE"]]}], ["FEV 1 /FVC\u2009<\u20090.7 at baseline was as significant predictor in patients with COPD and in the whole sample of patients regarding treatment with antibiotics ( P \u2009=\u20090.004 and P \u2009=\u20090.001, respectively) and treatment with systemic corticosteroids ( P \u2009=\u20090.004 and P \u2009=\u20090.001, respectively).", {"entities": [[0, 3, "GENE"]]}], ["Chest findings, raised CRP value and decreased oxygen saturation were stronger predictors of prescribing of antibiotics and systemic corticosteroids than were respiratory symptoms.", {"entities": [[23, 26, "GENE"]]}], ["Further evaluation of the importance of these findings to guide treatment of asthma and COPD exacerbations is warranted.", {"entities": [[77, 83, "DISEASE"]]}], ["We recently showed that dendritic cells (DCs) activated by thymic stromal lymphopoietin (TSLP) prime naive CD4 \u03b1 (TNF- \u03b1 ), but no interleukin (IL)-10.", {"entities": [[89, 93, "GENE"], [107, 110, "GENE"]]}], ["Here we report that TSLP induced human DCs to express OX40 ligand (OX40L) but not IL-12.", {"entities": [[20, 24, "GENE"]]}], ["TSLP-induced OX40L on DCs was required for triggering naive CD4 \u03b1 , but inhibited IL-10 production in developing Th2 cells; (b) OX40L lost the ability to polarize Th2 cells in the presence of IL-12; and (c) OX40L exacerbated IL-12\u2013induced Th1 cell inflammation by promoting TNF- \u03b1 , while inhibiting IL-10.", {"entities": [[60, 63, "GENE"]]}], ["We conclude that OX40L on TSLP-activated DCs triggers Th2 cell polarization in the absence of IL-12, and propose that OX40L can switch IL-10\u2013producing regulatory Th cell responses into TNF- \u03b1 \u2013producing inflammatory Th cell responses.", {"entities": []}], ["This work aimed to investigate the effects of the administration of cannabidiol in a kidney ischemia/reperfusion animal model.", {"entities": [[92, 100, "DISEASE"]]}], ["Kidney injury was induced by 45 minutes of renal ischemia followed by reperfusion.", {"entities": [[49, 57, "DISEASE"]]}], ["Cannabidiol (5mg/kg) was administered immediately after reperfusion.", {"entities": []}], ["Ischemia/reperfusion increased the IL-1 and TNF levels, and these levels were attenuated by cannabidiol treatment.", {"entities": [[0, 8, "DISEASE"], [44, 47, "GENE"]]}], ["Additionally, cannabidiol was able to decrease lipid and protein oxidative damage, but not the nitrite/nitrate levels.", {"entities": []}], ["Kidney injury after ischemia/reperfusion seemed to be independent of the cannabidiol receptor 1 and cannabidiol receptor 2 (CB1 and CB2) expression levels, as there was no significant increase in these receptors after reperfusion.", {"entities": [[20, 28, "DISEASE"]]}], ["The cannabidiol treatment had a protective effect against inflammation and oxidative damage in the kidney ischemia/reperfusion model.", {"entities": [[106, 114, "DISEASE"]]}], ["These effects seemed to be independent of CB1/CB2 receptor activation.", {"entities": []}], ["A small number of individuals with B-cell-related primary immunodeficiency diseases (PIDs) may exhibit long-term (prolonged or chronic) excretion of immunodeficiency-associated vaccine-derived polioviruses (iVDPVs) following infection with oral poliovirus vaccine (OPV).", {"entities": []}], ["These individuals pose a risk of live poliovirus reintroduction into the population after global wild poliovirus eradication and subsequent OPV cessation.", {"entities": []}], ["Treatment with polio antiviral drugs may potentially stop excretion in some of these individuals and thus may reduce the future population risk.", {"entities": []}], ["We developed a discrete event simulation model to characterize the global prevalence of long-term iVDPV excretors based on the best available evidence.", {"entities": []}], ["We explored the impact of different assumptions about the effectiveness of polio antiviral drugs and the fraction of long-term excretors identified and treated.", {"entities": []}], ["Due to the rarity of long-term iVDPV excretion and limited data on the survival of PID patients in developing countries, uncertainty remains about the current and future prevalence of long-term iVDPV excretors.", {"entities": []}], ["While the model suggests only approximately 30 current excretors globally and a rapid decrease after OPV cessation, most of these excrete asymptomatically and remain undetected.", {"entities": []}], ["The possibility that one or more PID patients may continue to excrete iVDPVs for several years after OPV cessation represents a risk for reintroduction of live polioviruses after OPV cessation, particularly for middle-income countries.", {"entities": []}], ["With the effectiveness of a single polio antiviral drug possibly as low as 40\u00a0% and no system in place to identify and treat asymptomatic excretors, the impact of passive use of a single polio antiviral drug to treat identified excretors appears limited.", {"entities": []}], ["Higher drug effectiveness and active efforts to identify long-term excretors will dramatically increase the benefits of polio antiviral drugs.", {"entities": []}], ["Efforts to develop a second polio antiviral compound to increase polio antiviral effectiveness and/or to maximize the identification and treatment of affected individuals represent important risk management opportunities for the polio endgame.", {"entities": []}], ["Better data on the survival of PID\u00a0patients in developing countries and more longitudinal data on their exposure to and recovery from OPV infections would improve our understanding of the risks associated with iVDPV excretors and the benefits of further investments in polio antiviral drugs.", {"entities": []}], ["Inflammation induced during infection can both promote and suppress immunity.", {"entities": []}], ["This contradiction suggests that inflammatory cytokines impact the immune system in a context-dependent manner.", {"entities": []}], ["Here we show that non-specific bystander inflammation conditioned na\u00efve CD4 in vivo via Foxp3-dependent effect on antigen-specific na\u00efve CD4", {"entities": [[72, 75, "GENE"], [137, 140, "GENE"], [72, 75, "GENE"], [137, 140, "GENE"]]}], ["Exacerbations of COPD represent an important medical and health care problem.", {"entities": []}], ["Certain susceptible patients suffer recurrent exacerbations and as a consequence have a poorer prognosis.", {"entities": []}], ["The effects of bronchial infection, either acute or chronic, and of the inflammation characteristic of the disease itself raise the question of the possible role of antibiotics and anti-inflammatory agents in modulating the course of the disease.", {"entities": []}], ["However, clinical guidelines base their recommendations on clinical trials that usually exclude more severe patients and patients with more comorbidities, and thus often fail to reflect the reality of clinicians attending more severe patients.", {"entities": []}], ["In order to discuss aspects of clinical practice of relevance to pulmonologists in the treatment and prevention of recurrent exacerbations in patients with severe COPD, a panel discussion was organized involving expert pulmonologists who devote most of their professional activity to day hospital care.", {"entities": []}], ["This article summarizes the scientific evidence currently available and the debate generated in relation to the following aspects: bacterial and viral infections, chronic bronchial infection and its treatment with cyclic oral or inhaled antibiotics, inflammatory mechanisms and their treatment, and the role of computerized tomography as a diagnostic tool in patients with severe COPD and frequent exacerbations.", {"entities": []}], ["In an area representative of a moderate climate zone (Lubuskie Province in Poland), mycological tests in over 270 flats demonstrated the occurrence of 82 species of moulds.", {"entities": []}], ["Aspergillus versicolor Tiraboschi was often encountered on building partitions (frequency 4: frequently).", {"entities": []}], ["The ability to synthesize the carcinogenic sterigmatocystin (ST) means that it poses a risk to humans and animals.", {"entities": []}], ["Biotoxicological tests of biomasses of A. versicolor were conducted in the Microbiological and Toxicological Laboratory, using the planarians Dugesia tigrina (Girard).", {"entities": []}], ["The obtained results of the tests covered a broad range of toxicity levels of isolated strains: from weakly toxic (100\u20131000 mg\u00b7L A. versicolor strains to synthesize sterigmatocystin.", {"entities": []}], ["All of the samples of the air-dry biomasses of the fungi contained ST in the range between 0.03 and 534.38 mg\u00b7kg A. versicolor belongs to category 1.", {"entities": []}], ["Additionally, A. versicolor is an allergenic mould.", {"entities": []}], ["It is revealed that circulating fibrocytes are elevated in patients/animals with cardiac fibrosis, and this review aims to provide an introduction to circulating fibrocytes and their role in cardiac fibrosis.", {"entities": []}], ["This review is based on the data from 1994 to present obtained from PubMed.", {"entities": []}], ["The search terms were \u201ccirculating fibrocytes\u201d and \u201ccardiac fibrosis\u201d.", {"entities": []}], ["Articles and critical reviews, which are related to circulating fibrocytes and cardiac fibrosis, were selected.", {"entities": []}], ["Circulating fibrocytes, which are derived from hematopoietic stem cells, represent a subset of peripheral blood mononuclear cells exhibiting mixed morphological and molecular characteristics of hematopoietic and mesenchymal cells (CD34 Circulating fibrocytes are effector cells in cardiac fibrosis.", {"entities": [[231, 235, "GENE"]]}], ["Pneumocystis pneumonia (PCP) is an emerging infectious disease in immunocompromised hosts.", {"entities": [[13, 22, "DISEASE"]]}], ["However, the clinical characteristics of these patients are poorly understood in mainland China.", {"entities": []}], ["We performed a retrospective study of PCP from 2008 to 2012.", {"entities": []}], ["Information was collected regarding clinical manifestations, hospitalization, and outcome.", {"entities": []}], ["A prognostic analysis was performed using a Cox regression model.", {"entities": []}], ["151 cases of PCP were included; 46 non-HIV and 105 HIV cases.", {"entities": []}], ["All-cause mortality (15.2% vs. 12.4%, p \u200a=\u200a0.64) and the results of time-to-event analysis (log-rank test, p \u200a=\u200a0.62) were similar between non-HIV and HIV infected cases, respectively.", {"entities": []}], ["From 2008 to 2012, time from admission to initial treatment in non-HIV infected PCP patients showed declining trend [median (range) 20 (9\u201344) vs. 12 (4\u201324) vs. 9 (2\u201323) vs. 7 (2\u201322) vs. 7 (1\u201314) days].", {"entities": []}], ["A similar trend was observed for all-cause mortality (33.3% vs. 20.0% vs.14.3% vs. 14.3% vs. 6.7%).", {"entities": []}], ["Patients with four or more of the following clinical manifestations (cough, dyspnea, fever, chest pain, and weight loss) [adjusted HR (AHR) 29.06, 95% CI 2.13\u2013396.36, P \u200a=\u200a0.01] and admission to intensive care unit (ICU) [AHR 22.55, 95% CI 1.36\u2013375.06, P \u200a=\u200a0.03] were independently associated with all-cause mortality in non-HIV infected PCP patients.", {"entities": [[131, 133, "GENE"], [135, 138, "GENE"], [222, 225, "GENE"], [135, 138, "GENE"], [222, 225, "GENE"]]}], ["Variables associated with mortality in HIV infected PCP patients were admission to ICU (AHR 72.26, 95% CI 11.76\u2013443.87, P <0.001) and albumin \u226430 g/L (AHR 9.93 95% CI 1.69\u201358.30, P \u200a=\u200a0.01).", {"entities": [[88, 91, "GENE"], [151, 154, "GENE"], [88, 91, "GENE"], [151, 154, "GENE"]]}], ["Upon admission comprehensive clinical assessment including assessment of four or more clinical manifestations (cough, dyspnea, fever, chest pain, and weight loss) in non-HIV infected PCP patients and albumin \u226430 g/L in HIV infected patients might improve prognosis.", {"entities": []}], ["Although cigarette smoking is known to be related to the exacerbation of asthma symptoms, several studies have indicated that the prevalence of cigarette smoking among asthmatic adolescents is similar to or even higher than that among non-asthmatic adolescents.", {"entities": [[73, 79, "DISEASE"]]}], ["The aim of this study was to evaluate the relationship between asthma and cigarette use behaviors and whether or not the presence of suicidal ideation modifies this relationship among Korean adolescents.", {"entities": [[63, 69, "DISEASE"]]}], ["We analyzed data from the 2008 Korea Youth Risk Behavior Web-based Survey, which included a nationally representative sample of middle and high school students.", {"entities": []}], ["Multiple logistic regression models were used to calculate odd ratios and 95% confidence intervals of cigarette use behaviors among current asthmatics, former asthmatics, and non-asthmatics, after adjusting for gender, grade, school records, socioeconomic status, current alcohol use, and suicidal ideation.", {"entities": []}], ["Of 75 238 study participants, 3.5% were current asthmatics and 4.5% were former asthmatics.", {"entities": []}], ["Compared with non-asthmatics, asthmatics were more likely to report current cigarette use, frequent and heavy cigarette use, and cigarette use before 13 years of age.", {"entities": []}], ["There were statistically significant interactions between asthma and suicidal ideation in cigarette use behaviors.", {"entities": [[58, 64, "DISEASE"]]}], ["This study demonstrated that asthmatic adolescents are more likely than non-asthmatic adolescents to engage in cigarette use behaviors and the presence of suicidal ideation is an effect modifier of the relationship between asthma and cigarette use behaviors.", {"entities": [[223, 229, "DISEASE"]]}], ["Particular attention should be paid to the awareness of health risks of cigarette smoking and mental health problems among asthmatic adolescents.", {"entities": []}], ["Classification methods used in microarray studies for gene expression are diverse in the way they deal with the underlying complexity of the data, as well as in the technique used to build the classification model.", {"entities": []}], ["The MAQC II study on cancer classification problems has found that performance was affected by factors such as the classification algorithm, cross validation method, number of genes, and gene selection method.", {"entities": [[21, 27, "DISEASE"]]}], ["In this paper, we study the hypothesis that the disease under study significantly determines which method is optimal, and that additionally sample size, class imbalance, type of medical question (diagnostic, prognostic or treatment response), and microarray platform are potentially influential.", {"entities": []}], ["A systematic literature review was used to extract the information from 48 published articles on non-cancer microarray classification studies.", {"entities": [[101, 107, "DISEASE"]]}], ["The impact of the various factors on the reported classification accuracy was analyzed through random-intercept logistic regression.", {"entities": []}], ["The type of medical question and method of cross validation dominated the explained variation in accuracy among studies, followed by disease category and microarray platform.", {"entities": []}], ["In total, 42% of the between study variation was explained by all the study specific and problem specific factors that we studied together.", {"entities": []}], ["Alopecia areata (AA) frequently occur in association with other autoimmune diseases such as thyroid disorders, anemias and other skin disorders with autoimmune etiology.", {"entities": [[0, 15, "DISEASE"], [0, 8, "DISEASE"]]}], ["Despite numerous studies related to individual disease associations in alopecia areata, there is paucity of literature regarding comprehensive studies on concomitant cutaneous and systemic diseases.", {"entities": [[71, 86, "DISEASE"], [71, 79, "DISEASE"]]}], ["The present study has been designed to determine if there is a significant association between alopecia areata and other autoimmune diseases.", {"entities": [[95, 110, "DISEASE"], [95, 103, "DISEASE"]]}], ["This study covers 71 patients with the diagnosis of alopecia areata as the case group and 71 patients with no evidence of alopecia areata as the control group.", {"entities": [[52, 67, "DISEASE"], [122, 137, "DISEASE"], [52, 60, "DISEASE"], [122, 130, "DISEASE"]]}], ["Among the cutaneous diseases associated with AA, atopic dermatitis (AD) showed maximum frequency with an O/E ratio of 2.5, which indicates that it is two to three times more common in patients with alopecia areata.", {"entities": [[49, 66, "DISEASE"], [198, 213, "DISEASE"], [198, 206, "DISEASE"], [56, 66, "DISEASE"]]}], ["In our study, thyroid disorders showed the highest frequency with on O/E ratio of 3.2 and a P value of 0.01, which is statistically highly significant.", {"entities": []}], ["Among the thyroid disorders, hypothyroidism was the most frequent association (14.1%) in our study.", {"entities": [[29, 43, "DISEASE"]]}], ["Since systemic involvement is not infrequent in patients with alopecia areata, it is imperative to screen these patients for associated disorders, particularly atopy, thyroid diseases, anemias and other autoimmune disorders, especially if alopecia areata is chronic, recurrent and extensive.", {"entities": [[62, 77, "DISEASE"], [239, 254, "DISEASE"], [62, 70, "DISEASE"], [239, 247, "DISEASE"]]}], ["Despite the well-established morbidity, mortality, long-term effects, and unnecessary extra-cost burden associated with cesarean section delivery (CSD) worldwide, its rate has grown exponentially.", {"entities": []}], ["This has become a great topical challenge for the international healthcare community and individual countries.", {"entities": []}], ["Estimated at three times the acceptable rate as defined by the World Health Organization in 1985, the continued upward trend has been fuelled by higher income countries.", {"entities": []}], ["Some low- and middle-income countries (LMICs) have now taken the lead, and the factors contributing to this situation are poorly understood.", {"entities": []}], ["The expansion of the private healthcare sector may be playing a significant role.", {"entities": []}], ["Distinguishing between the public and private hospitals\u2019 role is critical in this investigation as it has not yet been approached.", {"entities": []}], ["This review aims to systematically synthesize knowledge on the determinants of the CSD rate rise in private and public hospitals in LMICs and to investigate materno-fetal and materno-infant outcomes of CSD in perinatal period, between private and public hospitals.", {"entities": []}], ["We will include studies published in English, French, Spanish, and Portuguese since 2000, using any experimental design, including randomized controlled trials (RCTs), non-RCTs, quasi-experimental, before and after studies, and interrupted time series.", {"entities": []}], ["Outcomes of interest are the determinants of CSD and materno-fetal and materno-infant outcomes.", {"entities": []}], ["We will only include studies carried out in private and public hospitals in LMICs.", {"entities": []}], ["The literature searches will be conducted in the following databases: MEDLINE, Embase, CINAHL, Cochrane database, LILACS, and HINARI.", {"entities": []}], ["We will also include unpublished studies in the gray literature (theses and technical reports).", {"entities": []}], ["Using the two-person approach, two independent review authors will screen eligible articles, extract data, and assess risk of bias.", {"entities": []}], ["Disagreements will be resolved through discussion with a third author.", {"entities": []}], ["Results will be presented as structured summaries of the included studies.", {"entities": []}], ["If possible, a meta-analysis will be conducted and, subsequently, an analysis for heterogeneity will be implemented.", {"entities": []}], ["The proposed systematic review of the CSD rate rise will provide up-to-date evidence in regard to differences in proportions, determinants, and materno-fetal and materno-infant outcomes in perinatal period, between private and public hospitals in LMICs.", {"entities": []}], ["We believe that this knowledge synthesis will help to shed light on the evidence and support evidence-informed decision-making with a view to addressing the issue in LMICs.", {"entities": []}], ["PROSPERO CRD42016036871 The online version of this article (doi:10.1186/s13643-016-0402-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Most diseases are thought to arise from interactions between environmental factors and the host genotype.", {"entities": []}], ["To detect gene\u2013environment interactions in the development of lifestyle-related diseases, and especially cancer, the Japan Multi-institutional Collaborative Cohort (J-MICC) Study was launched in 2005.", {"entities": [[105, 111, "DISEASE"]]}], ["We initiated a cross-sectional study to examine associations of genotypes with lifestyle and clinical factors, as assessed by questionnaires and medical examinations.", {"entities": []}], ["The 4519 subjects were selected from among participants in the J-MICC Study in 10 areas throughout Japan.", {"entities": []}], ["In total, 108 polymorphisms were chosen and genotyped using the Invader assay.", {"entities": []}], ["The study group comprised 2124 men and 2395 women with a mean age of 55.8 \u00b1 8.9 years (range, 35\u201369 years) at baseline.", {"entities": []}], ["Among the 108 polymorphisms examined, 4 were not polymorphic in our study population.", {"entities": []}], ["Among the remaining 104 polymorphisms, most variations were common (minor allele frequency \u22650.05 for 96 polymorphisms).", {"entities": []}], ["The allele frequencies in this population were comparable with those in the HapMap-JPT data set for 45 Japanese from Tokyo.", {"entities": []}], ["Only 5 of 88 polymorphisms showed allele-frequency differences greater than 0.1.", {"entities": []}], ["Of the 108 polymorphisms, 32 showed a highly significant difference in minor allele frequency among the study areas ( P < 0.001).", {"entities": []}], ["This comprehensive data collection on lifestyle and clinical factors will be useful for elucidating gene\u2013environment interactions.", {"entities": []}], ["In addition, it is likely to be an informative reference tool, as free access to genotype data for a large Japanese population is not readily available.", {"entities": []}], ["Chlamydiae are intracellular bacteria that commonly cause infections of the respiratory and genital tracts, which are major clinical problems.", {"entities": []}], ["Infections are also linked to the aetiology of diseases such as asthma, emphysema and heart disease.", {"entities": [[86, 99, "DISEASE"], [64, 70, "DISEASE"]]}], ["The clinical management of infection is problematic and antibiotic resistance is emerging.", {"entities": []}], ["Increased understanding of immune processes that are involved in both clearance and immunopathology of chlamydial infection is critical for the development of improved treatment strategies.", {"entities": []}], ["Here, we show that IL-13 was produced in the lungs of mice rapidly after Chlamydia muridarum ( Cmu ) infection and promoted susceptibility to infection.", {"entities": []}], ["Wild-type (WT) mice had increased disease severity, bacterial load and associated inflammation compared to IL-13 deficient (\u2212/\u2212) mice as early as 3 days post infection (p.i.).", {"entities": []}], ["Intratracheal instillation of IL-13 enhanced bacterial load in IL-13\u2212/\u2212 mice.", {"entities": []}], ["There were no differences in early IFN-g and IL-10 expression between WT and IL-13\u2212/\u2212 mice and depletion of CD4+ T cells did not affect infection in IL-13\u2212/\u2212 mice.", {"entities": []}], ["Collectively, these data demonstrate a lack of CD4+ T cell involvement and a novel role for IL-13 in innate responses to infection.", {"entities": []}], ["We also showed that IL-13 deficiency increased macrophage uptake of Cmu in vitro and in vivo .", {"entities": []}], ["Moreover, the depletion of IL-13 during infection of lung epithelial cells in vitro decreased the percentage of infected cells and reduced bacterial growth.", {"entities": []}], ["Our results suggest that enhanced IL-13 responses in the airways, such as that found in asthmatics, may promote susceptibility to chlamydial lung infection.", {"entities": []}], ["Importantly the role of IL-13 in regulating infection was not limited to the lung as we showed that IL-13 also promoted susceptibility to Cmu genital tract infection.", {"entities": []}], ["Collectively our findings demonstrate that innate IL-13 release promotes infection that results in enhanced inflammation and have broad implications for the treatment of chlamydial infections and IL-13-associated diseases.", {"entities": []}], ["Chlamydial infections are a common cause of respiratory, genital tract and eye diseases, and infections are clinically associated with the aetiology of asthma, emphysema, heart disease and Alzheimer's.", {"entities": [[171, 184, "DISEASE"], [152, 158, "DISEASE"]]}], ["However, it is not known what immune factors regulate enhanced susceptibility to infection and immunopathology.", {"entities": []}], ["In this study we have investigated the role of the immune factor, interleukin-13 (IL-13), in C. muridarum infections in mice.", {"entities": []}], ["IL-13 is produced rapidly after respiratory infection in normal mice.", {"entities": []}], ["However, mice deficient in IL-13 have reduced clinical symptoms and numbers of C. muridarum in their lungs after infection.", {"entities": []}], ["The immune cells of mice deficient in IL-13 phagocytose more C. muridarum and their lung cells have less infection.", {"entities": []}], ["The role of IL-13 is not restricted to the lung as IL-13-deficient mice have significantly lower levels of bacterial replication and more mild disease during genital tract infection.", {"entities": []}], ["Our results suggest that IL-13 responses enhance chlamydial infections and that this factor may be a new therapeutic target for the treatment of disease.", {"entities": []}], ["We studied host factors that could predispose women to develop recurrent vulvovaginal candidiasis (RVVC), including glycemia, insulin resistance, chronic stress, antioxidant capacity, overall immune status, local inflammation and vaginal microbiota.", {"entities": [[73, 97, "DISEASE"], [86, 97, "DISEASE"]]}], ["The presence of yeasts in vaginal culture was screened in 277 women, with or without signs and symptoms of VVC and RVVC.", {"entities": []}], ["The presence of an inflammatory process and microbiota were analyzed through vaginal bacterioscopy and cervical-vaginal cytology, respectively.", {"entities": []}], ["Fasting-blood samples were collected by standard venipuncture for biochemical analyses.", {"entities": []}], ["Flow cytometry was employed to obtain the T helper/T cytotoxic lymphocyte ratio, and insulin resistance was assessed by the HOMA index (HI).", {"entities": []}], ["Yeasts were isolated from 71 (26%) women: 23 (32.4%) with a positive culture but without symptoms (COL), 22 (31%) in an acute episode (VVC), and 26 (36.6%) with RVVC.", {"entities": []}], ["albicans was the main yeast isolated in all clinical profiles.", {"entities": []}], ["The control group (negative culture) comprised 206 women.", {"entities": []}], ["Diabetes mellitus and insulin resistance were more associated with the positive-culture groups (COL, VVC and RVVC) than with negative ones.", {"entities": []}], ["The RVVC group showed lower mean levels of cortisol than the control group and lower antioxidant capacity than all other groups.", {"entities": []}], ["The T Helper/T cytotoxic lymphocyte ratio was similar in all groups.", {"entities": []}], ["The RVVC group showed a similar level of vaginal inflammation to the control group, and lower than in the COL and VVC groups.", {"entities": []}], ["Only the CVV group showed a reduction in vaginal lactobacillus microbiota.", {"entities": []}], ["Our data suggest that both chronic stress (decreased early-morning cortisol levels) and reduced antioxidant capacity can be host predisposing factors to RVVC.", {"entities": []}], ["Cigarette smoking\u2014a crucial modifiable risk factor for organ system diseases and cancer\u2014remains prevalent in the United States and globally.", {"entities": [[81, 87, "DISEASE"]]}], ["In this literature review, we aim to summarize the epidemiology of cigarette smoking and tobacco use in the United States, pharmacology of nicotine\u2014the active constituent of tobacco, and health consequence of cigarette smoking.", {"entities": []}], ["This article also reviews behavioral and pharmacologic interventions for cigarette smokers and provides cost estimates for approved pharmacologic interventions in the United States.", {"entities": []}], ["A literature search was conducted on Google Scholar, EBSCOhost, ClinicalKey, and PubMed databases using the following headings in combination or separately: cigarette smoking, tobacco smoking, epidemiology in the United States, health consequences of cigarette smoking, pharmacologic therapy for cigarette smoking, and non-pharmacologic therapy for cigarette smoking.", {"entities": []}], ["This review found that efficacious non-pharmacologic interventions and pharmacologic therapy are available for cessation of cigarette smoking.", {"entities": []}], ["Given the availability of efficacious interventions for cigarette smoking cessation, concerted efforts should be made by healthcare providers and public health professionals to promote smoking cessation as a valuable approach for reducing non-smokers\u2019 exposure to environmental tobacco smoke.", {"entities": []}], ["Neuroinflammation occurs as a result of microglial activation in response to invading micro-organisms or other inflammatory stimuli within the central nervous system.", {"entities": []}], ["According to our earlier findings, Kr\u00fcppel-like factor 4 (Klf4), a zinc finger transcription factor, is involved in microglial activation and subsequent release of proinflammatory cytokines, tumor necrosis factor alpha, macrophage chemoattractant protein-1 and interleukin-6 as well as proinflammatory enzymes, inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-treated microglial cells.", {"entities": [[58, 62, "GENE"]]}], ["Our current study focuses on finding the molecular mechanism of the anti-inflammatory activities of honokiol in lipopolysaccharide-treated microglia with emphasis on the regulation of Klf4.", {"entities": [[184, 188, "GENE"]]}], ["For in vitro studies, mouse microglial BV-2 cell lines as well as primary microglia were treated with 500 ng/mL lipopolysaccharide as well as 1 \u03bcM and 10 \u03bcM of honokiol.", {"entities": []}], ["We cloned full-length Klf4 cDNA in pcDNA3.1 expression vector and transfected BV-2 cells with this construct using lipofectamine for overexpression studies.", {"entities": [[22, 26, "GENE"]]}], ["For in vivo studies, brain tissues were isolated from BALB/c mice treated with 5 mg/kg body weight of lipopolysaccharide either with or without 2.5 or 5 mg/kg body weight of honokiol.", {"entities": []}], ["Expression of Klf4, cyclooxygenase-2, inducible nitric oxide synthase and phospho-nuclear factor-kappa B was measured using immunoblotting.", {"entities": [[14, 18, "GENE"]]}], ["We also measured the levels of cytokines, reactive oxygen species and nitric oxide in different conditions.", {"entities": []}], ["Our findings suggest that honokiol can substantially downregulate the production of proinflammatory cytokines and inflammatory enzymes in lipopolysaccharide-stimulated microglia.", {"entities": []}], ["In addition, honokiol downregulates lipopolysaccharide-induced upregulation of both Klf4 and phospho-nuclear factor-kappa B in these cells.", {"entities": [[84, 88, "GENE"]]}], ["We also found that overexpression of Klf4 in BV-2 cells suppresses the anti-inflammatory action of honokiol.", {"entities": [[37, 41, "GENE"]]}], ["Honokiol potentially reduces inflammation in activated microglia in a Klf4-dependent manner.", {"entities": []}], ["Helminth infection is frequently associated with the expansion of regulatory T cells (Tregs) and suppression of immune responses to bystander antigens.", {"entities": []}], ["We show that infection of mice with the chronic gastrointestinal helminth Heligmosomoides polygyrus drives rapid polyclonal expansion of Foxp3 in vivo , including suppression of alternatively activated macrophage and granulomatous responses at the sites of infection.", {"entities": [[137, 142, "GENE"]]}], ["IL-2C also increased innate lymphoid cell (ILC) numbers, indicating that Treg functions dominate over ILC effects in this setting.", {"entities": []}], ["Surprisingly, complete removal of Tregs in transgenic Foxp3-DTR mice also resulted in increased worm burdens, with \u201cimmunological chaos\u201d evident in high levels of the pro-inflammatory cytokines IL-6 and interferon-\u03b3.", {"entities": []}], ["In contrast, worm clearance could be induced by anti-CD25 antibody\u2013mediated partial depletion of early Treg, alongside increased T helper type 2 responses and without incurring pathology.", {"entities": []}], ["These findings highlight the overarching importance of the early Treg response to infection and the non-linear association between inflammation and the prevailing Treg frequency.", {"entities": []}], ["Use of smokeless tobacco is common in South Asia.", {"entities": []}], ["Tobacco is a major preventable cause of morbidity and mortality.", {"entities": []}], ["Doctors make one of the best avenues to influence patients' tobacco use.", {"entities": []}], ["However, medical students addicted to tobacco are likely to retain this habit as physicians and are unlikely to counsel patients against using tobacco.", {"entities": []}], ["With this background, this study was conducted with the objective of determining the prevalence of smokeless tobacco among Pakistani medical students.", {"entities": []}], ["A cross sectional study was carried out in three medical colleges of Pakistan \u2013 one from the north and two from the southern region.", {"entities": []}], ["1025 students selected by convenient sampling completed a peer reviewed, pre-tested, self-administered questionnaire.", {"entities": []}], ["Questions were asked regarding lifetime use (at least once or twice in their life), current use (at least once is the last 30 days), and established use (more than 100 times in their life) of smokeless tobacco.", {"entities": []}], ["Chi square and logistic regression analyses were used.", {"entities": []}], ["Two hundred and twenty (21.5%) students had used tobacco in some form (smoked or smokeless) in their lifetime.", {"entities": []}], ["Sixty six (6.4%) students were lifetime users of smokeless tobacco.", {"entities": []}], ["Thirteen (1.3%) were daily users while 18 (1.8%) fulfilled the criterion for established users.", {"entities": []}], ["Niswar was the most commonly used form of smokeless tobacco followed by paan and nass.", {"entities": []}], ["Most naswar users belonged to NWFP while most paan users studied in Karachi.", {"entities": []}], ["On univariate analysis, lifetime use of smokeless tobacco showed significant associations with the use of cigarettes, student gender (M > F), student residence (boarders > day scholars) and location of the College (NWFP > Karachi).", {"entities": []}], ["Multivariate analysis showed independent association of lifetime use of smokeless tobacco with concomitant cigarette smoking, student gender and location of the medical college.", {"entities": []}], ["The use of smokeless tobacco among medical students cannot be ignored.", {"entities": []}], ["The governments should add the goal of eliminating smokeless tobacco to existing drives against cigarette smoking.", {"entities": []}], ["Drives in Karachi should focus more on eliminating paan usage while those in NWFP should focus more on the use of naswar.", {"entities": []}], ["Medical colleges should provide greater education about the myths and hazards of smokeless tobacco.", {"entities": []}], ["To investigate the correlation between respiratory syncytial viral load and length of hospitalization in infants with acute wheezing episodes.", {"entities": []}], ["This was a two-year, cross-sectional study of infants \u2264 12 months of age with bronchiolitis at the time of admission to a tertiary hospital.", {"entities": [[78, 91, "DISEASE"]]}], ["For the identification of respiratory viruses, nasopharyngeal secretions were collected.", {"entities": []}], ["Samples were analyzed (throughout the study period) by direct immunofluorescence and (in the second year of the study) by quantitative real-time PCR.", {"entities": []}], ["We screened for three human viruses: rhinovirus, respiratory syncytial virus, and metapneumovirus.", {"entities": []}], ["Of 110 samples evaluated by direct immunofluorescence, 56 (50.9%) were positive for a single virus, and 16 (14.5%) were positive for two or more viruses.", {"entities": []}], ["Among those 72 samples, the most prevalent virus was respiratory syncytial virus, followed by influenza.", {"entities": [[94, 103, "DISEASE"]]}], ["Of 56 samples evaluated by quantitative real-time PCR, 24 (42.8%) were positive for a single virus, and 1 (1.7%) was positive for two viruses.", {"entities": []}], ["Among those 25 samples, the most prevalent virus was again respiratory syncytial virus, followed by human rhinovirus.", {"entities": []}], ["Coinfection did not influence the length of the hospital stay or other outcome s. In addition, there was no association between respiratory syncytial virus load and the length of hospitalization.", {"entities": []}], ["Neither coinfection nor respiratory syncytial viral load appears to influence the outcomes of acute bronchiolitis in infants.", {"entities": [[100, 113, "DISEASE"]]}], ["Biological network data, such as metabolic-, signaling- or physical interaction graphs of proteins are increasingly available in public repositories for important species.", {"entities": []}], ["Tools for the quantitative analysis of these networks are being developed today.", {"entities": []}], ["Protein network-based drug target identification methods usually return protein hubs with large degrees in the networks as potentially important targets.", {"entities": []}], ["Some known, important protein targets, however, are not hubs at all, and perturbing protein hubs in these networks may have several unwanted physiological effects, due to their interaction with numerous partners.", {"entities": []}], ["Here, we show a novel method applicable in networks with directed edges (such as metabolic networks) that compensates for the low degree (non-hub) vertices in the network, and identifies important nodes, regardless of their hub properties.", {"entities": []}], ["Our method computes the PageRank for the nodes of the network, and divides the PageRank by the in-degree (i.e., the number of incoming edges) of the node.", {"entities": []}], ["This quotient is the same in all nodes in an undirected graph (even for large- and low-degree nodes, that is, for hubs and non-hubs as well), but may differ significantly from node to node in directed graphs.", {"entities": []}], ["We suggest to assign importance to non-hub nodes with large PageRank/in-degree quotient.", {"entities": []}], ["Consequently, our method gives high scores to nodes with large PageRank, relative to their degrees: therefore non-hub important nodes can easily be identified in large networks.", {"entities": []}], ["We demonstrate that these relatively high PageRank scores have biological relevance: the method correctly finds numerous already validated drug targets in distinct organisms ( Mycobacterium tuberculosis, Plasmodium falciparum and MRSA Staphylococcus aureus ), and consequently, it may suggest new possible protein targets as well.", {"entities": [[190, 202, "DISEASE"]]}], ["Additionally, our scoring method was not chosen arbitrarily: its value for all nodes of all undirected graphs is constant; therefore its high value captures importance in the directed edge structure of the graph.", {"entities": []}], ["Allergic rhinitis is associated with elevated serum IgE levels.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["IgE response is mediated by the high-affinity IgE receptor (Fc\u03b5RI), which is polymorphic.", {"entities": []}], ["Studies analyzing the association between allergic rhinitis and Fc\u03b5RI variants have been conducted with controversial results.", {"entities": [[42, 59, "DISEASE"], [51, 59, "DISEASE"]]}], ["The objective of this study is to analyze, in 1,041 individuals, the putative clinical association of allergic rhinitis with common polymorphisms in Fc\u03b5RI subunits genes.", {"entities": [[102, 119, "DISEASE"], [111, 119, "DISEASE"]]}], ["These SNPs included FECR1A rs2494262, rs2427837 and rs2251746; FECR1B rs1441586, rs569108 and rs512555; FCER1G rs11587213, rs2070901 and rs11421.", {"entities": [[104, 110, "GENE"]]}], ["Statistically significant differences were observed for the FCER1B rs569108 and rs512555 polymorphisms frequencies when comparing patients with allergic rhinitis without asthma and controls.", {"entities": [[144, 161, "DISEASE"], [153, 161, "DISEASE"], [170, 176, "DISEASE"]]}], ["The OR (95% CI) value for the 237Gly allele (rs569108) is equal to 0.26 (0.08\u20130.86, P\u2009=\u20090.017) and for the G allele (rs512555) it is equal to 0.27 (0.08\u20130.88, P\u2009=\u20090.020).", {"entities": []}], ["These two SNPs are linked (D\u2019\u2009=\u20091.0, LOD\u2009=\u200956.05).", {"entities": []}], ["Also observed was a statistically significant trend towards lower IgE values among allergic rhinitis patients with variant alleles for both SNPs.", {"entities": [[83, 100, "DISEASE"], [92, 100, "DISEASE"]]}], ["In conclusion, in patients with allergic rhinitis without asthma, the FCER1B rs569108 and rs512555 polymorphisms are associated with increased risk of developing allergic rhinitis and with lower IgE levels.", {"entities": [[32, 49, "DISEASE"], [162, 179, "DISEASE"], [41, 49, "DISEASE"], [171, 179, "DISEASE"], [58, 64, "DISEASE"]]}], ["Obesity influences metabolism and increases the incidence of clinical complications and worsens outcomes in pediatric burn patients.", {"entities": []}], ["Retrospective, single-center study.", {"entities": []}], ["Five hundred ninety-two severely burned pediatric patients who had burns covering more than 30% of the total body surface area and who were treated between 2001 and 2008 were enrolled in this study.", {"entities": []}], ["Patients were divided into \u2265 85th percentile (n = 277) and normal (n = 315) weight groups based on body mass index percentiles.", {"entities": []}], ["Patients stratified below (normal) and \u2265 85 p < 0.05 for both) as well as high levels of triglycerides and the acute-phase protein, C-reactive protein ( p < 0.05 for both) up to 60 days after injury.", {"entities": []}], ["Patients \u2265 85 p < 0.001).", {"entities": []}], ["Insulin-dependent or type 1 diabetes is a prototypic autoimmune disease whose incidence steadily increased over the past decades in industrialized countries.", {"entities": []}], ["Recent evidence suggests the importance of the gut microbiota to explain this trend.", {"entities": []}], ["Here, non-obese diabetic (NOD) mice that spontaneously develop autoimmune type 1 diabetes were treated with different antibiotics to explore the influence of a targeted intestinal dysbiosis in the progression of the disease.", {"entities": []}], ["A mixture of wide spectrum antibiotics (i.e.", {"entities": []}], ["streptomycin, colistin and ampicillin) or vancomycin alone were administered orally from the moment of conception, treating breeding pairs, and during the postnatal and adult life until the end of follow-up at 40 weeks.", {"entities": []}], ["Diabetes incidence significantly and similarly increased in male mice following treatment with these two antibiotic regimens.", {"entities": []}], ["In NOD females a slight yet not significant trend towards an increase in disease incidence was observed.", {"entities": []}], ["Changes in gut microbiota composition were assessed by sequencing the V3 region of bacterial 16S rRNA genes.", {"entities": []}], ["Administration of the antibiotic mixture resulted in near complete ablation of the gut microbiota.", {"entities": []}], ["Vancomycin treatment led to increased Escherichia , Lactobacillus and Sutterella genera and decreased members of the Clostridiales order and Lachnospiraceae , Prevotellaceae and Rikenellaceae families, as compared to control mice.", {"entities": []}], ["Massive elimination of IL-17-producing cells, both CD4+TCR\u03b1\u03b2+ and TCR\u03b3\u03b4+ T cells was observed in the lamina propria of the ileum and the colon of vancomycin-treated mice.", {"entities": []}], ["These results show that a directed even partial ablation of the gut microbiota, as induced by vancomycin, significantly increases type 1 diabetes incidence in male NOD mice thus prompting for caution in the use of antibiotics in pregnant women and newborns.", {"entities": []}], ["Polymorphism in the neuropeptide S receptor gene NPSR1 is associated with asthma and inflammatory bowel disease.", {"entities": [[85, 111, "DISEASE"], [74, 80, "DISEASE"], [49, 54, "GENE"]]}], ["NPSR1 is expressed in the brain, where it modulates anxiety and responses to stress, but also in other tissues and cell types including lymphocytes, the lungs, and the intestine, where it appears to be up-regulated in inflammation.", {"entities": [[0, 5, "GENE"]]}], ["We sought to determine whether genetic variability at the NPSR1 locus influences the susceptibility and clinical manifestation of rheumatoid arthritis (RA).", {"entities": [[130, 150, "DISEASE"], [141, 150, "DISEASE"], [58, 63, "GENE"]]}], ["From the Epidemiological Investigation of Rheumatoid Arthritis (EIRA) case-control study, 1,888 rheumatoid arthritis patients and 888 controls were genotyped for 19 single-nucleotide polymorphisms (SNPs) spanning the entire NPSR1 gene and 220 KB of DNA on chromosome 7p14.", {"entities": [[42, 62, "DISEASE"], [96, 116, "DISEASE"], [53, 62, "DISEASE"], [107, 116, "DISEASE"], [224, 229, "GENE"]]}], ["The association between individual genetic markers and their haplotypic combinations, respectively, and diagnosis of RA, presence of autoantibodies to citrullinated proteins (ACPA), and disease activity score based on 28 joints (DAS28) was tested.", {"entities": []}], ["There was no association between diagnosis of RA and NPSR1 variants.", {"entities": [[53, 58, "GENE"]]}], ["However, several associations of nominal significance were detected concerning susceptibility to ACPA-negative RA and disease activity measures (DAS28).", {"entities": []}], ["Among these, the association of SNP rs324987 with ACPA-negative RA [(p\u200a=\u200a0.004, OR\u200a=\u200a0.674 (95% CI 0.512\u20130.888)] and that of SNP rs10263447 with DAS28 [p\u200a=\u200a0.0002, OR\u200a=\u200a0.380 (95% CI 0.227\u20130.635)] remained significant after correction for multiple comparisons.", {"entities": []}], ["NPSR1 polymorphism may be relevant to RA susceptibility and its clinical manifestation.", {"entities": [[0, 5, "GENE"]]}], ["Specific alleles at the NPSR1 locus may represent common risk factors for chronic inflammatory diseases, including RA.", {"entities": [[24, 29, "GENE"]]}], ["Staphylococcus aureus is a versatile human pathogen that produces an array of virulence factors, including several proteases.", {"entities": []}], ["Of these, six proteases called the Spls are the least characterized.", {"entities": []}], ["Previous evidence suggests that the Spls are expressed during human infection; however, their function is unknown.", {"entities": []}], ["Our study shows that the Spls are required for S.\u00a0aureus to cause disseminated lung damage during pneumonia.", {"entities": [[98, 107, "DISEASE"]]}], ["Further, we present the first example of a human protein cut by an Spl protease.", {"entities": []}], ["Although the Spls were predicted not to cut staphylococcal proteins, we also show that an spl mutant has altered abundance of both secreted and surface-associated proteins.", {"entities": []}], ["This work provides novel insight into the function of Spls during infection and their potential ability to degrade both staphylococcal and human proteins.", {"entities": []}], ["The Spl proteases are a group of six serine proteases that are encoded on the \u03bdSa\u03b2 pathogenicity island and are unique to Staphylococcus aureus .", {"entities": []}], ["Despite their interesting biochemistry, their biological substrates and functions in virulence have been difficult to elucidate.", {"entities": []}], ["We found that an spl operon mutant of the community-associated methicillin-resistant S.\u00a0aureus USA300 strain LAC induced localized lung damage in a rabbit model of pneumonia, characterized by bronchopneumonia observed histologically.", {"entities": [[164, 173, "DISEASE"], [192, 208, "DISEASE"]]}], ["Disease in the mutant-infected rabbits was restricted in distribution compared to that in wild-type USA300-infected rabbits.", {"entities": []}], ["We also found that SplA is able to cleave the mucin 16 glycoprotein from the surface of the CalU-3 lung cell line, suggesting a possible mechanism for wild-type USA300 spreading pneumonia to both lungs.", {"entities": [[178, 187, "DISEASE"]]}], ["Investigation of the secreted and surface proteomes of wild-type USA300 and the spl mutant revealed multiple alterations in metabolic proteins and virulence factors.", {"entities": []}], ["This study demonstrates that the Spls modulate S.\u00a0aureus physiology and virulence, identifies a human target of SplA, and suggests potential S.\u00a0aureus targets of the Spl proteases.", {"entities": []}], ["IMPORTANCE Staphylococcus aureus is a versatile human pathogen that produces an array of virulence factors, including several proteases.", {"entities": []}], ["Of these, six proteases called the Spls are the least characterized.", {"entities": []}], ["Previous evidence suggests that the Spls are expressed during human infection; however, their function is unknown.", {"entities": []}], ["Our study shows that the Spls are required for S.\u00a0aureus to cause disseminated lung damage during pneumonia.", {"entities": [[98, 107, "DISEASE"]]}], ["Further, we present the first example of a human protein cut by an Spl protease.", {"entities": []}], ["Although the Spls were predicted not to cut staphylococcal proteins, we also show that an spl mutant has altered abundance of both secreted and surface-associated proteins.", {"entities": []}], ["This work provides novel insight into the function of Spls during infection and their potential ability to degrade both staphylococcal and human proteins.", {"entities": []}], ["Patient acceptability of a medicinal product is a key aspect in the development and prescribing of medicines.", {"entities": []}], ["Children and older adults differ in many aspects from the other age subsets of population and require particular considerations in medication acceptability.", {"entities": []}], ["This review highlights the similarities and differences in these two age groups in relation to factors affecting acceptability of medicines.", {"entities": []}], ["New and conventional formulations of medicines are considered regarding their appropriateness for use in children and older people.", {"entities": []}], ["Aspects of a formulation that impact acceptability in these patient groups are discussed, including, for example, taste/smell/viscosity of a liquid and size/shape of a tablet.", {"entities": []}], ["A better understanding of the acceptability of existing formulations highlights opportunities for the development of new and more acceptable medicines and facilitates safe and effective prescribing for the young and older populations.", {"entities": []}], ["The online version of this article (doi:10.1007/s40265-014-0297-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Type 1 diabetes is an autoimmune disease, while allergic contact dermatitis although immune mediated, is considered an exposure driven disease that develops due to epicutanous contact with reactive low-molecular chemicals.", {"entities": [[57, 75, "DISEASE"], [48, 75, "DISEASE"], [65, 75, "DISEASE"]]}], ["The objective of the present study was to experimentally study the effect of contact allergens on the development of diabetes in NOD mice.", {"entities": []}], ["As the link between contact allergy and diabetes is yet unexplained we also examined the effect of provocation with allergens on Natural Killer T (NKT) cells, since involvement of NKT cells could suggest an innate connection between the two diseases.", {"entities": []}], ["NOD mice 4 weeks of age were exposed, on the ears, to two allergens, p-phenylenediamine and 2,4-dinitrochlorobenzene respectively, to investigate the diabetes development.", {"entities": []}], ["The mice were followed for a maximum of 32 weeks, and they were either repeatedly exposed to the allergens or only sensitized a week after arrival.", {"entities": []}], ["The stimulation of NKT cells by the two allergens were additionally studied in C57BL/6 mice.", {"entities": []}], ["The mice were sensitized and two weeks later provocated with the allergens.", {"entities": []}], ["The mice were subsequently euthanized at different time points after the provocation.", {"entities": []}], ["It was found that repeated application of p-phenylenediamine reduced the incidence of diabetes compared to application with water (47% vs. 93%, P\u200a=\u200a0.004).", {"entities": []}], ["Moreover it was shown that in C57BL/6 mice both allergens resulted in a slight increment in the quantity of NKT cells in the liver.", {"entities": []}], ["Application of the allergens at the same time resulted in an increased number of NKT cells in the draining auricular lymph node, and the increase appeared to be somewhat allergen specific as the accumulation was stronger for p-phenylenediamine.", {"entities": []}], ["The study showed that repeated topical application on the ears with a contact allergen could prevent the development of diabetes in NOD mice.", {"entities": []}], ["The contact allergens gave a non-visible, sub-clinical dermatitis on the application site.", {"entities": [[55, 65, "DISEASE"]]}], ["The preventive effect on diabetes may be due to stimulation of peripheral NKT cells, as shown for provocation with p-phenylenediamine in the C57BL/6 mouse.", {"entities": []}], ["This epicutanous procedure may lead to new strategies in prevention of type 1 diabetes in humans.", {"entities": []}], ["Studies on the association of birth by caesarean section (C/S) and allergies have produced conflicting findings.", {"entities": []}], ["Furthermore, evidence on whether this association may differ in those at risk of atopy is limited.", {"entities": []}], ["This study aims to investigate the association of mode of delivery with asthma and atopic sensitization and the extent to which any effect is modified by family history of allergies.", {"entities": [[72, 78, "DISEASE"]]}], ["Asthma outcomes were assessed cross-sectionally in 2216 children at age 8 on the basis of parents\u2019 responses to the ISAAC questionnaire whilst skin prick tests to eleven aeroallergens were also performed in a subgroup of 746 children.", {"entities": [[0, 6, "DISEASE"]]}], ["Adjusted odds ratios of asthma and atopy by mode of delivery were estimated in multivariable logistic models while evidence of effect modification was examined by introducing interaction terms in the models.", {"entities": [[24, 30, "DISEASE"]]}], ["After adjusting for potential confounders, children born by C/S appeared significantly more likely than those born vaginally to report ever wheezing (OR 1.36, 95% CI 1.07-1.71), asthma diagnosis (OR 1.41, 95% CI 1.09-1.83) and be atopic (OR 1.67, 95% CI 1.08-2.60).", {"entities": [[178, 184, "DISEASE"]]}], ["There was modest evidence that family history of allergies may modify the effect of C/S delivery on atopy (p for effect modification=0.06) but this was not the case for the asthma outcomes.", {"entities": [[173, 179, "DISEASE"]]}], ["Specifically, while more than a two-fold increase in the odds of being a topic was observed in children with a family history of allergies if born by C/S (OR 2.62, 95% CI 1.38-5.00), no association was observed in children without a family history of allergies (OR 1.16, 95% CI 0.64-2.11).", {"entities": []}], ["Birth by C/S is associated with asthma and atopic sensitization in childhood.", {"entities": [[32, 38, "DISEASE"]]}], ["The association of C/S and atopy appears more pronounced in children with family history of allergies.", {"entities": []}], ["Background: The prevalence of autistic disorder (AD), a serious developmental condition, has risen dramatically over the past two decades, but high-quality population-based research addressing etiology is limited.", {"entities": [[30, 47, "DISEASE"]]}], ["Objectives: We studied the influence of exposures to traffic-related air pollution during pregnancy on the development of autism using data from air monitoring stations and a land use regression (LUR) model to estimate exposures.", {"entities": []}], ["Methods: Children of mothers who gave birth in Los Angeles, California, who were diagnosed with a primary AD diagnosis at 3\u20135 years of age during 1998\u20132009 were identified through the California Department of Developmental Services and linked to 1995\u20132006 California birth certificates.", {"entities": []}], ["For 7,603 children with autism and 10 controls per case matched by sex, birth year, and minimum gestational age, birth addresses were mapped and linked to the nearest air monitoring station and a LUR model.", {"entities": []}], ["We used conditional logistic regression, adjusting for maternal and perinatal characteristics including indicators of SES.", {"entities": []}], ["Results: Per interquartile range (IQR) increase, we estimated a 12\u201315% relative increase in odds of autism for ozone [odds ratio (OR) = 1.12, 95% CI: 1.06, 1.19; per 11.54-ppb increase] and particulate matter \u2264 2.5 \u00b5m (OR = 1.15; 95% CI: 1.06, 1.24; per 4.68-\u03bcg/m Conclusion: Measured and estimated exposures from ambient pollutant monitors and LUR model suggest associations between autism and prenatal air pollution exposure, mostly related to traffic sources.", {"entities": []}], ["Oxidative stress plays a critical role in the pathophysiology of a wide range of diseases including cancer.", {"entities": [[100, 106, "DISEASE"]]}], ["This view has broadened significantly with the recent discoveries that reactive oxygen species initiated lipid peroxidation leads to the formation of potentially toxic lipid aldehyde species such as 4-hydroxy-trans-2-nonenal (HNE), acrolein, and malondialdehyde which activate various signaling intermediates that regulate cellular activity and dysfunction via a process called redox signaling.", {"entities": []}], ["The lipid aldehyde species formed during synchronized enzymatic pathways result in the posttranslational modification of proteins and DNA leading to cytotoxicity and genotoxicty.", {"entities": []}], ["Among the lipid aldehyde species, HNE has been widely accepted as a most toxic and abundant lipid aldehyde generated during lipid peroxidation.", {"entities": []}], ["HNE and its glutathione conjugates have been shown to regulate redox-sensitive transcription factors such as NF- \u03ba B and AP-1 via signaling through various protein kinase cascades.", {"entities": []}], ["Activation of redox-sensitive transcription factors and their nuclear localization leads to transcriptional induction of several genes responsible for cell survival, differentiation, and death.", {"entities": []}], ["In this review, we describe the mechanisms by which the lipid aldehydes transduce activation of NF- \u03ba B signaling pathways that may help to develop therapeutic strategies for the prevention of a number of inflammatory diseases.", {"entities": []}], ["Little is known about the acute effects of ozone on morbidity risk in China.", {"entities": []}], ["We conducted a time-series study to examine the association between ozone and daily emergency room visits (ERVs) in Beijing, China.", {"entities": []}], ["We identified 7,088,309 ERVs between January 1, 2014 and December 31, 2015.", {"entities": []}], ["A generalized additive model with Poisson regression incorporating penalized spline functions was employed to analyze ERVs in association with daily 8-h maximum ozone concentrations.", {"entities": []}], ["An increase of 10\u2009\u03bcg/m 2.5 , PM 10 , NO 2 , SO 2 , and CO.", {"entities": []}], ["In conclusion, our findings suggested significant effects of ozone exposure on daily ERVs in Beijing.", {"entities": []}], ["Improving air quality with even lower ozone level than the current CAAQS could yield important public health.", {"entities": []}], ["Dental caries remains the most prevalent chronic condition in children and a major contributor to poor general health.", {"entities": []}], ["There is ample evidence of a skewed distribution of oral health, with a small proportion of children in the population bearing the majority of the burden of the disease.", {"entities": []}], ["This minority group is comprised disproportionately of socioeconomically disadvantaged children.", {"entities": []}], ["An in-depth longitudinal study is needed to better understand the determinants of child oral health, in order to support effective evidence-based policies and interventions in improving child oral health.", {"entities": []}], ["The aim of the Study of Mothers\u2019 and Infants\u2019 Life Events Affecting Oral Health (SMILE) project is to identify and evaluate the relative importance and timing of critical factors that shape the oral health of young children and then to seek to evaluate those factors in their inter-relationship with socioeconomic influences.", {"entities": []}], ["This investigation will apply an observational prospective study design to a cohort of socioeconomically-diverse South Australian newborns and their mothers, intensively following these dyads as the children grow to toddler age.", {"entities": []}], ["Mothers of newborn children will be invited to participate in the study in the early post-partum period.", {"entities": []}], ["At enrolment, data will be collected on parental socioeconomic status, mothers\u2019 general and dental health conditions, details of the pregnancy, infant feeding practice and parental health behaviours and practices.", {"entities": []}], ["Data on diet and feeding practices, oral health behaviours and practices, and dental visiting patterns will be collected at 3, 6, 12 and 24 months of age.", {"entities": []}], ["When children turn 24-30 months, the children and their mothers/primary care givers will be invited to an oral examination to record oral health status.", {"entities": []}], ["Anthropometric assessment will also be conducted.", {"entities": []}], ["This prospective cohort study will examine a wide range of determinants influencing child oral health and related general conditions such as overweight.", {"entities": []}], ["It will lead to the evaluation of the inter-relationship among main influences and their relative effect on child oral health.", {"entities": []}], ["The study findings will provide high level evidence of pathways through which socio-environmental factors impact child oral health.", {"entities": []}], ["It will also provide an opportunity to examine the relationship between oral health and childhood overweight.", {"entities": []}], ["Moraxella catarrhalis is a gram negative diplococcus that causes a variety of upper and lower respiratory tract infections.", {"entities": []}], ["Patients with malignant, hematological disorders treated with intensive cytotoxic chemotherapy, and recipients of various forms of haematopoietic stem cell transplant receiving immunosuppressive agents are at high risk of developing severe infections and septic complications.", {"entities": []}], ["Early detection of the organism and prompt treatment with appropriate antibiotics provide both resolution of the infection and prevention of further consequences.", {"entities": []}], ["Two patients with haematopoietic stem cell transplant who developed pneumonia caused by M. catarrhalis at King Faisal Specialist Hospital and Research Centre in Riyadh are reported and the literature is reviewed.", {"entities": [[68, 77, "DISEASE"]]}], ["To our knowledge, these are the first case reports of M. catarrhalis pneumonia in haematopoietic stem cell transplant patients.", {"entities": [[69, 78, "DISEASE"]]}], ["Aldehydes are electrophilic compounds to which humans are pervasively exposed.", {"entities": []}], ["Despite a significant health risk due to exposure, the mechanisms of aldehyde toxicity are poorly understood.", {"entities": []}], ["This ambiguity is likely due to the structural diversity of aldehyde derivatives and corresponding differences in chemical reactions and biological targets.", {"entities": []}], ["To gain mechanistic insight, we have used parameters based on the hard and soft, acids and bases (HSAB) theory to profile the different aldehyde subclasses with respect to electronic character (softness, hardness), electrophilic reactivity (electrophilic index), and biological nucleophilic targets.", {"entities": []}], ["Our analyses indicate that short chain aldehydes and longer chain saturated alkanals are hard electrophiles that cause toxicity by forming adducts with hard biological nucleophiles, e.g., primary nitrogen groups on lysine residues.", {"entities": []}], ["In contrast, \u03b1,\u03b2-unsaturated carbonyl derivatives, alkenals, and the \u03b1-oxoaldehydes are soft electrophiles that preferentially react with soft nucleophilic thiolate groups on cysteine residues.", {"entities": []}], ["The aldehydes can therefore be grouped into subclasses according to common electronic characteristics (softness/hardness) and molecular mechanisms of toxicity.", {"entities": []}], ["As we will discuss, the toxic potencies of these subgroups are generally related to corresponding electrophilicities.", {"entities": []}], ["For some aldehydes, however, predictions of toxicity based on electrophilicity are less accurate due to inherent physicochemical variables that limit target accessibility, e.g., steric hindrance and solubility.", {"entities": []}], ["The unsaturated aldehydes are also members of the conjugated type-2 alkene chemical class that includes \u03b1,\u03b2-unsaturated amide, ketone, and ester derivatives.", {"entities": []}], ["Type-2 alkenes are electrophiles of varying softness and electrophilicity that share a common mechanism of toxicity.", {"entities": []}], ["Therefore, exposure to an environmental mixture of unsaturated carbonyl derivatives could cause \u201ctype-2 alkene toxicity\u201d through additive interactions.", {"entities": []}], ["Finally, we propose that environmentally derived aldehydes can accelerate diseases by interacting with endogenous aldehydes generated during oxidative stress.", {"entities": []}], ["This review provides a basis for understanding aldehyde mechanisms and environmental toxicity through the context of electronic structure, electrophilicity, and nucleophile target selectivity.", {"entities": []}], ["Epidemiologic reports by C.A.", {"entities": []}], ["Pope III et.", {"entities": []}], ["demonstrated that in the Utah Valley, closure of an open-hearth steel mill over the winter of 1987 was associated with reductions in respiratory disease and related hospital admissions in valley residents.", {"entities": []}], ["To better examine the relationship between plant-associated changes in ambient particulate matter (PM) and respiratory health effects, we obtained total suspended particulate filters originally collected near the steel mill during the winter of 1986 (before closure), 1987 (during closure), and 1988 (after plant reopening).", {"entities": []}], ["PM subcomponents were water-extracted from these filters and Sprague-Dawley rats were intratracheally instilled with equivalent masses of extract.", {"entities": []}], ["Data indicated that 24 hr later, rats exposed to 1986 or 1988 extracts developed significant pulmonary injury and neutrophilic inflammation.", {"entities": [[23, 25, "GENE"]]}], ["Additionally, 50% of rats exposed to 1986 or 1988 extracts had increased airway responsiveness to acetylcholine, compared to 17 and 25% of rats exposed to saline or the 1987 extract, respectively.", {"entities": []}], ["By 96 hr, these effects were largely resolved except for increases in lung lavage fluid neutrophils and lymphocytes in 1986 extract-exposed rats.", {"entities": [[6, 8, "GENE"]]}], ["Analogous effects were observed with lung histologic assessment.", {"entities": []}], ["Extract analysis using inductively coupled plasma-mass spectroscopy demonstrated in all three extracts nearly 70% of the mass appeared to be sodium-based salts derived from the glass filter matrix.", {"entities": []}], ["Interestingly, relative to the 1987 extract, the 1986/1988 extracts contained more sulfate, cationic salts (i.e., calcium, potassium, magnesium), and certain metals (i.e., copper, zinc, iron, lead, strontium, arsenic, manganese, nickel).", {"entities": []}], ["Although total metal content was (3/4) 1% of the extracts by mass, the greater quantity detected in the 1986 and 1988 extracts suggests metals may be important determinants of the pulmonary toxicity observed.", {"entities": []}], ["In conclusion, the pulmonary effects induced by exposure of rats to water-based extracts of local ambient PM filters were in good accord with the cross-sectional epidemiologic reports of adverse respiratory health effects in Utah Valley residents.", {"entities": []}], ["Matrix metalloproteinase-9 (MMP-9) plays an important role in the acute periods of spinal cord injury (SCI), and its expression is related to the inflammation which could cause the disruption of the blood-spinal barrier (BBB).", {"entities": []}], ["Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor that plays a crucial role in cytoprotection against inflammation.", {"entities": []}], ["The present study investigated the role of Nrf2 in upregulating of nuclear factor kappa B (NF- \u03ba B) activity, tumor necrosis factor- \u03b1 (TNF- \u03b1 ), and MMP-9 after SCI.", {"entities": []}], ["Wild-type Nrf2 (+/+) and Nrf2-deficient (Nrf (\u2212/\u2212)) mice were subjected to an SCI model induced by the application of vascular clips (force of 10\u2009g) to the dura after a three-level T8-T10 laminectomy.", {"entities": []}], ["We detected the wet/dry weight ratio of impaired spinal cord tissue, the activation of NF- \u03ba B, the mRNA and protein levels of TNF- \u03b1 and MMP-9, and the enzyme activity of MMP-9.", {"entities": []}], ["Nrf2 (\u2212/\u2212) mice were demonstrated to have more spinal cord edema, NF- \u03ba B activation, TNF- \u03b1 production, and MMP-9 expression after SCI compared with the wild-type controls.", {"entities": []}], ["The results suggest that Nrf2 may play an important role in limiting the upregulation of NF- \u03ba B activity, TNF- \u03b1 , and MMP-9 in spinal cord after SCI.", {"entities": []}], ["Differences in clinical presentation and outcomes among patients infected with pandemic 2009 influenza A H1N1 (pH1N1) compared to other respiratory viruses have not been fully elucidated.", {"entities": [[93, 102, "DISEASE"]]}], ["A retrospective study was performed of all hospitalized patients at the peak of the pH1N1 season in whom a single respiratory virus was detected by a molecular assay targeting 18 viruses/subtypes (RVP, Luminex xTAG).", {"entities": []}], ["Fifty-two percent (615/1192) of patients from October, 2009 to December, 2009 had a single respiratory virus (291 pH1N1; 207 rhinovirus; 45 RSV A/B; 37 parainfluenza; 27 adenovirus; 6 coronavirus; and 2 metapneumovirus).", {"entities": []}], ["No seasonal influenza A or B was detected.", {"entities": [[12, 21, "DISEASE"]]}], ["Individuals with pH1N1, compared to other viruses, were more likely to present with fever (92% & 70%), cough (92% & 86%), sore throat (32% & 16%), nausea (31% & 8%), vomiting (39% & 30%), abdominal pain (14% & 7%), and a lower white blood count (8,500/L & 13,600/L, all p-values<0.05).", {"entities": []}], ["In patients with cough and gastrointestinal complaints, the presence of subjective fever/chills independently raised the likelihood of pH1N1 (OR 10).", {"entities": []}], ["Fifty-five percent (336/615) of our cohort received antibacterial agents, 63% (385/615) received oseltamivir, and 41% (252/615) received steroids.", {"entities": []}], ["The mortality rate of our cohort was 1% (7/615) and was higher in individuals with pH1N1 compared to other viruses (2.1% & 0.3%, respectively; p\u200a=\u200a0.04).", {"entities": []}], ["During the peak pandemic 2009\u20132010 influenza season in Rhode Island, nearly half of patients admitted with influenza-like symptoms had respiratory viruses other than influenza A.", {"entities": [[35, 44, "DISEASE"], [107, 116, "DISEASE"], [166, 175, "DISEASE"]]}], ["A high proportion of patients were treated with antibiotics and pH1N1 infection had higher mortality compared to other respiratory viruses.", {"entities": []}], ["Eczema is common in children and in the UK most cases are managed in primary care.", {"entities": []}], ["The foundation of all treatment is the regular use of leave-on emollients to preserve and restore moisture to the skin.", {"entities": []}], ["This not only improves comfort but may also reduce the need for rescue treatment for \u2018flares\u2019, such as topical corticosteroids.", {"entities": []}], ["However, clinicians can prescribe many different types of emollient and there is a paucity of evidence to guide this choice.", {"entities": []}], ["One reason for this may be the challenges of conducting a clinical trial: are parents or carers of young children willing to be randomly allocated an emollient and followed up for a meaningful amount of time?", {"entities": []}], ["This is a single-centre feasibility study of a pragmatic, four-arm, single-masked, randomized trial.", {"entities": []}], ["Children with eczema who are eligible (from 1 month to less than 5 years of age, not known to be sensitive or allergic to any of study emollients or their constituents) are recruited via their general practices.", {"entities": []}], ["Participants are allocated Aveeno\u00ae lotion, Diprobase\u00ae cream, Doublebase\u00ae gel or Hydromol\u00ae ointment via a web-based system, using a simple randomization process in a 1:1:1:1 fashion.", {"entities": []}], ["Researchers are masked to the study emollient.", {"entities": []}], ["Participants are assessed at baseline and followed up for 3 months.", {"entities": []}], ["Data are collected by daily diaries, monthly researcher visits and review of electronic medical records.", {"entities": []}], ["Because this is a feasibility study, a formal sample size calculation for the estimation of treatment effectiveness has not be made but we aim to recruit 160 participants.", {"entities": []}], ["Recruitment is on-going.", {"entities": []}], ["At the end of the study, as well as being able to answer the question, \u2018Is it is possible to recruit and retain children with eczema from primary care into a four-arm randomized trial of emollients?\u2019, we will also have collected important data on the acceptability and effectiveness of four commonly used emollients.", {"entities": []}], ["Current Controlled Trials ISRCTN21828118 and Clinical Trials Register EudraCT2013-003001-26.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-015-0830-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options.", {"entities": [[11, 29, "DISEASE"]]}], ["To better understand the inflammatory responses that precede and concur with collagen deposition, we used three models of pulmonary fibrosis and identify a critical mechanistic role for IL-17A.", {"entities": [[122, 140, "DISEASE"]]}], ["After exposure to bleomycin (BLM), but not Schistosoma mansoni eggs, IL-17A produced by CD4 il17a mice confirmed an essential role for IL-17A.", {"entities": [[29, 32, "GENE"], [88, 91, "GENE"], [92, 97, "GENE"]]}], ["Mechanistically, using ifn\u03b3 , il10 , il10 , and il10 mice and TGF-\u03b2 blockade, we demonstrate that IL-17A\u2013driven fibrosis is suppressed by IL-10 and facilitated by IFN-\u03b3 and IL-12/23p40.", {"entities": [[30, 34, "GENE"], [37, 41, "GENE"], [48, 52, "GENE"], [30, 34, "GENE"], [37, 41, "GENE"], [48, 52, "GENE"], [30, 34, "GENE"], [37, 41, "GENE"], [48, 52, "GENE"]]}], ["BLM-induced IL-17A production was also TGF-\u03b2 dependent, and recombinant IL-17A\u2013mediated fibrosis required TGF-\u03b2, suggesting cooperative roles for IL-17A and TGF-\u03b2 in the development of fibrosis.", {"entities": []}], ["Finally, we show that fibrosis induced by IL-1\u03b2, which mimics BLM-induced fibrosis, is also highly dependent on IL-17A.", {"entities": []}], ["IL-17A and IL-1\u03b2 were also increased in the bronchoalveolar lavage fluid of patients with IPF.", {"entities": []}], ["Together, these studies identify a critical role for IL-17A in fibrosis, illustrating the potential utility of targeting IL-17A in the treatment of drug and inflammation-induced fibrosis.", {"entities": []}], ["Flaxseed (FS), a nutritional supplement consisting mainly of omega-3 fatty acids and lignan phenolics has potent anti-inflammatory, anti-fibrotic and antioxidant properties.", {"entities": []}], ["The usefulness of flaxseed as an alternative and complimentary treatment option has been known since ancient times.", {"entities": []}], ["We have shown that dietary FS supplementation ameliorates oxidative stress and inflammation in experimental models of acute and chronic lung injury in mice resulting from diverse toxicants.", {"entities": []}], ["The development of lung tissue damage in response to direct or indirect oxidant stress is a complex process, associated with changes in expression levels of a number of genes.", {"entities": []}], ["We therefore postulated that flaxseed might modulate gene expression of vital signaling pathways, thus interfering with the development of tissue injury.", {"entities": []}], ["We evaluated gene expression in lungs of flaxseed-fed (10%FS) mice under unchallenged, control conditions.", {"entities": []}], ["We reasoned that array technology would provide a powerful tool for studying the mechanisms behind this response and aid the evaluation of dietary flaxseed intervention with a focus on toxicologically relevant molecular gene targets.", {"entities": []}], ["Gene expression levels in lung tissues were analyzed using a large-scale array whereby 28,800 genes were evaluated.", {"entities": []}], ["3,713 genes (12.8 %) were significantly ( p \u2009<\u20090.05) differentially expressed, of which 2,088 had a >1.5-fold change.", {"entities": []}], ["Genes affected by FS include those in protective pathways such as Phase I and Phase II.", {"entities": []}], ["The array studies have provided information on how FS modulates gene expression in lung and how they might be related to protective mechanisms.", {"entities": []}], ["In addition, our study has confirmed that flaxseed is a nutritional supplement with potentially useful therapeutic applications in complementary and alternative (CAM) medicine especially in relation to treatment of lung disease.", {"entities": [[215, 227, "DISEASE"]]}], ["Previous studies have gauged support for implementing smoke-free multi-unit housing (MUH) policies in the United States, but none have specifically examined attitudes among racially and ethnically diverse elders living in low-income MUH.", {"entities": []}], ["We surveyed a convenience sample of elders 62\u00a0years of age and older ( n \u2009=\u2009807) across 24 low-income housing properties in Broward County, Florida in order to assess residents\u2019 smoking behaviors, exposure to second-hand smoke, and support for smoke-free policies.", {"entities": []}], ["The study sample was ethnically and racially diverse with Hispanics comprising more than 61\u00a0% of the population, and 22\u00a0% identifying as Black or other races.", {"entities": []}], ["Although close to 22\u00a0% of the sample were former smokers, only 9\u00a0% of residents reported being current smokers.", {"entities": []}], ["The majority of residents surveyed supported no-smoking policies: 75\u00a0% support no-smoking policies for individual units; 77\u00a0% supported no-smoking policies in common areas; and, 68\u00a0% supported no-smoking policies in outdoor areas.", {"entities": []}], ["Over 29\u00a0% of residents surveyed reported being exposed to secondhand smoke entering their units from elsewhere in their building.", {"entities": []}], ["Residents who reported having a home smoking rule were more than twice as likely to support an indoor policy compared to residents who allowed smoking anywhere in their home (OR\u2009=\u20092.36; 95%CI 1.25\u20134.43; p \u2009\u2264\u20090.01), and nonsmoking residents were nearly three times as likely to support an indoor policy compared to smokers (OR\u2009=\u20092.89; 95%CI 1.44\u20135.79; p \u2009\u2264\u20090.01).", {"entities": []}], ["Support for an indoor policy was not modified by age, gender, ethnicity or race.", {"entities": []}], ["This study demonstrates that elders living in low-income MUH properties overwhelmingly supported the implementation of smoke-free policies.", {"entities": []}], ["It is becoming increasingly appreciated that the non-coding genome may have a great impact on the regulation of chromatin structure and gene expression.", {"entities": []}], ["The innate immune response can be mediated upon lipopolysaccharide stimulation of macrophages which leads to immediate transcriptional activation of early responsive genes including tumor necrosis factor alpha ( Tnf\u03b1) .", {"entities": []}], ["The functional role of non-coding RNAs, such as lncRNAs and microRNAs, on the transcriptional activation of proinflammatory genes and the subsequent regulation of the innate immune response is still lacking mechanistic insights.", {"entities": []}], ["In this study we wanted to unravel the functional role of the lncRNA SeT , which is encoded from the murine Tnf\u03b1 gene locus, and miR-155 on the transcriptional regulation of the Tnf\u03b1 gene.", {"entities": [[129, 136, "GENE"]]}], ["We utilized genetically modified mice harboring either a deletion of the SeT promoter elements or the mature miR-155 and studied the response of macrophages to lipopolysaccharide (LPS) stimulation.", {"entities": [[109, 116, "GENE"]]}], ["We found that decreased expression of the lncRNA SeT in murine primary macrophages resulted in increased mortality of mice challenged with LPS, which was corroborated by increased Tnf\u03b1 steady state mRNA levels and a higher frequency of biallelically expressing macrophages.", {"entities": []}], ["On the contrary, miR-155 deletion resulted in reduced Tnf\u03b1 mRNA levels supported by a lower frequency of biallelically expressing macrophages upon stimulation with LPS.", {"entities": [[17, 24, "GENE"]]}], ["In both cases, in the absence of either lncRNA SeT or miR-155 we observed a deregulation of the Tnf\u03b1 allele homologous pairing, previously shown to regulate the switch from mono- to bi-allelic gene expression.", {"entities": [[54, 61, "GENE"]]}], ["Although lncRNA SeT was not found to be a direct target of miR-155 its stability was increased upon miR-155 deletion.", {"entities": [[59, 66, "GENE"], [100, 107, "GENE"], [59, 66, "GENE"], [100, 107, "GENE"]]}], ["This study suggests a role of the non-coding genome in mediating Tnf\u03b1 mRNA dosage control based on the regulation of homologous pairing of gene alleles and their subsequent biallelic expression.", {"entities": []}], ["Peridinin and fucoxanthin, which are natural carotenoids isolated from a symbiotic dinoflagellate, Symbiodinium sp., and a brown alga, Petalonia fascia , respectively, were compared for inhibitory effects on delayed-type hypersensitivity in mice.", {"entities": []}], ["The number of eosinophils at the site of inflammation and in peripheral blood was compared for the administration of peridinin and fucoxanthin applied by painting and intraperitoneally.", {"entities": []}], ["Peridinin, but not the structurally-related fucoxanthin, significantly suppressed the number of eosinophils in both the ear lobe and peripheral blood.", {"entities": []}], ["Furthermore, peridinin applied topically, but not administered intraperitoneally, suppressed the level of eotaxin in the ears of sensitized mice.", {"entities": []}], ["Fucoxanthin weakly suppressed the concentration of eotaxin in ears only by intraperitoneal administration.", {"entities": []}], ["Although both carotenoids inhibited the migration of eosinophils toward eotaxin, the inhibitory effect of peridinin was higher than that of fucoxanthin.", {"entities": []}], ["Peridinin may be a potential agent for suppressing allergic inflammatory responses, such as atopic dermatitis, in which eosinophils play a major role in the increase of inflammation.", {"entities": [[92, 109, "DISEASE"], [99, 109, "DISEASE"]]}], ["Identifying characteristics of HIV-infected adults likely to have poor treatment outcomes can be useful for targeting interventions efficiently.", {"entities": []}], ["Research in economics and psychology suggests that individuals\u2019 intertemporal time preferences, which indicate the extent to which they trade-off immediate vs. future cost and benefits, can influence various health behaviors.", {"entities": []}], ["While there is empirical support for the association between time preferences and various non-HIV health behaviors and outcomes, the extent to which time preferences predict outcomes of those receiving antiretroviral therapy (ART) has not been examined previously.", {"entities": []}], ["HIV-infected adults initiating ART were enrolled at a health facility in Kenya.", {"entities": []}], ["Participants\u2019 time preferences were measured at enrollment and used to classify them as having either a low or high discount rate for future benefits.", {"entities": []}], ["At 48 weeks, we assessed mortality and ART adherence, as measured by Medication Event Monitoring System (MEMS).", {"entities": []}], ["Logistic regression models adjusting for socio-economic characteristics and risk factors were used to determine the association between time preferences and mortality as well as MEMS adherence \u226590%.", {"entities": []}], ["Overall, 44% (96/220) of participants were classified as having high discount rates.", {"entities": []}], ["Participants with high discount rates had significantly higher 48-week mortality than participants with low discount rates (9.3% vs. 3.1%; adjusted odds ratio 3.84; 95% CI 1.03, 14.50).", {"entities": []}], ["MEMS adherence \u226590% was similar for participants with high vs. low discount rates (42.3% vs. 49.6%, AOR 0.70; 95% CI 0.40, 1.25).", {"entities": []}], ["High discount rates were associated with significantly higher risk of mortality among HIV-infected patients initiating ART.", {"entities": []}], ["Greater use of time preference measures may improve identification of patients at risk of poor clinical outcomes.", {"entities": []}], ["More research is needed to further identify mechanisms of action and also to build upon and test the generalizability of this finding.", {"entities": []}], ["Considerable attention has been given to the relationship between levels of fine particulate matter (particulate matter \u2264 2.5 \u03bcm in aerodynamic diameter; PM 2.5 ) in the atmosphere and health effects in human populations.", {"entities": []}], ["Since the U.S. Environmental Protection Agency began widespread monitoring of PM 2.5 levels in 1999, the epidemiologic community has performed numerous observational studies modeling mortality and morbidity responses to PM 2.5 levels using Poisson generalized additive models (GAMs).", {"entities": []}], ["Although these models are useful for relating ambient PM 2.5 levels to mortality, they cannot directly measure the strength of the effect of exposure to PM 2.5 on mortality.", {"entities": []}], ["In order to assess this effect, we propose a three-stage Bayesian hierarchical model as an alternative to the classical Poisson GAM.", {"entities": []}], ["Fitting our model to data collected in seven North Carolina counties from 1999 through 2001, we found that an increase in PM 2.5 exposure is linked to increased risk of cardiovascular mortality in the same day and next 2 days.", {"entities": []}], ["Specifically, a 10-\u03bcg/m 2.5 exposure is associated with a 2.5% increase in the relative risk of current-day cardiovascular mortality, a 4.0% increase in the relative risk of cardiovascular mortality the next day, and an 11.4% increase in the relative risk of cardiovascular mortality 2 days later.", {"entities": []}], ["Because of the small sample size of our study, only the third effect was found to have > 95% posterior probability of being > 0.", {"entities": []}], ["In addition, we compared the results obtained from our model to those obtained by applying frequentist (or classical, repeated sampling-based) and Bayesian versions of the classical Poisson GAM to our study population.", {"entities": []}], ["Eugenol has attracted considerable attention because of its potential for many pharmaceutical applications including anti-inflammatory, anti-tumorigenic and anti-oxidant properties.", {"entities": []}], ["Here, we have investigated the effect of eugenol on amyloid formation of selected globular proteins.", {"entities": []}], ["We find that both spontaneous and seed-induced aggregation processes of insulin and serum albumin (BSA) are significantly suppressed in the presence of eugenol.", {"entities": []}], ["Isothermal titration calorimetric data predict a single binding site for eugenol-insulin complex confirming the affinity of eugenol for native soluble insulin species.", {"entities": []}], ["We also find that eugenol suppresses amyloid-induced hemolysis.", {"entities": []}], ["Our findings reveal the inherent ability of eugenol to stabilize native proteins and to delay the conversion of protein species of native conformation into \u03b2-sheet assembled mature fibrils, which seems to be crucial for its inhibitory effect.", {"entities": []}], ["This study was performed within the scope of two multi-center European Commission-funded projects (HEPMEAP and PAMCHAR) concerning source-composition-toxicity relationship for particulate matter (PM) sampled in Europe.", {"entities": []}], ["The present study aimed to optimize the design for PM in vivo toxicity screening studies in terms of dose and time between a single exposure and the determination of the biological responses in a rat model mimicking human disease resulting in susceptibility to ambient PM.", {"entities": []}], ["Dust in thoracic PM size-range (aerodynamic diameter <10 \u03bcm) was sampled nearby a road tunnel (RTD) using a high volume cascade impactor.", {"entities": []}], ["Spontaneously hypertensive rats were exposed to urban dust collected in Ottawa, Canada (EHC-93 10 mg/kg of body weight; reference PM) or different RTD doses (0.3, 1, 3, 10 mg/kg of body weight) by intratracheal instillation.", {"entities": []}], ["Necropsy was performed at 4, 24, or 48 hr after exposure.", {"entities": [[39, 41, "GENE"]]}], ["The neutrophil numbers in bronchoalveolar lavage fluid increased tremendously after exposure to the highest RTD doses or EHC-93.", {"entities": []}], ["Furthermore, PM exposure slightly affected blood coagulation since there was a small but significant increase in the plasma fibrinogen levels (factor 1.2).", {"entities": []}], ["Pulmonary inflammation and oxidative stress as well as changes in blood coagulation factors and circulating blood cell populations were observed within the range of 3 to 10 mg PM/kg of body weight without significant pulmonary injury.", {"entities": []}], ["The optimal dose for determining the toxicity ranking of ambient derived PM samples in spontaneously hypertensive rats is suggested to be between 3 and 10 mg PM/kg of body weight under the conditions used in the present study.", {"entities": []}], ["At a lower dose only some inflammatory effects were detected, which will probably be too few to be able to discriminate between PM samples while a completely different response pattern was observed with the highest dose.", {"entities": []}], ["In addition to the dose, a 24-hr interval from exposure to sacrifice seemed appropriate to assess the relative toxic potency of PM since the majority of the health effects were observed one day after PM exposure compared to the other times examined.", {"entities": []}], ["The aforementioned considerations provide a good basis for conducting PM toxicity screening studies in spontaneously hypertensive rats.", {"entities": []}], ["Meta-analyses of genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) spanning the 5-hydroxytryptamine receptor 4 (5-HT 4 R) gene ( HTR4 ) associated with lung function.", {"entities": [[173, 177, "GENE"]]}], ["The aims of this study were to i) investigate the expression profile of HTR4 in adult and fetal lung tissue and cultured airway cells, ii) further define HTR4 gene structure and iii) explore the potential functional implications of key SNPs using a bioinformatic approach.", {"entities": [[72, 76, "GENE"], [154, 158, "GENE"], [72, 76, "GENE"], [154, 158, "GENE"]]}], ["Following reverse transcription (RT)-PCR in human brain, 5\u2032 rapid amplification of cDNA ends (5\u2032 RACE) was used to examine the exonic structure of HTR4 at the 5\u2032 end.", {"entities": [[147, 151, "GENE"]]}], ["Quantitative (Q)-PCR was used to quantify HTR4 mRNA expression in total RNA from cultured airway cells and whole lung tissue.", {"entities": [[42, 46, "GENE"]]}], ["Publically available gene microarray data on fetal samples of estimated gestational age 7\u201322 weeks were mined for HTR4 expression.", {"entities": [[114, 118, "GENE"]]}], ["Immunohistochemistry (IHC; in adult and fetal lung tissue) and a radioligand binding assay (in cultured airway cells) were used to analyze 5\u00adHT 4 R protein expression.", {"entities": []}], ["IHC in adult lung, irrespective of the presence of chronic obstructive pulmonary disease (COPD), suggested low level expression of 5-HT 4 R protein, which was most prominent in alveolar pneumocytes.", {"entities": [[51, 88, "DISEASE"]]}], ["There was evidence of differential 5-HT 4 R protein levels during gestation in fetal lung, which was also evident in gene expression microarray data.", {"entities": []}], ["HTR4 mRNA expression, assessed by Q-PCR, was <0.5% relative to brain in total adult lung tissue and in human airway smooth muscle (HASM) and bronchial epithelial cells (HBEC) derived from adult donors.", {"entities": [[0, 4, "GENE"]]}], ["Radioligand binding experiments also indicated that HBEC and HASM cells did not express a significant 5-HT 4 R population.", {"entities": []}], ["5\u2032 RACE in brain identified a novel N -terminal variant, containing an extended N- terminal sequence.", {"entities": []}], ["The functional significance of key HTR4 SNPs was investigated using the encyclopedia of DNA elements consortium (ENCODE) dataset.", {"entities": [[35, 39, "GENE"]]}], ["These analyses identified multiple alterations in regulatory motifs for transcription factors implicated in lung development, including Foxp1.", {"entities": [[136, 141, "GENE"]]}], ["Taken together, these data suggest a role for HTR4 in lung development, which may at least in part explain the genetic association with lung function.", {"entities": [[46, 50, "GENE"]]}], ["Renal cell carcinoma (RCC) is considered a cytokine-responsive tumor.", {"entities": [[11, 20, "DISEASE"]]}], ["However, with the lack of diagnostic screening biomarkers, early diagnosis of RCC is challenging.", {"entities": []}], ["Our study was investigated the association of IL1 gene polymorphisms and RCC risk.", {"entities": []}], ["We conducted a case-control study of 291 RCC cases and 463 controls to evaluation the IL1RN of single nucleotide polymorphisms (SNPs) on RCC risk.", {"entities": [[86, 91, "GENE"]]}], ["We selection of 16 SNPs in IL1RN, IL1A, IL1B genes were analyzed.", {"entities": [[27, 32, "GENE"], [34, 38, "GENE"], [40, 44, "GENE"]]}], ["Using the chi-squared (\u03c7", {"entities": []}], ["The avoidance of inhaled allergens or tobacco smoke has been known to have favorable effects on asthma control.", {"entities": [[96, 102, "DISEASE"]]}], ["However, it remains unclear whether other lifestyle-related factors are also related to asthma control.", {"entities": [[88, 94, "DISEASE"]]}], ["Therefore, a comprehensive study to examine the associations between various lifestyle factors and asthma control was conducted in Japanese asthmatic patients.", {"entities": [[99, 105, "DISEASE"]]}], ["The study subjects included 437 stable asthmatic patients recruited from our outpatient clinic over a one-year period.", {"entities": []}], ["A written, informed consent was obtained from each participant.", {"entities": []}], ["Asthma control was assessed using the asthma control test (ACT), and a structured questionnaire was administered to obtain information regarding lifestyle factors, including tobacco smoking, alcohol drinking, physical exercise, and diet.", {"entities": [[0, 6, "DISEASE"], [38, 44, "DISEASE"]]}], ["Both bivariate and multivariate analyses were conducted.", {"entities": []}], ["The proportions of total control (ACT = 25), well controlled (ACT = 20-24), and poorly controlled (ACT < 20) were 27.5%, 48.1%, and 24.5%, respectively.", {"entities": []}], ["The proportions of patients in the asthma treatment steps as measured by Global Initiative for Asthma 2007 in step 1, step 2, step 3, step 4, and step 5 were 5.5%, 17.4%, 7.6%, 60.2%, and 9.4%, respectively.", {"entities": [[35, 41, "DISEASE"], [95, 101, "DISEASE"]]}], ["Body mass index, direct tobacco smoking status and alcohol drinking were not associated with asthma control.", {"entities": [[93, 99, "DISEASE"]]}], ["On the other hand, younger age (< 65 years old), passive smoking, periodical exercise (> 3 metabolic equivalents-h/week), and raw vegetable intake (> 5 units/week) were significantly associated with good asthma control by bivariate analysis.", {"entities": [[204, 210, "DISEASE"]]}], ["Younger age, periodical exercise, and raw vegetable intake were significantly associated with good asthma control by multiple linear regression analysis.", {"entities": [[99, 105, "DISEASE"]]}], ["Periodical exercise and raw vegetable intake are associated with good asthma control in Japanese patients.", {"entities": [[70, 76, "DISEASE"]]}], ["CCL25/TECK and CCL28/MEC are CC chemokines primarily expressed in thymic dendritic cells and mucosal epithelial cells.", {"entities": []}], ["Their receptors, CCR9 and CCR10, are mainly expressed on T and B lymphocytes.", {"entities": [[17, 21, "GENE"], [26, 31, "GENE"]]}], ["In human, mouse, pig and sheep CCL25 and CCL28 play an important role in the segregation and the compartmentalization of the mucosal immune system.", {"entities": [[31, 36, "GENE"], [41, 46, "GENE"]]}], ["As evidenced by early comparisons of germ-free and conventional animals, the intestinal bacterial microflora has a marked effect on host intestinal immune functions.", {"entities": []}], ["However, little is known about the impact of bacterial colonization on constitutive and induced chemokine expressions as well as on the generation of anti-inflammatory mechanisms.", {"entities": []}], ["Therefore, we decided to focus by qPCR on the mRNA expression of two main gut chemokines, CCL25 and CCL28, their receptors CCR9 and CCR10, the Tregs marker Foxp3 and anti-inflammatory cytokines TGF-\u03b2 and IL-10 following colonization with different bacterial species within the small intestine.", {"entities": [[90, 95, "GENE"], [100, 105, "GENE"], [123, 127, "GENE"], [132, 137, "GENE"], [156, 161, "GENE"]]}], ["To accomplish this we used an original germ-free neonatal pig model and monoassociated pigs with a representative Gram-negative ( Escherichia coli ) or Gram-positive ( Lactobacillus fermentum ) commensal bacteria commonly isolated from the neonatal pig intestine.", {"entities": []}], ["Our results show a consistent and marked effect of microbial colonization on the mRNA expression of intestinal chemokines, chemokine receptors, Foxp3 and TGF-\u03b2.", {"entities": [[144, 149, "GENE"]]}], ["Moreover, as evidenced by in vitro experiments using two different cell lines, the pattern of regulation of CCL25 and CCL28 expression in the gut appears complex and suggests an additional role for in vivo factors.", {"entities": [[108, 113, "GENE"], [118, 123, "GENE"]]}], ["Taken together, the results highlight the key role of bacterial microflora in the development of a functional intestinal immune system in an elegant and relevant model for human immune system development.", {"entities": []}], ["The identification and validation of biomarkers to support the assessment of novel therapeutics for COPD continues to be an important area of research.", {"entities": []}], ["The aim of the current study was to identify systemic protein biomarkers correlated with measures of COPD severity, as well as specific protein signatures associated with comorbidities such as metabolic syndrome.", {"entities": [[203, 211, "DISEASE"]]}], ["142 protein analytes were measured in serum of 140 patients with stable COPD, 15 smokers without COPD and 30 non-smoking controls.", {"entities": []}], ["Seven analytes (sRAGE, EN-RAGE, NGAL, Fibrinogen, MPO, TGF-\u03b1 and HB-EGF) showed significant differences between severe/very severe COPD, mild/moderate COPD, smoking and non-smoking control groups.", {"entities": [[50, 53, "GENE"]]}], ["Within the COPD subjects, univariate and multivariate analyses identified analytes significantly associated with FEV 1 , FEV 1 /FVC and DLCO.", {"entities": [[113, 116, "GENE"], [121, 124, "GENE"], [113, 116, "GENE"], [121, 124, "GENE"]]}], ["Most notably, a set of 5 analytes (HB-EGF, Fibrinogen, MCP-4, sRAGE and Sortilin) predicted 21% of the variability in DLCO values.", {"entities": []}], ["To determine common functions/pathways, analytes were clustered in a correlation network by similarity of expression profile.", {"entities": []}], ["While analytes related to neutrophil function (EN-RAGE, NGAL, MPO) grouped together to form a cluster associated with FEV 1 related parameters, analytes related to the EGFR pathway (HB-EGF, TGF-\u03b1) formed another cluster associated with both DLCO and FEV 1 related parameters.", {"entities": [[62, 65, "GENE"], [118, 121, "GENE"], [250, 253, "GENE"], [168, 172, "GENE"], [118, 121, "GENE"], [250, 253, "GENE"]]}], ["Associations of Fibrinogen with DLCO and MPO with FEV 1 /FVC were stronger in patients without metabolic syndrome ( r \u200a=\u200a \u22120.52, p \u200a=\u200a0.005 and r \u200a=\u200a \u22120.61, p \u200a=\u200a0.023, respectively) compared to patients with coexisting metabolic syndrome ( r \u200a=\u200a \u22120.25, p \u200a=\u200a0.47 and r \u200a=\u200a \u22120.15, p \u200a=\u200a0.96, respectively), and may be driving overall associations in the general cohort.", {"entities": [[105, 113, "DISEASE"], [230, 238, "DISEASE"], [41, 44, "GENE"], [50, 53, "GENE"]]}], ["In summary, our study has identified known and novel serum protein biomarkers and has demonstrated specific associations with COPD disease severity, FEV 1 , FEV 1 /FVC and DLCO.", {"entities": [[149, 152, "GENE"], [157, 160, "GENE"], [149, 152, "GENE"], [157, 160, "GENE"]]}], ["These data highlight systemic inflammatory pathways, neutrophil activation and epithelial tissue injury/repair processes as key pathways associated with COPD.", {"entities": []}], ["Cancer clinical trials are essential for testing new treatments and represent state-of-the-art cancer treatment, but only a small percentage of patients ever enroll in a trial.", {"entities": [[0, 6, "DISEASE"], [95, 101, "DISEASE"]]}], ["Under-enrollment is an even greater problem among minorities, particularly African Americans, representing a racial/ethnic disparity in cancer care.", {"entities": [[136, 142, "DISEASE"]]}], ["One understudied cause is patient-physician communication, which is often of poor quality during clinical interactions between African-American patients and non-African-American physicians.", {"entities": []}], ["Partnering Around Cancer Clinical Trials (PACCT) involves a transdisciplinary theoretical model proposing that patient and physician individual attitudes and beliefs and their interpersonal communication during racially discordant clinical interactions influence outcomes related to patients\u2019 decisions to participate in a trial.", {"entities": [[18, 24, "DISEASE"]]}], ["The overall goal of the study is to test a multilevel intervention designed to increase rates at which African-American and White men with prostate cancer make an informed decision to participate in a clinical trial.", {"entities": [[148, 154, "DISEASE"], [139, 154, "DISEASE"]]}], ["Data collection will occur at two NCI-designated comprehensive cancer centers.", {"entities": [[63, 69, "DISEASE"]]}], ["Participants include physicians who treat men with prostate cancer and their African-American and White patients who are potentially eligible for a clinical trial.", {"entities": [[60, 66, "DISEASE"], [51, 66, "DISEASE"]]}], ["The study uses two distinct research designs to evaluate the effects of two behavioral interventions, one focused on patients and the other on physicians.", {"entities": []}], ["The primary goal is to increase the number of patients who decide to enroll in a trial; secondary goals include increasing rates of physician trial offers, improving the quality of patient-physician communication during video recorded clinical interactions in which trials may be discussed, improving patients\u2019 understanding of trials offered, and increasing the number of patients who actually enroll.", {"entities": []}], ["Aims are to 1) determine the independent and combined effects of the two interventions on outcomes; 2) compare the effects of the interventions on African-American versus White men; and 3) examine the extent to which patient-physician communication mediates the effect of the interventions on the outcomes.", {"entities": []}], ["PACCT has the potential to identify ways to increase clinical trial rates in a diverse patient population.", {"entities": []}], ["The research can also improve access to high quality clinical care for African American men bearing the disproportionate burden of disparities in prostate and other cancers.", {"entities": []}], ["Clinical Trials.gov registration number: NCT02906241 (September 8, 2016).", {"entities": []}], ["Global Critical Care is attracting increasing attention.", {"entities": []}], ["At several million deaths per year, the worldwide burden of critical illness is greater than generally appreciated.", {"entities": []}], ["Low income countries (LICs) have a disproportionally greater share of critical illness, and yet critical care facilities are scarce in such settings.", {"entities": []}], ["Routines utilizing abnormal vital signs to identify critical illness and trigger medical interventions have become common in high-income countries but have not been investigated in LICs.", {"entities": []}], ["The aim of the study was to assess whether the introduction of a vital signs directed therapy protocol improved acute care and reduced mortality in an Intensive Care Unit (ICU) in Tanzania.", {"entities": []}], ["Prospective, before-and-after interventional study in the ICU of a university hospital in Tanzania.", {"entities": []}], ["A context-appropriate protocol that defined danger levels of severely abnormal vital signs and stipulated acute treatment responses was implemented in a four week period using sensitisation, training, job aids, supervision and feedback.", {"entities": []}], ["Acute treatment of danger signs at admission and during care in the ICU and in-hospital mortality were compared pre and post-implementation using regression models.", {"entities": []}], ["Danger signs from 447 patients were included: 269 pre-implementation and 178 post-implementation.", {"entities": []}], ["Acute treatment of danger signs was higher post-implementation (at admission: 72.9% vs 23.1%, p<0.001; in ICU: 16.6% vs 2.9%, p<0.001).", {"entities": []}], ["A danger sign was five times more likely to be treated post-implementation (Prevalence Ratio (PR) 4.9 (2.9\u20138.3)).", {"entities": []}], ["Intravenous fluids were given in response to 35.0% of hypotensive episodes post-implementation, as compared to 4.1% pre-implementation (PR 6.4 (2.5\u201316.2)).", {"entities": []}], ["In patients admitted with hypotension, mortality was lower post-implementation (69.2% vs 92.3% p = 0.02) giving a numbers-needed-to-treat of 4.3.", {"entities": []}], ["Overall in-hospital mortality rates were unchanged (49.4% vs 49.8%, p = 0.94).", {"entities": []}], ["The introduction of a vital signs directed therapy protocol improved the acute treatment of abnormal vital signs in an ICU in a low-income country.", {"entities": []}], ["Mortality rates were reduced for patients with hypotension at admission but not for all patients.", {"entities": []}], ["Back pain is one of the UK's costliest and least understood health problems, whose prevalence still seems to be increasing.", {"entities": []}], ["Educational interventions for general practitioners on back pain appear to have had little impact on practice, but these did not include quality improvement learning, involve patients in the learning, record costs or document practice activities as well as patient outcomes.", {"entities": []}], ["We assessed the outcome of providing information about quality improvement techniques and evidence-based practice for back pain using the Clinical Value Compass.", {"entities": []}], ["This included clinical outcomes (Roland and Morris Disability Questionnaire), functional outcomes, costs of care and patient satisfaction.", {"entities": []}], ["We provided workshops which used an action learning approach and collected before and after data on routine practice activity from practice electronic databases.", {"entities": []}], ["In parallel, we studied outcomes in a separate cohort of patients with acute and sub-acute non-specific back pain recruited from the same practices over the same time period.", {"entities": []}], ["Patient data were analysed as a prospective, split-cohort study with assessments at baseline and eight weeks following the first consultation.", {"entities": []}], ["Data for 1014 patients were recorded in the practice database study, and 101 patients in the prospective cohort study.", {"entities": []}], ["We found that practice activities, costs and patient outcomes changed little after the intervention.", {"entities": []}], ["However, the intervention was associated with a small, but statistically significant reduction in disability in female patients.", {"entities": []}], ["Additionally, baseline disability, downheartedness, self-rated health and leg pain had small but statistically significant effects (p < 0.05) on follow-up disability scores in some subgroups.", {"entities": []}], ["GP education for back pain that both includes health improvement methodologies and involves patients may yield additional benefits for some patients without large changes in patterns of practice activity.", {"entities": []}], ["The effects in this study were small and limited and the reasons for them remain obscure.", {"entities": []}], ["However, such is the impact of back pain and its frequency of consultation in general practice that this kind of improvement methodology deserves further consideration.", {"entities": []}], ["ISRCTN: ISRCTN30420389", {"entities": []}], ["One study after another is finding strong associations between a variety of human illness and exposure to environmental tobacco smoke (ETS).", {"entities": []}], ["A 1986 report by the U.S.", {"entities": []}], ["Surgeon General concluded that ETS is a cause of disease, including lung cancer, in healthy nonsmokers.", {"entities": [[68, 79, "DISEASE"], [73, 79, "DISEASE"]]}], ["Other reports have documented causal associations between ETS and lower respiratory tract infections, middle ear disease and exacerbation of asthma in children, heart disease, retardation of fetal growth, sudden infant death syndrome, and nasal sinus cancer.", {"entities": [[102, 120, "DISEASE"], [161, 174, "DISEASE"], [225, 233, "DISEASE"], [205, 233, "DISEASE"], [141, 147, "DISEASE"], [251, 257, "DISEASE"]]}], ["However, the findings from many of these studies remain controversial.", {"entities": []}], ["A number of scientists remain skeptical about the association between ETS and serious illness in nonsmokers, charging that scientific journals either fail to publish pro-tobacco findings and meta-analyses or disregard those that are published.", {"entities": []}], ["They also claim that many epidemiological studies declare causal associations based on marginal odds ratios.", {"entities": []}], ["In a previous in vitro study, the standardized turmeric extract, HSS-888, showed strong inhibition of A\u03b2 aggregation and secretion in vitro , indicating that HSS-888 might be therapeutically important.", {"entities": []}], ["Therefore, in the present study, HSS-888 was evaluated in vivo using transgenic \u2018Alzheimer\u2019 mice (Tg2576) over-expressing A\u03b2 protein.", {"entities": []}], ["Following a six-month prevention period where mice received extract HSS-888 (5mg/mouse/day), tetrahydrocurcumin (THC) or a control through ingestion of customized animal feed pellets (0.1% w/w treatment), HSS-888 significantly reduced brain levels of soluble (~40%) and insoluble (~20%) A\u03b2 as well as phosphorylated Tau protein (~80%).", {"entities": []}], ["In addition, primary cultures of microglia from these mice showed increased expression of the cytokines IL-4 and IL-2.", {"entities": []}], ["In contrast, THC treatment only weakly reduced phosphorylated Tau protein and failed to significantly alter plaque burden and cytokine expression.", {"entities": []}], ["The findings reveal that the optimized turmeric extract HSS-888 represents an important step in botanical based therapies for Alzheimer\u2019s disease by inhibiting or improving plaque burden, Tau phosphorylation, and microglial inflammation leading to neuronal toxicity.", {"entities": []}], ["The introduction of pressurised metered dose inhalers (MDIs) in the mid-1950s completely transformed respiratory treatment.", {"entities": []}], ["Despite decades of availability and healthcare support and development of teaching aids and devices to promote better use, poor pMDI user technique remains a persistent issue.", {"entities": []}], ["The main pMDI user aid is the spacer/valved holding chamber (VHC) device.", {"entities": []}], ["Spacer/chamber features (size, shape, configuration, construction material, and hygiene considerations) can vie with clinical effectiveness (to deliver the same dose as a correctly used pMDI), user convenience, cost, and accessibility.", {"entities": []}], ["Unsurprisingly, improvised, low-cost alternatives (plastic drink bottles, paper cups, and paper towel rolls) have been pressed into seemingly effective service.", {"entities": []}], ["A UK law change permitting schools to hold emergency inhalers and spacers has prompted a development project to design a low-cost, user-friendly, disposable, and recyclable spacer.", {"entities": []}], ["This paper spacer requires neither preuse priming nor washing, and has demonstrated reproducible lung delivery of salbutamol sulphate pMDI, comparable to an industry-standard VHC, an alternative paperboard VHC, and pMDI alone.", {"entities": []}], ["This new device appears to perform better than these other VHC devices at the low flow rates thought achievable by paediatric patients.", {"entities": []}], ["The data suggest that this disposable spacer may have a place in the single-use emergency setting.", {"entities": []}], ["Exposure to molds and mycotoxins not only contributes to the onset of respiratory disease, it also affects the ocular surface.", {"entities": []}], ["Very few published studies concern the evaluation of the effect of mycotoxin exposure on ocular cells.", {"entities": []}], ["The present study investigates the effects of aflatoxin B 1 (AFB 1 ) and gliotoxin, two mycotoxins secreted by Aspergillus molds, on the biological activity of the human corneal epithelial (HCE) cells.", {"entities": []}], ["After 24, 48, and 72 h of exposure, cellular viability and inflammatory response were assessed.", {"entities": []}], ["Both endpoint cell viability colorimetric assays and continuous cell impedance measurements, providing noninvasive real-time assessment of the effect on cells, were performed.", {"entities": []}], ["Cytokine gene expression and interleukin-8 release were quantified.", {"entities": []}], ["Gliotoxin appeared more cytotoxic than AFB 1 but, at the same time, led to a lower increase of the inflammatory response reflecting its immunosuppressive properties.", {"entities": []}], ["Real-time cell impedance measurement showed a distinct profile of cytotoxicity for both mycotoxins.", {"entities": []}], ["HCE cells appeared to be a well-suited in vitro model to study ocular surface reactivity following biological contaminant exposure.", {"entities": []}], ["Low, but persistent inflammation, caused by environmental factors, such as fungal toxins, leads to irritation and sensitization, and could be responsible for allergic manifestations which, in turn, could lead to mucosal hyper-reactivity.", {"entities": []}], ["Microbial colonization of the gastrointestinal tract is an essential process that modulates host physiology and immunity.", {"entities": []}], ["Recently, researchers have begun to understand how and when these microorganisms colonize the gut and the early-life factors that impact their natural ecological establishment.", {"entities": []}], ["The vertical transmission of maternal microbes to the offspring is a critical factor for host immune and metabolic development.", {"entities": []}], ["Increasing evidence also points to a role in the wiring of the gut-brain axis.", {"entities": []}], ["This process may be altered by various factors such as mode of delivery, gestational age at birth, the use of antibiotics in early life, infant feeding, and hygiene practices.", {"entities": []}], ["In fact, these early exposures that impact the intestinal microbiota have been associated with the development of diseases such as obesity, type 1 diabetes, asthma, allergies, and even neurodevelopmental disorders.", {"entities": [[131, 138, "DISEASE"], [157, 163, "DISEASE"]]}], ["The present review summarizes the impact of cesarean birth on the gut microbiome and the health status of the developing infant and discusses possible preventative and restorative strategies to compensate for early-life microbial perturbations.", {"entities": []}], ["Long-acting \u03b2 2 -adrenergic agonists (LABAs) are recommended in combination with inhaled corticosteroids (ICSs) for asthma management.", {"entities": [[116, 122, "DISEASE"]]}], ["Abediterol is a novel, selective, potent, once-daily LABA in development for treatment of asthma and chronic obstructive pulmonary disease.", {"entities": [[101, 138, "DISEASE"], [90, 96, "DISEASE"]]}], ["This study aimed to determine abediterol doses with similar peak bronchodilatory effect to salbutamol 400 \u03bcg, and duration of action compatible with once-daily dosing in patients with persistent, stable asthma.", {"entities": [[203, 209, "DISEASE"]]}], ["This was a Phase II, randomized, double-blind, double-dummy, crossover, placebo-controlled, dose-ranging study (ClinicalTrials.gov NCT01425801) in 62 patients with mild-to-moderate asthma who were also receiving an ICS.", {"entities": [[181, 187, "DISEASE"]]}], ["Patients received single doses of abediterol 0.313, 0.625, 1.25, or 2.5 \u03bcg, salbutamol 400 \u03bcg, or placebo in the morning.", {"entities": []}], ["Spirometry was performed up to 36 h post-dose; safety and tolerability were assessed throughout the study.", {"entities": []}], ["The primary endpoint was change from baseline in peak forced expiratory volume in 1 s (FEV 1 ).", {"entities": [[87, 90, "GENE"]]}], ["Additional endpoints included trough FEV 1 , normalized area under the FEV 1 curve (FEV 1 AUC) up to 24 h post-dose, and peak and trough forced vital capacity (FVC).", {"entities": [[37, 40, "GENE"], [71, 74, "GENE"], [84, 87, "GENE"], [37, 40, "GENE"], [71, 74, "GENE"], [84, 87, "GENE"], [37, 40, "GENE"], [71, 74, "GENE"], [84, 87, "GENE"]]}], ["Abediterol produced dose-dependent improvements in peak FEV 1 from baseline compared with placebo, from 0.274 (95% CI 0.221, 0.327) to 0.405 L (95% CI 0.353, 0.458) for abediterol 0.313 to 2.5 \u03bcg, respectively (p\u2009<\u20090.0001 all doses).", {"entities": [[56, 59, "GENE"]]}], ["Abediterol 0.625, 1.25, and 2.5 \u03bcg had similar magnitude of peak FEV 1 effect to salbutamol.", {"entities": [[65, 68, "GENE"]]}], ["Dose-dependent changes from baseline in trough FEV 1 versus placebo were 0.219 (95% CI 0.136, 0.302) to 0.400 L (95% CI 0.317, 0.483) for abediterol 0.313 to 2.5 \u03bcg, respectively (p\u2009<\u20090.0001).", {"entities": [[47, 50, "GENE"]]}], ["All abediterol doses achieved significant improvements versus placebo in FEV 1 AUC 0\u20136, 0\u201312, and 0\u201324 h, and peak and trough FVC (p\u2009<\u20090.05).", {"entities": [[73, 76, "GENE"]]}], ["Less than 10% of patients experienced treatment-related adverse events for each dose of abediterol; most were mild to moderate in intensity and the most common were headache and nasopharyngitis.", {"entities": [[178, 193, "DISEASE"]]}], ["There were no clinically relevant changes in heart rate.", {"entities": []}], ["Abediterol 0.625\u20132.5 \u03bcg provided dose-dependent, clinically and statistically significant bronchodilation versus placebo in patients with asthma, with a peak effect similar to salbutamol and duration of action compatible with once-daily dosing.", {"entities": [[138, 144, "DISEASE"]]}], ["All doses of abediterol were well tolerated.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2466-14-176) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Growth hormone deficiency (GHD) treatment for children requires growth hormone injections, typically administered daily until the child reaches adult height.", {"entities": []}], ["Child GHD treatment burden is not well understood and no disease-specific measures exist to assess this burden.", {"entities": []}], ["The purpose of the study was to explore GHD treatment burden for children and their parents by conducting concept elicitation interviews supporting a theoretical model of the impact of GHD treatment.", {"entities": []}], ["Four focus groups (in Germany) and 52 telephone interviews (in the UK and USA) were conducted with children/adolescents with GHD aged 8 to <13\u00a0years and parents of children with GHD aged \u22654 to <13\u00a0years.", {"entities": []}], ["The purpose of the interviews was to understand the experience of GHD treatment from the child\u2019s perspective, and for parents, the impact of their child\u2019s treatment on themselves.", {"entities": []}], ["Interview transcripts were analyzed thematically based on modified grounded theory principles.", {"entities": []}], ["Interviews with 70 respondents who produced descriptions ( n \u00a0=\u00a073) of patients experiences with GHD treatment (three parents spoke for two children each) were conducted.", {"entities": []}], ["Analysis identified three major areas of GHD treatment burden for children: physical; emotional well-being; and interference.", {"entities": []}], ["Parent burdens identified were: emotional well-being and interference.", {"entities": []}], ["Modifiers such as treatment efficacy and duration, which may impact the degree of treatment burden severity, were identified.", {"entities": []}], ["Overall treatment burden of child GHD is considerable for children and their parents.", {"entities": []}], ["The concept elicitation and theoretical model can be used to develop a disease-specific outcome measure, which adequately reflects the burden of GHD treatment for children and their parents.", {"entities": []}], ["Severe osteoarthritis and thoracic aortic aneurysms have recently been associated with mutations in the SMAD3 gene, but the full clinical spectrum is incompletely defined.", {"entities": [[7, 21, "DISEASE"], [104, 109, "GENE"]]}], ["All SMAD3 gene mutation carriers coming to our centre and their families were investigated prospectively with a structured panel including standardized clinical workup, blood tests, total body computed tomography, joint X-rays.", {"entities": [[4, 9, "GENE"]]}], ["Electroneuromyography was performed in selected cases.", {"entities": []}], ["Thirty-four SMAD3 gene mutation carriers coming to our centre were identified and 16 relatives were considered affected because of aortic surgery or sudden death (total 50 subjects).", {"entities": [[12, 17, "GENE"]]}], ["Aortic disease was present in 72%, complicated with aortic dissection, surgery or sudden death in 56% at a mean age of 45 years.", {"entities": []}], ["Aneurysm or tortuosity of the neck arteries was present in 78%, other arteries were affected in 44%, including dissection of coronary artery.", {"entities": []}], ["Overall, 95% of mutation carriers displayed either aortic or extra-aortic arterial disease.", {"entities": []}], ["Acrocyanosis was also present in the majority of patients.", {"entities": []}], ["Osteoarticular manifestations were recorded in all patients.", {"entities": []}], ["Joint involvement could be severe requiring surgery in young patients, of unusual localization such as tarsus or shoulder, or mimicking crystalline arthropathy with fibrocartilage calcifications.", {"entities": [[148, 159, "DISEASE"]]}], ["Sixty eight percent of patients displayed neurological symptoms, and 9 suffered peripheral neuropathy.", {"entities": [[91, 101, "DISEASE"], [80, 101, "DISEASE"]]}], ["Electroneuromyography revealed an axonal motor and sensory neuropathy in 3 different families, very evocative of type II Charcot-Marie-Tooth (CMT2) disease, although none had mutations in the known CMT2 genes.", {"entities": [[59, 69, "DISEASE"]]}], ["Autoimmune features including Sjogren\u2019s disease, rheumatoid arthritis, Hashimoto\u2019s disease, or isolated autoantibodies- were found in 36% of patients.", {"entities": [[49, 69, "DISEASE"], [60, 69, "DISEASE"]]}], ["SMAD3 gene mutations are associated with aortic dilatation and osteoarthritis, but also autoimmunity and peripheral neuropathy which mimics type II Charcot-Marie-Tooth.", {"entities": [[116, 126, "DISEASE"], [105, 126, "DISEASE"], [63, 77, "DISEASE"], [0, 5, "GENE"]]}], ["The brain, in particular the hypothalamus, plays a role in regulating glucose homeostasis; however, it remains unclear if the brain is causally involved in diabetic development.", {"entities": []}], ["Here, we identified that hypothalamic TGF-\u03b2 is excessive under conditions of not only obesity but aging, which are two general etiological factors of diabetes.", {"entities": [[86, 93, "DISEASE"]]}], ["Pharmacological and genetic approaches consistently revealed that brain TGF-\u03b2 excess caused hyperglycemia and glucose intolerance in a body weight-independent manner.", {"entities": [[110, 129, "DISEASE"], [92, 105, "DISEASE"]]}], ["Cell-specific genetic models demonstrated that astrocytes are responsible for brain TGF-\u03b2 excess, and POMC neurons are crucial for the pro-diabetic effect of TGF-\u03b2 excess.", {"entities": [[102, 106, "GENE"]]}], ["Mechanistically, TGF-\u03b2 excess induced hypothalamic RNA stress response to accelerate I\u03baB\u03b1 mRNA decay, leading to an atypical, mRNA metabolism-driven hypothalamic NF-\u03baB activation which links obesity as well as aging to hypothalamic inflammation.", {"entities": [[191, 198, "DISEASE"]]}], ["In conclusion, brain TGF-\u03b2 excess and induction of RNA stress response and hypothalamic inflammation are important for the pro-diabetic effects of obesity or aging.", {"entities": [[147, 154, "DISEASE"]]}], ["For population based biorepositories to be of use, rigorous quality control and assurance must be maintained.", {"entities": []}], ["We have designed and validated a panel of polymorphisms for individual sample identification consisting of 36 common polymorphisms that have been implicated in a wide range of diseases and an additional sex marker.", {"entities": []}], ["This panel uniquely identifies our biorepository of approximately 20,000 samples and would continue to uniquely identify samples in biorepositories of over 100 million samples.", {"entities": []}], ["A panel of polymorphisms associated with at least one disease state in multiple populations was constructed using a cut-off of 0.20 or greater confirmed minor allele frequency in a European Caucasian population.", {"entities": []}], ["The fingerprinting assay was tested using the MALDI-TOF mass spectrometry method of allele determination on a Sequenom platform with a panel of 28 Caucasian HapMap samples; the results were compared with known genotypes to ensure accuracy.", {"entities": []}], ["The frequencies of the alleles were compared to the expected frequencies from dbSNP and any genotype that did not achieve Hardy Weinberg equilibrium was excluded from the final assay.", {"entities": []}], ["The final assay consisted of the AMG sex marker and 36 medically relevant polymorphisms with representation on each chromosome, encompassing polymorphisms on both the Illumina 550K bead array and the Affymetrix 6.0 chip (with over a million polymorphisms) platform.", {"entities": []}], ["The validated assay has a P(ID) of 6.132 \u00d7 10 sib (ID) of 3.077 \u00d7 10 The polymorphisms in this panel are currently represented on a number of common genotyping platforms making QA/QC flexible enough to accommodate a large number of studies.", {"entities": []}], ["In addition, this panel can serve as a resource for investigators who are interested in the effects of disease in a population, particularly for common diseases.", {"entities": []}], ["The epididymis maintains a state of immune tolerance towards spermatozoa while also protecting them and itself against infection and acute inflammation.", {"entities": []}], ["The immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (Ido1) participates in this delicate local equilibrium.", {"entities": [[60, 64, "GENE"]]}], ["Using the mouse Ido1 model, we show here that the absence of IDO1 expression leads in the epididymis but not in serum to (1) an increase in the inflammatory state as evidenced by changes in the content of cytokines and chemokines, (2) the engagement of a Th1-driven inflammatory response as evidenced by changes in the Th17/Treg as well as Th1/Th2 equilibria, as well as (3) differences in the content of lipid intermediates classically involved in inflammation.", {"entities": [[16, 20, "GENE"], [61, 65, "GENE"], [16, 20, "GENE"], [61, 65, "GENE"]]}], ["Despite this more pronounced inflammatory state, Ido1 animals succeed in preserving the local epididymal immune situation due to the activation of compensatory mechanisms that are discussed.", {"entities": [[49, 53, "GENE"]]}], ["As the flows of immigrant populations increase worldwide, their heterogeneity becomes apparent with respect to the differences in the prevalence of chronic physical and mental disease.", {"entities": []}], ["Multimorbidity provides a new framework in understanding chronic diseases holistically as the consequence of environmental, social, and personal risks that contribute to increased vulnerability to a wide variety of illnesses.", {"entities": []}], ["There is a lack of studies on multimorbidity among immigrants compared to native-born populations.", {"entities": []}], ["This nationwide multi-register study in Norway enabled us i) to study the associations between multimorbidity and immigrant origin, accounting for other known risk factors for multimorbidity such as gender, age and socioeconomic levels using logistic regression analyses, and ii) to identify patterns of multimorbidity in Norway for immigrants and Norwegian-born by means of exploratory factor analysis technique.", {"entities": []}], ["Multimorbidity rates were lower for immigrants compared to Norwegian-born individuals, with unadjusted odds ratios (OR) and 95% confidence intervals 0.38 (0.37\u20130.39) for Eastern Europe, 0.58 (0.57\u20130.59) for Asia, Africa and Latin America, and 0.67 (0.66\u20130.68) for Western Europe and North America.", {"entities": []}], ["Results remained significant after adjusting for socioeconomic factors.", {"entities": []}], ["Similar multimorbidity disease patterns were observed among Norwegian-born and immigrants, in particular between Norwegian-born and those from Western European and North American countries.", {"entities": []}], ["However, the complexity of patterns that emerged for the other immigrant groups was greater.", {"entities": []}], ["Despite differences observed in the development of patterns with age, such as ischemic heart disease among immigrant women, we were unable to detect the systematic development of the multimorbidity patterns among immigrants at younger ages.", {"entities": [[78, 100, "DISEASE"], [87, 100, "DISEASE"]]}], ["Our study confirms that migrants have lower multimorbidity levels compared to Norwegian-born.", {"entities": []}], ["The greater complexity of multimorbidity patterns for some immigrant groups requires further investigation.", {"entities": []}], ["Health care policies and practice will require a holistic approach for specific population groups in order to meet their health needs and to curb and prevent diseases.", {"entities": []}], ["Acute exacerbation of chronic bronchitis (AECB) is a commonly encountered problem and those suspected to be due to bacterial infections require antibiotic therapy.", {"entities": [[30, 40, "DISEASE"]]}], ["This randomized, controlled trial was designed to evaluate the effectiveness and safety of gemifloxacin, a new fluoroquinolone, versus cefpodoxime, an oral third-generation cephalosporin, for the treatment of mild to moderately severe cases of AECB.", {"entities": []}], ["Adult subjects diagnosed with chronic bronchitis with clinical symptoms suggestive of an Anthonisen type II acute exacerbation (any two of the following criteria \u2013 increased dyspnea, cough, sputum purulence) were eligible and those fulfilling the subject selection criteria were randomized to receive either gemifloxacin 320 mg once daily or cefpodoxime 200 mg twice daily orally for 7 days.", {"entities": [[38, 48, "DISEASE"]]}], ["The primary outcome measure was clinical success rate at day 14 visit and the secondary outcome measures were changes in Clinical Global impression (CGI) scales and incidence of adverse events (AEs).", {"entities": []}], ["Fifty-two subjects were enrolled: 26 in gemifloxacin group and 24 in the other and 2 were lost to follow-up.", {"entities": []}], ["The clinical success rates were comparable (84.6% in gemifloxacin group versus 83.3% in cefpodoxime group) and no statistically significant difference was observed between the groups.", {"entities": []}], ["AEs were mild, self-limiting and few (two in gemifloxacin and three in cefpodoxime arm) and tolerability was also good.", {"entities": []}], ["The results of this randomized, single-blind trial demonstrated that a 7-day course of gemifloxacin is therapeutically comparable to cefpodoxime in terms of both clinical effectiveness and safety for the treatment of type II Anthonisen category AECB patients.", {"entities": []}], ["Although T\u2010helper type 1 (Th1) cells are considered important in atherosclerosis, the relationships between Th1 and Th2 cells and atherosclerosis have not been examined in population\u2010based studies.", {"entities": [[65, 80, "DISEASE"], [130, 145, "DISEASE"]]}], ["We measured Th cells as a percentage of lymphocytes by flow cytometry using CD4 staining (%CD4) in 917 participants of the Multi\u2010Ethnic Study of Atherosclerosis.", {"entities": [[145, 160, "DISEASE"], [76, 79, "GENE"], [91, 94, "GENE"], [76, 79, "GENE"], [91, 94, "GENE"]]}], ["We also measured interferon gamma\u2013positive and interleukin\u20104\u2010positive CD4 P <0.0001).", {"entities": [[70, 73, "GENE"]]}], ["Whites had higher %CD4 and lower %Th1 and %Th2 values than other race/ethnic groups.", {"entities": [[19, 22, "GENE"]]}], ["Body mass index (BMI) and blood pressure were associated with %CD4, but no traditional cardiovascular disease (CVD) risk factors were associated with %Th1 or %Th2.", {"entities": [[63, 66, "GENE"]]}], ["In multivariable models, the major independent variable associated with %Th1 was cytomegalovirus (CMV) antibody titer, with minor contributions from age, sex, seasonality, and interleukin\u20106.", {"entities": []}], ["In models with coronary artery calcification level as the outcome, significant independent variables included age, sex, smoking status, and %Th1 (\u03b2=0.25; P \u22640.01).", {"entities": []}], ["Both %Th1 and %Th2 were associated with common carotid intimal media thickness (\u03b2=0.02 and \u22120.02, respectively; both P <0.05), as were age, sex, race/ethnicity, blood pressure, and BMI.", {"entities": []}], ["Th1 bias is associated with subclinical atherosclerosis in a multiethnic population.", {"entities": [[40, 55, "DISEASE"]]}], ["The main Th1 correlate was CMV infectious burden.", {"entities": []}], ["These findings are consistent with a role of Th1 cells in atherosclerosis and suggest the importance of prospective studies of T\u2010helper cell biasing in CVD.", {"entities": [[58, 73, "DISEASE"]]}], ["While genome-wide association studies (GWAS) have primarily examined populations of European ancestry, more recent studies often involve additional populations, including admixed populations such as African Americans and Latinos.", {"entities": []}], ["In admixed populations, linkage disequilibrium (LD) exists both at a fine scale in ancestral populations and at a coarse scale (admixture-LD) due to chromosomal segments of distinct ancestry.", {"entities": []}], ["Disease association statistics in admixed populations have previously considered SNP association (LD mapping) or admixture association (mapping by admixture-LD), but not both.", {"entities": []}], ["Here, we introduce a new statistical framework for combining SNP and admixture association in case-control studies, as well as methods for local ancestry-aware imputation.", {"entities": []}], ["We illustrate the gain in statistical power achieved by these methods by analyzing data of 6,209 unrelated African Americans from the CARe project genotyped on the Affymetrix 6.0 chip, in conjunction with both simulated and real phenotypes, as well as by analyzing the FGFR2 locus using breast cancer GWAS data from 5,761 African-American women.", {"entities": [[287, 300, "DISEASE"], [294, 300, "DISEASE"], [269, 274, "GENE"]]}], ["We show that, at typed SNPs, our method yields an 8% increase in statistical power for finding disease risk loci compared to the power achieved by standard methods in case-control studies.", {"entities": []}], ["At imputed SNPs, we observe an 11% increase in statistical power for mapping disease loci when our local ancestry-aware imputation framework and the new scoring statistic are jointly employed.", {"entities": []}], ["Finally, we show that our method increases statistical power in regions harboring the causal SNP in the case when the causal SNP is untyped and cannot be imputed.", {"entities": []}], ["Our methods and our publicly available software are broadly applicable to GWAS in admixed populations.", {"entities": []}], ["This paper presents improved methodologies for the analysis of genome-wide association studies in admixed populations, which are populations that came about by the mixing of two or more distant continental populations over a few hundred years (e.g., African Americans or Latinos).", {"entities": []}], ["Studies of admixed populations offer the promise of capturing additional genetic diversity compared to studies over homogeneous populations such as Europeans.", {"entities": []}], ["In admixed populations, correlation between genetic variants exists both at a fine scale in the ancestral populations and at a coarse scale due to chromosomal segments of distinct ancestry.", {"entities": []}], ["Disease association statistics in admixed populations have previously considered either one or the other type of correlation, but not both.", {"entities": []}], ["In this work we develop novel statistical methods that account for both types of genetic correlation, and we show that the combined approach attains greater statistical power than that achieved by applying either approach separately.", {"entities": []}], ["We provide analysis of simulated and real data from major studies performed in African-American men and women to show the improvement obtained by our methods over the standard methods for analyzing association studies in admixed populations.", {"entities": []}], ["Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects ~1% of the Caucasian population.", {"entities": [[11, 20, "DISEASE"]]}], ["Over the last decades, the availability of biological drugs targeting the proinflammatory cytokine tumour necrosis factor \u03b1, anti-TNF drugs, has improved the treatment of patients with RA.", {"entities": []}], ["However, one-third of the patients do not respond to the treatment.", {"entities": []}], ["We wanted to evaluate the status of pharmacogenomics of anti-TNF treatment.", {"entities": []}], ["We performed a PubMed literature search and all studies reporting original data on associations between genetic variants and anti-TNF treatment response in RA patients were included and results evaluated by meta-analysis.", {"entities": []}], ["In total, 25 single nucleotide polymorphisms were found to be associated with anti-TNF treatment response in RA (19 from genome-wide association studies and 6 from the meta-analyses), and these map to genes involved in T cell function, NF\u03baB and TNF signalling pathways (including CTCN5, TEC, PTPRC, FCGR2A , NFKBIB, FCGR2A, IRAK3) .", {"entities": [[83, 86, "GENE"], [245, 248, "GENE"], [292, 297, "GENE"], [299, 305, "GENE"], [316, 322, "GENE"], [308, 314, "GENE"], [299, 305, "GENE"], [316, 322, "GENE"], [324, 329, "GENE"]]}], ["Explorative prediction analyses found that biomarkers for clinical treatment selection are not yet available.", {"entities": []}], ["Lethal toxin (LT) is a major virulence factor of Bacillus anthracis .", {"entities": [[14, 16, "GENE"]]}], ["Sprague Dawley rats manifest pronounced lung edema and shock after LT treatments, resulting in high mortality.", {"entities": [[67, 69, "GENE"]]}], ["The heart failure that is induced by LT has been suggested to be a principal mechanism of lung edema and mortality in rodents.", {"entities": [[37, 39, "GENE"]]}], ["Since LT-induced death occurs more rapidly in rats than in mice, suggesting that other mechanisms in addition to the heart dysfunction may be contributed to the fast progression of LT-induced pathogenesis in rats.", {"entities": []}], ["Coagulopathy may contribute to circulatory failure and lung injury.", {"entities": []}], ["However, the effect of LT on coagulation-induced lung dysfunction is unclear.", {"entities": [[23, 25, "GENE"]]}], ["To investigate the involvement of coagulopathy in LT-mediated pathogenesis, the mortality, lung histology and coagulant levels of LT-treated rats were examined.", {"entities": []}], ["The effects of activated protein C (aPC) on LT-mediated pathogenesis were also evaluated.", {"entities": [[36, 39, "GENE"]]}], ["Fibrin depositions were detected in the lungs of LT-treated rats, indicating that coagulation was activated.", {"entities": []}], ["Increased levels of plasma D-dimer and thrombomodulin, and the ameliorative effect of aPC further suggested that the activation of coagulation-fibrinolysis pathways plays a role in LT-mediated pathogenesis in rats.", {"entities": [[86, 89, "GENE"]]}], ["Reduced mortality was associated with decreased plasma levels of D-dimer and thrombomodulin following aPC treatments in rats with LT-mediated pathogenesis.", {"entities": [[102, 105, "GENE"]]}], ["These findings suggest that the activation of coagulation in lung tissue contributes to mortality in LT-mediated pathogenesis in rats.", {"entities": []}], ["In addition, anticoagulant aPC may help to develop a feasible therapeutic strategy.", {"entities": [[27, 30, "GENE"]]}], ["The secreted, goblet cell-derived protein Clca1 (chloride channel regulator, calcium-activated-1) has been linked to diseases with mucus overproduction, including asthma and cystic fibrosis.", {"entities": [[174, 189, "DISEASE"], [163, 169, "DISEASE"], [42, 47, "GENE"]]}], ["In the intestine Clca1 is found in the mucus with an abundance and expression pattern similar to Muc2, the major structural mucus component.", {"entities": [[17, 22, "GENE"], [97, 101, "GENE"]]}], ["We hypothesized that Clca1 is required for the synthesis, structure or barrier function of intestinal mucus and therefore compared wild type and Clca1 -deficient mice under naive and at various time points of DSS (dextran sodium sulfate)-challenged conditions.", {"entities": [[21, 26, "GENE"], [145, 150, "GENE"], [21, 26, "GENE"], [145, 150, "GENE"]]}], ["The mucus phenotype in Clca1 -deficient compared to wild type mice was systematically characterized by assessment of the mucus protein composition using proteomics, immunofluorescence and expression analysis of selected mucin genes on mRNA level.", {"entities": [[23, 28, "GENE"]]}], ["Mucus barrier integrity was assessed in-vivo by analysis of bacterial penetration into the mucus and translocation into sentinel organs combined analysis of the fecal microbiota and ex-vivo by assessment of mucus penetrability using beads.", {"entities": []}], ["All of these assays revealed no relevant differences between wild type and Clca1 -deficient mice under steady state or DSS-challenged conditions in mouse colon.", {"entities": [[75, 80, "GENE"]]}], ["Clca1 is not required for mucus synthesis, structure and barrier function in the murine colon.", {"entities": [[0, 5, "GENE"]]}], ["This study provides an empirical test of two mechanisms (social capital and exposure to air pollution) that are theorized to mediate the effect of neighborhood on health and contribute to racial disparities in health outcomes.", {"entities": []}], ["To this end, we utilize the Social Capital Benchmark Study, a national survey of individuals nested within communities in the United States, to estimate how multiple dimensions of social capital and exposure to air pollution, explain racial disparities in self-rated health.", {"entities": []}], ["Our main findings show that when controlling for individual-confounders, and nesting within communities, our indicator of cognitive bridging, generalized trust, decreases the gap in self-rated health between African Americans and Whites by 84%, and the gap between Hispanics and Whites by 54%.", {"entities": []}], ["Our other indicator of cognitive social capital, cognitive linking as represented by engagement in politics, decreases the gap in health between Hispanics and Whites by 32%, but has little impact on African Americans.", {"entities": []}], ["We also assessed whether the gap in health was explained by respondents\u2019 estimated exposure to toxicity-weighted air pollutants from large industrial facilities over the previous year.", {"entities": []}], ["Our results show that accounting for exposure to these toxins has no effect on the racial gap in self-rated health in these data.", {"entities": []}], ["This paper contributes to the neighborhood effects literature by examining the impact that estimated annual industrial air pollution, and multiple measures of social capital, have on explaining the racial gap in health in a sample of individuals nested within communities across the United States.", {"entities": []}], ["Clinical trials of a combination therapy of an inhaled corticosteroid, fluticasone propionate (FP), with a long-acting \u03b2 2 -agonist, salmeterol (Sal), have demonstrated a greater improvement in lung function and in quality of life measures after the combination compared with either component of alone.", {"entities": []}], ["In a subanalysis of the data of the TRISTAN study, Sal/FP reduced exacerbation rates in COPD patients with a baseline FEV 1 <50% of predicted.", {"entities": [[118, 121, "GENE"]]}], ["A combination therapy of budesonide and formoterol improved quality of life and FEV 1 , and reduced exacerbations better than either component alone.", {"entities": [[80, 83, "GENE"]]}], ["In studies of FP or of Sal/FP in COPD, there was a reduction in all-cause mortality by 25% relative to placebo.", {"entities": []}], ["Sal/FP has anti-inflammatory effects in COPD airways.", {"entities": []}], ["FP inhibits markers of systemic inflammation, and it is not known whether Sal/FP has an advantage over FP alone.", {"entities": []}], ["While long-acting \u03b2 2 -agonists such as Sal can be recommended for treatment of moderate COPD, addition of inhaled steroid therapy such as FP should be considered in more severe disease.", {"entities": []}], ["Alpha 1 anti-trypsin (\u03b1 1 -AT), a serine protease inhibitor synthesized in the liver, is a major circulating antiprotease that provides defense against proteolytic damage in several tissues.", {"entities": []}], ["Its deficiency is associated with airflow obstruction.", {"entities": []}], ["The present study aimed to explore the role of \u03b1 1 -AT as a biomarker of airflow performance in chronic liver disease (CLD).", {"entities": [[104, 117, "DISEASE"]]}], ["Serum \u03b1 1 -AT levels and lung function (spirometry) were evaluated in non-primary \u03b1 1 -AT-deficient, alcoholic CLD patients without evident respiratory limitations.", {"entities": []}], ["Thirty-four patients with airflow obstruction (n=11), airflow restriction (n=12), and normal airflow (n=11, age-matched controls) were eligible.", {"entities": []}], ["\u03b11-AT was decreased in the airflow obstruction group.", {"entities": []}], ["ROC-cutoff \u03b1 1 -AT=24 mg/dL effectively discriminated airflow obstruction (AUC=0.687) and was associated with a 10-fold higher risk (p=0.0007).", {"entities": []}], ["Lower \u03b1 1 -AT increased the risk of airflow obstruction in CLD patients without primary \u03b1 1 -AT deficiency.", {"entities": []}], ["In countries where registration of vital events is lacking and the proportion of people who die at home without medical care is high, verbal autopsy is used to determine and estimate causes of death.", {"entities": []}], ["We conducted 723 verbal autopsy interviews of adult (15 years of age and above) deaths from September 2009 to January 2013.", {"entities": []}], ["Trained physicians interpreted the collected verbal autopsy data, and assigned causes of death according to the international classification of diseases (ICD-10).", {"entities": []}], ["We did analysis of specific as well as broad causes of death (i.e.", {"entities": []}], ["non-communicable diseases, communicable diseases and external causes of death) by sex and age using Stata version 11.1.", {"entities": []}], ["We performed logistic regression to identify socio-demographic predictors using odds ratio with 95% confidence interval and a p-value of 0.05.", {"entities": []}], ["Tuberculosis, cerebrovascular diseases and accidental falls were leading specific causes of death accounting for 15.9%, 7.3% and 3.9% of all deaths.", {"entities": [[0, 12, "DISEASE"]]}], ["Two hundred sixty three (36.4% [95% CI: 32.9, 39.9]), 252 (34.9% [95% CI: 31.4, 38.4]) and 89 (12.3% [95% CI: 10.1, 14.9]) deaths were due to non-communicable, communicable diseases, and external causes, respectively.", {"entities": []}], ["Females had 1.5 times (AOR\u200a=\u200a1.53 [95% CI: 1.10, 2.15]) higher odds of dying due to communicable diseases than males.", {"entities": []}], ["The odds of dying due to external causes were 4 times higher among 15\u201349 years of age (AOR\u200a=\u200a4.02 [95% CI: 2.25, 7.18]) compared to older ages.", {"entities": []}], ["Males also had 1.7 times (AOR\u200a=\u200a1.70 [95% CI: 1.01, 2.85]) higher odds of dying due to external causes than females.", {"entities": []}], ["Tuberculosis, cerebrovascular diseases and accidental falls were the top three causes of death among adults.", {"entities": [[0, 12, "DISEASE"]]}], ["Efforts to prevent tuberculosis and cerebrovascular diseases related deaths should be improved and safety efforts to reduce accidents should also receive attention.", {"entities": [[19, 31, "DISEASE"]]}], ["In-service training represents a significant financial investment for supporting continued competence of the health care workforce.", {"entities": []}], ["An integrative review of the education and training literature was conducted to identify effective training approaches for health worker continuing professional education (CPE) and what evidence exists of outcomes derived from CPE.", {"entities": [[172, 175, "GENE"], [227, 230, "GENE"], [172, 175, "GENE"], [227, 230, "GENE"]]}], ["A literature review was conducted from multiple databases including PubMed, the Cochrane Library and Cumulative Index to Nursing and Allied Health Literature (CINAHL) between May and June 2011.", {"entities": []}], ["The initial review of titles and abstracts produced 244 results.", {"entities": []}], ["Articles selected for analysis after two quality reviews consisted of systematic reviews, randomized controlled trials (RCTs) and programme evaluations published in peer-reviewed journals from 2000 to 2011 in the English language.", {"entities": []}], ["The articles analysed included 37 systematic reviews and 32 RCTs.", {"entities": []}], ["The research questions focused on the evidence supporting educational techniques, frequency, setting and media used to deliver instruction for continuing health professional education.", {"entities": []}], ["The evidence suggests the use of multiple techniques that allow for interaction and enable learners to process and apply information.", {"entities": []}], ["Case-based learning, clinical simulations, practice and feedback are identified as effective educational techniques.", {"entities": []}], ["Didactic techniques that involve passive instruction, such as reading or lecture, have been found to have little or no impact on learning outcomes.", {"entities": []}], ["Repetitive interventions, rather than single interventions, were shown to be superior for learning outcomes.", {"entities": []}], ["Settings similar to the workplace improved skill acquisition and performance.", {"entities": []}], ["Computer-based learning can be equally or more effective than live instruction and more cost efficient if effective techniques are used.", {"entities": []}], ["Effective techniques can lead to improvements in knowledge and skill outcomes and clinical practice behaviours, but there is less evidence directly linking CPE to improved clinical outcomes.", {"entities": [[156, 159, "GENE"]]}], ["Very limited quality data are available from low- to middle-income countries.", {"entities": []}], ["Educational techniques are critical to learning outcomes.", {"entities": []}], ["Targeted, repetitive interventions can result in better learning outcomes.", {"entities": []}], ["Setting should be selected to support relevant and realistic practice and increase efficiency.", {"entities": []}], ["Media should be selected based on the potential to support effective educational techniques and efficiency of instruction.", {"entities": []}], ["CPE can lead to improved learning outcomes if effective techniques are used.", {"entities": [[0, 3, "GENE"]]}], ["Limited data indicate that there may also be an effect on improving clinical practice behaviours.", {"entities": []}], ["The research agenda calls for well-constructed evaluations of culturally appropriate combinations of technique, setting, frequency and media, developed for and tested among all levels of health workers in low- and middle-income countries.", {"entities": []}], ["The objective is to investigate the influence of PM 2.5 exposure on peripheral blood lymphocyte subsets in pregnant mice and the antagonism of quercetin on adverse effects induced by PM 2.5 exposure.", {"entities": []}], ["Pregnant mice were randomly divided into control group, PM 2.5 model group and 3 quercetin intervention groups.", {"entities": []}], ["Dams in all groups except the control group were exposed to PM 2.5 suspension by intratracheal instillation on gestational day (GD) 3, 6, 9, 12 and 15.", {"entities": []}], ["Meanwhile, each dam was given 0.15% carboxymethylcellulose sodium (CMCS) (control group & PM 2.5 model group) and different doses of quercetin (quercetin intervention groups) by gavage once a day from GD0 to GD17.", {"entities": []}], ["The percentage of lymphocyte subsets, Biomarkers of systemic inflammation injuries (IL-2, IL-6, IL-8 & TNF-\u03b1) and oxidative stress indicators (CAT, GSH & HO-1) in peripheral blood of the dams were analyzed.", {"entities": []}], ["The number of T cells increased, accompanied by increased level of IL-2, IL-6, IL-8 and HO-1 due to PM 2.5 exposure.", {"entities": []}], ["Less CD4+ and CD8+ T cells were counted in 100 mg/kg quercetin intervention group, compared with PM 2.5 model group.", {"entities": []}], ["Quercetin may inhibit cytokine production, especially in IL-6 and IL-8 and may upgrade the level of HO-1.", {"entities": []}], ["Our findings indicate that PM 2.5 could significantly influence the distribution of T-lymphocyte subsets, activate inflammatory reaction and elevate oxidative stress level in peripheral blood of pregnant mice.", {"entities": []}], ["Certain dose of quercetin administration during pregnancy may protect the dams against the adverse effects through various ways.", {"entities": []}], ["Health utility (HU) measures are used as overall measures of quality of life and to determine quality adjusted life years (QALYs) in economic analyses.", {"entities": []}], ["We compared baseline values of three HUs including Short Form 6 Dimensions (SF-6D), and Health Utilities Index, Mark II and Mark III (HUI2 and HUI3) and the feeling thermometer (FT) among type 2 diabetes participants in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.", {"entities": []}], ["We assessed relationships between HU and FT values and patient demographics and clinical variables.", {"entities": []}], ["ACCORD was a randomized clinical trial to test if intensive controls of glucose, blood pressure and lipids can reduce the risk of major cardiovascular disease (CVD) events in type 2 diabetes patients with high risk of CVD.", {"entities": []}], ["The health-related quality of life (HRQOL) sub-study includes 2,053 randomly selected participants.", {"entities": []}], ["Interclass correlations (ICCs) and agreement between measures by quartile were used to evaluate relationships between HU\u2019s and the FT. Multivariable regression models specified relationships between patient variables and each HU and the FT.", {"entities": []}], ["The ICCs were 0.245 for FT/SF-6D, 0.313 for HUI3/SF-6D, 0.437 for HUI2/SF-6D, 0.338 for FT/HUI2, 0.337 for FT/HUI3 and 0.751 for HUI2/HUI3 ( P \u2009<\u20090.001 for all).", {"entities": []}], ["Common classification by quartile was found for the majority (62%) of values between HUI2 and HUI3, which was significantly ( P \u2009<\u20090.001) higher than between other HUs and the FT: SF-6D/HUI3\u2009=\u200940.8%, SF-6D/HUI2\u2009=\u200940.9%, FT/HUI3\u2009=\u200935.0%, FT/HUI2\u2009=\u200934.9%, and FT/SF-6D\u2009=\u200931.9%.", {"entities": []}], ["Common classification was higher between SF-6D/HUI2 and SF-6D/HUI3 ( P \u2009<\u20090.001) than between FT/SF-6D, FT/HUI2, and FT/HUI3.", {"entities": []}], ["The mean difference in HU values per patient ranged from \u22120.024\u2009\u00b1\u20090.225 for SF-6D/ HUI3 to \u22120.124\u2009\u00b1\u20090.133 for SF-6D/HUI2.", {"entities": []}], ["Regression models were significant; clinical and demographic variables explained 6.1% (SF-6D) to 7.7% (HUI3) of the variance in HUs.", {"entities": []}], ["The agreements between the different HUs were poor except for the two HUI measures; therefore HU values derived different measures may not be comparable.", {"entities": []}], ["The FT had low agreement with HUs.", {"entities": []}], ["The relationships between HUs and demographic and clinical measures demonstrate how severity of diabetes and other clinical and demographic factors are associated with HUs and FT measures.", {"entities": []}], ["ClinicalTrials.gov Identifier: NCT00000620", {"entities": []}], ["Southwest metropolitan Mexico City (SWMMC) inhabitants have been exposed several hours per day for the last 6 years to photochemical smog, ozone being the most important oxidant pollutant.", {"entities": []}], ["Subjects exposed to the SWMMC atmosphere develop several histopathological changes in their nasal mucosa: dysplasia is the most significant, affecting 78.72% of adult individuals within 60 or more days of residence in SWMMC.", {"entities": []}], ["This study was originally designed to explore whether chemical intervention could modify nasal dysplasia, as determined by nasal cytology, in a defined adult population.", {"entities": []}], ["In a placebo-controlled, randomized, double-blind trial, 177 healthy male subjects were divided into 5 groups to whom 5000 IU of vitamin A, 100 IU of vitamin E, a combination of vitamins A and E (5000 IU + 100 IU), 16 mg of beta-carotene, or placebo were administered daily for 4 months.", {"entities": []}], ["Sixteen clinical and cytological variables were monitored.", {"entities": []}], ["No effect on dysplasia was seen at the end of the 4-month trial; however, an apparent reversibility as well as progression of the dysplastic nasal lesions and high correlation coefficients between dysplasia and nasal cytology of polymorphonuclear leukocytes (PMNs; 0.85), squamous metaplasia (SM; 0.50), and nasal mucosa atrophy (NMA; 0.41) were found.", {"entities": []}], ["A mathematical theoretical nasal dysplasia (tD) predictor equation for SWMMC adult male inhabitants is proposed (tD = 0.85 delta PMNs + 0.50 delta SM + 0.41 delta NMA + 0.98), in which PMNs are the best single dysplasia predictor, and all variables are independent.", {"entities": []}], ["(ABSTRACT TRUNCATED AT 250 WORDS)", {"entities": []}], ["Immune abnormalities have been described in some individuals with autism spectrum disorders (ASD) as well as their family members.", {"entities": []}], ["However, few studies have directly investigated the role of prenatal cytokine and chemokine profiles on neurodevelopmental outcomes in humans.", {"entities": []}], ["In the current study, we characterized mid-gestational serum profiles of 22 cytokines and chemokines in mothers of children with ASD (N=415), developmental delay without ASD (DD) (N=188), and general population (GP) controls (N=428) using a bead-based multiplex technology.", {"entities": []}], ["The ASD group was further divided into those with intellectual disabilities (DQ<70) (ASD+ID, N=184) and those without (DQ\u226570) (ASD-noID, N=201).", {"entities": []}], ["Levels of cytokines and chemokines were compared between groups using multivariate logistic regression analyses, adjusting for maternal age, ethnicity, birth country, and weight, as well as infant gender, birth year, and birth month.", {"entities": []}], ["Mothers of children with ASD+ID had significantly elevated mid-gestational levels of numerous cytokines and chemokines, such as GM-CSF, IFN-\u03b3, IL-1\u03b1, and IL-6, compared to mothers of children with either ASD-noID, those with DD, or GP controls.", {"entities": []}], ["Conversely, mothers of children with either ASD-noID or with DD had significantly lower levels of the chemokines IL-8 and MCP-1 compared to mothers of GP controls.", {"entities": []}], ["This observed immunologic distinction between mothers of children with ASD+ID from mothers of children with ASD-noID or DD suggests that the intellectual disability (ID) associated with ASD might be etiologically distinct from DD without ASD.", {"entities": [[141, 164, "DISEASE"]]}], ["These findings contribute to the ongoing efforts toward identification of early biological markers specific to sub-phenotypes of ASD.", {"entities": []}], ["Falls are a major threat to older people\u2019s health and wellbeing.", {"entities": []}], ["Approximately half of falls occur in outdoor environments but little is known about the circumstances in which they occur.", {"entities": []}], ["We conducted a qualitative study to explore older people\u2019s experiences of outdoor falls to develop understanding of how they may be prevented.", {"entities": []}], ["We conducted nine focus groups across the UK (England, Wales, and Scotland).", {"entities": []}], ["Our sample was from urban and rural settings and different environmental landscapes.", {"entities": []}], ["Participants were aged 65+ and had at least one outdoor fall in the past year.", {"entities": []}], ["We analysed the data using framework and content analyses.", {"entities": []}], ["Forty-four adults aged 65 \u2013 92 took part and reported their experience of 88 outdoor falls.", {"entities": []}], ["Outdoor falls occurred in a variety of contexts, though reports suggested the following scenarios may have been more frequent: when crossing a road, in a familiar area, when bystanders were around, and with an unreported or unknown attribution.", {"entities": []}], ["Most frequently, falls resulted in either minor or moderate injury, feeling embarrassed at the time of the fall, and anxiety about falling again.", {"entities": []}], ["Ten falls resulted in fracture, but no strong pattern emerged in regard to the contexts of these falls.", {"entities": []}], ["Anxiety about falling again appeared more prevalent among those that fell in urban settings and who made more visits into their neighbourhood in a typical week.", {"entities": []}], ["This exploratory study has highlighted several aspects of the outdoor environment that may represent risk factors for outdoor falls and associated fear of falling.", {"entities": []}], ["Health professionals are recommended to consider outdoor environments as well as the home setting when working to prevent falls and increase mobility among older people.", {"entities": []}], ["The investigation of plant mixtures used in traditional medicine in Northern Peru yielded a total of 974 herbal preparations used to treat 164 different afflictions.", {"entities": []}], ["Psychosomatic disorders were, with almost 30% of all recipes applied, the most important afflictions treated.", {"entities": []}], ["In most cases, healers used only one or two mixtures to treat an illness.", {"entities": []}], ["However, up to 49 different preparations were used to treat the same disease.", {"entities": []}], ["This indicates a high degree of experimentation.", {"entities": []}], ["Altogether 330 plant species, representing almost 65% of the medicinal flora used in the region were applied in mixtures.", {"entities": []}], ["The overwhelming number of plant mixtures contained 2-7 different plant species, although in the most extreme case 27 distinct species were included.", {"entities": []}], ["The cluster analysis confirmed that mixtures used for applications like inflammations, infections and blood purification, as well as cough, cold, bronchitis or other respiratory disorders, or urinary infection and kidney problems had similar floristic compositions.", {"entities": [[146, 156, "DISEASE"]]}], ["Mixtures used for nervous system disorders, anxiety and heart problems often had a similar composition", {"entities": []}], ["To collectively evaluate the association of glucose-6-phosphatase catalytic unit 2 ( G6PC2 ) allele variants with elevated fasting glucose (FG) and type 2 diabetes (T2D).", {"entities": [[85, 90, "GENE"]]}], ["Meta-analysis PubMed, Web of Knowledge and Embase databases.", {"entities": []}], ["Full text articles of studies that identified an association of G6PC2 with T2D and elevated FG.", {"entities": [[64, 69, "GENE"]]}], ["There was no T2D patient involvement in the analyses on the association of FG with G6PC2 , there were T2D patients and non-diabetes patient involvement in the analyses on the association of T2D with G6PC2 .", {"entities": [[83, 88, "GENE"], [199, 204, "GENE"], [83, 88, "GENE"], [199, 204, "GENE"]]}], ["Random-effects meta-analyses were used to calculate the pool effect sizes.", {"entities": []}], ["I Of the 423 studies identified, 21 were eligible and included.", {"entities": []}], ["Data on three loci (rs560887, rs16856187 and rs573225) were available.", {"entities": []}], ["The G allele at rs560887 in three ethnicities, the C allele at rs16856187 and the A allele at rs573225 all had a positive association with elevated FG.", {"entities": []}], ["Per increment of G allele at rs560887 and A allele at rs573225 resulted in a FG 0.070 mmol/l and 0.075 mmol/l higher (\u00df (95% CI) = 0.070 (0.060, 0.079), p = 4.635e-50 and 0.075 (0.065, 0.085), p = 5.856e-48, respectively).", {"entities": []}], ["With regard to the relationship of rs16856187 and FG, an increase of 0.152 (95% CI: 0.034\u20130.270; p = 0.011) and 0.317 (95% CI: 0.193\u20130.442, p = 6.046e-07) was found in the standardized mean difference (SMD) of FG for the AC and CC genotypes, respectively, when compared with the AA reference genotype.", {"entities": []}], ["However, the G-allele of rs560887 in Caucasians under the additive model and the C-allele of rs16856187 under the allele and dominant models were associated with a decreased risk of T2D (OR (95% CI) = 0.964 (0.947, 0.981), p = 0.570e-4; OR (95% CI) = 0.892 (0.832, 0.956), p = 0.001; and OR (95% CI) = 0.923(0.892, 0.955), p = 5.301e-6, respectively).", {"entities": []}], ["Our meta-analyses demonstrate that all three allele variants of G6PC2 (rs560887, rs16856187 and rs573225) are associated with elevated FG, with two variants (rs560887 in the Caucasians subgroup and rs16856187 under the allele and dominant model) being associated with T2D as well.", {"entities": [[64, 69, "GENE"]]}], ["Further studies utilizing larger sample sizes and different ethnic populations are needed to extend and confirm these findings.", {"entities": []}], ["AUDIPOC is a nationwide clinical audit that describes the characteristics, interventions and outcomes of patients admitted to Spanish hospitals because of an exacerbation of chronic obstructive pulmonary disease (ECOPD), assessing the compliance of these parameters with current international guidelines.", {"entities": [[174, 211, "DISEASE"]]}], ["The present study describes hospital resources, hospital factors related to case recruitment variability, patients\u2019 characteristics, and adherence to guidelines.", {"entities": []}], ["An organisational database was completed by all participant hospitals recording resources and organisation.", {"entities": []}], ["Over an 8-week period 11,564 consecutive ECOPD admissions to 129 Spanish hospitals covering 70% of the Spanish population were prospectively identified.", {"entities": []}], ["At hospital discharge, 5,178 patients (45% of eligible) were finally included, and thus constituted the audited population.", {"entities": []}], ["Audited patients were reassessed 90 days after admission for survival and readmission rates.", {"entities": []}], ["A wide variability was observed in relation to most variables, hospital adherence to guidelines, and readmissions and death.", {"entities": []}], ["Median inpatient mortality was 5% (across-hospital range 0\u201335%).", {"entities": []}], ["Among discharged patients, 37% required readmission (0\u201362%) and 6.5% died (0\u201335%).", {"entities": []}], ["The overall mortality rate was 11.6% (0\u201350%).", {"entities": []}], ["Hospital size and complexity and aspects related to hospital COPD awareness were significantly associated with case recruitment.", {"entities": []}], ["Clinical management most often complied with diagnosis and treatment recommendations but rarely (<50%) addressed guidance on healthy life-styles.", {"entities": []}], ["The AUDIPOC study highlights the large across-hospital variability in resources and organization of hospitals, patient characteristics, process of care, and outcomes.", {"entities": []}], ["The study also identifies resources and organizational characteristics associated with the admission of COPD cases, as well as aspects of daily clinical care amenable to improvement.", {"entities": []}], ["The pathogenesis of lung disease in cystic fibrosis is characterised by decreased airway surface liquid volume and subsequent failure of normal mucociliary clearance.", {"entities": [[36, 51, "DISEASE"], [20, 32, "DISEASE"]]}], ["Mucus within the cystic fibrosis airways is enriched in negatively charged matrices composed of DNA released from colonizing bacteria or inflammatory cells, as well as F-actin and elevated concentrations of anionic glycosaminoglycans.", {"entities": [[17, 32, "DISEASE"]]}], ["Therapies acting against airway mucus in cystic fibrosis include aerosolized hypertonic saline.", {"entities": [[41, 56, "DISEASE"]]}], ["It has been shown that hypertonic saline possesses mucolytic properties and aids mucociliary clearance by restoring the liquid layer lining the airways.", {"entities": []}], ["However, recent clinical and bench-top studies are beginning to broaden our view on the beneficial effects of hypertonic saline, which now extend to include anti-infective as well as anti-inflammatory properties.", {"entities": []}], ["This review aims to discuss the described therapeutic benefits of hypertonic saline and specifically to identify novel models of hypertonic saline action independent of airway hydration.", {"entities": []}], ["Thromboxane and its receptor have emerged as key players in modulating vascular thrombotic events.", {"entities": []}], ["Thus, a dysfunctional hTP genetic variant may protect against (hypoactivity) or promote (hyperactivity) vascular events, based upon its activity on platelets.", {"entities": []}], ["After extensive in silico analysis, six hTP-\u03b1 variants were selected (C in silico predictions.", {"entities": []}], ["Variant biochemical profiles ranged from severe instability (C in silico , in vitro and \u201cin platelet\u201d evaluation of hTP variants to date and highlightscurrent inherent problems in evaluating genetic variants, with possible solutions.", {"entities": []}], ["The study additionally provides clinical relevance to characterized dysfunctional hTP variants.", {"entities": []}], ["Chronic spontaneous urticaria (CSU) is a common skin disorder with etiology that is not well understood.", {"entities": [[20, 29, "DISEASE"]]}], ["In this study, we evaluated the prevalence of autologous serum skin test (ASST) and skin prick testing (SPT) to house dust mite (HDM) in 862 CSU cases in China.", {"entities": []}], ["Clinical features, courses and treatment responses were also recorded.", {"entities": []}], ["The prevalence of positive ASST was 46.3%, and patients aged 30\u201339 years had the highest positive rate (52.1%).", {"entities": []}], ["Positive SPT to HDM was seen in 153 patients (17.7%) with the highest positive rate (34.2%) in patients aged 20 or less.", {"entities": []}], ["Patients with positive ASST had higher urticaria activity scores (UAS) (4.18\u00b10.65 vs. 3.67\u00b10.53) but lower positive rates of HDM (24.6% vs. 37.6%), as compared with those with negative ASST (odds ratio (OR) 1.84, 95% CI 1.38\u20132.47).", {"entities": [[39, 48, "DISEASE"]]}], ["Patients could be categorized into four groups based on the results of ASST and SPT to HDM and patients with positive ASST and positive SPT to HDM had the highest disease activity scores, experienced higher frequencies of angioedema, diseases duration, and required higher dosage of loratadine every month, compared with other subgroups ( P <0.0001).", {"entities": [[222, 232, "DISEASE"]]}], ["Patients with CSU showed varied responses of positive ASST and varied sensitivity to HDM, Patients with positive ASST and/or positive SPT had more disease activity compared with patients with negative ASST and/or negative SPT.", {"entities": []}], ["Further classification can be made based on the result of SPT and ASST.", {"entities": []}], ["Macrophages (M\u03a6) play an essential role in innate immune responses and can either display a pro-inflammatory, classically activated phenotype (M1) or undergo an alternative activation program (M2) promoting immune regulation.", {"entities": []}], ["M-CSF is used to differentiate monocytes into M\u03a6 and IFN-\u03b3 or IL-4+IL-13 to further polarize these cells towards M1 or M2, respectively.", {"entities": []}], ["Recently, differentiation using only GM-CSF or M-CSF has been described to induce a M1- or M2-like phenotype, respectively.", {"entities": []}], ["In this study, we combined both approaches by differentiating human M\u03a6 in GM-CSF or M-CSF followed by polarization with either IFN-\u03b3 or IL-4+IL-13.", {"entities": []}], ["We describe the phenotypic differences between CD14", {"entities": [[47, 51, "GENE"]]}], ["Dendritic cells (DCs) are key mediators of allergic airway inflammation.", {"entities": []}], ["Thus, it is important to understand the relationship between respiratory syncytial virus (RSV) infection and DCs, especially in children with RSV bronchiolitis.", {"entities": [[146, 159, "DISEASE"]]}], ["We collected peripheral blood from 71 children with RSV bronchiolitis at the time of admission and 28 children who were followed up 3 months following admission.", {"entities": [[56, 69, "DISEASE"]]}], ["Flow cytometry was performed to detect dendritic cell immunophenotypes.", {"entities": []}], ["Patients with RSV bronchiolitis exhibited significantly higher number of myeloid DCs and lower number of plasmacytoid DCs at the time of admission and 3 months following discharge, compared with healthy controls.", {"entities": [[18, 31, "DISEASE"]]}], ["These children had a significantly higher myeloid/plasmacytoid ratio 3 months after discharge compared with healthy controls.", {"entities": []}], ["Among children with RSV bronchiolitis, there is an imbalance in peripheral blood myeloid/plasmacytoid ratio.", {"entities": [[24, 37, "DISEASE"]]}], ["The low number of plasmacytoid DCs in peripheral blood indicates the development of bronchiolitis due to RSV infection.", {"entities": [[84, 97, "DISEASE"]]}], ["The aim of this study was to investigate the association between absolute volumes of lung spared from low-dose irradiation and radiation-induced lung injury (RILI) after intensity-modulated radiotherapy (IMRT) for lung cancer.", {"entities": [[214, 225, "DISEASE"], [219, 225, "DISEASE"]]}], ["The normal lung relative volumes receiving greater than 5, 10, 20 and 30 Gy (V5\u201330) mean lung dose (MLD), and absolute volumes spared from greater than 5, 10, 20 and 30 Gy (AVS5\u201330) for the bilateral and ipsilateral lungs of 83 patients were recorded.", {"entities": []}], ["Any association of clinical factors and dose\u2013volume parameters with Grade \u22652 RILI was analyzed.", {"entities": []}], ["The median follow-up was 12.3 months; 18 (21.7%) cases of Grade 2 RILI, seven (8.4%) of Grade 3 and two (2.4%) of Grade 4 were observed.", {"entities": []}], ["Univariate analysis revealed the located lobe of the primary tumor.", {"entities": []}], ["V5, V10, V20, MLD of the ipsilateral lung, V5, V10, V20, V30 and MLD of the bilateral lung, and AVS5 and AVS10 of the ipsilateral lung were associated with Grade \u22652 RILI ( P < 0.05).", {"entities": []}], ["Multivariate analysis indicated AVS5 of the ipsilateral lung was prognostic for Grade \u22652 RILI ( P = 0.010, OR = 0.272, 95% CI: 0.102\u20130.729).", {"entities": []}], ["Receiver operating characteristic curves indicated Grade \u22652 RILI could be predicted using AVS5 of the ipsilateral lung (area under curve, 0.668; cutoff value, 564.9 cm P = 0.008).", {"entities": []}], ["Low-dose irradiation relative volumes and MLD of the bilateral or ipsilateral lung were associated with Grade \u22652 RILI, and AVS5 of the ipsilateral lung was prognostic for Grade \u22652 RILI for lung cancer after IMRT.", {"entities": [[189, 200, "DISEASE"], [194, 200, "DISEASE"]]}], ["To determine whether the quality of life of adolescents with asthma correlates with parameters obtained prior to and after the six-minute step test (6MST); spirometric results after the 6MST; and level of physical activity.", {"entities": [[61, 67, "DISEASE"]]}], ["Nineteen adolescents with asthma, ranging from 11-15 years of age, were assessed with spirometry, 6MST, the International Physical Activity Questionnaire (IPAQ), the Pediatric Asthma Quality of Life Questionnaire (PAQLQ), and the 10-point Borg category-ratio scale.", {"entities": [[26, 32, "DISEASE"], [176, 182, "DISEASE"]]}], ["Sensation of dyspnea correlated negatively with the total PAQLQ score (r = \u22120.54) and with the scores of its activity limitation (AL) and symptoms domains (r = \u22120.64 and r = \u22120.63, respectively), leg fatigue also correlating negatively with those same domains (r = \u22120.49 and r = \u22120.56, respectively).", {"entities": []}], ["The total IPAQ score correlated with the total PAQLQ score (r = 0.47) and with the PAQLQ AL domain (r = 0.51); IPAQ time spent walking correlated with the PAQLQ symptoms domain (r = 0.45); and IPAQ time spent in vigorous activity correlated with the AL domain (r = 0.50).", {"entities": []}], ["In the regression analysis, only sensation of dyspnea remained significantly correlated with the total PAQLQ score and the PAQLQ AL domain; leg fatigue remained significantly correlated with the symptoms domain.", {"entities": []}], ["Higher levels of physical activity indicate better quality of life, as do lower perception of dyspnea and less leg fatigue.", {"entities": []}], ["The 6MST proved to be a viable option for evaluating exercise capacity in adolescents with asthma, because it reflects the discomfort that asthma causes during activities of daily living.", {"entities": [[91, 97, "DISEASE"], [139, 145, "DISEASE"]]}], ["\u03b2 2 -adrenoceptor agonists have been shown to reduce the lipopolysaccharide (LPS)-induced cytokine release by human monocyte-derived macrophages (MDMs).", {"entities": []}], ["We compare the expression of \u03b2 2 -adrenoceptors and the inhibitory effect of formoterol and salmeterol on the LPS-induced release of tumor necrosis factor (TNF)- \u03b1 , interleukin (IL)-1\u03b2, IL-6 and a range of chemokines (CCL2, 3, 4, and IL-8) by human lung macrophages (LMs) and MDMs.", {"entities": [[156, 159, "GENE"], [219, 223, "GENE"]]}], ["LMs were isolated from patients undergoing resection and MDMs were obtained from blood monocytes in the presence of GM-CSF.", {"entities": []}], ["LMs and MDMs were incubated in the absence or presence of formoterol or salmeterol prior to stimulation with LPS.", {"entities": []}], ["The effects of formoterol were also assessed in the presence of the phosphodiesterase inhibitor roflumilast.", {"entities": []}], ["LPS-induced cytokine production was higher in LMs than in MDMs.", {"entities": []}], ["Salmeterol and formoterol exerted an inhibitory effect on the LPS-induced production of TNF- \u03b1 , IL-6, CCL2, CCL3, and CCL4 in MDMs.", {"entities": [[103, 107, "GENE"], [109, 113, "GENE"], [119, 123, "GENE"]]}], ["In contrast, the \u03b2 2 -adrenoceptor agonists were devoid of any effect on LMs - even in the presence of roflumilast.", {"entities": []}], ["The expression of \u03b2 2 -adrenergic receptors was detected on Western blots in MDMs but not in LMs.", {"entities": []}], ["Concentrations of \u03b2 2 -adrenoceptor agonists that cause relaxation of the human bronchus can inhibit cytokine production by LPS-stimulated MDMs but not by LMs.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0613-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Antibodies with pH-dependent binding to both target antigens and neonatal Fc receptor (FcRn) provide an alternative tool to conventional neutralizing antibodies, particularly for therapies where reduction in antigen level is challenging due to high target burden.", {"entities": []}], ["However, the requirements for optimal binding kinetic framework and extent of pH dependence for these antibodies to maximize target clearance from circulation are not well understood.", {"entities": []}], ["We have identified a series of naturally-occurring high affinity antibodies with pH-dependent target binding properties.", {"entities": []}], ["By in vivo studies in cynomolgus monkeys, we show that pH-dependent binding to the target alone is not sufficient for effective target removal from circulation, but requires Fc mutations that increase antibody binding to FcRn.", {"entities": []}], ["Affinity-enhanced pH-dependent FcRn binding that is double-digit nM at pH 7.4 and single-digit nM at pH 6 achieved maximal target reduction when combined with similar target binding affinities in reverse pH directions.", {"entities": []}], ["Sustained target clearance below the baseline level was achieved 3 weeks after single-dose administration at 1.5 mg/kg.", {"entities": []}], ["Using the experimentally derived mechanistic model, we demonstrate the essential kinetic interplay between target turnover and antibody pH-dependent binding during the FcRn recycling, and identify the key components for achieving maximal target clearance.", {"entities": []}], ["These results bridge the demand for improved patient dosing convenience with the \u201cknow-how\u201d of therapeutic modality by design.", {"entities": []}], ["To investigate the effects of silica on circulating fibrocytes (cFbs), the present study established a primary culture model of rat alveolar macrophages and cFbs in vitro .", {"entities": []}], ["Macrophages were treated with free silica, and their supernatant was used to stimulate cFbs.", {"entities": []}], ["The mRNA expression levels of collagen I, collagen III and \u03b1-smooth muscle actin (SMA) in cFbs were analyzed by reverse transcription-quantitative polymerase chain reaction.", {"entities": []}], ["The intracellular and extracellular protein expression levels of collagen I, collagen III and \u03b1-SMA were detected by ELISA and immunofluorescence staining.", {"entities": []}], ["The results indicated that in the cell model, the free silica effectively increased the protein and mRNA expression levels of collagen-I, collagen-III and \u03b1-SMA.", {"entities": []}], ["The free silica significantly promoted the transdifferentiation of cFbs into myofibroblasts in a dose-and time-dependent manner.", {"entities": []}], ["Type 2 innate lymphoid cells (ILC2) share cytokine and transcription factor expression with CD4 h 2 cells, but functional diversity of the ILC2 lineage has yet to be fully explored.", {"entities": [[92, 95, "GENE"]]}], ["Here, we show induction of a molecularly distinct subset of activated lung ILC2, termed ILC2 10 .", {"entities": []}], ["These cells produce IL-10 and downregulate some pro-inflammatory genes.", {"entities": []}], ["Signals that generate ILC2 10 are distinct from those that induce IL-13 production, and gene expression data indicate that an alternative activation pathway leads to the generation of ILC2 10 .", {"entities": []}], ["In vivo, IL-2 enhances ILC2 10 generation and is associated with decreased eosinophil recruitment to the lung.", {"entities": []}], ["Unlike most activated ILC2, the ILC2 10 population contracts after cessation of stimulation in vivo, with maintenance of a subset that can be recalled by restimulation, analogous to T-cell effector cell and memory cell generation.", {"entities": []}], ["These data demonstrate the generation of a previously unappreciated IL-10 producing ILC2 effector cell population.", {"entities": []}], ["Type 2 innate lymphoid cells (ILC2) are thought to be a uniform population of effector cells that produce IL-5 and IL-13.", {"entities": []}], ["Here, the authors shown that, in mice, IL-33 can alternatively activate these cells to generate a molecularly distinct IL-10-producing subset designated\u00a0ILC2 10 .", {"entities": []}], ["The epidemiology of idiopathic central serous chorioretinopathy (CSCR) is not well understood in an Asian population.", {"entities": []}], ["The present study aimed to investigate the incidence and risk factors for corticosteroid-unrelated CSCR using Taiwan\u2019s National Health Insurance Research Database.", {"entities": []}], ["From 2001 to 2006, a total of 786 patients (500 [63.6%] males) who were newly diagnosed with CSCR, aged from 20 to 64 years and had no history of corticosteroid prescription were identified as incident cases of idiopathic CSCR.", {"entities": []}], ["3606 age-, gender-, and enrollment time-matched subjects were randomly selected as the control group.", {"entities": []}], ["The mean annual incidence was 0.21\u2030 (0.27\u2030 for males, and 0.15\u2030 for females; P <0.001), with a male/female ratio of 1.74.", {"entities": []}], ["The peak incidence was in the 35- to 39-year-old age group (0.30\u2030), followed by the 40- to 44-year-old age group (0.26\u2030).", {"entities": []}], ["Males had a significantly higher mean annual incidence than female only in the middle age groups.", {"entities": []}], ["Conditional logistic regression was used to estimate the odds ratios (ORs) for potential risk factors of idiopathic CSCR.", {"entities": []}], ["Only exposure to anti-anxiety drugs (OR, 1.63; 95% confidence interval, 1.09\u20132.44) was found to be independently associated with idiopathic CSCR among males.", {"entities": []}], ["No risk factors of idiopathic CSCR were found for females.", {"entities": []}], ["This study provides the nationwide, population-based data on the incidence of idiopathic CSCR in adult Asians, and suggests that exposure to anti-anxiety drugs is an independent risk factor for idiopathic CSCR among males.", {"entities": []}], ["Exposure to trichloramine (NCl 3 ) in indoor swimming-pool environments is known to cause mucous membrane irritation, but if it gives rise to changes in lung function or asthma in adults is not known.", {"entities": [[170, 176, "DISEASE"], [27, 30, "GENE"]]}], ["(1) We determined lung function in volunteers before and after exposure to indoor pool environments.", {"entities": []}], ["(2) We studied the occurrence of respiratory symptoms and asthma in a cohort of pool workers.", {"entities": [[58, 64, "DISEASE"]]}], ["(1) We studied two groups of volunteers, 37 previously non-exposed healthy persons and 14 pool workers, who performed exercise for 2\u2005h in an indoor pool environment.", {"entities": []}], ["NCl 3 in air was measured during pool exposures and in 10 other pool environments.", {"entities": [[0, 3, "GENE"]]}], ["Filtered air exposures were used as controls.", {"entities": []}], ["Lung function and biomarkers of pulmonary epithelial integrity were measured before and after exposure.", {"entities": []}], ["(2) We mailed a questionnaire to 1741 persons who indicated in the Swedish census 1990 that they worked at indoor swimming-pools.", {"entities": []}], ["(1) In previously non-exposed volunteers, statistically significant decreases in FEV 1 (forced expiratory volume) and FEV % (p=0.01 and 0.05, respectively) were found after exposure to pool air (0.23\u2005mg/m 3 ).", {"entities": [[81, 84, "GENE"], [118, 121, "GENE"], [81, 84, "GENE"], [118, 121, "GENE"]]}], ["In pool workers, a statistically significant decrease in FEV % (p=0.003) was seen (but no significant change of FEV 1 ) .", {"entities": [[57, 60, "GENE"], [112, 115, "GENE"], [57, 60, "GENE"], [112, 115, "GENE"]]}], ["In the 10 other pool environments the median NCl 3 concentration was 0.18\u2005mg/m This is the first study in adults showing statistically significant decreases in lung function after exposure to NCl 3 .", {"entities": [[45, 48, "GENE"], [192, 195, "GENE"], [45, 48, "GENE"], [192, 195, "GENE"]]}], ["An increased OR for asthma among highly exposed pool workers did not reach statistical significance, but the combined evidence supports the notion that current workroom exposures may contribute to asthma development.", {"entities": [[20, 26, "DISEASE"], [197, 203, "DISEASE"]]}], ["Further research on sensitive groups is warranted.", {"entities": []}], ["Bronchial asthma is one of the most prevalent diseases in Arab children.", {"entities": [[10, 16, "DISEASE"]]}], ["Environmental pollution has been suggested to be considered causative of asthma, nasal symptoms and bronchitis in both children and adult.", {"entities": [[73, 79, "DISEASE"], [100, 110, "DISEASE"]]}], ["The objectives of this study were to evaluate the association between serum polycyclic aromatic hydrocarbons (PAHs) levels, asthma and allergic outcomes among Saudi children aged up to 15\u00a0yrs.", {"entities": [[124, 130, "DISEASE"]]}], ["We hypothesized that increased serum PAHs are associated with allergy, asthma, or respiratory symptoms.", {"entities": [[71, 77, "DISEASE"]]}], ["A total of 195 Saudi children (98 asthma pediatric patients and 97 healthy controls) were randomly selected from the Riyadh Cohort Study for inclusion.", {"entities": [[34, 40, "DISEASE"]]}], ["The diagnosis of Asthma was based on established pediatric diagnosis and medications taken.", {"entities": [[17, 23, "DISEASE"]]}], ["Asthma related markers showed highly significant differences between children with and without asthma.", {"entities": [[0, 6, "DISEASE"], [95, 101, "DISEASE"]]}], ["Thus IgE, resistin and IL-4 were significantly increased ( p 0.004, 0.001 and 0.003, respectively) in children with asthma compared with non-asthma control subjects.", {"entities": [[116, 122, "DISEASE"], [141, 147, "DISEASE"]]}], ["GMCSF, IFN-\u03b3, IL-5, IL-8 and IL-10, on the other hand, were significantly decreased in children with asthma ( p 0.003, 0.03, 0.001, 0.004 and 0.03, respectively).", {"entities": [[101, 107, "DISEASE"]]}], ["Strong associations between serum PAHs levels and biomarkers of childhood asthma were detected in Arabic children.", {"entities": [[74, 80, "DISEASE"]]}], ["Data confirmed the role of naphthalene, 4H-cyclobenta[def]phenanthrene, 1,2-benzanthracene, chrysene and benzo(e)acephenanthrylene in childhood asthma; levels of these PAHs were correlated with asthma related biomarkers including IgE, resistin, GMCSF and IFN-\u03b3 as well as IL-4, IL-5, IL-8 and IL-10 cytokines.", {"entities": [[144, 150, "DISEASE"], [194, 200, "DISEASE"]]}], ["This data highlight the pivotal role of specific PAHs in childhood asthma.", {"entities": [[67, 73, "DISEASE"]]}], ["This study aimed to determine whether bisphosphonates exert an effect on preventing femoral head collapse after osteonecrosis of the femoral head (ONFH) in an animal model and in clinical trials.", {"entities": [[112, 125, "DISEASE"]]}], ["A systematic literature search was performed for studies published up to January 2017.", {"entities": []}], ["Twenty-three articles (16 animal studies, seven clinical trials) were included in the meta-analysis.", {"entities": []}], ["We found that the bisphosphonate group obtained significant improvement in epiphyseal quotients (MD\u2009=\u200915.32; 95% CI, 9.25\u201321.39) and provided better performance on bone volume (SMD\u2009=\u20091.57; 95% CI, 0.94\u20132.20), trabecular number (SMD\u2009=\u20091.30; 95% CI, 0.80\u20131.79), trabecular thickness (SMD\u2009=\u20090.77; 95% CI, 0.10\u20131.43) and trabecular separation (SMD\u2009=\u2009\u22121.44; 95% CI, \u22121.70 to \u22120.58) in the animal model.", {"entities": []}], ["However, the bisphosphonate group did not achieve better results in pain score, Harris score, the occurrence rate of femoral head collapse, or total hip arthroplasty in the clinical trials.", {"entities": []}], ["In conclusion, despite bisphosphonates significantly improving bone remodeling outcomes in animal models, no significant efficacy was observed in the treatment of ONFH in the clinical studies.", {"entities": []}], ["Further studies are required to solve the discordant outcomes between the animal and clinical studies.", {"entities": []}], ["People with mental illness have been identified as being more likely to experience type 2 diabetes and the complications arising from this, necessitating more complex chronic illness self-management.", {"entities": []}], ["Social support has been identified as a significant factor in the successful adoption of lifestyle change for people with type 2 diabetes, however people with mental illness often have impoverished social networks leading to greater reliance upon professional care givers.", {"entities": []}], ["This study maps the support provided by formal (paid and professional carers) and informal networks to people with mental illness and type 2 diabetes, comparing the experiences of people with a spouse with those without one.", {"entities": []}], ["Interviews were conducted with 29 clients of a community nursing service with mental health problems who receive professional support to self-manage type 2 diabetes.", {"entities": []}], ["Participants were asked to complete an egocentric social network map which involved mapping the people and services who support them to manage their health.", {"entities": []}], ["Demographic data was collected as was data about co-morbidities and service use within the last 6\u00a0months.", {"entities": []}], ["Network maps were supplemented by a series of open-ended questions about self-management practices, who supports these practices and what support they provide.", {"entities": []}], ["Participants identified small social networks with few friendship ties.", {"entities": []}], ["These networks had diminished due to illness.", {"entities": []}], ["For people with a spouse, this person provided significant support for chronic illness self-management performing a range of daily care and illness management tasks.", {"entities": []}], ["People without a spouse were more reliant on professional and paid care givers for daily care and illness management.", {"entities": []}], ["People without a spouse also demonstrated greater reliance upon weak social ties for emotional support and social connection and often developed friendships with formal caregivers.", {"entities": []}], ["Spousal support reduces the need for professional services.", {"entities": []}], ["In the absence of a spouse, participants were more reliant upon paid and professional carers and weaker social ties for chronic illness support and social connection leading to greater vulnerability of loss of support.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-015-0897-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Several regions of the genome have shown to be associated with COPD in genome-wide association studies of common variants.", {"entities": []}], ["To determine rare and potentially functional single nucleotide polymorphisms (SNPs) associated with the risk of COPD and severity of airflow limitation.", {"entities": []}], ["3226 current or former smokers of European ancestry with lung function measures indicative of Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2 COPD or worse were genotyped using an exome array.", {"entities": []}], ["An analysis of risk of COPD was carried out using ever smoking controls (n=4784).", {"entities": []}], ["Associations with %predicted FEV 1 were tested in cases.", {"entities": [[29, 32, "GENE"]]}], ["We followed-up signals of interest (p<10 Among the associated variants were two in regions previously unreported for COPD; a low frequency non-synonymous SNP in MOCS3 (rs7269297, p discovery =3.08\u00d710 replication =0.019) and a rare SNP in IFIT3 , which emerged in the meta-analysis (rs140549288, p meta =8.56\u00d710 1 in cases, the strongest association was shown for a splice variant in a previously unreported region, SERPINA12 (rs140198372, p meta =5.72\u00d710 MMP12, HHIP , GPR126 and CHRNA5 .", {"entities": [[161, 166, "GENE"], [238, 243, "GENE"], [415, 424, "GENE"], [455, 460, "GENE"], [462, 466, "GENE"], [469, 475, "GENE"], [480, 486, "GENE"]]}], ["No associations in novel regions reached a stringent exome-wide significance threshold (p<3.7\u00d710 This study identified several associations with the risk of COPD and severity of airflow limitation, including novel regions MOCS3 , IFIT3 and SERPINA12 , which warrant further study.", {"entities": [[222, 227, "GENE"], [230, 235, "GENE"], [240, 249, "GENE"]]}], ["We investigated the association between the use of inhaled bronchodilators and the risk of AMI.", {"entities": []}], ["A nested case-control study using the nationwide insurance claims database was conducted.", {"entities": []}], ["Overall, 11,054 AMI cases and 47,815 matched (up to 1:5) controls were identified from 1,036,119 subjects without acute major cardiovascular events in the past year.", {"entities": []}], ["Long-acting and short-acting \u03b2-agonists (LABAs and SABAs) were associated with increase in the risk of AMI, although an inhaled corticosteroid combined with a long-acting \u03b2-agonist was not.", {"entities": []}], ["Long-acting muscarinic antagonists (LAMAs) in a dry powder inhaler (DPI) were significantly associated with reduced risk of AMI, while LAMAs in a soft mist inhaler (SMI) didn\u2019t decrease the risk of it.", {"entities": []}], ["In hypertensive or diabetic patients, LAMAs in a DPI were associated with reduced risk of AMI, but LABAs were associated with increased risk.", {"entities": []}], ["Among the \u03b2-blocker users, the reduction of AMI risk by LAMAs was the most significant.", {"entities": []}], ["In conclusions, inhaled \u03b2-agonists were associated with increase in the risk of AMI, while LABAs accompanied by ICSs were not associated with increase in the risk of AMI.", {"entities": []}], ["LAMAs in a DPI use were associated with lower risk of AMI.", {"entities": []}], ["A number of studies have focused on the association between oral contraceptive (OC), hormonal replacement therapy (HRT) and reproductive factors and meningioma risk, but the results were inconsistent.", {"entities": [[149, 159, "DISEASE"]]}], ["Thus, a meta-analysis was performed to obtain more precise estimates of risk.", {"entities": []}], ["We conducted a literature search using PubMed and EMBASE databases to July2013, without any limitations.", {"entities": []}], ["Random effects models were used to summarize results.", {"entities": []}], ["Twelve case-control and six cohort studies were included in this meta-analysis.", {"entities": []}], ["We found that an increased risk of meningioma was associated with HRT use(RR\u200a=\u200a1.19, 95% CI\u200a=\u200a1.01\u20131.40), postmenopausal women(RR\u200a=\u200a1.32, 95% CI\u200a=\u200a1.07\u20131.64) and parity(RR\u200a=\u200a1.18, 95% CI\u200a=\u200a1.00\u20131.40).No significant associations were observed for OC use (RR\u200a=\u200a0.93, 95% CI\u200a=\u200a0.83\u20131.03), age at menarche(RR\u200a=\u200a1.06, 95% CI\u200a=\u200a0.92\u20131.21), age at menopause(RR\u200a=\u200a1.03, 95% CI\u200a=\u200a0.81\u20131.30), or age at first birth(RR\u200a=\u200a0.94, 95% CI\u200a=\u200a0.80\u20131.10).", {"entities": [[35, 45, "DISEASE"]]}], ["In conclusion, the results of our study support the hypothesis that longer exposure to effect of female sex hormones may increase the risk of meningioma in women, yet additional studies are warranted to confirm our findings and identify the underlying biological mechanisms.", {"entities": [[142, 152, "DISEASE"]]}], ["Objectives : This paper reports on the findings of a population-based study to evaluate the relationship between atmospheric fine particulate matter (PM 2.5 ) levels and hospital admissions for chronic obstructive pulmonary disease (COPD) in southwestern Taiwan over a three-year period, 2008\u20132010.", {"entities": [[194, 231, "DISEASE"]]}], ["Methods : Data on hospital admissions for COPD and PM 2.5 levels were obtained from the National Health Insurance Research database (NHIRD) and the Environmental Protection Administration from 2008 to 2010, respectively.", {"entities": []}], ["The lag structure of relative risks (RRs) of hospital admissions for COPD was estimated using a Poisson regression model.", {"entities": []}], ["Results : During the study period, the overall average hospitalization rate of COPD and mean 24-h average level of PM 2.5 was 0.18% and 39.37 \u03bcg/m 2.5 concentrations in southwestern Taiwan, with higher PM 2.5 concentrations in both spring (average: 48.54 \u03bcg/m 2.5 in both spring (February\u2013April) and winter (October\u2013January), with the relative risks (RRs) for every 10 \u03bcg/m 2.5 being 1.25 (95% CI = 1.22\u20131.27) and 1.24 (95% CI = 1.23\u20131.26), respectively, at a lag zero days ( i.e.", {"entities": []}], [", no lag days).", {"entities": []}], ["Lag effects on COPD admissions were observed for PM 2.5 , with the elevated RRs beginning at lag zero days and larger RRs estimates tending to occur at longer lags (up to six days, i.e.", {"entities": []}], [", lag 0\u20135 days).", {"entities": []}], ["Conclusions : In general, findings reveal an association between atmospheric fine particulate matter (PM 2.5 ) and hospital admissions for COPD in southwestern Taiwan, especially during both spring and winter seasons.", {"entities": []}], ["The FTO gene harbors variation with the strongest effect on adiposity and obesity risk.", {"entities": [[74, 81, "DISEASE"], [4, 7, "GENE"]]}], ["Previous data support a role for FTO variation in influencing food intake.", {"entities": [[33, 36, "GENE"]]}], ["We conducted a combined analysis of 16,094 boys and girls aged 1\u201318 years from 14 studies to examine the following: 1 ) the association between the FTO rs9939609 variant (or a proxy) and total energy and macronutrient intake; and 2 ) the interaction between the FTO variant and dietary intake, and the effect on BMI.", {"entities": [[148, 151, "GENE"], [262, 265, "GENE"], [148, 151, "GENE"], [262, 265, "GENE"]]}], ["We found that the BMI-increasing allele (minor allele) of the FTO variant was associated with increased total energy intake (effect per allele = 14.3 kcal/day [95% CI 5.9, 22.7 kcal/day], P = 6.5 \u00d7 10 FTO variant and BMI (interactive effect per allele = 0.08 SD [0.03, 0.12 SD], P for interaction = 7.2 \u00d7 10 FTO genotype and BMI was much stronger in individuals with high protein intake (effect per allele = 0.10 SD [0.07, 0.13 SD], P = 8.2 \u00d7 10 P = 0.02).", {"entities": [[62, 65, "GENE"], [201, 204, "GENE"], [308, 311, "GENE"], [62, 65, "GENE"], [201, 204, "GENE"], [308, 311, "GENE"], [62, 65, "GENE"], [201, 204, "GENE"], [308, 311, "GENE"]]}], ["Our results suggest that the FTO variant that confers a predisposition to higher BMI is associated with higher total energy intake, and that lower dietary protein intake attenuates the association between FTO genotype and adiposity in children and adolescents.", {"entities": [[29, 32, "GENE"], [205, 208, "GENE"], [29, 32, "GENE"], [205, 208, "GENE"]]}], ["Exacerbations constitute a major cause of morbidity and mortality in patients suffering from chronic obstructive pulmonary disease (COPD).", {"entities": [[93, 130, "DISEASE"]]}], ["Both bacterial infections, such as those with non-typeable Haemophilus influenzae (NTHi), and exposures to diesel engine emissions are known to contribute to exacerbations in COPD patients.", {"entities": []}], ["However, the effect of diesel exhaust (DE) exposure on the epithelial response to microbial stimulation is incompletely understood, and possible differences in the response to DE of epithelial cells from COPD patients and controls have not been studied.", {"entities": []}], ["Primary bronchial epithelial cells (PBEC) were obtained from age-matched COPD patients ( n \u2009=\u20097) and controls ( n \u2009=\u20095).", {"entities": []}], ["PBEC were cultured at the air-liquid interface (ALI) to achieve mucociliary differentiation.", {"entities": []}], ["ALI-PBECs were apically exposed for 1\u00a0h to a stream of freshly generated whole DE or air.", {"entities": []}], ["Exposure was followed by 3\u00a0h incubation in presence or absence of UV-inactivated NTHi before analysis of epithelial gene expression.", {"entities": []}], ["DE alone induced an increase in markers of oxidative stress (HMOX1, 50\u2013100-fold) and of the integrated stress response (CHOP, 1.5\u20132-fold and GADD34, 1.5-fold) in cells from both COPD patients and controls.", {"entities": [[61, 66, "GENE"]]}], ["Exposure of COPD cultures to DE followed by NTHi caused an additive increase in GADD34 expression (up to 3-fold).", {"entities": []}], ["Importantly, DE caused an inhibition of the NTHi-induced expression of the antimicrobial peptide S100A7, and of the chaperone protein HSP5A /BiP.", {"entities": [[97, 103, "GENE"]]}], ["Our findings show that DE exposure of differentiated primary airway epithelial cells causes activation of the gene expression of HMOX1 and markers of integrated stress response to a similar extent in cells from COPD donors and controls.", {"entities": [[129, 134, "GENE"]]}], ["Furthermore, DE further increased the NTHi-induced expression of GADD34, indicating a possible enhancement of the integrated stress response.", {"entities": []}], ["DE reduced the NTHi-induced expression of S100A7.", {"entities": [[42, 48, "GENE"]]}], ["These data suggest that DE exposure may cause adverse health effects in part by decreasing host defense against infection and by modulating stress responses.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0510-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A high percentage of type 2 diabetes mellitus (T2D) patients are also affected by dyslipidemia and chronic periodontitis (CP), but no studies have determined the gene expression in patients that are simultaneously affected by all three diseases.", {"entities": [[107, 120, "DISEASE"], [28, 45, "DISEASE"], [21, 45, "DISEASE"], [122, 124, "GENE"]]}], ["We investigated the systemic expression of immune-related genes in T2D, dyslipidemia, and CP patients.", {"entities": [[90, 92, "GENE"]]}], ["One hundred and fifty patients were separated into five groups containing 30 individuals each: (G1) poorly controlled T2D with dyslipidemia and CP; (G2) well-controlled T2D with dyslipidemia and CP; (G3) normoglycemic individuals with dyslipidemia and CP; (G4) healthy individuals with CP; (G5) systemic and periodontally healthy individuals.", {"entities": [[144, 146, "GENE"], [195, 197, "GENE"], [252, 254, "GENE"], [286, 288, "GENE"], [144, 146, "GENE"], [195, 197, "GENE"], [252, 254, "GENE"], [286, 288, "GENE"], [144, 146, "GENE"], [195, 197, "GENE"], [252, 254, "GENE"], [286, 288, "GENE"], [144, 146, "GENE"], [195, 197, "GENE"], [252, 254, "GENE"], [286, 288, "GENE"]]}], ["Blood analyses of lipid and glycemic profiles were carried out.", {"entities": []}], ["The expression of genes, including IL10, JAK1, STAT3, SOCS3, IP10, ICAM1, IFNA, IFNG, STAT1, and IRF1, was investigated by RT-qPCR.", {"entities": [[35, 39, "GENE"], [41, 45, "GENE"], [47, 52, "GENE"], [54, 59, "GENE"], [67, 72, "GENE"], [80, 84, "GENE"], [86, 91, "GENE"], [97, 101, "GENE"]]}], ["Patients with dyslipidemia demonstrated statistically higher expression of the IL10 and IFNA genes, while IFNG, IP10, IRF1, JAK1, and STAT3 were lower in comparison with nondyslipidemic patients.", {"entities": [[79, 83, "GENE"], [106, 110, "GENE"], [118, 122, "GENE"], [124, 128, "GENE"], [134, 139, "GENE"]]}], ["Anti-inflammatory genes, such as IL10 , positively correlated with parameters of glucose, lipid, and periodontal profiles, while proinflammatory genes, such as IFNG , were negatively correlated with these parameters.", {"entities": [[33, 37, "GENE"], [160, 164, "GENE"]]}], ["We conclude that dyslipidemia appears to be the primary disease that is associated with gene expression of immune-related genes, while parameters of T2D and CP were correlated with the expression of these important immune genes.", {"entities": [[157, 159, "GENE"]]}], ["Previous research has investigated utilization rates, who sees chiropractors, for what reasons, and the type of care that chiropractors provide.", {"entities": []}], ["However, these studies have not been comprehensively synthesized.", {"entities": []}], ["We aimed to give a global overview by summarizing the current literature on the utilization of chiropractic services, reasons for seeking care, patient profiles, and assessment and treatment provided.", {"entities": []}], ["Systematic searches were conducted in MEDLINE, CINAHL, and Index to Chiropractic Literature using keywords and subject headings (MeSH or ChiroSH terms) from database inception to January 2016.", {"entities": []}], ["Eligible studies: 1) were published in English or French; 2) were case series, descriptive, cross-sectional, or cohort studies; 3) described patients receiving chiropractic services; and 4) reported on the following theme(s): utilization rates of chiropractic services; reasons for attending chiropractic care; profiles of chiropractic patients; or, types of chiropractic services provided.", {"entities": []}], ["Paired reviewers independently screened all citations and data were extracted from eligible studies.", {"entities": []}], ["We provided descriptive numerical analysis, e.g.", {"entities": []}], ["identifying the median rate and interquartile range (e.g., chiropractic utilization rate) stratified by study population or condition.", {"entities": []}], ["The literature search retrieved 14,149 articles; 328 studies (reported in 337 articles) were relevant and reported on chiropractic utilization (245 studies), reason for attending chiropractic care (85 studies), patient demographics (130 studies), and assessment and treatment provided (34 studies).", {"entities": []}], ["Globally, the median 12-month utilization of chiropractic services was 9.1% (interquartile range (IQR): 6.7%-13.1%) and remained stable between 1980 and 2015.", {"entities": []}], ["Most patients consulting chiropractors were female (57.0%, IQR: 53.2%-60.0%) with a median age of 43.4 years (IQR: 39.6-48.0), and were employed (median: 77.3%, IQR: 70.3%-85.0%).", {"entities": []}], ["The most common reported reasons for people attending chiropractic care were (median) low back pain (49.7%, IQR: 43.0%-60.2%), neck pain (22.5%, IQR: 16.3%-24.5%), and extremity problems (10.0%, IQR: 4.3%-22.0%).", {"entities": []}], ["The most common treatment provided by chiropractors included (median) spinal manipulation (79.3%, IQR: 55.4%-91.3%), soft-tissue therapy (35.1%, IQR: 16.5%-52.0%), and formal patient education (31.3%, IQR: 22.6%-65.0%).", {"entities": []}], ["This comprehensive overview on the world-wide state of the chiropractic profession documented trends in the literature over the last four decades.", {"entities": []}], ["The findings support the diverse nature of chiropractic practice, although common trends emerged.", {"entities": []}], ["The online version of this article (10.1186/s12998-017-0165-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Incense burning has been reported to adversely affect respiratory health.", {"entities": []}], ["The aim of this study was to explore whether exposure to bakhour contributes to the prevalence of asthma and/or triggers its symptoms in Omani children by comparing two Omani regions with different prevalence of asthma.", {"entities": [[98, 104, "DISEASE"], [212, 218, "DISEASE"]]}], ["A randomly selected sample of 10 years old schoolchildren were surveyed using an Arabic version of ISAAC Phase II questionnaires with the addition of questions concerning the use and effect of Arabian incense on asthma symptoms.", {"entities": [[212, 218, "DISEASE"]]}], ["Current asthma was defined as positive response to wheeze in the past 12 months or positive response to \"ever had asthma\" together with a positive response to exercise wheeze or night cough in the past 12 months.", {"entities": [[8, 14, "DISEASE"], [114, 120, "DISEASE"]]}], ["Simple and multivariable logistic regression analyses were performed to estimate the effect of bakhour exposure and other variables on current asthma diagnosis and parents' response to the question: \"Does exposure to bakhour affect your child breathing?\"", {"entities": [[143, 149, "DISEASE"]]}], ["Of the 2441 surveyed children, 15.4% had current asthma.", {"entities": [[49, 55, "DISEASE"]]}], ["Bakhour use more than twice a week was three times more likely to affect child breathing compared to no bakhour use (adjusted OR 3.01; 95% CI 2.23\u20134.08) and this effect was 2.55 times higher in asthmatics (adjusted OR 2.55; 95% CI 1.97\u20133.31) compared to non-asthmatics.", {"entities": []}], ["In addition, bakhour caused worsening of wheeze in 38% of the asthmatics, making it the fourth most common trigger factor after dust (49.2%), weather (47.6%) and respiratory tract infections (42.2%).", {"entities": []}], ["However, there was no significant association between bakhour use and the prevalence of current asthma (adjusted OR 0.87; 95% CI 0.63\u20131.20).", {"entities": [[96, 102, "DISEASE"]]}], ["Arabian incense burning is a common trigger of wheezing among asthmatic children in Oman.", {"entities": []}], ["However, it is not associated with the prevalence asthma.", {"entities": [[50, 56, "DISEASE"]]}], ["Smoking is a crucial factor in respiratory diseases and lung inflammation, which are the reasons for high mortality worldwide.", {"entities": []}], ["Despite the negative impact that tobacco consumption causes on health, few metabolomics studies have compared the composition of biofluids from smoker and non-smoker individuals.", {"entities": []}], ["Exhaled breath condensate (EBC) is one of the biofluids less employed for clinical studies despite its non-invasive sampling and the foreseeable relationship between its composition and respiratory diseases.", {"entities": []}], ["EBC was used in this research as clinical sample to compare three groups of individuals: current smokers (CS), former smokers (FS) and never smokers (NS).", {"entities": [[106, 108, "GENE"]]}], ["Special attention was paid to the cumulative consumption expressed as smoked pack-year.", {"entities": []}], ["The levels of 12 metabolites found statistically significant among the three groups of individuals were discussed to find an explanation to their altered levels.", {"entities": []}], ["Significant compounds included monoacylglycerol derivatives, terpenes and other compounds, the presence of which could be associated to the influence of smoking on the qualitative and quantitative composition of the microbiome.", {"entities": []}], ["The use of chest radiograph (CXR) for the diagnosis of childhood community-acquired pneumonia (CAP) is controversial.", {"entities": [[84, 93, "DISEASE"]]}], ["We assessed if children with CAP diagnosed on clinical grounds, with or without radiologically-confirmed pneumonia on admission, evolved differently.", {"entities": [[105, 114, "DISEASE"]]}], ["Children aged\u2009\u2265\u20092\u00a0months, hospitalized with CAP diagnosed on clinical grounds, treated with 200,000\u00a0IU/Kg/day of aqueous penicillin G for\u2009\u2265\u200948\u00a0h and with CXR taken upon admission, without pleural effusion, were included in this retrospective cohort.", {"entities": []}], ["One researcher, blinded to the radiological diagnosis, collected data on demographics, clinical history and physical examination on admission, daily hospital course during the first 2\u00a0days of treatment, and outcome, all from medical charts.", {"entities": []}], ["Radiological confirmation of pneumonia was based on presence of pulmonary infiltrate detected by a paediatric radiologist who was also blinded to clinical data.", {"entities": [[29, 38, "DISEASE"]]}], ["Variables were initially compared by bivariate analysis.", {"entities": []}], ["Multi-variable logistic regression analysis assessed independent association between radiologically-confirmed pneumonia and factors which significantly differed during hospital course in the bivariate analysis.", {"entities": [[110, 119, "DISEASE"]]}], ["The multi-variable analysis was performed in a model adjusted for age and for the same factor present upon admission.", {"entities": []}], ["109 (38.5\u00a0%) children had radiologically-confirmed pneumonia, 143 (50.5\u00a0%) had normal CXR and 31 (11.0\u00a0%) had atelectasis or peribronchial thickening.", {"entities": [[51, 60, "DISEASE"]]}], ["Children without radiologically-confirmed pneumonia were younger than those with radiologically-confirmed pneumonia (median [IQR]: 14 [7\u201328 months versus 21 [12\u201344] months; P \u2009=\u20090.001).", {"entities": [[42, 51, "DISEASE"], [106, 115, "DISEASE"]]}], ["The subgroup with radiologically-confirmed pneumonia presented fever on D1 (33.7 vs .", {"entities": [[43, 52, "DISEASE"]]}], ["19.1; P \u2009=\u20090.015) and on D2 (31.6\u00a0% vs .", {"entities": []}], ["16.2\u00a0%; P \u2009=\u20090.004) more frequently.", {"entities": []}], ["The subgroup without radiologically-confirmed pneumonia had chest indrawing on D1 (22.4\u00a0% vs .", {"entities": [[46, 55, "DISEASE"]]}], ["11.9\u00a0%; P \u2009=\u20090.027) more often detected.", {"entities": []}], ["By multi-variable analysis, Fever on D2 (OR [95\u00a0% CI]: 2.16 [1.15-4.06]) was directly and independently associated with radiologically-confirmed pneumonia upon admission.", {"entities": [[145, 154, "DISEASE"]]}], ["The compared subgroups evolved differently.", {"entities": []}], ["In chronic obstructive pulmonary disease (COPD), oxidative stress regulates the inflammatory response of bronchial epithelium and monocytes/macrophages through kinase modulation and has been linked to glucocorticoid unresponsiveness.", {"entities": [[3, 40, "DISEASE"]]}], ["Glycogen synthase-3\u03b2 (GSK3\u03b2) inactivation plays a key role in mediating signaling processes upon reactive oxygen species (ROS) exposure.", {"entities": []}], ["We hypothesized that GSK3\u03b2 is involved in oxidative stress-induced glucocorticoid insensitivity in COPD.", {"entities": []}], ["We studied levels of phospho-GSK3\u03b2-Ser9, a marker of GSK3\u03b2 inactivation, in lung sections and cultured monocytes and bronchial epithelial cells of COPD patients, control smokers, and nonsmokers.", {"entities": []}], ["We observed increased levels of phospho-GSK3\u03b2-Ser9 in monocytes, alveolar macrophages, and bronchial epithelial cells from COPD patients and control smokers compared with nonsmokers.", {"entities": []}], ["Pharmacological inactivation of GSK3\u03b2 did not affect CXCL8 or granulocyte-macrophage colony-stimulating factor (GM-CSF) expression but resulted in glucocorticoid insensitivity in vitro in both inflammatory and structural cells.", {"entities": []}], ["Further mechanistic studies in monocyte and bronchial epithelial cell lines showed that GSK3\u03b2 inactivation is a common effector of oxidative stress-induced activation of the MEK/ERK-1/2 and phosphatidylinositol 3-kinase/Akt signaling pathways leading to glucocorticoid unresponsiveness.", {"entities": []}], ["In primary monocytes, the mechanism involved modulation of histone deacetylase 2 (HDAC2) activity in response to GSK3\u03b2 inactivation.", {"entities": [[82, 87, "GENE"]]}], ["In conclusion, we demonstrate for the first time that ROS-induced glucocorticoid unresponsiveness in COPD is mediated through GSK3\u03b2, acting as a ROS-sensitive hub.", {"entities": []}], ["A cDNA encoding a novel human chemokine was isolated by random sequencing of cDNA clones from human monocyte-derived macrophages.", {"entities": []}], ["This protein has been termed macrophagederived chemokine (MDC) because it appears to be synthesized specifically by cells of the macrophage lineage.", {"entities": []}], ["MDC has the four-cysteine motif and other highly conserved residues characteristic of CC chemokines, but it shares <35% identity with any of the known chemokines.", {"entities": []}], ["Recombinant MDC was expressed in Chinese hamster ovary cells and purified by heparin\u2013 Sepharose chromatography.", {"entities": []}], ["NH 2 -terminal sequencing and mass spectrophotometry were used to verify the NH 2 terminus and molecular mass of recombinant MDC (8,081 dalton).", {"entities": []}], ["In microchamber migration assays, monocyte-derived dendritic cells and IL-2\u2013activated natural killer cells migrated to MDC in a dose-dependent manner, with a maximal chemotactic response at 1 ng/ml.", {"entities": []}], ["Freshly isolated monocytes also migrated toward MDC, but with a peak response at 100 ng/ml MDC.", {"entities": []}], ["Northern analyses indicated MDC is highly expressed in macrophages and in monocyte-derived dendritic cells, but not in monocytes, natural killer cells, or several cell lines of epithelial, endothelial, or fibroblast origin.", {"entities": []}], ["High expression was also detected in normal thymus and less expression in lung and spleen.", {"entities": []}], ["Unlike most other CC chemokines, MDC is encoded on human chromosome 16.", {"entities": []}], ["MDC is thus a unique member of the CC chemokine family that may play a fundamental role in the function of dendritic cells, natural killer cells, and monocytes.", {"entities": []}], ["Nowadays, air pollution is a severe environmental problem in China.", {"entities": []}], ["To investigate the effects of ambient air pollution on health, a time series analysis of daily outpatient and inpatient visits in 2015 were conducted in Shenzhen (China).", {"entities": []}], ["Generalized additive model was employed to analyze associations between six air pollutants (namely SO 2 , CO, NO 2 , O 3 , PM 10 , and PM 2.5 ) and daily outpatient and inpatient visits after adjusting confounding meteorological factors, time and day of the week effects.", {"entities": []}], ["Significant associations between air pollutants and two types of hospital visits were observed.", {"entities": []}], ["The estimated increase in overall outpatient visits associated with each 10 \u00b5g/m 3 at lag 2) to 11.48% (SO 2 with 2-day moving average); for overall inpatient visits ranged from 0.73% (O 3 at lag 7) to 17.13% (SO 2 with 8-day moving average).", {"entities": []}], ["Our results also suggested a heterogeneity of the health effects across different outcomes and in different populations.", {"entities": []}], ["The findings in present study indicate that even in Shenzhen, a less polluted area in China, significant associations exist between air pollution and daily number of overall outpatient and inpatient visits.", {"entities": []}], ["Atypical femoral fracture (AFF) occurs with minor trauma in patients receiving antiresorptive drugs such as bisphosphonate and denosumab.", {"entities": []}], ["We hypothesized that patients with bone metastasis who receive higher doses of antiresorptive drugs tend to experience AFF more frequently.", {"entities": []}], ["This study aimed to investigate the prevalence rate of AFF in patients receiving antiresorptive drugs for bone metastasis of breast cancer.", {"entities": [[125, 138, "DISEASE"], [132, 138, "DISEASE"]]}], ["Based on the database from our hospital, patients with breast cancer between March and September 2014 were investigated.", {"entities": [[55, 68, "DISEASE"], [62, 68, "DISEASE"]]}], ["Thirty-two patients with bone metastasis who received higher doses of antiresorptive drugs were included for analysis and defined as the metastasis (M) group.", {"entities": []}], ["For the control (C) group, 32 patients in the same period with breast cancer without bone metastasis who did not undergo antiresorptive drug therapy were included.", {"entities": [[63, 76, "DISEASE"], [70, 76, "DISEASE"]]}], ["We evaluated the localized periosteal thickening of the lateral cortex (beaking) and femoral neck-shaft angle in CT scout view, the periods from induction of antiresorptive drugs to the appearance of beaking, and the occurrence rate of complete fracture.", {"entities": []}], ["The 2 groups were compared.", {"entities": []}], ["Of the 64 limbs in 32 patients of the M group, 8 limbs in 6 patients showed beaking at the subtrochanteric area (12.5%).", {"entities": []}], ["After the occurrence of beaking, 5 limbs in 3 patients eventually had a complete fracture with minor trauma (7.8%).", {"entities": []}], ["On the other hand, no beaking was observed in the C group.", {"entities": []}], ["The frequency of AFF in patients with breast cancer receiving bisphosphonate and/or denosumab for bone metastasis was high.", {"entities": [[38, 51, "DISEASE"], [45, 51, "DISEASE"]]}], ["More attention should be paid to the occurrence of AFF in these patients than osteoporotic patients.", {"entities": []}], ["The link between natural disasters and subsequent fungal infections in disaster-affected persons has been increasingly recognized.", {"entities": []}], ["Fungal respiratory conditions associated with disasters include coccidioidomycosis, and fungi are among several organisms that can cause near-drowning pneumonia.", {"entities": [[64, 82, "DISEASE"], [151, 160, "DISEASE"]]}], ["Wound contamination with organic matter can lead to post-disaster skin and soft tissue fungal infections, notably mucormycosis.", {"entities": []}], ["The role of climate change in the environmental growth, distribution, and dispersal mechanisms of pathogenic fungi is not fully understood; however, ongoing climate change could lead to increased disaster-associated fungal infections.", {"entities": []}], ["Fungal infections are an often-overlooked clinical and public health issue, and increased awareness by health care providers, public health professionals, and community members regarding disaster-associated fungal infections is needed.", {"entities": []}], ["Recent studies suggest that secreted phospholipases A 2 (sPLA 2 s) represent attractive potential tumour biomarkers and therapeutic targets for various cancers.", {"entities": []}], ["As a first step to address this issue in human colorectal cancer, we examined the expression of the full set of sPLA 2 s in sporadic adenocarcinomas and normal matched mucosa from 21 patients by quantitative PCR and immunohistochemistry.", {"entities": [[47, 64, "DISEASE"], [58, 64, "DISEASE"]]}], ["In normal colon, PLA2G2A and PLA2G12A were expressed at high levels, PLA2G2D , PLA2G5 , PLA2G10 and PLA2G12B at moderate levels, and PLA2G1B , PLA2G2F and PLA2G3 at low levels.", {"entities": [[17, 24, "GENE"], [29, 37, "GENE"], [69, 76, "GENE"], [79, 85, "GENE"], [88, 95, "GENE"], [100, 108, "GENE"], [133, 140, "GENE"], [143, 150, "GENE"], [155, 161, "GENE"]]}], ["In adenocarcinomas from left and right colon, the expression of PLA2G3 was increased by up to 40-fold, while that of PLA2G2D and PLA2G5 was decreased by up to 23- and 14-fold.", {"entities": [[64, 70, "GENE"], [117, 124, "GENE"], [129, 135, "GENE"]]}], ["The variations of expression for sPLA 2 -IID, sPLA 2 -III and sPLA 2 -V were confirmed at the protein level.", {"entities": []}], ["The expression pattern of these sPLA 2 s appeared to be linked respectively to the overexpression of interleukin-8 , defensin \u03b16 , survivin and matrilysin , and downregulation of SFRP-1 and RLPA-1 , all these genes being associated to colon cancer.", {"entities": [[235, 247, "DISEASE"], [241, 247, "DISEASE"]]}], ["This original sPLA 2 profile observed in adenocarcinomas highlights the potential role of certain sPLA 2 s in colon cancer and suggests that sPLA 2 -III might be a good candidate as a novel biomarker for both left and right colon cancers.", {"entities": [[110, 122, "DISEASE"], [116, 122, "DISEASE"]]}], ["Tongue diagnosis, as a unique method of traditional Chinese medicine (TCM), was used to discriminate physiological functions and pathological conditions by observing the changes of the tongue and tongue coating.", {"entities": []}], ["The aims of the present study were to explore a potential screening and early diagnosis method of cancer through evaluating the differences of the images of tongue and tongue coating and the microbiome on the tongue coating.", {"entities": [[98, 104, "DISEASE"]]}], ["The DS01-B tongue diagnostic information acquisition system was used to photograph and analyze the tongue and tongue coating.", {"entities": []}], ["The next-generation sequencing technology was used to determine the V2-V4 hypervariable regions of 16S rDNA to investigate the microbiome on the tongue coating.", {"entities": []}], ["Bioinformatics and statistical methods were used to analyze the microbial community structure and diversity.", {"entities": []}], ["Comparing with the healthy people, the number of mirror-like tongue, thick tongue coating and the moisture of tongue were increased in cancers.", {"entities": []}], ["The dominant color of the tongue in the healthy people was reddish while it was purple in the cancers.", {"entities": []}], ["The relative abundance of Neisseria , Haemophilus , Fusobacterium and Porphyromonas in the healthy people were higher than that in the cancers.", {"entities": []}], ["We also found 6 kinds of special microorganisms at species level in cancers.", {"entities": []}], ["The study suggested that tongue diagnosis may provide potential screening and early diagnosis method for cancer.", {"entities": [[105, 111, "DISEASE"]]}], ["Fibrillary glomerulonephritis (FibGN) is characterized by extracellular deposition of Congo red-negative microfibrils within the glomerular mesangium and leads to gross proteinuria or nephrotic syndrome.", {"entities": [[11, 29, "DISEASE"], [184, 202, "DISEASE"], [169, 180, "DISEASE"], [194, 202, "DISEASE"]]}], ["After diagnosis of FibGN, end-stage renal disease occurs within four years in 50% of patients.", {"entities": []}], ["A 36-year-old Caucasian woman with proteinuria and intermittent nephrotic syndrome due to FibGN intermittently received immunosuppressive therapies, including glucocorticoids, mycophenolate mofetil, and rituximab, for 10 years.", {"entities": [[64, 82, "DISEASE"], [35, 46, "DISEASE"], [74, 82, "DISEASE"]]}], ["However, disease remission was not achieved and progressive kidney injury developed.", {"entities": []}], ["Ultimately, in stage IV of chronic kidney disease (Kidney Disease: Improving Global Outcomes), three cycles of plasmapheresis of five to seven sessions each were performed every three to four months, reducing steady-state proteinuria from 7 to less than 1 g/day.", {"entities": [[35, 49, "DISEASE"], [51, 65, "DISEASE"], [222, 233, "DISEASE"]]}], ["Here, plasmapheresis led to a remission of nephrotic syndrome associated with FibGN.", {"entities": [[43, 61, "DISEASE"], [53, 61, "DISEASE"]]}], ["Plasmapheresis therapy is proposed as a further option for immunosuppressant-refractory FibGN.", {"entities": []}], ["Sphingosine-1-phosphate (S1P) is a bioactive phospholipid that acts as a signal transducer by binding to S1P receptors (S1PR) 1 to 5.", {"entities": []}], ["The S1P/S1PRs pathway has been associated with remodeling and allergic inflammation in asthma, but the expression pattern of S1PR and its effects on non-immune cells have not been completely clarified.", {"entities": [[87, 93, "DISEASE"]]}], ["The aim of this study was to examine the contribution of the signaling of S1P and S1PRs expressed in airway epithelial cells (ECs) to asthma responses in mice.", {"entities": [[134, 140, "DISEASE"]]}], ["Bronchial asthma was experimentally induced in BALB/c mice by ovalbumin (OVA) sensitization followed by an OVA inhalation challenge.", {"entities": [[10, 16, "DISEASE"]]}], ["The effects of S1PR antagonists on the development of asthma were analyzed 24\u00a0h after the OVA challenge.", {"entities": [[54, 60, "DISEASE"]]}], ["Immunohistological analysis revealed S1PR1-3 expression on mouse airway ECs.", {"entities": []}], ["Quantitative real-time polymerase chain reaction demonstrated that S1P greatly stimulated the induction of CCL3 and TIMP2 mRNA in human airway ECs, i.e., BEAS-2B cells, in a dose-dependent manner.", {"entities": [[107, 111, "GENE"], [116, 121, "GENE"]]}], ["Pretreatment with the S1PR2 antagonist JTE013 inhibited the CCL3 gene expression in BEAS-2B cells.", {"entities": [[22, 27, "GENE"], [60, 64, "GENE"]]}], ["Immunohistological analysis also showed that the expression level of CCL3 was attenuated by JTE013 in asthmatic mice.", {"entities": [[69, 73, "GENE"]]}], ["Furthermore, JTE013 as well as anti-CCL3 antibody attenuated allergic responses.", {"entities": []}], ["Intratracheal administration of JTE013 also attenuated eosinophilic reactions in bronchoalveolar lavage fluids.", {"entities": []}], ["S1P induced transcription factor NF\u03baB activation, while JTE013 greatly reduced the NF\u03baB activation.", {"entities": []}], ["JTE013 attenuated allergic airway reactions by regulating CCL3 production from bronchial ECs.", {"entities": [[58, 62, "GENE"]]}], ["The intratracheal administration of JTE013 may be a promising therapeutic strategy for bronchial asthma.", {"entities": [[97, 103, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12931-016-0465-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Gasdermin B (GSDMB) belongs to the Gasdermin protein family that comprises four members (GSDMA-D).", {"entities": [[13, 18, "GENE"]]}], ["Gasdermin B expression has been detected in some tumor types such as hepatocarcinomas, gastric and cervix cancers; and its over-expression has been related to tumor progression.", {"entities": []}], ["At least four splicing isoforms of GSDMB have been identified, which may play differential roles in cancer.", {"entities": [[100, 106, "DISEASE"], [35, 40, "GENE"]]}], ["However, the implication of GSDMB in carcinogenesis and tumor progression is not well understood.", {"entities": [[28, 33, "GENE"]]}], ["Here, we uncover for the first time the functional implication of GSDMB in breast cancer.", {"entities": [[75, 88, "DISEASE"], [82, 88, "DISEASE"], [66, 71, "GENE"]]}], ["Our data shows that high levels of GSDMB expression is correlated with reduced survival and increased metastasis in breast cancer patients included in an expression dataset (>1,000 cases).", {"entities": [[116, 129, "DISEASE"], [123, 129, "DISEASE"], [35, 40, "GENE"]]}], ["We demonstrate that GSDMB is upregulated in breast carcinomas compared to normal breast tissue, being the isoform 2 (GSDMB-2) the most differentially expressed.", {"entities": [[20, 25, "GENE"], [117, 122, "GENE"]]}], ["In order to evaluate the functional role of GSDMB in breast cancer two GSDMB isoforms were studied (GSDMB-1 and GSDMB-2).", {"entities": [[53, 66, "DISEASE"], [60, 66, "DISEASE"], [44, 49, "GENE"], [71, 76, "GENE"], [100, 105, "GENE"], [112, 117, "GENE"], [44, 49, "GENE"], [71, 76, "GENE"], [100, 105, "GENE"], [112, 117, "GENE"]]}], ["The overexpression of both isoforms in the MCF7 breast carcinoma cell line promotes cell motility and invasion, while its silencing in HCC1954 breast carcinoma cells decreases the migratory and invasive phenotype.", {"entities": [[55, 64, "DISEASE"], [150, 159, "DISEASE"], [48, 64, "DISEASE"], [143, 159, "DISEASE"]]}], ["Importantly, we demonstrate that both isoforms have a differential role on the activation of Rac-1 and Cdc-42 Rho-GTPases.", {"entities": []}], ["Moreover, our data support that GSMDB-2 induces a pro-tumorigenic and pro-metastatic behavior in mouse xenograft models as compared to GSDMB-1.", {"entities": []}], ["Finally, we observed that although both GSDMB isoforms interact in vitro with the chaperone Hsp90, only the GSDMB-2 isoform relies on this chaperone for its stability.", {"entities": [[40, 45, "GENE"], [108, 113, "GENE"]]}], ["Taken together, our results provide for the first time evidences that GSDMB-2 induces invasion, tumor progression and metastasis in MCF7 cells and that GSDMB can be considered as a new potential prognostic marker in breast cancer.", {"entities": [[216, 229, "DISEASE"], [223, 229, "DISEASE"], [70, 75, "GENE"], [152, 157, "GENE"]]}], ["In recent years, it has become clear that chronic systemic low-grade inflammation is at the root of many, if not all, typically Western diseases associated with the metabolic syndrome.", {"entities": [[175, 183, "DISEASE"]]}], ["While much focus has been given to sedentary lifestyle as a cause of chronic inflammation, it is less often appreciated that chronic inflammation may also promote a sedentary lifestyle, which in turn causes chronic inflammation.", {"entities": []}], ["Given that even minor increases in chronic inflammation reduce brain volume in otherwise healthy individuals, the bidirectional relationship between inflammation and sedentary behaviour may explain why humans have lost brain volume in the last 30,000 years and also intelligence in the last 30 years.", {"entities": []}], ["We review evidence that lack of physical activity induces chronic low-grade inflammation and, consequently, an energy conflict between the selfish immune system and the selfish brain.", {"entities": []}], ["Although the notion that increased physical activity would improve health in the modern world is widespread, here we provide a novel perspective on this truism by providing evidence that recovery of normal human behaviour, such as spontaneous physical activity, would calm proinflammatory activity, thereby allocating more energy to the brain and other organs, and by doing so would improve human health.", {"entities": []}], ["Little is known about the prevalence of atopic dermatitis and food allergy outside North America and Europe.", {"entities": [[40, 57, "DISEASE"], [62, 74, "DISEASE"], [47, 57, "DISEASE"]]}], ["We evaluated the prevalence of atopic dermatitis and food allergy with the comparison of prevalence between 1995 and 2000 in Korea and evaluated the correlation of prevalence between atopic dermatitis and food allergy.", {"entities": [[31, 48, "DISEASE"], [183, 200, "DISEASE"], [53, 65, "DISEASE"], [205, 217, "DISEASE"], [38, 48, "DISEASE"], [190, 200, "DISEASE"]]}], ["A cross-sectional questionnaire survey was conducted on random samples of schoolchildren 6 to 14 yr at two time points, 1995 and 2000 throughout Korea.", {"entities": []}], ["The last twelve months prevalence of atopic dermatitis in Korean school-aged children was increased from 1995 to 2000.", {"entities": [[37, 54, "DISEASE"], [44, 54, "DISEASE"]]}], ["The twelve-month prevalence of atopic dermatitis and food allergy were higher in Seoul than in any other provincial cities in 1995, but the prevalence of both diseases in Seoul and Provincial Centers became to be similar in 2000.", {"entities": [[31, 48, "DISEASE"], [53, 65, "DISEASE"], [38, 48, "DISEASE"]]}], ["The rate responded to food allergy of children with atopic dermatitis (9.5%) was lower than that of the western countries (60%).", {"entities": [[52, 69, "DISEASE"], [22, 34, "DISEASE"], [59, 69, "DISEASE"]]}], ["And our data demonstrated paternal and maternal allergy history is very significantly correlated to developing atopic dermatitis in their offspring.", {"entities": [[111, 128, "DISEASE"], [118, 128, "DISEASE"]]}], ["The further objective evaluations are required to confirm these outcomes because the environmental and risk factors may be different among the countries according to their living cultures.", {"entities": []}], ["Cigarette smoke plays a substantial role in the development of airway inflammatory diseases, including asthma and chronic rhinosinusitis (CRS).", {"entities": [[103, 109, "DISEASE"]]}], ["Interleukin (IL)-17A might contribute to cigarette smoke-related inflammation of the airway.", {"entities": []}], ["This study aimed to investigate the association between cigarette smoking and IL-17A expression in the nasal tissues of patients with CRS and asthma.", {"entities": [[142, 148, "DISEASE"]]}], ["We prospectively recruited 24 patients (13 smokers, 11 nonsmokers) with CRS and asthma and 6 patients with asthma but without CRS (control group) in a tertiary medical center.", {"entities": [[80, 86, "DISEASE"], [107, 113, "DISEASE"]]}], ["Nasal mucosa was obtained as part of the nasal surgery.", {"entities": []}], ["Protein and mRNA levels of IL-17A in the nasal tissues were determined by immunostaining and real-time polymerase chain reaction.", {"entities": []}], ["The number of unexpected emergency clinic visits for acute asthma attacks were higher among smokers than among nonsmokers.", {"entities": [[59, 65, "DISEASE"]]}], ["Interleukin-17A protein and mRNA levels in the nasal tissues of smokers were greater compared to those in the nasal tissues of nonsmokers ( P \u200a = \u200a0.02 both) and control patients ( P \u200a=\u200a0.05 and 0.04, respectively).", {"entities": []}], ["Cigarette smoking was associated with an increase in the number of unexpected emergency clinic visits due to acute asthma attack and in the expression of IL-17A in the nasal tissues of patients with airway inflammatory diseases.", {"entities": [[115, 121, "DISEASE"]]}], ["Computational approaches to tune the activation of intracellular signal transduction pathways both predictably and selectively will enable researchers to explore and interrogate cell biology with unprecedented precision.", {"entities": []}], ["Techniques to control complex nonlinear systems typically involve the application of control theory to a descriptive mathematical model.", {"entities": []}], ["For cellular processes, however, measurement assays tend to be too time consuming for real-time feedback control and models offer rough approximations of the biological reality, thus limiting their utility when considered in isolation.", {"entities": []}], ["We overcome these problems by combining nonlinear model predictive control with a novel adaptive weighting algorithm that blends predictions from multiple models to derive a compromise open-loop control sequence.", {"entities": []}], ["The proposed strategy uses weight maps to inform the controller of the tendency for models to differ in their ability to accurately reproduce the system dynamics under different experimental perturbations (i.e.", {"entities": []}], ["control inputs).", {"entities": []}], ["These maps, which characterize the changing model likelihoods over the admissible control input space, are constructed using preexisting experimental data and used to produce a model-based open-loop control framework.", {"entities": []}], ["In effect, the proposed method designs a sequence of control inputs that force the signaling dynamics along a predefined temporal response without measurement feedback while mitigating the effects of model uncertainty.", {"entities": []}], ["We demonstrate this technique on the well-known Erk/MAPK signaling pathway in T cells.", {"entities": []}], ["In silico assessment demonstrates that this approach successfully reduces target tracking error by 52% or better when compared with single model-based controllers and non-adaptive multiple model-based controllers.", {"entities": []}], ["In vitro implementation of the proposed approach in Jurkat cells confirms a 63% reduction in tracking error when compared with the best of the single-model controllers.", {"entities": []}], ["This study provides an experimentally-corroborated control methodology that utilizes the knowledge encoded within multiple mathematical models of intracellular signaling to design control inputs that effectively direct cell behavior in open-loop.", {"entities": []}], ["Most cell behavior arises as a response to external forces.", {"entities": []}], ["Signals from the extracellular environment are passed to the cell's nucleus through a complex network of interacting proteins.", {"entities": []}], ["Perturbing these pathways can change the strength or outcome of the signals, which could be used to treat or prevent a pathological response.", {"entities": []}], ["While manipulating these networks can be achieved using a variety of methods, the ability to do so predictably over time would provide an unprecedented level of control over cell behavior and could lead to new therapeutic design and research tools in medicine and systems biology.", {"entities": []}], ["Hence, we propose a practical computational framework to aid in the design of experimental perturbations to force cell signaling dynamics to follow a predefined response.", {"entities": []}], ["Our approach represents a novel merger of model-based control and information theory to blend the predictions from multiple mathematical models into a meaningful compromise solution.", {"entities": []}], ["We verify through simulation and experimentation that this solution produces excellent agreement between the cell readouts and several predefined trajectories, even in the presence of significant modeling uncertainty and without measurement feedback.", {"entities": []}], ["By combining elements of information and control theory, our approach will help advance the best practices in model-based control applications for medicine.", {"entities": []}], ["The pathological hallmarks of chronic obstructive pulmonary disease (COPD) are inflammation of the small airways (bronchiolitis) and destruction of lung parenchyma (emphysema).", {"entities": [[30, 67, "DISEASE"], [114, 127, "DISEASE"]]}], ["These forms of disease arise from chronic prolonged infections, which are usually never present in the normal lung.", {"entities": []}], ["Despite the fact that primary hygiene and defense of the airways presumably requires a well controlled fluid environment on the surface of the bronchiolar airway, very little is known of the fluid and electrolyte transport properties of airways of less than a few mm diameter.", {"entities": []}], ["We introduce a novel approach to examine some of these properties in a preparation of minimally traumatized porcine bronchioles of about 1 mm diameter by microperfusing the intact bronchiole.", {"entities": []}], ["In bilateral isotonic NaCl Ringer solutions, the spontaneous transepithelial potential (TEP; lumen to bath) of the bronchiole was small (mean \u00b1 sem: -3 \u00b1 1 mV; n = 25), but when gluconate replaced luminal Cl Inh -172* (5 \u03bcM).", {"entities": []}], ["RT-PCR gave identifying products for CFTR, \u03b1-, \u03b2-, and \u03b3-ENaC and NKCC1.", {"entities": [[37, 41, "GENE"]]}], ["Antibodies to CFTR localized specifically to the epithelial cells lining the lumen of the small airways.", {"entities": [[14, 18, "GENE"]]}], ["These results indicate that the small airway of the pig is characterized by a constitutively active Cl", {"entities": []}], ["While the gender disparity in health and mortality in various stages of life in India is well documented, there is limited evidence on female disadvantage in health-care expenditure (HCE).", {"entities": []}], ["Examine the gender difference in HCE in short-term and major morbidity in India, and understand the role of factors underlying the difference.", {"entities": []}], ["Using two rounds of nationally representative panel data\u2014the India Human Development Survey (IHDS) 2004\u20132005 and 2011\u20132012 (IHDS I & II)\u2014we calculate morbidity prevalence rate and mean HCE by gender, and examine the adjusted effect of gender on major morbidity-related HCE by using a two-part regression model.", {"entities": []}], ["Further, we performed Oaxaca-Blinder decomposition of the gender gap in HCE in major morbidity to understand the contribution of demographic and socio-economic factors.", {"entities": []}], ["Health-care expenditure on females was systematically lower than on males across all demographic and socio-economic groups.", {"entities": []}], ["Multivariate analysis confirms that female HCE is significantly lower than male HCE even after controlling demographic and socio-economic factors (\u03b2 = -0.148, p = 0.000, CI:-0.206\u20130.091).", {"entities": []}], ["For both short-term and major morbidity, a female disadvantage on HCE increased from IHDS I to IHDS II.", {"entities": []}], ["For instance, the male\u2013female gap in major morbidity related expenditure increased from INR 1298 to INR 4172.", {"entities": []}], ["A decomposition analysis of gender gap in HCE demonstrates that about 48% of the gap is attributable to differences in demographic and socio-economic factors (endowment effect), whereas 50% of the gap is due to the differential effect of the determinants (coefficient effect).", {"entities": []}], ["Indians spend less on female health care than on male health care.", {"entities": []}], ["Most of the gender gap in HCE is not due to differential distribution of factors affecting HCE.", {"entities": []}], ["Chronic diseases are increasing among children in Latin America.", {"entities": []}], ["To examine environmental risk factors for chronic disease in Latin American children and to develop a strategic initiative for control of these exposures, the World Health Organization (WHO) including the Pan American Health Organization (PAHO), the Collegium Ramazzini, and Latin American scientists reviewed regional and relevant global data.", {"entities": []}], ["Industrial development and urbanization are proceeding rapidly in Latin America, and environmental pollution has become widespread.", {"entities": []}], ["Environmental threats to children\u2019s health include traditional hazards such as indoor air pollution and drinking-water contamination; the newer hazards of urban air pollution; toxic chemicals such as lead, asbestos, mercury, arsenic, and pesticides; hazardous and electronic waste; and climate change.", {"entities": []}], ["The mix of traditional and modern hazards varies greatly across and within countries reflecting industrialization, urbanization, and socioeconomic forces.", {"entities": []}], ["To control environmental threats to children\u2019s health in Latin America, WHO, including PAHO, will focus on the most highly prevalent and serious hazards\u2014indoor and outdoor air pollution, water pollution, and toxic chemicals.", {"entities": []}], ["Strategies for controlling these hazards include developing tracking data on regional trends in children\u2019s environmental health (CEH), building a network of Collaborating Centres, promoting biomedical research in CEH, building regional capacity, supporting development of evidence-based prevention policies, studying the economic costs of chronic diseases in children, and developing platforms for dialogue with relevant stakeholders.", {"entities": []}], ["Laborde A, Tomasina F, Bianchi F, Brun\u00e9 MN, Buka I, Comba P, Corra L, Cori L, Duffert CM, Harari R, Iavarone I, McDiarmid MA, Gray KA, Sly PD, Soares A, Suk WA, Landrigan PJ.", {"entities": []}], ["Children\u2019s health in Latin America: the influence of environmental exposures.", {"entities": []}], ["Environ Health Perspect 123:201\u2013209;\u2002 http://dx.doi.org/10.1289/ehp.1408292", {"entities": []}], ["The mammalian circadian clock controls many physiological processes that include immune responses and allergic reactions.", {"entities": []}], ["Several studies have investigated the circadian regulation of intestinal permeability and tight junctions known to be affected by cytokines.", {"entities": []}], ["However, the contribution of circadian clock to food allergy symptoms remains unclear.", {"entities": [[48, 60, "DISEASE"]]}], ["Therefore, we investigated the role of the circadian clock in determining the severity of food allergies.", {"entities": []}], ["We prepared an ovalbumin food allergy mouse model, and orally administered ovalbumin either late in the light or late in the dark period under light-dark cycle.", {"entities": [[25, 37, "DISEASE"]]}], ["The light period group showed higher allergic diarrhea and weight loss than the dark period group.", {"entities": [[46, 54, "DISEASE"]]}], ["The production of type 2 cytokines, IL-13 and IL-5, from the mesenteric lymph nodes and ovalbumin absorption was higher in the light period group than in the dark period group.", {"entities": []}], ["Compared to the dark period group, the mRNA expression levels of the tight junction proteins were lower in the light period group.", {"entities": []}], ["We have demonstrated that increased production of type 2 cytokines and intestinal permeability in the light period induced severe food allergy symptoms.", {"entities": [[130, 142, "DISEASE"]]}], ["Our results suggest that the time of food antigen intake might affect the determination of the severity of food allergy symptoms.", {"entities": [[107, 119, "DISEASE"]]}], ["Transoral incisionless fundoplication (TIF) performed with the EsophyX device (Redmond, Washington, USA) is a totally endoscopic procedure with the objectives to mechanically repair a defective gastroesophageal valve and to reduce small hiatal hernias.", {"entities": []}], ["The recent publication of randomized controlled trials and long-term follow-up data offers the opportunity to reevaluate this treatment modality and its role in the management of patients with chronic gastroesophageal reflux disease (GERD).", {"entities": [[201, 232, "DISEASE"]]}], ["Randomized controlled trials have confirmed the ability of TIF to eliminate troublesome GERD symptoms, heal esophagitis, and improve distal esophageal acid exposure in appropriately selected patient populations.", {"entities": [[108, 119, "DISEASE"]]}], ["These studies establish TIF's superiority to conventional medical therapy, especially in clinical scenarios where proton-pump inhibitors fail to provide complete symptom relief across the spectrum of classic and atypical GERD manifestations, including regurgitation and laryngopharyngeal reflux.", {"entities": []}], ["Long-term data indicate sustained positive outcomes and durability up to 6 years after procedure.", {"entities": []}], ["These results were achieved with a low rate of serious adverse events and usually without introducing troublesome dysphagia, gas bloat, or flatulence.", {"entities": []}], ["Based on the most recent data, TIF appears to be a valuable treatment alternative for the management of appropriately selected patients with moderate to severe chronic GERD symptoms.", {"entities": []}], ["To report data from a multinational survey investigating the relationship between gastro-oesophageal reflux disease (GERD) symptoms, treatment and subjective well-being.", {"entities": []}], ["Patients formally diagnosed with GERD ( n = 929) and undiagnosed subjects with symptoms suggestive of GERD ( n = 924) were included.", {"entities": []}], ["Sixty per cent of diagnosed (mean age: 51.7 years) and 54% of undiagnosed (mean age: 44.3 years) participants were female.", {"entities": []}], ["Over 50% of participants were overweight or obese.", {"entities": []}], ["Most respondents consumed alcohol, and one-third were smokers.", {"entities": []}], ["In total, 78% of diagnosed subjects were currently receiving medication prescribed by their doctor, and 65% were taking over-the-counter (OTC) treatments.", {"entities": [[138, 141, "GENE"]]}], ["The majority (97%) of undiagnosed subjects were taking OTC medication, the most common of which were antacids (78%).", {"entities": [[55, 58, "GENE"]]}], ["Despite medication, 58% of diagnosed and 73% of undiagnosed subjects still experienced GERD symptoms some of the time.", {"entities": []}], ["Approximately one-third of subjects in each group reported that they ate less than usual, felt generally unwell, were tired/worn out or worried/fearful for the majority of the time because of their GERD symptoms, and around half reported decreased well-being, including reduced work or leisure time productivity.", {"entities": []}], ["These findings attest to the severity and impact of GERD symptoms, highlighting the need to improve the management of GERD in routine practice.", {"entities": []}], ["Many symptomatic and long-term sufferers, for example, may benefit from taking steps towards a healthier lifestyle (e.g.", {"entities": []}], ["weight reduction) in addition to optimisation of acid-suppressive therapy.", {"entities": []}], ["Several studies have reported a reduction in acute coronary events (ACEs) in the general population after the enforcement of smoking regulations, although there is uncertainty concerning the magnitude of the effect of such interventions.", {"entities": []}], ["We conducted a country-wide evaluation of the health effects of the introduction of a smoking ban in public places, using data on hospital admissions for ACEs from the Italian population after the implementation of a national smoking regulation in January 2005.", {"entities": []}], ["Rates of admission for ACEs in the 20 Italian regions from January 2002 to November 2006 were analysed using mixed-effect regression models that allowed for long-term trends and seasonality.", {"entities": []}], ["Standard methods for interrupted time-series were adopted to assess the immediate and gradual effects of the smoking ban.", {"entities": []}], ["Effect modification by age was investigated, with the assumption that exposure to passive smoking in public places would be greater among young people.", {"entities": []}], ["In total, 936,519 hospital admissions for ACEs occurred in the Italian population during the study period.", {"entities": []}], ["A 4% reduction in hospital admissions for ACEs among persons aged less than 70 years was evident after the introduction of the ban (Rate Ratio [RR], 0.96; 95% Confidence Interval [CI], 0.95\u20130.98).", {"entities": []}], ["No effect was found among persons aged at least 70 years (RR 1.00; 95% CI 0.99\u20131.02).", {"entities": []}], ["Effect modification by age was further suggested by analyses using narrower age categories.", {"entities": []}], ["Smoke-free policies can constitute a simple and inexpensive intervention for the prevention of cardiovascular diseases and thus should be included in prevention programmes.", {"entities": []}], ["Gami-Cheongyeul-Sodok-Eum (GCSE), an herbal formula of traditional Korean medicine, comprises nine herb components.", {"entities": []}], ["GCSE has various biological activities such as anti-inflammatory, anti-bacterial and anti-viral activities.", {"entities": []}], ["However, it is still unclear whether GCSE has any immunomodulatory effect on atopic dermatitis (AD).", {"entities": [[77, 94, "DISEASE"], [84, 94, "DISEASE"]]}], ["GCSE was treated to primary B cells and CD4+ T cells isolated from atopic mice to compare its inhibitory effects on IgE secretion and cytokine expression.", {"entities": []}], ["Experimental AD was established by alternative treatment of 2, 4-dinitrochlorobenzene (DNCB) and house dust mite extract to the ears of BALB/c mice.", {"entities": []}], ["GCSE was topically applied to ears of atopic mice every day for 3\u00a0weeks.", {"entities": []}], ["AD progression was analyzed by measuring ear thickness, serum IgE level, histological examination of ear tissue by H&E staining and cytokine profile of CD4+ T cells and CD19+ B cells by real time PCR and ELISA.", {"entities": []}], ["Treatment of GCSE significantly reduced IgE production and expression of AD associated pathogenic cytokines such as IL-4, IL-5, IL-10, IL-13, IL-17, TNF-\u03b1, and IFN-\u03b3 by lymphocytes isolated from AD-induced mice.", {"entities": []}], ["Topical application of GCSE on the ears of AD-induced mice significantly reduced ear thickness, clinical score and lymphocytes infiltration to ears as compared to control group.", {"entities": []}], ["GCSE treatment also reduced serum IgE level and the levels of major pathogenic cytokines such as IL-4, IL-5, IL-10, IL-13 and IL-17.", {"entities": []}], ["In addition, GCSE treatment significantly increased Foxp3 expression level.", {"entities": [[52, 57, "GENE"]]}], ["The protective effect of GCSE in experimental AD is mediated by inhibition of IgE production, by reduction in the levels of pathogenic cytokines and by induction of Foxp3, all of which are suggesting the beneficial effect of GCSE on modulating atopic dermatitis.", {"entities": [[244, 261, "DISEASE"], [251, 261, "DISEASE"], [165, 170, "GENE"]]}], ["Although there are ample data on the respiratory effects of exposure to fire extinguisher gas, the potential hematologic effects have not been fully documented.", {"entities": []}], ["We conducted this study to determine the possible etiologic agent(s) for a decrease in red blood cells among community residents in Taipei, Taiwan, after they were exposed to leakage of mixed fire extinguishants containing bromotrifluoromethane (CF 3 Br, Halon 1301), bromochlorodifluoromethane (CF 2 BrCl, Halon 1211), and dichlorodifluoromethane (CCl 2 F 2 , CFC-12).", {"entities": []}], ["We studied 117 exposed residents who came into one hospital for physical examinations.", {"entities": []}], ["We also selected age- and sex-matched referents for comparison from residents who came to the same hospital for health examinations.", {"entities": []}], ["Nine months after the exposure to mixed fire extinguishants, 91 of the exposed residents came back for a second physical examination.", {"entities": []}], ["In the first examination of the exposed residents, we found a significant reduction in red blood cell count and hemoglobin and a relationship between dose and response.", {"entities": []}], ["After excluding iron-deficiency anemia, thalassemia, and other possible agents, we suspected that the hematologic effects might have resulted from pyrolytic products of CFC-12 and Halon 1211, which may contain phosgene, among other products.", {"entities": [[40, 51, "DISEASE"], [21, 38, "DISEASE"], [32, 38, "DISEASE"]]}], ["The acute transient hematologic effects observed in the exposed residents were associated with the incident of leakage of mixed fire-extinguisher gases and were most likely caused by a small amount of pyrolytic products, probably phosgene.", {"entities": []}], ["Nine months after the exposure, we found a significant improvement in the abnormalities without any specific treatment.", {"entities": []}], ["(Pro)renin receptor [(P)RR], a new component of the tissue renin-angiotensin system (RAS), plays a crucial role in inflammation and angiogenesis in the eye, thus contributing to the development of proliferative diabetic retinopathy (PDR).", {"entities": [[211, 231, "DISEASE"], [197, 231, "DISEASE"]]}], ["In this study, we investigated systemic factors related to plasma levels of soluble form of (P)RR [s(P)RR] in patients with PDR.", {"entities": []}], ["Twenty type II diabetic patients with PDR and 20 age-matched, non-diabetic patients with idiopathic macular diseases were enrolled, and plasma levels of various molecules were measured by enzyme-linked immunosorbent assays.", {"entities": []}], ["Human retinal microvascular endothelial cells were stimulated with several diabetes-related conditions to evaluate changes in gene expression using real-time quantitative PCR.", {"entities": []}], ["Of various systemic parameters examined, the PDR patients had significantly higher blood sugar and serum creatinine levels than non-diabetic controls.", {"entities": []}], ["Protein levels of s(P)RR, prorenin, tumor necrosis factor (TNF)-\u03b1, complement factor D (CFD), and leucine-rich \u03b1-2-glycoprotein 1 (LRG1) significantly increased in the plasma of PDR subjects as compared to non-diabetes, with positive correlations detected between s(P)RR and these inflammatory molecules but not prorenin.", {"entities": [[59, 62, "GENE"], [88, 91, "GENE"], [131, 135, "GENE"]]}], ["Estimated glomerular filtration rate and serum creatinine were also correlated with plasma s(P)RR, but not prorenin, levels.", {"entities": []}], ["Among the inflammatory molecules correlated with s(P)RR in the plasma, TNF-\u03b1, but not CFD or LRG1, application to retinal endothelial cells upregulated the mRNA expression of (P)RR but not prorenin, while stimulation with high glucose enhanced both (P)RR and prorenin expression.", {"entities": [[86, 89, "GENE"], [93, 97, "GENE"]]}], ["These findings suggested close relationships between plasma s(P)RR and diabetes-induced factors including chronic inflammation, renal dysfunction, and hyperglycemia in patients with PDR.", {"entities": [[151, 164, "DISEASE"]]}], ["Tapentadol is a centrally acting analgesic that has been available for the management of acute and chronic pain in routine clinical practice since 2009.", {"entities": []}], ["This is the first integrated descriptive analysis of post-marketing safety data following the use of tapentadol in a broad range of pain conditions relating to the topics overall safety, dose administration above approved dosages, administration during pregnancy, serotonin syndrome, respiratory depression, and convulsion.", {"entities": [[274, 282, "DISEASE"]]}], ["The data analyzed pertain to spontaneous reports from healthcare and non-healthcare professionals and were put in the context of safety information known from interventional and non-interventional trials.", {"entities": []}], ["The first years of routine clinical practice experience with tapentadol have confirmed the tolerability profile that emerged from the clinical trials.", {"entities": []}], ["Moreover, the reporting of expected side effects such as respiratory depression and convulsion was low and no major risks were identified.", {"entities": []}], ["The evaluation of available post-marketing data did not confirm the theoretical risk of serotonin syndrome nor did it reveal unexpected side effects with administration of higher than recommended doses.", {"entities": [[98, 106, "DISEASE"]]}], ["More than 8\u00a0years after its first introduction, the favorable overall safety profile of tapentadol in the treatment of various pain conditions is maintained in the general population.", {"entities": []}], ["Gr\u00fcnenthal GmbH.", {"entities": []}], ["The online version of this article (10.1007/s12325-017-0654-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["With the easy availability of thyroid hormone assays, thyroid disorders are now recognised even in a subclinical state.", {"entities": []}], ["However, patients are still seen with advanced manifestations of the disease, particularly in developing countries.", {"entities": []}], ["This observational study analysed the predictors of outcome in patients with myxoedema coma and tested the validity of different modules to define morbidity and mortality in these patients.", {"entities": []}], ["Twenty-three consecutive patients with myxoedema coma who presented from January 1999 to August 2006 were studied.", {"entities": []}], ["The thyroid function test and random serum cortisol were measured in all patients at the time of admission.", {"entities": []}], ["Patients were given oral or intravenous (IV) thyroxine with intention to treat with the latter according to availability.", {"entities": []}], ["Various modules that predict outcome, including Glasgow Coma Scale (GCS), Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and Sequential Organ Failure Assessment (SOFA) score, were analysed.", {"entities": []}], ["SOFA score was repeated every 2 days until the time of discharge or demise.", {"entities": []}], ["Twenty-three patients (20 women; 87%) of 59.5 \u00b1 14.4 years of age (range, 30 to 89 years) were seen during the study period.", {"entities": []}], ["Nine (39%) patients were diagnosed with hypothyroidism for the first time at the time of presentation of myxoedema coma, whereas 14 (70%) were diagnosed with hypothyroidism previously.", {"entities": [[40, 54, "DISEASE"], [158, 172, "DISEASE"]]}], ["However, the treatment defaulters presented early to the hospital and had more severe manifestations than de novo subjects.", {"entities": []}], ["Nineteen (82%) had thyroprivic (primary) and 4 (17%) had trophoprivic (secondary) hypothyroidism.", {"entities": [[82, 96, "DISEASE"]]}], ["Fifteen (65%) patients presented in the winter and in 17 (74%) sepsis was the major accompanying comorbidity.", {"entities": []}], ["Twelve (52%) had a history of diuretic use, thereby delaying the initial diagnosis.", {"entities": []}], ["Patients who received oral L-thyroxine had no difference in outcome from those receiving IV thyroxine.", {"entities": []}], ["Twelve (52%) subjects died and sepsis was the predominant cause of death.", {"entities": []}], ["Various predictors of mortality included hypotension ( p = 0.01) and bradycardia ( p = 0.03) at presentation, need for mechanical ventilation ( p = 0.00), hypothermia unresponsive to treatment ( p = 0.01), sepsis ( p = 0.01), intake of sedative drugs ( p = 0.02), lower GCS ( p = 0.03), high APACHE II score ( p = 0.04), and high SOFA score ( p = 0.00).", {"entities": []}], ["However, SOFA score was more effective than other predictive models as baseline and day 3 SOFA scores of more than 6 were highly predictive of poor outcome.", {"entities": []}], ["L-Thyroxine treatment defaulters had more severe manifestations compared with de novo subjects.", {"entities": []}], ["Outcome was not influenced by either aetiology or route of administration of L-thyroxine, and SOFA score was the best outcome predictor model.", {"entities": []}], ["Environmental factors play an important role in the rise and manifestation of allergic conditions in genetically predisposed subjects.", {"entities": []}], ["Increased exposure to indoor/outdoor allergens is a significant factor in the development of allergic sensitization and asthma.", {"entities": [[120, 126, "DISEASE"]]}], ["Recently, strong relationships between the immune response to several highly purified allergens and specific human leukocyte antigen (HLA)-DQ and -DR haplotypes have been reported.", {"entities": [[134, 137, "GENE"]]}], ["The major antigens from clinically important allergens have been cloned and sequenced.", {"entities": []}], ["However, whether innate structural features of major allergens or peculiar immune recognition of these molecules contribute to the overly robust immune responses is not known.", {"entities": []}], ["We generated and used transgenic (tg) mice expressing single HLA class II transgene(s) to characterize the allergen epitopes presented by particular HLA class II molecules.", {"entities": [[34, 36, "GENE"], [61, 64, "GENE"], [149, 152, "GENE"], [61, 64, "GENE"], [149, 152, "GENE"]]}], ["Next, we generated in vivo models for asthma in the HLA tg mice by intranasal challenge with allergenic extracts.", {"entities": [[38, 44, "DISEASE"], [52, 55, "GENE"], [56, 58, "GENE"]]}], ["Furthermore, we used a single epitope to induce an allergic lung inflammation.", {"entities": []}], ["Our system offers a sophisticated technique for systematically identifying the genetic (individual human class II) and antigenic (individual allergenic epitopes) basis of asthma sensitivity and has important implications for new treatment strategies.", {"entities": [[171, 177, "DISEASE"]]}], ["A world-wide rise in the prevalence of obesity continues.", {"entities": [[39, 46, "DISEASE"]]}], ["This rise increases the occurrence of, risks of, and costs of treating obesity-related medical conditions.", {"entities": [[71, 78, "DISEASE"]]}], ["Diet and activity programs are largely inadequate for the long-term treatment of medically-complicated obesity.", {"entities": [[103, 110, "DISEASE"]]}], ["Physicians who deliver gastrointestinal care after completing traditional training programs, including gastroenterologists and general surgeons, are not uniformly trained in or familiar with available bariatric care.", {"entities": []}], ["It is certain that gastrointestinal physicians will incorporate new endoscopic methods into their practice for the treatment of individuals with medically-complicated obesity, although the long-term impact of these endoscopic techniques remains under investigation.", {"entities": [[167, 174, "DISEASE"]]}], ["It is presently unclear whether gastrointestinal physicians will be able to provide or coordinate important allied services in bariatric surgery, endocrinology, nutrition, psychological evaluation and support, and social work.", {"entities": []}], ["Obtaining longitudinal results examining the effectiveness of this ad hoc approach will likely be difficult, based on prior experience with other endoscopic measures, such as the adenoma detection rates from screening colonoscopy.", {"entities": [[179, 186, "DISEASE"]]}], ["As a long-term approach, development of a specific curriculum incorporating one year of subspecialty training in bariatrics to the present training of gastrointestinal fellows needs to be reconsidered.", {"entities": []}], ["This approach should be facilitated by gastrointestinal trainees\u2019 prior residency training in subspecialties that provide care for individuals with medical complications of obesity, including endocrinology, cardiology, nephrology, and neurology.", {"entities": [[173, 180, "DISEASE"]]}], ["Such training could incorporate additional rotations with collaborating providers in bariatric surgery, nutrition, and psychiatry.", {"entities": []}], ["Since such training would be provided in accredited programs, longitudinal studies could be developed to examine the potential impact on accepted measures of care, such as complication rates, outcomes, and costs, in individuals with medically-complicated obesity.", {"entities": [[255, 262, "DISEASE"]]}], ["Exhaled breath condensate (EBC) sampling has been considered an inventive and novel method for the isolation of respiratory viruses.", {"entities": []}], ["In our study, 102 volunteers experiencing upper airway infection were recruited over the winter and early spring of 2008/2009 and the first half of the winter of 2009/2010.", {"entities": []}], ["Ninety-nine EBCs were successfully obtained and screened for 14 commonly circulating respiratory viruses.", {"entities": []}], ["To investigate the efficiency of virus isolation from EBC, a nasal swab was taken in parallel from a subset of volunteers.", {"entities": []}], ["The combined use of the ECoVent device with the RTube\u2122 allowed the registration of the exhaled volume and breathing frequency during collection.", {"entities": []}], ["In this way, the number of exhaled viral particles per liter air or per minute can theoretically be estimated.", {"entities": []}], ["Viral screening resulted in the detection of 4 different viruses in EBC and/or nasal swabs: Rhinovirus, Human Respiratory Syncytial Virus B, Influenza A and Influenza B. Rhinovirus was detected in 6 EBCs and 1 EBC was Influenza B positive.", {"entities": []}], ["We report a viral detection rate of 7% for the EBCs, which is much lower than the detection rate of 46.8% observed using nasal swabs.", {"entities": []}], ["Although very promising, EBC collection using the RTube\u2122 is not reliable for diagnosis of respiratory infections.", {"entities": []}], ["Genetic variations in toll-like receptors and cytokine genes of the innate immune pathways have been implicated in controlling parasite growth and the pathogenesis of Plasmodium falciparum mediated malaria.", {"entities": [[198, 205, "DISEASE"]]}], ["We previously published genetic association of TLR4 non-synonymous and TNF-\u03b1 promoter polymorphisms with P.falciparum blood infection level and here we extend the study considerably by (i) investigating genetic dependence of parasite-load on interleukin-12B polymorphisms, (ii) reconstructing gene-gene interactions among candidate TLR s and cytokine loci, (iii) exploring genetic and functional impact of epistatic models and (iv) providing mechanistic insights into functionality of disease-associated regulatory polymorphisms.", {"entities": [[47, 51, "GENE"]]}], ["Our data revealed that carriage of AA (P\u200a=\u200a0.0001) and AC (P\u200a=\u200a0.01) genotypes of IL12B 3\u2032UTR polymorphism was associated with a significant increase of mean log-parasitemia relative to rare homozygous genotype CC.", {"entities": [[82, 87, "GENE"]]}], ["Presence of IL12B+1188 polymorphism in five of six multifactor models reinforced its strong genetic impact on malaria phenotype.", {"entities": [[110, 117, "DISEASE"]]}], ["Elevation of genetic risk in two-component models compared to the corresponding single locus and reduction of IL12B (2.2 fold) and lymphotoxin-\u03b1 (1.7 fold) expressions in patients'peripheral-blood-mononuclear-cells under TLR4Thr399Ile risk genotype background substantiated the role of Multifactor Dimensionality Reduction derived models.", {"entities": [[110, 115, "GENE"]]}], ["Marked reduction of promoter activity of TNF-\u03b1 risk haplotype (C-C-G-G) compared to wild-type haplotype (T-C-G-G) with (84%) and without (78%) LPS stimulation and the loss of binding of transcription factors detected in-silico supported a causal role of TNF-1031 .", {"entities": []}], ["Significantly lower expression of IL12B+1188 AA (5 fold) and AC (9 fold) genotypes compared to CC and under-representation (P\u200a=\u200a0.0048) of allele A in transcripts of patients' PBMCs suggested an Allele-Expression-Imbalance.", {"entities": []}], ["Allele ( A+1188C ) dependent differential stability (2 fold) of IL12B -transcripts upon actinomycin-D treatment and observed structural modulation (P\u200a=\u200a0.013) of RNA-ensemble were the plausible explanations for AEI.", {"entities": [[64, 69, "GENE"]]}], ["In conclusion, our data provides functional support to the hypothesis that de-regulated receptor-cytokine axis of innate immune pathway influences blood infection level in P. falciparum malaria.", {"entities": [[186, 193, "DISEASE"]]}], ["Objectives .", {"entities": []}], ["Physiologic and immunologic changes in pregnancy result in increased susceptibility to infection.", {"entities": []}], ["These shifts are more pronounced in pregnancies complicated by multiple gestation.", {"entities": []}], ["The objective of this study was to determine the association between multiple gestation and risk of infectious morbidity.", {"entities": []}], ["Study Design .", {"entities": []}], ["The Nationwide Inpatient Sample for the years 2008\u20132010 was used to identify pregnant women during admission for delivery with International Classification of Diseases codes.", {"entities": []}], ["Logistic regression was used to compute odds ratios and 95% confidence intervals for demographic data, preexisting medical conditions, and acute medical and infectious complications for women with multiple versus singleton gestations.", {"entities": []}], ["Among women with multiple gestation, 38.4 per 1,000 women had an infectious complication compared to 12.8 per 1,000 women with singletons.", {"entities": []}], ["The most significant infectious morbidity associated with multiple gestation was intestinal infections, pyelonephritis, influenza, and pneumonia.", {"entities": [[120, 129, "DISEASE"], [135, 144, "DISEASE"], [104, 118, "DISEASE"]]}], ["After controlling for confounding variables, infectious complications at delivery persisted for women with multiples, though the association was dependent on mode of delivery.", {"entities": []}], ["Conclusions .", {"entities": []}], ["Women with multiple gestations are at increased risk for infectious morbidity identified at the time of delivery.", {"entities": []}], ["This association was diminished among women who had a cesarean suggesting that operative delivery is not responsible for this association.", {"entities": []}], ["Studies investigating the prevalence of multiple chronic conditions (MCCs) and their associated health care cost and use among pediatric populations have been limited.", {"entities": []}], ["Among 14,404 pediatric patients receiving outpatient care in southeastern Michigan from 2008 through 2013, 82.1% had 0 chronic conditions, 16.2% had 1 chronic condition, and 1.6% had 2 or more chronic conditions.", {"entities": []}], ["Greater numbers of chronic conditions significantly predicted outpatient cost (\u03b2 = 581.7, P < .001), visit frequency (\u03b2 = 9.1, P < .001), and days between appointments (\u03b2 = \u221233.9, P < .001).", {"entities": []}], ["Further study of MCCs among pediatric patients is needed given their increasing prevalence and their associated health care cost and use.", {"entities": []}], ["Human rhinovirus (RV) infections are the principle cause of common colds and precipitate asthma and COPD exacerbations.", {"entities": [[89, 95, "DISEASE"]]}], ["There is currently no RV vaccine, largely due to the existence of \u223c150 strains.", {"entities": []}], ["We aimed to define highly conserved areas of the RV proteome and test their usefulness as candidate antigens for a broadly cross-reactive vaccine, using a mouse infection model.", {"entities": []}], ["Regions of the VP0 (VP4+VP2) capsid protein were identified as having high homology across RVs.", {"entities": []}], ["Immunization with a recombinant VP0 combined with a Th1 promoting adjuvant induced systemic, antigen specific, cross-serotype, cellular and humoral immune responses.", {"entities": []}], ["Similar cross-reactive responses were observed in the lungs of immunized mice after infection with heterologous RV strains.", {"entities": []}], ["Immunization enhanced the generation of heterosubtypic neutralizing antibodies and lung memory T cells, and caused more rapid virus clearance.", {"entities": []}], ["Conserved domains of the RV capsid therefore induce cross-reactive immune responses and represent candidates for a subunit RV vaccine.", {"entities": []}], ["Human rhinovirus infections cause the majority of common colds as well as asthma and chronic obstructive pulmonary disease (COPD) exacerbations.", {"entities": [[85, 122, "DISEASE"], [74, 80, "DISEASE"]]}], ["The disease burden attributable to rhinoviruses is therefore huge.", {"entities": []}], ["Despite this and the fact that human rhinoviruses were discovered over 50 years ago, there are currently no specific antiviral therapies or vaccine available.", {"entities": []}], ["The lack of a rhinovirus vaccine can at least in part be attributed to the fact that rhinoviruses like other pathogens have high variability in surface antibody binding regions, resulting in >100 serotypically distinct strains.", {"entities": []}], ["We have defined areas of the rhinovirus polyprotein which are highly conserved across strains and which may therefore induce cross-reactive immune responses capable of providing broader protection.", {"entities": []}], ["Using a mouse model, we show that immunization with a recombinant rhinovirus capsid protein induces cross-reactive cellular and humoral immune responses.", {"entities": []}], ["After subsequent infection, immunization enhances both neutralising antibody and lung effector and memory T cell responses, expediting virus clearance.", {"entities": []}], ["Importantly these effects were evident upon challenge with multiple heterologous rhinovirus serotypes, indicating that immunization with conserved rhinovirus capsid proteins may represent a viable strategy for producing a broadly cross-reactive vaccine.", {"entities": []}], ["Peste des petits ruminants virus (PPRV), the etiological agent of peste des petits ruminants (PPR), causes an acute or subacute disease in small ruminants.", {"entities": [[6, 9, "GENE"], [72, 75, "GENE"], [6, 9, "GENE"], [72, 75, "GENE"]]}], ["Although abortion is observed in an unusually large proportion of pregnant goats during outbreaks of PPR, the pathogenic mechanism underlying remains unclear.", {"entities": []}], ["Here, the gene expression profile of caprine endometrial epithelial cells (EECs) infected with PPRV Nigeria 75/1 was determined by DNA microarray to investigate the cellular response immediately after viral entry.", {"entities": []}], ["The microarray analysis revealed that a total of 146 genes were significantly dysregulated by PPRV internalization within 1\u00a0h post-infection (hpi).", {"entities": []}], ["Of these, 85 genes were upregulated and 61 genes were downregulated.", {"entities": []}], ["Most of these genes, including NFKB1A, JUNB, and IL1A, have not previously been reported in association with PPRV infection in goats.", {"entities": [[39, 43, "GENE"], [49, 53, "GENE"]]}], ["Following viral replication (24 hpi), the expression of 307 genes were significantly upregulated and that of 261 genes were downregulated.", {"entities": []}], ["The data for the genes differentially expressed in EECs were subjected to a time sequence profile analysis, gene network analysis and pathway analysis.", {"entities": []}], ["The gene network analysis showed that 13 genes (EIF2AK3, IL10, TLR4, ZO3, NFKBIB, RAC1, HSP90AA1, SMAD7, ARG2, JUNB, ZFP36, APP, and IL1A) were located in the core of the network.", {"entities": [[48, 55, "GENE"], [57, 61, "GENE"], [63, 67, "GENE"], [74, 80, "GENE"], [82, 86, "GENE"], [88, 96, "GENE"], [98, 103, "GENE"], [105, 109, "GENE"], [111, 115, "GENE"], [117, 122, "GENE"], [124, 127, "GENE"], [133, 137, "GENE"]]}], ["We clearly demonstrate that PPRV infection upregulates the expression of nectin-4 after 1\u00a0hpi, which peaked at 24\u00a0hpi in EECs.", {"entities": []}], ["In conclusion, this study demonstrates the early cellular gene expression in the caprine endometrial epithelial cells after the binding and entry of PPRV.", {"entities": []}], ["The online version of this article (10.1186/s13567-018-0504-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Tetramethylpyrazine, a natural compound from Ligusticum wallichii ( Chuan Xiong ), has been extensively used in China for cardiovascular and cerebrovascular diseases for about 40 years.", {"entities": []}], ["Because of its effectiveness in multisystems, especially in cardiovascular, its pharmacological action, clinical application, and the structural modification have attracted broad attention.", {"entities": []}], ["In this paper its mechanisms of action, the clinical status, and synthetic derivatives will be reviewed briefly.", {"entities": []}], ["Psoriasis is a chronic inflammatory skin disease that affects 2\u20133% of the global population, and there is still no known possibility of a cure.", {"entities": [[0, 9, "DISEASE"], [36, 48, "DISEASE"]]}], ["Lipoxin A4 (LXA4), an endogenous lipoxygenase-derived eicosanoid mediator, has potent dual pro-resolving and anti-inflammatory properties.", {"entities": []}], ["BML-111 (5(S)-6(R)-7-trihydroxyheptanoic acid methyl ester), a lipoxin receptor agonist, has been previously confirmed to be equivalent to LXA4 in the anti-inflammatory processes.", {"entities": []}], ["High mobility group box 1 (HMGB1) serves as an inflammatory cytokine when secreted extracellularly in psoriatic lesions and is involved in the development of psoriasis.", {"entities": [[158, 167, "DISEASE"], [27, 32, "GENE"]]}], ["Therefore, we investigated the effects of LXA4 and BML-111 on the HMGB1 signaling cascade and inflammation in lipopolysaccharide (LPS)-induced keratinocytes and imiquimod (IMQ)-induced psoriasiform dermatitis in mice.", {"entities": [[198, 208, "DISEASE"], [66, 71, "GENE"]]}], ["In the present study, we found that treatment with BML-111 attenuated the development of IMQ-induced psoriasiform dermatitis.", {"entities": [[114, 124, "DISEASE"]]}], ["Furthermore, treatment with BML-111 and LXA4 inhibited HMGB1 translocation from the nucleus to cytoplasm and downregulated the expression of toll-like receptor 4 (TLR4), receptor for advanced glycation end products (RAGE), p-ERK1/2, nuclear NF-\u03baB p65, and proinflammatory cytokines in vivo and in vitro .", {"entities": [[55, 60, "GENE"], [163, 167, "GENE"]]}], ["Our findings indicate that LXA4 and its analog may be potential therapeutic candidates for psoriasis because of their ability to modulate the translocation and expression of HMGB1.", {"entities": [[91, 100, "DISEASE"], [174, 179, "GENE"]]}], ["Atopic dermatitis (AD) is believed to result from complex interactions between genetic and environmental factors.", {"entities": [[7, 17, "DISEASE"]]}], ["A main feature of AD as well as other allergic disorders is serum and tissue eosinophilia.", {"entities": [[77, 89, "DISEASE"]]}], ["Human eosinophils contain high amounts of cationic granule proteins, including eosinophil cationic protein (ECP), eosinophil-derived neurotoxin (EDN), eosinophil peroxidase (EPO) and major basic protein (MBP).", {"entities": [[174, 177, "GENE"], [204, 207, "GENE"]]}], ["Recently, variation in genes encoding eosinophil granule proteins has been suggested to play a role in the pathogenesis of allergic disorders.", {"entities": []}], ["We therefore genotyped selected single nucleotide polymorphisms within the ECP, EDN, EPO and MBP genes in a cohort of 361 German AD patients and 325 healthy controls.", {"entities": [[85, 88, "GENE"], [93, 96, "GENE"]]}], ["Genotype and allele frequencies did not differ between patients and controls for all polymorphisms investigated in this study.", {"entities": []}], ["Haplotype analysis did not reveal any additional information.", {"entities": []}], ["We did not find evidence to support an influence of variation in genes encoding eosinophil granule proteins for AD pathogenesis in this German cohort.", {"entities": []}], ["The objective of this study was to document persistent pulmonary symptoms and pulmonary function abnormalities in adults surviving hantavirus pulmonary syndrome (HPS).", {"entities": [[131, 160, "DISEASE"], [152, 160, "DISEASE"]]}], ["Acute infection by most hantaviruses result in mortality rates of 25\u201335%, while in Panama the mortality rate of 10% is contrasted by an unusually high incidence.", {"entities": []}], ["In all types of HPS, the viral prodrome, cardiopulmonary phase due to massive pulmonary capillary leak syndrome, and spontaneous diuresis are followed by a convalescent phase with exertional dyspnea for 3\u20134\u00a0weeks, but the frequency of persistent symptoms is not known.", {"entities": [[103, 111, "DISEASE"], [88, 111, "DISEASE"]]}], ["In this observational study of a convenience sample, 14 survivors of HPS caused by Choclo virus infection in Panama and 9 survivors of HPS caused by Sin Nombre virus infection in New Mexico completed a questionnaire and pulmonary function tests up to 8\u00a0years after infection.", {"entities": []}], ["In both groups, exertional dyspnea persisted for 1\u20132\u00a0years after acute infection in 43% (Panama) and 77% (New Mexico) of survivors surveyed.", {"entities": []}], ["Reduction in midexpiratory flows (FEF 25\u201375% ), increased residual volume (RV), and reduced diffusion capacity (D L CO/VA) also were common in both populations; but the severity of reduced expiratory flow did not correlate with exertional dyspnea.", {"entities": []}], ["Symptoms referable to previous hantavirus infection had resolved within 3\u00a0years of acute infection in most but not all patients in the Panama group.", {"entities": []}], ["Temporary exertional dyspnea and reduced expiratory flow are common in early convalescence after HPS but resolves in almost all patients.", {"entities": []}], ["Please cite this paper as: Yuan et\u00a0al.", {"entities": []}], ["(2012) Initial HRCT findings of novel influenza A (H1N1) infection.", {"entities": [[38, 47, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 6(601), e114\u2013e119.", {"entities": [[0, 9, "DISEASE"]]}], ["Objectives\u2002 The aim of our study was to describe the presentation and illustrate the imaging features of chest high\u2010resolution computed tomography (HRCT) of patients with novel influenza A (H1N1) virus infection.", {"entities": [[177, 186, "DISEASE"]]}], ["Methods\u2002 Data were collected from 163 hospitalized patients between November 2009 and March 2011, who fulfilled the clinical criteria for H1N1 influenza infection and underwent HRCT examinations within 24\u2003hours of admission.", {"entities": [[143, 152, "DISEASE"]]}], ["Results\u2002 Abnormal findings were observed in 40\u00b75% of the patients.", {"entities": []}], ["The patients with positive imaging findings were significantly older than patients with normal HRCT findings ( P \u2003=\u20030\u00b702).", {"entities": []}], ["The most common finding was ground\u2010glass opacity (GGO) ( n \u2003=\u200335).", {"entities": []}], ["Interlobular septal thickening ( n \u2003=\u200331) and centrilobular nodules ( n \u2003=\u200330) were the second most frequent findings.", {"entities": []}], ["Other common findings were consolidation, reticulation, and linear shadow.", {"entities": []}], ["The most common imaging finding for lung involvement was GGO with a patchy pattern.", {"entities": []}], ["Pulmonary involvement of the disease may be extensive and variable, but the total volume of affected lung was mostly <1 lobe.", {"entities": []}], ["Conclusion\u2002 The baseline HRCT may be valuable and suggestive even for non\u2010severe H1N1 infections.", {"entities": []}], ["When a severe case or a evolution is suspected, chest CT could be essential both for determining the precise extent of parenchymal damage and for monitoring its evolution.", {"entities": []}], ["Ultimately, asthma is a disease characterized by constriction of airway smooth muscle (ASM).", {"entities": [[12, 18, "DISEASE"]]}], ["The earliest approach to the treatment of asthma comprised the use of xanthines and anti-cholinergics with the later introduction of anti-histamines and anti-leukotrienes.", {"entities": [[42, 48, "DISEASE"]]}], ["Agents directed at ion channels on the smooth muscle membrane (Ca", {"entities": []}], ["To review systematic reviews and meta-analyses of integrated care programmes in chronically ill patients, with a focus on methodological quality, elements of integration assessed and effects reported.", {"entities": []}], ["Meta-review of systematic reviews and meta-analyses identified in Medline (1946\u2013March 2012), Embase (1980\u2013March 2012), CINHAL (1981\u2013March 2012) and the Cochrane Library of Systematic Reviews (issue 1, 2012).", {"entities": []}], ["Methodological quality assessed by the 11-item Assessment of Multiple Systematic Reviews (AMSTAR) checklist; elements of integration assessed using a published list of 10 key principles of integration; effects on patient-centred outcomes, process quality, use of healthcare and costs.", {"entities": []}], ["Twenty-seven systematic reviews were identified; conditions included chronic heart failure (CHF; 12 reviews), diabetes mellitus (DM; seven reviews), chronic obstructive pulmonary disease (COPD; seven reviews) and asthma (five reviews).", {"entities": [[149, 186, "DISEASE"], [213, 219, "DISEASE"], [110, 127, "DISEASE"]]}], ["The median number of AMSTAR checklist items met was five: few reviewers searched for unpublished literature or described the primary studies and interventions in detail.", {"entities": []}], ["Most reviews covered comprehensive services across the care continuum or standardization of care through inter-professional teams, but organizational culture, governance structure or financial management were rarely assessed.", {"entities": []}], ["A majority of reviews found beneficial effects of integration, including reduced hospital admissions and re-admissions (in CHF and DM), improved adherence to treatment guidelines (DM, COPD and asthma) or quality of life (DM).", {"entities": [[193, 199, "DISEASE"]]}], ["Few reviews showed reductions in costs.", {"entities": []}], ["Systematic reviews of integrated care programmes were of mixed quality, assessed only some components of integration of care, and showed consistent benefits for some outcomes but not others.", {"entities": []}], ["\u2022 Knock out mice have been used to explore the role of PKCs in mast cell (MC) function.", {"entities": []}], ["\u2022 Individual PKC isoforms may positively or negatively regulate MC cytokine responses.", {"entities": []}], ["\u2022 Certain PKC isoforms in MCs are targeted by the parasitic worm product ES-62.", {"entities": []}], ["Knock out mice have been used to explore the role of PKCs in mast cell (MC) function.", {"entities": []}], ["Individual PKC isoforms may positively or negatively regulate MC cytokine responses.", {"entities": []}], ["Certain PKC isoforms in MCs are targeted by the parasitic worm product ES-62.", {"entities": []}], ["ES-62, a glycoprotein secreted by the filarial nematode Acanthocheilonema viteae , has been shown to modulate the immune system through subversion of signal transduction pathways operating in various immune system cells.", {"entities": []}], ["With respect to human bone marrow-derived mast cells (BMMCs), ES-62 was previously shown to inhibit Fc\u03f5RI-mediated mast cell functional responses such as degranulation and pro-inflammatory cytokine release through a mechanism involving the degradation of PKC-\u03b1.", {"entities": []}], ["At the same time, it was noted that the worm product was able to degrade certain other PKC isoforms but the significance of this was uncertain.", {"entities": []}], ["In this study, we have employed PKC isoform KO mice to investigate the role of PKC-\u03b1, -\u03b2 -\u03f5, and -\u03b8 in mouse BMMCs in order to establish their involvement in mast cell-mediated responses and also, if their absence impacts on ES-62\u2019s activity.", {"entities": []}], ["The data obtained support that in response to antigen cross-linking of IgE bound to Fc\u03f5RI, pro-inflammatory cytokine release is controlled in part by a partnership between one conventional and one novel isoform with PKC-\u03b1 and -\u03b8 acting as positive regulators of IL-6 and TNF-\u03b1 production, while PKC-\u03b2 and \u03f5 act as negative regulators of such cytokines.", {"entities": []}], ["Furthermore, ES-62 appears to target certain other PKC isoforms in addition to PKC-\u03b1 to inhibit cytokine release and this may enable it to more efficiently inhibit mast cell responses.", {"entities": []}], ["Alcohol misuse remains a major risk factor for contracting sexually transmitted diseases (STDs) not typically addressed in STD clinic settings.", {"entities": []}], ["Information and communication technology (ICT) can offer new avenues to deliver evidence-based screening and treatment for problematic drinking, however, few data exists regarding the utilization of ICT among STD clinic attendees with coexisting drinking problems.", {"entities": []}], ["The objectives of this study are to identify STD clinics attendees with hazardous drinking, to examine socio-demographic factors associated with ICT use, and to explore individuals\u2019 interests in engaging in ICT-based health interventions.", {"entities": []}], ["Cross-sectional questionnaires examining alcohol consumption and ICT use were administered to 396 persons attending two non-urban STD clinics.", {"entities": []}], ["Descriptive statistics for ICT use were calculated for both hazardous drinkers and the entire sample.", {"entities": []}], ["Multivariable logistic regression models among hazardous drinkers identified factors significantly associated with use of each kind of ICT.", {"entities": []}], ["The mean age of the 396 participants was 25\u00a0years, 66% were females and 60% were African-Americans.", {"entities": []}], ["One third of the sample met the criteria of hazardous drinking.", {"entities": []}], ["ICT use in hazardous drinkers included 94% reporting having internet access at least monthly, 82% reporting having an email account, 85% reporting currently owning a cell phone, and 91% reporting use of any cell phone application.", {"entities": []}], ["More than two thirds (73%) of hazardous drinkers were willing to play health-related video games during clinic waiting time, slightly higher than the entire sample (69%).", {"entities": []}], ["Multivariable analyses indicated that younger age were significantly related to monthly internet use, and multifunction cell phone use, while being males and younger age were significantly associated with monthly video game playing.", {"entities": []}], ["Our study demonstrates commonality of ICT use among STD clinic attendees with hazardous drinking, indicating the viability of using ICT to assist screening and behavioural intervention for alcohol misuse in STD clinic settings.", {"entities": []}], ["Future research is needed to demonstrate the effectiveness of ICT-based health behavioural interventions in the STD clinic settings or other venues that serve populations at high risk for substance abuse, HIV or other STDs.", {"entities": [[188, 203, "DISEASE"]]}], ["The aim of this study was to assess whether CT imaging using an ultra-high-resolution CT (UHRCT) scan with a small scan field of view (FOV) provides higher image quality and helps to reduce the follow-up period compared with a conventional high-resolution CT (CHRCT) scan.", {"entities": []}], ["We identified patients with at least one pulmonary nodule at our hospital from July 2015 to November 2015.", {"entities": []}], ["CHRCT and UHRCT scans were conducted in all enrolled patients.", {"entities": []}], ["Three experienced radiologists evaluated the image quality using a 5-point score and made diagnoses.", {"entities": []}], ["The paired images were displayed side by side in a random manner and annotations of scan information were removed.", {"entities": []}], ["The following parameters including image quality, diagnostic confidence of radiologists, follow-up recommendations and diagnostic accuracy were assessed.", {"entities": []}], ["A total of 52 patients (62 nodules) were included in this study.", {"entities": []}], ["UHRCT scan provides a better image quality regarding the margin of nodules and solid internal component compared to that of CHRCT (P < 0.05).", {"entities": []}], ["Readers have higher diagnostic confidence based on the UHRCT images than of CHRCT images (P<0.05).", {"entities": []}], ["The follow-up recommendations were significantly different between UHRCT and CHRCT images (P<0.05).", {"entities": []}], ["Compared with the surgical pathological findings, UHRCT had a relative higher diagnostic accuracy than CHRCT (P > 0.05).", {"entities": []}], ["These findings suggest that the UHRCT prototype scanner provides a better image quality of subsolid nodules compared to CHRCT and contributes significantly to reduce the patients' follow-up period.", {"entities": []}], ["This study documented elevated rates of emergency room (ER) visits for acute upper and lower respiratory infections and asthma-related conditions in the children of Quito, Ecuador associated with the eruption of Guagua Pichincha in April of 2000.", {"entities": [[120, 126, "DISEASE"]]}], ["We abstracted 5169 (43% females) ER records with primary respiratory conditions treated from January 1 \u2013 December 27, 2000 and examined the change in pediatric ER visits for respiratory conditions before, during, and after exposure events of April, 2000.", {"entities": []}], ["We applied a Poisson regression model adapted to time series of cases for three non-overlapping disease categories: acute upper respiratory infection (AURI), acute lower respiratory infection (ALRI), and asthma-related conditions in boys and girls for three age groups: 0\u20134, 5\u20139, and 10\u201315 years.", {"entities": [[204, 210, "DISEASE"]]}], ["At the main pediatric medical facility, the Baca Ortiz Pediatric Hospital, the rate of emergency room (ER) visits due to respiratory conditions substantially increased in the three weeks after eruption (RR = 2.22, 95%CI = [1.95, 2.52] and RR = 1.72 95%CI = [1.49, 1.97] for lower and upper respiratory tract infections respectively.", {"entities": []}], ["The largest impact of eruptions on respiratory distress was observed in children younger than 5 years (RR = 2.21, 95%CI = [1.79, 2.73] and RR = 2.16 95%CI = [1.67, 2.76] in boys and girls respectively).", {"entities": []}], ["The rate of asthma and asthma-related diagnosis doubled during the period of volcano fumarolic activity (RR = 1.97, 95%CI = [1.19, 3.24]).", {"entities": [[12, 18, "DISEASE"], [23, 29, "DISEASE"]]}], ["Overall, 28 days of volcanic activity and ash releases resulted in 345 (95%CI = [241, 460]) additional ER visits due to respiratory conditions.", {"entities": []}], ["The study has demonstrated strong relationship between ash exposure and respiratory effects in children.", {"entities": []}], ["There are approximately 2000 mobile health clinics operating in the United States.", {"entities": []}], ["While researchers have established that mobile health clinics can be cost effective and improve outcomes, there is scant research examining the healthcare experience on a mobile health clinic from patients\u2019 perspectives.", {"entities": []}], ["Data were gathered from interviews with 25 clients receiving care on a Boston-based mobile health clinic and analyzed using grounded theory methodology.", {"entities": []}], ["Emerging patterns in the data revealed three relational and three structural factors most significant to participants\u2019 experience of care on The Family Van.", {"entities": []}], ["Relational factors include providers who 1) Communicate understandably, 2) Create a culture of respect and inclusivity, and 3) Are diverse with knowledge of the community.", {"entities": []}], ["Structural factors include 1) A focus on preventative health and managing chronic disease, 2) Expeditious, free, and multiple services, and 3) Location.", {"entities": []}], ["The participant accounts in this report serve to expand on prior research exploring mobile health clinics\u2019 role in patients\u2019 healthcare, to more clearly define the most salient aspects of the mobile health clinic model for the patients they serve, and to give voice to patients too seldom heard in the academic literature.", {"entities": []}], ["The online version of this article (10.1186/s12939-017-0688-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The distribution of human disease-associated mutations is not random across the human genome.", {"entities": []}], ["Despite the fact that natural selection continually removes disease-associated mutations, an enrichment of these variants can be observed in regions of low recombination.", {"entities": []}], ["There are a number of mechanisms by which such a clustering could occur, including genetic perturbations or demographic effects within different populations.", {"entities": []}], ["Recent genome-wide association studies (GWAS) suggest that single nucleotide polymorphisms (SNPs) associated with complex disease traits are not randomly distributed throughout the genome, but tend to cluster in regions of low recombination.", {"entities": []}], ["Here we investigated whether deleterious mutations have accumulated in regions of low recombination due to the impact of recent positive selection and genetic hitchhiking.", {"entities": []}], ["Using publicly available data on common complex diseases and population demography, we observed an enrichment of hitchhiked disease associations in conserved gene clusters subject to selection pressure.", {"entities": []}], ["Evolutionary analysis revealed that these conserved gene clusters arose by multiple concerted rearrangements events across the vertebrate lineage.", {"entities": []}], ["We observed distinct clustering of disease-associated SNPs in evolutionary rearranged regions of low recombination and high gene density, which harbor genes involved in immunity, that is, the interleukin cluster on 5q31 or RhoA on 3p21.", {"entities": [[223, 227, "GENE"]]}], ["Our results suggest that multiple lineage specific rearrangements led to a physical clustering of functionally related and linked genes exhibiting an enrichment of susceptibility loci for complex traits.", {"entities": []}], ["This implies that besides recent evolutionary adaptations other evolutionary dynamics have played a role in the formation of linked gene clusters associated with complex disease traits.", {"entities": []}], ["The opinions held by the general population on obstructive lung disease and inhaler devices could influence asthma and chronic obstructive pulmonary disorder (COPD) management and treatment adherence.", {"entities": [[47, 71, "DISEASE"], [108, 114, "DISEASE"], [59, 71, "DISEASE"]]}], ["The aim of the present public pragmatic survey was to evaluate the opinions, beliefs and perceptions of Italian people with respect to respiratory diseases as well as their perspectives on the use of inhaler devices.", {"entities": []}], ["This survey was conducted on a group of 2,008 individuals forming a representative sample of the Italian population aged 15\u00a0years and over.", {"entities": []}], ["It was based on personal interviews that were administered in the homes of the respondents using a structured questionnaire that took approximately 30\u00a0minutes.", {"entities": []}], ["Awareness of obstructive lung diseases is poor.", {"entities": []}], ["Asthma, but not COPD, was perceived as a common and increasingly prevalent disease by the majority of the interviewees.", {"entities": [[0, 6, "DISEASE"]]}], ["Allergy, pollution and smoking were considered to be responsible for both of these diseases.", {"entities": []}], ["The rates at which the respondents claimed to be suffering from asthma and COPD were lower than expected (4% and 2%, respectively).", {"entities": [[64, 70, "DISEASE"]]}], ["Inhaled drugs were recognised as the main treatment by 65% of the respondents.", {"entities": []}], ["The great majority of respondents attributed positive characteristics to the inhaler device (e.g., safety, reliability, effectiveness, ease of use and practicality).", {"entities": []}], ["Compared to people who have never used inhaler devices, individuals who suffer from asthma or COPD were more confident in their use and showed a greater belief in their safety, reliability and trustworthiness.", {"entities": [[84, 90, "DISEASE"]]}], ["People older than 64\u00a0years showed less attention to the properties of these devices.", {"entities": []}], ["The present results highlight the need for public interventions aimed at improving awareness of obstructive lung disease and reveal various potentialities and critical issues for inhaler device usage.", {"entities": [[96, 120, "DISEASE"], [108, 120, "DISEASE"]]}], ["Switching of devices was considered feasible by most of the interviewees, as long as the choice is carefully explained by their physician.", {"entities": []}], ["With the prevalence of cardio-metabolic disorders reaching pandemic proportions, the search for modifiable causative factors has intensified.", {"entities": []}], ["One such potential factor is the vast microbial community inhabiting the human gastrointestinal tract, the gut microbiota.", {"entities": []}], ["For the past decade evidence has accumulated showing the association of distinct changes in gut microbiota composition and function with obesity, type 2 diabetes and cardiovascular disease.", {"entities": [[137, 144, "DISEASE"]]}], ["Although causality in humans and the pathophysiological mechanisms involved have yet to be decisively established, several studies have demonstrated that the gut microbiota, as an environmental factor influencing the metabolic state of the host, is readily modifiable through a variety of interventions.", {"entities": []}], ["In this review we provide an overview of the development of the gut microbiome and its compositional and functional changes in relation to cardio-metabolic disorders, and give an update on recent progress in how this could be exploited in microbiota-based therapeutics.", {"entities": []}], ["The online version of this article (doi:10.1186/s13073-015-0157-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Pirfenidone was recently approved for treatment of idiopathic pulmonary fibrosis.", {"entities": [[62, 80, "DISEASE"], [51, 80, "DISEASE"]]}], ["However, the therapeutic dose of pirfenidone is very high, causing side effects that limit its doses and therapeutic effectiveness.", {"entities": []}], ["Understanding the molecular mechanisms of action of pirfenidone could improve its safety and efficacy.", {"entities": []}], ["Because activated fibroblasts are critical effector cells associated with the progression of fibrosis, this study investigated the genes that change expression rapidly in response to pirfenidone treatment of pulmonary fibroblasts and explored their contributions to the anti-fibrotic effects of pirfenidone.", {"entities": []}], ["We used the GeneChip microarray to screen for genes that were rapidly up-regulated upon exposure of human lung fibroblast cells to pirfenidone, with confirmation for specific genes by real-time PCR and western blots.", {"entities": []}], ["Biochemical and functional analyses were used to establish their anti-fibrotic effects in cellular and animal models of pulmonary fibrosis.", {"entities": [[120, 138, "DISEASE"]]}], ["We identified Regulator of G-protein Signaling 2 (RGS2) as an early pirfenidone-induced gene.", {"entities": [[50, 54, "GENE"]]}], ["Treatment with pirfenidone significantly increased RGS2 mRNA and protein expression in both a human fetal lung fibroblast cell line and primary pulmonary fibroblasts isolated from patients without or with idiopathic pulmonary fibrosis.", {"entities": [[216, 234, "DISEASE"], [205, 234, "DISEASE"], [51, 55, "GENE"]]}], ["Pirfenidone treatment or direct overexpression of recombinant RGS2 in human lung fibroblasts inhibited the profibrotic effects of thrombin, whereas loss of RGS2 exacerbated bleomycin-induced pulmonary fibrosis and mortality in mice.", {"entities": [[191, 209, "DISEASE"], [62, 66, "GENE"], [156, 160, "GENE"], [62, 66, "GENE"], [156, 160, "GENE"]]}], ["Pirfenidone treatment reduced bleomycin-induced pulmonary fibrosis in wild-type but not RGS2 knockout mice.", {"entities": [[48, 66, "DISEASE"], [88, 92, "GENE"]]}], ["Endogenous RGS2 exhibits anti-fibrotic functions.", {"entities": [[11, 15, "GENE"]]}], ["Upregulated RGS2 contributes significantly to the anti-fibrotic effects of pirfenidone.", {"entities": [[12, 16, "GENE"]]}], ["The online version of this article (doi:10.1186/s12931-016-0418-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Human influenza A(H3N2) viruses that predominated during the moderately severe 2014-2015 influenza season differed antigenically from the vaccine component, resulting in reduced vaccine effectiveness (VE).", {"entities": [[6, 15, "DISEASE"], [89, 98, "DISEASE"]]}], ["To examine antibody responses to 2014-2015 inactivated influenza vaccine (IIV) and live-attenuated influenza vaccine (LAIV) among children and adolescents, we collected sera before and after vaccination from 150 children aged 3 to 17 years enrolled at health care facilities.", {"entities": [[55, 64, "DISEASE"], [99, 108, "DISEASE"]]}], ["Hemagglutination inhibition (HI) assays were used to assess the antibody responses to vaccine strains.", {"entities": []}], ["We evaluated cross-reactive antibody responses against two representative A(H3N2) viruses that had antigenically drifted from the A(H3N2) vaccine component using microneutralization (MN) assays.", {"entities": []}], ["Postvaccination antibody titers to drifted A(H3N2) viruses were higher following receipt of IIV (MN geometric mean titers [GMTs], 63 to 68; 38 to 45% achieved seroconversion) versus LAIV (MN GMT, 22; only 3 to 5% achieved seroconversion).", {"entities": []}], ["In 9- to 17-year-olds, the highest MN titers were observed among IIV-vaccinated individuals who had received LAIV in the previous season.", {"entities": []}], ["Among all IIV recipients aged 3 to 17 years, the strongest predictor of antibody responses to the drifted viruses was the prevaccination titers to the vaccine strain.", {"entities": []}], ["The results of our study suggest that in an antigenically drifted influenza season, vaccination still induced cross-reactive antibody responses to drifted circulating A(H3N2) viruses, although higher antibody titers may be required for protection.", {"entities": [[66, 75, "DISEASE"]]}], ["Antibody responses to drifted A(H3N2) viruses following vaccination were influenced by multiple factors, including vaccine type and preexisting immunity from prior exposure.", {"entities": []}], ["Better understanding of host-virus interaction is essential to produce effective vaccines against influenza (H5N1) viruses.", {"entities": [[98, 107, "DISEASE"]]}], ["Influenza A (H5N1) viruses are strong candidates for causing the next influenza pandemic if they acquire the ability for efficient human-to-human transmission.", {"entities": [[0, 9, "DISEASE"], [70, 79, "DISEASE"]]}], ["A major public health goal is to make efficacious vaccines against these viruses by using novel approaches, including cell-culture system, reverse genetics, and adjuvant development.", {"entities": []}], ["Important consideration for the strategy includes preparation of vaccines from a currently circulating strain to induce broad-spectrum immunity toward newly emerged human H5 strains.", {"entities": []}], ["This strategy would be a good solution early in a pandemic until an antigenically matched and approved vaccine is produced.", {"entities": []}], ["The concept of therapeutic vaccines (e.g., antidisease vaccine) directed at diminishing the cytokine storm frequently seen in subtype H5N1\u2013infected persons is underscored.", {"entities": []}], ["Better understanding of host\u2013virus interaction is essential to identify tools to produce effective vaccines against influenza (H5N1).", {"entities": [[116, 125, "DISEASE"]]}], ["Despite recommendations by the Centers for Disease Control (CDC) that all adults be offered non-targeted HIV screening in all care settings, screening in acute-care settings remains unacceptably low.", {"entities": []}], ["We performed an observational study to evaluate an HIV screening pilot in an academic-community partnership health center urgent care clinic.", {"entities": []}], ["We collected visit data via encounter forms and demographic and laboratory data from electronic medical records.", {"entities": []}], ["A post-pilot survey of perceptions of HIV screening was administered to providers and nurses.", {"entities": []}], ["Multivariable analysis was used to identify factors associated with completion of testing.", {"entities": []}], ["Visit provider and triage nurse were highly associated with both acceptance of screening and completion of testing, as were younger age, male gender, and race/ethnicity.", {"entities": []}], ["23.5% of patients completed tests, although 36.0% requested screening; time constraints as well as risk perceptions by both the provider and patient were cited as limiting completion of screening.", {"entities": []}], ["Post-pilot surveys showed mixed support for ongoing HIV screening in this setting by providers and little support by nurses.", {"entities": []}], ["Visit provider and triage nurse were strongly associated with acceptance of testing, which may reflect variable opinions of HIV screening in this setting by clinical staff.", {"entities": []}], ["Among patients accepting screening, visit provider remained strongly associated with completion of testing.", {"entities": []}], ["Despite longstanding recommendations for non-targeted HIV screening, further changes to improve the testing and results process, as well as provider education and buy-in, are needed to improve screening rates.", {"entities": []}], ["With the advent of nanotechnology, the prospects for using engineered nanomaterials with diameters of < 100 nm in industrial applications, medical imaging, disease diagnoses, drug delivery, cancer treatment, gene therapy, and other areas have progressed rapidly.", {"entities": [[190, 196, "DISEASE"]]}], ["The potential for nanoparticles (NPs) in these areas is infinite, with novel new applications constantly being explored.", {"entities": [[33, 36, "GENE"]]}], ["The possible toxic health effects of these NPs associated with human exposure are unknown.", {"entities": [[43, 46, "GENE"]]}], ["Many fine particles generally considered \u201cnuisance dusts\u201d are likely to acquire unique surface properties when engineered to nanosize and may exhibit toxic biological effects.", {"entities": []}], ["Consequently, the nuisance dust may be transported to distant sites and could induce adverse health effects.", {"entities": []}], ["In addition the beneficial uses of NPs in drug delivery, cancer treatment, and gene therapy may cause unintentional human exposure.", {"entities": [[57, 63, "DISEASE"], [35, 38, "GENE"]]}], ["Because of our lack of knowledge about the health effects associated with NP exposure, we have an ethical duty to take precautionary measures regarding their use.", {"entities": []}], ["In this review we highlight the possible toxic human health effects that can result from exposure to ultrafine particles (UFPs) generated by anthropogenic activities and their cardiopulmonary outcomes.", {"entities": []}], ["The comparability of engineered NPs to UFPs suggests that the human health effects are likely to be similar.", {"entities": [[32, 35, "GENE"]]}], ["Therefore, it is prudent to elucidate their toxicologic effect to minimize occupational and environmental exposure.", {"entities": []}], ["Highlighting the human health outcomes caused by UFPs is not intended to give a lesser importance to either the unprecedented technologic and industrial rewards of the nanotechnology or their beneficial human uses.", {"entities": []}], ["Vaginal hysterectomy is often used to correct uterovaginal prolapse, however, there is little information regarding outcomes after surgery in routine clinical practice.", {"entities": []}], ["The objective of this study was to investigate complications, sexual activity, urinary symptoms, and satisfaction with health care after vaginal hysterectomy due to prolapse.", {"entities": []}], ["We analyzed data from the Swedish National Register for Gynecological Surgery (SNRGS) from January 1997 to August 2005.", {"entities": []}], ["Women participating in the SNRGS were asked to complete surveys at two and six months postoperatively.", {"entities": []}], ["Of 941 women who underwent vaginal hysterectomy for uterovaginal prolapse, 791 responded to questionnaires at two months and 682 at six months.", {"entities": []}], ["Complications during surgery and hospital stay were investigated.", {"entities": []}], ["The two-month questionnaire investigated complications after discharge, and patients' satisfaction with their health care.", {"entities": []}], ["Sexual activity and urinary symptoms were reported and compared in preoperative and six-month postoperative questionnaires.", {"entities": []}], ["Almost 60% of women reported normal activity of daily life (ADL) within one week of surgery, irrespective of their age.", {"entities": []}], ["Severe complications occurred in 3% and were mainly intra-abdominal bleeding and vaginal vault hematomas.", {"entities": []}], ["Six months postoperative, sexual activity had increased for 20% (p = 0.006) of women and urinary urgency was reduced for 50% (p = 0.001); however, 14% (n = 76) of women developed urinary incontinence, 76% (n = 58) of whom reported urinary stress incontinence.", {"entities": []}], ["Patients were satisfied with the postoperative result in 93% of cases and 94% recommended the surgery.", {"entities": []}], ["Vaginal hysterectomy is a patient-evaluated efficient treatment for uterovaginal prolapse with swift recovery and a low rate of complication.", {"entities": []}], ["Sexual activity and symptoms of urinary urgency were improved.", {"entities": []}], ["However, 14% developed incontinence, mainly urinary stress incontinence (11%).", {"entities": []}], ["Therefore efforts to disclose latent stress incontinence should be undertaken preoperatively.", {"entities": []}], ["CD93 is receiving renewed attention as a biomarker of inflammation.", {"entities": [[0, 4, "GENE"]]}], ["We aimed to evaluate the potential for serum sCD93 to serve as a novel biomarker for allergic inflammation.", {"entities": []}], ["We enrolled 348 subjects with an allergic disease [allergic rhinitis (AR), chronic spontaneous urticaria (CSU), or bronchial asthma (BA)], including 14 steroid-na\u00efve BA patients who were serially followed-up.", {"entities": [[51, 68, "DISEASE"], [95, 104, "DISEASE"], [60, 68, "DISEASE"], [125, 131, "DISEASE"]]}], ["The serum sCD93 levels (ng/mL) in patients with exacerbated AR (mean\u00b1standard deviation, 153.1\u00b158.4) were significantly higher than in patients without AR (132.2\u00b149.0) or with stable AR (122.3\u00b142.1).", {"entities": []}], ["Serum sCD93 levels in exacerbated CSU (169.5\u00b142.8) were also significantly higher than those in non-CSU (132.4\u00b151.6) and stable CSU (122.8\u00b136.2).", {"entities": []}], ["This trend was also seen in BA.", {"entities": []}], ["Serum levels in patients with ICS-na\u00efve BA (161.4\u00b153.1) were significantly higher than those in healthy controls without BA (112.2\u00b130.8), low- and medium-dose ICS users.", {"entities": []}], ["Serum sCD93 levels in high-dose ICS users (72.2\u00b120.6) were significantly lower than those in low- and medium-dose users.", {"entities": []}], ["The serum sCD93 levels in steroid-na\u00efve patients with BA (195.1\u00b172.7) decreased after ICS use for 4 weeks (134.4\u00b142.8) and 8 weeks (100.7\u00b113.4), serially.", {"entities": []}], ["Elevated serum sCD93 levels reflected exacerbated status of allergic diseases, including CSU, AR, and asthma.", {"entities": [[102, 108, "DISEASE"]]}], ["ICS use significantly diminished serum sCD93 levels in steroid-na\u00efve patients with BA.", {"entities": []}], ["This result may suggest sCD93 in serum as a therapeutic marker for allergic inflammation.", {"entities": []}], ["Polymorphisms within NF-\u03baB pathway genes may be linked to hepatitis C virus (HCV) infection susceptibility and outcomes.", {"entities": [[58, 67, "DISEASE"]]}], ["We investigated the associations between single nucleotide polymorphisms (SNPs) in NF-\u03baB and the susceptibility as well as resolution of HCV infection.", {"entities": []}], ["A Chinese population, including 1125 uninfected control cases, 558 cases with spontaneous viral clearance and 898 cases with persistent HCV infection, was genotyped for four SNPs (rs11820062, rs230530, rs1056890 and rs3774963) using a TaqMan assay.", {"entities": []}], ["Our logistic analyses indicate that the subjects carrying RelA rs11820062 A allele had a significantly increased risk of HCV susceptibility ( P Bonferroni \u2009<\u20090.003125 in a dominant or additive model).", {"entities": [[58, 62, "GENE"]]}], ["In stratified analysis, the increased risk associated with rs11820062 A allele on HCV susceptibility remained in some case subgroups.", {"entities": []}], ["This study demonstrates that a genetic variant involved in the NF-\u03baB pathway gene (rs11820062 A allele) is associated with an increased HCV susceptibility within a high-risk Chinese population.", {"entities": []}], ["Please cite this paper as: Van Buynder et\u00a0al.", {"entities": []}], ["Increased reactions to pediatric influenza vaccination following concomitant pneumococcal vaccination Influenza and Other Respiratory Viruses 7(2) 184\u2013190.", {"entities": [[33, 42, "DISEASE"], [102, 111, "DISEASE"]]}], ["Background\u2002 Influenza in children causes significant morbidity and hospitalizations and also some mortality particularly in children <5\u2003years of age.", {"entities": [[12, 21, "DISEASE"]]}], ["Influenza vaccination in children has been shown to be safe and effective, but in 2010 the pediatric influenza vaccination program was suspended in Western Australia after the rate of febrile convulsions observed (9/1000 doses) was 55 times the previously reported rate.", {"entities": [[0, 9, "DISEASE"], [101, 110, "DISEASE"]]}], ["In 2009, over 80% of all children in New Brunswick were vaccinated with an adjuvanted monovalent H1N1 vaccine shown to have very high effectiveness, raising the prospect of potential hyper\u2010responsiveness because of residual protection.", {"entities": []}], ["We conducted enhanced post\u2010marketing surveillance to monitor local and general reactions.", {"entities": []}], ["Methods\u2002 Parents of participating children seen at dedicated vaccination clinics were given influenza vaccine survey kits to record local and general symptoms up to 3\u2003days following receipt of season influenza vaccine.", {"entities": [[92, 101, "DISEASE"], [200, 209, "DISEASE"]]}], ["Results\u2002 Febrile reactions of \u226538\u00b0 occurred in <10% of children who received a first dose of seasonal influenza vaccine ( n \u2003=\u2003660) and severe febrile incidents with fever \u226539\u00b0 were uncommon.", {"entities": [[102, 111, "DISEASE"]]}], ["Concurrent administration of other vaccine(s) including conjugated pneumococcal vaccine appeared to increase reactogenicity.", {"entities": []}], ["No child in the study had a febrile convulsion.", {"entities": []}], ["Conclusion\u2002 Influenza vaccines in children are safe, and this study provides a baseline for rapid assessment studies at the start of a vaccine season.", {"entities": [[12, 21, "DISEASE"]]}], ["Parents should be aware of increased fevers with concurrent vaccine administration, and antipyretics should be considered.", {"entities": []}], ["The right to a healthy pregnancy and to giving birth in a safe environment is source of comprehensive research.", {"entities": []}], ["Decent birth facilities, respect, and no discrimination are already recognized as fundamental rights, but an accurate look at the outdoor environment is required.", {"entities": []}], ["Air pollution is a dangerous factor to pregnant women and newborns, many of whom highly exposed to traffic-related atmospheric pollutants in urban areas.", {"entities": []}], ["Such exposure can lead to low birth weight and long-lasting effects, such as respiratory diseases and premature death.", {"entities": []}], ["Thus, this commentary, based on the analysis of literature, presents the importance of the exposome concept and of epigenetics in identifying the role of the environment for better health conditions of pregnant women and newborns.", {"entities": []}], ["In the final considerations, this study proposes the deepening of the subject and the mobilization in this regard, with a human rights-based approach to environmental health and to the increased awareness of pregnant women on the risks of air pollution and its effects on health.", {"entities": []}], ["Since the risk of developing allergic disease increases in individuals exposed to allergens previously, even during the neonatal period, the immunologic status of a fetus may be important in the subsequent development of allergy.", {"entities": []}], ["We evaluated the fetal factors to predict atopic dermatitis (AD) at 12 months in 412 infants of a COhort for Childhood Origin of Asthma and Allergic Diseases (COCOA) in the general Korean population.", {"entities": [[42, 59, "DISEASE"], [49, 59, "DISEASE"]]}], ["Cord blood mononuclear cells (CBMCs) were stimulated with ovalbumin and phytohemagglutinin and cellular proliferative response and concentrations of interleukin-13 and interferon-\u03b3, were measured.", {"entities": []}], ["The risk of developing AD was greater in boys than girls (OR 1.97, 95% CI 1.26-3.09), infants delivered by cesarean section than vaginally (OR 1.93, 95% CI 1.14-3.26) and infants with than without parental history of AD (OR 2.34, 95% CI 1.29-4.24).", {"entities": []}], ["The CBMC proliferative response to phytohemagglutinin stimulation was higher in infants with than without AD ( P = 0.048), but no difference was observed in ovalbumin-stimulated cells ( P = 0.771).", {"entities": []}], ["Risk factors for the development of AD at 12 months include male gender, delivery by cesarean section and parental history of AD.", {"entities": []}], ["Increased CBMC proliferative response to phytohemagglutinin stimulation may predict the development of AD at 12 months.", {"entities": []}], ["Objective .", {"entities": []}], ["To observe the effects of empirical prescriptions of traditional Chinese medicine (TCM) on inflammatory mediators in pediatric asthma and to explore the underlying molecular mechanism in the treatment of asthma.", {"entities": [[127, 133, "DISEASE"], [204, 210, "DISEASE"]]}], ["A total of 182 children with asthma were randomly placed into either the TCM group ( n = 97) or the salbutamol and montelukast (SM) group ( n = 85).", {"entities": [[29, 35, "DISEASE"]]}], ["Patients in the TCM group were treated with a series of empirical prescriptions of TCM, while those in the SM group received salbutamol and montelukast.", {"entities": []}], ["Both groups received their respective treatment for 12 weeks.", {"entities": []}], ["There were 35 patients in TCM group and 34 patients in SM group providing venous blood.", {"entities": []}], ["Real-time PCR was used to determine the mRNA expression levels of interleukin- (IL-) 10, IL-17, matrix metalloproteinase-9 (MMP-9), and transforming growth factor \u03b2 1 (TGF- \u03b2 1) in peripheral blood mononuclear cells before and after treatment.", {"entities": []}], ["Enzyme-linked immunosorbent assay was used to measure the levels of IL-10, IL-17, MMP-9, and TGF- \u03b2 1 in peripheral blood before and after treatment.", {"entities": []}], ["The mRNA expression of TGF- \u03b2 1 in the SM group was downregulated ( P = 0.00) after treatment.", {"entities": []}], ["No significant differences were found between the TCM group and the SM group after treatment ( P > 0.05).", {"entities": []}], ["In the TCM group, the levels of IL-10, IL-17, and MMP-9 significantly decreased after treatment ( P = 0.01, 0.04, and 0.03, resp.).", {"entities": []}], ["In the SM group, IL-17, MMP-9, and TGF- \u03b2 1 levels significantly decreased after treatment ( P = 0.00, 0.03, and 0.00, resp.).", {"entities": []}], ["There was no significant difference between the two groups regarding the levels of IL-10, IL-17, TGF- \u03b2 1, and MMP-9 ( P > 0.05).", {"entities": []}], ["The difference of the level of IL-17 was negatively correlated with the change of C-ACT score in TCM group and SM group.", {"entities": []}], ["Conclusion .", {"entities": []}], ["TCM has a regulatory effect on the balance of some inflammatory mediators in pediatric asthma.", {"entities": [[87, 93, "DISEASE"]]}], ["Acute heart failure (AHF) is a life threatening clinical syndrome with a progressively increasing incidence in general population.", {"entities": [[57, 65, "DISEASE"]]}], ["Turkey is a country with a high cardiovascular mortality and recent national statistics show that the population structure has turned to an \u2018aged\u2019 population.", {"entities": []}], ["As a consequence, AHF has become one of the main reasons of admission to cardiology clinics.", {"entities": []}], ["This consensus report summarizes clinical and prognostic classification of AHF, its worldwide and national epidemiology, diagnostic work-up, principles of approach in emergency department, intensive care unit and ward, treatment in different clinical scenarios and approach in special conditions and how to plan hospital discharge.", {"entities": []}], ["Francisella tularensis , the etiological agent of the inhalation tularemia, multiplies in a variety of cultured mammalian cells.", {"entities": [[65, 74, "DISEASE"]]}], ["Nevertheless, evidence for its in vivo intracellular residence is less conclusive.", {"entities": []}], ["Dendritic cells (DC) that are adapted for engulfing bacteria and migration towards lymphatic organs could serve as potential targets for bacterial residence and trafficking.", {"entities": []}], ["Here, we focus on the in vivo interactions of F. tularensis with DC following airway infection of mice.", {"entities": []}], ["Lethal airway infection of mice with the live vaccine strain (LVS) results in trafficking of a CD11b F. tularensis in the early stages of infection, and that DC trafficking plays a role in pathogen dissemination.", {"entities": []}], ["This underscores the therapeutic potential of DC migration impairing drugs in tularemia treatment.", {"entities": [[78, 87, "DISEASE"]]}], ["The high infectivity of Francisella tularensis via inhalation led to its classification as a Category-A bio-threat agent and renewed the interest in this pathogen.", {"entities": []}], ["Here, we characterize early events in respiratory tularemia, which could be instrumental in designing new therapeutic approaches.", {"entities": [[50, 59, "DISEASE"]]}], ["We focus on the interaction of F. tularensis with dendritic cells, which serve as first-line sentinels for invading bacteria and are expected to be pivotal in initiation of host protective response.", {"entities": []}], ["In this study, we show that lethal airway infection of mice with F. tularensis results in accumulation of both bacteria and dendritic cells in the draining lymph node, and that viable bacteria can be detected in dendritic cells that have been recently imported from the airways.", {"entities": []}], ["The correlation between trafficking of dendritic cell and bacteria is further substantiated by demonstrating that impairment of dendritic cell migration to the draining lymph node through two independent pathways results in decreased bacterial accumulation in the lymph node.", {"entities": []}], ["Taken together, our observations suggest that F. tularensis actually harnesses dendritic cells to facilitate bacterial dissemination and to enhance host invasion.", {"entities": []}], ["These findings call for examination of the therapeutic potential of drugs that impair dendritic cell migration as countermeasures for tularemia.", {"entities": [[134, 143, "DISEASE"]]}], ["Second-hand smoke (SHS) exposure during pregnancy is associated with poor pregnancy and foetal outcomes.", {"entities": []}], ["Theory-based behaviour change interventions (BCI) have been used successfully to change smoking related behaviours and offer the potential to reduce exposure of SHS in pregnant women.", {"entities": []}], ["Systematic reviews conducted so far do not evaluate the generalisability and scalability of interventions.", {"entities": []}], ["The objectives of this review were to (1) report the BCIs for reduction in home exposure to SHS for pregnant women; and (2) critically appraise intervention-reporting, generalisability, feasibility and scalability of the BCIs employed.", {"entities": []}], ["Standard methods following PRISMA guidelines were employed.", {"entities": []}], ["Eight databases were searched from 2000 to 2015 in English.", {"entities": []}], ["The studies included used BCIs on pregnant women to reduce their home SHS exposure by targeting husbands/partners.", {"entities": []}], ["The Workgroup for Intervention Development and Evaluation Research (WIDER) guidelines were used to assess intervention reporting.", {"entities": []}], ["Generalisability, feasibility and scalability were assessed against criteria described by Bonell and Milat.", {"entities": []}], ["Of 3479 papers identified, six studies met the inclusion criteria.", {"entities": []}], ["These studies found that BCIs led to increased knowledge about SHS harms, reduction or husbands quitting smoking, and increased susceptibility and change in level of actions to reduce SHS at home.", {"entities": []}], ["Two studies reported objective exposure measures, and one reported objective health outcomes.", {"entities": []}], ["The studies partially followed WIDER guidelines for reporting, and none met all generalisability, feasibility and scalability criteria.", {"entities": []}], ["There is a dearth of literature in this area and the quality of studies reviewed was moderate to low.", {"entities": []}], ["The BCIs appear effective in reducing SHS, however, weak study methodology (self-reported exposure, lack of objective outcome assessment, short follow-up, absence of control group) preclude firm conclusion.", {"entities": []}], ["Some components of the WIDER checklist were followed for BCI reporting, scalability and feasibility of the studies were not described.", {"entities": []}], ["More rigorous studies using biochemical and clinical measures for exposures and health outcomes in varied study settings are required.", {"entities": []}], ["Studies should report interventions in detail using WIDER checklist and assess them for generalisability, feasibility and scalability.", {"entities": []}], ["CRD40125026666.", {"entities": []}], ["Simkania negevensis is a novel Chlamydia -related bacterium and the founding member of the Simkaniaceae family within the Chlamydiales order.", {"entities": []}], ["Little is known about the biology and pathogenesis of this bacterium.", {"entities": []}], ["So far, S. negevensis has been considered as an amoebal symbiont, but its natural host remains unknown.", {"entities": []}], ["Moreover, evidence of human exposition has been reported worldwide and an association with pneumonia and bronchiolitis is suspected.", {"entities": [[91, 100, "DISEASE"], [105, 118, "DISEASE"]]}], ["Here, we evaluated the ability of S. negevensis to replicate in potential environmental reservoirs, namely amoebae and arthropods, as well as in mammalian cells (Vero cells, pneumocytes and endometrial cells) and further evaluated the characteristics of its replicative vacuole.", {"entities": []}], ["We demonstrated that S. negevensis efficiently replicates in all cell lines tested, with the shortest doubling time and an increased adhesion observed in pneumocytes.", {"entities": []}], ["Our work highlights the specificities of the Simkania -containing vacuole compared to other Chlamydiales ; contrarily to Chlamydia trachomatis , S. negevensis does not disrupt the Golgi apparatus.", {"entities": []}], ["Importantly, our work suggests that S. negevensis infection is associated with few cytopathic effects and might persist for a prolonged time in infected cells.", {"entities": []}], ["Further evaluation of its implication in human diseases is required; an implication in chronic or subacute respiratory infections might be suspected.", {"entities": []}], ["Simkania negevensis , an emerging Chlamydia -related bacterium, efficiently grows in human cells, suggesting a potential implication in human diseases, and harbors growth characteristics that differ from other known Chlamydiales .", {"entities": []}], ["Experimental design is important when studying mixtures/combinations of chemicals.", {"entities": []}], ["The traditional approach for studying mixtures/combinations of multiple chemicals involves response surface methodology, often supported by factorial designs.", {"entities": []}], ["Although such an approach permits the investigation of both the effects of individual chemicals and their interactions, the number of design points needed to study the chemical mixtures becomes prohibitive when the number of compounds increases.", {"entities": []}], ["Fixed ratio ray designs have been developed to reduce the amount of experimental effort when interest can be restricted to a specific ray.", {"entities": []}], ["We focus on the design and analysis issues involved in studying mixtures/combinations of compounds along fixed ratio rays of the compounds.", {"entities": []}], ["To obtain the inference regarding the interactions among the compounds, we show that the only data required are those along the fixed ratio ray.", {"entities": []}], ["This study had two aims: (a) to test the hypothesis that advanced age is associated with lower levels of tolerability and clinical benefit to experimental Phase I trial agents; (b) to assess the validity of the Royal Marsden Hospital (RMH) prognostic score as a patient selection tool in older patients.", {"entities": []}], ["Clinico-pathological characteristics and treatment outcomes of all patients treated consecutively from 2005 to 2009 in phase I trials at the RMH were recorded.", {"entities": []}], ["All toxicity and clinical outcome data were compared between patients aged below and above 65 years of age.", {"entities": []}], ["One thousand and four patients were treated in 30 Phase I trials, with 315 (31%) patients aged 65 years and older.", {"entities": []}], ["Grade 3\u20135 toxicities (22.8% vs 24.8% ( P =0.52)), trial discontinuation (6% vs 4% P =0.33), and dose interruptions (8.0% vs 8.0% ( P =0.96)) were observed at similar rates in patients below and above 65 years of age, respectively.", {"entities": []}], ["The overall response rate 5.2% vs 4.1%, progression-free survival (PFS) 1.9 vs 3.5 months and clinical benefit rate (CBR) at 6 months 15.2% vs 14.3% were comparable in both groups.", {"entities": []}], ["To avoid bias due to the potential therapeutic benefit of abiraterone, comparisons were repeated excluding prostate cancer patients with similar results (ORR 4.6% vs 4%, PFS 1.8 vs 3.0 months, CBR at 6 months 13.5% vs 9.5%).", {"entities": [[116, 122, "DISEASE"], [107, 122, "DISEASE"]]}], ["Multivariate analysis indicated that the previously identified RMH score (including albumin and lactate dehydrogenase levels) was an accurate predictor of outcome.", {"entities": []}], ["Phase I clinical trials should be considered in patients with advanced cancers regardless of age, as older patients who enter these have similar safety and efficacy outcomes as their younger counterparts.", {"entities": []}], ["The RMH prognostic score can assist in the selection of suitable older patients.", {"entities": []}], ["To examine the medical status of children with biliary atresia (BA) surviving with native livers.", {"entities": [[47, 62, "DISEASE"]]}], ["In this cross-sectional review, data collected included complications of chronic liver disease (CLD) (cholangitis in the preceding 12 mo, portal hypertension, variceal bleeding, fractures, hepatopulmonary syndrome, portopulmonary hypertension) and laboratory indices (white cell and platelet counts, total bilirubin, albumin, international normalized ratio, alanine aminotransferase, aspartate aminotransferase, \u03b3-glutamyl transpeptidase).", {"entities": [[145, 157, "DISEASE"], [230, 242, "DISEASE"], [189, 213, "DISEASE"], [138, 157, "DISEASE"], [81, 94, "DISEASE"], [205, 213, "DISEASE"], [102, 113, "DISEASE"]]}], ["Ideal medical outcome was defined as absence of clinical evidence of CLD or abnormal laboratory indices.", {"entities": []}], ["Fifty-two children [females = 32, 62%; median age 7.4 years, n = 35 (67%) older than 5 years] with BA (median age at surgery 60 d, range of 30 to 148 d) survived with native liver.", {"entities": []}], ["Common complications of CLD noted were portal hypertension (40%, n = 21; 2 younger than 5 years), cholangitis (36%) and bleeding varices (25%, n = 13; 1 younger than 5 years).", {"entities": [[46, 58, "DISEASE"], [39, 58, "DISEASE"], [98, 109, "DISEASE"]]}], ["Fifteen (29%) had no clinical complications of CLD and three (6%) had normal laboratory indices.", {"entities": []}], ["Ideal medical outcome was only seen in 1 patient (2%).", {"entities": []}], ["Clinical or laboratory evidence of CLD are present in 98% of children with BA living with native livers after hepatoportoenterostomy.", {"entities": []}], ["Portal hypertension and variceal bleeding may be seen in children younger than 5 years of age, underscoring the importance of medical surveillance for complications of BA starting at a young age.", {"entities": [[7, 19, "DISEASE"], [0, 19, "DISEASE"]]}], ["Several classes of compounds that have no intrinsic activity on aminergic systems nonetheless enhance the potency of aminergic receptor ligands three-fold or more while significantly increasing their duration of activity, preventing tachyphylaxis and reversing fade.", {"entities": []}], ["Enhancer compounds include ascorbic acid, ethylenediaminetetraacetic acid, cortico-steroids, opioid peptides, opiates and opiate antagonists.", {"entities": []}], ["This paper provides the first review of aminergic enhancement, demonstrating that all enhancers have a common, inobvious molecular motif and work through a common mechanism that is manifested by three common characteristics.", {"entities": []}], ["First, aminergic enhancers bind directly to the amines they enhance, suggesting that the common structural motif is reflected in common binding targets.", {"entities": []}], ["Second, one common target is the first extracellular loop of aminergic receptors.", {"entities": []}], ["Third, at least some enhancers are antiphosphodiesterases.", {"entities": []}], ["These observations suggest that aminergic enhancers act on the extracellular surface of aminergic receptors to keep the receptor in its high affinity state, trapping the ligand inside the receptor.", {"entities": []}], ["Enhancer binding produces allosteric modifications of the receptor structure that interfere with phosphorylation of the receptor, thereby inhibiting down-regulation of the receptor.", {"entities": []}], ["The mechanism explains how enhancers potentiate aminergic activity and increase duration of activity and makes testable predictions about additional compounds that should act as aminergic enhancers.", {"entities": []}], ["Airborne contaminants produced by industrial agricultural facilities contain chemical and biological compounds that can impact the health of residents living in close proximity.", {"entities": []}], ["Settled dust can be a reservoir for these contaminants and can influence long-term exposures.", {"entities": []}], ["In this study, we sampled the indoor- and outdoor-settled dust from 40 homes that varied in proximity to industrial-scale dairies (ISD; industrial-scale dairy, a term used in this paper to describe a large dairy farm and adjacent waste sprayfields, concentrated animal feeding operation or animal feeding operation, that uses industrial processes) in the Yakima Valley, Washington.", {"entities": []}], ["We analyzed settled dust samples for cow allergen (Bos d2, a cow allergen associated with dander, hair, sweat and urine, it is a member of the lipocalin family of allergens associated with mammals), mouse allergen (Mus m1; major mouse allergen, a mouse urinary allergen, in the lipocalin family), dust mite allergens (Der p1 ( Dermatophagoides pteronissinus 1) and Der f1 ( Dermatophagoides farinae 1)), and endotoxin (a component of the cell walls of gram negative bacteria, lipopolysaccharide, which can be found in air and dust and can produce a strong inflammatory response).", {"entities": []}], ["A concentration gradient was observed for Bos d2 and endotoxin measured in outdoor-settled dust samples based on proximity to ISD.", {"entities": []}], ["Indoor-settled dust concentrations of Bos d2 and endotoxin were also highest in proximal homes.", {"entities": []}], ["While the associated health effects of exposure to cow allergen in settled dust is unknown, endotoxin at concentrations observed in these proximal homes (100\u2009EU/mg) has been associated with increased negative respiratory health effects.", {"entities": []}], ["These findings document that biological contaminants emitted from ISDs are elevated in indoor- and outdoor-settled dust samples at homes close to these facilities and extend to as much as three miles (4.8\u2009km) away.", {"entities": []}], ["The small bowel is responsible for most of the body\u2019s nutritional uptake and for the development of intestinal and systemic tolerance towards microbes.", {"entities": []}], ["Nevertheless, the human small bowel microbiota has remained poorly characterized, mainly owing to sampling difficulties.", {"entities": []}], ["Sample collection directly from the distal ileum was performed during radical cystectomy with urinary diversion.", {"entities": []}], ["Material from the ileal mucosa were analysed using massive parallel sequencing of the 16S rRNA gene.", {"entities": []}], ["Samples from 27 Caucasian patients were included.", {"entities": []}], ["In total 280 unique Operational Taxonomic Units were identified, whereof 229 could be assigned to a species or a species group.", {"entities": []}], ["The most frequently detected bacteria belonged to the genera Streptococcus , Granulicatella , Actinomyces , Solobacterium , Rothia , Gemella and TM7(G-1) .", {"entities": []}], ["Among these, the most abundant species were typically streptococci within the mitis and sanguinis groups, Streptococcus salivarius , Rothia mucilaginosa and Actinomyces from the A .", {"entities": []}], ["meyeri/odontolyticus group .", {"entities": []}], ["The amounts of Proteobacteria and strict anaerobes were low.", {"entities": []}], ["The microbiota of the distal part of the human ileum is oral-like and strikingly different from the colonic microbiota.", {"entities": []}], ["Although our patient population is elderly and hospitalized with a high prevalence of chronic conditions, our results provide new and valuable insights into a lesser explored part of the human intestinal ecosystem.", {"entities": []}], ["Infections are often associated to comorbidity that increases the risk of medical conditions which can lead to further morbidity and mortality.", {"entities": []}], ["SARS is a threat which is similar to MERS virus, but the comorbidity is the key aspect to underline their different impacts.", {"entities": [[0, 4, "GENE"]]}], ["One UK doctor says \"I\u2019d rather have HIV than diabetes\" as life expectancy among diabetes patients is lower than that of HIV.", {"entities": []}], ["However, HIV has a comorbidity impact on the diabetes.", {"entities": []}], ["We present a quantitative framework to compare and explore comorbidity between diseases.", {"entities": []}], ["By using neighbourhood based benchmark and topological methods, we have built comorbidity relationships network based on the OMIM and our identified significant genes.", {"entities": []}], ["Then based on the gene expression, PPI and signalling pathways data, we investigate the comorbidity association of these 2 infective pathologies with other 7 diseases (heart failure, kidney disorder, breast cancer, neurodegenerative disorders, bone diseases, Type 1 and Type 2 diabetes).", {"entities": [[200, 213, "DISEASE"], [207, 213, "DISEASE"]]}], ["Phenotypic association is measured by calculating both the Relative Risk as the quantified measures of comorbidity tendency of two disease pairs and the \u03d5 -correlation to measure the robustness of the comorbidity associations.", {"entities": []}], ["The differential gene expression profiling strongly suggests that the response of SARS affected patients seems to be mainly an innate inflammatory response and statistically dysregulates a large number of genes, pathways and PPIs subnetworks in different pathologies such as chronic heart failure (21 genes), breast cancer (16 genes) and bone diseases (11 genes).", {"entities": [[309, 322, "DISEASE"], [316, 322, "DISEASE"], [82, 86, "GENE"]]}], ["HIV-1 induces comorbidities relationship with many other diseases, particularly strong correlation with the neurological, cancer, metabolic and immunological diseases.", {"entities": [[122, 128, "DISEASE"]]}], ["Similar comorbidities risk is observed from the clinical information.", {"entities": []}], ["Moreover, SARS and HIV infections dysregulate 4 genes (ANXA3, GNS, HIST1H1C, RASA3) and 3 genes (HBA1, TFRC, GHITM) respectively that affect the ageing process.", {"entities": [[10, 14, "GENE"], [55, 60, "GENE"], [62, 65, "GENE"], [67, 75, "GENE"], [77, 82, "GENE"], [97, 101, "GENE"], [103, 107, "GENE"], [109, 114, "GENE"]]}], ["It is notable that HIV and SARS similarly dysregulated 11 genes and 3 pathways.", {"entities": [[27, 31, "GENE"]]}], ["Only 4 significantly dysregulated genes are common between SARS-CoV and MERS-CoV, including NFKBIA that is a key regulator of immune responsiveness implicated in susceptibility to infectious and inflammatory diseases.", {"entities": [[92, 98, "GENE"]]}], ["Our method presents a ripe opportunity to use data-driven approaches for advancing our current knowledge on disease mechanism and predicting disease comorbidities in a quantitative way.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2105-15-333) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Little population-level information exists about the delivery of palliative care across multiple health sectors, important in providing a complete picture of current care and gaps in care.", {"entities": []}], ["Provide a population perspective on end-of-life palliative care delivery across health sectors.", {"entities": []}], ["Retrospective population-level cohort study, describing palliative care in the last year of life using linked health administrative databases.", {"entities": []}], ["All decedents in Ontario, Canada, from 1 April 2010 to 31 March 2012 ( n \u2009=\u2009177,817).", {"entities": []}], ["Across all health sectors, about half (51.9%) of all decedents received at least one record of palliative care in the last year of life.", {"entities": []}], ["Being female, middle-aged, living in wealthier and urban neighborhoods, having cancer, and less multi-morbidity were all associated with higher odds of palliative care receipt.", {"entities": [[79, 85, "DISEASE"]]}], ["Among 92,276 decedents receiving palliative care, 84.9% received care in acute care hospitals.", {"entities": []}], ["Among recipients, 35\u2009mean days of palliative care were delivered.", {"entities": []}], ["About half (49.1%) of all palliative care days were delivered in the last 2\u2009months of life, and half (50.1%) had palliative care initiated in this period.", {"entities": []}], ["Only about one-fifth of all decedents (19.3%) received end-of-life care through publicly funded home care.", {"entities": []}], ["Less than 10% of decedents had a record of a palliative care home visit from a physician.", {"entities": []}], ["We describe methods to capture palliative care using administrative data.", {"entities": []}], ["Despite an estimate of overall reach (51.9%) that is higher than previous estimates, we have shown that palliative care is infrequently delivered particularly in community settings and to non-cancer patients and occurs close to death.", {"entities": [[192, 198, "DISEASE"]]}], ["To determine whether dietary compounds targeting NFE2-related factor 2 (Nrf2) activation can be used to attenuate renal damage and preserve renal function during the course of streptozotocin (STZ)-induced diabetic nephropathy.", {"entities": []}], ["Diabetes was induced in Nrf2 SF or CA significantly attenuated common metabolic disorder symptoms associated with diabetes in Nrf2 We provide experimental evidence indicating that dietary compounds targeting Nrf2 activation can be used therapeutically to improve metabolic disorder and relieve renal damage induced by diabetes.", {"entities": []}], ["To assess glycated albumin (GA) as a potential glycemic index in managing gestational diabetes mellitus (GDM).", {"entities": [[74, 94, "DISEASE"], [86, 103, "DISEASE"]]}], ["Eligible pregnant women were divided into the GDM group with abnormal result on a 75\u2010g oral glucose tolerance test (OGTT) and the control (normal) group.", {"entities": []}], ["GA measurements, Pearson's correlation analysis, multiple logistic regression and receiver operating characteristic curve analysis were obtained at the follow\u2010up examination of participants in the two groups.", {"entities": []}], ["A total of 2,118 women were assigned to the GDM group ( n \u00a0=\u00a0639) and control group ( n \u00a0=\u00a01,479).", {"entities": []}], ["The mean level of serum GA in GDM group was significantly greater than that in the control group at both 24\u201328 and 36\u201338\u00a0weeks of gestation ( P \u00a0<\u00a00.05).", {"entities": []}], ["The area under the receiver operating characteristic curve for GA defining good glycemic control in GDM was 0.874 (95% confidence interval 0.811\u20130.938).", {"entities": []}], ["The cut\u2010off point for the GA levels derived from the receiver operating characteristic curve was 11.60%, which had sensitivity and specificity for detecting a poor glycemic status of 75.93% and 86.36%, respectively.", {"entities": []}], ["The risk of birthweight \u22653,500\u00a0g and macrosomia increased significantly with GA levels \u226513.00% at 24\u201328\u00a0weeks and \u226512.00% at 36\u201338\u00a0weeks of gestation.", {"entities": []}], ["GA might be an appropriate and conveniently measured index that can detect poor glycemic control and predict birthweights in GDM women.", {"entities": []}], ["The three most widely used utility measures are the Health Utilities Index Mark 2 and 3 (HUI2 and HUI3), the EuroQol-5D (EQ-5D) and the Short-Form-6D (SF-6D).", {"entities": []}], ["In line with guidelines for economic evaluation from agencies such as the National Institute for Health and Clinical Excellence (NICE) and the Canadian Agency for Drugs and Technologies in Health (CADTH), these measures are currently being used to evaluate the cost-effectiveness of different interventions in MS.", {"entities": []}], ["However, the challenge of using such measures in people with a specific health condition, such as MS, is that they may not capture all of the domains that are impacted upon by the condition.", {"entities": []}], ["If important domains are missing from the generic measures, the value derived will be higher than the real impact creating invalid comparisons across interventions and populations.", {"entities": []}], ["Therefore, the objective of this study is to estimate the extent to which generic utility measures capture important domains that are affected by MS.", {"entities": []}], ["The available study population consisted of men and women who had been registered after 1994 in three participating MS clinics in Greater Montreal, Quebec, Canada.", {"entities": []}], ["Subjects were first interviewed on an individualized measure of quality of life (QOL) called the Patient Generated Index (PGI).", {"entities": []}], ["The domains identified with the PGI were then classified and grouped together using the World Health Organization\u2019s International Classification of Functioning, Disability and Health (ICF), and mapped onto the HUI2, HUI3, EQ-5D and SF-6D.", {"entities": []}], ["A total of 185 persons with MS were interviewed on the PGI.", {"entities": []}], ["The sample was relatively young (mean age 43) and predominantly female.", {"entities": []}], ["Both men and women had mild disability with a median Expanded Disability Status Scale (EDSS) score of 2.", {"entities": []}], ["The top 10 domains that patients identified to be the most affected by their MS were, work (62%), fatigue (48%), sports (39%), social life (28%), relationships (23%), walking/mobility (22%), cognition (21%), balance (14%), housework (12%) and mood (11%).", {"entities": []}], ["The SF-6D included the most number of domains (6 domains) important to people with MS, followed by the EQ-5D (4 domains) and the HUI2 (4 domains) and then the HUI3 (3 domains).", {"entities": []}], ["The mean and standard deviation (SD) for the PGI, EQ-5D and the SF-6D were 0.50 (SD 0.25), 0.69 (0.18) and 0.69 (0.13), respectively.", {"entities": []}], ["The magnitude of difference between the PGI and the generic utility measures was large and statistically significant.", {"entities": []}], ["Although the generic utility measures included certain items that were important to people with MS, there were several that were missing.", {"entities": []}], ["An important consequence of this mismatch was that values of QOL derived from the PGI were importantly and significantly lower than those estimated using any of the generic utility measures.", {"entities": []}], ["This could have a substantial impact in evaluating the effect of interventions for people with MS.", {"entities": []}], ["Influenza is a serious public health problem, since seasonal epidemics affect approximately 5-10% of the population and thus give rise to a heavy social and healthcare burden.", {"entities": [[0, 9, "DISEASE"]]}], ["The heavy burden of disease is due to several factors, one of which is the biological features of the pathogen.", {"entities": []}], ["Indeed influenza viruses display high mutation rates and undergo frequent genetic reassortment.", {"entities": [[7, 16, "DISEASE"]]}], ["Minor variations cause seasonal epidemics and major variations, which result from the hybridization of viruses typical of different animal species, can lead to pandemics.", {"entities": []}], ["Vaccination remains the most efficacious means of mitigating the harmful healthcare and social effects of influenza.", {"entities": [[106, 115, "DISEASE"]]}], ["Influenza vaccines have evolved over time in order to offer broader protection against circulating strains.", {"entities": [[0, 9, "DISEASE"]]}], ["Trivalent vaccines containing two A viruses and one B virus are currently available.", {"entities": []}], ["However, given the co-circulation of both B virus lineages (B/Yamagata and B/Victoria), quadrivalent vaccines have recently been developed.", {"entities": []}], ["The new quadrivalent vaccines constitute a great advance, in that they can offer broader strain coverage.", {"entities": []}], ["Despite the availability of effective and safe influenza vaccines, the Italian public's trust in vaccination has declined and, in the last few years, influenza vaccination coverage rates have decreased both among the elderly and among at-risk adults.", {"entities": [[47, 56, "DISEASE"], [150, 159, "DISEASE"]]}], ["It is therefore necessary that users, in their own interests, regain trust in this important means of disease prevention.", {"entities": []}], ["In order to mitigate the damage wreaked by influenza, it seems important to: (i) improve clinical-epidemiological and virological surveillance of the disease; (ii) promote the development of new efficacious vaccines, as has recently been done through the introduction of the quadrivalent vaccine; (iii) extend free vaccination to the entire population, as in the US and Canada; (iv) ensure that general healthcare professionals are properly informed and always updated with regard to vaccination; (v) promote public campaigns to raise the population's awareness of the importance of vaccination; (vi) inform politicians and other decision-makers of scientific results in the field of vaccination; (vii) fight the antivaccination lobbies with every available weapon.", {"entities": [[43, 52, "DISEASE"]]}], ["The chemokine receptor CCR4 has at least two natural agonist ligands, MDC (CCL22) and TARC (CCL17) which bind to the same orthosteric site with a similar affinity.", {"entities": [[23, 27, "GENE"], [75, 80, "GENE"], [92, 97, "GENE"]]}], ["Both ligands are known to evoke chemotaxis of CCR4-bearing T cells and also elicit CCR4 receptor internalization.", {"entities": [[46, 50, "GENE"], [83, 87, "GENE"]]}], ["A series of small molecule allosteric antagonists have been described which displace the agonist ligand, and inhibit chemotaxis.", {"entities": []}], ["The aim of this study was to determine which cellular coupling pathways are involved in internalization, and if antagonists binding to the CCR4 receptor could themselves evoke receptor internalization.", {"entities": [[139, 143, "GENE"]]}], ["CCL22 binding coupled CCR4 efficiently to \u03b2-arrestin and stimulated GTP\u03b3S binding however CCL17 did not couple to \u03b2-arrestin and only partially stimulated GTP\u03b3S binding.", {"entities": [[0, 5, "GENE"], [22, 26, "GENE"], [90, 95, "GENE"]]}], ["CCL22 potently induced internalization of almost all cell surface CCR4, while CCL17 showed only weak effects.", {"entities": [[0, 5, "GENE"], [66, 70, "GENE"], [78, 83, "GENE"]]}], ["We describe four small molecule antagonists that were demonstrated to bind to two distinct allosteric sites on the CCR4 receptor, and while both classes inhibited agonist ligand binding and chemotaxis, one of the allosteric sites also evoked receptor internalization.", {"entities": [[115, 119, "GENE"]]}], ["Furthermore, we also characterize an N-terminally truncated version of CCL22 which acts as a competitive antagonist at the orthosteric site, and surprisingly also evokes receptor internalization without demonstrating any agonist activity.", {"entities": [[71, 76, "GENE"]]}], ["Collectively this study demonstrates that orthosteric and allosteric antagonists of the CCR4 receptor are capable of evoking receptor internalization, providing a novel strategy for drug discovery against this class of target.", {"entities": [[88, 92, "GENE"]]}], ["In the present study the antioxidant potential of a methanol extract of Phyllanthus emblica leaves (PELE) was determined by in vitro methods as well as by an in vivo animal model, along with HPLC-DAD screening for phyto-constituents.", {"entities": []}], ["The in vitro antioxidant potential of PELE was assessed by scavenging of DPPH, nitric oxide and anti-lipid peroxidation assays.", {"entities": []}], ["For in vivo evaluation, a 60-day experimental plan was followed in which Sprague Dawley rats were administered with 1\u00a0mL/kg of CCl 4 (CCl 4 : DMSO\u2009+\u2009Olive oil; 30\u00a0%\u00a0v/v) alone or with different doses of PELE (200, 400\u00a0mg/kg p.o.).", {"entities": []}], ["Silymarin (100\u00a0mg/kg) as standard drug was also administered to CCl 4 treated rats.", {"entities": []}], ["HPLC-DAD analysis was performed to quantify polyphenolic phytochemicals.", {"entities": []}], ["PELE exhibited an appreciable in vitro antioxidant activity and scavenged the DPPH radical (IC 50 \u2009=\u200939.73\u2009\u00b1\u20092.12\u00a0\u03bcg/mL) and nitric oxide (IC 50 \u2009=\u200939.14\u2009\u00b1\u20092.31\u00a0\u03bcg/mL) while for anti-lipid peroxidation moderate antioxidant activity was noticed.", {"entities": []}], ["Reduced levels of antioxidant enzyme activities viz., superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and reduced glutathione (GSH) whereas enhanced levels of total extractable proteins, lipid peroxides (TBARS), nitrite and H 2 O 2 were induced by CCl 4 administration in lungs of rat.", {"entities": []}], ["Co-administration of PELE to rats exhibited a dose dependent decline in the oxidative injuries induced in these parameters.", {"entities": []}], ["Histopathological damages such as disrupted alveoli, infiltration of macrophages and modified architecture of Clara cells was reversed to the normal state with co-administration of PELE.", {"entities": []}], ["HPLC-DAD analysis indicated the presence of gallic acid, rutin, kaempferol and caffeic acid in the PELE.", {"entities": []}], ["The findings of this study demonstrate that presence of polyphenolics and other active constituents in PELE might play a significant role in repairing the pulmonary damages instigated with CCl 4 .", {"entities": []}], ["Inflammation plays a key role in the pathophysiology of ischemic stroke.", {"entities": []}], ["Some proinflammatory mediators, such as cytokines and chemokines, are produced in stroke.", {"entities": []}], ["Chemokine-like factor 1 (CKLF1), as a novel C-C chemokine, displays chemotactic activities in a wide spectrum of leukocytes and plays an important role in brain development.", {"entities": []}], ["In previous studies, we have found that the expression of CKLF1 increased in rats after focal cerebral ischemia and treatment with the CKLF1 antagonist C19 peptide decreased the infarct size and water content.", {"entities": [[103, 111, "DISEASE"]]}], ["However, the role of CKLF1 in stroke is still unclear.", {"entities": []}], ["The objective of the present study was to ascertain the possible roles and mechanism of CKLF1 in ischemic brain injury by applying anti-CKLF1 antibody.", {"entities": []}], ["Male Sprague\u2013Dawley rats were subjected to one-hour middle cerebral artery occlusion.", {"entities": [[59, 84, "DISEASE"]]}], ["Antibody to CKLF1 was applied to the right cerebral ventricle immediately after reperfusion; infarct volume and neurological score were measured at 24 and 72 hours after cerebral ischemia.", {"entities": [[179, 187, "DISEASE"]]}], ["RT-PCR, Western blotting and ELISA were utilized to characterize the expression of adhesion molecules, inflammatory factors and MAPK signal pathways.", {"entities": []}], ["Immunohistochemical staining and myeloperoxidase activity was used to determine the extent of neutrophil infiltration.", {"entities": []}], ["Treatment with anti-CKLF1 antibody significantly decreased neurological score and infarct volume in a dose-dependent manner at 24 and 72 hours after cerebral ischemia.", {"entities": [[158, 166, "DISEASE"]]}], ["Administration with anti-CKLF1 antibody lowered the level of inflammatory factors TNF-\u03b1, IL-1\u03b2, MIP-2 and IL-8, the expression of adhesion molecules ICAM-1 and VCAM-1 in a dose-dependent manner.", {"entities": []}], ["The results of immunohistochemical staining and detection of MPO activity indicated that anti-CKLF1 antibody inhibited neutrophil infiltration.", {"entities": [[61, 64, "GENE"]]}], ["Further studies suggested MAPK pathways associated with neutrophil infiltration in cerebral ischemia.", {"entities": [[92, 100, "DISEASE"]]}], ["Selective inhibition of CKLF1 activity significantly protects against ischemia/reperfusion injury by decreasing production of inflammatory mediators and expression of adhesion molecules, thereby reducing neutrophils recruitment to the ischemic area, possibly via inhibiting MAPK pathways.", {"entities": [[70, 78, "DISEASE"]]}], ["Therefore, CKLF1 may be a novel target for the treatment of stroke.", {"entities": []}], ["To evaluate whether midsagittal (abdominal) obesity in magnetic resonance imaging (MRI), waist circumference (WC) and body fat percentage are associated with lumbar disc degeneration in early adulthood.", {"entities": [[44, 51, "DISEASE"]]}], ["We obtained the lumbar MRI (1.5-T scanner) of 325 females and 233 males at a mean age of 21 years.", {"entities": []}], ["Lumbar disc degeneration was evaluated using Pfirrmann classification.", {"entities": []}], ["We analysed the associations of MRI measures of obesity (abdominal diameter (AD), sagittal diameter (SAD), ventral subcutaneous thickness (VST), and dorsal subcutaneous thickness (DST)), WC and body fat percentage with disc degeneration sum scores using ordinal logistic regression.", {"entities": [[48, 55, "DISEASE"], [180, 183, "GENE"]]}], ["A total of 155 (48%) females and 147 (63%) males had disc degeneration.", {"entities": []}], ["AD and SAD were associated with a disc degeneration sum score of \u22653 compared to disc degeneration sum score of 0\u20132 (OR 1.67; 95% confidence interval (CI) 1.20\u20132.33 and OR 1.40; 95% CI 1.12\u20131.75, respectively) among males, but we found no association among females.", {"entities": []}], ["WC was also associated with disc degeneration among males (OR 1.03 per one cm; 95% CI 1.00\u20131.05), but not among females.", {"entities": []}], ["Measures of abdominal obesity in MRI and waist circumference were associated with disc degeneration among 21-year-old males.", {"entities": [[22, 29, "DISEASE"]]}], ["The most important symptom as well as one of the major diagnostic criteria for eczema is itch.", {"entities": []}], ["Although oral antihistamines continue to be prescribed for people with eczema, it is unclear if they are effective and safe in relieving itch and skin lesions.", {"entities": []}], ["We sought to evaluate the available evidence on effectiveness of oral antihistamines (H1 antagonists) as monotherapy in children and adults with eczema.", {"entities": []}], ["Searches included 10 databases and trial registers as well as conference proceedings (January 2014).", {"entities": []}], ["Randomised controlled trials that assessed the effects of oral H1 antihistamines as monotherapy in children and adults with eczema were included.", {"entities": []}], ["Our searches retrieved 757 references, but no randomised controlled trial met our inclusion criteria.", {"entities": []}], ["Most studies allowed concomitant treatments, making the assessment of the individual effects of oral H1 antihistamines impossible.", {"entities": []}], ["There is currently no high-level evidence to support or refute the efficacy or safety of oral H1 antihistamines used as monotherapy for eczema.", {"entities": []}], ["A further review of studies that assesses the effects of oral H1 antihistamines as \u2018add-on\u2019 therapy together with concomitant treatments is warranted to determine the beneficial effects of this group of medications in the treatment of eczema.", {"entities": []}], ["Background: A primary goal of asthma management is the reduction of exacerbation risk.", {"entities": [[30, 36, "DISEASE"]]}], ["We assessed the occurrence of oral corticosteroid-requiring exacerbations (OCS exacerbations) with long-term fluticasone/formoterol therapy, and compared it with the occurrence of similar events reported with other inhaled corticosteroid/long acting \u03b2 2 -agonist (ICS/LABA) combinations.", {"entities": []}], ["Methods: The occurrence of OCS exacerbations was assessed in two open-label trials of fixed-dose fluticasone/formoterol administered for between 26 to 60 weeks in adults and adolescents with asthma.", {"entities": [[191, 197, "DISEASE"]]}], ["The incidence of OCS exacerbations with fluticasone/formoterol was compared with those reported in three recent Cochrane meta-analyses of other ICS/LABAs.", {"entities": []}], ["Results: The pooled incidence of OCS exacerbations with long-term fluticasone/formoterol was 2.1% (95% CI: 1.1, 3.2%, n/N \u2009=\u200916/752).", {"entities": []}], ["In only two of the nineteen treatment arms summarized by Cochrane did OCS exacerbation incidence approximate that seen in the two fluticasone/formoterol trials (single-inhaler fluticasone/salmeterol [2.9%]; separate inhaler budesonide, beclometasone, or flunisolide plus formoterol [3.4%]).", {"entities": []}], ["In Lasserson's review the pooled incidence of OCS exacerbations for single-inhaler combinations was 9.5% (95% CI: 8.4, 10.6%; n/N \u2009=\u2009239/2516) for fluticasone/salmeterol, and 10.6% (95% CI: 9.3, 11.8%; n/N \u2009=\u2009257/2433) for budesonide/formoterol.", {"entities": []}], ["In Ducharme's and Chauhan's meta-analyses (primarily incorporating separate inhaler combinations [fluticasone, budesonide, beclometasone, or flunisolide plus salmeterol or formoterol]), the pooled incidences of OCS exacerbations were 16.0% (95% CI: 14.2, 17.8%, n/N \u2009=\u2009258/1615) and 16.7% (95% CI: 14.9, 18.5, n/N \u2009=\u2009275/1643), respectively.", {"entities": []}], ["Conclusions: The incidence of exacerbations in two fixed-dose fluticasone/formoterol studies was low and less than in the majority of comparable published studies involving other ICS/LABA combinations.", {"entities": []}], ["This difference could not be readily explained by differences in features of the respective studies and may be related to the favorable pharmacological/mechanistic characteristics of the constituent components fluticasone and formoterol compared to other drugs in their respective classes.", {"entities": []}], ["A common inflammatome signature, as well as disease-specific expression patterns, was identified from 11 different rodent inflammatory disease models.", {"entities": []}], ["Causal regulatory networks and the drivers of the inflammatome signature were uncovered and validated.", {"entities": []}], ["Representative inflammatome gene signatures, as well as disease model-specific gene signatures, were identified from 12 gene expression profiling data sets derived from 9 different tissues isolated from 11 rodent inflammatory disease models.", {"entities": []}], ["The inflammatome signature is highly enriched for immune response-related genes, disease causal genes, and drug targets.", {"entities": []}], ["Regulatory relationships among the inflammatome signature genes were examined in over 70 causal networks derived from a number of large-scale genetic studies of multiple diseases, and the potential key drivers were uncovered and validated prospectively.", {"entities": []}], ["Over 70% of the inflammatome signature genes and over 50% of the key driver genes have not been reported in previous studies of common signatures in inflammatory conditions.", {"entities": []}], ["Representative inflammatome gene signatures, as well as disease model-specific gene signatures, were identified from 12 gene expression profiling data sets derived from 9 different tissues isolated from 11 rodent inflammatory disease models.", {"entities": []}], ["The inflammatome signature is highly enriched for immune response-related genes, disease causal genes, and drug targets.", {"entities": []}], ["Regulatory relationships among the inflammatome signature genes were examined in over 70 causal networks derived from a number of large-scale genetic studies of multiple diseases, and the potential key drivers were uncovered and validated prospectively.", {"entities": []}], ["Over 70% of the inflammatome signature genes and over 50% of the key driver genes have not been reported in previous studies of common signatures in inflammatory conditions.", {"entities": []}], ["Common inflammatome gene signatures as well as disease-specific signatures were identified by analyzing 12 expression profiling data sets derived from 9 different tissues isolated from 11 rodent inflammatory disease models.", {"entities": []}], ["The inflammatome signature significantly overlaps with known drug targets and co-expressed gene modules linked to metabolic disorders and cancer.", {"entities": [[138, 144, "DISEASE"]]}], ["A large proportion of genes in this signature are tightly connected in tissue-specific Bayesian networks (BNs) built from multiple independent mouse and human cohorts.", {"entities": []}], ["Both the inflammatome signature and the corresponding consensus BNs are highly enriched for immune response-related genes supported as causal for adiposity, adipokine, diabetes, aortic lesion, bone, muscle, and cholesterol traits, suggesting the causal nature of the inflammatome for a variety of diseases.", {"entities": []}], ["Integration of this inflammatome signature with the BNs uncovered 151 key drivers that appeared to be more biologically important than the non-drivers in terms of their impact on disease phenotypes.", {"entities": []}], ["The identification of this inflammatome signature, its network architecture, and key drivers not only highlights the shared etiology but also pinpoints potential targets for intervention of various common diseases.", {"entities": []}], ["In the United States, the National Center for Drug Free Sport manages the drug-testing programs for athletes of the National Collegiate Athletic Association (NCAA).", {"entities": []}], ["Through its Resource Exchange Center (REC), Drug Free Sport supports athletic staff and athletes with information regarding drugs and dietary supplements.", {"entities": []}], ["To characterize the types of drug-related and dietary supplement\u2013related inquiries submitted to Drug Free Sport through the REC.", {"entities": []}], ["Cross-sectional study.", {"entities": []}], ["All inquiries submitted to the REC for the period of September 1, 2005, through June 30, 2006, were reviewed.", {"entities": []}], ["The data were categorized by the method of inquiry submission; the name of the substance in question; the sex, sport, and NCAA division of the athlete involved; the nature of the inquiry; and the response provided by the REC regarding the NCAA\u2019s status of the substance in question.", {"entities": []}], ["Pseudoephedrine, acetaminophen/hydrocodone, and albuterol were the most commonly self-searched medications; stimulants accounted for the majority of banned medications.", {"entities": []}], ["Dietary supplements accounted for 80% of all inquiries submitted to the REC via the Banned Drug Inquiry Form.", {"entities": []}], ["Among all dietary supplements, creatine was the most commonly inquired.", {"entities": []}], ["Banned substances accounted for 29% of all inquiries.", {"entities": []}], ["There were more than 10 000 inquiries regarding the status of medications, dietary supplements, and other substances for NCAA athletes during the 2005-2006 academic year.", {"entities": []}], ["It is helpful for athletes to have resources that help them navigate banned-substance lists and so avoid the inadvertent use of banned substances.", {"entities": []}], ["Educating athletes regarding the stimulant content of various dietary supplements and addressing the lack of clinical trials to support stated claims and safety appear critical.", {"entities": []}], ["Bacterial infections of the respiratory tract contribute to exacerbations and disease progression in chronic obstructive pulmonary disease (COPD).", {"entities": [[101, 138, "DISEASE"]]}], ["There is also an increased risk of invasive pneumococcal disease in COPD.", {"entities": []}], ["The underlying mechanisms are not fully understood but include impaired mucociliary clearance and structural remodeling of the airways.", {"entities": []}], ["In addition, antimicrobial proteins that are constitutively expressed or induced during inflammatory conditions are an important part of the airway innate host defense.", {"entities": []}], ["In the present study, we show that osteopontin (OPN), a multifunctional glycoprotein that is highly upregulated in the airways of COPD patients co-localizes with several antimicrobial proteins expressed in the airways.", {"entities": []}], ["In vitro , OPN bound lactoferrin, secretory leukocyte peptidase inhibitor (SLPI), midkine, human beta defensin-3 (hBD-3), and thymic stromal lymphopoietin (TSLP) but showed low or no affinity for lysozyme and LL-37.", {"entities": [[75, 79, "GENE"], [156, 160, "GENE"]]}], ["Binding of OPN impaired the antibacterial activity against the important bacterial pathogens Streptococcus pneumoniae and Pseudomonas aeruginosa .", {"entities": []}], ["Interestingly, OPN reduced lysozyme-induced killing of S .", {"entities": []}], ["pneumoniae , a finding that could be explained by binding of OPN to the bacterial surface, thereby shielding the bacteria.", {"entities": []}], ["A fragment of OPN generated by elastase of P .", {"entities": []}], ["aeruginosa retained some inhibitory effect.", {"entities": []}], ["Some antimicrobial proteins have additional functions.", {"entities": []}], ["However, the muramidase-activity of lysozyme and the protease inhibitory function of SLPI were not affected by OPN.", {"entities": [[85, 89, "GENE"]]}], ["Taken together, OPN can contribute to the impairment of innate host defense by interfering with the function of antimicrobial proteins, thus increasing the vulnerability to acquire infections during COPD.", {"entities": []}], ["Pneumonia remains the leading cause of death in young children globally and improved diagnostics are needed to better identify cases and reduce case fatality.", {"entities": [[0, 9, "DISEASE"]]}], ["Metabolomics, a rapidly evolving field aimed at characterizing metabolites in biofluids, has the potential to improve diagnostics in a range of diseases.", {"entities": []}], ["The objective of this pilot study is to apply metabolomic analysis to childhood pneumonia to explore its potential to improve pneumonia diagnosis in a high-burden setting.", {"entities": [[80, 89, "DISEASE"], [126, 135, "DISEASE"]]}], ["Eleven children with World Health Organization (WHO)-defined severe pneumonia of non-homogeneous aetiology were selected in The Gambia, West Africa, along with community controls.", {"entities": [[68, 77, "DISEASE"]]}], ["Metabolomic analysis of matched plasma and urine samples was undertaken using Ultra Performance Liquid Chromatography (UPLC) coupled to Time-of-Flight Mass Spectrometry (TOFMS).", {"entities": []}], ["Biomarker extraction was done using SIMCA-P Metabolomic analysis clearly distinguished severe pneumonia patients from community controls.", {"entities": [[94, 103, "DISEASE"]]}], ["The metabolites identified are important for the host response to infection through antioxidant, inflammatory and antimicrobial pathways, and energy metabolism.", {"entities": []}], ["Larger studies are needed to determine whether these findings are pneumonia-specific and to distinguish organism-specific responses.", {"entities": [[66, 75, "DISEASE"]]}], ["Metabolomics has considerable potential to improve diagnostics for childhood pneumonia.", {"entities": [[77, 86, "DISEASE"]]}], ["Exertional-induced bronchoconstriction is a condition in which the physical activity causes constriction of airways in patients with airway hyper- responsiveness.", {"entities": []}], ["In this study, we tried to study and evaluate any relationship between the findings of cardiopulmonary exercise testing (CPET) and the response to methacholine challenge test (MCT) in patients with dyspnea after activity.", {"entities": []}], ["Thirty patients with complaints of dyspnea following activity referred to \u201cLung Clinic\u201d of Baqiyatallah Hospital but not suffering from asthma were entered into the study.", {"entities": [[136, 142, "DISEASE"]]}], ["The subjects were excluded from the study if: Suffering from any other pulmonary diseases, smoking more than 1 cigarette a week in the last year, having a history of smoking more than 10 packets of cigarettes/year, having respiratory infection in the past 4 weeks, having abnormal chest X-ray or electrocardiogram, and cannot discontinue the use of medicines interfering with bronchial provocation.", {"entities": []}], ["Baseline spirometry was performed for all the patients, and the values of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV/FVC were recorded.", {"entities": []}], ["The MCT and then the CPET were performed on all patients.", {"entities": []}], ["The mean VO 2 (volume oxygen) in patients with positive methacholine test (20.45 mL/kg/min) was significantly lower than patients with negative MCT (28.69 mL/kg/min) ( P = 0.000).", {"entities": []}], ["Respiratory rates per minute (RR) and minute ventilation in the group with positive MCT (38.85 and 1.636 L) were significantly lower than the group with negative methacholine test (46.78 and 2.114 L) ( P < 0.05).", {"entities": []}], ["Also, the O 2 pulse rate in the group with negative methacholine test (116.27 mL/beat) was significantly higher than the group with positive methacholine test (84.26 mL/beat) ( P < 0.001).", {"entities": []}], ["Pulmonary response to exercise in patients with positive methacholine test is insufficient.", {"entities": []}], ["The dead space ventilation in these patients has increased.", {"entities": []}], ["Also, dynamic hyperinflation in patients with positive methacholine test causes the reduced stroke volume and O 2 pulse in these patients.", {"entities": []}], ["Galectin-3 (Gal-3) regulates basic cellular functions such as cell\u2013cell and cell\u2013matrix interactions, growth, proliferation, differentiation, and inflammation.", {"entities": []}], ["It is not surprising, therefore, that this protein is involved in the pathogenesis of many relevant human diseases, including cancer, fibrosis, chronic inflammation and scarring affecting many different tissues.", {"entities": [[126, 132, "DISEASE"]]}], ["The papers published in the literature have progressively increased in number during the last decades, testifying the great interest given to this protein by numerous researchers involved in many different clinical contexts.", {"entities": []}], ["Considering the crucial role exerted by Gal-3 in many different clinical conditions, Gal-3 is emerging as a new diagnostic, prognostic biomarker and as a new promising therapeutic target.", {"entities": []}], ["The current review aims to extensively examine the studies published so far on the role of Gal-3 in all the clinical conditions and diseases, listed in alphabetical order, where it was analyzed.", {"entities": []}], ["The diagnostic and prognostic value of arterial blood gas analysis (ABGA) parameters in unselected patients presenting with acute dyspnea to the Emergency Department (ED) is largely unknown.", {"entities": []}], ["We performed a post-hoc analysis of two different prospective studies to investigate the diagnostic and prognostic value of ABGA parameters in patients presenting to the ED with acute dyspnea.", {"entities": []}], ["We enrolled 530 patients (median age 74 years).", {"entities": []}], ["ABGA parameters were neither useful to distinguish between patients with pulmonary disorders and other causes of dyspnea nor to identify specific disorders responsible for dyspnea.", {"entities": []}], ["Only in patients with hyperventilation from anxiety disorder, the diagnostic accuracy of pH and hypoxemia rendered valuable with an area under the receiver operating characteristics curve (AUC) of 0.86.", {"entities": [[44, 60, "DISEASE"]]}], ["Patients in the lowest pH tertile more often required admission to intensive care unit (28% vs 12% in the first tertile, P < 0.001) and had higher in-hospital (14% vs 5%, P = 0.003) and 30-day mortality (17% vs 7%, P = 0.002).", {"entities": []}], ["Cumulative mortality rate was higher in the first (37%), than in the second (28%), and the third tertile (23%, P = 0.005) during 12 months follow-up.", {"entities": []}], ["pH at presentation was an independent predictor of 12-month mortality in multivariable Cox proportional hazard analysis both for patients with pulmonary (P = 0.043) and non-pulmonary disorders (P = 0.038).", {"entities": []}], ["ABGA parameters provide limited diagnostic value in patients with acute dyspnea, but pH is an independent predictor of 12 months mortality.", {"entities": []}], ["Dengue is an arboviral infection clinically recognized as an acute and self-limited disease.", {"entities": []}], ["Persistence of dengue symptoms is known, but it has been little studied.", {"entities": []}], ["The aim of this study was to characterize persistent symptoms in 113 patients with dengue followed up clinically and by laboratory testing at a tertiary hospital.", {"entities": []}], ["Symptoms that persisted for more than 14 days were observed in 61 (54.0%) patients, and six (6.2%) of them had symptoms for 6 months or more.", {"entities": []}], ["The persistent symptoms identified were myalgia, weakness, hair loss, memory loss, reduced resistance to physical effort, headache, reasoning problems, arthralgia, sleepiness- and emotional lability.", {"entities": []}], ["The progression to persistent symptoms was significantly associated with hospitalization, older age, more severe disease, the presence of bleeding and comorbidities upon univariate analysis.", {"entities": []}], ["Upon multivariate analysis, the presence of persistent symptoms continued to be significantly associated only with increased age and dengue with warning signs.", {"entities": []}], ["The platelet count during the acute phase of the disease was significantly lower in the group with persistent symptoms.", {"entities": []}], ["In conclusion, the frequency of progression to persistent symptoms in dengue is relevant in patients seen at a tertiary hospital and the persistence of symptoms is more common in patients with dengue with warning signs.", {"entities": []}], ["Lower respiratory tract infection (LRTI) commonly causes hospitalization in adults.", {"entities": []}], ["Because bacterial diagnostic tests are not accurate, antibiotics are frequently prescribed.", {"entities": []}], ["Peripheral blood gene expression to identify subjects with bacterial infection is a promising strategy.", {"entities": []}], ["We evaluated whole blood profiling using RNASeq to discriminate infectious agents in adults with microbiologically defined LRTI.", {"entities": []}], ["Hospitalized adults with LRTI symptoms were recruited.", {"entities": []}], ["Clinical data and blood was collected, and comprehensive microbiologic testing performed.", {"entities": []}], ["Gene expression was measured using RNASeq and qPCR.", {"entities": []}], ["Genes discriminatory for bacterial infection were identified using the Bonferroni-corrected Wilcoxon test.", {"entities": []}], ["Constrained logistic models to predict bacterial infection were fit using screened LASSO.", {"entities": []}], ["We enrolled 94 subjects who were microbiologically classified; 53 as \u201cnon-bacterial\u201d and 41 as \u201cbacterial\u201d.", {"entities": []}], ["RNAseq and qPCR confirmed significant differences in mean expression for 10 genes previously identified as discriminatory for bacterial LRTI.", {"entities": []}], ["A novel dimension reduction strategy selected three pathways (lymphocyte, \u03b1-linoleic acid metabolism, IGF regulation) including eleven genes as optimal markers for discriminating bacterial infection (na\u00efve AUC\u2009=\u20090.94; nested CV-AUC\u2009=\u20090.86).", {"entities": []}], ["Using these genes, we constructed a classifier for bacterial LRTI with 90% (79% CV) sensitivity and 83% (76% CV) specificity.", {"entities": []}], ["This novel, pathway-based gene set displays promise as a method to distinguish bacterial from nonbacterial LRTI.", {"entities": []}], ["COPD is considered a complex disease and global problem that is predicted to be the third most common cause of death by 2030.", {"entities": []}], ["While managing this chronic condition, primary health care practitioners are faced with the ongoing challenge of achieving good quality of life and overall \u201cwellness\u201d for those affected.", {"entities": []}], ["As such, a practical tool for monitoring quality of life in a clinical setting is required.", {"entities": []}], ["However, due to the wide variety of general and disease-specific tools from which to choose, primary health care practitioners are given minimal guidance as to which tool may be most appropriate.", {"entities": []}], ["To address these challenges, the International Primary Care Respiratory Group (IPCRG) proposed the creation of a user\u2019s guide for primary health care practitioners to assess \u201cwellness\u201d in COPD patients in an everyday clinical setting.", {"entities": []}], ["This short report outlines the process by which the IPCRG Users\u2019 Guide to COPD \u201cWellness\u201d Tools was developed.", {"entities": []}], ["It also describes why this guide has the potential to be of great value in guiding primary health care practitioners to improve patient wellness.", {"entities": []}], ["The innate immune system regulates initial responses to pathogen invasion through a set of conserved pattern recognition receptors (PRR).", {"entities": []}], ["The best-characterized PRRs are the Toll-like receptors, which regulate not only the initial pathogen defense response, but also adaptive immune responses.", {"entities": []}], ["Thus, insight into the function of PRRs has major implications for our understanding of the physiology of vaccination and the pathophysiology of human disease.", {"entities": []}], ["Recent advances in our understanding of a new class of pattern recognition receptors\u2013NOD-like receptors (NLR)\u2013have similarly provided insight into both innate and adaptive immunity.", {"entities": []}], ["In particular, the NLR Nlrp3 (also known as Nalp3 or Cias1) forms an intracellular multimolecular complex with active caspase-1, called an inflammasome, creating a platform for regulating secretion of interleukin-1 (IL-1) family members.", {"entities": [[23, 28, "GENE"]]}], ["Given the important role of IL-1 in inflammatory diseases, from gout to rheumatoid arthritis, the importance of understanding the regulation of such a cytokine cannot be underestimated.", {"entities": [[72, 92, "DISEASE"], [83, 92, "DISEASE"], [64, 68, "DISEASE"]]}], ["In this review, we address new evidence supporting a role for adaptive immune activation by recently identified NLR agonists, with a particular focus on Nlrp3.", {"entities": [[153, 158, "GENE"]]}], ["Basic questions in our understanding of Nlrp3 inflammasome activation are also presented.", {"entities": [[40, 45, "GENE"]]}], ["Objectives .", {"entities": []}], ["The objective of this narrative review was to examine the usage of ketamine as a postoperative analgesic agent across a wide variety of surgeries.", {"entities": []}], ["A literature search was performed using the phrases \u201cketamine\u201d and \u201cpostoperative pain.\u201d The authors analyzed the studies that involved testing ketamine's effectiveness at controlling postoperative pain.", {"entities": []}], ["Effectiveness was assessed through various outcomes such as the amount of opiate consumption, visual analog scale (VAS) pain scores, and persistent postoperative pain at long-term follow-up.", {"entities": []}], ["While many different administration protocols were evaluated, delivering ketamine both as a pre- or perioperative bolus and postoperative infusion for up to 48 hours appeared to be the most effective.", {"entities": []}], ["These effects are dose-dependent.", {"entities": []}], ["However, a number of studies analyzed showed no benefit in using ketamine versus placebo for controlling postoperative pain.", {"entities": []}], ["While ketamine is a safe and well-tolerated drug, it does have adverse effects, and there are concerns for possible neurotoxicity and effects on memory.", {"entities": []}], ["Conclusions .", {"entities": []}], ["In a number of limited situations, ketamine has shown some efficacy in controlling postoperative pain and decreasing opioid consumption.", {"entities": []}], ["More randomized controlled trials are necessary to determine the surgical procedures and administrations (i.e., intravenous, epidural) that ketamine is best suited for.", {"entities": []}], ["The current therapy on allergic inflammation is unsatisfactory.", {"entities": []}], ["Probiotics improve the immunity in the body.", {"entities": []}], ["This study aims to test a hypothesis that administration with Clostridium butyricum (C. butyricum) enforces the effect of specific immunotherapy (SIT) on intestinal allergic inflammation.", {"entities": []}], ["In this study, an ovalbumin (OVA) specific allergic inflammation mouse model was created.", {"entities": []}], ["The mice were treated with SIT or/and C. butyricum .", {"entities": []}], ["The results showed that the intestinal allergic inflammation was only moderately alleviated by SIT, which was significantly enforced by a combination with C. butyricum ; treating with C. butyricum alone did not show much inhibitory efficacy.", {"entities": []}], ["The increase in the frequency of the interleukin (IL)-10-producing OVA-specific B cell (OVAsBC) was observed in mice in parallel to the inhibitory effect on the intestinal allergic inflammation.", {"entities": []}], ["The in vitro treatment of the OVAsBCs with OVA increased the histone deacetylase-1 (HDAC1) phosphorylation, modulated the transcription of the Bcl6 gene, and triggered the OVAsBCs to differentiate to the IgE-producing plasma cells.", {"entities": [[84, 89, "GENE"], [143, 147, "GENE"]]}], ["Exposure to both OVA and butyrate sodium in the culture increased the expression of IL-10 in OVAsBCs.", {"entities": []}], ["In conclusion, administration with C. butyricum enforces the inhibitory effect of SIT on allergic inflammation in the mouse intestine.", {"entities": []}], ["To prospectively investigate patients with seasonal allergic conjunctivitis (SAC) during the pollen season and test associations between tears total IgE, eotaxin concentrations, and SAC severity.", {"entities": [[52, 75, "DISEASE"], [61, 75, "DISEASE"]]}], ["Enrolled patients presented ocular symptoms and clinical signs of SAC at the time of presentation.", {"entities": []}], ["Ocular itching, hyperaemia, chemosis, eyelid swelling, and tearing were scored, and the sum of these scores was defined as the clinical score.", {"entities": []}], ["Conjunctival papillae were separately graded.", {"entities": []}], ["We measured eotaxin concentration in tears by an enzyme-linked immunosorbent assay (ELISA) and total tear IgE by Lacrytest strip.", {"entities": []}], ["Among thirty patients (30 eyes), 11 showed neither tear IgE nor tear eotaxin, while 15 out of 19 patients with positive IgE values presented a positive amount of eotaxin in their tears (Fisher\u2019s test: p \u2009<\u20090.001).", {"entities": []}], ["The mean eotaxin concentration was 641\u2009\u00b1\u2009154 (SEM) pg/ml.", {"entities": []}], ["In patients with no amount of tear IgE, we observed a lower conjunctival papilla grade than in patients whose tears contained some amount of IgE (trend test: p \u2009=\u20090.032).", {"entities": []}], ["In the 15 patients whose tear eotaxin concentration was null, tear IgE concentration was 5.3\u2009\u00b1\u20093.5 arbitrary units; in the other 15 patients whose eotaxin was positive, IgE reached 21\u2009\u00b1\u20094.3 arbitrary U (Mann\u2013Whitney: p \u2009<\u20090.001).", {"entities": []}], ["We measured 127\u2009\u00b1\u200947\u00a0pg/ml eotaxin in patients with no history of SAC but newly diagnosed as suffering from SAC, and 852\u2009\u00b1\u2009218\u00a0pg/ml eotaxin in patients with a known SAC ( p \u2009=\u20090.008).", {"entities": []}], ["In contrast, tear IgE concentrations of both groups did not differ statistically significantly ( p \u2009=\u20090.947).", {"entities": []}], ["If IgE and eotaxin secreted in tears are major contributors in SAC pathogenesis, they however act at different steps of the process.", {"entities": []}], ["Topical microbicides are intended for frequent use by women in reproductive age.", {"entities": []}], ["Hence, it is essential to evaluate their impact on mucosal immune function in the vagina.", {"entities": []}], ["In the present study, we evaluated nisin, a naturally occurring antimicrobial peptide (AMP), for its efficacy as an intravaginal microbicide.", {"entities": []}], ["Its effect on the vaginal immune function was determined by localizing Toll-like receptors (TLRs-3, 9) and cytokines (IL-4, 6 , 10 and TNF- \u03b1 ) in the rabbit cervicovaginal epithelium following intravaginal administration of high dose of nisin gel for 14 consecutive days.", {"entities": []}], ["The results revealed no alteration in the expression of TLRs and cytokines at both protein and mRNA levels.", {"entities": []}], ["However, in SDS gel-treated group, the levels were significantly upregulated with the induction of NF- \u03ba B signalling cascade.", {"entities": [[12, 15, "GENE"]]}], ["Thus, TLRs and cytokines appear as sensitive indicators for screening immunotoxic potential of candidate microbicides.", {"entities": []}], ["Osteoarthritis (OA) is the most common type of arthritis, causing significant joint pain and disability.", {"entities": [[47, 56, "DISEASE"]]}], ["It is already a major cause of healthcare expenditure and its incidence will further increase with the ageing population.", {"entities": []}], ["Current treatments for OA have major limitations and new analgesic treatments are needed.", {"entities": []}], ["Synovitis is prevalent in OA and is associated with pain.", {"entities": [[0, 9, "DISEASE"]]}], ["Hydroxychloroquine is used in routine practice for treating synovitis in inflammatory arthritides, such as rheumatoid arthritis.", {"entities": [[107, 127, "DISEASE"], [118, 127, "DISEASE"], [60, 69, "DISEASE"]]}], ["We propose that treating patients with symptomatic hand OA with hydroxychloroquine will be a practical and safe treatment to reduce synovitis and pain.", {"entities": [[132, 141, "DISEASE"]]}], ["HERO is an investigator-initiated, multicentre, randomized, double-blind, placebo-controlled trial.", {"entities": []}], ["A total of 252 subjects with symptomatic hand OA will be recruited across primary and secondary care sites in the UK and randomized on a 1:1 basis to active treatment or placebo for 12 months.", {"entities": []}], ["Daily medication dose will range from 200 to 400 mg according to ideal body weight.", {"entities": []}], ["The primary endpoint is change in average hand pain during the previous two weeks (measured on a numerical rating scale (NRS)) between baseline and six months.", {"entities": []}], ["Secondary endpoints include other self-reported pain, function and quality-of-life measures and radiographic structural change at 12 months.", {"entities": []}], ["A health economics analysis will also be performed.", {"entities": []}], ["An ultrasound substudy will be conducted to examine baseline levels of synovitis.", {"entities": [[71, 80, "DISEASE"]]}], ["Linear and logistic regression will be used to compare changes between groups using univariable and multivariable modelling analyses.", {"entities": []}], ["All analyses will be conducted on an intention-to-treat basis.", {"entities": []}], ["The HERO trial is designed to examine whether hydroxychloroquine is an effective analgesic treatment for OA and whether it provides any long-term structural benefit.", {"entities": []}], ["The ultrasound substudy will address whether baseline synovitis is a predictor of therapeutic response.", {"entities": [[54, 63, "DISEASE"]]}], ["This will potentially provide a new treatment for OA, which could be of particular use in the primary care setting.", {"entities": []}], ["ISRCTN91859104 .", {"entities": []}], ["The zinc finger transcription factor Zbtb46 specifically marks cDCs and their committed precursors and, when overexpressed in BM progenitors, promotes cDC development at the expense of granulocytes.", {"entities": [[37, 43, "GENE"]]}], ["Distinguishing dendritic cells (DCs) from other cells of the mononuclear phagocyte system is complicated by the shared expression of cell surface markers such as CD11c.", {"entities": []}], ["In this study, we identified Zbtb46 ( BTBD4 ) as a transcription factor selectively expressed by classical DCs (cDCs) and their committed progenitors but not by plasmacytoid DCs (pDCs), monocytes, macrophages, or other lymphoid or myeloid lineages.", {"entities": [[29, 35, "GENE"]]}], ["Using homologous recombination, we replaced the first coding exon of Zbtb46 with GFP to inactivate the locus while allowing detection of Zbtb46 expression.", {"entities": [[69, 75, "GENE"], [137, 143, "GENE"], [69, 75, "GENE"], [137, 143, "GENE"]]}], ["GFP expression in Zbtb46 mice recapitulated the cDC-specific expression of the native locus, being restricted to cDC precursors (pre-cDCs) and lymphoid organ\u2013 and tissue-resident cDCs.", {"entities": [[18, 24, "GENE"]]}], ["GFP Zbtb46 was expressed in committed erythroid progenitors and endothelial cell populations.", {"entities": [[4, 10, "GENE"]]}], ["Zbtb46 overexpression in bone marrow progenitor cells inhibited granulocyte potential and promoted cDC development, and although cDCs developed in Zbtb46 ( Zbtb46 deficient) mice, they maintained expression of granulocyte colony-stimulating factor and leukemia inhibitory factor receptors, which are normally down-regulated in cDCs.", {"entities": [[252, 260, "DISEASE"], [0, 6, "GENE"], [147, 153, "GENE"], [156, 162, "GENE"], [0, 6, "GENE"], [147, 153, "GENE"], [156, 162, "GENE"], [0, 6, "GENE"], [147, 153, "GENE"], [156, 162, "GENE"]]}], ["Thus, Zbtb46 may help enforce cDC identity by restricting responsiveness to non-DC growth factors and may serve as a useful marker to identify rare cDC progenitors and distinguish between cDCs and other mononuclear phagocyte lineages.", {"entities": [[6, 12, "GENE"]]}], ["The ST2/IL-33 pathway has been related to ulcerative colitis (UC), and soluble ST2 (sST2), to disease severity.", {"entities": [[42, 60, "DISEASE"]]}], ["We tested the potential usefulness of sST2 as a predictive marker of treatment response and patients\u2019 outcome.", {"entities": []}], ["Twenty-six patients with active UC were prospectively recruited and grouped according to an endoscopic score and therapy response.", {"entities": []}], ["Colonoscopic biopsies were collected at baseline and 6\u00a0months or when patients showed clinical activity.", {"entities": []}], ["The protocol was reinitiated in patients requiring rescue therapy.", {"entities": []}], ["Blood and stool were collected at baseline, 1, 3, 6 and 12\u00a0months.", {"entities": []}], ["Serum and mucosal ST2, and fecal calprotectin (FC) content were determined by ELISA and correlated to Mayo clinical and endoscopic subscore.", {"entities": []}], ["Intestinal ST2 was evaluated by immunofluorescence.", {"entities": []}], ["Wilcoxon signed rank test and Spearman correlations (Rs) were applied ( p <0.05).", {"entities": []}], ["Follow-up was completed in 24 patients.", {"entities": []}], ["sST2 levels (median and range) varied from 173.5 [136.6\u2013274.0] to 86.5 [54.6\u2013133.2] in responders ( p \u2009<\u20090.05), and 336.3 [211.0\u2013403.2] to 385.3\u00a0pg/mL [283.4\u2013517.3] in non-responders at baseline and 6\u00a0months, respectively.", {"entities": []}], ["sST2 levels correlated with Mayo clinical and endoscopic subscore, mucosal ST2 and FC (Rs\u2009=\u20090.57, 0.66, 0.74 and 0.42, respectively; p \u2009<\u20090.0001) and showed a trend similar to that of FC in responders.", {"entities": []}], ["Non-responders revealed an increased ST2 content, restricted to the lamina propria\u2019s cellular infiltrate.", {"entities": []}], ["Consecutive sST2 measurement to follow changes in inflammatory activity of UC patients who respond or not to treatment identifies sST2, like FC, as a useful biomarker in predicting clinical outcome of UC patients.", {"entities": []}], ["The online version of this article (doi:10.1186/s12876-016-0520-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["BCG vaccination is administered in infancy in most countries with the aim of providing protection against tuberculosis.", {"entities": [[106, 118, "DISEASE"]]}], ["There is increasing interest in the role of vitamin D in immunity to tuberculosis.", {"entities": [[69, 81, "DISEASE"]]}], ["This study objective was to determine if there was an association between circulating 25(OH)D concentrations and BCG vaccination status and cytokine responses following BCG vaccination in infants.", {"entities": []}], ["Blood samples were collected from UK infants who were vaccinated with BCG at 3 (n\u200a=\u200a47) and 12 (n\u200a=\u200a37) months post BCG vaccination.", {"entities": []}], ["These two time-points are denoted as time-point 1 and time-point 2.", {"entities": []}], ["Two blood samples were also collected from age-matched unvaccinated infants (n\u200a=\u200a32 and 28 respectively), as a control group.", {"entities": []}], ["Plasma vitamin D concentrations (25(OH)D) were measured by radio-immunoassay.", {"entities": []}], ["The cytokine IFN\u03b3 was measured in supernatants from diluted whole blood stimulated with M.tuberculosis ( M.tb ) PPD for 6 days.", {"entities": [[90, 102, "DISEASE"]]}], ["58% of infants had some level of hypovitaminosis (25(OH)D <30ng/ml) at time-point 1, and this increased to 97% 9 months later.", {"entities": []}], ["BCG vaccinated infants were almost 6 times (CI: 1.8\u201318.6) more likely to have sufficient vitamin D concentrations than unvaccinated infants at time-point 1, and the association remained strong after controlling for season of blood collection, ethnic group and sex.", {"entities": []}], ["Among vaccinees, there was also a strong inverse association between IFN\u03b3 response to M.tb PPD and vitamin D concentration, with infants with higher vitamin D concentrations having lower IFN\u03b3 responses.", {"entities": []}], ["Vitamin D may play an immuno-regulatory role following BCG vaccination.", {"entities": []}], ["The increased vitamin D concentrations in BCG vaccinated infants could have important implications: vitamin D may play a role in immunity induced by BCG vaccination and may contribute to non-specific effects observed following BCG vaccination.", {"entities": []}], ["Cosmetic products contain various chemical substances that may be potential carcinogen and endocrine disruptors.", {"entities": []}], ["Women\u2019s changes in cosmetics use during pregnancy and their risk perception of these products have not been extensively investigated.", {"entities": []}], ["The main objective of this study was to describe the proportion of pregnant women changing cosmetics use and the proportion of non-pregnant women intending to do so if they became pregnant.", {"entities": []}], ["The secondary objectives were to compare, among the pregnant women, the proportions of those using cosmetics before and during pregnancy, and to describe among pregnant and non-pregnant women, the risk perception of these products.", {"entities": []}], ["A cross-sectional study was carried out in a gynaecology clinic and four community pharmacies.", {"entities": []}], ["One hundred and twenty-eight women (60 non-pregnant and 68 pregnant women) replied to a self-administered questionnaire.", {"entities": []}], ["Cosmetics use was identified for 28 products.", {"entities": []}], ["The results showed that few women intended to change or had changed cosmetics use during pregnancy.", {"entities": []}], ["Nail polish was used by fewer pregnant women compared to the period before pregnancy ( p < 0.05).", {"entities": []}], ["Fifty-five percent of the women considered cosmetics use as a risk during pregnancy and 65% would have appreciated advice about these products.", {"entities": []}], ["Our findings indicate that all perinatal health professionals should be ready to advise women about the benefits and risks of using cosmetics during pregnancy.", {"entities": []}], ["Observational outcome studies of patients with obstructive sleep apnea (OSA) require adjustment for co-morbidity to produce valid results.", {"entities": []}], ["The aim of this study was to evaluate whether the combination of administrative data and self-reported data provided a more complete estimate of co-morbidity among patients referred for sleep diagnostic testing.", {"entities": []}], ["A retrospective observational study of 2149 patients referred for sleep diagnostic testing in Calgary, Canada.", {"entities": []}], ["Self-reported co-morbidity was obtained with a questionnaire; administrative data and validated algorithms (when available) were also used to define the presence of these co-morbid conditions within a two-year period prior to sleep testing.", {"entities": []}], ["Patient self-report of co-morbid conditions had varying levels of agreement with those derived from administrative data, ranging from substantial agreement for diabetes (\u03ba = 0.79) to poor agreement for cardiac arrhythmia (\u03ba = 0.14).", {"entities": []}], ["The enhanced measure of co-morbidity using either self-report or administrative data had face validity, and provided clinically meaningful trends in the prevalence of co-morbidity among this population.", {"entities": []}], ["An enhanced measure of co-morbidity using self-report and administrative data can provide a more complete measure of the co-morbidity among patients with OSA when agreement between the two sources is poor.", {"entities": []}], ["This methodology will aid in the adjustment of these coexisting conditions in observational studies in this area.", {"entities": []}], ["To evaluate in-patient mortality and predictors of death associated with convulsive status epilepticus (SE) in a large, multi-center, pediatric cohort.", {"entities": []}], ["We identified our cohort from the KID Inpatient Database for the years 1997, 2000, 2003 and 2006.", {"entities": []}], ["We queried the database for convulsive SE, associated diagnoses, and for inpatient death.", {"entities": []}], ["Univariate logistic testing was used to screen for potential risk factors.", {"entities": []}], ["These risk factors were then entered into a stepwise backwards conditional multivariable logistic regression procedure.", {"entities": []}], ["P- values less than 0.05 were taken as significant.", {"entities": []}], ["We identified 12,365 (5,541 female) patients with convulsive SE aged 0\u201320 years (mean age 6.2 years, standard deviation 5.5 years, median 5 years) among 14,965,571 pediatric inpatients (0.08%).", {"entities": []}], ["Of these, 117 died while in the hospital (0.9%).", {"entities": []}], ["The most frequent additional admission ICD-9 code diagnoses in addition to SE were cerebral palsy, pneumonia, and respiratory failure.", {"entities": [[114, 133, "DISEASE"], [99, 108, "DISEASE"], [83, 97, "DISEASE"]]}], ["Independent risk factors for death in patients with SE, assessed by multivariate calculation, included near drowning (Odds ratio [OR] 43.2; Confidence Interval [CI] 4.4\u2013426.8), hemorrhagic shock (OR 17.83; CI 6.5\u201349.1), sepsis (OR 10.14; CI 4.0\u201325.6), massive aspiration (OR 9.1; CI 1.8\u201347), mechanical ventilation >96 hours (OR9; 5.6\u201314.6), transfusion (OR 8.25; CI 4.3\u201315.8), structural brain lesion (OR7.0; CI 3.1\u201316), hypoglycemia (OR5.8; CI 1.75\u201319.2), sepsis with liver failure (OR 14.4; CI 5\u201341.9), and admission in December (OR3.4; CI 1.6\u20134.1).", {"entities": [[422, 434, "DISEASE"]]}], ["African American ethnicity (OR 0.4; CI 0.2\u20130.8) was associated with a decreased risk of death in SE.", {"entities": []}], ["Pediatric convulsive SE occurs in up to 0.08% of pediatric inpatient admissions with a mortality of up to 1%.", {"entities": []}], ["There appear to be several risk factors that can predict mortality.", {"entities": []}], ["These may warrant additional monitoring and aggressive management.", {"entities": []}], ["Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults.", {"entities": []}], ["For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015), we estimated the incidence, prevalence, and years lived with disability for diseases and injuries at the global, regional, and national scale over the period of 1990 to 2015.", {"entities": []}], ["We estimated incidence and prevalence by age, sex, cause, year, and geography with a wide range of updated and standardised analytical procedures.", {"entities": []}], ["Improvements from GBD 2013 included the addition of new data sources, updates to literature reviews for 85 causes, and the identification and inclusion of additional studies published up to November, 2015, to expand the database used for estimation of non-fatal outcomes to 60\u2008900 unique data sources.", {"entities": []}], ["Prevalence and incidence by cause and sequelae were determined with DisMod-MR 2.1, an improved version of the DisMod-MR Bayesian meta-regression tool first developed for GBD 2010 and GBD 2013.", {"entities": []}], ["For some causes, we used alternative modelling strategies where the complexity of the disease was not suited to DisMod-MR 2.1 or where incidence and prevalence needed to be determined from other data.", {"entities": []}], ["For GBD 2015 we created a summary indicator that combines measures of income per capita, educational attainment, and fertility (the Socio-demographic Index [SDI]) and used it to compare observed patterns of health loss to the expected pattern for countries or locations with similar SDI scores.", {"entities": []}], ["We generated 9\u00b73 billion estimates from the various combinations of prevalence, incidence, and YLDs for causes, sequelae, and impairments by age, sex, geography, and year.", {"entities": []}], ["In 2015, two causes had acute incidences in excess of 1 billion: upper respiratory infections (17\u00b72 billion, 95% uncertainty interval [UI] 15\u00b74\u201319\u00b72 billion) and diarrhoeal diseases (2\u00b739 billion, 2\u00b730\u20132\u00b750 billion).", {"entities": []}], ["Eight causes of chronic disease and injury each affected more than 10% of the world's population in 2015: permanent caries, tension-type headache, iron-deficiency anaemia, age-related and other hearing loss, migraine, genital herpes, refraction and accommodation disorders, and ascariasis.", {"entities": [[218, 232, "DISEASE"], [208, 216, "DISEASE"], [278, 288, "DISEASE"]]}], ["The impairment that affected the greatest number of people in 2015 was anaemia, with 2\u00b736 billion (2\u00b735\u20132\u00b737 billion) individuals affected.", {"entities": []}], ["The second and third leading impairments by number of individuals affected were hearing loss and vision loss, respectively.", {"entities": []}], ["Between 2005 and 2015, there was little change in the leading causes of years lived with disability (YLDs) on a global basis.", {"entities": []}], ["NCDs accounted for 18 of the leading 20 causes of age-standardised YLDs on a global scale.", {"entities": []}], ["Where rates were decreasing, the rate of decrease for YLDs was slower than that of years of life lost (YLLs) for nearly every cause included in our analysis.", {"entities": []}], ["For low SDI geographies, Group 1 causes typically accounted for 20\u201330% of total disability, largely attributable to nutritional deficiencies, malaria, neglected tropical diseases, HIV/AIDS, and tuberculosis.", {"entities": [[194, 206, "DISEASE"], [142, 149, "DISEASE"]]}], ["Lower back and neck pain was the leading global cause of disability in 2015 in most countries.", {"entities": []}], ["The leading cause was sense organ disorders in 22 countries in Asia and Africa and one in central Latin America; diabetes in four countries in Oceania; HIV/AIDS in three southern sub-Saharan African countries; collective violence and legal intervention in two north African and Middle Eastern countries; iron-deficiency anaemia in Somalia and Venezuela; depression in Uganda; onchoceriasis in Liberia; and other neglected tropical diseases in the Democratic Republic of the Congo.", {"entities": []}], ["Ageing of the world's population is increasing the number of people living with sequelae of diseases and injuries.", {"entities": []}], ["Shifts in the epidemiological profile driven by socioeconomic change also contribute to the continued increase in years lived with disability (YLDs) as well as the rate of increase in YLDs.", {"entities": []}], ["Despite limitations imposed by gaps in data availability and the variable quality of the data available, the standardised and comprehensive approach of the GBD study provides opportunities to examine broad trends, compare those trends between countries or subnational geographies, benchmark against locations at similar stages of development, and gauge the strength or weakness of the estimates available.", {"entities": []}], ["Bill & Melinda Gates Foundation.", {"entities": []}], ["Nowadays, palliative care is considered as a care continuum that may start early in the course of the disease.", {"entities": []}], ["In order to address the evolving needs of patients for palliative care in time, GPs should be aware in good time of the diagnosis and of the imminence of death.", {"entities": []}], ["The aim of the study was to gain insight into how long before a non-sudden death the diagnosis of the disease ultimately leading to death is made and on what kind of information the diagnosis is based.", {"entities": []}], ["In addition, we aimed to explore when, and based on what kind of information, GPs become aware that death of a patient will be in the foreseeable future.", {"entities": []}], ["A written questionnaire focusing on the GPs\u2019 experiences with their last patient who died non-suddenly was sent to a random representative sample of 850 GPs in the Netherlands.", {"entities": []}], ["The data were analysed of the 297 GPs who responded.", {"entities": []}], ["76% of the reported cases were cancer patients and 24% were patients with another non-sudden cause of death.", {"entities": [[31, 37, "DISEASE"]]}], ["The diagnosis was made only in the last week of life for 15% of the non-cancer patients and 1% of the patients with cancer.", {"entities": [[72, 78, "DISEASE"], [116, 122, "DISEASE"]]}], ["GPs were most likely to have been informed of the diagnosis by the medical specialist, although particularly in the case of non-cancer patients GPs also relied on their own assessment of the diagnosis or on other information sources.", {"entities": [[128, 134, "DISEASE"]]}], ["The GP remained unaware that the patient would die in the foreseeable future until the last week of life in 26% of the non-cancer group, while this was the case for only 6% of the cancer patients.", {"entities": [[123, 129, "DISEASE"], [180, 186, "DISEASE"]]}], ["GP\u2019s awareness was most likely to be based on the GP\u2019s own observations of problems and/or symptoms.", {"entities": []}], ["The GP often only becomes aware of a fatal diagnosis and of death in the foreseeable future at a late stage in the disease trajectory, particularly in the case of non-cancer patients.", {"entities": [[167, 173, "DISEASE"]]}], ["It can be assumed that if the diagnosis and the nearing death are only recognised at a late stage, palliative care is either started at a very late stage or not at all.", {"entities": []}], ["In the last decade, more than half of U.S. children were born to working mothers and 65% of working men and women were of reproductive age.", {"entities": []}], ["In 2004 more than 28 million women age 18\u201344 were employed full time.", {"entities": []}], ["This implies the need for clinicians to possess an awareness about the impact of work on the health of their patients and their future offspring.", {"entities": []}], ["Most chemicals in the workplace have not been evaluated for reproductive toxicity, and where exposure limits do exist, they were generally not designed to mitigate reproductive risk.", {"entities": []}], ["Therefore, many toxicants with unambiguous reproductive and developmental effects are still in regular commercial or therapeutic use and thus present exposure potential to workers.", {"entities": []}], ["Examples of these include heavy metals, (lead, cadmium), organic solvents (glycol ethers, percholoroethylene), pesticides and herbicides (ethylene dibromide) and sterilants, anesthetic gases and anti-cancer drugs used in healthcare.", {"entities": [[200, 206, "DISEASE"]]}], ["Surprisingly, many of these reproductive toxicants are well represented in traditional employment sectors of women, such as healthcare and cosmetology.", {"entities": []}], ["Environmental exposures also figure prominently in evaluating a woman\u2019s health risk and that to a pregnancy.", {"entities": []}], ["Food and water quality and pesticide and solvent usage are increasingly topics raised by women and men contemplating pregnancy.", {"entities": []}], ["The microenvironment of a woman, such as her choices of hobbies and leisure time activities also come into play.", {"entities": []}], ["Caregivers must be aware of their patients\u2019 potential environmental and workplace exposures and weigh any risk of exposure in the context of the time-dependent window of reproductive susceptibility.", {"entities": []}], ["This will allow informed decision-making about the need for changes in behavior, diet, hobbies or the need for added protections on the job or alternative duty assignment.", {"entities": []}], ["Examples of such environmental and occupational history elements will be presented together with counseling strategies for the clinician.", {"entities": []}], ["This study assessed the efficacy of maintenance treatment with multimatrix mesalazine following achievement of complete or partial remission after induction treatment with high-dose multimatrix mesalazine.", {"entities": []}], ["In this phase 3b/4, open-label, multicentre, prospective, single-arm study, patients with mild-to-moderate ulcerative colitis were treated with multimatrix mesalazine 4.8g/day once daily for 8 weeks [induction phase].", {"entities": [[107, 125, "DISEASE"]]}], ["At Week 8, those who achieved complete or partial remission, based on predefined clinical and endoscopic criteria, were eligible to receive 12 months of multimatrix mesalazine 2.4g/day once daily maintenance therapy.", {"entities": []}], ["The primary endpoint was the proportion of patients in complete remission at Month 12.", {"entities": []}], ["A total of 717 patients received induction treatment; 25.9% and 39.3% of patients achieved complete and partial remission, respectively, at Week 8.", {"entities": []}], ["A total of 461 patients entered the maintenance phase.", {"entities": []}], ["The likelihood of remaining in/achieving complete remission at Month 12 was higher for patients who entered the maintenance phase in complete remission compared with those who began maintenance in partial remission [47.8% vs 26.0%; p < 0.001].", {"entities": []}], ["At Month 12, mucosal healing [endoscopy score \u2264 1] was demonstrated in 76.4% [139/182] and 63.5% [176/277] of those who were in complete and partial remission, respectively, at the end of induction.", {"entities": []}], ["Patients achieving complete remission before dose reduction were more likely to remain in remission at Month 12.", {"entities": []}], ["The ISAR study is a prospective, longitudinal, observational cohort study to improve the cardiovascular risk stratification in endstage renal disease (ESRD).", {"entities": []}], ["The major goal is to characterize the cardiovascular phenotype of the study subjects, namely alterations in micro- and macrocirculation and to determine autonomic function.", {"entities": []}], ["We intend to recruit 500 prevalent dialysis patients in 17 centers in Munich and the surrounding area.", {"entities": []}], ["Baseline examinations include: (1) biochemistry, (2) 24-h Holter Electrocardiography (ECG) recordings, (3) 24-h ambulatory blood pressure measurement (ABPM), (4) 24\u00a0h pulse wave analysis (PWA) and pulse wave velocity (PWV), (5) retinal vessel analysis (RVA) and (6) neurocognitive testing.", {"entities": []}], ["After 24\u00a0months biochemistry and determination of single PWA, single PWV and neurocognitive testing are repeated.", {"entities": []}], ["Patients will be followed up to 6\u00a0years for (1) hospitalizations, (2) cardiovascular and (3) non-cardiovascular events and (4) cardiovascular and (5) all-cause mortality.", {"entities": []}], ["We aim to create a complex dataset to answer questions about the insufficiently understood pathophysiology leading to excessively high cardiovascular and non-cardiovascular mortality in dialysis patients.", {"entities": []}], ["Finally we hope to improve cardiovascular risk stratification in comparison to the use of classical and non-classical (dialysis-associated) risk factors and other models of risk stratification in ESRD patients by building a multivariable Cox-Regression model using a combination of the parameters measured in the study.", {"entities": []}], ["ClinicalTrials.gov NCT01152892 (June 28, 2010)", {"entities": []}], ["The association between type 1 diabetes mellitus (T1DM) and asthma remains controversial and has led to new interest in these 2 disorders.", {"entities": [[24, 48, "DISEASE"], [60, 66, "DISEASE"], [31, 48, "DISEASE"]]}], ["The purpose of this study was to examine the associations among young people with T1DM and asthma and offer a clinical demonstration of the balance between Th1 and Th2 responses.", {"entities": [[91, 97, "DISEASE"]]}], ["We conducted a retrospective cohort study by using data from the National Health Insurance (NHI) system of Taiwan.", {"entities": []}], ["The cohort consisted of 3545 T1DM cases and 14,180 controls established during the 1998 to 2011 period.", {"entities": []}], ["Of the 3545 T1DM patients, 55.1% were girls and 26.5% were in the age group <8 years.", {"entities": []}], ["The overall incidence of asthma was 47% higher in the T1DM cohort than in the control cohort (6.49 vs 4.42 per 1000 person-y), with an adjusted hazard ratio (HR) of 1.34 (95% confidence interval [CI]\u200a=\u200a1.11\u20131.62).", {"entities": [[25, 31, "DISEASE"], [158, 160, "GENE"]]}], ["Moreover, T1DM patients who visited the emergency room (ER) more than twice for diabetes had a higher adjusted HR of 17.4 (95% CI\u200a=\u200a12.9\u201323.6) of developing asthma.", {"entities": [[157, 163, "DISEASE"], [111, 113, "GENE"]]}], ["The adjusted HR of asthma was 38.6 (95% CI\u200a=\u200a28.5\u201352.2) in T1DM patients who had been hospitalized more than twice for diabetes.", {"entities": [[19, 25, "DISEASE"], [13, 15, "GENE"]]}], ["We observed a significantly higher incidence of asthma in young patients with T1DM than in the general population.", {"entities": [[48, 54, "DISEASE"]]}], ["Among young people of T1DM with more ER visits or frequent hospitalization because of diabetes mellitus were associated with risk of asthma, may indicate that poor glycemic control significantly contributes to asthma risk.", {"entities": [[133, 139, "DISEASE"], [210, 216, "DISEASE"], [86, 103, "DISEASE"]]}], ["The burning of biomass fuels results in exposure to high levels of indoor air pollution, with consequent health effects.", {"entities": []}], ["Possible interventions to reduce the exposure include changing cooking practices and introduction of smoke-free stoves supported by health education.", {"entities": []}], ["Social, cultural and financial constraints are major challenges to implementation and success of interventions.", {"entities": []}], ["The objective of this study is to determine awareness of women in Gondar, Ethiopia to the harmful health effects of cooking smoke and to assess their willingness to change cooking practices.", {"entities": []}], ["We used a single, administered questionnaire which included questions on household circumstances, general health, awareness of health impact of cooking smoke and willingness to change.", {"entities": []}], ["We interviewed 15 women from each of rural, urban-traditional and middle class backgrounds.", {"entities": []}], ["Eighty percent of rural women cooked indoors using biomass fuel with no ventilation.", {"entities": []}], ["Rural women reported two to three times more respiratory disease in their children and in themselves compared to the other two groups.", {"entities": []}], ["Although aware of the negative effect of smoke on their own health, only 20% of participants realised it caused problems in children, and 13% thought it was a cause for concern.", {"entities": []}], ["Once aware of adverse effects, women were willing to change cooking practices but were unable to afford cleaner fuels or improved stoves.", {"entities": []}], ["Increasing the awareness of the health-effects of indoor biomass cooking smoke may be the first step in implementing a programme to reduce exposure.", {"entities": []}], ["Generation Scotland: the Scottish Family Health Study aims to identify genetic variants accounting for variation in levels of quantitative traits underlying the major common complex diseases (such as cardiovascular disease, cognitive decline, mental illness) in Scotland.", {"entities": []}], ["Generation Scotland will recruit a family-based cohort of up to 50,000 individuals (comprising siblings and parent-offspring groups) across Scotland.", {"entities": []}], ["It will be a six-year programme, beginning in Glasgow and Tayside in the first two years (Phase 1) before extending to other parts of Scotland in the remaining four years (Phase 2).", {"entities": []}], ["In Phase 1, individuals aged between 35 and 55 years, living in the East and West of Scotland will be invited to participate, along with at least one (and preferably more) siblings and any other first degree relatives aged 18 or over.", {"entities": []}], ["The total initial sample size will be 15,000 and it is planned that this will increase to 50,000 in Phase 2.", {"entities": []}], ["All participants will be asked to contribute blood samples from which DNA will be extracted and stored for future investigation.", {"entities": []}], ["The information from the DNA, along with answers to a life-style and medical history questionnaire, clinical and biochemical measurements taken at the time of donation, and subsequent health developments over the life course (traced through electronic health records) will be stored and used for research purposes.", {"entities": []}], ["In addition, a detailed public consultation process will begin that will allow respondents' views to shape and develop the study.", {"entities": []}], ["This is an important aspect to the research, and forms the continuation of a long-term parallel engagement process.", {"entities": []}], ["As well as gene identification, the family-based study design will allow measurement of the heritability and familial aggregation of relevant quantitative traits, and the study of how genetic effects may vary by parent-of-origin.", {"entities": []}], ["Long-term potential outcomes of this research include the targeting of disease prevention and treatment, and the development of screening tools based on the new genetic information.", {"entities": []}], ["This study approach is complementary to other population-based genetic epidemiology studies, such as UK Biobank, which are established primarily to characterise genes and genetic risk in the population.", {"entities": []}], ["The extract from Ginkgo biloba leaves has become a very popular plant medicine and herbal supplement for its potential benefit in alleviating symptoms associated with peripheral vascular disease, dementia, asthma and tinnitus.", {"entities": [[196, 204, "DISEASE"], [178, 194, "DISEASE"], [167, 194, "DISEASE"], [206, 212, "DISEASE"]]}], ["Most research on G. biloba leaves focus on the leaves collected in July and August from four to seven year-old trees, however a large number of leaves from fruit cultivars (trees older than 10 years) are ignored and become obsolete after fruit harvest season (November).", {"entities": []}], ["In this paper, we expand the tree age range (from one to 300 years) and first comparatively analyze the total flavonol glycosides and terpene lactones at different ages, from different cultivation sources and genders of G. biloba leaves collected in November by using the validated HPLC-ELSD and HPLC-PDA methods.", {"entities": []}], ["The results show that the contents of total terpene lactones and flavonol glycosides in the leaves of young ginkgo trees are higher than those in old trees, and they are higher in male trees than in female trees.", {"entities": []}], ["Geographical factors appear to have a significant influence on the contents as well.", {"entities": []}], ["These results will provide a good basis for the comprehensive utilization of G. biloba leaves, especially the leaves from fruit cultivars.", {"entities": []}], ["Several studies suggest an important role of Interleukin-27 in the development of atherosclerosis.", {"entities": [[82, 97, "DISEASE"]]}], ["The aim of this study was to establish whether the IL-27p28 gene polymorphisms are associated with premature coronary artery disease and/or other cardiovascular risk factors.", {"entities": []}], ["Four IL-27p28 gene polymorphisms were selected and genotyped in 1162 premature coronary artery disease cases and 1107 controls.", {"entities": []}], ["rs26528 T and rs40837 A alleles were significantly associated with a lower risk of premature coronary artery disease under different inheritance models (P dominant = 0.046; P over-dominant = 0.002; P co-dominant1 = 0.007 for rs26528T; P over-dominant = 0.008 and P co-dominant1 = 0.031 for rs40837).", {"entities": []}], ["The rs40837 A allele was also associated with a lower risk of insulin resistance, in cases (P over-dominant = 0.037) and controls (P additive = 0.008; P dominant = 0.047; P recessive = 0.014; P co-dominant2 = 0.006), while the rs26528 T allele was associated with a lower risk of insulin resistance only in the control group (P recessive = 0.016; P co-dominant2 = 0.021).", {"entities": []}], ["Interleukin-27 plasma levels were measured in 450 controls and 450 cases, and were significantly higher in cases compared to controls (P = 0.004).", {"entities": []}], ["However, Interleukin-27 plasma levels were not associated with IL-27p28 polymorphisms.", {"entities": []}], ["Luciferase assays showed that co-transfection of the rs40837 A allele and miR-379-5p significantly decreased luciferase gene expression.", {"entities": []}], ["Our study shows for the first time, that IL -27p28 gene polymorphisms are associated with premature coronary artery disease and with some metabolic parameters.", {"entities": []}], ["The rs40837 A allele in presence of miR-379-5p significantly decreased luciferase gene expression.", {"entities": []}], ["This study aimed to compare the regulatory T cells in cord blood of appropriate for gestational age (AGA) neonates with those of small for gestational age (SGA) neonates.", {"entities": []}], ["Umbilical cord blood was collected upon labor in 108 healthy full-term (between 37 and 41 gestational weeks) neonates, who were born between November 2010 and April 2012.", {"entities": []}], ["Among them, 77 samples were obtained from AGA neonates, and 31 samples were obtained from SGA neonates.", {"entities": []}], ["Regulatory T cells and lymphocyte subsets were determined using a flow cytometer.", {"entities": []}], ["Student's t-test for independent samples was used to compare differences between AGA and SGA neonates.", {"entities": []}], ["Regulatory T cells in cord blood were increased in the SGA group compared with normal controls ( p =0.041).", {"entities": []}], ["However, cytotoxic T cells in cord blood were significantly decreased in the SGA group compared with normal controls ( p =0.007).", {"entities": []}], ["This is the first study to compare the distribution of lymphocyte subsets including regulatory T cells in cord blood between AGA neonates and SGA neonates.", {"entities": []}], ["A lack of physical activity and excessive sitting can contribute to poor physical health and wellbeing.", {"entities": []}], ["The high percentage of the UK adult population in employment, and the prolonged sitting associated with desk-based office-work, make these workplaces an appropriate setting for interventions to reduce sedentary behaviour and increase physical activity.", {"entities": []}], ["This pilot study aims to determine the effect of an office-based sit-stand workstation intervention, compared with usual desk use, on daily sitting, standing and physical activity, and to examine the factors that underlie sitting, standing and physical activity, within and outside, the workplace.", {"entities": []}], ["A randomised control trial (RCT) comparing the effects of a sit-stand workstation only and a multi-component sit-stand workstation intervention, with usual desk-based working practice (no sit-stand workstation) will be conducted with office workers across two organisations, over a 12\u00a0month period (N\u2009=\u200930).", {"entities": []}], ["The multicomponent intervention will comprise organisational, environmental and individual elements.", {"entities": []}], ["Objective data will be collected at baseline, and after 2-weeks, 3-months, 6-months and 12-months of the intervention.", {"entities": []}], ["Objective measures of sitting, standing, and physical activity will be made concurrently (ActivPAL3\u2122 and ActiGraph (GT3X+)).", {"entities": []}], ["Activity diaries, ethnographic participant observation, and interviews with participants and key organisational personnel will be used to elicit understanding of the influence of organisational culture on sitting, standing and physical activity behaviour in the workplace.", {"entities": []}], ["This study will be the first long-term sit-stand workstation intervention study utilising an RCT design, and incorporating a comprehensive process evaluation.", {"entities": []}], ["The study will generate an understanding of the factors that encourage and restrict successful implementation of sit-stand workstation interventions, and will help inform future occupational wellbeing policy and practice.", {"entities": []}], ["Other strengths include the objective measurement of physical activity during both work and non-work hours.", {"entities": []}], ["Clinicaltrials.gov identifier NCT02172599 , 22nd June 2014.", {"entities": []}], ["GP training in Australia can be professionally isolating, with trainees spread across large geographic areas, leading to problems with rural workforce retention.", {"entities": []}], ["Virtual communities of practice (VCoPs) may provide a way of improving knowledge sharing and thus reducing professional isolation.", {"entities": []}], ["The goal of our study was to review the usefulness of a 7-step framework for implementing a VCoP for general practitioner (GP) training and then evaluated the usefulness of the resulting VCoP in facilitating knowledge sharing and reducing professional isolation.", {"entities": []}], ["The case was set in an Australian general practice training region involving 55 first-term trainees (GPT1s), from January to July 2012.", {"entities": []}], ["ConnectGPR was a secure, online community site that included standard community options such as discussion forums, blogs, newsletter broadcasts, webchats, and photo sharing.", {"entities": []}], ["A mixed-methods case study methodology was used.", {"entities": []}], ["Results are presented and interpreted for each step of the VCoP 7-step framework and then in terms of the outcomes of knowledge sharing and overcoming isolation.", {"entities": []}], ["Step 1, Facilitation: Regular, personal facilitation by a group of GP trainers with a co-ordinating facilitator was an important factor in the success of ConnectGPR.", {"entities": []}], ["Step 2, Champion and Support: Leadership and stakeholder engagement were vital.", {"entities": []}], ["Further benefits are possible if the site is recognized as contributing to training time.", {"entities": []}], ["Step 3, Clear Goals: Clear goals of facilitating knowledge sharing and improving connectedness helped to keep the site discussions focused.", {"entities": []}], ["Step 4, A Broad Church: The ConnectGPR community was too narrow, focusing only on first-term trainees (GPT1s).", {"entities": []}], ["Ideally there should be more involvement of senior trainees, trainers, and specialists.", {"entities": []}], ["Step 5, A Supportive Environment: Facilitators maintained community standards and encouraged participation.", {"entities": []}], ["Step 6, Measurement Benchmarking and Feedback: Site activity was primarily driven by centrally generated newsletter feedback.", {"entities": []}], ["Viewing comments by other participants helped users benchmark their own knowledge, particularly around applying guidelines.", {"entities": []}], ["Step 7, Technology and Community: All the community tools were useful, but chat was limited and users suggested webinars in future.", {"entities": []}], ["A larger user base and more training may also be helpful.", {"entities": []}], ["Time is a common barrier.", {"entities": []}], ["Trust can be built online, which may have benefit for trainees that cannot attend face-to-face workshops.", {"entities": []}], ["Knowledge sharing and isolation outcomes: 28/34 (82%) of the eligible GPT1s enrolled on ConnectGPR.", {"entities": []}], ["Trainees shared knowledge through online chat, forums, and shared photos.", {"entities": []}], ["In terms of knowledge needs, GPT1s rated their need for cardiovascular knowledge more highly than supervisors.", {"entities": []}], ["Isolation was a common theme among interview respondents, and ConnectGPR users felt more supported in their general practice (13/14, 92.9%).", {"entities": []}], ["The 7-step framework for implementation of an online community was useful.", {"entities": []}], ["Overcoming isolation and improving connectedness through an online knowledge sharing community shows promise in GP training.", {"entities": []}], ["Time and technology are barriers that may be overcome by training, technology, and valuable content.", {"entities": []}], ["In a VCoP, trust can be built online.", {"entities": []}], ["This has implications for course delivery, particularly in regional areas.", {"entities": []}], ["VCoPs may also have a specific role assisting overseas trained doctors to interpret their medical knowledge in a new context.", {"entities": []}], ["This systematic review and meta-analysis rigorously examines the relationship between glyphosate exposure and risk of lymphohematopoietic cancer (LHC) including NHL, Hodgkin lymphoma (HL), multiple myeloma (MM), and leukemia.", {"entities": [[198, 205, "DISEASE"], [189, 205, "DISEASE"], [174, 182, "DISEASE"], [216, 224, "DISEASE"], [138, 144, "DISEASE"]]}], ["Meta-relative risks (meta-RRs) were positive and marginally statistically significant for the association between any versus no use of glyphosate and risk of NHL (meta-RR = 1.3, 95% confidence interval (CI) = 1.0\u20131.6, based on six studies) and MM (meta-RR = 1.4, 95% CI = 1.0\u20131.9; four studies).", {"entities": []}], ["Associations were statistically null for HL (meta-RR = 1.1, 95% CI = 0.7\u20131.6; two studies), leukemia (meta-RR = 1.0, 95% CI = 0.6\u20131.5; three studies), and NHL subtypes except B-cell lymphoma (two studies each).", {"entities": [[182, 190, "DISEASE"], [92, 100, "DISEASE"]]}], ["Bias and confounding may account for observed associations.", {"entities": []}], ["Meta-analysis is constrained by few studies and a crude exposure metric, while the overall body of literature is methodologically limited and findings are not strong or consistent.", {"entities": []}], ["Thus, a causal relationship has not been established between glyphosate exposure and risk of any type of LHC.", {"entities": []}], ["The importance of energy homeostasis brain circuitry in the context of obesity is well established, however, the developmental ontogeny of this circuitry in humans is currently unknown.", {"entities": [[71, 78, "DISEASE"]]}], ["Here, we investigate the prospective association between newborn gray matter (GM) volume in the insula, a key brain region underlying energy homeostasis, and change in percent body fat accrual over the first six months of postnatal life, an outcome that represents among the most reliable infant predictors of childhood obesity risk.", {"entities": [[320, 327, "DISEASE"]]}], ["52 infants (29 male, 23 female, gestational age at birth=39[1.5] weeks) were assessed using structural MRI shortly after birth (postnatal age at MRI scan=25.9[12.2] days), and serial Dual X-Ray Absorptiometry shortly after birth (postnatal age at DXA scan 1=24.6[11.4] days) and at six months of age (postnatal age at DXA scan 2=26.7[3.3] weeks).", {"entities": []}], ["Insula GM volume was inversely associated with change in percent body fat from birth to six-months postnatal age and accounted for 19% of its variance (\u03b2=-3.6%/S.D., p=0.001).", {"entities": []}], ["This association was driven by the central-posterior portion of the insula, a region of particular importance for gustation and interoception.", {"entities": []}], ["The direction of this effect is in concordance with observations in adults, and the results remained statistically significant after adjusting for relevant covariates and potential confounding variables.", {"entities": []}], ["Together, these findings suggest an underlying neural basis of childhood obesity that precedes the influence of the postnatal environment.", {"entities": [[73, 80, "DISEASE"]]}], ["The identification of plausible brain-related biomarkers of childhood obesity risk that predate the influence of the postnatal obesogenic environment may contribute to an improved understanding of propensity for obesity, early identification of at-risk individuals, and intervention targets for primary prevention.", {"entities": [[70, 77, "DISEASE"], [212, 219, "DISEASE"]]}], ["YKL-40 is associated with tissue injury and inflammation, and consequently to diseases in which these mechanisms lead to tissue degradation, for example, asthma and rheumatoid arthritis.", {"entities": [[165, 185, "DISEASE"], [176, 185, "DISEASE"], [154, 160, "DISEASE"]]}], ["The purpose of the present study was to investigate if YKL-40 is also a significant factor in osteoarthritis (OA) by assessing associations of YKL-40 with mediators related to the pathogenesis of OA: cartilage destructing matrix metalloproteinases (MMPs) and proinflammatory cytokines interleukin-6 (IL-6) and interleukin-17 (IL-17).", {"entities": [[94, 108, "DISEASE"]]}], ["Cartilage, synovial fluid (SF), and plasma samples were obtained from 100 OA patients undergoing total knee replacement surgery.", {"entities": []}], ["SF levels of YKL-40 (1027.9\u2009\u00b1\u200978.3\u2009ng/mL) were considerably higher than plasma levels (67.2\u2009\u00b1\u20094.5\u2009ng/mL) and correlated with YKL-40 released from cartilage samples obtained from the same patients ( r = 0.37, P = 0.010), indicating that YKL-40 is produced by OA cartilage.", {"entities": []}], ["Interestingly, YKL-40 concentrations in OA SF correlated positively with MMP-1 ( r = 0.36, P = 0.014), MMP-3 ( r = 0.46, P = 0.001), IL-6 ( r = 0.57, P < 0.001), and IL-17 ( r = 0.52, P = 0.010) levels.", {"entities": []}], ["Moreover, IL-6 and IL-17 enhanced YKL-40 production in human primary chondrocyte cultures.", {"entities": []}], ["The present study introduces YKL-40 as a cartilage-derived factor associated with mediators of inflammation and cartilage destruction involved in the pathogenesis of OA.", {"entities": []}], ["Beta-blockers have cardioprotective, metabolic and immunomodulating effects that may be beneficial to patients in intensive care.", {"entities": []}], ["We examined the association between preadmission beta-blocker use and 30-day mortality following intensive care.", {"entities": []}], ["We identified 8,087 patients over age 45 admitted to one of three multidisciplinary intensive care units (ICUs) between 1999 and 2005.", {"entities": []}], ["Data on the use of beta-blockers and medications, diagnosis, comorbidities, surgery, markers of socioeconomic status, laboratory tests upon ICU admission, and complete follow-up for mortality were obtained from medical databases.", {"entities": []}], ["We computed probability of death within 30 days following ICU admission for beta-blocker users and non-users, and the odds ratio (OR) of death as a measure of relative risk using conditional logistic regression and also did a propensity score-matched analysis.", {"entities": []}], ["Inclusion of all 8,087 ICU patients in a logistic regression analysis yielded an adjusted OR of 0.82 (95% confidence interval (CI): 0.71 to 0.94) for beta-blocker users compared with non-users.", {"entities": []}], ["In the propensity score-matched analysis we matched all 1,556 beta-blocker users (19.2% of the entire cohort) with 1,556 non-users; the 30-day mortality was 25.7% among beta-blocker users and 31.4% among non-users (OR 0.74 (95% CI: 0.63 to 0.87)].", {"entities": []}], ["The OR was 0.69 (95% CI: 0.54 to 0.88) for surgical ICU patients and 0.71 (95% CI: 0.51 to 0.98) for medical ICU patients.", {"entities": []}], ["The OR was 0.99 (95% CI: 0.67 to 1.47) among users of non-selective beta-blockers, and 0.70 (95% CI: 0.58 to 0.83) among users of cardioselective beta-blockers.", {"entities": []}], ["Preadmission beta-blocker use is associated with reduced mortality following ICU admission.", {"entities": []}], ["Both atopy and smoking are known to be associated with increased bronchial responsiveness.", {"entities": []}], ["Fraction of nitric oxide (NO) in the exhaled air (FE NO ), a marker of airways inflammation, is decreased by smoking and increased by atopy.", {"entities": []}], ["NO has also a physiological bronchodilating and bronchoprotective role.", {"entities": []}], ["To investigate how the relation between FE NO and bronchial responsiveness is modulated by atopy and smoking habits.", {"entities": []}], ["Exhaled NO measurements and methacholine challenge were performed in 468 subjects from the random sample of three European Community Respiratory Health Survey II centers: Turin (Italy), Gothenburg and Uppsala (both Sweden).", {"entities": []}], ["Atopy status was defined by using specific IgE measurements while smoking status was questionnaire-assessed.", {"entities": []}], ["Increased bronchial responsiveness was associated with increased FE NO levels in non-smokers (p\u200a=\u200a0.02) and decreased FE NO levels in current smokers (p\u200a=\u200a0.03).", {"entities": []}], ["The negative association between bronchial responsiveness and FE NO was seen only in the group smoking less <10 cigarettes/day (p\u200a=\u200a0.008).", {"entities": []}], ["Increased bronchial responsiveness was associated with increased FE NO in atopic subjects (p\u200a=\u200a0.04) while no significant association was found in non-atopic participants.", {"entities": []}], ["The reported interaction between FE NO and smoking and atopy, respectively were maintained after adjusting for possible confounders (p-values<0.05).", {"entities": []}], ["The present study highlights the interactions of the relationship between FE NO and bronchial responsiveness with smoking and atopy, suggesting different mechanisms behind atopy- and smoking-related increases of bronchial responsiveness.", {"entities": []}], ["This study aims to explore the correlations of genetic polymorphisms in LIG4 and HSPB1 genes with the radiation-induced lung injury (RILI), especially radiation pneumonitis (RP), in lung cancer patients.", {"entities": [[182, 193, "DISEASE"], [187, 193, "DISEASE"], [72, 76, "GENE"], [81, 86, "GENE"]]}], ["A total of 160 lung cancer patients, who were diagnosed with inoperable lung cancer and received radiotherapy, were included in the present study from September 2009 to December 2011.", {"entities": [[15, 26, "DISEASE"], [72, 83, "DISEASE"], [20, 26, "DISEASE"], [77, 83, "DISEASE"]]}], ["TaqMan Real-Time PCR (RT-PCR) was used to verify the SNPs of LIG4 and HSPB1 genes.", {"entities": [[61, 65, "GENE"], [70, 75, "GENE"]]}], ["Chi-square criterion was used to compare the differences in demographic characteristics, exposure to risk factors, and SNPs genotypes.", {"entities": []}], ["Crude odds ratios (ORs) with 95% confidence intervals (95% CI) were calculated by logistic regression analysis.", {"entities": []}], ["All statistical analyses were conducted in SPSS 18.0.", {"entities": []}], ["A total of 32 (20.0%) lung cancer patients had RP after receiving radiotherapy.", {"entities": [[22, 33, "DISEASE"], [27, 33, "DISEASE"]]}], ["Of the 32 cases, 4 cases were of grade 2, 24 cases were of grade 3, and 4 cases were of grade 4.", {"entities": []}], ["However, our results indicated that the general condition and treatment of all patients had no significant difference with RP risk ( P > 0.05).", {"entities": []}], ["Meanwhile, our results revealed that there was no significant association between the frequencies of LIG4 rs1805388 and HSPB1 rs2868371 genotype distribution and the risk of RP ( P > 0.05).", {"entities": [[101, 105, "GENE"], [120, 125, "GENE"]]}], ["Conclusion.", {"entities": []}], ["In conclusion, we demonstrated that the genetic polymorphisms in LIG4 rs1805388 and HSPB1 rs2868371 were not obviously correlated with the risk of RP and RILI of lung cancer.", {"entities": [[162, 173, "DISEASE"], [167, 173, "DISEASE"], [65, 69, "GENE"], [84, 89, "GENE"]]}], ["This Health Impact Assessment (HIA) informed the decision of expanding public transportation services to rural, low income communities of southern Do\u00f1a Ana County, New Mexico on the U.S./Mexico border.", {"entities": []}], ["The HIA focused on impacts of access to health care services, education, and economic development opportunities.", {"entities": []}], ["Qualitative and quantitative data were collected from surveys of community members, key informant interviews, a focus group with community health workers, and passenger surveys during an initial introduction of the transit system.", {"entities": []}], ["Results from the survey showed that a high percentage of respondents would use the bus system to access the following: (1) 84% for health services; (2) 83% for formal and informal education opportunities; and (3) 81% for economic opportunities.", {"entities": []}], ["Results from interviews and the focus group supported the benefits of access to services but many were concerned with the high costs of providing bus service in a rural area.", {"entities": []}], ["We conclude that implementing the bus system would have major impacts on resident\u2019s health through improved access to: (1) health services, and fresh foods, especially for older adults; (2) education opportunities, such as community colleges, universities, and adult learning, especially for young adults; and (3) economic opportunities, especially jobs, job training, and consumer goods and services.", {"entities": []}], ["We highlight the challenges associated with public transportation in rural areas where there are: (1) long distances to travel; (2) difficulties in scheduling to meet all needs; and (3) poor road and walking conditions for bus stops.", {"entities": []}], ["The results are applicable to low income and fairly disconnected rural areas, where access to health, education, and economic opportunities are limited.", {"entities": []}], ["Systemic Lupus Erythematosus (SLE) is an autoimmune disorder characterized by excessive production of a variety of autoantibodies and a wide range of clinical manifestations.", {"entities": []}], ["Pathogenesis of SLE is complex and not fully understood.", {"entities": []}], ["There is however evidence that B and T cells are critical to the development of disease, and that T cell-derived cytokines are involved in the SLE-associated inflammatory response.", {"entities": []}], ["One such cytokine seems to be interleukin (IL)-21, the latest identified member of the \u03b3 -chain-related cytokine family.", {"entities": []}], ["IL-21 has an important role in the control of the growth, survival, differentiation, and function of both T and B cells, and excessive production of IL-21 has been associated with the development of multiple immune-mediated diseases.", {"entities": []}], ["Here we review data supporting the involvement of IL-21 in the pathogenesis of SLE.", {"entities": []}], ["Nasopharyngeal carcinoma (NPC) is a head and neck cancer with high incidence in South China and East Asia.", {"entities": [[15, 24, "DISEASE"], [50, 56, "DISEASE"]]}], ["To provide a theoretical basis for NPC risk screening and early prevention, we conducted a meta-analysis of relevant literature on the association of single nucleotide polymorphisms (SNP)s with NPC susceptibility.", {"entities": []}], ["Further, expression of 15 candidate SNPs identified in the meta-analysis was evaluated in a cohort of NPC patients and healthy volunteers using next-generation sequencing technology.", {"entities": []}], ["Among the 15 SNPs detected in the meta-analysis, miR-146a (rs2910164, C>G), HCG9 (rs3869062, A>G), HCG9 (rs16896923, T>C), MMP2 (rs243865, C>T), GABBR1 (rs2076483, T>C), and TP53 (rs1042522, C>G) were associated with decreased susceptibility to NPC, while GSTM1 (+/DEL), IL-10 (rs1800896, A>G), MDM2 (rs2279744, T>G), MDS1-EVI1 (rs6774494, G>A), XPC (rs2228000, C>T), HLA-F (rs3129055, T>C), SPLUNC1 (rs2752903, T>C; and rs750064, A>G), and GABBR1 (rs29232, G>A) were associated with increased susceptibility to NPC.", {"entities": [[49, 57, "GENE"], [123, 127, "GENE"], [145, 151, "GENE"], [441, 447, "GENE"], [174, 178, "GENE"], [256, 261, "GENE"], [295, 299, "GENE"], [346, 349, "GENE"], [368, 373, "GENE"], [145, 151, "GENE"], [441, 447, "GENE"]]}], ["In our case-control study, an association with increased risk for NPC was found for the AG vs AA genotype in HCG9 (rs3869062, A>G).", {"entities": []}], ["In addition, heterozygous deletion of the GSTM1 allele was associated with increased susceptibility to NPC, while an SNP in GABBR1 (rs29232, G>A) was associated with decreased risk, and might thus have a protective role on NPC carcinogenesis.", {"entities": [[42, 47, "GENE"], [124, 130, "GENE"]]}], ["This work provides the first comprehensive assessment of SNP expression and its relationship to NPC risk.", {"entities": []}], ["It suggests the need for well-designed, larger confirmatory studies to validate its findings.", {"entities": []}], ["The purpose of this study was to determine, among the Indian community of Chatsworth, South Africa, the prevalence and utilisation patterns of complementary and alternative medicine (CAM), attitudes associated with CAM use and communication patterns of CAM users with their primary care doctors.", {"entities": []}], ["Face-to-face structured interviews were conducted in Chatsworth, a suburb of Durban in which South Africans of Indian origin predominantly reside.", {"entities": []}], ["Participants were 200 randomly selected adult English-speaking Indian residents.", {"entities": []}], ["The prevalence of CAM usage for period 2000/2001 was 38.5% (95% confidence interval 31.7% to 45.6%).", {"entities": []}], ["Spiritual healing and herbal/natural medicines, including vitamins were the most common types of CAM used, accounting for 42.8% and 48.1% respectively of overall CAM usage.", {"entities": []}], ["People used CAM to treat conditions including diabetes mellitus, headaches, arthritis and joint pains, stress, skin disorders, backaches, hypertension and nasal disorders.", {"entities": [[138, 150, "DISEASE"], [76, 85, "DISEASE"], [46, 63, "DISEASE"]]}], ["Half of the CAM users used allopathic medicines concurrently.", {"entities": []}], ["The cost of CAM utilization over this 1-year period, incurred by 80.5% of users for the duration of therapy for their most troublesome condition was below R500 (approximately US$50).", {"entities": []}], ["Age, sex, marital status, religion, level of education and income were shown not to influence the use of CAM.", {"entities": []}], ["Greater than half (51.9%) of CAM users did so either upon the advice of someone they knew, or after noticing a CAM advertisement in the local press.", {"entities": []}], ["Seventy-nine percent of CAM users indicated that they had positive outcomes with their treatments.", {"entities": []}], ["Fifty four percent of CAM users (excluding those using spiritual healing only) failed to inform their doctors that they used CAM.", {"entities": []}], ["The main reason given by half of this group was that informing their doctors did not seem necessary.", {"entities": []}], ["The prevalence of CAM in Chatsworth is similar to findings in other parts of the world.", {"entities": []}], ["Although CAM was used to treat many different ailments, this practice could not be attributed to any particular demographic profile.", {"entities": []}], ["The majority of CAM users were satisfied with the effects of CAM.", {"entities": []}], ["Findings support a need for greater integration of allopathic medicine and CAM, as well as improved communication between patients and caregivers regarding CAM usage.", {"entities": []}], ["This study was designed to evaluate the utility of transdermal fentanyl (transdermal fentanyl, TDF) for the treatment of pain due to osteoarthritis (osteoarthritis, OA) of the knee and hip, which was not adequately controlled by nonopioid analgesics or weak opioids.", {"entities": [[133, 147, "DISEASE"], [149, 163, "DISEASE"]]}], ["WOMAC is a reliable, valid, and responsive multidimensional, self-administrated outcome measure designed specifically to evaluate patients with OA of the knee or hip.", {"entities": []}], ["TDF significantly increased pain control and improved functioning and quality of life.", {"entities": []}], ["Metoclopramide appeared to be of limited value in preventing nausea and vomiting.", {"entities": []}], ["To investigate the association of chemokine gene polymorphisms and Behcet's disease (BD) and Vogt Koyanagi Harada (VKH) disease in a Chinese Han population.", {"entities": []}], ["A case-control study was performed.", {"entities": []}], ["Three hundred and seventy-one BD patients, 371 VKH disease patients, and 605 healthy controls were recruited to determine genetic variants of 26 SNPs in 12 chemokine genes with iPLEX Gold genotyping assay and Sequenom MassARRAY or TaqMan SNP assays.", {"entities": []}], ["In this study, P uncorr values showed a weak association of five SNPs of five genes in BD and three SNPs of three genes in VKH disease.", {"entities": []}], ["However, after Bonferroni correction, the 26 investigated SNPs showed no significant differences in genetic variants, including genotype and allele frequencies, between BD or VKH disease patients and healthy individuals.", {"entities": []}], ["Haplotype analysis for the chemokine genes showed a significant association with the TC haplotype of CXCL12 in VKH.", {"entities": [[101, 107, "GENE"]]}], ["Stratified gender analysis and genotype-phenotype analysis were conducted to analyze the association of the 26 SNPs of 12 chemokine genes with BD and VKH disease.", {"entities": []}], ["However, no significant association was observed after Bonferroni correction.", {"entities": []}], ["This study showed no association of 26 SNPs in 12 chemokine genes with both BD and VKH disease in a Chinese Han population.", {"entities": []}], ["The bronchial microbiome in chronic lung diseases presents an abnormal pattern, but its microbial composition and regional differences in severe asthma have not been sufficiently addressed.", {"entities": [[145, 151, "DISEASE"]]}], ["The aim of the study was to describe the bacterial community in bronchial mucosa and secretions of patients with severe chronic asthma chronically treated with corticosteroids in addition to usual care according to Global Initiative for Asthma.", {"entities": [[128, 134, "DISEASE"], [237, 243, "DISEASE"]]}], ["Bacterial community composition was obtained by 16S rRNA gene amplification and sequencing, and functional capabilities through PICRUSt.", {"entities": []}], ["Thirteen patients with severe asthma were included and provided 11 bronchial biopsies (BB) and 12 bronchial aspirates (BA) suitable for sequence analyses.", {"entities": [[30, 36, "DISEASE"]]}], ["Bacteroidetes, Firmicutes, Proteobacteria and Actinobacteria showed relative abundances (RAs) over 5% in BB, a cutoff that was reached by Streptococcus and Prevotella at genus level.", {"entities": []}], ["Legionella genus attained a median RA of 2.7 (interquartile range 1.1\u20134.7) in BB samples.", {"entities": []}], ["In BA a higher RA of Fusobacteria was found, when compared with BB [8.7 (5.9\u201311.4) vs 4.2 (0.8\u20137.5), p \u2009=\u20090.037], while the RA of Proteobacteria was lower in BA [4.3 (3.7\u20136.5) vs 17.1 (11.2\u201333.4), p \u2009=\u20090.005].", {"entities": []}], ["RA of the Legionella genus was also significantly lower in BA [0.004 (0.001\u20130.02) vs. 2.7 (1.1\u20134.7), p \u2009=\u20090.005].", {"entities": []}], ["Beta-diversity analysis confirmed the differences between the microbial communities in BA and BB (R p \u2009=\u20090.001, Adonis test), and functional analysis revealed also statistically significant differences between both types of sample on Metabolism , Cellular processes , Human diseases , Organismal systems and Genetic information processing pathways.", {"entities": []}], ["The microbiota in the bronchial mucosa of severe asthma has a specific pattern that is not accurately represented in bronchial secretions, which must be considered a different niche of bacteria growth.", {"entities": [[49, 55, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12866-017-0933-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Ziziphora tenuior L. (Kakuti in Persian) is used in traditional medicine for treatment of gastrointestinal disorders as carminative and analgesic plant.", {"entities": []}], ["The other usages of this plant are included treatment of diarrhea and nausea.", {"entities": [[57, 65, "DISEASE"]]}], ["Therefore in the present study we evaluated the immunomodulatory effects of the ethanolic extract of this plant on the dendritic cells (DCs).", {"entities": []}], ["Ziziphora tenuior L. extract significantly (p\u2009=\u20090.002) increased the level of surface expression of CD40 as an important co-stimulatory marker on DCs compared to the control.", {"entities": [[100, 104, "GENE"]]}], ["However this extract did not change CD86 and MHC-II molecules, so it could promote DCs phenotypic maturation.", {"entities": [[36, 40, "GENE"]]}], ["Treatment of DCs with the extract resulted in slightly increased of the production of (IL-12); however, this change was not significant.", {"entities": []}], ["In addition, the ability of treated DCs to stimulate allogenic T cells proliferation and cytokines secretion was examined in the co-cuture of these cells with T cells in mixed lymphocyte reaction (MLR).", {"entities": []}], ["Z. tenuior L. at the 100\u00a0\u03bcg/ml concentration inhibited the proliferation of allogenic T cells and also significantly (P\u2009<\u20090.001) increased the level of IL-10.", {"entities": []}], ["Moreover, the extract at 10\u2013100\u00a0\u03bcg/ml concentration caused slightly increase in IFN-\u03b3 production and decreased IL-4 cytokines but these changes were not significant.", {"entities": []}], ["These findings indicated that Z. tenuior L. extract can modulate immune response by induction of CD40 expression on DCs and cytokine production; whereas it can inhibit T cell stimulating activity of DCs in high concentration.", {"entities": [[97, 101, "GENE"]]}], ["These findings possibly in part explain the traditional use of this plant in treatment of immune-mediated disorders.", {"entities": []}], ["However future studies are needed.", {"entities": []}], ["Chronic lung inflammation commonly induces a multitude of structural and functional adaptations within the lung tissue and airspaces.", {"entities": []}], ["Yet the impact of a persistent inflammatory environment on alveolar macrophages is still incompletely understood.", {"entities": []}], ["Here, we examined morphology and function of alveolar macrophages in a transgenic mouse model of chronic lung disease.", {"entities": [[105, 117, "DISEASE"]]}], ["Imaging flow cytometry, flow cytometry, and microscopic evaluation of alveolar macrophages isolated from healthy and inflamed lungs were performed.", {"entities": []}], ["Gene expression of polarization markers was compared by quantitative real-time RT-PCR.", {"entities": []}], ["The pro-inflammatory immune response of alveolar macrophages toward bacterial ligands was assessed in in vivo clodronate-liposome depletion studies.", {"entities": []}], ["Chronic lung inflammation is associated with a substantially altered, activated alveolar macrophage morphology, and blunted TNF- \u03b1 response by these cells following stimulation with ligands derived from the respiratory pathogen Streptococcus pneumoniae .", {"entities": []}], ["These results demonstrate pleiotropic effects of pulmonary inflammation on alveolar macrophage phenotype and function and suggest a functional impairment of these cells during infection with airborne pathogens.", {"entities": []}], ["Articular cartilage has poor capability for repair following trauma or degenerative pathology due to avascular property, low cell density and migratory ability.", {"entities": []}], ["Discovery of novel therapeutic approaches for articular cartilage repair remains a significant clinical need.", {"entities": []}], ["Hypoxia is a hallmark for cartilage development and pathology.", {"entities": []}], ["Hypoxia inducible factor-1alpha (HIF-1\u03b1) has been identified as a key mediator for chondrocytes to response to fluctuations of oxygen availability during cartilage development or repair.", {"entities": []}], ["This suggests that HIF-1\u03b1 may serve as a target for modulating chondrocyte functions.", {"entities": []}], ["In this study, using phenotypic cellular screen assays, we identify that Icariin, an active flavonoid component from Herba Epimedii, activates HIF-1\u03b1 expression in chondrocytes.", {"entities": []}], ["We performed systemic in vitro and in vivo analysis to determine the roles of Icariin in regulation of chondrogenesis.", {"entities": []}], ["Our results show that Icariin significantly increases hypoxia responsive element luciferase reporter activity, which is accompanied by increased accumulation and nuclear translocation of HIF-1\u03b1 in murine chondrocytes.", {"entities": []}], ["The phenotype is associated with inhibiting PHD activity through interaction between Icariin and iron ions.", {"entities": []}], ["The upregulation of HIF-1\u03b1 mRNA levels in chondrocytes persists during chondrogenic differentiation for 7 and 14 days.", {"entities": []}], ["Icariin (10 Sox9 , collagen type 2 ( Col2\u03b1 1) and aggrecan as determined by real-time PCR and promotes extracellular matrix (ECM) synthesis indicated by Alcian blue staining.", {"entities": [[12, 16, "GENE"]]}], ["ELISA assays show dramatically increased production of aggrecan and hydroxyproline in Icariin-treated cultures at day 14 of chondrogenic differentiation as compared with the controls.", {"entities": []}], ["Meanwhile, the expression of chondrocyte catabolic marker genes including Mmp2 , Mmp9 , Mmp13 , Adamts4 and Adamts5 was downregulated following Icariin treatment for 14 days.", {"entities": [[74, 78, "GENE"], [81, 85, "GENE"], [88, 93, "GENE"], [96, 103, "GENE"], [108, 115, "GENE"]]}], ["In a differentiation assay using bone marrow mesenchymal stem cells (MSCs) carrying HIF-1\u03b1 floxed allele, the promotive effect of Icariin on chondrogenic differentiation is largely decreased following Cre recombinase-mediated deletion of HIF-1\u03b1 in MSCs as indicated by Alcian blue staining for proteoglycan synthesis.", {"entities": []}], ["In an alginate hydrogel 3D culture system, Icariin increases Safranin O positive (SO+) cartilage area.", {"entities": []}], ["This phenotype is accompanied by upregulation of HIF-1\u03b1, increased proliferating cell nuclear antigen positive (PCNA+) cell numbers, SOX9+ chondrogenic cell numbers, and Col2 expression in the newly formed cartilage.", {"entities": []}], ["Coincide with the micromass culture, Icariin treatment upregulates mRNA levels of Sox9 , Col2\u03b11 , aggrecan and Col10\u03b11 in the 3D cultures.", {"entities": [[82, 86, "GENE"]]}], ["We then generated alginate hydrogel 3D complexes incorporated with Icariin.", {"entities": []}], ["The 3D complexes were transplanted in a mouse osteochondral defect model.", {"entities": []}], ["ICRS II histological scoring at 6 and 12 weeks post-transplantation shows that 3D complexes incorporated with Icariin significantly enhance articular cartilage repair with higher scores particularly in selected parameters including SO+ cartilage area, subchondral bone and overall assessment than that of the controls.", {"entities": []}], ["The results suggest that Icariin may inhibit PHD activity likely through competition for cellular iron ions and therefore it may serve as an HIF-1\u03b1 activator to promote articular cartilage repair through regulating chondrocyte proliferation, differentiation and integration with subchondral bone formation.", {"entities": []}], ["This study involved a randomized, controlled, single-blind 12-month treatment study of a comprehensive nutritional and dietary intervention.", {"entities": []}], ["Participants were 67 children and adults with autism spectrum disorder (ASD) ages 3\u201358 years from Arizona and 50 non-sibling neurotypical controls of similar age and gender.", {"entities": [[46, 70, "DISEASE"]]}], ["Treatment began with a special vitamin/mineral supplement, and additional treatments were added sequentially, including essential fatty acids, Epsom salt baths, carnitine, digestive enzymes, and a healthy gluten-free, casein-free, soy-free (HGCSF) diet.", {"entities": []}], ["There was a significant improvement in nonverbal intellectual ability in the treatment group compared to the non-treatment group (+6.7 \u00b1 11 IQ points vs. \u22120.6 \u00b1 11 IQ points, p = 0.009) based on a blinded clinical assessment.", {"entities": []}], ["Based on semi-blinded assessment, the treatment group, compared to the non-treatment group, had significantly greater improvement in autism symptoms and developmental age.", {"entities": []}], ["The treatment group had significantly greater increases in EPA, DHA, carnitine, and vitamins A, B2, B5, B6, B12, folic acid, and Coenzyme Q10.", {"entities": []}], ["The positive results of this study suggest that a comprehensive nutritional and dietary intervention is effective at improving nutritional status, non-verbal IQ, autism symptoms, and other symptoms in most individuals with ASD.", {"entities": []}], ["Parents reported that the vitamin/mineral supplements, essential fatty acids, and HGCSF diet were the most beneficial.", {"entities": []}], ["Non-infectious inhaled microbial particles can cause illness by triggering an inappropriate immunological response.", {"entities": []}], ["From the pathogenic point of view these illnesses can be seen to be related to on one hand autoimmune diseases and on the other infectious diseases.", {"entities": []}], ["In this review three such illnesses are discussed in some detail.", {"entities": []}], ["Hypersensitivity pneumonitis (HP) is the best known of these illnesses and it has also been widely studied in animal models and clinically.", {"entities": [[30, 32, "GENE"]]}], ["In contrast to HP Pulmonary mycotoxicosis (PM) is not considered to involve immunological memory, it is an acute self-limiting condition is caused by an immediate \"toxic\" effect.", {"entities": [[15, 17, "GENE"]]}], ["Damp building related illness (DBRI) is a controversial and from a diagnostic point poorly defined entity that is however causing, or attributed to cause, much more morbidity than the two other diseases.", {"entities": []}], ["In the recent decade there has been a shift in the focus of immunology from the lymphocyte centered, adaptive immunity towards innate immunity.", {"entities": []}], ["The archetypal cell in innate immunity is the macrophage although many other cell types participate.", {"entities": []}], ["Innate immunity relies on a limited number of germline coded receptors for the recognition of pathogens and signs of cellular damage.", {"entities": []}], ["The focus on innate immunity has opened new paths for the understanding of many chronic inflammatory diseases.", {"entities": []}], ["The purpose of this review is to discuss the impact of some recent studies, that include aspects concerning innate immunity, on our understanding of the pathogenesis of inflammatory diseases associated with exposure to inhaled microbial matter.", {"entities": []}], ["Interferon-\u03b3 (IFN-\u03b3) plays a crucial role in Mycobacterium tuberculosis induced pleural responses.", {"entities": [[59, 71, "DISEASE"]]}], ["Interleukin (IL)-33 up-regulates the production of IFN-\u03b3.", {"entities": []}], ["We aimed to identify whether an association between pleural IL-33 levels and tuberculous pleurisy exists and determine its diagnostic value.", {"entities": [[89, 97, "DISEASE"]]}], ["Pleural IL-33, ST2 (a receptor of IL-33), adenosine deaminase (ADA), and IFN-\u03b3, as well as serum IL-33 and ST2 were measured in 220 patients with pleural effusions (PEs).", {"entities": [[63, 66, "GENE"]]}], ["Patients with malignant (MPEs), parapneumonic (PPEs), tuberculous (TPEs), and cardiogenic (CPEs) pleural effusions were included.", {"entities": []}], ["Pleural and serum IL-33 levels were highest or tended to be higher in patients with TPEs than in those with other types of PEs.", {"entities": []}], ["The median pleural fluid-to-serum IL-33 ratio was higher in TPE cases (\u2265 0.91) than in other PE cases (\u2264 0.56).", {"entities": []}], ["Pleural IL-33 levels correlated with those of pleural ADA and IFN-\u03b3.", {"entities": [[54, 57, "GENE"]]}], ["However, the diagnostic accuracies of pleural IL-33 (0.74) and pleural fluid-to-serum IL-33 ratio (0.75) were lower than that of ADA (0.95) or IFN-\u03b3 (0.97).", {"entities": [[129, 132, "GENE"]]}], ["Pleural ST2 levels in patients with MPEs were higher than in patients with TPEs.", {"entities": []}], ["Serum ST2 levels did not differ among the groups.", {"entities": []}], ["We identified an association between elevated pleural IL-33 levels and tuberculous pleurisy.", {"entities": [[83, 91, "DISEASE"]]}], ["However, we recommend conventional pleural markers (ADA or IFN-\u03b3) as diagnostic markers of TPE.", {"entities": [[52, 55, "GENE"]]}], ["Nonspecific interstitial pneumonia (NSIP) has been identified as a distinct entity with a more favorable prognosis and better response to immunosuppressive therapies than usual interstitial pneumonia (UIP).", {"entities": [[25, 34, "DISEASE"], [190, 199, "DISEASE"]]}], ["However the inflammatory profile of NSIP has not been characterized.", {"entities": []}], ["Using immunohistochemistry techniques on open lung biopsy specimens, the infiltrate in NSIP was characterized in terms of T and B cells, and macrophages, and the T cell population further identified as either CD4 (helper) or CD8 (suppressor-cytotoxic) T cells.", {"entities": [[209, 212, "GENE"]]}], ["The extent of Th1 and Th2 cytokine producing cells was determined and compared to specimens from patients with UIP.", {"entities": []}], ["In ten NSIP tissue samples 41.4 \u00b1 4% of mononuclear cells expressed CD3, 24.7 \u00b1 1.8% CD4, 19.1 \u00b1 2% CD8, 27.4 \u00b1 3.9% CD20, and 14.3 \u00b1 1.6% had CD68 expression.", {"entities": [[85, 88, "GENE"], [143, 147, "GENE"]]}], ["Mononuclear cells expressed INF\u03b3 21.9 \u00b1 1.9% of the time and IL-4 in 3.0 \u00b1 1%.", {"entities": []}], ["In contrast, biopsies from eight patients with UIP demonstrated substantially less cellular staining for either cytokine (INF\u03b3; 4.6 \u00b1 1.7% and IL-4; 0.6 \u00b1 0.3%).", {"entities": []}], ["Significant populations of CD20 positive B-cells were also identified.", {"entities": []}], ["The lymphocytic infiltrate in NSIP is characterized by an elevated CD4/CD8 T-cell ratio, and is predominantly of Th1 type, with additional populations rich in B-cells.", {"entities": []}], ["Such features are consistent with the favorable clinical course observed in patients with NSIP compared to UIP.", {"entities": []}], ["NHS general practice payments in England include pay for performance elements and a weighted component designed to compensate for workload, but without measures of specific deprivation or ethnic groups.", {"entities": [[0, 3, "GENE"]]}], ["To determine whether population factors related to health needs predicted variations in NHS payments to individual general practices in England.", {"entities": [[88, 91, "GENE"]]}], ["Cross-sectional study of all practices in England, in financial years 2013\u20132014 and 2014\u20132015.", {"entities": []}], ["Descriptive statistics, univariable analyses (examining correlations between payment and predictors), and multivariable analyses (undertaking multivariable linear regressions for each year, with logarithms of payments as the dependent variables, and with population, practice, and performance factors as independent variables) were undertaken.", {"entities": []}], ["Several population variables predicted variations in adjusted total payments, but inconsistently.", {"entities": []}], ["Higher payments were associated with increases in deprivation, patients of older age, African Caribbean ethnic group, and asthma prevalence.", {"entities": [[122, 128, "DISEASE"]]}], ["Lower payments were associated with an increase in smoking prevalence.", {"entities": []}], ["Long-term health conditions, South Asian ethnic group, and diabetes prevalence were not predictive.", {"entities": []}], ["The adjusted R Population factors related to health needs were, overall, poor predictors of variations in adjusted total practice payments and in the payment component designed to compensate for workload.", {"entities": []}], ["Revising the weighting formula and extending weighting to other payment components might better support practices to address these needs.", {"entities": []}], ["A major challenge in immunology is how to translate data into knowledge given the inherent complexity and dynamics of human physiology.", {"entities": []}], ["Both the physiology and engineering communities have rich histories in applying computational approaches to translate data obtained from complex systems into knowledge of system behavior.", {"entities": []}], ["However, there are some differences in how disciplines approach problems.", {"entities": []}], ["By referring to mathematical models as mathematical prototypes, we aim to highlight aspects related to the process (i.e., prototyping) rather than the product (i.e., the model).", {"entities": []}], ["The objective of this paper is to review how two related engineering concepts, specifically prototyping and \u201cfitness for use,\u201d can be applied to overcome the pressing challenge in translating data into improved knowledge of basic immunology that can be used to improve therapies for disease.", {"entities": []}], ["These concepts are illustrated using two immunology-related examples.", {"entities": []}], ["The prototypes presented focus on the beta cell mass at the onset of type 1 diabetes and the dynamics of dendritic cells in the lung.", {"entities": []}], ["This paper is intended to illustrate some of the nuances associated with applying mathematical modeling to improve understanding of the dynamics of disease progression in humans.", {"entities": []}], ["We show that distinct subsets of mast cells (MCs) expand with sequential oncogenic events in small bowel cancer.", {"entities": [[105, 111, "DISEASE"]]}], ["Mucosal mast cells (MMCs) previously detected early during Trichinella spiralis infection expand in adenomatous polyps in an IL-10\u2013dependent manner.", {"entities": []}], ["Connective tissue mast cells (CTMCs), earlier shown to expand during the resolution of inflammation following clearance of T. spiralis, are independent of IL-10 and associate with the transition of polyps to adenocarcinoma.", {"entities": [[208, 222, "DISEASE"]]}], ["IL-33 upregulates the CTMC lineage-specific protease murine mast cell protease 6 (mMCP6).", {"entities": []}], ["Ablation of mMCP6 attenuates tumor growth.", {"entities": []}], ["Thus, tissue sentinel cells respond to oncogenic events and cellular transformation in effect to help promote cancer.", {"entities": [[110, 116, "DISEASE"]]}], ["Delineating the types of MCs present at various stages of disease offers actionable cellular targets for therapeutic intervention in disease progression.", {"entities": []}], ["Mast cells (MCs) are tissue resident sentinels that mature and orchestrate inflammation in response to infection and allergy.", {"entities": []}], ["While they are also frequently observed in tumors, the contribution of MCs to carcinogenesis remains unclear.", {"entities": []}], ["Here, we show that sequential oncogenic events in gut epithelia expand different types of MCs in a temporal-, spatial-, and cytokine-dependent manner.", {"entities": []}], ["The first wave of MCs expands focally in benign adenomatous polyps, which have elevated levels of IL-10, IL-13, and IL-33, and are rich in type-2 innate lymphoid cells (ILC2s).", {"entities": []}], ["These vanguard MCs adhere to the transformed epithelial cells and express murine mast cell protease 2 (mMCP2; a typical mucosal MC protease) and, to a lesser extent, the connective tissue mast cell (CTMC) protease mMCP6.", {"entities": []}], ["Persistence of MCs is strictly dependent on T cell-derived IL-10, and their loss in the absence of IL-10\u2013expressing T cells markedly delays small bowel (SB) polyposis.", {"entities": []}], ["MCs expand profusely in polyposis-prone mice when T cells overexpress IL-10.", {"entities": []}], ["The frequency of polyp-associated MCs is unaltered in response to broad-spectrum antibiotics, arguing against a microbial component driving their recruitment.", {"entities": []}], ["Intriguingly, when polyps become invasive, a second wave of mMCP5", {"entities": []}], ["Glycosylation of glycoproteins is one of many molecular changes that accompany malignant transformation.", {"entities": []}], ["Post-translational modifications of proteins are closely associated with the adhesion, invasion, and metastasis of tumor cells.", {"entities": []}], ["CD147, a tumor-associated antigen that is highly expressed on the cell surface of various tumors, is a potential target for cancer diagnosis and therapy.", {"entities": [[124, 130, "DISEASE"]]}], ["A significant biochemical property of CD147 is its high level of glycosylation.", {"entities": []}], ["Studies on the structure and function of CD147 glycosylation provide valuable clues to the development of targeted therapies for cancer.", {"entities": [[129, 135, "DISEASE"]]}], ["Here, we review current understanding of the glycosylation characteristics of CD147 and the glycosyltransferases involved in the biosynthesis of CD147 N -glycans.", {"entities": []}], ["Finally, we discuss proteins regulating CD147 glycosylation and the biological functions of CD147 glycosylation.", {"entities": []}], ["To investigate the underlying causes of chemoresistance in malignant pleural mesothelioma, we have studied mesothelioma cell lines as 3D spheroids, which acquire increased chemoresistance compared to 2D monolayers.", {"entities": [[59, 89, "DISEASE"]]}], ["We asked whether the gene expression of 3D spheroids would reveal mechanisms of resistance.", {"entities": []}], ["To address this, we measured gene expression of three mesothelioma cell lines, M28, REN and VAMT, grown as 2D monolayers and 3D spheroids.", {"entities": [[84, 87, "GENE"]]}], ["A total of 209 genes were differentially expressed in common by the three cell lines in 3D (138 upregulated and 71 downregulated), although a clear resistance pathway was not apparent.", {"entities": []}], ["We then compared the list of 3D genes with two publicly available datasets of gene expression of 56 pleural mesotheliomas compared to normal tissues.", {"entities": []}], ["Interestingly, only three genes were increased in both 3D spheroids and human tumors: argininosuccinate synthase 1 (ASS1), annexin A4 (ANXA4) and major vault protein (MVP); of these, ASS1 was the only consistently upregulated of the three genes by qRT-PCR.", {"entities": [[116, 120, "GENE"], [183, 187, "GENE"], [135, 140, "GENE"], [167, 170, "GENE"], [116, 120, "GENE"], [183, 187, "GENE"]]}], ["To measure ASS1 protein expression, we stained 2 sets of tissue microarrays (TMA): one with 88 pleural mesothelioma samples and the other with additional 88 pleural mesotheliomas paired with matched normal tissues.", {"entities": [[11, 15, "GENE"]]}], ["Of the 176 tumors represented on the two TMAs, ASS1 was expressed in 87 (50%; staining greater than 1 up to 3+).", {"entities": [[47, 51, "GENE"]]}], ["For the paired samples, ASS1 expression in mesothelioma was significantly greater than in the normal tissues.", {"entities": [[24, 28, "GENE"]]}], ["Reduction of ASS1 expression by siRNA significantly sensitized mesothelioma spheroids to the pro-apoptotic effects of bortezomib and of cisplatin plus pemetrexed.", {"entities": [[13, 17, "GENE"]]}], ["Although mesothelioma is considered by many to be an ASS1-deficient tumor, our results show that ASS1 is elevated at the mRNA and protein levels in mesothelioma 3D spheroids and in human pleural mesotheliomas.", {"entities": [[53, 57, "GENE"], [97, 101, "GENE"]]}], ["We also have uncovered a survival role for ASS1, which may be amenable to targeting to undermine mesothelioma multicellular resistance.", {"entities": [[43, 47, "GENE"]]}], ["Few validated measures exist to evaluate self-management of diabetes in families with limited English proficiency.", {"entities": []}], ["The present study evaluated the psychometric properties and the factorial equivalence of a Spanish translation of the parent report version of the Diabetes Self-Management Profile (DSMP-Parent-Sp).", {"entities": []}], ["Hispanic families of youth (mean 13.7 years old) with type 1 diabetes were recruited from three clinics in South Florida and represented a wide range of nationalities and acculturation levels.", {"entities": []}], ["A total of 127 parents reported on their child's self-management behaviors using either the original DSMP-Parent (59.8%) or the DSMP-Parent-Sp (40.2%).", {"entities": []}], ["In addition, youth reported their self-management using the original DSMP in English, and physicians rated their perceptions of the youth's self-management.", {"entities": []}], ["Glycemic control was indexed by A1C in the past 3 months and collected from medical chart review.", {"entities": []}], ["Item analysis confirmed that the DSMP-Parent-Sp items related to the overall composite score in expected ways, and internal consistency estimates were adequate.", {"entities": []}], ["Paired correlations demonstrated strong parent-child concordance and a significant relationship with physician perceptions of self-management.", {"entities": []}], ["Evidence of concurrent and convergent validity, as well as \u201cstrict factorial invariance,\u201d was demonstrated.", {"entities": []}], ["These preliminary findings indicate that the DSMP-Parent-Sp is a reliable and valid parent report measure of the diabetes self-management behaviors of Hispanic youths.", {"entities": []}], ["In addition, there is preliminary evidence that the translated measure may be considered equivalent to the original English measure when used to measure self-management in Hispanic youth with diabetes.", {"entities": []}], ["The large-scale production of G-protein coupled receptors (GPCRs) for functional and structural studies remains a challenge.", {"entities": []}], ["Recent successes have been made in the expression of a range of GPCRs using Pichia pastoris as an expression host.", {"entities": []}], ["P. pastoris has a number of advantages over other expression systems including ability to post-translationally modify expressed proteins, relative low cost for production and ability to grow to very high cell densities.", {"entities": []}], ["Several previous studies have described the expression of GPCRs in P. pastoris using shaker flasks, which allow culturing of small volumes (500 ml) with moderate cell densities (OD600 ~15).", {"entities": []}], ["The use of bioreactors, which allow straightforward culturing of large volumes, together with optimal control of growth parameters including pH and dissolved oxygen to maximise cell densities and expression of the target receptors, are an attractive alternative.", {"entities": []}], ["The aim of this study was to compare the levels of expression of the human Adenosine 2A receptor (A 2A R) in P. pastoris under control of a methanol-inducible promoter in both flask and bioreactor cultures.", {"entities": []}], ["Bioreactor cultures yielded an approximately five times increase in cell density (OD600 ~75) compared to flask cultures prior to induction and a doubling in functional expression level per mg of membrane protein, representing a significant optimisation.", {"entities": []}], ["Furthermore, analysis of a C-terminally truncated A 2A R, terminating at residue V334 yielded the highest levels (200 pmol/mg) so far reported for expression of this receptor in P. pastoris .", {"entities": []}], ["This truncated form of the receptor was also revealed to be resistant to C-terminal degradation in contrast to the WT A 2A R, and therefore more suitable for further functional and structural studies.", {"entities": []}], ["Large-scale expression of the A 2A R in P. pastoris bioreactor cultures results in significant increases in functional expression compared to traditional flask cultures.", {"entities": []}], ["Aerosolized therapeutics hold great potential for effective treatment of various diseases including lung cancer.", {"entities": [[100, 111, "DISEASE"], [105, 111, "DISEASE"]]}], ["In this context, there is an urgent need to develop novel nanocarriers suitable for drug delivery by nebulization.", {"entities": []}], ["To address this need, we synthesized and characterized a biocompatible drug delivery vehicle following surface coating of Fe 3 O 4 magnetic nanoparticles (MNPs) with a polymer poly(lactic-co-glycolic acid) (PLGA).", {"entities": []}], ["The polymeric shell of these engineered nanoparticles was loaded with a potential anti-cancer drug quercetin and their suitability for targeting lung cancer cells via nebulization was evaluated.", {"entities": [[145, 156, "DISEASE"], [87, 93, "DISEASE"], [150, 156, "DISEASE"]]}], ["Average particle size of the developed MNPs and PLGA-MNPs as measured by electron microscopy was 9.6 and 53.2 nm, whereas their hydrodynamic swelling as determined using dynamic light scattering was 54.3 nm and 293.4 nm respectively.", {"entities": []}], ["Utilizing a series of standardized biological tests incorporating a cell-based automated image acquisition and analysis procedure in combination with real-time impedance sensing, we confirmed that the developed MNP-based nanocarrier system was biocompatible, as no cytotoxicity was observed when up to 100 \u03bcg/ml PLGA-MNP was applied to the cultured human lung epithelial cells.", {"entities": []}], ["Moreover, the PLGA-MNP preparation was well-tolerated in vivo in mice when applied intranasally as measured by glutathione and IL-6 secretion assays after 1, 4, or 7 days post-treatment.", {"entities": []}], ["To imitate aerosol formation for drug delivery to the lungs, we applied quercitin loaded PLGA-MNPs to the human lung carcinoma cell line A549 following a single round of nebulization.", {"entities": [[117, 126, "DISEASE"], [112, 126, "DISEASE"]]}], ["The drug-loaded PLGA-MNPs significantly reduced the number of viable A549 cells, which was comparable when applied either by nebulization or by direct pipetting.", {"entities": []}], ["We have developed a magnetic core-shell nanoparticle-based nanocarrier system and evaluated the feasibility of its drug delivery capability via aerosol administration.", {"entities": []}], ["This study has implications for targeted delivery of therapeutics and poorly soluble medicinal compounds via inhalation route.", {"entities": []}], ["Despite known benefits, a significant proportion of patients with COPD do not complete pulmonary rehabilitation (PR).", {"entities": []}], ["Little is known regarding which factors promote successful completion of PR.", {"entities": []}], ["We analyzed data from a prospectively maintained database of subjects with COPD who attended a PR program at the University of Alabama at Birmingham, from 1996 to 2013.", {"entities": []}], ["Subjects were categorized as either completers or non-completers, based on successful completion of at least 8 weeks of PR.", {"entities": []}], ["Demographics and comorbidities were recorded.", {"entities": []}], ["Short Form 36 Health Survey, Beck Depression Inventory-II, and San Diego Shortness of Breath Questionnaire were administered to all participants at baseline and on completion of PR to assess participants\u2019 perception of their health status, severity of depression, and dyspnea with performance of activities of daily living.", {"entities": []}], ["Univariate and multivariable analyses were performed to identify predictors of successful completion of PR.", {"entities": []}], ["Four hundred and forty subjects were included, of whom 229 completed PR.", {"entities": []}], ["Forty-one percent were female, and 17% were African American.", {"entities": []}], ["Compared with non-completers, completers had greater Short Form 36 Health Survey pain score, lower forced expiratory volume in the first second, and lower Beck Depression Inventory score, and included a lower percentage of current smokers.", {"entities": []}], ["On multivariate analysis, cigarette smoking at enrollment was associated with lower likelihood of completion of PR (adjusted odds ratio 0.38, 95% confidence interval 0.16\u20130.90; P =0.02).", {"entities": []}], ["Cigarette smoking was the sole independent predictor of PR dropout, and smoking cessation may warrant greater emphasis prior to enrollment.", {"entities": []}], ["The potency of T regulatory (TREG) cells to inhibit T helper (Th)-driven immune cell responses has been linked to increased intracellular cyclic-AMP (cAMP) levels of TREG cells.", {"entities": []}], ["In an ovalbumin (OVA)-driven allergic asthma mouse model, moderate aerobic exercise increases TREG cell function in a contact-dependent manner that leads to a significant reduction in chronic inflammation and restoration of lung function.", {"entities": [[29, 44, "DISEASE"], [38, 44, "DISEASE"]]}], ["However, the mechanism, whereby exercise increases TREG function, remains unknown and was the focus of these investigations.", {"entities": []}], ["Exercise can communicate with TREG cells by their expression of \u03b22-adrenergic receptors (\u03b22-AR).", {"entities": []}], ["Activation of these receptors results in an increase in intracellular levels of cyclic-AMP, potentially creating a potent inhibitor of Th cell responses.", {"entities": []}], ["For the allergic asthma model, female wildtype BALB/c\u00a0mice were challenged with OVA, and exercised (13.5\u00a0m/min for 45\u00a0min) 3\u00d7/week for 4\u00a0weeks.", {"entities": [[8, 23, "DISEASE"], [17, 23, "DISEASE"]]}], ["TREG cells were isolated from all mouse asthma/exercise groups, including \u03b22-AR These studies offer a novel role for \u03b22-AR in regulating cAMP intracellular levels that can modify suppressive function in TREG cells.", {"entities": [[40, 46, "DISEASE"]]}], ["The coexistence of gastroesophageal reflux disease (GERD) and COPD has been recognized, but there has been no comprehensive evaluation of the impact of GERD on COPD-related health status and patient-centered outcomes.", {"entities": [[19, 50, "DISEASE"]]}], ["Cross-sectional and longitudinal study of 4,483 participants in the COPDGene cohort who met GOLD criteria for COPD.", {"entities": []}], ["Physician-diagnosed GERD was ascertained by questionnaire.", {"entities": []}], ["Clinical features, spirometry and imaging were compared between COPD subjects without versus with GERD.", {"entities": []}], ["We evaluated the relationship between GERD and symptoms, exacerbations and markers of microaspiration in univariate and multivariate models.", {"entities": []}], ["Associations were additionally tested for the confounding effect of covariates associated with a diagnosis of GERD and the use of proton-pump inhibitor medications (PPIs).", {"entities": []}], ["To determine whether GERD is simply a marker for the presence of other conditions independently associated with worse COPD outcomes, we also tested models incorporating a GERD propensity score.", {"entities": []}], ["GERD was reported by 29% of subjects with female predominance.", {"entities": []}], ["Subjects with GERD were more likely to have chronic bronchitis symptoms, higher prevalence of prior cardiovascular events (combined myocardial infarction, coronary artery disease and stroke 21.3% vs. 13.4.0%, p\u2009<\u20090.0001).", {"entities": [[132, 153, "DISEASE"], [52, 62, "DISEASE"]]}], ["Subjects with GERD also had more severe dyspnea (MMRC score 2.2 vs. 1.8, p\u2009<\u20090.0001), and poorer quality of life (QOL) scores (St. George\u2019s Respiratory Questionnaire (SGRQ) total score 41.8 vs. 34.9, p\u2009<\u20090.0001; SF36 Physical Component Score 38.2 vs. 41.4, p\u2009<\u20090.0001).", {"entities": []}], ["In multivariate models, a significant relationship was detected between GERD and SGRQ (3.4 points difference, p\u2009<\u20090.001) and frequent exacerbations at baseline (\u22652 exacerbation per annum at inclusion OR 1.40, p\u2009=\u20090.006).", {"entities": []}], ["During a mean follow-up time of two years, GERD was also associated with frequent (\u22652/year exacerbations OR 1.40, p\u2009=\u20090.006), even in models in which PPIs, GERD-PPI interactions and a GERD propensity score were included.", {"entities": []}], ["PPI use was associated with frequent exacerbator phenotype, but did not meaningfully influence the GERD-exacerbation association.", {"entities": []}], ["In COPD the presence of physician-diagnosed GERD is associated with increased symptoms, poorer QOL and increased frequency of exacerbations at baseline and during follow-up.", {"entities": []}], ["These associations are maintained after controlling for PPI use.", {"entities": []}], ["The PPI-exacerbations association could result from confounding-by-indication.", {"entities": []}], ["The use of analgesic anti-inflammatory agents in patients with asthma is clinically challenging because of the prevalence (10\u201320%) of aspirin hypersensitivity.", {"entities": [[63, 69, "DISEASE"]]}], ["Aspirin-exacerbated respiratory disease (AERD), or aspirin-induced asthma, is characterized by asthma and rhinitis triggered by the ingestion of aspirin and non-steroidal anti-inflammatory drugs.", {"entities": [[106, 114, "DISEASE"], [67, 73, "DISEASE"], [95, 101, "DISEASE"]]}], ["AERD is associated with upper and lower respiratory-tract mucosal inflammation, progressive sinusitis, nasal polyposis, and asthma regardless of whether patients avoid triggering drugs.", {"entities": [[92, 101, "DISEASE"], [124, 130, "DISEASE"]]}], ["The mechanism underlying the propensity of aspirin and non-steroidal anti-inflammatory drugs to cause this reaction is thought to involve inhibition of the synthesis of protective prostaglandins (PGs), resulting in an increase in the synthesis of cysteinyl leukotrienes by eosinophils and mast cells.", {"entities": []}], ["Clinical data suggest that protective PGs are derived from cyclooxygenase (COX)-1 because studies have now confirmed that drugs specifically inhibiting COX-2 are not cross-reactive with aspirin in patients with AERD.", {"entities": []}], ["Objectives .", {"entities": []}], ["Platelet endothelial cell adhesion molecule-1 (PECAM-1) plays a key role in the transendothelial migration of circulating leukocytes during inflammation and in the maintenance of vascular endothelial integrity.", {"entities": []}], ["We hypothesized that genetic variation in PECAM-1 gene could be associated with diabetic nephropathy (DN) and with the level of soluble PECAM-1 in Caucasians with type 2 diabetes mellitus (T2DM).", {"entities": [[170, 187, "DISEASE"], [163, 187, "DISEASE"]]}], ["Design and Methods .", {"entities": []}], ["We analyzed the rs688 single nucleotide polymorphism of PECAM-1 gene C373G (Leu125Val) at exon 3, which encodes the first extracellular Ig-like domain that mediates the homophilic binding of PECAM-1, in 276 T2DM subjects with documented DN (cases) and 375 T2DM subjects without DN (controls), using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) strategy.", {"entities": []}], ["Level of plasma soluble PECAM-1 (sPECAM-1) was measured by ELISA in a subpopulation of 120 diabetics with DN.", {"entities": []}], ["We found no association between the Leu125Val polymorphism and DN in subjects with T2DM.", {"entities": []}], ["Likewise, the Leu125Val polymorphism was not associated with serum sPECAM-1 levels in a subpopulation of 120 diabetics with DN.", {"entities": []}], ["Conclusion .", {"entities": []}], ["The Leu125Val polymorphism of PECAM-1 and the level of sPECAM-1 are not associated with DN in T2DM subjects of Slovenian origin.", {"entities": []}], ["With growing evidence of an increase in the prevalence, food allergy has been emerged as a new public health problem.", {"entities": [[56, 68, "DISEASE"]]}], ["As treatment and management of food allergy remain challenging, more attention has been paid to the importance of prevention of food allergy.", {"entities": [[31, 43, "DISEASE"], [128, 140, "DISEASE"]]}], ["Although the exact mechanism of recent epidemic is not fully understood, it is suggested that nutritional exposure in early life may play an important role in food allergy development.", {"entities": [[159, 171, "DISEASE"]]}], ["The underlying hypothesis is that nutritional status or food exposure in the critical period of fetal development can affect the programming of immune system and modify the risk of immunologic reactions to foods in postnatal life.", {"entities": []}], ["We review accumulating epidemiological studies to examine an association between nutritional exposure during pregnancy or early infancy and food allergy development in children.", {"entities": [[140, 152, "DISEASE"]]}], ["We also discuss recent advances in the studies of the genetic and epigenetic regulation of food allergy and evaluate the role of early nutrition in food allergy development to provide a new perspective on the prevention of food allergy.", {"entities": [[91, 103, "DISEASE"], [148, 160, "DISEASE"], [223, 235, "DISEASE"]]}], ["Common variable immunodeficiency is the most common form of symptomatic primary antibody failure in adults and children.", {"entities": []}], ["Replacement immunoglobulin is the standard treatment of these patients.", {"entities": []}], ["By using a differential proteomic approach based on 2D-DIGE, we examined serum samples from normal donors and from matched, naive, and immunoglobulin-treated patients.", {"entities": []}], ["The results highlighted regulated expression of serum proteins in naive patients.", {"entities": []}], ["Among the identified proteins, clusterin/ApoJ serum levels were lower in naive patients, compared to normal subjects.", {"entities": []}], ["This finding was validated in a wider collection of samples from newly enrolled patients.", {"entities": []}], ["The establishment of a cellular system, based on a human hepatocyte cell line HuH7, allowed to ascertain a potential role in the regulation of CLU gene expression by immunoglobulins.", {"entities": [[143, 146, "GENE"]]}], ["People who have complex health care needs frequently access emergency departments for treatment of acute illness and injury.", {"entities": []}], ["In particular, evidence suggests that those who are homeless, or suffer mental illness, or have a history of substance misuse, are often repeat users of emergency departments.", {"entities": []}], ["The aim of this study was to describe the socio-demographic and clinical characteristics of emergency department re-presentations.", {"entities": []}], ["Re-presentation was defined as a return visit to the same emergency department within 28 days of discharge from hospital.", {"entities": []}], ["A retrospective cohort study was conducted of emergency department presentations occurring over a 24-month period to an Australian inner-city hospital.", {"entities": []}], ["Characteristics were examined for their influence on the binary outcome of re-presentation within 28 days of discharge using logistic regression with the variable patient fitted as a random effect.", {"entities": []}], ["From 64,147 presentations to the emergency department the re-presentation rate was 18.0% (n = 11,559) of visits and 14.4% (5,894/40,942) of all patients.", {"entities": []}], ["Median time to re-presentation was 6 days, with more than half occurring within one week of discharge (60.8%; n = 6,873), and more than three-quarters within two weeks (80.9%; n = 9,151).", {"entities": []}], ["The odds of re-presentation increased three-fold for people who were homeless compared to those living in stable accommodation (adjusted OR 3.09; 95% CI, 2.83 to 3.36).", {"entities": []}], ["Similarly, the odds of re-presentation were significantly higher for patients receiving a government pension compared to those who did not (adjusted OR 1.73; 95% CI, 1.63 to 1.84), patients who left part-way through treatment compared to those who completed treatment and were discharged home (adjusted OR 1.64; 95% CI, 1.36 to 1.99), and those discharged to a residential-care facility compared to those who were discharged home (adjusted OR 1.46: 95% CI, 1.03 to 2.06).", {"entities": []}], ["Emergency department re-presentation rates cluster around one week after discharge and rapidly decrease thereafter.", {"entities": []}], ["Housing status and being a recipient of a government pension are the most significant risk factors.", {"entities": []}], ["Early identification and appropriate referrals for those patients who are at risk of emergency department re-presentation will assist in the development of targeted strategies to improve health service delivery to this vulnerable group.", {"entities": []}], ["Sensitization to environmental allergens remains one of the strongest risk factors for asthma, and there is likely a genetic basis.", {"entities": [[87, 93, "DISEASE"]]}], ["We sought to identify genetic determinants for the development of allergic sensitization to environmental allergens, particularly cockroach allergen, in early childhood.", {"entities": []}], ["A total of 631 children with the information about genotypic data on 895 single nucleotide polymorphisms (SNPs) in 179 candidate genes were selected from an existing dataset (Boston Birth Cohort).", {"entities": []}], ["Genetic analysis was performed for allergic sensitizations among all subjects and sub-population, Black/African, respectively.", {"entities": []}], ["Eight SNPs in seven genes showed significant association with allergic sensitization with P \u2009<\u20090.05, including two top SNPs, rs7851969 in JAK2 (P \u2009 = \u20090.003 ) and rs11739089 in CNOT6 (P \u2009 = \u20090.008 ) .", {"entities": [[138, 142, "GENE"], [177, 182, "GENE"]]}], ["When analyses were specifically performed for cockroach sensitization, 16 SNPs in 13 genes showed P \u2009<\u20090.05, including five genes with SNPs at P \u2009<\u20090.01 ( JAK1 , JAK3 , IL5RA , FCER1A , and ADAM33) .", {"entities": [[155, 159, "GENE"], [162, 166, "GENE"], [169, 174, "GENE"], [177, 183, "GENE"], [190, 196, "GENE"]]}], ["Particularly, haplotype analyses demonstrated that multiple-haplotypes in FCER1A were significantly associated with cockroach sensitization with the strongest association for a 2-marker haplotype (rs6665683T-rs12136904T, P \u2009 = \u20090.001).", {"entities": [[74, 80, "GENE"]]}], ["Furthermore, SNP rs6665683 was marginally associated with the levels of cockroach allergen specific IgE.", {"entities": []}], ["When a similar analysis was performed for house dust mite, four SNPs in three genes ( JAK2, MAML1 , and NOD1 ) had P \u2009<\u20090.01.", {"entities": [[86, 90, "GENE"], [92, 97, "GENE"], [104, 108, "GENE"]]}], ["Of these, JAK2 appeared to be an only gene showing association across the sensitizations we analyzed.", {"entities": [[10, 14, "GENE"]]}], ["Some of findings were further validated when analysis was limited to black population.", {"entities": []}], ["Our study identified several loci that may confer the susceptibility to allergic sensitization, and suggested that sensitization to allergens may depend on their unique loci.", {"entities": []}], ["Many smokers find the cost of smoking cessation medications a barrier.", {"entities": []}], ["Financial coverage for these medications increases utilization of pharmacotherapies.", {"entities": []}], ["This study assesses whether financial coverage increases the proportion of successful quitters.", {"entities": []}], ["A pragmatic, open-label, randomized, controlled trial was conducted in 58 Canadian sites between March 2009 and September 2010.", {"entities": []}], ["Smokers (\u226510 cigarettes/day) without insurance coverage who were motivated to quit within 14\u00a0days were randomized (1:1) in a blinded manner to receive either full coverage eligibility for 26\u00a0weeks or no coverage.", {"entities": []}], ["Pharmacotherapies covered were varenicline, bupropion, or nicotine patches/gum.", {"entities": []}], ["Investigators/subjects were unblinded to study group assignment after randomization and prior to choosing a smoking cessation method(s).", {"entities": []}], ["All subjects received brief smoking cessation counseling.", {"entities": []}], ["The primary outcome measure was self-reported 7-day point prevalence of abstinence (PPA) at week 26.", {"entities": []}], ["Of the 1380 randomized subjects (coverage, 696; no coverage, 684), 682 (98.0%) and 435 (63.6%), respectively, were dispensed at least one smoking cessation medication dose.", {"entities": []}], ["The 7-day PPA at week 26 was higher in the full coverage versus no coverage group: 20.8% ( n \u2009=\u2009145) and 13.9% ( n \u2009=\u200995), respectively; odds ratio (OR)\u2009=\u20091.64, 95% confidence interval (CI) 1.23\u20132.18; p \u2009=\u20090.001.", {"entities": []}], ["Urine cotinine-confirmed 7-day PPA at week 26 was 15.7% ( n \u2009=\u2009109) and 10.1% ( n \u2009=\u200969), respectively; OR\u2009=\u20091.68, 95% CI 1.21\u20132.33; p \u2009=\u20090.002.", {"entities": []}], ["After pharmacotherapy, coverage eligibility was withdrawn from the full coverage group, continuous abstinence between weeks 26 and 52 was 6.6% ( n \u2009=\u200946) and 5.6% ( n \u2009=\u200938), in the full coverage and no coverage groups, respectively; OR\u2009=\u20091.19, 95% CI 0.76\u20131.87; p \u2009=\u20090.439.", {"entities": []}], ["In this study, the adoption of a smoking cessation medication coverage drug policy was an effective intervention to improve 26-week quit rates in Canada.", {"entities": []}], ["The advantages were lost once coverage was discontinued.", {"entities": []}], ["Further study is required on the duration of coverage to prevent relapse to smoking.", {"entities": []}], ["(clinicaltrials.gov identifier: NCT00818207; the study was sponsored by Pfizer Inc.).", {"entities": []}], ["Factors that can interfere with the successful treatment of Mycobacterium avium lung infection have been inadequately studied.", {"entities": []}], ["To identify a potent predictor of therapeutic responses of M.\u00a0avium lung infection, we analyzed variable number tandem repeats (VNTR) at 16 minisatellite loci of M.\u00a0avium clinical isolates.", {"entities": []}], ["Associations between the VNTR profiling data and a therapeutic response were evaluated in 59 subjects with M.\u00a0avium lung infection.", {"entities": []}], ["M.\u00a0avium lung infection of 30 subjects in whom clarithromycin-containing regimens produced microbiological and radiographic improvement was defined as responsive disease, while that of the remaining 29 subjects was defined as refractory disease.", {"entities": []}], ["In phylogenetic analysis using the genotypic distance aggregated from 16-dimensional VNTR data, 59\u00a0 M.\u00a0avium isolates were divided into three clusters, which showed a nearly significant association with therapeutic responses (p 0.06).", {"entities": []}], ["We then subjected the raw 16-dimensional VNTR data directly to principal component analysis, and identified the genetic features that were significantly associated with the therapeutic response (p\u00a0<0.05).", {"entities": []}], ["By further analysis of logistic regression with a stepwise variable-selection, we constructed the highest likelihood multivariate model, adjusted for age, to predict a therapeutic response, using VNTR data from only four minisatellite loci.", {"entities": []}], ["In conclusion, we identified four mycobacterial minisatellite loci that together were associated with the therapeutic response of M.\u00a0avium lung infections.", {"entities": []}], ["General practitioners (GPs) manage the drug therapies of people with chronic diseases, and poor adherence to medication remains a major challenge.", {"entities": []}], ["This qualitative study examined GPs\u2019 insights into non-adherence and ways of overcoming this problem.", {"entities": []}], ["We ran four focus groups comprising 16 GPs at the Kirkkonummi Health Centre (Southern Finland).", {"entities": []}], ["Interviews were audiotaped, transcribed verbatim and analysed by inductive content analysis.", {"entities": []}], ["The two main themes in the discussions with the GPs were non-adherence in the care of chronic disease and increased need for medicine information.", {"entities": []}], ["The medication management challenges identified were related to: patient-specific factors, the healthcare system, characteristics of drug therapies and the function and role of healthcare professionals as a team.", {"entities": []}], ["To improve the situation, the GPs offered a number of solutions: improved coordination of care, better patient education and IT systems as well as enhanced interprofessional involvement in the follow-up of patients.", {"entities": []}], ["With an ageing population, the GPs were increasingly confronted with non-adherence in the care of chronic diseases.", {"entities": []}], ["They had mostly a positive attitude towards organising care in a more interprofessional manner.", {"entities": []}], ["To support medication adherence and self-management, the GPs appreciated pharmacists\u2019 assistance especially with patients with polypharmacy and chronic diseases.", {"entities": []}], ["We have previously demonstrated that intranasal vaccination of highly susceptible BALB/c mice with whole Leishmania amazonensis antigens (LaAg) leads to protection against murine cutaneous leishmaniasis.", {"entities": [[189, 202, "DISEASE"], [179, 202, "DISEASE"]]}], ["Here, we evaluate the response of partially resistant C57BL/6 mice to vaccination as a more representative experimental model of human cutaneous leishmaniasis.", {"entities": [[145, 158, "DISEASE"], [135, 158, "DISEASE"]]}], ["C57BL/6 mice from different animal facilities were infected with L. amazonensis (Josefa strain) to establish the profile of infection.", {"entities": []}], ["Intranasal vaccination was performed before the infection challenge with two doses of 10 \u03bcg of LaAg alone or associated with the adjuvant ADDAVAX\u00ae by instillation in the nostrils.", {"entities": []}], ["The lesion progression was measured with a dial caliper and the parasite load by limited dilution assay in the acute and chronic phases of infection.", {"entities": []}], ["Cytokines were quantified by ELISA in the homogenates of infected footpads.", {"entities": []}], ["C57BL/6 mice from different animal facilities presented the same L. amazonensis infection profile, displaying a progressive acute phase followed by a controlled chronic phase.", {"entities": []}], ["Parasites cultured in M199 and Schneider\u2019s media were equally infective.", {"entities": []}], ["Intranasal vaccination with LaAg led to milder acute and chronic phases of the disease.", {"entities": []}], ["The mechanism of protection was associated with increased production of IFN-gamma in the infected tissue as measured in the acute phase.", {"entities": []}], ["Association with the ADDAVAX\u00ae adjuvant did not improve the efficacy of intranasal LaAg vaccination.", {"entities": []}], ["Rather, ADDAVAX\u00ae reduced vaccination efficacy.", {"entities": []}], ["This study demonstrates that the efficacy of adjuvant-free intranasal vaccination with LaAg is extendable to the more resistant C57Bl/6 mouse model of infection with L. amazonensis , and is thus not exclusive to the susceptible BALB/c model.", {"entities": []}], ["These results imply that mucosal immunomodulation by LaAg leads to peripheral protection irrespective of the genetic background of the host.", {"entities": []}], ["The online version of this article (doi:10.1186/s13071-016-1822-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Consolidated knowledge is accumulating as to the role of epigenetic regulatory mechanisms in the physiology of vascular development and vascular tone as well as in the pathogenesis of cardiovascular disease.", {"entities": []}], ["The modulation of gene expression through modification of the epigenome by structural changes of the chromatin architecture without alterations of the associated genomic DNA sequence is part of the cellular response to environmental changes.", {"entities": []}], ["Such environmental conditions, which are finally being translated into adaptations of the cardiovascular system, also comprise pathological conditions such as atherosclerosis or myocardial infarction.", {"entities": [[159, 174, "DISEASE"], [178, 199, "DISEASE"]]}], ["This review summarizes recent findings on the epigenetics of vascular regulation and disease and presents nutritional and pharmacological approaches as novel epigenetic strategies in the prevention and treatment of cardiovascular disease.", {"entities": []}], ["A global proteomic strategy was used to identify proteins, which are differentially expressed in the murine model of severe malaria in the hope of facilitating future development of novel diagnostic, disease monitoring and treatment strategies.", {"entities": [[124, 131, "DISEASE"]]}], ["Mice (4-week-old CD1 male mice) were infected with Plasmodium berghei ANKA strain, and infection allowed to establish until a parasitaemia of 30% was attained.", {"entities": []}], ["Total plasma and albumin depleted plasma samples from infected and control (non-infected) mice were separated by two-dimensional gel electrophoresis (2-DE).", {"entities": []}], ["After staining, the gels were imaged and differential protein expression patterns were interrogated using image analysis software.", {"entities": []}], ["Spots of interest were then digested using trypsin and the proteins identified using matrix-assisted laser desorption and ionization-time of flight (MALDI-TOF) mass spectrometry (MS) and peptide mass fingerprinting software.", {"entities": []}], ["Master gels of control and infected mice, and the corresponding albumin depleted fractions exhibited distinctly different 2D patterns comparing control and infected plasma, respectively.", {"entities": []}], ["A wide range of proteins demonstrated altered expression including; acute inflammatory proteins, transporters, binding proteins, protease inhibitors, enzymes, cytokines, hormones, and channel/receptor-derived proteins.", {"entities": []}], ["Malaria-infection in mice results in a wide perturbation of the host serum proteome involving a range of proteins and functions.", {"entities": [[0, 7, "DISEASE"]]}], ["Of particular interest is the increased secretion of anti-inflammatory and anti apoptotic proteins.", {"entities": []}], ["Nitric oxide- (NO-) dependent oxidative stress results in mitochondrial ultrastructural alterations and DNA damage in cases of Alzheimer disease (AD).", {"entities": []}], ["However, little is known about these pathways in human cancers, especially during the development as well as the progression of primary brain tumors and metastatic colorectal cancer.", {"entities": [[164, 181, "DISEASE"], [175, 181, "DISEASE"]]}], ["One of the key features of tumors is the deficiency in tissue energy that accompanies mitochondrial lesions and formation of the hypoxic smaller sized mitochondria with ultrastructural abnormalities.", {"entities": []}], ["We speculate that mitochondrial involvement may play a significant role in the etiopathogenesis of cancer.", {"entities": [[99, 105, "DISEASE"]]}], ["Recent studies also demonstrate a potential link between AD and cancer, and anticancer drugs are being explored for the inhibition of AD-like pathology in transgenic mice.", {"entities": [[64, 70, "DISEASE"]]}], ["Severity of the cancer growth, metastasis, and brain pathology in AD (in animal models that mimic human AD) correlate with the degree of mitochondrial ultrastructural abnormalities.", {"entities": [[16, 22, "DISEASE"]]}], ["Recent advances in the cell-cycle reentry of the terminally differentiated neuronal cells indicate that NO-dependent mitochondrial abnormal activities and mitotic cell division are not the only important pathogenic factors in pathogenesis of cancer and AD, but open a new window for the development of novel treatment strategies for these devastating diseases.", {"entities": [[242, 248, "DISEASE"]]}], ["Dendritic cells (DCs) control immunity and play a role in the pathogenesis of chronic obstructive pulmonary disease (COPD).", {"entities": [[78, 115, "DISEASE"]]}], ["However, the expression of function-associated surface molecules on circulating DCs in COPD is unknown.", {"entities": []}], ["Four-colour flow cytometry was used to compare blood DC surface molecules of 54 patients with COPD (median age: 59\u00a0years; median FEV 1 : 38% predicted, median CAT score: 24) with two age-matched control groups with normal lung function: 21 current smokers and 21 never-smokers.", {"entities": [[129, 132, "GENE"]]}], ["Concentrations of plasmacytoid DCs (pDCs) and myeloid DCs (mDCs) and the mDC/pDC ratio did not differ between the groups.", {"entities": []}], ["The increased expression of BDCA-1, BDCA-3, CD86 and CCR5 on mDCs in patients with COPD did not significantly differ from smokers with normal lung function.", {"entities": [[44, 48, "GENE"], [53, 57, "GENE"]]}], ["In contrast, COPD was specifically characterised by a decreased expression of the anti-inflammatory co-stimulatory molecule PD-L1 on pDCs and an increased expression of the pro-inflammatory co-stimulatory molecule OX40 ligand (OX40L) on mDCs.", {"entities": []}], ["These changes were not confined to patients with elevated systemic inflammation markers (leukocytes, c-reactive protein, interleukin-6, fibrinogen).", {"entities": []}], ["The ratio of OX40L to PD-L1 expression (OX40L/PD-L1 ratio), a quantitative measure of imbalanced DC co-stimulation, correlated with the severity of pulmonary emphysema in patients with COPD.", {"entities": [[148, 167, "DISEASE"]]}], ["An imbalance of DC co-stimulation might contribute to the pathogenesis of COPD.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0174-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Depressive disorder is the largest contributor to years lived with disability in the Caribbean, adding 948 per 100,000 in 2013.", {"entities": []}], ["Depression is also a major risk factor for suicidal behaviour.", {"entities": []}], ["Social inequalities influence the occurrence of depression, yet little is known about the social inequalities of this condition in the Caribbean.", {"entities": []}], ["In support of the 2011 Rio Political Declaration on addressing health inequities, this article presents a systematic review of the role of social determinants on depression and its suicidal behaviours in the Caribbean.", {"entities": []}], ["Eight databases were searched for observational studies reporting associations between social determinants and depression frequency, severity, or outcomes.", {"entities": []}], ["Based on the PROGRESS-plus checklist, we considered 9 social determinant groups (of 15 endpoints) for 6 depression endpoints, totalling 90 possible ways (\u2018relationship groups\u2019) to explore the role of social determinants on depression.", {"entities": []}], ["Studies with \u226550 participants conducted in Caribbean territories between 2004 and 2014 were eligible.", {"entities": []}], ["The review was conducted according to STROBE and PRISMA guidelines.", {"entities": []}], ["Results were planned as a narrative synthesis, with meta-analysis if possible.", {"entities": []}], ["From 3951 citations, 55 articles from 45 studies were included.", {"entities": []}], ["Most were classified as serious risk of bias.", {"entities": []}], ["Fifty-seven relationship groups were reported by the 55 included articles, leaving 33 relationship groups (37%) without an evidence base.", {"entities": []}], ["Most associations were reported for gender, age, residence, marital status, and education.", {"entities": []}], ["Depression, its severity, and its outcomes were more common among females (except suicide which was more common among males), early and middle adolescents (among youth), and those with lower levels of education.", {"entities": []}], ["Marriage emerged as both a risk and protective factor for depression score and prevalence, while several inequality relationships in Haiti were in contrast to typical trends.", {"entities": []}], ["The risk of bias and few numbers of studies within relationship groups restricted the synthesis of Caribbean evidence on social inequalities of depression.", {"entities": []}], ["Along with more research focusing on regional social inequalities, attempts at standardizing reporting guidelines for observational studies of inequality and studies examining depression is necessitated.", {"entities": []}], ["This review offers as a benchmark to prioritize future research into the social determinants of depression frequency and outcomes in the Caribbean.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-017-4371-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The identification of new methods of evaluating patients with osteoporotic fracture should focus on their usefulness in clinical situations such that they are easily measured and applicable to all patients.", {"entities": []}], ["Thus, the purpose of this study was to examine the association between iliocostal distance and vertebral and non-vertebral fractures in patients seen in a clinical setting.", {"entities": []}], ["Patient data were obtained from the Canadian Database of Osteoporosis and Osteopenia (CANDOO).", {"entities": [[57, 69, "DISEASE"]]}], ["A total of 549 patients including 508 women and 41 men participated in this cross-sectional study.", {"entities": []}], ["There were 142 women and 18 men with prevalent vertebral fractures, and 185 women and 21 men with prevalent non-vertebral fractures.", {"entities": []}], ["In women multivariable regression analysis showed that iliocostal distance was negatively associated with the number of vertebral fractures (-0.18, CI: -0.27, -0.09; adjusted for bone mineral density at the Ward's triangle, epilepsy, cerebrovascular disease, inflammatory bowel disease, etidronate use, and calcium supplement use) and for the number of non-vertebral fractures (-0.09, CI: -0.15, -0.03; adjusted for bone mineral density at the trochanter, cerebrovascular disease, inflammatory bowel disease, and etidronate use).", {"entities": [[259, 285, "DISEASE"], [481, 507, "DISEASE"], [234, 257, "DISEASE"], [456, 479, "DISEASE"]]}], ["However, in men, multivariable regression analysis did not demonstrate a significant association between iliocostal distance and the number of vertebral and non-vertebral fractures.", {"entities": []}], ["The examination of iliocostal distance may be a useful clinical tool for assessment of the possibility of vertebral fractures.", {"entities": []}], ["The identification of high-risk patients is important to effectively use the growing number of available osteoporosis therapies.", {"entities": [[105, 117, "DISEASE"]]}], ["Comparative analysis of gene expression in human tissues is important for understanding the molecular mechanisms underlying tissue-specific control of gene expression.", {"entities": []}], ["It can also open an avenue for using gene expression in blood (which is the most easily accessible human tissue) to predict gene expression in other (less accessible) tissues, which would facilitate the development of novel gene expression based models for assessing disease risk and progression.", {"entities": []}], ["Until recently, direct comparative analysis across different tissues was not possible due to the scarcity of paired tissue samples from the same individuals.", {"entities": []}], ["In this study we used paired whole blood/lung gene expression data from the Genotype-Tissue Expression (GTEx) project.", {"entities": []}], ["We built a generalized linear regression model for each gene using gene expression in lung as the outcome and gene expression in blood, age and gender as predictors.", {"entities": []}], ["For ~18\u00a0% of the genes, gene expression in blood was a significant predictor of gene expression in lung.", {"entities": []}], ["We found that the number of single nucleotide polymorphisms (SNPs) influencing expression of a given gene in either blood or lung, also known as the number of quantitative trait loci (eQTLs), was positively associated with efficacy of blood-based prediction of that gene\u2019s expression in lung.", {"entities": []}], ["This association was strongest for shared eQTLs: those influencing gene expression in both blood and lung.", {"entities": []}], ["In conclusion, for a considerable number of human genes, their expression levels in lung can be predicted using observable gene expression in blood.", {"entities": []}], ["An abundance of shared eQTLs may explain the strong blood/lung correlations in the gene expression.", {"entities": []}], ["The online version of this article (doi:10.1186/s12920-015-0152-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Despite the research importance of rhinovirus detection in asymptomatic healthy infants, the literature remains sparse.", {"entities": []}], ["To investigate the prevalence of respiratory syncytial virus (RSV) and rhinovirus (and its species).", {"entities": []}], ["We conducted a cross-sectional study of 110 healthy, non-hospitalized infants without acute illness at an academic medical center from November 2013 through May 2014.", {"entities": []}], ["We tested nasal swab specimens by using polymerase chain reaction and genetic sequencing.", {"entities": []}], ["Overall, the median age was 3.8\u00a0months (IQR 2.0\u20135.1\u00a0months), 56\u00a0% were male, and 90\u00a0% were born\u00a0>37\u00a0weeks.", {"entities": []}], ["RSV was detected in nasal swabs from infants (1.8\u00a0%).", {"entities": []}], ["By contrast, rhinovirus was detected in nasal swabs from 16 infants (14.5\u00a0%).", {"entities": []}], ["Molecular typing assay revealed rhinovirus species: six rhinovirus-A (5.5\u00a0%), one rhinovirus-B (0.9\u00a0%), eight rhinovirus-C (7.3\u00a0%), and one untypeable (0.9\u00a0%).", {"entities": []}], ["In this cross-sectional study of healthy, community-based infants, RSV was rare (<2\u00a0%) in nasal swabs, while rhinovirus was detected in 14.5\u00a0% with a predominance of rhinovirus-A and -C. These finding are important for understanding the clinical significance of rhinovirus detection among infants hospitalized for bronchiolitis.", {"entities": [[314, 327, "DISEASE"]]}], ["Recently, we reported a neuroprotective effect for Hawthorn ( Crataegus oxyacantha ) ethanolic extract in middle cerebral artery occlusion-(MCAO) induced stroke in rats.", {"entities": [[113, 138, "DISEASE"]]}], ["The present study sheds more light on the extract's mechanism of neuroprotection, especially its immunomodulatory effect.", {"entities": []}], ["After 15 days of treatment with Hawthorn extract [100 mg/kg, pretreatment (oral)], male Sprague Dawley rats underwent transient MCAO for 75 mins followed by reperfusion (either 3 or 24 hrs).", {"entities": []}], ["We measured pro-inflammatory cytokines (IL-1\u03b2, TNF-\u03b1, IL-6), ICAM-1, IL-10 and pSTAT-3 expression in the brain by appropriate methods.", {"entities": []}], ["We also looked at the cytotoxic T cell sub-population among leukocytes (FACS) and inflammatory cell activation and recruitment in brain (using a myeloperoxidase activity assay) after ischemia and reperfusion (I/R).", {"entities": [[183, 191, "DISEASE"]]}], ["Apoptosis (TUNEL), and Bcl-xL- and Foxp3- (T reg marker) positive cells in the ipsilateral hemisphere of the brain were analyzed separately using immunofluorescence.", {"entities": []}], ["Our results indicate that occlusion followed by 3 hrs of reperfusion increased pro-inflammatory cytokine and ICAM-1 gene expressions in the ipsilateral hemisphere, and that Hawthorn pre-treatment significantly ( p \u2264 0.01) lowered these levels.", {"entities": []}], ["Furthermore, such pre-treatment was able to increase IL-10 levels and Foxp3-positive cells in brain after 24 hrs of reperfusion.", {"entities": []}], ["The increase in cytotoxic T cell population in vehicle rats after 24 hrs of reperfusion was decreased by at least 40% with Hawthorn pretreatment.", {"entities": []}], ["In addition, there was a decrease in inflammatory cell activation and infiltration in pretreated brain.", {"entities": []}], ["Hawthorn pretreatment elevated pSTAT-3 levels in brain after I/R.", {"entities": []}], ["We also observed an increase in Bcl-xL-positive cells, which in turn may have influenced the reduction in TUNEL-positive cells compared to vehicle-treated brain.", {"entities": []}], ["In summary, Hawthorn extract helped alleviate pro-inflammatory immune responses associated with I/R-induced injury, boosted IL-10 levels, and increased Foxp3-positive T regs in the brain, which may have aided in suppression of activated inflammatory cells.", {"entities": []}], ["Such treatment also minimizes apoptotic cell death by influencing STAT-3 phosphorylation and Bcl-xL expression in the brain.", {"entities": []}], ["Taken together, the immunomodulatory effect of Hawthorn extract may play a critical role in the neuroprotection observed in this MCAO-induced stroke model.", {"entities": []}], ["Previous reports have suggested a possible role for vitamin D in the etiology of chronic spontaneous urticaria (CSU); however, little information is available regarding the role of other micronutrients.", {"entities": [[101, 110, "DISEASE"]]}], ["We, therefore, analyzed vitamin D, vitamin B12, and ferritin levels in CSU patients ( n = 282) from a preexisting database at Southampton General Hospital.", {"entities": []}], ["Data were compared against mean micronutrient levels of the general population of the UK, obtained from the National Diet and Nutrition Survey.", {"entities": []}], ["Vitamin D levels of CSU patients were found to be higher than those of the general UK population ( P = 0.001).", {"entities": []}], ["B12 levels were lower in patients with CSU ( P < 0.001) than in the general population.", {"entities": []}], ["Ferritin levels were found to be lower in male CSU patients than in the general male population ( P = 0.009).", {"entities": []}], ["This association between low B12 and iron levels and CSU might indicate a causal link, with micronutrient replacement as a potential therapeutic option.", {"entities": []}], ["Impaired lung function is a risk factor for cardiovascular (CV) events.", {"entities": []}], ["However, it has not been well established whether FVC reduction even within normal range is associated with cardiovascular disease (CVD) risk and whether reduced FVC is an independent relationship of CVD irrespective of metabolic syndrome.", {"entities": [[230, 238, "DISEASE"]]}], ["Thus, we aimed to explore the relationship between FVC and CV-event risk using the FRS beyond the presence of metabolic syndrome or abdominal obesity in a representative Korean population based on data from the nationwide Korea National Health and Nutrition Examination Survey (KNHANES IV).", {"entities": [[142, 149, "DISEASE"], [120, 128, "DISEASE"]]}], ["The study population included 9688 subjects \u2265 30 years of age with no previous diagnosis of CVD and obstructive lung disease.", {"entities": [[100, 124, "DISEASE"], [112, 124, "DISEASE"]]}], ["Using a logistic regression model and area under the curve (AUC) analysis, we evaluated the relationship between FVC quintiles and CV-event risk using the Framingham Risk Score (FRS; \u2265 10% or \u2265 20%).", {"entities": []}], ["In addition, we examined the effect of FVC on CV-event risk based on the presence of metabolic syndrome (MetS) and abdominal obesity.", {"entities": [[125, 132, "DISEASE"], [95, 103, "DISEASE"]]}], ["After adjusting for covariates, comparison of subjects in the lowest FVC (% pred) quintile (Q1) with those in the highest quintile (Q5) yielded an odds ratio (OR) of 2.27 (95% CI, 1.91\u20132.71) for intermediate and high risk, and 2.89 (95% CI, 2.31\u20133.61) for high risk.", {"entities": []}], ["The ORs for cardiovascular risk using FRS also increased irrespective of the presence of abdominal obesity and MetS without significant interaction.", {"entities": [[99, 106, "DISEASE"]]}], ["Furthermore, the addition of FVC status to MetS status and abdominal obesity status significantly increased the AUC of the model predicting CV-event risk ( P \u200a<\u200a0.001 and P \u200a<\u200a0.001).", {"entities": [[69, 76, "DISEASE"]]}], ["Our study demonstrates that FVC is inversely associated with 10-year CV-event risk, irrespective of MetS and abdominal obesity in the general population without obstructive lung disease.", {"entities": [[161, 185, "DISEASE"], [119, 126, "DISEASE"], [173, 185, "DISEASE"]]}], ["Furthermore, the addition of FVC to MetS or abdominal obesity increased prediction of CVD event risks, implying a potential role of FVC to predict CV events.", {"entities": [[54, 61, "DISEASE"]]}], ["Increasing evidence suggests that lycopene, the major carotenoid present in tomato, may be preventive against smoke-induced cell damage.", {"entities": []}], ["However, the mechanisms of such a prevention are still unclear.", {"entities": []}], ["The aim of this study was to investigate the role of lycopene on the production of the pro-inflammatory cytokine IL-8 induced by cigarette smoke and the possible mechanisms implicated.", {"entities": []}], ["Therefore, human THP-1 macrophages were exposed to cigarette smoke extract (CSE), alone and following a 6-h pre-treatment with lycopene (0.5\u20132 \u00b5M).", {"entities": []}], ["CSE enhanced IL-8 production in a time- and a dose-dependent manner.", {"entities": []}], ["Lycopene pre-treatment resulted in a significant inhibition of CSE-induced IL-8 expression at both mRNA and protein levels.", {"entities": []}], ["NF-kB controlled the transcription of IL-8 induced by CSE, since PDTC prevented such a production.", {"entities": []}], ["Lycopene suppressed CSE-induced NF-kB DNA binding, NF-kB/p65 nuclear translocation and phosphorylation of IKK\u03b1 and IkB\u03b1.", {"entities": []}], ["Such an inhibition was accompanied by a decrease in CSE-induced ROS production and NOX-4 expression.", {"entities": []}], ["Lycopene further inhibited CSE-induced phosphorylation of the redox-sensitive ERK1/2, JNK and p38 MAPKs.", {"entities": []}], ["Moreover, the carotenoid increased PPAR\u03b3 levels which, in turn, enhanced PTEN expression and decreased pAKT levels in CSE-exposed cells.", {"entities": [[73, 77, "GENE"]]}], ["Such effects were abolished by the PPAR\u03b3 inhibitor GW9662.", {"entities": []}], ["Taken together, our data indicate that lycopene prevented CSE-induced IL-8 production through a mechanism involving an inactivation of NF-kB.", {"entities": []}], ["NF-kB inactivation was accompanied by an inhibition of redox signalling and an activation of PPAR\u03b3 signalling.", {"entities": []}], ["The ability of lycopene in inhibiting IL-8 production, NF-kB/p65 nuclear translocation, and redox signalling and in increasing PPAR\u03b3 expression was also found in isolated rat alveolar macrophages exposed to CSE.", {"entities": []}], ["These findings provide novel data on new molecular mechanisms by which lycopene regulates cigarette smoke-driven inflammation in human macrophages.", {"entities": []}], ["Patient non-adherence to medicines represents a significant waste of health resource and lost opportunity for health gain.", {"entities": []}], ["Medicine management services are a key health policy strategy to encourage patients to take medicines as they are prescribed.", {"entities": []}], ["One such service is the English Medicines Use Review (MUR) which is an NHS-funded community pharmacy service involving a patient-pharmacist consultation aiming to improve patients\u2019 knowledge of medicines and their use.", {"entities": []}], ["To date the evidence for MURs to improve patient health outcomes is equivocal and GPs are reported to be sceptical about the value of the service.", {"entities": []}], ["This paper presents the patient\u2019s perspective of the MUR service and focuses on the importance of GP-pharmacist collaboration for patient care.", {"entities": []}], ["Suggestions on how MURs may have value to GPs through the delivery of increased patient benefit are discussed.", {"entities": []}], ["A qualitative study involving ten weeks of ethnographic observations in two English community pharmacies.", {"entities": []}], ["Observations were made of all pharmacy activities including patient-pharmacist MUR consultations.", {"entities": []}], ["Subsequent interviews with these patients were conducted to explore their experience of the service.", {"entities": []}], ["Interviews with the pharmacy staff were conducted after the period of observations.", {"entities": []}], ["A thematic approach was used to analyse the data.", {"entities": []}], ["Fifty-four patients agreed to have their MUR observed of which thirty-four were interviewed.", {"entities": []}], ["Seventeen pharmacy staff were also interviewed.", {"entities": []}], ["Patients reported positive views about MURs.", {"entities": []}], ["However, there was little evidence suggesting that pharmacists and GPs were working collaboratively or communicating outcomes resulting from MURs.", {"entities": []}], ["MURs were conducted in isolation from other aspects of patient care.", {"entities": []}], ["Patients considered GPs to have authority over medicines making a few wary that MURs had the potential to cause tensions between these professionals and possibly adversely affect their own relationship with their doctor.", {"entities": []}], ["This study reveals the potential for effective GP-pharmacist collaboration to improve the capacity of the MUR service to support patient medicine taking.", {"entities": []}], ["Closer collaboration between GPs and pharmacists could potentially improve patients\u2019 use of medicines and associated health care outcomes.", {"entities": []}], ["The current lack of such collaboration constitutes a missed opportunity for pharmacists and GPs to work together with patients to improve effective prescribing and optimise patient use of medicines.", {"entities": []}], ["Moxibustion is a traditional East Asian medical therapy that uses the heat generated by burning herbal preparations containing Artemisia vulgaris to stimulate acupuncture points.", {"entities": []}], ["The aim of this review was to evaluate previously published clinical evidence for the use of moxibustion as a treatment for hypertension.", {"entities": [[124, 136, "DISEASE"]]}], ["We searched 15 databases without language restrictions from their respective dates of inception until March 2010.", {"entities": []}], ["We included randomized controlled trials (RCTs) comparing moxibustion to either antihypertensive drugs or no treatment.", {"entities": []}], ["The risk of bias was assessed for each RCT.", {"entities": []}], ["During the course of our search, we identified 519 relevant articles.", {"entities": []}], ["A total of 4 RCTs met all the inclusion criteria, two of which failed to report favorable effects of moxibustion on blood pressure (BP) compared to the control (antihypertensive drug treatment alone).", {"entities": []}], ["However, a third RCT showed significant effects of moxibustion as an adjunct treatment to antihypertensive drug therapy for lowering BP compared to antihypertensive drug therapy alone.", {"entities": []}], ["The fourth RCT included in this review addressed the immediate BP-lowering effects of moxibustion compared to no treatment.", {"entities": []}], ["None of the included RCTs reported the sequence generation, allocation concealment and evaluator blinding.", {"entities": []}], ["There is insufficient evidence to suggest that moxibustion is an effective treatment for hypertension.", {"entities": [[89, 101, "DISEASE"]]}], ["Rigorously designed trials are warranted to answer the many remaining questions.", {"entities": []}], ["Human Rhinoviruses (HRVs) have high genetic diversity and three species have been described: HRV-A, HRV-B, and the recently recognized HRV-C, which has been rapidly identified worldwide.", {"entities": []}], ["In the present study, we report the frequency and diversity of Human Rhinovirus (HRV) strains circulating in Panama from children hospitalized with respiratory infections.", {"entities": []}], ["HRVs of species A, B and C have been identified with a predominance of HRV-A and HRV-C over HRV-B, and marked genetic diversity within each species.", {"entities": []}], ["Tobacco use remains the leading cause of preventable death in the United States.", {"entities": []}], ["Following the 1998 Master Settlement Agreement with the tobacco industry, Washington State dedicated substantial funding to the creation of a statewide, comprehensive tobacco control program.", {"entities": []}], ["This report documents the history and observed effectiveness of that program.", {"entities": []}], ["In 2000, the Washington legislature allocated $100 million out of the first Master Settlement payment of $320 million to tobacco control.", {"entities": []}], ["The comprehensive tobacco control program was launched late that same year with an annual budget of $15 million.", {"entities": []}], ["We used existing data from state and national health behavior surveillance systems to describe smoking prevalence among adults and youth.", {"entities": []}], ["For adult measures, we used data from the Washington State Behavioral Risk Factor Surveillance System and the National Health Interview Survey.", {"entities": []}], ["For youth measures, we used data from the Washington State Healthy Youth Survey and the national Monitoring the Future survey.", {"entities": []}], ["We used the National Cancer Institute's \"Joinpoint\" software to compare trends.", {"entities": []}], ["Between 1990 and 2001, adult smoking prevalence in Washington was nearly unchanged, as it was in the United States as a whole.", {"entities": []}], ["However, from 2001, one year after Washington instituted its comprehensive tobacco control program, to 2005, the prevalence of smoking among adults in Washington declined significantly from 22.5% to 17.6%, and by a significantly larger amount than it did nationally during the same period (22.7% to 20.9%).", {"entities": []}], ["In addition, the prevalence of youth smoking also declined faster in Washington than it did nationally; for example, from 2000 to 2004, smoking prevalence among 8th graders declined from 12.5% in 2000 to 7.8% in 2004 in Washington but only from 12.2% in to 9.3% nationally.", {"entities": []}], ["Significant reductions in smoking prevalence among Washington residents following the implementation of a comprehensive tobacco control program funded at a level near that recommended by the Centers for Disease Control and Prevention indicate that tobacco control programs are an effective investment for states committed to improving public health.", {"entities": []}], ["The rapid expansion of the available genomic data continues to greatly impact biomedical science and medicine.", {"entities": []}], ["Fulfilling the clinical potential of genetic discoveries requires the development of therapeutics that can specifically modulate the expression of disease-relevant genes.", {"entities": []}], ["RNA-based drugs, including short interfering RNAs and antisense oligonucleotides, are particularly promising examples of this newer class of biologics.", {"entities": []}], ["For over two decades, researchers have been trying to overcome major challenges for utilizing such RNAs in a therapeutic context, including intracellular delivery, stability, and immune response activation.", {"entities": []}], ["This research is finally beginning to bear fruit as the first RNA drugs gain FDA approval and more advance to the final phases of clinical trials.", {"entities": []}], ["Furthermore, the recent advent of CRISPR, an RNA-guided gene-editing technology, as well as new strides in the delivery of messenger RNA transcribed in vitro, have triggered a major expansion of the RNA-therapeutics field.", {"entities": []}], ["In this review, we discuss the challenges for clinical translation of RNA-based therapeutics, with an emphasis on recent advances in delivery technologies, and present an overview of the applications of RNA-based drugs for modulation of gene/protein expression and genome editing that are currently being investigated both in the laboratory as well as in the clinic.", {"entities": []}], ["Recent high-throughput sequencing technology has led to an expansion of knowledge regarding the microbial communities (microbiome) across various built environments (BEs).", {"entities": []}], ["The microbiome of the BE is dependent upon building factors and conditions that govern how outdoor microbes enter and persist in the BE.", {"entities": []}], ["Additionally, occupants are crucial in shaping the microbiome of the BE by releasing human-associated microorganisms and resuspending microbes on floors and surfaces.", {"entities": []}], ["Therefore, both the outdoors and occupants act as major sources of microorganisms found in the BE.", {"entities": []}], ["However, most characterizations of the microbiome of the BE have been conducted in the Western world.", {"entities": []}], ["Notably, outdoor locations and population groups present geographical variations in outdoor and human microbiomes, respectively.", {"entities": []}], ["Given the influences of the outdoor and human microbiomes on BE microbiology, and the geographical variations in outdoor and human microbiomes, it is likely that the microbiomes of BEs also vary by location.", {"entities": []}], ["The summation of microbiomes between BEs contribute to a potential BE pan-microbiome, which will both consist of microbes that are ubiquitous in indoor environments around the world, and microbes that appear to be endemic to particular geographical locations.", {"entities": []}], ["Importantly, the BE pan-microbiome can potentially question the global application of our current views on indoor microbiology.", {"entities": []}], ["In this review, we first provide an assessment on the roles of building and occupant properties on shaping the microbiome of the BE.", {"entities": []}], ["This is then followed by a description of geographical variations in the microbiomes of the outdoors and humans, the two main sources of microbes in BEs.", {"entities": []}], ["We present evidence of differences in microbiomes of BEs around the world, demonstrating the existence of a global pan-microbiome of the BE that is larger than the microbiome of any single indoor environment.", {"entities": []}], ["Finally, we discuss the significance of understanding the BE pan-microbiome and identifying universal and location-specific relationships between building and occupant characteristics and indoor microbiology.", {"entities": []}], ["This review highlights the much needed efforts towards determining the pan-microbiome of the BE, thereby identifying general and location-specific links between the microbial communities of the outdoors, human, and BE ecosystems, ultimately improving the health, comfort, and productivity of occupants around the world.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-016-0165-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Gram-negative bacilli are a cause of serious infections in the pediatric population.", {"entities": []}], ["Carbapenem are the treatment of choice for infections caused by multidrug-resistant Gram-negative bacilli, but the emergence of carbapenem resistance has substantially reduced access to effective antimicrobial regimens.", {"entities": []}], ["Children are a population vulnerable to bacterial infections and the emergence of resistance can worsen prognosis.", {"entities": []}], ["The aim of this study is to describe the clinical and molecular characteristics of infections caused by carbapenem-resistant Gram-negative bacilli in pediatric patients from five tertiary-care hospitals in Medell\u00edn, Colombia.", {"entities": []}], ["A cross-sectional study was conducted in five tertiary-care hospitals from June 2012 to June 2014.", {"entities": []}], ["All pediatric patients infected by carbapenem-resistant Gram-negative bacilli were included.", {"entities": []}], ["Clinical information for each patient was obtained from medical records.", {"entities": []}], ["Molecular analyses included PCR for detection of bla VIM , bla IMP bla NDM, bla OXA-48 and bla KPC genes and PFGE and MLST for molecular typing.", {"entities": []}], ["A total of 59 patients were enrolled, most of them less than 1\u00a0year old (40.7\u00a0% n \u2009=\u200924), with a previous history of antibiotic use (94.9\u00a0%; n \u2009=\u200956) and healthcare-associated infections - predominately urinary tract infections (31.0\u00a0%; n \u2009=\u200918).", {"entities": []}], ["Klebsiella pneumoniae was the most frequent bacteria (47.4\u00a0%), followed by Enterobacter cloacae (40.7\u00a0%) and Pseudomonas aeruginosa (11.9\u00a0%).", {"entities": []}], ["For K. pneumoniae , KPC was the predominant resistance mechanism (85.7\u00a0%; n \u2009=\u200924) and ST14 was the most common clone (39.3\u00a0% n \u2009=\u200911), which included strains closely related by PFGE.", {"entities": [[87, 91, "GENE"]]}], ["In contrast, E. cloacae and P. aeruginosa were prevailing non-carbapenemase-producing isolates (only KPC and VIM were detected in 1 and 3 isolates, respectively) and high genetic diversity according to PFGE and MLST was found in the majority of the cases.", {"entities": []}], ["In recent years, increasing carbapenem-resistant bacilli in children has become in a matter of great concern.", {"entities": []}], ["It is important to conduct systemic surveillance and take measures to prevent dissemination of multidrug-resistant bacteria.", {"entities": []}], ["Apoptosis signal-regulating kinase 1 (ASK1) is a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family that activates downstream MAP kinases (MAPKs), c-Jun N-terminal kinases (JNKs) and p38 MAPKs, in response to various stresses, such as reactive oxygen species (ROS), endoplasmic reticulum (ER) stress, lipopolysaccharide, and calcium overload.", {"entities": []}], ["Activation of the JNK and p38 pathways induces stress responses such as cell death, differentiation, and the production of inflammatory cytokines.", {"entities": []}], ["A series of studies using ASK1-deficient mice have indicated that ASK1 plays important roles in many stress-related diseases, including cardiovascular and neurodegenerative diseases, suggesting that small compounds that inhibit ASK1 activity could possibly be used for the amelioration of the development and/or progression of these diseases.", {"entities": []}], ["In this review, we provide an overview of the pathophysiological roles of ASK1-dependent signaling pathways and discuss the mechanistic basis for how these could serve as potential therapeutic targets.", {"entities": []}], ["This research was conducted to verify the structural and functional characteristics of mast cells in the electroacupuncture (EA) effects on bradycardia.", {"entities": []}], ["First, we examined the mast cell density at PC 6, adjacent acupoint LU 7, and a non-acupoint.", {"entities": [[44, 46, "GENE"]]}], ["We tested the effects of EA at PC 6 on heart rate (HR) and blood pressure (BP) in rabbits with pituitrin-induced bradycardia.", {"entities": [[31, 33, "GENE"], [51, 53, "GENE"]]}], ["We also injected sodium cromolyn (Cro), a mast cell membrane stabilizer, at PC 6 30\u2009min before EA to investigate if it affected the EA effects.", {"entities": [[76, 78, "GENE"]]}], ["The results showed that in both PC 6 and LU 7, the mast cell densities were higher than in the non-acupoint ( P \u2009<\u20090.05).", {"entities": [[32, 34, "GENE"]]}], ["EA could induce mast cell degranulation at PC 6, which could be suppressed by sodium cromolyn ( P \u2009<\u20090.05).", {"entities": [[43, 45, "GENE"]]}], ["EA improved HR, though the change was relatively small in the initial stage with a significant change at 35\u2009min after modelling ( P \u2009<\u20090.05).", {"entities": [[12, 14, "GENE"]]}], ["BP significantly improved at 10\u2009min after the onset of pituitrin-induced bradycardia ( P \u2009<\u20090.05).", {"entities": []}], ["The EA effects on both HR and BP were suppressed by sodium cromolyn ( P \u2009<\u20090.05).", {"entities": [[23, 25, "GENE"]]}], ["Therefore, we concluded that mast cells in the acupoint are important for the EA effects against pituitrin-induced bradycardia in rabbits.", {"entities": []}], ["Forced oscillation technique (FOT) has been reported to be useful in the evaluation and management of obstructive lung disease, including COPD.", {"entities": [[102, 126, "DISEASE"], [114, 126, "DISEASE"]]}], ["To date, no data are available concerning long-term changes in respiratory system impedance measured by FOT.", {"entities": []}], ["Additionally, although exacerbations have been reported to be associated with excessive lung function decline in COPD, the impact of exacerbations on the results of FOT has not been demonstrated.", {"entities": []}], ["The aim of this study was to investigate the longitudinal changes in respiratory system impedance and the influence of exacerbations thereon.", {"entities": []}], ["Between March 2011 and March 2012, outpatients who attended Kobe City Medical Center West Hospital with a diagnosis of COPD were assessed for eligibility.", {"entities": []}], ["Baseline patient characteristics (age, sex, body mass index, smoking history, current smoking status, COPD stage), lung function (post-bronchodilator forced expiratory volume in 1 second [FEV 1 ]), blood tests (neutrophils and eosinophils), FOT, and COPD assessment test results were collected at enrollment.", {"entities": [[188, 191, "GENE"]]}], ["Lung function and FOT were examined every 6 months until March 2016.", {"entities": []}], ["Annual changes in FEV 1 and FOT parameters were obtained from the slope of the linear regression curve.", {"entities": [[18, 21, "GENE"]]}], ["The patients were divided into 2 groups based on exacerbation history.", {"entities": []}], ["Fifty-one of 58 patients with COPD were enrolled in this study.", {"entities": []}], ["The median follow-up period was 57 (52\u201359) months.", {"entities": []}], ["Twenty-five (49%) patients experienced exacerbations.", {"entities": []}], ["A significant annual decline in FEV 1 and respiratory system impedance were shown.", {"entities": [[32, 35, "GENE"]]}], ["Additionally, annual changes in FEV 1 , respiratory system resistance at 5 Hz, respiratory system reactance at 5 Hz, and resonant frequency were greater in patients with exacerbations than in those without exacerbations.", {"entities": [[32, 35, "GENE"]]}], ["Exacerbations of COPD lead not only to a decline in lung function but also to an increase in respiratory system impedance.", {"entities": []}], ["Low circulating vitamin D levels have been associated with risk of asthma, atopic dermatitis, and elevated total immunoglobulin E (IgE).", {"entities": [[75, 92, "DISEASE"], [67, 73, "DISEASE"], [82, 92, "DISEASE"]]}], ["These epidemiological associations, if true, would have public health importance, since vitamin D insufficiency is common and correctable.", {"entities": []}], ["We aimed to test whether genetically lowered vitamin D levels were associated with risk of asthma, atopic dermatitis, or elevated serum IgE levels, using Mendelian randomization (MR) methodology to control bias owing to confounding and reverse causation.", {"entities": [[99, 116, "DISEASE"], [91, 97, "DISEASE"], [106, 116, "DISEASE"]]}], ["The study employed data from the UK Biobank resource and from the SUNLIGHT, GABRIEL and EAGLE eczema consortia.", {"entities": []}], ["Using four single-nucleotide polymorphisms (SNPs) strongly associated with 25-hydroxyvitamin D (25OHD) levels in 33,996 individuals, we conducted MR studies to estimate the effect of lowered 25OHD on the risk of asthma ( n = 146,761), childhood onset asthma ( n = 15,008), atopic dermatitis ( n = 40,835), and elevated IgE level ( n = 12,853) and tested MR assumptions in sensitivity analyses.", {"entities": [[273, 290, "DISEASE"], [212, 218, "DISEASE"], [251, 257, "DISEASE"], [280, 290, "DISEASE"]]}], ["None of the four 25OHD-lowering alleles were associated with asthma, atopic dermatitis, or elevated IgE levels ( p \u2265 0.2).", {"entities": [[69, 86, "DISEASE"], [61, 67, "DISEASE"], [76, 86, "DISEASE"]]}], ["The MR odds ratio per standard deviation decrease in log-transformed 25OHD was 1.03 (95% confidence interval [CI] 0.90\u20131.19, p = 0.63) for asthma, 0.95 (95% CI 0.69\u20131.31, p = 0.76) for childhood-onset asthma, and 1.12 (95% CI 0.92\u20131.37, p = 0.27) for atopic dermatitis, and the effect size on log-transformed IgE levels was \u22120.40 (95% CI \u22121.65 to 0.85, p = 0.54).", {"entities": [[251, 268, "DISEASE"], [139, 145, "DISEASE"], [201, 207, "DISEASE"], [258, 268, "DISEASE"]]}], ["These results persisted in sensitivity analyses assessing population stratification and pleiotropy and vitamin D synthesis and metabolism pathways.", {"entities": []}], ["The main limitations of this study are that the findings do not exclude an association between the studied outcomes and 1,25-dihydoxyvitamin D, the active form of vitamin D, the study was underpowered to detect effects smaller than an OR of 1.33 for childhood asthma, and the analyses were restricted to white populations of European ancestry.", {"entities": [[260, 266, "DISEASE"]]}], ["This research has been conducted using the UK Biobank Resource and data from the SUNLIGHT, GABRIEL and EAGLE Eczema consortia.", {"entities": []}], ["In this study, we found no evidence that genetically determined reduction in 25OHD levels conferred an increased risk of asthma, atopic dermatitis, or elevated total serum IgE, suggesting that efforts to increase vitamin D are unlikely to reduce risks of atopic disease.", {"entities": [[129, 146, "DISEASE"], [121, 127, "DISEASE"], [136, 146, "DISEASE"]]}], ["In a Mendelian randomization analysis, J. Brent Richards and colleagues investigate possible relations between genetic elements associated with vitamin D levels and atopic susceptibility.", {"entities": []}], ["Observational epidemiological studies have reported associations of low vitamin D levels with risk of asthma, atopic dermatitis, and elevated immunoglobulin E (IgE) levels.", {"entities": [[110, 127, "DISEASE"], [102, 108, "DISEASE"], [117, 127, "DISEASE"]]}], ["However, these studies are susceptible to confounding and reverse causation, and thus it remains unclear whether these associations are genuine.", {"entities": []}], ["The randomized controlled trials published to date on this topic have been inconclusive.", {"entities": []}], ["If vitamin D insufficiency did cause atopic diseases, this would be of clinical relevance, since vitamin D insufficiency is common and safely correctable.", {"entities": []}], ["We applied a Mendelian randomization study design, which greatly limits bias due to confounding and prevents bias due to reverse causation, to understand if vitamin D levels are associated with a higher risk of adult and pediatric asthma, atopic dermatitis, or elevated IgE levels.", {"entities": [[239, 256, "DISEASE"], [231, 237, "DISEASE"], [246, 256, "DISEASE"]]}], ["Despite high statistical power, our study showed no evidence of an unconfounded association between vitamin D and the studied outcomes.", {"entities": []}], ["Our findings suggest that the previous epidemiological associations between vitamin D and atopic diseases could be due to confounding.", {"entities": []}], ["Efforts to increase vitamin D levels will probably not result in decreased risk of adult and pediatric asthma, atopic dermatitis, or elevated IgE levels.", {"entities": [[111, 128, "DISEASE"], [103, 109, "DISEASE"], [118, 128, "DISEASE"]]}], ["The major cat allergen, Fel d 1, is a structurally complex protein with two N-glycosylation sites that may be filled by different glycoforms.", {"entities": []}], ["In addition, the protein contains three putative Ca 2 activity.", {"entities": []}], ["As these results increase our understanding of Fel d 1 structural biology, they may offer new support for understanding its physiological role and impact into cat-promoted allergy.", {"entities": []}], ["While the health effects of air pollution have been an international public health concern since at least the 1950s, recent research has focused on two broad sources of air pollution, namely, biomass fuel (BMF) and motor vehicle exhaust (MVE).", {"entities": [[206, 209, "GENE"]]}], ["Many studies have shown associations between air pollution PM and exacerbations of pre-existing COPD, but the role of air pollution PM in the development and progression of COPD is still uncertain.", {"entities": []}], ["The current study indicates that rats can develop pronounced COPD following chronic exposure to air pollution PM (BMF and MVE), as characterized by lung function reduction, mucus metaplasia, lung and systemic inflammation, emphysema, and small airway remodeling.", {"entities": [[114, 117, "GENE"]]}], ["Comparative analyses demonstrate that both BMF and MVE activate similar pathogenesis that are linked to the development of COPD.", {"entities": [[43, 46, "GENE"]]}], ["These findings also show that some differences are found in the lungs of rats exposed to BMF or MVE, which might result in different phenotypes of COPD.", {"entities": [[89, 92, "GENE"]]}], ["The homing of mesenchymal stem cells to injured tissue, which is important for the correction of conditions such as ischemia-reperfusion injury (IRI) and immunolesions, has been performed previously, but with poor efficiency.", {"entities": [[116, 124, "DISEASE"]]}], ["Substantial improvements in engraftment are required to derive clinical benefits from MSC transplantation.", {"entities": [[86, 89, "GENE"]]}], ["Chemokines are the most important factors that control cellular migration.", {"entities": []}], ["Stromal derived factor-1 ( SDF-1 ) is up-regulated during tissue/organ ischemia damage, and its cognate receptor, chemokine receptor 4 ( CXCR4 ), is involved in stem cell migration.", {"entities": [[71, 79, "DISEASE"], [137, 142, "GENE"]]}], ["The aim of our study was to investigate CXCR4 expression in MSCs and to validate both its role in mediating migration to transplanted kidneys and its immunoregulatory effects in renal protection.", {"entities": [[40, 45, "GENE"]]}], ["Specifically, the present study was designed to investigate the short-term tissue homing of MSCs carrying genetically modified CXCR4 in a rat renal transplantation model.", {"entities": [[127, 132, "GENE"]]}], ["We tested the hypothesis that MSCs with CXCR4 over-expression can more efficiently regulate immunological reactions.", {"entities": [[40, 45, "GENE"]]}], ["Lentiviral vectors were used to over-express CXCR4 or to introduce a short hairpin ribonucleic acid (shRNA) construct targeting endogenous CXCR4 in rat MSCs.", {"entities": [[45, 50, "GENE"], [139, 144, "GENE"], [45, 50, "GENE"], [139, 144, "GENE"]]}], ["MSCs were labeled with enhanced green fluorescent protein (eGFP).", {"entities": []}], ["After cell sorting, recipient kidneys were regionally perfused; recipient animals were injected with transduced MSCs, native MSCs, or PBS via tail vein following renal transplantation; and the effects of MSC injection were observed.", {"entities": [[204, 207, "GENE"]]}], ["The ADAM33 gene is associated with the pathophysiology of Chronic Obstructive Pulmonary Disease (COPD) and atherosclerosis.", {"entities": [[107, 122, "DISEASE"], [4, 10, "GENE"]]}], ["In this study we investigated all-cause, COPD and cardiovascular mortality, in relation to single nucleotide polymorphisms (SNPs) in ADAM33 (Q_1, S_1, S_2, T_1 and T_2) that were genotyped in 1,390 subjects from the Vlagtwedde/Vlaardingen cohort.", {"entities": [[133, 139, "GENE"]]}], ["Participants were examined at entry in 1989/1990 and followed up till evaluation of the vital status on December 31 1 , height, place of residence and packyears of smoking.", {"entities": []}], ["Additionally, we performed stratified analyses according to gender and smoking habits.", {"entities": []}], ["After 18 years, 284 (20.4%) subjects had died (107 due to cardiovascular disease and 20 due to COPD).", {"entities": []}], ["Individuals homozygous for the minor allele of SNP T_2 had an increased risk of all-cause and cardiovascular mortality compared to wild types: hazard ratio 3.6 (95% confidence interval 2.0 to 6.7) and 3.4 (1.2 to 9.5) respectively.", {"entities": []}], ["Individuals homozygous for the minor allele of S_1, S_2, T_2 or Q_1 had a significantly increased risk of COPD mortality.", {"entities": []}], ["In stratified analyses the risk of all-cause mortality associated with SNP T_2 did not change: females 3.5 (1.5 to 8.3), males 3.1 (1.2 to 7.6), never smokers 3.8 (0.9 to 16.3), ever smokers 3.6 (1.8 to 7.2).", {"entities": []}], ["This study shows for the first time that ADAM33 is a pleiotropic gene that is associated with all-cause, COPD and cardiovascular mortality, independent of potential confounders.", {"entities": [[41, 47, "GENE"]]}], ["Evidence is inconsistent as to whether or not there are health inequalities in adolescence according to socio-economic position (SEP) and whether or when they emerge in early adulthood.", {"entities": []}], ["Despite the large health inequalities literature, few studies have simultaneously compared the relative importance of \u2018health selection\u2019 versus \u2018social causation\u2019 at this life-stage.", {"entities": []}], ["This study followed a cohort through the youth-adult transition to: (1) determine whether, and if so, when, health inequalities became evident according to both class of origin and current SEP; (2) compare the importance of health selection and social causation mechanisms; and (3) investigate whether these phenomena vary by gender.", {"entities": []}], ["Data are from a West-of-Scotland cohort, surveyed five times between age 15 (in 1987, N =1,515, response=85%) and 36.", {"entities": []}], ["Self-reported physical and mental health were obtained at each survey.", {"entities": []}], ["SEP was based on parental occupational class at 15, a combination of own education or occupational status at 18 and own occupational class (with an additional non-employment category) at older ages.", {"entities": []}], ["In respect of when inequalities emerged, we used the relative index of inequality to examine associations between both parental and own current SEP and health at each age.", {"entities": []}], ["In respect of mechanisms, path models, including SEP and health at each age, investigated both inter and intra-generational paths from SEP to health (\u2018causation\u2019) and from health to SEP (\u2018selection\u2019).", {"entities": []}], ["Analyses were conducted separately for physical and mental health, and stratified by gender.", {"entities": []}], ["Associations between both physical and mental health and parental SEP were non-significant at every age.", {"entities": []}], ["Inequalities according to own SEP emerged for physical health at 24 and for mental health at 30.", {"entities": []}], ["There was no evidence of selection based on physical health, but some evidence of associations between mental health in early adulthood and later SEP (intra-generational selection).", {"entities": []}], ["Paths indicated intra-generational (males) and inter-generational (females) social causation of physical health inequalities, and intra-generational (males and females) and inter-generational (females) social causation of mental health inequalities.", {"entities": []}], ["The results suggest complex and reciprocal relationships between SEP and health and highlight adolescence and early adulthood as a sensitive period for this process, impacting on future life-chances and health.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-2674-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Introduction : There are limited data linking serum levels of surfactant protein D, its genetic polymorphisms to the risk of Chronic Obstructive Pulmonary Disease (COPD).", {"entities": []}], ["Objectives : We sought to investigate these relationships using a case control study design.", {"entities": []}], ["Methods : Post bronchodilator values of FEV1/FVC <0.7 were used to diagnose COPD patients ( n = 115).", {"entities": []}], ["Controls were healthy subjects with normal spirometry ( n = 106) Single nucleotide polymorphisms (rs721917, rs2243639, rs3088308) were genotyped using polymerase chain reaction (PCR) and restriction analysis.", {"entities": []}], ["Serum SP-D levels were measured using a specific immunoassay.", {"entities": []}], ["Results: Allele \u2018A\u2019 at rs3088308 ( p < 0.00, B = \u22120.41) and \u2018C\u2019 allele at rs721917 ( p = 0.03; B = \u22120.30) were associated with reduced serum SP-D levels.", {"entities": []}], ["Genotype \u2018T/T\u2019 at rs721917 was significantly associated with risk of COPD ( p = 0.01).", {"entities": []}], ["Patients with repeat exacerbations had significantly higher serum SP-D even after adjusting for genetic factors.", {"entities": []}], ["Conclusions: We report for the first time that rs3088308 is an important factor influencing systemic SP-D levels and confirm the previous association of rs721917 to the risk of COPD and serum SP-D levels.", {"entities": []}], ["This study revealed activation-dependent and coordinated relocation of Medicago sativa SIMKK and SIMK after salt stress.", {"entities": []}], ["Arabidopsis seedlings stably overexpressing YFP-tagged SIMKK showed altered salt sensitivity and proteome changes.", {"entities": []}], ["Dual-specificity mitogen-activated protein kinases kinases (MAPKKs) are the immediate upstream activators of MAPKs.", {"entities": []}], ["They simultaneously phosphorylate the TXY motif within the activation loop of MAPKs, allowing them to interact with and regulate multiple substrates.", {"entities": []}], ["Often, the activation of MAPKs triggers their nuclear translocation.", {"entities": []}], ["However, the spatiotemporal dynamics and the physiological consequences of the activation of MAPKs, particularly in plants, are still poorly understood.", {"entities": []}], ["Here, we studied the activation and localization of the Medicago sativa stress-induced MAPKK (SIMKK)\u2013SIMK module after salt stress.", {"entities": []}], ["In the inactive state, SIMKK and SIMK co-localized in the cytoplasm and in the nucleus.", {"entities": []}], ["Upon salt stress, however, a substantial part of the nuclear pool of both SIMKK and SIMK relocated to cytoplasmic compartments.", {"entities": []}], ["The course of nucleocytoplasmic shuttling of SIMK correlated temporally with the dual phosphorylation of the pTEpY motif.", {"entities": []}], ["SIMKK function was further studied in Arabidopsis plants overexpressing SIMKK\u2013yellow fluorescent protein (YFP) fusions.", {"entities": []}], ["SIMKK\u2013YFP plants showed enhanced activation of Arabidopsis MPK3 and MPK6 kinases upon salt treatment and exhibited high sensitivity against salt stress at the seedling stage, although they were salt insensitive during seed germination.", {"entities": []}], ["Proteomic analysis of SIMKK\u2013YFP overexpressors indicated the differential regulation of proteins directly or indirectly involved in salt stress responses.", {"entities": []}], ["These proteins included catalase, peroxiredoxin, glutathione S -transferase, nucleoside diphosphate kinase 1, endoplasmic reticulum luminal-binding protein 2, and finally plasma membrane aquaporins.", {"entities": []}], ["In conclusion, Arabidopsis seedlings overexpressing SIMKK\u2013YFP exhibited higher salt sensitivity consistent with their proteome composition and with the presumptive MPK3/MPK6 hijacking of the salt response pathway.", {"entities": []}], ["A model that combines reactive and anticipatory care within routine consultations has become recognized as a cost-effective means of providing preventive health care, challenging the need of the periodic health examination.", {"entities": []}], ["As such, opportunistic screening may be preferable to organized screening.", {"entities": []}], ["Provision of comprehensive preventive healthcare within the primary care system depends on regular attendance of the general population to primary care physicians (PCPs).", {"entities": []}], ["Objectives: To assess the proportion of patients who do not visit a PCP even once during a four-year period, and to describe the characteristics of this population.", {"entities": []}], ["An observational study, based on electronic medical records of 421,012 individuals who were members of one district of Clalit Health Services, the largest health maintenance organization in Israel.", {"entities": []}], ["The average annual number of visits to PCPs was 7.6\u2009\u00b1\u20098.7 to 8.3\u2009\u00b1\u20099.0 (median 5, 25%-75% interval 1\u201311) and 9.5\u2009\u00b1\u200910.0 to10.2\u2009\u00b1\u200910.4 (median 6, 25%-75% interval 1\u201314) including visits to direct access consultants) in the four years of the study.", {"entities": []}], ["During the first year of the study 87.2% of the population visited a PCP.", {"entities": []}], ["During the four year study period, only 1.5% did not visit a PCP even once.", {"entities": []}], ["In a multivariate analysis having fewer chronic diseases (for each additional chronic disease the OR, 95% CI was 0.40 (0.38\u00ac0.42)), being a new immigrant (OR, 95% CI 2.46 (2.32\u00ac2.62)), and being male (OR, 95% CI 1.66 (1.58\u00ac1.75)) were the strongest predictors of being a non-attender to a PCP for four consecutive years.", {"entities": []}], ["The rate of nonattendance to PCPs in Israel is low.", {"entities": []}], ["Other than new immigrant status, none of the characteristics identified for nonattendance suggest increased need for healthcare services.", {"entities": []}], ["Compared to men, women report greater morbidity and make greater use of health-care services.", {"entities": []}], ["This study examines potential determinants of gender differences in the utilization of health-care services among the elderly.", {"entities": []}], ["Cross-sectional study covering 3030 subjects, representative of the non-institutionalized Spanish population aged 60 years and over.", {"entities": []}], ["Potential determinants of gender differences in the utilization of health services were classified into predisposing factors (age and head-of-family status), need factors (lifestyles, chronic diseases, functional status, cognitive deficit and health-related quality of life (HRQL)) and enabling factors (educational level, marital status, head-of-family employment status and social network).", {"entities": []}], ["Relative differences in the use of each service between women and men were summarized using odds ratios (OR), obtained from logistic regression.", {"entities": []}], ["The contribution of the variables of interest to the gender differences in the use of such services was evaluated by comparing the OR before and after adjustment for such variables.", {"entities": []}], ["As compared to men, a higher percentage of women visited a medical practitioner (OR: 1.24; 95% confidence limits (CL): 1.07\u20131.44), received home medical visits (OR: 1.67; 95% CL: 1.34\u20132.10) and took \u22653 medications (OR: 1.54; 95% CL: 1.34\u20131.79), but there were no gender differences in hospital admission or influenza vaccination.", {"entities": [[307, 316, "DISEASE"]]}], ["Adjustment for need or enabling factors led to a reduction in the OR of women compared to men for utilization of a number of services studied.", {"entities": []}], ["On adjusting for the number of chronic diseases, the OR (95% CL) of women versus men for ingestion of \u22653 medications was 1.24 (1.06\u20131.45).", {"entities": []}], ["After adjustment for HRQL, the OR was 1.03 (0.89\u20131.21) for visits to medical practitioners, 1.24 (0.98\u20131.58) for home medical visits, 0.71 (0.58\u20130.87) for hospitalization, and 1.14 (0.97\u20131.33) for intake of \u22653 medications.", {"entities": []}], ["After adjustment for the number of chronic diseases and HRQL, the OR of hospitalization among women versus men was 0.68 (0.56\u20130.84).", {"entities": []}], ["The factors that best explain the greater utilization of health-care services by elderly women versus men are the number of chronic diseases and HRQL.", {"entities": []}], ["For equal need, certain inequality was observed in hospital admission, in that it proved less frequent among women.", {"entities": []}], ["Evidence for the use of telephone consultation in childhood inflammatory bowel disease (IBD) is lacking.", {"entities": [[60, 86, "DISEASE"]]}], ["We aimed to assess the effectiveness and cost consequences of telephone consultation compared with the usual out-patient face-to-face consultation for young people with IBD.", {"entities": []}], ["We conducted a randomised-controlled trial in Manchester, UK, between July 12, 2010 and June 30, 2013.", {"entities": []}], ["Young people (aged 8\u201316\u00a0years) with IBD were randomized to receive telephone consultation or face-to-face consultation for 24\u00a0months.", {"entities": []}], ["The primary outcome measure was the paediatric IBD-specific IMPACT quality of life (QOL) score at 12\u00a0months.", {"entities": []}], ["Secondary outcome measures included patient satisfaction with consultations, disease course, anthropometric measures, proportion of consultations attended, duration of consultations, and costs to the UK National Health Service (NHS).", {"entities": [[228, 231, "GENE"]]}], ["Analysis was by intention to treat.", {"entities": []}], ["This trial is registered with ClinicalTrials.gov, number NCT02319798 .", {"entities": []}], ["Eighty six patients were randomised to receive either telephone consultation (n\u00a0=\u00a044) or face-to-face consultation (n\u00a0=\u00a042).", {"entities": []}], ["Baseline characteristics of the two groups were well balanced.", {"entities": []}], ["At 12\u00a0months, there was no evidence of difference in QOL scores (estimated treatment effect in favour of the telephone consultation group was 5.7 points, 95% CI \u2212\u00a02.9 to 14.3; p\u00a0=\u00a00.19).", {"entities": []}], ["Mean consultation times were 9.8\u00a0min (IQR 8 to 12.3) for telephone consultation, and 14.3\u00a0min (11.6 to 17.0) for face-to-face consultation with an estimated reduction (95% CI) of 4.3 (2.8 to 5.7) min in consultation times (p\u00a0<\u00a00.001).", {"entities": []}], ["Telephone consultation had a mean cost of UK\u00a335.41 per patient consultation compared with \u00a351.12 for face-face consultation, difference \u00a315.71 (95% CI 11.8\u201319.6; P\u00a0<\u00a00.001).", {"entities": []}], ["We found no suggestion of inferiority of telephone consultation compared with face-to-face consultation with regard to improvements in QOL scores, and telephone consultation reduced consultation time and NHS costs.", {"entities": [[204, 207, "GENE"]]}], ["Telephone consultation is a cost-effective alternative to face-to-face consultation for the routine outpatient follow-up of children and adolescents with IBD.", {"entities": []}], ["Research for Patient Benefit Programme, UK National Institute for Health Research.", {"entities": []}], ["\u2022 This is the first randomised controlled trial that has formally investigated the role of telephone consultation in paediatric inflammatory bowel disease.", {"entities": [[128, 154, "DISEASE"]]}], ["\u2022 This study contributes evidence showing that telephone consultation as a substitute for routine outpatient follow-up is feasible and effective.", {"entities": []}], ["\u2022 There was no suggestion of inferiority of telephone consultation compared with face-to-face consultation with regard to improvements in quality of life scores, and telephone consultation reduced consultation time and NHS costs.", {"entities": [[219, 222, "GENE"]]}], ["\u2022 Telephone consultation is a cost-effective alternative to face-to-face consultation for the routine outpatient follow-up of children and adolescents with inflammatory bowel disease.", {"entities": [[156, 182, "DISEASE"]]}], ["This is the first randomised controlled trial that has formally investigated the role of telephone consultation in paediatric inflammatory bowel disease.", {"entities": [[126, 152, "DISEASE"]]}], ["This study contributes evidence showing that telephone consultation as a substitute for routine outpatient follow-up is feasible and effective.", {"entities": []}], ["There was no suggestion of inferiority of telephone consultation compared with face-to-face consultation with regard to improvements in quality of life scores, and telephone consultation reduced consultation time and NHS costs.", {"entities": [[217, 220, "GENE"]]}], ["Telephone consultation is a cost-effective alternative to face-to-face consultation for the routine outpatient follow-up of children and adolescents with inflammatory bowel disease.", {"entities": [[154, 180, "DISEASE"]]}], ["Habitual snoring, a prominent symptom of sleep-disordered breathing, is an important indicator for a number of health problems in children.", {"entities": []}], ["Compared to adults, large epidemiological studies on childhood habitual snoring and associated predisposing factors are extremely scarce.", {"entities": []}], ["The present study aimed to assess the prevalence and associated factors of habitual snoring among Chinese school-aged children.", {"entities": []}], ["A random sample of 20,152 children aged 5.08 to 11.99 years old participated in a cross-sectional survey, which was conducted in eight cities of China.", {"entities": []}], ["Parent-administrated questionnaires were used to collect information on children's snoring frequency and the possible correlates.", {"entities": []}], ["The prevalence of habitual snoring was 12.0% (14.5% for boys vs. 9.5% for girls) in our sampled children.", {"entities": []}], ["Following factors were associated with an increased risk for habitual snoring: lower family income (adjusted odds ratio [OR] = 1.46), lower father's education (OR = 1.38 and 1.14 for middle school or under and high school of educational level, respectively), breastfeeding duration < 6 months (OR = 1.17), pregnancy maternal smoking (OR = 1.51), obesity (OR = 1.50), overweight (OR = 1.35), several respiratory problems associated with atopy and infection, such as chronic/allergic rhinitis (OR = 1.94), asthma (OR = 1.43), adenotonsillar hypertrophy (OR = 2.17), and chronic otitis media (OR = 1.31), and family history of habitual snoring (OR = 1.70).", {"entities": [[473, 490, "DISEASE"], [576, 588, "DISEASE"], [482, 490, "DISEASE"], [346, 353, "DISEASE"], [504, 510, "DISEASE"]]}], ["The prevalence of habitual snoring in Chinese children was similar to that observed in other countries.", {"entities": []}], ["The potential predisposing factors covered socioeconomic characteristics, environmental exposures, chronic health problems, and family susceptibility.", {"entities": []}], ["Compared to socioeconomic status and family susceptibility, environmental exposures and chronic health problems had greater impact, indicating childhood habitual snoring could be partly prevented by health promotion and environmental intervention.", {"entities": []}], ["Human rhinoviruses (HRVs) are the predominant cause of common cold.", {"entities": [[55, 66, "DISEASE"]]}], ["In addition, HRVs are implicated in the worsening of COPD and asthma, as well as the loss of lung transplants.", {"entities": [[62, 68, "DISEASE"]]}], ["Despite significant efforts, no anti-viral agent is approved for the prevention or treatment of HRV-infection.", {"entities": []}], ["In this study we demonstrate that Iota-Carrageenan, a sulphated polysaccharide derived from red seaweed, is a potent anti-rhinoviral substance in-vitro.", {"entities": []}], ["Iota-Carrageenan reduces HRV growth and inhibits the virus induced cythopathic effect of infected HeLa cells.", {"entities": []}], ["In addition, Iota-Carrageenan effectively prevents the replication of HRV1A, HRV2, HRV8, HRV14, HRV16, HRV83 and HRV84 in primary human nasal epithelial cells in culture.", {"entities": []}], ["The data suggest that Iota-Carrageenan acts primarily by preventing the binding or the entry of virions into the cells.", {"entities": []}], ["Since HRV infections predominately occur in the nasal cavity and the upper respiratory tract, a targeted treatment with a product containing Iota-Carrageenan is conceivable.", {"entities": []}], ["Clinical trials are needed to determine whether Iota-Carrageenan-based products are effective in the treatment or prophylaxis of HRV infections.", {"entities": []}], ["Airplane Headache (AH) occurs during flights and often appears as an intense, short lasting headache during take-off or landing.", {"entities": []}], ["Reports are limited on pathological mechanisms underlying the occurrence of this headache.", {"entities": []}], ["Proper diagnosis and treatments would benefit from identification of potential pathways involved in AH pathogenesis.", {"entities": []}], ["This study aimed at providing a simulated airplane headache condition as a proxy towards identification of its underlying mechanisms.", {"entities": []}], ["Fourteen participants including 7 volunteers suffering from AH and 7 healthy matched controls were recruited after meeting the diagnostic and safety criteria based on an approved study protocol.", {"entities": []}], ["Simulation of AH was achieved by entering a pressure chamber with similar characteristics of an airplane flight.", {"entities": []}], ["Selected potential biomarkers including salivary prostaglandin E 2 (PGE 2 ), cortisol, facial thermo-images, blood pressure, pulse, and saturation pulse oxygen (SPO) were defined and values were collected before, during and after flight simulation in the pressure chamber.", {"entities": []}], ["Salivary samples were analyzed with ELISA techniques, while data analysis and statistical tests were handled with SPSS version 22.0.", {"entities": []}], ["All participants in the AH-group experienced a headache attack similar to AH experience during flight.", {"entities": []}], ["The non-AH-group did not experience any headaches.", {"entities": []}], ["Our data showed that the values for PGE 2 , cortisol and SPO were significantly different in the AH-group in comparison with the non-AH-group during the flight simulation in the pressure chamber.", {"entities": []}], ["The pressure chamber proved useful not only to provoke AH-like attack but also to study potential biomarkers for AH in this study.", {"entities": []}], ["PGE 2 , and cortisol levels together with SPO presented dysregulation during the simulated AH-attack in affected individuals compared with healthy controls.", {"entities": []}], ["Based on these findings we propose to use pressure chamber as a model to induce AH, and thus assess new potential biomarkers for AH in future studies.", {"entities": []}], ["The American short form Patient Activation Measure (PAM) is a 13-item instrument which assesses patient (or consumer) self-reported knowledge, skills and confidence for self-management of one\u2019s health or chronic condition.", {"entities": []}], ["In this study the PAM was translated into a Dutch version; psychometric properties of the Dutch version were established and the instrument was validated in a panel of chronically ill patients.", {"entities": []}], ["The translation was done according to WHO guidelines.", {"entities": []}], ["The PAM 13-Dutch was sent to 4178 members of the Dutch National Panel of people with Chronic illness or Disability (NPCD) in April 2010 (study A) and again to a sub sample of this group (N\u2009=\u2009973) in June 2010 (study B).", {"entities": []}], ["Internal consistency, test-retest reliability and cross-validation with the SBSQ-D (a measure for Health literacy) were computed.", {"entities": []}], ["The Dutch results were compared to similar Danish and American data.", {"entities": []}], ["The psychometric properties of the PAM 13-Dutch were generally good.", {"entities": []}], ["The level of internal consistency is good (\u03b1\u2009=\u20090.88) and item-rest correlations are moderate to strong.", {"entities": []}], ["The Dutch mean PAM score (61.3) is comparable to the American (61.9) and lower than the Danish (64.2).", {"entities": []}], ["The test-retest reliability was moderate.", {"entities": []}], ["The association with Health literacy was weak to moderate.", {"entities": []}], ["The PAM-13 Dutch is a reliable instrument to measure patient activation.", {"entities": []}], ["More research is needed into the validity of the Patient Activation Measure, especially with respect to a more comprehensive measure of Health literacy.", {"entities": []}], ["Data on treatment of glucocorticoid-induced osteoporosis (GIO) in men are scarce.", {"entities": [[44, 56, "DISEASE"]]}], ["We performed a randomized, open-label trial in men who have taken glucocorticoids (GC) for \u22653 months, and had an areal bone mineral density (aBMD) T -score \u2264 \u20131.5 standard deviations.", {"entities": [[83, 85, "GENE"]]}], ["Subjects received 20 \u03bcg/d teriparatide ( n = 45) or 35 mg/week risedronate ( n = 47) for 18 months.", {"entities": []}], ["Primary objective was to compare lumbar spine (L 1 \u2013L 3 ) BMD measured by quantitative computed tomography (QCT).", {"entities": []}], ["Secondary outcomes included BMD and microstructure measured by high-resolution QCT (HRQCT) at the 12th thoracic vertebra, biomechanical effects for axial compression, anterior bending, and axial torsion evaluated by finite element (FE) analysis from HRQCT data, aBMD by dual X-ray absorptiometry, biochemical markers, and safety.", {"entities": []}], ["Computed tomography scans were performed at 0, 6, and 18 months.", {"entities": []}], ["A mixed model repeated measures analysis was performed to compare changes from baseline between groups.", {"entities": []}], ["Mean age was 56.3 years.", {"entities": []}], ["Median GC dose and duration were 8.8 mg/d and 6.4 years, respectively; 39.1% of subjects had a prevalent fracture, and 32.6% received prior bisphosphonate treatment.", {"entities": [[7, 9, "GENE"]]}], ["At 18 months, trabecular BMD had significantly increased for both treatments, with significantly greater increases with teriparatide (16.3% versus 3.8%; p = 0.004).", {"entities": []}], ["HRQCT trabecular and cortical variables significantly increased for both treatments with significantly larger improvements for teriparatide for integral and trabecular BMD and bone surface to volume ratio (BS/BV) as a microstructural measure.", {"entities": []}], ["Vertebral strength increases at 18 months were significant in both groups (teriparatide: 26.0% to 34.0%; risedronate: 4.2% to 6.7%), with significantly higher increases in the teriparatide group for all loading modes (0.005 < p < 0.015).", {"entities": []}], ["Adverse events were similar between groups.", {"entities": []}], ["None of the patients on teriparatide but five (10.6%) on risedronate developed new clinical fractures ( p = 0.056).", {"entities": []}], ["In conclusion, in this 18-month trial in men with GIO, teriparatide showed larger improvements in spinal BMD, microstructure, and FE-derived strength than risedronate.", {"entities": []}], ["To assess the prevalence of the use of medicines and other products for therapeutic purposes in the Brazilian pediatric population and test whether demographic, socioeconomic and health factors are associated with use.", {"entities": []}], ["A cross-sectional population-based study (National Survey on Access, Use and Promotion of Rational Use of Medicines \u2013 PNAUM), including 7,528 children aged 12 or younger, living in urban areas in Brazil.", {"entities": []}], ["Medicine use to treat chronic or acute diseases was reported by the primary caregiver present at the household interview.", {"entities": []}], ["Associations between independent variables and medicine use were investigated by Poisson regression.", {"entities": []}], ["The overall prevalence of medicine use was 30.7% (95%CI 28.3\u201333.1).", {"entities": []}], ["The prevalence of medicine use for chronic diseases was 5.6% (95%CI 4.7\u20136.7) and for acute conditions, 27.1% (95%CI 24.8\u201329.4).", {"entities": []}], ["The factors significantly associated with overall use were five years old or under, living in the Northeast region, having health insurance and using health services in the last 12 months (emergency visits and hospitalizations).", {"entities": []}], ["The following were associated with drug use for chronic diseases: age \u2265 2 years, Southeast and South regions, and use of health services.", {"entities": []}], ["For drug use in treating acute conditions, the following associated factors were identified: \u2264 5 years, North, Northeast or Midwest regions, health insurance, and one or more emergency visits.", {"entities": []}], ["The most commonly used drugs among children under two years of age were paracetamol, ascorbic acid, and dipyrone; for children aged two years or over they were dipyrone, paracetamol, and amoxicillin.", {"entities": []}], ["The use of medicine by children is considerable, especially in treating acute medical conditions.", {"entities": []}], ["Children using drugs for chronic diseases have a different demographic profile from those using drugs for acute conditions in relation to gender, age, and geographic region.", {"entities": []}], ["Although evidence shows the positive health effects of physical activity, most of the adult population in Colombia are sedentary.", {"entities": []}], ["It is, therefore, important to implement strategies that generate changes in lifestyle behaviours.", {"entities": []}], ["This protocol describes a study in which we will compare the effects of 12\u00a0weeks of high-intensity interval training (HIIT), resistance training (RT) or combined training (HIIT\u2009+\u2009RT) on the improvement of body composition, endothelial function, blood pressure, blood lipids, and cardiorespiratory fitness in a cohort of sedentary, overweight adults (aged 30\u201350 years).", {"entities": []}], ["Sixty sedentary, overweight adults attending primary care in Bogot\u00e1, Colombia will be included in a factorial randomised controlled trial.", {"entities": []}], ["Participants will be randomly assigned to the following intervention groups: (1) non-exercise group: usual care with dietary support, (2) HIIT group: 4\u2009\u00d7\u20094-min intervals at 85\u201395\u00a0% maximum heart rate (HRmax) (with the target zone maintained for at least 2\u00a0minutes), interspersed with a 4-min recovery period, at 65\u00a0% HRmax, (3) RT group: completing a resistance circuit (including upper and lower muscle groups) as many times as needed according to subject\u2019s weight until an expenditure of 500\u00a0kcal at 40\u201380\u00a0% of one-rep max (1RM) has been achieved, and (4) combined group: HIIT\u2009+\u2009RT.", {"entities": [[521, 524, "GENE"]]}], ["The primary end point for effectiveness is vascular function as measured by flow-mediated vasodilatation 1\u00a0week after the end of exercise training.", {"entities": []}], ["The results of this study will provide new information about the possible effect of the programme in improving the cardiometabolic health of overweight adults, making a more efficient use of an adult\u2019s resources over time.", {"entities": []}], ["ClinicalTrials.gov ID: NCT02715063 .", {"entities": []}], ["Registered on 8 March 2016.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-016-1422-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Previous studies have found that up to 60% of children with neurologic conditions have tried complementary and alternative medicine (CAM).", {"entities": []}], ["To assess the use of CAM among patients presenting to neurology clinics at two academic centers in Canada.", {"entities": []}], ["A survey instrument was developed to inquire about use of CAM products and therapies, including reasons for use, perceived helpfulness, and concurrent use with conventional medicine, and administered to patients or their parents/guardians at the Stollery Children's Hospital in Edmonton and the Children's Hospital of Eastern Ontario (CHEO) in Ottawa.", {"entities": []}], ["Overall CAM use at the Stollery was 78%, compared to 48% at CHEO.", {"entities": []}], ["The most common CAM products used were multi-vitamins (84%), vitamin C (37%), homeopathic remedies (24%), and fish oil/omega 3 s (22%).", {"entities": []}], ["The most common CAM practices used were massage (47%), chiropractic (37%), faith healing (18%), aromatherapy (16%), homeopathy (16%), and relaxation (16%).", {"entities": []}], ["Many patients used CAM products at the same time as conventional medicine but just over half (57%) discussed this concurrent use with their physician.", {"entities": []}], ["CAM use is common in pediatric neurology patients and most respondents felt that it was helpful, with few or no harms associated.", {"entities": []}], ["However, this use is often undisclosed, increasing possibility of interactions with conventional drugs.", {"entities": []}], ["We urge clinicians to inquire about CAM use during routine history taking at every patient visit.", {"entities": []}], ["Parents would clearly like more information about CAM from their specialty clinics; such information would be easier to share if more primary data were available about the safety and effectiveness of commonly used therapies.", {"entities": []}], ["Due to the lack of real life clinical and educational studies, \u201cIo e l\u2019Asma\u201d Centre performed this implementation research (IR).", {"entities": []}], ["Evaluate long-term effectiveness on bronchial asthma control of an integrated clinical and educational pathway for asthmatic children and adolescents.", {"entities": [[46, 52, "DISEASE"]]}], ["An observational retrospective pre-post intervention IR study was conducted among 262 children with asthma, ages 6-15\u00a0yrs.", {"entities": [[100, 106, "DISEASE"]]}], ["The intervention protocol included three clinical visits 8\u00a0weeks apart; an educational course at visit 1, post intervention consisted in two follow-up visits 6\u00a0months apart.", {"entities": []}], ["The primary outcome was to verify the percentage of children who achieved bronchial asthma control at each visit.", {"entities": [[84, 90, "DISEASE"]]}], ["Secondary outcomes were based on daily therapy modulation, hospital admissions and the number of school days missed.", {"entities": []}], ["An economic assessment was also included.", {"entities": []}], ["Two hundred sixty two children with bronchial asthma completed the pathway and were included in the analysis.", {"entities": [[46, 52, "DISEASE"]]}], ["The percentage of children who obtained disease control increased from 44% at visit 1 to 79% at visit 3 and at 1-year follow-up was 83%.", {"entities": []}], ["Hospital admissions represent 11% of children: 8% before the intervention, 2% during the intervention, and 1% before and during the intervention; no hospitalizations related to bronchial asthma exacerbations were reported during the 2 follow-up visits.", {"entities": [[187, 193, "DISEASE"]]}], ["The therapeutic-educational pathway was adapted according to the international guidelines and the primary performance indicators.", {"entities": []}], ["Our findings confirmed that the clinical plus educational approach, shared between specialists and family physicians, is an effective template for asthma management.", {"entities": [[147, 153, "DISEASE"]]}], ["These findings also demonstrated a strong economic advantage.", {"entities": []}], ["Biological effects of low-level exposures (BELLE) may be very important in characterizing the potential health risks of environmental pollutants.", {"entities": []}], ["Before some features of BELLE, such as effects that may be modulated by adaptive or defense mechanisms, can be taken into greater consideration in U.S. Environmental Protection Agency risk assessments, however adequate information on a toxicant's mode of action and answers to other questions are needed.", {"entities": []}], ["Bacterial biofilms are associated with numerous human infections.", {"entities": []}], ["The predominant protein expressed in enteric biofilms is the amyloid curli, which forms highly immunogenic complexes with DNA.", {"entities": []}], ["Infection with curli-expressing bacteria or systemic exposure to purified curli-DNA complexes triggers autoimmunity via the generation of type I interferons (IFNs) and anti-double-stranded DNA antibodies.", {"entities": []}], ["Here, we show that DNA complexed with amyloid curli powerfully stimulates Toll-like receptor 9 (TLR9) through a two-step mechanism.", {"entities": [[96, 100, "GENE"]]}], ["First, the cross beta-sheet structure of curli is bound by cell-surface Toll-like receptor 2 (TLR2), enabling internalization of the complex into endosomes.", {"entities": [[94, 98, "GENE"]]}], ["After internalization, the curli-DNA immune complex binds strongly to endosomal TLR9, inducing production of type I IFNs.", {"entities": [[80, 84, "GENE"]]}], ["Analysis of wild-type and TLR2-deficient macrophages showed that TLR2 is the major receptor that drives the internalization of curli-DNA complexes.", {"entities": [[26, 30, "GENE"], [65, 69, "GENE"]]}], ["Suppression of TLR2 internalization via endocytosis inhibitors led to a significant decrease in Ifn\u03b2 expression.", {"entities": [[15, 19, "GENE"]]}], ["Confocal microscopy analysis confirmed that the TLR2-bound curli was required for shuttling of DNA to endosomal TLR9.", {"entities": [[112, 116, "GENE"]]}], ["Structural analysis using small-angle X-ray scattering revealed that incorporation of DNA into curli fibrils resulted in the formation of ordered curli-DNA immune complexes.", {"entities": []}], ["Curli organizes parallel, double-stranded DNA rods at an inter-DNA spacing that matches up well with the steric size of TLR9.", {"entities": [[120, 124, "GENE"]]}], ["We also found that production of anti-double-stranded DNA autoantibodies in response to curli-DNA was attenuated in TLR2- and TLR9-deficient mice and in mice deficient in both TLR2 and TLR9 compared to wild-type mice, suggesting that both innate immune receptors are critical for shaping the autoimmune adaptive immune response.", {"entities": [[116, 120, "GENE"], [176, 180, "GENE"], [126, 130, "GENE"], [185, 189, "GENE"]]}], ["We also detected significantly lower levels of interferon-stimulated gene expression in response to purified curli-DNA in TLR2 and TLR9 deficient mice compared to wild-type mice, confirming that TLR2 and TLR9 are required for the induction of type I IFNs.", {"entities": [[122, 126, "GENE"], [195, 199, "GENE"], [131, 135, "GENE"], [204, 208, "GENE"], [122, 126, "GENE"], [195, 199, "GENE"], [131, 135, "GENE"], [204, 208, "GENE"]]}], ["Finally, we showed that curli-DNA complexes, but not cellulose, were responsible elicitation of the immune responses to bacterial biofilms.", {"entities": []}], ["This study defines the series of events that lead to the severe pro-autoimmune effects of amyloid-expressing bacteria and suggest a mechanism by which amyloid curli acts as a carrier to break immune tolerance to DNA, leading to the activation of TLR9, production of type I IFNs, and subsequent production of autoantibodies.", {"entities": [[246, 250, "GENE"]]}], ["Bacterial amyloids are conserved proteins expressed by many bacteria in biofilms.", {"entities": []}], ["Bacterial amyloid curli and DNA form highly immunogenic complexes that stimulate autoimmunity and accelerate the progression of systemic lupus erythematosus.", {"entities": [[137, 156, "DISEASE"], [128, 156, "DISEASE"]]}], ["Here, we show that the innate immune receptors TLR2 and TLR9 are critical for shaping the autoimmune adaptive immune response to curli-DNA complexes.", {"entities": [[47, 51, "GENE"], [56, 60, "GENE"]]}], ["Mice deficient in these receptors show attenuated production of anti-double-stranded DNA autoantibodies and type I IFNs.", {"entities": []}], ["The cross beta-sheet structure of curli is recognized by TLR2, leading to endosomal internalization of the curli-DNA complex and subsequent binding to TLR9.", {"entities": [[57, 61, "GENE"], [151, 155, "GENE"]]}], ["Synchrotron diffraction studies suggest that curli-DNA immune complexes present double-stranded DNA rods at an inter-DNA spacing that matches well to the steric size of TLR9, thus promote multivalent amplification of binding and TLR9 activation.", {"entities": [[169, 173, "GENE"], [229, 233, "GENE"], [169, 173, "GENE"], [229, 233, "GENE"]]}], ["Overall, our results identify a novel series of events pivotal to induction of autoimmunity by amyloid-expressing bacteria.", {"entities": []}], ["In rooms with moisture damage, the indoor air can be enriched with microorganisms causing a variety of symptoms.", {"entities": []}], ["Due to the highly diverse composition of bioaerosols and the multiple effects on humans, an assessment of the health risk is not sufficiently possible.", {"entities": []}], ["The aim of this study was to characterize the features of innate immunity using blood from subjects exposed to moisture damage compared to control subjects living in houses without visible moisture damage.", {"entities": []}], ["We investigated the expression of TLR-2, TLR-4 and dectin-1 on the surface of monocytes from both fresh blood and after in vitro stimulation with the model substances E.\u00a0coli endotoxin, zymosan A, Pam 3 Cys and Aspergillus versicolor in 25 exposed subjects and 25 control subjects.", {"entities": []}], ["In vitro stimulation of whole blood with the same components was performed for 20 h and the release of inflammatory mediators IL-8 and IL-1\u03b2 were quantified.", {"entities": []}], ["In addition to an enhanced number of blood leucocytes, the expression of the receptors TLR-2, TLR-4 and dectin-1 on blood monocytes was significantly enhanced in exposed subjects.", {"entities": []}], ["In contrast, no different alteration in expression was detected between exposed and control group after in vitro stimulation with the model substances.", {"entities": []}], ["The release of IL-8 and IL-1\u03b2 after stimulation of whole blood with A. versicolor was increased in subjects exposed to moisture damage.", {"entities": []}], ["Furthermore, in the exposed subjects the IL-1\u03b2 release was significantly enhanced after in vitro stimulation with E. coli endotoxin (1000 pg/mL).", {"entities": []}], ["In conclusion, features of the innate immune system (receptor expression and mediator release of monocytes) are altered in subjects exposed to moisture damage which may be a potential explanation for the increased incidence of respiratory health diseases observed in these populations.", {"entities": []}], ["Adults with certain comorbid conditions have a higher risk of pneumonia than the overall population.", {"entities": [[62, 71, "DISEASE"]]}], ["If treatment of pneumonia is more costly in certain predictable situations, this would affect the value proposition of populations for pneumonia prevention.", {"entities": [[16, 25, "DISEASE"], [135, 144, "DISEASE"]]}], ["We estimate the economic impact of community-acquired pneumonia (CAP) for adults with asthma, diabetes, chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF) in a large U.S. commercially-insured working age population.", {"entities": [[153, 177, "DISEASE"], [54, 63, "DISEASE"], [104, 141, "DISEASE"], [86, 92, "DISEASE"]]}], ["Data sources consisted of 2003 through 2007 Thomson Reuters MarketScan Commercial Claims and Encounters and Thomson Reuters Health Productivity and Management (HPM) databases.", {"entities": []}], ["Pneumonia episodes and selected comorbidities were identified by ICD-9-CM diagnosis codes.", {"entities": [[0, 9, "DISEASE"]]}], ["By propensity score matching, controls were identified for pneumonia patients.", {"entities": [[59, 68, "DISEASE"]]}], ["Excess direct medical costs and excess productivity cost were estimated by generalized linear models (GLM).", {"entities": []}], ["We identified 402,831 patients with CAP between 2003 through 2007, with 25,560, 32,677, 16,343, and 5,062 episodes occurring in patients with asthma, diabetes, COPD and CHF, respectively.", {"entities": [[142, 148, "DISEASE"]]}], ["Mean excess costs (and standard error, SE) of CAP were $14,429 (SE=44) overall.", {"entities": []}], ["Mean excess costs by comorbidity subgroup were lowest for asthma ($13,307 (SE=123)), followed by diabetes ($21,395 (SE=171)) and COPD ($23,493 (SE=197)); mean excess costs were highest for patients with CHF ($34,436 (SE=549)).", {"entities": [[58, 64, "DISEASE"]]}], ["On average, indirect costs comprised 21% of total excess costs, ranging from 8% for CHF patients to 27% for COPD patients.", {"entities": []}], ["Compared to patients without asthma, diabetes, COPD, or CHF, the excess cost of CAP is nearly twice as high for patients with diabetes and COPD and nearly three times as high for patients with CHF.", {"entities": [[29, 35, "DISEASE"]]}], ["Indirect costs made up a significant but varying portion of excess CAP costs.", {"entities": []}], ["Returns on prevention of pneumonia would therefore be higher in adults with these comorbidities.", {"entities": [[25, 34, "DISEASE"]]}], ["\u2022 Antibiotics damage the intestinal microbiota and disrupt colonization resistance predisposing us to recurrent C. difficile infection (CDI).", {"entities": []}], ["\u2022 Faecal microbiota transplantation (FMT) is a promising treatment for recurrent C. difficile infection.", {"entities": []}], ["\u2022 Mixtures of beneficial bacteria known as bacteriotherapy should be developed for treatment of CDI and other diseases linked to dysbiosis in the intestinal microbiota.", {"entities": []}], ["Antibiotics damage the intestinal microbiota and disrupt colonization resistance predisposing us to recurrent C. difficile infection (CDI).", {"entities": []}], ["Faecal microbiota transplantation (FMT) is a promising treatment for recurrent C. difficile infection.", {"entities": []}], ["Mixtures of beneficial bacteria known as bacteriotherapy should be developed for treatment of CDI and other diseases linked to dysbiosis in the intestinal microbiota.", {"entities": []}], ["Faecal microbiota transplantation (FMT) has been used for more than five decades to treat a variety of intestinal diseases associated with pathological imbalances within the resident microbiota, termed dysbiosis.", {"entities": []}], ["FMT has been particularly effective for treating patients with recurrent Clostridium difficile infection who are left with few clinical options other than continued antibiotic therapy.", {"entities": []}], ["Our increasing knowledge of the structure and function of the human intestinal microbiota and C. difficile pathogenesis has led to the understanding that FMT promotes intestinal ecological restoration and highlights the microbiota as a viable therapeutic target.", {"entities": []}], ["However, the use of undefined faecal samples creates a barrier for widespread clinical use because of safety and aesthetic issues.", {"entities": []}], ["An emerging concept of bacteriotherapy, the therapeutic use of a defined mixture of harmless, health-associated bacteria, holds promise for the treatment of patients with severe C. difficile infection, and possibly represents a paradigm shift for the treatment of diseases linked to intestinal dysbiosis.", {"entities": []}], ["Several systemic diseases share clinical, pathologic and radiologic characteristics.", {"entities": []}], ["This article emphasizes similarities and differences in the clinical and chest radiographic manifestations of six diseases with both pulmonary and renal abnormalities-Goodpasture's syndrome, Wegener's granulomatosis, lymphomatoid granulomatosis, Churg-Strauss syndrome, systemic lupus erythematosus, and scleroderma.", {"entities": [[279, 298, "DISEASE"], [181, 189, "DISEASE"], [260, 268, "DISEASE"], [270, 298, "DISEASE"], [304, 315, "DISEASE"]]}], ["Diagnosis of mast cell activation disease (MCAD), i.e.", {"entities": []}], ["systemic mastocytosis (SM) and idiopathic systemic mast cell activation syndrome (MCAS), usually requires demonstration of increased mast cell (MC) mediator release.", {"entities": [[9, 21, "DISEASE"], [72, 80, "DISEASE"], [0, 21, "DISEASE"]]}], ["Since only a few MC mediators are currently established as biomarkers of MCAD, the sensitivity of plasma heparin level (pHL) as an indicator of increased MC activation was compared with that of serum tryptase, chromogranin A and urinary N-methylhistamine levels in 257 MCAD patients.", {"entities": []}], ["Basal pHL had a sensitivity of 41% in MCAS patients and 27% in SM patients.", {"entities": []}], ["Non-pharmacologic stimulation of MC degranulation by obstruction of venous flow for 10 minutes increased the sensitivity of pHL in MCAS patients to 59% and in SM patients to 47%.", {"entities": []}], ["In MCAS patients tryptase, chromogranin A, and N-methylhistamine levels exhibited low sensitivities (10%, 12%, and 22%, respectively), whereas sensitivities for SM were higher (73%, 63%, and 43%, respectively).", {"entities": []}], ["Taken together, these data suggest pHL appears more sensitive than the other mediators for detecting systemic MC activity in patients with MCAS.", {"entities": []}], ["The simple, brief venous occlusion test appears to be a useful indicator of the presence of pathologically irritable MCs, at least in the obstructed compartment of the body.", {"entities": []}], ["The Whole School, Whole Community, Whole Child (WSCC) model shows the interrelationship between health and learning and the potential for improving educational outcomes by improving health outcomes.", {"entities": []}], ["However, current descriptions do not explain how to implement the model.", {"entities": []}], ["The existing literature, including scientific articles, programmatic guidance, and publications by national agencies and organizations, was reviewed and synthesized to describe an overview of interrelatedness of learning and health and the 10 components of the WSCC model.", {"entities": []}], ["The literature suggests potential benefits of applying the WSCC model at the district and school level.", {"entities": []}], ["But, the model lacks specific guidance as to how this might be made actionable.", {"entities": []}], ["A collaborative approach to health and learning is suggested, including a 10-step systematic process to help schools and districts develop an action plan for improving health and education outcomes.", {"entities": []}], ["Essential preliminary actions are suggested to minimize the impact of the challenges that commonly derail systematic planning processes and program implementation, such as lack of readiness, personnel shortages, insufficient resources, and competing priorities.", {"entities": []}], ["All new models require testing and evidence to confirm their value.", {"entities": []}], ["District and schools will need to test this model and put plans into action to show that significant, substantial, and sustainable health and academic outcomes can be achieved.", {"entities": []}], ["Interest in how to implement evidence-based practices into routine health care has never been greater.", {"entities": []}], ["Primary care faces challenges in managing the increasing burden of chronic disease in an ageing population.", {"entities": []}], ["Reliable prescriptions for translating knowledge into practice, however, remain elusive, despite intense research and publication activity.", {"entities": []}], ["This study seeks to explore this dilemma in general practice by challenging the current way of thinking about healthcare improvement and asking what can be learned by looking at change through a complexity lens.", {"entities": []}], ["This paper reports the local level of an embedded case study of organisational change for better chronic illness care over more than a decade.", {"entities": []}], ["We used interviews, document review and direct observation to explore how improved chronic illness care developed in one practice.", {"entities": []}], ["This formed a critical case to compare, using pattern matching logic, to the common prescription for local implementation of best evidence and a rival explanation drawn from complexity sciences interpreted through modern sociology and psychology.", {"entities": []}], ["The practice changed continuously over more than a decade to deliver better chronic illness care in line with research findings and policy initiatives \u2013 re-designing care processes, developing community linkages, supporting patient self-management, using guidelines and clinical information systems, and integrating nurses into the practice team.", {"entities": []}], ["None of these improvements was designed and implemented according to an explicit plan in response to a documented gap in chronic disease care.", {"entities": []}], ["The process that led to high quality chronic illness care exhibited clear complexity elements of co-evolution, non-linearity, self-organisation, emergence and edge of chaos dynamics in a network of agents and relationships where a stable yet evolving way of organizing emerged from local level communicative interaction, power relating and values based choices.", {"entities": []}], ["The current discourse of implementation science as planned system change did not match organisational reality in this critical case of improvement in general practice.", {"entities": []}], ["Complexity concepts translated in human terms as complex responsive processes of relating fit the pattern of change more accurately.", {"entities": []}], ["They do not provide just another fashionable blueprint for change but inform how researchers, policymakers and providers participate in improving healthcare.", {"entities": []}], ["Macrophage migration inhibitory factor (MIF) is a critical immunoregulatory pluripotent cytokine.", {"entities": [[40, 43, "GENE"]]}], ["It has been re-evaluated as a proinflammatory cytokine, pituitary hormone and glucocorticoid-induced immunoregulatory protein.", {"entities": []}], ["MIF exists in human epidermis, especially in the basal layer and also is expressed constitutively by monocytes/macrophages, T cells, B cells, endocrine, and epithelial cells.", {"entities": [[0, 3, "GENE"]]}], ["In the field of dermatology, MIF is believed to be a detrimental factor in inflammatory dermatological diseases including atopic dermatitis (AD), psoriasis, vitiligo, pemphigus vulgaris, bullous pemphigoid (BP), alopecia areata (AA) as well as other conditions such as photoaging, and photocarcinigenesis.", {"entities": [[157, 165, "DISEASE"], [146, 155, "DISEASE"], [122, 139, "DISEASE"], [212, 227, "DISEASE"], [212, 220, "DISEASE"], [187, 205, "DISEASE"], [129, 139, "DISEASE"], [29, 32, "GENE"]]}], ["The objective of this review is to gather and summarize MIF related disorders in dermatology and present valuable information for readers and researchers.", {"entities": [[56, 59, "GENE"]]}], ["Psychological stress negatively influences food intake and food choices, thereby contributing to the development of childhood obesity.", {"entities": [[126, 133, "DISEASE"]]}], ["Physical activity can also moderate eating behavior and influence calorie intake.", {"entities": []}], ["However, it is unknown if acute physical activity influences food intake and overall energy balance after acute stress exposure in children.", {"entities": []}], ["We therefore investigated the impact of acute physical activity on overall energy balance (food intake minus energy expenditure), food intake, and choice in the setting of acute social stress in normal weight (NW) and overweight/obese (OW/OB) children as well as the impact of psychological risk factors.", {"entities": []}], ["After receiving written consent from their parents, 26 NW (BMI\u2009<\u200990 Lower overall energy balance ( p \u2009=\u20090.019) and a decreased choice of low density salty foods (p\u2009<\u20090.001) in NW children compared with OW/OB children was found after acute moderate physical activity but not sedentary activity.", {"entities": []}], ["Independent of their allocation, OW/OB children ate more high density salty foods (104\u00a0kcal (34 to 173), p \u2009=\u20090.004) following stress.", {"entities": []}], ["They scored higher on impulsive behavior ( p \u2009=\u20090.005), restrained eating ( p \u2009<\u20090.001) and parental corporal punishment ( p \u2009=\u20090.03), but these psychological factors were not related to stress-induced food intake/choice.", {"entities": []}], ["Positive parenting tended to be related to lower intake of sweet high density food (\u2212132\u00a0kcal, \u2212277 to 2, p \u2009=\u20090.054).", {"entities": []}], ["In the setting of stress, acute moderate physical activity can address energy balance in children, a benefit which is especially pronounced in the OW/OB.", {"entities": []}], ["Positive parenting may act as a protective factor preventing stress-induced eating of comfort food.", {"entities": []}], ["clinicaltrials.gov NCT01693926 The study was a pilot study of a project funded by the Swiss National Science Foundation (CRSII3_147673).", {"entities": []}], ["Growing evidence supports comorbidity of asthma and allergies with mood disorders and various connections between these diseases.", {"entities": [[41, 47, "DISEASE"]]}], ["It still remains unclear whether this comorbidity is caused by the same pathophysiological factors or whether there are other links between asthma and depression.", {"entities": [[140, 146, "DISEASE"]]}], ["There is no definite answer to the question of an optimal treatment to deal with both asthma and depression, when they occur simultaneously.", {"entities": [[86, 92, "DISEASE"]]}], ["Epidemiological and clinical trials on the influence of nutrition on certain diseases suggest the effects of \u03c93 polyunsaturated fatty acids (PUFAs) in aiding treatment of mood disorders and inflammatory conditions.", {"entities": []}], ["This is an overview showing the connections between asthma, allergic disease, and mood disorders, and the influence of nutrition on these conditions.", {"entities": [[52, 58, "DISEASE"]]}], ["Evidence indicates positive correlations between consumption of PUFAs and mood correction.", {"entities": []}], ["Several analyses show the connection between diet and asthma.", {"entities": [[54, 60, "DISEASE"]]}], ["They may form a basis for potential recommending \u03c93 PUFAs as an adjuvant in prevention and treatment of mental disorders, asthma, and allergy.", {"entities": [[122, 128, "DISEASE"]]}], ["Previous studies have reported large socioeconomic inequalities in mortality from conditions amenable to medical intervention, but it is unclear whether these can be attributed to inequalities in access or quality of health care, or to confounding influences such as inequalities in background risk of diseases.", {"entities": []}], ["We therefore studied whether inequalities in mortality from conditions amenable to medical intervention vary between countries in patterns which differ from those observed for other (non-amenable) causes of death.", {"entities": []}], ["More specifically, we hypothesized that, as compared to non-amenable causes, inequalities in mortality from amenable causes are more strongly associated with inequalities in health care use and less strongly with inequalities in common risk factors for disease such as smoking.", {"entities": []}], ["Cause-specific mortality data for people aged 30\u201374 years were obtained for 14 countries, and were analysed by calculating age-standardized mortality rates and relative risks comparing a lower with a higher educational group.", {"entities": []}], ["Survey data on health care use and behavioural risk factors for people aged 30\u201374 years were obtained for 12 countries, and were analysed by calculating age-and sex-adjusted odds ratios comparing a low with a higher educational group.", {"entities": []}], ["Patterns of association were explored by calculating correlation coefficients.", {"entities": []}], ["In most countries and for most amenable causes of death substantial inequalities in mortality were observed, but inequalities in mortality from amenable causes did not vary between countries in patterns that are different from those seen for inequalities in non-amenable mortality.", {"entities": []}], ["As compared to non-amenable causes, inequalities in mortality from amenable causes are not more strongly associated with inequalities in health care use.", {"entities": []}], ["Inequalities in mortality from amenable causes are also not less strongly associated with common risk factors such as smoking.", {"entities": []}], ["We did not find evidence that inequalities in mortality from amenable conditions are related to inequalities in access or quality of health care.", {"entities": []}], ["Further research is needed to find the causes of socio-economic inequalities in mortality from amenable conditions, and caution should be exercised in interpreting these inequalities as indicating health care deficiencies.", {"entities": []}], ["We have previously identified Urokinase Plasminogen Activator Receptor ( PLAUR ) as an asthma susceptibility gene.", {"entities": [[87, 93, "DISEASE"], [73, 78, "GENE"]]}], ["In the current study we tested the hypothesis that PLAUR single nucleotide polymorphisms (SNPs) determine baseline lung function and contribute to the development of Chronic Obstructive Pulmonary Disease (COPD) in smokers.", {"entities": [[51, 56, "GENE"]]}], ["25 PLAUR SNPs were genotyped in COPD subjects and individuals with smoking history (n = 992).", {"entities": [[3, 8, "GENE"]]}], ["Linear regression was used to determine the effects of polymorphism on baseline lung function (FEV 1 , FEV 1 /FVC) in all smokers.", {"entities": [[95, 98, "GENE"], [103, 106, "GENE"], [95, 98, "GENE"], [103, 106, "GENE"]]}], ["Genotype frequencies were compared in spirometry defined smoking controls (n = 176) versus COPD cases (n = 599) and COPD severity (GOLD stratification) using logistic regression.", {"entities": []}], ["Five SNPs showed a significant association (p < 0.01) with baseline lung function; rs2302524(Lys220Arg) and rs2283628(intron 3) were associated with lower and higher FEV 1 respectively.", {"entities": [[166, 169, "GENE"]]}], ["rs740587(-22346), rs11668247(-20040) and rs344779(-3666) in the 5'region were associated with increased FEV 1 /FVC ratio.", {"entities": [[104, 107, "GENE"]]}], ["rs740587 was also protective for COPD susceptibility and rs11668247 was protective for COPD severity although no allele dose relationship was apparent.", {"entities": []}], ["Interestingly, several of these associations were driven by male smokers not females.", {"entities": []}], ["This study provides tentative evidence that the asthma associated gene PLAUR also influences baseline lung function in smokers.", {"entities": [[48, 54, "DISEASE"], [71, 76, "GENE"]]}], ["However the case-control analyses do not support the conclusion that PLAUR is a major COPD susceptibility gene in smokers.", {"entities": [[69, 74, "GENE"]]}], ["PLAUR is a key serine protease receptor involved in the generation of plasmin and has been implicated in airway remodelling.", {"entities": [[0, 5, "GENE"]]}], ["Research in the field of cardiopulmonary disease in Brazil has been very active in recent decades.", {"entities": []}], ["The combination of PUBMED, SCieLO, open access and online searching has provided a significant increase in the visibility of Brazilian journals.", {"entities": []}], ["This newly acquired international visibility has in turn resulted in the appearance of more original research reports in the Brazilian scientific press.", {"entities": []}], ["This review is intended to highlight part of this work for the benefit of the readers of \u201cClinics.\u201d We searched through PUBMED for noteworthy articles published in Brazilian medical journals included in the Journal of Citation Reports of the Institute of Scientific Information to better expose them to our readership.", {"entities": []}], ["The following journals were examined: \u201cArquivos Brasileiros de Cardiologia,\u201d \u201cArquivos Brasileiros de Endocrinologia e Metabologia,\u201d \u201cBrazilian Journal of Medical and Biological Reviews,\u201d \u201cJornal Brasileiro de Pneumologia,\u201d \u201cJornal de Pediatria,\u201d \u201cRevista Brasileira de Cirurgia Cardiovascular,\u201d \u201cRevista da Associa\u00e7\u00e3o M\u00e9dica Brasileira,\u201d Revista da Escola de Enfermagem U.S.P.\u201d and \u201cS\u00e3o Paulo Medical Journal.\u201d These journals publish original investigations in the field of cardiopulmonary disease.", {"entities": []}], ["The search produced 71 references, which are briefly examined.", {"entities": []}], ["The etiology of ulcerative colitis (UC) is to be understood.", {"entities": [[16, 34, "DISEASE"]]}], ["The basic pathological feature of UC is intestinal chronic inflammation.", {"entities": []}], ["Superantigen, such as Staphylococcus enterotoxin B (SEB), is reported to compromise intestinal barrier function by increasing epithelial permeability and initiate inflammation in the intestinal mucosa.", {"entities": []}], ["Inasmuch as anatomic position of the sinus, chronic sinusitis-derived SEB may follow the secretion and to be swallowed down to the gastrointestinal tract and induce lesions to the intestinal mucosa.", {"entities": [[52, 61, "DISEASE"]]}], ["Sinus wash fluid (SWF, containing SEB) was collected from a group of patients with both chronic sinusitis (CS) and UC.", {"entities": [[96, 105, "DISEASE"], [107, 109, "GENE"]]}], ["A group of mice were sensitized to ovalbumin (OVA) in the presence of SWF.", {"entities": []}], ["The sensitized mice were challenged with the specific antigen OVA.", {"entities": []}], ["The inflammatory status of the colonic tissue was determined with histology, serology and electron microscopy.", {"entities": []}], ["Using horseradish peroxidase (HRP) as a tracer, another group of mice was stimulated with SWF for 2 hours.", {"entities": []}], ["The HRP activity was detected in the colonic tissue with enzymatic approaches and electron microscopy.", {"entities": []}], ["Epithelial hyperpermeability in colonic epithelium was induced by stimulating with SWF.", {"entities": []}], ["The HRP activity in the colonic mucosa was almost 11 times more in the SWF treated group (3.2 \u00b1 0.6 \u03bcg/g tissue) than the control group (0.3 \u00b1 0.1 \u03bcg/g tissue).", {"entities": []}], ["Mice were sensitized using a mixture of SWF and OVA (serum OVA-specific IgE was detected with a highest titer as 1:64).", {"entities": []}], ["Challenge with OVA induced extensive inflammation in the colonic mucosa by showing (1) marked degranulation in mast cells (MC, 46.3 \u00b1 4.5%) and eosinophils (Eo, 55.7 \u00b1 4.2%); (2) inflammatory cell infiltration (MC = 145.2 \u00b1 11.4; Eo = 215.8 \u00b1 12.5; mononuclear cell = 258.4 \u00b1 15.3/mm Introducing Sinusitis-derived SEB-containing SWF to the gastrointestinal tract compromised colonic mucosal barrier function increasing epithelial permeability to luminal macromolecular protein in mice.", {"entities": [[296, 305, "DISEASE"]]}], ["The SWF facilitated colonic mucosal sensitization to luminal antigen.", {"entities": []}], ["Multiple challenging the sensitized colonic mucosa with specific antigen OVA induced inflammation, induced a condition similar to human ulcerative colitis.", {"entities": [[136, 154, "DISEASE"]]}], ["In low-income countries, only about a third of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) patients eligible for anti-retroviral treatment currently receive it.", {"entities": []}], ["Providing decentralized treatment close to where patients live is crucial to a faster scale up, however, a key obstacle is limited health system capacity due to a shortage of trained health-care workers and challenges of integrating HIV/AIDS care with other primary care services (e.g.", {"entities": []}], ["tuberculosis, malaria, respiratory conditions).", {"entities": [[0, 12, "DISEASE"], [14, 21, "DISEASE"]]}], ["This study will test an adapted primary care health care worker training and guideline intervention, Practical Approach to Lung Health and HIV/AIDS Malawi (PALM PLUS), on staff retention and satisfaction, and quality of patient care.", {"entities": []}], ["A cluster-randomized trial design is being used to compare usual care with a standardized clinical guideline and training intervention, PALM PLUS.", {"entities": []}], ["The intervention targets middle-cadre health care workers (nurses, clinical officers, medical assistants) in 30 rural primary care health centres in a single district in Malawi.", {"entities": []}], ["PALM PLUS is an integrated, symptom-based and user-friendly guideline consistent with Malawian national treatment protocols.", {"entities": []}], ["Training is standardized and based on an educational outreach approach.", {"entities": []}], ["Trainers will be front-line peer healthcare workers trained to provide outreach training and support to their fellow front-line healthcare workers during focused (1-2 hours), intermittent, interactive sessions on-site in health centers.", {"entities": []}], ["Primary outcomes are health care worker retention and satisfaction.", {"entities": []}], ["Secondary outcomes are clinical outcomes measured at the health centre level for HIV/AIDS, tuberculosis, prevention-of-mother-to-child-transmission of HIV and other primary care conditions.", {"entities": [[91, 103, "DISEASE"]]}], ["Effect sizes and 95% confidence intervals for outcomes will be presented.", {"entities": []}], ["Assessment of outcomes will occur at 1 year post- implementation.", {"entities": []}], ["The PALM PLUS trial aims to address a key problem: strengthening middle-cadre health care workers to support the broader scale up of HIV/AIDS services and their integration into primary care.", {"entities": []}], ["The trial will test whether the PALM PLUS intervention improves staff satisfaction and retention, as well as the quality of patient care, when compared to usual practice.", {"entities": []}], ["Current controlled Trials: ISRCTN47805230", {"entities": []}], ["Hyaluronan (HA) and its receptor CD44 are expressed at the maternal-fetal interface, but its role in early pregnancy remains unclear.", {"entities": [[33, 37, "GENE"]]}], ["Here, we found that primary decidual stromal cells (DSCs) continuously secreted HA and expressed its receptor CD44.", {"entities": [[110, 114, "GENE"]]}], ["Pregnancy-associated hormones up-regulated HA synthetase (HAS) 2 transcription and HA release from DSCs.", {"entities": []}], ["High molecular weight-HA (HMW-HA), but not medium molecular weight (MMW-HA) or low molecular weight (LMW-HA), promoted proliferation and inhibited apoptosis of DSCs in a CD44-dependent manner.", {"entities": []}], ["The in-cell Western analysis revealed HMW-HA activated PI3K/AKT and mitogen-activated protein kinase (MAPK)/ERK1/2 signaling pathways time-dependently.", {"entities": []}], ["Blocking these pathways by specific inhibitor LY294002 or U0126 abrogated HMW-HA-regulated DSc proliferation and apoptosis.", {"entities": []}], ["Finally, we have found that HA content, HA molecular weight, HAS2 mRNA level, and CD44 expression were significantly decreased in DSCs from unexplained miscarriage compared with the normal pregnancy.", {"entities": [[61, 65, "GENE"], [82, 86, "GENE"]]}], ["Collectively, our results indicate that higher level and greater molecular mass of HA at maternal-fetal interface contributes to DSc growth and maintenance of DSCs in human early pregnancy.", {"entities": []}], ["The Lung Function Questionnaire (LFQ) was developed and validated as a case-finding tool to identify patients at risk of airflow obstruction (AO) that should be evaluated further using spirometry.", {"entities": []}], ["Our objective was to assess the usability and validity of additional questionnaire-administration modes, including Web-based, interactive voice response system (IVRS)-based, and interviewer-based modes.", {"entities": []}], ["This multicenter, prospective, noninterventional data-collection study enrolled 149 individuals aged \u226540 years with current or former smoking history.", {"entities": []}], ["A two-visit crossover design was employed; patients completed the paper-based LFQ and were randomly assigned to complete one of three alternate modes.", {"entities": []}], ["Statistical evaluation included item-level, scale-level, and AO risk-classification comparisons; a satisfaction survey assessed patient preference.", {"entities": []}], ["This study showed a great degree of concordance between alternate forms of the LFQ and the paper version.", {"entities": []}], ["Results indicated an absence of floor and ceiling effects and the average LFQ item-level means were consistent across modes.", {"entities": []}], ["LFQ scores were stable between assessments, (administered approximately one week apart) showed exceptionally good agreement, and AO risk classification using the LFQ cut point was consistent across modes.", {"entities": []}], ["The LFQ is an important case-finding tool to aid primary care physicians in further evaluating symptomatic patients at risk of AO.", {"entities": []}], ["The alternate modes will further facilitate the implementation and widespread uptake of this tool.", {"entities": []}], ["T H 17 cells are recognized as a unique subset of T helper cells that have critical roles in the pathogenesis of autoimmunity and tissue inflammation.", {"entities": []}], ["Although ROR\u03b3t is necessary for the generation of T H 17 cells, the molecular mechanisms underlying the functional diversity of T H 17 cells are not fully understood.", {"entities": []}], ["Here we show that a member of interferon regulatory factor (IRF) family of transcription factors, IRF8, has a critical role in silencing T H 17-cell differentiation.", {"entities": [[98, 102, "GENE"]]}], ["Mice with a conventional knockout, as well as a T cell-specific deletion, of the Irf8 gene exhibited more efficient T H 17 cells.", {"entities": [[81, 85, "GENE"]]}], ["Indeed, studies of an experimental model of colitis showed that IRF8 deficiency resulted in more severe inflammation with an enhanced T H 17 phenotype.", {"entities": [[64, 68, "GENE"]]}], ["IRF8 was induced steadily and inhibited T H 17-cell differentiation during T H 17 lineage commitment at least in part through its physical interaction with ROR\u03b3t.", {"entities": [[0, 4, "GENE"]]}], ["These findings define IRF8 as a novel intrinsic transcriptional inhibitor of T H 17-cell differentiation.", {"entities": [[22, 26, "GENE"]]}], ["The molecular mechanisms that regulate T H 17 cell diversity are poorly understood.", {"entities": []}], ["Ouyang et al.", {"entities": []}], ["show that the transcription factor interferon regulatory factor-8 is required for T H 17-cell differentiation and that its absence increases the severity of an experimental model of colitis.", {"entities": []}], ["During the course of establishing an animal model of chronic asthma, we tried to elucidate the time sequence of airway hyperresponsiveness (AHR), airway inflammation, airway remodeling, and associated cytokines.", {"entities": [[61, 67, "DISEASE"], [140, 143, "GENE"]]}], ["Seven-week-old female BALB/c mice were studied as a chronic asthma model using ovalbumin (OVA).", {"entities": [[60, 66, "DISEASE"]]}], ["After sensitization, mice were exposed twice weekly to aerosolized OVA, and were divided into three groups depending on the duration of 4 weeks, 8 weeks, and 12 weeks.", {"entities": []}], ["At each time point, airway responsiveness, inflammatory cells, cytokines in bronchoalveolar lavage fluids (BALF), serum OVA-specific IgE, IgG1, IgG2a, and histological examination were carried out.", {"entities": []}], ["AHR to methacholine, increased levels of OVA-specific IgG1 and IgG2a, and goblet cell hyperplasia were continuously sustained at each time point of weeks.", {"entities": [[0, 3, "GENE"]]}], ["In contrast, we observed a time-dependent decrease in serum OVA-specific IgE, BALF eosinophils, BALF cytokines such as IL-13, transforming growth factor-beta1, and a time-dependent increase in BALF promatrix metalloproteinase-9 and peribronchial fibrosis.", {"entities": []}], ["In this OVA-induced chronic asthma model, we observed airway remodelings as well as various cytokines and inflammatory cells being involved in different time-dependent manners.", {"entities": [[28, 34, "DISEASE"]]}], ["However, increased airway fibrosis did not directly correlate with a further increase in airway hyperresponsiveness.", {"entities": []}], ["Housed pigs are often exposed to elevated concentrations of atmospheric ammonia.", {"entities": []}], ["This aerial pollutant is widely considered to be an environmental stressor that also predisposes to reduced growth rates and poor health, although evidence to support this view is limited.", {"entities": []}], ["Hepatic gene expression is very responsive to stress and metabolic effects.", {"entities": []}], ["Two batches of growing pigs were therefore exposed to a nominal concentration of atmospheric ammonia of either 5 ppm (low) or 20 ppm (high) from 4 weeks of age for 15 weeks.", {"entities": []}], ["Growth rates were monitored.", {"entities": []}], ["Samples of liver were taken after slaughter (at \u223c19 weeks of age).", {"entities": []}], ["Samples from the second batch were analysed for global gene expression using 23 K Affymetrix GeneChip porcine genome arrays.", {"entities": []}], ["Samples from both batches were subsequently tested for five candidate genes using quantitative real-time PCR (qPCR).", {"entities": []}], ["The array analysis failed to detect any significant changes in hepatic gene expression following chronic exposure to atmospheric ammonia.", {"entities": []}], ["Animals clustered into two main groups but this was not related to the experimental treatment.", {"entities": []}], ["There was also no difference in growth rates between groups.", {"entities": []}], ["The qPCR analyses validated the array results by showing similar fold changes in gene expression to the arrays.", {"entities": []}], ["They revealed a significant batch effect in expression of lipin 1 ( LPIN1 ), Chemokine (C-X-C motif) ligand 14 ( CXCL14 ), serine dehydratase ( SDS ) and hepcidin antimicrobial peptide ( HAMP ).", {"entities": [[68, 73, "GENE"], [113, 119, "GENE"], [144, 147, "GENE"], [187, 191, "GENE"]]}], ["Only CXCL14, a chemotactic cytokine for monocytes, was significantly down-regulated in response to ammonia.", {"entities": [[5, 11, "GENE"]]}], ["As chronic exposure to atmospheric ammonia did not have a clear influence on hepatic gene expression, this finding implies that 20 ppm of atmospheric ammonia did not pose a significant material risk to the health or metabolism of housed pigs.", {"entities": []}], ["Systems biology makes it possible to study larger and more intricate systems than before, so it is now possible to look at the molecular basis of several diseases in parallel.", {"entities": []}], ["Analyzing the interaction network of proteins in the cell can be the key to understand how complex processes lead to diseases.", {"entities": []}], ["Novel tools in network analysis provide the possibility to quantify the key interacting proteins in large networks as well as proteins that connect them.", {"entities": []}], ["Here we suggest a new method to study the relationships between topology and functionality of the protein-protein interaction network, by identifying key mediator proteins possibly maintaining indirect relationships among proteins causing various diseases.", {"entities": []}], ["Based on the i2d and OMIM databases, we have constructed (i) a network of proteins causing five selected diseases (DP, disease proteins) plus their interacting partners (IP, non-disease proteins), the DPIP network and (ii) a protein network showing only these IPs and their interactions, the IP network.", {"entities": []}], ["The five investigated diseases were (1) various cancers, (2) heart diseases, (3) obesity, (4) diabetes and (5) autism.", {"entities": [[81, 88, "DISEASE"]]}], ["We have quantified the number and strength of IP-mediated indirect effects between the five groups of disease proteins and hypothetically identified the most important mediator proteins linking heart disease to obesity or diabetes in the IP network.", {"entities": [[194, 207, "DISEASE"], [211, 218, "DISEASE"]]}], ["The results present the relationship between mediator role and centrality, as well as between mediator role and functional properties of these proteins.", {"entities": []}], ["We show that a protein which plays an important indirect mediator role between two diseases is not necessarily a hub in the PPI network.", {"entities": []}], ["This may suggest that, even if hub proteins and disease proteins are trivially of great interest, mediators may also deserve more attention, especially if disease-disease associations are to be understood.", {"entities": []}], ["Identifying the hubs may not be sufficient to understand particular pathways.", {"entities": []}], ["We have found that the mediators between heart diseases and obesity, as well as heart diseases and diabetes are of relatively high functional importance in the cell.", {"entities": [[60, 67, "DISEASE"]]}], ["The mediator proteins suggested here should be experimentally tested as products of hypothetical disease-related proteins.", {"entities": []}], ["Investigations focusing and implementing on the impact of cancer on health-related quality of life (HRQoL) by the way of a mean comparison between cancer patients and subjects from the general population, are scarce and usually cross-sectional.", {"entities": [[58, 64, "DISEASE"], [147, 153, "DISEASE"]]}], ["Longitudinal application of HRQoL instruments to a general, initially healthy population allows for change to be assessed as an event occurs, rather than afterwards.", {"entities": []}], ["The objective of the present study was to investigate the impact of new cancer on HRQoL.", {"entities": [[72, 78, "DISEASE"]]}], ["The 36-item Short Form (SF-36) and 12-item General Health Questionnaire (GHQ-12) were applied to the French SU.VI.MAX cohort in 1996 and 1998.", {"entities": []}], ["A controlled longitudinal study was used to determine the impact on HRQoL of newly diagnosed cancer: 84 patients with cancer that occurred between the 2 HRQoL measures were compared with 420 age- and sex-matched cancer-free controls.", {"entities": [[93, 99, "DISEASE"], [118, 124, "DISEASE"], [212, 218, "DISEASE"]]}], ["Initial HRQoL level was similar in the two groups.", {"entities": []}], ["A new cancer had a particularly marked effect on the SF-36 Physical functioning, Role-physical and General health dimensions (more than 6.6-point difference in change in HRQoL evolution on a 0\u2013100 scale).", {"entities": [[6, 12, "DISEASE"]]}], ["The Bodily pain and Vitality dimensions were less severely affected (difference in change varying from 4.4 to 6.3 points), and there was no effect on either the GHQ-12 score or the SF-36 Mental health, Role-emotional and Social functioning dimensions.", {"entities": []}], ["The negative impact of cancer on the lives of patients was assessed in terms of HRQoL.", {"entities": [[23, 29, "DISEASE"]]}], ["The aspects most likely to be affected were those with a physical component, and general health perceptions.", {"entities": []}], ["These results can thus help quantify the impact of a new cancer on HRQoL evolution and potentially facilitate early intervention by identifying the most affected HRQoL domains.", {"entities": [[57, 63, "DISEASE"]]}], ["Combined therapy of metronomic cyclophosphamide, methotrexate and high-dose celecoxib targeting angiogenesis was used in a phase II trial.", {"entities": []}], ["Patients with advanced cancer received oral cyclophosphamide 50\u2009mg o.d., celecoxib 400\u2009mg b.d.", {"entities": [[23, 29, "DISEASE"]]}], ["and methotrexate 2.5\u2009mg b.d.", {"entities": []}], ["for two consecutive days each week.", {"entities": []}], ["Response was determined every 8 weeks; toxicity was evaluated according to CTC version 2.0.", {"entities": []}], ["Plasma markers of inflammation, coagulation and angiogenesis were measured.", {"entities": []}], ["Sixty-seven of 69 patients were evaluable for response.", {"entities": []}], ["Twenty-three patients had stable disease (SD) after 8 weeks, but there were no objective responses to therapy.", {"entities": []}], ["Median time to progression was 57 days.", {"entities": []}], ["There was a low incidence of toxicities.", {"entities": []}], ["Among plasma markers, levels of tissue factor were higher in the SD group of patients at baseline, and levels of both angiopoietin-1 and matrix metalloproteinase-9 increased in the progressive disease group only.", {"entities": []}], ["There were no changes in other plasma markers.", {"entities": []}], ["This metronomic approach has negligible activity in advanced cancer albeit with minimal toxicity.", {"entities": [[61, 67, "DISEASE"]]}], ["Analysis of plasma markers indicates minimal effects on endothelium in this trial.", {"entities": []}], ["These data for this particular regimen do not support basic tenets of metronomic chemotherapy, such as the ability to overcome resistant tumours by targeting the endothelium.", {"entities": []}], ["A high prevalence of CAM use has been documented worldwide in children and adolescents with chronic illnesses.", {"entities": []}], ["Only a small number of studies, however, have been conducted in the United Kingdom.", {"entities": []}], ["The primary aim of this study was to examine the use of CAM by children and adolescents with a wide spectrum of acute and chronic medical problems in a tertiary children's hospital in Wales.", {"entities": []}], ["Structured personal interviews of 100 inpatients and 400 outpatients were conducted over a 2-month period in 2004.", {"entities": []}], ["The yearly and monthly prevalence of CAM use were assessed and divided into medicinal and non-medicinal therapies.", {"entities": []}], ["This use was correlated with socio-demographic factors.", {"entities": []}], ["There were 580 patients approached to attain 500 completed questionnaires.", {"entities": []}], ["The use of at least one type of CAM in the past year was 41% (95% CI 37\u201346%) and past month 26% (95% CI 23\u201330%).", {"entities": []}], ["The yearly prevalence of medicinal CAM was 38% and non-medicinal 12%.", {"entities": []}], ["The users were more likely to have parents that were tertiary educated (mother: OR = 2.3, 95%CI 1.6\u20133.3) and a higher family income (Pearson chi-square for trend = 14.3, p < 0.001).", {"entities": []}], ["The most common medicinal types of CAM were non-prescribed vitamins and minerals (23%) and herbal therapies (10%).", {"entities": []}], ["Aromatherapy (5%) and reflexology (3%) were the most prevalent non-medicinal CAMs.", {"entities": []}], ["None of the inpatient medical records documented CAM use in the past month.", {"entities": []}], ["Fifty-two percent of medicinal and 38% of non-medicinal CAM users felt their doctor did not need to know about CAM use.", {"entities": []}], ["Sixty-six percent of CAM users did not disclose the fact to their doctor.", {"entities": []}], ["Three percent of all participants were using herbs and prescription medicines concurrently.", {"entities": []}], ["There is a high prevalence of CAM use in our study population.", {"entities": []}], ["Paediatricians need to ensure that they ask parents and older children about their CAM usage and advise caution with regard to potential interactions.", {"entities": []}], ["CAM is a rapidly expanding industry that requires further evidence-based research to provide more information on the effectiveness and safety of many CAM therapies.", {"entities": []}], ["Statutory or self-regulation of the different segments of the industry is important.", {"entities": []}], ["Integration of CAM with allopathic western medicine through education and better communication is slowly progressing.", {"entities": []}], ["The Consultation and Relational Empathy (CARE) Measure is a widely used patient-rated experience measure which has recently been translated into Chinese and has undergone preliminary qualitative and quantitative validation.", {"entities": []}], ["The objective of this study was to determine the reliability of the Chinese-version of the CARE Measure in reliably differentiating between doctors in a primary care setting in Hong Kong Data were collected from 984 primary care patients attending 20 doctors with differing levels of training in family medicine in 5 public clinics in Hong Kong.", {"entities": []}], ["The acceptability of the Chinese-CARE measure to patients was assessed.", {"entities": []}], ["The reliability of the measure in discriminating effectively between doctors was analysed by Generalisability-theory (G-Theory) The items in the Chinese-CARE measure were regarded as important by patients and there were few 'not applicable' responses.", {"entities": []}], ["The measure showed high internal reliability (coefficient 0.95) and effectively differentiated between doctors with only 15-20 patient ratings per doctor (inter-rater reliability > 0.8).", {"entities": []}], ["Doctors' mean CARE measure scores varied widely, ranging from 24.1 to 45.9 (maximum possible score 50) with a mean of 34.6.", {"entities": []}], ["CARE Measure scores were positively correlated with level of training in family medicine (Spearman's rho 0.493, p < 0.05).", {"entities": []}], ["These data demonstrate the acceptability, feasibility and reliability of using the Chinese-CARE Measure in primary care in Hong Kong to differentiate between doctors interpersonal competencies.", {"entities": []}], ["Training in family medicine appears to enhance these key interpersonal skills.", {"entities": []}], ["The Engaging with older adults in the development of strategies for the self management of chronic pain (EOPIC) study aims to design and develop self management strategies to enable older adults to manage their own pain.", {"entities": []}], ["Involving older adults in research into chronic pain management will better enable the identification and development of strategies that are more appropriate for their use, but how can perspectives really be utilised to the best possible outcomes?", {"entities": []}], ["Seven older adults were recruited through a local advertising campaign to take part.", {"entities": []}], ["We also invited participants from the local pain services, individuals who had been involved in earlier phase of the EOPIC study and a previous ESRC funded project.", {"entities": []}], ["The group undertook library training and research skills training to facilitate searching of the literature and identified sources of material.", {"entities": []}], ["A grading tool was developed using perceived essential criteria identified by the older adults and material was graded according to the criteria within this scale.", {"entities": []}], ["Fifty-seven resources from over twenty-eight sources were identified.", {"entities": []}], ["These materials were identified as being easily accessible, readable and relevant.", {"entities": []}], ["Many of the web based materials were not always easy to find or readily available so they were excluded by the participants.", {"entities": []}], ["All but one were UK based.", {"entities": []}], ["Forty-four items were identified as meeting the key criteria for inclusion in the study.", {"entities": []}], ["This included five key categories as follows; books, internet, magazines, leaflets, CD\u2019s/Tapes.", {"entities": []}], ["This project was able to identify a number of exemplars of self management material along with some general rules regarding the categories identified.", {"entities": []}], ["We must point out that the materials identified were not age specific, were often locally developed and would need to be adapted to older adults with chronic pain.", {"entities": []}], ["For copyright issues we have not included them in this paper.", {"entities": []}], ["The key message is really related to the format rather than the content.", {"entities": []}], ["However, the group acknowledge that these may vary according to the requirements of each individual older adult and therefore recommend the development of a leaflet to help others in their search for resources.", {"entities": []}], ["This leaflet has been developed as part of Phase IV of the EOPIC study.", {"entities": []}], ["Chronic infection with the gastric bacterial pathogen Helicobacter pylori causes gastritis and predisposes carriers to a high risk of developing gastric and duodenal ulcers, gastric cancer, and gastric lymphoma, but has also recently been shown to protect against certain allergic and chronic inflammatory disorders.", {"entities": [[81, 90, "DISEASE"], [194, 210, "DISEASE"], [202, 210, "DISEASE"], [182, 188, "DISEASE"]]}], ["The immunomodulatory properties that allow the bacteria to persist for decades in infected individuals in the face of a vigorous, yet ultimately non-protective, innate, and adaptive immune response may at the same time confer protection against allergies, asthma, and inflammatory bowel diseases.", {"entities": [[256, 262, "DISEASE"]]}], ["Experimental evidence from mouse models suggests that H. pylori has evolved to skew the adaptive immune response toward immune tolerance rather than immunity, which promotes persistent infection on the one hand, and inhibits auto-aggressive and allergic T-cell responses on the other.", {"entities": []}], ["Regulatory T-cells mediating peripheral immune tolerance have emerged as key cellular players in facilitating persistent infection as well as protection from allergies, in both observational studies in humans and experimental work in mice.", {"entities": []}], ["Recent data suggest that H. pylori actively targets dendritic cells to promote tolerance induction.", {"entities": []}], ["The findings discussed in this review raise the possibility of harnessing the immunomodulatory properties of H. pylori for the prevention and treatment of allergic and auto-immune diseases, and also provide new insights relevant for H. pylori -specific vaccine development.", {"entities": []}], ["Guided migration of chondrogenically differentiated cells has not been well studied, even though it may be critical for growth, repair, and regenerative processes.", {"entities": []}], ["The chemokine CCL25 is believed to play a critical role in the directional migration of leukocytes and stem cells.", {"entities": [[14, 19, "GENE"]]}], ["To investigate the motility effect of serum- or CCL25-mediated chemotaxis on chondrogenically differentiated cells, mesenchymal stem cells (MSCs) were induced to chondrogenic lineage cells.", {"entities": []}], ["MSC-derived chondrogenically differentiated cells were characterized for morphology, histology, immunohistochemistry, quantitative polymerase chain reaction (qPCR), surface profile, and serum- or CCL25-mediated cell migration.", {"entities": []}], ["Additionally, the chemokine receptor, CCR9, was examined in different states of MSCs.", {"entities": [[38, 42, "GENE"]]}], ["The chondrogenic differentiated state of MSCs was positive for collagen type II and Alcian blue staining, and showed significantly upregulated expression of COL2A1 and SOX9 , and downregulated expression of CD44, CD73, CD90, CD105 and CD166, in contrast to the undifferentiated and dedifferentiated states of MSCs.", {"entities": [[157, 163, "GENE"], [168, 172, "GENE"], [207, 211, "GENE"]]}], ["For the chondrogenic differentiated, undifferentiated, and dedifferentiated states of MSCs, the serum-mediated chemotaxis was in a percentage ratio of 33%:84%:85%, and CCL25-mediated chemotaxis was in percentage ratio of 12%:14%:13%, respectively.", {"entities": []}], ["On the protein level, CCR9, receptor of CCL25, was expressed in the form of extracellular and intracellular domains.", {"entities": [[22, 26, "GENE"], [40, 45, "GENE"]]}], ["On the gene level, qPCR confirmed the expression of CCR9 in different states of MSCs.", {"entities": [[52, 56, "GENE"]]}], ["CCL25 is an effective cue to guide migration in a directional way.", {"entities": [[0, 5, "GENE"]]}], ["In CCL25-mediated chemotaxis, the cell-migration rate was almost the same for different states of MSCs.", {"entities": []}], ["In serum-mediated chemotaxis, the cell-migration rate of chondrogenically differentiated cells was significantly lower than that in undifferentiated or dedifferentiated cells.", {"entities": []}], ["Current knowledge of the surface CD profile and cell migration could be beneficial for regenerative cellular therapies.", {"entities": []}], ["The acute gout flare results from a localised self-limiting innate immune response to monosodium urate (MSU) crystals deposited in joints in hyperuricaemic individuals.", {"entities": [[10, 14, "DISEASE"]]}], ["Activation of the caspase recruitment domain-containing protein 8 (CARD8) NOD-like receptor pyrin-containing 3 (NLRP3) inflammasome by MSU crystals and production of mature interleukin-1\u03b2 (IL-1\u03b2) is central to acute gouty arthritis.", {"entities": [[222, 231, "DISEASE"], [67, 72, "GENE"], [112, 117, "GENE"]]}], ["However very little is known about genetic control of the innate immune response involved in acute gouty arthritis.", {"entities": [[105, 114, "DISEASE"]]}], ["Therefore our aim was to test functional single nucleotide polymorphism (SNP) variants in the toll-like receptor (TLR)-inflammasome-IL-1\u03b2 axis for association with gout.", {"entities": [[164, 168, "DISEASE"]]}], ["1,494 gout cases of European and 863 gout cases of New Zealand (NZ) Polynesian (M\u0101ori and Pacific Island) ancestry were included.", {"entities": [[6, 10, "DISEASE"], [37, 41, "DISEASE"]]}], ["Gout was diagnosed by the 1977 ARA gout classification criteria.", {"entities": [[0, 4, "DISEASE"], [35, 39, "DISEASE"]]}], ["There were 1,030 Polynesian controls and 10,942 European controls including from the publicly-available Atherosclerosis Risk in Communities (ARIC) and Framingham Heart (FHS) studies.", {"entities": []}], ["The ten SNPs were either genotyped by Sequenom MassArray or by Affymetrix SNP array or imputed in the ARIC and FHS datasets.", {"entities": []}], ["Allelic association was done by logistic regression adjusting by age and sex with European and Polynesian data combined by meta-analysis.", {"entities": []}], ["Sample sets were pooled for multiplicative interaction analysis, which was also adjusted by sample set.", {"entities": []}], ["Eleven SNPs were tested in the TLR2 , CD14 , IL1B , CARD8 , NLRP3 , MYD88 , P2RX7 , DAPK1 and TNXIP genes.", {"entities": [[31, 35, "GENE"], [38, 42, "GENE"], [45, 49, "GENE"], [52, 57, "GENE"], [60, 65, "GENE"], [68, 73, "GENE"], [76, 81, "GENE"], [84, 89, "GENE"]]}], ["Nominally significant ( P \u2009<\u20090.05) associations with gout were detected at CARD8 rs2043211 (OR\u2009=\u20091.12, P\u2009= \u20090.007), IL1B rs1143623 (OR\u2009=\u20091.10, P \u2009=\u20090.020) and CD14 rs2569190 (OR\u2009=\u20091.08; P \u2009=\u20090.036) .", {"entities": [[53, 57, "DISEASE"], [75, 80, "GENE"], [116, 120, "GENE"], [159, 163, "GENE"]]}], ["There was significant multiplicative interaction between CARD8 and IL1B ( P \u2009=\u20090.005), with the IL1B risk genotype amplifying the risk effect of CARD8.", {"entities": [[57, 62, "GENE"], [145, 150, "GENE"], [67, 71, "GENE"], [96, 100, "GENE"], [67, 71, "GENE"], [96, 100, "GENE"], [57, 62, "GENE"], [145, 150, "GENE"]]}], ["There is evidence for association of gout with functional variants in CARD8, IL1B and CD14 .", {"entities": [[37, 41, "DISEASE"], [70, 75, "GENE"], [77, 81, "GENE"], [86, 90, "GENE"]]}], ["The gout-associated allele of IL1B increases expression of IL-1\u03b2 \u2013 the multiplicative interaction with CARD8 would be consistent with a synergy of greater inflammasome activity (resulting from reduced CARD8) combined with higher levels of pre-IL-1\u03b2 expression leading to increased production of mature IL-1\u03b2 in gout.", {"entities": [[4, 8, "DISEASE"], [311, 315, "DISEASE"], [30, 34, "GENE"], [103, 108, "GENE"], [201, 206, "GENE"], [103, 108, "GENE"], [201, 206, "GENE"]]}], ["The online version of this article (doi:10.1186/s13075-015-0802-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Smoking rates among women are currently low, but they are the fastest growing segment of cigarette smoking population in developing countries.", {"entities": []}], ["We aimed to assess the knowledge and perceptions towards smoking and to identify the factors related with level of knowledge and perceptions among adult women in urban slums.", {"entities": []}], ["This was a cross sectional study conducted on 250 adult (\u226518 years of age) women attending primary care clinics in three slums of Karachi, Pakistan.", {"entities": []}], ["A pre-tested and structured, interviewer administered questionnaire was used for data collection.", {"entities": []}], ["Factors associated with level of understanding about smoking were analyzed with chi-square test.", {"entities": []}], ["Most of the women knew that smoking has adverse effects on women and children's health but the knowledge of specific health effects was limited.", {"entities": []}], ["About one third of the women knew that active smoking can cause lung disease, but only a small percentage (7%) knew that it could lead to heart disease.", {"entities": [[138, 151, "DISEASE"], [64, 76, "DISEASE"]]}], ["None of the women were aware that smoking contributes to infertility and osteoporosis.", {"entities": [[73, 85, "DISEASE"], [57, 68, "DISEASE"]]}], ["A small proportion of women were aware that smoking can lead to low birth weight (7%), congenital anomalies (5%) and less than 1% of women knew that it contributes to pregnancy loss, still birth and preterm delivery.", {"entities": []}], ["The understanding of passive smoking affecting children's lung was low (20%) and a similar proportion voiced concern about the bad influence of maternal smoking on children.", {"entities": []}], ["Educated women had better knowledge of health effects of smoking.", {"entities": []}], ["Education was associated with having better knowledge about effects on women health in general (p = 0.02) and specific effects like lung (p = 0.03) and reproductive health effects (p < 0.001).", {"entities": []}], ["Education was also associated with knowledge regarding effects on fetus (p < 0.001) and children (p < 0.005).", {"entities": []}], ["Although most of the women disliked being around smokers, more than one third thought that smoking decreases boredom (39%), tension (38%) and also helps to relax (40%).", {"entities": []}], ["A large proportion (48%) of women had the misconception that smoking helps to reduce weight.", {"entities": []}], ["This study reveals that women are aware of the general ill effects of smoking but fail to identify smoking to be associated with female maladies particularly those who were illiterate and had lower levels of education.", {"entities": []}], ["Understanding and attitudes needs to be improved by increasing health awareness and education of women in these urban communities with special emphasis on the effects of smoking on women's health.", {"entities": []}], ["Studies have shown a correlation between bipolar disorder and diabetes mellitus.", {"entities": [[41, 57, "DISEASE"], [62, 79, "DISEASE"]]}], ["It is unclear if this correlation is a part of common pathophysiological pathways, or if medication for bipolar disorder has negative effects on blood sugar regulation.", {"entities": [[104, 120, "DISEASE"]]}], ["The Norwegian prescription database was analyzed.", {"entities": []}], ["Prescriptions for lithium, lamotrigine, carbamazepine and valproate were used as proxies for bipolar disorder.", {"entities": [[93, 109, "DISEASE"]]}], ["Prescriptions for insulin and oral anti-diabetic agents were used as proxies for diabetes mellitus.", {"entities": [[81, 98, "DISEASE"]]}], ["We explored the association between medication for bipolar disorder and diabetes medication by logistic regression We found a strong association between concomitant use of medication to treat diabetes mellitus and mood stabilizers for the treatment of bipolar disorder.", {"entities": [[51, 67, "DISEASE"], [252, 268, "DISEASE"], [192, 209, "DISEASE"]]}], ["Females had a 30% higher risk compared to men of being treated for both disorders.", {"entities": []}], ["Persons using oral anti-diabetic agents had higher odds of receiving valproate than either lithium or lamotrigine.", {"entities": []}], ["Use of insulin as monotherapy seemed to have lower odds than oral anti-diabetic agents of co-prescription of mood stabilizers, compared to the general population.", {"entities": []}], ["This study showed a strong association between the use of mood stabilizers and anti-diabetic agents.", {"entities": []}], ["The association was stronger among women than men.", {"entities": []}], ["Depression is a public health concern that warrants accurate population estimates.", {"entities": []}], ["The patient health questionnaire 8 (PHQ-8) offers high sensitivity and specificity for assessing depression but is time-consuming to administer, answer, and score.", {"entities": []}], ["We sought to determine whether 1 of 3 simpler instruments \u2014 the shorter PHQ-2 or 2 single questions from the health-related quality of life (HRQOL) module of the Behavioral Risk Factor Surveillance System (BRFSS) \u2014 could offer accuracy comparable to the PHQ-8.", {"entities": []}], ["We compared the depression and mental distress indicators of 2006 Rhode Island BRFSS data by using\u00a04 types of analyses: 1) sensitivity and specificity estimates, 2) prevalence estimates, 3) multivariable logistic regression modeling of the relationship between each of the 4 indicators and 11 demographic and health risk variables, and 4) geographic distribution of prevalence.", {"entities": []}], ["Compared with the PHQ-8, the 3 other measures have high levels of specificity but lower sensitivity.", {"entities": []}], ["Depression prevalence estimates ranged from 8.6% to 10.3%.", {"entities": []}], ["The adjusted odds ratios from logistic regression modeling were consistent.", {"entities": []}], ["Each of the indicators was significantly associated with low income, being unable to work, current smoking, and having a disability.", {"entities": []}], ["The PHQ-8 indicator is the most sensitive and specific and can assess depression severity.", {"entities": []}], ["The HRQOL and PHQ-2 indicators are adequate to obtain population prevalence estimates if questionnaire length is limited.", {"entities": []}], ["Patient: Female, 33 Final Diagnosis: S1Q3T3 electrocardiographic abnormality in a pregnant asthmatic during acute bronchospasm Symptoms: Cough \u2022 shortness of breath Medication: \u2014 Clinical Procedure: EKG Specialty: Pulmonology Rare co-existance of disease or pathology Asthma is the most common chronic pulmonary disease during pregnancy.", {"entities": [[268, 274, "DISEASE"]]}], ["Several previous reports have documented reversible electrocardiographic changes during severe acute asthma attacks, including tachycardia, P pulmonale, right bundle branch block, right axis deviation, and ST segment and T wave abnormalities.", {"entities": [[153, 178, "DISEASE"], [101, 107, "DISEASE"]]}], ["We present the case of a pregnant patient with asthma exacerbation in which acute bronchospasm caused S1Q3T3 abnormality on an electrocardiogram (ECG).", {"entities": [[47, 53, "DISEASE"]]}], ["The complete workup of ECG findings of S1Q3T3 was negative and correlated with bronchospasm.", {"entities": []}], ["The S1Q3T3 electrocardiographic abnormality can be seen in acute bronchospasm in pregnant women.", {"entities": []}], ["The other causes like pulmonary embolism, pneumothorax, acute lung disease, cor pulmonale, and left posterior fascicular block were excluded.", {"entities": [[76, 89, "DISEASE"], [22, 40, "DISEASE"], [42, 54, "DISEASE"], [62, 74, "DISEASE"]]}], ["Asthma exacerbations are of considerable concern during pregnancy due to their adverse effect on the fetus, and optimization of asthma treatment during pregnancy is vital for achieving good outcomes.", {"entities": [[0, 6, "DISEASE"], [128, 134, "DISEASE"]]}], ["Prompt recognition of electrocardiographic abnormality and early treatment can prevent adverse perinatal outcomes.", {"entities": []}], ["Adverse health effects at relatively low levels of ambient air pollution have consistently been reported in the last years.", {"entities": []}], ["We conducted a time-series panel study of subjects with chronic obstructive pulmonary disease (COPD), asthma, and ischemic heart disease (IHD) to evaluate whether daily levels of air pollutants have a measurable impact on the lung function of adult subjects with pre-existing lung or heart diseases.", {"entities": [[114, 136, "DISEASE"], [123, 136, "DISEASE"], [56, 93, "DISEASE"], [102, 108, "DISEASE"]]}], ["Twenty-nine patients with COPD, asthma, or IHD underwent repeated lung function tests by supervised spirometry in two one-month surveys.", {"entities": [[32, 38, "DISEASE"]]}], ["Daily samples of coarse (PM 10\u20132.5 ) and fine (PM 2.5 ) particulate matter were collected by means of dichotomous samplers, and the dust was gravimetrically analyzed.", {"entities": []}], ["The particulate content of selected metals (cadmium, chrome, iron, nickel, lead, platinum, vanadium, and zinc) was determined by atomic absorption spectrometry.", {"entities": []}], ["Ambient concentrations of nitrogen dioxide (NO 2 ), carbon monoxide (CO), ozone (O 3 ), and sulphur dioxide (SO 2 ) were obtained from the regional air-quality monitoring network.", {"entities": []}], ["The relationships between concentrations of air pollutants and lung function parameters were analyzed by generalized estimating equations (GEE) for panel data.", {"entities": []}], ["Decrements in lung function indices (FVC and/or FEV 1 ) associated with increasing concentrations of PM 2.5 , NO 2 and some metals (especially zinc and iron) were observed in COPD cases.", {"entities": [[48, 51, "GENE"]]}], ["Among the asthmatics, NO 2 was associated with a decrease in FEV 1 .", {"entities": [[61, 64, "GENE"]]}], ["No association between average ambient concentrations of any air pollutant and lung function was observed among IHD cases.", {"entities": []}], ["This study suggests that the short-term negative impact of exposure to air pollutants on respiratory volume and flow is limited to individuals with already impaired respiratory function.", {"entities": []}], ["The fine fraction of ambient PM seems responsible for the observed effects among COPD cases, with zinc and iron having a potential role via oxidative stress.", {"entities": []}], ["The respiratory function of the relatively young and mild asthmatics included in this study seems to worsen when ambient levels of NO 2 increase.", {"entities": []}], ["Interleukin 17 (IL-17) is an important pro-inflammatory cytokine and plays critical roles in the immune response to pathogens and in the pathogenesis of inflammatory and autoimmune diseases.", {"entities": []}], ["Despite its important functions, the origin and evolution of IL-17 in animal phyla have not been characterized.", {"entities": []}], ["As determined in this study, the distribution of the IL-17 family among 10 invertebrate species and 7 vertebrate species suggests that the IL-17 gene may have originated from Nematoda but is absent from Saccoglossus kowalevskii (Hemichordata) and Insecta.", {"entities": []}], ["Moreover, the gene number, protein length and domain number of IL-17 differ widely.", {"entities": []}], ["A comparison of IL-17-containing domains and conserved motifs indicated somewhat low amino acid sequence similarity but high conservation at the motif level, although some motifs were lost in certain species.", {"entities": []}], ["The third disulfide bond for the cystine knot fold is formed by two cysteine residues in invertebrates, but these have been replaced by two serine residues in Chordata and vertebrates.", {"entities": []}], ["One third of invertebrate IL-17 proteins were found to have no predicted signal peptide.", {"entities": []}], ["Furthermore, an analysis of phylogenetic trees and exon\u2013intron structures indicated that the IL-17 family lacks conservation and displays high divergence.", {"entities": []}], ["These results suggest that invertebrate IL-17 proteins have undergone complex differentiation and that their members may have developed novel functions during evolution.", {"entities": []}], ["During the past decade, coal-based sponge iron plants, a highly polluted industry, have grown rapidly in Barjora, India.", {"entities": []}], ["The toxic effects of particulate matters and gaseous pollutants include various respiratory diseases.", {"entities": []}], ["Understanding workers\u2019 perception of respiratory health is essential in people-centred healthcare.", {"entities": []}], ["The aim of the study was to assess their respiratory health status and to determine its predictors.", {"entities": []}], ["Cross-sectional study.", {"entities": []}], ["Coal-based sponge iron plants in Barjora, India.", {"entities": []}], ["258 coal-based sponge iron plant workers.", {"entities": []}], ["Respiratory health status was measured using the St. George's respiratory questionnaire (SGRQ) total score.", {"entities": []}], ["100 and 0 represent the worst and best possible respiratory health status, respectively.", {"entities": []}], ["The two-part model (frequency (any worse respiratory health status) and severity (amount of worse respiratory health status)) was developed for the score, as the data were positively skewed with many zeros.", {"entities": []}], ["The mean (SD) SGRQ total score was 7.7 (14.5), the median (IQR) was 0.9 (9.0), and the observed range was 0\u201386.6.", {"entities": []}], ["The best possible SGRQ total score was reported by 46.9% of workers.", {"entities": []}], ["Independent predictors of worse respiratory health status were cleaner domestic cooking fuel (coefficient \u22120.76, 95% CI \u22121.46 to \u22120.06, p=0.034) and personal history of any respiratory disease (1.76, 1.04 to 2.47, p<0.001) in case of frequency; and family history of any respiratory disease (0.43, 0.02 to 0.83, p=0.039) and personal history (1.19, 0.83 to 1.54, p<0.001) in case of severity.", {"entities": []}], ["Less than half of the coal-based sponge iron plant workers in Barjora have the best possible respiratory health status.", {"entities": []}], ["The predictors of worse respiratory health status were identified.", {"entities": []}], ["The study findings could be taken into consideration in future interventional studies aimed at improving the respiratory health status of these workers.", {"entities": []}], ["Based on findings from a systematic literature search, we present and discuss the evidence for an association between exposure to cement dust and non-malignant respiratory effects in cement production workers.", {"entities": []}], ["Systematic literature searches (MEDLINE and Embase) were performed.", {"entities": []}], ["Outcomes were restricted to respiratory symptoms, lung function indices, asthma, chronic bronchitis, chronic obstructive pulmonary disease, pneumoconiosis, induced sputum or fraction of exhaled nitric oxide (FeNO) measurements.", {"entities": [[101, 138, "DISEASE"], [73, 79, "DISEASE"], [140, 154, "DISEASE"], [89, 99, "DISEASE"]]}], ["The studies included exposed cement production workers and non-exposed or low-exposed referents.", {"entities": []}], ["The searches yielded 594 references, and 26 articles were included.", {"entities": []}], ["Cross-sectional studies show reduced lung function levels at or above 4.5\u2005mg/m 1 /FVC was 1\u20136% lower in exposed than in controls.", {"entities": []}], ["Cohort studies reported a high yearly decline in FEV 1 /FVC ranging from 0.8% to 1.7% for exposed workers.", {"entities": [[49, 52, "GENE"]]}], ["1 longitudinal study reported airflow limitation at levels of exposure comparable to \u223c1\u2005mg/m Lack of power, adjustment for possible confounders and other methodological issues are limitations of many of the included studies.", {"entities": []}], ["Hence, no firm conclusions can be drawn.", {"entities": []}], ["There are few longitudinal data, but recent studies report a dose\u2013response relationship between cement production dust exposure and declining lung function indicating a causal relationship, and underlining the need to reduce exposure among workers in this industry.", {"entities": []}], ["Sleep disorders can lead to significant morbidity.", {"entities": []}], ["Information on sleep in healthy children is necessary to evaluate sleep disorders in clinical practice, but data from different societies cannot be simply generalized.", {"entities": []}], ["The aims of this study were to (1) assess the prevalence of sleep disturbances in Dutch healthy children, (2) describe sleep habits and problems in this population, (3) collect Dutch norm data for future reference, and (4) compare sleep in children from different cultural backgrounds.", {"entities": []}], ["A population-based descriptive study was conducted using the Children\u2019s sleep habits questionnaire and the sleep self-report.", {"entities": []}], ["One thousand five hundred seven proxy-reports and 262 self-reports were analyzed.", {"entities": []}], ["Mean age was 8.5\u00a0years (95% confidence interval, 8.4\u20138.6), 52% were boys.", {"entities": []}], ["Sleep problems in Dutch children were present in 25%, i.e., comparable to other populations.", {"entities": []}], ["Sleep habits were age-related.", {"entities": []}], ["Problem sleepers scored significantly higher on all scales.", {"entities": []}], ["Correlations between parental and self-assessments were low to moderate.", {"entities": []}], ["Dutch children had significantly more sleep disturbances than children from the USA and less than Chinese children.", {"entities": []}], ["Cognitions and attitudes towards what is considered normal sleep seem to affect the appraisal of sleep, this probably accounts partly for cultural differences.", {"entities": []}], ["For a better understanding of cultural influences on sleep, more information on these determinants and the establishment of cultural norms are mandatory.", {"entities": []}], ["Complement is involved in many immune-mediated diseases.", {"entities": []}], ["However, the association of its copy number variations (CNVs) and polymorphisms with Behcet\u2019s disease (BD) and Vogt-Koyanagi-Harada syndrome (VKH) is unknown.", {"entities": [[132, 140, "DISEASE"]]}], ["We examined copy number and mRNA expression by real-time PCR.", {"entities": []}], ["Cytokine production by stimulated peripheral blood mononuclear cells (PBMCs) in genotyped individuals was measured by ELISA.", {"entities": []}], ["The frequencies of having more than two copies of C3 were significantly increased in BD and VKH, whereas CNV of C5 was only associated with BD.", {"entities": [[50, 52, "GENE"], [112, 114, "GENE"]]}], ["Increased frequencies of the GG genotype of C3 rs408290 and C5 rs2269067 were found in BD.", {"entities": [[44, 46, "GENE"], [60, 62, "GENE"]]}], ["No association was observed between C3 and C5 SNPs and VKH.", {"entities": [[36, 38, "GENE"], [43, 45, "GENE"]]}], ["mRNA expression in the high CNV group and GG cases of C3 and C5 was significantly higher compared to other genotypes.", {"entities": [[54, 56, "GENE"], [61, 63, "GENE"]]}], ["Increased interleukin-17 and IFN-\u03b3 was observed in the high CNV group and GG genotype cases of C3.", {"entities": [[95, 97, "GENE"]]}], ["Interleukin-17 but not IFN-\u03b3 was increased in the high CNV group and GG genotype cases of C5.", {"entities": [[90, 92, "GENE"]]}], ["No effect of C3 or C5 genetic variants was seen on the production of TNF-\u03b1, IL-10, IL-1\u03b2, MCP-1, IL-6 and IL-8.", {"entities": [[13, 15, "GENE"], [19, 21, "GENE"]]}], ["Our study thus provides further evidence for a role of complement in the pathogenesis of uveitis.", {"entities": [[89, 96, "DISEASE"]]}], ["Twelve blockhouses were built in Helsinki in the 1970s on a former dump area containing industrial and household waste.", {"entities": []}], ["We investigated whether the exposure to landfill caused cancer or other chronic diseases in the inhabitants of these houses.", {"entities": [[56, 62, "DISEASE"]]}], ["From the Population Register, we identified 2,000 persons who had ever lived in houses built on the dump area and a similar reference cohort from similar houses elsewhere in Helsinki.", {"entities": []}], ["We identified their cancer cases from the Cancer Registry, and the other chronic diseases eligible for free medication from the Finnish Social Insurance Institution.", {"entities": [[20, 26, "DISEASE"], [42, 48, "DISEASE"]]}], ["At the end of 1998, 88 cases of cancer had been diagnosed, whereas the expected number based on the incidence rates among all inhabitants of Helsinki was 76.1.", {"entities": [[32, 38, "DISEASE"]]}], ["The excess cases were entirely attributable to males and to follow-up >or= 5 years after moving into the dump area [standardized incidence ratio (SIR) in this category, 1.61; 95% confidence interval (CI), 1.11-2.24], and they were distributed evenly over primary sites.", {"entities": []}], ["The relative risk increased slightly with the number of years lived in the area.", {"entities": []}], ["The relative risk of cancer between the dump area and reference houses was 1.50 (1.08-2.09), similar in both sexes.", {"entities": [[21, 27, "DISEASE"]]}], ["Of the other chronic diseases, the SIRs for asthma (1.63; CI, 1.27-2.07) and chronic pancreatitis (19.3; CI, 2.34-69.7) were significantly increased.", {"entities": [[85, 97, "DISEASE"], [44, 50, "DISEASE"]]}], ["The possibility of a causal association between dump exposure and incidence of cancer and asthma cannot be fully excluded.", {"entities": [[90, 96, "DISEASE"], [79, 85, "DISEASE"]]}], ["The Helsinki City Council decided to demolish the houses in the dump area, and most houses have already been destroyed.", {"entities": []}], ["Short chain fatty acids (SCFA) are metabolites of intestinal bacteria resulting from fermentation of dietary fiber.", {"entities": []}], ["SCFA are protective in various animal models of inflammatory disease.", {"entities": []}], ["We investigated the effects of exogenous administration of SFCAs, particularly propionate, on uveitis using an inducible model of experimental autoimmune uveitis (EAU).", {"entities": [[94, 101, "DISEASE"], [154, 161, "DISEASE"]]}], ["Oral SCFA administration attenuated uveitis severity in a mouse strain-dependent manner through regulatory T cell induction among lymphocytes in the intestinal lamina propria (LPL) and cervical lymph nodes (CLN).", {"entities": [[36, 43, "DISEASE"], [176, 179, "GENE"]]}], ["SCFA also suppressed effector T cell induction in the CLN and mesenteric lymph nodes (MLN).", {"entities": [[86, 89, "GENE"]]}], ["Alterations in intestinal morphology and gene expression demonstrated in the EAU model prior to the onset of uveitis were blunted by oral SCFA administration.", {"entities": [[109, 116, "DISEASE"]]}], ["Using a Kaede transgenic mouse, we demonstrated enhanced leukocyte trafficking between the intestine and the eye in EAU.", {"entities": []}], ["Propionate suppressed T effector cell migration between the intestine and the spleen in EAU Kaede mice.", {"entities": []}], ["In conclusion, our findings support exogenous administration of SCFAs as a potential treatment strategy for uveitis through the stabilization of subclinical intestinal alterations that occur in inflammatory diseases including uveitis, as well as prevention of trafficking of leukocytes between the gastrointestinal tract and extra-intestinal tissues.", {"entities": [[108, 115, "DISEASE"], [226, 233, "DISEASE"]]}], ["The relative quantification of proteins using liquid chromatography mass spectrometry (LC-MS) has allowed researchers to compile lists of potential disease markers.", {"entities": []}], ["These complex quantitative workflows often include isobaric labeling of enzymatically-produced peptides to analyze their relative abundances across multiple samples in a single LC-MS run.", {"entities": []}], ["Recent efforts by our lab have provided scientists with cost-effective alternatives to expensive commercial labels.", {"entities": []}], ["Although the quantitative performance of these dimethyl leucine (DiLeu) labels has been reported using known ratios of complex protein and peptide standards, their potential in large-scale proteomics studies using a clinically relevant system has never been investigated.", {"entities": []}], ["Our work rectifies this oversight by implementing 4-plex DiLeu to quantify proteins in the urine of aging human males who suffer from lower urinary tract symptoms (LUTS).", {"entities": []}], ["Protein abundances in 25 LUTS and 15 control patients were compared, revealing that of the 836 proteins quantified, 50 were found to be differentially expressed (>20% change) and statistically significant (p-value <0.05).", {"entities": []}], ["Gene ontology (GO) analysis of the differentiated proteins showed that many were involved in inflammatory responses and implicated in fibrosis.", {"entities": []}], ["While confirmation of individual protein abundance changes would be required to verify protein expression, this study represents the first report using the custom isobaric label, 4-plex DiLeu, to quantify protein abundances in a clinically relevant system.", {"entities": []}], ["CCL17 (TARC) function can be completely abolished by mAbs that block either one of two distinct sites required for CCR4 signaling.", {"entities": [[0, 5, "GENE"], [115, 119, "GENE"]]}], ["This chemokine is elevated in sera of asthma patients and is responsible for establishing inflammatory sites through CCR4-mediated recruitment of immune cells.", {"entities": [[38, 44, "DISEASE"]]}], ["CCL17 shares the GPCR CCR4, with CCL22 (MDC) but these two chemokines differentially affect the immune response.", {"entities": [[0, 5, "GENE"], [22, 26, "GENE"], [33, 38, "GENE"]]}], ["To better understand chemokine mediated effects through CCR4, we have generated chimeric anti-mouse CCL17 surrogate antibodies that inhibit function of this ligand in vitro and in vivo .", {"entities": [[56, 60, "GENE"], [100, 105, "GENE"]]}], ["The affinities of the surrogate antibodies for CCL17 range from 685 pM for B225 to 4.9 nM for B202.", {"entities": [[47, 52, "GENE"]]}], ["One antibody, B202, also exhibits weak binding to CCL22 (K D \u223c2 \u00b5M) and no binding to CCL22 is detectable with the second antibody, B225.", {"entities": [[50, 55, "GENE"], [86, 91, "GENE"], [50, 55, "GENE"], [86, 91, "GENE"]]}], ["In vitro , both antibodies inhibit CCL17-mediated calcium mobilization, \u03b2-arrestin recruitment and chemotaxis; B202 can also partially inhibit CCL22-mediated \u03b2-arrestin recruitment.", {"entities": []}], ["Both B202 and B225 antibodies neutralize CCL17 in vivo as demonstrated by reduction of methacholine-induced airway hyperreactivity in the A. fumigatus model of asthma.", {"entities": [[160, 166, "DISEASE"], [41, 46, "GENE"]]}], ["That both antibodies block CCL17 function but only B202 shows any inhibition of CCL22 function suggests that they bind CCL17 at different sites.", {"entities": [[27, 32, "GENE"], [119, 124, "GENE"], [80, 85, "GENE"], [27, 32, "GENE"], [119, 124, "GENE"]]}], ["Competition binding studies confirm that these two antibodies recognize unique epitopes that are non-overlapping despite the small size of CCL17.", {"entities": [[139, 144, "GENE"]]}], ["Taking into consideration the data from both the functional and binding studies, we propose that effective engagement of CCR4 by CCL17 involves two distinct binding domains and interaction with both is required for signaling.", {"entities": [[121, 125, "GENE"], [129, 134, "GENE"]]}], ["Our previous research suggested that an integrated analysis of microRNA (miRNA) and messenger RNA (mRNA) expression is helpful to explore miRNA-mRNA interactions and to uncover the molecular mechanisms of male infertility.", {"entities": [[205, 221, "DISEASE"], [210, 221, "DISEASE"]]}], ["In this study, microarrays were used to compare the differences in the miRNA and mRNA expression profiles in the testicular tissues of severe oligozoospermia (SO) patients with obstructive azoospermia (OA) controls with normal spermatogenesis.", {"entities": [[189, 200, "DISEASE"]]}], ["Four miRNAs (miR-1246, miR-375, miR-410, and miR-758) and six mRNAs (SLC1A3, PRKAR2B, HYDIN, WDR65, PRDX1, and ADATMS5) were selected to validate the microarray data using quantitative real-time PCR.", {"entities": [[13, 21, "GENE"], [23, 30, "GENE"], [32, 39, "GENE"], [45, 52, "GENE"], [69, 75, "GENE"], [77, 84, "GENE"], [86, 91, "GENE"], [93, 98, "GENE"], [100, 105, "GENE"]]}], ["Using statistical calculations and bioinformatics predictions, we identified 33 differentially expressed miRNAs and 1,239 differentially expressed mRNAs, among which one potential miRNA-target gene pair, miR-34c-3p and PLCXD3 (Phosphatidylinositol-Specific Phospholipase C, X Domain Containing 3), was identified.", {"entities": [[204, 214, "GENE"], [219, 225, "GENE"]]}], ["Immunohistochemical analysis indicated that PLCXD3 was located within the germ cells of the mouse and human testis.", {"entities": [[44, 50, "GENE"]]}], ["Moreover, we found that miR-34c-3p was able to decrease PLCXD3 expression in mouse (GC-1 and TM4) and human (NCM460) cell lines, presumably indicating the possibility that miR-34c-3p acts as an intracellular mediator in germinal lineage differentiation.", {"entities": [[24, 34, "GENE"], [172, 182, "GENE"], [56, 62, "GENE"], [24, 34, "GENE"], [172, 182, "GENE"]]}], ["Notably, we reported the expression of the PLCXD3 protein in a man with normal spermatogenesis and the lack of the PLCXD3 protein in a man with SO.", {"entities": [[43, 49, "GENE"], [115, 121, "GENE"], [43, 49, "GENE"], [115, 121, "GENE"]]}], ["Therefore, the identified miRNA and mRNA may represent a potentially novel molecular regulatory network and therapeutic targets for the study or treatment of SO, which might provide a better understanding of the molecular basis of spermatogenesis dysfunction.", {"entities": []}], ["A paucity of literature exists on risk factors for mortality in charcoal burning suicide.", {"entities": []}], ["In this observational study, we analyzed the data of 126 patients with charcoal burning suicide that seen between 2002 and 2013.", {"entities": []}], ["Patients were grouped according to status of renal damage as acute kidney injury (N\u2009=\u200949) or non-acute kidney injury (N\u2009=\u200977).", {"entities": []}], ["It was found that patients with acute kidney injury suffered severer complications such as respiratory failure (P\u2009=\u20090.002), myocardial injury (P\u2009=\u20090.049), hepatic injury (P\u2009<\u20090.001), rhabdomyolysis (P\u2009=\u20090.045) and out-of-hospital cardiac arrest (P\u2009=\u20090.028) than patients without acute kidney injury.", {"entities": [[91, 110, "DISEASE"]]}], ["Moreover, patients with acute kidney injury suffered longer hospitalization duration (16.9\u2009\u00b1\u200918.3 versus 10.7\u2009\u00b1\u200910.9, P\u2009=\u20090.002) and had higher mortality rate (8.2% versus 0%, P\u2009=\u20090.011) than patients without injury.", {"entities": []}], ["In a multivariate Cox regression model, it was demonstrated that serum creatinine level (P\u2009=\u20090.019) and heart rate (P\u2009=\u20090.022) were significant risk factors for mortality.", {"entities": []}], ["Finally, Kaplan-Meier analysis revealed that patients with acute kidney injury suffered lower cumulative survival than without injury (P\u2009=\u20090.016).", {"entities": []}], ["In summary, the overall mortality rate of charcoal burning suicide population was 3.2%, and acute kidney injury was a powerful predictor of mortality.", {"entities": []}], ["Further studies are warranted.", {"entities": []}], ["Chronic respiratory diseases cause a significant health and economic burden around the world.", {"entities": []}], ["In Canada, Aboriginal populations are at increased risk of asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[70, 107, "DISEASE"], [59, 65, "DISEASE"]]}], ["There is little known, however, about these diseases in the Canadian M\u00e9tis population, who have mixed Aboriginal and European ancestry.", {"entities": []}], ["A population-based study was conducted to quantify asthma and COPD prevalence and health services use in the M\u00e9tis population of Ontario, Canada\u2019s largest province.", {"entities": [[51, 57, "DISEASE"]]}], ["The M\u00e9tis Nation of Ontario Citizenship Registry was linked to provincial health administrative databases to measure and compare burden of asthma and COPD between the M\u00e9tis and non-M\u00e9tis populations of Ontario between 2009 and 2012.", {"entities": [[139, 145, "DISEASE"]]}], ["Asthma and COPD prevalence, health services use (general physician and specialist visits, emergency department visits, hospitalizations), and mortality were measured.", {"entities": [[0, 6, "DISEASE"]]}], ["Prevalences of asthma and COPD were 30% and 70% higher, respectively, in the M\u00e9tis compared to the general Ontario population (p<0.001).", {"entities": [[15, 21, "DISEASE"]]}], ["General physician and specialist visits were significantly lower in M\u00e9tis with asthma, while general physician visits for COPD were significantly higher.", {"entities": [[79, 85, "DISEASE"]]}], ["Emergency department visits and hospitalizations were generally higher for M\u00e9tis compared to non-M\u00e9tis with either disease.", {"entities": []}], ["All-cause mortality in M\u00e9tis with COPD was 1.3 times higher compared to non-M\u00e9tis with COPD (p\u200a=\u200a0.01).", {"entities": []}], ["There is a high burden of asthma and COPD in Ontario M\u00e9tis, with significant prevalence and acute health services use related to these diseases.", {"entities": [[26, 32, "DISEASE"]]}], ["Lower rates of physician visits suggest barriers in access to primary care services.", {"entities": []}], ["Depression is a common mental health condition now viewed as chronic or long-term.", {"entities": []}], ["More than 50\u00a0% of people will have at least one further episode of depression after their first, and therefore it requires long-term management.", {"entities": []}], ["However, little is known about the effectiveness of self-management in depression, in particular from the patients\u2019 perspective.", {"entities": []}], ["This study aimed to understand how people with longer-term depression manage the condition, how services can best support self-management and whether the principles and concepts of the recovery approach would be advantageous.", {"entities": []}], ["Semi-structured in depth interviews were carried out with 21 participants, recruited from a range of sources using maximum variation sampling.", {"entities": []}], ["Interpretative Phenomenological Analysis was used by a diverse team comprised of service users, practitioners and academics.", {"entities": []}], ["Four super-ordinate themes were found: experience of depression, the self, the wider environment, self-management strategies.", {"entities": []}], ["Within these, several prominent sub-themes emerged of importance to the participants.", {"entities": []}], ["These included how aspects of themselves such as hope, confidence and motivation could be powerful agents; and how engaging in a wide range of chosen activities could contribute to their emotional, mental, physical, social, spiritual and creative wellbeing.", {"entities": []}], ["Services in general were not perceived to be useful in specifically facilitating self-management.", {"entities": []}], ["Increased choice and control were needed and a greater emphasis on an individualised holistic model.", {"entities": []}], ["Improved information was needed about how to develop strategies and locate resources, especially during the first episode of depression.", {"entities": []}], ["These concepts echoed those of the recovery approach, which could therefore be seen as valuable in aiding the self-management of depression.", {"entities": []}], ["The online version of this article (doi:10.1186/s12888-015-0550-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Indoleamine 2,3-dioxygenase (IDO) catalyzes the degradation of tryptophan, which plays a critical role in immune suppression through regulating the production of a series of metabolites that are generally referred to as kynurenines.", {"entities": []}], ["It has become increasingly clear that epithelial cells (ECs) play an active role in maintaining lung homeostasis by modulating the function of immune cells via producing cytokines, chemokines, and anti-microbial mediators.", {"entities": []}], ["In this study we assessed the regulation of IDO activity and expression in human primary ECs and EC lines under steady state conditions and in response to bacterial and allergenic stimuli.", {"entities": []}], ["We also investigated the potential immune modulatory functions of IDO expression in human airway ECs.", {"entities": []}], ["Our data clearly show that airway ECs produce IDO, which is down-regulated in response to allergens and TLR ligands while up-regulated in response to IFN-\u03b3.", {"entities": []}], ["Using gene silencing, we further demonstrate that IDO plays a key role in the EC-mediated suppression of antigen-specific and polyclonal proliferation of T cells.", {"entities": []}], ["Interestingly, our data also show that ECs lose their inhibitory effect on T cell activation in response to different TLR agonists mimicking bacterial or viral infections.", {"entities": []}], ["In conclusion, our work provides an understanding of how IDO is regulated in ECs as well as demonstrates that \u201cresting\u201d ECs can suppress T cell activation in an IDO dependent manner.", {"entities": []}], ["These data provide new insight into how ECs, through the production of IDO, can influence downstream innate and adaptive responses as part of their function in maintaining immune homeostasis in the airways.", {"entities": []}], ["Supplemental digital content is available in the text.", {"entities": []}], ["Awareness of being monitored can influence participants\u2019 habitual physical activity (PA) behavior.", {"entities": []}], ["This reactivity effect may threaten the validity of PA assessment.", {"entities": []}], ["Reports on reactivity when measuring the PA of children and adolescents have been inconsistent.", {"entities": []}], ["The aim of this study was to investigate whether PA outcomes measured by accelerometer devices differ from measurement day to measurement day and whether the day of the week and the day on which measurement started influence these differences.", {"entities": []}], ["Accelerometer data (counts per minute [cpm]) of children and adolescents ( n = 2081) pooled from eight studies in Switzerland with at least 10 h of daily valid recording were investigated for effects of measurement day, day of the week, and start day using mixed linear regression.", {"entities": [[39, 42, "GENE"]]}], ["The first measurement day was the most active day.", {"entities": []}], ["Counts per minute were significantly higher than on the second to the sixth day, but not on the seventh day.", {"entities": []}], ["Differences in the age-adjusted means between the first and consecutive days ranged from 23 to 45 cpm (3.6%\u20137.1%).", {"entities": [[98, 101, "GENE"]]}], ["In preschoolchildren, the differences almost reached 10%.", {"entities": []}], ["The start day significantly influenced PA outcome measures.", {"entities": []}], ["Reactivity to accelerometer measurement of PA is likely to be present to an extent of approximately 5% on the first day and may introduce a relevant bias to accelerometer-based studies.", {"entities": []}], ["In preschoolchildren, the effects are larger than those in elementary and secondary schoolchildren.", {"entities": []}], ["As the day of the week and the start day significantly influence PA estimates, researchers should plan for at least one familiarization day in school-age children and randomly assign start days.", {"entities": []}], ["Lactobacillus rhamnosus GG (LGG) is one of the most widely used probiotic strains.", {"entities": []}], ["Various health effects are well documented including the prevention and treatment of gastro-intestinal infections and diarrhea, and stimulation of immune responses that promote vaccination or even prevent certain allergic symptoms.", {"entities": [[118, 126, "DISEASE"]]}], ["However, not all intervention studies could show a clinical benefit and even for the same conditions, the results are not univocal.", {"entities": []}], ["Clearly, the host phenotype governed by age, genetics and environmental factors such as the endogenous microbiota, plays a role in whether individuals are responders or non-responders.", {"entities": []}], ["However, we believe that a detailed knowledge of the bacterial physiology and the LGG molecules that play a key role in its host-interaction capacity is crucial for a better understanding of its potential health benefits.", {"entities": []}], ["Molecules that were yet identified as important factors governing host interactions include its adhesive pili or fimbriae, its lipoteichoic acid molecules, its major secreted proteins and its galactose-rich exopolysaccharides, as well as specific DNA motifs.", {"entities": []}], ["Nevertheless, future studies are needed to correlate specific health effects to these molecular effectors in LGG, and also in other probiotic strains.", {"entities": []}], ["Recently, we have reported that asthma is associated with enhanced plasma thrombin formation and impaired fibrinolysis.", {"entities": [[32, 38, "DISEASE"]]}], ["The mechanisms underlying the prothrombotic state in this disease are unknown.", {"entities": []}], ["Our aim was to investigate whether prothrombotic alterations in asthmatics are associated with inflammation.", {"entities": []}], ["We studied 164 adult, white, stable asthmatics and 72 controls matched for age, sex, body mass index (BMI), and smoking.", {"entities": []}], ["Plasma tumor necrosis factor \u03b1 (TNF\u03b1), interleukin (IL)-6, and serum periostin were evaluated using ELISAs, and their associations with thrombin generation, fibrinolytic capacity, expressed as clot lysis time (CLT), and platelet markers were later analyzed.", {"entities": []}], ["Asthma was characterized by 62% higher plasma IL-6 and 35% higher TNF\u03b1 (both, p \u00a0<\u00a00.0001).", {"entities": [[0, 6, "DISEASE"]]}], ["Inflammatory cytokines were higher in sporadic and persistent asthmatics compared to controls, also after adjustment for potential confounders.", {"entities": []}], ["IL-6 was inversely related to the forced expiratory volume in 1\u00a0s/vital capacity (FEV 1 /VC) spirometry index after correction for age, sex, and BMI.", {"entities": [[82, 85, "GENE"]]}], ["IL-6 and TNF\u03b1 were associated with C-reactive protein in asthmatics ( \u03b2 \u00a0=\u00a00.6 [95% CI, 0.54\u20130.67] and \u03b2 \u00a0=\u00a00.33 [95% CI, 0.25\u20130.41], respectively) and controls ( \u03b2 \u00a0=\u00a00.43 [95% CI, 0.29\u20130.57] and \u03b2 \u00a0=\u00a00.33 [95% CI, 0.18\u20130.48], respectively).", {"entities": []}], ["In asthma, IL-6 and TNF\u03b1 positively correlated with the endogenous thrombin potential ( \u03b2 \u00a0=\u00a00.35 [95% CI, 0.28\u20130.42] and \u03b2 \u00a0=\u00a00.15 [95% CI, 0.07\u20130.23], respectively) but not with CLT or platelet markers.", {"entities": [[3, 9, "DISEASE"]]}], ["However, TNF\u03b1 predicted CLT in a multiple linear regression model.", {"entities": []}], ["Periostin was not associated with any hemostatic parameters.", {"entities": []}], ["Enhanced thrombin generation is driven in asthma by a systemic inflammatory state mediated by IL-6 and to a lesser extent TNF\u03b1, however, not periostin.", {"entities": [[42, 48, "DISEASE"]]}], ["TNF\u03b1 might contribute to impaired fibrinolysis.", {"entities": []}], ["Most of the natural cases of pneumonia in feedlot cattle are characterized by a longer clinical course due to chronic lung lesions.", {"entities": [[29, 38, "DISEASE"]]}], ["Microscopically, these lesions include interstitial fibroplasia, bronchitis, bronchiectasis, bronchiolitis obliterans, and epithelial metaplasia of the airways.", {"entities": [[77, 91, "DISEASE"], [93, 117, "DISEASE"], [93, 106, "DISEASE"], [65, 75, "DISEASE"]]}], ["Herein, the aim was to review, under a medical perspective, the pathologic mechanisms operating in these chronic pneumonic lesions in calves.", {"entities": []}], ["Based on the similarities of these changes to those reported in bronchiolitis obliterans/organising pneumonia (BO/OP) and chronic obstructive pulmonary disease (COPD) in human beings, calves are proposed as an alternative animal model.", {"entities": [[100, 109, "DISEASE"], [122, 159, "DISEASE"], [64, 88, "DISEASE"], [64, 77, "DISEASE"]]}], ["The Canadian health care system has striven to remove financial or other barriers to access to medically necessary health care services since the establishment of the Canada Health Act 20 years ago.", {"entities": []}], ["Evidence has been conflicting as to what extent the Canadian health care system has met this goal of equitable access.", {"entities": []}], ["The objective of this study was to examine whether and where socioeconomic inequities in health care utilization occur in Canada.", {"entities": []}], ["We used a nationally representative cross-sectional survey, the 2000/01 Canadian Community Health Survey, which provides a large sample size (about 110,000) and permits more comprehensive adjustment for need indicators than previous studies.", {"entities": []}], ["We separately examined general practitioner, specialist, and hospital services using two-part hurdle models: use versus non-use by logistic regression, and the intensity of use among users by zero-truncated negative binomial regression.", {"entities": []}], ["We found that lower income was associated with less contact with general practitioners, but among those who had contact, lower income and education were associated with greater intensity of use of general practitioners.", {"entities": []}], ["Both lower income and education were associated with less contact with specialists, but there was no statistically significant relationship between these socioeconomic variables and intensity of specialist use among the users.", {"entities": []}], ["Neither income nor education was statistically significantly associated with use or intensity of use of hospitals.", {"entities": []}], ["Our study unveiled possible socioeconomic inequities in the use of health care services in Canada.", {"entities": []}], ["Bitter taste receptors (TAS2Rs) have attracted a great deal of interest because of their recently described bronchodilator and anti-inflammatory properties.", {"entities": []}], ["The aim of this study was to identify natural direct TAS2R14 agonists from Radix Bupleuri that can inhibit mast cell degranulation.", {"entities": [[53, 60, "GENE"]]}], ["A ligand-based virtual screening was conducted on a library of chemicals contained in compositions of Radix Bupleuri , and these analyses were followed by cell-based functional validation through a HEK293-TAS2R14-G16gust44 cell line and IgE-induced mast cell degranulation assays, respectively.", {"entities": []}], ["Saikosaponin b (SSb) was confirmed for the first time to be a specific agonist of TAS2R14 and had an EC 50 value of 4.9\u2009\u03bcM.", {"entities": [[16, 19, "GENE"], [82, 89, "GENE"]]}], ["A molecular docking study showed that SSb could directly bind to a TAS2R14 model through H-bond interactions with Arg160, Ser170 and Glu259.", {"entities": [[38, 41, "GENE"], [67, 74, "GENE"]]}], ["Moreover, SSb showed the ability to inhibit IgE-induced mast cell degranulation, as measured with a \u03b2-hexosaminidase release model and real-time cell analysis (RTCA).", {"entities": [[10, 13, "GENE"]]}], ["In a cytotoxicity bioassay, SSb showed no significant cytotoxicity to HEK293 cells within 24\u2009hours.", {"entities": [[28, 31, "GENE"]]}], ["This study demonstrated that SSb is a direct TAS2R14 agonist that inhibit IgE-induced mast cell degranulation.", {"entities": [[29, 32, "GENE"], [45, 52, "GENE"]]}], ["Although the target and in vitro bioactivity of SSb were revealed in this study, it still need in vivo study to further verify the anti-asthma activity of SSb.", {"entities": [[136, 142, "DISEASE"], [48, 51, "GENE"], [155, 158, "GENE"], [48, 51, "GENE"], [155, 158, "GENE"]]}], ["Targeting of the protein degradation pathway, in particular, the ubiquitin-proteasome system, has emerged as an attractive novel cancer chemotherapeutic modality.", {"entities": [[129, 135, "DISEASE"]]}], ["Although proteasome inhibitors have been most successfully applied in the treatment of hematological malignancies, they also received continuing interest for the treatment of solid tumors.", {"entities": []}], ["In this review, we summarize the current positioning of proteasome inhibitors in the treatment of common solid malignancies (e.g., lung, colon, pancreas, breast, and head and neck cancer), addressing topics of their mechanism(s) of action, predictive factors and molecular mechanisms of resistance.", {"entities": [[180, 186, "DISEASE"]]}], ["A key event in chronic allergic asthma is the TGF-\u03b2-induced activation of fibroblasts into \u03b1-SMA-positive myofibroblasts which synthesize type-I collagen.", {"entities": [[23, 38, "DISEASE"], [32, 38, "DISEASE"]]}], ["In the present study we investigated the effect of the anti-fibrotic molecule BMP-7 in asthma.", {"entities": [[87, 93, "DISEASE"]]}], ["Balb/c mice were immunized i.p.", {"entities": []}], ["with ovalbumin in alum and challenged every 2 days with ovalbumin aerosol (two or six challenges for acute and chronic protocols, respectively).", {"entities": []}], ["The lung was evaluated for: \u03b1-SMA and type-I collagen by immunohistochemistry; BMP-7 and TGF- \u03b21 gene expression by qRT-PCR; type-I collagen and Smads 2 and 3 by immunoblotting; mucus by PSA staining.", {"entities": []}], ["Type-I collagen around bronchi, \u03b1-SMA, mucus secretion, TGF- \u03b21 and BMP-7 gene expression were all increased in asthma.", {"entities": [[112, 118, "DISEASE"]]}], ["The TGF- \u03b21/BMP-7 ratio was higher in the chronic group and correlated with higher levels of collagen.", {"entities": []}], ["Fibroblasts isolated from asthmatic and healthy lungs produced type-I collagen upon stimulation with TGF- \u03b21 via phosphorylation of Smad-2, Smad-3.", {"entities": []}], ["Pre-treatment of the fibroblasts with BMP-7 reduced collagen production and Smads phosphorylation.", {"entities": []}], ["Intranasal treatment of asthmatic mice with recombinant BMP-7 during the immunization protocol reduced lung inflammation and type I collagen deposition.", {"entities": []}], ["These results suggest a protective role for BMP-7 in lung allergic inflammation, opposing the pro-fibrotic effects of TGF- \u03b21.", {"entities": []}], ["The receptor for glycation end products (RAGE) has been previously implicated in shaping the adaptive immune response.", {"entities": []}], ["RAGE is expressed in T cells after activation and constitutively in T cells from patients with diabetes.", {"entities": []}], ["The effects of RAGE on adaptive immune responses are not clear: Previous reports show that RAGE blockade affects Th1 responses.", {"entities": []}], ["To clarify the role of RAGE in adaptive immune responses and the mechanisms of its effects, we examined whether RAGE plays a role in T cell activation in a Th2 response involving ovalbumin (OVA)-induced asthma in mice.", {"entities": [[203, 209, "DISEASE"]]}], ["WT and RAGE deficient wild-type and OT-II mice, expressing a T cell receptor specific for OVA, were immunized intranasally with OVA.", {"entities": []}], ["Lung cellular infiltration and T cell responses were analyzed by immunostaining, FACS, and multiplex bead analyses for cytokines.", {"entities": []}], ["RAGE deficient mice showed reduced cellular infiltration in the bronchial alveolar lavage fluid and impaired T cell activation in the mediastinal lymph nodes when compared with WT mice.", {"entities": []}], ["In addition, RAGE deficiency resulted in reduced OT-II T cell infiltration of the lung and impaired IFN\u03b3 and IL-5 production when compared with WT mice and reduced infiltration when transferred into WT hosts.", {"entities": []}], ["When cultured under conditions favoring the differentiation of T cells subsets, RAGE deficient T cells showed reduced production of IFN\u03b3 but increased production of IL-17.", {"entities": []}], ["Our data show a stimulatory role for RAGE in T activation in OVA-induced asthma.", {"entities": [[73, 79, "DISEASE"]]}], ["This role is largely mediated by the effects of RAGE on T cell proliferation and differentiation.", {"entities": []}], ["These findings suggest that RAGE may play a regulatory role in T cell responses following immune activation.", {"entities": []}], ["Manual chest physiotherapy (MCP) techniques involving chest percussion, vibration, and shaking have long been used in the treatment of respiratory conditions.", {"entities": []}], ["However, methodological limitations in existing research have led to a state of clinical equipoise with respect to this treatment.", {"entities": []}], ["Thus, for patients hospitalised with an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), clinical preference tends to dictate whether MCP is given to assist with sputum clearance.", {"entities": []}], ["We standardised the delivery of MCP and assessed its effectiveness on disease-specific quality of life.", {"entities": []}], ["In this randomised, controlled trial powered for equivalence, 526 patients hospitalised with acute COPD exacerbation were enrolled from four centres in the UK.", {"entities": []}], ["Patients were allocated to receive MCP plus advice on airway clearance or advice on chest clearance alone.", {"entities": []}], ["The primary outcome was a COPD specific quality of life measure, the Saint Georges Respiratory Questionnaire (SGRQ) at six months post randomisation.", {"entities": []}], ["Analyses were by intention to treat (ITT).", {"entities": []}], ["This study was registered, ISRCTN13825248.", {"entities": []}], ["All patients were included in the analyses, of which 372 (71%) provided evaluable data for the primary outcome.", {"entities": []}], ["An effect size of 0\u00b73 standard deviations in SGRQ score was specified as the threshold for superiority.", {"entities": []}], ["The ITT analyses showed no significant difference in SGRQ for patients who did, or did not receive MCP (95% CI \u22120\u00b714 to 0\u00b719).", {"entities": []}], ["These data do not lend support to the routine use of MCP in the management of acute exacerbation of COPD.", {"entities": []}], ["However, this does not mean that MCP is of no therapeutic value to COPD patients in specific circumstances.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterized by irreversible, progressive obstruction of lung airflow.", {"entities": []}], ["Dyspnea (shortness of breath [SOB]) is the COPD symptom which most negatively impacts patients\u2019 daily activities.", {"entities": []}], ["To assess how SOB affects daily activities, 37 items were drafted through focus group discussions and cognitive interviews with COPD patients to develop a patient-reported outcome instrument: the Shortness of Breath with Daily Activities questionnaire (SOBDA).", {"entities": []}], ["Psychometric analysis was conducted to reduce the number of items and evaluate the measurement properties of the final SOBDA.", {"entities": []}], ["Prospective, observational study of 334 COPD patients, recruited from 24 pulmonology and internal medicine clinics in the United States.", {"entities": []}], ["The 37-item SOBDA was administered to patients each evening for 28\u00a0days using an electronic diary.", {"entities": []}], ["Patients answered every item and rated their level of SOB experienced that day during specific activities.", {"entities": []}], ["Item selection was conducted by examining item characteristics, dimensionality, and Rasch model analysis results.", {"entities": []}], ["The decision to delete an item was based on psychometric evidence, content validity, and expert clinical input.", {"entities": []}], ["The final SOBDA instrument was evaluated for internal consistency, reproducibility, convergent validity, known-groups validity, and responsiveness.", {"entities": []}], ["Twenty-four items from the 37-item pool were removed following the item selection process: nine items were removed due to high item-to-item correlations; five due to floor effects; three due to infrequent activity; one due to gender bias; two due to low factor loadings; three due to unordered response options; and one due to expert\u2019s discretion.", {"entities": []}], ["Internal consistency and reproducibility of the final SOBDA were demonstrated by Cronbach Alpha\u2009=\u20090.87, and intra-class correlation coefficient\u2009=\u20090.91.", {"entities": []}], ["Convergent validity was demonstrated by high correlation with the CRQ-SAS (0.60) and SGRQ-C (0.61).", {"entities": []}], ["Known groups validity was demonstrated by significant difference between ratings of the mMRC and clinical global rating of severity.", {"entities": []}], ["Evaluation of the ability to detect change was not performed owing to too few responders at the end of the study.", {"entities": []}], ["Through the empirical item reduction process, 13 items were selected from the 37-item pool generated during qualitative development.", {"entities": []}], ["The final 13-item SOBDA is a reliable and valid instrument for use in clinical trials.", {"entities": []}], ["Statins are currently the preferred pharmacological therapy in individuals with familial hypercholesterolemia (FH) with the aim to prevent premature atherosclerosis.", {"entities": [[149, 164, "DISEASE"], [80, 109, "DISEASE"], [111, 113, "GENE"]]}], ["In adults, these agents have been proven to be safe and well tolerated; however, non-adherence is a significant clinical issue.", {"entities": []}], ["In this study, we evaluated tolerability and adherence to statin therapy in young adult FH patients 10\u00a0years after this was initiated in their childhood.", {"entities": [[88, 90, "GENE"]]}], ["A questionnaire including items on medical history, adherence and reasons for discontinuation was sent to 214 young adult FH patients that initiated statin therapy at least 10\u00a0years ago.", {"entities": [[122, 124, "GENE"]]}], ["Tolerability was defined as 100\u00a0% minus the percentage of patients that discontinued statin therapy due to side effects.", {"entities": []}], ["Adherence was defined as the extent to which patients took their medication as prescribed by their physician.", {"entities": []}], ["We labelled patients adherent if they took 80\u00a0% or more of their pills in the month preceding our assessment.", {"entities": []}], ["Follow-up was successful in 205 (95.8\u00a0%) subjects (age 18\u201330\u00a0years).", {"entities": []}], ["A history of side effects was reported by 40 (19.5\u00a0%) of the patients, and mainly consisted of muscle complaints and gastrointestinal symptoms.", {"entities": []}], ["Three patients (1.5\u00a0%) discontinued statin therapy because of side effects.", {"entities": []}], ["Rhadbomyolysis or other serious adverse events were not reported.", {"entities": []}], ["In fact, 169 (82.4\u00a0%) of 205 patients remained on statin treatment and 78.7\u00a0% (148 out of 188) were adherent.", {"entities": []}], ["None of the patient characteristics were significantly associated with adherence.", {"entities": []}], ["Individuals with FH who started statin therapy in childhood demonstrated good adherence during ten years of treatment.", {"entities": [[17, 19, "GENE"]]}], ["Furthermore, statin therapy was well tolerated; only a small minority discontinued therapy because of side effects and the side effects that were reported were mild in nature.", {"entities": []}], ["A cross-sectional study was conducted to investigate the weight status and the relationship of infant-feeding variables, birthweight and birth order with BMI in a group of Iranian children.", {"entities": []}], ["Five hundred and eleven students of both sexes at the first grade in elementary schools (aged 7 years) were recruited randomly from all 19 educational districts of Tehran.", {"entities": []}], ["Weights and heights of children and their mothers were measured.", {"entities": []}], ["Data on breastfeeding (BF), formula-feeding, the timing of introduction of complementary foods (CF), birthweight, and birth order were collected from the mothers.", {"entities": []}], ["The 2007 WHO reference value was used for determining child's weight status.", {"entities": []}], ["Regression analysis in single and a 2-level linear regression models was used for examining the independent relationships of infant-feeding variables, birthweight and birth order with childhood BMI.", {"entities": []}], ["The prevalence of underweight and overweight in this group of children was 7.6% and 19.7%, respectively.", {"entities": []}], ["Total time of BF and duration of exclusive BF were not associated with childhood BMI.", {"entities": []}], ["The timing of introduction of CF was inversely related to childhood BMI after controlling for other variables (\u03b2:-0.34; 95% CI:-0.58,-0.10).", {"entities": []}], ["Children with an early introduction of CF had significantly higher mean BMI (p for linear trend=0.012).", {"entities": []}], ["Birth order and birthweight were related to childhood BMI significantly.", {"entities": []}], ["These data suggest that overweight and obesity are nutritional problems among 7 years old Teharani children.", {"entities": [[39, 46, "DISEASE"]]}], ["The timing of introduction of CF, birth order, and birthweight were independent predictors of childhood BMI.", {"entities": []}], ["Neither total time of BF nor duration of exclusive breastfeeding was associated with adiposity in children.", {"entities": []}], ["In 2008, the Ministry of Health, Welfare and Sport commissioned the National Care for the Elderly Programme.", {"entities": []}], ["While numerous research projects in older persons\u2019 health care were to be conducted under this national agenda, the Programme further advocated the development of The Older Persons and Informal Caregivers Survey Minimum DataSet (TOPICS-MDS) which would be integrated into all funded research protocols.", {"entities": []}], ["In this context, we describe TOPICS data sharing initiative ( www.topics-mds.eu ).", {"entities": []}], ["A working group drafted TOPICS-MDS prototype, which was subsequently approved by a multidisciplinary panel.", {"entities": []}], ["Using instruments validated for older populations, information was collected on demographics, morbidity, quality of life, functional limitations, mental health, social functioning and health service utilisation.", {"entities": []}], ["For informal caregivers, information was collected on demographics, hours of informal care and quality of life (including subjective care-related burden).", {"entities": []}], ["Between 2010 and 2013, a total of 41 research projects contributed data to TOPICS-MDS, resulting in preliminary data available for 32,310 older persons and 3,940 informal caregivers.", {"entities": []}], ["The majority of studies sampled were from primary care settings and inclusion criteria differed across studies.", {"entities": []}], ["TOPICS-MDS is a public data repository which contains essential data to better understand health challenges experienced by older persons and informal caregivers.", {"entities": []}], ["Such findings are relevant for countries where increasing health-related expenditure has necessitated the evaluation of contemporary health care delivery.", {"entities": []}], ["Although open sharing of data can be difficult to achieve in practice, proactively addressing issues of data protection, conflicting data analysis requests and funding limitations during TOPICS-MDS developmental phase has fostered a data sharing culture.", {"entities": []}], ["To date, TOPICS-MDS has been successfully incorporated into 41 research projects, thus supporting the feasibility of constructing a large (>30,000 observations), standardised dataset pooled from various study protocols with different sampling frameworks.", {"entities": []}], ["This unique implementation strategy improves efficiency and facilitates individual-level data meta-analysis.", {"entities": []}], ["This study assesses trends in horizontal equity in the utilization of healthcare services from 1998 to 2008--a period of major economic and social change in Brazil.", {"entities": []}], ["Data are from nationally representative surveys repeated in 1998, 2003, and 2008.", {"entities": []}], ["We apply established methods for assessing horizontal inequity in healthcare access (the principle that people with the same healthcare needs should have similar access to healthcare services).", {"entities": []}], ["Horizontal inequity is calculated as the difference between observed healthcare utilization and utilization predicted by healthcare needs.", {"entities": []}], ["Outcomes examined include the probability of a medical, dental, or hospital visit during the past 12\u2009months; any health service use in the past two weeks; and having a usual source of healthcare.", {"entities": []}], ["We use monthly family income to measure differences in socioeconomic position.", {"entities": []}], ["Healthcare needs include age, sex, self-rated health, and chronic conditions.", {"entities": []}], ["Non-need factors include income, education, geography, health insurance, and Family Health Strategy coverage.", {"entities": []}], ["The probability of having at least one doctor visit in the past 12\u2009months became substantially more equitable over time, ending with a slightly pro-rich orientation in 2008.", {"entities": []}], ["Any hospitalization in the past 12\u2009months was found to be pro-poor in all periods but became slightly less so in 2008.", {"entities": []}], ["Dental visits showed the largest absolute decrease in horizontal inequity, although they were still the most inequitably (pro-rich) distributed outcome in 2008.", {"entities": []}], ["Service use in the past two weeks showed decreased inequity in 2003 but exhibited no significant change between 2003 and 2008.", {"entities": []}], ["Having a usual source of care became less pro-rich over time and was nearly income-neutral by 2008.", {"entities": []}], ["Factors associated with greater inequities include income, having a private health plan, and geographic location.", {"entities": []}], ["Factors associated with greater equity included health needs, schooling, and enrolment in the Family Health Strategy.", {"entities": []}], ["Healthcare utilization in Brazil appears to have become increasingly equitable over the past 10\u2009years.", {"entities": []}], ["Although this does not imply that equity in health outcomes has improved correspondingly, it does suggest that government policies aimed at increasing access, especially to primary care, have helped to make healthcare utilization in Brazil fairer over time.", {"entities": []}], ["Our aim was to estimate the longitudinal effect of Socioeconomic status (SES) on lung function growth of Mexican children and adolescents.", {"entities": []}], ["A cohort of Mexican children in third grade of primary school was followed with spirometry twice a year for 6 years through secondary school.", {"entities": []}], ["Multilevel mixed-effects lineal models were fitted for the spirometric variables of 2,641 respiratory-healthy Mexican children.", {"entities": []}], ["Monthly family income (in 2002 U.S. dollars [USD]) and parents\u2019 years completed at school were used as proxies of SES.", {"entities": []}], ["Individuals with higher SES tended to have greater height for age, and smaller sitting height/standing height and crude lung function.", {"entities": []}], ["For each 1-year increase of parents\u2019 schooling, Forced expiratory volume in 1 sec (FEV 1 ) and Forced vital capacity (FVC) increased 8.5 (0.4%) and 10.6 mL (0.4%), respectively ( p <0.05) when models were adjusted for gender.", {"entities": [[83, 86, "GENE"]]}], ["Impact of education on lung function was reduced drastically or abolished on adjusting by anthropometric variables and ozone.", {"entities": []}], ["Higher parental schooling and higher monthly family income were associated with higher lung function in healthy Mexican children, with the majority of the effect likely due to the increase in height-for-age.", {"entities": []}], ["The objective was to estimate temporal associations between mental disorders and physical diseases in adolescents with mental-physical comorbidities.", {"entities": []}], ["This article bases upon weighted data (N = 6483) from the National Comorbidity Survey Adolescent Supplement (participant age: 13\u201318 years), a nationally representative United States cohort.", {"entities": []}], ["Onset of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition lifetime mental disorders was assessed with the fully structured World Health Organization Composite International Diagnostic Interview, complemented by parent report.", {"entities": []}], ["Onset of lifetime medical conditions and doctor-diagnosed diseases was assessed by self-report.", {"entities": []}], ["The most substantial temporal associations with onset of mental disorders preceding onset of physical diseases included those between affective disorders and arthritis (hazard ratio (HR) = 3.36, 95%-confidence interval (CI) = 1.95 to 5.77) and diseases of the digestive system (HR = 3.39, CI = 2.30 to 5.00), between anxiety disorders and skin diseases (HR = 1.53, CI = 1.21 to 1.94), and between substance use disorders and seasonal allergies (HR = 0.33, CI = 0.17 to 0.63).", {"entities": [[158, 167, "DISEASE"], [183, 185, "GENE"], [278, 280, "GENE"], [354, 356, "GENE"], [445, 447, "GENE"], [183, 185, "GENE"], [278, 280, "GENE"], [354, 356, "GENE"], [445, 447, "GENE"], [183, 185, "GENE"], [278, 280, "GENE"], [354, 356, "GENE"], [445, 447, "GENE"], [183, 185, "GENE"], [278, 280, "GENE"], [354, 356, "GENE"], [445, 447, "GENE"]]}], ["The most substantial temporal associations with physical diseases preceding mental disorders included those between heart diseases and anxiety disorders (HR = 1.89, CI = 1.41 to 2.52), epilepsy and eating disorders (HR = 6.27, CI = 1.58 to 24.96), and heart diseases and any mental disorder (HR = 1.39, CI = 1.11 to 1.74).", {"entities": [[154, 156, "GENE"], [216, 218, "GENE"], [292, 294, "GENE"], [154, 156, "GENE"], [216, 218, "GENE"], [292, 294, "GENE"], [154, 156, "GENE"], [216, 218, "GENE"], [292, 294, "GENE"]]}], ["Findings suggest that mental disorders are antecedent risk factors of certain physical diseases in early life, but also vice versa.", {"entities": []}], ["Our results expand the relevance of mental disorders beyond mental to physical health care, and vice versa, supporting the concept of a more integrated mental-physical health care approach, and open new starting points for early disease prevention and better treatments, with relevance for various medical disciplines.", {"entities": []}], ["The promotion of physical activity (PA) in young children requires effective interventions.", {"entities": []}], ["This article reviews the evidence on PA interventions in childcare by applying a socio-ecological approach.", {"entities": []}], ["A computer-based literature search for intervention studies aimed at increasing children\u2019s PA levels was run across four databases: SPORTDiscus, ISI Web of Science, PsycINFO and ERIC.", {"entities": []}], ["The participants had to be in childcare, aged 2-6-year-old, and their pre- and post- intervention PA levels measured.", {"entities": []}], ["Selection was restricted to peer-reviewed publications and to studies conducted in childcare settings.", {"entities": []}], ["Twenty-three studies met the inclusion criteria and their methodological quality was assessed.", {"entities": []}], ["Seven studies exhibited high methodological quality; twelve were rated as moderate and four low.", {"entities": []}], ["The effectiveness of the interventions was determined according to the post-intervention behavioral changes reported in children\u2019s PA. Fourteen studies found increases in PA levels or reductions in sedentary time, although the changes were modest.", {"entities": []}], ["The data remain too limited to allow firm conclusions to be drawn on the effectiveness of the components mediating PA interventions, although PA-specific in-service teacher training seems a potential strategy.", {"entities": []}], ["The findings of this review indicate that children\u2019s PA remained low and did not approach the 180\u00a0min/day criteria.", {"entities": []}], ["It may be that more intensive multilevel and multicomponent interventions based on a comprehensive model are needed.", {"entities": []}], ["Pyocyanin is a virulence factor uniquely produced by the pathogen Pseudomonas aeruginosa .", {"entities": []}], ["The fast and selective detection of pyocyanin in clinical samples can reveal important information about the presence of this microorganism in patients.", {"entities": []}], ["Electrochemical sensing of the redox-active pyocyanin is a route to directly quantify pyocyanin in real time and in situ in hospitals and clinics.", {"entities": []}], ["The selective quantification of pyocyanin is, however, limited by other redox-active compounds existing in human fluids and by other metabolites produced by pathogenic bacteria.", {"entities": []}], ["Here we present a direct selective method to detect pyocyanin in a complex electroactive environment using commercially available electrodes.", {"entities": []}], ["It is shown that cyclic voltammetry measurements between \u22121.0 V to 1.0 V reveal a potential detection window of pyocyanin of 0.58\u20130.82 V that is unaffected by other redox-active interferents.", {"entities": []}], ["The linear quantification of pyocyanin has an R n = 5) from the known added pyocyanin concentration to the samples.", {"entities": []}], ["This inexpensive procedure is suggested for clinical use in monitoring the presence and state of P. aeruginosa infection in patients.", {"entities": []}], ["Background: The test-negative design (TND) to evaluate influenza vaccine effectiveness is based on patients seeking care for acute respiratory infection, with those who test positive for influenza as cases and the test-negatives serving as controls.", {"entities": [[55, 64, "DISEASE"], [187, 196, "DISEASE"]]}], ["This design has not been validated for the inpatient setting where selection bias might be different from an outpatient setting.", {"entities": []}], ["Methods: We derived mathematical expressions for vaccine effectiveness (VE) against laboratory-confirmed influenza hospitalizations and used numerical simulations to verify theoretical results exploring expected biases under various scenarios.", {"entities": [[105, 114, "DISEASE"]]}], ["We explored meaningful interpretations of VE estimates from inpatient TND studies.", {"entities": []}], ["Results: VE estimates from inpatient TND studies capture the vaccine-mediated protection of the source population against laboratory-confirmed influenza hospitalizations.", {"entities": [[143, 152, "DISEASE"]]}], ["If vaccination does not modify disease severity, these estimates are equivalent to VE against influenza virus infection.", {"entities": [[94, 103, "DISEASE"]]}], ["If chronic cardiopulmonary individuals are enrolled because of non-infectious exacerbation, biased VE estimates (too high) will result.", {"entities": []}], ["If chronic cardiopulmonary disease status is adjusted for accurately, the VE estimates will be unbiased.", {"entities": []}], ["If chronic cardiopulmonary illness cannot be adequately be characterized, excluding these individuals may provide unbiased VE estimates.", {"entities": []}], ["Conclusions: The inpatient TND offers logistic advantages and can provide valid estimates of influenza VE.", {"entities": [[93, 102, "DISEASE"]]}], ["If highly vaccinated patients with respiratory exacerbation of chronic cardiopulmonary conditions are eligible for study inclusion, biased VE estimates will result unless this group is well characterized and the analysis can adequately adjust for it.", {"entities": []}], ["Otherwise, such groups of subjects should be excluded from the analysis.", {"entities": []}], ["Interferon regulatory factors (IRF) have critical functions in lymphoid development and in immune response regulation.", {"entities": []}], ["Although many studies have described the function of IRF4 in CD4 Il9 transcription.", {"entities": [[53, 57, "GENE"], [61, 64, "GENE"], [65, 68, "GENE"]]}], ["By contrast, IRF8 deficiency promotes the expression of other genes such as Il4 , as IRF8 dimerises with the transcriptional repressor ETV6 and inhibits Il4 expression.", {"entities": [[13, 17, "GENE"], [85, 89, "GENE"], [76, 79, "GENE"], [153, 156, "GENE"], [13, 17, "GENE"], [85, 89, "GENE"], [135, 139, "GENE"], [76, 79, "GENE"], [153, 156, "GENE"]]}], ["In vivo, IRF8 is essential for the anti-tumour effects of Th9 cells in mouse melanoma models.", {"entities": [[77, 85, "DISEASE"], [9, 13, "GENE"]]}], ["Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.", {"entities": [[210, 216, "DISEASE"], [22, 26, "GENE"], [144, 148, "GENE"], [71, 74, "GENE"], [22, 26, "GENE"], [144, 148, "GENE"]]}], ["Interferon regulatory factors IRF regulate lymphoid development, but the specific function of IRF8 in helper T-cell polarization is unclear.", {"entities": [[94, 98, "GENE"]]}], ["Here the authors show that IRF8 forms a complex with IRF4, PU.1 and BATF to modulate the Th9 transcription program and expression of IL-4 and IL-9.", {"entities": [[27, 31, "GENE"], [53, 57, "GENE"], [68, 72, "GENE"]]}], ["Various parts of Piper nigrum, Piper betle and Gnetum gnemon are used as food sources by Malaysians.", {"entities": []}], ["The purpose of this study is to examine the anti-quorum sensing (anti-QS) properties of P. nigrum , P. betle and G. gnemon extracts.", {"entities": []}], ["The hexane, chloroform and methanol extracts of these plants were assessed in bioassays involving Pseudomonas aeruginosa PA01, Escherichia coli [pSB401], E. coli [pSB1075] and Chromobacterium violaceum CV026.", {"entities": []}], ["It was found that the extracts of these three plants have anti-QS ability.", {"entities": []}], ["Interestingly, the hexane, chloroform and methanol extracts from P. betle showed the most potent anti-QS activity as judged by the bioassays.", {"entities": []}], ["Since there is a variety of plants that serve as food sources in Malaysia that have yet to be tested for anti-QS activity, future work should focus on identification of these plants and isolation of the anti-QS compounds.", {"entities": []}], ["Although a number of studies have documented the relationship between lung function and traffic-related pollution among children, few have focused on adult lung function or examined community-based populations.", {"entities": []}], ["We examined the relationship between black carbon (BC), a surrogate of traffic-related particles, and lung function among women in the Maternal\u2013Infant Smoking Study of East Boston, an urban cohort in Boston, Massachusetts.", {"entities": []}], ["We estimated local BC levels using a validated spatiotemporal land-use regression model, derived using ambient and indoor monitor data.", {"entities": []}], ["We examined associations between percent predicted pulmonary function and predicted BC using linear regression, adjusting for sociodemographics (individual and neighborhood levels), smoking status, occupational exposure, type of cooking fuel, and a diagnosis of asthma or chronic bronchitis.", {"entities": [[262, 268, "DISEASE"], [280, 290, "DISEASE"]]}], ["The sample of 272 women 18\u201342 years of age included 57% who self-identified as Hispanic versus 43% white, and 18% who were current smokers.", {"entities": []}], ["Mean \u00b1 SD predicted annual BC exposure level was 0.62 \u00b1 0.2 \u03bcg/m In this cohort, exposure to traffic-related BC, a component of particulate matter, independently predicted decreased lung function in urban women, when adjusting for tobacco smoke, asthma diagnosis, and socioeconomic status.", {"entities": [[246, 252, "DISEASE"]]}], ["Unintentional injuries are a major cause of death among children.", {"entities": []}], ["Data suggest that the retention of knowledge and skills about first aid declined over time.", {"entities": []}], ["The purpose of this study was to assess the effects of pediatric first aid training among teachers.", {"entities": []}], ["A stratified random sampling method was used to select 1,067 teachers.", {"entities": []}], ["The selected trainees received pediatric first aid training.", {"entities": []}], ["Follow-up assessments were conducted 6\u00a0months, 9\u00a0months and 4\u00a0years following the training.", {"entities": []}], ["A standardized collection of demographics was performed, and participants were given a questionnaire to indicate knowledge of and emotions about first aid.", {"entities": []}], ["In the pretest, 1067 people responded with a mean of 21.0 correct answers to 37 questions, whereas in the post-test period, the mean score increased to 32.2 correct answers of 37 questions ( P <0.001).", {"entities": []}], ["There was a decrease in scores from post-test to 6\u00a0months, 9\u00a0months and 4\u00a0years after the training.", {"entities": []}], ["However, the mean at the 6-month, 9-month and 4-year marks were higher than the pretest mean ( P \u2009<\u20090.001).", {"entities": []}], ["A total of 82.8% of the participants achieved a pass mark of 80% or above; 42.8% of participants achieved the pass mark at 6\u00a0months, 41.7% at 9\u00a0months and 11.7% at 4\u00a0years (compared with pre-test, P \u2009<\u20090.001).", {"entities": []}], ["The mean score of the subjects\u2019 emotions in the post-test period increased to 81 ( P \u2009<\u20090.001).", {"entities": []}], ["The mean scores of emotions at 9\u00a0months or 4\u00a0years were higher than the pretest mean ( P \u2009<\u20090.001).", {"entities": []}], ["At the 4-year mark, the majority of preschool staff (>70%) had administered correct first aid for injuries.", {"entities": []}], ["This study demonstrated that the acquisition of knowledge, both short and long term, significantly improves.", {"entities": []}], ["Despite appreciable decreases in knowledge long term, knowledge retention was modest but stable.", {"entities": []}], ["Eosinphilic gastroenteritis (EG) is a gastrointestinal disorder characterized by eosinophilic infiltration with various manifestations.", {"entities": [[12, 27, "DISEASE"]]}], ["The diagnosis is usually confirmed by an endoscopic biopsy, which is considered a safe and routine procedure for the majority.", {"entities": []}], ["We report a 54-year-old male who was presented with intermittent periumbilical pain and melena, and only revealed verrucous gastritis by endoscopy.", {"entities": [[124, 133, "DISEASE"]]}], ["The patient's condition worsened two days after the endoscopic biopsy, and another endoscopy found hematoma and ulcers in upper gastrointestinal tract.", {"entities": []}], ["He was diagnosed with EG by the pathological analysis of biopsy specimen.", {"entities": []}], ["Oral methylprednisolone and Montelukast were prescribed.", {"entities": []}], ["The patient got remission after initiation of the treatment.", {"entities": []}], ["This case highlights an extremely rare but potentially severe complication of endoscopic biopsies in patients with EG.", {"entities": []}], ["Physicians should be cautious with hematoma or ulceration, and consider it in such patients who undergo this procedure.", {"entities": []}], ["Thymic stromal lymphopoietin (TSLP) is a mucosal tissue-associated cytokine that has been widely studied in the context of T helper type 2 (Th2)-driven inflammatory disorders.", {"entities": [[30, 34, "GENE"]]}], ["Although TSLP is also produced upon viral infection in vitro , the role of TSLP in antiviral immunity is unknown.", {"entities": [[9, 13, "GENE"], [75, 79, "GENE"], [9, 13, "GENE"], [75, 79, "GENE"]]}], ["In this study we report a novel role for TSLP in promoting viral clearance and virus-specific CD8+ T-cell responses during influenza A infection.", {"entities": [[123, 132, "DISEASE"], [41, 45, "GENE"]]}], ["Comparing the immune responses of wild-type and TSLP receptor (TSLPR)-deficient mice, we show that TSLP was required for the expansion and activation of virus-specific effector CD8+ T cells in the lung, but not the lymph node.", {"entities": [[48, 52, "GENE"], [99, 103, "GENE"], [48, 52, "GENE"], [99, 103, "GENE"]]}], ["The mechanism involved TSLPR signaling on newly recruited CD11b+ inflammatory dendritic cells (DCs) that acted to enhance interleukin-15 production and expression of the costimulatory molecule CD70.", {"entities": [[193, 197, "GENE"]]}], ["Taken together, these data highlight the pleiotropic activities of TSLP and provide evidence for its beneficial role in antiviral immunity.", {"entities": [[67, 71, "GENE"]]}], ["Recent studies suggest that acute sleep deprivation disrupts cellular immune responses by shifting T helper (Th) cell activity towards a Th2 cytokine profile.", {"entities": []}], ["Since little is known about more long-term effects, we investigated how five days of sleep restriction would affect pro-inflammatory, chemotactic, Th1- and Th2 cytokine secretion.", {"entities": []}], ["Nine healthy males participated in an experimental sleep protocol with two baseline sleep-wake cycles (sleep 23.00 \u2013 07.00 h) followed by 5 days with restricted sleep (03.00 \u2013 07.00 h).", {"entities": []}], ["On the second baseline day and on the fifth day with restricted sleep, samples were drawn every third hour for determination of cytokines/chemokines (tumor necrosis factor alpha (TNF-\u03b1), interleukin (IL) -1\u03b2, IL-2, IL-4 and monocyte chemoattractant protein-1 (MCP-1)) after in vitro stimulation of whole blood samples with the mitogen phytohemagglutinin (PHA).", {"entities": []}], ["Also leukocyte numbers, mononuclear cells and cortisol were analysed.", {"entities": []}], ["5-days of sleep restriction affected PHA-induced immune responses in several ways.", {"entities": []}], ["There was a general decrease of IL-2 production (p<.05).", {"entities": []}], ["A shift in Th1/Th2 cytokine balance was also evident, as determined by a decrease in IL2/IL4 ratio.", {"entities": []}], ["No other main effects of restricted sleep were shown.", {"entities": []}], ["Two significant interactions showed that restricted sleep resulted in increased TNF-\u03b1 and MCP-1 in the late evening and early night hours (p\u2019s<.05).", {"entities": []}], ["In addition, all variables varied across the 24 h day.", {"entities": []}], ["5-days of sleep restriction is characterized by a shift towards Th2 activity (i.e.", {"entities": []}], ["lower 1L-2/IL-4 ratio) which is similar to the effects of acute sleep deprivation and psychological stress.", {"entities": []}], ["This may have implications for people suffering from conditions characterized by excessive Th2 activity like in allergic disease, such as asthma, for whom restricted sleep could have negative consequences.", {"entities": [[138, 144, "DISEASE"]]}], ["Cerebral malaria (CM) is the most severe outcome of Plasmodium falciparum infection and a major cause of death in children from 2 to 4 years of age.", {"entities": [[9, 16, "DISEASE"]]}], ["A hospital based study in Ghana showed that P. falciparum induces eosinophilia and found a significantly higher serum level of eosinophil cationic protein (ECP) in CM patients than in uncomplicated malaria (UM) and severe malaria anemia (SA) patients.", {"entities": [[198, 205, "DISEASE"], [222, 229, "DISEASE"], [66, 78, "DISEASE"], [230, 236, "DISEASE"]]}], ["Single nucleotide polymorphisms (SNPs) have been described in the ECP encoding-gene (RNASE3) of which the c.371G>C polymorphism (rs2073342) results in an arginine to threonine amino acid substitution p.R124T in the polypeptide and abolishes the cytotoxicity of ECP.", {"entities": [[85, 91, "GENE"]]}], ["The present study aimed to investigate the potential association between polymorphisms in RNASE3 and CM.", {"entities": [[90, 96, "GENE"]]}], ["The RNASE3 gene and flanking regions were sequenced in 206 Ghanaian children enrolled in a hospital based malaria study.", {"entities": [[106, 113, "DISEASE"], [4, 10, "GENE"]]}], ["An association study was carried out to assess the significance of five SNPs in CM (n\u200a=\u200a45) and SA (n\u200a=\u200a56) cases, respectively.", {"entities": []}], ["The two severe case groups (CM and SA) were compared with the non-severe control group comprising children suffering from UM (n\u200a=\u200a105).", {"entities": []}], ["The 371G allele was significantly associated with CM (p\u200a=\u200a0.00945, OR\u200a=\u200a2.29, 95% CI\u200a=\u200a1.22\u20134.32) but not with SA.", {"entities": []}], ["Linkage disequilibrium analysis demonstrated significant linkage between three SNPs and the haplotype combination 371G/*16G/*94A was strongly associated with susceptibility to CM (p \u200a=\u200a0.000913, OR\u200a=\u200a4.14, 95% CI\u200a=\u200a1.79\u20139.56), thus, defining a risk haplotype.", {"entities": []}], ["The RNASE3 371GG genotype was found to be under frequency-dependent selection.", {"entities": [[4, 10, "GENE"]]}], ["The 371G allele of RNASE3 is associated with susceptibility to CM and forms part of a risk associated haplotype GGA defined by the markers: rs2073342 (G-allele), rs2233860 (G-allele) and rs8019343 (A-allele) respectively.", {"entities": [[19, 25, "GENE"]]}], ["Collectively, these results suggest a hitherto unrecognized role for eosinophils in CM pathogenesis.", {"entities": []}], ["Although a large body of literature is available that describes the effects of smoking, asthma and COPD on lung function, most studies are restricted to a small age range and to one factor.", {"entities": [[88, 94, "DISEASE"]]}], ["As a consequence, available results are incomplete and often difficult to compare, also due to the ways the effects are expressed.", {"entities": []}], ["Furthermore, current approaches consider one type of measurement only or several types separately.", {"entities": []}], ["We propose a probabilistic model that expresses the effects as number of years added to chronological age or, in other words, that estimates the biological age of the lungs.", {"entities": []}], ["Using biological age as a measure of the effects has the advantage of facilitating the understanding of their severity and comparison of results.", {"entities": []}], ["In our model, chronological age and other factors affecting the health status of the lungs generate biological age, which in turn generates lung function measurements.", {"entities": []}], ["This structure enables the use of multiple types of measurement to obtain a more precise estimate of the effects and parameter sharing for characterization over large age ranges and of co-occurrence of factors with little data.", {"entities": []}], ["We treat the parameters that model smoking habits and lung diseases as random variables to obtain uncertainty in the estimated effects.", {"entities": []}], ["We use the model to investigate the effects of smoking, asthma and COPD on the TwinsUK Registry.", {"entities": [[56, 62, "DISEASE"]]}], ["Our results suggest that the combination of smoking with lung disease(s) has higher effect than smoking or lung disease(s) alone, and that in smokers, co-occurrence of asthma and COPD is more detrimental than asthma or COPD alone.", {"entities": [[168, 174, "DISEASE"], [209, 215, "DISEASE"], [57, 69, "DISEASE"], [107, 119, "DISEASE"]]}], ["The proposed model or other models based on a similar approach could be of help in improving the understanding of factors affecting lung function by enabling characterizations over large age ranges and of co-occurrence of factors with little data and the use of multiple types of measurement.", {"entities": []}], ["The software implementing the model can be downloaded at the first author\u2019s webpage.", {"entities": []}], ["Recently, a cutaneous force-frequency relation recording system based on first heart sound amplitude vibrations has been validated.", {"entities": []}], ["A further application is the assessment of Second Heart Sound (S2) amplitude variations at increasing heart rates.", {"entities": []}], ["The aim of this study was to assess the relationship between second heart sound amplitude variations at increasing heart rates and hemodynamic changes.", {"entities": []}], ["The transcutaneous force sensor was positioned in the precordial region in 146 consecutive patients referred for exercise (n = 99), dipyridamole (n = 41), or pacing stress (n = 6).", {"entities": []}], ["The curve of S2 peak amplitude variation as a function of heart rate was computed as the increment with respect to the resting value.", {"entities": []}], ["A consistent S2 signal was obtained in all patients.", {"entities": []}], ["Baseline S2 was 7.2 \u00b1 3.3 m g , increasing to 12.7 \u00b1 7.7 m g at peak stress.", {"entities": []}], ["S2 percentage increase was + 133 \u00b1 104% in the 99 exercise, + 2 \u00b1 22% in the 41 dipyridamole, and + 31 \u00b1 27% in the 6 pacing patients (p < 0.05).", {"entities": []}], ["Significant determinants of S2 amplitude were blood pressure, heart rate, and cardiac index with best correlation (R = .57) for mean pressure.", {"entities": []}], ["S2 recording quantitatively documents systemic pressure changes.", {"entities": []}], ["Muscle strength declines on average by one percent annually from midlife on.", {"entities": []}], ["In postmenopausal women this decrement coincides with a rapid decline in estrogen production.", {"entities": []}], ["The genetics underlying the effects of estrogen on skeletal muscle remains unclear.", {"entities": []}], ["In the present study, we examined whether polymorphisms within COMT and ESR1 are associated with muscle properties and assessed their interaction and their combined effects with physical activity.", {"entities": [[63, 67, "GENE"], [72, 76, "GENE"]]}], ["A cross-sectional data analysis was conducted with 434 63-76-year-old women from the population-based Finnish Twin Study on Aging.", {"entities": []}], ["Body anthropometry, muscle cross-sectional area (mCSA), isometric hand grip and knee extension strengths, and leg extension power were measured.", {"entities": []}], ["COMT Val158Met and ESR1 PvuII genotypes were determined by the RFLP method.", {"entities": [[0, 4, "GENE"], [19, 23, "GENE"]]}], ["mCSA differed by COMT genotypes (p\u200a=\u200a0.014) being significantly larger in LL than HL individuals in unadjusted (p\u200a=\u200a0.001) and age- and height-adjusted model (p\u200a=\u200a0.004).", {"entities": [[17, 21, "GENE"]]}], ["When physical activity and age were entered into GEE model, COMT genotype had a significant main effect (p\u200a=\u200a0.038) on mCSA.", {"entities": [[60, 64, "GENE"]]}], ["Furthermore, sedentary individuals with the HH genotype had lower muscle mass, strength and power, but they also appeared to benefit the most from physical activity.", {"entities": []}], ["No association of ESR1 PvuII polymorphism with any of the muscle outcomes was observed.", {"entities": [[18, 22, "GENE"]]}], ["The present study suggests that the COMT polymorphism, affecting the activity of the enzyme, is associated with muscle mass.", {"entities": [[36, 40, "GENE"]]}], ["Furthermore, sedentary individuals with potential high enzyme activity were the weakest group, but they may potentially benefit the most from physical activity.", {"entities": []}], ["This observation elucidates the importance of both environmental and genetic factors in muscle properties.", {"entities": []}], ["Recent research show that polycystic ovary syndrome (PCOS) may have an association with low-grade chronic inflammation, IL-18 is considered as a strong risk marker of inflammation.", {"entities": [[26, 51, "DISEASE"], [43, 51, "DISEASE"]]}], ["To investigate serum IL-18 concentrations in PCOS patients and focus on its relationship between obesity and insulin resistance (IR).", {"entities": [[97, 104, "DISEASE"]]}], ["Sixty consecutive women with PCOS and thirty controls were recruited.", {"entities": []}], ["Serum level of IL-18 and fasting blood glucose, fasting insulin, follicle-stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) were measured.", {"entities": []}], ["Serum levels of IL-18 was significantly higher in the PCOS group than in the control group.", {"entities": []}], ["Serum level of IL-18 was higher in the PCOS group with IR than in the PCOS group without IR.", {"entities": []}], ["Serum level of IL-18 was higher in obese PCOS patients than in lean PCOS patients.", {"entities": []}], ["Serum level of IL-18 was higher in lean PCOS patients than in the lean control group.", {"entities": []}], ["Serum level of IL-18 in the PCOS group was positively related to BMI, IR index and T. IL-18 level was increased in PCOS patients, and correlated with insulin resistance, obesity and hyperandrogenism.", {"entities": [[182, 198, "DISEASE"], [170, 177, "DISEASE"]]}], ["Smoking cessation in chronic obstructive pulmonary disease (COPD) reduces accelerated forced expiratory volume in 1\u2005s decline, but impact on key health outcomes is less clear.", {"entities": [[21, 58, "DISEASE"]]}], ["We studied the relationship of smoking status to mortality and hospitalisation in a UK primary care COPD population.", {"entities": []}], ["Using patient-anonymised routine data in the Hampshire Health Record Analytical Database, we identified a prevalent COPD cohort, categorising patients by smoking status (current, ex- or never-smokers).", {"entities": []}], ["Three outcomes were measured over 3\u2005years (2011\u20132013): all-cause mortality, respiratory-cause unplanned hospital admission and respiratory-cause emergency department attendance.", {"entities": []}], ["Survival analysis using multivariable Cox regression after multiple imputation was used to estimate hazard ratios for each outcome by smoking status, adjusting for measured confounders (including age, lung function, socioeconomic deprivation, inhaled medication and comorbidities).", {"entities": []}], ["We identified 16\u200a479 patients with COPD, mean\u00b1 sd age 70.1\u00b111.1\u2005years.", {"entities": []}], ["Smoking status was known in 91.3%: 35.1% active smokers, 54.3% ex-smokers, 1.9% never-smokers.", {"entities": []}], ["Active smokers predominated among younger patients.", {"entities": []}], ["Compared with active smokers (n=5787), ex-smokers (n=8941) had significantly reduced risk of death, hazard ratio (95% confidence interval) 0.78 (0.70\u20130.87), hospitalisation, 0.82 (0.74\u20130.89) and emergency department attendance, 0.78 (0.70\u20130.88).", {"entities": []}], ["After adjusting for confounders, ex-smokers had significantly better outcomes, emphasising the importance of effective smoking cessation support, regardless of age or lung function.", {"entities": []}], ["Many COPD patients smoke: better outcomes in ex-smokers suggest many deaths and admissions avoidable if smokers quit http://ow.ly/l85u30aizmK", {"entities": []}], ["Vitamin D may have a role in many chronic conditions in addition to bone health.", {"entities": []}], ["Nutritional surveys among Americans have reported high levels of vitamin D insufficiency, especially among Blacks and Latinos.", {"entities": []}], ["Our study examined variation in vitamin D supplementation practices in an adult health plan population by age, gender, and race-ethnicity.", {"entities": []}], ["Self-report data from a 2008 general health survey in a large Northern California health plan were used to characterize number and types of sources of vitamin D supplementation (multivitamin, calcium with D, singular D) among women and men aged 25-85, overall, by race-ethnicity, and for obese, diabetic, and hypertensive subgroups.", {"entities": []}], ["In this population, 40% of women and 54% of men \u2264 50, and 24% of women and 53% of men aged 51-85 get no vitamin D from dietary supplements.", {"entities": []}], ["Higher vitamin D supplementation among women > 50 is associated with higher reported intake of calcium with D. Black and Latina women aged 25-85 and Filipinas in the \u2264 50 age group were significantly less likely than non-Hispanic Whites to get vitamin D from supplements, whereas vitamin D supplementation practices among Chinese women did not significantly differ from non-Hispanic Whites.", {"entities": []}], ["Among men, Latinos aged 25-85 and Black and Chinese \u2264 50 were significantly less likely than non-Hispanic Whites to get vitamin D from supplements.", {"entities": []}], ["Similar race-ethnic differences in vitamin D supplementation patterns were observed for people in the obese, diabetic, and hypertensive groups.", {"entities": []}], ["Our survey results suggest that in 2008, a large percentage of women and an even larger percentage of men in a large Northern California health plan get no vitamin D from dietary supplements, and that Blacks and Latinos and obese adults, who are at higher risk of vitamin D deficiency, are also the least likely to get any vitamin D from dietary supplements.", {"entities": []}], ["The human illness designated as possible estuarine-associated syndrome (PEAS) by the Centers for Disease Control and Prevention (CDC) has been associated with exposure to estuaries inhabited by toxin-forming dinoflagellates, including members of the fish-killing toxic Pfiesteria complex (TPC), Pfiesteria piscicida and Pfiesteria shumwayae.", {"entities": [[62, 70, "DISEASE"]]}], ["Humans may be exposed through direct contact with estuarine water or by inhalation of aerosolized or volatilized toxin(s).", {"entities": []}], ["The five cases reported here demonstrate the full spectrum of symptoms experienced during acute and chronic stages of this suspected neurotoxin-mediated illness.", {"entities": []}], ["The nonspecific symptoms most commonly reported are cough, secretory diarrhea, headache, fatigue, memory impairment, rash, difficulty in concentrating, light sensitivity, burning skin upon water contact, muscle ache, and abdominal pain.", {"entities": [[69, 77, "DISEASE"], [59, 77, "DISEASE"]]}], ["Less frequently encountered symptoms are upper airway obstruction, shortness of breath, confusion, red or tearing eyes, weakness, and vertigo.", {"entities": []}], ["Some patients experience as few as four of these symptoms.", {"entities": []}], ["The discovery that an indicator of visual pattern-detection ability, visual contrast sensitivity (VCS), is sharply reduced in affected individuals has provided an objective indicator that is useful in diagnosing and monitoring PEAS.", {"entities": []}], ["VCS deficits are present in both acute and chronic PEAS, and VCS recovers during cholestyramine treatment coincident with symptom abatement.", {"entities": []}], ["Although PEAS cannot yet be definitively associated with TPC exposure, resolution with cholestyramine treatment suggests a neurotoxin-mediated illness.", {"entities": []}], ["Allergic diseases, such as asthma and allergic rhinitis, are common.", {"entities": [[38, 55, "DISEASE"], [47, 55, "DISEASE"], [27, 33, "DISEASE"]]}], ["Therefore, the discovery of therapeutic drugs for these conditions is essential.", {"entities": []}], ["Methyleugenol (ME) is a natural compound with antiallergic, antianaphylactic, antinociceptive, and anti-inflammatory effects.", {"entities": []}], ["This study examined the antiallergic effect of ME on IgE-mediated inflammatory responses and its antiallergy mechanism in the mast cell line, RBL-2H3.", {"entities": []}], ["We found that ME significantly inhibited the release of \u03b2 -hexosaminidase, tumor necrosis factor- (TNF-) \u03b1 , and interleukin- (IL-) 4, and was not cytotoxic at the tested concentrations (0\u2013100\u2009 \u03bc M).", {"entities": []}], ["Additionally, ME markedly reduced the production of the proinflammatory lipid mediators prostaglandin E 2 (PGE 2 ), prostaglandin D 2 (PGD 2 ), leukotriene B 4 (LTB 4 ), and leukotriene C 4 (LTC 4 ).", {"entities": [[135, 138, "GENE"], [161, 164, "GENE"]]}], ["We further evaluated the effect of ME on the early stages of the Fc \u03b5 RI cascade.", {"entities": []}], ["ME significantly inhibited Syk phosphorylation and expression but had no effect on Lyn.", {"entities": [[27, 30, "GENE"], [83, 86, "GENE"]]}], ["Furthermore, it suppressed ERK1/2, p38, and JNK phosphorylation, which is implicated in proinflammatory cytokine expression.", {"entities": []}], ["ME also decreased cytosolic phospholipase A 2 (cPLA 2 ) and 5-lipoxygenase (5-LO) phosphorylation and cyclooxygenase-2 (COX-2) expression.", {"entities": []}], ["These results suggest that ME inhibits allergic response by suppressing the activation of Syk, ERK1/2, p38, JNK, cPLA 2 , and 5-LO.", {"entities": [[90, 93, "GENE"]]}], ["Furthermore, the strong inhibition of COX-2 expression may also contribute to the antiallergic action of ME.", {"entities": []}], ["Our study provides further information about the biological functions of ME.", {"entities": []}], ["The Italian project MATRICE aimed to assess how well cases of type 2 diabetes (T2DM), hypertension, ischaemic heart disease (IHD) and heart failure (HF) and their levels of severity can be automatically extracted from the Health Search/CSD Longitudinal Patient Database (HSD).", {"entities": [[86, 98, "DISEASE"], [110, 123, "DISEASE"]]}], ["From the medical records of the general practitioners (GP) who volunteered to participate, cases were extracted by algorithms based on diagnosis codes, keywords, drug prescriptions and results of diagnostic tests.", {"entities": []}], ["A random sample of identified cases was validated by interviewing their GPs.", {"entities": []}], ["HSD is a database of primary care medical records.", {"entities": []}], ["A panel of 12 GPs participated in this validation study.", {"entities": []}], ["300 patients were sampled for each disease, except for HF, where 243 patients were assessed.", {"entities": []}], ["The positive predictive value (PPV) was assessed for the presence/absence of each condition against the GP's response to the questionnaire, and Cohen's \u03ba was calculated for agreement on the severity level.", {"entities": []}], ["The PPV was 100% (99% to 100%) for T2DM and hypertension, 98% (96% to 100%) for IHD and 55% (49% to 61%) for HF.", {"entities": [[44, 56, "DISEASE"]]}], ["Cohen's kappa for agreement on the severity level was 0.70 for T2DM and 0.69 for hypertension and IHD.", {"entities": [[81, 93, "DISEASE"]]}], ["This study shows that individuals with T2DM, hypertension or IHD can be validly identified in HSD by automated identification algorithms.", {"entities": [[45, 57, "DISEASE"]]}], ["Automatic queries for levels of severity of the same diseases compare well with the corresponding clinical definitions, but some misclassification occurs.", {"entities": []}], ["For HF, further research is needed to refine the current algorithm.", {"entities": []}], ["To assess whether wheezing and atopic dermatitis were associated with constipation in preschool children and to what extent shared risk factors contribute to this relationship.", {"entities": [[70, 82, "DISEASE"], [31, 48, "DISEASE"], [38, 48, "DISEASE"]]}], ["A population-based sample of 4651 preschool children was used.", {"entities": []}], ["At the age of 24, 36 and 48\u2005months, a parental report of functional constipation was available according to the Rome II criteria, and data on atopic dermatitis and wheezing were available using age-adapted questionnaires from the International Study of Asthma and Allergies in Childhood.", {"entities": [[68, 80, "DISEASE"], [142, 159, "DISEASE"], [253, 259, "DISEASE"], [149, 159, "DISEASE"]]}], ["Stepwise multivariate analyses were performed to assess whether body mass index, infection exposure, food allergy and infant nutrition, and parental stress explained the association between wheezing, atopic dermatitis and constipation.", {"entities": [[222, 234, "DISEASE"], [200, 217, "DISEASE"], [101, 113, "DISEASE"], [207, 217, "DISEASE"]]}], ["Out of 4651 children, 12\u201317% had functional constipation between 24 and 48\u2005months.", {"entities": [[44, 56, "DISEASE"]]}], ["Symptoms of wheezing decreased from 20% to 12% and atopic dermatitis decreased from 30% to 18% at the age of 24 and 48 months respectively.", {"entities": [[51, 68, "DISEASE"], [58, 68, "DISEASE"]]}], ["Between the age of 24 and 48\u2005months, wheezing symptoms were significantly associated with functional constipation (OR 1.17; 1.02 to 1.34) but these results were mainly explained by the child's exposure to infections and use of antibiotics (adjusted odds ratio 1.08; 95% CI 0.95 to 1.24).", {"entities": [[101, 113, "DISEASE"]]}], ["No significant association was found between symptoms of atopic dermatitis and functional constipation (OR 1.08; 95% CI 0.94 to 1.23).", {"entities": [[90, 102, "DISEASE"], [57, 74, "DISEASE"], [64, 74, "DISEASE"]]}], ["These findings suggest that functional constipation coexists with wheezing in childhood but is mainly explained by the child's infection exposure and use of antibiotics.", {"entities": [[39, 51, "DISEASE"]]}], ["Therefore, an independent association between respiratory symptoms and functional bowel disorders as suggested in previous studies is questionable.", {"entities": []}], ["Constipation, wheezing and atopic dermatitis are common symptoms in children.", {"entities": [[0, 12, "DISEASE"], [27, 44, "DISEASE"], [34, 44, "DISEASE"]]}], ["Functional bowel disorders are linked to asthma and atopy in adults.", {"entities": [[41, 47, "DISEASE"]]}], ["Functional bowel disorders, asthma and atopic disease may share common risk-factors that may explain coexistence of these symptoms.", {"entities": [[28, 34, "DISEASE"]]}], ["Wheezing, but not atopic dermatitis, is associated with functional constipation in preschool children.", {"entities": [[67, 79, "DISEASE"], [18, 35, "DISEASE"], [25, 35, "DISEASE"]]}], ["The association is mainly explained by a history of infection exposure.", {"entities": []}], ["Hence, the association between wheezing and functional constipation is not independent.", {"entities": [[55, 67, "DISEASE"]]}], ["Further research is needed to explore whether this result also applies to the outcome of asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["Population-based study population.", {"entities": []}], ["The study group were not selected according to medical care.", {"entities": []}], ["This study addresses a topical area that has not been studied sufficiently and can contribute to the discussion of how asthma or atopy may be associated with functional bowel disorders.", {"entities": [[119, 125, "DISEASE"]]}], ["This study took into account multiple shared risk factors of wheezing and constipation to shed light on the suggested association in literature.", {"entities": [[74, 86, "DISEASE"]]}], ["Symptoms were available only from parental-reported questionnaires.", {"entities": []}], ["This may lead to misclassification of the symptoms.", {"entities": []}], ["Early wheezing in infancy is not a sufficient predictor of childhood asthma.", {"entities": [[69, 75, "DISEASE"]]}], ["No data were available regarding parental concerns of the child's health status.", {"entities": []}], ["Bias may occur when parents with high concerns are more likely to report symptoms in their child as wheezing, constipation and infectious disease.", {"entities": [[110, 122, "DISEASE"]]}], ["No data were available on IgE sensitisation, thus conclusions on the assocation between allergic disease and constipation should be made with caution.", {"entities": [[109, 121, "DISEASE"]]}], ["In many laboratories, researchers store experimental data on their own workstation using spreadsheets.", {"entities": []}], ["However, this approach poses a number of problems, ranging from sharing issues to inefficient data-mining.", {"entities": []}], ["Standard spreadsheets are also error-prone, as data do not undergo any validation process.", {"entities": []}], ["To overcome spreadsheets inherent limitations, a number of proprietary systems have been developed, which laboratories need to pay expensive license fees for.", {"entities": []}], ["Those costs are usually prohibitive for most laboratories and prevent scientists from benefiting from more sophisticated data management systems.", {"entities": []}], ["In this paper, we propose the EnzymeTracker, a web-based laboratory information management system for sample tracking, as an open-source and flexible alternative that aims at facilitating entry, mining and sharing of experimental biological data.", {"entities": []}], ["The EnzymeTracker features online spreadsheets and tools for monitoring numerous experiments conducted by several collaborators to identify and characterize samples.", {"entities": []}], ["It also provides libraries of shared data such as protocols, and administration tools for data access control using OpenID and user/team management.", {"entities": []}], ["Our system relies on a database management system for efficient data indexing and management and a user-friendly AJAX interface that can be accessed over the Internet.", {"entities": []}], ["The EnzymeTracker facilitates data entry by dynamically suggesting entries and providing smart data-mining tools to effectively retrieve data.", {"entities": []}], ["Our system features a number of tools to visualize and annotate experimental data, and export highly customizable reports.", {"entities": []}], ["It also supports QR matrix barcoding to facilitate sample tracking.", {"entities": []}], ["The EnzymeTracker was designed to be easy to use and offers many benefits over spreadsheets, thus presenting the characteristics required to facilitate acceptance by the scientific community.", {"entities": []}], ["It has been successfully used for 20 months on a daily basis by over 50 scientists.", {"entities": []}], ["The EnzymeTracker is freely available online at http://cubique.fungalgenomics.ca/enzymedb/index.html under the GNU GPLv3 license.", {"entities": []}], ["Attention deficit hyperactivity disorder (ADHD) is a frequently diagnosed disorder in child- and adulthood with a high impact affecting multiple facets of social life.", {"entities": []}], ["Therefore, patients suffering from ADHD are at high risk to be confronted with stigma, prejudices, and discrimination.", {"entities": []}], ["A review of the empirical research in the field of ADHD with regard to stigma was performed.", {"entities": []}], ["The findings of investigations in this field were clustered in different categories, including stigma in children with ADHD, stigma in adults with ADHD, stigma in relatives or in people close to a patient with ADHD, and the influence of stigma on authorities\u2019 attitudes toward patients with ADHD.", {"entities": []}], ["Variables identified to contribute to stigma in ADHD are public\u2019s uncertainty concerning the reliability/validity of an ADHD diagnosis and the related diagnostic assessment, public\u2019s perceived dangerousness of individuals with ADHD, socio-demographical factors as age, gender, and ethnicity of the respondent or the target individual with ADHD, stigmatization of ADHD treatment, for example public\u2019s skepticism toward ADHD medication and disclosure of diagnostic status as well as medication status of the individual with ADHD.", {"entities": []}], ["The contribution of stigma associated with ADHD can be conceptualized as an underestimated risk factor, affecting treatment adherence, treatment efficacy, symptom aggravation, life satisfaction, and mentally well-being of individuals affected by ADHD.", {"entities": []}], ["Public as well as health professionals\u2019 concepts about ADHD are highly diverse, setting individuals with an ADHD diagnosis at greater risk to get stigmatized.", {"entities": []}], ["This review proposes a critical reassessment (based entirely on published evidence) of the following seven common beliefs about chronic obstructive pulmonary disease (COPD): (1) COPD is one disease.", {"entities": [[128, 165, "DISEASE"]]}], ["(2) There is a valid definition for COPD.", {"entities": []}], ["(The current definition includes cases of irreversible asthma and bronchiectasis, and occasionally, other obstructive lung conditions).", {"entities": [[66, 80, "DISEASE"], [55, 61, "DISEASE"]]}], ["(3) Irreversible asthma in smokers and COPD cannot be differentiated.", {"entities": [[17, 23, "DISEASE"]]}], ["(4) A \u201cchronic bronchitis\u201d form of COPD exists and is characterized by blue bloater status and normal carbon monoxide diffusion studies.", {"entities": [[15, 25, "DISEASE"]]}], ["(5) Phenotyping has no bearing on medication choice in COPD.", {"entities": []}], ["(6) Computerized scoring of lung attenuation on CT scans can diagnose emphysema.", {"entities": []}], ["(Emphysema scores overlap in irreversible asthma and COPD); however, qualitative visual changes may be useful for differentiation.", {"entities": [[42, 48, "DISEASE"]]}], ["(7) A definable entity called the overlap (of COPD and asthma) syndrome exists.", {"entities": [[63, 71, "DISEASE"], [55, 61, "DISEASE"]]}], ["Conflict over the abovementioned points denies patients proper phenotype-guided therapy and encourages a multidrug approach to COPD management.", {"entities": []}], ["The recently coined term, overlap syndrome, invites a double-barreled therapy aimed at asthma and COPD, despite the absence of any agreement about how to define the syndrome and the lack of any related drug trials (in the area of inhaled corticosteroids).", {"entities": [[34, 42, "DISEASE"], [165, 173, "DISEASE"], [87, 93, "DISEASE"]]}], ["A diagnosis of COPD is associated with high morbidity and escalating costs, suggesting the need for a thorough new examination of the evidence.", {"entities": []}], ["Bias due to social desirability has long been of concern to evaluators relying on self-report data.", {"entities": []}], ["It is conceivable that health program evaluation is particularly susceptible to social desirability bias as individuals may be inclined to present themselves or certain health behaviors in a more positive light and/or appease the course leader.", {"entities": []}], ["Thus, the influence of social desirability bias on self-report outcomes was explored in the present study.", {"entities": []}], ["Data were collected from 331 participants of group-based chronic disease self-management interventions using the highly robust eight-scale Health Education Impact Questionnaire (heiQ) and the 13-item short form Marlowe-Crowne Social Desirability Scale (MC-C).", {"entities": []}], ["The majority of self-management courses were run by community-based organizations across Australia between February 2005 and December 2006 where 6 to 12 individuals have the opportunity to develop considerable rapport with course leaders and each other over about six weeks.", {"entities": []}], ["Pre-test data were collected on the first day of courses, while post-test and social desirability scores were assessed at the end of courses.", {"entities": []}], ["A model of partial mediation within the framework of structural equation modeling was developed with social desirability as the mediating variable between pre-test and post-test.", {"entities": []}], ["The \u2018Defensiveness\u2019 factor of the MC-C showed clear association with heiQ pre-test data, a prerequisite for investigating mediation; however, when investigating the eight full pre-test/post-test models \u2018Defensiveness\u2019 was only associated with one heiQ scale.", {"entities": []}], ["This effect was small, explaining 8% of the variance in the model.", {"entities": []}], ["No other meditational effects through social desirability were observed.", {"entities": []}], ["The overall lack of association of social desirability with heiQ outcomes was surprising as it had been expected that it would explain at least some of the variance observed between pre-test and post-test.", {"entities": []}], ["With the assumption that the MC-C captures the propensity for an individual to provide socially desirable answers, this study concludes that change scores in chronic disease self-management program evaluation are not biased by social desirability.", {"entities": []}], ["Household air pollution (HAP) due to biomass cooking fuel use is an important risk factor for a range of diseases, especially among adult women who are primary cooks, in India.", {"entities": []}], ["About 80% of rural households in India use biomass fuel for cooking.", {"entities": []}], ["The aim of this study is to estimate the attributable cases (AC) for four major diseases/conditions associated with biomass cooking fuel use among adult Indian women.", {"entities": []}], ["We used the population attributable fraction (PAF) method to calculate the AC of chronic bronchitis, tuberculosis (TB), cataract, and stillbirths due to exposure to biomass cooking fuel.", {"entities": [[120, 128, "DISEASE"], [101, 113, "DISEASE"], [89, 99, "DISEASE"]]}], ["A number of data sources were accessed to obtain population totals and disease prevalence rates.", {"entities": []}], ["A meta-analysis was conducted to obtain adjusted pooled odds ratios (ORs) for strength of association.", {"entities": []}], ["Using this, PAF and AC were calculated using a standard formula.", {"entities": []}], ["Results were presented as number of AC and 95% confidence intervals (CI).", {"entities": []}], ["The fixed effects pooled OR obtained from the meta-analysis were 2.37 (95% CI: 1.59, 3.54) for chronic bronchitis, 2.33 (1.65, 3.28) for TB, 2.16 (1.42, 3.26) for cataract, and 1.26 (1.12, 1.43) for stillbirths.", {"entities": [[163, 171, "DISEASE"], [103, 113, "DISEASE"]]}], ["PAF varied across conditions being maximum (53%) for chronic bronchitis in rural areas and least (1%) for cataract in older age and urban areas.", {"entities": [[106, 114, "DISEASE"], [61, 71, "DISEASE"]]}], ["About 2.4 (95% CI: 1.4, 3.1) of 5.6 m cases of chronic bronchitis, 0.3 (0.2, 0.4) of 0.76 m cases of TB, 5.0 (2.8, 6.7) of 51.4 m cases of cataract among adult Indian women and 0.02 (0.01, 0.03) of 0.15 m stillbirths across India are attributable to HAP due to biomass cooking fuel.", {"entities": [[139, 147, "DISEASE"], [55, 65, "DISEASE"]]}], ["These estimates should be cautiously interpreted in the light of limitations discussed which relate to exposure assessment, exposure characterization, and age-specific prevalence of disease.", {"entities": []}], ["HAP due to biomass fuel has diverse and major impacts on women\u2019s health in India.", {"entities": []}], ["Although challenging, incorporating the agenda of universal clean fuel access or cleaner technology within the broader framework of rural development will go a long way in reducing disease burden.", {"entities": []}], ["Benefit-cost analyses of environmental regulations are increasingly mandated in the United States.", {"entities": []}], ["Evaluations of criteria air pollutants have focused on benefits and costs associated with adverse health effects.", {"entities": []}], ["Children are significantly affected by the health benefits of improved air quality, yet key environmental health policy analyses have not previously focused specifically on children's effects.", {"entities": []}], ["In this article we present a \"meta-analysis\" approach to child-specific health impacts derived from the U.S. Clean Air Act (CAA).", {"entities": []}], ["On the basis of data from existing studies, reductions in criteria air pollutants predicted to occur by 2010 because of CAA regulations are estimated to produce the following impacts: 200 fewer expected cases of postneonatal mortality; 10,000 fewer asthma hospitalizations in children 1-16 years old, with estimated benefits ranging from 20 million U.S. dollars to 46 million U.S. dollars (1990 U.S. dollars); 40,000 fewer emergency department visits in children 1-16 years old, with estimated benefits ranging from 1.3 million U.S. dollars to 5.8 million U.S. dollars; 20 million school absences avoided by children 6-11 years old, with estimated benefits of 0.7-1.8 billion U.S. dollars; and 10,000 fewer infants of low birth weight, with estimated benefits of 230 million U.S. dollars.", {"entities": [[249, 255, "DISEASE"]]}], ["Inclusion of limited child-specific data on hospitalizations, emergency department visits, school absences, and low birth weight could be expected to add 1-2 billion U.S. dollars (1990 U.S. dollars) to the 8 billion U.S. dollars in health benefits currently estimated to result from decreased morbidity, and 600 million U.S. dollars to the 100 billion U.S. dollars estimated to result from decreased mortality.", {"entities": []}], ["These estimates highlight the need for increased consideration of children's health effects.", {"entities": []}], ["Key needs for environmental health policy analyses include improved information for children's health effects, additional life-stage-specific information, and improved health economics information specific for children.", {"entities": []}], ["Inflammation in the airways and lung parenchyma underlies fixed airway obstruction in chronic obstructive pulmonary disease.", {"entities": [[86, 123, "DISEASE"]]}], ["The exact role of smoking as promoting factor of inflammation in chronic obstructive pulmonary disease is not clear, partly because studies often do not distinguish between current and ex-smokers.", {"entities": [[65, 102, "DISEASE"]]}], ["We investigated airway inflammation in sputum and bronchial biopsies of 34 smokers with chronic obstructive pulmonary disease (9 Global initiative for Chronic Obstructive Lung Disease stage 0, 9 stage I, 10 stage II and 6 stage III) and 26 asymptomatic smokers, and its relationship with past and present smoking habits and airway obstruction.", {"entities": [[88, 125, "DISEASE"]]}], ["Neutrophil percentage, interleukin-8 and eosinophilic-cationic-protein levels in sputum were higher in chronic obstructive pulmonary disease (stage I-III) than asymptomatic smokers.", {"entities": [[103, 140, "DISEASE"]]}], ["Inflammatory cell numbers in bronchial biopsies were similar in both groups.", {"entities": []}], ["Current smoking correlated positively with macrophages: in bronchial biopsies in both groups, and in sputum in chronic obstructive pulmonary disease.", {"entities": [[111, 148, "DISEASE"]]}], ["Pack-years smoking correlated positively with biopsy macrophages only in chronic obstructive pulmonary disease.", {"entities": [[73, 110, "DISEASE"]]}], ["Inflammatory effects of current smoking may mask the underlying ongoing inflammatory process pertinent to chronic obstructive pulmonary disease.", {"entities": [[106, 143, "DISEASE"]]}], ["This may have implications for future studies, which should avoid including mixed populations of smokers and ex-smokers.", {"entities": []}], ["The setting for this study was the Pacific island nation of Vanuatu, an archipelago of 82 islands, located in the South Pacific Ocean.", {"entities": []}], ["Our objective was to assess the knowledge, attitudes and practices of tuberculosis (TB) patients towards TB.", {"entities": [[70, 82, "DISEASE"]]}], ["This was a descriptive study using qualitative and quantitative methods.", {"entities": []}], ["Quantitative analysis was based on the responses provided to closed questions, and we present frequencies to describe the TB patients\u2019 knowledge, attitudes and practice relating to TB.", {"entities": []}], ["Qualitative analysis was based on open questions permitting fuller explanations.", {"entities": []}], ["We used thematic analysis and developed a posteriori inductive categories to draw conclusions.", {"entities": []}], ["Thirty five TB patients were interviewed; 22 (63%) were male.", {"entities": []}], ["They attributed TB to cigarettes, kava, alcohol, contaminated food, sharing eating utensils and \u201c kastom\u201d (the local term for the traditional way of life, but also for sorcery).", {"entities": []}], ["Most (94%) did not attribute TB to a bacterial cause.", {"entities": []}], ["However, almost all TB patients (89%) thought that TB was best treated at a hospital with antibiotics.", {"entities": []}], ["Three quarters (74%) experienced stigma after their TB diagnosis.", {"entities": []}], ["Seeking health care from a traditional healer was common; 54% of TB patients stated that they would first consult a traditional healer for any illness.", {"entities": []}], ["When seeking a diagnosis for signs and symptoms of TB, 34% first consulted a traditional healer.", {"entities": []}], ["Patients cited cost, distance and beliefs about TB causation as reasons for first consulting a traditional healer or going to the hospital.", {"entities": []}], ["Of the TB patients who consulted a traditional healer first, there was an average of two weeks delay before they consulted the health service.", {"entities": []}], ["In some cases, however, the delay was up to six years.", {"entities": []}], ["The majority of the TB patients interviewed did not attribute TB to a bacterial cause.", {"entities": []}], ["Consulting a traditional healer for health care, including while seeking a diagnosis for TB symptoms, was common and may have delayed diagnosis.", {"entities": []}], ["People require better information about TB to correct commonly held misperceptions about the disease.", {"entities": []}], ["Traditional healers could also be engaged with the national TB programme, in order to refer people with signs and symptoms of TB to the nearest health service.", {"entities": []}], ["Macrophages promote tissue remodeling but few mechanisms exist to modulate their activity during tissue fibrosis.", {"entities": []}], ["Serum amyloid P (SAP), a member of the pentraxin family of proteins, signals through Fc\u03b3 receptors which are known to affect macrophage activation.", {"entities": []}], ["We determined that IPF/UIP patients have increased protein levels of several alternatively activated pro-fibrotic (M2) macrophage-associated proteins in the lung and monocytes from these patients show skewing towards an M2 macrophage phenotype.", {"entities": []}], ["SAP therapeutically inhibits established bleomycin-induced pulmonary fibrosis, when administered systemically or locally to the lungs.", {"entities": [[59, 77, "DISEASE"]]}], ["The reduction in aberrant collagen deposition was associated with a reduction in M2 macrophages in the lung and increased IP10/CXCL10.", {"entities": []}], ["These data highlight the role of macrophages in fibrotic lung disease, and demonstrate a therapeutic action of SAP on macrophages which may extend to many fibrotic indications caused by over-exuberant pro-fibrotic macrophage responses.", {"entities": [[57, 69, "DISEASE"]]}], ["This trial aims at testing the efficacy of weekly reminder and motivational text messages, compared to usual care in improving adherence to Highly Active Antiretroviral Treatment in patients attending a clinic in Yaound\u00e9, Cameroon.", {"entities": []}], ["This is a single-centered randomized controlled single-blinded trial.", {"entities": []}], ["A central computer generated randomization list will be generated using random block sizes.", {"entities": []}], ["Allocation will be determined by sequentially numbered sealed opaque envelopes.", {"entities": []}], ["198 participants will either receive the mobile phone text message or usual care.", {"entities": []}], ["Our hypothesis is that weekly motivational text messages can improve adherence to Highly Active Antiretroviral Treatment and other clinical outcomes in the control group by acting as a reminder, a cue to action and opening communication channels.", {"entities": []}], ["Data will be collected at baseline, three months and six months.", {"entities": []}], ["A blinded program secretary will send out text messages and record delivery.", {"entities": []}], ["Our primary outcomes are adherence measured by the visual analogue scale, self report, and pharmacy refill data.", {"entities": []}], ["Our secondary outcomes are clinical: weight, body mass index, opportunistic infections, all cause mortality and retention; biological: Cluster Designation 4 count and viral load; and quality of life.", {"entities": []}], ["Analysis will be by intention-to-treat.", {"entities": []}], ["Covariates and subgroups will be taken into account.", {"entities": []}], ["This trial investigates the potential of SMS motivational reminders to improve adherence to Highly Active Antiretroviral Treatment in Cameroon.", {"entities": [[41, 44, "GENE"]]}], ["The intervention targets non-adherence due to forgetfulness and other forms of non-adherence.", {"entities": []}], ["Pan-African Clinical Trials Registry PACTR201011000261458 http://clinicaltrials.gov/ NCT01247181", {"entities": []}], ["Airway hyperresponsiveness (AHR) is classically found in asthma, and persistent AHR is associated with poor asthma control.", {"entities": [[57, 63, "DISEASE"], [108, 114, "DISEASE"], [28, 31, "GENE"], [80, 83, "GENE"], [28, 31, "GENE"], [80, 83, "GENE"]]}], ["Although airway smooth muscle (ASM) cells play a critical pathophysiologic role in AHR, the paracrine contributions of surrounding cells such as fibroblasts to the contractile phenotype of ASM cells have not been examined fully.", {"entities": [[83, 86, "GENE"]]}], ["This study addresses the hypothesis that nicotine promotes a contractile ASM cell phenotype by stimulating fibroblasts to increase nerve growth factor (NGF) secretion into the environment.", {"entities": [[152, 155, "GENE"]]}], ["Primary lung fibroblasts isolated from wild type and \u03b17 nicotinic acetylcholine receptor (\u03b17 nAChR) deficient mice were treated with nicotine (50 \u00b5g/ml) in vitro for 72 hours.", {"entities": []}], ["NGF levels were measured in culture media and in bronchoalveolar lavage (BAL) fluid from asthmatic, smoking and non-smoking subjects by ELISA.", {"entities": [[0, 3, "GENE"]]}], ["The role of the NF\u03baB pathway in nicotine-induced NGF expression was investigated by measuring NF\u03baB nuclear translocation, transcriptional activity, chromatin immunoprecipitation assays, and si-p65 NF\u03baB knockdown.", {"entities": [[49, 52, "GENE"]]}], ["The ability of nicotine to stimulate a fibroblast-mediated, contractile ASM cell phenotype was confirmed by examining expression of contractile proteins in ASM cells cultured with fibroblast-conditioned media or BAL fluid.", {"entities": []}], ["NGF levels were elevated in the bronchoalveolar lavage fluid of nicotine-exposed mice, current smokers, and asthmatic children.", {"entities": [[0, 3, "GENE"]]}], ["Nicotine increased NGF secretion in lung fibroblasts in vitro in a dose-dependent manner and stimulated NF\u03baB nuclear translocation, p65 binding to the NGF promoter, and NF\u03baB transcriptional activity.", {"entities": [[19, 22, "GENE"], [151, 154, "GENE"], [19, 22, "GENE"], [151, 154, "GENE"]]}], ["These responses were attenuated in \u03b17 nAChR deficient fibroblasts and in wild type fibroblasts following NF\u03baB inhibition.", {"entities": []}], ["Nicotine-treated, fibroblast-conditioned media increased expression of contractile proteins in ASM cells.", {"entities": []}], ["Nicotine stimulates NGF release by lung fibroblasts through \u03b17 nAChR and NF\u03baB dependent pathways.", {"entities": [[20, 23, "GENE"]]}], ["These novel findings suggest that the nicotine-\u03b17 nAChR-NF\u03baB- NGF axis may provide novel therapeutic targets to attenuate tobacco smoke-induced AHR.", {"entities": [[62, 65, "GENE"], [144, 147, "GENE"]]}], ["District nurses (DNs) provide home care for old persons with a mixture of chronic diseases, symptoms and reduced functional ability.", {"entities": []}], ["Family physicians (FPs) have been criticised for their lack of involvement in this care.", {"entities": []}], ["The aim of this study was to obtain increased knowledge concerning the FP's experience of providing medical treatment for patients with home care provided by DNs by developing a theoretical model that elucidates how FPs handle the problems they encounter regarding the individual patients and their conditions.", {"entities": []}], ["Semi-structured interviews were conducted with 13 Swedish FPs concerning one of their registered patients with home care by a DN, and the treatment of this patient.", {"entities": []}], ["Grounded theory methodology (GTM) was used in the analyses.", {"entities": []}], ["The core category was the effort to stay in charge of the medical treatment.", {"entities": []}], ["This involved three types of problems: gaining sufficient insight, making adequate decisions, and maintaining appropriate medical treatment.", {"entities": []}], ["For three categories of patients, the FPs had problems staying in charge.", {"entities": []}], ["Patients with reduced functional ability had problems providing information and maintaining treatment.", {"entities": []}], ["Patients who were \"fixed in their ways\" did not provide information and did not comply with recommendations, and for patients with complex conditions, making adequate decisions could be problematic.", {"entities": []}], ["To overcome the problems, four different strategies were used: relying on information from others, supporting close observation and follow-up by others, being constantly ready to change the goal of the treatment, and relying on others to provide treatment.", {"entities": []}], ["The patients in this study differed from most other patients seen at the healthcare centre as the consultation with the patient could not provide the usual foundation for decisions concerning medical treatment.", {"entities": []}], ["Information from and collaboration with the DN and other home care providers was essential for the FP's effort to stay in charge of the medical treatment.", {"entities": []}], ["The complexity of the situation made it problematic for the FP to make adequate decisions about the goal of the medical treatment.", {"entities": []}], ["The goal of the treatment had to be constantly evaluated based on information from the DN and other care providers, and thus this information was absolutely crucial.", {"entities": []}], ["Asthma exacerbations are associated with subsequent deficits in lung function.", {"entities": [[0, 6, "DISEASE"]]}], ["Here, we tested the hypothesis that a specific pattern of inflammatory responses during acute exacerbations may be associated with chronic airway obstruction.", {"entities": []}], ["Gene coexpression networks were characterized in induced sputum obtained during an acute exacerbation, from asthmatic children with or without chronic airflow limitation.", {"entities": []}], ["The data showed that activation of Th1-like/cytotoxic and interferon signalling pathways during acute exacerbations was decreased in asthmatic children with deficits in baseline lung function.", {"entities": []}], ["These associations were independent of the identification of picornaviruses in nasal secretions or the use of medications at the time of the exacerbation.", {"entities": []}], ["Th2-related pathways were also detected in the responses, but variations in these pathways were not related to chronic airways obstruction.", {"entities": []}], ["Our findings demonstrate that decreased activation of Th1-like/cytotoxic and interferon pathways is a hallmark of acute exacerbation responses in asthmatic children with evidence of chronic airways obstruction.", {"entities": []}], ["Class\u2010switching of B\u00a0cells to IgA can be induced via both T\u2010cell\u2010dependent and T\u2010cell\u2010independent mechanisms.", {"entities": []}], ["IgA is most predominantly produced mucosally and is important for combating infections and allergies.", {"entities": []}], ["In contrast to mice, humans have two forms of IgA; IgA1 and IgA2 with diverse tissue distribution.", {"entities": []}], ["In early life, IgA levels might be sub\u2010optimal especially during the fall season when bacterial and viral infections are more common.", {"entities": []}], ["Therefore, we investigated using human B\u00a0cells whether T\u2010cell\u2010independent factors \u2010promoting cell survival, class switching and immunoglobulin secretion\u2010 BAFF, APRIL, IL\u201010 and retinoic acid can boost IgA production in the context of viral or bacterial infection.", {"entities": []}], ["To this end total and naive peripheral blood B\u00a0cells were stimulated with these factors for 6 days in the presence or absence of TLR7/8 agonist R848 (mimicking viral infection) or TLR9 agonist CpG\u2010ODN (mimicking bacterial infection).", {"entities": [[180, 184, "GENE"]]}], ["We show that BAFF significantly augments IgA2 production in TLR7/8 stimulated mature, but not na\u00efve B\u00a0cells.", {"entities": []}], ["In addition, BAFF augments IL\u201010 production and viability in TLR7/8 and TLR9 stimulated mature B\u00a0cells.", {"entities": [[72, 76, "GENE"]]}], ["These data warrant further investigation of its role in immune regulation both in the periphery and mucosal tissues in early life or during disease.", {"entities": []}], ["The purpose of this study was to examine the accuracy of total body density and percent body fat (% fat) using air displacement plethysmography (ADP) and hydrostatic weighing (HW) in children.", {"entities": []}], ["Sixty-six male and female subjects (40 males: 12.4 \u00b1 1.3 yrs, 47.4 \u00b1 14.8 kg, 155.4 \u00b1 11.9 cm, 19.3 \u00b1 4.1 kg/m For the entire group (Y = 0.835x + 0.171, R P = 0.08) or for females (R = 0.02; P = 0.92), however bias existed in males (R = -0.37; P \u2264 0.05).", {"entities": []}], ["Bland-Altman analysis revealed no bias between HW and ADP % fat for the entire group (R = 0.21; P = 0.10) or in females (R = 0.10; P = 0.57), however bias was indicated for males by a significant correlation (R = 0.36; P \u2264 0.05), with ADP underestimating % fat at lower fat values and overestimating at the higher % fat values.", {"entities": []}], ["A significant difference in total body density and % fat was observed between ADP and HW in children 10\u201315 years old with a potential gender difference being detected.", {"entities": []}], ["Upon further investigation it was revealed that the study was inadequately powered, thus we recommend that larger studies that are appropriately powered be conducted to better understand this potential gender difference.", {"entities": []}], ["Respiratory infections are well-known triggers of chronic respiratory diseases.", {"entities": []}], ["Recently, culture-independent tools have indicated that lower airway microbiota may contribute to pathophysiologic processes associated with asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[152, 189, "DISEASE"], [141, 147, "DISEASE"]]}], ["However, the relationship between upper airway microbiota and chronic respiratory diseases remains unclear.", {"entities": []}], ["This study was undertaken to define differences of microbiota in the oropharynx of asthma and COPD patients relative to those in healthy individuals.", {"entities": [[83, 89, "DISEASE"]]}], ["To account for the qualitative and quantitative diversity of the 16S rRNA gene in the oropharynx, the microbiomes of 18 asthma patients, 17 COPD patients, and 12 normal individuals were assessed using a high-throughput next-generation sequencing analysis.", {"entities": [[120, 126, "DISEASE"]]}], ["In the 259,572 total sequence reads, \u03b1 and \u03b2 diversity measurements and a generalized linear model revealed that the oropharynx microbiota are diverse, but no significant differences were observed between asthma and COPD patients.", {"entities": [[205, 211, "DISEASE"]]}], ["Pseudomonas spp.", {"entities": []}], ["of Proteobacteria and Lactobacillus spp.", {"entities": []}], ["of Firmicutes were highly abundant in asthma and COPD.", {"entities": [[38, 44, "DISEASE"]]}], ["By contrast, Streptococcus , Veillonella , Prevotella , and Neisseria of Bacteroidetes dominated in the healthy oropharynx.", {"entities": []}], ["These findings are consistent with previous studies conducted in the lower airways and suggest that oropharyngeal airway microbiota are important for understanding the relationships between the various parts of the respiratory tract with regard to bacterial colonization and comprehensive assessment of asthma and COPD.", {"entities": [[303, 309, "DISEASE"]]}], ["Since the discovery that Der p 1 is a cysteine protease, the role of proteolytic activity in allergic sensitization has been explored.", {"entities": []}], ["There are many allergens with proteolytic activity; however, exposure from dust mites is not limited to allergens.", {"entities": []}], ["In this paper, genomic, transcriptomic and proteomic data on Dermatophagoides pteronyssinus (DP) was mined for information regarding the complete degradome of this house dust mite.", {"entities": []}], ["D. pteronyssinus has more proteases than the closely related Acari, Dermatophagoides farinae (DF) and Sarcoptes scabiei (SS).", {"entities": []}], ["The group of proteases in D. pteronyssinus is found to be more highly transcribed than the norm for this species.", {"entities": []}], ["The distribution of protease types is dominated by the cysteine proteases like Der p 1 that account for about half of protease transcription by abundance, and Der p 1 in particular accounts for 22% of the total protease transcripts.", {"entities": []}], ["In an analysis of protease stability, the group of allergens (Der p 1, Der p 3, Der p 6, and Der p 9) is found to be more stable than the mean.", {"entities": []}], ["It is also statistically demonstrated that the protease allergens are simultaneously more highly expressed and more stable than the group of D. pteronyssinus proteases being examined, consistent with common assumptions about allergens in general.", {"entities": []}], ["There are several significant non-allergen outliers from the normal group of proteases with high expression and high stability that should be examined for IgE binding.", {"entities": []}], ["This paper compiles the first holistic picture of the D. pteronyssinus degradome to which humans may be exposed.", {"entities": []}], ["Media interventions can potentially play a major role in influencing health policies.", {"entities": []}], ["This integrative systematic review aimed to assess the effects of planned media interventions\u2014including social media\u2014on the health policy-making process.", {"entities": []}], ["Eligible study designs included randomized and non-randomized designs, economic studies, process evaluation studies, stakeholder analyses, qualitative methods, and case studies.", {"entities": []}], ["We electronically searched Medline, EMBASE, Communication and Mass Media Complete, Cochrane Central Register of Controlled Trials, and the WHO Global Health Library.", {"entities": []}], ["We followed standard systematic review methodology for study selection, data abstraction, and risk of bias assessment.", {"entities": []}], ["Twenty-one studies met our eligibility criteria: 10 evaluation studies using either quantitative ( n \u2009=\u20097) or qualitative ( n \u2009=\u20093) designs and 11 case studies.", {"entities": []}], ["None of the evaluation studies were on social media.", {"entities": []}], ["The findings of the evaluation studies suggest that media interventions may have a positive impact when used as accountability tools leading to prioritizing and initiating policy discussions, as tools to increase policymakers\u2019 awareness, as tools to influence policy formulation, as awareness tools leading to policy adoption, and as awareness tools to improve compliance with laws and regulations.", {"entities": []}], ["In one study, media-generated attention had a negative effect on policy advocacy as it mobilized opponents who defeated the passage of the bills that the media intervention advocated for.", {"entities": []}], ["We judged the confidence in the available evidence as limited due to the risk of bias in the included studies and the indirectness of the evidence.", {"entities": []}], ["There is currently a lack of reliable evidence to guide decisions on the use of media interventions to influence health policy-making.", {"entities": []}], ["Additional and better-designed, conducted, and reported primary research is needed to better understand the effects of media interventions, particularly social media, on health policy-making processes, and the circumstances under which media interventions are successful.", {"entities": []}], ["PROSPERO 2015: CRD42015020243 The online version of this article (doi:10.1186/s13012-017-0581-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Background In India, coping mechanisms for inpatient care costs have been explored in rural areas, but seldom among urbanites.", {"entities": []}], ["This study aims to explore and compare mechanisms employed by the urban and rural poor for coping with inpatient expenditures, in order to help identify formal mechanisms and policies to provide improved social protection for health care.", {"entities": []}], ["Methods A three-step methodology was used: (1) six focus-group discussions; (2) 800 exit survey interviews with users of public and private facilities in both urban and rural areas; and (3) 18 in-depth interviews with poor (below 30th percentile of socio-economic status) hospital users, to explore coping mechanisms in greater depth.", {"entities": []}], ["Results Users of public hospitals, in both urban and rural areas, were poor relative to users of private hospitals.", {"entities": []}], ["Median expenditures per day were much higher at private than at public facilities.", {"entities": []}], ["Most respondents using public facilities (in both urban and rural areas) were able to pay out of their savings or income; or by borrowing from friends, family or employer.", {"entities": []}], ["Those using private facilities were more likely to report selling land or other assets as the primary source of coping (particularly in rural areas) and they were more likely to have to borrow money at interest (particularly in urban areas).", {"entities": []}], ["Poor individuals who used private facilities cited as reasons their closer proximity and higher perceived quality of care.", {"entities": []}], ["Conclusions In India, national and state governments should invest in improving the quality and access of public first-referral hospitals.", {"entities": []}], ["This should be done selectively\u2014with a focus, for example, on rural areas and urban slum areas\u2014in order to promote a more equitable distribution of resources.", {"entities": []}], ["Policy makers should continue to explore and support efforts to provide financial protection through insurance mechanisms.", {"entities": []}], ["Past experience suggests that these efforts must be carefully monitored to ensure that the poorer among the insured are able to access scheme benefits, and the quality and quantity of health care provided must be monitored and regulated.", {"entities": []}], ["Personalized health care (PHC) is an evolving field of medicine aimed at providing the right therapy to the right patient at the right time.", {"entities": []}], ["This approach often incorporates the use of companion diagnostics (CDx) assays that provide information essential for the safe and effective use of the corresponding drug.", {"entities": []}], ["In addition to oncology, many other therapy areas, such as cardiovascular, neurological, and infectious and inflammatory diseases, may benefit from PHC, owing to disease complexity and heterogeneity.", {"entities": []}], ["Furthermore, although most U.S. Food and Drug Administration\u2013approved CDx are based on molecular\u2010based technologies, immunoassays can provide a significant contribution to the evolution of CDx in patient management.", {"entities": []}], ["In this review we discuss how the incorporation of biomarker immunoassays into routine diagnostic testing may allow early and definitive detection of Alzheimer's disease and enable population enrichment in clinical trials.", {"entities": []}], ["In addition, we will describe how biomarker\u2010based CDx immunoassays have potential utility for stratifying patients with asthma based on their potential response to therapy and for selecting treatment according to phenotypic profile.", {"entities": [[120, 126, "DISEASE"]]}], ["Continued research into the underlying disease pathology and development of accurate and reliable diagnostic assays may ensure that PHC becomes the future standard for many indications.", {"entities": []}], ["Currently there are few studies characterising the nature and aetiology of human schistosome-related inflammatory processes.", {"entities": []}], ["The aim of this study was to determine the relationship between Chitinase 3-like 1 (CHI3L1), also known as YKL-40, a molecule associated with inflammatory processes, and schistosome infection, morbidity and systemic cytokine levels.", {"entities": [[84, 90, "GENE"]]}], ["Serological levels of CHI3L1 and a panel of cytokines (IFN-y, IL-4/5/6/9/10/13 and 17) were measured in two Zimbabwean populations resident in a high and low schistosome infection area.", {"entities": [[22, 28, "GENE"]]}], ["CHI3L1 levels were related to schistosome infection, haematuria status and cytokine levels after allowing for confounding variables.", {"entities": [[0, 6, "GENE"]]}], ["The effect of antihelminthic treatment with praziquantel on CHI3L1 levels was determined in 246 participants 6 weeks post-treatment.", {"entities": [[60, 66, "GENE"]]}], ["CHI3L1 levels increased with age in both areas but were significantly higher in the high infection areas compared to the low infection area.", {"entities": [[0, 6, "GENE"]]}], ["CHI3L1 levels were also higher in infected compared to uninfected individuals with this difference being significant in the youngest age group.", {"entities": [[0, 6, "GENE"]]}], ["Curative antihelminthic treatment resulted in a significant decrease in CHI3L1 levels.", {"entities": [[72, 78, "GENE"]]}], ["Of the cytokines, only IL-10 and IL-17 had a significant association with CHI3L1 levels, and this association was negative.", {"entities": [[74, 80, "GENE"]]}], ["Serum CHI3L1 levels differ between infected and uninfected people before and after antihelminthic treatment.", {"entities": [[6, 12, "GENE"]]}], ["The greatest difference occurs in the youngest age group, in keeping with the period when schistosome-related pathological processes are initiated.", {"entities": []}], ["Following from previous studies in non-infectious diseases showing that CHI3L1 is a biomarker for the inflammatory process, this study suggests that the potential for CHI3L1 as a biomarker for schistosome-related pathology should be explored further.", {"entities": [[72, 78, "GENE"], [167, 173, "GENE"], [72, 78, "GENE"], [167, 173, "GENE"]]}], ["Over 100 million people, mainly living in sub-Saharan Africa, are infected with the blood fluke Schistosoma haematobium .", {"entities": []}], ["Morbidity includes anaemia, malnutrition, impaired cognition and physical growth as well as pathology of the urogenital tract.", {"entities": []}], ["Urogenital morbidity is initiated by eggs laid at the site of infection causing mechanical damage and leading to haematuria, or blood in the urine.", {"entities": []}], ["Eggs also secrete antigens, triggering a protective granuloma to form around the eggs which can lead to fibrosis and organ failure.", {"entities": []}], ["Currently there are few non invasive markers of schistosome-related pathology hampering diagnosis and evaluation of control programmes.", {"entities": []}], ["Chitinase 3-like 1 (CHI3L1) has been associated with several inflammatory disorders involving tissue remodelling.", {"entities": [[20, 26, "GENE"]]}], ["In this study we assessed the levels of CHI3L1 in a group of individuals from a schistosomiasis endemic area in Zimbabwe.", {"entities": [[80, 95, "DISEASE"], [40, 46, "GENE"]]}], ["We showed that CHI3L1 is elevated in schistosomiasis infected individuals over uninfected individuals, with the strongest association seen in the youngest age group who have a shorter history of schistosome infection.", {"entities": [[37, 52, "DISEASE"], [15, 21, "GENE"]]}], ["Treating individuals with a drug that eliminates the adult worm leads to a decrease in CHI3L1 in infected individuals.", {"entities": [[87, 93, "GENE"]]}], ["These results suggest that the potential for CHI3L1 as a biomarker for schistosomerelated pathology should be explored further in different human populations.", {"entities": [[45, 51, "GENE"]]}], ["Although Lactobacillus rhamnosus GG ATCC 53103 (LGG) has been consumed by 2 to 5 million people daily since the mid 1990s, there are few clinical trials describing potential harms of LGG, particularly in the elderly.", {"entities": []}], ["The primary objective of this open label clinical trial is to assess the safety and tolerability of 1\u00d710 Fifteen elderly volunteers, aged 66\u201380 years received LGG capsules containing 1\u00d710 There were no serious adverse events.", {"entities": []}], ["The 15 volunteers had a total of 47 events (range 1\u20137 per volunteer), 39 (83%) of which were rated as mild and 40% of which were considered related to consuming LGG.", {"entities": []}], ["Thirty-one (70%) of the events were expected, prompted symptoms while 16 were unexpected events.", {"entities": []}], ["The most common adverse events were gastrointestinal (bloating, gas, and nausea), 27 rated as mild and 3 rated as moderate.", {"entities": []}], ["In the exploratory analysis, the pro-inflammatory cytokine interleukin 8 decreased during LGG consumption, returning towards baseline one month after discontinuing LGG (p\u200a=\u200a0.038) while there was no difference in other pro- or anti-inflammatory plasma cytokines.", {"entities": []}], ["Lactobacillus rhamnosus GG ATCC 53103 is safe and well tolerated in healthy adults aged 65 years and older.", {"entities": []}], ["ClinicalTrials.gov NCT 01274598", {"entities": []}], ["Information on the economic effect of poor population health is needed to engage the business community in population health improvement.", {"entities": []}], ["In a competitive global market, the United States has high health care costs and poor outcomes (measured by such factors as healthy and productive lives) compared with other countries.", {"entities": []}], ["US business needs to understand population health and not focus just on the health of employees at the worksite.", {"entities": []}], ["We describe a long-term approach to population health, including incentives, and identify what is needed to engage business leadership in population health improvement.", {"entities": []}], ["Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infection in infants, causing significant morbidity and mortality.", {"entities": []}], ["No vaccine or specific, effective treatment is currently available.", {"entities": []}], ["A more complete understanding of the key components of effective host response to RSV and novel preventative and therapeutic interventions are urgently required.", {"entities": []}], ["Cathelicidins are host defense peptides, expressed in the inflamed lung, with key microbicidal and modulatory roles in innate host defense against infection.", {"entities": []}], ["In this article, we demonstrate that the human cathelicidin LL-37 mediates an antiviral effect on RSV by inducing direct damage to the viral envelope, disrupting viral particles and decreasing virus binding to, and infection of, human epithelial cells in vitro.", {"entities": []}], ["In addition, exogenously applied LL-37 is protective against RSV-mediated disease in vivo, in a murine model of pulmonary RSV infection, demonstrating maximal efficacy when applied concomitantly with virus.", {"entities": []}], ["Furthermore, endogenous murine cathelicidin, induced by infection, has a fundamental role in protection against disease in vivo postinfection with RSV.", {"entities": []}], ["Finally, higher nasal levels of LL-37 are associated with protection in a healthy human adult RSV infection model.", {"entities": []}], ["These data lead us to propose that cathelicidins are a key, nonredundant component of host defense against pulmonary infection with RSV, functioning as a first point of contact antiviral shield and having additional later-phase roles in minimizing the severity of disease outcome.", {"entities": []}], ["Consequently, cathelicidins represent an inducible target for preventative strategies against RSV infection and may inform the design of novel therapeutic analogs for use in established infection.", {"entities": []}], ["To describe the frequency of popular myths about and features of asthma treatment in children and adolescents in an urban area in southern Brazil.", {"entities": [[65, 71, "DISEASE"]]}], ["The parents or legal guardians of public school students (8-16 years of age) completed a specific questionnaire regarding their understanding of asthma, asthma control, and treatment characteristics.", {"entities": [[145, 151, "DISEASE"], [153, 159, "DISEASE"]]}], ["The sample included parents or legal guardians of students with asthma (n = 127) and healthy controls (n = 124).", {"entities": [[64, 70, "DISEASE"]]}], ["The study involved 251 parents or legal guardians, of whom 127 (68.5%) were the mothers and 130 (51.8%) were White.", {"entities": []}], ["The mean age of these participants was 38.47 \u00b1 12.07 years.", {"entities": []}], ["Of the participants in the asthma and control groups, 37 (29.1%) and 26 (21.0%), respectively, reported being afraid of using asthma medications, whereas 61 (48%) and 56 (45.2%), respectively, believed that using a metered dose inhaler can lead to drug dependence.", {"entities": [[248, 263, "DISEASE"], [27, 33, "DISEASE"], [126, 132, "DISEASE"]]}], ["However, only 17 (13.4%) and 17 (13.7%) of the participants in the asthma and control groups, respectively, reported being afraid of using oral corticosteroids.", {"entities": [[67, 73, "DISEASE"]]}], ["In the asthma group, 55 students (43.3%) were diagnosed with uncontrolled asthma, only 41 (32.3%) had a prescription or written treatment plan, and 38 (29.9%) used asthma medications regularly.", {"entities": [[7, 13, "DISEASE"], [74, 80, "DISEASE"], [164, 170, "DISEASE"]]}], ["Popular myths about asthma treatment were common in our sample, as were uncontrolled asthma and inappropriate asthma management.", {"entities": [[20, 26, "DISEASE"], [85, 91, "DISEASE"], [110, 116, "DISEASE"]]}], ["Further studies in this field should be conducted in other developing countries, as should evaluations of pediatric asthma treatment programs in public health systems.", {"entities": [[116, 122, "DISEASE"]]}], ["Ischiospinal dysostosis (ISD) is a polytopic dysostosis characterized by ischial hypoplasia, multiple segmental anomalies of the cervicothoracic spine, hypoplasia of the lumbrosacral spine and occasionally associated with nephroblastomatosis.", {"entities": [[13, 23, "DISEASE"], [45, 55, "DISEASE"]]}], ["ISD is similar to, but milder than the lethal/semilethal condition termed diaphanospondylodysostosis (DSD), which is associated with homozygous or compound heterozygous mutations of bone morphogenetic protein-binding endothelial regulator protein ( BMPER ) gene.", {"entities": [[249, 254, "GENE"]]}], ["Here we report for the first time biallelic BMPER mutations in two patients with ISD, neither of whom had renal abnormalities.", {"entities": [[44, 49, "GENE"]]}], ["Our data supports and further extends the phenotypic variability of BMPER- related skeletal disorders.", {"entities": []}], ["The online version of this article (doi:10.1186/s13023-015-0380-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Numerous chemicals are capable of disrupting androgen production, but the possibility that they might act together to produce effects greater than those of the most effective component in the mixture has not been studied directly in human tissues.", {"entities": []}], ["Suppression of androgen synthesis in fetal life has been associated with testis maldescent, malformations of the genitalia at birth, and poor semen quality later in life.", {"entities": []}], ["Our aim was to investigate whether chemicals can act together to disrupt androgen production in human fetal testis explants and to evaluate the importance of mixture effects when characterizing the hazard of individual chemicals.", {"entities": []}], ["We used an organotypic culture system of human fetal testes explants called FEtal Gonad Assay (FEGA) with tissue obtained at 10 and 12 gestational wk (GW 10\u201312), to screen 27 chemicals individually for their possible anti-androgenic effect.", {"entities": []}], ["Based on the results of the screen, we selected 11 compounds and tested them as mixtures.", {"entities": []}], ["We evaluated mixtures composed of four and eight antiandrogens that contained the pharmaceuticals ketoconazole and theophylline and several previously untested chemicals, such as the pesticides imazalil and propiconazole.", {"entities": []}], ["Mixtures of antiandrogens can suppress testosterone synthesis in human fetal testicular explants to an extent greater than that seen with individual chemicals.", {"entities": []}], ["This revealed itself as a shift towards lower doses in the dose\u2013response curves of individual antiandrogens that became more pronounced as the number of components increased from four to eight.", {"entities": []}], ["Our results with the FEGA provide the foundations of a predictive human mixture risk assessment approach for anti-androgenic exposures in fetal life.", {"entities": []}], ["https://doi.org/10.1289/EHP1014", {"entities": []}], ["Most of general practitioners (GPs) use advertising in their waiting rooms for patient\u2019s education purposes.", {"entities": []}], ["Patients vaccinated against seasonal influenza have been gradually lessening.", {"entities": [[37, 46, "DISEASE"]]}], ["The objective of this trial was to assess the effect of an advertising campaign for influenza vaccination using posters and pamphlets in GPs\u2019 waiting rooms.", {"entities": [[84, 93, "DISEASE"]]}], ["Registry based 2/1 cluster randomized controlled trial, a cluster gathering the enlisted patients of 75 GPs aged over 16 years.", {"entities": []}], ["The trial, run during the 2014\u20132015 influenza vaccination campaign, compared patient\u2019s awareness from being in 50 GPs\u2019 standard waiting rooms (control group) versus that of waiting in 25 rooms from GPs who had received and exposed pamphlets and one poster on influenza vaccine (intervention group), in addition to standard mandatory information.", {"entities": [[36, 45, "DISEASE"], [259, 268, "DISEASE"]]}], ["The main outcome was the number of vaccination units delivered in pharmacies.", {"entities": []}], ["Data were extracted from the SIAM-ERASME claim database of the Health Insurance Fund of Lille-Douai (France).", {"entities": []}], ["The association between the intervention (yes/no) and the main outcome was assessed through a generalized estimating equation.", {"entities": []}], ["Seventy-five GPs enrolled 10,597 patients over 65 years or suffering from long lasting diseases (intervention/control as of 3781/6816 patients) from October 15, 2014 to February 28, 2015.", {"entities": []}], ["No difference was found regarding the number of influenza vaccination units delivered (Relative Risk (RR) = 1.01; 95% Confidence interval: 0.97 to 1.05; p = 0 .", {"entities": [[48, 57, "DISEASE"]]}], ["Effects of the monothematic campaign promoting vaccination against influenza using a poster and pamphlets exposed in GPs\u2019 waiting rooms could not be demonstrated.", {"entities": [[67, 76, "DISEASE"]]}], ["Lipopolysaccharide (LPS) is involved in a variety of inflammatory disorders.", {"entities": []}], ["Under stress conditions, endoplasmic reticulum (ER) loses the homeostasis in its functions, which is defined as ER stress.", {"entities": []}], ["Little is known how ER stress is implicated in LPS-induced lung inflammation.", {"entities": []}], ["In this study, effects of inhibition of ER stress on LPS-induced lung inflammation and transcriptional regulation were examined.", {"entities": []}], ["An ER stress regulator, 4-phenylbutyrate (PBA) reduced LPS-induced increases of various ER stress markers in the lung.", {"entities": []}], ["Furthermore, inhibition of ER stress reduced the LPS-induced lung inflammation.", {"entities": []}], ["Moreover, LPS-induced increases of NF-\u03baB and HIF-1\u03b1 activity were lowered by inhibition of ER stress.", {"entities": []}], ["These results suggest that inhibition of ER stress ameliorates LPS-induced lung inflammation through modulation of NF-\u03baB/I\u03baB and HIF-1\u03b1 signaling pathway.", {"entities": []}], ["Background.", {"entities": []}], ["Chemokines may be involved in the pathogenesis of urticaria, but their correlation with disease severity as well as eruption type is unclear.", {"entities": [[50, 59, "DISEASE"]]}], ["Objectives.", {"entities": []}], ["The aim of this study was to explore the expression of chemokines in patients with urticaria.", {"entities": [[83, 92, "DISEASE"]]}], ["The association between disease severity and levels of chemokines was analysed.", {"entities": []}], ["Materials and Methods.", {"entities": []}], ["Serums CCL11, CCL17, CCL26, and CCL27, D-dimer, C-reactive protein, and total IgE were measured in 51 patients with urticaria and in 25 healthy control subjects.", {"entities": [[116, 125, "DISEASE"], [7, 12, "GENE"], [14, 19, "GENE"], [21, 26, "GENE"], [32, 37, "GENE"]]}], ["Serums CCL11, CCL17, CCL26, and CCL27 were significantly higher in patients with urticaria than in the healthy controls ( P < 0.05).", {"entities": [[81, 90, "DISEASE"], [7, 12, "GENE"], [14, 19, "GENE"], [21, 26, "GENE"], [32, 37, "GENE"]]}], ["Serum CCL27 strongly correlated with urticarial disease severity.", {"entities": [[6, 11, "GENE"]]}], ["Serums CCL17, CCL26, and CCL27 significantly correlated with D-dimer, while innercorrelations were noted among the chemokines.", {"entities": [[7, 12, "GENE"], [14, 19, "GENE"], [25, 30, "GENE"]]}], ["Conclusion.", {"entities": []}], ["Our findings reveal that chemokines participate in the pathogenesis of urticaria.", {"entities": [[71, 80, "DISEASE"]]}], ["Further study in larger cohort is needed to testify whether they could be the biomarkers for predicting the severity of urticaria.", {"entities": [[120, 129, "DISEASE"]]}], ["Surfactant protein C (SP-C) is important for the function of pulmonary surfactant.", {"entities": []}], ["Heterozygous mutations in SFTPC , the gene encoding SP-C, cause sporadic and familial interstitial lung disease (ILD) in children and adults.", {"entities": [[86, 111, "DISEASE"], [99, 111, "DISEASE"], [26, 31, "GENE"]]}], ["Mutations mapping to the BRICHOS domain located within the SP-C proprotein result in perinuclear aggregation of the proprotein.", {"entities": []}], ["In this study, we investigated the effects of the mutation A116D in the BRICHOS domain of SP-C on cellular homeostasis.", {"entities": []}], ["We also evaluated the ability of drugs currently used in ILD therapy to counteract these effects.", {"entities": []}], ["SP-C Stable expression of SP-C We show that the A116D mutation leads to impaired processing of proSP-C in alveolar epithelial cells, alters cell viability and lipid composition, and also activates cells of the immune system.", {"entities": []}], ["In addition, we show that some of the effects of the mutation on cellular homeostasis can be antagonized by application of pharmaceuticals commonly applied in ILD therapy.", {"entities": []}], ["Our findings shed new light on the pathomechanisms underlying SP-C deficiency associated ILD and provide insight into the mechanisms by which drugs currently used in ILD therapy act.", {"entities": []}], ["This paper reports the results of a clinical study that tested the effect of systemic treatment with the botanical product Gene-Eden-VIR/Novirin on the clearance rate (also called time to clearance) of the human papillomavirus (HPV).", {"entities": []}], ["The study compared the clearance rate in treated and untreated individuals suffering from a symptomatic HPV infection.", {"entities": []}], ["The data on the untreated individuals were obtained by reverse engineering of the Kaplan\u2013Meier figures in five published papers.", {"entities": []}], ["The study included 59 treated participants.", {"entities": []}], ["All participants were suffering from a symptomatic HPV infection prior to the commencement of treatment.", {"entities": []}], ["The treatment was one to four capsules of Gene-Eden-VIR/Novirin per day.", {"entities": []}], ["The duration of treatment was 2\u201312 months.", {"entities": []}], ["The study included five groups of external controls with diverse characteristics.", {"entities": []}], ["The mean time to clearance in Gene-Eden-VIR/Novirin-treated individuals was 5.1 months or 151.5 days (95% CI: 4.2\u20135.9 months or 95% CI: 125.7\u2013177.3 days, respectively).", {"entities": []}], ["The median time to clearance was 3.5 months.", {"entities": []}], ["The mean time to clearance in the five untreated groups ranged from 6.9 to 20.0 months ( P <0.0001 for the difference between treatment group and each untreated group).", {"entities": []}], ["Also, 100% of the participants in the treatment group were HPV free at the end of 12 months vs 53%, 52%, 65%, 20%, and 77% in the untreated control groups.", {"entities": []}], ["The treated participants reported no adverse experiences.", {"entities": []}], ["This clinical study has two major contributions.", {"entities": []}], ["First, it showed that systemic treatment with the natural Gene-Eden-VIR/Novirin decreased the time to HPV clearance, increased the percentage of HPV-free individuals, and caused no adverse experiences in individuals suffering from a symptomatic HPV infection.", {"entities": []}], ["Since there are no other systemic treatments for symptomatic HPV infections, this study presents highly valuable information on the clinical effects of the first treatment in this category.", {"entities": []}], ["Second, the study presents a new method for conducting clinical studies that addresses one of the major deficiencies associated with the practice of the randomized controlled trial method.", {"entities": []}], ["Epigenetic mechanisms, such as DNA methylation, DNA hydroxymethylation, post-translational modifications (PTMs) of histone proteins affecting nucleosome remodelling, and regulation by small and large non-coding RNAs (ncRNAs) work in concert with cis and trans acting elements to drive appropriate gene expression.", {"entities": [[106, 110, "GENE"]]}], ["Advances in detection methods and development of dedicated platforms and methylation arrays resulted in an explosion of information on aberrantly methylated sequences linking deviations in epigenetic landscape with the initiation and progression of complex diseases.", {"entities": []}], ["Here, we consider how DNA methylation changes in malignancies, such as breast, pancreatic, colorectal, and gastric cancer could be exploited for the purpose of developing specific diagnostic tools.", {"entities": [[115, 121, "DISEASE"]]}], ["DNA methylation changes can be applicable as biomarkers for detection of malignant disease in easily accessible tissues.", {"entities": []}], ["Methylation signatures are already proving to be an important marker for determination of drug sensitivity.", {"entities": []}], ["Even more, promoter methylation patterns of some genes, such as MGMT, SHOX2 , and SEPT9 , have already been translated into commercial clinical assays aiding in patient assessment as adjunct diagnostic tools.", {"entities": [[64, 68, "GENE"], [70, 75, "GENE"], [82, 87, "GENE"]]}], ["In conclusion, the changes in DNA methylation patterns in tumour cells are slowly gaining entrance into routine diagnostic tests as promising biomarkers and as potential therapeutic targets.", {"entities": []}], ["Multifunctional calcium/calmodulin-dependent kinase II (CaMKII) is activated by angiotensin II (Ang II) in cultured vascular smooth muscle cells (VSMCs), but its function in experimental hypertension has not been explored.", {"entities": [[187, 199, "DISEASE"], [96, 99, "GENE"]]}], ["The aim of this study was to determine the impact of CaMKII inhibition selectively in VSMCs on Ang II hypertension.", {"entities": [[102, 114, "DISEASE"], [95, 98, "GENE"]]}], ["Transgenic expression of a CaMKII peptide inhibitor in VSMCs (TG SM-CaMKIIN model) reduced the blood pressure response to chronic Ang II infusion.", {"entities": [[62, 64, "GENE"], [130, 133, "GENE"]]}], ["The aortic depressor nerve activity was reset in hypertensive versus normotensive wild-type animals but not in TG SM-CaMKIIN mice, suggesting that changes in baroreceptor activity account for the blood pressure difference between genotypes.", {"entities": [[111, 113, "GENE"]]}], ["Accordingly, aortic pulse wave velocity, a measure of arterial wall stiffness and a determinant of baroreceptor activity, increased in hypertensive versus normotensive wild-type animals but did not change in TG SM-CaMKIIN mice.", {"entities": [[208, 210, "GENE"]]}], ["Moreover, examination of blood pressure and heart rate under ganglionic blockade revealed that VSMC CaMKII inhibition abolished the augmented efferent sympathetic outflow and renal and splanchnic nerve activity in Ang II hypertension.", {"entities": [[221, 233, "DISEASE"], [214, 217, "GENE"]]}], ["Consequently, we hypothesized that VSMC CaMKII controls baroreceptor activity by modifying arterial wall remodeling in Ang II hypertension.", {"entities": [[126, 138, "DISEASE"], [119, 122, "GENE"]]}], ["Gene expression analysis in aortas from normotensive and Ang II\u2013infused mice revealed that TG SM-CaMKIIN aortas were protected from Ang II\u2013induced upregulation of genes that control extracellular matrix production, including collagen.", {"entities": [[57, 60, "GENE"], [132, 135, "GENE"], [91, 93, "GENE"], [57, 60, "GENE"], [132, 135, "GENE"]]}], ["VSMC CaMKII inhibition also strongly altered the expression of muscle contractile genes under Ang II.", {"entities": [[94, 97, "GENE"]]}], ["CaMKII in VSMCs regulates blood pressure under Ang II hypertension by controlling structural gene expression, wall stiffness, and baroreceptor activity.", {"entities": [[54, 66, "DISEASE"], [47, 50, "GENE"]]}], ["Eosinophils are the source of various immunoregulatory cytokines, but the membrane molecules involved in their secretion have not been clearly identified.", {"entities": []}], ["Here we show that peripheral blood eosinophils from hypereosinophilic patients could express membrane CD86 but not CD80.", {"entities": [[102, 106, "GENE"], [115, 119, "GENE"]]}], ["The T cell costimulatory molecule CD28 is also detected on the eosinophil surface.", {"entities": [[34, 38, "GENE"]]}], ["CD28 ligation but not CD86 ligation resulted in interleukin (IL)-2 and interferon (IFN)-\u03b3 secretion by eosinophils, whereas IL-4, IL-5, and IL-10 were not detected.", {"entities": [[0, 4, "GENE"], [22, 26, "GENE"]]}], ["In contrast to T cells requiring two signals for effective stimulation, CD28 ligation alone was sufficient for optimal eosinophil activation.", {"entities": [[72, 76, "GENE"]]}], ["Eosinophil-derived IL-2 and IFN-\u03b3 were biologically active, as supernatants from anti-CD28\u2013treated cells were able to induce CTLL-2 proliferation and major histocompatibility complex class II expression on the colon carcinoma cell line Colo 205, respectively.", {"entities": [[216, 225, "DISEASE"], [210, 225, "DISEASE"]]}], ["Addition of secretory immunoglobulin (Ig)A\u2013anti-IgA complexes, which could induce the release of IL-10, very significantly inhibited both CD28-mediated IL-2 and IFN-\u03b3 release.", {"entities": []}], ["These results suggest that the release of type 1 (IFN-\u03b3 and IL-2) versus type 2 cytokines by eosinophils is not only differential but also dependent on cross-regulatory signals.", {"entities": []}], ["They confirm that through activation of costimulatory molecules, eosinophils could function as an immunoregulatory cell involved in the release of both type 1 and type 2 cytokines.", {"entities": []}], ["The incidence of allergic diseases in most industrialized countries has increased.", {"entities": []}], ["Although the exact mechanisms behind this rapid increase in prevalence remain uncertain, a variety of air pollutants have been attracting attention as one causative factor.", {"entities": []}], ["Epidemiological and toxicological research suggests a causative relationship between air pollution and the increased incidence of asthma, allergic rhinitis, and other allergic disorders.", {"entities": [[138, 155, "DISEASE"], [147, 155, "DISEASE"], [130, 136, "DISEASE"]]}], ["These include ozone, nitrogen dioxide and, especially particulate matter, produced by traffic-related and industrial activities.", {"entities": []}], ["Strong epidemiological evidence supports a relationship between air pollution and the exacerbation of asthma and other respiratory diseases.", {"entities": [[102, 108, "DISEASE"]]}], ["Recent studies have suggested that air pollutants play a role in the development of asthma and allergies.", {"entities": [[84, 90, "DISEASE"]]}], ["Researchers have elucidated the mechanisms whereby these pollutants induce adverse effects; they appear to affect the balance between antioxidant pathways and airway inflammation.", {"entities": []}], ["Gene polymorphisms involved in antioxidant pathways can modify responses to air pollution exposure.", {"entities": []}], ["While the characterization and monitoring of pollutant components currently dictates pollution control policies, it will be necessary to identify susceptible subpopulations to target therapy/prevention of pollution-induced respiratory diseases.", {"entities": []}], ["Glucocorticoids (GC) and 1,25-dihydroxyvitamin D3 (1,25(OH) 2 D3) are steroid hormones with anti-inflammatory properties with enhanced effects when combined.", {"entities": [[17, 19, "GENE"]]}], ["We previously showed that transcriptional response to GCs was correlated with inter-individual and inter-ethnic cellular response.", {"entities": []}], ["Here, we profiled cellular and transcriptional responses to 1,25(OH) 2 D3 from the same donors.", {"entities": []}], ["We studied cellular response to combined treatment with GCs and 1,25(OH) 2 D3 in a subset of individuals least responsive to GCs.", {"entities": []}], ["We found that combination treatment had significantly greater inhibition of proliferation than with either steroid hormone alone.", {"entities": []}], ["Overlapping differentially expressed (DE) genes between the two hormones were enriched for adaptive and innate immune processes.", {"entities": []}], ["Non-overlapping differentially expressed genes with 1,25(OH) 2 D3 treatment were enriched for pathways involving the electron transport chain, while with GC treatment, non-overlapping genes were enriched for RNA-related processes.", {"entities": [[154, 156, "GENE"]]}], ["These results suggest that 1,25(OH) 2 D3 enhances GC anti-inflammatory properties through a number of shared and non-shared transcriptionally-mediated pathways.", {"entities": [[50, 52, "GENE"]]}], ["The complement system modulates the intensity of innate and specific immunity.", {"entities": []}], ["While it protects against infections by extracellular bacteria its role in infection with obligate intracellular bacteria, such as the avian and human pathogen Chlamydia (C.) psittaci , is still unknown.", {"entities": []}], ["In the present study, knockout mice lacking C3 and thus all main complement effector functions were intranasally infected with C. psittaci strain DC15.", {"entities": [[44, 46, "GENE"]]}], ["Clinical parameters, lung histology, and cytokine levels were determined.", {"entities": []}], ["A subset of infections was additionally performed with mice lacking C5 or C5a receptors.", {"entities": [[68, 70, "GENE"]]}], ["Complement activation occurred before symptoms of pneumonia appeared.", {"entities": [[50, 59, "DISEASE"]]}], ["Mice lacking C3 were \u223c100 times more susceptible to the intracellular bacteria compared to wild-type mice, with all C3 C. psittaci .", {"entities": [[13, 15, "GENE"], [116, 118, "GENE"], [13, 15, "GENE"], [116, 118, "GENE"]]}], ["A major barrier to accessing free government-provided antiretroviral treatment (ART) in South Africa is the shortage of suitably skilled health professionals.", {"entities": []}], ["Current South African guidelines recommend that only doctors should prescribe ART, even though most primary care is provided by nurses.", {"entities": []}], ["We have developed an effective method of educational outreach to primary care nurses in South Africa.", {"entities": []}], ["Evidence is needed as to whether primary care nurses, with suitable training and managerial support, can initiate and continue to prescribe and monitor ART in the majority of ART-eligible adults.", {"entities": []}], ["This is a protocol for a pragmatic cluster randomised trial to evaluate the effectiveness of a complex intervention based on and supporting nurse-led antiretroviral treatment (ART) for South African patients with HIV/AIDS, compared to current practice in which doctors are responsible for initiating ART and continuing prescribing.", {"entities": []}], ["We will randomly allocate 31 primary care clinics in the Free State province to nurse-led or doctor-led ART.", {"entities": []}], ["Two groups of patients aged 16 years and over will be included: a) 7400 registering with the programme with CD4 counts of \u2264 350 cells/mL (mainly to evaluate treatment initiation) and b) 4900 already receiving ART (to evaluate ongoing treatment and monitoring).", {"entities": [[108, 111, "GENE"]]}], ["The primary outcomes will be time to death (in the first group) and viral suppression (in the second group).", {"entities": []}], ["Patients' survival, viral load and health status indicators will be measured at least 6-monthly for at least one year and up to 2 years, using an existing province-wide clinical database linked to the national death register.", {"entities": []}], ["Controlled Clinical Trials ISRCTN46836853", {"entities": []}], ["Sudden infant death syndrome (SIDS) is marked by \u2018the sudden death of an infant that is unexpected by history and remains unexplained after a thorough forensic autopsy and a detailed death scene investigation\u2019.", {"entities": [[20, 28, "DISEASE"]]}], ["The cause is unknown.", {"entities": []}], ["Excessive subglottic submucosal glandular tissue and excessive sulphated mucus glycoprotein in the larynges of SIDS babies have been previously reported from our institution.", {"entities": []}], ["We now report on laryngeal immunohistology.", {"entities": []}], ["Larynges from 7 children who died from Sudden Infant Death Syndrome (SIDS) at under 16 weeks of age were examined immunohistologically and compared to those from 8 age- matched control infants who died from other causes.", {"entities": [[59, 67, "DISEASE"]]}], ["The SIDS babies had increased inflammatory changes in the laryngeal epithelium and sub- epithelium with raised numbers of cells staining for elastase (p<0.01), EG2(a marker for activated eosinophils) (p<0.01) and CD4(p<0.05) suggesting that some SIDS deaths involve preceding inflammation.", {"entities": [[213, 216, "GENE"]]}], ["Although death may be sudden and unexpected it appears that, at least in some SIDS victims, there is a preceding inflammatory process in the larynx which may allow hyper-reactivity of laryngeal reflexes and consequent apnoea.", {"entities": []}], ["This observation concurs with others in the SIDS literature and offers a field for further research and possible prevention.", {"entities": []}], ["Acute lower respiratory infections (ALRI) are a major cause of hospitalisation in young children.", {"entities": []}], ["Many factors can lead to increased risk of ALRI in children and predispose a child to hospitalisation, but population attributable fractions for different risk factors and how these fractions differ between Indigenous and non-Indigenous children is unknown.", {"entities": []}], ["This study investigates population attributable fractions of known infant and maternal risk factors for ALRI to inform prevention strategies that target high-risk groups or particular risk factors.", {"entities": []}], ["A retrospective population-based data linkage study of 245,249 singleton births in Western Australia.", {"entities": []}], ["Population attributable fractions of known maternal and infant risk factors for hospitalisation with ALRI between 1996 and 2005 were calculated using multiple logistic regression.", {"entities": []}], ["The overall ALRI hospitalisation rate was 16.1/1,000 person-years for non-Aboriginal children and 93.0/1,000 for Aboriginal children.", {"entities": []}], ["Male gender, being born in autumn, gestational age <33 weeks, and multiple previous pregnancies were significant risk factors for ALRI in both Aboriginal and non-Aboriginal children.", {"entities": []}], ["In non-Aboriginal children, maternal smoking during pregnancy accounted for 6.3% (95%CI: 5.0, 7.6) of the population attributable fraction for ALRI, being born in autumn accounted for 12.3% (10.8, 13.8), being born to a mother with three or more previous pregnancies accounted for 15.4% (14.1, 17.0) and delivery by elective caesarean accounted for 4.1% (2.8, 5.3).", {"entities": []}], ["In Aboriginal children, being born to a mother with three or more previous pregnancies accounted for 16.5% (11.8, 20.9), but remote location at birth accounted for 11.7% (8.5, 14.8), maternal age <20 years accounted for 11.2% (7.8, 14.5), and being in the most disadvantaged socio-economic group accounted for 18.4% (-6.5, 37.4) of the population attributable fraction.", {"entities": []}], ["The population attributable fractions estimated in this study should help in guiding public health interventions to prevent ALRI.", {"entities": []}], ["A key risk factor for all children is maternal smoking during pregnancy, and multiple previous pregnancies and autumnal births are important high-risk groups.", {"entities": []}], ["Specific key target areas are reducing elective caesareans in non-Aboriginal women and reducing teenage pregnancies and improving access to services and living conditions for the Aboriginal population.", {"entities": []}], ["The host defense system with lysozyme and secretory phospholipase A2 (sPLA2) was immunohistochemically investigated in rat respiratory tract under healthy conditions.", {"entities": []}], ["In the nasal epithelium, a large number of non-ciliated and non-microvillous cells (NC) and a small number of goblet cells (GC) were immunopositive for lysozyme and sPLA2.", {"entities": [[124, 126, "GENE"]]}], ["A few acinar cells and almost all epithelial cells of intercalated ducts were immunopositive for both bactericidal substances in the nasal glands.", {"entities": []}], ["In the laryngeal and tracheal epithelia, few NC and GC were immunopositive for both bactericidal substances.", {"entities": [[52, 54, "GENE"]]}], ["In the laryngeal and tracheal glands, a few acinar cells and most ductal epithelial cells were immunopositive for both bactericidal substances.", {"entities": []}], ["In extra-pulmonary bronchus, small numbers of NC and GC were immunopositive for lysozyme and sPLA2, whereas few NC and no GC were immunopositive in the intra-pulmonary bronchus.", {"entities": [[53, 55, "GENE"], [122, 124, "GENE"], [53, 55, "GENE"], [122, 124, "GENE"]]}], ["No secretory source of either bactericidal substance was located in the bronchioles.", {"entities": []}], ["In the alveolus, many glandular epithelial cells and alveolar macrophages were immunopositive for lysozyme but immunonegative for sPLA2.", {"entities": []}], ["Moreover, lysozyme and sPLA2 were detected in the mucus layer and in the periciliary layer from the nose to the extra-pulmonary bronchus.", {"entities": []}], ["These findings suggest that secretory sources of lysozyme and sPLA2 are distributed in almost all the respiratory tract.", {"entities": []}], ["Their secretory products are probably transported to the pharynx and contribute to form the first line of defense against inhaled bacteria throughout the respiratory tract.", {"entities": []}], ["The microbial residents of the human gut are a major factor in the development and lifelong maintenance of health.", {"entities": []}], ["The gut microbiota differs to a large degree from person to person and has an important influence on health and disease due to its interaction with the human immune system.", {"entities": []}], ["Its overall composition and microbial ecology have been implicated in many autoimmune diseases, and it represents a particularly important area for translational research as a new target for diagnostics and therapeutics in complex inflammatory conditions.", {"entities": []}], ["Determining the biomolecular mechanisms by which altered microbial communities contribute to human disease will be an important outcome of current functional studies of the human microbiome.", {"entities": []}], ["In this review, we discuss functional profiling of the human microbiome using metagenomic and metatranscriptomic approaches, focusing on the implications for inflammatory conditions such as inflammatory bowel disease and rheumatoid arthritis.", {"entities": [[190, 216, "DISEASE"], [221, 241, "DISEASE"], [232, 241, "DISEASE"]]}], ["Common themes in gut microbial ecology have emerged among these diverse diseases, but they have not yet been linked to targetable mechanisms such as microbial gene and genome composition, pathway and transcript activity, and metabolism.", {"entities": []}], ["Combining these microbial activities with host gene, transcript and metabolic information will be necessary to understand how and why these complex interacting systems are altered in disease-associated inflammation.", {"entities": []}], ["There is conflicting evidence about resting carbon dioxide levels in asthmatic individuals.", {"entities": []}], ["We wanted to determine if transcutaneously measured carbon dioxide levels prior and during bronchial provocation testing differ according to asthma status reflecting dysfunctional breathing.", {"entities": [[141, 147, "DISEASE"]]}], ["We investigated active firefighters and policemen by means of a validated questionnaire on respiratory symptoms, spirometry, bronchial challenge testing with methacholine (MCT) and measurement of transcutaneous blood carbon dioxide partial pressure (PtcCO 2 ) at rest prior performing spirometry, one minute and five minutes after termination of MCT.", {"entities": []}], ["A respiratory physician blinded to the PtcCO 2 results assigned a diagnosis of asthma after reviewing the available study data and the files of the workers medical screening program.", {"entities": [[79, 85, "DISEASE"]]}], ["The study sample consisted of 128 male and 10 female individuals.", {"entities": []}], ["Fifteen individuals (11%) had physician-diagnosed asthma.", {"entities": [[50, 56, "DISEASE"]]}], ["There was no clinically important difference in median PtcCO 2 at rest, one and five minutes after recovery from MCT in asthmatics compared to non-asthmatics (35.6 vs 35.7 mmHg, p\u200a=\u200a0.466; 34.7 vs 33.4 mmHg, p\u200a=\u200a0.245 and 37.4 vs 36.4 mmHg, p\u200a=\u200a0.732).", {"entities": []}], ["The median drop in PtcCO 2 during MCT and the increase after MCT was lower in asthmatics compared to non-asthmatics (0.1 vs 3.2 mmHg, p\u200a=\u200a0.014 and 1.9 vs 2.9 mmHg, p\u200a=\u200a0.025).", {"entities": []}], ["PtcCO 2 levels at rest prior and during recovery after MCT do not differ in individuals with or without physician diagnosed asthma.", {"entities": [[124, 130, "DISEASE"]]}], ["The fall and subsequent increase in PtcCO 2 levels are higher in non-asthmatics than in asthmatics and seems to be related with increased number of respiratory maneuvers during MCT.", {"entities": []}], ["Rhinovirus (RV) infection is a major cause of asthma exacerbations which may be due to a deficient innate immune response in the bronchial epithelium.", {"entities": [[46, 52, "DISEASE"]]}], ["We hypothesized that the pleiotropic cytokine, TGF-\u03b2, influences interferon (IFN) production by primary bronchial epithelial cells (PBECs) following RV infection.", {"entities": []}], ["Exogenous TGF-\u03b2 2 increased RV replication and decreased IFN protein secretion in response to RV or double-stranded RNA (dsRNA).", {"entities": []}], ["Conversely, neutralizing TGF-\u03b2 antibodies decreased RV replication and increased IFN expression in response to RV or dsRNA.", {"entities": []}], ["Endogenous TGF-\u03b2 2 levels were higher in conditioned media of PBECs from asthmatic donors and the suppressive effect of anti-TGF-\u03b2 on RV replication was significantly greater in these cells.", {"entities": []}], ["Basal SMAD-2 activation was reduced when asthmatic PBECs were treated with anti-TGF-\u03b2 and this was accompanied by suppression of SOCS-1 and SOCS-3 expression.", {"entities": [[129, 135, "GENE"]]}], ["Our results suggest that endogenous TGF-\u03b2 contributes to a suppressed IFN response to RV infection possibly via SOCS-1 and SOCS-3.", {"entities": [[112, 118, "GENE"]]}], ["Mechanical properties of living cells can be used as reliable markers of their state, such as the presence of a pathological state or their differentiation phase.", {"entities": []}], ["The mechanical behavior of cells depends on the organization of their cytoskeletal network and the main contribution typically comes from the actomyosin contractile system, in both suspended and adherent cells.", {"entities": []}], ["In the present study, we investigated the effect of a pharmaceutical formulation (OTC \u2013 Ossitetraciclina liquida 20%) used as antibiotic, on the mechanical properties of K562 cells by using the Micropipette Aspiration Technique (MAT).", {"entities": [[82, 85, "GENE"]]}], ["This formulation has been shown to increase in a time dependent way the inflammation and toxicity in terms of apoptosis in in vitro experiments on K562 and other types of cells.", {"entities": []}], ["Here we show that by measuring the mechanical properties of cells exposed to OTC for different incubation times, it is possible to infer modifications induced by the formulation to the actomyosin contractile system.", {"entities": [[77, 80, "GENE"]]}], ["We emphasize that this system is involved in the first stages of the apoptotic process where an increase of the cortical tension leads to the formation of blebs.", {"entities": []}], ["We discuss the possible relation between the observed mechanical behavior of cells aspirated inside a micropipette and apoptosis.", {"entities": []}], ["There is emerging evidence of the role of certain nutrients as risk factors for frailty.", {"entities": []}], ["However, people eat food, rather than nutrients, and no previous study has examined the association between dietary patterns empirically derived from food consumption and the risk of frailty in older adults.", {"entities": []}], ["This is a prospective cohort study of 1,872 non-institutionalized individuals aged \u226560\u00a0years recruited between 2008 and 2010.", {"entities": []}], ["At baseline, food consumption was obtained with a validated diet history and, by using factor analysis, two dietary patterns were identified: a \u2018prudent\u2019 pattern, characterized by high intake of olive oil and vegetables, and a \u2018Westernized\u2019 pattern, with a high intake of refined bread, whole dairy products, and red and processed meat, as well as low consumption of fruit and vegetables.", {"entities": []}], ["Participants were followed-up until 2012 to assess incident frailty, defined as at least three of the five Fried criteria (exhaustion, weakness, low physical activity, slow walking speed, and unintentional weight loss).", {"entities": []}], ["Over a 3.5-year follow-up, 96 cases of incident frailty were ascertained.", {"entities": []}], ["The multivariate odds ratios (95% confidence interval) of frailty among those in the first (lowest), second, and third tertile of adherence to the prudent dietary pattern were 1, 0.64 (0.37\u20131.12), and 0.40 (0.2\u20130.81), respectively; P -trend\u2009=\u20090.009.", {"entities": []}], ["The corresponding values for the Westernized pattern were 1, 1.53 (0.85\u20132.75), and 1.61 (0.85\u20133.03); P -trend\u2009=\u20090.14.", {"entities": []}], ["Moreover, a greater adherence to the Westernized pattern was associated with an increasing risk of slow walking speed and weight loss.", {"entities": []}], ["In older adults, a prudent dietary pattern showed an inverse dose-response relationship with the risk of frailty while a Westernized pattern had a direct relationship with some of their components.", {"entities": []}], ["Clinical trials should test whether a prudent pattern is effective in preventing or delaying frailty.", {"entities": []}], ["To evaluate the effects of boceprevir (BOC) and telaprevir (TVR) on the pharmacokinetics (PK) of maraviroc (MVC) in healthy volunteers.", {"entities": [[39, 42, "GENE"]]}], ["In this open-label, fixed-sequence study, 14 volunteers received MVC 150 mg twice daily alone for 5 days (period 1), followed by MVC + BOC 800 mg 3 times daily and MVC + TVR 750 mg 3 times daily, each for 10 days in periods 2 and 3, respectively, with a \u226510-day wash-out.", {"entities": [[135, 138, "GENE"]]}], ["PK was analyzed on day 5 of period 1 and day 10 of periods 2 and 3.", {"entities": []}], ["Safety was also assessed.", {"entities": []}], ["Ratios of the adjusted geometric means (90% confidence intervals) for MVC area under the curve from predose to 12 hours, maximum plasma concentration, and plasma concentration at 12 hours were 3.02 (2.53 to 3.59), 3.33 (2.54 to 4.36), and 2.78 (2.40 to 3.23), respectively, for MVC + BOC versus MVC alone, and 9.49 (7.94 to 11.34), 7.81 (5.92 to 10.32), and 10.17 (8.73 to 11.85), respectively, for MVC + TVR versus MVC alone.", {"entities": [[284, 287, "GENE"]]}], ["PK profiles for MVC + BOC or TVR were consistent with historic values for BOC and TVR monotherapy.", {"entities": [[22, 25, "GENE"], [74, 77, "GENE"], [22, 25, "GENE"], [74, 77, "GENE"]]}], ["Adverse event incidence was higher with MVC + BOC and MVC + TVR versus MVC alone.", {"entities": [[46, 49, "GENE"]]}], ["Dysgeusia (50%) and pruritus (29%) occurred most commonly with MVC + BOC, and fatigue (46%) and headache (31%) with MVC + TVR.", {"entities": [[69, 72, "GENE"]]}], ["There were no serious adverse events.", {"entities": []}], ["MVC exposures were significantly increased with BOC or TVR, therefore MVC should be dosed at 150 mg twice daily when coadministered with these newly approved hepatitis C protease inhibitors.", {"entities": [[158, 167, "DISEASE"], [48, 51, "GENE"]]}], ["No dose adjustment for BOC or TVR is warranted with MVC.", {"entities": [[23, 26, "GENE"]]}], ["MVC + BOC or TVR was generally well tolerated with no unexpected safety findings.", {"entities": [[6, 9, "GENE"]]}], ["Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS).", {"entities": []}], ["In recent years, it has been found that cells such as human amnion epithelial cells (hAECs) have the ability to modulate immune responses in vitro and in vivo and can differentiate into multiple cell lineages.", {"entities": []}], ["Accordingly, we investigated the immunoregulatory effects of hAECs as a potential therapy in an MS-like disease, EAE (experimental autoimmune encephalomyelitis), in mice.", {"entities": [[142, 159, "DISEASE"]]}], ["Using flow cytometry, the phenotypic profile of hAECs from different donors was assessed.", {"entities": []}], ["The immunomodulatory properties of hAECs were examined in vitro using antigen-specific and one-way mixed lymphocyte proliferation assays.", {"entities": []}], ["The therapeutic efficacy of hAECs was examined using a relapsing-remitting model of EAE in NOD/Lt mice.", {"entities": []}], ["T cell responsiveness, cytokine secretion, T regulatory, and T helper cell phenotype were determined in the peripheral lymphoid organs and CNS of these animals.", {"entities": []}], ["In vitro, hAECs suppressed both specific and non-specific T cell proliferation, decreased pro-inflammatory cytokine production, and inhibited the activation of stimulated T cells.", {"entities": []}], ["Furthermore, T cells retained their na\u00efve phenotype when co-cultured with hAECs.", {"entities": []}], ["In vivo studies revealed that hAECs not only suppressed the development of EAE but also prevented disease relapse in these mice.", {"entities": []}], ["T cell responses and production of the pro-inflammatory cytokine interleukin (IL)-17A were reduced in hAEC-treated mice, and this was coupled with a significant increase in the number of peripheral T regulatory cells and na\u00efve CD4+ T cells.", {"entities": []}], ["Furthermore, increased proportions of Th2 cells in the peripheral lymphoid organs and within the CNS were observed.", {"entities": []}], ["The therapeutic effect of hAECs is in part mediated by inducing an anti-inflammatory response within the CNS, demonstrating that hAECs hold promise for the treatment of autoimmune diseases like MS.", {"entities": []}], ["Macrophage migration inhibitory factor ( MIF ) is a master regulator of proinflammatory cytokines and plays pathological roles when not properly regulated in rheumatoid arthritis, lupus, atherosclerosis, asthma and cancer.", {"entities": [[187, 202, "DISEASE"], [158, 178, "DISEASE"], [169, 178, "DISEASE"], [204, 210, "DISEASE"], [215, 221, "DISEASE"], [41, 44, "GENE"]]}], ["Unlike canonical cytokines, MIF has vestigial keto\u2010enol tautomerase activity.", {"entities": [[28, 31, "GENE"]]}], ["Most of the current MIF inhibitors were screened for the inhibition of this enzymatic activity.", {"entities": [[20, 23, "GENE"]]}], ["However, only some of the enzymatic inhibitors inhibit receptor\u2010mediated biological functions of MIF , such as cell recruitment, through an unknown molecular mechanism.", {"entities": [[97, 100, "GENE"]]}], ["The goal of this study was to understand the molecular basis underlying the pharmacological inhibition of biological functions of MIF .", {"entities": [[130, 133, "GENE"]]}], ["Here, we demonstrate how the structural changes caused upon inhibitor binding translate into the alteration of MIF \u2010induced downstream signalling.", {"entities": [[111, 114, "GENE"]]}], ["Macrophage migration inhibitory factor activates phosphoinositide 3\u2010kinases ( PI 3Ks) that play a pivotal role in immune cell recruitment in health and disease.", {"entities": []}], ["There are several different PI 3K isoforms, but little is known about how they respond to MIF .", {"entities": [[90, 93, "GENE"]]}], ["We demonstrate that MIF up\u2010regulates the expression of Class IB PI 3Ks in leucocytes.", {"entities": [[20, 23, "GENE"]]}], ["We also demonstrate that MIF tautomerase active site inhibitors down\u2010regulate the expression of Class IB PI 3Ks as well as leucocyte recruitment in vitro and in vivo .", {"entities": [[25, 28, "GENE"]]}], ["Finally, based on our MIF :inhibitor complex crystal structures, we hypothesize that the reduction in Class IB PI 3K expression occurs because of the displacement of Pro1 towards the second loop of MIF upon inhibitor binding, which results in increased flexibility of the loop 2 and sub\u2010optimal MIF binding to its receptors.", {"entities": [[22, 25, "GENE"], [198, 201, "GENE"], [295, 298, "GENE"], [22, 25, "GENE"], [198, 201, "GENE"], [295, 298, "GENE"], [22, 25, "GENE"], [198, 201, "GENE"], [295, 298, "GENE"]]}], ["These results will provide molecular insights for fine\u2010tuning the biological functions of MIF .", {"entities": [[90, 93, "GENE"]]}], ["Some studies have suggested that the immunogenicity of oats depends on the cultivar.", {"entities": []}], ["RP-HPLC has been proposed as a useful technique to select varieties of oats with reduced immunogenicity.", {"entities": []}], ["The aim of this study was to identify both the avenin protein patterns associated with low gluten content and the available variability for the development of new non-toxic oat cultivars.", {"entities": []}], ["The peaks of alcohol-soluble avenins of a collection of landraces and cultivars of oats have been characterized based on the RP-HPLC elution times.", {"entities": []}], ["The immunotoxicity of oat varieties for patients with celiac disease (CD) has been tested using a competitive ELISA based on G12 monoclonal antibody.", {"entities": [[54, 68, "DISEASE"]]}], ["The oat lines show, on average, seven avenin peaks giving profiles with certain similarities.", {"entities": []}], ["Based on this similarity, most of the accessions have been grouped into avenin patterns.", {"entities": []}], ["The variability of RP-HPLC profiles of the collection is great, but not sufficient to uniquely identify the different varieties of the set.", {"entities": []}], ["Overall, the immunogenicity of the collection is less than 20\u2009ppm.", {"entities": []}], ["However, there is a different distribution of toxicity ranges between the different peak patterns.", {"entities": []}], ["We conclude that the RP-HPLC technique is useful to establish groups of varieties differing in degree of toxicity for CD patients.", {"entities": []}], ["Supplemental Digital Content is available in the text.", {"entities": []}], ["Multiple studies of ovarian cancer and genital talc use have led only to consensus about possible carcinogenicity.", {"entities": [[20, 34, "DISEASE"], [28, 34, "DISEASE"]]}], ["Seeking greater clarity, we examined this association in 2,041 cases with epithelial ovarian cancer and 2,100 age- and-residence-matched controls.", {"entities": [[85, 99, "DISEASE"], [93, 99, "DISEASE"]]}], ["We defined genital talc use as regular application to the genital/rectal area directly, on sanitary napkins, tampons, or underwear.", {"entities": []}], ["To estimate \u201ctalc-years,\u201d we multiplied applications per year by years used.", {"entities": []}], ["Unconditional logistic regression, Wald statistics, likelihood-ratio tests, and polytomous logistic regression were used to calculate adjusted odds ratios (OR) and 95% confidence intervals (CI), trends, effect-modification, and heterogeneity by ovarian cancer histologic subtype.", {"entities": [[245, 259, "DISEASE"], [253, 259, "DISEASE"]]}], ["Overall, genital talc use was associated with an OR (95% CI) of 1.33 (1.16, 1.52), with a trend for increasing risk by talc-years.", {"entities": []}], ["Women who used talc were more likely to be older, heavier, asthma sufferers, and regular analgesic users\u2014none of which was a confounder.", {"entities": [[59, 65, "DISEASE"]]}], ["Dose\u2013responses were more apparent for premenopausal women, especially nonsmokers and those heavier or postmenopausal users of menopausal hormones (hormone therapy [HT]).", {"entities": []}], ["Subtypes of ovarian cancer more likely to be associated with talc included invasive serous and endometrioid tumors and borderline serous and mucinous tumors.", {"entities": [[12, 26, "DISEASE"], [20, 26, "DISEASE"]]}], ["Premenopausal women and postmenopausal HT users with these subtypes who had accumulated >24 talc-years had ORs (95% CI) of 2.33 (1.32, 4.12) and 2.57 (1.51, 4.36), respectively.", {"entities": []}], ["Risks for epithelial ovarian cancer from genital talc use vary by histologic subtype, menopausal status at diagnosis, HT use, weight, and smoking.", {"entities": [[21, 35, "DISEASE"], [29, 35, "DISEASE"]]}], ["These observations suggest that estrogen and/or prolactin may play a role via macrophage activity and inflammatory response to talc.", {"entities": []}], ["Medical masks are commonly used by sick individuals with influenza-like illness (ILI) to prevent spread of infections to others, but clinical efficacy data are absent.", {"entities": [[57, 66, "DISEASE"]]}], ["Determine whether medical mask use by sick individuals with ILI protects well contacts from related respiratory infections.", {"entities": []}], ["6 major hospitals in 2 districts of Beijing, China.", {"entities": []}], ["Cluster randomised controlled trial.", {"entities": []}], ["245 index cases with ILI.", {"entities": []}], ["Index cases with ILI were randomly allocated to medical mask (n=123) and control arms (n=122).", {"entities": []}], ["Since 43 index cases in the control arm also used a mask during the study period, an as-treated post hoc analysis was performed by comparing outcomes among household members of index cases who used a mask (mask group) with household members of index cases who did not use a mask (no-mask group).", {"entities": []}], ["Primary outcomes measured in household members were clinical respiratory illness, ILI and laboratory-confirmed viral respiratory infection.", {"entities": []}], ["In an intention-to-treat analysis, rates of clinical respiratory illness (relative risk (RR) 0.61, 95% CI 0.18 to 2.13), ILI (RR 0.32, 95% CI 0.03 to 3.13) and laboratory-confirmed viral infections (RR 0.97, 95% CI 0.06 to 15.54) were consistently lower in the mask arm compared with control, although not statistically significant.", {"entities": []}], ["A post hoc comparison between the mask versus no-mask groups showed a protective effect against clinical respiratory illness, but not against ILI and laboratory-confirmed viral respiratory infections.", {"entities": []}], ["The study indicates a potential benefit of medical masks for source control, but is limited by small sample size and low secondary attack rates.", {"entities": []}], ["Larger trials are needed to confirm efficacy of medical masks as source control.", {"entities": []}], ["ACTRN12613000852752; Results.", {"entities": []}], ["To describe and analyze the causes of death in a pediatric secondary-care hospital (run by M\u00e9decins sans Fronti\u00e8res ), in Monrovia, Liberia, 6 years post-civil war, to determine the quality of care and mortality in a setting with limited resources.", {"entities": []}], ["Data were retrospectively collected from March 2009 to October 2009.", {"entities": []}], ["Patient charts and laboratory records were reviewed to verify cause of death.", {"entities": []}], ["Additionally, charts of patients aged over 1 month with an infectious cause of death were analyzed for decompensated septic shock, or fluid-refractory septic shock.", {"entities": []}], ["Of 8,254 admitted pediatric patients, 531 died, with a mortality rate of 6.4%.", {"entities": []}], ["Ninety percent of deaths occurred in children <5 years old.", {"entities": []}], ["Most deaths occurred within 24 hours of admission.", {"entities": []}], ["The main cause of death (76%) was infectious disease.", {"entities": []}], ["Seventy-eight (23.6%) patients >1 month old with infectious disease met the criteria for septic shock, and 28 (8.6%) for decompensated or fluid-refractory septic shock.", {"entities": []}], ["Since the end of Liberia's devastating civil war, Island Hospital has improved care and mortality outcomes, despite operating with limited resources.", {"entities": []}], ["Based on the available data, mortality in Island Hospital appears to be lower than that of other Liberian and African institutions and similar to other hospitals run by M\u00e9decins sans Fronti\u00e8res across Africa.", {"entities": []}], ["This can be explained by the financial and logistic support of M\u00e9decins sans Fronti\u00e8res .", {"entities": []}], ["The highest mortality burden is related to infectious diseases and neonatal conditions.", {"entities": []}], ["The mortality of sepsis varied among different infections.", {"entities": []}], ["This suggests that further mortality reduction can be obtained by tackling sepsis management and improving neonatal care.", {"entities": []}], ["Noncommunicable diseases are an increasing health concern worldwide, but particularly in low- and middle-income countries.", {"entities": []}], ["This study quantified and compared education- and wealth-based inequalities in the prevalence of five noncommunicable diseases (angina, arthritis, asthma, depression and diabetes) and comorbidity in low- and middle-income country groups.", {"entities": [[136, 145, "DISEASE"], [147, 153, "DISEASE"]]}], ["Using 2002\u201304 World Health Survey data from 41 low- and middle-income countries, the prevalence estimates of angina, arthritis, asthma, depression, diabetes and comorbidity in adults aged 18\u2009years or above are presented for wealth quintiles and five education levels, by sex and country income group.", {"entities": [[117, 126, "DISEASE"], [128, 134, "DISEASE"]]}], ["Symptom-based classification was used to determine angina, arthritis, asthma and depression rates, and diabetes diagnoses were self-reported.", {"entities": [[59, 68, "DISEASE"], [70, 76, "DISEASE"]]}], ["Socioeconomic inequalities according to wealth and education were measured absolutely, using the slope index of inequality, and relatively, using the relative index of inequality.", {"entities": []}], ["Wealth and education inequalities were more pronounced in the low-income country group than the middle-income country group.", {"entities": []}], ["Both wealth and education were inversely associated with angina, arthritis, asthma, depression and comorbidity prevalence, with strongest inequalities reported for angina, asthma and comorbidity.", {"entities": [[65, 74, "DISEASE"], [76, 82, "DISEASE"], [172, 178, "DISEASE"]]}], ["Diabetes prevalence was positively associated with wealth and, to a lesser extent, education.", {"entities": []}], ["Adjustments for confounding variables tended to decrease the magnitude of the inequality.", {"entities": []}], ["Noncommunicable diseases are not necessarily diseases of the wealthy, and showed unequal distribution across socioeconomic groups in low- and middle-income country groups.", {"entities": []}], ["Disaggregated research is warranted to assess the impact of individual noncommunicable diseases according to socioeconomic indicators.", {"entities": []}], ["The aim of this retrospective study is to evaluate the safety and performance of the Perceval sutureless valve in patients undergoing aortic valve replacement.", {"entities": []}], ["We report the 30-day clinical outcomes of 139 patients.", {"entities": []}], ["From January 2014 to December 2016, 139 patients underwent sutureless aortic valve replacement.", {"entities": []}], ["Their operation notes, National Adult Cardiac Surgery Database and perioperative transoesophageal echocardiography findings were studied retrospectively.", {"entities": []}], ["Ninety-two patients underwent isolated aortic valve replacement (group A) with Perceval valve and 47 patients had combined procedures of aortic valve replacement and coronary artery bypass grafting (group B).", {"entities": []}], ["The patients received a size S (n=23), M (n=39), L (n=42) or XL (n=35) prosthesis.", {"entities": []}], ["Perceval valve was successfully implanted in 135 (97.1%) patients.", {"entities": []}], ["Mean cross-clamping time and bypass time were 40 and 63 minutes for isolated cases, while 68 and 107 minutes for combined cases.", {"entities": []}], ["Three (2.1%) patients died within 30 days.", {"entities": []}], ["Four patients suffered stroke and 5 patients went into acute renal failure.", {"entities": []}], ["Median intensive care unit and hospital stay was 2 and 8.5, respectively.", {"entities": []}], ["Four valves were explanted due to significant paravalvular leak after surgery.", {"entities": []}], ["Five patients had permanent pacemaker as a result of complete heart block and mean postoperative drainage was 295 mL for isolated case and 457 mL for combined cases.", {"entities": []}], ["The mean gradient across Perceval valve was 12.5 mmHg while its effective orifice area was 1.5 cm Early postoperative results showed that Perceval valve is safe.", {"entities": []}], ["Further follow up is needed to evaluate the long-term outcome with this bioprosthesis.", {"entities": []}], ["To investigate the relationship between pathological oropharyngeal (OP) acid exposure and esophageal motility in patients with extra-esophageal syndromes.", {"entities": []}], ["In this prospective study we enrolled consecutive outpatients with extra-esophageal symptoms suspected to be related to gastroesophageal reflux disease (GERD).", {"entities": [[120, 151, "DISEASE"]]}], ["We enrolled only patients with a reflux symptom index (RSI) score-higher than 13 and with previous lung, allergy and ear, nose and throat evaluations excluding other specific diagnoses.", {"entities": []}], ["All patients underwent 24-h OP pH-metry with the Dx probe and esophageal high-resolution manometry (HRM).", {"entities": []}], ["Patients were divided into two groups on the basis of a normal or pathological pH-metric finding (Ryan Score) and all manometric characteristics of the two groups were compared.", {"entities": []}], ["We examined 135 patients with chronic extra-esophageal syndromes.", {"entities": []}], ["Fifty-one were considered eligible for the study.", {"entities": []}], ["Of these, 42 decided to participate in the protocol.", {"entities": []}], ["Patients were divided into two groups on the basis of normal or pathological OP acid exposure.", {"entities": []}], ["All the HRM parameters were compared for the two groups.", {"entities": []}], ["Significant differences were found in the median upper esophageal sphincter resting pressure (median 71 mmHg vs 126 mmHg, P = 0.004) and the median proximal contractile integral (median 215.5 cm\u2022mmHg\u2022s vs 313.5 cm\u2022mmHg\u2022s, P = 0.039), both being lower in the group with pathological OP acid exposure, and the number of contractions with small or large breaks, which were more frequent in the same group.", {"entities": []}], ["This group also had a larger number of peristaltic contractions with breaks in the 20 mmHg isobaric contour (38.7% vs 15.38%, P < 0.0001).", {"entities": []}], ["In patients with suspected GERD-related extra-esophageal syndromes pathological OP acid exposure was associated with weaker proximal esophageal motility.", {"entities": []}], ["Leptin is a hormone produced by adipose tissue that regulates various physiological processes.", {"entities": []}], ["Recent studies have shown that the level of circulating leptin is elevated in obese patients and have suggested a relationship between obesity and postoperative lymphedema.", {"entities": [[135, 142, "DISEASE"], [161, 171, "DISEASE"]]}], ["However, the mechanisms by which postoperative lymphedema develops in obese patients and the mechanisms by which leptin regulates lymphatic endothelial cell homeostasis such as tube formation and cell proliferation remain unknown.", {"entities": [[47, 57, "DISEASE"]]}], ["Here we report that leptin regulates tube formation and cell proliferation in human dermal lymphatic endothelial cells (HDLECs) by activation of the signal transducer and activator of transcription 3 pathway, which is downstream signaling of the leptin receptor.", {"entities": []}], ["Additionally, we found that upregulation of suppressor of cytokine signaling 3 underlies the mechanisms by which a high dose of leptin inhibits cell proliferation and tube formation.", {"entities": []}], ["Leptin also enhanced expression of the proinflammatory cytokine IL-6 in HDLECs.", {"entities": []}], ["Interestingly, IL-6 rescues the compromised cell proliferation and tube formation caused by treatment with a high dose of leptin in an autocrine or paracrine manner.", {"entities": []}], ["Taken together, our findings reveal a novel mechanism by which compromised HDLECs maintain their homeostasis during inflammation mediated by leptin and IL-6.", {"entities": []}], ["Thus, regulating the level of leptin or IL-6 may be a viable strategy to reduce the incidence of postoperative lymphedema.", {"entities": [[111, 121, "DISEASE"]]}], ["To assess and compare multiple measurements of socioeconomic position (SEP) in order to determine the relationship with adverse perinatal outcomes across various contexts.", {"entities": []}], ["A birth registry, the Nova Scotia Atlee Perinatal Database, was confidentially linked to income tax and related information for the year in which delivery occurred.", {"entities": []}], ["Multiple logistic regression was used to examine odds ratios between multiple indicators of SEP and multiple adverse perinatal outcomes in 117734 singleton births between 1988 and 2003.", {"entities": []}], ["Models for after tax family income were also adjusted for neighborhood deprivation to gauge the relative magnitude of effects related to SEP at both levels.", {"entities": []}], ["Effects of SEP were stratified by single- versus multiple-parent family composition, and by urban versus rural location of residence.", {"entities": []}], ["The risk of small for gestational age and spontaneous preterm birth was higher across all the indicators of lower SEP, while risk for large for gestational age was lower across indicators of lower SEP. Higher risk of postneonatal death was demonstrated for several measures of lower SEP. Higher material deprivation in the neighborhood of residence was associated with increased risk for perinatal death, small for gestational age birth, and iatrogenic and spontaneous preterm birth.", {"entities": []}], ["Family composition and urbanicity were shown to modify the association between income and some perinatal outcomes.", {"entities": []}], ["This study highlights the importance of understanding the definitions of SEP and the mechanisms that lead to the association between income and poor perinatal outcomes, and broadening the types of SEP measures used in some cases.", {"entities": []}], ["Short-course oral corticosteroids are commonly used in children but are known to be associated with adverse drug reactions (ADRs).", {"entities": []}], ["This review aimed to identify the most common and serious ADRs and to determine their relative risk levels.", {"entities": []}], ["A literature search of EMBASE, MEDLINE, International Pharmaceutical Abstracts, CINAHL, Cochrane Library and PubMed was performed with no language restrictions to identify studies in which oral corticosteroids were administered to patients aged 28\u2005days to 18\u2005years of age for up to and including 14\u2005days of treatment.", {"entities": []}], ["Each database was searched from their earliest dates to December 2013.", {"entities": []}], ["All studies providing clear information on ADRs were included.", {"entities": []}], ["Thirty-eight studies including 22 randomised controlled trials (RCTs) met the inclusion criteria.", {"entities": []}], ["The studies involved a total of 3200 children in whom 850 ADRs were reported.", {"entities": []}], ["The three most frequent ADRs were vomiting, behavioural changes and sleep disturbance, with respective incidence rates of 5.4%, 4.7% and 4.3% of patients assessed for these ADRs.", {"entities": []}], ["Infection was one of the most serious ADRs; one child died after contracting varicella zoster.", {"entities": []}], ["When measured, 144 of 369 patients showed increased blood pressure; 21 of 75 patients showed weight gain; and biochemical hypothalamic\u2013pituitary\u2013adrenal axis suppression was detected in 43 of 53 patients.", {"entities": []}], ["Vomiting, behavioural changes and sleep disturbance were the most frequent ADRs seen when short-course oral corticosteroids were given to children.", {"entities": []}], ["Increased susceptibility to infection was the most serious ADR.", {"entities": []}], ["CRD42014008774.", {"entities": []}], ["By PROSPERO International prospective register of systematic reviews.", {"entities": []}], ["To assess the effect of telecare on health related quality of life, self-care, hospital use, costs and the experiences of patients, informal carers and health care professionals.", {"entities": []}], ["Patients were randomly assigned either to usual care or to additionally entering their data into a commercially-available electronic device that uploaded data once a day to a nurse-led monitoring station.", {"entities": []}], ["Patients had congestive heart failure (Site A), chronic obstructive pulmonary disease (Site B), or any long-term condition, mostly diabetes (Site C).", {"entities": [[13, 37, "DISEASE"], [48, 85, "DISEASE"]]}], ["Site C contributed only intervention patients \u2013 they considered a usual care option to be unethical.", {"entities": []}], ["The study took place in New Zealand between September 2010 and February 2012, and lasted 3 to 6 months for each patient.", {"entities": []}], ["The primary outcome was health-related quality of life (SF36).", {"entities": []}], ["Data on experiences were collected by individual and group interviews and by questionnaire.", {"entities": []}], ["There were 171 patients (98 intervention, 73 control).", {"entities": []}], ["Quality of life, self-efficacy and disease-specific measures did not change significantly, while anxiety and depression both decreased significantly with the intervention.", {"entities": []}], ["Hospital admissions, days in hospital, emergency department visits, outpatient visits and costs did not differ significantly between the groups.", {"entities": []}], ["Patients at all sites were universally positive.", {"entities": []}], ["Many felt safer and more cared-for, and said that they and their family had learned more about managing their condition.", {"entities": []}], ["Staff could all see potential benefits of telecare, and, after some initial technical problems, many staff felt that telecare enabled them to effectively monitor more patients.", {"entities": []}], ["Strongly positive patient and staff experiences and attitudes complement and contrast with small or non-significant quantitative changes.", {"entities": []}], ["Telecare led to patients and families taking a more active role in self-management.", {"entities": []}], ["It is likely that subgroups of patients benefitted in ways that were not measured or visible within the quantitative data, especially feelings of safety and being cared-for.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry ACTRN12610000269033", {"entities": []}], ["Extracelluar nucleotides have been identified as regulatory factors in asthmatic pathogenesis by activating purinergic receptors.", {"entities": []}], ["This research aimed to investigate the function of the purinergic receptor P2Y 6 in mediating airway inflammation in allergic asthma.", {"entities": [[117, 132, "DISEASE"], [126, 132, "DISEASE"]]}], ["Wild-type (WT) and P2Y 6 -deficient mice were stimulated with ovalbumin (OVA) to construct asthmatic mouse models.", {"entities": []}], ["Overexpression of P2Y 6 and uridine 5\u2032-diphosphate (UDP)-releasing were demonstrated in lung tissues in ovalbumin-induced asthmatic mice.", {"entities": []}], ["The release of the cytokine IL-4, mast cell invasion, and the airway remodeling phenotypes were more severe following the application of UDP in asthmatic mice.", {"entities": []}], ["However, P2Y 6 deficiency reduced these asthmatic pathogeneticsymptoms markedly in a mouse model.", {"entities": []}], ["In vitro , we found that P2Y 6 in purified mast cells enhanced the functions of mast cells in the inflammatory response in the asthmatic process by triggering their capability for migration, cytokine secretion and granule release.", {"entities": []}], ["Moreover, P2Y 6 stimulated the function of mast cells through activation of the AKT signaling pathway.", {"entities": []}], ["Our data provides evidence that P2Y 6 contributes to allergic airway inflammation and remodeling by enhancing the functions of mast cells in ovalbumin-induced asthmatic mice.", {"entities": []}], ["Practice facilitation involves trained individuals working with practice staff to conduct quality improvement activities and support delivery of evidence-based clinical services.", {"entities": []}], ["We examined the feasibility of using practice facilitation to assist federally qualified health centers (FQHCs) to increase colorectal cancer screening rates in North Carolina.", {"entities": [[124, 141, "DISEASE"], [135, 141, "DISEASE"]]}], ["The intervention consisted of 12 months of facilitation in 3 FQHCs.", {"entities": []}], ["We conducted chart audits to obtain data on changes in documented recommendation for colorectal cancer screening and completed screening.", {"entities": [[85, 102, "DISEASE"], [96, 102, "DISEASE"]]}], ["Key informant interviews provided qualitative data on barriers to and facilitators of implementing office systems.", {"entities": []}], ["Overall, the percentage of eligible patients with a documented colorectal cancer screening recommendation increased from 15% to 29% ( P < .001).", {"entities": [[63, 80, "DISEASE"], [74, 80, "DISEASE"]]}], ["The percentage of patients up to date with colorectal cancer screening rose from 23% to 34% ( P = .03).", {"entities": [[43, 60, "DISEASE"], [54, 60, "DISEASE"]]}], ["Key informants in all 3 clinics said the implementation support from the practice facilitator was critical for initiating or improving office systems and that modifying the electronic medical record was the biggest challenge and most time-consuming aspect of implementing office systems changes.", {"entities": []}], ["Other barriers were staff turnover and reluctance on the part of local gastroenterology practices to perform free or low-cost diagnostic colonoscopies for uninsured or underinsured patients.", {"entities": []}], ["Practice facilitation is a feasible, acceptable, and promising approach for supporting universal colorectal cancer screening in FQHCs.", {"entities": [[97, 114, "DISEASE"], [108, 114, "DISEASE"]]}], ["A larger-scale study is warranted.", {"entities": []}], ["Gallbladder cancer (GBC) is a multifactorial disease with complex interplay between multiple genetic variants.", {"entities": [[0, 18, "DISEASE"], [12, 18, "DISEASE"]]}], ["We performed Classification and Regression Tree Analysis (CART) and Grade of Membership (GoM) analysis to identify combinations of alleles among the DNA repair, inflammatory and apoptotic pathway genetic variants in modifying the risk for GBC.", {"entities": []}], ["We analyzed 16 polymorphisms in 8 genes involved in DNA repair, apoptotic and inflammatory pathways to find out combinations of genetic variants contributing to GBC risk.", {"entities": []}], ["The genes included in the study were XRCC1 , OGG1 , ERCC2 , MSH2 , CASP8 , TLR2 , TLR4 and PTGS2 .", {"entities": [[37, 42, "GENE"], [45, 49, "GENE"], [52, 57, "GENE"], [60, 64, "GENE"], [67, 72, "GENE"], [75, 79, "GENE"], [82, 86, "GENE"], [91, 96, "GENE"]]}], ["Single locus analysis by logistic regression showed association of MSH2 IVS1+9G>C (rs2303426), ERCC2 Asp312Asn (rs1799793), OGG1 Ser326Cys (rs1052133), OGG1 IVS4-15C>G (rs2072668), CASP8 -652 6N ins/del (rs3834129), PTGS 2 -1195G>A (rs689466), PTGS2 -765G>C (rs20417), TLR4 Ex4+936C>T (rs4986791) and TLR2 \u2013196 to \u2013174del polymorphisms with GBC risk.", {"entities": [[67, 71, "GENE"], [95, 100, "GENE"], [124, 128, "GENE"], [152, 156, "GENE"], [124, 128, "GENE"], [152, 156, "GENE"], [181, 186, "GENE"], [244, 249, "GENE"], [269, 273, "GENE"], [301, 305, "GENE"]]}], ["The CART analysis revealed OGG1 Ser326Cys, and OGG1 IVS4-15C>G polymorphisms as the best polymorphic signature for discriminating between cases and controls.", {"entities": [[27, 31, "GENE"], [47, 51, "GENE"], [27, 31, "GENE"], [47, 51, "GENE"]]}], ["In the GoM analysis, the data was categorized into six sets representing risk for GBC with respect to the investigated polymorphisms.", {"entities": []}], ["Sets I, II and III described low intrinsic risk (controls) characterized by multiple protective alleles while sets IV, V and VI represented high intrinsic risk groups (GBC cases) characterized by the presence of multiple risk alleles.", {"entities": []}], ["The CART and GoM analyses also showed the importance of PTGS2 - 1195G>A polymorphism in susceptibility to GBC risk.", {"entities": [[56, 61, "GENE"]]}], ["In conclusion, the present multigenic approach can be used to define individual risk profiles for gallbladder cancer in North Indian population.", {"entities": [[98, 116, "DISEASE"], [110, 116, "DISEASE"]]}], ["Objective .", {"entities": []}], ["To review the literature on the impact of educational asthma interventions in schools regarding the knowledge and morbidity of the disease among children and adolescents.", {"entities": [[54, 60, "DISEASE"]]}], ["A systematic review was conducted for controlled clinical trials investigating the effectiveness of educational asthma interventions for students, asthmatic or nonasthmatic, families, and school staff.", {"entities": [[112, 118, "DISEASE"]]}], ["Databases were CENTRAL, PubMed, LILACS, MEDLINE, and SciELO.", {"entities": []}], ["Articles published in any language were considered, in the period from 2005 to 2014, according to the PRISMA guidelines.", {"entities": []}], ["Seventeen articles were selected ( N = 5,879 subjects).", {"entities": []}], ["94% of the interventions (16 of 17 studies) were applied in developed countries that were led by health professionals and most of them targeted asthmatics.", {"entities": []}], ["Asthma education promotes the improvement of knowledge about the disease in at least one of the evaluated areas.", {"entities": [[0, 6, "DISEASE"]]}], ["29% of the interventions (5 of 17 studies) showed a reduction of the asthma symptoms, 35% (6 of 17 studies) reduction of the hospitalization instances and emergency visits, 29% (5 of 17 studies) reduction of school absenteeism, and 41% (7 of 17 studies) increase in the quality of life of the individuals.", {"entities": [[69, 75, "DISEASE"]]}], ["Conclusions .", {"entities": []}], ["Educational interventions in schools raise the awareness of asthma and weaken the impact of morbidity indicators.", {"entities": [[60, 66, "DISEASE"]]}], ["Panel studies have shown adverse effects of air pollution from biomass burning on children's health.", {"entities": []}], ["This study estimated the effect of current levels of outdoor air pollution in the Amazonian dry season on peak expiratory flow (PEF).", {"entities": []}], ["A panel study with 234 schoolchildren from 6 to 15 years old living in the municipality of Tangar\u00e1 da Serra, Brazil was conducted.", {"entities": []}], ["PEF was measured daily in the dry season in 2008.", {"entities": []}], ["Mixed-effects models and unified modelling repeated for every child were applied.", {"entities": []}], ["Time trends, temperature, humidity, and subject characteristics were regarded.", {"entities": []}], ["Inhalable particulate matter (PM 10 ), fine particulate matter (PM 2.5 ), and black carbon (BC) effects were evaluated based on 24-hour exposure lagged by 1 to 5 days and the averages of 2 or 3 days.", {"entities": []}], ["Polynomial distributed lag models (PDLM) were also applied.", {"entities": []}], ["The analyses revealed reductions in PEF for PM 10 and PM 2.5 increases of 10 \u00b5g/m 10 , the reductions varied from 0.15 (confidence interval (CI)95%: \u22120.29; \u22120.01) to 0.25 l/min (CI95%: \u22120.40; \u22120.10).", {"entities": []}], ["For PM 2.5 , they ranged from 0.46 (CI95%: \u22120.86 to \u22120.06) to 0.54 l/min (CI95%:\u22120.95; \u22120.14).", {"entities": []}], ["As for BC, the reduction was approximately 1.40 l/min.", {"entities": []}], ["In relation to PDLM, adverse effects were noticed in models based on the exposure on the current day through the previous 3 days (PDLM 0\u20133) and on the current day through the previous 5 days (PDLM 0\u20135), specially for PM 10 .", {"entities": []}], ["For all children, for PDLM 0\u20135 the global effect was important for PM 10 , with PEF reduction of 0.31 l/min (CI95%: \u22120.56; \u22120.05).", {"entities": []}], ["Also, reductions in lags 3 and 4 were observed.", {"entities": []}], ["These associations were stronger for children between 6 and 8 years old.", {"entities": []}], ["Reductions in PEF were associated with air pollution, mainly for lagged exposures of 3 to 5 days and for younger children.", {"entities": []}], ["Human milk is an important source of bacteria for the developing infant and has been shown to influence the bacterial composition of the neonatal gut, which in turn can affect disease risk later in life.", {"entities": []}], ["Human milk is also an important source of nutrients, influencing bacterial composition but also directly affecting the host.", {"entities": []}], ["While recent studies have emphasized the adverse effects of antibiotic therapy on the infant microbiota, the effects of maternal chemotherapy have not been previously studied.", {"entities": []}], ["Here we report the effects of drug administration on the microbiota and metabolome of human milk.", {"entities": []}], ["Mature milk was collected every two weeks over a four month period from a lactating woman undergoing chemotherapy for Hodgkin\u2019s lymphoma.", {"entities": [[128, 136, "DISEASE"]]}], ["Mature milk was also collected from healthy lactating women for comparison.", {"entities": []}], ["Microbial profiles were analyzed by 16S sequencing and the metabolome by gas chromatography\u2013mass spectrometry.", {"entities": []}], ["Chemotherapy caused a significant deviation from a healthy microbial and metabolomic profile, with depletion of genera Bifidobacterium , Eubacterium , Staphylococcus and Cloacibacterium in favor of Acinetobacter , Xanthomonadaceae and Stenotrophomonas .", {"entities": []}], ["The metabolites docosahexaenoic acid and inositol known for their beneficial effects were also decreased.", {"entities": []}], ["With milk contents being critical for shaping infant immunity and development, consideration needs to be given to the impact of drugs administered to the mother and the long-term potential consequences for the health of the infant.", {"entities": []}], ["The rapid development of nanotechnology allowed the fabrication of a wide range of different nanomaterials, raising many questions about their safety and potential risks for the human health and environment.", {"entities": []}], ["Most of the current nanotoxicology research is not standardized, hampering any comparison or reproducibility of the obtained results.", {"entities": []}], ["Drosophotoxicology encompasses the plethora of methodological approaches addressing the use of Drosophila melanogaster as a choice organism in toxicology studies.", {"entities": []}], ["Drosophila melanogaster model offers several important advantages, such as a relatively simple genome structure, short lifespan, low maintenance cost, readiness of experimental manipulation comparative to vertebrate models from both ethical and technical points of view, relevant gene homology with higher organisms, and ease of obtaining mutant phenotypes.", {"entities": []}], ["The molecular pathways, as well as multiple behavioral and developmental parameters, can be evaluated using this model in lower, medium or high throughput type assays, allowing a systematic classification of the toxicity levels of different nanomaterials.", {"entities": []}], ["The purpose of this paper is to review the current research on the applications of Drosophila melanogaster model for the in vivo assessment of nanoparticles toxicity and to reveal the huge potential of this model system to provide results that could enable a proper selection of different nanostructures for a certain biomedical application.", {"entities": []}], ["There is a demand for strategies to promote smoking cessation in high-risk populations like smoking pregnant women and their partners.", {"entities": []}], ["The objectives of this study were to investigate parental smoking behaviour during pregnancy after introduction of a prenatal, structured, multi-disciplinary smoking cessation programme in primary care, and to compare smoking behaviour among pregnant women in the city of Trondheim with Bergen and Norway.", {"entities": []}], ["Sequential birth cohorts were established to evaluate the intervention programme from September 2000 to December 2004 in primary care as a part of the Prevention of Allergy among Children in Trondheim study (PACT).", {"entities": []}], ["The primary outcome variables were self reported smoking behaviour at inclusion and six weeks postnatal.", {"entities": []}], ["Data from the Medical Birth Registry of Norway (MBR) were used to describe smoking cessation during pregnancy in Trondheim, Bergen and Norway 1999\u20132004.", {"entities": []}], ["Maternal smoking prevalence at inclusion during pregnancy were 5% (CI 95% 4\u20136) in the intervention cohort compared to 7% (CI 95% 6\u20139), p = 0.03, in the control cohort.", {"entities": []}], ["Of the pre-pregnancy maternal smokers 25% (CI 95% 20\u201331) and 32% (CI 95% 26\u201338), p = 0.17, were still smoking at inclusion in the intervention and control cohorts, respectively.", {"entities": []}], ["Six weeks postnatal 72% (CI 95% 59\u201383) and 68% (CI 95% 57\u201377), p = 0.34 of the maternal smokers at inclusion still smoked.", {"entities": []}], ["No significant difference in paternal smoking between the cohorts was found after the intervention period.", {"entities": []}], ["Data from the MBR showed a significantly higher proportion of women who stopped smoking during pregnancy in Trondheim than in Bergen in 2003 and 2004, p = 0.03 and < 0.001, respectively.", {"entities": []}], ["No impact on parental smoking behaviour between the cohorts was observed after the smoking intervention programme.", {"entities": []}], ["Of the women who stopped smoking during pregnancy most of them stopped smoking before the intervention.", {"entities": []}], ["However, we observed a significantly higher quitting rate in Trondheim than in Bergen in 2003 and 2004 which may have been facilitated by the supplemental attention on smoking behaviour the PACT study initiated.", {"entities": []}], ["The prevalence of penicillin-nonsusceptible pneumococci is sharply divided between France (43%) and Germany (7%).", {"entities": []}], ["These differences may be explained on different levels: antibiotic- prescribing practices for respiratory tract infections; patient-demand factors and health-belief differences; social determinants, including differing child-care practices; and differences in regulatory practices.", {"entities": []}], ["Understanding these determinants is crucial for the success of possible interventions.", {"entities": []}], ["Finally, we emphasize the overarching importance of a sociocultural approach to preventing antibiotic resistance in the community.", {"entities": []}], ["To analyze the association between negative self-rated health and indicators of health, wellbeing and sociodemographic variables in older adults.", {"entities": []}], ["Cross-sectional study that used data from a population-based health survey with a probability cluster sample that was carried out in Campinas, SP, Southeastern Brazil,, in 2008 and 2009.", {"entities": []}], ["The participants were older adults (\u2265 60 years) and the dependent variable was self-rated health, categorized as: excellent, very good, good, bad and very bad.", {"entities": []}], ["The adjusted prevalence ratios were estimated by means of Poisson multiple regression.", {"entities": []}], ["The highest prevalences of bad/very bad self-rated health were observed in the individuals who never attended school, in those with lower level of schooling, with monthly per capita family income lower than one minimum salary.", {"entities": []}], ["Individuals who scored five or more in the physical health indicator also had bad self-rated health, as well as those who scored five or more in the Self-Reporting Questionnaire 20 and those who did not refer feeling happiness all the time.", {"entities": []}], ["The independent effects of material life conditions, physical and mental health and subjective wellbeing, observed in self-rated health, suggest that older adults can benefit by health policies supported by a global and integrative view of old age.", {"entities": []}], ["We demonstrated earlier that individuals homozygous for conserved major histocompatibility complex (MHC)-extended haplotypes have low natural killer (NK) activity as measured by cytolysis of the K562 tumor cell lines.", {"entities": []}], ["In the present study, we investigated the segregation and MHC linkage of NK activity in families in which MHC haplotypes of human histocompatibility leukocyte antigens (HLA)-A, -C, and -B, complotype, and DR specificities are known.", {"entities": [[169, 172, "GENE"]]}], ["In two informative families, low activity was inherited as a recessive trait linked to the MHC.", {"entities": []}], ["By using individuals homozygous for specific fragments of extended haplotypes or for HLA-B alleles, we found that the HLA-C and -B and not the complotype or HLA-DR region contains genes controlling NK activity.", {"entities": [[85, 90, "GENE"], [118, 123, "GENE"]]}], ["The majority of the unrelated individuals with low NK activity were homozygous or doubly heterozygous for HLA-B7 (Cw7), B8 (Cw7), B44 (Cw5), B18, or B57 (Cw6).", {"entities": []}], ["Thus, these alleles form one complementation group designated NKB1.", {"entities": []}], ["Another less frequent group, NKB2, was also identified, and consisted of individuals homozygous for B35 (Cw4).", {"entities": []}], ["NK activity was correlated with the number of circulating NK (CD16+ CD56+) cells.", {"entities": []}], ["Individuals homozygous for the NKB complementation groups have fewer circulating NK cells than individuals heterozygous for these alleles and alleles of other complementation groups, possibly explaining the low activity of cells in these subjects.", {"entities": []}], ["These findings suggest that during the maturation of NK cells there is NK cellular deletion in donors homozygous for NKB genes resulting in low NK cell numbers and activity.", {"entities": []}], ["The most recently characterized H4 histamine receptor (H4R) is expressed preferentially in the bone marrow, raising the question of its role during hematopoiesis.", {"entities": []}], ["Here we show that both murine and human progenitor cell populations express this receptor subtype on transcriptional and protein levels and respond to its agonists by reduced growth factor-induced cell cycle progression that leads to decreased myeloid, erythroid and lymphoid colony formation.", {"entities": []}], ["H4R activation prevents the induction of cell cycle genes through a cAMP/PKA-dependent pathway that is not associated with apoptosis.", {"entities": []}], ["It is mediated specifically through H4R signaling since gene silencing or treatment with selective antagonists restores normal cell cycle progression.", {"entities": []}], ["The arrest of growth factor-induced G1/S transition protects murine and human progenitor cells from the toxicity of the cell cycle-dependent anticancer drug Ara-C in vitro and reduces aplasia in a murine model of chemotherapy.", {"entities": []}], ["This first evidence for functional H4R expression in hematopoietic progenitors opens new therapeutic perspectives for alleviating hematotoxic side effects of antineoplastic drugs.", {"entities": []}], ["The Consolidated Standards for Reporting Trials (CONSORT) are aimed to standardize clinical trial reporting.", {"entities": []}], ["Our objective is to compare the quality of randomized clinical trials (RCTs) of traditional Chinese medicine (TCM) published in 2005\u20132009 and 2011\u20132012 according to the current CONSORT statements and Jadad scale.", {"entities": []}], ["Data Sources: Reports on RCTs of TCM in the China National Knowledge Infrastructure database (CNKI database) for manuscripts published from 2005 to 2009 and 2011\u20132012.", {"entities": []}], ["Search terms included TCM and clinical trial.", {"entities": []}], ["Study Selection: Manuscripts that reported RCTs of TCM were included.", {"entities": []}], ["Data Extraction: Independent extraction of articles was done by 3 authors.", {"entities": []}], ["Disagreement was discussed until agreement was reached.", {"entities": []}], ["According to the CONSORT checklist, an item was scored as 1 when the item was described in the paper.", {"entities": []}], ["Otherwise the item was scored as 0.", {"entities": []}], ["A total of 4133 trials in 2005\u20132009 and 2861 trials in 2011\u20132012 were identified respectively.", {"entities": []}], ["There was a significant increase in proportion of reports that included details of background (24.71% vs 35.20%, P \u2009<\u20090.001), participants (49.79% vs 65.26%, P \u2009<\u20090.001), the methods of random sequence generation (13.77% vs 19.85%, P \u2009<\u20090.001), statistical methods (63.00% vs 72.77%, P \u2009<\u20090.001) and recruitment date (70.14% vs 80.36%, P \u2009<\u20090.001) in 2011\u20132012 compared to 2005\u20132009.", {"entities": []}], ["However, the percentage of reports with trial design decreased from 4.45% to 3.25% ( P \u2009=\u20090.011).", {"entities": []}], ["Few reports described the blinding methods, and there was a decreasing tendency (4.77% vs 2.48%, P \u2009<\u20090.001).", {"entities": []}], ["There was a similar decreasing tendency on the reporting of funding (6.53% vs 5.00%, P \u2009=\u20090.007).", {"entities": []}], ["There were no significant differences in the other CONSORT items.", {"entities": []}], ["In terms of Jadad Score, the proportion of reports with a score of 2 was markedly increased (15.15% vs 19.71%, P \u2009<\u20090.001).", {"entities": []}], ["Although the quality of reporting RCTs of TCM was improved in 2011\u20132012 compared to 2005\u20132009, the percentages of high-quality reports are both very low in terms of Jadad score.", {"entities": []}], ["There is a need for improving standards for reporting RCTs in China.", {"entities": []}], ["Although the efficacy of propranolol for the treatment of infantile hemangiomas (IHs) has been well documented, there is a paucity of clinical data regarding the safety and tolerance of propranolol in neonates.", {"entities": []}], ["A prospective study of 51 patients less than 30 days of age with severe IH was conducted.", {"entities": []}], ["All patients were admitted to the hospital for monitoring during initial propranolol treatment at day 0 with dose adjustments at days 7 and 28.", {"entities": []}], ["Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), blood glucose (BG) levels and potential side effects were evaluated during treatment.", {"entities": [[12, 14, "GENE"], [74, 77, "GENE"]]}], ["There were significant decreases in mean heart rate and SBP after the initiation of propranolol therapy ( P \u2009<\u20090.05).", {"entities": []}], ["In contrast, no significant differences in mean DBP and BG levels were observed after each dose during hospitalization ( P \u2009>\u20090.05).", {"entities": [[48, 51, "GENE"]]}], ["Bradycardia and hypotension were noted in at least 1 recorded instance in 11.8% and 5.9% of patients, respectively.", {"entities": []}], ["These hemodynamic changes were not persistent and were asymptomatic.", {"entities": []}], ["Two patients who had a history of neonatal pneumonia reported severe bronchial hyperreactivity during treatment.", {"entities": [[43, 52, "DISEASE"]]}], ["This study demonstrated that propranolol administered to properly selected young infants was safe and well tolerated.", {"entities": []}], ["However, close monitoring should be considered in high-risk young patients.", {"entities": []}], ["Vascular Endothelial Growth Factor (VEGF) is the main player in angiogenesis.", {"entities": []}], ["Because of its crucial role in this process, the study of the genetic factors controlling VEGF variability may be of particular interest for many angiogenesis-associated diseases.", {"entities": []}], ["Although some polymorphisms in the VEGF gene have been associated with a susceptibility to several disorders, no genome-wide search on VEGF serum levels has been reported so far.", {"entities": []}], ["We carried out a genome-wide linkage analysis in three isolated populations and we detected a strong linkage between VEGF serum levels and the 6p21.1 VEGF region in all samples.", {"entities": []}], ["A new locus on chromosome 3p26.3 significantly linked to VEGF serum levels was also detected in a combined population sample.", {"entities": []}], ["A sequencing of the gene followed by an association study identified three common single nucleotide polymorphisms (SNPs) influencing VEGF serum levels in one population (Campora), two already reported in the literature (rs3025039, rs25648) and one new signal (rs3025020).", {"entities": []}], ["A fourth SNP (rs41282644) was found to affect VEGF serum levels in another population (Cardile).", {"entities": []}], ["All the identified SNPs contribute to the related population linkages (35% of the linkage explained in Campora and 15% in Cardile).", {"entities": []}], ["Interestingly, none of the SNPs influencing VEGF serum levels in one population was found to be associated in the two other populations.", {"entities": []}], ["These results allow us to exclude the hypothesis that the common variants located in the exons, intron-exon junctions, promoter and regulative regions of the VEGF gene may have a causal effect on the VEGF variation.", {"entities": []}], ["The data support the alternative hypothesis of a multiple rare variant model, possibly consisting in distinct variants in different populations, influencing VEGF serum levels.", {"entities": []}], ["The Clinical Practice Research Datalink (CPRD) is an ongoing primary care database of anonymised medical records from general practitioners, with coverage of over 11.3 million patients from 674 practices in the UK.", {"entities": []}], ["With 4.4 million active (alive, currently registered) patients meeting quality criteria, approximately 6.9% of the UK population are included and patients are broadly representative of the UK general population in terms of age, sex and ethnicity.", {"entities": []}], ["General practitioners are the gatekeepers of primary care and specialist referrals in the UK.", {"entities": []}], ["The CPRD primary care database is therefore a rich source of health data for research, including data on demographics, symptoms, tests, diagnoses, therapies, health-related behaviours and referrals to secondary care.", {"entities": []}], ["For over half of patients, linkage with datasets from secondary care, disease-specific cohorts and mortality records enhance the range of data available for research.", {"entities": []}], ["The CPRD is very widely used internationally for epidemiological research and has been used to produce over 1000 research studies, published in peer-reviewed journals across a broad range of health outcomes.", {"entities": []}], ["However, researchers must be aware of the complexity of routinely collected electronic health records, including ways to manage variable completeness, misclassification and development of disease definitions for research.", {"entities": []}], ["This randomized, controlled, double-blind study was designed to determine the optimal dose of remifentanil for preventing complications associated with the removal of a laryngeal mask airway (LMA) without delaying emergence.", {"entities": []}], ["This study randomly assigned 128 patients to remifentanil effect-site concentrations (Ce) of 0 ng/mL (group R0), 0.5 ng/mL (group R0.5), 1.0 ng/mL (group R1.0), and 1.5 ng/mL (group R1.5) during emergence.", {"entities": []}], ["The emergence and recovery profiles were recorded.", {"entities": []}], ["Adverse events such as coughing, airway obstruction, breath-holding, agitation, desaturation, nausea, and vomiting were also evaluated.", {"entities": []}], ["The number of patients with respiratory complications such as coughing and breath-holding was significantly lower in the R1.0 and R1.5 groups than in the R0 group ( p <0.05).", {"entities": []}], ["Emergence agitation also decreased in the R1.0 and R1.5 groups ( p <0.0083).", {"entities": []}], ["The time to LMA removal was significantly longer in the R1.5 group than in the other groups ( p <0.05).", {"entities": []}], ["Maintaining a remifentanil Ce of 1.0 ng/mL during emergence may suppress adverse events such as coughing, breath-holding, and agitation following the removal of LMA without delayed awakening.", {"entities": []}], ["Health care systems increasingly rely on patients\u2019 data entry efforts to organize and assist in care delivery through health information exchange.", {"entities": []}], ["We sought to determine (1) the variation in burden imposed on parents by data entry efforts across paper-based and computer-based environments, and (2) the impact, if any, of parents\u2019 health literacy on the task burden.", {"entities": []}], ["We completed a randomized controlled trial of parent-completed data entry tasks.", {"entities": []}], ["Parents of children with attention deficit hyperactivity disorder (ADHD) were randomized based on the Test of Functional Health Literacy in Adults (TOFHLA) to either a paper-based or computer-based environment for entry of health information on their children.", {"entities": [[25, 65, "DISEASE"]]}], ["The primary outcome was the National Aeronautics and Space Administration Task Load Index (TLX) total weighted score.", {"entities": []}], ["We screened 271 parents: 194 (71.6%) were eligible, and 180 of these (92.8%) constituted the study cohort.", {"entities": []}], ["We analyzed 90 participants from each arm.", {"entities": []}], ["Parents who completed information tasks on paper reported a higher task burden than those who worked in the computer environment: mean (SD) TLX scores were 22.8 (20.6) for paper and 16.3 (16.1) for computer.", {"entities": []}], ["Assignment to the paper environment conferred a significant risk of higher task burden (F 1,178 = 4.05, P = .046).", {"entities": []}], ["Adequate literacy was associated with lower task burden (decrease in burden score of 1.15 SD, P = .003).", {"entities": []}], ["After adjusting for relevant child and parent factors, parents\u2019 TOFHLA score (beta = -.02, P = .02) and task environment (beta = .31, P = .03) remained significantly associated with task burden.", {"entities": []}], ["A tailored computer-based environment provided an improved task experience for data entry compared to the same tasks completed on paper.", {"entities": []}], ["Health literacy was inversely related to task burden.", {"entities": []}], ["Clinicaltrials.gov NCT00543257; http://www.clinicaltrials.gov/ct2/show/NCT00543257 (Archived by WebCite at http://www.webcitation.org/5vUVH2DYR)", {"entities": []}], ["In 2011/12 approximately 2.3 million children, 17% of children in the UK, were estimated to be in relative poverty.", {"entities": []}], ["Cigarette smoking is expensive and places an additional burden on household budgets, and is strongly associated with socioeconomic deprivation.", {"entities": []}], ["The aim of this study was to provide an illustrative first estimate of the extent to which parental smoking exacerbates child poverty in the UK.", {"entities": []}], ["Findings from the 2012 Households Below Average Income report and the 2012 Opinions and Lifestyle Survey were combined to estimate the number of children living in poor households containing smokers; the expenditure of typical smokers in these households on tobacco; and the numbers of children drawn into poverty if expenditure on smoking is subtracted from household income.", {"entities": []}], ["1.1 million children - almost half of all children in poverty - were estimated to be living in poverty with at least one parent who smokes; and a further 400,000 would be classed as being in poverty if parental tobacco expenditure were subtracted from household income.", {"entities": []}], ["Smoking exacerbates poverty for a large proportion of children in the UK.", {"entities": []}], ["Tobacco control interventions which effectively enable low income smokers to quit can play an important role in reducing the financial burden of child poverty.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-1797-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Protein arginine methyltransferase 1 (PRMT1) catalyzes methylation of histones and other cellular proteins, and thus regulates gene transcription and protein activity.", {"entities": [[38, 43, "GENE"]]}], ["In antigen-induced pulmonary inflammation (AIPI) PRMT1 was up-regulated in the epithelium, while in chronic AIPI, increased PRMT1 shifted to fibroblasts.", {"entities": [[49, 54, "GENE"], [124, 129, "GENE"], [49, 54, "GENE"], [124, 129, "GENE"]]}], ["In this study we investigated the cell type specific regulatory mechanism of PRMT1.", {"entities": [[77, 82, "GENE"]]}], ["Epithelial cells and fibroblasts were stimulated with IL-4 or IL-1\u03b2.", {"entities": []}], ["Gene and protein expression were determined by RT-qPCR, immunohistochemistry staining and Western blotting.", {"entities": []}], ["Signaling pathway inhibitors, siRNAs and shRNA were used to determine the regulatory mechanism of PRMT1.", {"entities": [[98, 103, "GENE"]]}], ["The results showed that IL-4 up-regulated PRMT1 through STAT6 signaling in epithelial cells, while IL-1\u03b2 regulated PRMT1 through NF-\u03baB in fibroblasts.", {"entities": [[42, 47, "GENE"], [115, 120, "GENE"], [56, 61, "GENE"], [42, 47, "GENE"], [115, 120, "GENE"]]}], ["The NF-kB inhibitor protein RKIP was highly expressed in epithelial cells and blocked IL-1\u03b2 induced PRMT1 up-regulation; while the STAT6 inhibitor protein PIAS1 was expressed in fibroblasts and suppressed IL-4 induced PRMT1 expression.", {"entities": [[100, 105, "GENE"], [218, 223, "GENE"], [131, 136, "GENE"], [155, 160, "GENE"], [100, 105, "GENE"], [218, 223, "GENE"]]}], ["Furthermore, IL-4 stimulated epithelial cells to release IL-1\u03b2 which up-regulated PRMT1 expression in fibroblasts.", {"entities": [[82, 87, "GENE"]]}], ["In conclusion, the inhibitor proteins RKIP and PIAS1 regulated the cell type and signaling specific expression of PRMT1.", {"entities": [[47, 52, "GENE"], [114, 119, "GENE"]]}], ["Thus PRMT1 expression in structural lung cells in asthma can be considered as potential target for new therapeutic intervention.", {"entities": [[50, 56, "DISEASE"], [5, 10, "GENE"]]}], ["Excessive exposure to solar UV (SUV) is related with numerous human skin disorders, such as skin inflammation, photoaging and carcinogenesis.", {"entities": []}], ["T-LAK cell- originated protein kinase (TOPK), an upstream of p38 mitogen-activated protein kinase (p38) and c-Jun N-terminal kinases (JNKs), plays an important role in SUV -induced skin inflammation, and targeting TOPK has already been a strategy to prevent skin inflammation.", {"entities": []}], ["In this study, we found that the expression of TOPK, phosphorylation of p38 or JNKs was increased in human solar dermatitis tissues.", {"entities": [[113, 123, "DISEASE"]]}], ["The level of phosphorylation of p38 or JNKs increased in a dose and time dependent manner in HaCat cells or JB6 Cl41 cells after SUV treatment.", {"entities": []}], ["Paeonol is an active component isolated from traditional Chinese herbal medicines, and MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2H-tetrazdium) assay showed that it has no toxicity to cells.", {"entities": []}], ["Microscale thermophoresis (MST) assay showed that paeonol can bind TOPK ex vivo .", {"entities": []}], ["In vitro kinase assay showed paeonol can inhibit TOPK activity.", {"entities": []}], ["Ex vivo studies further showed paeonol suppressed SUV-induced phosphorylation level of p38, JNKs, MSK1 and histone H2AX by inhibiting TOPK activity in a time and dose dependent manner.", {"entities": []}], ["Paeonol inhibited the secretion of IL-6 and TNF-\u03b1 in HaCat and JB6 cells ex vivo .", {"entities": []}], ["In vivo studies demonstrated that paeonol inhibited SUV-induced increase of TOPK, the phosphorylation of p38, JNKs and H2AX, and the secretion of IL-6 and TNF-\u03b1 in Babl/c mouse.", {"entities": []}], ["In summary, our data indicated a protective role of paeonol against SUV-induced inflammation by targeting TOPK, and paeonol could be a promising agent for the treatment of SUV-induced skin inflammation.", {"entities": []}], ["Health care providers value ready access to reliable synthesized information to support point-of-care decision making.", {"entities": []}], ["Web-based communities, facilitated by the adoption of social media tools such as Facebook, Twitter, and YouTube, are increasingly being used for knowledge dissemination, bridging the gap between knowledge generation and synthesis and knowledge implementation.", {"entities": []}], ["Our objective was to implement and evaluate a structured social media strategy, using multiple platforms, to disseminate Cochrane Child Health evidence to health care providers caring for children.", {"entities": []}], ["Our social media strategy had three components: daily \u201ctweets\u201d using the Cochrane Child Health Twitter account, weekly WordPress blog posts, and a monthly journal club on Twitter (\u201ctweet chat\u201d).", {"entities": []}], ["Each tweet, blog, and journal club shared Cochrane evidence on a child health topic.", {"entities": []}], ["We evaluated the strategy through (1) Twitter and blog site analytics, (2) traceable link (Bitly) statistics, (3) Altmetric.com scores for promoted evidence, and (4) participant feedback.", {"entities": []}], ["We also tracked the resources required to write the blog, tweet content, and manage the strategy.", {"entities": []}], ["The 22-week social media strategy ran between November 2014 and April 2015.", {"entities": []}], ["We created 25 blog posts, sent 585 tweets, and hosted 3 tweet chats.", {"entities": []}], ["Monthly blog visits and views and Twitter account followers increased over time.", {"entities": []}], ["During the study period, the blog received 2555 visitors and 3967 page views from a geographically diverse audience of health care providers, academics, and health care organizations.", {"entities": []}], ["In total, 183 traceable Bitly links received 3463 clicks, and the Twitter account gained 469 new followers.", {"entities": []}], ["The most visited and viewed blog posts included gastrointestinal topics (lactose avoidance), research on respiratory conditions (honey for cough and treatments for asthma), and maternal newborn care (skin-to-skin contact).", {"entities": [[164, 170, "DISEASE"]]}], ["On Twitter, popular topics were related to public health (vaccination) and pain management.", {"entities": []}], ["We collected Altmetric.com scores for 61 studies promoted during the study period and recorded an average increase of 11 points.", {"entities": []}], ["Research staff (n=3) contributed approximately 433 hours to promotion activities and planning (6.5 hours each per week) to implement the social media strategy, and study investigators reviewed all content (blog posts and tweets).", {"entities": []}], ["This study provides empirical evidence on the use of a coordinated social media strategy for the dissemination of evidence to professionals providing health services to children and youth.", {"entities": []}], ["The results and lessons learned from our study provide guidance for future knowledge dissemination activities using social media tools.", {"entities": []}], ["The efficacy of many of pain-relieving drugs is based on mechanisms by which the drugs interfere with the body\u2019s natural pain-mediating pathways.", {"entities": []}], ["By contrast, although it is less popular, other drugs including opioids exert more powerful analgesic actions by augmenting endogenous inhibitory neural circuits for pain mediation.", {"entities": []}], ["Recently, a novel endogenous pain-inhibitory principle was suggested and is now attracting both scientific and clinical attentions.", {"entities": []}], ["The central players for the actions are particular body lipids: resolvins.", {"entities": []}], ["Although research is in the preclinical phase, multiple hypotheses have actively been matured regarding the potency and molecular and neural processes of the analgesic effects of these substances.", {"entities": []}], ["Consistently, accumulating experimental evidence has been demonstrating that treatment with these lipid substances is strongly effective at controlling diverse types of pain.", {"entities": []}], ["Treatment of resolvins does not appear to disturb the body homeostasis as severely as many other therapeutic agents that interrupt the body\u2019s natural signaling flow, which enables us to predict their fewer adverse effects.", {"entities": []}], ["This paper serves as a review of currently documented painkilling actions of resolvins, summarizes the potential cellular and receptor-mediated mechanisms to date, and discusses the many clinical uses for these therapeutic lipids that have not yet been tested.", {"entities": []}], ["Future scientific efforts will more concentrate to unveil such aspects of the substances and to construct clear proofs of concept for pain relief.", {"entities": []}], ["Accurate measurement of health inequities is indispensable to track progress or to identify needs for health equity policy interventions.", {"entities": []}], ["A key empirical task is to measure the extent to which observed inequality in health \u2013 a difference in health \u2013 is inequitable.", {"entities": []}], ["Empirically operationalizing definitions of health inequity has generated an important question not considered in the conceptual literature on health inequity.", {"entities": []}], ["Empirical analysis can explain only a portion of observed health inequality.", {"entities": []}], ["This paper demonstrates that the treatment of unexplained inequality is not only a methodological but ethical question and that the answer to the ethical question \u2013 whether unexplained health inequality is unfair \u2013 determines the appropriate standardization method for health inequity analysis and can lead to potentially divergent estimates of health inequity.", {"entities": []}], ["We use the American sample of the 2002\u201303 Joint Canada/United States Survey of Health and measure health by the Health Utilities Index (HUI).", {"entities": []}], ["We model variation in the observed HUI by demographic, socioeconomic, health behaviour, and health care variables using Ordinary Least Squares.", {"entities": []}], ["We estimate unfair HUI by standardizing fairness, removing the fair component from the observed HUI.", {"entities": []}], ["We consider health inequality due to factors amenable to policy intervention as unfair.", {"entities": []}], ["We contrast estimates of inequity using two fairness-standardization methods: direct (considering unexplained inequality as ethically acceptable) and indirect (considering unexplained inequality as unfair).", {"entities": []}], ["We use the Gini coefficient to quantify inequity.", {"entities": []}], ["Our analysis shows that about 75% of the variation in the observed HUI is unexplained by the model.", {"entities": []}], ["The direct standardization results in a smaller inequity estimate (about 60% of health inequality is inequitable) than the indirect standardization (almost all inequality is inequitable).", {"entities": []}], ["The choice of the fairness-standardization method is ethical and influences the empirical health inequity results considerably.", {"entities": []}], ["More debate and analysis is necessary regarding which treatment of the unexplained inequality has the stronger foundation in equity considerations.", {"entities": []}], ["The online version of this article (doi:10.1186/s12939-015-0138-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The etiology of a child\u2019s cognitive ability is complex, with research suggesting that it is not attributed to a single determinant or even a defined period of exposure.", {"entities": []}], ["Rather, cognitive development is the product of cumulative interactions with the environment, both negative and positive, over the life course.", {"entities": []}], ["The aim of this systematic scoping review was to collate evidence associated with children\u2019s cognitive health, including inherent factors as well as chemical and non-chemical stressors from the built, natural, and social environments.", {"entities": []}], ["Three databases were used to identify recent epidemiological studies (2003\u20132013) that examined exposure factors associated with general cognitive ability in children.", {"entities": []}], ["Over 100 factors were evaluated from 258 eligible studies.", {"entities": []}], ["We found that recent literature mainly assessed the hypothesized negative effects of either inherent factors or chemical exposures present in the physical environment.", {"entities": []}], ["Prenatal growth, sleep health, lead and water pollutants showed consistent negative effects.", {"entities": []}], ["Of the few studies that examined social stressors, results consistently showed cognitive development to be influenced by both positive and negative social interactions at home, in school or the community.", {"entities": []}], ["Among behavioral factors related to diet and lifestyle choices of the mother, breastfeeding was the most studied, showing consistent positive associations with cognitive ability.", {"entities": []}], ["There were mostly inconsistent results for both chemical and non-chemical stressors.", {"entities": []}], ["The majority of studies utilized traditional exposure assessments, evaluating chemical and non-chemical stressors separately.", {"entities": []}], ["Collective evidence from a limited number of studies revealed that cumulative exposure assessment that incorporates multiple chemical and non-chemical stressors over the life course may unravel the variability in effect on cognitive development and help explain the inconsistencies across studies.", {"entities": []}], ["Future research examining the interactions of multiple stressors within a child\u2019s total environment, depicting a more real-world exposure, will aid in understanding the cumulative effects associated with a child\u2019s ability to learn.", {"entities": []}], ["Allergic rhinitis (AR) is common among children with asthma and exacerbates asthma symptoms.", {"entities": [[9, 17, "DISEASE"], [53, 59, "DISEASE"], [76, 82, "DISEASE"]]}], ["To assess the incremental utilization and cost of asthma-related health services due to concomitant AR among asthmatic children.", {"entities": [[50, 56, "DISEASE"]]}], ["Asthma-related claims were extracted from the Korean National Health Insurance (NHI) claims database, which covers 97% of the population.", {"entities": [[0, 6, "DISEASE"]]}], ["Per-capita utilization and costs of asthma-related services were determined from the societal perspective.", {"entities": [[36, 42, "DISEASE"]]}], ["Of 319,714 children (1 - 14 years old) with chronic asthma in 2003, 195,026 had concomitant AR (prevalence 610 per 1,000 asthmatic children).", {"entities": [[52, 58, "DISEASE"]]}], ["Children with AR had 1.14 times more outpatient visits, 1.30 times more emergency department (ED) visits, and 1.49 times more hospitalizations than children without AR.", {"entities": []}], ["More children with AR used general hospitals (7.17%) than children without AR (3.23%).", {"entities": []}], ["The ratios of unit pharmaceutical costs per outpatient visit, ED visit, and admission between children with and without AR were 1.27, 1.20, and 1.14.", {"entities": []}], ["Total annual expenditure combining direct health care, transportation, and caregivers' costs, were $273 and $217 for children with and without AR, respectively.", {"entities": []}], ["Health service utilization and costs for asthma were greater for asthmatic children with AR.", {"entities": [[41, 47, "DISEASE"]]}], ["More frequent ED visits and admissions among asthmatic children with AR suggest poorer control and more frequent exacerbations.", {"entities": []}], ["Higher unit cost of pharmaceuticals during visits, tendency to receive asthma care from a higher-level facility, and greater risk of ED visit or admission all contributed to the additional economic burden of AR.", {"entities": [[71, 77, "DISEASE"]]}], ["In this review, we will integrate recent knowledge on endoplasmic reticulum (ER) stress and allergy, thereby highlighting the therapeutic potential of ER stress in the context of precision medicine for allergic diseases.", {"entities": []}], ["Emerging evidence suggests that allergic diseases are very heterogeneous having numerous endotypes.", {"entities": []}], ["This leads to the new era of modern medicine, which assumes that a particular endotype-driven therapy, called precision medicine, would be more efficacious in a specific group of patients rather than in all patients.", {"entities": []}], ["Currently, a dichotomy involving type 2/non-type 2 immune response underlies most of the studies on inflammatory and immunologic mechanisms of allergic disorders.", {"entities": []}], ["Whereas there are several approved or investigational endotype-driven therapeutic agents targeting type 2 immune responses, investigation of mechanisms and endotype-driven interventions regarding non-type 2 immune response lags far behind.", {"entities": []}], ["Considering that non-type 2 immune response may represent a significant proportion of allergic disease, particularly corticosteroid-resistant severe disease, defining a novel concept of endotype-driven approach may be essential.", {"entities": []}], ["Recently, stress responses originate from the endoplasmic reticulum (ER) and the associated inflammatory molecular platform has been suggested as a crucial player of immune and inflammatory responses.", {"entities": []}], ["This implies that ER stress-related pathways may represent a new endotype-driven therapeutic strategy in the treatment of allergic diseases.", {"entities": []}], ["To assess the efficacy and safety of low-dose prednisone chronotherapy using a new modified-release (MR) formulation for the treatment of rheumatoid arthritis (RA).", {"entities": [[138, 158, "DISEASE"], [149, 158, "DISEASE"]]}], ["In this 12-week, double-blind, placebo-controlled study, patients with active RA (n=350) were randomised 2:1 to receive MR prednisone 5 mg or placebo once daily in the evening in addition to their existing RA disease-modifying antirheumatic drug (DMARD) treatment.", {"entities": []}], ["The primary end point was the percentage of patients achieving a 20% improvement in RA signs and symptoms according to American College of Rheumatology criteria (ie, an ACR20 response) at week 12.", {"entities": []}], ["Changes in morning pain, duration of morning stiffness, 28-joint Disease Activity Score and health-related quality of life were also assessed.", {"entities": []}], ["MR prednisone plus DMARD treatment produced higher response rates for ACR20 (48% vs 29%, p<0.001) and ACR50 (22% vs 10%, p<0.006) and a greater median relative reduction from baseline in morning stiffness (55% vs 35%, p<0.002) at week 12 than placebo plus DMARD treatment.", {"entities": []}], ["Significantly greater reductions in severity of RA (Disease Activity Score 28) (p<0.001) and fatigue (Functional Assessment of Chronic Illness Therapy-Fatigue score) (p=0.003) as well as a greater improvement in physical function (36-item Short-Form Health Survey score) (p<0.001) were seen at week 12 for MR prednisone versus placebo.", {"entities": []}], ["The incidence of adverse events was similar for MR prednisone (43%) and placebo (49%).", {"entities": []}], ["Low-dose MR prednisone added to existing DMARD treatment produced rapid and relevant improvements in RA signs and symptoms.", {"entities": []}], ["NCT00650078", {"entities": []}], ["This article gives an overview of the ongoing cohort and dietary studies underlying the assessment of population health in the Arctic.", {"entities": []}], ["The emphasis here is on a description of the material, methods and results or preliminary results for each study.", {"entities": []}], ["Detailed exposure information is available in an article in this journal, whereas another paper describes the effects associated with contaminant exposure in the Arctic.", {"entities": []}], ["The cohort descriptions have been arranged geographically, beginning in Norway and moving east to Finland, Sweden, Russia and the other Arctic countries and ultimately to the Faroe Islands.", {"entities": []}], ["No cohort studies have been reported for Alaska or Iceland.", {"entities": []}], ["To assess frequency and distribution of infusion reactions (IRs) in responders and nonresponders in randomized clinical trials (RCTs) of intravenous pegloticase and the utility of the National Institute of Allergy and Infectious Disease/Food and Allergy and Anaphylaxis Network (NIAID/FAAN) criteria for identifying anaphylaxis in subjects experiencing IRs.", {"entities": []}], ["IRs from two RCTs of pegloticase were evaluated and categorized as anaphylaxis, hypersensitivity, or other.", {"entities": []}], ["Serum levels of tryptase and total hemolytic complement (CH50) were evaluated at the time of all IRs.", {"entities": []}], ["Frequency of IRs by each category was evaluated in all subjects, responders or nonresponders to pegloticase.", {"entities": []}], ["There were 113 IRs in 1695 infusions.", {"entities": []}], ["Of the 113 IRs, 6 met criteria for anaphylaxis, 53 had one feature of anaphylaxis and were designated as \u201chypersensitivity\u201d, and 54 had no features and were designated \u201cother\u201d.", {"entities": []}], ["In subjects receiving pegloticase every 2\u00a0weeks (Q2w), a total of 852 infusions were administered and the IR frequency was 0.5% in responders and 9.7% in nonresponders.", {"entities": []}], ["In subjects receiving pegloticase every 4\u00a0weeks (Q4w), a total of 846 infusions were given and the IR frequency was 2.6% in responders and 12.2% in nonresponders.", {"entities": []}], ["There were no differences among the three categories of IRs with regard to clinical course or biochemical evidence of immune activation determined by CH50 or tryptase levels.", {"entities": []}], ["IRs mostly occurred in nonresponders.", {"entities": []}], ["NIAID/FAAN criteria for anaphylaxis did not identify pegloticase-related IRs as having a higher frequency of immune activation or a more severe course.", {"entities": []}], ["The results are consistent with the conclusion that discontinuance of pegloticase if uric acid rises to >6\u00a0mg/dL will decrease the frequency of IRs.", {"entities": []}], ["Genetic variation in the innate immune system of the host may play a role in determining the risk of developing infection, as well as outcome from infection.", {"entities": []}], ["Infectious complications were retrospectively determined in 293 (233 African-American (AA), 57 Caucasian and 3 Hispanic) mechanically ventilated very low birth weight (VLBW) infants (<1500 grams at birth) who were genotyped for the IL-6 -174 G/C, IL-10 -1082 G/A and CD14 -260 C/T single nucleotide polymorphisms (SNPs).", {"entities": [[267, 271, "GENE"]]}], ["The IL-6 -174C allele was associated with an increased incidence of late blood stream infection (BSI) in AA but not Caucasian infants.", {"entities": []}], ["In AA infants with the C allele the incidence of late BSI was 20/29 (69%) compared to 94/204 (46%) in homozygous GG infants (RR 2.6, 95% CI: 1.1\u20136.0, p = 0.021).", {"entities": []}], ["The IL-10 -1082A allele was associated with an increased incidence of late BSI.", {"entities": []}], ["One or more episodes of late BSI developed in 14 (35%) of 40 infants with the GG genotype, 71 (49%) of 145 infants with the GA genotype and 63 (58%) of 108 infants with the AA genotype (p = 0.036).", {"entities": []}], ["Infants with the A allele (AA or GA genotypes) had an incidence of late BSI that was 134/253 (53%) compared to 14/40 (35%) in homozygous GG infants (RR 2.1, 95% CI: 1.04\u20134.19, p = 0.035).", {"entities": []}], ["The CD14 -260 C/T SNP did not alter the overall risk for BSI in ventilated VLBW infants.", {"entities": [[4, 8, "GENE"]]}], ["Multiple BSI episodes were more common in the TT genotype group (CC: 17%, CT: 11%, TT: 30%, p = 0.022).", {"entities": []}], ["This effect was due to the strong effect of the TT genotype on the incidence of multiple BSI in AA infants (CC: 15%, CT: 11%, TT: 39%, p = 0.003).", {"entities": []}], ["The IL-6 -174 G/C, IL-10 -1082 G/A and CD14 -260 C/T SNPs may alter risk for BSI in ventilated VLBW infants.", {"entities": [[39, 43, "GENE"]]}], ["Unsaturated oxidative formaldehyde is a noxious aldehyde in cigarette smoke that causes edematous acute lung injury.", {"entities": []}], ["However, the mechanistic effects of formaldehyde on lung fluid transport are still poorly understood.", {"entities": []}], ["We examined how formaldehyde regulates human epithelial sodium channels (ENaC) in H441 and expressed in Xenopus oocytes and exposed mice in vivo .", {"entities": []}], ["Our results showed that formaldehyde reduced mouse transalveolar fluid clearance in vivo .", {"entities": []}], ["Formaldehyde caused a dose-dependent inhibition of amiloride-sensitive short-circuit Na", {"entities": []}], ["Over the past few decades, obesity has reached epidemic proportions, and is a major contributor to the global burden of chronic diseases and disability.", {"entities": [[27, 34, "DISEASE"]]}], ["There is little evidence on obesity related co-morbidities in BRICS countries.", {"entities": [[28, 35, "DISEASE"]]}], ["The first objective is to examine the factors associated with overweight and obesity in four of the five BRICS countries (China, India, Russia and South Africa).", {"entities": [[77, 84, "DISEASE"]]}], ["The second is to examine the linkage of obesity with selected morbidities.", {"entities": [[40, 47, "DISEASE"]]}], ["We used data from the Study on Global Ageing and Adult Health (SAGE) survey conducted by the World Health Organization (WHO) in China, India, Russia and South Africa during 2007\u201310.", {"entities": []}], ["The morbidities included in the analysis are Hypertension, Diabetes, Angina, Stroke, Arthritis and Depression.", {"entities": []}], ["The prevalence of obesity was highest in South Africa (35%) followed by Russia (22%), China (5%) and India (3%).", {"entities": [[18, 25, "DISEASE"]]}], ["The prevalence of obesity was significantly higher in females as compared to males in all the countries.", {"entities": [[18, 25, "DISEASE"]]}], ["While the wealth quintile was associated with overweight in India and China, engaging in work requiring physical activity was associated with obesity in China and South Africa.", {"entities": [[142, 149, "DISEASE"]]}], ["Overweight/obesity was positively associated with Hypertension and Diabetes in all the four countries.", {"entities": [[11, 18, "DISEASE"]]}], ["Obesity was also positively associated with Arthritis and Angina in China, Russia and South Africa.", {"entities": [[0, 7, "DISEASE"]]}], ["In comparison, overweight/obesity was not associated with Stroke and Depression in any of the four countries.", {"entities": [[26, 33, "DISEASE"]]}], ["Obesity was statistically associated with Hypertension, Angina, Diabetes and Arthritis in China, Russia and South Africa.", {"entities": [[0, 7, "DISEASE"]]}], ["In India, obesity was associated only with Hypertension and Diabetes.", {"entities": [[10, 17, "DISEASE"]]}], ["Nimesulide, an anti-inflammatory and analgesic drug, is reported to cause severe hepatotoxicity.", {"entities": []}], ["In this study, molecular mechanisms involved in deranged oxidant-antioxidant homeostasis and mitochondrial dysfunction during nimesulide-induced hepatotoxicity and its attenuation by plant derived terpenes, camphene and geraniol has been explored in male Sprague-Dawley rats.", {"entities": []}], ["Hepatotoxicity due to nimesulide (80 mg/kg BW) was evident from elevated SGPT, SGOT, bilirubin and histo-pathological changes.", {"entities": []}], ["Antioxidants and key redox enzymes (iNOS, mt NOS, Cu/Zn-SOD, Mn-SOD, GPx and GR) were altered significantly as assessed by their mRNA expression, Immunoblot analysis and enzyme activities.", {"entities": []}], ["Redox imbalance along with oxidative stress was evident from decreased NAD(P)H and GSH (56% and 74% respectively; P <0.001), increased superoxide and secondary ROS/RNS generation along with oxidative damage to cellular macromolecules.", {"entities": []}], ["Nimesulide reduced mitochondrial activity, depolarized mitochondria and caused membrane permeability transition (MPT) followed by release of apoptotic proteins (AIF; apoptosis inducing factor, EndoG; endonuclease G, and Cyto c ; cytochrome c).", {"entities": [[193, 198, "GENE"]]}], ["It also significantly activated caspase-9 and caspase-3 and increased oxidative DNA damage (level of 8-Oxoguanine glycosylase; P <0.05).", {"entities": []}], ["A combination of camphene and geraniol (CG; 1\u22361), when pre-administered in rats (10 mg/kg BW), accorded protection against nimesulide hepatotoxicity in vivo, as evident from normalized serum biomarkers and histopathology.", {"entities": []}], ["mRNA expression and activity of key antioxidant and redox enzymes along with oxidative stress were also normalized due to CG pre-treatment.", {"entities": []}], ["Downstream effects like decreased mitochondrial swelling, inhibition in release of apoptotic proteins, prevention of mitochondrial depolarization along with reduction in oxidized NAD(P)H and increased mitochondrial electron flow further supported protective action of selected terpenes against nimesulide toxicity.", {"entities": []}], ["Therefore CG, a combination of natural terpenes prevented nimesulide induced cellular damage and ensuing hepatotoxicity.", {"entities": []}], ["A significant proportion of patients with chronic obstructive pulmonary disease (COPD) remain undiagnosed.", {"entities": [[42, 79, "DISEASE"]]}], ["Characterizing these patients can increase our understanding of the \u2018hidden\u2019 burden of COPD and the effectiveness of case detection interventions.", {"entities": []}], ["We conducted a systematic review and meta-analysis to compare patient and disease factors between patients with undiagnosed persistent airflow limitation and those with diagnosed COPD.", {"entities": []}], ["We searched MEDLINE and EMBASE for observational studies of adult patients meeting accepted spirometric definitions of COPD.", {"entities": []}], ["We extracted and pooled summary data on the proportion or mean of each risk factor among diagnosed and undiagnosed patients (unadjusted analysis), and coefficients for the adjusted association between risk factors and diagnosis status (adjusted analysis).", {"entities": []}], ["Two thousand eighty-three records were identified through database searching and 16 articles were used in the meta-analyses.", {"entities": []}], ["Diagnosed patients were less likely to have mild (v. moderate to very severe) COPD (odds ratio [OR] 0.30, 95%CI 0.24\u20130.37, 6 studies) in unadjusted analysis.", {"entities": []}], ["This association remained significant but its strength was attenuated in the adjusted analysis (OR 0.72, 95%CI 0.58\u20130.89, 2 studies).", {"entities": []}], ["Diagnosed patients were more likely to report respiratory symptoms such as wheezing (OR 3.51, 95%CI 2.19\u20135.63, 3 studies) and phlegm (OR 2.16, 95% CI 1.38\u20133.38, 3 studies), had more severe dyspnea (mean difference in modified Medical Research Council scale 0.52, 95%CI 0.40\u20130.64, 3 studies), and slightly greater smoking history than undiagnosed patients.", {"entities": []}], ["Patient age, sex, current smoking status, and the presence of coughing were not associated with a previous diagnosis.", {"entities": []}], ["Undiagnosed patients had less severe airflow obstruction and fewer respiratory symptoms than diagnosed patients.", {"entities": []}], ["The lower disease burden in undiagnosed patients may significantly delay the diagnosis of COPD.", {"entities": []}], ["The online version of this article (10.1186/s12931-018-0731-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Bone mineral density is known to be a heritable, polygenic trait whereas genetic variants contributing to lean mass variation remain largely unknown.", {"entities": []}], ["We estimated the shared SNP heritability and performed a bivariate GWAS meta-analysis of total-body lean mass (TB-LM) and total-body less head bone mineral density (TBLH-BMD) regions in 10,414 children.", {"entities": []}], ["The estimated SNP heritability is 43% (95% CI: 34\u201352%) for TBLH-BMD, and 39% (95% CI: 30\u201348%) for TB-LM, with a shared genetic component of 43% (95% CI: 29\u201356%).", {"entities": []}], ["We identify variants with pleiotropic effects in eight loci, including seven established bone mineral density loci: WNT4 , GALNT3 , MEPE , CPED1/WNT16 , TNFSF11 , RIN3 , and PPP6R3/LRP5 .", {"entities": [[116, 120, "GENE"], [123, 129, "GENE"], [132, 136, "GENE"], [153, 160, "GENE"], [163, 167, "GENE"]]}], ["Variants in the TOM1L2/SREBF1 locus exert opposing effects TB-LM and TBLH-BMD, and have a stronger association with the former trait.", {"entities": []}], ["We show that SREBF1 is expressed in murine and human osteoblasts, as well as in human muscle tissue.", {"entities": [[13, 19, "GENE"]]}], ["This is the first bivariate GWAS meta-analysis to demonstrate genetic factors with pleiotropic effects on bone mineral density and lean mass.", {"entities": []}], ["Bone mineral density and lean skeletal mass are heritable traits.", {"entities": []}], ["Here, Medina-Gomez and colleagues perform bivariate GWAS analyses of total body lean mass and bone mass density in children, and show genetic loci with pleiotropic effects on both traits.", {"entities": []}], ["Potential links between eczema and obstructive pulmonary diseases have been postulated.", {"entities": []}], ["Previously we have reported the prevalence of upper and lower respiratory diseases and the relation to environmental and socio-economic factors in a randomly selected adult population in southern Sweden using a postal questionnaire.", {"entities": []}], ["In the present study we wanted to analyse the prevalence of eczema and its relation to socio-economic status, heredity factors and environmental factors in an adult population.", {"entities": []}], ["Self-reported eczema, upper and lower respiratory symptoms, asthma and Chronic Bronchitis Emphysema (CBE) were examined in 12,071 adults, aged 20\u201359 years, living in southern Sweden by using a postal questionnaire.", {"entities": [[60, 66, "DISEASE"]]}], ["There were comparable numbers of males and females in all age groups.", {"entities": []}], ["Multiple logistic regression analysis (forward conditional) was applied to estimate the association between the proposed risk factors (heredity, self-reported asthma and CBE, nasal symptoms, socio-economic group, environmental factors, age, gender and smoking habits) and self-reported eczema.", {"entities": [[159, 165, "DISEASE"]]}], ["The response rate was 70.1%.", {"entities": []}], ["In all, 1240 subjects (14.6%) stated that they had eczema.", {"entities": []}], ["In all age cohorts self-reported eczema was more frequently reported by women than by men (p < 0.05).", {"entities": []}], ["The prevalence of self-reported eczema among the economically active population varied from 17.1% to 8.2% with the highest rates among assistant non-manual employees.", {"entities": []}], ["However, when controlling for age, gender and risk occupation there was no association between low social position and eczema.", {"entities": []}], ["Living close to heavy traffic (OR = 1.45, 95% CI 1.25\u20131.67) and living seaside (OR = 1.17, 95% CI 1.01\u20131.35) but not urban/suburban living was associated with eczema.", {"entities": []}], ["Heredity of eczema (OR = 5.77, 95% CI 5.02\u20136.64), self reported allergic rhinitis (OR = 2.31, 95% CI 2.00\u20132.68), self reported asthma (OR = 1.98, 95% CI 1.56\u20132.51) and self reported CBE (OR = 1.42, 95% CI 1.08\u20131.87) were all associated with eczema.", {"entities": [[64, 81, "DISEASE"], [73, 81, "DISEASE"], [127, 133, "DISEASE"]]}], ["In this epidemiological study we see that self-reported eczema is a common disease in an adult population especially among women.", {"entities": []}], ["Eczema seems to be linked to environment factors, obstructive pulmonary diseases and rhinitis.", {"entities": [[85, 93, "DISEASE"]]}], ["To investigate the potential local health benefits of adopting greenhouse gas (GHG) mitigation policies, we develop scenarios of GHG mitigation for M\u00e9xico City, M\u00e9xico; Santiago, Chile; S\u00e3o Paulo, Brazil; and New York, New York, USA using air pollution health impact factors appropriate to each city.", {"entities": []}], ["We estimate that the adoption of readily available technologies to lessen fossil fuel emissions over the next two decades in these four cities alone will reduce particulate matter and ozone and avoid approximately 64,000 (95% confidence interval [CI] 18,000-116,000) premature deaths (including infant deaths), 65,000 (95% CI 22,000-108,000) chronic bronchitis cases, and 46 million (95% CI 35-58 million) person-days of work loss or other restricted activity.", {"entities": [[350, 360, "DISEASE"]]}], ["These findings illustrate that GHG mitigation can provide considerable local air pollution-related public health benefits to countries that choose to abate GHG emissions by reducing fossil fuel combustion.", {"entities": []}], ["Most particulate matter (PM) health effects studies use outdoor (ambient) PM as a surrogate for personal exposure.", {"entities": []}], ["However, people spend most of their time indoors exposed to a combination of indoor-generated particles and ambient particles that have infiltrated.", {"entities": []}], ["Thus, it is important to investigate the differential health effects of indoor- and ambient-generated particles.", {"entities": []}], ["We combined our recently adapted recursive model and a predictive model for estimating infiltration efficiency to separate personal exposure ( E ) to PM 2.5 (PM with aerodynamic diameter \u22642.5 \u03bcm) into its indoor-generated ( E ig ) and ambient-generated ( E ag ) components for 19 children with asthma.", {"entities": [[294, 300, "DISEASE"]]}], ["We then compared E ig and E ag to changes in exhaled nitric oxide (eNO), a marker of airway inflammation.", {"entities": []}], ["Based on the recursive model with a sample size of eight children, E ag was marginally associated with increases in eNO [5.6 ppb per 10-\u03bcg/m 2.5 ; 95% confidence interval (CI), \u22120.6 to 11.9; p = 0.08].", {"entities": []}], ["E ig was not associated with eNO (\u22120.19 ppb change per 10\u03bcg/m E ag and E ig for all 19 children.", {"entities": []}], ["For those combined estimates, only E ag was significantly associated with an increase in eNO ( E ag : 5.0 ppb per 10-\u03bcg/m 2.5; 95% CI, 0.3 to 9.7; p = 0.04; E ig : 3.3 ppb per 10-\u03bcg/m 2.5 ; 95% CI, \u22121.1 to 7.7; p = 0.15).", {"entities": []}], ["Effects were seen only in children who were not using corticosteroid therapy.", {"entities": []}], ["We conclude that the ambient-generated component of PM 2.5 exposure is consistently associated with increases in eNO and the indoor-generated component is less strongly associated with eNO.", {"entities": []}], ["Hereditary angioedema is characterized by sudden episodes of nonpitting edema that cause discomfort and pain.", {"entities": [[0, 21, "DISEASE"], [11, 21, "DISEASE"]]}], ["Typically the extremities, genitalia, trunk, gastrointestinal tract, face, and larynx are affected by attacks of swelling.", {"entities": []}], ["Laryngeal swelling carries significant risk for asphyxiation.", {"entities": []}], ["The disease results from mutations in the C1 esterase inhibitor gene that cause C1 esterase inhibitor deficiency.", {"entities": []}], ["Attacks of hereditary angioedema result from contact, complement, and fibrinolytic plasma cascade activation, where C1 esterase inhibitor irreversibly binds substrates.", {"entities": [[11, 32, "DISEASE"], [22, 32, "DISEASE"]]}], ["Patients with hereditary angioedema cannot replenish C1 esterase inhibitor levels on pace with its binding.", {"entities": [[14, 35, "DISEASE"], [25, 35, "DISEASE"]]}], ["When C1 esterase inhibitor is depleted in these patients, vasoactive plasma cascade products cause swelling attacks.", {"entities": []}], ["Trauma is a known trigger for hereditary angioedema attacks, and patients have been denied surgical procedures because of this risk.", {"entities": [[30, 51, "DISEASE"], [41, 51, "DISEASE"]]}], ["However, uncomplicated surgeries have been reported.", {"entities": []}], ["Appropriate prophylaxis can reduce peri-operative morbidity in these patients, despite proteolytic cascade and complement activation during surgical trauma.", {"entities": []}], ["We report a case of successful short-term prophylaxis with C1 esterase inhibitor in a 51-year-old man with hereditary angioedema who underwent redo mitral valve reconstructive surgery.", {"entities": [[107, 128, "DISEASE"], [118, 128, "DISEASE"]]}], ["Benign hereditary chorea (BHC) is a childhood-onset, hyperkinetic movement disorder normally with little progression of motor symptoms into adult life.", {"entities": []}], ["The disorder is caused by mutations to the NKX2.1 (TITF1) gene and also forms part of the \u201cbrain\u2013lung\u2013thyroid syndrome\u201d, in which additional developmental abnormalities of lung and thyroid tissue are observed.", {"entities": [[110, 118, "DISEASE"]]}], ["In this review, we summarize the main clinical findings in \u201cclassical\u201d BHC syndrome and discuss more recently reported atypical features, including non-choreiform movement phenotypes.", {"entities": [[75, 83, "DISEASE"]]}], ["We highlight additional non-motor characteristics such as cognitive impairment and psychiatric symptoms, while discussing the evidence for BHC as a developmental disorder involving impaired neural migration and other multisystem developmental abnormalities.", {"entities": []}], ["Finally, we will discuss the efficacy of available therapies in both affected pediatric and adult cohorts.", {"entities": []}], ["Delineation of the BHC disease spectrum will no doubt expand our understanding of this disorder, facilitating better targeting of genetic testing and establish a framework for future clinical trials.", {"entities": []}], ["Human tissues perform diverse metabolic functions.", {"entities": []}], ["Mapping out these tissue-specific functions in genome-scale models will advance our understanding of the metabolic basis of various physiological and pathological processes.", {"entities": []}], ["The global knowledgebase of metabolic functions categorized for the human genome ( Human Recon 1) coupled with abundant high-throughput data now makes possible the reconstruction of tissue-specific metabolic models.", {"entities": []}], ["However, the number of available tissue-specific models remains incomplete compared with the large diversity of human tissues.", {"entities": []}], ["We developed a method called metabolic Context-specificity Assessed by Deterministic Reaction Evaluation (mCADRE).", {"entities": []}], ["mCADRE is able to infer a tissue-specific network based on gene expression data and metabolic network topology, along with evaluation of functional capabilities during model building.", {"entities": []}], ["mCADRE produces models with similar or better functionality and achieves dramatic computational speed up over existing methods.", {"entities": []}], ["Using our method, we reconstructed draft genome-scale metabolic models for 126 human tissue and cell types.", {"entities": []}], ["Among these, there are models for 26 tumor tissues along with their normal counterparts, and 30 different brain tissues.", {"entities": []}], ["We performed pathway-level analyses of this large collection of tissue-specific models and identified the eicosanoid metabolic pathway, especially reactions catalyzing the production of leukotrienes from arachidnoic acid, as potential drug targets that selectively affect tumor tissues.", {"entities": []}], ["This large collection of 126 genome-scale draft metabolic models provides a useful resource for studying the metabolic basis for a variety of human diseases across many tissues.", {"entities": []}], ["The functionality of the resulting models and the fast computational speed of the mCADRE algorithm make it a useful tool to build and update tissue-specific metabolic models.", {"entities": []}], ["The disruption and hyperpermeability of bronchial epithelial barrier are closely related to the pathogenesis of asthma.", {"entities": [[112, 118, "DISEASE"]]}], ["House dust mite (HDM), one of the most important allergens, could increase the airway epithelial permeability.", {"entities": []}], ["Heat shock protein (Hsp) 90\u03b1 is also implicated in the lung endothelial barrier dysfunction by disrupting RhoA signaling.", {"entities": [[106, 110, "GENE"]]}], ["However, the effect of extracellular Hsp90\u03b1 (eHsp90\u03b1) on the bronchial epithelial barrier disruption induced by HDM has never been reported.", {"entities": []}], ["To investigate the involvement of eHsp90\u03b1 in the bronchial epithelial barrier disruption induced by HDM, normal human bronchial epithelial cell line 16HBE14o- (16HBE) cells were treated by HDM, human recombinant (hr) Hsp90\u03b1 and hrHsp90\u03b2 respectively and pretreated by1G6-D7, a specific anti-secreted Hsp90\u03b1 monoclonal antibody (mAb).", {"entities": [[213, 215, "GENE"]]}], ["Hsp90\u03b1-silencing cells were also constructed.", {"entities": []}], ["To further evaluate the role of RhoA signaling in this process, cells were pretreated by inhibitors of Rho kinase, GSK429286A and Y27632 2HCl.", {"entities": [[32, 36, "GENE"]]}], ["Transepithelial electrical resistance (TEER) and FITC-dextran flux (FITC-DX) were examined as the epithelial barrier function.", {"entities": []}], ["Expression and localization of adherens junctional proteins E-cadherin and \u03b2-catenin were evaluated by western blotting and immunofluorescence respectively.", {"entities": []}], ["The level of eHsp90\u03b1 was investigated by concentration and purification of condition media.", {"entities": []}], ["RhoA activity was determined by using a Rho G-LISA\u00ae RhoA activation assay kit The epithelial barrier disruption and the loss of adherens junctional proteins E-cadherin and \u03b2-catenin in cytomembrane were observed in HDM-treated 16HBE cells, paralleled with the increase of eHsp90\u03b1 secretion.", {"entities": [[0, 4, "GENE"], [52, 56, "GENE"], [0, 4, "GENE"], [52, 56, "GENE"]]}], ["All of which were rescued in Hsp90\u03b1-silencing cells or by pretreating 16HBE cells with 1G6-D7.", {"entities": []}], ["Also, 1G6-D7 suppressed RhoA activity and MLC phosphorylation induced by HDM.", {"entities": [[24, 28, "GENE"]]}], ["Furthermore, inhibitors of Rho kinase prevented and restored the airway barrier disruption.", {"entities": []}], ["Consistently, it was hrHsp90\u03b1 instead of hrHsp90\u03b2 that promoted barrier dysfunction and activated RhoA/MLC signaling in 16HBE cells.", {"entities": []}], ["The eHsp90\u03b1 mediates HDM-induced human bronchial epithelial barrier dysfunction by activating RhoA/MLC signaling, suggesting that eHsp90\u03b1 is a potential therapeutic target for treatment of asthma.", {"entities": [[189, 195, "DISEASE"]]}], ["Combining computational toxicology with ExpoCast exposure estimates and ToxCast\u2122 assay data gives us access to predictions of human health risks stemming from exposures to chemical mixtures.", {"entities": []}], ["We explored, through mathematical modeling and simulations, the size of potential effects of random mixtures of aromatase inhibitors on the dynamics of women's menstrual cycles.", {"entities": []}], ["We simulated random exposures to millions of potential mixtures of 86 aromatase inhibitors.", {"entities": []}], ["A pharmacokinetic model of intake and disposition of the chemicals predicted their internal concentration as a function of time (up to 2 y).", {"entities": []}], ["A ToxCast\u2122 aromatase assay provided concentration\u2013inhibition relationships for each chemical.", {"entities": []}], ["The resulting total aromatase inhibition was input to a mathematical model of the hormonal hypothalamus\u2013pituitary\u2013ovarian control of ovulation in women.", {"entities": []}], ["Above 10% inhibition of estradiol synthesis by aromatase inhibitors, noticeable (eventually reversible) effects on ovulation were predicted.", {"entities": []}], ["Exposures to individual chemicals never led to such effects.", {"entities": []}], ["In our best estimate, \u223c 10 % of the combined exposures simulated had mild to catastrophic impacts on ovulation.", {"entities": []}], ["A lower bound on that figure, obtained using an optimistic exposure scenario, was 0.3%.", {"entities": []}], ["These results demonstrate the possibility to predict large-scale mixture effects for endocrine disrupters with a predictive toxicology approach that is suitable for high-throughput ranking and risk assessment.", {"entities": []}], ["The size of the effects predicted is consistent with an increased risk of infertility in women from everyday exposures to our chemical environment.", {"entities": [[74, 85, "DISEASE"]]}], ["https://doi.org/10.1289/EHP742", {"entities": []}], ["The short consultation length in primary care is a source of concern, and the wish for more consultation time is a common reason for patients to seek complementary medicine.", {"entities": []}], ["Physicians practicing anthroposophic medicine have prolonged consultations with their patients, taking an extended history, addressing constitutional, psychosocial, and biographic aspect of patients' illness, and selecting optimal therapy.", {"entities": []}], ["In Germany, health benefit programs have included the reimbursement of this additional physician time.", {"entities": []}], ["The purpose of this study was to describe clinical outcomes in patients with chronic diseases treated by anthroposophic physicians after an initial prolonged consultation.", {"entities": []}], ["In conjunction with a health benefit program in Germany, 233 outpatients aged 1\u201374 years, treated by 72 anthroposophic physicians after a consultation of at least 30 min participated in a prospective cohort study.", {"entities": []}], ["Main outcomes were disease severity (Disease and Symptom Scores, physicians' and patients' assessment on numerical rating scales 0\u201310) and quality of life (adults: SF-36, children aged 8\u201316: KINDL, children 1\u20137: KITA).", {"entities": []}], ["Disease Score was documented after 0, 6 and 12 months, other outcomes after 0, 3, 6, 12, 18, 24, and (Symptom Score and SF-36) 48 months.", {"entities": []}], ["Most common indications were mental disorders (17.6% of patients; primarily depression and fatigue), respiratory diseases (15.5%), and musculoskeletal diseases (11.6%).", {"entities": []}], ["Median disease duration at baseline was 3.0 years (interquartile range 0.5\u20139.8 years).", {"entities": []}], ["The consultation leading to study enrolment lasted 30\u201360 min in 51.5% (120/233) of patients and > 60 min in 48.5%.", {"entities": []}], ["During the following year, patients had a median of 3.0 (interquartile range 1.0\u20137.0) prolonged consultations with their anthroposophic physicians, 86.1% (167/194) of patients used anthroposophic medication.", {"entities": []}], ["All outcomes except KITA Daily Life subscale and KINDL showed significant improvement between baseline and all subsequent follow-ups.", {"entities": []}], ["Improvements from baseline to 12 months were: Disease Score from mean (standard deviation) 5.95 (1.74) to 2.31 (2.29) (p < 0.001), Symptom Score from 5.74 (1.81) to 3.04 (2.16) (p < 0.001), SF-36 Physical Component Summary from 44.01 (10.92) to 47.99 (10.43) (p < 0.001), SF-36 Mental Component Summary from 42.34 (11.98) to 46.84 (10.47) (p < 0.001), and KITA Psychosoma subscale from 62.23 (19.76) to 76.44 (13.62) (p = 0.001).", {"entities": []}], ["All these improvements were maintained until the last follow-up.", {"entities": []}], ["Improvements were similar in patients not using diagnosis-related adjunctive therapies within the first six study months.", {"entities": []}], ["Patients treated by anthroposophic physicians after an initial prolonged consultation had long-term reduction of chronic disease symptoms and improvement of quality of life.", {"entities": []}], ["Although the pre-post design of the present study does not allow for conclusions about comparative effectiveness, study findings suggest that physician-provided anthroposophic therapy may play a beneficial role in the long-term care of patients with chronic diseases.", {"entities": []}], ["Decision-making about the expected value of an experience or behavior can explain hearing health behaviors in older adults with hearing loss.", {"entities": []}], ["Forty-four middle-aged to older adults (68.45\u2009\u00b1\u20097.73 years) performed a task in which they were asked to decide whether information from a surgeon or an administrative assistant would be important to their health in hypothetical communication scenarios across visual\u00a0signal-to-noise ratios (SNR).", {"entities": []}], ["Participants also could choose to view the briefly presented sentences multiple times.", {"entities": []}], ["The number of these effortful attempts to read the stimuli served as a measure of demand for information to make a health importance decision.", {"entities": []}], ["Participants with poorer high frequency hearing more frequently decided that information was important to their health compared to participants with better high frequency hearing.", {"entities": []}], ["This appeared to reflect a response bias because participants with high frequency hearing loss demonstrated shorter response latencies when they rated the sentences as important to their health.", {"entities": []}], ["However, elevated high frequency hearing thresholds did not predict demand for information to make a health importance decision.", {"entities": []}], ["The results highlight the utility of a performance-based measure to characterize effort and expected value from performing tasks in older adults with hearing loss.", {"entities": []}], ["Granulomatosis with polyangiitis (GPA) formerly called Wegener\u2019s granulomatosis is a chronic necrotizing granulomatous inflammatory disease with systemic vasculitis involving the upper and lower respiratory tract, and kidneys.", {"entities": [[154, 164, "DISEASE"]]}], ["The typical histopathology is that of necrotizing granulomatous inflammation with palisading histiocytes, neutrophils, and lymphocytes.", {"entities": []}], ["We report a case of a 57-year-old lady presenting with left eye swelling, left ear pain and discharge, but with no pulmonary or renal symptoms.", {"entities": []}], ["Investigations revealed positive cytoplasmic antineutrophil cytoplasmic antibodies and proteinase 3 antibodies.", {"entities": []}], ["The CT and MRI showed meningeal thickening and bilateral structural changes of the orbits and mastoids.", {"entities": []}], ["Lacrimal gland biopsy showed non necrotizing granulation with an eosinophilic infiltration.", {"entities": []}], ["She was diagnosed with eosinophilic variant of GPA of the eyes and mastoid bones bilaterally extending to dura and sparing the lungs and kidneys.", {"entities": []}], ["She responded to corticosteroids and rituximab.", {"entities": []}], ["Background: Environmental exposures to phthalates, particularly high-molecular-weight (HMW) phthalates, are suspected to contribute to allergy.", {"entities": []}], ["Objective: We assessed whether phthalate metabolites are associated with allergic symptoms and sensitization in a large nationally representative sample.", {"entities": []}], ["Methods: We used data on urinary phthalate metabolites and allergic symptoms (hay fever, rhinitis, allergy, wheeze, asthma) and sensitization from participants \u2265 6 years of age in the National Health and Nutrition Examination Survey (NHANES) 2005\u20132006.", {"entities": [[89, 97, "DISEASE"], [116, 122, "DISEASE"]]}], ["Allergen sensitization was defined as a positive response to at least one of 19 specific IgE antigens (\u2265 0.35 kU/L).", {"entities": []}], ["Odds ratios (ORs) per one log 10 unit change in phthalate concentration were estimated using logistic regression adjusting for age, race, body mass index, gender, creatinine, and cotinine.", {"entities": []}], ["Separate analyses were conducted for children (6\u201317 years of age) and adults.", {"entities": []}], ["Results: The HMW phthalate metabolite monobenzyl phthalate (MBzP) was the only metabolite positively associated with current allergic symptoms in adults (wheeze, asthma, hay fever, and rhinitis).", {"entities": [[185, 193, "DISEASE"], [162, 168, "DISEASE"]]}], ["Mono-(3-carboxypropyl) phthalate and the sum of diethylhexyl phthalate metabolites (both representing HMW phthalate exposures) were positively associated with allergic sensitization in adults.", {"entities": []}], ["Conversely, in children, HMW phthalate metabolites were inversely associated with asthma and hay fever.", {"entities": [[82, 88, "DISEASE"]]}], ["Of the low-molecular-weight phthalate metabolites, monoethyl phthalate was inversely associated with allergic sensitization in adults (OR = 0.79; 95% CI: 0.70, 0.90).", {"entities": []}], ["Conclusion: In this cross-sectional analysis of a nationally representative sample, HMW phthalate metabolites, particularly MBzP, were positively associated with allergic symptoms and sensitization in adults, but there was no strong evidence for associations between phthalates and allergy in children 6\u201317 years of age.", {"entities": []}], ["Citation: Hoppin JA, Jaramillo R, London SJ, Bertelsen RJ, Salo PM, Sandler DP, Zeldin DC.", {"entities": []}], ["Phthalate exposure and allergy in the U.S. population: results from NHANES 2005\u20132006.", {"entities": []}], ["Environ Health Perspect 121:1129\u20131134;\u2002 http://dx.doi.org/10.1289/ehp.1206211 [Online 25 June 2013].", {"entities": []}], ["Growing knowledge about the cytokine network response has led to a better comprehension of mechanisms of pathologies and to the development of new treatments with biological drugs, able to block specific molecules of the immune response.", {"entities": []}], ["Indeed, when the cytokine production is deregulated, diseases often occur.", {"entities": []}], ["The understanding of the physiological mechanism of the cytokine network would be useful to better comprehend pathological conditions.", {"entities": []}], ["Moreover, since the immune system and response change their properties with development, differences in patients' age should be taken into account, both in physiological and in pathological conditions.", {"entities": []}], ["In this study, we analyzed the profile of 48 cytokines and chemokines in the serum of healthy subjects, comparing adults (\u226518 years) with young children and children (1\u20136 and 7\u201317 years).", {"entities": []}], ["We found that a certain number of cytokines were not being produced in healthy subjects; others showed a constant serum level amongst the groups.", {"entities": []}], ["Certain cytokines exhibited a downward or an upward trend with increasing age.", {"entities": []}], ["The remaining cytokines were up- or downregulated in the group of the children with respect to the other groups.", {"entities": []}], ["In conclusion, we drew some kinds of guidelines about the physiological production of cytokines and chemokines, underling the difference caused by aging.", {"entities": []}], ["To compare the incidence of complications and the duration of hospitalization of patients undergoing bariatric surgery admitted to the intensive care unit or a post-surgical hospitalization unit.", {"entities": []}], ["This retrospective observational study included 828 patients admitted between January 2010 and February 2015 during the immediate postoperative period of bariatric surgery in a hospital.", {"entities": []}], ["Data were collected via electronic medical records.", {"entities": []}], ["The Mann-Whitney test was used to compare continuous variables, and the chi-square was used to compare categorical variables.", {"entities": []}], ["Patients in both groups had similar demographic characteristics, with no significant differences in anthropometric data and comorbidities.", {"entities": []}], ["There was no significant difference in the comparison of complications between the two groups.", {"entities": []}], ["However, the group admitted to the intensive care unit had longer hospitalization times (median of 3 days versus 2 days, p < 0.05), and hospital costs were 8% higher.", {"entities": []}], ["The present study found no benefit in the routine admittance of patients to the intensive care unit after undergoing bariatric surgery.", {"entities": []}], ["This practice increased hospitalization time and hospital costs, which wasted resources.", {"entities": []}], ["It is necessary to create objective criteria to identify patients requiring intensive care unit admission after bariatric surgery.", {"entities": []}], ["YKL-40 and C-reactive protein (CRP) are biomarkers that may reflect cancer-related subclinical inflammation.", {"entities": [[68, 74, "DISEASE"], [31, 34, "GENE"]]}], ["We assessed elevated YKL-40 and CRP levels as combined risk predictors for cancer.", {"entities": [[75, 81, "DISEASE"], [32, 35, "GENE"]]}], ["We measured plasma YKL-40 and CRP at baseline in 8706 individuals from the Danish general population.", {"entities": [[30, 33, "GENE"]]}], ["Hazard ratio (HR) of gastrointestinal cancer for a doubling of YKL-40 levels was 1.37 (95% CI: 1.17\u20131.61) and indifferent to adjustment for CRP levels.", {"entities": [[38, 44, "DISEASE"], [14, 16, "GENE"], [140, 143, "GENE"]]}], ["Hazard ratio of lung cancer for a doubling of CRP levels was 1.35 (1.17\u20131.56) and indifferent to adjustment for YKL-40 levels.", {"entities": [[16, 27, "DISEASE"], [21, 27, "DISEASE"], [46, 49, "GENE"]]}], ["Compared to individuals with both low CRP (<1.7\u2009mg\u2009l \u03bc g\u2009l Elevated YKL-40 levels are associated with increased risk of gastrointestinal cancer, independently of CRP levels, whereas elevated CRP levels are associated with increased risk of lung cancer, independently of YKL-40 levels.", {"entities": [[240, 251, "DISEASE"], [137, 143, "DISEASE"], [245, 251, "DISEASE"], [38, 41, "GENE"], [162, 165, "GENE"], [191, 194, "GENE"], [38, 41, "GENE"], [162, 165, "GENE"], [191, 194, "GENE"], [38, 41, "GENE"], [162, 165, "GENE"], [191, 194, "GENE"]]}], ["Genetic variations in TGFB1 gene have been studied in relation to coronary heart disease (CHD) risk, but the results were inconsistent.", {"entities": [[75, 88, "DISEASE"], [66, 88, "DISEASE"], [22, 27, "GENE"]]}], ["We performed a systematic review of published studies on the potential role of TGFB1 genetic variation in CHD risk.", {"entities": [[79, 84, "GENE"]]}], ["Articles that reported the association of TGFB1 genetic variants with CHD as primary outcome were searched via Medline and HuGE Navigator through July 2011.", {"entities": [[42, 47, "GENE"]]}], ["The reference lists from included articles were also reviewed.", {"entities": []}], ["Data were available from 4 studies involving 1777 cases and 7172 controls for rs1800468, 7 studies involving 5935 cases and 10677 controls for rs1800469, 7 studies involving 6634 cases and 9620 controls for rs1982073, 5 studies involving 5452 cases and 9999 controls for rs1800471, and 4 studies involving 5143 cases and 4229 controls for rs1800472.", {"entities": []}], ["The pooled odds ratios (ORs) for CHD among minor T allele carriers of rs1800469, minor C allele carriers of rs1982073, and minor C allele carriers of rs1800471 versus homozygous major allele carriers was 1.14 (95% confidence interval [CI]: 1.05-1.24), 1.18 (95% CI: 1.04-1.35), and 1.16 (95% CI: 1.02-1.32), respectively.", {"entities": []}], ["No substantial heterogeneity for ORs was detected among the included Caucasian populations for all SNPs.", {"entities": []}], ["However, for rs1800471, the statistical significance disappeared after adjusting for potential publication bias.", {"entities": []}], ["No significant association was found between rs1800468 and rs1800472 variants and CHD risk.", {"entities": []}], ["Minor allele carriers of two genetic variants (rs1800469 and rs1982073) in TGFB1 have a 15% increased risk of CHD.", {"entities": [[75, 80, "GENE"]]}], ["COPD and obstructive sleep apnea (OSA) share similar pathological processes and cardiovascular sequelae.", {"entities": []}], ["Coexisting OSA in COPD \u2013 \u201coverlap syndrome\u201d \u2013 has worse prognosis than either condition alone, and appropriate treatment improves survival.", {"entities": [[34, 42, "DISEASE"]]}], ["Our objectives were to ascertain the frequency at which COPD coexists with the risk of OSA in Taiwan and to compare the risk factors, COPD symptoms, and life quality metrics between COPD subgroups with versus without risk of OSA.", {"entities": []}], ["We conducted a random cross-sectional national telephone survey of adults >40 years old in Taiwan.", {"entities": []}], ["Participants fulfilling an epidemiological case definition of COPD completed a questionnaire to assess COPD symptoms and OSA risk, comorbidities, and performance of daily activities.", {"entities": []}], ["Data from COPD cohorts with and without risk of OSA were analyzed and compared.", {"entities": []}], ["Of 6,600 interviews completed, 404 subjects fit the epidemiological case definition of COPD \u2013 an overall prevalence of 6.1% in this national sample.", {"entities": []}], ["Data on OSA risk were available for 292 of this COPD cohort, of whom 29.5% were at risk of OSA.", {"entities": []}], ["Compared to those without risk of OSA, those with risk of OSA were significantly more likely to have hypertension or cardiovascular disease and diabetes, had significantly higher body mass index and COPD Assessment Test scores, and reported impaired work performance and leisure activities.", {"entities": [[101, 113, "DISEASE"]]}], ["Among adults in Taiwan who fulfill epidemiologic criteria for COPD, 29.5% have coexisting risk of OSA.", {"entities": []}], ["Comorbid hypertension or cardiovascular disease and diabetes are common and significantly more prevalent among the COPD population at risk of OSA than those who are not.", {"entities": [[9, 21, "DISEASE"]]}], ["OSA screening is warranted in patients with COPD with those risk factors that are more prevalent in COPD with risk of OSA than without, to target early interventions to reduce adverse cardiovascular sequelae from overlap syndrome.", {"entities": [[221, 229, "DISEASE"]]}], ["To undertake a review of the methods and findings of published research evaluating the influence of season on accelerometer-determined sedentary behaviour (SB) and physical activity (PA) in children.", {"entities": []}], ["A literature search was carried out using PubMed, Embase, Medline and Web of Science up to, and including, June 2011.", {"entities": []}], ["The search strategy focused on four key elements: children, SB or PA, season and accelerometer.", {"entities": []}], ["Articles were eligible for inclusion if they were published in English, included healthy study participants aged\u2009\u2264\u200918\u2009years, reported at least one outcome variable derived from accelerometer-determined measurements, and compared SB or PA between two or more seasons, or controlled for season of measurement.", {"entities": []}], ["Eligible papers were reviewed and evidence tables compiled reporting on publication year, country studied, study recruitment, consent rate, sample descriptives, study design, accelerometer protocol, valid accelerometer data receipt, season definition, statistical methods and key findings.", {"entities": []}], ["Sixteen of 819 articles were eligible for inclusion: children aged two to five years, six to twelve, or six to 18\u2009years were included in five, six and five articles respectively.", {"entities": []}], ["Six articles were from the UK, six from other European countries, three from the USA and one from New Zealand.", {"entities": []}], ["Study sample sizes ranged from 64 to 5595.", {"entities": []}], ["PA was reported in all articles but SB in only three.", {"entities": []}], ["Only four studies were longitudinal and none of these reported SB.", {"entities": []}], ["Seasonal variation in PA was reported in all UK studies, being highest in summer and lowest in winter.", {"entities": []}], ["In four non-UK studies seasonal variation in PA was not found.", {"entities": []}], ["Findings were inconclusive for SB.", {"entities": []}], ["There is sufficient evidence to support public health interventions aimed at increasing PA during winter in UK children.", {"entities": []}], ["No conclusions can be drawn regarding the effect of season on children\u2019s SB reflecting few studies of small sample size, lack of repeat measures, incomparable definitions of season and inconsistent accelerometer protocols.", {"entities": []}], ["Future research should determine factors that drive seasonal patterns in PA and SB in children such as age, sex, and geographic and climatic setting to inform interventions and target populations.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a common disease characterized by airflow obstruction and lung hyperinflation leading to dyspnea and exercise capacity limitation.", {"entities": []}], ["The present study was designed to evaluate whether an extra-fine combination of beclomethasone and formoterol (BDP/F) was effective in reducing air trapping in COPD patients with hyperinflation.", {"entities": []}], ["Fluticasone salmeterol (FP/S) combination treatment was the active control.", {"entities": []}], ["COPD patients with forced expiratory volume in one second <65% and plethysmographic functional residual capacity \u2265120% of predicted were randomized to a doubleblind, double-dummy, 12-week, parallel group, treatment with either BDP/F 400/24 \u03bcg/day or FP/S 500/100 \u03bcg/day.", {"entities": []}], ["Lung volumes were measured with full body plethysmography, and dyspnea was measured with transition dyspnea index.", {"entities": []}], ["Eighteen patients were evaluable for intention to treat.", {"entities": []}], ["A significant reduction in air trapping and clinically meaningful improvement in transition dyspnea index total score was detected in the BDP/F group but not in the FP/S group.", {"entities": []}], ["Functional residual capacity, residual volume (RV) and total lung capacity significantly improved from baseline in the BDP/F group only.", {"entities": []}], ["With regard to group comparison, a significantly greater reduction in RV was observed with BDP/F versus FP/S.", {"entities": []}], ["BDP/F extra-fine combination is effective in reducing air trapping and dyspnea in COPD patients with lung hyperinflation.", {"entities": []}], ["Background: More than a decade of satellite observations offers global information about the trend and magnitude of human exposure to fine particulate matter (PM 2.5 ).", {"entities": []}], ["Objective: In this study, we developed improved global exposure estimates of ambient PM 2.5 mass and trend using PM 2.5 concentrations inferred from multiple satellite instruments.", {"entities": []}], ["Methods: We combined three satellite-derived PM 2.5 sources to produce global PM 2.5 estimates at about 10 km \u00d7 10 km from 1998 through 2012.", {"entities": []}], ["For each source, we related total column retrievals of aerosol optical depth to near-ground PM 2.5 using the GEOS\u2013Chem chemical transport model to represent local aerosol optical properties and vertical profiles.", {"entities": []}], ["We collected 210 global ground-based PM 2.5 observations from the literature to evaluate our satellite-based estimates with values measured in areas other than North America and Europe.", {"entities": []}], ["Results: We estimated that global population-weighted ambient PM 2.5 concentrations increased 0.55 \u03bcg/m 2.5 in some developing regions drove this global change, despite decreasing PM 2.5 in some developed regions.", {"entities": []}], ["The estimated proportion of the population of East Asia living above the World Health Organization (WHO) Interim Target-1 of 35 \u03bcg/m r = 0.81; n = 210; slope = 0.68).", {"entities": []}], ["The low bias in satellite-derived estimates suggests that true global concentrations could be even greater.", {"entities": []}], ["Conclusions: Satellite observations provide insight into global long-term changes in ambient PM 2.5 concentrations.", {"entities": []}], ["Satellite-derived estimates and ground-based PM 2.5 observations from this study are available for public use.", {"entities": []}], ["Citation: van Donkelaar A, Martin RV, Brauer M, Boys BL.", {"entities": []}], ["Use of satellite observations for long-term exposure assessment of global concentrations of fine particulate matter.", {"entities": []}], ["Environ Health Perspect 123:135\u2013143;\u2002 http://dx.doi.org/10.1289/ehp.1408646", {"entities": []}], ["New evidence shows high prevalence of vitamin D deficiency in many countries and some studies suggest a possible link between vitamin D status and allergic diseases.", {"entities": []}], ["The objectives of this study were to determine the prevalence of suboptimal vitamin D status in a population sample of Asian children and to investigate the relationship of vitamin D status with allergic diseases and atopy.", {"entities": []}], ["Children aged 5\u201318 years (N\u200a=\u200a1315) in the Prediction of Allergies in Taiwanese CHildren (PATCH) study were evaluated using questionnaires, anthropometric measurements, and serum levels of 25-hydroxyvitamin D [25(OH)D] and total and specific immunoglobulin E (IgE).", {"entities": []}], ["The mean concentration of serum 25(OH)D was 20.4 ng/mL (SD: 7.1 ng/mL).", {"entities": []}], ["Vitamin D deficiency (defined as serum 25(OH)D<20 ng/mL) was present in 670 subjects (51.0%), while vitamin D insufficiency (defined as serum 25(OH)D<30 ng/mL) was observed in 1187 subjects (90.3%).", {"entities": []}], ["Older age ( P <0.001), female gender ( P <0.001), higher body mass index ( P \u200a=\u200a0.001), winter and spring seasons (compared to summer; P both<0.001), and passive smoking ( P \u200a=\u200a0.011) were independently associated with low serum 25(OH)D levels.", {"entities": []}], ["After adjusting for potential confounders, serum 25(OH)D status had no association with asthma, rhinitis, eczema, atopy, or total serum IgE (all P >0.05).", {"entities": [[96, 104, "DISEASE"], [88, 94, "DISEASE"]]}], ["Low serum 25(OH)D levels are remarkably common in this population sample of Asian children, suggesting that millions of children living in Taiwan may have suboptimal levels of vitamin D, which should be a matter of public health concern.", {"entities": []}], ["Our results provides epidemiological evidence against the association of vitamin D status with various allergic diseases and atopy in Asian children.", {"entities": []}], ["Background .", {"entities": []}], ["We aimed to study the prevalence of chronic comorbidities in asthma patients and the costs of health care use associated with asthma with comorbidities.", {"entities": [[61, 67, "DISEASE"], [126, 132, "DISEASE"]]}], ["Material and Methods .", {"entities": []}], ["We analysed the prevalence of the four most common chronic diseases in asthma patients in 2008\u20132014 in Finland.", {"entities": [[71, 77, "DISEASE"]]}], ["Prevalence of coronary artery disease, diabetes and dyslipidaemia, hypertension, epilepsy, inflammatory bowel disease, rheumatic diseases, and severe psychiatric disease was studied by register of the Social Insurance Institution of Finland.", {"entities": [[91, 117, "DISEASE"], [67, 79, "DISEASE"]]}], ["The costs of health care services were collected from the registries maintained by the National Institute for Health and Welfare (THL).", {"entities": []}], ["Prevalence of asthma was 4.6% in 2014.", {"entities": [[14, 20, "DISEASE"]]}], ["Diabetes was among the four most common comorbidities in all the age groups.", {"entities": []}], ["The other common comorbidities were hypertension (\u226546 years; 12.9\u201337.6%), severe psychiatric disorders (age groups of 16\u201359 years; 1.4\u20133.5%), and ischaemic heart disease (\u226560 years; 10\u201325%).", {"entities": [[36, 48, "DISEASE"], [156, 169, "DISEASE"]]}], ["In patients with both asthma and diabetes, the costs of hospitalization were approximately 169% compared with patients with asthma alone.", {"entities": [[22, 28, "DISEASE"], [124, 130, "DISEASE"]]}], ["Conclusions .", {"entities": []}], ["Prevalence of asthma increases by tenfold when aging.", {"entities": [[14, 20, "DISEASE"]]}], ["The comorbidity diversity and rate are age-dependent.", {"entities": []}], ["Prevalence of diabetes as comorbidity in asthma has increased.", {"entities": [[41, 47, "DISEASE"]]}], ["Costs of hospitalizations in asthma approximately double with chronic comorbidities.", {"entities": [[29, 35, "DISEASE"]]}], ["Bronchiolitis is considered one of the earliest and most common causes of hospitalisation in young children.", {"entities": [[0, 13, "DISEASE"]]}], ["Development of molecular technologies allowed a better understanding of bronchiolitis aetiology.", {"entities": [[72, 85, "DISEASE"]]}], ["Results from cohort studies evaluating the association between single, multiple viral infections and clinical outcomes are conflicting.", {"entities": []}], ["Data on viral bronchiolitis in children were found to be limited in Qatar.", {"entities": [[14, 27, "DISEASE"]]}], ["This study aimed to determine frequency and seasonal trends of viral pathogens causing acute bronchiolitis, and to explore association between viral pathogens, disease severity and length of stay (LOS).", {"entities": [[93, 106, "DISEASE"]]}], ["This is a retrospective descriptive study, including children admitted in 2010 and 2011 with acute bronchiolitis.", {"entities": [[99, 112, "DISEASE"]]}], ["Presenting history, physical examination and respiratory viral co-infections as detected by molecular assays were analysed.", {"entities": []}], ["At least one virus was detected in 315/369 (85.4%) of included children with single and multiple viruses in 67 and 33% of cases respectively.", {"entities": []}], ["Respiratory syncytial virus (RSV) was the most detected virus, accounting for 51.2% followed by rhinovirus (RV) in 25.5% of cases.", {"entities": []}], ["Fall and summer admissions were associated with longer LOS.", {"entities": []}], ["On multivariate logistic regression analysis, retraction (OR 3.96; 95% CI 1.64,9.59) and age group 1\u20133 months (OR 3.09; 95% CI 1.06,9.05) were associated with longer LOS.", {"entities": []}], ["Crepitation (OR 9.15; 95% CI 1.58,53.13), retraction (OR 4.10; 95% CI 1.05,16.12) and respiratory rate (OR 1.46; 95% CI 1.28,1.66) were associated with moderate to severe bronchiolitis.", {"entities": [[171, 184, "DISEASE"]]}], ["Identifying the viral agent did not influence disease severity or LOS.", {"entities": []}], ["Clinical presentation is of more relevance to LOS and disease severity than the detected viruses.", {"entities": []}], ["Future studies should investigate the interplay between climate characteristics, population\u2019s factors and the most detectable circulating viruses.", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-017-2225-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Introduction Strategies are needed to improve the efficacy of paraprofessional home visitors for pregnant women in the United States.", {"entities": []}], ["This study evaluates the maternal and child outcomes when evidence-based practices (EBP) are replicated with flexibility, rather than fidelity to a manualized intervention.", {"entities": [[84, 87, "GENE"]]}], ["Methods Pregnant mothers (N\u2009=\u2009203) in five clinics were recruited in the waiting rooms and randomized to standard clinic care as the control condition (n\u2009=\u2009104) or standard care plus home visiting (n\u2009=\u200999).", {"entities": []}], ["Home visitors (n\u2009=\u20099) were selected, trained in foundational skills common to EBP and four problem domains (weight control, breastfeeding, daily habits, and depression).", {"entities": [[78, 81, "GENE"]]}], ["Independent interviewers assessed targeted outcomes at birth (82%) and 6 months later (83%).", {"entities": []}], ["Results : Home visitors, called Mentor Mothers [MM], made an average of 14.9 home visits or telephone contacts (SD\u2009=\u20099; total contacts\u2009=\u20091491) addressing maternal daily habits, breastfeeding, and depression.", {"entities": []}], ["Intervention and control mothers were similar in weight, Body Mass Index (BMI), depression and social support at baseline and 6 months later.", {"entities": []}], ["The percentage of low birth weight babies was similar; intervention infants\u2019 growth (weight/height Z score) tended to be significantly better compared to the control condition.", {"entities": []}], ["Discussion : There are many explanations for the failure to find significant benefits: insufficient statistical power; the benefits of repeated assessments by warm, supportive peers to improve outcomes; or the failure of EBP and the need to maintain replication with fidelity.", {"entities": [[221, 224, "GENE"]]}], ["All study mothers had better outcomes than documented among comparable published samples of low-income, Latina and Korean\u2013American mothers in Los Angeles, CA.", {"entities": []}], ["ClinicalTrials.gov registration NCT01687634.", {"entities": []}], ["Morbidity in humans infected with Schistosoma mansoni results primarily from the deposition of parasite eggs in portal areas where they induce a granulomatous response.", {"entities": []}], ["In mice infected with this helminth granuloma formation is a CD4+ T helper (Th) cell-dependent process that is associated with a strong Th2 cytokine response which appears to evolve through a Th0 phase.", {"entities": []}], ["In this report, we asked whether endogenously synthesized or exogenously induced interferon (IFN)gamma through its suppression of Th2 cell expansion exerts a regulatory role on egg pathology.", {"entities": []}], ["Depletion of IFN-gamma or natural killer cells resulted in a marked enhancement of granuloma formation around intravenously injected eggs and was associated with increased Th2 and decreased Th1 and interleukin (IL)12 mRNA expression.", {"entities": []}], ["Similar changes occurred when egg- injected mice were treated with neutralizing monoclonal antibodies specific for IL-12 indicating a role for this cytokine in the regulation of the granulomatous response.", {"entities": []}], ["In contrast, treatment with exogenous rIL-12 profoundly inhibited primary granuloma formation while increasing IFN-gamma, IL-2, IL-10, and IL-12 pulmonary mRNA levels and suppressing IL-4, IL-5, IL-6, and IL-13 mRNA expression.", {"entities": []}], ["Cytokine depletion studies indicated that the effects of IL-12 could be attributed primarily to increased IFN-gamma.", {"entities": []}], ["Importantly, IL-12 also inhibited secondary granuloma formation in mice presensitized with eggs demonstrating a role for the cytokine in reversing established Th2-type responses.", {"entities": []}], ["Moreover, mice sensitized with eggs in combination with IL- 12 to precommit them toward a Th1 response developed only minimal granulomas upon subsequent egg challenge.", {"entities": []}], ["The latter findings suggest that simultaneous vaccination with antigen plus IL-12 may provide a strategy for the prevention of schistosome egg pathology as well as other diseases stemming from Th2 cytokine production.", {"entities": []}], ["Neck pain caused by cervical spondylosis has become a common health problem worldwide among >40-year-old adults.", {"entities": [[29, 40, "DISEASE"]]}], ["Acupuncture intervention is one of the most popular treatment measures for this disorder.", {"entities": []}], ["However, evidence for its efficacy in relieving neck pain and recovering neck physiological function has not been established in randomized, placebo-controlled trials.", {"entities": []}], ["The primary aim of this trial is to assess the efficacy and safety of active acupuncture compared with sham acupuncture intervention for neck pain caused by cervical spondylosis.", {"entities": [[166, 177, "DISEASE"]]}], ["We will conduct a randomized, double-blind, parallel-group, placebo-controlled trial comparing active acupuncture with placebo (sham acupuncture).", {"entities": []}], ["A total of 456 patients with neck pain caused by cervical spondylosis who meet the eligibility criteria from outpatient clinics of the Second People\u2019s Hospital of Fujian Province and the Affiliated Rehabilitation Hospital, Fujian University of Traditional Chinese Medicine will be recruited and randomized into an active acupuncture or sham acupuncture group.", {"entities": [[58, 69, "DISEASE"]]}], ["The participants will undergo treatment sessions with either active or sham acupuncture intervention five times a week for 2 weeks.", {"entities": []}], ["Evaluation by blinded assessors at baseline and at intervention for 1 and 2 weeks will include demographic characteristics, validated questionnaires (Northwick Park Neck Pain Questionnaire (NPQ) scale, Short-Form 36 (SF-36) scale, and McGill pain scale), examination of neck physiological function, and adverse events.", {"entities": []}], ["All included patients will be followed up and investigated for relapse of neck pain at 4, 8, and 12 weeks after intervention.", {"entities": []}], ["This paper describes the rationale and design of a randomized double-blind, placebo-controlled trial that aims to determine the efficacy and safety of acupuncture intervention for neck pain caused by cervical spondylosis.", {"entities": [[209, 220, "DISEASE"]]}], ["The primary outcomes are changes in the NPQ score and neck physiological function.", {"entities": []}], ["Secondary outcome measures include quality of life, adverse events, and relapse of neck pain.", {"entities": []}], ["If successful, this project will provide evidence of the efficacy and safety of acupuncture for neck pain caused by cervical spondylosis.", {"entities": [[125, 136, "DISEASE"]]}], ["Chinese Clinical Trial Registry: ChiCTR-TRC-12002206 .", {"entities": []}], ["Registration date: 11 May 2012.", {"entities": []}], ["RNU2 exists in two functional forms (RNU2-1 and RNU2-2) distinguishable by the presence of a unique 4-bases motif.", {"entities": []}], ["Detailed investigation of datasets obtained from deep sequencing of five human lung primary tumors revealed that both forms express at a high rate a 19\u201322nt fragment (miR-U2-1 and -2) from its 3\u2032 region and contains the 4-bases motif.", {"entities": []}], ["Deep sequencing of independent pools of serum samples from healthy donors and lung cancer patients revealed that miR-U2-1 and -2 are pervasively processed in lung tissue by means of endonucleolytic cleavages and stably exported to the blood.", {"entities": [[78, 89, "DISEASE"], [83, 89, "DISEASE"]]}], ["Then, microarrays hybridization experiments of matched normal/tumor samples revealed a significant over-expression of miR-U2-1 in 14 of 18 lung primary tumors.", {"entities": []}], ["Subsequently, qRT-PCR of miR-U2-1 using serum from 62 lung cancer patients and 96 various controls demonstrated that its expression levels identify lung cancer patients with 79% sensitivity and 80% specificity.", {"entities": [[54, 65, "DISEASE"], [148, 159, "DISEASE"], [59, 65, "DISEASE"], [153, 159, "DISEASE"]]}], ["miR-U2-1 expression correlated with the presence or absence of lung cancer in patients with chronic obstructive pulmonary disease (COPD), other diseases of the lung \u2013 not cancer, and in healthy controls.", {"entities": [[63, 74, "DISEASE"], [92, 129, "DISEASE"], [68, 74, "DISEASE"], [171, 177, "DISEASE"]]}], ["These data suggest that RNU2-1 is a new bi-functional ncRNA that produces a 19\u201322nt fragment which may be useful in detecting lung cancer non-invasively in high risk patients.", {"entities": [[126, 137, "DISEASE"], [131, 137, "DISEASE"]]}], ["Allergic rhinitis is a common health problem affecting the immune system.", {"entities": [[9, 17, "DISEASE"]]}], ["The homeostasis of the immune system is regulated by apoptosis.", {"entities": []}], ["In this study, serum circulating soluble TRAIL levels of allergic rhinoconjunctivitis patients before and after allergen-specific immunotherapy were evaluated.", {"entities": []}], ["The sTRAIL levels of pre- and post-treated allergic rhinoconjunctivitis patients (n=25) were compared to age- and sex-matched healthy individuals (n=25).", {"entities": []}], ["sTRAIL levels were measured by ELISA.", {"entities": []}], ["The skin prick test (SPT) results were recorded before and after treatment.", {"entities": []}], ["The sTRAIL levels between the pre-treated and control groups were significantly different (p<0.0001).", {"entities": []}], ["However, there was no significant difference between the post-treated group and healthy individuals (p=0,801).", {"entities": []}], ["SPT was a statistically significant difference between the values of the research group before and after immunotherapy (grasses mixture, barley mixture, Oleaauropeae, D. Pteronyssinus, D. farinae).", {"entities": []}], ["The sTRAIL levels were decreased after allergen-specific immunotherapy to healthy levels and may be of use as a marker of efficacy of immunotherapy in allergic rhinoconjunctivitis patients.", {"entities": []}], ["Some asthmatic individuals undergoing allergen inhalation challenge develop an isolated early response whereas others develop a dual response (early plus late response).", {"entities": []}], ["In the present study we have used transcriptomics (microarrays) and metabolomics (mass spectrometry) of peripheral blood to identify molecular patterns that can discriminate allergen-induced isolated early from dual asthmatic responses.", {"entities": []}], ["Peripheral blood was obtained prior to (pre-) and 2 hours post allergen inhalation challenge from 33 study participants.", {"entities": []}], ["In an initial cohort of 14 participants, complete blood counts indicated significant differences in neutrophil and lymphocyte counts at pre-challenge between early and dual responders.", {"entities": []}], ["At post-challenge, significant genes ( ALOX15 , FADS2 and LPCAT2 ) and metabolites (lysolipids) were enriched in lipid metabolism pathways.", {"entities": [[39, 45, "GENE"], [48, 53, "GENE"], [58, 64, "GENE"]]}], ["Enzymes encoding for these genes are involved in membrane biogenesis and metabolism of fatty acids into pro-inflammatory and anti-inflammatory mediators.", {"entities": []}], ["Correlation analysis indicated a strong negative correlation between ALOX15 , FADS2 , and IL5RA expression with 2-arachidonoylglycerophosphocholine levels in dual responders.", {"entities": [[69, 75, "GENE"], [78, 83, "GENE"], [90, 95, "GENE"]]}], ["However, measuring arachidonic acid and docosahexaenoic acid levels in a validation cohort of 19 participants indicated that the free form of DHA (nmoles/\u00b5g of protein) was significantly (p\u200a=\u200a0.03) different between early and dual responders after allergen challenge.", {"entities": []}], ["Collectively these results may suggest an imbalance in lipid metabolism which dictates pro- (anti-) inflammatory and pro-resolving mechanisms.", {"entities": []}], ["Future studies with larger sample sizes may reveal novel mechanisms and therapeutic targets of the late phase asthmatic response.", {"entities": []}], ["Chronic exocrine pancreatic insufficiency can lead to osteoporosis.", {"entities": [[54, 66, "DISEASE"], [8, 41, "DISEASE"]]}], ["However, the incidence and risk of osteoporosis after acute inflammation of pancreas remained known.", {"entities": [[35, 47, "DISEASE"]]}], ["Thus, we conducted a population-based cohort study to clarify the association between acute pancreatitis (AP) and osteoporosis.", {"entities": [[92, 104, "DISEASE"], [114, 126, "DISEASE"], [86, 104, "DISEASE"]]}], ["Patients newly diagnosed with AP with index date between 2000 and 2011 were identified from the National Health Insurance Research Database.", {"entities": []}], ["Osteoporosis were defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification codes.", {"entities": [[0, 12, "DISEASE"]]}], ["We applied age-, sex-, and comorbidities-adjusted variable Cox proportional hazard models for assessing the association between AP and osteoporosis.", {"entities": [[135, 147, "DISEASE"]]}], ["Moreover, these models were used to adjust for the influences of patient characteristics and comorbidities.", {"entities": []}], ["In this study, 4,016 patients were included in the AP cohort (males, 67.9%; mean age, 51.8 years) and 4,016 matched controls in the non-AP cohort.", {"entities": []}], ["After a mean follow-up period of 4.97 and 5.21 years in the AP and non-AP cohorts, respectively, the incidence of osteoporosis was 8.22 per 1000 person-years in the AP cohort.", {"entities": [[114, 126, "DISEASE"]]}], ["The AP cohort had a higher risk [adjusted hazard ratio (aHR) = 1.27, 95% confidence interval (CI) = 1.02\u20131.58] of osteoporosis than did the non-AP cohort.", {"entities": [[114, 126, "DISEASE"], [56, 59, "GENE"]]}], ["The risk of osteoporosis was highest in the female patients of the AP cohort (aHR = 2.26, 95% CI = 1.85\u20132.76) and patients aged 50\u201364 years (aHR = 4.14, 95% CI = 3.13\u20135.47).", {"entities": [[12, 24, "DISEASE"], [78, 81, "GENE"], [141, 144, "GENE"], [78, 81, "GENE"], [141, 144, "GENE"]]}], ["AP patients are at a risk of osteoporosis, especially female gender and age 50\u201364 years.", {"entities": [[29, 41, "DISEASE"]]}], ["Those with > 3 episodes of AP had highest significant risk of developing osteoporosis.", {"entities": [[73, 85, "DISEASE"]]}], ["Having information about preexisting chronic diseases and available public health assets is critical to ensuring an adequate public health response to natural disasters and acts of terrorism.", {"entities": []}], ["We describe a method to derive this information using a combination of data from the Behavioral Risk Factor Surveillance System and geographic information systems (GIS) technology.", {"entities": []}], ["Our demonstration focuses on counties in states that are within 100 miles of the Gulf of Mexico and the Atlantic Ocean coastlines.", {"entities": []}], ["To illustrate the flexible nature of planning made possible through the interactive use of a GIS, we use a hypothetical scenario of a hurricane making landfall in Myrtle Beach, South Carolina.", {"entities": []}], ["The neuropeptide alpha-melanocyte-stimulating hormone is well known as a mediator of skin pigmentation.", {"entities": []}], ["More recently, it has been shown that alpha-melanocyte-stimulating hormone also plays pivotal roles in energy homeostasis, sexual function, and inflammation or immunomodulation.", {"entities": []}], ["Alpha-melanocyte-stimulating hormone exerts its antiinflammatory and immunomodulatory effects by binding to the melanocortin-1 receptor, and since T cells are important effectors during immune responses, we investigated the effects of alpha-melanocyte-stimulating hormone on T cell function.", {"entities": []}], ["T cells were treated with alpha-melanocyte-stimulating hormone, and subsequently, their phenotype and function was analyzed in a contact allergy as well as a melanoma model.", {"entities": [[158, 166, "DISEASE"]]}], ["Furthermore, the relevance of alpha-melanocyte-stimulating hormone\u2013mediated signaling for the induction of cytotoxicity was assessed in CD8 Together, these results point to an important role of alpha-melanocyte-stimulating hormone in MHC class I-restricted cytotoxicity.", {"entities": []}], ["Therefore, treatment of contact allergies or skin cancer with alpha-melanocyte-stimulating hormone or other more stable agonists of melanocortin-1 receptor might ameliorate disease or improve antitumoral immune responses.", {"entities": [[45, 56, "DISEASE"], [50, 56, "DISEASE"]]}], ["Introduction: Different clinical and molecular patterns of food allergy have been reported in different areas of the world.", {"entities": [[59, 71, "DISEASE"]]}], ["The aim of the study is to evaluate differences in allergen patterns among nut-allergic patients in two different areas of Spain.", {"entities": []}], ["Material and methods: A total of 77 patients with nut allergy from two different regions of Spain (Madrid and Asturias) were evaluated.", {"entities": []}], ["Results: Hazelnut, peanut, and walnut were the three most frequent nuts eliciting allergy in both regions, but in a different order.", {"entities": []}], ["Patients from Madrid experienced systemic reactions more often than patients from Asturias (73.5% Madrid vs. 50.0%, p < 0.05).", {"entities": []}], ["The percentage of sensitizations to LTP (Lipid Transfer Protein) was higher than Bet v 1 ( p < 0.05) in the Madrid area.", {"entities": []}], ["The percentage of sensitizations in Asturias area was similar to LTP than Bet v 1 (Pru p 3 46.4%, Bet v 1 42.9%, ns).", {"entities": []}], ["Bet v 1 was the predominant allergen involved among hazelnut-allergic patients (56.2%), while LTP was more common in peanut-allergic patients (61.5%).", {"entities": []}], ["Conclusion: Walnut, hazelnut, and peanut were the most frequent nuts eliciting allergy in Spain.", {"entities": []}], ["Despite this, important differences in molecular pattern were appreciated not only between both regions, but also among nut-allergic patients in Asturias.", {"entities": []}], ["The different molecular pattern was linked to the frequency of systemic symptoms.", {"entities": []}], ["TAK\u2010648 is a PDE4 inhibitor with demonstrated preclinical antidiabetic properties.", {"entities": []}], ["Our objective was to develop a translational pharmacokinetic/pharmacodynamic (PK/PD) model for human type 2 diabetes (T2D) dose prediction using HbA 1c results from a db/db mouse study.", {"entities": []}], ["Estimated parameters in combination with tPDE4i values calculated for the clinical roflumilast dose of 500 \u03bcg were used to translate preclinical effects of TAK\u2010648 to required exposure in humans.", {"entities": []}], ["A first\u2010in\u2010human study with single TAK\u2010648 doses of 0.05\u20130.85 mg in healthy volunteers yielded mean maximum TAK\u2010648 concentrations (Cmax) and area under the curve (AUC) values from 0.62\u201311.9 \u03bcg/L and 4.58\u201393.8 \u03bcg*h/L, respectively.", {"entities": []}], ["Based on the performed pharmacokinetic/pharmacodynamic analysis and clinical PK results, clinical efficacy would be expected at a daily dose of 0.1 mg, which is well within the investigated clinical dose range.", {"entities": []}], ["This result significantly enhanced the confidence in TAK\u2010648 for type 2 diabetes treatment and underlines the necessity of translational approaches in early preclinical phases.", {"entities": []}], ["Les diab\u00e9tologues sont confront\u00e9s \u00e0 des diab\u00e9tiques le plus souvent hypertendus et polypathologiques, les rendant peu observants des diff\u00e9rentes th\u00e9rapeutiques prescrites.", {"entities": [[36, 39, "GENE"], [129, 132, "GENE"], [36, 39, "GENE"], [129, 132, "GENE"]]}], ["Le but de notre \u00e9tude est d\u2019\u00e9valuer l'observance au traitement chez les patients diab\u00e9tiques hypertendus.", {"entities": []}], ["Il s'agit d'une \u00e9tude descriptive prospective transversale.", {"entities": []}], ["La population est faite de patients diab\u00e9tiques de type 2 hypertendus vus aux urgences, \u00e0 la consultation ou hospitalis\u00e9s au service d'Endocrinologie.", {"entities": []}], ["L\u2019\u00e9chantillon est non probabiliste.", {"entities": []}], ["La population est faite de 61 patients, d'un \u00e2ge moyen de 48,9 ans avec une hypertension (HTA) de type systolique dans 59%, diastolique dans 16% et systolo-diastolique dans 25% des cas.", {"entities": [[76, 88, "DISEASE"], [90, 93, "GENE"], [177, 180, "GENE"]]}], ["Les patients sont \u00e9quilibr\u00e9s sur le plan glyc\u00e9mique dans 65% des cas, alors que l\u2019\u00e9quilibre tensionnel n'est atteint que dans 41% des cas.", {"entities": [[61, 64, "GENE"], [130, 133, "GENE"], [61, 64, "GENE"], [130, 133, "GENE"]]}], ["En ce qui concerne l'observance th\u00e9rapeutique, 24% des patients sont observant totalement au traitement prescrit, 33% ne sont pas observant au traitement et 43% ont une observance partielle au traitement dont 73.68% pr\u00e9f\u00e8rent le traitement destin\u00e9 au diab\u00e8te et 26,32% prennent le traitement anti hypertenseur.", {"entities": [[51, 54, "GENE"]]}], ["Les facteurs alt\u00e9rant l'observance au traitement m\u00e9dicamenteux sont un surco\u00fbt du traitement un nombre \u00e9lev\u00e9 de m\u00e9dicaments prescrits, un nombre important de prises quotidiennes de m\u00e9dicaments, une intol\u00e9rance au traitement et une mauvaise information du patient sur la justification du traitement.", {"entities": []}], ["Enfin, les patients diab\u00e9tiques hypertendus sont class\u00e9s comme patients \u00e0 haut risque cardiovasculaire ce qui impose l'application de strat\u00e9gies th\u00e9rapeutiques parfois lourdes.", {"entities": []}], ["Cette polym\u00e9dication entrave la qualit\u00e9 de l'observance th\u00e9rapeutique des patients ayant une pathologie chronique dont la compliance au traitement constitue la pierre angulaire de la prise en charge, et ce pour plusieurs raisons en particulier d'ordre \u00e9conomique.", {"entities": [[70, 73, "GENE"]]}], ["Helium is a noble gas with a low density, allowing for lower driving pressures and increased carbon dioxide (CO 2 ) diffusion.", {"entities": []}], ["Since application of protective ventilation can be limited by the development of hypoxemia or acidosis, we hypothesized that therefore heliox facilitates ventilation in an animal model of ventilator\u2013induced lung injury.", {"entities": []}], ["Sprague-Dawley rats (N=8 per group) were mechanically ventilated with heliox (50% oxygen; 50% helium).", {"entities": []}], ["Controls received a standard gas mixture (50% oxygen; 50% air).", {"entities": []}], ["VILI was induced by application of tidal volumes of 15 mL kg 2 within 4.5-5.5 kPa, according to hourly drawn arterial blood gases.", {"entities": []}], ["After 4 hours, bronchoalveolar lavage fluid (BALF) was obtained.", {"entities": []}], ["Data are mean (SD).", {"entities": []}], ["VILI resulted in an increase in BALF protein compared to low tidal ventilation (629 (324) vs. 290 (181) \u03bcg mL 2 levels and tidal volumes remained unchanged, according to protocol.", {"entities": []}], ["There was no effect of heliox on inspiratory pressure, while compliance was reduced.", {"entities": []}], ["In this mild lung injury model, heliox did not exert anti-inflammatory effects.", {"entities": []}], ["Heliox allowed for a reduction in respiratory rate and respiratory minute volume during VILI, while maintaining normal acid-base balance.", {"entities": []}], ["Use of heliox may be a useful approach when protective tidal volume ventilation is limited by the development of severe acidosis.", {"entities": []}], ["Phthalates are a group of endocrine disrupting chemicals, suspected to influence the immune system.", {"entities": []}], ["The aim of this study was to investigate the influence of phthalates on cytokine secretion from human peripheral blood mononuclear cells.", {"entities": []}], ["Escherichia coli lipopolysaccharide and phytohemagglutinin-P were used for stimulation of monocytes/macrophages and T cells, respectively.", {"entities": []}], ["Cells were exposed for 20 to 22 hours to either di-ethyl, di-n-butyl or mono-n-butyl phthalate at two different concentrations.", {"entities": []}], ["Both diesters were metabolised to their respective monoester and influenced cytokine secretion from both monocytes/macrophages and T cells in a similar pattern: the secretion of interleukin (IL)-6, IL-10 and the chemokine CXCL8 by monocytes/macrophages was enhanced, while tumour necrosis factor (TNF)-\u03b1 secretion by monocytes/macrophages was impaired, as was the secretion of IL-2 and IL-4, TNF-\u03b1 and interferon-\u03b3 by T cells.", {"entities": [[297, 300, "GENE"], [392, 395, "GENE"]]}], ["The investigated phthalate monoester also influenced cytokine secretion from monocytes/macrophages similar to that of the diesters.", {"entities": []}], ["In T cells, however, the effect of the monoester was different compared to the diesters.", {"entities": []}], ["The influence of the phthalates on the cytokine secretion did not seem to be a result of cell death.", {"entities": []}], ["Thus, results indicate that both human innate and adaptive immunity is influenced in vitro by phthalates, and that phthalates therefore may affect cell differentiation and regenerative and inflammatory processes in vivo .", {"entities": []}], ["Digital government is typically defined as the production and delivery of information and services inside government and between government and the public using a range of information and communication technologies.", {"entities": []}], ["Two types of government relationships with other entities are government-to-citizen and government-to-government relationships.", {"entities": []}], ["Both offer opportunities and challenges.", {"entities": []}], ["Assessment of a public health agency's readiness for digital government includes examination of technical, managerial, and political capabilities.", {"entities": []}], ["Public health agencies are especially challenged by a lack of funding for technical infrastructure and expertise, by privacy and security issues, and by lack of Internet access for low-income and marginalized populations.", {"entities": []}], ["Public health agencies understand the difficulties of working across agencies and levels of government, but the development of new, integrated e-programs will require more than technical change \u2014 it will require a profound change in paradigm.", {"entities": []}], ["The naturally-occurring omega (\u03c9)-3 polyunsaturated fatty acid (PUFA) eicosapentaenoic acid (EPA) reduces colorectal adenoma (polyp) number and size in patients with familial adenomatous polyposis.", {"entities": [[117, 124, "DISEASE"], [166, 196, "DISEASE"]]}], ["The safety profile and potential cardiovascular benefits associated with \u03c9-3 PUFAs make EPA a strong candidate for colorectal cancer (CRC) chemoprevention, alone or in combination with aspirin, which itself has recognized anti-CRC activity.", {"entities": [[115, 132, "DISEASE"], [126, 132, "DISEASE"]]}], ["Colorectal adenoma number and size are recognized as biomarkers of future CRC risk and are established as surrogate end-points in CRC chemoprevention trials.", {"entities": [[11, 18, "DISEASE"]]}], ["The seAFOod Polyp Prevention Trial is a randomized, double-blind, placebo-controlled, 2\u2009\u00d7\u20092 factorial \u2018efficacy\u2019 study, which will determine whether EPA prevents colorectal adenomas, either alone or in combination with aspirin.", {"entities": []}], ["Participants are 55\u201373\u00a0year-old patients, who have been identified as \u2018high risk\u2019 (detection of \u22655 small adenomas or \u22653 adenomas with at least one being \u226510\u00a0mm in diameter) at screening colonoscopy in the English Bowel Cancer Screening Programme (BCSP).", {"entities": [[219, 225, "DISEASE"]]}], ["Exclusion criteria include the need for more than one repeat endoscopy within the three-month BCSP screening period, malignant change in an adenoma, regular use of aspirin or non-aspirin non-steroidal anti-inflammatory drugs, regular use of fish oil supplements and concomitant warfarin or anti-platelet agent therapy.", {"entities": [[140, 147, "DISEASE"]]}], ["Patients are randomized to either EPA-free fatty acid 1\u00a0g twice daily or identical placebo AND aspirin 300\u00a0mg once daily or identical placebo, for approximately 12\u00a0months.", {"entities": []}], ["The primary end-point is the number of participants with one or more adenomas detected at routine one-year BCSP surveillance colonoscopy.", {"entities": []}], ["Secondary end-points include the number of adenomas (total and \u2018advanced\u2019) per patient, the location (left versus right colon) of colorectal adenomas and the number of participants re-classified as \u2018intermediate risk\u2019 for future surveillance.", {"entities": []}], ["Exploratory end-points include levels of bioactive lipid mediators such as \u03c9-3 PUFAs, resolvin E1 and PGE-M in plasma, urine, erythrocytes and rectal mucosa in order to gain insights into the mechanism(s) of action of EPA and aspirin, alone and in combination, as well as to discover predictive biomarkers of chemopreventive efficacy.", {"entities": []}], ["The recruitment target is 904 patients.", {"entities": []}], ["Current Controlled Trials ISRCTN05926847", {"entities": []}], ["Botanical products are frequently used for treatment of nasal allergy.", {"entities": []}], ["Three of these substances, Cinnamomum zeylanicum , Malpighia glabra , and Bidens pilosa , have been shown to have a number of anti-allergic properties in-vitro .", {"entities": []}], ["The current study was conducted to determine the effects of these combined ingredients upon the nasal response to allergen challenge in patients with seasonal allergic rhinitis.", {"entities": [[159, 176, "DISEASE"], [168, 176, "DISEASE"]]}], ["Twenty subjects were randomized to receive the combination botanical product, (CBP) 2 tablets three times a day, loratadine, 10 mg once a day in the morning, or placebo, using a randomized, double-blinded crossover design.", {"entities": []}], ["Following 2 days of each treatment and during the third day of treatment, subjects underwent a nasal allergen challenge (NAC), in which nasal symptoms were assessed after each challenge dose and every 2 hours for 8 hours.", {"entities": []}], ["Nasal lavage fluid was assessed for tryptase, prostaglandin D2, and leukotriene E4 concentrations and inflammatory cells.", {"entities": []}], ["Loratadine significantly reduced the total nasal symptom score during the NAC compared with placebo (P = 0.04) while the CBP did not.", {"entities": []}], ["During the 8 hour period following NAC, loratadine and the CBP both reduced NSS compared with placebo (P = 0.034 and P = 0.029, respectively).", {"entities": []}], ["Analysis of nasal lavage fluid demonstrated that the CBP prevented the increase in prostaglandin D2 release following NAC, while neither loratadine nor placebo had this effect.", {"entities": []}], ["None of the treatments significantly affected tryptase or leukotriene E4 release or inflammatory cell infiltration.", {"entities": []}], ["The CBP significantly reduced NSS during the 8 hours following NAC and marginally inhibited the release of prostaglandin D2 into nasal lavage fluid, suggesting potential clinical utility in patients with allergic rhinitis.", {"entities": [[204, 221, "DISEASE"], [213, 221, "DISEASE"]]}], ["Binding of glucocorticoid to the glucocorticoid receptor (GR/NR3C1) may repress inflammatory gene transcription via direct, protein synthesis-independent processes (transrepression), or by activating transcription (transactivation) of multiple anti-inflammatory/repressive factors.", {"entities": []}], ["Using human pulmonary A549 cells, we showed that 34 out of 39 IL-1\u03b2-inducible mRNAs were repressed to varying degrees by the synthetic glucocorticoid, dexamethasone.", {"entities": []}], ["Whilst these repressive effects were GR-dependent, they did not correlate with either the magnitude of IL-1\u03b2-inducibility or the NF-\u03baB-dependence of the inflammatory genes.", {"entities": []}], ["This suggests that induction by IL-1\u03b2 and repression by dexamethasone are independent events.", {"entities": []}], ["Roles for transactivation were investigated using the protein synthesis inhibitor, cycloheximide.", {"entities": []}], ["However, cycloheximide reduced the IL-1\u03b2-dependent expression of 13 mRNAs, which, along with the 5 not showing repression by dexamethasone, were not analysed further.", {"entities": []}], ["Of the remaining 21 inflammatory mRNAs, cycloheximide significantly attenuated the dexamethasone-dependent repression of 11 mRNAs that also showed a marked time-dependence to their repression.", {"entities": []}], ["Such effects are consistent with repression occurring via the de novo synthesis of a new product, or products, which subsequently cause repression (i.e., repression via a transactivation mechanism).", {"entities": []}], ["Conversely, 10 mRNAs showed completely cycloheximide-independent, and time-independent, repression by dexamethasone.", {"entities": []}], ["This is consistent with direct GR transrepression.", {"entities": []}], ["Importantly, the inflammatory mRNAs showing attenuated repression by dexamethasone in the presence of cycloheximide also showed a significantly greater extent of repression and a higher potency to dexamethasone compared to those mRNAs showing cycloheximide-independent repression.", {"entities": []}], ["This suggests that the repression of inflammatory mRNAs by GR transactivation-dependent mechanisms accounts for the greatest levels of repression and the most potent repression by dexamethasone.", {"entities": []}], ["In conclusion, our data indicate roles for both transrepression and transactivation in the glucocorticoid-dependent repression of inflammatory gene expression.", {"entities": []}], ["However, transactivation appears to account for the more potent and efficacious mechanism of repression by glucocorticoids on these IL-1\u03b2-induced genes.", {"entities": []}], ["Burkholderia mallei and Burkholderia pseudomallei are potentially lethal pathogens categorized as biothreat agents due, in part, to their ability to be disseminated via aerosol.", {"entities": []}], ["There are no protective vaccines against these pathogens and treatment options are limited and cumbersome.", {"entities": []}], ["Since disease severity is greatest when these agents are inhaled, efforts to develop pre- or post-exposure prophylaxis focus largely on inhalation models of infection.", {"entities": []}], ["Here, we demonstrate a non-invasive and technically simple method for affecting the inhalational challenge of BALB/c mice with B. pseudomallei and B. mallei .", {"entities": []}], ["In this model, two investigators utilized common laboratory tools such as forceps and a micropipette to conduct and characterize an effective and reproducible inhalational challenge of BALB/c mice with B. mallei and B. pseudomallei .", {"entities": []}], ["Challenge by oropharyngeal aspiration resulted in acute disease.", {"entities": []}], ["Additionally, 50% endpoints for B. pseudomallei K96243 and B. mallei ATCC 23344 were nearly identical to published aerosol challenge methods.", {"entities": []}], ["Furthermore, the pathogens disseminated to all major organs typically targeted by these agents where they proliferated.", {"entities": []}], ["The pro-inflammatory cytokine production in the proximal and peripheral fluids demonstrated a rapid and robust immune response comparable to previously described murine and human studies.", {"entities": []}], ["These observations demonstrate that OA is a viable alternative to aerosol exposure.", {"entities": []}], ["Asthma, dyspnea, and chronic cough are well-established risk factors of COPD and often associated with exacerbation of the disease, which is a leading cause of morbidity and mortality in South Asian countries.", {"entities": [[0, 6, "DISEASE"]]}], ["The aims of this study were to, 1) measure the prevalence of asthma, dyspnea, and chronic cough, and 2) assess the relationship between these respiratory problems and self-reported health status among South Asians.", {"entities": [[61, 67, "DISEASE"]]}], ["Data for this research came from the World Health Survey (2002\u20132003) conducted by the World Health Organization.", {"entities": []}], ["Subjects were 35,929 men and women, aged 18 years and older, selected from Bangladesh, India, Nepal, Pakistan, and Sri Lanka.", {"entities": []}], ["Crude prevalence rates of asthma, dyspnea, and chronic cough were presented as percentages, and the results of their association with subjective health status were presented as odds ratios and corresponding 95% CIs.", {"entities": [[26, 32, "DISEASE"]]}], ["Prevalence of daily smoking was highest in Bangladesh (39.9%) and lowest in Sri Lanka (14.1%).", {"entities": []}], ["Prevalence of asthma was highest in India (6.3%), while Nepal had the highest prevalence of dyspnea (11.3%) and chronic cough (15.3%).", {"entities": [[14, 20, "DISEASE"]]}], ["Overall prevalence of asthma and dyspnea was higher among women, while that of chronic cough was higher among men.", {"entities": [[22, 28, "DISEASE"]]}], ["Significant differences were observed in the prevalence rates of all the conditions among regular, occasional, and nonsmokers.", {"entities": []}], ["A majority of the men and women who had asthma, dyspnea, and chronic cough had higher likelihood of reporting poor health status compared to those who did not have these diseases.", {"entities": [[40, 46, "DISEASE"]]}], ["Findings suggest that prevalence rates of asthma, dyspnea, and chronic cough were considerably high in all the countries and were significantly associated with poor subjective health.", {"entities": [[42, 48, "DISEASE"]]}], ["Being a high COPD-prone region, programs targeted to address these diseases could help reduce the burden of COPD and respiratory disease-related mortalities in South Asia.", {"entities": []}], ["The costimulatory molecule OX40 and its ligand, OX40L, mediate key aspects of allergic airway inflammation in animal models of asthma, including eosinophilic airway inflammation, airway hyperresponsiveness, and T helper 2 polarization.", {"entities": [[127, 133, "DISEASE"]]}], ["We sought to examine OX40/OX40L and interleukin (IL)-4 expression in asthma across severities.", {"entities": [[69, 75, "DISEASE"]]}], ["Bronchial biopsies were obtained from 27 subjects with asthma (mild Global Initiative for Asthma [GINA] 1 [n = 10], moderate GINA 2-3 [n = 7], and severe GINA 4-5 [n = 10]) and 13 healthy controls.", {"entities": [[55, 61, "DISEASE"], [90, 96, "DISEASE"]]}], ["The number of OX40 The number of OX40 OX40/OX40L expression is increased in the bronchial submucosa in mild asthma, but not in moderate-to-severe disease, and is related to the degree of tissue eosinophilia and IL-4 expression.", {"entities": [[194, 206, "DISEASE"], [108, 114, "DISEASE"]]}], ["Whether these costimulatory molecules have a role as targets for asthma requires further investigation.", {"entities": [[65, 71, "DISEASE"]]}], ["Swyer-James-MacLeod syndrome or unilateral hyperlucent lung syndrome is a rare entity associated with postinfectious bronchiolitis obliterans occurring in childhood.", {"entities": [[20, 28, "DISEASE"], [60, 68, "DISEASE"], [117, 141, "DISEASE"], [43, 59, "DISEASE"], [117, 130, "DISEASE"]]}], ["It is characterized by hypoplasia and/or agenesis of the pulmonary arteries resulting in pulmonary parenchyma hypoperfusion.", {"entities": []}], ["Here we report the case of a 53-year-old Caucasian woman with Swyer-James-MacLeod syndrome found in the differential diagnosis workup for a new onset of heart failure, secondary to pulmonary arterial hypertension complicated by a patent ductus arteriosus.", {"entities": [[200, 212, "DISEASE"], [230, 254, "DISEASE"], [82, 90, "DISEASE"]]}], ["Typically, this disorder is diagnosed in childhood after evaluation for recurrent respiratory infections, but sometimes an indolent course means diagnosis is not made until adulthood.", {"entities": []}], ["While evidence-based medicine (EBM) has advanced medical practice, the health care system has been inconsistent in translating EBM into improvements in health.", {"entities": []}], ["Disparities in health and health care play out through patients\u2019 limited ability to incorporate the advances of EBM into their daily lives.", {"entities": []}], ["Assisting patients to self-manage their chronic conditions and paying attention to unhealthy community factors could be added to EBM to create a broader paradigm of evidence-based health.", {"entities": []}], ["A perspective of evidence-based health may encourage physicians to consider their role in upstream efforts to combat socially patterned chronic disease.", {"entities": []}], ["Cockroach allergen exposure elicits cockroach sensitization and poses an increased risk for asthma.", {"entities": [[92, 98, "DISEASE"]]}], ["However, the major components in cockroach allergen and the mechanisms underlying the induction of cockroach allergen\u2010induced allergy and asthma remain largely elusive.", {"entities": [[138, 144, "DISEASE"]]}], ["We sought to examine the role of cockroach\u2010associated glycan in regulating human basophil function.", {"entities": []}], ["N\u2010linked glycans from naturally purified cockroach allergen Bla g 2 were characterized by MALDI\u2010TOF mass spectrometry.", {"entities": []}], ["Binding of cockroach allergen to serum IgE from cockroach allergic subjects was determined by solid\u2010phase binding immunoassays.", {"entities": []}], ["Role of cockroach associated glycan in histamine release and IL\u20104 production from human basophils was examined.", {"entities": []}], ["Expression of C\u2010type lectin receptors (CLRs) and their role in mediating glycan\u2010uptake in the basophils was also investigated.", {"entities": []}], ["MALDI\u2010TOF mass spectrometric analysis of N\u2010glycan from Bla g 2 showed complex hybrid\u2010types of glycans that terminated with mannose, galactose, and/or N\u2010acetyl glucosamine (GlcNAc).", {"entities": []}], ["Deglycosylated Bla g 2 showed reduced binding to IgE and was less capable of inducing histamine release from human basophils.", {"entities": []}], ["In contrast, N\u2010glycan derived from Bla g 2 significantly inhibited histamine release and IL\u20104 production from basophils passively sensitized with serum from cockroach allergic subjects.", {"entities": []}], ["An analysis of CLRs revealed the expression of DC\u2010SIGN and DCIR, but not MRC1 and dectin\u20101, in human basophils.", {"entities": [[73, 77, "GENE"]]}], ["Neutralizing antibody to DCIR, but not DC\u2010SIGN, significantly inhibited Bla g 2 uptake by human basophils.", {"entities": []}], ["A dose\u2010dependent bindings of cockroach allergen to DCIR was also observed.", {"entities": []}], ["These observations indicate a previously unrecognized role for cockroach allergen\u2010associated glycans in allergen\u2010induced immune reactions, and DCIR may play a role in mediating the regulation of glycan on basophil function.", {"entities": []}], ["The extent to which A(H1N1)pdm09 influenza vaccines prevented hospital admissions with pneumonia and influenza (P&I) during the 2009 pandemic remains poorly understood.", {"entities": [[33, 42, "DISEASE"], [101, 110, "DISEASE"], [87, 96, "DISEASE"]]}], ["We evaluated the effectiveness of the A(H1N1)pdm09 and seasonal influenza vaccines (TIV) used during the 2009 mass vaccination campaign in Manitoba (Canada) in preventing P&I hospitalization.", {"entities": [[64, 73, "DISEASE"]]}], ["A population-based record-linkage nested case-control study.", {"entities": []}], ["Cases (N = 1,812) were persons hospitalized with influenza (ICD-10:J09-J11) or pneumonia (ICD-10:J12-J18) during the study period.", {"entities": [[49, 58, "DISEASE"], [79, 88, "DISEASE"]]}], ["Age-, gender- and area of residence-matched controls (N = 7,915) were randomly sampled from Manitoba\u2019s Population Registry.", {"entities": []}], ["Information on receipt of A(H1N1)pdm09 vaccine and TIV was obtained from the Manitoba Immunization Monitoring System, a province-wide vaccine registry.", {"entities": []}], ["Overall, the adjuvanted A(H1N1)pdm09 vaccine was 27% (95%CI 13\u201339%) effective against P&I hospitalization \u2265 14 days following administration.", {"entities": []}], ["Effectiveness seemed lower among older (\u2265 65 years) adults (10%; \u221216\u201330%), particularly when compared to under-5 children (58%; 30\u201375%).", {"entities": []}], ["The number-needed-to-vaccinate to prevent 1 P&I admission was lowest among <4 year-olds (928) and \u226565 years (1,721).", {"entities": []}], ["VE against hospitalization with laboratory-confirmed A(H1N1)pdm09 was 70% (39\u201385%) overall and (91%; 62\u201398%) \u2265 14 days following vaccination.", {"entities": []}], ["Our data suggest that the adjuvanted A(H1N1)pdm09 vaccine was effective in preventing about 55\u201360% of P&I hospitalizations among children and younger adults who were at much higher risk of infection.", {"entities": []}], ["Unfortunately, the vaccine was less effective among 65 or older adults.", {"entities": []}], ["Despite that the vaccine still had a significant population-based impact especially among the very young (<5) and the older (\u2265 65 years).", {"entities": []}], ["The concentrations of environmental tobacco smoke (ETS) to which workers are exposed have been measured, using nicotine or other tracers, in diverse workplaces.", {"entities": []}], ["Policies restricting workplace smoking to a few designated areas have been shown to reduce concentrations of ETS, although the effectiveness of such policies varies among work sites.", {"entities": []}], ["Policies that ban smoking in the workplace are the most effective and generally lower all nicotine concentrations to less than 1 microg/m3; by contrast, mean concentrations measured in workplaces that allow smoking generally range from 2 to 6 microg/m3 in offices, from 3 to 8 microg/m3 in restaurants, and from 1 to 6 microg/m3 in the workplaces of blue-collar workers.", {"entities": []}], ["Mean nicotine concentrations from 1 to 3 microg/m3 have been measured in the homes of smokers.", {"entities": []}], ["Furthermore, workplace concentrations are highly variable, and some concentrations are more than 10 times higher than the average home levels, which have been established to cause lung cancer, heart disease, and other adverse health effects.", {"entities": [[180, 191, "DISEASE"], [193, 206, "DISEASE"], [185, 191, "DISEASE"]]}], ["For the approximately 30% of workers exposed to ETS in the workplace but not in the home, workplace exposure is the principal source of ETS.", {"entities": []}], ["Among those with home exposures, exposures at work may exceed those resulting from home.", {"entities": []}], ["We conclude that a significant number of U.S. workers are exposed to hazardous levels of ETS.", {"entities": []}], ["Activated platelets release serotonin at sites of inflammation where it acts as inflammatory mediator and enhances recruitment of neutrophils.", {"entities": []}], ["Chronic treatment with selective serotonin reuptake inhibitors (SSRI) depletes the serotonin storage pool in platelets, leading to reduced leukocyte recruitment in murine experiments.", {"entities": []}], ["Here, we examined the direct and acute effects of SSRI on leukocyte recruitment in murine peritonitis.", {"entities": [[90, 101, "DISEASE"]]}], ["C57Bl/6 and Tph1\u2212/\u2212 (Tryptophan hydroxylase1) mice underwent acute treatment with the SSRI fluoxetine or vehicle.", {"entities": []}], ["Serotonin concentrations were measured by ELISA.", {"entities": []}], ["Leukocyte rolling and adhesion on endothelium was analyzed by intravital microscopy in mesentery venules with and without lipopolysaccharide challenge.", {"entities": []}], ["Leukocyte extravasation in sterile peritonitis was measured by flow cytometry of abdominal lavage fluid.", {"entities": [[35, 46, "DISEASE"]]}], ["Plasma serotonin levels were elevated 2 hours after fluoxetine treatment (0.70\u00b10.1 \u00b5g/ml versus 0.27\u00b10.1, p\u200a=\u200a0.03, n\u200a=\u200a14), while serum serotonin did not change.", {"entities": []}], ["Without further stimulation, acute fluoxetine treatment increased the number of rolling leukocytes (63\u00b18 versus 165\u00b117/0.04 mm Acute fluoxetine treatment increased plasma serotonin concentrations and promoted leukocyte-endothelial interactions in-vivo , suggesting that serotonin is a promoter of acute inflammation.", {"entities": []}], ["E-selectin was upregulated on endothelial cells in the presence of serotonin, possibly explaining the observed increase in leukocyte-endothelial interactions.", {"entities": []}], ["However transmigration of neutrophils in sterile peritonitis was not affected by higher serotonin concentrations, indicating that the effect of fluoxetine was restricted to early steps in the leukocyte recruitment.", {"entities": [[49, 60, "DISEASE"]]}], ["Whether SSRI use in humans alters leukocyte recruitment remains to be investigated.", {"entities": []}], ["Gene expression genetic studies in human tissues and cells identify cis - and trans -acting expression quantitative trait loci (eQTLs).", {"entities": []}], ["These eQTLs provide insights into regulatory mechanisms underlying disease risk.", {"entities": []}], ["However, few studies systematically characterized eQTL results across cell and tissues types.", {"entities": []}], ["We synthesized eQTL results from >50 datasets, including new primary data from human brain, peripheral plaque and kidney samples, in order to discover features of human eQTLs.", {"entities": []}], ["We find a substantial number of robust cis -eQTLs and far fewer trans -eQTLs consistent across tissues.", {"entities": []}], ["Analysis of 45 full human GWAS scans indicates eQTLs are enriched overall, and above nSNPs, among positive statistical signals in genetic mapping studies, and account for a significant fraction of the strongest human trait effects.", {"entities": []}], ["Expression QTLs are enriched for gene centricity, higher population allele frequencies, in housekeeping genes, and for coincidence with regulatory features, though there is little evidence of 5\u2032 or 3\u2032 positional bias.", {"entities": []}], ["Several regulatory categories are not enriched including microRNAs and their predicted binding sites and long, intergenic non-coding RNAs.", {"entities": []}], ["Among the most tissue-ubiquitous cis -eQTLs, there is enrichment for genes involved in xenobiotic metabolism and mitochondrial function, suggesting these eQTLs may have adaptive origins.", {"entities": []}], ["Several strong eQTLs ( CDK5RAP2, NBPF s) coincide with regions of reported human lineage selection.", {"entities": [[23, 31, "GENE"]]}], ["The intersection of new kidney and plaque eQTLs with related GWAS suggest possible gene prioritization.", {"entities": []}], ["For example, butyrophilins are now linked to arterial pathogenesis via multiple genetic and expression studies.", {"entities": []}], ["Expression QTL and GWAS results are made available as a community resource through the NHLBI GRASP database [ http://apps.nhlbi.nih.gov/grasp/ ].", {"entities": []}], ["Expression QTLs inform the interpretation of human trait variability, and may account for a greater fraction of phenotypic variability than protein-coding variants.", {"entities": []}], ["The synthesis of available tissue eQTL data highlights many strong cis -eQTLs that may have important biologic roles and could serve as positive controls in future studies.", {"entities": []}], ["Our results indicate some strong tissue-ubiquitous eQTLs may have adaptive origins in humans.", {"entities": []}], ["Efforts to expand the genetic, splicing and tissue coverage of known eQTLs will provide further insights into human gene regulation.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2164-15-532) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Meta-ethnography is a unique, systematic, qualitative synthesis approach widely used to provide robust evidence on patient and clinician beliefs and experiences and understandings of complex social phenomena.", {"entities": []}], ["It can make important theoretical and conceptual contributions to health care policy and practice.", {"entities": []}], ["Since beliefs, experiences, health care contexts and social phenomena change over time, the continued relevance of the findings from meta-ethnographies cannot be assumed.", {"entities": []}], ["However, there is little guidance on whether, when and how meta-ethnographies should be updated; Cochrane guidance on updating reviews of intervention effectiveness is unlikely to be fully appropriate.", {"entities": []}], ["This is the first in-depth discussion on updating a meta-ethnography; it explores why, when and how to update a meta-ethnography.", {"entities": []}], ["Three main methods of updating the analysis and synthesis are examined.", {"entities": []}], ["Advantages and disadvantages of each method are outlined, relating to the context, purpose, process and output of the update and the nature of the new data available.", {"entities": []}], ["Recommendations are made for the appropriate use of each method, and a worked example of updating a meta-ethnography is provided.", {"entities": []}], ["This article makes a unique contribution to this evolving area of meta-ethnography methodology.", {"entities": []}], ["The online version of this article (doi:10.1186/s13643-016-0218-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Tobacco smoke air pollution (TSAP) measurement may persuade parents to adopt smoke-free homes and thereby reduce harm to children from tobacco smoke in the home.", {"entities": []}], ["In a pilot study involving 29 smoking families, a Sidepak was used to continuously monitor home PM 2.5 during an 8-h period, Sidepak and/or Dylos monitors provided real-time feedback, and passive nicotine monitors were used to measure home air nicotine for one week.", {"entities": []}], ["Feedback was provided to participants in the context of motivational interviews.", {"entities": []}], ["Home PM 2.5 levels recorded by continuous monitoring were not well-accepted by participants because of the noise level.", {"entities": []}], ["Also, graphs from continuous monitoring showed unexplained peaks, often associated with sources unrelated to indoor smoking, such as cooking, construction, or outdoor sources.", {"entities": []}], ["This hampered delivery of a persuasive message about the relationship between home smoking and TSAP.", {"entities": []}], ["By contrast, immediate real-time PM 2.5 feedback (with Sidepak or Dylos monitor) was feasible and provided unambiguous information; the Dylos had the additional advantages of being more economical and quieter.", {"entities": []}], ["Air nicotine sampling was complicated by the time-lag for feedback and questions regarding shelf-life.", {"entities": []}], ["Improvement in the science of TSAP measurement in the home environment is needed to encourage and help maintain smoke-free homes and protect vulnerable children.", {"entities": []}], ["Recent advances in the use of mobile devices for real-time feedback are promising and warrant further development, as do accurate methods for real-time air nicotine air monitoring.", {"entities": []}], ["H. pylori infection is an important etiologic impetus usually leading to gastric disease and urease enzyme is the most crucial role is to protect the bacteria in the acidic environment of the stomach.", {"entities": []}], ["Then urease inhibitors would increase sensitivity of the bacteria in acidic medium.", {"entities": []}], ["137 Iranian traditional medicinal plants were examined against Jack bean urease activity by Berthelot reaction.", {"entities": []}], ["Each herb was extracted using 50% aqueous methanol.", {"entities": []}], ["The more effective extracts were further tested and their IC 50 values were determined.", {"entities": []}], ["37 plants out of the 137 crude extracts revealed strong urease inhibitory activity (more than 70% inhibition against urease activity at 10 mg/ml concentration).", {"entities": []}], ["Nine of the whole studied plants crude extracts were found as the most effective with IC 50 values less than 500 \u03bcg/ml including; Rheum ribes, Sambucus ebulus, Pistachia lentiscus, Myrtus communis, Areca catechu, Citrus aurantifolia, Myristica fragrans, Cinnamomum zeylanicum and Nicotiana tabacum.", {"entities": []}], ["The most potent urease inhibitory was observed for Sambucus ebulus and Rheum ribes extracts with IC 50 values of 57 and 92 \u03bcg/ml, respectively.", {"entities": []}], ["Chronic noncommunicable diseases (NCDs) have emerged as a huge global health problem in low- and middle-income countries.", {"entities": []}], ["The magnitude of the rise of NCDs is particularly visible in Southeast Asia where limited resources have been used to address this rising epidemic, as in the case of Indonesia.", {"entities": []}], ["Robust evidence to measure growing NCD-related burdens at national and local levels and to aid national discussion on social determinants of health and intra-country inequalities is needed.", {"entities": []}], ["The aim of this review is (i) to illustrate the burden of risk factors, morbidity, disability, and mortality related to NCDs; (ii) to identify existing policy and community interventions, including disease prevention and management strategies; and (iii) to investigate how and why an inequitable distribution of this burden can be explained in terms of the social determinants of health.", {"entities": []}], ["Our review followed the PRISMA guidelines for identifying, screening, and checking the eligibility and quality of relevant literature.", {"entities": []}], ["We systematically searched electronic databases and gray literature for English- and Indonesian-language studies published between Jan 1, 2000 and October 1, 2015.", {"entities": []}], ["We synthesized included studies in the form of a narrative synthesis and where possible meta-analyzed their data.", {"entities": []}], ["On the basis of deductive qualitative content analysis, 130 included citations were grouped into seven topic areas: risk factors; morbidity; disability; mortality; disease management; interventions and prevention; and social determinants of health.", {"entities": []}], ["A quantitative synthesis meta-analyzed a subset of studies related to the risk factors smoking, obesity, and hypertension.", {"entities": [[109, 121, "DISEASE"], [96, 103, "DISEASE"]]}], ["Our findings echo the urgent need to expand routine risk factor surveillance and outcome monitoring and to integrate these into one national health information system.", {"entities": []}], ["There is a stringent necessity to reorient and enhance health system responses to offer effective, realistic, and affordable ways to prevent and control NCDs through cost-effective interventions and a more structured approach to the delivery of high-quality primary care and equitable prevention and treatment strategies.", {"entities": []}], ["Research on social determinants of health and policy-relevant research need to be expanded and strengthened to the extent that a reduction of the total NCD burden and inequalities therein should be treated as related and mutually reinforcing priorities.", {"entities": []}], ["At least 511 species of birds occur in the semiarid region of northeastern Brazil and many of them interact with human populations in a number of different ways, including their use in zootherapeutics and their links with local beliefs.", {"entities": []}], ["The present work examined these types of birds/human interactions (use in zootherapeutics and their links with local beliefs) in the semiarid region of Rio Grande do Norte State in northeastern Brazil.", {"entities": []}], ["Information was obtained through semi-structured interviews with 120 local residents.", {"entities": []}], ["A total of 16 wild bird species distributed among 11 families were found to interact directly with humans, with Columbidae being the best represented family.", {"entities": []}], ["Seven species were identified in the medicinal category, five were related to symbolic aspects, while four species were identified as being related to both categories (medicinal and symbolic).", {"entities": []}], ["The accumulated folk knowledge, beliefs, and practices involving the avifauna in the semiarid region of Brazil, whether symbolic or medicinal, demonstrated the cultural importance of this vertebrate group to local human populations and revealed a belief system intrinsically related to cynegetic practices in the region.", {"entities": []}], ["No semi\u00e1rido do Brasil ocorrem 511 esp\u00e9cies de aves, algumas das quais interagem frequentemente com as popula\u00e7\u00f5es humanas locais de diferentes formas, incluindo o uso como zooter\u00e1pico e a inser\u00e7\u00e3o em cren\u00e7as.", {"entities": []}], ["Esta pesquisa registrou as aves diretamente associadas a essas formas de intera\u00e7\u00e3o (o uso como zooter\u00e1pico e a inser\u00e7\u00e3o em cren\u00e7as) na regi\u00e3o semi\u00e1rida do Estado do Rio Grande do Norte, Nordeste do Brasil.", {"entities": []}], ["As informa\u00e7\u00f5es foram obtidas atrav\u00e9s de entrevistas semiestruturadas aplicadas a 120 moradores locais.", {"entities": []}], ["Foram registradas 16 esp\u00e9cies de aves silvestres distribu\u00eddas em 11 fam\u00edlias, sendo Columbidae a que apresentou o maior n\u00famero de representantes.", {"entities": []}], ["Sete esp\u00e9cies foram indicadas apenas na categoria medicinal, cinco esp\u00e9cies apenas relacionadas a aspectos simb\u00f3licos e quatro foram indicadas como relacionadas a ambas as categorias (medicinal e simb\u00f3lica).", {"entities": []}], ["Os conhecimentos, cren\u00e7as e pr\u00e1ticas relacionadas \u00e0 avifauna no semi\u00e1rido brasileiro, seja no aspecto simb\u00f3lico ou medicinal, demonstra a import\u00e2ncia cultural que esse grupo de vertebrados representa para as popula\u00e7\u00f5es locais, revelando um sistema de cren\u00e7as que est\u00e1 intrinsicamente relacionado \u00e0s pr\u00e1ticas cineg\u00e9ticas na regi\u00e3o.", {"entities": []}], ["Chronic diseases (CD) are a public health emergency in Mexico.", {"entities": []}], ["Despite concern regarding the financial burden of CDs in the country, economic studies have focused only on diabetes, hypertension, and cancer.", {"entities": [[118, 130, "DISEASE"], [136, 142, "DISEASE"]]}], ["Furthermore, these estimated financial burdens were based on hypothetical epidemiology models or ideal healthcare scenarios.", {"entities": []}], ["The present study estimates the annual expenditure per patient and the financial burden for the nine most prevalent CDs, excluding cancer, for each of the two largest public health providers in the country: the Ministry of Health (MoH) and the Mexican Institute of Social Security (IMSS).", {"entities": [[131, 137, "DISEASE"]]}], ["Using the Mexican National Health and Nutrition Survey 2012 (ENSANUT) as the main source of data, health services consumption related to CDs was obtained from patient reports.", {"entities": []}], ["Unit costs for each provided health service (e.g.", {"entities": []}], ["consultation, drugs, hospitalization) were obtained from official reports.", {"entities": []}], ["Prevalence data was obtained from the published literature.", {"entities": []}], ["Annual expenditure due to health services consumption was calculated by multiplying the quantity of services consumed by the unit cost of each health service.", {"entities": []}], ["The most expensive CD in both health institutions was chronic kidney disease (CKD), with an annual unit cost for MoH per patient of US$ 8,966 while for IMSS the expenditure was US$ 9,091.", {"entities": [[62, 76, "DISEASE"]]}], ["Four CDs (CKD, arterial hypertension, type 2 diabetes, and chronic ischemic heart disease) accounted for 88% of the total CDs financial burden (US$ 1.42 billion) in MoH and 85% (US$ 3.96 billion) in IMSS.", {"entities": [[24, 36, "DISEASE"], [67, 89, "DISEASE"], [76, 89, "DISEASE"]]}], ["The financial burden of the nine CDs analyzed represents 8% and 25% of the total annual MoH and IMSS health expenditure, respectively.", {"entities": []}], ["The financial burden from the nine most prevalent CDs, excluding cancer, is already high in Mexico.", {"entities": [[65, 71, "DISEASE"]]}], ["This finding by itself argues for the need to improve health promotion and disease detection, diagnosis, and treatment to ensure CD primary and secondary prevention.", {"entities": []}], ["If the status quo remains, the financial burden could be higher.", {"entities": []}], ["In estimating the impact of an intervention, ignoring the effect of improving the health of one member of the caregiver/child dyad on the Health Related Quality of Life (HRQoL) of the other member may lead to an underestimation of the utility gained.", {"entities": []}], ["This may be particularly true for infants/young children and their caregivers.", {"entities": []}], ["The aim of this study was to quantify the interaction between the child\u2019s perceived general health as assessed by the newly developed Toddler and Infant Questionnaire (TANDI) on the reporting of the caregiver\u2019s own HRQoL as assessed by the EQ-5D-3\u00a0L. A sample of 187 caregivers participated.", {"entities": []}], ["A total of 60 caregivers of acutely-ill (AI) and 60 caregivers of chronically-ill (CI) children were recruited from a children\u2019s hospital.", {"entities": []}], ["The 67 caregivers of general population (GP) children were recruited at a pre-school.", {"entities": []}], ["Each caregiver completed the proxy rating of their child\u2019s HRQoL on the TANDI (The TANDI is an experimental HRQoL instrument, modelled on the EQ-5D-Y proxy, for children aged 1-36\u00a0months), which comprises of six dimensions of health and a rating of general health on a Visual Analogue Scale (VAS).", {"entities": []}], ["The caregiver completed the EQ-5D-3\u00a0L, a self-report measure of their own HRQoL.", {"entities": []}], ["Forward stepwise regression models were developed with 1) the VAS score of the caregiver and 2) the VAS score of the child as dependent variables.", {"entities": []}], ["The independent variables for the caregiver included dummy variables for the presence or absence of problems on the EQ-5D-3\u00a0L and the VAS score of the child.", {"entities": []}], ["The independent variables for the child included dummy variables for each TANDI dimension and the VAS of the caregiver.", {"entities": []}], ["The TANDI results indicated that in five of the six dimensions AI children had more problems than the other two groups and the GP children were reported to have a significantly higher VAS than the other two groups.", {"entities": []}], ["The child\u2019s VAS was significantly correlated with the caregiver\u2019s VAS in all groups, but most strongly in the AI group.", {"entities": []}], ["The preference based scores (using the UK TTO tariff) were only correlated in the AI group.", {"entities": []}], ["The inclusion of the child\u2019s VAS increased the variance accounted for 11% of the VAS score of the caregiver.", {"entities": []}], ["Anxiety and depression was the only dimension which accounted for more variance (18%).", {"entities": []}], ["Similarly the perceived health state, VAS of the caregiver accounted for 14% of the variance in the child\u2019s VAS, second only to problems with play (25%).", {"entities": []}], ["There does indeed appear to be a strong relationship between the VAS scores of the children and their caregivers.", {"entities": []}], ["The perceived general health of the child influences the caregivers reporting of their general health, more than their own report of experiencing pain or discomfort or problems with mobility.", {"entities": []}], ["Thus, improving the HRQoL of the very young child may improve the caregiver\u2019s HRQoL as well.", {"entities": []}], ["Conversely, if the caregiver has a lower perceived HRQoL this may result in a decrement in the reported VAS of the child, independent of the presence or absence of problems in the different dimensions.", {"entities": []}], ["This improvement is not currently captured by Cost Utility Analysis (CUA).", {"entities": []}], ["It is recommended that future research investigates this effect with regards to CUA calculations.", {"entities": []}], ["Environmental factors have long been known to influence immune responses.", {"entities": []}], ["In particular, clinical studies about the association between migration and increased risk of atopy/asthma have provided important information on the role of migration associated large sets of environmental exposures in the development of allergic diseases.", {"entities": [[100, 106, "DISEASE"]]}], ["However, investigations about environmental effects on immune responses are mostly limited in candidate environmental exposures, such as air pollution.", {"entities": []}], ["The influences of large sets of environmental exposures on immune responses are still largely unknown.", {"entities": []}], ["A simulated 520-d Mars mission provided an opportunity to investigate this topic.", {"entities": [[18, 22, "GENE"]]}], ["Six healthy males lived in a closed habitat simulating a spacecraft for 520 days.", {"entities": []}], ["When they exited their \u201cspacecraft\u201d after the mission, the scenario was similar to that of migration, involving exposure to a new set of environmental pollutants and allergens.", {"entities": []}], ["We measured multiple immune parameters with blood samples at chosen time points after the mission.", {"entities": []}], ["At the early adaptation stage, highly enhanced cytokine responses were observed upon ex vivo antigen stimulations.", {"entities": []}], ["For cell population frequencies, we found the subjects displayed increased neutrophils.", {"entities": []}], ["These results may presumably represent the immune changes occurred in healthy humans when migrating, indicating that large sets of environmental exposures may trigger aberrant immune activity.", {"entities": []}], ["GLUCOCORTICOIDS are potent inhibitors of inflammatory processes and are widely used in the treatment of asthma.", {"entities": [[104, 110, "DISEASE"]]}], ["The anti-inflammatory effects are mediated either by direct binding of the glucocorticoid/glucocorticoid receptor complex to glucocorticoid responsive elements in the promoter region of genes, or by an interaction of this complex with other transcription factors, in particular activating protein-1 or nuclear factor-kappaB.", {"entities": []}], ["Glucocorticoids inhibit many inflammation-associated molecules such as cytokines, chemokines, arachidonic acid metabolites, and adhesion molecules.", {"entities": []}], ["In contrast, anti-inflammatory mediators often are up-regulated by glucocorticoids.", {"entities": []}], ["In vivo studies have shown that treatment of asthmatic patients with inhaled glucocorticoids inhibits the bronchial inflammation and simultaneously improves their lung function.", {"entities": []}], ["In this review, our current knowledge of the mechanism of action of glucocorticoids and their anti-inflammatory potential in asthma is described.", {"entities": [[125, 131, "DISEASE"]]}], ["Since bronchial epithelial cells may be important targets for glucocorticoid therapy in asthma, the effects of glucocorticoids on epithelial expressed inflammatory genes will be emphasized.", {"entities": [[88, 94, "DISEASE"]]}], ["Up to 5% of the US population has suffered anaphylaxis.", {"entities": []}], ["Fatal outcome is rare, such that even for people with known venom or food allergy, fatal anaphylaxis constitutes less than 1% of total mortality risk.", {"entities": [[69, 81, "DISEASE"]]}], ["The incidence of fatal anaphylaxis has not increased in line with hospital admissions for anaphylaxis.", {"entities": []}], ["Fatal drug anaphylaxis may be increasing, but rates of fatal anaphylaxis to venom and food are stable.", {"entities": []}], ["Risk factors for fatal anaphylaxis vary according to cause.", {"entities": []}], ["For fatal drug anaphylaxis, previous cardiovascular morbidity and older age are risk factors, with beta-lactam antibiotics, general anesthetic agents, and radiocontrast injections the commonest triggers.", {"entities": []}], ["Fatal food anaphylaxis most commonly occurs during the second and third decades.", {"entities": []}], ["Delayed epinephrine administration is a risk factor; common triggers are nuts, seafood, and in children, milk.", {"entities": []}], ["For fatal venom anaphylaxis, risk factors include middle age, male sex, white race, cardiovascular disease, and possibly mastocytosis; insect triggers vary by region.", {"entities": [[121, 133, "DISEASE"]]}], ["Upright posture is a feature of fatal anaphylaxis to both food and venom.", {"entities": []}], ["The rarity of fatal anaphylaxis and the significant quality of life impact of allergic conditions suggest that quality of life impairment should be a key consideration when making treatment decisions in patients at risk for anaphylaxis.", {"entities": []}], ["Several forms of cessation support have been shown effective in increasing the chance of successful smoking cessation, but cessation support is still underutilized among smokers.", {"entities": []}], ["Proactive outreach to target audiences may increase use of cessation support.", {"entities": []}], ["The present study evaluated the efficiency of using study invitation letters distributed through primary schools in recruiting smoking parents into cessation support (quitline support or a self-help brochure).", {"entities": []}], ["Use and evaluation of cessation support among smoking parents were examined.", {"entities": []}], ["Findings indicate that recruitment of smokers into cessation support remains challenging.", {"entities": []}], ["Once recruited, cessation support was well received by smoking parents.", {"entities": []}], ["Of smokers allocated to quitline support, 88% accepted at least one counselling call.", {"entities": []}], ["The average number of calls taken was high (5.7 out of 7 calls).", {"entities": []}], ["Of smokers allocated to receive self-help material, 84% read at least some parts of the brochure.", {"entities": []}], ["Of the intention-to-treat population, 81% and 69% were satisfied with quitline support or self-help material, respectively.", {"entities": []}], ["Smoking parents were significantly more positive about quitline support compared to self-help material ( p <.001).", {"entities": []}], ["Cessation support is well-received and well-used among smoking parents recruited through primary schools.", {"entities": []}], ["Future studies need to examine factors that influence the response to offers of cessation support in samples of nonvolunteer smokers.", {"entities": []}], ["The protocol for this study is registered with the Netherlands Trial Register NTR2707", {"entities": []}], ["Inequalities in society, culture, and finance have resulted in civil unrest, rioting, and intentional violence throughout our history.", {"entities": []}], ["Nowhere is this currently more apparent than in the cities of Ferguson and Baltimore.", {"entities": []}], ["It is not the civil unrest itself, but the resulting rioting and intentional violence that can create a disaster situation.", {"entities": []}], ["This increases the care burden of health care providers during times when the governmental structure may be overwhelmed or functioning in a less than optimal manner.", {"entities": []}], ["Beginning with the death of Michael Brown, civil unrest over the last 2 years has necessitated a closer examination of the role nurse leaders play in preparing their staff and facilities for potential results of this civil unrest.", {"entities": []}], ["The similarities between the results of rioting and violence and natural disaster are obvious, but the differences are significant.", {"entities": []}], ["Without adequate preparation, providers may not offer the appropriate response.", {"entities": []}], ["Attention to the 10 \u201cmusts\u201d for preparedness for civil unrest will facilitate a planning process and provide for a better response and recovery when communities face these issues.", {"entities": []}], ["Honey bees ( Apis mellifera L.) are bioindicators of environmental pollution levels.", {"entities": []}], ["During their wide-ranging foraging activity, these hymenopterans are exposed to pollutants, thus becoming a useful tool to trace the environmental contaminants as heavy metals, pesticides, radionuclides and volatile organic compounds.", {"entities": []}], ["In the present work we demonstrate that bees can also be used as active samplers of airborne particulate matter.", {"entities": []}], ["Worker bees were collected from hives located in a polluted postmining area in South West Sardinia (Italy) that is also exposed to dust emissions from industrial plants.", {"entities": []}], ["The area is included in an official list of sites of national interest for environmental remediation, and has been characterized for the effects of pollutants on the health of the resident population.", {"entities": []}], ["The head, wings, hind legs and alimentary canal of the bees were investigated with Scanning Electron Microscopy coupled with X-ray spectroscopy (SEM-EDX).", {"entities": []}], ["The analyses pointed to specific morphological and chemical features of the particulate, and resulted into the identification of three categories of particles: industry -, postmining -, and soil \u2013derived.", {"entities": []}], ["With the exception of the gut, all the analyzed body districts displayed inorganic particles, mostly concentrated in specific areas of the body (i.e.", {"entities": []}], ["along the costal margin of the fore wings, the medial plane of the head, and the inner surface of the hind legs).", {"entities": []}], ["The role of both past mining activities and the industrial activity close to the study area as sources of the particulate matter is also discussed.", {"entities": []}], ["We conclude that honey bees are able to collect samples of the main airborne particles emitted from different sources, therefore could be an ideal tool for monitoring such a kind of pollutants.", {"entities": []}], ["Despite economic growth and improved health outcomes over the past few decades, China still experiences striking urban-rural health inequalities.", {"entities": []}], ["Urban and rural residents distinguished by the hukou system may experience profound disparities because of institutional effect.", {"entities": []}], ["The aim of this study is to estimate trends in urban-rural disparities in self-care, outpatient care, and inpatient care utilization from a perspective of the hukou system.", {"entities": []}], ["Data were extracted from the seven latest waves of the China Health and Nutrition Survey (CHNS).", {"entities": []}], ["We used the hukou system to distinguish between urban and rural residents.", {"entities": []}], ["Chi-square tests were performed to examine urban-rural gaps in self-care, outpatient care, and inpatient care utilization.", {"entities": []}], ["Multinomial logistic regression was employed to confirm these disparities and to explore whether the urban-rural gaps have narrowed or widened from 1993 to 2011 once known determinants of utilization are taken into account according to Andersen/Aday\u2019s Health Behaviour Model.", {"entities": []}], ["The urban-rural disparities were evident after controlling for confounding variables: urban adults were 3.24 ( p \u2009<\u20090.05), 2.23 ( p \u2009<\u20090.1), and 4.77 ( p \u2009<\u20090.01) times more likely to choose self-care vs. no care, outpatient care vs. no care, and inpatient care vs. no care than their rural counterparts, respectively.", {"entities": []}], ["The results showed upward trends in self-care, outpatient care, and inpatient care utilization from 2004 to 2011.", {"entities": []}], ["The urban-rural gaps in health care utilization gradually narrowed during the period of 1993\u20132011.", {"entities": []}], ["The hukou distinctions of self-care, outpatient care, and inpatient care in 2011 were only 33.3%, 35.5%, and 9.6% of that in 1993, respectively.", {"entities": []}], ["Although rural residents were underutilizing health care when compared to their urban counterparts, the significant decrements in urban-rural disparities reflect the positive effect of the on-going health system reform in China.", {"entities": []}], ["To maintain an equitable distribution of health care utilization, policy makers need to be aware of challenges due to aging problems and health expenditure increment.", {"entities": []}], ["Gefitinib, an EGFR-tyrosine kinase inhibitor, significantly improve prognosis in patients with advanced non-small cell lung cancer (NSCLC).", {"entities": [[119, 130, "DISEASE"], [124, 130, "DISEASE"]]}], ["The aim of this study was to evaluate the usefulness of MUC1 and vascular endothelial growth factor (VEGF) mRNA expression in peripheral blood as means of predicting benefit from gefitinib therapy in NSCLC patients.", {"entities": [[56, 60, "GENE"]]}], ["MUC1 and VEGF mRNA expressions were detected in peripheral blood of 66 patients with advanced NSCLC before (B0) and 4\u00a0weeks after treatment (B4w) with gefitinib, using real-time quantitative-PCR assay.", {"entities": [[0, 4, "GENE"]]}], ["Correlations between blood MUC1 and VEGF mRNA expression at B0 and B4w and the response to gefitinib treatment and survival were analyzed.", {"entities": [[27, 31, "GENE"]]}], ["Blood levels of MUC1 and VEGF mRNA at B0 and at B4w were significantly higher in patients with progressive disease than in those with partial response and stable disease.", {"entities": [[16, 20, "GENE"]]}], ["Furthermore, blood MUC1 and VEGF mRNA positivity at two time points were strongly associated with shorter progression-free survival (PFS) and overall survival (OS) (P\u2009=\u20090.005 and P\u2009=\u20090.008 at B0, and P\u2009<\u20090.001 and P\u2009=\u20090.001 at B4w, respectively, for MUC1; P\u2009=\u20090.004 and P\u2009=\u20090.009 at B0, and P\u2009=\u20090.001 and P\u2009<\u20090.001 at B4w, respectively, for VEGF).", {"entities": [[19, 23, "GENE"], [250, 254, "GENE"], [19, 23, "GENE"], [250, 254, "GENE"]]}], ["Multivariate analyses demonstrated that blood MUC1 and VEGF mRNA positivity at B0 and B4w were independent factors for predicting worse PFS and OS.", {"entities": [[46, 50, "GENE"]]}], ["MUC1 and VEGF mRNA positivity in blood seem to be indicators of unfavorable response and poor PFS and OS in patients with advanced NSCLC treated with gefitinib and may be promising noninvasive and repeatable markers for predicting efficacy of gefitinib treatment.", {"entities": [[0, 4, "GENE"]]}], ["In traditional herbal medicine, comprehensive understanding of bioactive constituent is important in order to analyze its true medicinal function.", {"entities": []}], ["We investigated the chemical properties of medicinal and edible ginger cultivars using a liquid-chromatography mass spectrometry (LC-MS) approach.", {"entities": []}], ["Our PCA results indicate the importance of acetylated derivatives of gingerol, not gingerol or shogaol, as the medicinal indicator.", {"entities": []}], ["A newly developed ginger cultivar, Z. officinale cv.", {"entities": []}], ["Ogawa Umare or \u201cOgawa Umare\u201d (OG), contains more active ingredients, showing properties as a new resource for the production of herbal medicines derived from ginger in terms of its chemical constituents and rhizome yield.", {"entities": []}], ["Background: Immunoglobulin E (IgE) plays a central role in allergic disease.", {"entities": []}], ["The B-cell receptor CD23 is pivotal in regulating IgE synthesis.", {"entities": []}], ["Results: Ca Conclusion: Mechanism for Ca Significance: Ca Immunoglobulin E (IgE) antibodies play a fundamental role in allergic disease and are a target for therapeutic intervention.", {"entities": []}], ["IgE functions principally through two receptors, Fc\u03f5RI and CD23 (Fc\u03f5RII).", {"entities": []}], ["Minute amounts of allergen trigger mast cell or basophil degranulation by cross-linking IgE-bound Fc\u03f5RI, leading to an inflammatory response.", {"entities": []}], ["The interaction between IgE and CD23 on B-cells regulates IgE synthesis.", {"entities": []}], ["CD23 is unique among Ig receptors in that it belongs to the C-type (calcium-dependent) lectin-like superfamily.", {"entities": []}], ["Although the interaction of CD23 with IgE is carbohydrate-independent, calcium has been reported to increase the affinity for IgE, but the structural basis for this activity has previously been unknown.", {"entities": []}], ["We have determined the crystal structures of the human lectin-like head domain of CD23 in its Ca trans to the cis configuration with a concomitant conformational change and ordering of residues in the loop.", {"entities": []}], ["Anorexia nervosa is a potentially life-threatening disorder with a typical onset in adolescence and high rates of medical complications and psychiatric comorbidity.", {"entities": []}], ["This article summarizes issues relating to classification in DSM-5 and presents a narrative review of key evidence-based medical and behavioral interventions for adolescent AN and subthreshold restricting eating disorders, mainly, but not exclusively published between 2012 and 2014.", {"entities": []}], ["In addition, it systematically compares the clinical guidelines of four European countries (Germany, Spain, The Netherlands, and United Kingdom) and outlines common clinical practice, in relation to treatment settings, nutritional rehabilitation, family-oriented and individual psychotherapy, and psychopharmacological treatment.", {"entities": []}], ["With the exception of family-based treatment, which is mainly evaluated and practiced in Anglo-American countries, the evidence base is weak, especially for medical interventions such as refeeding and pharmacological intervention.", {"entities": []}], ["There is a need for common European research efforts, to improve the available evidence base and resulting clinical guidance.", {"entities": []}], ["The goal of this study was to determine if selected mycotoxins (trichothecenes, aflatoxins, and ochratoxins) could be extracted and identified in human tissue and body fluids from patients exposed to toxin producing molds in their environment.", {"entities": []}], ["Human urine and methanol extracted tissues and sputum were examined.", {"entities": []}], ["Trichothecenes were tested using competitive ELISA techniques.", {"entities": []}], ["Aflatoxins B1, B2, G1, and G2, and ochratoxin A were tested by using immunoaffinity columns and fluorometry.", {"entities": []}], ["Test sensitivity and specificity were determined.", {"entities": []}], ["Levels of detection for the various mycotoxins varied from 0.2 ppb for trichothecenes, 1.0 ppb for aflatoxins, and 2.0 ppb for ochratoxins.", {"entities": []}], ["Trichothecene levels varied in urine, sputum, and tissue biopsies (lung, liver, brain) from undetectable (<0.2 ppb) to levels up to 18 ppb.", {"entities": []}], ["Aflatoxin levels from the same types of tissues varied from 1.0 to 5.0 ppb.", {"entities": []}], ["Ochratoxins isolated in the same type of tissues varied from 2.0 ppb to > 10.0 ppb.", {"entities": []}], ["Negative control patients had no detectable mycotoxins in their tissues or fluids.", {"entities": []}], ["These data show that mycotoxins can be detected in body fluids and human tissue from patients exposed to mycotoxin producing molds in the environment, and demonstrate which human tissues or fluids are the most likely to yield positive results.", {"entities": []}], ["Understanding the relationship between diseases based on the underlying biological mechanisms is one of the greatest challenges in modern biology and medicine.", {"entities": []}], ["Exploring disease-disease associations by using system-level biological data is expected to improve our current knowledge of disease relationships, which may lead to further improvements in disease diagnosis, prognosis and treatment.", {"entities": []}], ["We took advantage of diverse biological data including disease-gene associations and a large-scale molecular network to gain novel insights into disease relationships.", {"entities": []}], ["We analysed and compared four publicly available disease-gene association datasets, then applied three disease similarity measures, namely annotation-based measure, function-based measure and topology-based measure, to estimate the similarity scores between diseases.", {"entities": []}], ["We systematically evaluated disease associations obtained by these measures against a statistical measure of comorbidity which was derived from a large number of medical patient records.", {"entities": []}], ["Our results show that the correlation between our similarity measures and comorbidity scores is substantially higher than expected at random, confirming that our similarity measures are able to recover comorbidity associations.", {"entities": []}], ["We also demonstrated that our predicted disease associations correlated with disease associations generated from genome-wide association studies significantly higher than expected at random.", {"entities": []}], ["Furthermore, we evaluated our predicted disease associations via mining the literature on PubMed, and presented case studies to demonstrate how these novel disease associations can be used to enhance our current knowledge of disease relationships.", {"entities": []}], ["We present three similarity measures for predicting disease associations.", {"entities": []}], ["The strong correlation between our predictions and known disease associations demonstrates the ability of our measures to provide novel insights into disease relationships.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2105-15-304) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a complex disorder involving both airways and lung parenchyma, usually associated with progressive and poorly reversible airflow limitation.", {"entities": []}], ["In order to better characterize the phenotypic heterogeneity and the prognosis of patients with COPD, there is currently an urgent need for discovery and validation of reliable disease biomarkers.", {"entities": []}], ["Within this context, proteomic and peptidomic techniques are emerging as very valuable tools that can be applied to both systemic and pulmonary samples, including peripheral blood, induced sputum, exhaled breath condensate, bronchoalveolar lavage fluid, and lung tissues.", {"entities": []}], ["Identification of COPD biomarkers by means of proteomic and peptidomic approaches can thus also lead to discovery of new molecular targets potentially useful to improve and personalize the therapeutic management of this widespread respiratory disease.", {"entities": []}], ["People with asthma who live near or downwind from a source of toxic emissions commonly express concerns about the possible impact of hazardous air pollution on their health, especially when these emissions are visible or odorous.", {"entities": [[12, 18, "DISEASE"]]}], ["Citizens frequently turn to their local and state health departments for answers, but health departments face many challenges in addressing these concerns.", {"entities": []}], ["These challenges include a lack of asthma statistics at the local level, limited exposure information, and a paucity of scientific knowledge about the contributions of hazardous air pollutants to asthma induction or exacerbation.", {"entities": [[35, 41, "DISEASE"], [196, 202, "DISEASE"]]}], ["Health agencies are creatively developing methods to address these challenges while working toward improving asthma surveillance data at the state and local levels.", {"entities": [[109, 115, "DISEASE"]]}], ["Recent community health investigations suggest that hazardous air pollutants that are occupational asthmagens or associated with odors may deserve more attention.", {"entities": []}], ["In seeking to address community concerns about hazardous air pollution and asthma, community health investigations may also help to fill gaps in our scientific knowledge and identify areas for further research or environmental intervention.", {"entities": [[75, 81, "DISEASE"]]}], ["The solutions to community problems associated with environmental contamination and asthma, however, require sustained, coordinated efforts by public and private groups and citizens.", {"entities": [[84, 90, "DISEASE"]]}], ["Public health agencies can make a unique contribution to this effort, but additional resources and support will be required to develop information systems and epidemiologic capacity at the state and local levels.", {"entities": []}], ["Over the last decades hospital at home (HaH) programmes have been set up in many, mainly European, countries.", {"entities": []}], ["The Cuban HaH programme is not hospital driven, but the responsibility of the first line health services, and family doctors play a pivotal role.", {"entities": []}], ["We analyse the structure and functioning of the Cuban programme.", {"entities": []}], ["In this descriptive study, information was prospectively collected on HaH patients admitted between July 1 Admission rates varied between areas from 0.014 to 0.035 per person per year (ppy).", {"entities": [[185, 188, "GENE"]]}], ["The < 1y and 1\u20134y age groups had the highest admission rates.", {"entities": []}], ["In one area the follow-up of pregnancy problems led to high 15\u201324y and 25\u201349y female admission rates (0,070 and 0,058 respectively).", {"entities": []}], ["Respiratory affections were the most frequent reason for admission (32,6%), followed by early hospital discharge (16,0%) and gynaeco-obstetrical problems (10.8%).", {"entities": []}], ["The median length of stay varied from 5 to 7 days between regions and from 5 days (early discharge) to 7 days (gynaeco-obstetrical problems) in function of the reason for admission.", {"entities": []}], ["On average an HaH episode entailed 1.4 and 1.6 contacts per patient-day with the family doctor and nurse respectively.", {"entities": []}], ["Difference in admission criteria in function of geography, distance to the hospital, transport facilities, and staff factors, as well as differences in hospital policy on early discharge explain the observed variability.", {"entities": []}], ["The programme plays an important role in the integrated approach to quality care in the Cuban health system, but could benefit from more uniform admission criteria.", {"entities": []}], ["The purpose of this paper was to report tests of the validity and reliability of a new instrument, the Assessment of Quality of Life (AQoL)-8D, which was constructed to improve the evaluation of health services that have an impact upon the psychosocial aspects of the quality of life.", {"entities": []}], ["Australian and US data from a large multi-instrument comparison survey were used to conduct tests of convergent, predictive and content validity using as comparators five other multi-attribute utility (MAU) instruments\u2014the EQ-5D, SF-6D, Health Utilities Index (HUI) 3, 15D and the Quality of Well-Being (QWB)\u2014as well as four non-utility instruments\u2014the SF-36 and three measures of subjective well-being (SWB).", {"entities": []}], ["A separate three part Australian survey was used to assess test\u2013retest reliability.", {"entities": []}], ["Results indicate that AQoL-8D correlates more highly with both the SWB instruments and the psychosocial dimensions of the SF-36, and that it is similar to the other MAU instruments in terms of its convergent and predictive validity.", {"entities": []}], ["The second Australian survey demonstrated high test\u2013retest reliability.", {"entities": []}], ["The results indicate that the AQoL-8D is a reliable and valid instrument which offers an alternative to the MAU instruments presently used in economic evaluation studies, and one which is particularly suitable when psychosocial elements of health are of importance.", {"entities": []}], ["Although the flavor and fragrance industry is about 150 years old, the use of synthetic materials started more than 100 years ago, and the awareness of the respiratory hazard presented by some flavoring substances emerged only recently.", {"entities": []}], ["In 2001, the US National Institute of Occupational Safety and Health (NIOSH) identified for the first time inhalation exposure to flavoring substances in the workplace as a possible occupational hazard.", {"entities": []}], ["As a consequence, manufacturers must comply with a variety of workplace safety requirements, and management has to ensure the improvement of health and safety of the employees exposed to hazardous volatile organic compounds.", {"entities": []}], ["In this sensitive context, MANE opened its facilities to an intensive measuring campaign with the objective to better estimate the real level of hazardous respiratory exposure of workers.", {"entities": []}], ["In this study, exposure to 27 hazardous volatile substances were measured during several types of handling operations (weighing-mixing, packaging, reconditioning-transferring), 430 measurement results were generated, and were exploited to propose an improved model derived from the well-known ECETOC-TRA model.", {"entities": []}], ["The quantification of volatile substances in the working atmosphere involved three main steps: adsorption of the chemicals on a solid support, thermal desorption, followed by analysis by gas chromatography-mass spectrometry.", {"entities": []}], ["Our approach was to examine experimental measures done in various manufacturing workplaces and to define correction factors to reflect more accurately working conditions and habits.", {"entities": []}], ["Four correction factors were adjusted in the ECETOC-TRA to integrate important exposure variation factors: exposure duration, percentage of the substance in the composition, presence of collective protective equipment and wearing of personal protective equipment.", {"entities": []}], ["Verification of the validity of the model is based on the comparison of the values obtained after adaptation of the ECETOC-TRA model, according to various exposure scenarios, with the experimental values measured under real conditions.", {"entities": []}], ["After examination of the predicted results, 98% of the values obtained with the proposed new model were above the experimental values measured in real conditions.", {"entities": []}], ["This must be compared with the results of the classical ECETOC-TRA system, which generates only 37% of overestimated values.", {"entities": []}], ["As the values generated by the new model intended to help decision-makers of the industry to implement adapted protective action and information, and considering the high variability of the working environments, it was of the utmost importance to us not to underestimate the exposure level.", {"entities": []}], ["The proposed correction factors have been designed to achieve this goal.", {"entities": []}], ["We wish to propose the present method as an improved monitoring tool to improve respiratory health and safety in the flavor and fragrance manufacturing facilities.", {"entities": []}], ["Background: Congenital hypothyroidism (CH) is defined as the lack of thyroid hormones at birth.", {"entities": [[23, 37, "DISEASE"]]}], ["Mutations in at least 15 different genes have been associated with this disease.", {"entities": []}], ["While up to 20% of CH cases are hereditary, the majority of cases are sporadic with unknown etiology.", {"entities": []}], ["Apart from a monogenic pattern of inheritance, multigenic mechanisms have been suggested to play a role in CH.", {"entities": []}], ["The genetics of CH has not been studied in Finland so far.", {"entities": []}], ["Therefore, multigenic sequencing of CH candidate genes was performed in a Finnish patient cohort with both familial and sporadic CH.", {"entities": []}], ["Methods: A targeted next-generation sequencing (NGS) panel, covering all exons of the major CH genes, was applied for 15 patients with sporadic and 11 index cases with familial CH.", {"entities": []}], ["Results: Among the familial cases, six pathogenic mutations were found in the TPO , PAX8 , and TSHR genes.", {"entities": [[78, 81, "GENE"], [84, 88, "GENE"], [95, 99, "GENE"]]}], ["Furthermore, pathogenic NKX2.1 and TG mutations were identified from sporadic cases, together with likely pathogenic variants in the TG , NKX2.5 , SLC26A4 , and DUOX2 genes.", {"entities": [[35, 37, "GENE"], [133, 135, "GENE"], [35, 37, "GENE"], [133, 135, "GENE"], [147, 154, "GENE"], [161, 166, "GENE"]]}], ["All identified novel pathogenic mutations were confirmed by Sanger-sequencing and characterized in silico and/or in vitro .", {"entities": []}], ["Conclusion: In summary, the CH panel provides an efficient, cost-effective, and multigenic screening tool for both known and novel CH gene mutations.", {"entities": []}], ["Hence, it may be a useful method to identify accurately the genetic etiology for dyshormogenic, familial, or syndromic forms of CH.", {"entities": []}], ["Frailty is a common geriatric syndrome characterized by increased risk of disability, hospitalization, and mortality.", {"entities": [[30, 38, "DISEASE"]]}], ["Hypertension (HTN) is one of the most common chronic medical conditions in the elderly.", {"entities": []}], ["However, there have been few studies regarding the association between frailty and HTN prevalence, treatment, and control rates.", {"entities": []}], ["We analyzed data of 4,352 older adults (age\u2009\u2265\u200965 years) from the fifth Korea National Health and Nutrition Examination Survey.", {"entities": []}], ["We constructed a frailty index based on 42 items and classified participants as robust, pre-frail, or frail.", {"entities": []}], ["Of the subjects, 2,697 (62.0%) had HTN and 926 (21.3%) had pre-HTN.", {"entities": []}], ["Regarding frailty status, 721 (16.6%), 1,707 (39.2%), and 1,924 (44.2%) individuals were classified as robust, pre-frail and frail, respectively.", {"entities": []}], ["HTN prevalence was higher in frail elderly (67.8%) than pre-frail (60.8%) or robust elderly (49.2%) ( P \u2009<\u20090.001).", {"entities": []}], ["Among hypertensive patients, frail elderly were more likely to be treated than pre-frail or robust elderly ( P \u2009<\u20090.001), but the proportion of patients whose blood pressure was under control (\u2009<\u2009150/90\u2009mmHg) was lower in frail elderly ( P \u2009=\u20090.005).", {"entities": []}], ["Considering the adverse cardiovascular outcomes associated with frailty, more attention should be paid to the blood pressure control of the frail elderly.", {"entities": []}], ["For youth living with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), nonadherence to antiretroviral therapy (ART) can lead to poor health outcomes and significantly decreased life expectancy.", {"entities": [[83, 91, "DISEASE"], [57, 91, "DISEASE"]]}], ["To evaluate the feasability, acceptability, and preliminary efficacy of short message service (SMS) or text message reminders to improve adherence to ART for youth living with HIV/AIDS.", {"entities": [[95, 98, "GENE"]]}], ["We conducted this prospective pilot study using a pre\u2013post design from 2009 to 2010 at a community-based health center providing clinical services to youth living with HIV/AIDS.", {"entities": []}], ["Eligibility criteria included HIV-positive serostatus, age 14\u201329 years, use of a personal cell phone, English-speaking, and being on ART with documented poor adherence.", {"entities": []}], ["During the 24-week study period, participants received personalized daily SMS reminders and a follow-up message 1 hour later assessing whether they took the medication, and asking participants to respond via text message with the number 1 if they took the medication and 2 if they did not.", {"entities": [[74, 77, "GENE"]]}], ["Outcome measures were feasibility, acceptability, and adherence.", {"entities": []}], ["Self-reported adherence was determined using the visual analog scale (VAS) and AIDS Clinical Trial Group (ACTG) questionnaire 4-day recall.", {"entities": []}], ["Viral load and CD4 cell count were followed as biomarkers of adherence and disease progression at 0, 12, and 24 weeks.", {"entities": [[15, 18, "GENE"]]}], ["Participants (N = 25) were mean age 23 (range 14\u201329) years, 92% (n = 23) male, 60% (n = 15) black, and 84% (n = 21) infected through unprotected sex.", {"entities": []}], ["Mean VAS scores significantly increased at 12 and 24 weeks in comparison with baseline (week 0: 74.7, week 12: 93.3, P < .001; week 24: 93.1, P < .001).", {"entities": []}], ["ACTG questionnaire 4-day recall also improved (week 0: 2.33, week 12: 3.24, P = .002; week 24: 3.19, P = .005).", {"entities": []}], ["There was no significant difference in CD4 cell count or viral load between baseline and 12- or 24-week follow-up, although there was a trend toward improvement of these biomarkers and a small to moderate standardized effect size (range of Cohen d : \u20130.51 to 0.22).", {"entities": [[39, 42, "GENE"]]}], ["Of 25 participants, 21 (84%) were retained, and 20 of the 21 (95%) participants who completed the study found the intervention helpful to avoid missing doses.", {"entities": []}], ["In this pilot study, personalized, interactive, daily SMS reminders were feasible and acceptable, and they significantly improved self-reported adherence.", {"entities": [[54, 57, "GENE"]]}], ["Larger controlled studies are needed to determine the impact of this intervention on ART adherence and other related health outcomes for youth living with HIV/AIDS.", {"entities": []}], ["Genome-wide association studies have identified novel genetic associations for asthma, but without taking into account the role of active tobacco smoking.", {"entities": [[79, 85, "DISEASE"]]}], ["This study aimed to identify novel genes that interact with ever active tobacco smoking in adult onset asthma.", {"entities": [[103, 109, "DISEASE"]]}], ["We performed a genome-wide interaction analysis in six studies participating in the GABRIEL consortium following two meta-analyses approaches based on 1) the overall interaction effect and 2) the genetic effect in subjects with and without smoking exposure.", {"entities": []}], ["We performed a discovery meta-analysis including 4,057 subjects of European descent and replicated our findings in an independent cohort (LifeLines Cohort Study), including 12,475 subjects.", {"entities": []}], ["First approach: 50 SNPs were selected based on an overall interaction effect at p<10 int = 0.50, p = 7.63*10 int = 0.65, p = 0.02).", {"entities": []}], ["Second approach: 35 SNPs were selected based on the overall genetic effect in exposed subjects (p <10 int = 1.50, p = 1.21*10 int = 1.40, p = 0.03).", {"entities": []}], ["Using two genome-wide interaction approaches, we identified novel polymorphisms in non-annotated intergenic regions on chromosomes 9 and 12, that showed suggestive evidence for interaction with active tobacco smoking in the onset of adult asthma.", {"entities": [[239, 245, "DISEASE"]]}], ["A proinflammatory cytokine IL-32 acts as an intracellular mediator.", {"entities": []}], ["IL-32\u03b1 interacts with many intracellular molecules, but there are no reports of interaction with a transcriptional repressor BCL6.", {"entities": [[125, 129, "GENE"]]}], ["In this study, we showed that PMA induces an interaction between IL-32\u03b1, PKC\u03b5, and BCL6, forming a trimer.", {"entities": [[83, 87, "GENE"]]}], ["To identify the mechanism of the interaction, we treated cells with various inhibitors.", {"entities": []}], ["In HEK293 and THP-1 cell lines, treatment with a pan-PKC inhibitor, PKC\u03b5 inhibitor, and PKC\u03b4 inhibitor decreased BCL6 and IL-32\u03b1 protein expression.", {"entities": [[113, 117, "GENE"]]}], ["MAPK inhibitors and classical PKC inhibitor did not decrease PMA-induced BCL6 and IL-32\u03b1 protein expression.", {"entities": [[73, 77, "GENE"]]}], ["Further, the pan-PKC inhibitor and PKC\u03b5 inhibitor disrupted PMA-induced interaction between IL-32\u03b1 and BCL6.", {"entities": [[103, 107, "GENE"]]}], ["These data demonstrate that the intracellular interaction between IL-32\u03b1 and BCL6 is induced by PMA-activated PKC\u03b5.", {"entities": [[77, 81, "GENE"]]}], ["PMA induces post-translational modification of BCL6 by conjugation to SUMO-2, while IL-32\u03b1 inhibits.", {"entities": [[47, 51, "GENE"]]}], ["PKC\u03b5 inhibition eliminated PMA-induced SUMOylation of BCL6.", {"entities": [[54, 58, "GENE"]]}], ["Inhibition of BCL6 SUMOylation by IL-32\u03b1 affected the cellular function and activity of the transcriptional repressor BCL6 in THP-1 cells.", {"entities": [[14, 18, "GENE"], [118, 122, "GENE"], [14, 18, "GENE"], [118, 122, "GENE"]]}], ["Thus, we showed that IL-32\u03b1 is a negative regulator of the transcriptional repressor BCL6.", {"entities": [[85, 89, "GENE"]]}], ["IL-32\u03b1 inhibits BCL6 SUMOylation by activating PKC\u03b5, resulting in the modulation of BCL6 target genes and cellular functions of BCL6.", {"entities": [[16, 20, "GENE"], [84, 88, "GENE"], [128, 132, "GENE"], [16, 20, "GENE"], [84, 88, "GENE"], [128, 132, "GENE"], [16, 20, "GENE"], [84, 88, "GENE"], [128, 132, "GENE"]]}], ["Biomarkers for the progression of lung function in COPD are currently scarce.", {"entities": []}], ["Plasma fetuin-B (FETUB) was identified by iTRAQ-based proteomics and was verified by ELISA in another group.", {"entities": [[17, 22, "GENE"]]}], ["Information regarding acute exacerbation (AE) was collected in a one-year follow-up programme.", {"entities": []}], ["FETUB concentrations (1652\u2009\u00b1\u2009427\u2009ng/ml) were greater in COPD patients than in controls (1237\u2009\u00b1\u200977\u2009ng/ml).", {"entities": [[0, 5, "GENE"]]}], ["The concentrations of FETUB in GOLD II (1762\u2009\u00b1\u2009427\u2009ng/ml), III (1650\u2009\u00b1\u2009375\u2009ng/ml) and IV (1800\u2009\u00b1\u2009451\u2009ng/ml) groups were greater than those in the controls (1257\u2009\u00b1\u2009414\u2009ng/ml) and the GOLD I (1345\u2009\u00b1\u2009391\u2009ng/ml) group.", {"entities": [[22, 27, "GENE"]]}], ["ROCs indicated that FETUB distinguished COPD patients from controls (AUC 0.747, 95% CI: 0.642\u20130.834) and also GOLD II, III and IV from GOLD I COPD patients (AUC: 0.770, 95% CI: 0.634\u20130.874).", {"entities": [[20, 25, "GENE"]]}], ["The combination of FETUB and fibrinogen performed better (AUC: 0.804, 95% CI: 0.705\u20130.881).", {"entities": [[19, 24, "GENE"]]}], ["FETUB also predicted the occurrence of AE (AUC: 0.707, 95% CI: 0.566\u20130.824) or frequent AE (AUC: 0.727, 95% CI: 0.587\u20130.840).", {"entities": [[0, 5, "GENE"]]}], ["FETUB concentrations were negatively correlated with FEV1%pred ( r \u2009=\u2009\u22120.446, p \u2009=\u20090.000) and positively correlated with RV%pred ( r \u2009=\u20090.317, p \u2009=\u20090.004), RV/TLC% ( r \u2009=\u20090.360, p \u2009=\u20090.004), CT emphysema% ( r \u2009=\u20090.322, p \u2009=\u20090.008) and grades of lung function ( r \u2009=\u20090.437, p \u2009=\u20090.000).", {"entities": [[0, 5, "GENE"]]}], ["In conclusion, FETUB is likely to assist the diagnosis and management of COPD as a complement for other markers.", {"entities": [[15, 20, "GENE"]]}], ["Genetic variations in the IL-27 gene have been proven to be associated with various types of human cancers and diseases.", {"entities": []}], ["The purpose of the current study was to clarify the associations of the IL-27 rs153109 A>G and rs181206 T>C variants with human diseases using a meta-analysis study.", {"entities": []}], ["A comprehensive electronic and manual search was carried out to find potential eligible studies.", {"entities": []}], ["The effect size was represented by the unadjusted odds ratios (ORs).", {"entities": []}], ["A 95% confidence interval (95%CI) was tested for the pooled OR using the Z test.", {"entities": []}], ["A total of 17 case-control studies (cases=4185, healthy controls=4077) were included in our study.", {"entities": []}], ["Our study showed that the carriers of the rs181206 T>C and rs153109 A>G polymorphism in the IL-27 gene have elevated risks of diseases in the allele model (rs181206 T>C: OR=0.76, 95%CI=0.69~0.84, P <0.001; rs153109 A>G: OR=0.85, 95%CI=0.76~0.94, P =0.002) and dominant model (rs181206 T>C: OR=0.77, 95%CI=0.69~0.87, P <0.001; rs153109 A>G: OR=0.84, 95%CI=0.71~0.99, P =0.033).", {"entities": []}], ["Disease type-stratified subgroup analysis yielded increased risk of related diseases in IL-27 rs181206 T>C carriers in the allele model in immune thrombocytopenia (ITP), asthma, and esophageal cancer (EC) subgroups (ITP: OR=0.69, 95%CI=0.53~0.88, P =0.004; asthma: OR=0.60, 95%CI=0.41~0.89, P =0.010; EC: OR=0.79, 95%CI=0.64~0.97, P =0.026); and IL-27 rs153109 A>G polymorphism was remarkably associated with the increased risk of related diseases in the allele model in ovarian cancer (OC), systemic lupus erythematosus (SLE), tuberculosis (TB), ulcerative colitis (UC), and chronic obstructive pulmonary disease (COPD) subgroups (all P <0.05).", {"entities": [[471, 485, "DISEASE"], [182, 199, "DISEASE"], [576, 613, "DISEASE"], [528, 540, "DISEASE"], [501, 520, "DISEASE"], [146, 162, "DISEASE"], [170, 176, "DISEASE"], [257, 263, "DISEASE"], [492, 520, "DISEASE"], [193, 199, "DISEASE"], [479, 485, "DISEASE"], [547, 565, "DISEASE"]]}], ["Our results indicate that the genetic polymorphisms of IL-27 rs153109 and rs181206 may be involved in the progression of human cancers and diseases, especially of TB, UC, COPD, OC, and ITP.", {"entities": []}], ["Mechanobiology has shifted our understanding of fundamental cellular and physiological functions.", {"entities": []}], ["Changes to the stiffness of the extracellular matrix, cell rigidity, or shape of the cell environment were considered in the past to be a consequence of aging or pathological processes.", {"entities": []}], ["We now understand that these factors can actually be causative biological mediators of cell growth to control organ size.", {"entities": []}], ["Mechanical cues are known to trigger a relatively fast translocation of specific transcriptional co-factors such as MRTFs, YAP and TAZ from the cytoplasm to the cell nucleus to initiate discrete transcriptional programs.", {"entities": [[131, 134, "GENE"]]}], ["The focus of this review is the molecular mechanisms by which biophysical stimuli that induce changes in cytoplasmic actin dynamics are communicated within cells to elicit gene-specific transcription via nuclear localisation or activation of specialized transcription factors, namely MRTFs and the Hippo pathway effectors YAP and TAZ.", {"entities": [[330, 333, "GENE"]]}], ["We propose here that MRTFs, YAP and TAZ closely collaborate as mechano-effectors.", {"entities": [[36, 39, "GENE"]]}], ["Synthesizing outcomes of underreported primary studies can pose a serious threat to the validity of outcomes and conclusions of systematic reviews.", {"entities": []}], ["To address this problem, the Cochrane Collaboration recommends reviewers to contact authors of eligible primary studies to obtain additional information on poorly reported items.", {"entities": []}], ["In this protocol, we present a cross-sectional study and a survey to assess (1) how reviewers of new Cochrane intervention reviews report on procedures and outcomes of contacting of authors of primary studies to obtain additional data, (2) how authors reply, and (3) the consequences of these additional data on the outcomes and quality scores in the review.", {"entities": []}], ["All research questions and methods were pilot tested on 2\u00a0months of Cochrane reviews and were subsequently fine-tuned.", {"entities": []}], ["Eligibility criteria are (1) all new (not-updates) Cochrane intervention reviews published in 2016, (2) reviews that included one or more primary studies, and (3) eligible interventions refer to contacting of authors of the eligible primary studies included in the review to obtain additional research data (e.g., information on unreported or missing data, individual patient data, research methods, and bias issues).", {"entities": []}], ["Searching for eligible reviews and data extraction will be conducted by two authors independently.", {"entities": []}], ["The cross-sectional study will primarily focus on how contacting of authors is conducted and reported, how contacted authors reply, and how reviewers report on obtained additional data and their consequences for the review.", {"entities": []}], ["The same eligible reviews for the cross-sectional study will also be eligible for the survey.", {"entities": []}], ["Surveys will be sent to the contact addresses of these reviews according to a pre-defined protocol.", {"entities": []}], ["We will use Google Forms as our survey platform.", {"entities": []}], ["Surveyees are asked to answer eight questions.", {"entities": []}], ["The survey will primarily focus on the consequences of contacting authors of eligible primary studies for the risk of bias and Grading of Recommendations, Assessment, Development and Evaluation scores and the primary and secondary outcomes of the review.", {"entities": []}], ["The findings of this study could help improve methods of contacting authors and reporting of these procedures and their outcomes.", {"entities": []}], ["Patients, clinicians, researchers, guideline developers, research sponsors, and the general public will all be beneficiaries.", {"entities": []}], ["The online version of this article (10.1186/s13643-017-0643-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Many studies showed abnormal serotonin transporter (5-HTT) function and heart rate variability (HRV) in panic disorder patients.", {"entities": [[104, 118, "DISEASE"]]}], ["The present study investigated the relationship between HRV power spectral analysis findings and platelet serotonin uptake in panic disorder patients.", {"entities": [[126, 140, "DISEASE"]]}], ["Short-term HRV over 5 min and platelet serotonin transporter uptake parameters (V max and K m ) were measured both in 45 patients with panic disorder and in 30 age-matched normal healthy control subjects.", {"entities": [[135, 149, "DISEASE"], [82, 85, "GENE"]]}], ["Low frequency power (LF) normalized unit (nu) and LF/high frequency power (HF) were significantly higher, whereas HF and HF nu were lower in the patient group than in the control group.", {"entities": []}], ["V max and K m were all significantly lower (i.e., reflects decreased 5-HTT function) in patients with panic disorder than in normal controls.", {"entities": [[102, 116, "DISEASE"], [2, 5, "GENE"]]}], ["In the patient group, K m was negatively correlated with LF/HF and LF nu whereas no such correlations between them were found in the control group.", {"entities": []}], ["By multivariate analysis based on multiple hierarchical linear regression, a low K m independently predicted an increased LF nu even after controlling for age, sex, and body mass index in the patient group.", {"entities": []}], ["These results suggest that impaired 5-HTT function is closely related to dysregulation of autonomic nervous system in panic disorder.", {"entities": [[118, 132, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is associated with substantial morbidity, including impaired health-related quality of life (HRQoL).", {"entities": []}], ["Despite the prominent role of occupational factors in the aetiology of COPD, the relationship between these exposures and HRQoL has not been well elucidated.", {"entities": []}], ["A subpopulation from an epidemiological study, designed to assess the workplace contribution to COPD, was administered the EQ5D HRQoL tool.", {"entities": []}], ["Demographics, an index of economic deprivation, health endpoints including the presence of COPD and lung function were also recorded.", {"entities": []}], ["Workplace exposures were categorised using both self-reported exposures and also by the use of an established job exposure matrix (JEM).", {"entities": []}], ["A total of 623 individuals participated (mean age 67.1\u00a0years).", {"entities": []}], ["One hundred and forty-eight (24\u00a0%) reported having received a physician diagnosis of COPD, 355 (57\u00a0%) were male, and 386 (62\u00a0%) were ever smokers.", {"entities": []}], ["As anticipated, the presence of COPD was associated with a poorer HRQoL.", {"entities": []}], ["Additionally, however, HRQoL was significantly lower in the presence of both self-reported vapours, gases, dusts and fumes exposure and JEM-based exposure irrespective of the presence of COPD.", {"entities": []}], ["Regression analysis, adjusting for a variety of covariates including the presence of COPD, confirmed a persisting higher likelihood of occupational exposure categorised by JEM being associated with poorer HRQoL scores ( \u03b2 estimate: \u22120.069; p \u00a0<\u00a00.05).", {"entities": []}], ["Our findings suggest that work may have an important link to HRQoL and that this effect can persist even among those who have retired.", {"entities": []}], ["In those with COPD, HRQoL is worse than among those without this condition, but the work-associated decrement appears to be similar across both groups.", {"entities": []}], ["Common complications of thoracic radiotherapy include esophagitis and radiation pneumonitis.", {"entities": [[54, 65, "DISEASE"]]}], ["However, it is important to be aware of uncommon post-radiotherapy complications such as bronchiolitis obliterans organizing pneumonia (BOOP).", {"entities": [[125, 134, "DISEASE"], [89, 134, "DISEASE"], [89, 113, "DISEASE"], [89, 102, "DISEASE"]]}], ["We report on two patients with carcinoma of the breast who developed an interstitial lung disease consistent with BOOP.", {"entities": [[31, 40, "DISEASE"], [72, 97, "DISEASE"], [85, 97, "DISEASE"]]}], ["BOOP responds to treatment with corticosteroids and the prognosis is generally good despite of the need for long-term administration of corticosteroids as relapses can occur during tapering of steroids.", {"entities": []}], ["This report provides guidelines for the evaluation and treatment of patients with pulmonary infiltrates after radiotherapy.", {"entities": []}], ["A protective role for glucocorticoid therapy in animal models of sepsis was shown many decades ago.", {"entities": []}], ["In human sepsis, there is new interest in glucocorticoid therapy at a physiological dose after reports of improved response to vasopressor drugs and decreased mortality in a selected group of patients.", {"entities": []}], ["However, other reports have not confirmed these results.", {"entities": []}], ["Cellular glucocorticoid resistance could explain a possible cause of that.", {"entities": []}], ["To evaluate this hypothesis, we evaluated the expression of glucocorticoid receptor beta, the dominant negative isoform of glucocorticoid receptor, in peripheral mononuclear cells of septic patients and the effect of serum septic patients over glucocorticoid receptor expression and glucocorticoid sensitivity in immune cells culture.", {"entities": []}], ["A prospective cohort study and an in vitro experimental study with matched controls were developed.", {"entities": []}], ["Nine patients with septic shock and nine healthy controls were prospectively enrolled.", {"entities": []}], ["Mononuclear cells and serum samples were obtained from the patients with sepsis on admission to the Intensive Care Unit and on the day of discharge from hospital, and from healthy volunteers matched by age and sex with the patients.", {"entities": []}], ["Glucocorticoid receptor alpha and beta expression from patients and from immune cell lines cultured in the presence of serum from septic patients were studied by western blot.", {"entities": []}], ["Glucocorticoid sensitivity was studied in control mononuclear cells cultured in the presence of serum from normal or septic patients.", {"entities": []}], ["A statistical analysis was performed using a Mann-Whitney test for non-parametric data and analysis of variance for multiple comparison; P < 0.05 was considered significant.", {"entities": []}], ["The patients' glucocorticoid receptor beta expression was significantly higher on admission than on discharge, whereas the alpha receptor was not significantly different.", {"entities": []}], ["In vitro , septic serum induced increased expression of both receptors in T and B cells in culture, with a greater effect on receptor beta than the control serum.", {"entities": []}], ["Septic serum induced glucocorticoid resistance in control mononuclear cells.", {"entities": []}], ["There is a transient increased expression of glucocorticoid receptor beta in mononuclear cells from septic patients.", {"entities": []}], ["Serum from septic patients induces cell glucocorticoid resistance in vitro .", {"entities": []}], ["Our findings support a possible cell glucocorticoid resistance in sepsis.", {"entities": []}], ["Data on specific IgE sensitization prevalence in children with allergy-like symptoms seen in the primary care setting are rare.", {"entities": []}], ["Early diagnosis of allergic diseases is important to prevent clinical manifestations, exacerbations or expansion of allergic diseases to other organ systems.", {"entities": []}], ["The present study aims to assess the usefulness of early serological diagnosis in children with common allergic symptoms.", {"entities": []}], ["532 children (<15\u00a0years of age), with at least one of ten allergy-like symptoms, from 21 primary care centers in two geographic areas of Italy and Spain were included in the study.", {"entities": []}], ["Patients were tested with, either Phadiatop\u00ae Infant (0\u20135 years of age) or Phadiatop\u00ae and food mix (fx5e) (>5\u00a0years of age) to discriminate atopic from non-atopic subjects.", {"entities": []}], ["A blood sample of atopic subjects was taken for additional 6\u201326 specific IgE antibody determinations from a predefined panel using the ImmunoCAP 267 children (50.2\u00a0%) were positive in the initial test and were classified as atopic.", {"entities": []}], ["14\u00a0% were mono-sensitized, 37\u00a0% were sensitized to 2\u20133 allergens and 49\u00a0% to more than 3 allergens.", {"entities": []}], ["The average number of symptoms in the atopic group was 3.3 vs 2.8 in the non-atopic group.", {"entities": []}], ["The prevalence of sensitization to single allergens was highest for grass and ragweed pollen and house-dust mites (19\u201328\u00a0%).", {"entities": []}], ["Sensitization to tree allergens was highest for olive tree (16.5\u00a0%).", {"entities": []}], ["Cow\u2019s milk and egg white were the most sensitizing foods (~15\u00a0%).", {"entities": []}], ["Food allergen sensitization predominated in younger children (OR\u2009=\u20092.8) whereas the inverse occurred with inhalant allergens (OR\u2009=\u20092.5 to 5.6).", {"entities": []}], ["A significant positive correlation between patient age and the number of sensitizations was found.", {"entities": []}], ["Specific IgE sensitization in children with allergy-like symptoms is common.", {"entities": []}], ["Multiple sensitization is predominating.", {"entities": []}], ["Number of clinical symptoms was higher in the atopic group compared to the non-atopic without a correlation with the number of positive allergens.", {"entities": []}], ["Age seems to play a crucial role in the development of sensitization with a significant positive correlation between patient age and the number of sensitizations.", {"entities": []}], ["Nanomaterial-modified detection systems represent a chief driver towards the adoption of electrochemical methods, since nanomaterials enable functional tunability, ability to self-assemble, and novel electrical, optical and catalytic properties that emerge at this scale.", {"entities": []}], ["This results in tremendous gains in terms of sensitivity, selectivity and versatility.", {"entities": []}], ["We review the electrochemical methods and mechanisms that may be applied to the detection of neurological drugs.", {"entities": []}], ["We focus on understanding how specific nano-sized modifiers may be applied to influence the electron transfer event to result in gains in sensitivity, selectivity and versatility of the detection system.", {"entities": []}], ["This critical review is structured on the basis of the Anatomical Therapeutic Chemical (ATC) Classification System, specifically ATC Code N (neurotransmitters).", {"entities": []}], ["Specific sections are dedicated to the widely used electrodes based on the carbon materials, supporting electrolytes, and on electrochemical detection paradigms for neurological drugs and neurotransmitters within the groups referred to as ATC codes N01 to N07.", {"entities": []}], ["We finally discuss emerging trends and future challenges such as the development of strategies for simultaneous detection of multiple targets with high spatial and temporal resolutions, the integration of microfluidic strategies for selective and localized analyte pre-concentration, the real-time monitoring of neurotransmitter secretions from active cell cultures under electro- and chemotactic cues, aptamer-based biosensors, and the miniaturization of the sensing system for detection in small sample volumes and for enabling cost savings due to manufacturing scale-up.", {"entities": []}], ["The Electronic Supporting Material ( a values, half-life of drugs and their electrochemical mechanisms.", {"entities": []}], ["The Figure \u115f \u115f The online version of this article (doi:10.1007/s00604-014-1308-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Previous studies have suggested that asthma, like other common diseases, has at least part of its origin early in life.", {"entities": [[37, 43, "DISEASE"]]}], ["Low birth weight has been shown to be associated with increased risks of asthma, chronic obstructive airway disease, and impaired lung function in adults, and increased risks of respiratory symptoms in early childhood.", {"entities": [[73, 79, "DISEASE"]]}], ["The developmental plasticity hypothesis suggests that the associations between low birth weight and diseases in later life are explained by adaptation mechanisms in fetal life and infancy in response to various adverse exposures.", {"entities": []}], ["Various pathways leading from adverse fetal and infant exposures to growth adaptations and respiratory health outcomes have been studied, including fetal and early infant growth patterns, maternal smoking and diet, children\u2019s diet, respiratory tract infections and acetaminophen use, and genetic susceptibility.", {"entities": []}], ["Still, the specific adverse exposures in fetal and early postnatal life leading to respiratory disease in adult life are not yet fully understood.", {"entities": []}], ["Current studies suggest that both environmental and genetic factors in various periods of life, and their epigenetic mechanisms may underlie the complex associations of low birth weight with respiratory disease in later life.", {"entities": []}], ["New well-designed epidemiological studies are needed to identify the specific underlying mechanisms.", {"entities": []}], ["This review is focused on specific adverse fetal and infant growth patterns and exposures, genetic susceptibility, possible respiratory adaptations and perspectives for new studies.", {"entities": []}], ["Sickle Cell Disease (SCD), which is characterized by a mutation in the gene encoding beta hemoglobin, causes bodily dysfunctions such as impaired pulmonary function and reduced functional capacity.", {"entities": [[21, 24, "GENE"]]}], ["To assess changes in pulmonary function and functional capacity in patients with SCD and to identify the relationships between these variables.", {"entities": [[81, 84, "GENE"]]}], ["We evaluated sociodemographic, anthropometric, lung function (spirometry), respiratory (manovacuometer), peripheral muscle strength (Handgrip strength - HS) and functional capacity (i.e., the six-minute walk test) parameters in 21 individuals with SCD (average age of 29\u00b16 years).", {"entities": [[248, 251, "GENE"]]}], ["Shapiro-Wilk, paired Student's, Wilcoxon, Pearson and Spearman correlation tests were used for statistical analyses, and the significance threshold was set at p<0.05.", {"entities": []}], ["A total of 47.6% of the study subjects exhibited an altered ventilation pattern, 42.8% had a restrictive ventilatory pattern (RVP) and 4.8% exhibited a mixed ventilatory pattern (MVP).", {"entities": [[179, 182, "GENE"]]}], ["The observed maximal inspiratory pressure (MIP) values were below the predicted values for women (64 cmH 2 O), and the maximum expiratory pressure (MEP) values, HS values and distance walked during the 6MWT were below the predicted values for both men (103 cmH 2 O, 39 Kgf and 447 m, respectively) and women (64 cmH 2 O; 27 Kgf; 405 m, respectively).", {"entities": [[43, 46, "GENE"]]}], ["Positive correlations were observed between maximum voluntary ventilation (MVV) and MEP (r=0.4; p=0.046); MVV and BMI (r=0.6; p=0.003); and between HS and MIP (r=0.7; p=0.001), MEP (r=0.6; p=0.002), MVV (r=0.5; p=0.015), distance walked in the 6MWT (r=0.4; p=0.038) and BMI (r=0.6; p=0.004).", {"entities": [[155, 158, "GENE"]]}], ["SCD promoted changes in lung function and functional capacity, including RVPs and a reduction in the distance walked in the 6MWT when compared to the predictions.", {"entities": [[0, 3, "GENE"]]}], ["In addition, significant correlations between the variables were observed.", {"entities": []}], ["Many Gram-positive bacteria produce pore-forming exotoxins that contain a highly conserved, 12-residue domain (ECTGLAWEWWRT) that binds cholesterol.", {"entities": []}], ["This domain is usually flanked N-terminally by arginine and C-terminally by valine.", {"entities": []}], ["We used this 14-residue sequence as a template to create a small library of peptides that bind cholesterol and other lipids.", {"entities": []}], ["Several of these peptides manifested anti-inflammatory properties in a predictive in vitro monocyte chemotactic assay, and some also diminished the pro-inflammatory effects of low-density lipoprotein in apoE-deficient mice.", {"entities": []}], ["The most potent analog, Oxpholipin-11D (OxP-11D), contained D-amino acids exclusively and was identical to the 14-residue design template except that diphenylalanine replaced cysteine-3.", {"entities": []}], ["In surface plasmon resonance binding studies, OxP-11D bound oxidized (phospho)lipids and sterols in much the same manner as D-4F, a widely studied cardioprotective apoA-I-mimetic peptide with anti-inflammatory properties.", {"entities": []}], ["In contrast to D-4F, which adopts a stable \u03b1-helical structure in solution, the OxP-11D structure was flexible and contained multiple turn-like features.", {"entities": []}], ["Given the substantial evidence that oxidized phospholipids are pro-inflammatory in vivo , OxP-11D and other Oxpholipins may have therapeutic potential.", {"entities": []}], ["Identifying and characterizing how mixtures of exposures are associated with health endpoints is challenging.", {"entities": []}], ["We demonstrate how classification and regression trees can be used to generate hypotheses regarding joint effects from exposure mixtures.", {"entities": []}], ["We illustrate the approach by investigating the joint effects of CO, NO2, O3, and PM2.5 on emergency department visits for pediatric asthma in Atlanta, Georgia.", {"entities": [[133, 139, "DISEASE"]]}], ["Pollutant concentrations were categorized as quartiles.", {"entities": []}], ["Days when all pollutants were in the lowest quartile were held out as the referent group (n\u2009=\u2009131) and the remaining 3,879\u00a0days were used to estimate the regression tree.", {"entities": []}], ["Pollutants were parameterized as dichotomous variables representing each ordinal split of the quartiles (e.g.", {"entities": []}], ["comparing CO quartile 1 vs. CO quartiles 2\u20134) and considered one at a time in a Poisson case-crossover model with control for confounding.", {"entities": []}], ["The pollutant-split resulting in the smallest P- value was selected as the first split and the dataset was partitioned accordingly.", {"entities": []}], ["This process repeated for each subset of the data until the P- values for the remaining splits were not below a given alpha, resulting in the formation of a \u201cterminal node\u201d.", {"entities": []}], ["We used the case-crossover model to estimate the adjusted risk ratio for each terminal node compared to the referent group, as well as the likelihood ratio test for the inclusion of the terminal nodes in the final model.", {"entities": []}], ["The largest risk ratio corresponded to days when PM2.5 was in the highest quartile and NO2 was in the lowest two quartiles (RR: 1.10, 95% CI: 1.05, 1.16).", {"entities": []}], ["A simultaneous Wald test for the inclusion of all terminal nodes in the model was significant, with a chi-square statistic of 34.3 (p\u2009=\u20090.001, with 13 degrees of freedom).", {"entities": []}], ["Regression trees can be used to hypothesize about joint effects of exposure mixtures and may be particularly useful in the field of air pollution epidemiology for gaining a better understanding of complex multipollutant exposures.", {"entities": []}], ["A recent observational study in a large cohort of critically ill patients confirms the association between hyperlactatemia and mortality.", {"entities": []}], ["The mechanisms regulating the rates of lactate production and clearance in critical illness remain poorly understood.", {"entities": []}], ["During exercise, hyperlactatemia clearly results from an imbalance between oxygen delivery and energy requirements.", {"entities": []}], ["In critically ill patients, the genesis of hyperlactatemia is significantly more complex.", {"entities": []}], ["Possible mechanisms include regional hypoperfusion, an inflammation-induced upregulation of the glycolitic flux, alterations in lactate-clearing mechanisms, and increases in the work of breathing.", {"entities": []}], ["Understanding how these complex processes interact to produce elevations in lactate continues to be an important area of research.", {"entities": []}], ["Our aim was to investigate the prevalence and clinical relevance of inherited complement and antibody deficiency states in a large series of patients with various autoimmune rheumatologic diseases (ARD) with juvenile onset.", {"entities": []}], ["A total number of 117 consecutive patients from 2 tertiary referral hospitals were included in the study.", {"entities": []}], ["All patients underwent genetic screening for type I C2 deficiency and C4 allotyping.", {"entities": [[52, 54, "GENE"]]}], ["Serum levels of immunoglobulin classes measured systematically throughout their regular medical care were recorded retrospectively.", {"entities": []}], ["Our cohort of patients included 84 with juvenile idiopathic arthritis (JIA), 21 with systemic lupus erythematosus (SLE), 6 with systemic vasculitis, 2 with juvenile scleroderma, 2 with idiopathic uveitis, 1 with mixed connective tissue disease and 1 with SLE/scleroderma overlap syndrome.", {"entities": [[212, 243, "DISEASE"], [94, 113, "DISEASE"], [279, 287, "DISEASE"], [137, 147, "DISEASE"], [60, 69, "DISEASE"], [218, 243, "DISEASE"], [85, 113, "DISEASE"], [196, 203, "DISEASE"], [165, 176, "DISEASE"], [259, 270, "DISEASE"]]}], ["We have found 16 patients with evidence of primary immunodeficiency in our series (13.7\u00a0%), including 7 with C4 deficiency, 5 with selective IgA deficiency, 3 with C2 deficiency and 2 with unclassified hypogammaglobulinemia (one also presented C4D).", {"entities": [[164, 166, "GENE"]]}], ["Of the 84 patients with JIA, 4 (4.8\u00a0%) had a complement deficiency, which was less prevalent than in the SLE cohort (23.8\u00a0%), but all of them have exhibited an aggressive disease.", {"entities": [[45, 66, "DISEASE"]]}], ["Most of our patients with primary antibody deficiencies showed a more complicated and severe disease course and even the co-occurrence of two associated autoimmune diseases (SLE/scleroderma overlap syndrome and SLE/autoimmune hepatitis type 1 overlap).", {"entities": [[215, 235, "DISEASE"], [198, 206, "DISEASE"], [226, 235, "DISEASE"], [178, 189, "DISEASE"]]}], ["Our findings among others demonstrate that complement and immunoglobulin immunodeficiencies need careful consideration in patients with ARD, as they are common and might contribute to a more severe clinical course of the disease.", {"entities": []}], ["Valeriana jatamansi is an indigenous medicinal plant used in the treatment of a number of diseases.", {"entities": []}], ["In the present study, chemical composition of the essential oil was determined by GC-MS.", {"entities": []}], ["Seven major components were identified in Valeriana jatamansi essential oil, namely, \u03b2 -vatirenene, \u03b2 -patchoulene, dehydroaromadendrene, \u03b2 -gurjunene, patchoulic alcohol, \u03b2 -guaiene, and \u03b1 -muurolene.", {"entities": []}], ["Methanolic, aqueous, and chloroform extracts of Valeriana jatamansi roots were also prepared and analyzed for their polyphenols and flavonoid content.", {"entities": []}], ["Antioxidant activity of essential oil and different extracts of Valeriana jatamansi roots was determined by DPPH radical scavenging and chelation power assay.", {"entities": []}], ["A linear correlation has been obtained by comparing the antioxidant activity and polyphenols and flavonoid content of the extracts.", {"entities": []}], ["Results indicated that antioxidant activity of methanolic extract could be attributed to the presence of rich amount of polyphenols and flavonoid.", {"entities": []}], ["Essential oil of Valeriana jatamansi roots showed moderate antioxidant activity.", {"entities": []}], ["Physical activity is difficult to measure in individuals with COPD.", {"entities": []}], ["The Community Healthy Activities Model Program for Seniors (CHAMPS) questionnaire demonstrated strong clinometric properties when used with the elderly and with those affected by chronic disease.", {"entities": []}], ["Study objectives were to translate, culturally adapt the CHAMPS into French, and reexamine its test-retest reliability and construct validity in French and English Canadians with COPD.", {"entities": []}], ["This paper presents the cross-cultural adaptation of the CHAMPS; results of its clinometric testing will be described in another article.", {"entities": []}], ["The CHAMPS examines the degree of physical activity performed in a typical week through two summary scales, caloric expenditure and activity frequency.", {"entities": []}], ["The CHAMPS was only in English; thus, a cross-cultural adaptation was needed to translate the CHAMPS into French for use in French Canadians with COPD.", {"entities": []}], ["Cross-cultural adaptation consisted of forward and back translation, with expert review at each stage of translation: minor inconsistencies were uncovered and rectified.", {"entities": []}], ["Five French participants with COPD completed the finalized Canadian French CHAMPS and participated in cognitive debriefing; no problematic items were identified.", {"entities": []}], ["A structured and stepwise, cross-cultural adaptation process produced the Canadian French CHAMPS, with items of equivalent meaning to the English version, for use in French Canadians with COPD.", {"entities": []}], ["Community-acquired pneumonia (CAP) requiring intensive care unit (ICU) admission remains a severe medical condition, presenting ICU mortality rates reaching 30%.", {"entities": [[19, 28, "DISEASE"]]}], ["The aim of this study was to assess the value of different patterns of C-reactive protein (CRP)-ratio response to antibiotic therapy in patients with severe CAP requiring ICU admission as an early maker of outcome.", {"entities": [[91, 94, "GENE"]]}], ["In total, 191 patients with severe CAP were prospectively included and CRP was sampled every other day from D1 to D7 of antibiotic prescription.", {"entities": [[71, 74, "GENE"]]}], ["CRP-ratio was calculated in relation to D1 CRP concentration.", {"entities": [[0, 3, "GENE"], [43, 46, "GENE"]]}], ["Patients were classified according to an individual pattern of CRP-ratio response with the following criteria: fast response - when D5 CRP was less than or equal to 0.4 of D1 CRP concentration; slow response - when D5 CRP was > 0.4 and D7 less than or equal to 0.8 of D1 CRP concentration; nonresponse - when D7 CRP was > 0.8 of D1 CRP concentration.", {"entities": [[63, 66, "GENE"], [135, 138, "GENE"], [175, 178, "GENE"], [218, 221, "GENE"], [271, 274, "GENE"], [312, 315, "GENE"], [332, 335, "GENE"], [63, 66, "GENE"], [135, 138, "GENE"], [175, 178, "GENE"], [218, 221, "GENE"], [271, 274, "GENE"], [312, 315, "GENE"], [332, 335, "GENE"], [63, 66, "GENE"], [135, 138, "GENE"], [175, 178, "GENE"], [218, 221, "GENE"], [271, 274, "GENE"], [312, 315, "GENE"], [332, 335, "GENE"], [63, 66, "GENE"], [135, 138, "GENE"], [175, 178, "GENE"], [218, 221, "GENE"], [271, 274, "GENE"], [312, 315, "GENE"], [332, 335, "GENE"], [63, 66, "GENE"], [135, 138, "GENE"], [175, 178, "GENE"], [218, 221, "GENE"], [271, 274, "GENE"], [312, 315, "GENE"], [332, 335, "GENE"], [63, 66, "GENE"], [135, 138, "GENE"], [175, 178, "GENE"], [218, 221, "GENE"], [271, 274, "GENE"], [312, 315, "GENE"], [332, 335, "GENE"]]}], ["Comparison between ICU survivors and non-survivors was performed.", {"entities": []}], ["CRP-ratio from D1 to D7 decreased faster in survivors than in non-survivors (p = 0.01).", {"entities": []}], ["The ability of CRP-ratio by D5 to predict ICU outcome assessed by the area under the ROC curve was 0.73 (95% Confidence Interval, 0.64 - 0.82).", {"entities": []}], ["By D5, a CRP concentration above 0.5 of the initial level was a marker of poor outcome (sensitivity 0.81, specificity 0.58, positive likelihood ratio 1.93, negative likelihood ratio 0.33).", {"entities": [[9, 12, "GENE"]]}], ["The time-dependent analysis of CRP-ratio of the three patterns (fast response n = 66; slow response n = 81; nonresponse n = 44) was significantly different between groups (p < 0.001).", {"entities": []}], ["The ICU mortality rate was considerably different according to the patterns of CRP-ratio response: fast response 4.8%, slow response 17.3% and nonresponse 36.4% (p < 0.001).", {"entities": []}], ["In severe CAP, sequential evaluation of CRP-ratio was useful in the early identification of patients with poor outcome.", {"entities": []}], ["The evaluation of CRP-ratio pattern of response to antibiotics during the first week of therapy was useful in the recognition of the individual clinical evolution.", {"entities": []}], ["Tumor necrosis factor (TNF) and TNF receptor superfamily (TNFR)-mediated immune response play an essential role in the pathogenesis of severe sepsis.", {"entities": [[23, 26, "GENE"], [32, 35, "GENE"], [23, 26, "GENE"], [32, 35, "GENE"]]}], ["Studies examining associations of TNF and lymphotoxin-\u03b1 ( LTA ) single nucleotide polymorphisms (SNPs) with severe sepsis have produced conflicting results.", {"entities": [[34, 37, "GENE"], [58, 61, "GENE"]]}], ["The objective of this study was to investigate whether genetic variation in TNF , LTA , TNFRSF1A and TNFRSF1B was associated with susceptibility to or death from severe sepsis in Chinese Han population.", {"entities": [[76, 79, "GENE"], [82, 85, "GENE"], [88, 96, "GENE"], [101, 109, "GENE"]]}], ["Ten SNPs in TNF , LTA , TNFRSF1A and TNFRSF1B were genotyped in samples of patients with severe sepsis (n\u200a=\u200a432), sepsis (n\u200a=\u200a384) and healthy controls (n\u200a=\u200a624).", {"entities": [[12, 15, "GENE"], [18, 21, "GENE"], [24, 32, "GENE"], [37, 45, "GENE"]]}], ["Our results showed that rs1800629, a SNP in the promoter region of TNF , was significantly associated with risk for severe sepsis.", {"entities": [[67, 70, "GENE"]]}], ["The minor allele frequency of rs1800629 was significantly higher in severe sepsis patients than that in both healthy controls (P adj \u200a=\u200a0.00046, odds ratio (OR) adj \u200a=\u200a1.92) and sepsis patients (P adj \u200a=\u200a0.002, OR adj \u200a=\u200a1.56).", {"entities": []}], ["Further, we investigated the correlation between rs1800629 genotypes and TNF-\u03b1 concentrations in peripheral blood mononuclear cells (PBMCs) of healthy volunteers exposed to lipopolysaccharides (LPS) ex vivo , and the association between rs1800629 and TNF-\u03b1 serum levels in severe sepsis patients.", {"entities": []}], ["After exposure to LPS, the TNF-\u03b1 concentration in culture supernatants of PBMCs was significantly higher in the subjects with AA+AG genotypes than that with GG genotype (P\u200a=\u200a0.007).", {"entities": []}], ["Moreover, in patients with severe sepsis, individuals with AA+AG genotypes had significantly higher TNF-\u03b1 serum concentrations than those with GG genotype (P adj \u200a=\u200a0.02).", {"entities": []}], ["However, there were no significant associations between SNPs in the four candidate genes and 30 day mortality for patients with severe sepsis.", {"entities": []}], ["Our findings suggested that the functional TNF gene SNP rs1800629 was strongly associated with susceptibility to severe sepsis, but not with lethality in Chinese Han population.", {"entities": [[43, 46, "GENE"]]}], ["An in silico chemical genomics approach is developed to predict drug repositioning (DR) candidates for three types of cancer: glioblastoma, lung cancer, and breast cancer.", {"entities": [[126, 138, "DISEASE"], [140, 151, "DISEASE"], [157, 170, "DISEASE"], [118, 124, "DISEASE"], [145, 151, "DISEASE"], [164, 170, "DISEASE"]]}], ["It is based on a recent large-scale dataset of ~20,000 drug-induced expression profiles in multiple cancer cell lines, which provides i) a global impact of transcriptional perturbation of both known targets and unknown off-targets, and ii) rich information on drug\u2019s mode-of-action.", {"entities": [[100, 106, "DISEASE"]]}], ["First, the drug-induced expression profile is shown more effective than other information, such as the drug structure or known target, using multiple HTS datasets as unbiased benchmarks.", {"entities": []}], ["Particularly, the utility of our method was robustly demonstrated in identifying novel DR candidates.", {"entities": []}], ["Second, we predicted 14 high-scoring DR candidates solely based on expression signatures.", {"entities": []}], ["Eight of the fourteen drugs showed significant anti-proliferative activity against glioblastoma; i .", {"entities": [[83, 95, "DISEASE"]]}], ["e ., ivermectin, trifluridine, astemizole, amlodipine, maprotiline, apomorphine, mometasone, and nortriptyline.", {"entities": []}], ["Our DR score strongly correlated with that of cell-based experimental results; the top seven DR candidates were positive, corresponding to an approximately 20-fold enrichment compared with conventional HTS.", {"entities": []}], ["Despite diverse original indications and known targets, the perturbed pathways of active DR candidates show five distinct patterns that form tight clusters together with one or more known cancer drugs, suggesting common transcriptome-level mechanisms of anti-proliferative activity.", {"entities": [[188, 194, "DISEASE"]]}], ["Rhododendron species have been traditionally used in countries like China, Nepal, Russia and North America for treating human diseases.", {"entities": []}], ["These species are known to be a good source of polyphenolic plant secondary plant metabolites.", {"entities": []}], ["They are known to have beneficial health properties for humans and have been used to treat diseases like asthma, skin diseases.", {"entities": [[105, 111, "DISEASE"]]}], ["In this contribution we investigate the phenolic profile and antibacterial activity of extracts from several plant organs including for the first time from leaves of different development stages.", {"entities": []}], ["In this study, the polyphenolic profile of fruits, flowers and leaves of different ages of Rhododendron ambiguum and Rhododendron cinnabarinum were studied by using HPLC\u2013MS and compounds identified based on high resolution masses and identity of tandem mass spectra, UV/VIS spectra and retention times if compared to standards.", {"entities": []}], ["Fifty-nine different polyphenols including isomers were identified in these species by their fragmentation pattern and high resolution data.", {"entities": []}], ["Also, the antibacterial activity of these parts (leaves, fruits and flowers) against gram-positive bacteria was studied.", {"entities": []}], ["The leaves and fruits contained more polyphenols than the flowers.", {"entities": []}], ["With the exception of flowers, the fruits and leaves of both species were also determined to have a significant antibacterial effect against four gram-positive bacteria.", {"entities": []}], ["The online version of this article (doi:10.1186/s13104-017-2601-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The ferret cisplatin emesis model has been used for ~30\u00a0years and enabled identification of clinically used anti-emetics.", {"entities": []}], ["We provide an objective assessment of this model including efficacy of 5-HT 3 receptor antagonists to assess its translational validity.", {"entities": []}], ["A systematic review identified available evidence and was used to perform meta-analyses.", {"entities": []}], ["Of 182 potentially relevant publications, 115 reported cisplatin-induced emesis in ferrets and 68 were included in the analysis.", {"entities": []}], ["The majority ( n \u00a0=\u00a053) used a 10\u00a0mg\u00a0kg n \u00a0=\u00a011) also used 5\u00a0mg\u00a0kg 3 receptor antagonists reduced cisplatin (5\u00a0mg\u00a0kg P \u00a0<\u00a00.001), during the delayed phase (days 2, 3).", {"entities": []}], ["In an analysis focused on the acute phase, the efficacy of ondansetron was dependent on the dosage and observation period but not on the dose of cisplatin.", {"entities": []}], ["Our analysis enabled novel findings to be extracted from the literature including factors which may impact on the applicability of preclinical results to humans.", {"entities": []}], ["It reveals that the efficacy of ondansetron is similar against low and high doses of cisplatin.", {"entities": []}], ["Additionally, we showed that 5-HT 3 receptor antagonists have a similar efficacy during acute and delayed emesis, which provides a novel insight into the pharmacology of delayed emesis in the ferret.", {"entities": []}], ["Recent studies reported seasonal differences in gene expression in white blood cells, adipose tissue, and inflammatory biomarkers of the immune system.", {"entities": []}], ["There is no data on the seasonal variations of these biomarkers in the US general population of both children and adults.", {"entities": []}], ["Then aim of this study is to explore the seasonal trends in complete blood count (CBC), and C-reactive protein (CRP) in a large non-institutionalized US population.", {"entities": [[112, 115, "GENE"]]}], ["Seven cross-sectional data collected in the National Health and Nutrition Examination Survey (NHANES) during 1999\u20132012 were aggregated; participants reporting recent use of prescribed steroids, chemotherapy, immunomodulators and antibiotics were excluded.", {"entities": []}], ["Linear regression models were used to compare levels of CBC and CRP between winter-spring (November-April) and summer-fall (May-October), adjusting for demographics, personal behavioral factors, and chronic disease conditions.", {"entities": [[64, 67, "GENE"]]}], ["A total of 27,478 children and 36,644 adults (\u226518 years) were included in the study.", {"entities": []}], ["Levels of neutrophils, white blood cell count (WBC), and CRP were higher in winter-spring than summer-fall (p\u22640.05).", {"entities": [[57, 60, "GENE"]]}], ["Red blood cell components were lower in winter-spring than in summer-fall, while the opposite was seen for platelets.", {"entities": []}], ["This large population-based study found notable seasonal variations in blood cell composition and inflammatory biomarkers, with a more pro-inflammatory immune system seen in winter-spring than summer-fall.", {"entities": []}], ["The red blood cell patterns could have implications for the observed cardio-vascular seasonality.", {"entities": []}], ["A recent publication in this journal reported interesting changes in electroencephalographic (EEG) waves that occurred in 10 young, male volunteers following inhalation for one hour of elevated levels of diesel-engine exhaust fumes [ et al .", {"entities": []}], ["EEG findings to casual mechanisms about how ambient levels of DEE particulate might affect electrical signals in the brain, and subsequently to how DEE particulate might alter disease risk, are premature.", {"entities": []}], ["Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder.", {"entities": [[62, 78, "DISEASE"]]}], ["It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages.", {"entities": []}], ["In the general population, its incidence is approximately 1/40,000 to 1/60,000 births, rising to 1/800 in Ashkenazi Jews.", {"entities": []}], ["The main cause of the cytopenia, splenomegaly, hepatomegaly, and bone lesions associated with the disease is considered to be the infiltration of the bone marrow, spleen, and liver by Gaucher cells.", {"entities": []}], ["Type-1 Gaucher disease, which affects the majority of patients (90% in Europe and USA, but less in other regions), is characterized by effects on the viscera, whereas types 2 and 3 are also associated with neurological impairment, either severe in type 2 or variable in type 3.", {"entities": []}], ["A diagnosis of GD can be confirmed by demonstrating the deficiency of acid glucocerebrosidase activity in leukocytes.", {"entities": []}], ["Mutations in the GBA1 gene should be identified as they may be of prognostic value in some cases.", {"entities": []}], ["Patients with type-1 GD\u2014but also carriers of GBA1 mutation\u2014have been found to be predisposed to developing Parkinson\u2019s disease, and the risk of neoplasia associated with the disease is still subject to discussion.", {"entities": []}], ["Disease-specific treatment consists of intravenous enzyme replacement therapy (ERT) using one of the currently available molecules (imiglucerase, velaglucerase, or taliglucerase).", {"entities": []}], ["Orally administered inhibitors of glucosylceramide biosynthesis can also be used (miglustat or eliglustat).", {"entities": []}], ["It is now recognized that asthma can present in different forms.", {"entities": [[26, 32, "DISEASE"]]}], ["Typically, asthma present with symptoms of wheeze, breathlessness and cough.", {"entities": [[11, 17, "DISEASE"]]}], ["Atypical forms of asthma such as cough variant asthma (CVA) or chest tightness variant asthma (CTVA) do not wheeze.", {"entities": [[33, 53, "DISEASE"], [18, 24, "DISEASE"], [47, 53, "DISEASE"], [87, 93, "DISEASE"]]}], ["We hypothesize that these different forms of asthma may have distinctive cellular and molecular features.", {"entities": [[45, 51, "DISEASE"]]}], ["30 patients with typical or classical asthma (CA), 27 patients with CVA, 30 patients with CTVA, and 30 healthy control adults were enrolled in this prospective study.", {"entities": [[38, 44, "DISEASE"]]}], ["We measured serum IgE, lung function, sputum eosinophils, nitric oxide in exhaled breath (FeNO).", {"entities": []}], ["We performed proteomic analysis of induced-sputum supernatants by mass spectrometry.", {"entities": []}], ["There were no significant differences in atopy and FEV 1 among patients with CA, CVA, and CTVA.", {"entities": [[51, 54, "GENE"]]}], ["Serum IgE, sputum eosinophil percentages, FeNO, anxiety and depression scores were significantly increased in the three presentations of asthmatic patients as compared with healthy controls but there was no difference between the asthmatic groups.", {"entities": []}], ["Comprehensive mass spectrometric analysis revealed more than a thousand proteins in the sputum from patients with CA, CVA, and CTVA, among which 23 secreted proteins were higher in patients than that in controls.", {"entities": []}], ["Patients with CA, CVA, or CTVA share common clinical characteristics of eosinophilic airway inflammation.", {"entities": []}], ["And more importantly, their sputum samples were composed with common factors with minor distinctions.", {"entities": []}], ["These findings support the concept that these three different presentations of asthma have similar pathogenetic mechanism in terms of an enhanced Th2 associated with eosinophilia.", {"entities": [[166, 178, "DISEASE"], [79, 85, "DISEASE"]]}], ["In addition, this study identified a pool of novel biomarkers for diagnosis of asthma and to label its subtypes.", {"entities": [[79, 85, "DISEASE"]]}], ["Trial registration http://www.chictr.org.cn (ChiCTR-OOC-15006221) The online version of this article (doi:10.1186/s12967-017-1264-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Several studies conducted during the 1990s indicated that childhood allergic diseases were increasing worldwide, but more recent investigations in some Western countries have suggested that the trend is stabilizing or may even be reversing.", {"entities": []}], ["However, few data are available on the current status of allergic disease prevalence in Chinese children.", {"entities": []}], ["The aim of the present study was to investigate the prevalence rates of asthma, allergic rhinitis, and eczema in children of three major cities of China, to determine the status of allergic diseases among Chinese children generally, and to evaluate the prevalence of allergic diseases in children of different ages.", {"entities": [[80, 97, "DISEASE"], [89, 97, "DISEASE"], [72, 78, "DISEASE"]]}], ["We conducted a cross-sectional survey between October 2008 and May 2009 in three major cities of China (Beijing, Chongqing, and Guangzhou) to evaluate the prevalence rates of childhood allergic diseases including asthma, allergic rhinitis, and eczema, using a questionnaire of the International Study of Asthma and Allergies in Childhood (ISAAC) group.", {"entities": [[221, 238, "DISEASE"], [230, 238, "DISEASE"], [213, 219, "DISEASE"], [304, 310, "DISEASE"]]}], ["A total of 24,290 children aged 0-14 years were interviewed, using a multi-stage sampling method.", {"entities": []}], ["To acquire data on children aged 3-14 years, we visited schools and kindergartens.", {"entities": []}], ["To access children too young to attend school or kindergarten, we extended our survey to community health service centers.", {"entities": []}], ["Each questionnaire was completed by a parent or guardian of a child after an informed consent form was signed.", {"entities": []}], ["Of the 24,290 children in our study, 12,908 (53.14%) were males and 11,382 (46.86%) females; 10,372 (42.70%) were from Beijing, 9,846 (40.53%) from Chongqing, and 4,072 (16.77%) from Guangzhou.", {"entities": []}], ["Our survey indicated that in Beijing, Chongqing, and Guangzhou, the prevalence rates of asthma were 3.15%, 7.45%, and 2.09%, respectively; the rates of allergic rhinitis were 14.46%, 20.42%, and 7.83%; and the rates of eczema were 20.64%, 10.02%, and 7.22%.", {"entities": [[152, 169, "DISEASE"], [161, 169, "DISEASE"], [88, 94, "DISEASE"]]}], ["The prevalence of allergic diseases varied with age.", {"entities": []}], ["Asthma was relatively less common both in children aged under 2 years, and in those aged 9 years or more, in each of the three cities.", {"entities": [[0, 6, "DISEASE"]]}], ["The prevalence of allergic rhinitis was also lower in children younger than 2 years.", {"entities": [[18, 35, "DISEASE"], [27, 35, "DISEASE"]]}], ["The prevalence of eczema fell with age.", {"entities": []}], ["A marked increase in the prevalence rates of allergic diseases in China (compared with earlier data) was evident.", {"entities": []}], ["Further studies exploring the precise causes of this increase are warranted.", {"entities": []}], ["Increased mast cell numbers are observed at sites of allergic inflammation and restoration of normal mast cell numbers is critical to the resolution of these responses.", {"entities": []}], ["Early studies showed that cytokines protect mast cells from apoptosis, suggesting a simple model in which diminished cytokine levels during resolution leads to cell death.", {"entities": []}], ["The report that prostaglandins can contribute both to recruitment and to the resolution of inflammation together with the demonstration that mast cells express all four PGE 2 receptors raises the question of whether a single PGE 2 receptor mediates the ability of PGE 2 to regulate mast cell survival and apoptosis.", {"entities": []}], ["We report here that PGE 2 through the EP3 receptor promotes cell death of mast cells initiated by cytokine withdrawal.", {"entities": []}], ["Furthermore, the ability of PGE 2 to limit reconstitution of tissues with cultured mast cells is lost in cell lacking the EP3 receptor.", {"entities": []}], ["Apoptosis is accompanied by higher dissipation of mitochondrial potential (\u0394\u03a8 m ), increased caspase-3 activation, chromatin condensation, and low molecular weight DNA cleavage.", {"entities": []}], ["PGE 2 augmented cell death is dependent on an increase in intracellular calcium release, calmodulin dependent kinase II and MAPK activation.", {"entities": []}], ["Synergy between the EP3 pathway and the intrinsic mitochondrial apoptotic pathway results in increased Bim expression and higher sensitivity of mast cells to cytokine deprivation.", {"entities": []}], ["This supports a model in which PGE 2 can contribute to the resolution of inflammation in part by augmenting the removal of inflammatory cells in this case, mast cells.", {"entities": []}], ["Air filtration is frequently recommended as a component of environmental control measures for patients with allergic respiratory disease.", {"entities": []}], ["Residential air filtration can be provided by whole house filtration via the home\u2019s heating, ventilation, or air conditioning system, by portable room air cleaners, or a combination of the two.", {"entities": []}], ["Appliances to filter the sleep breathing zone also have been developed.", {"entities": []}], ["High-efficiency whole house filtration, high-efficiency particulate air sleep zone air filtration, and high-efficiency particulate air room air cleaners all appear to provide various degrees of benefit.", {"entities": []}], ["Recent studies of various types of filtration, used alone or as part of more comprehensive environmental control measures, are reviewed.", {"entities": []}], ["Laidlaw et al.", {"entities": []}], ["show that Ephrin-B1 is a specific marker of mature germinal center (GC) B cells.", {"entities": [[68, 70, "GENE"]]}], ["Use of Ephrin-B1 allows for the identification of phenotypically distinct GC B cell subsets, including a population that may represent memory precursor B cells.", {"entities": [[74, 76, "GENE"]]}], ["Identification of germinal center (GC) B cells is typically reliant on the use of surface activation markers that exhibit a wide range of expression.", {"entities": [[35, 37, "GENE"]]}], ["Here, we identify Ephrin-B1, a ligand for Eph-related receptor tyrosine kinases, as a specific marker of mature GC B cells.", {"entities": [[112, 114, "GENE"]]}], ["The number of Ephrin-B1 S1pr2 , and Aicda relative to their Ephrin-B1 S1pr2 and express markers associated with memory B cells, such as CD38 and EBI2.", {"entities": [[24, 29, "GENE"], [70, 75, "GENE"], [36, 41, "GENE"], [24, 29, "GENE"], [70, 75, "GENE"], [136, 140, "GENE"]]}], ["Transcriptional analysis indicates that these cells are developmentally related to memory B cells, and likely represent a population of GC memory precursor (PreMem) B cells.", {"entities": [[136, 138, "GENE"]]}], ["GC PreMem cells display enhanced survival relative to bulk GC B cells, localize near the edge of the GC, and are predominantly found within the light zone.", {"entities": [[0, 2, "GENE"], [59, 61, "GENE"], [101, 103, "GENE"], [0, 2, "GENE"], [59, 61, "GENE"], [101, 103, "GENE"], [0, 2, "GENE"], [59, 61, "GENE"], [101, 103, "GENE"]]}], ["These findings offer insight into the significant heterogeneity that exists within the GC B cell population and provide tools to further dissect signals regulating the differentiation of GC B cells.", {"entities": [[87, 89, "GENE"], [187, 189, "GENE"], [87, 89, "GENE"], [187, 189, "GENE"]]}], ["To determine the impact of supplemental zinc, vitamin A, and glutamine alone or in combination on growth, intestinal barrier function, stress and satiety-related hormones among Brazilian shantytown children with low median height-for-age z-scores.", {"entities": []}], ["A randomized, double-blind, placebo-controlled trial was conducted in children aged two months to nine years from the urban shanty compound community of Fortaleza, Brazil.", {"entities": []}], ["Demographic and anthropometric information was assessed.", {"entities": []}], ["The random treatment groups available for testing (a total of 120 children) were as follows: (1) glutamine alone, n\u200a=\u200a38; (2) glutamine plus vitamin A plus zinc, n\u200a=\u200a37; and a placebo (zinc plus vitamin A vehicle) plus glycine (isonitrogenous to glutamine) control treatment, n\u200a=\u200a38.", {"entities": []}], ["Leptin, adiponectin, insulin-like growth factor (IGF-1), and plasma levels of cortisol were measured with immune-enzymatic assays; urinary lactulose/mannitol and serum amino acids were measured with high-performance liquid chromatography.", {"entities": []}], ["ClinicalTrials.gov: NCT00133406.", {"entities": []}], ["Glutamine treatment significantly improved weight-for-height z-scores compared to the placebo-glycine control treatment.", {"entities": []}], ["Either glutamine alone or all nutrients combined prevented disruption of the intestinal barrier function, as measured by the percentage of lactulose urinary excretion and the lactulose:mannitol absorption ratio.", {"entities": []}], ["Plasma leptin was negatively correlated with plasma glutamine ( p \u200a=\u200a0.002) and arginine ( p \u200a=\u200a0.001) levels at baseline.", {"entities": []}], ["After glutamine treatment, leptin was correlated with weight-for-age (WAZ) and weight-for-height z-scores (WHZ) ( p \u22640.002) at a 4-month follow-up.", {"entities": []}], ["In addition, glutamine and all combined nutrients (glutamine, vitamin A, and zinc) improved the intestinal barrier function in these children.", {"entities": []}], ["Taken together, these findings reveal the benefits of glutamine alone or in combination with other gut-trophic nutrients in growing children via interactions with leptin.", {"entities": []}], ["Tracheal tumors are often misdiagnosed as asthma and are treated with inhaled steroids and bronchodilators without resolution.", {"entities": [[42, 48, "DISEASE"]]}], ["Here, a patient with tracheal adenoid cystic carcinoma who had been previously diagnosed with difficult asthma was reported.", {"entities": [[45, 54, "DISEASE"], [30, 54, "DISEASE"], [104, 110, "DISEASE"]]}], ["The possibility of the presence of localized airway obstruction was raised when the flow-volume curve suggesting fixed airway obstruction, was obtained.", {"entities": []}], ["The presenting case report emphasizes the fact that not all wheezes are asthma.", {"entities": [[72, 78, "DISEASE"]]}], ["It is critical to bear in mind that if a patient does not respond to appropriate anti-asthma therapy, localized obstructions should be ruled out before establishing the diagnosis of asthma.", {"entities": [[86, 92, "DISEASE"], [182, 188, "DISEASE"]]}], ["Impairment of lung function was reported to be associated with cardiovascular disease (CVD).", {"entities": []}], ["The aim of the present study is to evaluate the relationship between lung function and carotid intima-media thickness (cIMT) in participants without chronic pulmonary disease.", {"entities": []}], ["A total of 6,423 participants aged 40 years and above were recruited from Jiading District, Shanghai, China.", {"entities": []}], ["Lung function, evaluated by forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) was measured with standard spirometry.", {"entities": []}], ["CIMT was measured with high-resolution ultrasonography by trained physicians.", {"entities": []}], ["Mean values of FVC (% pred) and FEV1 (% pred) in participants with elevated cIMT were significantly lower than in those without (0.92\u00b10.20 vs. 0.99\u00b10.19, 0.83\u00b10.24 vs. 0.90\u00b10.22; both p-values < 0.0001).", {"entities": []}], ["The levels of cIMT in the lowest quartile of FVC (% pred) and FEV 1 (% pred) were markedly higher than in the second, third and fourth quartile, respectively (p < 0.0001 for all).", {"entities": [[62, 65, "GENE"]]}], ["The lowest quartile of FVC (% pred) and FEV1 (% pred) was associated with increased odds of elevated cIMT, with the fully adjusted odds ratio of 1.34 and 1.41 (95% confidence interval (CI) 1.09\u20131.65, p \u200a=\u200a 0.006, 95% CI 1.15\u20131.72, p \u200a=\u200a 0.0008), respectively.", {"entities": []}], ["Impaired lung function is associated with elevated cIMT in middle-aged and elderly Chinese.", {"entities": []}], ["These findings suggest the need to screen impairment of lung function in people without respiratory disease for the presence of subclinical atherosclerosis in CVD prevention.", {"entities": [[140, 155, "DISEASE"]]}], ["Invariant NKT (iNKT) cells can be activated to stimulate a broad inflammatory response.", {"entities": []}], ["In murine models of sickle cell disease (SCD), interruption of iNKT cell activity prevents tissue injury from vaso-occlusion.", {"entities": [[41, 44, "GENE"]]}], ["NKTT120 is an anti-iNKT cell monoclonal antibody that has the potential to rapidly and specifically deplete iNKT cells and, potentially, prevent vaso-occlusion.", {"entities": []}], ["We conducted an open-label, multi-center, single-ascending-dose study of NKTT120 to determine its pharmacokinetics, pharmacodynamics and safety in steady-state patients with SCD.", {"entities": [[174, 177, "GENE"]]}], ["Doses were escalated in a 3+3 study design over a range from 0.001 mg/kg to 1.0 mg/kg.", {"entities": []}], ["Twenty-one adults with SCD were administered NKTT120 as part of 7 dose cohorts.", {"entities": [[23, 26, "GENE"]]}], ["Plasma levels of NKTT120 predictably increased with higher doses.", {"entities": []}], ["Median half-life of NKTT120 was 263 hours.", {"entities": []}], ["All subjects in the higher dose cohorts (0.1 mg/kg, 0.3 mg/kg, and 1 mg/kg) demonstrated decreased iNKT cells below the lower limit of quantification within 6 hours after infusion, the earliest time point at which they were measured.", {"entities": []}], ["In those subjects who received the two highest doses of NKTT120 (0.3, 1 mg/kg), iNKT cells were not detectable in the peripheral blood for a range of 2 to 5 months.", {"entities": []}], ["There were no serious adverse events in the study deemed to be related to NKTT120.", {"entities": []}], ["In adults with SCD, NKTT120 produced rapid, specific and sustained iNKT cell depletion without any infusional toxicity or attributed serious adverse events.", {"entities": [[15, 18, "GENE"]]}], ["The next step is a trial to determine NKTT120\u2019s ability to decrease rate of vaso-occlusive pain episodes.", {"entities": []}], ["Trial Registration: clinicaltrials.gov NCT01783691 .", {"entities": []}], ["The ways in which humans affect and are affected by their environments have been studied from many different perspectives over the past decades.", {"entities": []}], ["However, it was not until the 1970s that the discussion of the ethical relationship between humankind and the environment formalized as an academic discipline with the emergence of environmental ethics.", {"entities": []}], ["A few decades later, environmental health emerged as a discipline focused on the assessment and regulation of environmental factors that affect living beings.", {"entities": []}], ["Our goal here is to begin a discussion specifically about the impact of modern environmental change on biomedical and social understandings of brain and mental health, and to align this with ethical considerations.", {"entities": []}], ["We refer to this focus as Environmental Neuroethics, offer a case study to illustrate key themes and issues, and conclude by offering a five-tier framework as a starting point of analysis.", {"entities": []}], ["With the trend of an increasing aged population worldwide, Alzheimer's disease (AD), an age-related neurodegenerative disorder, as one of the major causes of dementia in elderly people is of growing concern.", {"entities": [[158, 166, "DISEASE"]]}], ["Despite the many hard efforts attempted during the past several decades in trying to elucidate the pathological mechanisms underlying AD and putting forward potential therapeutic strategies, there is still a lack of effective treatments for AD.", {"entities": []}], ["The efficacy of many potential therapeutic drugs for AD is of main concern in clinical practice.", {"entities": []}], ["For example, large bodies of evidence show that the anti-tumor histone deacetylase (HDAC) inhibitor, suberoylanilidehydroxamic acid (SAHA), may be of benefit for the treatment of AD; however, its extensive inhibition of HDACs makes it a poor therapeutic.", {"entities": []}], ["Moreover, the natural flavonoid, curcumin, may also have a potential therapeutic benefit against AD; however, it is plagued by low bioavailability.", {"entities": []}], ["Therefore, the integrative effects of SAHA and curcumin were investigated as a protection against amyloid-beta neurotoxicity in vitro.", {"entities": []}], ["We hypothesized that at low doses their synergistic effect would improve therapeutic selectivity, based on experiments that showed that at low concentrations SAHA and curcumin could provide comprehensive protection against A\u03b2 25\u201335 -induced neuronal damage in PC12 cells, strongly implying potent synergism.", {"entities": []}], ["Furthermore, network analysis suggested that the possible mechanism underlying their synergistic action might be derived from restoration of the damaged functional link between Akt and the CBP/p300 pathway, which plays a crucial role in the pathological development of AD.", {"entities": []}], ["Thus, our findings provided a feasible avenue for the application of a synergistic drug combination, SAHA and curcumin, in the treatment of AD.", {"entities": []}], ["Calmodulin (CaM) phosphorylated at different serine/threonine and tyrosine residues is known to exert differential regulatory effects on a variety of CaM-binding enzymes as compared to non-phosphorylated CaM.", {"entities": []}], ["In this report we describe the preparation and characterization of a series of phospho-(Y)-mimetic CaM mutants in which either one or the two tyrosine residues present in CaM (Y99 and Y138) were substituted to aspartic acid or glutamic acid.", {"entities": []}], ["It was expected that the negative charge of the respective carboxyl group of these amino acids mimics the negative charge of phosphate and reproduce the effects that distinct phospho-(Y)-CaM species may have on target proteins.", {"entities": []}], ["We describe some physicochemical properties of these CaM mutants as compared to wild type CaM, after their expression in Escherichia coli and purification to homogeneity, including: i) changes in their electrophoretic mobility in the absence and presence of Ca in vitro .", {"entities": []}], ["Integrins are a large family of transmembrane heterodimeric proteins that constitute the main receptors for extracellular matrix components.", {"entities": []}], ["Integrins were initially thought to be primarily involved in the maintenance of cell adhesion and tissue integrity.", {"entities": []}], ["However, it is now appreciated that integrins play important roles in many other biological processes such as cell survival, proliferation, differentiation, migration, cell shape and polarity.", {"entities": []}], ["Lung cells express numerous combinations and permutations of integrin heterodimers.", {"entities": []}], ["The complexity and diversity of different integrin heterodimers being implicated in different lung diseases present a major challenge for drug development.", {"entities": []}], ["Here we provide a comprehensive overview of the current knowledge of integrins from studies in cell culture to integrin knockout mouse models and provide an update of results from clinical trials for which integrins are therapeutic targets with a focus on respiratory diseases (asthma, emphysema, pneumonia, lung cancer, pulmonary fibrosis and sarcoidosis).", {"entities": [[308, 319, "DISEASE"], [297, 306, "DISEASE"], [344, 355, "DISEASE"], [321, 339, "DISEASE"], [278, 284, "DISEASE"], [313, 319, "DISEASE"]]}], ["Human induced pluripotent stem cells (iPSCs) possess remarkable self-renewal capacity and the potential to differentiate into novel cell types, such as mesenchymal stem cells (MSCs).", {"entities": []}], ["iPSC-MSCs have been shown to enhance tissue regeneration and attenuate tissue ischaemia; however, their contribution to the immune regulation of Th2-skewed allergic rhinitis (AR) and asthma remains unclear.", {"entities": [[156, 173, "DISEASE"], [165, 173, "DISEASE"], [183, 189, "DISEASE"]]}], ["This study compared the immunomodulatory effects of iPSC-MSCs and bone marrow-derived MSCs (BM-MSCs) on lymphocyte proliferation, T-cell phenotypes and cytokine production in peripheral blood mononuclear cells (PBMCs) in patients with AR, and investigated the possible molecular mechanisms underlying the immunomodulatory properties of iPSC-MSCs.", {"entities": []}], ["In co-cultures of PBMCs with iPSC-MSCs or BM-MSCs, lymphocyte proliferation was evaluated using 3H-thymidine (3H-TdR) uptake, carboxyfluorescein diacetate, succinimidyl ester (CFDA-SE) assays; the regulatory T-cell (Treg) phenotype was determined by flow cytometry, and cytokine levels were measured using an enzyme-linked immunosorbent assay.", {"entities": []}], ["The immunomodulatory properties of both MSCs were further evaluated using NS398 and transwell experiments.", {"entities": []}], ["Similar to BM-MSCs, we determined that iPSC-MSCs significantly inhibit lymphocyte proliferation and promote Treg response in PBMCs ( P < 0.05).", {"entities": []}], ["Accordingly, the cytokine milieu (IFN-\u03b3, IL-4, IL-5, IL-10 and IL-13) in the supernatants of PBMCs changed significantly ( P < 0.05).", {"entities": []}], ["The immunomodulatory properties of iPSC-MSCs and BM-MSCs were associated with prostaglandin E2 (PGE2) production and cell\u2013cell contact.", {"entities": []}], ["These data demonstrate that iPSC-MSCs are capable of modulating T-cell phenotypes towards Th2 suppression through inducing Treg expansion, suggesting that iPSC-MSCs can be used as an alternative candidate to adult MSCs to treat allergic airway diseases.", {"entities": []}], ["Objective An individual\u2019s birth month has a significant impact on the diseases they develop during their lifetime.", {"entities": []}], ["Previous studies reveal relationships between birth month and several diseases including atherothrombosis, asthma, attention deficit hyperactivity disorder, and myopia, leaving most diseases completely unexplored.", {"entities": [[161, 167, "DISEASE"], [115, 155, "DISEASE"], [107, 113, "DISEASE"]]}], ["This retrospective population study systematically explores the relationship between seasonal affects at birth and lifetime disease risk for 1688 conditions.", {"entities": []}], ["Methods We developed a hypothesis-free method that minimizes publication and disease selection biases by systematically investigating disease-birth month patterns across all conditions.", {"entities": []}], ["Our dataset includes 1 749 400 individuals with records at New York-Presbyterian/Columbia University Medical Center born between 1900 and 2000 inclusive.", {"entities": []}], ["We modeled associations between birth month and 1688 diseases using logistic regression.", {"entities": []}], ["Significance was tested using a chi-squared test with multiplicity correction.", {"entities": []}], ["Results We found 55 diseases that were significantly dependent on birth month.", {"entities": []}], ["Of these 19 were previously reported in the literature ( P \u2009<\u2009.001), 20 were for conditions with close relationships to those reported, and 16 were previously unreported.", {"entities": []}], ["We found distinct incidence patterns across disease categories.", {"entities": []}], ["Conclusions Lifetime disease risk is affected by birth month.", {"entities": []}], ["Seasonally dependent early developmental mechanisms may play a role in increasing lifetime risk of disease.", {"entities": []}], ["The effect of indoor nitrogen dioxide concentrations on asthma morbidity among inner-city preschool children is uncertain.", {"entities": [[56, 62, "DISEASE"]]}], ["Our goal was to estimate the effect of indoor NO 2 concentrations on asthma morbidity in an inner-city population while adjusting for other indoor pollutants.", {"entities": [[69, 75, "DISEASE"]]}], ["We recruited 150 children (2\u20136 years of age) with physician-diagnosed asthma from inner-city Baltimore, Maryland.", {"entities": [[70, 76, "DISEASE"]]}], ["Indoor air was monitored over a 72-hr period in the children\u2019s bedrooms at baseline and 3 and 6 months.", {"entities": []}], ["At each visit, the child\u2019s caregiver completed a questionnaire assessing asthma symptoms over the previous 2 weeks and recent health care utilization.", {"entities": [[73, 79, "DISEASE"]]}], ["Children were 58% male, 91% African American, and 42% from households with annual income < $25,000; 63% had persistent asthma symptoms.", {"entities": [[119, 125, "DISEASE"]]}], ["The mean (\u00b1 SD) in-home NO 2 concentration was 30.0 \u00b1 33.7 (range, 2.9\u2013394.0) ppb.", {"entities": []}], ["The presence of a gas stove and the use of a space heater or oven/stove for heat were independently associated with higher NO 2 concentrations.", {"entities": []}], ["Each 20-ppb increase in NO 2 exposure was associated significantly with an increase in the number of days with limited speech [incidence rate ratio (IRR) = 1.15; 95% confidence interval (CI), 1.05\u20131.25], cough (IRR = 1.10; 95% CI, 1.02\u20131.18), and nocturnal symptoms (IRR = 1.09; 95% CI, 1.02\u20131.16), after adjustment for potential confounders.", {"entities": []}], ["NO 2 concentrations were not associated with increased health care utilization.", {"entities": []}], ["Higher indoor NO 2 concentrations were associated with increased asthma symptoms in preschool inner-city children.", {"entities": [[65, 71, "DISEASE"]]}], ["Interventions aimed at lowering NO 2 concentrations in inner-city homes may reduce asthma morbidity in this vulnerable population.", {"entities": [[83, 89, "DISEASE"]]}], ["To assess the quantity and quality of randomised, sham-controlled studies of surgery and invasive procedures and estimate the treatment-specific and non-specific effects of those procedures.", {"entities": []}], ["Systematic review and meta-analysis.", {"entities": []}], ["We searched PubMed, EMBASE, CINAHL, CENTRAL (Cochrane Library), PILOTS, PsycInfo, DoD Biomedical Research, clinicaltrials.gov, NLM catalog and NIH Grantee Publications Database from their inception through January 2015.", {"entities": []}], ["We included randomised controlled trials of surgery and invasive procedures that penetrated the skin or an orifice and had a parallel sham procedure for comparison.", {"entities": []}], ["Three authors independently extracted data and assessed risk of bias.", {"entities": []}], ["Studies reporting continuous outcomes were pooled and the standardised mean difference (SMD) with 95% CIs was calculated using a random effects model for difference between true and sham groups.", {"entities": []}], ["55 studies (3574 patients) were identified meeting inclusion criteria; 39 provided sufficient data for inclusion in the main analysis (2902 patients).", {"entities": []}], ["The overall SMD of the continuous primary outcome between treatment/sham-control groups was 0.34 (95% CI 0.20 to 0.49; p<0.00001; I The non-specific effects of surgery and other invasive procedures are generally large.", {"entities": []}], ["Particularly in the field of pain-related conditions, more evidence from randomised placebo-controlled trials is needed to avoid continuation of ineffective treatments.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is hallmarked by inflammatory processes and a progressive decline of lung function.", {"entities": []}], ["YKL-40 is a potential biomarker of inflammation and mortality in patients suffering from inflammatory lung disease, but its prognostic value in patients with COPD remains unknown.", {"entities": [[102, 114, "DISEASE"]]}], ["We investigated whether high plasma YKL-40 was associated with increased mortality in patients with moderate to very severe COPD.", {"entities": []}], ["Four hundred and ninety-three patients with moderate to very severe COPD were followed prospectively for up to 10\u00a0years.", {"entities": []}], ["Patients were divided into two groups according to plasma YKL-40: concentration higher than the 75 Median plasma YKL-40 was increased in patients with COPD (81\u00a0ng/ml, p\u2009<\u20090.001) compared to healthy subjects (40\u00a0ng/ml).", {"entities": []}], ["Patients with high plasma YKL-40 had a hazard ratio (HR) of 1.42 (95% CI: 1.15\u20131.75, p\u2009=\u20090.001) for all-cause mortality.", {"entities": [[53, 55, "GENE"]]}], ["Multivariate analysis showed that YKL-40 (HR 1.38; 95% CI: 1.11\u20131.72, p\u2009=\u20090.004), age (HR 1.05; 95% CI: 1.03\u20131.06, p\u2009<\u20090.0001), Severe COPD (HR 1.35; 95 CI: 1.03-1.76, p\u2009=\u20090.03) very severe COPD (HR 2.19; 95% CI: 1.60 - 2.99\u2009<\u20090.0001), neutrophil granulocyte count (HR 1.05; 95% CI: 1.01-1.08, p\u2009=\u20090.01), and a smoking history of\u2009>\u200940\u00a0years (HR 1.38; 95% CI: 1.11-1.71, p\u2009=\u20090.003) were independent prognostic markers of OS.", {"entities": [[42, 44, "GENE"], [87, 89, "GENE"], [141, 143, "GENE"], [196, 198, "GENE"], [266, 268, "GENE"], [342, 344, "GENE"], [42, 44, "GENE"], [87, 89, "GENE"], [141, 143, "GENE"], [196, 198, "GENE"], [266, 268, "GENE"], [342, 344, "GENE"], [42, 44, "GENE"], [87, 89, "GENE"], [141, 143, "GENE"], [196, 198, "GENE"], [266, 268, "GENE"], [342, 344, "GENE"], [42, 44, "GENE"], [87, 89, "GENE"], [141, 143, "GENE"], [196, 198, "GENE"], [266, 268, "GENE"], [342, 344, "GENE"], [42, 44, "GENE"], [87, 89, "GENE"], [141, 143, "GENE"], [196, 198, "GENE"], [266, 268, "GENE"], [342, 344, "GENE"], [42, 44, "GENE"], [87, 89, "GENE"], [141, 143, "GENE"], [196, 198, "GENE"], [266, 268, "GENE"], [342, 344, "GENE"]]}], ["High plasmaYKL-40 is associated with increased mortality in patients with moderate to very severe COPD, suggesting a role for YKL-40 as a potential biomarker of mortality in this patient group.", {"entities": []}], ["ClinicalTrials.gov: NCT00132860 .", {"entities": []}], ["Objective \u00a0To determine whether feeding infants with hydrolysed formula reduces their risk of allergic or autoimmune disease.", {"entities": []}], ["Design \u00a0Systematic review and meta-analysis, as part of a series of systematic reviews commissioned by the UK Food Standards Agency to inform guidelines on infant feeding.", {"entities": []}], ["Two authors selected studies by consensus, independently extracted data, and assessed the quality of included studies using the Cochrane risk of bias tool.", {"entities": []}], ["Data sources \u00a0Medline, Embase, Web of Science, CENTRAL, and LILACS searched between January 1946 and April 2015.", {"entities": []}], ["Eligibility criteria for selecting studies \u00a0Prospective intervention trials of hydrolysed cows\u2019 milk formula compared with another hydrolysed formula, human breast milk, or a standard cows\u2019 milk formula, which reported on allergic or autoimmune disease or allergic sensitisation.", {"entities": []}], ["Results \u00a037 eligible intervention trials of hydrolysed formula were identified, including over 19 000 participants.", {"entities": []}], ["There was evidence of conflict of interest and high or unclear risk of bias in most studies of allergic outcomes and evidence of publication bias for studies of eczema and wheeze.", {"entities": []}], ["Overall there was no consistent evidence that partially or extensively hydrolysed formulas reduce risk of allergic or autoimmune outcomes in infants at high pre-existing risk of these outcomes.", {"entities": []}], ["Odds ratios for eczema at age 0-4, compared with standard cows\u2019 milk formula, were 0.84 (95% confidence interval 0.67 to 1.07; I Conclusion \u00a0These findings do not support current guidelines that recommend the use of hydrolysed formula to prevent allergic disease in high risk infants.", {"entities": []}], ["Review registration \u00a0PROSPERO CRD42013004252.", {"entities": []}], ["Socioeconomic status (SES) is a well-established risk factor for many health outcomes.", {"entities": []}], ["Recently, we developed an SES measure based on 4 housing-related characteristics (termed HOUSES) and demonstrated its ability to assess health disparities.", {"entities": []}], ["In this study, we aimed to evaluate whether fewer housing-related characteristics could be used to provide a similar representation of SES.", {"entities": []}], ["We performed a cross-sectional study using parents/guardians of children aged 1\u201317\u2005years from 2 US Midwestern counties (n=728 in Olmsted County, Minnesota, and n=701 in Jackson County, Missouri).", {"entities": []}], ["For each participant, housing-related characteristics used in the formulation of HOUSES (assessed housing value, square footage, number of bedrooms and number of bathrooms) were obtained from the local government assessor's offices, and additional SES measures and health outcomes with known associations to SES (obesity, low birth weight and smoking exposure) were collected from a telephone survey.", {"entities": [[313, 320, "DISEASE"]]}], ["Housing characteristics with the greatest contribution for predicting the health outcomes were added to formulate a modified HOUSES index.", {"entities": []}], ["Among the 4 housing characteristics used in the original HOUSES, the strongest contributions for predicting health outcomes were observed from assessed housing value and square footage (combined contribution ranged between 89% and 96%).", {"entities": []}], ["Based on this observation, these 2 were used to calculate a modified HOUSES index.", {"entities": []}], ["Correlation between modified HOUSES and other SES measures was comparable to the original HOUSES for both locations.", {"entities": []}], ["Consistent with the original HOUSES formula, the strongest association with modified HOUSES was observed with smoking exposure (OR=0.24 with 95% CI 0.11 to 0.49 for comparing participants in highest HOUSES vs lowest group; overall p<0.001).", {"entities": []}], ["The modified HOUSES requires only 2 readily available housing characteristics thereby improving the feasibility of using this index as a proxy for SES in multiple communities, especially in the US Midwestern region.", {"entities": []}], ["Psychological ownership is rarely considered in health discourse related to chronic illness or disease state.", {"entities": []}], ["Construction of identity is an important consideration within this framework.", {"entities": []}], ["This autoethnographic study explores psychological ownership and identity related to prostate cancer and chronic illness.", {"entities": [[94, 100, "DISEASE"], [85, 100, "DISEASE"]]}], ["Conclusions about the nature of psychological ownership and identity were gathered from the relevant literature and personal experience.", {"entities": []}], ["Themes include the patient\u2013healthcare professional relationship and that psychological ownership is personal and grounded in an individual's sense of identity, control and perceived capacity to control illness or disease.", {"entities": []}], ["Personal reflection through autoethnography guides discussion of psychological ownership and identity.", {"entities": []}], ["The purpose of this study was to determine the impact of sex and race/ethnicity on metabolic risk and health behaviors in minority youth.", {"entities": []}], ["A total of 173 seventh graders (46% male and 54% female; 49% Hispanic and 51% African American) with BMI \u226585th percentile and a family history of diabetes were assessed with weight, height, BMI, percent body fat, and waist circumference measures.", {"entities": []}], ["Laboratory indexes included 2-h oral glucose tolerance tests with insulin levels at 0 and 2 h, fasting A1C, and lipids.", {"entities": []}], ["Insulin resistance was estimated by homeostasis model assessment (HOMA-IR).", {"entities": []}], ["Youth also completed questionnaires evaluating health behaviors.", {"entities": []}], ["Average BMI (31.6 \u00b1 6.4 kg/m Screening high-risk youth for insulin resistance and lipid abnormalities is recommended.", {"entities": []}], ["Promoting acceptable physical activities and healthy food choices may be especially important for Hispanic and female youth.", {"entities": []}], ["Baylisascaris procyonis , a roundworm infection of raccoons, is emerging as an important helminthic zoonosis, principally affecting young children.", {"entities": []}], ["Raccoons have increasingly become peridomestic animals living in close proximity to human residences.", {"entities": []}], ["When B. procyonis eggs are ingested by a host other than a raccoon, migration of larvae through tissue, termed larval migrans, ensues.", {"entities": []}], ["This larval infection can invade the brain and eye, causing severe disease and death.", {"entities": []}], ["The prevalence of B .", {"entities": []}], ["procyonis infection in raccoons is often high, and infected animals can shed enormous numbers of eggs in their feces.", {"entities": []}], ["These eggs can survive in the environment for extended periods of time, and the infectious dose of B. procyonis is relatively low.", {"entities": []}], ["Therefore, the risk for human exposure and infection may be greater than is currently recognized.", {"entities": []}], ["Invasive pulmonary aspergillosis (IPA) is a life-threatening lung disease of hematological malignancy or bone marrow transplant patients caused by the ubiquitous environmental fungus Aspergillus fumigatus .", {"entities": [[19, 32, "DISEASE"], [61, 73, "DISEASE"]]}], ["Current diagnostic tests for the disease lack sensitivity as well as specificity, and culture of the fungus from invasive lung biopsy, considered the gold standard for IPA detection, is slow and often not possible in critically ill patients.", {"entities": []}], ["In a previous study, we reported the development of a novel non-invasive procedure for IPA diagnosis based on antibody-guided positron emission tomography and magnetic resonance imaging (immunoPET/MRI) using a [ Aspergillus .", {"entities": []}], ["To enable translation of the tracer to the clinical setting, we report here the development of a humanised version of the antibody (hJF5), and pre-clinical imaging of lung infection using a [ in vivo biodistribution in A. fumigatus infected lungs compared to its radiolabeled murine counterpart [ f ) present in a diagnostic mannoprotein antigen released by the pathogen during invasive growth in the lung.", {"entities": []}], ["The absence of the epitope Gal f in mammalian carbohydrates, coupled with the enhanced imaging capabilities of the hJF5 antibody, means that the [", {"entities": []}], ["Breast milk is a natural food and important component of infant nutrition.", {"entities": []}], ["Apart from the alimentary substances, breast milk contains many important bioactive compounds, including endogenous microRNA molecules (miRNAs).", {"entities": []}], ["These regulatory molecules were identified in various mammalian biological fluids and were shown to be mostly packed in exosomes.", {"entities": []}], ["Recently, it was revealed that plant food-derived miRNAs are stably present in human blood and regulate the expression of specific human genes.", {"entities": []}], ["Since then, the scientific community has focused its efforts on contradicting or confirming this discovery.", {"entities": []}], ["With the same intention, qRT-PCR experiments were performed to evaluate the presence of five plant food-derived miRNAs (miR166a, miR156a, miR157a, miR172a and miR168a) in breast milk (whole milk and exosomes) from healthy volunteers.", {"entities": []}], ["In whole milk samples, all examined miRNAs were identified, while only two of these miRNAs were confirmed to be present in exosomes.", {"entities": []}], ["The plant miRNA concentration in the samples ranged from 4 to 700 fM.", {"entities": []}], ["Complementary bioinformatics analysis suggests that the evaluated plant miRNAs may potentially influence several crucial biological pathways in the infant organism.", {"entities": []}], ["Technical quality (TQ) in health care refers to clinical or disease-specific aspects of care and largely reflecting issues related to health care providers.", {"entities": []}], ["In relation to TQ Global Initiative of National Asthma (GINA) introduce guidelines for the Management of Asthma and define a minimal standard of care that can be used to assess health care quality for patients with asthma.", {"entities": [[48, 54, "DISEASE"], [105, 111, "DISEASE"], [215, 221, "DISEASE"]]}], ["This study aimed to assess technical quality for people with asthma from the patients' perspective.", {"entities": [[61, 67, "DISEASE"]]}], ["A cross-sectional study was conducted with 180 people with asthma who were received care from specialist clinics of Tabriz University of medical sciences in 2013.", {"entities": [[59, 65, "DISEASE"]]}], ["Technical Quality was measured using questionnaire.", {"entities": []}], ["The questionnaire set based on issued guidelines internationally which considered as proxy measure of technical quality.", {"entities": []}], ["Validity of the study questionnaire was reviewed by 11 experts and its reliability was confirmed according to Cronbach's alpha index (\u03b1=0.86), based on a pilot study by participate of 30 patients.", {"entities": []}], ["Data analyzed using the SPSS-17 statistical package.", {"entities": []}], ["Technical Quality score for people with asthma from the patient perspective had the range between 0% and 77%.", {"entities": [[40, 46, "DISEASE"]]}], ["The lowest scores were for the items: Asthma Control Test, written asthma action plan, measuring peak expiratory flow and assessing patient's self-care program.", {"entities": [[38, 44, "DISEASE"], [67, 73, "DISEASE"]]}], ["The highest scores belonged to visit by specialist and education about quit smoking.", {"entities": []}], ["Asthma control status had significant relationship with continuity of care (patients who receives continuous care, expressed better asthma status) (P=0.012) and patients with complications reported higher TQ score than who haven't complications (P<0.001).", {"entities": [[0, 6, "DISEASE"], [132, 138, "DISEASE"]]}], ["According to study findings, overall technical quality for people with asthma from the patient perspective was relatively low.", {"entities": [[71, 77, "DISEASE"]]}], ["The largest gap in medical care, related to self-care program and management standards, suggests that new systems and new ways of improving such aspects of care need to be considered.", {"entities": []}], ["The importance of multidisciplinary care for asthma and active engagement of the patient in their asthma management have been repeatedly emphasized.", {"entities": [[45, 51, "DISEASE"], [98, 104, "DISEASE"]]}], ["Potential changes include wider measurement of asthma Control and peak expiratory flow, having specific written asthma action plan, clinician and patient incentives to increase the relevant activities and a patient reminder system.", {"entities": [[47, 53, "DISEASE"], [112, 118, "DISEASE"]]}], ["Allergic rhinitis (AR) is a complex disorder with a polygenic, multifactorial aetiology.", {"entities": [[9, 17, "DISEASE"]]}], ["Twin studies have found the genetic contribution to be substantial.", {"entities": []}], ["We collected and clinically characterised a sample consisting of 127 Danish nuclear families with at least two siblings suffering from AR or allergic conjunctivitis including 540 individuals (286 children and 254 parents).", {"entities": [[141, 164, "DISEASE"], [150, 164, "DISEASE"]]}], ["A whole-genome linkage scan, using 424 microsatellite markers, was performed on both this sample and an earlier collected sample consisting of 130 families with atopic dermatitis and other atopic disorders.", {"entities": [[161, 178, "DISEASE"], [168, 178, "DISEASE"]]}], ["A third sib-pair family sample, which was previously collected and genotyped, was added to the analysis increasing the total sample size to 357 families consisting of 1508 individuals.", {"entities": []}], ["In total, 190 families with AR was included.", {"entities": []}], ["The linkage analysis software Genehunter NPL, Genehunter MOD, and Genehunter Imprinting were used to obtain nonparametric and parametric linkage results.", {"entities": [[41, 44, "GENE"]]}], ["Family-based association analysis of positional candidate SNPs was carried out using the FBAT program.", {"entities": []}], ["We obtained genome-wide significant linkage to a novel AR locus at 1p13 and suggestive linkage to two novel regions at 1q31-q32 and 20p12, respectively.", {"entities": []}], ["Family-based association analysis of SNPs in the candidate locus DNND1B/CRB1 at 1q31 showed no significant association and could not explain the linkage signal observed.", {"entities": []}], ["Suggestive evidence of linkage was also obtained at three AR loci previously reported (2q14-q23, 2q23, and 12p13) and indication of linkage was observed at a number of additional loci.", {"entities": []}], ["Likely maternal imprinting was observed at 2q23, and possible maternal imprinting at 3q28.", {"entities": []}], ["Background: Flavonoids exert anti-inflammatory properties and modulate oxidative stress in vitro, suggesting a protective effect on lung function, but epidemiological studies examining this association are scarce.", {"entities": []}], ["Methods: A stratified random sample was drawn from the GA 1 ) and FVC (FEV 1 /FVC), FVC below lower limit of normal (FVC < LLN), and FEV 1 /FVC < LLN were calculated.", {"entities": [[71, 74, "GENE"], [133, 136, "GENE"], [71, 74, "GENE"], [133, 136, "GENE"]]}], ["Intake of the six main subclasses of flavonoids was estimated using the GA 1 /FVC was associated with higher intakes of total flavonoids and pro-anthocyanidins (adjusted correlation coefficient (a \u03b2-coeff 0.33; 0.10, 0.57 and a \u03b2-coeff 0.44; 95% CI 0.19, 0.69, respectively).", {"entities": []}], ["After Simes\u2019 procedure, the statistical significance of each of these associations was attenuated but remained below 0.05, with the exception of total flavonoids and airway restriction.", {"entities": []}], ["Conclusions: This population-based study in European adults provides cross-sectional evidence of a positive association of total flavonoid intake and pro-anthocyanidins and ventilatory function, and a negative association with spirometric restriction in European adults.", {"entities": []}], ["Human rhinoviruses (HRV) are a major cause of exacerbations of airways disease.", {"entities": []}], ["Aspects of cell signalling responses to HRV infection remain unclear, particularly with regard to signalling via PI3K, and the PI3K-dependent pathway, autophagy.", {"entities": []}], ["We investigated the roles of PI3K and autophagy in the responses of epithelial cells to major and minor group HRV infection.", {"entities": []}], ["The PI3K inhibitor 3-MA, commonly used to inhibit autophagy, markedly reduced HRV-induced cytokine induction.", {"entities": []}], ["Further investigation of potential targets of 3-MA and comparison of results using this inhibitor to a panel of general and class I-selective PI3K inhibitors showed that several PI3Ks cooperatively regulate responses to HRV.", {"entities": []}], ["Targeting by siRNA of the autophagy proteins Beclin-1, Atg7, LC3, alone or in combination, or targeting of the autophagy-specific class III PI3K had at most only modest effects on HRV-induced cell signalling as judged by induction of proinflammatory cytokine production.", {"entities": [[55, 59, "GENE"]]}], ["Our data indicate that PI3K and mTOR are involved in induction of proinflammatory cytokines after HRV infection, and that autophagy has little role in the cytokine response to HRV or control of HRV replication.", {"entities": [[32, 36, "GENE"]]}], ["Graft rejection in transplant patients is managed clinically by suppressing T-cell function with immunosuppressive drugs such as prednisolone and methylprednisolone.", {"entities": []}], ["In such immunocompromised hosts, human cytomegalovirus (HCMV) is an important opportunistic pathogen and can cause severe morbidity and mortality.", {"entities": []}], ["Currently, the effect of glucocorticosteroids (GCSs) on the HCMV life cycle remains unclear.", {"entities": []}], ["Previous reports showed enhanced lytic replication of HCMV in vitro in the presence of GCSs.", {"entities": []}], ["In the present study, we explored the implications of steroid exposure on latency and reactivation.", {"entities": []}], ["We observed a direct effect of several GCSs used in the clinic on the activation of a quiescent viral major immediate-early promoter in stably transfected THP-1 monocytic cells.", {"entities": []}], ["This activation was prevented by the glucocorticoid receptor (GR) antagonist Ru486 and by shRNA-mediated knockdown of the GR.", {"entities": []}], ["Consistent with this observation, prednisolone treatment of latently infected primary monocytes resulted in HCMV reactivation.", {"entities": []}], ["Analysis of the phenotype of these cells showed that treatment with GCSs was correlated with differentiation to an anti-inflammatory macrophage-like cell type.", {"entities": []}], ["On the basis that these observations may be pertinent to HCMV reactivation in post-transplant settings, we retrospectively evaluated the incidence, viral kinetics and viral load of HCMV in liver transplant patients in the presence or absence of GCS treatment.", {"entities": []}], ["We observed that combination therapy of baseline prednisolone and augmented methylprednisolone, upon organ rejection, significantly increased the incidence of HCMV infection in the intermediate risk group where donor and recipient are both HCMV seropositive (D+R+) to levels comparable with the high risk D+R\u2212 group.", {"entities": []}], ["Epithelial tubes are the functional units of many organs, and proper tube geometry is crucial for organ function.", {"entities": []}], ["Here, we characterize serrano ( sano ), a novel cytoplasmic protein that is apically enriched in several tube-forming epithelia in Drosophila , including the tracheal system.", {"entities": []}], ["Loss of sano results in elongated tracheae, whereas Sano overexpression causes shortened tracheae with reduced apical boundaries.", {"entities": []}], ["Sano overexpression during larval and pupal stages causes planar cell polarity (PCP) defects in several adult tissues.", {"entities": []}], ["In Sano-overexpressing pupal wing cells, core PCP proteins are mislocalized and prehairs are misoriented; sano loss or overexpression in the eye disrupts ommatidial polarity and rotation.", {"entities": []}], ["Importantly, Sano binds the PCP regulator Dishevelled (Dsh), and loss or ectopic expression of many known PCP proteins in the trachea gives rise to similar defects observed with loss or gain of sano , revealing a previously unrecognized role for PCP pathway components in tube size control.", {"entities": []}], ["Tubular organ formation is a ubiquitous process required to sustain life in multicellular organisms.", {"entities": []}], ["In this study, we focused on the tracheal system of the fruit fly, Drosophila melanogaster , and identified Serrano (Sano) as a novel protein expressed in several embryonic tubular organs, including trachea.", {"entities": []}], ["sano loss results in over-elongated trachea, whereas Sano overexpression causes shortened trachea, suggesting that sano is required for proper tracheal tube length.", {"entities": []}], ["Interestingly, Sano overexpression results in typical planar cell polarity (PCP) defects in many adult tissues and pupal wing cells.", {"entities": []}], ["The PCP pathway is highly conserved from flies to mammals and it has been known to control cell polarity within the plane of epithelial tissues.", {"entities": []}], ["Importantly, we found that Sano binds Dishevelled (Dsh), a key PCP regulator, and loss or ectopic expression of many known PCP proteins in the trachea give rise to similar defects observed with loss or gain of sano , suggesting a new role for the PCP genes in tube length control.", {"entities": []}], ["Interestingly, the changes in tube length and PCP defects in the wing were linked to changes in apical domain size, suggesting that Sano and the PCP components affect either membrane recycling and/or the linkage of the membrane to the cytoskeleton.", {"entities": []}], ["The association between bronchial obstruction severity and mortality in Chronic Obstructive Pulmonary Disease (COPD) is well established, but it is unknown whether disease-specific health status measures and multidimensional assessment (MDA) have comparable prognostic value.", {"entities": []}], ["We analyzed data coming from the Salute Respiratoria nell'Anziano (Respiratory Health in the Elderly \u2013 SaRA) study, enrolling elderly people attending outpatient clinics for respiratory and non-respiratory problems.", {"entities": []}], ["From this population we selected 449 patients with bronchial obstruction (77.3% men, mean age 73.1).", {"entities": []}], ["We classified patients' health status using tertiles of the Saint George Respiratory Questionnaire (SGRQ) and a MDA including functional (the 6' walking test, WT), cognitive (Mini-Mental State Examination, MMSE) and affective status (Geriatric Depression Scale, GDS).", {"entities": []}], ["The agreement of the classification methods was calculated using the kappa statistic, and survival associated with group membership was evaluated using survival analysis.", {"entities": []}], ["Pulmonary function, expressed by the FEV1, worsened with increasing SGRQ or MDA scores.", {"entities": []}], ["Cognitive function was not associated with the SGRQ, while physical performance and mood status were impaired only in the highest tertile of SGRQ.", {"entities": []}], ["A poor agreement was found between the two classification systems tested (k = 0.194).", {"entities": []}], ["Compared to people in the first tertile of SGRQ score, those in the second tertile had a sex-adjusted HR of 1.22 (0.75 \u2013 1.98) and those in the third tertile of 2.90 (1.92 \u2013 4.40).", {"entities": [[102, 104, "GENE"]]}], ["The corresponding figures of the MDA were 1.49 (95% CI 1.02 \u2013 2.18) and 2.01 (95% CI: 1.31 \u2013 3.08).", {"entities": []}], ["After adjustment for severity of obstruction, only a SGRQ in the upper tertile was associated with mortality (HR: 1.86; 95% CI: 1.14 \u2013 3.02).", {"entities": [[110, 112, "GENE"]]}], ["In elderly outpatients with mild-moderate COPD, a disease-specific health status index seems to be a better predictor of death compared to a MDA.", {"entities": []}], ["For parents and caregivers of food hypersensitive (FH) children, accommodating their child\u2019s dietary needs when eating out can be a challenging experience.", {"entities": [[51, 53, "GENE"]]}], ["This study explored caregivers\u2019 experiences and behaviours when eating out with their FH child in order to gain insights into how they support and prepare their child in negotiating safe eating out experiences.", {"entities": [[86, 88, "GENE"]]}], ["A cross-sectional, qualitative design was used.", {"entities": []}], ["In depth, semi-structured interviews were carried out with 15 caregivers of children with FH.", {"entities": [[90, 92, "GENE"]]}], ["Interviews were analysed using framework analysis.", {"entities": []}], ["Caregivers reported a number of issues relating to eating out with their FH child, or allowing their child to eat out without their supervision.", {"entities": [[73, 75, "GENE"]]}], ["Through themes of \u2018family context\u2019, \u2018child-focused concerns\u2019, and \u2018venue issues\u2019, caregivers described how they managed these and explained the limitations and sacrifices that FH imposed on their child, themselves, and family members.", {"entities": [[176, 178, "GENE"]]}], ["Through deeper understanding of the anxieties, negotiations and compromises experienced by caregivers of children with FH when they are eating out, clinicians and support charities can tailor their support to meet the needs of caregivers and children.", {"entities": [[119, 121, "GENE"]]}], ["Support and education provision should focus on providing caregivers of children with FH the tools and strategies to help enable safe eating out experiences.", {"entities": [[86, 88, "GENE"]]}], ["The online version of this article (doi:10.1186/s12889-017-4594-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In a randomized, placebo-controlled, phase 2b clinical trial, an adjuvanted vaccine containing the respiratory syncytial virus (RSV) fusion protein was immunogenic but did not protect older adults from disease caused by RSV.", {"entities": []}], ["Respiratory syncytial virus (RSV) is an important cause of illness in older adults.", {"entities": []}], ["This study assessed efficacy of a vaccine for prevention of RSV-associated acute respiratory illness (ARI), defined by specified symptoms with virologic confirmation.", {"entities": []}], ["This phase 2b study evaluated RSV postfusion F protein (120 \u00b5g) with glucopyranosyl lipid adjuvant (5 \u00b5g) in 2% stable emulsion.", {"entities": []}], ["Subjects aged \u226560 years were randomly assigned at a ratio of 1:1 to receive vaccine or placebo (all received inactivated influenza vaccine).", {"entities": [[121, 130, "DISEASE"]]}], ["Ill subjects recorded symptoms and provided blood and nasal swab samples.", {"entities": []}], ["In the per-protocol population (n = 1894), the incidence of RSV-associated ARI occurring \u226514 days after dosing was 1.7% and 1.6% in the vaccine and placebo groups, respectively, for a vaccine efficacy (VE) of \u20137.1% (90% confidence interval [CI], \u2013106.9%\u201344.3%).", {"entities": []}], ["Efficacy was not observed in secondary analyses that included seroresponse to nonvaccine RSV antigens (VE, 8.9%; 90% CI, \u201328.5%\u201335.4%) or symptoms combined with seroresponse (VE, 10.0%; 90% CI, \u201345.4%\u201344.4%).", {"entities": []}], ["On day 29, 92.9% of vaccinees had an anti-F immunoglobulin G antibody seroresponse.", {"entities": []}], ["Overall, 48.5% and 30.9% of RSV vaccine recipients reported local and systemic solicited symptoms, respectively.", {"entities": []}], ["The RSV vaccine was immunogenic but did not protect older adults from RSV illness.", {"entities": []}], ["NCT02508194.", {"entities": []}], ["Airway smooth muscle (ASM) hyperplasia is a key feature of airway remodeling in development of lung diseases such as asthma.", {"entities": [[117, 123, "DISEASE"]]}], ["Anomalous proliferation of ASM cells directly contributes to ASM hyperplasia.", {"entities": []}], ["However, the molecular mechanisms controlling ASM cell proliferation are not completely understood.", {"entities": []}], ["Semaphorins are versatile regulators of various cellular processes including cell growth and proliferation.", {"entities": []}], ["The role of semaphorins in ASM cell proliferation has remained to be addressed.", {"entities": []}], ["Here, we report that semaphorin 3A (Sema3A) receptor, neuropilin 1 (Nrp1), is expressed on human ASM cells (HASMC) isolated from healthy and asthmatic donors and treatment of these cells with exogenous Sema3A inhibits growth factor-induced proliferation.", {"entities": [[36, 42, "GENE"], [202, 208, "GENE"], [68, 72, "GENE"], [36, 42, "GENE"], [202, 208, "GENE"]]}], ["Sema3A inhibitory effect on HASMC proliferation is associated with decreased tyrosine phosphorylation of PDGFR, downregulation of Rac1 activation, STAT3 and GSK-3\u03b2 phosphorylation.", {"entities": [[0, 6, "GENE"], [130, 134, "GENE"], [147, 152, "GENE"]]}], ["Bronchial sections from severe asthmatics displayed immunoreactivity of Nrp1, suggestive of functional contribution of Sema3A-Nrp1 axis in airway remodeling.", {"entities": [[72, 76, "GENE"], [126, 130, "GENE"]]}], ["Together, our data suggest Sema3A-Nrp1 signaling as a novel regulatory pathway of ASM hyperplasia.", {"entities": []}], ["Laypeople increasingly use the Internet as a source of health information, but finding and discovering the right information remains problematic.", {"entities": []}], ["These issues are partially due to the mismatch between the design of consumer health websites and the needs of health information seekers, particularly the lack of support for \u201cexploring\u201d health information.", {"entities": []}], ["The aim of this research was to create a design for consumer health websites by supporting different health information\u2013seeking behaviors.", {"entities": []}], ["We created a website called Better Health Explorer with the new design.", {"entities": []}], ["Through the evaluation of this new design, we derive design implications for future implementations.", {"entities": []}], ["Better Health Explorer was designed using a user-centered approach.", {"entities": []}], ["The design was implemented and assessed through a laboratory-based observational study.", {"entities": []}], ["Participants tried to use Better Health Explorer and another live health website.", {"entities": []}], ["Both websites contained the same content.", {"entities": []}], ["A mixed-method approach was adopted to analyze multiple types of data collected in the experiment, including screen recordings, activity logs, Web browsing histories, and audiotaped interviews.", {"entities": []}], ["Overall, 31 participants took part in the observational study.", {"entities": []}], ["Our new design showed a positive result for improving the experience of health information seeking, by providing a wide range of information and an engaging environment.", {"entities": []}], ["The results showed better knowledge acquisition, a higher number of page reads, and more query reformulations in both focused and exploratory search tasks.", {"entities": []}], ["In addition, participants spent more time to discover health information with our design in exploratory search tasks, indicating higher engagement with the website.", {"entities": []}], ["Finally, we identify 4 design considerations for designing consumer health websites and health information\u2013seeking apps: (1) providing a dynamic information scope; (2) supporting serendipity; (3) considering trust implications; and (4) enhancing interactivity.", {"entities": []}], ["Better Health Explorer provides strong support for the heterogeneous and shifting behaviors of health information seekers and eases the health information\u2013seeking process.", {"entities": []}], ["Our findings show the importance of understanding different health information\u2013seeking behaviors and highlight the implications for designers of consumer health websites and health information\u2013seeking apps.", {"entities": []}], ["The goal of this study was to identify distinct frailty trajectories (clusters of individuals following a similar progression of frailty over time) in an ageing population and to determine social and behavioural factors associated with frailty trajectories.", {"entities": []}], ["Population-based cohort study.", {"entities": []}], ["Olmsted County, Minnesota.", {"entities": []}], ["Olmsted County, Minnesota residents aged 60\u201389 in 2005.", {"entities": []}], ["Changes in frailty over an 8-year period from 2005 to 2012, measured by constructing a yearly frailty index.", {"entities": []}], ["Frailty trajectories by decade of age were determined using k-means cluster modelling for longitudinal data.", {"entities": []}], ["After adjustment for age and sex, all social and behavioural factors (education, marital status, living arrangements, smoking status and alcohol use) were significantly associated with frailty trajectories in those aged 60\u201369 and 70\u201379\u2005years.", {"entities": []}], ["After further adjustment for baseline frailty, the likelihood of being in the high frailty trajectory was greatest among those reporting concerns from relatives/friends about alcohol consumption (OR (95% CI) 2.26 (1.19 to 4.29)) and those with less than a high school education (OR (95% CI) 1.98 (1.32 to 2.96)) in the 60\u201369\u2005year olds.", {"entities": []}], ["In the 70\u201379\u2005year olds, the largest associations were observed among those with concerns from oneself about alcohol consumption (OR (95% CI) 1.92 (1.23 to 3.00)), those with less than a high school education (OR (95% CI) 1.57 (1.12 to 2.22)), and those living with family (vs spouse; OR (95% CI) 1.76 (1.05 to 2.94)).", {"entities": []}], ["No factors remained associated with frailty trajectories in the 80\u201389\u2005year olds after adjustment for baseline frailty.", {"entities": []}], ["Social and behavioural factors are associated with frailty, with stronger associations observed in younger ages.", {"entities": []}], ["Recognition of social and behavioural factors associated with increasing frailty may inform interventions for individuals at risk of worsening frailty, specifically when targeted at younger individuals.", {"entities": []}], ["Federal nutritional guidelines apply to school foods provided through the national school lunch and breakfast programs, but few federal regulations apply to other foods and drinks sold in schools (labeled \"competitive foods\"), which are often high in calories, fat and sugar.", {"entities": []}], ["Competitive food policies among school districts are increasingly viewed as an important modifiable factor in the school nutrition environment, particularly to address rising rates of childhood overweight.", {"entities": []}], ["Congress passed legislation in 2004 requiring all school districts to develop a Wellness Policy that includes nutrition guidelines for competitive foods starting in 2006\u20132007.", {"entities": []}], ["In addition, the Institute of Medicine (IOM) recently published recommendations for schools to address childhood obesity.", {"entities": [[113, 120, "DISEASE"]]}], ["Representatives of school districts with the largest student enrollment in each state and D.C. (N = 51) were interviewed in October-November 2004 about each school district's nutrition policies on \"competitive foods.\"", {"entities": []}], ["District policies were examined and compared to the Institute of Medicine's recommendations for schools to address childhood obesity.", {"entities": [[125, 132, "DISEASE"]]}], ["Information about state competitive food policies was accessed via the Internet, and through state and district contacts.", {"entities": []}], ["The 51 districts accounted for 5.9 million students, representing 11% of US students.", {"entities": []}], ["Nineteen of the 51 districts (39%) had competitive food policies beyond state or federal requirements.", {"entities": []}], ["The majority of these district policies (79%) were adopted since 2002.", {"entities": []}], ["School district policies varied in scope and requirements.", {"entities": []}], ["Ten districts (53%) set different standards by grade level.", {"entities": []}], ["Most district policies had criteria for food and beverage content (74%) and prohibited the sale of soda in all schools (63%); fewer policies restricted portion size of foods (53%) or beverages (47%).", {"entities": []}], ["Restrictions more often applied to vending machines (95%), cafeteria \u00e0 la carte (79%), and student stores (79%) than fundraising activities (47%).", {"entities": []}], ["Most of the policies did not address more comprehensive approaches to the school nutrition environment, such as nutrition education (32%) or advertising to students (26%), nor did they include guidelines on physical education (11%).", {"entities": []}], ["In addition, few policies addressed monitoring (32%) or consequences for non-compliance (11%).", {"entities": []}], ["No policy restricted foods sold for after-school fundraising or required monitoring physical health indicators (e.g.", {"entities": []}], ["When compared to the Institute of Medicine's recommendations for schools' role in preventing obesity, none of the nutrition policies among each state's largest school district had addressed all the recommendations by 2004\u20132005.", {"entities": [[93, 100, "DISEASE"]]}], ["Nutritionists, nurses, pediatricians, parents, and others concerned about child health have an unprecedented opportunity to help shape and implement more comprehensive school district nutrition policies as part of the Congressional requirement for a \"Wellness Policy\" by 2006\u20132007.", {"entities": []}], ["Humans apparently differ greatly in their sensitivity and tolerance to tobacco smoke, thereby creating conflicts in the workplace.", {"entities": []}], ["Resolution of conflicts in a large office complex at the authors' institution required an objective measure of smoke levels.", {"entities": []}], ["A gas chromatographic technique was devised for collection and analysis of nicotine concentrations in the building air as an indicator of tobacco smoke pollution.", {"entities": []}], ["Segregation of smokers and nonsmokers in the large office complex still resulted in substantial exposure of the nonsmoker to tobacco smoke, although a gradient of exposure was certainly observed.", {"entities": []}], ["Passive tobacco smoke consumption in the smoking area of the office complex was calculated to be equivalent to 1.1 cigarettes per 8-hr period, and nicotine density in this area was 1.96 microgram/m.", {"entities": []}], ["The restriction of smoking to a foyer area outside the office complex resulted in a slow but eventual reduction in nicotine concentrations in the office complex.", {"entities": []}], ["Observed \"background\" nicotine concentration levels corresponding to 4 to 7% of those encountered in smoking areas demonstrate that central air circulation systems and people movement increase the nicotine level throughout all rooms of a building, regardless of the smoking policies of an individual office complex.", {"entities": []}], ["Recent documentation of the relationship between passive smoking and cancer, heart disease, pulmonary dysfunction, and allergic responses argues for restriction of smoking to building exteriors.", {"entities": [[77, 90, "DISEASE"], [69, 75, "DISEASE"]]}], ["In Australia, almost half of HIV-positive people are now aged over 50 and are predominately gay and bisexual men (GBM).", {"entities": []}], ["Compared to the general HIV-negative population, GBM engage more in behaviours that may increase the risk of age-related comorbidities, including smoking, high alcohol consumption and recreational drug use.", {"entities": []}], ["The objective of APPLES was to compare comorbidities and risk factors in HIV-positive older GBM with an appropriate control group of HIV-negative GBM.", {"entities": []}], ["We undertook a prospectively recruited cross-sectional sample of HIV-positive and HIV-negative GBM \u2265 55 years.", {"entities": []}], ["Detailed data collection included clinic data, a health and lifestyle survey, and blood sample collection.", {"entities": []}], ["We report key demographic, laboratory markers and self-reported comorbidities by HIV status.", {"entities": []}], ["For selected comorbidities we also adjust HIV status a priori for age, smoking and body mass index.", {"entities": []}], ["Over 16 months 228 HIV-positive and 218 HIV-negative men were recruited.", {"entities": []}], ["Median age was 63 years (IQR: 59\u201367).", {"entities": []}], ["Although more HIV-positive men reported having ever smoked, smoking status was not statistically different between HIV positive and HIV negative men (p = 0.081).", {"entities": []}], ["Greater alcohol use was reported by HIV-negative men (p = 0.002), and recreational drug use reported more often by HIV-positive men (p<0.001).", {"entities": []}], ["After adjustment, HIV-positive men had significantly increased odds of diabetes (adjusted Odds ratio (aOR): 1.97, p = 0.038), thrombosis (aOR: 3.08, p = 0.007), neuropathy (aOR: 34.6, P<0.001), and non-significantly increased odds for heart-disease (aOR: 1.71, p = 0.077).", {"entities": [[161, 171, "DISEASE"]]}], ["In conclusion, HIV-positive GBM have significantly increased odds for key self-reported comorbidities.", {"entities": []}], ["This study underscores the importance of an appropriate HIV-negative control group for more accurate evaluation of the risk and attribution of age-related comorbidities in HIV-positive people.", {"entities": []}], ["The prevalence of obesity is increasing worldwide and significantly affects fertility and reproduction in both men and women.", {"entities": [[18, 25, "DISEASE"]]}], ["Our recent study has shown that excess body fat accelerates ovarian follicle development and follicle loss in rats.", {"entities": []}], ["The aim of the present study is to explore the effect of SIRT1 activator SRT1720 on the reserve of ovarian follicle pool and ovarian lifespan of obese mice and the underlying mechanism associated with SIRT1 and mTOR signaling.", {"entities": [[57, 62, "GENE"], [201, 206, "GENE"], [57, 62, "GENE"], [201, 206, "GENE"], [211, 215, "GENE"]]}], ["Adult female Kunming mice (n = 36) were randomly divided into three groups: the normal control (NC) group (n = 8), the caloric restriction (CR) group (fed 70% food of the NC group, n = 8) and the high-fat diet (HF) group (fed a rodent chow containing 20% fat, n = 20).", {"entities": []}], ["After 4\u00a0months, the HF mice were further randomly divided into three groups: the control high-fat diet (CHF, n = 8) group (treated every day with an intraperitoneal injection of vehicle), the SRT1720 (SRT, n = 6) group (treated every other day with an intraperitoneal injection of SRT1720 (50\u00a0mg/kg)), the SRT1720 and nicotinamide (NAM, n = 6) group (treated every other day with an intraperitoneal injection of SRT1720 (50\u00a0mg/kg) and every day with an intraperitoneal injection of nicotinamide (100\u00a0mg/kg)).", {"entities": []}], ["After 6\u00a0weeks of treatment, ovaries were harvested for histological and Western blotting analyses.", {"entities": []}], ["The body weight, ovary weight and visceral fat in the SRT group were significantly lower than those in the CHF group at the end of treatment.", {"entities": []}], ["Histological analysis showed that the SRT mice had significantly greater number and percentage of primordial follicles, but lower number and percentage of corpora lutea and atretic follicles than the CHF mice and NAM mice.", {"entities": []}], ["Western blot analysis demonstrated that the levels of SIRT1, SIRT6, FOXO3a and NRF-1 protein expression significantly increased in the ovaries of SRT mice, whereas those of mTORC1, p-mTOR, p-p70S6K, NF\u03baB and p53 decreased compared to the CHF and NAM mice.", {"entities": [[54, 59, "GENE"], [61, 66, "GENE"]]}], ["Our study suggests that SRT1720 may improve the follicle pool reserve in HF diet-induced obese female mice via activating SIRT1 signaling and suppressing mTOR signaling, thus extending the ovarian lifespan.", {"entities": [[122, 127, "GENE"], [154, 158, "GENE"]]}], ["To identify, synthesize, and summarize issues and challenges related to the culture and language differences of the health workforce in Saudi Arabia.", {"entities": []}], ["A comprehensive systematic review was conducted in May 2014 to locate published articles.", {"entities": []}], ["Two independent researchers in consultation with several experts used 4 electronic databases (ISI Web of Knowledge, Science Direct, PubMed, and Cochrane) to scrutinize articles published from January 2000 - March 2014.", {"entities": []}], ["Each of the studies was given a quality assessment rating of weak, moderate, or strong, and was evaluated for methodological soundness using Russell and Gregory\u2019s criteria.", {"entities": []}], ["The online literature search identified 12 studies that met the inclusion criteria.", {"entities": []}], ["Lack of knowledge of non-Muslim nurses or culture in Saudi Arabia, difficulties in achieving cultural competence, and culture shock were documented as cultural difference factors.", {"entities": []}], ["Issues in language difference include the clarity of language use by health care providers in giving information and providing adequate explanation regarding their activities.", {"entities": []}], ["The available information provided by this review study shows that there is a communication barrier between patients and health care workers such as healthcare workers demonstrate low cultural competency.", {"entities": []}], ["Despite the fact that the government provides programs for expatriate healthcare workers, there is a need to further improve educational and orientation programs regarding the culture and language in Saudi Arabia.", {"entities": []}], ["Researchers say that endocrine-disrupting chemicals can permanently damage the developing organism and may even promote obesity.", {"entities": [[120, 127, "DISEASE"]]}], ["But the chemical industry doesn't want you to believe them.", {"entities": []}], ["Adiposity has been linked to both higher risk of asthma and reduced lung function.", {"entities": [[49, 55, "DISEASE"]]}], ["The effects of adiposity on asthma may depend on both atopic status and gender, while the relationship is less clear with respect to lung function.", {"entities": [[28, 34, "DISEASE"]]}], ["This study aimed to explore longitudinal weight changes to changes in forced expiratory volume in first second (FEV1) and forced vital capacity (FVC), as well as to incident cases of asthma and wheezing, according to atopy and gender.", {"entities": [[183, 189, "DISEASE"]]}], ["A general population sample aged 19\u201372 years was examined with the same methodology five years apart.", {"entities": []}], ["Longitudinal changes in weight, body mass index, waist circumference, and fat percentage (bio-impedance) were analyzed with respect to changes of FEV1 and FVC (spirometry), and incidence of asthma and wheezing (questionnaire).", {"entities": [[190, 196, "DISEASE"]]}], ["Gender, atopy (serum specific IgE-positivity to inhalant allergens) and adipose tissue mass prior to adiposity changes were examined as potential effect modifiers.", {"entities": []}], ["A total of 2,308 persons participated in both baseline and five-year follow-up examinations.", {"entities": []}], ["Over the entire span of adiposity changes, adiposity gain was associated with decreasing levels of lung function, whereas adiposity loss was associated with increasing levels of lung function.", {"entities": []}], ["All associations were dependent on gender (p-interactions\u2009<\u20090.0001).", {"entities": []}], ["For one standard deviation weight gain or weight loss, FEV1 changed with (+/\u2212)72\u00a0ml (66-78\u00a0ml) and FVC with (+/\u2212)103\u00a0ml (94-112\u00a0ml) in males.", {"entities": []}], ["In females FEV1 changed with (+/\u2212) 27\u00a0ml (22-32\u00a0ml) and FVC with (+/\u2212) 36\u00a0ml (28-44\u00a0ml).", {"entities": []}], ["There were no changes in the FEV1/FVC-ratio.", {"entities": []}], ["The effect of adiposity changes increased with the level of adipose tissue mass at the start of the study (baseline), thus, indicating an aggregate effect of the total adipose tissue mass.", {"entities": []}], ["Atopy did not modify these associations.", {"entities": []}], ["There were no statistically significant associations between changes in adiposity measures and risk of incident asthma or wheeze.", {"entities": [[112, 118, "DISEASE"]]}], ["Over a five-year period, increasing adiposity was associated with decreasing lung function, whereas decreasing adiposity was associated with increasing lung function.", {"entities": []}], ["This effect was significantly greater in males than in females and increased with pre-existing adiposity, but was independent of atopy.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2466-14-208) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The diagnosis of childhood asthma covers a broad spectrum of pathological mechanisms that can lead to similarly presenting clinical symptoms, but may nonetheless require different treatment approaches.", {"entities": [[27, 33, "DISEASE"]]}], ["Distinct underlying inflammatory patterns are thought to influence responsiveness to standard asthma medication.", {"entities": [[94, 100, "DISEASE"]]}], ["The purpose of the PACMAN2 study is to identify inflammatory phenotypes that can discriminate uncontrolled childhood asthma from controlled childhood asthma by measures in peripheral blood and exhaled air.", {"entities": [[117, 123, "DISEASE"], [150, 156, "DISEASE"]]}], ["PACMAN2 is a nested, case\u2013control follow-up study to the ongoing pharmacy-based \u201cPharmacogenetics of Asthma medication in Children: Medication with Anti-inflammatory effects\u201d (PACMAN) study.", {"entities": [[101, 107, "DISEASE"]]}], ["The original PACMAN cohort consists of children aged 4\u201312\u00a0years with reported use of asthma medication.", {"entities": [[85, 91, "DISEASE"]]}], ["The PACMAN2 study will be conducted within the larger PACMAN cohort, and will focus on detailed phenotyping of a subset of the PACMAN children.", {"entities": []}], ["The selected participants will be invited to a follow-up visit in a clinical setting at least six months after their baseline visit based on their adherence to usage of inhaled corticosteroids, their asthma symptoms in the past year, and their age (\u2265 8\u00a0years).", {"entities": [[200, 206, "DISEASE"]]}], ["During the follow-up visit, current and long-term asthma symptoms, medication use, environmental factors, medication adherence and levels of exhaled nitric oxide will be reassessed.", {"entities": [[50, 56, "DISEASE"]]}], ["The following measures will also be examined: pulmonary function, exhaled volatile organic compounds, as well as inflammatory markers in peripheral blood and blood plasma.", {"entities": []}], ["Comparative analysis and cluster-analyses will be used to identify markers that differentiate children with uncontrolled asthma despite their use of inhaled corticosteroids (ICS) (cases) from children whose asthma is controlled by the use of ICS (controls).", {"entities": [[121, 127, "DISEASE"], [207, 213, "DISEASE"]]}], ["Asthmatic children with distinct inflammatory phenotypes may respond differently to anti-inflammatory therapy.", {"entities": []}], ["Therefore, by identifying inflammatory phenotypes in children with the PACMAN2 study, we may greatly impact future personalised treatment strategies, uncover new leads for therapeutic targets and improve the design of future clinical studies in the assessment of the efficacy of novel therapeutics.", {"entities": []}], ["Rheumatoid arthritis (RA) is a complex and systematic autoimmune disease, which is usually influenced by both genetic and environmental factors.", {"entities": [[11, 20, "DISEASE"]]}], ["Pathway analyses based on a single data type such as microarray data or SNP data have successfully revealed some biology pathways associated with RA.", {"entities": []}], ["However, we found that the pathway analysis based on a single data type only provide limited understanding about the pathogenesis of RA.", {"entities": []}], ["Gene-disease association is usually caused by many ways, such as genotype, gene expression and so on.", {"entities": []}], ["Therefore, the integrative analysis method combining multiple levels of evidence can more precisely and comprehensively identify the pathway associations.", {"entities": []}], ["In this study, we performed a pathway analysis by integrating GWAS and gene expression analysis to detect the RA-related pathways.", {"entities": []}], ["The integrative analysis identified 28 pathways associated with RA.", {"entities": []}], ["Among these pathways, 18 pathways were also found by both GWAS and gene expression analysis, 7 pathways are novel RA-related pathways, such as B cell receptor signaling pathway, Toll-like receptor signaling pathway, Fc gamma R-mediated phagocytosis and so on.", {"entities": []}], ["Compared with pathway analyses using only one type genomic data, we found integrative analysis can increase the power to identify the real associations and provided more stable and accurate results.", {"entities": []}], ["We believe these results will contribute to perform future genetic studies in RA pathogenesis and may promote the development of new therapeutic strategies by targeting these pathways.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) patients are at higher risk of developing lung cancer and its metastasis, but no suitable biomarker has been reported for differential diagnosis of these patients.", {"entities": [[87, 98, "DISEASE"], [92, 98, "DISEASE"]]}], ["Levels of serum biomarkers (VEGF, IL-8, MMP-9 and MMP-2) were analyzed in these patients, which were compared with healthy donors (HD).", {"entities": []}], ["Levels of VEGF (P\u2009<\u20090.005) and MMP-9 (P\u2009<\u20090.05) were significantly higher in COPD patients than HD.", {"entities": []}], ["Compared to HD, a decrease in IL-8 (~8.1 folds; P\u2009<\u20090.0001) but an increase in MMP-9 (~1.6 folds; P\u2009<\u20090.05) levels were observed in the lung cancer patients.", {"entities": [[136, 147, "DISEASE"], [141, 147, "DISEASE"]]}], ["Cancer patients showed significantly (P\u2009<\u20090.005) lower levels of serum VEGF (1.9 folds) and IL-8 (~9 folds) than the COPD patients.", {"entities": [[0, 6, "DISEASE"]]}], ["VEGF level was significantly higher (2.6 folds; P\u2009<\u20090.0005) in metastatic than non-metastatic cancer patients.", {"entities": [[94, 100, "DISEASE"]]}], ["However, MMP-2 didn\u2019t show significant variation in these patients.", {"entities": []}], ["The Youden\u2019s index (YI) values for lung cancer diagnosis in HD using IL-8 was 0.55 with 83.3% overall accuracy.", {"entities": [[35, 46, "DISEASE"], [40, 46, "DISEASE"]]}], ["VEGF was able to diagnose COPD in HD with better YI (0.38) and overall accuracy (70.6%).", {"entities": []}], ["IL-8 was able to diagnose cancer in COPD patients and HD with YI values of 0.35, 0.55 with 71% and 83.3% overall accuracy, respectively.", {"entities": [[26, 32, "DISEASE"]]}], ["Cigarette smoking (CS) is the main risk factor for the development of chronic obstructive pulmonary disease (COPD) and most COPD exacerbations are caused by respiratory infections including influenza.", {"entities": [[190, 199, "DISEASE"], [70, 107, "DISEASE"], [19, 21, "GENE"]]}], ["Influenza infections are more severe in smokers.", {"entities": [[0, 9, "DISEASE"]]}], ["The mechanism of the increased risk and severity of infections in smokers is likely multifactorial, but certainly includes changes in immunologic host defenses.", {"entities": []}], ["We investigated retinoic acid-inducible protein I (RIG-I) and interferon (IFN) induction by influenza A virus (IAV) in human bronchial epithelial cells (HBEC) isolated from smokers or nonsmokers.", {"entities": [[92, 101, "DISEASE"]]}], ["Subcultured HBEC cells were infected with A/Puerto Rico/8/1934 (PR8) IAV at an MOI of 1.", {"entities": []}], ["After 24\u00a0h of infection, cells and supernatants were collected for qRT-PCR, immunoblot or ELISA to determine RIG-I, Toll-like receptor3 (TLR3) and IFN expression levels.", {"entities": [[137, 141, "GENE"]]}], ["IAV exposure induced a vigorous IFN-\u03b2, IFN-\u03bb 1 and IFN-\u03bb 2/3 antiviral response in HBEC from nonsmokers and significant induction of RIG-I and TLR3.", {"entities": [[143, 147, "GENE"]]}], ["In cells from smokers, viral RIG-I and TLR3 mRNA induction was reduced 87 and 79\u00a0% compared to the response from nonsmokers.", {"entities": [[39, 43, "GENE"]]}], ["CS exposure history was associated with inhibition of viral induction of the IFN-\u03b2, IFN-\u03bb1 and IFN-\u03bb 2/3 mRNA response by 85, 96 and 95\u00a0%, respectively, from that seen in HBEC from nonsmokers.", {"entities": [[0, 2, "GENE"]]}], ["The demethylating agent 5-Aza-2-deoxycytidine reversed the immunosuppressive effects of CS exposure in HBEC since viral induction of all three IFNs was restored.", {"entities": [[88, 90, "GENE"]]}], ["IFN-\u03b2 induction of RIG-I and TLR3 was also suppressed in the cells from smokers.", {"entities": [[29, 33, "GENE"]]}], ["Our results suggest that active smoking reduces expression of antiviral cytokines in primary HBEC cells.", {"entities": []}], ["This effect likely occurs via downregulation of RIG-I and TLR3 due to smoke-induced epigenetic modifications.", {"entities": [[58, 62, "GENE"]]}], ["Reduction in lung epithelial cell RIG-I and TLR3 responses may be a major mechanism contributing to the increased risk and severity of viral respiratory infections in smokers and to viral-mediated acute exacerbations of COPD.", {"entities": [[44, 48, "GENE"]]}], ["It is very difficult to prevent pulmonary tuberculosis (TB) due to the lack of specific and diagnostic markers, which could lead to a high incidence of pulmonary TB.", {"entities": [[42, 54, "DISEASE"], [32, 54, "DISEASE"]]}], ["We screened the differentially expressed serum microRNAs (miRNAs) as potential biomarkers for the diagnosis of pulmonary TB.", {"entities": []}], ["In this study, serum miRNAs were screened using the Solexa sequencing method as the potential biomarkers for the diagnosis of pulmonary TB.", {"entities": []}], ["The stem-loop quantitative reverse-transcription polymerase chain reaction (qRT-PCR) assay was used to verify differentially expressed serum miRNAs.", {"entities": []}], ["The receiver operating characteristic (ROC) curve and logistic regression model were used to analyze the sensitivity and specificity of the single miRNA and a combination of miRNAs for diagnosis, respectively.", {"entities": []}], ["Using the predicted target genes, we constructed the regulatory networks of miRNAs and genes that were related to pulmonary TB.", {"entities": []}], ["The Solexa sequencing data showed that 91 serum miRNAs were differentially expressed in pulmonary TB patients, compared to healthy controls.", {"entities": []}], ["Following qRT-PCR confirmation, six serum miRNAs (hsa-miR-378, hsa-miR-483-5p, hsa-miR-22, hsa-miR-29c, hsa-miR-101 and hsa-miR-320b) showed significant difference among pulmonary TB patients, healthy controls ( P <0.001) and differential diagnosis groups (including patients with pneumonia, lung cancer and chronic obstructive pulmonary disease) ( P <0.05).", {"entities": [[292, 303, "DISEASE"], [281, 290, "DISEASE"], [308, 345, "DISEASE"], [297, 303, "DISEASE"]]}], ["The logistic regression analysis of a combination of six serum miRNAs revealed that the sensitivity and the specificity of TB diagnosis were 95.0% and 91.8% respectively.", {"entities": []}], ["The miRNAs-gene regulatory networks revealed that several miRNAs may regulate some target genes involved in immune pathways and participate in the pathogenesis of pulmonary TB.", {"entities": []}], ["Our study suggests that a combination of six serum miRNAs have great potential to serve as non-invasive biomarkers of pulmonary TB.", {"entities": []}], ["Smoking rates in Australian Aboriginal and Torres Strait Islander peoples remain high, with limited impact of government measures for many subgroups.", {"entities": []}], ["The aim of this cross-sectional study was to investigate differences in organisational practice for developing anti-tobacco messages for these target populations.", {"entities": []}], ["Telephone interviews were conducted with 47 organisation representatives using a structured questionnaire based on health communication and health promotion frameworks.", {"entities": []}], ["Responses were coded into phases of message development, message types (educational, threat, positive or advocacy), target groups, message recommendations, and evaluations undertaken.", {"entities": []}], ["Cultural sensitivity for message development was divided into surface structure (use of images, language, demographics) and deep structure (use of socio-cultural values).", {"entities": []}], ["A categorical principal component analysis explored the key dimensions of the findings and their component relationships.", {"entities": []}], ["Among organisations interviewed, a community-orientated, bottom-up approach for developing anti-tobacco messages was reported by 47% (n\u2009=\u200924); 55% based message development on a theoretical framework; 87% used a positive benefit appeal; 38% used threat messages.", {"entities": []}], ["More Aboriginal Medical Services (AMSs) targeted youth (p\u2009<\u20090.005) and advised smokers to quit (p\u2009<\u20090.05) than other types of organisations.", {"entities": []}], ["AMSs were significantly more likely to report using deep structure in tailoring messages compared with non-government (p\u2009<\u20090.05) and government organisations (p\u2009<\u20090.05).", {"entities": []}], ["Organisations that were oriented to the general population were more likely to evaluate their programs (p\u2009<\u20090.05).", {"entities": []}], ["A two-dimensional non-linear principal component analysis extracted components interpreted as \u201ccultural understanding\u201d (bottom-up, community-based approaches, deep structures) and \u201crigour\u201d (theoretical frameworks, and planned/completed evaluations), and accounted for 53% of the variability in the data.", {"entities": []}], ["Message features, associated with successful campaigns in other populations, are starting to be used for Aboriginal and Torres Strait Islander peoples.", {"entities": []}], ["A model is proposed to facilitate the development of targeted anti-tobacco messages for Aboriginal and Torres Strait Islander peoples.", {"entities": []}], ["Organisations could consider incorporating both components of cultural understanding-rigour to enable the growth of evidence-based practice.", {"entities": []}], ["COPD patients with community-acquired pneumonia (CAP) have worse clinical outcomes, as compared to those without COPD.", {"entities": [[38, 47, "DISEASE"]]}], ["Cardiovascular disease (CVD) is a common comorbidity for COPD patients.", {"entities": []}], ["Whether COPD with comorbid CVD will increase the risk of CAP is not well investigated.", {"entities": []}], ["The incidence and factors associated with CAP in COPD patients with and without CVD were analyzed.", {"entities": []}], ["The medical records of patients with newly diagnosed COPD between 2007 and 2010 were reviewed.", {"entities": []}], ["The patients\u2019 characteristics, medical history of CVD, occurrence of CAP, and type of medication were recorded.", {"entities": []}], ["Kaplan\u2013Meier curves were used to assess the differences in cumulative incidence of CAP.", {"entities": []}], ["Cox\u2019s proportional hazards regression model was used to determine the adjusted hazard ratios with 95% confidence intervals in relation to factors associated with CAP in COPD patients with and without CVD.", {"entities": []}], ["Among 2,440 patients, 475 patients (19.5%) developed CAP during the follow-up period.", {"entities": []}], ["COPD patients who developed CAP were significantly older, had lower forced expiratory volume in 1 second, frequent severe exacerbation and comorbid CVD, as well as received inhaled corticosteroid (ICS)-containing therapy than those without CAP.", {"entities": []}], ["The cumulative incidence of CAP was higher in COPD patients with CVD compared to those without CVD.", {"entities": []}], ["Patients who received ICS-containing therapy had significantly increased risk of developing CAP compared to those who did not.", {"entities": []}], ["For patients with COPD, comorbid CVD is an independent risk factor for developing CAP.", {"entities": []}], ["ICS-containing therapy may increase the risk of CAP among COPD patients.", {"entities": []}], ["Community-acquired pneumonia (CAP) remains a common cause of morbidity and a potentially life-threatening illness throughout the world mainly in elderly patients.", {"entities": [[19, 28, "DISEASE"]]}], ["Initial antibacterial treatment, usually empirical, should be as effective as possible in order to assure rapid clinical resolution and reduce high rates of hospitalization and mortality especially affecting aged patients.", {"entities": []}], ["New fluoroquinolones with potent activity against the most important respiratory pathogens including Streptococcus pneumoniae , a key pathogen mainly in old patients with CAP, have been recently suggested by several international guidelines as monotherapy for the treatment of most CAP patient categories.", {"entities": []}], ["Among newer derivatives, moxifloxacin, an advanced generation 8-methoxy quinolone, has demonstrated good clinical and bacteriological efficacy in large, well designed clinical trials both in adults and old patients with CAP, achieving also in aged people efficacy comparable with that of standard treatments.", {"entities": []}], ["Good pharmacokinetic characteristics such as excellent penetration into respiratory tract tissues and fluids, optimal bioavailability, simplicity of once-daily dosing, and good tolerability, represent potential advantages of moxifloxacin over other therapies.", {"entities": []}], ["In addition, primarily due to a shorter length of hospital stay, moxifloxacin has been shown to save costs compared with standard therapy.", {"entities": []}], ["Increased physical activity levels benefit both an individuals' health and productivity at work.", {"entities": []}], ["The purpose of the current study was to explore the impact and cost-effectiveness of a workplace physical activity intervention designed to increase physical activity levels.", {"entities": []}], ["A total of 1260 participants from 44 UK worksites (based within 5 organizations) were recruited to a cluster randomized controlled trial with worksites randomly allocated to an intervention or control condition.", {"entities": []}], ["Measurement of physical activity and other variables occurred at baseline, and at 0 months, 3 months and 9 months post-intervention.", {"entities": []}], ["Health outcomes were measured during a 30 minute health check conducted in worksites at baseline and 9 months post intervention.", {"entities": []}], ["The intervention consisted of a 3 month tool-kit of activities targeting components of the Theory of Planned Behavior, delivered in-house by nominated facilitators.", {"entities": []}], ["Self-reported physical activity (measured using the IPAQ short-form) and health outcomes were assessed.", {"entities": []}], ["Multilevel modelling found no significant effect of the intervention on MET minutes of activity (from the IPAQ) at any of the follow-up time points controlling for baseline activity.", {"entities": []}], ["However, the intervention did significantly reduce systolic blood pressure (B = -1.79 mm/Hg) and resting heart rate (B = -2.08 beats) and significantly increased body mass index (B = .18 units) compared to control.", {"entities": []}], ["The intervention was found not to be cost-effective, however the substantial variability round this estimate suggested that further research is warranted.", {"entities": []}], ["The current study found mixed support for this worksite physical activity intervention.", {"entities": []}], ["The paper discusses some of the tensions involved in conducting rigorous evaluations of large-scale randomized controlled trials in real-world settings.", {"entities": []}], ["Current controlled trials ISRCTN08807396", {"entities": []}], ["Some evidence suggests that attitude toward computer-based instruction is an important determinant of success in online learning.", {"entities": []}], ["We sought to determine how comfort using computers and perceptions of prior online learning experiences have changed over the past decade, and how these associate with learning outcomes.", {"entities": []}], ["Each year from 2003\u20132011 we conducted a prospective trial of online learning.", {"entities": []}], ["As part of each year\u2019s study, we asked medicine residents about their comfort using computers and if their previous experiences with online learning were favorable.", {"entities": []}], ["We assessed knowledge using a multiple-choice test.", {"entities": []}], ["We used regression to analyze associations and changes over time.", {"entities": []}], ["371 internal medicine and family medicine residents participated.", {"entities": []}], ["Neither comfort with computers nor perceptions of prior online learning experiences showed a significant change across years (p\u2009>\u20090.61), with mean comfort rating 3.96 (maximum 5\u2009=\u2009very comfortable) and mean experience rating 4.42 (maximum 6\u2009=\u2009strongly agree [favorable]).", {"entities": []}], ["Comfort showed no significant association with knowledge scores (p\u2009=\u20090.39) but perceptions of prior experiences did, with a 1.56% rise in knowledge score for a 1-point rise in experience score (p\u2009=\u20090.02).", {"entities": []}], ["Correlations among comfort, perceptions of prior experiences, and number of prior experiences were all small and not statistically significant.", {"entities": []}], ["Comfort with computers and perceptions of prior experience with online learning remained stable over nine years.", {"entities": []}], ["Prior good experiences (but not comfort with computers) demonstrated a modest association with knowledge outcomes, suggesting that prior course satisfaction may influence subsequent learning.", {"entities": []}], ["No universally accepted definition of multimorbidity (MM) exists, and implications of different definitions have not been explored.", {"entities": []}], ["This study examined the performance of the count and cluster definitions of multimorbidity on the sociodemographic profile and health-related quality of life (HRQoL) in a general population.", {"entities": []}], ["Data were derived from the nationally representative 2007 Australian National Survey of Mental Health and Wellbeing ( n \u2009=\u20098841).", {"entities": []}], ["The HRQoL scores were measured using the Assessment of Quality of Life (AQoL-4D) instrument.", {"entities": []}], ["The simple count (2+ & 3+ conditions) and hierarchical cluster methods were used to define/identify clusters of multimorbidity.", {"entities": []}], ["Linear regression was used to assess the associations between HRQoL and multimorbidity as defined by the different methods.", {"entities": []}], ["The assessment of multimorbidity, which was defined using the count method, resulting in the prevalence of 26% (MM2+) and 10.1% (MM3+).", {"entities": []}], ["Statistically significant clusters identified through hierarchical cluster analysis included heart or circulatory conditions (CVD)/arthritis (cluster-1, 9%) and major depressive disorder (MDD)/anxiety (cluster-2, 4%).", {"entities": [[161, 186, "DISEASE"], [131, 140, "DISEASE"]]}], ["A sensitivity analysis suggested that the stability of the clusters resulted from hierarchical clustering.", {"entities": []}], ["The sociodemographic profiles were similar between MM2+, MM3+ and cluster-1, but were different from cluster-2.", {"entities": []}], ["HRQoL was negatively associated with MM2+ (\u03b2: \u22120.18, SE: \u22120.01, p \u2009<\u20090.001), MM3+ (\u03b2: \u22120.23, SE: \u22120.02, p \u2009<\u20090.001), cluster-1 (\u03b2: \u22120.10, SE: 0.01, p \u2009<\u20090.001) and cluster-2 (\u03b2: \u22120.36, SE: 0.01, p \u2009<\u20090.001).", {"entities": []}], ["Our findings confirm the existence of an inverse relationship between multimorbidity and HRQoL in the Australian population and indicate that the hierarchical clustering approach is validated when the outcome of interest is HRQoL from this head-to-head comparison.", {"entities": []}], ["Moreover, a simple count fails to identify if there are specific conditions of interest that are driving poorer HRQoL.", {"entities": []}], ["Researchers should exercise caution when selecting a definition of multimorbidity because it may significantly influence the study outcomes.", {"entities": []}], ["Pediatric chronic pain often emerges in adolescence and cooccurs with internalizing mental health issues and sleep impairments.", {"entities": []}], ["Emerging evidence suggests that sleep problems may precede the onset of chronic pain as well as anxiety and depression.", {"entities": []}], ["Studies conducted in pediatric populations with pain-related chronic illnesses suggest that internalizing mental health symptoms may mediate the sleep-pain relationship; however, this has not been examined in youth with primary pain disorders.", {"entities": []}], ["To examine whether anxiety and depressive symptoms mediated relationships between sleep quality and pain outcomes among youth with chronic pain.", {"entities": []}], ["Participants included 147 youth (66.7% female) aged 8\u201318 years who were referred to a tertiary-level chronic pain program.", {"entities": []}], ["At intake, the youth completed psychometrically sound measures of sleep quality, pain intensity, pain interference, and anxiety and depressive symptoms.", {"entities": []}], ["As hypothesized, poor sleep quality was associated with increased pain intensity and pain interference, and anxiety and depressive symptoms mediated these sleep-pain relationships.", {"entities": []}], ["For youth with chronic pain, poor sleep quality may worsen pain through alterations in mood and anxiety; however, prospective research using objective measures is needed.", {"entities": []}], ["Future research should examine whether targeting sleep and internalizing mental health symptoms in treatments improve pain outcomes in these youth.", {"entities": []}], ["L'exacerbation d'asthme est un ph\u00e9nom\u00e8ne paroxystique qui peut mettre en jeu le pronostic vital.", {"entities": []}], ["Le but de l\u2019\u00e9tude est d\u2019\u00e9valuer le profil \u00e9pid\u00e9miologique et les modalit\u00e9s de prise en charge de l'exacerbation d'asthme chez les enfants \u00e2g\u00e9s de 2 \u00e0 15 ans dans l'unit\u00e9 de pneumoallergologie p\u00e9diatrique de l'h\u00f4pital d'enfants de Rabat au Maroc.", {"entities": []}], ["Il s'agit d'une \u00e9tude r\u00e9trospective qui a concern\u00e9 1461 enfants hospitalis\u00e9s pour exacerbation d'asthme mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re durant une p\u00e9riode d'un an allant de d\u00e9cembre 2011 \u00e0 novembre 2012, les exacerbations l\u00e9g\u00e8res \u00e9tant trait\u00e9es en ambulatoire.", {"entities": []}], ["Les hospitalisations pour exacerbation d'asthme chez les enfants ont repr\u00e9sent\u00e9 34% de l'ensemble des hospitalisations avec trois pics en mai, septembre et d\u00e9cembre.", {"entities": [[98, 101, "GENE"]]}], ["L\u2019\u00e2ge moyen de survenue \u00e9tait de 3 ans et demi avec une pr\u00e9dominance masculine nette.", {"entities": []}], ["L'exacerbation d'asthme \u00e9tait inaugurale dans 22% des cas.", {"entities": [[50, 53, "GENE"]]}], ["Les infections respiratoires virales dominaient les facteurs d\u00e9clenchants des exacerbations d'asthme.", {"entities": [[74, 77, "GENE"]]}], ["Le s\u00e9jour hospitalier \u00e9tait en moyenne de 3 jours.", {"entities": []}], ["Un transfert en r\u00e9animation a \u00e9t\u00e9 n\u00e9cessaire dans 2% des cas.", {"entities": [[53, 56, "GENE"]]}], ["L\u2019\u00e9volution sous traitement a toujours \u00e9t\u00e9 favorable et la mortalit\u00e9 a \u00e9t\u00e9 nulle.", {"entities": []}], ["La pr\u00e9valence des hospitalisations pour exacerbation d'asthme suit un profil saisonnier li\u00e9 aux effets environnementaux.", {"entities": [[14, 17, "GENE"]]}], ["La plupart de ces hospitalisations pourraient cependant \u00eatre \u00e9vit\u00e9es gr\u00e2ce \u00e0 un meilleur contr\u00f4le de l'asthme et \u00e0 l'am\u00e9lioration de l\u2019\u00e9ducation th\u00e9rapeutique de l'enfant asthmatique et de son entourage.", {"entities": []}], ["Skin sensitizers induce allergic reactions through the induction of reactive oxygen species.", {"entities": []}], ["Allyl nitrile from cruciferous vegetables has been reported to induce antioxidants and phase II detoxification enzymes in various tissues.", {"entities": []}], ["We assessed the effects of repeated exposure to allyl nitrile on sensitizer-induced allergic reactions.", {"entities": []}], ["Mice were dosed with allyl nitrile (0\u2013200 \u03bcmol/kg), and then received a dermal application of 1 of 3 sensitizers on the left ear or 1 of 2 vehicles on the right ear.", {"entities": []}], ["Quantitative assessment of edema was carried out by measuring the difference in weight between the portions taken from the right and left ears.", {"entities": []}], ["We tested enzymes (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and thiobarbituric acid reactive substances (TBARS) in ears.", {"entities": []}], ["Repeated exposure to allyl nitrile reduced edemas induced by glutaraldehyde and by 2, 4-dinitrochlorobenzene (DNCB), but not by formaldehyde.", {"entities": []}], ["The repeated exposure decreased levels of TBARS, a marker of oxidative stress, induced by glutaraldehyde and by DNCB, but not by formaldehyde.", {"entities": []}], ["Allyl nitrile elevated SOD levels for the 3 sensitizers, and CAT levels for formaldehyde and DNCB.", {"entities": []}], ["Allyl nitrile also increased GPx levels for formaldehyde and DNCB, but not for glutaraldehyde.", {"entities": []}], ["The reduced edemas were associated with changes in oxidative stress levels and antioxidant enzymes.", {"entities": []}], ["Repeated exposure to allyl nitrile reduced allergic reactions induced by glutaraldehyde and by DNCB, but not by formaldehyde.", {"entities": []}], ["This reduction was associated with changes in ROS levels and antioxidant enzyme activities.", {"entities": []}], ["Recently, a new developmental pathway for CD4 T cells that is mediated by major histocompatibility complex class II\u2013positive thymocytes was identified (Choi, E.Y., K.C.", {"entities": [[42, 45, "GENE"]]}], ["Park, D.H. Chung, J.S.", {"entities": []}], ["Yang, E. Simpson, and S.H.", {"entities": []}], ["23:387\u2013396; Li, W., M.G.", {"entities": []}], ["Gourley, B.P.", {"entities": []}], ["McCarthy, D.B.", {"entities": []}], ["Sant'angelo, and C.H.", {"entities": []}], ["23:375\u2013386).", {"entities": []}], ["We demonstrate that thymocyte-selected CD4 (T-CD4) T cells can rapidly produce interferon \u03b3 and interleukin (IL) 4 upon in vivo and in vitro T cell receptor stimulation.", {"entities": [[39, 42, "GENE"], [46, 49, "GENE"]]}], ["These T-CD4 T cells appear to be effector cells producing both T helper type 1 (Th1) and Th2 cytokines, and they maintain a potential to produce Th2 cytokines under Th1-skewing conditions in a signal transducer and activator of transcription 6\u2013independent manner.", {"entities": []}], ["The IL-4 mRNA level is high in CD4 single-positive thymocytes if they are selected on thymocytes, which is at least partly caused by enhanced histone acetylation of the IL-4 locus.", {"entities": [[31, 34, "GENE"]]}], ["However, mice that can generate T-CD4 T cells showed attenuated immune responses in an allergen-induced airway inflammation model, suggesting a protective role for T-CD4 T cells during an airway challenge.", {"entities": []}], ["Our results imply that this thymic selection pathway plays an important role in determining the effector function of the resulting CD4 cells and in regulating immune response.", {"entities": [[131, 134, "GENE"]]}], ["Dendritic cells (DCs) as professional antigen presenting cells (APCs) play a critical role in the regulation of host immune responses.", {"entities": [[64, 68, "GENE"]]}], ["DCs evolve from immature, antigen-capturing cells, to mature antigen-presenting cells.", {"entities": []}], ["The relative contribution of DCs to cigarette smoke-induced inflammation is not well documented.", {"entities": []}], ["In the current study, we investigated a modulatory effect of cigarette smoke extract (CSE) on differentiation, maturation and function of DCs.", {"entities": []}], ["Primary murine DCs were grown from bone marrow cells with GM-CSF.", {"entities": []}], ["Development of DC was analyzed by expression of CD11c, MHCII, CD86, CD40 and CD83 using flow cytometry.", {"entities": [[62, 66, "GENE"], [68, 72, "GENE"], [77, 81, "GENE"]]}], ["Murine DC\u2019s and human L428 cells were co-cultured with CSE for various periods of time.", {"entities": []}], ["Functional activity was analyzed by measuring FITC-dextran uptake, cytokine production and the ability to stimulate T cell activation in a mixed lymphocyte reaction.", {"entities": []}], ["Our results show that short-term CSE stimulation (~24\u00a0h) influence the maturation status of newly differentiated and immature DCs towards more mature cells as revealed by upregulation of MHCII, CD83, CD86, CD40, reduction in antigen up-take capacity and enhanced secretion of pro-inflammatory (IL-12, IL-6 and TNF-\u03b1) cytokines.", {"entities": [[194, 198, "GENE"], [200, 204, "GENE"], [206, 210, "GENE"]]}], ["Interestingly, long-term CSE exposure, time- and concentration-dependently, suppressed the development of functional DCs.", {"entities": []}], ["This suppression was demonstrated by a decline in CD11c/MHCII, CD83, CD86 and CD40 expression, the production of cytokines and ability to stimulate T lymphocytes.", {"entities": [[63, 67, "GENE"], [69, 73, "GENE"], [78, 82, "GENE"]]}], ["Moreover, CSE significantly suppressed the endocytosis function of mouse DCs which was not due to diminished DC viability.", {"entities": []}], ["Similar to mouse DCs, long-term co-culturing of the human L428 DC cell line with CSE time-dependently suppressed the expression of CD54.", {"entities": []}], ["The present study provides evidence that CSE modulates DC-mediated immune responses via affecting both the function and maturation of DCs.", {"entities": []}], ["The suppressive effects of cigarette smoke on DC function might lead to impaired immune responses to various infections.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-015-0291-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma is a common yet incompletely understood health problem associated with a high morbidity burden.", {"entities": [[0, 6, "DISEASE"]]}], ["A wide variety of seasonally variable environmental stimuli such as viruses and air pollution are believed to influence asthma morbidity.", {"entities": [[120, 126, "DISEASE"]]}], ["This study set out to examine the seasonal patterns of asthma hospitalisations in relation to age and gender for the province of Ontario over a period of 12 years.", {"entities": [[55, 61, "DISEASE"]]}], ["A retrospective, population-based study design was used to assess temporal patterns in hospitalisations for asthma from April 1, 1988 to March 31, 2000.", {"entities": [[108, 114, "DISEASE"]]}], ["Approximately 14 million residents of Ontario eligible for universal healthcare coverage during this time were included for analysis.", {"entities": []}], ["Time series analyses were conducted on monthly aggregations of hospitalisations.", {"entities": []}], ["There is strong evidence of an autumn peak and summer trough seasonal pattern occurring every year over the 12-year period (Fisher-Kappa (FK) = 23.93, p > 0.01; Bartlett Kolmogorov Smirnov (BKS) = 0.459, p < 0.01).", {"entities": []}], ["This pattern was observed in both sexes.", {"entities": []}], ["However, young males (0\u20134 years) were hospitalised at two to three times the rate of females of the same age.", {"entities": []}], ["Rates were much lower in the older age groups.", {"entities": []}], ["A downward trend in asthma hospitalisations was observed in the total population over the twelve-year period (beta = -0.980, p < 0.01).", {"entities": [[20, 26, "DISEASE"]]}], ["A clear and consistent seasonal pattern was observed in this study for asthma hospitalisations.", {"entities": [[71, 77, "DISEASE"]]}], ["These findings have important implications for the development of effective management and prevention strategies.", {"entities": []}], ["Patients with COPD who remain symptomatic on long-acting bronchodilator monotherapy may benefit from step-up therapy to a long-acting bronchodilator combination.", {"entities": []}], ["This study evaluated the efficacy and safety of umeclidinium (UMEC)/vilanterol (VI) in patients with moderate COPD who remained symptomatic on tiotropium (TIO).", {"entities": []}], ["In this randomized, blinded, double-dummy, parallel-group study (NCT01899742), patients (N=494) who were prescribed TIO for \u22653 months at screening (forced expiratory volume in 1 s [FEV 1 ]: 50%\u201370% of predicted; modified Medical Research Council [mMRC] score \u22651) and completed a 4-week run-in with TIO were randomized to UMEC/VI 62.5/25 \u00b5g or TIO 18 \u00b5g for 12 weeks.", {"entities": [[181, 184, "GENE"]]}], ["Efficacy assessments included trough FEV 1 at Day 85 (primary end point), 0\u20133 h serial FEV 1 , rescue medication use, Transition Dyspnea Index (TDI), St George\u2019s Respiratory Questionnaire (SGRQ), and COPD Assessment Test (CAT).", {"entities": [[37, 40, "GENE"], [87, 90, "GENE"], [37, 40, "GENE"], [87, 90, "GENE"]]}], ["Safety evaluations included adverse events (AEs).", {"entities": []}], ["Compared with TIO, UMEC/VI produced greater improvements in trough FEV 1 (least squares [LS] mean difference: 88 mL at Day 85 [95% confidence interval {CI}: 45\u2013131]; P <0.001) and FEV 1 after 5 min on Day 1 (50 mL [95% CI: 27\u201372]; P <0.001).", {"entities": [[67, 70, "GENE"], [180, 183, "GENE"], [67, 70, "GENE"], [180, 183, "GENE"]]}], ["Reductions in rescue medication use over 12 weeks were greater with UMEC/VI versus TIO (LS mean change: \u22120.1 puffs/d [95% CI: \u22120.2\u20130.0]; P \u22640.05).", {"entities": []}], ["More patients achieved clinically meaningful improvements in TDI score (\u22651 unit) with UMEC/VI (63%) versus TIO (49%; odds ratio at Day 84=1.78 [95% CI: 1.21\u20132.64]; P \u22640.01).", {"entities": []}], ["Improvements in SGRQ and CAT scores were similar between treatments.", {"entities": []}], ["The incidence of AEs was similar with UMEC/VI (30%) and TIO (31%).", {"entities": []}], ["UMEC/VI step-up therapy provides clinical benefit over TIO monotherapy in patients with moderate COPD who are symptomatic on TIO alone.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) impairs quality of life and leads to premature mortality.", {"entities": []}], ["COPD sufferers experience progressive deterioration of lung function and decreased ability to undertake day-to-day activities.", {"entities": []}], ["Ginseng has been used for thousands of years in Chinese medicine for respiratory symptoms.", {"entities": []}], ["Several controlled clinical trials using ginseng for COPD have shown promising clinical effect, however these studies were generally small and with some potential bias, prompting the need for rigorously designed studies.", {"entities": []}], ["The objective of this study is to evaluate the therapeutic value and safety profile of a standardised root extract of Panax ginseng C.A Meyer (ginseng) for symptomatic relief, with a focus on quality of life (QoL) improvements in individuals with moderate (Stage II) COPD FEV1/FVC < 0.7 and FEV 1 50% - 80% predicted.", {"entities": [[291, 294, "GENE"]]}], ["This paper describes the design of a randomised, multi-centre, double-blind, placebo controlled, two-armed parallel clinical trial.", {"entities": []}], ["Two trial sites in Melbourne Australia will proportionately randomise a total of 168 participants to receive either ginseng capsule (100 mg) or matching placebo twice daily for 24 weeks.", {"entities": []}], ["The primary outcomes will be based on three validated QoL questionnaires, St Georges Respiratory Questionnaire (SGRQ), Short Form Health Survey (SF-36) and the COPD Assessment Test (CAT).", {"entities": []}], ["Secondary outcomes are based on lung function testing, relief medication usage and exacerbation frequency and severity.", {"entities": []}], ["Safety endpoints include blood tests and adverse event reporting.", {"entities": []}], ["Intention-to-treat will be applied to all data analyses.", {"entities": []}], ["Findings from this study may lead to new therapeutic development for chronic respiratory diseases, particularly COPD.", {"entities": []}], ["This protocol may also guide other investigators to develop quality herbal medicine clinical trials in the future.", {"entities": []}], ["Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12610000768099", {"entities": []}], ["Pandemic influenza A (H1N1) 2009 virus emerged in 2009 and caused pandemic with high morbidity and mortality in India and worldwide.", {"entities": [[9, 18, "DISEASE"]]}], ["The number of H1N1-positive cases varied in different years in Rajasthan.", {"entities": []}], ["The objective of the study was to present the epidemiological profile of pandemic influenza A (H1N1) 2009 virus cases in Rajasthan from January to March 2015.", {"entities": [[82, 91, "DISEASE"]]}], ["A retrospective descriptive, record-based analysis of suspected and confirmed cases of pandemic influenza A (H1N1) 2009 virus infection in Rajasthan, India, from January to March 2015 was performed.", {"entities": [[96, 105, "DISEASE"]]}], ["Testing was done as per the Centers for Disease Control guidelines at nine laboratories approved by the Government of Rajasthan.", {"entities": []}], ["Data were analyzed in terms of demographic characteristics, clinical presentation and outcome.", {"entities": []}], ["Among 18,187 tested cases, 6203 (34.10%) were positive.", {"entities": []}], ["Death occurred in 378 cases, with six per cent case fatality rate.", {"entities": []}], ["Maximum number of cases ( n =2801) and deaths ( n =101) were from Jaipur zone.", {"entities": []}], ["The highest number of cases, 47.60 per cent (2953/6203) and deaths, 52.11 per cent (197/378) were in the age group of 26-50 yr; 52.64 per cent (199/378) of deaths occurred in females.", {"entities": []}], ["The highest number (63.5%) of deaths was from urban areas.", {"entities": []}], ["Associated risk factors were observed in 59.44 per cent of the death cases, pregnancy being the predominant predisposing factor.", {"entities": []}], ["In 61.92 per cent of patients, death occurred within three days of hospitalization.", {"entities": []}], ["H1N1 epidemic caused high morbidity and mortality in early 2015, particularly in the younger and middle-aged population and pregnant women in Rajasthan State of India.", {"entities": []}], ["The study highlights the regular surveillance of influenza like illness, early diagnosis and timely initiation of therapy in suspected cases.", {"entities": [[49, 58, "DISEASE"]]}], ["Asthma is a chronic allergic disease characterized by airway inflammation, airway hyper-responsiveness (AHR), and mucus hypersecretion.", {"entities": [[0, 6, "DISEASE"], [104, 107, "GENE"]]}], ["T-lymphocytes are involved in the pathogenesis of asthma, mediating airway inflammatory reactions by secreting cytokines.", {"entities": [[50, 56, "DISEASE"]]}], ["The phosphoinositide 3-kinase (PI3K) and Notch signaling pathways are associated with T cell signaling, proliferation, and differentiation, and are important in the progression of asthma.", {"entities": [[180, 186, "DISEASE"]]}], ["Thus, compounds that can modulate T cell proliferation and function may be of clinical value.", {"entities": []}], ["Here, we assessed the effects of tangeretin, a plant-derived flavonoid, in experimental asthma.", {"entities": [[88, 94, "DISEASE"]]}], ["BALB/c mice at postnatal day (P) 12 were challenged with ovalbumin (OVA).", {"entities": []}], ["Separate groups of mice (n=18/group) were administered tangeretin at 25 or 50 mg/kg body weight by oral gavage.", {"entities": []}], ["Dexamethasone was used as a positive control.", {"entities": []}], ["Tangeretin treatment reduced inflammatory cell infiltration in bronchoalveolar lavage fluid (BALF) and also restored the normal histology of lung tissues.", {"entities": []}], ["OVA-specific IgE levels in serum and BALF were reduced.", {"entities": []}], ["AHR, as determined by airway resistance and lung compliance, was normalized.", {"entities": [[0, 3, "GENE"]]}], ["Flow cytometry analyses revealed a reduced Th17 cell population.", {"entities": []}], ["Tangeretin reduced the levels of Th2 and Th17 cytokines and raised IFN-\u03b3 levels.", {"entities": []}], ["PI3K signaling was inhibited.", {"entities": []}], ["The expressions of the Notch 1 receptor and its ligands Jagged 1 and 2 were downregulated by tangeretin.", {"entities": []}], ["Our findings support the possible use of tangeretin for treating allergic asthma.", {"entities": [[65, 80, "DISEASE"], [74, 80, "DISEASE"]]}], ["Inhaled bronchodilator medications are central to the management of COPD and are frequently given on a regular basis to prevent or reduce symptoms.", {"entities": []}], ["While short-acting bronchodilators are a treatment option for people with relatively few COPD symptoms and at low risk of exacerbations, for the majority of patients with significant breathlessness at the time of diagnosis, long-acting bronchodilators may be required.", {"entities": []}], ["Dual bronchodilation with a long-acting \u03b2 2 -agonist and long-acting muscarinic antagonist may be more effective treatment for some of these patients, with the aim of improving symptoms.", {"entities": []}], ["This combination may also reduce the rate of exacerbations compared with a bronchodilator-inhaled corticosteroid combination in those with a history of exacerbations.", {"entities": []}], ["However, there is currently a lack of guidance on clinical indicators suggesting which patients should step up from mono- to dual bronchodilation.", {"entities": []}], ["In this article, we discuss a number of clinical indicators that could prompt a patient and physician to consider treatment escalation, while being mindful of the need to avoid unnecessary polypharmacy.", {"entities": []}], ["These indicators include insufficient symptomatic response, a sustained increased requirement for rescue medication, suboptimal 24-hour symptom control, deteriorating symptoms, the occurrence of exacerbations, COPD-related hospitalization, and reductions in lung function.", {"entities": []}], ["Future research is required to provide a better understanding of the optimal timing and benefits of treatment escalation and to identify the appropriate tools to inform this decision.", {"entities": []}], ["Marine n-3 fatty acids and \u03b3-linolenic acid both have anti-inflammatory effects and may be useful to help treat inflammatory diseases.", {"entities": []}], ["The effects of these alone or combined were examined in patients with arthritis in a randomized controlled trial.", {"entities": [[70, 79, "DISEASE"]]}], ["Patients with rheumatoid arthritis or psoriatic arthritis were randomized into four groups in a double-blind, placebo-controlled parallel designed study.", {"entities": [[14, 34, "DISEASE"], [25, 34, "DISEASE"], [48, 57, "DISEASE"], [38, 57, "DISEASE"]]}], ["Patients received the respective capsules (1: 3.0 g n-3 LC-PUFA/d; 2: 3.2 g \u03b3-linolenic acid/d; 3: 1.6 g n-3 LC-PUFA + 1.8 g \u03b3-linolenic acid/d; 4: 3.0 g olive oil) for a twelve week period.", {"entities": []}], ["Clinical status was evaluated and blood samples were taken at the beginning and at the end of the period.", {"entities": []}], ["Differences before and after intervention were tested with paired t-test or with Wilcoxon test for non-normal data distribution.", {"entities": []}], ["60 patients (54 rheumatoid arthritis, 6 psoriatic arthritis) were randomised, 47 finished per protocol.", {"entities": [[16, 36, "DISEASE"], [27, 36, "DISEASE"], [50, 59, "DISEASE"], [40, 59, "DISEASE"]]}], ["In group 1, the ratio of arachidonic acid (AA)/eicosapentaenoic acid (EPA) decreased from 6.5 \u00b1 3.7 to 2.7 \u00b1 2.1 in plasma lipids and from 25.1 \u00b1 10.1 to 7.2 \u00b1 4.7 in erythrocyte membranes (p \u2264 0.001).", {"entities": []}], ["There was no significant influence on AA/EPA ratio due to interventions in group 2-4.", {"entities": []}], ["In group 2, the intake of \u03b3-linolenic acid resulted in a strong rise of \u03b3-linolenic acid and dihomo-\u03b3-linolenic acid concentrations in plasma lipids, cholesteryl esters, and erythrocyte membranes.", {"entities": []}], ["The combination of n-3 LC-PUFA and \u03b3-linolenic acid (group 3) led to an increase of \u03b3-linolenic acid and dihomo-\u03b3-linolenic acid concentrations in plasma lipids, cholesteryl esters, and erythrocyte mem-branes.", {"entities": []}], ["This increase was only half of that in group 2.", {"entities": []}], ["Incorporation of eicosanoid precursor FAs was influenced by an intake of n-3 LC-PUFA and \u03b3-linolenic acid suggesting a possible benefit for therapy of chronic inflammatory diseases.", {"entities": [[38, 41, "GENE"]]}], ["ClinicalTrials NCT01179971", {"entities": []}], ["The exponential increase in health-related online platforms has made the Internet one of the main sources of health information globally.", {"entities": []}], ["The quality of health contents disseminated on the Internet has been a central focus for many researchers.", {"entities": []}], ["To date, however, few comparative content analyses of pro- and anti-vaccination websites have been conducted, and none of them compared the quality of information.", {"entities": []}], ["The main objective of this study was therefore to bring new evidence on this aspect by comparing the quality of pro- and anti-vaccination online sources.", {"entities": []}], ["Based on past literature and health information quality evaluation initiatives, a 40-categories assessment tool (Online Vaccination Information Quality Codebook) was developed and used to code a sample of 1093 webpages retrieved via Google and two filtered versions of the same search engine.", {"entities": []}], ["The categories investigated were grouped into four main quality dimensions: web-related design quality criteria (10 categories), health-specific design quality criteria (3 categories), health related content attributes (12 categories) and vaccination-specific content attributes (15 categories).", {"entities": []}], ["Data analysis comprised frequency counts, cross tabulations, Pearson\u2019s chi-square, and other inferential indicators.", {"entities": []}], ["The final sample included 514 webpages in favor of vaccination, 471 against, and 108 neutral.", {"entities": []}], ["Generally, webpages holding a favorable view toward vaccination presented more quality indicators compared to both neutral and anti-vaccination pages.", {"entities": []}], ["However, some notable exceptions to this rule were observed.", {"entities": []}], ["In particular, no differences were found between pro- and anti-vaccination webpages as regards vaccination-specific content attributes.", {"entities": []}], ["Our analyses showed that the overall quality of pro-vaccination webpages is superior to anti-vaccination online sources.", {"entities": []}], ["The developed coding scheme was proven to be a helpful and reliable tool to judge the quality of vaccination-related webpages.", {"entities": []}], ["Based on the results, we advance recommendations for online health information providers as well as directions for future research in this field.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-016-2722-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Robustness measures the performance of estimation methods when they work under non-ideal conditions.", {"entities": []}], ["We compared the robustness of artificial neural networks (ANNs) and multilinear fitting (MLF) methods in estimating respiratory system compliance ( C RS ) during mechanical ventilation (MV).", {"entities": []}], ["Twenty-four anaesthetized pigs underwent MV.", {"entities": []}], ["Airway pressure, flow and volume were recorded at fixed intervals after the induction of acute lung injury.", {"entities": []}], ["After consecutive mechanical breaths, an inspiratory pause (BIP) was applied in order to calculate C RS using the interrupter technique.", {"entities": []}], ["From the breath preceding the BIP, ANN and MLF had to compute C RS in the presence of two types of perturbations: transient sensor disconnection (TD) and random noise (RN).", {"entities": []}], ["Performance of the two methods was assessed according to Bland and Altman.", {"entities": []}], ["The ANN presented a higher bias and scatter than MLF during the application of RN, except when RN was lower than 2% of peak airway pressure.", {"entities": []}], ["During TD, MLF algorithm showed a higher bias and scatter than ANN.", {"entities": []}], ["After the application of RN, ANN and MLF maintain a stable performance, although MLF shows better results.", {"entities": []}], ["ANNs have a more stable performance and yield a more robust estimation of C RS than MLF in conditions of transient sensor disconnection.", {"entities": []}], ["The online version of this article (doi:10.1007/s11517-017-1631-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The anti-inflammatory activity of Andrographis paniculata (Acanthaceae), a traditional medicine widely used in Asia, is commonly attributed to andrographolide, its main secondary metabolite.", {"entities": []}], ["Commercial A. paniculata extracts are standardised to andrographolide content.", {"entities": []}], ["We undertook the present study to investigate 1) how selective enrichment of andrographolide in commercial A. paniculata extracts affects the variability of non-standardised phytochemical components and 2) if variability in the non-standardised components of the extract affects the pharmacological activity of andrographolide itself.", {"entities": []}], ["We characterized 12 commercial, standardised (\u226530% andrographolide) batches of A. paniculata extracts from India by HPLC profiling.", {"entities": []}], ["We determined the antioxidant capacity of the extracts using 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, oxygen radical antioxidant capacity (ORAC) and a Folin-Ciocalteu (FC) antioxidant assays.", {"entities": []}], ["Their anti-inflammatory activity was assessed by assaying their inhibitory effect on the release of tumor necrosis factor alpha (TNF-\u03b1) in the human monocytic cell line THP-1.", {"entities": []}], ["The andrographolide content in the samples was close to the claimed value (32.2\u2009\u00b1\u20092.1%, range 27.5 to 35.9%).", {"entities": []}], ["Twenty-one non-standardised constituents exhibited more than 2-fold variation in HPLC peak intensities in the tested batches.", {"entities": []}], ["The chlorogenic acid content of the batches varied more than 30-fold.", {"entities": []}], ["The DPPH free radical scavenging activity varied ~3-fold, the ORAC and FC antioxidant capacity varied ~1.5 fold among batches.", {"entities": []}], ["In contrast, the TNF-\u03b1 inhibitory activity of the extracts exhibited little variation and comparison with pure andrographolide indicated that it was mostly due to their andrographolide content.", {"entities": []}], ["Standardised A. paniculata extracts contained the claimed amount of andrographolide but exhibited considerable phytochemical background variation.", {"entities": []}], ["DPPH radical scavenging activity of the extracts was mostly due to the flavonoid/phenlycarboxylic acid compounds in the extracts.", {"entities": []}], ["The inhibitory effect of andrographolide on the release of TNF-\u03b1 was little affected by the quantitative variation of the non-standardised constituents.", {"entities": []}], ["Exposure to cotton or grain dust causes an obstructive bronchitis in certain subjects, mechanisms of which are poorly understood.", {"entities": [[55, 65, "DISEASE"]]}], ["A difficulty encountered in discerning mechanisms of this airway disease is the lack of knowledge of the active components of these dusts.", {"entities": []}], ["Clinical features suggest common but not exact mechanisms of the airway disease associated with these vegetable dusts.", {"entities": []}], ["Human and animal studies show evidence of acellular and cellular inflammatory mechanisms of the bronchoconstriction and inflammation associated with these disorders.", {"entities": []}], ["Potential cellular sources include alveolar macrophages, polymorphonuclear leukocytes, mast cells, basophils, eosinophils and lymphocytes.", {"entities": []}], ["Acellular origins include the complement and humoral antibody systems, both of which have been implicated, although their pathogenic role in grain or cotton dust disorders is uncertain.", {"entities": []}], ["In this review we critically address potential inflammatory mechanisms of airway alterations resulting from cotton or grain dust exposure.", {"entities": []}], ["General mechanisms of bronchoconstriction are first presented, then specific studies dealing with either of the two dusts are discussed.", {"entities": []}], ["We believe this area of research may be fruitful in dissecting mechanisms of bronchoconstriction and airway inflammation, especially as more human studies are undertaken.", {"entities": []}], ["In most natural environments, the large majority of mammals harbour parasitic helminths that often live as adults within the intestine for prolonged periods (1\u20132\u00a0years)", {"entities": []}], ["This study investigated the incidence of potentially preventable hospitalisations in the first two years of life among children in the National Health Insurance (NHI) system of Taiwan.", {"entities": []}], ["It also examined income disparities in potentially preventable hospitalisations across four economic categories: below a government-established poverty line and low-, middle-, and upper-income.", {"entities": []}], ["Five major diseases causing potentially preventable hospitalisations were investigated: gastroenteritis and dehydration, asthma and chronic bronchitis, acute upper respiratory infections, lower respiratory infections, and acute injuries and poisonings.", {"entities": [[88, 103, "DISEASE"], [121, 127, "DISEASE"], [140, 150, "DISEASE"]]}], ["NHI data on enrolee registrations and use of ambulatory and hospital care by all children born between July 1, 2003 and June 30, 2004 (n = 218,158) was used for the study.", {"entities": []}], ["The negative binomial regression method was used to identify factors associated with total inpatient care and the severity level for various types of potentially preventable hospitalisations during the first two years of life.", {"entities": []}], ["This study found high inpatient expenses for lower respiratory infections for children in all income categories.", {"entities": []}], ["Furthermore, results from the multivariate analysis indicate that children in the lowest economic category used inpatient care to a much greater extent than better-off children for problems considered potentially avoidable through primary prevention or through timely outpatient care.", {"entities": []}], ["This was especially true for acute injuries and poisonings and for lower respiratory infections.", {"entities": []}], ["On average, and controlling for other variables, a child in poverty spent 6.1 times more days in inpatient care for acute injuries and poisonings (p < 0.01) and 2.7 times more days for lower respiratory infections (p < 0.01) before age two, compared with a similarly-aged high-income child.", {"entities": []}], ["The results also suggest a connection between economic status and the severity of a condition causing a potentially avoidable hospital admission.", {"entities": []}], ["On average, length of stay for each admission for gastroenteritis and dehydration for children in poverty was 1.3 times that for high-income children (p < 0.01).", {"entities": [[50, 65, "DISEASE"]]}], ["Both the ratios for lower respiratory infections and for acute upper respiratory infections were 1.2 (p < 0.01 for both).", {"entities": []}], ["There were high hospital admission rates and lengths of stays for lower respiratory infections among young children in all income categories.", {"entities": []}], ["Hospital care use of young children in the poorest category was significantly higher for acute injuries and poisonings as well as for lower respiratory infections, compared with those of better-off children.", {"entities": []}], ["The findings suggest the need for increased attention to these two disease types.", {"entities": []}], ["It particularly calls for more research on the causes of high hospital care use for lower respiratory infections and on the reasons for large economic disparities in hospital care use for acute injuries and poisonings.", {"entities": []}], ["Current dietary supplement use in Australia is not well described.", {"entities": []}], ["We investigated the prevalence and predictors of supplement use in the Australian population ( n = 19,257) using data from the 2014\u20132015 National Health Survey.", {"entities": []}], ["We reported the prevalence of supplement use by sex and age group and investigated the independent predictors of supplement use in adults, adolescents, and children using multiple logistic regression models.", {"entities": []}], ["A total of 43.2% of adults (34.9% of males, 50.3% of females), 20.1% of adolescents (19.7% of males, 20.6% of females), and 23.5% of children (24.4% of males, 22.5% of females) used at least one dietary supplement in the previous two weeks.", {"entities": []}], ["The most commonly used supplements were multivitamins and/or multiminerals and fish oil preparations.", {"entities": []}], ["In adults, independent predictors of supplement use included being female, increasing age, being born outside Australia and other main English-speaking countries, having a higher education level, having a healthy BMI compared to those who were obese, being physically active, and being a non-smoker.", {"entities": []}], ["To our knowledge, this is the first detailed investigation of dietary supplement use in a nationally-representative sample of the Australian population.", {"entities": []}], ["Future studies investigating the contribution of supplements to overall dietary intakes of vitamins, minerals, and omega-3 fatty acids are warranted.", {"entities": []}], ["Multimorbidity receives increasing scientific attention.", {"entities": []}], ["So does the detrimental health impact of adverse childhood experiences (ACE).", {"entities": []}], ["Aetiological pathways from ACE to complex disease burdens are under investigation.", {"entities": []}], ["In this context, the concept of allostatic overload is relevant, denoting the link between chronic detrimental stress, widespread biological perturbations and disease development.", {"entities": []}], ["This study aimed to explore associations between self-reported childhood quality, biological perturbations and multimorbidity in adulthood.", {"entities": []}], ["We included 37 612 participants, 30\u201369 years, from the Nord-Tr\u00f8ndelag Health Study, HUNT3 (2006\u20138).", {"entities": []}], ["Twenty one chronic diseases, twelve biological parameters associated with allostatic load and four behavioural factors were analysed.", {"entities": []}], ["Participants were categorised according to the self-reported quality of their childhood, as reflected in one question, alternatives ranging from \u2018very good\u2019 to \u2018very difficult\u2019.", {"entities": []}], ["The association between childhood quality, behavioural patterns, allostatic load and multimorbidity was compared between groups.", {"entities": []}], ["Overall, 85.4% of participants reported a \u2018good\u2019 or \u2018very good\u2019 childhood; 10.6% average, 3.3% \u2018difficult\u2019 and 0.8% \u2018very difficult\u2019.", {"entities": []}], ["Childhood difficulties were reported more often among women, smokers, individuals with sleep problems, less physical activity and lower education.", {"entities": []}], ["In total, 44.8% of participants with a very good childhood had multimorbidity compared to 77.1% of those with a very difficult childhood (Odds ratio: 5.08; 95% CI: 3.63\u20137.11).", {"entities": []}], ["Prevalences of individual diseases also differed significantly according to childhood quality; all but two (cancer and hypertension) showed a significantly higher prevalence (p<0.05) as childhood was categorised as more difficult.", {"entities": [[119, 131, "DISEASE"], [108, 114, "DISEASE"]]}], ["Eight of the 12 allostatic parameters differed significantly between childhood groups.", {"entities": []}], ["We found a general, graded association between self-reported childhood difficulties on the one hand and multimorbidity, individual disease burden and biological perturbations on the other.", {"entities": []}], ["The finding is in accordance with previous research which conceptualises allostatic overload as an important route by which childhood adversities become biologically embodied.", {"entities": []}], ["Valvular heart disease may be a pre-existing complication of pregnancy or it may be diagnosed for the first time during pregnancy.", {"entities": [[9, 22, "DISEASE"]]}], ["Accurate diagnosis, tailored therapy and an understanding of the physiology and pathophysiology of pregnancy are necessary components of management, best achieved through the use of multidisciplinary clinics.", {"entities": []}], ["This review outlines the management of specific lesions, with particular reference to post-rheumatic valvular heart disease.", {"entities": [[110, 123, "DISEASE"]]}], ["The highly nutritional and ecofriendly Spirulina ( Arthrospira platensis ) has hypolipidemic, hypoglycemic, and antihypertensive properties.", {"entities": []}], ["Spirulina contains functional compounds, such as phenolics, phycocyanins, and polysaccharides, with antioxidant, anti-inflammatory, and immunostimulating effects.", {"entities": []}], ["Studies conducted on Spirulina suggest that it is safe in healthy subjects, but attitude to eating probably affects the acceptability of Spirulina containing foods.", {"entities": []}], ["Although the antioxidant effect of Spirulina is confirmed by the intervention studies, the concerted modulation of antioxidant and inflammatory responses, suggested by in vitro and animal studies, requires more confirmation in humans.", {"entities": []}], ["Spirulina supplements seem to affect more effectively the innate immunity, promoting the activity of natural killer cells.", {"entities": []}], ["The effects on cytokines and on lymphocytes' proliferation depend on age, gender, and body weight differences.", {"entities": []}], ["In this context, ageing and obesity are both associated with chronic low grade inflammation, immune impairment, and intestinal dysbiosis.", {"entities": [[28, 35, "DISEASE"]]}], ["Microbial-modulating activities have been reported in vitro, suggesting that the association of Spirulina and probiotics could represent a new strategy to improve the growth of beneficial intestinal microbiota.", {"entities": []}], ["Although Spirulina might represent a functional food with potential beneficial effects on human health, the human interventions used only supplements.", {"entities": []}], ["Therefore, the effect of food containing Spirulina should be evaluated in the future.", {"entities": []}], ["Simulation is increasingly used in medical education, promoting active learning and retention; however, increasing use also requires considerable instructor resources.", {"entities": []}], ["Simulation may provide a safe environment for students to teach each other, which many will need to do when they enter residency.", {"entities": []}], ["Along with reinforcing learning and increasing retention, peer teaching could decrease instructor demands.", {"entities": []}], ["Our objective was to determine the effectiveness of peer-taught simulation compared to physician-led simulation.", {"entities": []}], ["We hypothesized that peer-taught simulation would lead to equivalent knowledge acquisition when compared to physician-taught sessions and would be viewed positively by participants.", {"entities": []}], ["This was a quasi-experimental study in an emergency medicine clerkship.", {"entities": []}], ["The control group was faculty taught.", {"entities": []}], ["In the peer-taught intervention group, students were assigned to teach one of the three simulation-based medical emergency cases.", {"entities": []}], ["Each student was instructed to master their topic and teach it to their peers using the provided objectives and resource materials.", {"entities": []}], ["The students were assigned to groups of three, with all three cases represented; students took turns leading their case.", {"entities": []}], ["Three groups ran simultaneously.", {"entities": []}], ["During the intervention sessions, one physician was present to monitor the accuracy of learning and to answer questions, while three physicians were required for the control groups.", {"entities": []}], ["Outcomes compared pre-test and post-test knowledge and student reaction between control and intervention groups.", {"entities": []}], ["Both methods led to equally improved knowledge; mean score for the post-test was 75% for both groups (p=0.6) and were viewed positively.", {"entities": []}], ["Students in the intervention group agreed that peer-directed learning was an effective way to learn.", {"entities": []}], ["However, students in the control group scored their simulation experience more favorably.", {"entities": []}], ["In general, students\u2019 response to peer teaching was positive, students learned equally well, and found peer-taught sessions to be interactive and beneficial.", {"entities": []}], ["The electronic nose (e-nose) detects volatile organic compounds (VOCs) in exhaled air.", {"entities": []}], ["We hypothesized that the exhaled VOCs print is different in stable vs. exacerbated patients with chronic obstructive pulmonary disease (COPD), particularly if the latter is associated with airway bacterial infection, and that the e-nose can distinguish them.", {"entities": [[97, 134, "DISEASE"]]}], ["Smell-prints of the bacteria most commonly involved in exacerbations of COPD (ECOPD) were identified in vitro .", {"entities": []}], ["Subsequently, we tested our hypothesis in 93 patients with ECOPD, 19 of them with pneumonia, 50 with stable COPD and 30 healthy controls in a cross-sectional case-controlled study.", {"entities": [[82, 91, "DISEASE"]]}], ["Secondly, ECOPD patients were re-studied after 2 months if clinically stable.", {"entities": []}], ["Exhaled air was collected within a Tedlar bag and processed by a Cynarose 320 e-nose.", {"entities": []}], ["Breath-prints were analyzed by Linear Discriminant Analysis (LDA) with \u201cOne Out\u201d technique and Sensor logic Relations (SLR).", {"entities": []}], ["Sputum samples were collected for culture.", {"entities": []}], ["ECOPD with evidence of infection were significantly distinguishable from non-infected ECOPD ( p = 0.018), with better accuracy when ECOPD was associated to pneumonia.", {"entities": [[156, 165, "DISEASE"]]}], ["The same patients with ECOPD were significantly distinguishable from stable COPD during follow-up ( p = 0.018), unless the patient was colonized.", {"entities": []}], ["Additionally, breath-prints from COPD patients were significantly distinguished from healthy controls.", {"entities": []}], ["Various bacteria species were identified in culture but the e-nose was unable to identify accurately the bacteria smell-print in infected patients.", {"entities": []}], ["E-nose can identify ECOPD, especially if associated with airway bacterial infection or pneumonia.", {"entities": [[87, 96, "DISEASE"]]}], ["The aim of this review is to examine the causes, pathophysiology and experimental models of non-infectious pharyngitis (sore throat).", {"entities": [[107, 118, "DISEASE"]]}], ["The causes of sore throat can be infectious (viruses, bacteria, and fungi) or non-infectious, although the relative proportion of each is not well documented.", {"entities": []}], ["A PubMed database search was performed for studies of non-infectious sore throat.", {"entities": []}], ["Non-infectious causes of sore throat include: physico-chemical factors, such as smoking, snoring, shouting, tracheal intubation, medications, or concomitant illness; and environmental factors including indoor and outdoor air pollutants, temperature and humidity, and hazardous or occupational irritants.", {"entities": []}], ["The pathophysiology underlying non-infectious sore throat is largely uncharacterised, although neurogenic inflammation looks to be a promising candidate.", {"entities": []}], ["It is likely that there will be individual disposition factors or the coincidence of more than one irritant with possible\u2014up to now unknown\u2014interactions between them.", {"entities": []}], ["Therefore, experimental models with defined conditions and objective endpoints are needed.", {"entities": []}], ["A new model using cold dry air to directly induce pharyngeal irritation in humans, with pharyngeal lavage to measure biomarkers, may provide a useful tool for the study of mechanisms and treatment of non-infectious sore throat.", {"entities": []}], ["The implementation of electronic medical records (EMR) is becoming increasingly common.", {"entities": []}], ["Error and data loss reduction, patient-care efficiency increase, decision-making assistance and facilitation of event surveillance, are some of the many processes that EMRs help improve.", {"entities": []}], ["In addition, they show a lot of promise in terms of data collection to facilitate observational epidemiological studies and their use for this purpose has increased significantly over the recent years.", {"entities": []}], ["Even though the quantity and availability of the data are clearly improved thanks to EMRs, still, the problem of the quality of the data remains.", {"entities": []}], ["This is especially important when attempting to determine if an event has actually occurred or not.", {"entities": []}], ["We sought to assess the sensitivity, specificity, and agreement level of a codes-based algorithm for the detection of clinically relevant cardiovascular (CaVD) and cerebrovascular (CeVD) disease cases, using data from EMRs.", {"entities": []}], ["Three family physicians from the research group selected clinically relevant CaVD and CeVD terms from the international classification of primary care, Second Edition (ICPC-2), the ICD 10 version 2015 and SNOMED-CT 2015 Edition.", {"entities": []}], ["These terms included both signs, symptoms, diagnoses and procedures associated with CaVD and CeVD.", {"entities": []}], ["Terms not related to symptoms, signs, diagnoses or procedures of CaVD or CeVD and also those describing incidental findings without clinical relevance were excluded.", {"entities": []}], ["The algorithm yielded a positive result if the patient had at least one of the selected terms in their medical records, as long as it was not recorded as an error.", {"entities": []}], ["Else, if no terms were found, the patient was classified as negative.", {"entities": []}], ["This algorithm was applied to a randomly selected sample of the active patients within the hospital\u2019s HMO by 1/1/2005 that were 40\u201379\u00a0years old, had at least one year of seniority in the HMO and at least one clinical encounter.", {"entities": []}], ["Thus, patients were classified into four groups: (1) Negative patients (2) Patients with CaVD but without CeVD; (3) Patients with CeVD but without disease CaVD; (4) Patients with both diseases.", {"entities": []}], ["To facilitate the validation process, a stratified sample was taken so that each of the groups represented approximately 25% of the sample.", {"entities": []}], ["Manual chart review was used as the gold standard for assessing the algorithm\u2019s performance.", {"entities": []}], ["One-third of the patients were assigned randomly to each reviewer (Cohen\u2019s kappa 0.91).", {"entities": []}], ["Both coded and un-coded (free text) sections of the EMR were reviewed.", {"entities": []}], ["This was done from the first present clinical note in the patients chart to the last one registered prior to 1/1/2005.", {"entities": []}], ["The performance of the algorithm was compared against manual chart review.", {"entities": []}], ["It yielded high sensitivity (0.99, 95% CI 0.938\u20130.9971) and acceptable specificity (0.86, 95% CI 0.818\u20130.895) for detecting cases of CaVD and CeVD combined.", {"entities": []}], ["A qualitative analysis of the false positives and false negatives was performed.", {"entities": []}], ["We developed a simple algorithm, using only standardized and non-standardized coded terms within an EMR that can properly detect clinically relevant events and symptoms of CaVD and CeVD.", {"entities": []}], ["We believe that combining it with an analysis of the free text using an NLP approach would yield even better results.", {"entities": []}], ["The online version of this article (doi:10.1186/s13104-017-2600-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A growing body of literature highlights that racial discrimination has negative impacts on child health, although most studies have been limited to an examination of direct forms of racism using cross-sectional data.", {"entities": []}], ["We aim to provide further insights on the impact of early exposure to racism on child health using longitudinal data among Indigenous children in Australia and multiple indicators of racial discrimination.", {"entities": []}], ["We used data on 1239 Indigenous children aged 5\u201310\u00a0years from Waves 1\u20136 (2008\u20132013) of Footprints in Time , a longitudinal study of Indigenous children across Australia.", {"entities": []}], ["We examined associations between three dimensions of carer-reported racial discrimination (measuring the direct experiences of children and vicarious exposure by their primary carer and family) and a range of physical and mental health outcomes.", {"entities": []}], ["Analysis was conducted using multivariate logistic regression within a multilevel framework.", {"entities": []}], ["Two-fifths (40%) of primary carers, 45% of families and 14% of Indigenous children aged 5\u201310\u00a0years were reported to have experienced racial discrimination at some point in time, with 28\u201340% of these experiencing it persistently (reported at multiple time points).", {"entities": []}], ["Primary carer and child experiences of racial discrimination were each associated with poor child mental health status (high risk of clinically significant emotional or behavioural difficulties), sleep difficulties, obesity and asthma, but not with child general health or injury.", {"entities": [[216, 223, "DISEASE"], [228, 234, "DISEASE"]]}], ["Children exposed to persistent vicarious racial discrimination were more likely to have sleep difficulties and asthma in multivariate models than those with a time-limited exposure.", {"entities": [[111, 117, "DISEASE"]]}], ["The findings indicate that direct and persistent vicarious racial discrimination are detrimental to the physical and mental health of Indigenous children in Australia, and suggest that prolonged and more frequent exposure to racial discrimination that starts in the early lifecourse can impact on multiple domains of health in later life.", {"entities": []}], ["Tackling and reducing racism should be an integral part of policy and intervention aimed at improving the health of Australian Indigenous children and thereby reducing health disparities between Indigenous and non-Indigenous children.", {"entities": []}], ["The online version of this article (doi:10.1186/s12939-017-0612-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A number of articles addressing various aspects of health-related quality of life (HRQoL) were published in the Health and Quality of Life Outcomes (HQLO) journal in 2012 and 2013.", {"entities": []}], ["This review provides a summary of studies describing recent methodological advances and innovations in HRQoL felt to be of relevance to clinicians and researchers.", {"entities": []}], ["Scoping review of original research articles, reviews and short reports published in the HQLO journal in 2012 and 2013.", {"entities": []}], ["Publications describing methodological advances and innovations in HRQoL were reviewed in detail, summarized and grouped into thematic categories.", {"entities": []}], ["358 titles and abstracts were screened initially, and 16 were considered relevant and incorporated in this review.", {"entities": []}], ["Two studies discussed development and interpretation of HRQoL outcomes; two described pediatric HRQoL measurement; four involved incorporation of HRQoL in economic evaluations; and eight described methodological issues and innovations in HRQoL measures.", {"entities": []}], ["Several studies describing important advancements and innovations in HRQoL, such as the development of the PROMIS pediatric proxy-item bank and guidelines for constructing patient-reported outcome (PRO) instruments, were published in the HQLO journal in 2012 and 2013.", {"entities": []}], ["Proposed future directions for the majority of these studies include extension and further validation of the research across a diverse range of health conditions.", {"entities": []}], ["COPD symptoms show a diurnal variability.", {"entities": []}], ["However, morning and night variability has generally not been taken into consideration in disease management plans.", {"entities": []}], ["The aims of this study were to cross-sectionally assess morning and night symptom prevalence and correlation with health status and disease severity in COPD, and to determine to what extent they could predict longitudinal outcomes, exacerbations and health status.", {"entities": []}], ["A further aim is to explore whether the CCQ is able to depict this morning/night symptomatology.", {"entities": []}], ["We included 2,269 primary care COPD patients (58% male, 49% current smokers, with a mean age of 65\u00b111 years) from a Dutch Asthma/COPD service.", {"entities": []}], ["Spirometry, patient history, the Clinical COPD Questionnaire(CCQ) and the Asthma Control Questionnaire(ACQ) were assessed; we used the latter to evaluate morning (question 2) and night symptoms (question 1).", {"entities": []}], ["A total of 1159 (51.9%) patients reported morning symptoms (ACQ question 2>0) and 879 (39.4%) had night complaints (ACQ question 1>0).", {"entities": []}], ["Patients with morning/night symptoms were mostly smokers and had on average poorer lung function, higher CCQ scores and used more rescue inhalers ( P <0.0001).", {"entities": []}], ["Patients using long-acting muscarinic antagonists (LAMAs) had less night symptoms, showing a possible favourable effect.", {"entities": []}], ["Only a small proportion of stable or slightly unstable patients (CCQ total scores <2) had severe morning symptoms (ACQ 2\u2a7e4: n =19, 1.1%) or severe night symptoms (ACQ 1\u2a7e4: n =11, 0.7%).", {"entities": []}], ["Night symptoms seemed to predict future exacerbations; however, baseline exacerbations were the strongest predictors ( n =346, OR:4.13, CI: 2.45\u22126.95, P <0.000).", {"entities": []}], ["Morning symptoms increased the odds of poor health status at follow-up ( n =346, OR:12.22, CI:4.76\u221231.39, P <0.000).", {"entities": []}], ["Morning and night symptoms in COPD patients are common, and they are associated with poor health status and predicted future exacerbations.", {"entities": []}], ["Our study showed that patients with morning/night symptoms have higher scores in CCQ, and therefore we do not really miss patients with high morning/night symptomatology when we only measure CCQ.", {"entities": []}], ["Severe morning symptoms predicted worsening of COPD health status.", {"entities": []}], ["Arthropods of different taxonomic identity including chironomid midges are known to induce allergic response in humans.", {"entities": []}], ["The present study was done to access two common chironomid species Chironomus circumdatus and Polypedilum nubifer for their sensitizing potential as an allergen in atopic patients and controls.", {"entities": []}], ["Following preparation of allergenic extracts of the two chironomid species separately, 198 atopic patients attending an allergy clinic and 50 age matched controls were tested along with a routine panel of allergens to assess sensitization.", {"entities": []}], ["The skin prick test (SPT) results revealed that 189 of the 198 patients (95.4%) demonstrated sensitization to both the chironomid species.", {"entities": []}], ["Higher levels of total IgE was observed in atopic subjects than in the control group.", {"entities": []}], ["The results suggest that the chironomid midges Chironomus circumdatus and Polypedilum nubifer can elicit sensitization in humans.", {"entities": []}], ["A potential risk for allergic reactions by susceptible individuals exists due to these chironomid species, owing to their abundance and chances of contact with human beings.", {"entities": []}], ["Further studies may be initiated to characterize the nature of the allergens and to assess their clinical relevance.", {"entities": []}], ["Volatile organic compounds (VOCs) are carbon-compounds that easily evaporate at room temperature.", {"entities": []}], ["Toxins are biologically produced poisons; mycotoxins are those toxins produced by microscopic fungi.", {"entities": []}], ["All fungi emit blends of VOCs; the qualitative and quantitative composition of these volatile blends varies with the species of fungus and the environmental situation in which the fungus is grown.", {"entities": []}], ["These fungal VOCs, produced as mixtures of alcohols, aldehydes, acids, ethers, esters, ketones, terpenes, thiols and their derivatives, are responsible for the characteristic moldy odors associated with damp indoor spaces.", {"entities": []}], ["There is increasing experimental evidence that some of these VOCs have toxic properties.", {"entities": []}], ["Laboratory tests in mammalian tissue culture and Drosophila melanogaster have shown that many single VOCs, as well as mixtures of VOCs emitted by growing fungi, have toxic effects.", {"entities": []}], ["This paper describes the pros and cons of categorizing toxigenic fungal VOCs as mycotoxins, uses genomic data to expand on the definition of mycotoxin, and summarizes some of the linguistic and other conventions that can create barriers to communication between the scientists who study VOCs and those who study toxins.", {"entities": []}], ["We propose that \u201cvolatoxin\u201d might be a useful term to describe biogenic volatile compounds with toxigenic properties.", {"entities": []}], ["SIDS and ALTE are different entities that somehow show some similarities.", {"entities": []}], ["Both constitute heterogeneous conditions.", {"entities": []}], ["The Netherlands is a low-incidence country for SIDS.", {"entities": []}], ["To study whether the same would hold for ALTE, we studied the incidence, etiology, and current treatment of ALTE in The Netherlands.", {"entities": []}], ["Using the Dutch Pediatric Surveillance Unit, pediatricians working in second- and third-level hospitals in the Netherlands were asked to report any case of ALTE presented in their hospital from January 2002 to January 2003.", {"entities": []}], ["A questionnaire was subsequently sent to collect personal data, data on pregnancy and birth, condition preceding the incident, the incident itself, condition after the incident, investigations performed, monitoring or treatment initiated during admission, any diagnosis made at discharge, and treatment or parental support offered after discharge.", {"entities": []}], ["A total of 115 cases of ALTE were reported, of which 110 questionnaires were filled in and returned (response rate 97%).", {"entities": []}], ["Based on the national birth rate of 200,000, the incidence of ALTE amounted 0.58/1,000 live born infants.", {"entities": []}], ["No deaths occurred.", {"entities": []}], ["Clinical diagnoses could be assessed in 58.2%.", {"entities": []}], ["Most frequent diagnoses were (percentages of the total of 110 cases) gastro-esophageal reflux and respiratory tract infection (37.3% and 8.2%, respectively); main symptoms were change of color and muscle tone, choking, and gagging.", {"entities": []}], ["The differences in diagnoses are heterogeneous.", {"entities": []}], ["In 34%, parents shook their infants, which is alarmingly high.", {"entities": []}], ["Pre- and postmature infants were overrepresented in this survey (29.5% and 8.2%, respectively).", {"entities": []}], ["Ten percent had recurrent ALTE.", {"entities": []}], ["In total, 15.5% of the infants were discharged with a home monitor.", {"entities": []}], ["In conclusion, ALTE has a low incidence in second- and third-level hospitals in the Netherlands.", {"entities": []}], ["Parents should be systematically informed about the possible devastating effects of shaking an infant.", {"entities": []}], ["Careful history taking and targeted additional investigations are of utmost importance.", {"entities": []}], ["This study aims to assess the fit of a number of exploratory and confirmatory factor analysis models to the 2010 Medical Council of Canada Qualifying Examination Part I (MCCQE1) clinical decision-making (CDM) cases.", {"entities": []}], ["The outcomes of this study have important implications for a range of domains, including scoring and test development.", {"entities": []}], ["The examinees included all first-time Canadian medical graduates and international medical graduates who took the MCCQE1 in spring or fall 2010.", {"entities": []}], ["The fit of one- to five-factor exploratory models was assessed for the item response matrix of the 2010 CDM cases.", {"entities": []}], ["Five confirmatory factor analytic models were also examined with the same CDM response matrix.", {"entities": []}], ["The structural equation modeling software program Mplus was used for all analyses.", {"entities": []}], ["Out of the five exploratory factor analytic models that were evaluated, a three-factor model provided the best fit.", {"entities": []}], ["Factor 1 loaded on three medicine cases, two obstetrics and gynecology cases, and two orthopedic surgery cases.", {"entities": []}], ["Factor 2 corresponded to pediatrics, and the third factor loaded on psychiatry cases.", {"entities": []}], ["Among the five confirmatory factor analysis models examined in this study, three- and four-factor lifespan period models and the five-factor discipline models provided the best fit.", {"entities": []}], ["The results suggest that knowledge of broad disciplinary domains best account for performance on CDM cases.", {"entities": []}], ["In test development, particular effort should be placed on developing CDM cases according to broad discipline and patient age domains; CDM testlets should be assembled largely using the criteria of discipline and age.", {"entities": []}], ["Exacerbations of chronic obstructive pulmonary disease (COPD) are an important measure of disease severity in terms of impaired disease progression, increased recovery time, healthcare resource utilization, overall morbidity and mortality.", {"entities": [[17, 54, "DISEASE"]]}], ["We aimed to quantify exacerbation and healthcare resource utilization rates among COPD patients in Sweden with respect to baseline treatments, exacerbation history, and comorbidities.", {"entities": []}], ["Patients with a COPD or chronic bronchitis (CB) diagnosis in secondary care at age of \u226540\u00a0years on 1.7.2009 were identified and followed until 1.7.2010 or death.", {"entities": [[32, 42, "DISEASE"]]}], ["Severe exacerbations were defined as hospitalizations due to respiratory disease, and healthcare resource utilization was measured by all-cause hospitalizations and secondary care visits.", {"entities": []}], ["Poisson regression was used adjusting for age, gender, time since COPD/CB diagnosis, and Charlson comorbidity index.", {"entities": []}], ["In 88,548 patients (54% females, mean age 72\u00a0years), previous respiratory hospitalizations and current high use of COPD medication (double or triple therapy) predicted an 8.3-fold increase in severe exacerbation rates and 1.8-fold increase in healthcare resource utilization rates in the following year, compared to patients without combination treatment and/or history of severe exacerbations.", {"entities": []}], ["COPD/CB patients with history of severe exacerbations and high use of COPD medication experienced a significantly increased rate of severe exacerbations and healthcare resource utilization during the one-year follow-up.", {"entities": []}], ["The online version of this article (10.1186/s12890-018-0573-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cockroach (CR) is an important inhalant allergen and can induce allergic asthma.", {"entities": [[64, 79, "DISEASE"], [73, 79, "DISEASE"]]}], ["However, the mechanism by which CR induces airway allergic inflammation and the role of endotoxin in CR extract are not clearly understood in regards to the development of airway inflammation.", {"entities": []}], ["In this study, we evaluated whether endotoxin is essential to the development of CR induced airway allergic inflammation in mice.", {"entities": []}], ["Airway allergic inflammation was induced by intranasal administration of either CR extract, CR with additional endotoxin, or endotoxin depleted CR extract, respectively, in BALB/c wild type mice.", {"entities": []}], ["CR induced inflammation was also evaluated with toll like receptor-4 (TLR-4) mutant (C3H/HeJ) and wild type (C3H/HeN) mice.", {"entities": []}], ["Intranasal administration of CR extracts significantly induced airway hyperresponsiveness (AHR), eosinophilic and neutrophilic airway inflammation, as well as goblet cell hyperplasia in a dose-dependent manner.", {"entities": [[91, 94, "GENE"]]}], ["The addition of endotoxin along with CR allergen attenuated eosinophilic inflammation, interleukin (IL)-13 level, and goblet cell hyperplasia of respiratory epithelium; however, it did not affect the development of AHR.", {"entities": [[215, 218, "GENE"]]}], ["Endotoxin depletion in CR extract did not attenuate eosinophilic inflammation and lymphocytosis in BAL fluid, AHR and IL-13 expression in the lungs compared to CR alone.", {"entities": [[110, 113, "GENE"]]}], ["The attenuation of AHR, eosinophilic inflammation, and goblet cell hyperplasia induced by CR extract alone was not different between TLR-4 mutant and the wild type mice.", {"entities": [[19, 22, "GENE"]]}], ["In addition, heat inactivated CR extract administration induced attenuated AHR and eosinophilic inflammation.", {"entities": [[75, 78, "GENE"]]}], ["Endotoxin in CR extracts may not be essential to the development of airway inflammation.", {"entities": []}], ["The environment plays a pivotal role as a human health determinant and presence of hazardous pollutants in the environment is often implicated in human disease.", {"entities": []}], ["That pollutants cause human diseases however is often controversial because data connecting exposure to environmental hazards and human diseases are not well defined, except for some cancers and syndromes such as asthma.", {"entities": [[213, 219, "DISEASE"]]}], ["Understanding the complex nature of human-environment interactions and the role they play in determining the state of human health is one of the more compelling problems in public health.", {"entities": []}], ["We are becoming more aware that the reductionist approach promulgated by current methods has not, and will not yield answers to the broad questions of population health risk analysis.", {"entities": []}], ["If substantive applications of environment-gene interactions are to be made, it is important to move to a systems level approach, to take advantage of epidemiology and molecular genomic advances.", {"entities": []}], ["Systems biology is the integration of genomics, transcriptomics, proteomics, and metabolomics together with computer technology approaches to elucidate environmentally caused disease in humans.", {"entities": []}], ["We discuss the applications of environmental systems biology as a route to solution of environmental health problems.", {"entities": []}], ["Air pollution is a major risk factor for cardiovascular disease, of which ozone is a major contributor.", {"entities": []}], ["Several studies have found associations between ozone and cardiovascular morbidity, but the results have been inconclusive.", {"entities": []}], ["We investigated associations between ozone and changes across biological pathways associated with cardiovascular disease.", {"entities": []}], ["Using a panel study design, 13 participants with coronary artery disease were assessed for markers of systemic inflammation, heart rate variability and repolarization, lipids, blood pressure, and endothelial function.", {"entities": []}], ["Daily measurements of ozone and particulate matter (PM 2.5 ) were obtained from central monitoring stations.", {"entities": []}], ["Single (ozone) and two-pollutant (ozone and PM 2.5 ) models were used to assess percent changes in measurements per interquartile ranges of pollutants.", {"entities": []}], ["Per interquartile increase in ozone, changes in tissue plasminogen factor (6.6%, 95% confidence intervals (CI)\u00a0=\u00a00.4, 13.2), plasminogen activator inhibitor-1 (40.5%, 95% CI\u00a0=\u00a08.7, 81.6), neutrophils (8.7% 95% CI\u00a0=\u00a01.5, 16.4), monocytes (10.2%, 95% CI\u00a0=\u00a01.0, 20.1), interleukin-6 (15.9%, 95% CI\u00a0=\u00a03.6, 29.6), large-artery elasticity index (\u221219.5%, 95% CI\u00a0=\u00a0\u221234.0, \u22121.7), and the baseline diameter of the brachial artery (\u22122.5%, 95% CI\u00a0=\u00a0\u22125.0, 0.1) were observed.", {"entities": []}], ["These associations were robust in the two-pollutant model.", {"entities": []}], ["We observed alterations across several pathways associated with cardiovascular disease in 13 coronary artery disease patients following ozone exposures, independent of PM 2.5 .", {"entities": []}], ["The results support the biological plausibility of ozone-induced cardiovascular effects.", {"entities": []}], ["The effects were found at concentrations below the EPA National Ambient Air Quality Standards for both ozone and PM 2.5 .", {"entities": []}], ["The online version of this article (10.1186/s12940-017-0335-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Formaldehyde (FA) is classified as a human carcinogen and has been linked to increased leukemia rates in some epidemiologic studies.", {"entities": [[87, 95, "DISEASE"]]}], ["Inhalation of FA induces sensory irritation at relatively low concentrations.", {"entities": []}], ["However, little is known concerning the cellular alterations observed after FA exposure in humans.", {"entities": []}], ["Our aim was to profile global gene expression in Hs 680.Tr human tracheal fibroblasts exposed to FA and to develop biomarkers for the evaluation of FA exposure in humans.", {"entities": []}], ["We used gene expression analysis, and identified 54 genes designated as FA responsive.", {"entities": []}], ["On the basis of these data, we conducted an exploratory analysis of the expression of these genes in human subjects exposed to high or low levels of FA.", {"entities": []}], ["We monitored FA exposure by measuring the urinary concentration of thiazolidine-4-carboxylate (TZCA), a stable and quantitative cysteinyl adduct of FA.", {"entities": []}], ["Nine genes were selected for real-time PCR analysis; of these, BHLHB2, CCNL1, SE20-4, C8FW, PLK2 , and SGK showed elevated expression in subjects with high concentrations of TZCA.", {"entities": [[71, 76, "GENE"], [92, 96, "GENE"]]}], ["The identification of gene marker candidates in vitro using microarray analysis and their validation using human samples obtained from exposed subjects is a good tool for discovering genes of potential mechanistic interest and biomarkers of exposure.", {"entities": []}], ["Thus, these genes are differentially expressed in response to FA and are potential effect biomarkers of FA exposure.", {"entities": []}], ["Clinical data of 288 chronic rhinosinusitis patients were retrospectively analyzed to investigate the risk factors of clinical prognosis, aiming to provide clinical evidence for the diagnosis and treatment of chronic rhinosinusitis.", {"entities": []}], ["A total of 288 patients diagnosed with chronic rhinosinusitis in the Department of Otolaryngology of the First Affiliated Hospital of Xinjiang Medical University were recruited.", {"entities": []}], ["Among all participants, 177 were male and 111 were female, aged from 22 to 83 years, (52\u00b114) years on average.", {"entities": []}], ["Subsequent follow-up was conducted to evaluate surgical efficacy.", {"entities": []}], ["Influencing factors of clinical prognosis were analyzed by univariate and multivariate logistic regression analyses.", {"entities": []}], ["After functional endoscopic sinus surgery by Messerklinger technique, 187 (64.9%) patients were fully recovered, 72 (25.0%) presented with improvement, and 28 (10.1%) were untreated.", {"entities": []}], ["Univariate logistic regression analysis revealed that 11 variables were correlated with the clinical prognosis of chronic rhinosinusitis.", {"entities": []}], ["Multivariate logistic regression analysis demonstrated that age, history of allergic rhinitis, severity of dysosmia, history of nasosinusitis surgery, and long-term use of nasal decongestant were the risk factors, whereas comprehensive therapy after surgery was a protective factor.", {"entities": [[76, 93, "DISEASE"], [85, 93, "DISEASE"]]}], ["More emphasis should be placed upon the factors associated with the clinical prognosis of patients with chronic rhinosinusitis following undergoing endoscopic sinus surgery, offering consolidated evidence for the prevention and treatment of chronic rhinosinusitis.", {"entities": []}], ["Ranunculus arvensis L. ( R. arvensis ) has long been used to treat a variety of medical conditions such as arthritis, asthma, hay fever, rheumatism, psoriasis, gut diseases and rheumatic pain.", {"entities": [[149, 158, "DISEASE"], [107, 116, "DISEASE"], [118, 124, "DISEASE"]]}], ["Here, we screened R. arvensis for antioxidant activity, phytochemical and high performance liquid chromatography (HPLC) analyses.", {"entities": []}], ["The chloroform, chloroform:methanol, methanol, methanol:acetone, acetone, methanol:water and water extracts of R. arvensis were examined for DPPH (1, 1-diphenyl-2-picrylhydrazyl) free radical scavenging assay, hydrogen peroxide scavenging assay, phosphomolybdenum assay, reducing power assay, flavonoid content, phenolic content and high performance liquid chromatography analysis.", {"entities": []}], ["Significant antioxidant activity was displayed by methanol extract ( IC 50 34.71\u00a0\u00b1\u00a00.02) in DPPH free radical scavenging assay.", {"entities": []}], ["Total flavonoids and phenolics ranged 0.96\u20136.0\u00a0mg/g of extract calculated as rutin equivalent and 0.48\u20131.43\u00a0mg/g of extract calculated as gallic acid equivalent respectively.", {"entities": []}], ["Significant value of rutin and caffeic acid was observed via high performance liquid chromatography.", {"entities": []}], ["These results showed that extracts of R. arvensis exhibited significant antioxidant activities.", {"entities": []}], ["Moreover, R. arvensis is a rich source of rutin, flavonoids and phenolics.", {"entities": []}], ["We describe the serological response following H1N1-2009 influenza A infections confirmed by reverse-transcriptase polymerase chain reaction (RT-PCR).", {"entities": [[57, 66, "DISEASE"]]}], ["The study included patients admitted to hospital, subjects of a seroepidemiologic cohort study, and participants identified from outbreak studies in Singapore.", {"entities": []}], ["Baseline (first available blood sample) and follow-up blood samples were analyzed for antibody titers to H1N1-2009 and recently circulating seasonal influenza A virus strains by hemagglutination inhibition (HI) and virus micro-neutralization (VM) assays.", {"entities": [[149, 158, "DISEASE"]]}], ["267 samples from 118 cases of H1N1-2009 were analyzed.", {"entities": []}], ["Geometric mean titers by HI peaked at 123 (95% confidence interval, CI 43-356) between days 30 to 39.", {"entities": []}], ["The chance of observing seroconversion (four-fold or greater increase of antibodies) was maximized when restricting analysis to 45 participants with baseline sera collected within 5 days of onset and follow-up sera collected 15 or more days after onset; for these participants, 82% and 89% seroconverted to A/California/7/2009 H1N1 by HI and VM respectively.", {"entities": []}], ["A four-fold or greater increase in cross-reactive antibody titers to seasonal A/Brisbane/59/2007 H1N1, A/Brisbane/10/2007 H3N2 and A/Wisconsin/15/2009 H3N2 occurred in 20%, 18% and 16% of participants respectively.", {"entities": []}], ["Appropriately timed paired serology detects 80\u201390% RT-PCR confirmed H1N1-2009; Antibodies from infection with H1N1-2009 cross-reacted with seasonal influenza viruses.", {"entities": [[148, 157, "DISEASE"]]}], ["Background: 64% of young medical professionals in Germany do not feel adequately prepared for the practical requirements of the medical profession.", {"entities": []}], ["The goal of \u201coutcome-orientated training\u201d is to structure medical curricula based on the skills needed when entering the workforce after completing undergraduate medical education, and thus to bridge the gap between the skills graduates have attained and those necessary for a career in the medical profession.", {"entities": []}], ["Outcome frameworks (OFs) are used for this purpose.", {"entities": []}], ["In preparation for developing the National Competence-Based Catalogue of Learning Objectives for Medicine (NKLM) \u2013 the German OF \u2013 the \u201cConsensus Statement of Practical Skills in Undergraduate Medical Education\u201d (which structures the teaching and acquisition of practical skills in Germany and which strongly influenced the \u201cClinical-Practical Skills\u201d chapter of the NKLM) was published in 2011.", {"entities": []}], ["It is not uncommon for at least a decade to elapse between the definition and implementation of an OF and the students\u2019 graduation, which can further increase the gap between necessary and acquired skills.", {"entities": []}], ["Thus, the purpose of this paper is to posit theses for future development in healthcare and to apply these theses to a current OF.", {"entities": []}], ["Methodology: Partially structured interviews with experts were used to generate theses pertaining to general, future development in healthcare.", {"entities": []}], ["These theses were assessed by physician experts based on the likelihood of implementation by the year 2025.", {"entities": []}], ["The 288 learning goals of the consensus statement were assessed for their relevance for medical education in the interim.", {"entities": []}], ["Results: 11 theses were generated for the development of medicine, and these theses were assessed and discussed by 738 experts.", {"entities": []}], ["These theses include the increase in diseases associated with old age, the increasing significance of interprofessional cooperation, and the growing prevalence of telemedicine applications.", {"entities": []}], ["Of the 288 learning goals of the consensus statement, 231 of the goals were assessed as relevant, and 57 were deemed irrelevant for the short-term future.", {"entities": []}], ["Discussion: The theses on the future of healthcare, which were generated in this study and which were validated by numerous experts, provide indications of future developments of overall requirements for medical school graduates.", {"entities": []}], ["For example, when applied to the content of the \u201cClinical-Practical Skills\u201d NKLM chapter, they largely validate the future relevance of developing practical skills while also providing indications for their further development as applied to the consensus statement.", {"entities": []}], ["Transcription factor GATA-1 reprograms immature myeloid cells to three different hematopoietic lineages-erythroid cells, megakaryocytes, and eosinophils.", {"entities": []}], ["GATA-1 is essential for maturation of erythroid and megakaryocytic precursors, as revealed by gene targeting in mice.", {"entities": []}], ["Here we demonstrate that deletion of a high-affinity GATA-binding site in the GATA-1 promoter, an element presumed to mediate positive autoregulation of GATA-1 expression, leads to selective loss of the eosinophil lineage.", {"entities": []}], ["These findings suggest that GATA-1 is required for specification of this lineage during hematopoietic development.", {"entities": []}], ["Mice lacking the ability to produce eosinophils should prove useful in ascertaining the role of eosinophils in a variety of inflammatory or allergic disorders.", {"entities": []}], ["Birth weight is an indicator of newborn health and a strong predictor of health outcomes in later life.", {"entities": []}], ["Significant variation in diet during pregnancy between ethnic groups in high-income countries provides an ideal opportunity to investigate the influence of maternal diet on birth weight.", {"entities": []}], ["Four multiethnic birth cohorts based in Canada (the NutriGen Alliance).", {"entities": []}], ["3997 full-term mother\u2013infant pairs of diverse ethnic groups who had principal component analysis-derived diet pattern scores\u2014plant-based, Western and health-conscious\u2014and birth weight data.", {"entities": []}], ["No associations were identified between the Western and health-conscious diet patterns and birth weight; however, the plant-based dietary pattern was inversely associated with birth weight (\u03b2=\u221267.6\u2009g per 1-unit increase; P<0.001), and an interaction with non-white ethnicity and birth weight was observed.", {"entities": []}], ["Ethnically stratified analyses demonstrated that among white Europeans, maternal consumption of a plant-based diet associated with lower birth weight (\u03b2=\u221265.9\u2009g per 1-unit increase; P<0.001), increased risk of small-for-gestational age (SGA; OR=1.46; 95%\u2009CI 1.08 to 1.54;P=0.005) and reduced risk of large-for-gestational age (LGA; OR=0.71; 95%\u2009CI 0.53 to 0.95;P=0.02).", {"entities": []}], ["Among South Asians, maternal consumption of a plant-based diet associated with a higher birth weight (\u03b2=+40.5\u2009g per 1-unit increase; P=0.01), partially explained by cooked vegetable consumption.", {"entities": []}], ["Maternal consumption of a plant-based diet during pregnancy is associated with birth weight.", {"entities": []}], ["Among white Europeans, a plant-based diet is associated with lower birth weight, reduced odds of an infant born LGA and increased odds of SGA, whereas among South Asians living in Canada, a plant-based diet is associated with increased birth weight.", {"entities": []}], ["Children are increasingly being diagnosed with primary hypertension.", {"entities": [[55, 67, "DISEASE"]]}], ["The absence of comparative effectiveness research of antihypertensive medications in children has contributed to considerable differences in prescribing practices among physicians treating children with primary hypertension.", {"entities": [[211, 223, "DISEASE"]]}], ["Even if parallel-group trials had established a best overall choice for most of these children, the best medication for an individual may differ from the best overall medication.", {"entities": []}], ["This project consists of a series of systematically administered n-of-1 trials among older children to verify the need for ongoing antihypertensive treatment and, if so, to identify the preferred single drug therapy from among the three major classes of drugs commonly used for primary hypertension (angiotensin-converting enzyme inhibitors, calcium channel blockers, and diuretics).", {"entities": [[286, 298, "DISEASE"]]}], ["We will determine whether one of these is the preferred therapy for the great majority of patients.", {"entities": []}], ["The \u201cpreferred\u201d therapy is the drug which produces normal ambulatory blood pressure, with the greatest reduction in blood pressure without unacceptable side effects.", {"entities": []}], ["We will recruit 50 patients from the Houston Pediatric and Adolescent Hypertension Program clinic.", {"entities": [[70, 82, "DISEASE"]]}], ["For each patient, the three drugs will be prescribed in random order and each drug will be taken for 2\u00a0weeks.", {"entities": []}], ["The effectiveness of each therapy will be measured with 24-h ambulatory blood pressure monitoring, and tolerability will be assessed using a side effect questionnaire.", {"entities": []}], ["Participants will rotate through treatment periods, repeating drugs and adjusting doses until the preferred therapy is identified.", {"entities": []}], ["In assessing whether one of the medications is most effective for the majority of subjects, the primary outcome will be the percentage of participants for whom each drug is selected as the preferred therapy.", {"entities": []}], ["We hypothesize that no drug will be selected for the great majority of the subjects, a finding that would support consideration of clinical use of n-of-1 trials.", {"entities": []}], ["Secondary analyses will explore whether patient characteristics predict which medication will be selected as a preferred drug.", {"entities": []}], ["This study will help optimize care of participating patients and provide evidence regarding the usefulness of n-of-1 trials in identifying appropriate treatment for children with hypertension and potentially other disorders.", {"entities": [[179, 191, "DISEASE"]]}], ["Clinicaltrials.gov NCT02412761 (registered 4/8/2015).", {"entities": []}], ["Although radon therapy is indicated for hyperuricemia, the underlying mechanisms of action have not yet been elucidated in detail.", {"entities": [[40, 53, "DISEASE"]]}], ["Therefore, we herein examined the inhibitory effects of radon inhalation and hot spring water drinking on potassium oxonate (PO)\u2013induced hyperuricemia in mice.", {"entities": [[137, 150, "DISEASE"]]}], ["Mice inhaled radon at a concentration of 2000 Bq/m", {"entities": []}], ["Altogether 95 children with primary bone fragility were screened for variants in PLS3 , the gene underlying X-linked osteoporosis.", {"entities": [[117, 129, "DISEASE"], [81, 85, "GENE"]]}], ["Two children with multiple peripheral and spinal fractures and low BMD had novel disease-causing PLS3 variants.", {"entities": [[97, 101, "GENE"]]}], ["Children with milder phenotypes had no pathogenic variants.", {"entities": []}], ["PLS3 screening is indicated in childhood-onset primary osteoporosis.", {"entities": [[55, 67, "DISEASE"], [0, 4, "GENE"]]}], ["The study aimed to determine the role of pathogenic PLS3 variants in children\u2019s bone fragility and to elucidate the associated phenotypic features.", {"entities": [[52, 56, "GENE"]]}], ["Two cohorts of children with bone fragility were screened for variants in PLS3 , the gene underlying X-linked osteoporosis.", {"entities": [[110, 122, "DISEASE"], [74, 78, "GENE"]]}], ["Cohort I comprised 31 patients with childhood-onset primary osteoporosis of unknown etiology.", {"entities": [[60, 72, "DISEASE"]]}], ["Cohort II comprised 64 children who had sustained multiple fractures but were otherwise healthy.", {"entities": []}], ["Clinical and radiological data were reviewed.", {"entities": []}], ["Peripheral blood DNA was Sanger sequenced for coding exons and flanking intronic regions of PLS3 .", {"entities": [[92, 96, "GENE"]]}], ["In two patients of cohort I , where other common genetic causes had been excluded, we identified two novel disease-causing PLS3 variants.", {"entities": [[123, 127, "GENE"]]}], ["Patient 1 was a male with bilateral femoral fractures at 10\u00a0years, low BMD (Z-score \u22124.1; 18\u00a0years), and multiple vertebral compression fractures.", {"entities": []}], ["He had a novel nonsense variant in PLS3 .", {"entities": [[35, 39, "GENE"]]}], ["Patient 2 was a girl with multiple long bone and vertebral fractures and low BMD (Z-score \u22126.6 at 6\u00a0years).", {"entities": []}], ["She had a de novo missense variant in PLS3 ; whole exome sequencing and array-CGH identified no other genetic causes.", {"entities": [[38, 42, "GENE"]]}], ["Iliac crest bone biopsies confirmed low-turnover osteoporosis in both patients.", {"entities": [[49, 61, "DISEASE"]]}], ["In cohort II , no pathogenic PLS3 variants were identified in any of the subjects.", {"entities": [[29, 33, "GENE"]]}], ["Two novel disease-causing variants in PLS3 were identified in a boy and a girl with multiple peripheral and spinal fractures and very low BMD while no pathogenic variants were identified in children with less severe skeletal fragility.", {"entities": [[38, 42, "GENE"]]}], ["PLS3 screening is warranted in male and female patients with childhood-onset primary osteoporosis.", {"entities": [[85, 97, "DISEASE"], [0, 4, "GENE"]]}], ["The online version of this article (doi:10.1007/s00198-017-4150-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In May 2000, AstraZeneca launched a Web service for asthma patients and health-care providers called LinkMedica, which includes an asthma diary for monitoring and self-management.", {"entities": [[52, 58, "DISEASE"], [131, 137, "DISEASE"]]}], ["In the diary, the patient enters his or her peak flow, number of doses of rescue medication, and if there have been any asthma symptoms during the previous 24 hours.", {"entities": [[120, 126, "DISEASE"]]}], ["The patient receives an immediate response from LinkMedica, telling him or her if the asthma is under control and what to do if not, eg, increase the dose of inhaled steroid.", {"entities": [[86, 92, "DISEASE"]]}], ["Health-care providers have access to the patient diary.", {"entities": []}], ["The primary objective of the study was to describe patients' and health-care providers' use of LinkMedica.", {"entities": []}], ["Secondary objectives were to evaluate their perception of the system and how the users' interaction with the system is influenced by their everyday lives.", {"entities": []}], ["Site statistics regarding number of registered users and diary usage were analyzed.", {"entities": []}], ["An online survey among users (85 respondents), a mailed questionnaire to health-care providers (131 respondents; response rate 26.8%), as well as in-depth interviews with 10 patients and 5 general practitioners, elicited further quantitative and qualitative data on users' perceptions.", {"entities": []}], ["In February 2003, a total of 7653 users had registered.", {"entities": []}], ["During 2002, the growth in registered users averaged 50 per month.", {"entities": []}], ["In the same period, the number of unique diary users per month decreased from 307 to 138.", {"entities": []}], ["Patients usually stopped using the diary after a short time; the doctors were reluctant to introduce the diary to patients because of time constraints.", {"entities": []}], ["Several user subtypes were identified among patients and their relatives.", {"entities": []}], ["The self-selected survey responses and in-depth interviews indicated that LinkMedica is generally considered a trustworthy and reliable site by both patients and doctors.", {"entities": []}], ["However, there was a contrast between users' positive perception of LinkMedica and their unwillingness to use the site for more than short periods.", {"entities": []}], ["The primary reason for this was that LinkMedica did not fit into their everyday lives because of technical and psychological aspects.", {"entities": []}], ["A number of recommendations to improve LinkMedica are suggested.", {"entities": []}], ["Y-chromosomal microdeletions (YCMD) are the major genetic cause of male infertility.", {"entities": [[67, 83, "DISEASE"], [72, 83, "DISEASE"]]}], ["To date, it is not known which global changes are induced by the presence of AZFc or AZFb\u00a0+\u00a0c deletions in the human testicular transcriptome.", {"entities": []}], ["We investigated this question by microarray analysis in which we had to eliminate the \u2018germ cell effect\u2019, i.e., the dominating effect of germ cell transcripts due to the quantitative difference in germ cell composition in samples with/without YCMD.", {"entities": []}], ["This problem was tackled by selecting 26 samples from an initial cohort of 34 samples by their homogeneity in respect to cellular composition as obtained from gene expression clustering.", {"entities": []}], ["This way, the \u2018germ cell effect\u2019 was minimized, and a distinct \u2018deletion effect\u2019 became more apparent.", {"entities": []}], ["Several hundred genes are influenced by YCMD as shown on the three different phenotypes hypospermatogenesis, meiotic arrest, and Sertoli-cell only syndrome.", {"entities": [[147, 155, "DISEASE"]]}], ["We validated on an independent cohort of samples five genes by quantitative real-time PCR that are expressed in germ cells or the somatic compartment and which are exclusively altered by the presence of YCMD.", {"entities": []}], ["We conclude that the deletion of Y-chromosomal genes has a significant effect on spermatogenesis by modulating the transcriptional network of the germ cell and somatic compartment.", {"entities": []}], ["The online version of this article (doi:10.1007/s00439-010-0865-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["11\u03b2-hydroxysteroid dehydrogenases type 2 (11\u03b2-HSD2), a key regulator for pre-receptor metabolism of glucocorticoids (GCs) by converting active GC, cortisol, to inactive cortisone, has been shown to be present in a variety of tumors.", {"entities": [[143, 145, "GENE"]]}], ["But its expression and roles have rarely been discussed in hematological malignancies.", {"entities": []}], ["Proteasome inhibitor bortezomib has been shown to not only possess antitumor effects but also potentiate the activity of other chemotherapeutics.", {"entities": []}], ["In this study, we demonstrated that 11\u03b2-HSD2 was highly expressed in two GC-resistant T-cell leukemic cell lines Jurkat and Molt4.", {"entities": []}], ["In contrast, no 11\u03b2-HSD2 expression was found in two GC-sensitive non-hodgkin lymphoma cell lines Daudi and Raji as well as normal peripheral blood T cells.", {"entities": [[78, 86, "DISEASE"], [66, 86, "DISEASE"]]}], ["Inhibition of 11\u03b2-HSD2 by 11\u03b2-HSD inhibitor 18\u03b2-glycyrrhetinic acid or 11\u03b2-HSD2 shRNA significantly increased cortisol-induced apoptosis in Jurkat cells.", {"entities": []}], ["Additionally, pretreatment of Jurkat cells with low-dose bortezomib resulted in increased cellular sensitivity to GC as shown by elevated induction of apoptosis, more cells arrested at G1 stage and up-regulation of GC-induced leucine zipper which is an important mediator of GC action.", {"entities": [[114, 116, "GENE"], [215, 217, "GENE"], [275, 277, "GENE"], [114, 116, "GENE"], [215, 217, "GENE"], [275, 277, "GENE"]]}], ["Furthermore, we clarified that bortezomib could dose-dependently inhibit 11\u03b2-HSD2 messenger RNA and protein levels as well as activity (cortisol-cortisone conversion) through p38 mitogen-activated protein kinase signaling pathway.", {"entities": []}], ["Therefore, we suggest 11\u03b2-HSD2 is, at least partially if not all, responsible for impaired GC suppression in Jurkat cells and also indicate a novel mechanism by which proteasome inhibitor bortezomib may influence GC action.", {"entities": [[91, 93, "GENE"], [213, 215, "GENE"], [91, 93, "GENE"], [213, 215, "GENE"]]}], ["The oncogenic transcription factor E2A-PBX1 is expressed consequent to chromosomal translocation 1;19 and is an important oncogenic driver in cases of pre-B-cell acute lymphoblastic leukemia (ALL).", {"entities": [[182, 190, "DISEASE"], [168, 190, "DISEASE"]]}], ["Elucidating the mechanism by which E2A-PBX1 induces lymphoid leukemia would be expedited by the availability of a tractable experimental model in which enforced expression of E2A-PBX1 in hematopoietic progenitors induces pre-B-cell ALL.", {"entities": [[52, 69, "DISEASE"], [61, 69, "DISEASE"]]}], ["However, hematopoietic reconstitution of irradiated mice with bone marrow infected with E2A-PBX1-expressing retroviruses consistently gives rise to myeloid, not lymphoid, leukemia.", {"entities": [[171, 179, "DISEASE"]]}], ["Here, we elucidate the hematopoietic consequences of forced E2A-PBX1 expression in primary murine hematopoietic progenitors.", {"entities": []}], ["We show that introducing E2A-PBX1 into multipotent progenitors permits the retention of myeloid potential but imposes a dense barrier to lymphoid development prior to the common lymphoid progenitor stage, thus helping to explain the eventual development of myeloid, and not lymphoid, leukemia in transplanted mice.", {"entities": [[284, 292, "DISEASE"]]}], ["Our findings also indicate that E2A-PBX1 enforces the aberrant, persistent expression of some genes that would normally have been down-regulated in the subsequent course of hematopoietic maturation.", {"entities": []}], ["We show that enforced expression of one such gene, Hoxa9 , a proto-oncogene associated with myeloid leukemia, partially reproduces the phenotype produced by E2A-PBX1 itself.", {"entities": [[92, 108, "DISEASE"], [100, 108, "DISEASE"], [51, 56, "GENE"]]}], ["Existing evidence suggests that the 1;19 translocation event takes place in committed B-lymphoid progenitors.", {"entities": []}], ["However, we find that retrovirus-enforced expression of E2A-PBX1 in committed pro-B-cells results in cell cycle arrest and apoptosis.", {"entities": []}], ["Our findings indicate that the neoplastic phenotype induced by E2A-PBX1 is determined by the developmental stage of the cell into which the oncoprotein is introduced.", {"entities": []}], ["The superiority of tiotropium/olodaterol is demonstrated in improvement of lung function, dyspnea, lung hyperinflation, and quality of life compared with either monotherapy in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[190, 227, "DISEASE"]]}], ["Japanese Respiratory Society Guidelines for COPD management include improvement of exercise tolerance and daily physical activity as the treatment goals; however, there is limited evidence in Japanese patients with COPD.", {"entities": []}], ["A protocol is developed for the VESUTO A total of 180 Japanese patients with COPD, aged \u226540\u00a0years will be enrolled into the double-blind, multicenter, active-controlled, crossover study (NCT02629965) and will be randomized to receive either tiotropium/olodaterol FDC or tiotropium for 6\u00a0weeks each [two puffs via RESPIMAT The VESUTO 2 -agonist (LABA) combination therapy on patients\u2019 physical activities as well as lung function.", {"entities": []}], ["ClinicalTrials.gov: NCT02629965 (registered on December 1, 2015).", {"entities": []}], ["The VESUTO study was funded by Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan.", {"entities": []}], ["The online version of this article (doi:10.1007/s12325-017-0554-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In our previous studies we showed antitumor and anti-inflammatory activities of protein kinases inhibitor pyrrol derivate 1-(4-Cl-benzyl)-3-Cl-4-(CF3-fenylamino)-1H-pyrrol-2,5-dione (MI-1) on rat colon cancer model.", {"entities": [[196, 208, "DISEASE"], [202, 208, "DISEASE"]]}], ["Therefore anti-inflammatory effect of MI-1 on rat acetic acid induced ulcerative colitis (UC) model was aimed to be discovered.", {"entities": [[70, 88, "DISEASE"]]}], ["The anti-inflammatory effects of MI-1 (2.7\u2009mg/kg daily) compared to reference drug Prednisolone (0.7\u2009mg/kg daily) after 14-day usage were evaluated on macro- and light microscopy levels and expressed in 21-grade scale.", {"entities": []}], ["Redox status of bowel mucosa was also estimated.", {"entities": []}], ["It was shown that in UC group the grade of total injury (GTI) was equal to 9.6 (GTI control = 0).", {"entities": []}], ["Increase of malonic dialdehyde (MDA) by 89% and protein carbonyl groups (PCG) by 60% and decrease of superoxide dismutase (SOD) by 40% were also observed.", {"entities": []}], ["Prednisolone decreased GTI to 3 and leveled SOD activity, but MDA and PCG remained higher than control ones by 52% and 42%, respectively.", {"entities": []}], ["MI-1 restored colon mucosa integrity and decreased mucosa inflammation down to GTI = 0.5 and leveled PCG and SOD.", {"entities": []}], ["Thus, MI-1 possessed anti-inflammatory properties, which were more expressed that Prednisolone ones, as well as normalized mucosa redox balance, and so has a prospect for correction of inflammatory processes.", {"entities": []}], ["Background: Upon antigen exposure, cord blood derived T cells respond to ubiquitous environmental antigens by high proliferation.", {"entities": []}], ["To date it remains unclear whether these \u201cexcessive\u201d responses relate to different regulatory properties of the putative T regulatory cell (Treg) compartment or even expansion of the Treg compartment itself.", {"entities": []}], ["Methods: Cord blood (>37 week of gestation) and peripheral blood (healthy controls) were obtained and different Treg cell subsets were isolated.", {"entities": []}], ["The suppressive potential of Treg populations after antigen exposure was evaluated via functional inhibition assays ([ Results: Cord blood derived CD4 Conclusion: Cord blood harbors a very small subset of CD4", {"entities": [[147, 150, "GENE"], [205, 208, "GENE"], [147, 150, "GENE"], [205, 208, "GENE"]]}], ["Numerous consumer health information websites have been developed to provide consumers access to health information.", {"entities": []}], ["However, lookup search is insufficient for consumers to take full advantage of these rich public information resources.", {"entities": []}], ["Exploratory search is considered a promising complementary mechanism, but its efficacy has never before been rigorously evaluated for consumer health information retrieval interfaces.", {"entities": []}], ["This study aims to (1) introduce a novel Conjunctive Exploratory Navigation Interface (CENI) for supporting effective consumer health information retrieval and navigation, and (2) evaluate the effectiveness of CENI through a search-interface comparative evaluation using crowdsourcing with Amazon Mechanical Turk (AMT).", {"entities": []}], ["We collected over 60,000 consumer health questions from NetWellness, one of the first consumer health websites to provide high-quality health information.", {"entities": []}], ["We designed and developed a novel conjunctive exploratory navigation interface to explore NetWellness health questions with health topics as dynamic and searchable menus.", {"entities": []}], ["To investigate the effectiveness of CENI, we developed a second interface with keyword-based search only.", {"entities": []}], ["A crowdsourcing comparative study was carefully designed to compare three search modes of interest: (A) the topic-navigation-based CENI, (B) the keyword-based lookup interface, and (C) either the most commonly available lookup search interface with Google, or the resident advanced search offered by NetWellness.", {"entities": []}], ["To compare the effectiveness of the three search modes, 9 search tasks were designed with relevant health questions from NetWellness.", {"entities": []}], ["Each task included a rating of difficulty level and questions for validating the quality of answers.", {"entities": []}], ["Ninety anonymous and unique AMT workers were recruited as participants.", {"entities": []}], ["Repeated-measures ANOVA analysis of the data showed the search modes A, B, and C had statistically significant differences among their levels of difficulty ( P <.001).", {"entities": []}], ["Wilcoxon signed-rank test (one-tailed) between A and B showed that A was significantly easier than B ( P <.001).", {"entities": []}], ["Paired t tests (one-tailed) between A and C showed A was significantly easier than C ( P <.001).", {"entities": []}], ["Participant responses on the preferred search modes showed that 47.8% (43/90) participants preferred A, 25.6% (23/90) preferred B, 24.4% (22/90) preferred C. Participant comments on the preferred search modes indicated that CENI was easy to use, provided better organization of health questions by topics, allowed users to narrow down to the most relevant contents quickly, and supported the exploratory navigation by non-experts or those unsure how to initiate their search.", {"entities": []}], ["We presented a novel conjunctive exploratory navigation interface for consumer health information retrieval and navigation.", {"entities": []}], ["Crowdsourcing permitted a carefully designed comparative search-interface evaluation to be completed in a timely and cost-effective manner with a relatively large number of participants recruited anonymously.", {"entities": []}], ["Accounting for possible biases, our study has shown for the first time with crowdsourcing that the combination of exploratory navigation and lookup search is more effective than lookup search alone.", {"entities": []}], ["Background .", {"entities": []}], ["Allergic asthma is one of the most common chronic inflammatory diseases of airways.", {"entities": [[0, 15, "DISEASE"], [9, 15, "DISEASE"]]}], ["Severe asthma may lead to hospitalization and death.", {"entities": [[7, 13, "DISEASE"]]}], ["Sesame oil is a natural product with anti-inflammatory property.", {"entities": []}], ["However, the effect of sesame oil on allergic asthma has never been studied.", {"entities": [[37, 52, "DISEASE"], [46, 52, "DISEASE"]]}], ["Objective .", {"entities": []}], ["We investigate the effect of sesame oil on pulmonary inflammation in allergic asthma model.", {"entities": [[69, 84, "DISEASE"], [78, 84, "DISEASE"]]}], ["Allergic airway inflammation was induced by sensitizing with two doses of 10\u2009mg ovalbumin (OVA) and then challenged with 1% OVA nebulizer exposure (1\u2009h/day) for 3 days.", {"entities": []}], ["Sesame oil (0.25, 0.5, or 1\u2009mL/kg/day) was given orally 30\u2009min before each challenge.", {"entities": []}], ["Samples were collected 24\u2009h after the last challenge.", {"entities": []}], ["Data showed that sesame oil inhibited pulmonary edema and decreased interleukin (IL)-1 \u03b2 and IL-6 levels in bronchoalveolar lavage fluid in OVA-treated mice.", {"entities": [[38, 53, "DISEASE"]]}], ["Sesame oil also decreased pulmonary nitrite level, inducible nitric oxide synthase expression, and neutrophil infiltration induced by OVA.", {"entities": []}], ["Further, sesame oil decreased serum IgE level in OVA-treated mice.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Sesame oil may attenuate pulmonary edema and bronchial neutrophilic inflammation by inhibiting systemic IgE level in allergic asthma.", {"entities": [[117, 132, "DISEASE"], [25, 40, "DISEASE"], [126, 132, "DISEASE"]]}], ["The transient receptor potential ankyrin 1 (TRPA1) channel has been implicated in pathophysiological processes that include asthma, cough, and inflammatory pain.", {"entities": [[124, 130, "DISEASE"], [44, 49, "GENE"]]}], ["Agonists of TRPA1 such as mustard oil and its key component allyl isothiocyanate (AITC) cause pain and neurogenic inflammation in humans and rodents, and TRPA1 antagonists have been reported to be effective in rodent models of pain.", {"entities": [[12, 17, "GENE"], [154, 159, "GENE"], [12, 17, "GENE"], [154, 159, "GENE"]]}], ["In our pursuit of TRPA1 antagonists as potential therapeutics, we generated AMG0902, a potent (IC 90 of 300\u2009nM against rat TRPA1), selective, brain penetrant (brain to plasma ratio of 0.2), and orally bioavailable small molecule TRPA1 antagonist.", {"entities": [[18, 23, "GENE"], [123, 128, "GENE"], [229, 234, "GENE"], [18, 23, "GENE"], [123, 128, "GENE"], [229, 234, "GENE"], [18, 23, "GENE"], [123, 128, "GENE"], [229, 234, "GENE"]]}], ["AMG0902 reduced mechanically evoked C-fiber action potential firing in a skin-nerve preparation from mice previously injected with complete Freund\u2019s adjuvant, supporting the role of TRPA1 in inflammatory mechanosensation.", {"entities": [[182, 187, "GENE"]]}], ["In\u00a0vivo target coverage of TRPA1 by AMG0902 was demonstrated by the prevention of AITC-induced flinching/licking in rats.", {"entities": [[27, 32, "GENE"]]}], ["However, oral administration of AMG0902 to rats resulted in little to no efficacy in models of inflammatory, mechanically evoked hypersensitivity; and no efficacy was observed in a neuropathic pain model.", {"entities": []}], ["Unbound plasma concentrations achieved in pain models were about 4-fold higher than the IC 90 concentration in the AITC target coverage model, suggesting that either greater target coverage is required for efficacy in the pain models studied or TRPA1 may not contribute significantly to the underlying mechanisms.", {"entities": [[245, 250, "GENE"]]}], ["Aim: To confirm the efficacy of vildagliptin in patients with type 2 diabetes (T2D) by testing the hypothesis that glycosylated haemoglobin (HbA1c) reduction with vildagliptin is superior to that with voglibose after 12 weeks of treatment.", {"entities": []}], ["Methods: In this 12-week, randomized, double-blind, active-controlled, parallel-group study, the efficacy and safety of vildagliptin (50 mg bid, n = 188) was compared with that of voglibose (0.2 mg tid, n = 192) in patients with T2D who were inadequately controlled with diet and exercise.", {"entities": []}], ["Results: The characteristics of two groups were well matched at baseline.", {"entities": []}], ["The mean age, body mass index (BMI) and HbA1c were 59.1 years, 24.9 kg/m Conclusions: Vildagliptin (50 mg bid) showed superior efficacy and better tolerability compared with voglibose in Japanese patients with T2D.", {"entities": []}], ["In 2009, a new influenza A (H1N1) virus affected many persons around the world.", {"entities": [[15, 24, "DISEASE"]]}], ["There is an urgent need for finding biomarkers to distinguish between influenza A (H1N1)pdm09 and seasonal influenza virus.", {"entities": [[70, 79, "DISEASE"], [107, 116, "DISEASE"]]}], ["We investigated these possible biomarkers in the lung of fatal cases of confirmed influenza A (H1N1)pdm09.", {"entities": [[82, 91, "DISEASE"]]}], ["Cytokines (inflammatory and anti-inflammatory) and cellular markers (macrophages and lymphocytes subpopulation markers) were analyzed in lung tissue from both influenza A (H1N1)pdm09 and seasonal influenza virus.", {"entities": [[159, 168, "DISEASE"], [196, 205, "DISEASE"]]}], ["High levels of IL-17, IFN- \u03b3 , and TNF- \u03b1 positive cells were identical in lung tissue from the influenza A (H1N1)pdm09 and seasonal cases when compared with healthy lung tissue ( P < 0.05).", {"entities": [[96, 105, "DISEASE"]]}], ["Increased IL-4+ cells, and CD4+ and CD14+ cells were also found in high levels in both influenza A (H1N1)pdm09 and seasonal influenza virus ( P < 0.05).", {"entities": [[87, 96, "DISEASE"], [124, 133, "DISEASE"]]}], ["Low levels of CD206+ cells (marker of alternatively activated macrophages marker in lung) were found in influenza A (H1N1)pdm09 when compared with seasonal influenza virus ( P < 0.05), and the ratio of CD206/CD14+ cells was 2.5-fold higher in seasonal and noninfluenza group compared with influenza A (H1N1)pdm09 ( P < 0.05).", {"entities": [[104, 113, "DISEASE"], [156, 165, "DISEASE"], [289, 298, "DISEASE"]]}], ["In conclusion, CD206+ cells differentiate between influenza A (H1N1)pdm09 and seasonal influenza virus in lung tissue of fatal cases.", {"entities": [[50, 59, "DISEASE"], [87, 96, "DISEASE"]]}], ["Heavy industry emits many potentially hazardous pollutants into the air which can affect health.", {"entities": []}], ["However, the effects of air pollution from heavy industry on lung function and respiratory symptoms have been investigated scarcely.", {"entities": []}], ["Our aim was to investigate the associations of long-term air pollution from heavy industry with lung function and respiratory symptoms in school children.", {"entities": []}], ["A cross-sectional lung function study was conducted among school children (7\u201313\u00a0years) in the vicinity of an area with heavy industry.", {"entities": []}], ["Lung function measurements were conducted during school hours.", {"entities": []}], ["Parents of the children were asked to complete a questionnaire about the health of their children.", {"entities": []}], ["A dispersion model was used to characterize the additional individual-level exposures to air pollutants from the industry in the area.", {"entities": []}], ["Associations between PM 2.5 and NO X exposure with lung function and presence of respiratory symptoms were investigated by linear and/or logistic regression analysis.", {"entities": []}], ["Participation in the lung function measurements and questionnaires was 84% (665/787) and 77% (603/787), respectively.", {"entities": []}], ["The range of the elevated PM 2.5 and NO X five years average concentrations (2008\u20132012) due to heavy industry were 0.04\u20131.59\u00a0\u03bcg/m 2.5 and NO X (per interquartile range of 0.56 and 7.43\u00a0\u03bcg/m X (per interquartile range of 7.43\u00a0\u03bcg/m 2.5 or NO X and respiratory symptoms except for PM 2.5 and dry cough (OR 1.40, 95%CI 1.00 to 1.94).", {"entities": []}], ["Exposure to PM 2.5 and NO X from industry was associated with decreased lung function.", {"entities": []}], ["Exposure to PM 2.5 was also associated with parents\u2019 reports of dry cough among their children.", {"entities": []}], ["The online version of this article (10.1186/s12940-018-0373-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To investigate risk factors for postherpetic neuralgia, the neuropathic pain that commonly follows herpes zoster.", {"entities": [[99, 112, "DISEASE"]]}], ["Using primary care data from the Clinical Practice Research Datalink, we fitted multivariable logistic regression models to investigate potential risk factors for postherpetic neuralgia (defined as pain \u226590 days after zoster, based on diagnostic or prescription codes), including demographic characteristics, comorbidities, and characteristics of the acute zoster episode.", {"entities": []}], ["We also assessed whether the effects were modified by antiviral use.", {"entities": []}], ["Of 119,413 zoster patients, 6,956 (5.8%) developed postherpetic neuralgia.", {"entities": []}], ["Postherpetic neuralgia risk rose steeply with age, most sharply between 50 and 79 years (adjusted odds ratio [OR] for a 10-year increase, 1.70, 99% confidence interval 1.63\u20131.78).", {"entities": []}], ["Postherpetic neuralgia risk was higher in women (6.3% vs 5.1% in men: OR 1.19, 1.10\u20131.27) and those with severely immunosuppressive conditions, including leukemia (13.7%: 2.07, 1.08\u20133.96) and lymphoma (12.7%: 2.45, 1.53\u20133.92); autoimmune conditions, including rheumatoid arthritis (9.1%: 1.20, 0.99\u20131.46); and other comorbidities, including asthma and diabetes.", {"entities": [[260, 280, "DISEASE"], [192, 200, "DISEASE"], [271, 280, "DISEASE"], [154, 162, "DISEASE"], [341, 347, "DISEASE"]]}], ["Current and ex-smokers, as well as underweight and obese individuals, were at increased risk of postherpetic neuralgia.", {"entities": []}], ["Antiviral use was not associated with postherpetic neuralgia (OR 1.04, 0.97\u20131.11).", {"entities": []}], ["However, the increased risk associated with severe immunosuppression appeared less pronounced in patients given antivirals.", {"entities": []}], ["Postherpetic neuralgia risk was increased for a number of patient characteristics and comorbidities, notably with age and among those with severe immunosuppression.", {"entities": []}], ["As zoster vaccination is contraindicated for patients with severe immunosuppression, strategies to prevent zoster in these patients, which could include the new subunit zoster vaccine, are an increasing priority.", {"entities": []}], ["The research reported in this paper addresses the relationship between quality of open space and health related lifestyle in urban residential areas.", {"entities": []}], ["The research was performed in the residential developments in Ljubljana, Slovenia, dating from the time of political and economic changes in the early nineties.", {"entities": []}], ["Compared to the older neighborhoods, these are typically single-use residential areas, with small open spaces and poor landscape design.", {"entities": []}], ["The research is concerned with the quality of life in these areas, especially from the perspective of the vulnerable users, like the elderly and children.", {"entities": []}], ["Both depend on easily accessible green areas in close proximity to their homes.", {"entities": []}], ["The hypothesis is that the poor open space quality affects their health-related behavior and their perceived health status.", {"entities": []}], ["The research has three methodological phases: (1) a comparison between urban residential areas by criteria describing their physical characteristics; (2) behavior observation and mapping and (3) a resident opinion survey.", {"entities": []}], ["The results confirm differences between open spaces of the selected residential areas as well as their relation with outdoor activities: a lack of outdoor programs correlates with poor variety of outdoor activities, limited to transition type, less time spent outdoors and lower satisfaction with their home environment.", {"entities": []}], ["The survey also disclosed a strong influence of a set of socio-economic variables such as education and economic status on physical activity and self-perceived health status of people.", {"entities": []}], ["The results therefore confirm the hypothesis especially for less affluent and educated; i.e.", {"entities": []}], [", vulnerable groups.", {"entities": []}], ["Along with food and drug allergic reactions, a Hymenoptera insect Sting (Apoidea, Vespidae, Formicidae) is one of the most common causes of anaphylaxis worldwide.", {"entities": []}], ["Diagnoses of Hymenoptera venom allergy (HVA) and specific immunotherapy (SIT) have been based on the use of crude venom extracts.", {"entities": []}], ["However, the incidence of cross-reactivity and low levels of sensibility during diagnosis, as well as the occurrence of nonspecific sensitization and undesired side effects during SIT, encourage the search for novel allergenic materials.", {"entities": []}], ["Recombinant allergens are an interesting approach to improve allergy diagnosis and SIT because they circumvent major problems associated with the use of crude venom.", {"entities": []}], ["Production of recombinant allergens depends on the profound molecular characterization of the natural counterpart by combining some \u201comics\u201d approaches with high-throughput screening techniques and the selection of an appropriate system for heterologous expression.", {"entities": []}], ["To date, several clinically relevant allergens and novel venom toxins have been identified, cloned and characterized, enabling a better understanding of the whole allergenic and envenoming processes.", {"entities": []}], ["Here, we review recent findings on identification, molecular characterization and recombinant expression of Hymenoptera venom allergens and on the evaluation of these heterologous proteins as valuable tools for tackling remaining pitfalls on HVA diagnosis and immunotherapy.", {"entities": []}], ["Based on the panel data of 306 cities in China from 2002 to 2012, this paper investigates China\u2019s road transport fuel (i.e., gasoline and diesel) demand system by using the Almost Ideal Demand System (AIDS) and the Quadratic AIDS (QUAIDS) models.", {"entities": []}], ["The results indicate that own-price elasticities for different vehicle categories range from \u2212 1 .", {"entities": []}], ["215 to \u2212 0 .", {"entities": []}], ["459 (by AIDS) and from \u2212 1 .", {"entities": []}], ["399 to \u2212 0 .", {"entities": []}], ["369 (by QUAIDS).", {"entities": []}], ["Then, this study estimates the air pollution emissions ( CO , NO x and PM 2 .", {"entities": []}], ["5 ) and public health damages from the road transport sector under different oil price shocks.", {"entities": []}], ["Compared to the base year 2012, results show that a fuel price rise of 30% can avoid 1,147,270 tonnes of pollution emissions; besides, premature deaths and economic losses decrease by 16,149 cases and 13,817.953 million RMB yuan respectively; while based on the non-linear health effect model, the premature deaths and total economic losses decrease by 15,534 and 13,291.4 million RMB yuan respectively.", {"entities": []}], ["Our study combines the fuel demand and health evaluation models and is the first attempt to address how oil price changes influence public health through the fuel demand system in China.", {"entities": []}], ["Given its serious air pollution emission and substantial health damages, this paper provides important insights for policy makers in terms of persistent increasing in fuel consumption and the associated health and economic losses.", {"entities": []}], ["Allergic rhinitis (AR) is one of the most common allergic diseases, which adversely affect patients' quality of life.", {"entities": [[9, 17, "DISEASE"]]}], ["Mahuang Fuzi Xixin decoction (MFXD) has been widely used to treat AR in clinics in Asian countries.", {"entities": []}], ["This study investigated the effect and possible therapeutic mechanisms of MFXD in the treatment of AR.", {"entities": []}], ["A Wistar rat model of ovalbumin- (OVA-) induced AR was established and then treated with three doses of MFXD; AR symptoms, serum total immunoglobulin E, histamine, histopathological features, and release and expression of factors related to type 1 helper T (Th1) and type 2 helper T (Th2) responses were analyzed.", {"entities": []}], ["Our study demonstrated that MFXD has a good therapeutic effect on OVA-induced allergic inflammation in an AR rat model as manifested in reduced frequencies of sneezing and nasal scratching and in reduced serum levels of total IgE and HIS.", {"entities": []}], ["In addition, MFXD regulates imbalance in Th1/Th2 cells caused by AR by simultaneously attenuating Th1 and Th2 responses, such as by reducing the serum levels of IFN- \u03b3 and IL-4 and mRNA expression levels of IFN- \u03b3 , IL-4, GATA-3, and STAT-6.", {"entities": []}], ["This study provided valuable information on the immunoregulatory effect of MFXD for the treatment of AR in future clinical studies.", {"entities": []}], ["The complex correlation structure of a collection of orthologous DNA sequences is uniquely captured by the \u201cancestral recombination graph\u201d (ARG), a complete record of coalescence and recombination events in the history of the sample.", {"entities": []}], ["However, existing methods for ARG inference are computationally intensive, highly approximate, or limited to small numbers of sequences, and, as a consequence, explicit ARG inference is rarely used in applied population genomics.", {"entities": []}], ["Here, we introduce a new algorithm for ARG inference that is efficient enough to apply to dozens of complete mammalian genomes.", {"entities": []}], ["The key idea of our approach is to sample an ARG of chromosomes conditional on an ARG of chromosomes, an operation we call \u201cthreading.\u201d Using techniques based on hidden Markov models, we can perform this threading operation exactly, up to the assumptions of the sequentially Markov coalescent and a discretization of time.", {"entities": []}], ["An extension allows for threading of subtrees instead of individual sequences.", {"entities": []}], ["Repeated application of these threading operations results in highly efficient Markov chain Monte Carlo samplers for ARGs.", {"entities": []}], ["We have implemented these methods in a computer program called ARGweaver .", {"entities": []}], ["Experiments with simulated data indicate that ARGweaver converges rapidly to the posterior distribution over ARGs and is effective in recovering various features of the ARG for dozens of sequences generated under realistic parameters for human populations.", {"entities": []}], ["In applications of ARGweaver to 54 human genome sequences from Complete Genomics, we find clear signatures of natural selection, including regions of unusually ancient ancestry associated with balancing selection and reductions in allele age in sites under directional selection.", {"entities": []}], ["The patterns we observe near protein-coding genes are consistent with a primary influence from background selection rather than hitchhiking, although we cannot rule out a contribution from recurrent selective sweeps.", {"entities": []}], ["The unusual and complex correlation structure of population samples of genetic sequences presents a fundamental statistical challenge that pervades nearly all areas of population genetics.", {"entities": []}], ["Historical recombination events produce an intricate network of intertwined genealogies, which impedes demography inference, the detection of natural selection, association mapping, and other applications.", {"entities": []}], ["It is possible to capture these complex relationships using a representation called the ancestral recombination graph (ARG), which provides a complete description of coalescence and recombination events in the history of the sample.", {"entities": []}], ["However, previous methods for ARG inference have not been adequately fast and accurate for practical use with large-scale genomic sequence data.", {"entities": []}], ["In this article, we introduce a new algorithm for ARG inference that has vastly improved scaling properties.", {"entities": []}], ["Our algorithm is implemented in a computer program called ARGweaver , which is fast enough to be applied to sequences megabases in length.", {"entities": []}], ["With the aid of a large computer cluster, ARGweaver can be used to sample full ARGs for entire mammalian genome sequences.", {"entities": []}], ["We show that ARGweaver performs well in simulation experiments and demonstrate that it can be used to provide new insights about both demographic processes and natural selection when applied to real human genome sequence data.", {"entities": []}], ["Cia5a is a locus on rat chromosome 10 that regulates disease severity and joint damage in two models of rheumatoid arthritis, collagen- and pristane-induced arthritis (PIA).", {"entities": [[104, 124, "DISEASE"], [115, 124, "DISEASE"], [157, 166, "DISEASE"]]}], ["In this study, we aimed to identify cellular and molecular processes regulated by Cia5a using microarray-based gene expression analysis of synovial tissues from MHC identical DA (severe erosive disease) and DA.F344(Cia5a) congenics (mild non-erosive disease) rats.", {"entities": []}], ["Synovial tissues from six DA and eight DA.F344(Cia5a) rats were analyzed 21 days after the induction of PIA using the Illumina RatRef-12 BeadChip (21,922 genes) and selected data confirmed with qPCR.", {"entities": []}], ["There was a significantly increased expression of pro-inflammatory mediators such as Il1b (5-fold), Il18 (3.9-fold), Cxcl1 (10-fold), Cxcl13 (7.5-fold) and Ccl7 (7.9-fold), and proteases like Mmp3 (23-fold), Mmp9 (32-fold), Mmp14 (4.4-fold) and cathepsins in synovial tissues from DA, with reciprocally reduced levels in congenics.", {"entities": [[85, 89, "GENE"], [100, 104, "GENE"], [117, 122, "GENE"], [134, 140, "GENE"], [156, 160, "GENE"], [192, 196, "GENE"], [208, 212, "GENE"], [224, 229, "GENE"]]}], ["mRNA levels of 47 members of the Spleen Tyrosine Kinase ( Syk ) pathway were significantly increased in DA synovial tissues compared with DA.F344(Cia5a), and included Syk (5.4-fold), Syk-activating receptors and interacting proteins, and genes regulated by Syk such as NFkB, and NAPDH oxidase complex genes.", {"entities": [[58, 61, "GENE"], [167, 170, "GENE"], [183, 186, "GENE"], [257, 260, "GENE"], [58, 61, "GENE"], [167, 170, "GENE"], [183, 186, "GENE"], [257, 260, "GENE"], [58, 61, "GENE"], [167, 170, "GENE"], [183, 186, "GENE"], [257, 260, "GENE"]]}], ["Nuclear receptors (NR) such as Rxrg , Pparg and Rev-erba were increased in the protected congenics, and so was the anti-inflammatory NR-target gene Scd1 (54-fold increase).", {"entities": [[31, 35, "GENE"], [38, 43, "GENE"]]}], ["Tnn (72-fold decrease) was the gene most significantly increased in DA.", {"entities": [[0, 3, "GENE"]]}], ["Analyses of gene expression in synovial tissues revealed that the arthritis severity locus Cia5a regulates the expression of key mediators of inflammation and joint damage, as well as the expression of members of the Syk pathway.", {"entities": [[66, 75, "DISEASE"], [217, 220, "GENE"]]}], ["This expression pattern correlates with disease severity and joint damage and along with the gene accounting for Cia5a could become a useful biomarker to identify patients at increased risk for severe and erosive disease.", {"entities": []}], ["The identification of the gene accounting for Cia5a has the potential to generate a new and important target for therapy and prognosis.", {"entities": []}], ["Particulate matter, especially ultrafine particles (UFPs), may cause health effects through generation of oxidative stress, with resulting damage to DNA and other macromolecules.", {"entities": []}], ["We investigated oxidative damage to DNA and related repair capacity in peripheral blood mononuclear cells (PBMCs) during controlled exposure to urban air particles with assignment of number concentration (NC) to four size modes with average diameters of 12, 23, 57, and 212 nm.", {"entities": []}], ["Twenty-nine healthy adults participated in a randomized, two-factor cross-over study with or without biking exercise for 180 min and with exposure to particles (NC 6169-15362/cm The levels of DNA strand breaks (SBs), oxidized purines as formamidopyrimidine DNA glycolase (FPG) sites, and activity of 7,8-dihydro-8-oxoguanine-DNA glycosylase (OGG1) in PBMCs were measured by the Comet assay.", {"entities": [[342, 346, "GENE"]]}], ["mRNA levels of OGG1, nucleoside diphosphate linked moiety X-type motif 1 ( NUDT1 ), and heme oxygenase-1 ( HO1 ) were determined by real-time reverse transcriptase\u2013polymerase chain reaction.", {"entities": [[15, 19, "GENE"], [75, 80, "GENE"]]}], ["Exposure to UFPs for 6 and 24 hr significantly increased the levels of SBs and FPG sites, with a further insignificant increase after physical exercise.", {"entities": [[30, 32, "GENE"]]}], ["The OGG1 activity and expression of OGG1, NUDT1, and HO1 were unaltered.", {"entities": [[4, 8, "GENE"], [36, 40, "GENE"], [4, 8, "GENE"], [36, 40, "GENE"], [42, 47, "GENE"]]}], ["There was a significant dose\u2013response relationship between NC and DNA damage, with the 57-nm mode as the major contributor to effects.", {"entities": []}], ["Concomitant exposure to ozone, nitrogen oxides, and carbon monoxide had no influence.", {"entities": []}], ["Our results indicate that UFPs, especially the 57-nm soot fraction from vehicle emissions, causes systemic oxidative stress with damage to DNA and no apparent compensatory up-regulation of DNA repair within 24 hr.", {"entities": [[210, 212, "GENE"]]}], ["The aim of this study was to investigate the expression level of maspin mRNA in pulmonary adenocarcinoma and to clarify its clinical significance in prediction of prognosis.", {"entities": [[90, 104, "DISEASE"]]}], ["RNA was extracted from formalin-fixed paraffin-embedded (FFPE) tumor tissue blocks of 30 pairs of pulmonary adenocarcinoma (AC) tissues and adjacent noncancerous tissues (ANT) and in another 81 AC tissues.", {"entities": [[108, 122, "DISEASE"]]}], ["Expression of maspin mRNA was tested by quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and the potential relationship between maspin mRNA expression and clinic pathological features of AC patients was analyzed.", {"entities": []}], ["The expression of maspin mRNA was upregulated in AC samples compared with the ANT (p<0.001).", {"entities": []}], ["Patients at advanced clinical stage (III) and patients with lymphatic metastasis showed higher maspin mRNA expression level than those in early-stage patients (I and II) (p=0.038) or with non-lymphatic metastasis (p=0.034).", {"entities": []}], ["The Kaplan-Meier survival curves indicated that disease-free survival (DFS) was significantly worse in high maspin mRNA expression AC patients (p=0.007).", {"entities": []}], ["Furthermore, multivariate analysis revealed that the expression of maspin mRNA was an independent prognostic marker for AC (p=0.040).", {"entities": []}], ["Our study reveals that maspin mRNA was significantly up-regulated in tissues of AC patients.", {"entities": []}], ["Maspin mRNA may be useful as a new marker of prognosis in AC.", {"entities": []}], ["Stress has been associated with poor eating behaviors and diet quality, as well as high body mass index (BMI).", {"entities": []}], ["Low-income women may be particularly vulnerable to stress and severe obesity.", {"entities": [[69, 76, "DISEASE"]]}], ["Yet it is unknown how stress increases the risk of severe obesity through disordered eating behaviors and poor diet quality or through mechanisms independent of diet.", {"entities": [[58, 65, "DISEASE"]]}], ["We examined cross-sectional data from women ( n \u2009=\u2009101) with a child enrolled in the Special Supplemental Nutrition Program for Women, Infants, and Children in Cumberland County, North Carolina (spring 2012).", {"entities": []}], ["We collected measured heights and weights to calculate BMI.", {"entities": []}], ["Using structural equation modeling, we differentiated pathways from stress to weight status: (1) indirectly through eating behaviors (cognitive restraint, emotional eating, and uncontrolled eating) and diet quality, which we examined with the Healthy Eating Index 2010 and 24-h dietary recalls, and (2) directly through possible unmeasured risk factors independent of diet.", {"entities": []}], ["The analysis controlled for race/ethnicity, income, age, whether the dietary recall day was typical, and whether the respondent completed one or two 24-h dietary recalls.", {"entities": []}], ["Perceived stress was positively associated with uncontrolled eating (\u03b2\u2009=\u20090.38, p \u2009<\u20090.001) and emotional eating (\u03b2\u2009=\u20090.50, p \u2009<\u20090.001).", {"entities": []}], ["However, higher stress was not associated with weight status through eating behaviors and diet quality.", {"entities": []}], ["Independent of eating behaviors and diet quality, stress was positively associated with severe obesity (\u03b2\u2009=\u20090.26, p \u2009=\u20090.007).", {"entities": [[95, 102, "DISEASE"]]}], ["Improving stress coping strategies for low-income women may improve eating behaviors and reduce severe obesity.", {"entities": [[103, 110, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12937-015-0110-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Since the fundamental principles of the medical profession were clearly defined in a physician charter in 2002, special considerations have been expressed about the adequate distribution of health care resources taking in account the individual patient needs to optimize the health care service.", {"entities": []}], ["The correct application of procedures represents a key point in order to reach the appropriateness of care, that means to avoid unnecessary or inappropriate procedures as well as the underutilization of the necessary procedures.", {"entities": []}], ["In this context, the Choosing wisely campaign have been widely used and disclosed and even the Italian Society of Pediatric Allergology and Immunology - SIAIP has been working to make recommendations in order to ensure the appropriateness of care in the field of allergy and optimize the use of health care resources.", {"entities": []}], ["Whereas 400 million distinct compounds are now purchasable within the span of a few weeks, the biological activities of most are unknown.", {"entities": []}], ["To facilitate access to new chemistry for biology, we have combined the Similarity Ensemble Approach (SEA) with the maximum Tanimoto similarity to the nearest bioactive to predict activity for every commercially available molecule in ZINC.", {"entities": []}], ["This method, which we label SEA+TC, outperforms both SEA and a na\u00efve-Bayesian classifier via predictive performance on a 5-fold cross-validation of ChEMBL\u2019s bioactivity data set (version 21).", {"entities": []}], ["Using this method, predictions for over 40% of compounds (>160 million) have either high significance (pSEA \u2265 40), high similarity (ECFP4MaxTc \u2265 0.4), or both, for one or more of 1382 targets well described by ligands in the literature.", {"entities": []}], ["Using a further 1347 less-well-described targets, we predict activities for an additional 11 million compounds.", {"entities": []}], ["To gauge whether these predictions are sensible, we investigate 75 predictions for 50 drugs lacking a binding affinity annotation in ChEMBL.", {"entities": []}], ["The 535 million predictions for over 171 million compounds at 2629 targets are linked to purchasing information and evidence to support each prediction and are freely available via https://zinc15.docking.org and https://files.docking.org .", {"entities": []}], ["Published association studies have investigated the correlation between interleukin-8 (IL-8) gene polymorphism \u2013251T>A and susceptibility to Alzheimer's disease (AD); however, the results are conflicting.", {"entities": []}], ["Thus, we conducted the meta-analysis to reassess the effect of IL-8 gene \u2013251T>A variant on the risk of AD.", {"entities": []}], ["Relevant studies regarding this association were electronically searched and identified from the PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, and the Chinese Biomedicine Database.", {"entities": []}], ["The odds ratios (ORs) with the corresponding 95% confidence intervals (95% CIs) were pooled to calculate the strength of this association.", {"entities": []}], ["Nine studies with a total of 1406 cases and 2152 controls were included in the meta-analysis.", {"entities": []}], ["Overall, a significant association of IL-8 gene \u2013251T>A polymorphism with increased risk of AD was observed in several genetic models (allele, A vs T: OR=1.32, 95%CI=1.16-1.50; homozygous, AA vs TT: OR=1.70, 95%CI=1.21\u20132.21; heterozygous, TA vs TT: OR=1.37, 95%CI=1.12\u20131.69; recessive, AA vs TA+TT: OR=1.40, 95%CI=1.12\u20131.75).", {"entities": []}], ["Similarly, such association was also revealed both in Asian and European populations in the subgroup analysis by ethnicity.", {"entities": []}], ["The current study suggested that IL-8 gene polymorphism \u2013251T>A may contribute to the susceptibility to AD.", {"entities": []}], ["Disability-Adjusted Life Years (DALYs) have the advantage that effects on total health instead of on a specific disease incidence or mortality can be estimated.", {"entities": []}], ["Our aim was to address several methodological points related to the computation of DALYs at an individual level in a follow-up study.", {"entities": []}], ["DALYs were computed for 33,507 men and women aged 20\u201370 years when participating in the EPIC-NL study in 1993\u20137.", {"entities": []}], ["DALYs are the sum of the Years Lost due to Disability (YLD) and the Years of Life Lost (YLL) due to premature mortality.", {"entities": []}], ["Premature mortality was defined as death before the estimated date of individual Life Expectancy (LE).", {"entities": []}], ["Different methods to compute LE were compared as well as the effect of different follow-up periods using a two-part model estimating the effect of smoking status on health as an example.", {"entities": []}], ["During a mean follow-up of 12.4 years, there were 69,245 DALYs due to years lived with a disease or premature death.", {"entities": []}], ["Current-smokers had lost 1.28 healthy years of their life (1.28 DALYs 95%CI 1.10; 1.46) compared to never-smokers.", {"entities": []}], ["The outcome varied depending on the method used for estimating LE, completeness of disease and mortality ascertainment and notably the percentage of extinction (duration of follow-up) of the cohort.", {"entities": []}], ["We conclude that the use of DALYs in a cohort study is an appropriate way to assess total disease burden in relation to a determinant.", {"entities": []}], ["The outcome is sensitive to the LE calculation method and the follow-up duration of the cohort.", {"entities": []}], ["Lower respiratory tract infections (LRTI) are the leading cause of death world-wide, with Streptococcus pneumoniae (Pnc) as the most prevalent pathogen.", {"entities": []}], ["Local immune mechanisms appear central to protection against the disease, yet they are poorly characterized.", {"entities": []}], ["Infections at other, non-respiratory mucosal sites are associated with a transient circulation of mucosa-originating lymphocytes from the mucosal site to blood and back to the mucosa.", {"entities": []}], ["The present study explored whether pathogen-specific plasmablasts appear in the circulation also in patients with infection of the lower respiratory tract.", {"entities": []}], ["16 patients with bacteremic Pnc pneumonia and 14 healthy volunteers were explored for circulating plasmablasts secreting antibodies against their own pathogenic Pnc strain isolated in blood cultures (patients) or against several pathogenic strains from pneumonia patients (14 controls) or a mixture of nine different purified pneumococcal polysaccharides (8 controls).", {"entities": [[32, 41, "DISEASE"], [253, 262, "DISEASE"]]}], ["Both patients and volunteers were studied for all plasmablasts.", {"entities": []}], ["The cells were identified with ELISPOT as Pnc-specific antibody-secreting cells (ASC) and as all immunoglobulin-secreting cells (ISC).", {"entities": []}], ["High numbers of circulating Pnc-specific ASC were found in the acute phase of the disease in all patients with pneumonia (median 97 ASC/10", {"entities": [[111, 120, "DISEASE"]]}], ["Observational data show that nonsteroidal anti-inflammatory drug (NSAID) use is associated with a lower rate of breast cancer.", {"entities": [[112, 125, "DISEASE"], [119, 125, "DISEASE"]]}], ["We evaluated the effect of etodolac, an FDA-approved NSAID reported to inhibit cyclooxygenase (COX) enzymes and the retinoid X receptor alpha (RXR), on rationally identified potential biomarkers in breast cancer.", {"entities": [[198, 211, "DISEASE"], [205, 211, "DISEASE"]]}], ["Patients with resectable breast cancer planned for initial management with surgical resection were enrolled and took 400\u00a0mg of etodolac twice daily prior to surgery.", {"entities": [[25, 38, "DISEASE"], [32, 38, "DISEASE"]]}], ["Protein and gene expression levels for genes related to COX-2 and RXR \u03b1 were evaluated in tumor samples from before and after etodolac exposure.", {"entities": []}], ["Thirty subjects received etodolac and 17 subjects were assayed as contemporaneous or opportunistic controls.", {"entities": []}], ["After etodolac exposure mean cyclin D1 protein levels, assayed by immunohistochemistry, decreased ( P \u00a0=\u00a00.03).", {"entities": []}], ["Notably, pre- versus post cyclin D1 gene expression change went from positive to negative with greater duration of etodolac exposure ( r \u00a0=\u00a0\u22120.64, P \u00a0=\u00a00.01).", {"entities": []}], ["Additionally, etodolac exposure was associated with a significant increase in COX-2 gene expression levels (fold change: 3.25 [95% CI: 1.9, 5.55]) and a trend toward increased \u03b2 -catenin expression (fold change: 2.03 [95% CI: 0.93, 4.47]).", {"entities": []}], ["In resectable breast cancer relatively brief exposure to the NSAID etodolac was associated with reduced cyclin D1 protein levels.", {"entities": [[14, 27, "DISEASE"], [21, 27, "DISEASE"]]}], ["Effect was also observed on cyclin D1 gene expression with decreasing levels with longer durations of drug exposure.", {"entities": []}], ["Increased COX-2 gene expression was seen, possibly due to compensatory feedback.", {"entities": []}], ["These data highlight the utility of even small clinical trials with access to biospecimens for pharmacodynamic studies.", {"entities": []}], ["Phospholipase C\u03b5 (PLC\u03b5) is an effector of Ras and Rap small GTPases and expressed in non-immune cells.", {"entities": []}], ["It is well established that PLC\u03b5 plays an important role in skin inflammation, such as that elicited by phorbol ester painting or ultraviolet irradiation and contact dermatitis that is mediated by T helper (Th) 1 cells, through upregulating inflammatory cytokine production by keratinocytes and dermal fibroblasts.", {"entities": [[158, 176, "DISEASE"], [166, 176, "DISEASE"]]}], ["However, little is known about whether PLC\u03b5 is involved in regulation of inflammation in the respiratory system, such as Th2-cells-mediated allergic asthma.", {"entities": [[140, 155, "DISEASE"], [149, 155, "DISEASE"]]}], ["We prepared a mouse model of allergic asthma using PLC\u03b5 PLC\u03b5 PLC\u03b5 genotypes were immunized with ovalbumin (OVA) followed by the challenge with an OVA-containing aerosol to induce asthmatic response, which was assessed by analyzing airway hyper-responsiveness, bronchoalveolar lavage fluids, inflammatory cytokine levels, and OVA-specific immunoglobulin (Ig) levels.", {"entities": [[29, 44, "DISEASE"], [38, 44, "DISEASE"]]}], ["Effects of PLC\u03b5 genotype on cytokine production were also examined with primary-cultured bronchial epithelial cells.", {"entities": []}], ["After OVA challenge, the OVA-immunized PLC\u03b5 PLC\u03b5 genotype, suggesting that sensitization was PLC\u03b5-independent.", {"entities": []}], ["In the challenged mice, PLC\u03b5 deficiency reduced proinflammatory cytokine production in the bronchial epithelial cells.", {"entities": []}], ["Primary-cultured bronchial epithelial cells prepared from PLC\u03b5 PLC\u03b5 PLC\u03b5 deficiency.", {"entities": []}], ["PLC\u03b5 plays an important role in the pathogenesis of bronchial asthma through upregulating inflammatory cytokine production by the bronchial epithelial cells.", {"entities": [[62, 68, "DISEASE"]]}], ["Ozone increases IL-33 in the lungs, and obesity augments the pulmonary effects of acute ozone exposure.", {"entities": [[40, 47, "DISEASE"]]}], ["We assessed the role of IL-33 in the augmented effects of ozone observed in obese mice.", {"entities": []}], ["Lean wildtype and obese db/db mice were pretreated with antibodies blocking the IL-33 receptor, ST2, and then exposed to ozone (2 ppm for 3 hr).", {"entities": [[140, 142, "GENE"]]}], ["Airway responsiveness was assessed, bronchoalveolar lavage (BAL) was performed, and lung cells harvested for flow cytometry 24 hr later.", {"entities": [[127, 129, "GENE"]]}], ["Effects of ozone were also assessed in obese and lean mice deficient in \u03b3\u03b4 T cells and their wildtype controls.", {"entities": []}], ["and Discussion: Ozone caused greater increases in BAL IL-33, neutrophils, and airway responsiveness in obese than lean mice.", {"entities": []}], ["Anti-ST2 reduced ozone-induced airway hyperresponsiveness and inflammation in obese mice but had no effect in lean mice.", {"entities": []}], ["Obesity also augmented ozone-induced increases in BAL CXCL1 and IL-6, and in BAL type 2 cytokines, whereas anti-ST2 treatment reduced these cytokines.", {"entities": [[0, 7, "DISEASE"], [54, 59, "GENE"]]}], ["In obese mice, ozone increased lung IL-13+ innate lymphoid cells type 2 (ILC2) and IL-13+ \u03b3\u03b4 T cells.", {"entities": []}], ["Ozone increased ST2+ \u03b3\u03b4 T cells, indicating that these cells can be targets of IL-33, and \u03b3\u03b4 T cell deficiency reduced obesity-related increases in the response to ozone, including increases in type 2 cytokines.", {"entities": [[119, 126, "DISEASE"]]}], ["Our data indicate that IL-33 contributes to augmented responses to ozone in obese mice.", {"entities": []}], ["Obesity and ozone also interacted to promote type 2 cytokine production in \u03b3\u03b4 T cells and ILC2 in the lungs, which may contribute to the observed effects of IL-33.", {"entities": [[0, 7, "DISEASE"]]}], ["Mathews JA, Krishnamoorthy N, Kasahara DI, Cho Y, Wurmbrand AP, Ribeiro L, Smith D, Umetsu D, Levy BD, Shore SA.", {"entities": []}], ["IL-33 drives augmented responses to ozone in obese mice.", {"entities": []}], ["Environ Health Perspect 125:246\u2013253;\u2002http://dx.doi.org/10.1289/EHP272", {"entities": []}], ["Atopic dermatitis (AD) is the most common skin disorder in young children worldwide, with a high impact on morbidity and quality of life.", {"entities": [[7, 17, "DISEASE"]]}], ["To date, no prospective study has been published on the incidence and potential predictors of AD in South East Asian populations.", {"entities": []}], ["The Indonesian Prospective Study of Atopic Dermatitis in Infants (ISADI) will address the genetic, metabolic and dietary characteristics of mothers and their offspring, as well as potential determinants of AD within the first year of infant life.", {"entities": [[43, 53, "DISEASE"]]}], ["This prospective study will be undertaken in about 400 infants to investigate the direct and indirect effects of filaggrin ( FLG ) gene mutations, the genetic variants of FADS1 , FADS2 and FADS3 and the role of long-chain polyunsaturated fatty acids (LCPUFA) on the development of AD.", {"entities": [[125, 128, "GENE"], [171, 176, "GENE"], [179, 184, "GENE"], [189, 194, "GENE"]]}], ["We will use standardised protocols for subject recruitment, umbilical artery plasma analysis, buccal cell sampling for genotyping, fatty acid analysis, physical exams, 3-day food-intake recall of mothers and children, as well as comprehensive questionnaires on environmental, socioeconomic and AD-related factors, including family history.", {"entities": []}], ["Monthly monitoring by telephone and physical exams every 3\u2005months will be carried out to assess participants' anthropometry, medical history and incidence of AD diagnosis during the first year of life.", {"entities": []}], ["Hypotheses-driven analyses of quality-controlled dietary, genetic and metabolic data will be performed with state-of-the-art statistical methods (eg, AD-event history, haplotype, dietary or metabolic factor analysis).", {"entities": []}], ["Direct and indirect effects of genetics and LCPUFA in buccal cell and cord plasma glycerophospholipids as potential mediators of inflammation on AD development will be evaluated by path analysis.", {"entities": []}], ["The Permanent Medical Research Ethics Committee in Medicine and Health/Faculty of Medicine Universitas Indonesia/Dr Cipto Mangunkusumo Hospital (No.", {"entities": []}], ["47/H2.F1/ETIK/2014) approved the study protocol (extended by the letter no.", {"entities": []}], ["148/UN2.F1/ETIK/2015).", {"entities": []}], ["We aim to disseminate our findings via publication in an international journal with high impact factor.", {"entities": []}], ["The present study aims to investigate the effect of Liuweibuqi (LWBQ) capsules on the expression of matrix metalloproteinase (MMP)-9 and TIMP1 and cell viability of alveolar macrophages (AMs) in chronic obstructive pulmonary disease (COPD).", {"entities": [[195, 232, "DISEASE"], [137, 142, "GENE"]]}], ["Rats were randomly divided into normal control (NC) group, model control (MC) group, Jinshuibao (JSB) group, spleen aminopeptidase (PAT) group, and low dose of LWBQ (LWBQ low), mid dose of LWBQ (LWBQ mid), and high dose of LWBQ (LWBQ high) group ( n =10).", {"entities": []}], ["Lung function was measured with a spirometer.", {"entities": []}], ["Serum cytokines including tumor necrosis factor-\u03b1 (TNF-\u03b1) and interleukin-6 (IL-6) were detected using ELISA.", {"entities": []}], ["The expressions of MMP-9 and TIMP1 were detected by quantitative real-time PCR (qRT-PCR) and Western blot.", {"entities": [[29, 34, "GENE"]]}], ["MTT assay and flow cytometry were used to measure cell viability and apoptosis.", {"entities": []}], ["Compared with the NC group, body weight and lung function were reduced in the MC group.", {"entities": []}], ["In addition, the serum levels of IL-6 and TNF-\u03b1 were higher in the MC group than those in the NC group.", {"entities": []}], ["The expression of MMP-9 protein in the AMs from rats was higher, and TIMP1 protein was lower in the MC group compared with the NC group.", {"entities": [[69, 74, "GENE"]]}], ["After LWBQ capsules treatment, compared with the MC group, the expression of inflammatory cytokines and MMP-9 were lower and TIMP1 was higher.", {"entities": [[125, 130, "GENE"]]}], ["Moreover, after LWBQ-medicated serum treatment, the release of inflammatory cytokines was reduced from AMs.", {"entities": []}], ["Besides, LWBQ-medicated serum decreased the expression of MMP-9 and increased the expression of TIMP1 and cell viability compared with those in MC group.", {"entities": [[96, 101, "GENE"]]}], ["In conclusion, LWBQ capsules can inhibit the release of inflammatory cytokines, promote cell viability in AMs, and regulate the expression of MMP-9 and TIMP1.", {"entities": [[152, 157, "GENE"]]}], ["Emerging models for predicting risk of chronic obstructive pulmonary disease (COPD) require external validation in order to assess their clinical value.", {"entities": [[39, 76, "DISEASE"]]}], ["We validated a previous model for predicting new onset COPD in a different database.", {"entities": []}], ["We randomly drew 38,597 case-control pairs (total N \u2009=\u200977,194) of individuals aged \u226535 years and matched for sex, age, and general practice from the United Kingdom Clinical Practice Research Datalink database.", {"entities": []}], ["We assessed accuracy of the model to discriminate between COPD cases and non-cases by calculating area under the receiver operator characteristic (ROC AUC ) for the prediction scores.", {"entities": []}], ["Analogous to the development model, ever smoking (OR 6.70; 95%CI 6.41\u20136.99), prior asthma (OR 6.43; 95%CI 5.85\u20137.07), and higher socioeconomic deprivation (OR 2.90; 95%CI 2.72\u20133.09 for highest vs. lowest quintile) increased the risk of COPD.", {"entities": [[83, 89, "DISEASE"]]}], ["The validated prediction scores ranged from 0\u20135.71 (ROC AUC 0.66; 95%CI 0.65\u20130.66) for males and 0\u20135.95 (ROC AUC 0.71; 95%CI 0.70\u20130.71) for females.", {"entities": []}], ["We have confirmed that smoking, prior asthma, and socioeconomic deprivation are key risk factors for new onset COPD.", {"entities": [[38, 44, "DISEASE"]]}], ["Our model seems externally valid at identifying patients at risk of developing COPD.", {"entities": []}], ["An impact assessment now needs to be undertaken to assess whether this prediction model can be applied in clinical care settings.", {"entities": []}], ["Particulate matter with an aerodynamic diameter less than 2.5\u00a0\u03bcM (PM 2.5 ) is one of the major environmental pollutants in China.", {"entities": []}], ["In this study, we carried out a metabolomics profile study on PM 2.5 -induced inflammation.", {"entities": []}], ["PM 2.5 from Beijing, China, was collected and given to rats through intra-tracheal instillation in vivo .", {"entities": []}], ["Acute pulmonary injury were observed by pulmonary function assessment and H.E.", {"entities": []}], ["The lipid metabolic profile was also altered with increased phospholipid and sphingolipid metabolites in broncho-alveolar lavage fluid (BALF) after PM 2.5 instillation.", {"entities": []}], ["Organic component analysis revealed that benzo[a]pyrene (BaP) is one of the most abundant and toxic components in the PM 2.5 collected on the fiber filter.", {"entities": []}], ["In vitro , BaP was used to treat A549 cells, an alveolar type II cell line.", {"entities": []}], ["BaP (4\u00a0\u03bcM, 24\u00a0h) induced inflammation in the cells.", {"entities": []}], ["Metabolomics analysis revealed that BaP (4\u00a0\u03bcM, 6\u00a0h) treatment altered the cellular lipid metabolic profile with increased phospholipid metabolites and reduced sphingolipid metabolites and free fatty acids (FFAs).", {"entities": []}], ["The proportion of \u03c9\u20133 polyunsaturated fatty acid (PUFA) was also decreased.", {"entities": []}], ["Mechanically, BaP (4\u00a0\u03bcM) increased the phospholipase A2 (PLA2) activity at 4\u00a0h as well as the mRNA level of Pla2g2a at 12\u00a0h. The pro-inflammatory effect of BaP was reversed by the cytosolic PLA2 (cPLA2) inhibitor and chelator of intracellular Ca 2.5 , induces pulmonary injury by activating PLA2 and elevating lysophosphatidylcholine (LPC) in a Ca fx1 \u2022 PM 2.5 instillation increases pro-inflammatory lipid metabolism in the lung.", {"entities": [[108, 115, "GENE"]]}], ["\u2022 BaP promotes the metabolism of phospholipid in alveolar type II cells.", {"entities": []}], ["\u2022 BaP activates cPLA2 in a Ca PM 2.5 instillation increases pro-inflammatory lipid metabolism in the lung.", {"entities": []}], ["BaP promotes the metabolism of phospholipid in alveolar type II cells.", {"entities": []}], ["BaP activates cPLA2 in a Ca", {"entities": []}], ["The United Arab Emirates (UAE) government aspires to build a world class health system to improve the quality of healthcare and the health outcomes for its population.", {"entities": []}], ["To achieve this it has implemented extensive health system reforms in the past 10\u00a0years.", {"entities": []}], ["The nature, extent and success of these reforms has not recently been comprehensively reviewed.", {"entities": []}], ["In this paper we review the progress and outcomes of health systems reform in the UAE.", {"entities": []}], ["We searched relevant databases and other sources to identify published and unpublished studies and other data available between 01 January 2002 and 31 March 2016.", {"entities": []}], ["Eligible studies were appraised and data were descriptively and narratively synthesized.", {"entities": []}], ["Seventeen studies were included covering the following themes: the UAE health system, population health, the burden of disease, healthcare financing, healthcare workforce and the impact of reforms.", {"entities": []}], ["Few, if any, studies prospectively set out to define and measure outcomes.", {"entities": []}], ["A central part of the reforms has been the introduction of mandatory private health insurance, the development of the private sector and the separation of planning and regulatory responsibilities from provider functions.", {"entities": []}], ["The review confirmed the commitment of the UAE to build a world class health system but amongst researchers and commentators opinion is divided on whether the reforms have been successful although patient satisfaction with services appears high and there are some positive indications including increasing coverage of hospital accreditation.", {"entities": []}], ["The UAE has a rapidly growing population with a unique age and sex distribution, there have been notable successes in improving child and maternal mortality and extending life expectancy but there are high levels of chronic diseases.", {"entities": []}], ["The relevance of the reforms for public health and their impact on the determinants of chronic diseases have been questioned.", {"entities": []}], ["From the existing research literature it is not possible to conclude whether UAE health system reforms are working.", {"entities": []}], ["We recommend that research should continue in this area but that research questions should be more clearly defined, focusing whenever possible on outcomes rather than processes.", {"entities": []}], ["The online version of this article (10.1186/s12913-017-2597-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The application of new proteomics and genomics technologies support a view in which few drugs act solely by inhibiting a single cellular target.", {"entities": []}], ["Indeed, drug activity is modulated by complex, often incompletely understood cellular mechanisms.", {"entities": []}], ["Therefore, efforts to decipher mode of action through genetic perturbation such as RNAi typically yields \u201chits\u201d that fall into several categories.", {"entities": []}], ["Of particular interest to the present study, we aimed to characterize secondary activities of drugs on cells.", {"entities": []}], ["Inhibiting a known target can result in clinically relevant synthetic phenotypes.", {"entities": []}], ["In one scenario, drug perturbation could, for example, improperly activate a protein that normally inhibits a particular kinase.", {"entities": []}], ["In other cases, additional, lower affinity targets can be inhibited as in the example of inhibition of c-Kit observed in Bcr-Abl\u2212positive cells treated with Gleevec.", {"entities": []}], ["Drug transport and metabolism also play an important role in the way any chemicals act within the cells.", {"entities": []}], ["Finally, RNAi per se can also affect cell fitness by more general off-target effects, e.g.", {"entities": []}], [", via the modulation of apoptosis or DNA damage repair.", {"entities": []}], ["Regardless of the root cause of these unwanted effects, understanding the scope of a drug\u2019s activity and polypharmacology is essential for better understanding its mechanism(s) of action, and such information can guide development of improved therapies.", {"entities": []}], ["We describe a rapid, cost-effective approach to characterize primary and secondary effects of small-molecules by using small-scale libraries of virally integrated short hairpin RNAs.", {"entities": []}], ["We demonstrate this principle using a \u201cminipool\u201d composed of shRNAs that target the genes encoding the reported protein targets of approved drugs.", {"entities": []}], ["Among the 28 known reported drug\u2212target pairs, we successfully identify 40% of the targets described in the literature and uncover several unanticipated drug\u2212target interactions based on drug-induced synthetic lethality.", {"entities": []}], ["We provide a detailed protocol for performing such screens and for analyzing the data.", {"entities": []}], ["This cost-effective approach to mammalian knockdown screens, combined with the increasing maturation of RNAi technology will expand the accessibility of similar approaches in academic settings.", {"entities": []}], ["Respiratory symptoms are often associated with gastroesophageal reflux disease (GERD).", {"entities": [[47, 78, "DISEASE"]]}], ["Although the role of multichannel intraluminal impedance\u2013pH (MII-pH) monitoring in GERD is clear, little is known regarding the characteristics of patients with respiratory symptoms based on MII-pH monitoring and anti-reflux therapy.", {"entities": []}], ["We evaluated a cohort of GERD patients to identify the MII-pH parameters of GERD-related respiratory symptoms and to assess the anti-reflux therapy outcomes.", {"entities": []}], ["We undertook a prospective study of patients who were referred for GERD evaluation from January 2011 to January 2012.", {"entities": []}], ["One hundred ninety-five patients underwent MII-pH monitoring and esophageal manometry, and one hundred sixty-five patients underwent invasive anti-reflux therapy that included laparoscopic Toupet fundoplication (LTF) and the Stretta procedure.", {"entities": [[212, 215, "GENE"]]}], ["The patient characteristics and MII-pH parameters were analyzed, and the symptom scores were assessed at baseline and at 1- and 3-year follow-up evaluations.", {"entities": []}], ["Of the 195 patients, 96 (49.2%) exhibited respiratory symptoms and significantly more reflux episodes (70.7\u00b129.3) than patients without respiratory symptoms (64.7\u00b124.4, p = 0.044) based on the MII-pH monitoring results.", {"entities": []}], ["Moreover, the group of patients with respiratory symptoms exhibited more proximal reflux episodes (35.2\u00b121.3) than the non-respiratory symptomatic group (28.3\u00b117.9, p = 0.013).", {"entities": []}], ["One hundred twenty-five patients following the Stretta procedure (n = 60, 31 with respiratory symptoms) or LTF (n = 65, 35 with respiratory symptoms) completed the designated 3-year follow-up period and were included in the final analysis.", {"entities": [[107, 110, "GENE"]]}], ["The symptom scores after anti-reflux therapy all decreased relative to the corresponding baseline values ( p <0.05), and there were no significant differences in the control of respiration between the Stretta procedure and LTF ( p >0.05).", {"entities": [[223, 226, "GENE"]]}], ["However, LTF significantly reduced the recurrence (re-operation) rate compared with the Stretta procedure (0 vs. 19.4%, p = 0.006).", {"entities": [[9, 12, "GENE"]]}], ["MII-pH monitoring effectively detected respiratory-related predictive parameters, including total/proximal reflux episodes and symptom correlations.", {"entities": []}], ["We found that GERD patients with respiratory symptoms exhibited more proximal and total reflux episodes but not more acid-related episodes, as determined by MII-pH monitoring.", {"entities": []}], ["Thus, such monitoring could be useful for diagnosing atypical GERD patients with respiratory symptoms.", {"entities": []}], ["Furthermore, LTF exhibited a more significant effect on controlling typical symptoms in all GERD patients and reducing the recurrence rate than the Stretta procedure in patients with respiratory symptoms.", {"entities": [[13, 16, "GENE"]]}], ["Osteoporosis is common in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[40, 77, "DISEASE"], [0, 12, "DISEASE"]]}], ["Data regarding the relationship between adipokines and bone mineral density (BMD) in this population is lacking.", {"entities": []}], ["The purpose of this pilot study was to determine associations between the adipokines tumor necrosis factor-alpha (TNF-\u03b1), leptin, adiponectin and resistin, body composition, and BMD in men with severe COPD.", {"entities": []}], ["This was a cross-sectional study of men with severe COPD who visited the University of Colorado Hospital COPD Center.", {"entities": []}], ["Bone density and parameters of body composition were measured by dual-energy X-ray absorptiometry.", {"entities": []}], ["Twenty-three men were included (mean age = 66 years, mean percent predicted forced expiratory volume in one second = 32%).", {"entities": []}], ["On bivariate analysis, there was no association between TNF-\u03b1 and BMD.", {"entities": []}], ["Parameters of body composition and serum concentrations of leptin and adiponectin were significantly associated with total hip and spine bone density.", {"entities": []}], ["However, with partial correlation analysis, total body mass was the only independent predictor of total hip BMD, explaining approximately 50% of the variability.", {"entities": []}], ["Overall, 18 out of 23 men enrolled (78%) had low bone density by T-score, and nine (39%) were classified as having osteoporosis.", {"entities": [[115, 127, "DISEASE"]]}], ["The men with osteoporosis had lower parameters of body composition, lower mean serum leptin concentrations, and a greater impairment in measures of lung function compared to the men without osteoporosis.", {"entities": [[13, 25, "DISEASE"], [190, 202, "DISEASE"]]}], ["We conclude that the effect of adipokines on BMD does not appear to be independent of body mass.", {"entities": []}], ["However, larger studies are needed to further evaluate the relationship between adipokines, body weight, and BMD in patients with COPD.", {"entities": []}], ["One of the most important transitions in the continuum of care for children is discharge to home.", {"entities": []}], ["Optimal discharge communication between healthcare providers and caregivers (e.g., parents or other guardians) who present to the emergency department (ED) with their children is not well understood.", {"entities": []}], ["The lack of policies and considerable variation in practice regarding discharge communication in pediatric EDs pose a quality and safety risk for children and their parents.", {"entities": []}], ["The aim of this mixed methods study is to better understand the process and structure of discharge communication in a pediatric ED context to contribute to the design and development of discharge communication interventions.", {"entities": []}], ["We will use surveys, administrative data and real-time video observation to characterize discharge communication for six common illness presentations in a pediatric ED: (1) asthma, (2) bronchiolitis, (3) abdominal pain, (4) fever, (5) diarrhea and vomiting, and (6) minor head injury.", {"entities": [[235, 243, "DISEASE"], [173, 179, "DISEASE"], [185, 198, "DISEASE"]]}], ["Participants will be recruited from one of two urban pediatric EDs in Canada.", {"entities": []}], ["Video recordings will be analyzed using Observer XT.", {"entities": []}], ["We will use logistic regression to identify potential demographic and visit characteristic cofounders and multivariate logistic regression to examine association between verbal and non-verbal behaviours and parent recall and comprehension.", {"entities": []}], ["Video recording of discharge communication will provide an opportunity to capture important data such as temporality, sequence and non-verbal behaviours that might influence the communication process.", {"entities": []}], ["Given the importance of better characterizing discharge communication to identify potential barriers and enablers, we anticipate that the findings from this study will contribute to the development of more effective discharge communication policies and interventions.", {"entities": []}], ["To evaluate the impact of anti\u2013tumor necrosis factor (anti-TNF) therapies on quality of life (QOL) and functional status in psoriatic arthritis (PsA) patients and study potential predictors for QOL improvements.", {"entities": [[134, 143, "DISEASE"], [124, 143, "DISEASE"]]}], ["The study was based on a cohort of 596 PsA patients receiving anti-TNF therapies.", {"entities": []}], ["Changes in functional status and QOL were assessed using the Health Assessment Questionnaire (HAQ) and Short Form 36 (SF-36) questionnaire on a 6-month basis.", {"entities": []}], ["The Short Form 6D (SF-6D) was calculated as a utility score.", {"entities": []}], ["Univariate and multivariate linear regression models were developed to examine potential predictors of QOL improvements at 6 months, using a range of demographic, baseline disease-specific, and therapeutic variables.", {"entities": []}], ["At 6 months, significant improvements in all SF-36 subscale scores were found, with the greatest percentage improvement from baseline related to physical role (113.8%; 95% confidence interval [95% CI] 102.6, 125.0).", {"entities": []}], ["The percent improvement for the physical component scale was 53.2% (95% CI 44.5, 61.9) at 6 months, whereas that for the mental component scale was 16.9% (95% CI 14.7, 19.2).", {"entities": []}], ["The mean \u00b1 SD SF-6D score was 0.58 \u00b1 0.07 at baseline, and this improved to 0.63 \u00b1 0.06 at 6 months.", {"entities": []}], ["The median HAQ score at baseline was 1.88 (interquartile range [IQR] 1.38\u20132.25) for the entire cohort, and this improved to 1.25 (IQR 0.63\u20131.88) at 6 months.", {"entities": []}], ["Improvements in Disease Activity Score in 28 joints at 6 months were found to be significantly associated with QOL improvements at the same time point.", {"entities": []}], ["Anti-TNF therapy is associated with improvement in both physical and mental status in PsA patients.", {"entities": []}], ["These improvements were most substantial in patients who also had improvements in their disease activity.", {"entities": []}], ["Mast cells (MC) are present in most vascularized tissues around the vasculature likely exerting immunomodulatory functions.", {"entities": []}], ["Endowed with diverse mediators, resident MC represent first-line fine-tuners of local microenvironment.", {"entities": []}], ["Sphingosine-1-phosphate (S1P) functions as a pluripotent signaling sphingolipid metabolite in health and disease.", {"entities": []}], ["S1P formation occurs at low levels in resting MC and is upregulated upon activation.", {"entities": []}], ["Its export can result in type 2 S1P receptor- (S1PR2-) mediated stimulation of MC, further fueling inflammation.", {"entities": []}], ["However, the role of S1PR2 ligation in proangiogenic vascular endothelial growth factor- (VEGF-) A and matrix metalloproteinase- (MMP-) 2 release from MC is unknown.", {"entities": [[21, 26, "GENE"]]}], ["Using a preclinical MC-dependent model of acute allergic responses and in vitro stimulated primary mouse bone marrow-derived MC (BMMC) or human primary skin MC, we report that S1P signaling resulted in substantial amount of VEGF-A release.", {"entities": []}], ["Similar experiments using S1pr2 -deficient mice or BMMC or selective S1P receptor agonists or antagonists demonstrated that S1P/S1PR2 ligation on MC is important for VEGF-A secretion.", {"entities": [[26, 31, "GENE"], [128, 133, "GENE"]]}], ["Further, we show that S1P stimulation triggered transcriptional upregulation of VEGF-A and MMP-2 mRNA in human but not in mouse MC.", {"entities": []}], ["S1P exposure also triggered MMP-2 secretion from human MC.", {"entities": []}], ["These studies identify a novel proangiogenic axis encompassing MC/S1P/S1PR2 likely relevant to inflammation.", {"entities": []}], ["Gastroesophageal reflux (GER) is a disorder that is common by seen in childhood and may lead to severe complications.", {"entities": []}], ["In this study, we ascertained the incidence of GER among the children who had typical and atypical complaints of GER and whether there was a difference between two groups comparing the findings of 24-hour pH-meter.", {"entities": []}], ["39 out of 70 patients with typical and atypical GER symptoms were diagnosed as GER by 24-hour pH-meter monitoring.", {"entities": []}], ["The patients were divided into three groups, those having gastrointestinal complaints, those having respiratory complaints and those having both gastrointestinal and respiratory symptoms.", {"entities": []}], ["Evaluated the GER prevalence in these groups, it was found to be 60% in the gastrointestinal group, 48.6% in the respiratory group and 75% in the mixed group.", {"entities": []}], ["When pH-meter measurements of GER positive patients were compared within the clinical groups, the fraction of time that pH was lower than 4 was found to be significantly higher in the mixed group (p = 0.004).", {"entities": []}], ["The coexistence of gastrointestinal and respiratory symptoms in the patients with GER may be related to the severe reflux.", {"entities": []}], ["Patients with major depressive disorder (MDD) often fail to respond to first-line antidepressant treatments (ADTs); subsequent strategies include dosage increase, switch to a different ADT, or addition of another ADT or other drug.", {"entities": [[14, 39, "DISEASE"]]}], ["The objective of this prospective, case review study was to identify factors that influence the decision to prescribe adjunctive antipsychotics for patients with MDD and inadequate response to ADT.", {"entities": []}], ["Psychiatrists or primary care physicians ( n \u00a0=\u00a0411) based in the USA and Europe each completed an online survey for ten consecutive adults with MDD and inadequate response to ADTs, and for whom a treatment change was considered.", {"entities": []}], ["A t test was used to compare survey responses between groups of patients.", {"entities": []}], ["The survey was completed for 4018 patients; an adjunctive antipsychotic was considered for 961/4018 patients (23.9%) and actually prescribed for 514/4018 (12.8%).", {"entities": []}], ["Compared with patients not considered for an adjunctive antipsychotic, those who were considered for this treatment had more previous major depressive episodes (MDEs), longer duration of the current MDE, more severe illness both at ADT initiation and current consultation, and more treatment changes.", {"entities": []}], ["Patients who were prescribed adjunctive antipsychotics had at baseline more functional impairment and absences from work than those considered for but not prescribed this treatment.", {"entities": []}], ["Key symptoms that prompted physicians to consider antipsychotics were psychotic symptoms, psychomotor agitation, hostility, irritability, impulsivity, and anger bursts.", {"entities": []}], ["Anxious mood and irritability were mentioned significantly more often by physicians who actually prescribed adjunctive antipsychotics.", {"entities": []}], ["Obstacles to prescribing included a tendency to wait to see if symptoms improved and concern over side effects.", {"entities": []}], ["This real-world study suggested that the decision to prescribe an adjunctive antipsychotic for patients with MDD and inadequate response to ADT is influenced by a broad spectrum of factors, predominantly related to severity of illness, functional impairment, and symptom profile.", {"entities": []}], ["Otsuka Pharmaceutical Development & Commercialization, Inc. (Princeton, USA) and H. Lundbeck A/S (Valby, Denmark).", {"entities": []}], ["The online version of this article (doi:10.1007/s12325-015-0207-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Fueled by the promise of regenerative medicine, currently there is unprecedented interest in stem cells.", {"entities": []}], ["Furthermore, there have been revolutionary, but somewhat controversial, advances in our understanding of stem cell biology.", {"entities": []}], ["Stem cells likely play key roles in the repair of diverse lung injuries.", {"entities": []}], ["However, due to very low rates of cellular proliferation in vivo in the normal steady state, cellular and architectural complexity of the respiratory tract, and the lack of an intensive research effort, lung stem cells remain poorly understood compared to those in other major organ systems.", {"entities": []}], ["In the present review, we concisely explore the conceptual framework of stem cell biology and recent advances pertinent to the lungs.", {"entities": []}], ["We illustrate lung diseases in which manipulation of stem cells may be physiologically significant and highlight the challenges facing stem cell-related therapy in the lung.", {"entities": []}], ["The present study aimed to investigate potential gene markers for predicting the formation of carotid atheroma plaques using high-throughput bioinformatics methods.", {"entities": []}], ["The GSE43292 gene expression profile was downloaded from the Gene Expression Omnibus database.", {"entities": []}], ["Following data processing, differentially expressed genes (DEGs) were screened using a paired t-test in the Linear Models for Microarray Data package with the criteria of a false discovery rate of P<0.05 and |log2 fold-change| \u22650.58, followed by functional enrichment, protein-protein interaction (PPI) network construction, key node and module analysis, and prediction of transcription factors (TFs) targeting genes in the significant modules.", {"entities": []}], ["The results revealed that the gene expression profiles from 32 paired samples of carotid atheroma plaque tissue and macroscopically intact tissue were obtained, based on which 886 DEGs, including 513 upregulated genes and 373 downregulated genes, were identified.", {"entities": []}], ["The upregulated and downregulated gene sets were enriched in 24 and 13 pathways, respectively.", {"entities": []}], ["The PPI network constructed with these DEGs comprised 35 key nodes with degrees \u226520, among which spleen tyrosine kinase (SYK), LYN and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit \u03b3 (PIK3CG) were the three highest.", {"entities": [[121, 124, "GENE"], [127, 130, "GENE"], [203, 209, "GENE"]]}], ["A significant module was mined in the PPI network, which consisted of 29 DEGs targeted by 11 TFs.", {"entities": []}], ["The DEGs between the carotid atheroma plaque and macroscopically intact tissue samples may be involved in carotid atherogenesis.", {"entities": []}], ["Key nodes in the PPI network constructed from these DEGs and the genes involved in the significant module, including SYK, LYN and PIK3CG, are promising for the prediction of carotid plaque formation.", {"entities": [[117, 120, "GENE"], [122, 125, "GENE"], [130, 136, "GENE"]]}], ["Asthma prevalence is generally lower in rural locations with some indication of an urban-rural gradient.", {"entities": [[0, 6, "DISEASE"]]}], ["However, among children with asthma, certain rural exposures thought to protect against the development of asthma could aggravate the condition.", {"entities": [[29, 35, "DISEASE"], [107, 113, "DISEASE"]]}], ["We examined childhood asthma prevalence and related conditions along an urban-rural gradient and also examined the characteristics of those with asthma along the urban-rural gradient.", {"entities": [[22, 28, "DISEASE"], [145, 151, "DISEASE"]]}], ["In 2013 we completed a cross-sectional survey of 3509 children aged 5\u201314 years living in various population densities of Saskatchewan, Canada.", {"entities": []}], ["Location of dwelling was identified as belonging to one of the following population densities: large urban region (approximately 200,000), small urban (approximately 35,000), or rural (small town of <1,500 or farm dweller).", {"entities": []}], ["Physician-diagnosed asthma and asthma-related symptoms were ascertained from responses in the parental-completed questionnaires.", {"entities": [[20, 26, "DISEASE"], [31, 37, "DISEASE"]]}], ["Of the study population, 69% lived in a large urban region, 11% lived in a small urban centre and 20% were rural dwellers.", {"entities": []}], ["Overall, asthma prevalence was 19.6% with differences in asthma prevalence with differences between locations (large urban\u2009=\u200920.7%; small urban\u2009=\u200921.5%; rural\u2009=\u200915.1%; p \u2009=\u20090.003).", {"entities": [[9, 15, "DISEASE"], [57, 63, "DISEASE"]]}], ["After adjustment for potential confounders, the association between location of dwelling and asthma remained significant.", {"entities": [[93, 99, "DISEASE"]]}], ["Despite a lower prevalence of asthma in the rural area, the prevalence and risk of ever wheeze and having more than 3 wheezing episodes in the past 12\u00a0months among those who reported asthma, was higher in rural locations after adjustment for potential confounders.", {"entities": [[30, 36, "DISEASE"], [183, 189, "DISEASE"]]}], ["The results of this study support the evidence of a difference in childhood asthma prevalence between urban and rural locations and that once a child has asthma, certain rural exposures may aggravate the disease.", {"entities": [[76, 82, "DISEASE"], [154, 160, "DISEASE"]]}], ["In healthy human subjects, the simultaneous aerosol administration of histamine and methacholine results in a pronounced decrease in maximum flow rates on partial expiratory flow-volume (PEFV) curves.", {"entities": []}], ["When given alone in the same concentrations, these drugs produced no or minimal decreases in flow rates.", {"entities": []}], ["The results suggest an interaction of histamine and cholinergic stimuli on airway smooth muscle (ASM).", {"entities": []}], ["This mechanism might explain many experiments where vagal blockade diminished or abolished ASM response to histamine and other stimuli, simply by interfering with histamine-cholinergic interaction at the ASM level.", {"entities": []}], ["These findings confirm similar findings of animal in vitro experiments.", {"entities": []}], ["The experiments clearly confirm the sensitivity and value of assessing drug effects prior to a deep breath.", {"entities": []}], ["Flow-rate changes after a full inspiration, taken from the maximum expiratory flow-volume (MEFV) curve, show either no relationship to the concentration of inhaled methacholine or significantly less effect than that seen on the PEFV curve.", {"entities": [[91, 95, "GENE"]]}], ["In the last two decades, mesenchymal stem cells (MSCs) have been pre-clinically utilized in the treatment of a variety of kinds of diseases including chronic obstructive pulmonary disease (COPD).", {"entities": [[150, 187, "DISEASE"]]}], ["The aim of the current study was to systematically review and conduct a meta-analysis on the published pre-clinical studies of MSC administration in the treatment of COPD in animal models.", {"entities": [[127, 130, "GENE"]]}], ["A systematic search of electronic databases was performed.", {"entities": []}], ["Statistical analysis was performed using the Comprehensive Meta-Analysis software (Version 3).", {"entities": []}], ["The pooled Hedges\u2019s g with 95% confidence intervals (95% CIs) was adopted to assess the effect size.", {"entities": []}], ["Random effect model was used due to the heterogeneity between the studies.", {"entities": []}], ["A total of 20 eligible studies were included in the current systematic review.", {"entities": []}], ["The overall meta-analysis showed that MSC administration was significantly in favor of attenuating acute lung injury (Hedges\u2019s g = -2.325 \u00b1 0.145 with 95% CI: -2.609 ~ -2.040, P < 0.001 for mean linear intercept, MLI; Hedges\u2019s g = -3.488 \u00b1 0.504 with 95% CI: -4.476 ~ -2.501, P < 0.001 for TUNEL staining), stimulating lung tissue repair (Hedges\u2019s g = 3.249 \u00b1 0.586 with 95% CI: 2.103~ 4.394, P < 0.001) and improving lung function (Hedges\u2019s g = 2.053 \u00b1 0.408 with 95% CI: 1.253 ~ 2.854, P < 0.001).", {"entities": [[38, 41, "GENE"]]}], ["The mechanism of MSC therapy in COPD is through ameliorating airway inflammation (Hedges\u2019s g = -2.956 \u00b1 0.371 with 95% CI: -3.683 ~ -2.229, P < 0.001) and stimulating cytokine synthesis that involves lung tissue repair (Hedges\u2019s g = 3.103 \u00b1 0.734 with 95% CI: 1.664 ~ 4.541, P < 0.001).", {"entities": [[17, 20, "GENE"]]}], ["This systematic review and meta-analysis suggest a promising role for MSCs in COPD treatment.", {"entities": []}], ["Although the COPD models may not truly mimic COPD patients, these pre-clinical studies demonstrate that MSC hold promise in the treatment of chronic lung diseases including COPD.", {"entities": [[104, 107, "GENE"]]}], ["The mechanisms of MSCs role in preclinical COPD treatment may be associated with attenuating airway inflammation as well as stimulating lung tissue repair.", {"entities": []}], ["Little is known as to whether primary care teams\u2019 perceptions of how well they have implemented the Chronic Care Model (CCM) corresponds with their patients\u2019 own experience of chronic illness care.", {"entities": []}], ["We examined the extent to which practice members\u2019 perceptions of how well they organized to deliver care consistent with the CCM were associated with their patients\u2019 perceptions of the chronic illness care they have received.", {"entities": []}], ["Analysis of baseline measures from a cluster randomized controlled trial testing a practice facilitation intervention to implement the CCM in small, community-based primary care practices.", {"entities": []}], ["All practice \u201cmembers\u201d (i.e., physician providers, non-physician providers, and staff) completed the Assessment of Chronic Illness Care (ACIC) survey and adult patients with 1 or more chronic illnesses completed the Patient Assessment of Chronic Illness Care (PACIC) questionnaire.", {"entities": []}], ["Two sets of hierarchical linear regression models accounting for nesting of practice members (N\u2009=\u2009283) and patients (N\u2009=\u20091,769) within 39 practices assessed the association between practice member perspectives of CCM implementation (ACIC scores) and patients\u2019 perspectives of CCM (PACIC).", {"entities": []}], ["ACIC summary score was not significantly associated with PACIC summary score or most of PACIC subscale scores, but four of the ACIC subscales [Self-management Support (p\u2009<\u20090.05); Community Linkages (p\u2009<\u20090.02), Delivery System Design (p\u2009<\u20090.02), and Organizational Support (p\u2009<\u20090.02)] were consistently associated with PACIC summary score and the majority of PACIC subscale scores after controlling for patient characteristics.", {"entities": []}], ["The magnitude of the coefficients, however, indicates that the level of association is weak.", {"entities": []}], ["The ACIC and PACIC scales appear to provide complementary and relatively unique assessments of how well clinical services are aligned with the CCM.", {"entities": []}], ["Our findings underscore the importance of assessing both patient and practice member perspectives when evaluating quality of chronic illness care.", {"entities": []}], ["NCT00482768", {"entities": []}], ["To determine the prevalence and risk factors of allergic rhinitis among bakers in Douala.", {"entities": [[48, 65, "DISEASE"], [57, 65, "DISEASE"]]}], ["A cross-sectional study; the logistic regression model was use to find the risk factors of allergic rhinitis.", {"entities": [[91, 108, "DISEASE"], [100, 108, "DISEASE"]]}], ["The study was conducted in 42 bakeries randomly selected among a total of 151 bakeries in the city of Douala.", {"entities": []}], ["All bakers who consented to participate in the study between 1 May and 31 July 2013.", {"entities": []}], ["Allergic rhinitis was the outcome of interest.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["It was defined as the presence of the following symptoms: itchy nose, rhinorrhea, nasal obstruction and sneezing.", {"entities": []}], ["During the study period, a total of 273 bakers were invited and 229 finally agreed to participate in this study.", {"entities": []}], ["Males were the most represented gender with 222 (96.9%) participants.", {"entities": []}], ["The mean age of the participants was 36.29\u00b18.9\u2005years.", {"entities": []}], ["Smoking was found in 55 participants (24.5%).", {"entities": []}], ["The symptoms of allergic rhinitis were observed in 24.5% of participants.", {"entities": [[16, 33, "DISEASE"], [25, 33, "DISEASE"]]}], ["Work related nasal symptoms were present in 15% of participants.", {"entities": []}], ["Sensitisation to wheat flour and \u03b1-amylase was found in 16.6% and 8.3% of participants, respectively.", {"entities": []}], ["The Prick test was positive for mites in 12.2% of participants.", {"entities": []}], ["After multivariate analysis, sensitisation to flour (OR 3.95, 95% CI 1.85 to 8.47) and storage mites (OR 3.44, 95% CI 1.45 to 8.18) were the factors independently associated with symptoms of allergic rhinitis.", {"entities": [[191, 208, "DISEASE"], [200, 208, "DISEASE"]]}], ["Allergic rhinitis is frequent among bakers in Cameroon.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["Implementation of preventive measures against inhalation of airborne allergens in bakeries and clinical monitoring of bakers sensitised to wheat flour and mites could help to reduce the prevalence of allergic rhinitis among bakers.", {"entities": [[200, 217, "DISEASE"], [209, 217, "DISEASE"]]}], ["Drug-induced liver injury (DILI) is one of the most common adverse reactions leading to product withdrawal post-marketing.", {"entities": []}], ["Recently, genome-wide association studies have identified a number of human leukocyte antigen (HLA) alleles associated with DILI; however, the cellular and chemical mechanisms are not fully understood.", {"entities": [[95, 98, "GENE"]]}], ["To study these mechanisms, we established an HLA-typed cell archive from 400 healthy volunteers.", {"entities": []}], ["In addition, we utilized HLA genotype data from more than four million individuals from publicly accessible repositories such as the Allele Frequency Net Database, Major Histocompatibility Complex Database and Immune Epitope Database to study the HLA alleles associated with DILI.", {"entities": [[25, 28, "GENE"], [247, 250, "GENE"], [25, 28, "GENE"], [247, 250, "GENE"]]}], ["We utilized novel in silico strategies to examine HLA haplotype relationships among the alleles associated with DILI by using bioinformatics tools such as NetMHCpan, PyPop, GraphViz, PHYLIP and TreeView.", {"entities": [[50, 53, "GENE"]]}], ["We demonstrated that many of the alleles that have been associated with liver injury induced by structurally diverse drugs (flucloxacillin, co-amoxiclav, ximelagatran, lapatinib, lumiracoxib) reside on common HLA haplotypes, which were present in populations of diverse ethnicity.", {"entities": [[209, 212, "GENE"]]}], ["Our bioinformatic analysis indicates that there may be a connection between the different HLA alleles associated with DILI caused by therapeutically and structurally different drugs, possibly through peptide binding of one of the HLA alleles that defines the causal haplotype.", {"entities": [[90, 93, "GENE"], [230, 233, "GENE"], [90, 93, "GENE"], [230, 233, "GENE"]]}], ["Further functional work, together with next-generation sequencing techniques, will be needed to define the causal alleles associated with DILI.", {"entities": []}], ["The purpose of this review was to summarize existing epidemiological evidence of the association between quantitative estimates of indoor air pollution and all-day personal exposure with adverse birth outcomes including fetal growth, prematurity and miscarriage.", {"entities": []}], ["We carried out a systematic literature search of MEDLINE and EMBASE databases with the aim of summarizing and evaluating the results of peer-reviewed epidemiological studies undertaken in \u201cwesternized\u201d countries that have assessed indoor air pollution and all-day personal exposure with specific quantitative methods.", {"entities": []}], ["This comprehensive literature search identified 16 independent studies which were deemed relevant for further review and two additional studies were added through searching the reference lists of all included studies.", {"entities": []}], ["Two reviewers independently and critically appraised all eligible articles using the Critical Appraisal Skills Programme (CASP) tool.", {"entities": []}], ["Of the 18 selected studies, 14 adopted a prospective cohort design, three were case-controls and one was a retrospective cohort study.", {"entities": []}], ["In terms of pollutants of interest, seven studies assessed exposure to electro-magnetic fields, four studies assessed exposure to polycyclic aromatic hydrocarbons, four studies assessed PM 2.5 exposure and three studies assessed benzene, phthalates and noise exposure respectively.", {"entities": []}], ["Furthermore, 12 studies examined infant growth as the main birth outcome of interest, six examined spontaneous abortion and three studies assessed gestational age at birth and preterm delivery.", {"entities": []}], ["This survey demonstrates that there is insufficient research on the possible association of indoor exposure and early life effects and that further research is needed.", {"entities": []}], ["To translate, adapt and validate the Itch Severity Scale to a Brazilian version (ISS-Ped) in order to measure the severity of pruritus in children and adolescents with atopic dermatitis.", {"entities": [[168, 185, "DISEASE"], [175, 185, "DISEASE"]]}], ["This is a methodological study of validation of an instrument following recommended protocols.", {"entities": []}], ["The translated version was evaluated by a group of experts including one professional with experience in instrument validation, three English teachers, one linguistics teacher and seven allergists.", {"entities": []}], ["After this, the scale was applied to 42 parents of children aged between 2 and 18 years old with atopic dermatitis, and 42 parents of children without pruritic diseases.", {"entities": [[97, 114, "DISEASE"], [104, 114, "DISEASE"]]}], ["Results were evaluated according to the severity of atopic dermatitis and disease control, and they were compared between groups with and without atopic dermatitis.", {"entities": [[52, 69, "DISEASE"], [146, 163, "DISEASE"], [59, 69, "DISEASE"], [153, 163, "DISEASE"]]}], ["More than 90% of the questions were clear to the parents.", {"entities": []}], ["The ISS-Ped showed a strong positive correlation with the severity of atopic dermatitis (Pearson: 0.74; p <0.001) and a good correlation with the control of dermatitis (point-biserial correlation coefficient: 0.65; p <0.001).", {"entities": [[70, 87, "DISEASE"], [77, 87, "DISEASE"], [157, 167, "DISEASE"]]}], ["The scale showed excellent internal consistency (Cronbach\u2019s \u03b1: 0.96) and adequate test and retest agreement (95% confidence interval of intraclass correlation coefficient: 0.89-0.99; p <0.001).", {"entities": []}], ["The ISS-Ped is a feasible, valid, reliable and satisfactorily equivalent.", {"entities": []}], ["The translated scale was appropriate to assess the severity of itching in children and adolescents with eczema, allowing comparisons in the clinical practice and in the research setting.", {"entities": []}], ["The primary purpose of this study is to examine whether use of source data is effective in increasing the number of arterial segments that can be interpreted from maximum intensity projections of lower limb MR angiograms.", {"entities": []}], ["Correlation between sites of arterial disease and venous contamination was also measured.", {"entities": []}], ["Interpretation of source data is performed routinely by radiologists, but the value of this has not been well studied with randomized studies.", {"entities": []}], ["The proportion of segments visible above the knee was 87% using maximal intensity projection alone (MIP) and 88% when the MIP was combined with source data.", {"entities": [[100, 103, "GENE"], [122, 125, "GENE"], [100, 103, "GENE"], [122, 125, "GENE"]]}], ["The proportions were 67% for MIP and 72% for MIP plus source data below the knee.", {"entities": [[29, 32, "GENE"], [45, 48, "GENE"], [29, 32, "GENE"], [45, 48, "GENE"]]}], ["There was substantial agreement between presence of arterial disease and venous contamination in the calf and thigh.", {"entities": []}], ["The use of source data increases the number of assessable segments, but not individuals, by a statistically significant but small amount (1.2%, p <0.05).", {"entities": []}], ["This study supports the association between arterial disease and venous contamination.", {"entities": []}], ["Background.", {"entities": []}], ["In the last few decades, a better knowledge of the inflammatory pathways involved in the pathogenesis of Inflammatory Bowel Disease (IBD) has promoted biological therapy as an important tool to treat IBD patients.", {"entities": []}], ["However, in spite of a wider spectrum of biological drugs, a significant proportion of patients is unaffected by or lose their response to these compounds, along with increased risks of infections and malignancies.", {"entities": []}], ["For these reasons there is an urgent need to look for new pharmacological targets.", {"entities": []}], ["The novel Phosphodiesterase 4 (PDE4) inhibitors have been recently introduced as new modulators of intracellular signals and gene transcription for the treatment of IBD.", {"entities": []}], ["To discuss and describe the state of the art of this new class of compounds in the IBD field, with particular attention to apremilast.", {"entities": []}], ["Published articles selected from PubMed were comprehensively reviewed, with key words including apremilast, inflammatory disease, IBD, psoriasis, psoriatic arthritis, pathogenesis, therapies, and treatment.", {"entities": [[135, 144, "DISEASE"], [156, 165, "DISEASE"], [146, 165, "DISEASE"]]}], ["PDE4 inhibitors generate elevated intracellular levels of cyclic Adenosine Monophosphate (cAMP), that consequently down-regulate the release of pro-inflammatory cytokines in the mucosa of IBD patients.", {"entities": []}], ["The newly developed apremilast is one of these drugs and has already been approved for the treatment of dermatologic/rheumatologic inflammatory conditions; studies in psoriasis and psoriatic arthritis have in fact demonstrated its clinical activity.", {"entities": [[167, 176, "DISEASE"], [191, 200, "DISEASE"], [181, 200, "DISEASE"]]}], ["However, no clinical trials have yet been published on the use of apremilast in IBD.", {"entities": []}], ["Conclusion.", {"entities": []}], ["In light of the similarity of pro-inflammatory signaling pathways across the gut, the skin, and joints, apremilast is likely supposed to show its efficacy also in IBD.", {"entities": []}], ["The incidence of enterovirus D68 (EV-D68) and the spectrum of clinical disease in children are not well known in European countries.", {"entities": []}], ["We have designed a study with the objective of describing the clinical impact of EV-D68 detected in children with respiratory tract infections.", {"entities": []}], ["As a part of a prospective study to identify the etiology and clinical characteristics of viral respiratory infections in children in Spain, we performed the analysis of the cases of EV infections in all children hospitalized in a secondary hospital in Madrid, during the epidemic respiratory season 2012\u20132013.", {"entities": []}], ["A second group of samples was corresponded to infants of the same area, with ambulatory respiratory infection or asymptomatic.", {"entities": []}], ["Phylogenetic EV-D68 analysis was made using the viral protein 1 gene (VP1).", {"entities": []}], ["Clinical data of EV-D68 patients were compared with those infected by rhinovirus in the same period and population.", {"entities": []}], ["The study population consisted of 720 patients corresponding to 399 episodes of hospitalization for respiratory causes, 44 episodes of ambulatory respiratory infections and 277 children determined as a healthy control group.", {"entities": []}], ["A total of 22 patients were positive for EVs (3.05%), and 12 of them were specifically typed as EV-D68 (11/443 respiratory infections, 2.5%).", {"entities": []}], ["The most frequent diagnosis in the 10 hospitalized children with EV-D68 detection was recurrent wheezing.", {"entities": []}], ["Hypoxia was present in 70% of cases, but admission in the intensive care unit was not required.", {"entities": []}], ["No neurological signs or symptoms were observed.", {"entities": []}], ["One patient had an ambulatory mild bronchiolitis and another was asymptomatic.", {"entities": [[35, 48, "DISEASE"]]}], ["No differences were found with rhinovirus infections except less duration of hypoxia and fever in EV-D68 group.", {"entities": []}], ["EV-D68 infections were detected in 3.05% of respiratory studied samples (2.5% of admissions).", {"entities": []}], ["The infection was associated with wheezing episodes with hypoxia.", {"entities": []}], ["No admissions to intensive care unit or neurological symptoms were found.", {"entities": []}], ["A common reason for giving research participants post-trial access (PTA) to the trial intervention appeals to reciprocity, the principle, stated most generally, that if one person benefits a second, the second should reciprocate: benefit the first in return.", {"entities": []}], ["Many authors consider it obvious that reciprocity supports PTA.", {"entities": []}], ["Yet their reciprocity principles differ, with many authors apparently unaware of alternative versions.", {"entities": []}], ["This article is the first to gather the range of reciprocity principles.", {"entities": []}], ["It finds that: (1) most are false.", {"entities": []}], ["(2) The most plausible principle, which is also problematic, applies only when participants experience significant net risks or burdens.", {"entities": []}], ["(3) Seldom does reciprocity support PTA for participants or give researchers stronger reason to benefit participants than equally needy non-participants.", {"entities": []}], ["(4) Reciprocity fails to explain the common view that it is bad when participants in a successful trial have benefited from the trial intervention but lack PTA to it.", {"entities": []}], ["Whilst there is broad agreement on what constitutes high quality health care for people with diabetes, there is little consensus on the most efficient way of delivering it.", {"entities": []}], ["Structured recall systems can improve the quality of care but the systems evaluated to date have been of limited sophistication and the evaluations have been carried out in small numbers of relatively unrepresentative settings.", {"entities": []}], ["Hartlepool, Easington and Stockton currently operate a computerised diabetes register which has to date produced improvements in the quality of care but performance has now plateaued leaving substantial scope for further improvement.", {"entities": []}], ["This study will evaluate the effectiveness and efficiency of an area wide 'extended' system incorporating a full structured recall and management system, actively involving patients and including clinical management prompts to primary care clinicians based on locally-adapted evidence based guidelines.", {"entities": []}], ["The study design is a two-armed cluster randomised controlled trial of 61 practices incorporating evaluations of the effectiveness of the system, its economic impact and its impact on patient wellbeing and functioning.", {"entities": []}], ["Cigarette smoke induces injury and neutrophilic inflammation in the airways of smokers.", {"entities": []}], ["The stability and activity of inflammatory effectors, IL8 and neutrophil elastase (NE), can be prolonged by binding to airway heparan sulfate (HS)/syndecan-1, posing risk for developing chronic obstructive pulmonary disease(COPD).", {"entities": [[186, 223, "DISEASE"], [54, 57, "GENE"]]}], ["We hypothesize that antagonizing HS/syndecan-1 binding of the inflammatory effectors could reduce smoking-related neutrophil-mediated airway inflammation.", {"entities": []}], ["Analysis of bronchoalveolar lavage fluid(BALF) of COPD patients found both total and unopposed NE levels to be significantly higher among smokers with COPD than non-COPD subjects.", {"entities": []}], ["Similar NE burden was observed in smoke-exposed rats compared to sham air controls.", {"entities": []}], ["We chose sulfated-maltoheptaose(SM), a heparin-mimetic, to antagonize HS/sydecan-1 binding of the inflammatory mediators in airway fluids and lung tissues of the smoke-exposed rat model.", {"entities": []}], ["Airway treatment with SM resulted in displacement of CINC-1 and NE from complexation with bronchio-epithelial HS/syndecan-1, dissipating the chemokine gradient for neutrophil flux across to the bronchial lumen.", {"entities": []}], ["Following SM displacement of NE from shed HS/syndecan-1 in bronchial fluids, NE became accessible to inhibition by \u03b1 1 -antitrypsin endogenous in test samples.", {"entities": []}], ["The antagonistic actions of SM against syndecan-1 binding of NE and CINC-1 in smoke-exposed airways suggest new therapeutic opportunities for modulating airway inflammation in smokers with SM delivery.", {"entities": []}], ["Consistent with their essential role in cell adhesion to the extracellular matrix, integrins and their associated signaling pathways have been shown to be involved in cell proliferation, migration, invasion and survival, processes required in both tumorigenesis and metastasis.", {"entities": []}], ["\u03b21-integrins represent the predominantly expressed integrins in mammary epithelial cells and have been proven crucial for mammary gland development and differentiation.", {"entities": []}], ["Here we provide an overview of the studies that have used transgenic mouse models of mammary tumorigenesis to establish \u03b21-integrin as a critical mediator of breast cancer progression and thereby as a potential therapeutic target for the development of new anticancer strategies.", {"entities": [[158, 171, "DISEASE"], [165, 171, "DISEASE"]]}], ["Epithelial tissues form a selective barrier that separates the external environment from the internal tissue milieu.", {"entities": []}], ["Single epithelial cells are densely packed and associate via distinct intercellular junctions.", {"entities": []}], ["Intercellular junction proteins not only control barrier properties of the epithelium but also play an important role in regulating epithelial homeostasis that encompasses cell proliferation, migration, differentiation and regulated shedding.", {"entities": []}], ["Recent studies have revealed that several proteases target epithelial junction proteins during physiological maturation as well as in pathologic states such as inflammation and cancer.", {"entities": [[177, 183, "DISEASE"]]}], ["This review discusses mechanisms and biological consequences of transmembrane junction protein cleavage.", {"entities": []}], ["The influence of junction protein cleavage products on pathogenesis of inflammation and cancer is discussed.", {"entities": [[88, 94, "DISEASE"]]}], ["Case management programs for chronically ill, homeless people improve health and resource utilization by linking patients with case managers focused on improving management of medical and psychosocial problems.", {"entities": []}], ["Little is known about participants\u2019 perspectives on case management interventions.", {"entities": []}], ["This qualitative study used in-depth, one-on-one interviews to understand the impact of a case management program from the perspective of participants.", {"entities": []}], ["A standardized interview guide with open-ended questions explored experiences with the case management program and feelings about readiness to leave the program.", {"entities": []}], ["Four recurrent themes emerged: (1) Participants described profound social isolation prior to case management program enrollment; (2) Participants perceived that caring personal relationships with case managers were key to the program; (3) Participants valued assistance with navigating medical and social systems; and (4) Participants perceived that their health improved through both the interpersonal and the practical aspects of case management.", {"entities": []}], ["Chronically ill, homeless people enrolled in a case management program perceived that social support from case managers resulted in improved health.", {"entities": []}], ["Programs for this population should consider explicitly including comprehensive social support interventions.", {"entities": []}], ["Further research on case management should explore the impact of different types of social support on outcomes for homeless chronically ill patients.", {"entities": []}], ["The analysis of chromatin fine structure and transcription factor occupancy of differentially expressed genes by in vivo footprinting and ligation-mediated-PCR (LMPCR) is a powerful tool to understand the impact of chromatin on gene expression.", {"entities": []}], ["However, as with all PCR-based techniques, the accuracy of the experiments has often been reduced by sequence similarities and the presence of GC-rich or repeat sequences, and some sequences are completely refractory to analysis.", {"entities": []}], ["Here we describe a novel method, pyrophosphorolysis activated polymerization LMPCR or PAP-LMPCR, which is capable of generating accurate and reproducible footprints specific for individual alleles and can read through sequences previously not accessible for analysis.", {"entities": []}], ["In addition, we have adapted this technique for automation, thus enabling the simultaneous and rapid analysis of chromatin structure at many different genes.", {"entities": []}], ["Short-course oral corticosteroids are routinely used to treat acute asthma and croup.", {"entities": [[79, 84, "DISEASE"], [68, 74, "DISEASE"]]}], ["We evaluated their tolerability and palatability in Saudi Arabian (SA) and UK children.", {"entities": []}], ["Prospective observational/interview study (3\u2009months in each country).", {"entities": []}], ["Palatability was evaluated using a 5-point facial Hedonicscale and tolerability by direct questioning of patient/parents.", {"entities": []}], ["In SA, of 122 patients (2\u201310\u2009years) recruited, 52 received prednisolone base tablets, 37 prednisolone sodium phosphate syrup and 33 received dexamethasone elixir.", {"entities": []}], ["In the UK, of 133 patients (2\u201316\u2009years), 38 received prednisolone base tablets (mainly crushed and dispersed), 42 prednisolone sodium phosphate soluble tablets and 53 received dexamethasone sodium phosphate oral solution.", {"entities": []}], ["In both countries, dexamethasone had the highest palatability scores (SA mean: 1.97; UK mean: 3) and prednisolone base tablets had the lowest (SA mean: 1.12; UK mean: 1.39).", {"entities": []}], ["Palatability scores improved for all formulations of prednisolone with each subsequent daily dose.", {"entities": []}], ["In SA, prednisolone base tablets were associated with more nausea (24vs7 patients) and vomiting (5vs0 patients) than sodium phosphate syrup (p=0.008\u2009and p=0.073,\u2009respectively).", {"entities": []}], ["In the UK, vomiting occurred more frequently with prednisolone base (8 patients) than sodium phosphate soluble tablets (2 patients) (p=0.041).", {"entities": []}], ["In both centres, dexamethasone was associated with less side effects.", {"entities": []}], ["Vomiting (1vs0 patients), nausea (7vs3 patients) and abdominal pain (10vs8 patients) occurred more with dexamethasone sodium phosphate solution than dexamethasone elixir.", {"entities": []}], ["Dexamethasone sodium phosphate solution was the most palatable preparation.", {"entities": []}], ["Prednisolone base tablets were rated least palatable and were least well tolerated.", {"entities": []}], ["Palatability scores improved with each dose taken.", {"entities": []}], ["Xenoestrogens (XEs) are chemicals derived from a variety of natural and anthropogenic sources that can interfere with endogenous estrogens by either mimicking or blocking their responses via non-genomic and/or genomic signaling mechanisms.", {"entities": []}], ["Disruption of estrogens\u2019 actions through the less-studied non-genomic pathway can alter such functional end points as cell proliferation, peptide hormone release, catecholamine transport, and apoptosis, among others.", {"entities": []}], ["Studies of potentially adverse effects due to mixtures and to low doses of endocrine-disrupting chemicals have recently become more feasible, though few so far have included actions via the non-genomic pathway.", {"entities": []}], ["Physiologic estrogens and XEs evoke non-monotonic dose responses, with different compounds having different patterns of actions dependent on concentration and time, making mixture assessments all the more challenging.", {"entities": []}], ["In order to understand the spectrum of toxicities and their mechanisms, future work should focus on carefully studying individual and mixture components across a range of concentrations and cellular pathways in a variety of tissue types.", {"entities": []}], ["Recent studies suggest that HCV infection is associated with progressive declines in pulmonary function in patients with underlying pulmonary diseases such as asthma and chronic obstructive pulmonary disease.", {"entities": [[170, 207, "DISEASE"], [159, 165, "DISEASE"]]}], ["Few molecular studies have addressed the inflammatory aspects of HCV-associated pulmonary disease.", {"entities": []}], ["Because IL-8 plays a fundamental role in reactive airway diseases, we examined IL-8 signaling in normal human lung fibroblasts (NHLF) in response to the HCV nucleocapsid core protein, a viral antigen shown to modulate intracellular signaling pathways involved in cell proliferation, apoptosis and inflammation.", {"entities": []}], ["NHLF were treated with HCV core protein and assayed for IL-8 expression, phosphorylation of the p38 MAPK pathway, and for the effect of p38 inhibition.", {"entities": []}], ["Our studies demonstrate that soluble HCV core protein induces significant increases in both IL-8 mRNA and protein expression in a dose- and time-dependent manner.", {"entities": []}], ["Treatment with HCV core led to phosphorylation of p38 MAPK, and expression of IL-8 was dependent upon p38 activation.", {"entities": []}], ["Using TNF\u03b1 as a co-stimulant, we observed additive increases in IL-8 expression.", {"entities": []}], ["HCV core-mediated expression of IL-8 was inhibited by blocking gC1qR, a known receptor for soluble HCV core linked to MAPK signaling.", {"entities": []}], ["These studies suggest that HCV core protein can lead to enhanced p38- and gC1qR-dependent IL-8 expression.", {"entities": []}], ["Such a pro-inflammatory role may contribute to the progressive deterioration in pulmonary function recently recognized in individuals chronically infected with HCV.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is one of the most common chronic illnesses in the world.", {"entities": []}], ["The disease encompasses emphysema, chronic bronchitis, and small airway obstruction and can be caused by environmental exposures, primarily cigarette smoking.", {"entities": [[43, 53, "DISEASE"]]}], ["Since only a small subset of smokers develop COPD, it is believed that host factors interact with the environment to increase the propensity to develop disease.", {"entities": []}], ["The major pathogenic factors causing disease include infection and inflammation, protease and antiprotease imbalance, and oxidative stress overwhelming antioxidant defenses.", {"entities": []}], ["In this review, we will discuss the major environmental and host sources for oxidative stress; discuss how oxidative stress regulates chronic bronchitis; review the latest information on genetic predisposition to COPD, specifically focusing on oxidant/antioxidant imbalance; and review future antioxidant therapeutic options for COPD.", {"entities": [[142, 152, "DISEASE"]]}], ["The complexity of COPD will necessitate a multi-target therapeutic approach.", {"entities": []}], ["It is likely that antioxidant supplementation and dietary antioxidants will have a place in these future combination therapies.", {"entities": []}], ["Uric acid was proposed to have anti-oxidant property and possible neuroprotective effects.", {"entities": []}], ["We examined the association between gout and dementia with population database.", {"entities": [[45, 53, "DISEASE"], [36, 40, "DISEASE"]]}], ["The study utilized the claims data from the nationwide representative sample of Taiwan National Health Insurance Research Database (NHIRD).", {"entities": []}], ["We ascertained patients with gout and dementia covering vascular and non-vascular (including Alzheimer\u2019s) subtypes using International Classification of Diseases Ninth Revision, Clinical Modification (ICD9-CM) codes.", {"entities": [[38, 46, "DISEASE"], [29, 33, "DISEASE"]]}], ["A control group matched on sex, age, and index date of gout patients was randomly sampled with a ratio of 1:4 from the same database for comparison.", {"entities": [[55, 59, "DISEASE"]]}], ["From 2002 to 2008, 28,769 gout patients who were older than 50 years old were identified, and 114,742 control patients was matched into the study.", {"entities": [[26, 30, "DISEASE"]]}], ["During follow-up, 7,119 patients developed dementia (1,214 with gout, and 5,905 without gout).", {"entities": [[43, 51, "DISEASE"], [64, 68, "DISEASE"], [88, 92, "DISEASE"]]}], ["After adjusting for age, sex, and relevant comorbidities, a Cox regression analysis showed that gout patients had a lower risk of developing non-vascular dementia (hazard ratio (HR): 0.77; 95% confidence interval (CI): 0.72 - 0.83; p < 0.001) and vascular dementia (HR: 0.76; 95% CI: 0.65 - 0.88; p < 0.001).", {"entities": [[154, 162, "DISEASE"], [256, 264, "DISEASE"], [96, 100, "DISEASE"], [145, 162, "DISEASE"], [247, 264, "DISEASE"], [178, 180, "GENE"], [266, 268, "GENE"], [178, 180, "GENE"], [266, 268, "GENE"]]}], ["Patients with gout have a lower risk of developing dementia.", {"entities": [[51, 59, "DISEASE"], [14, 18, "DISEASE"]]}], ["This phenomenon exists for both non-vascular and vascular types of dementia.", {"entities": [[67, 75, "DISEASE"]]}], ["Papillary renal cell carcinoma (pRCC) is a mixed group of tumors that constitutes about 15-20% of all renal cortical cancers.", {"entities": [[21, 30, "DISEASE"], [0, 30, "DISEASE"], [10, 30, "DISEASE"], [32, 36, "GENE"]]}], ["Strong enhancement on computerized tomography (CT) is a feature of clear cell, but not of pRCC making the differentiation of papillary tumors from benign cysts a diagnostic problem in some cases.", {"entities": [[90, 94, "GENE"]]}], ["We report here a case of a female patient with pRCC that was initially diagnosed as a benign renal cyst.", {"entities": [[47, 51, "GENE"]]}], ["The patient is a 66\u00a0year old Caucasian female who initially presented with an ultrasound showing a 2.6\u00a0cm hypo-echoic lesion within the inferior pole of her left kidney.", {"entities": []}], ["This was followed by a contrast enhanced computerized tomography that suggested the hypo-echoic lesion to be a hyper-attenuating benign renal cyst.", {"entities": []}], ["Follow-up CT scan 4\u00a0months later demonstrated an increase in the size of the lesion to 3.2\u00a0cm with equivocal enhancement.", {"entities": []}], ["A dual energy computerized tomography (DECT) showed the lesion to be a solid mass suspicious for renal cell carcinoma.", {"entities": [[108, 117, "DISEASE"], [97, 117, "DISEASE"]]}], ["A robotic partial nephrectomy revealed a papillary renal cell carcinoma with negative margins.", {"entities": [[62, 71, "DISEASE"], [41, 71, "DISEASE"], [51, 71, "DISEASE"]]}], ["In this case report, we reviewed the literature on variations in enhancement of renal tumors and the possible role of dual energy contract enhanced CT in differentiating papillary tumors with low enhancement from benign kidney cystic lesions.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2490-14-102) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A low FEV 1 /FVC from post-bronchodilator spirometry is required to diagnose COPD.", {"entities": [[6, 9, "GENE"]]}], ["Both the FEV 1 and the FVC can vary over time; therefore, individuals can be given a diagnosis of mild COPD at one visit, but have normal spirometry during the next appointment, even without an intervention.", {"entities": [[9, 12, "GENE"]]}], ["We analyzed two population-based surveys of adults with spirometry carried out for the same individuals 5-9 years after their baseline examination.", {"entities": []}], ["We determined the factors associated with a change in the spirometry interpretation from one exam to the next utilizing different criteria commonly used to diagnose COPD.", {"entities": []}], ["The rate of an inconsistent diagnosis of mild COPD was 11.7% using FEV 1 /FVC <0.70, 5.9% using FEV 1 /FEV 6 <the lower limit of the normal range, LLN and 4.1% using the GOLD stage 2-4 criterion.", {"entities": [[67, 70, "GENE"], [96, 99, "GENE"], [103, 106, "GENE"], [67, 70, "GENE"], [96, 99, "GENE"], [103, 106, "GENE"]]}], ["The most important factor associated with diagnostic inconsistency was the closeness of the ratio to the LLN during the first examination.", {"entities": []}], ["Inconsistency decreased with a lower FEV 1 .", {"entities": [[37, 40, "GENE"]]}], ["Using FEV 1 /FEV 6 <LLN or GOLD stage 2-4 as the criterion for airflow obstruction reduces inconsistencies in the diagnosis of mild COPD.", {"entities": [[6, 9, "GENE"], [13, 16, "GENE"]]}], ["Further improvement could be obtained by defining a borderline zone around the LLN (e.g.", {"entities": []}], ["plus or minus 0.6 SD), or repeating the test in patients with borderline results.", {"entities": []}], ["Regulatory B cells (Bregs), a newly described subset of B cells, have been proved to play a suppressive role in immune system.", {"entities": []}], ["Bregs can inhibit other immune cells through cytokines secretion and antigen presentation, which give them the role in the pathogenesis of autoimmune diseases and cancers.", {"entities": []}], ["There are no clear criteria to identify Bregs; different markers were used in the different experimental conditions.", {"entities": []}], ["Massive researches had described the functions of immune cells such as regulatory T cells (Tregs), dendritic cells (DCs), and B cells in the autoimmune disorder diseases and cancers.", {"entities": []}], ["More and more researches focused on the roles of Bregs and the cytokines such as Interleukin-10 (IL-10) and transforming growth factor beta (TGF- \u03b2 ) secreted by Bregs.", {"entities": []}], ["The aim of this review is to summarize the characteristics of Bregs and the roles of Bregs in cancer.", {"entities": [[94, 100, "DISEASE"]]}], ["Regional rates of hospitalization for ambulatory care sensitive conditions (ACSC) are used to compare the availability and quality of ambulatory care but the risk adjustment for population health status is often minimal.", {"entities": []}], ["The objectives of the study was to examine the impact of more extensive risk adjustment on regional comparisons and to investigate the relationship between various area-level factors and the properly adjusted rates.", {"entities": []}], ["Our study is an observational study based on routine data of 2 million anonymous insured in 26 Swiss cantons followed over one or two years.", {"entities": []}], ["A binomial negative regression was modeled with increasingly detailed information on health status (age and gender only, inpatient diagnoses, outpatient conditions inferred from dispensed drugs and frequency of physician visits).", {"entities": []}], ["Hospitalizations for ACSC were identified from principal diagnoses detecting 19 conditions, with an updated list of ICD-10 diagnostic codes.", {"entities": []}], ["Co-morbidities and surgical procedures were used as exclusion criteria to improve the specificity of the detection of potentially avoidable hospitalizations.", {"entities": []}], ["The impact of the adjustment approaches was measured by changes in the standardized ratios calculated with and without other data besides age and gender.", {"entities": []}], ["25% of cases identified by inpatient main diagnoses were removed by applying exclusion criteria.", {"entities": []}], ["Cantonal ACSC hospitalizations rates varied from to 1.4 to 8.9 per 1,000 insured, per year.", {"entities": []}], ["Morbidity inferred from diagnoses and drugs dramatically increased the predictive performance, the greatest effect found for conditions linked to an ACSC.", {"entities": []}], ["More visits were associated with fewer PAH although very high users were at greater risk and subjects who had not consulted at negligible risk.", {"entities": []}], ["By maximizing health status adjustment, two thirds of the cantons changed their adjusted ratio by more than 10 percent.", {"entities": []}], ["Cantonal variations remained substantial but unexplained by supply or demand.", {"entities": []}], ["Additional adjustment for health status is required when using ACSC to monitor ambulatory care.", {"entities": []}], ["Drug-inferred morbidities are a promising approach.", {"entities": []}], ["The chitinase-like protein YKL-40 was found to be increased in patients with severe asthma and chronic obstructive pulmonary disease (COPD), two disease conditions featuring neutrophilic infiltrates.", {"entities": [[95, 132, "DISEASE"], [84, 90, "DISEASE"]]}], ["Based on these studies and a previous report indicating that neutrophils secrete YKL-40, we hypothesized that YKL-40 plays a key role in cystic fibrosis (CF) lung disease, a prototypic neutrophilic disease.", {"entities": [[137, 152, "DISEASE"], [158, 170, "DISEASE"]]}], ["The aim of this study was (i) to analyze YKL-40 levels in human and murine CF lung disease and (ii) to investigate whether YKL-40 single-nucleotide polymorphisms (SNPs) modulate CF lung disease severity.", {"entities": [[78, 90, "DISEASE"], [181, 193, "DISEASE"]]}], ["YKL-40 protein levels were quantified in serum and sputum supernatants from CF patients and control individuals.", {"entities": []}], ["Levels of the murine homologue BRP-39 were analyzed in airway fluids from CF-like \u03b2ENaC-Tg mice.", {"entities": []}], ["YKL-40 SNPs were analyzed in CF patients.", {"entities": []}], ["YKL-40 levels were increased in sputum supernatants and in serum from CF patients compared to healthy control individuals.", {"entities": []}], ["Within CF patients, YKL-40 levels were higher in sputum than in serum.", {"entities": []}], ["BRP-39 levels were increased in airways fluids from \u03b2ENaC-Tg mice compared to wild-type littermates.", {"entities": []}], ["In both CF patients and \u03b2ENaC-Tg mice, YKL-40/BRP-39 airway levels correlated with the severity of pulmonary obstruction.", {"entities": []}], ["Two YKL-40 SNPs (rs871799 and rs880633) were found to modulate age-adjusted lung function in CF patients.", {"entities": []}], ["YKL-40/BRP-39 levelsare increased in human and murine CF airway fluids, correlate with pulmonary function and modulate CF lung disease severity genetically.", {"entities": [[122, 134, "DISEASE"]]}], ["These findings suggest YKL-40 as a potential biomarker in CF lung disease.", {"entities": [[61, 73, "DISEASE"]]}], ["Proactive palliative care is not yet common practice for patients with COPD.", {"entities": []}], ["Important barriers are the identification of patients with a poor prognosis and the organization of proactive palliative care dedicated to the COPD patient.", {"entities": []}], ["Recently a set of indicators has been developed to identify those patients with COPD hospitalized for an acute exacerbation who are at risk for post-discharge mortality.", {"entities": []}], ["Only after identification of these patients with poor prognosis a multi disciplinary approach to proactive palliative care with support of a specialized palliative care team can be initiated.", {"entities": []}], ["The PROLONG study is a prospective cluster controlled trial in which 6 hospitals will participate.", {"entities": []}], ["Three hospitals are selected for the intervention condition based on the presence of a specialized palliative care team.", {"entities": []}], ["The study population consists of patients with COPD and their main informal caregivers.", {"entities": []}], ["Patients will be included during hospitalization for an acute exacerbation.", {"entities": []}], ["All patients in the study receive standard care (usual care).", {"entities": []}], ["Besides, patients in the intervention condition who meet two or more criteria of the set of indicators for proactive palliative care will have additionally regular consultations with a specialized palliative care team.", {"entities": []}], ["The objectives of the PROLONG study are: 1) to assess the discriminating power of the proposed set of indicators (indicator study) and 2) to assess the effects of proactive palliative care for qualifying patients with COPD on the wellbeing of these patients and their informal caregivers (intervention study).", {"entities": []}], ["The primary outcome measure of the indicator study is time to death for any cause.", {"entities": []}], ["The primary outcome measure of the intervention study is the change in quality of life measured by the St George Respiratory Questionnaire (SGRQ) three months after inclusion.", {"entities": []}], ["The PROLONG study may lead to better understanding of the conditions to start and the effectiveness of proactive palliative care for patients with COPD.", {"entities": []}], ["Innovative aspects of the PROLONG study are the use of a set of indicators for proactive palliative care, the active involvement of a specialized palliative care team and the use of a patient-tailored proactive palliative care plan.", {"entities": []}], ["Netherlands Trial Register (NTR): NTR4037", {"entities": []}], ["We evaluated the prevalence and severity of myocardial perfusion abnormalities among inmates undergoing cardiac single-photon emission computed tomography.", {"entities": []}], ["We also compared the results with those obtained in a cohort of non-inmates.", {"entities": []}], ["Between January 2009 and December 2013, 2420 consecutive subjects (258 inmates and 2162 non-inmates) with suspected or known coronary artery disease underwent stress myocardial perfusion single-photon emission computed tomography (MPS) to our institution.", {"entities": []}], ["The decision to submit inmates to MPS was taken by the physicians of the penal institutions or ordered by the court based on the survey of part.", {"entities": []}], ["To account for differences in clinical characteristics between inmates and non-inmates, we created a propensity score-matched cohort considering clinical variables and stress type.", {"entities": []}], ["Before matching, inmates were younger and had higher prevalence of male gender, smoking, chest pain, and previous myocardial infarction or revascularization (all p < 0.001).", {"entities": [[114, 135, "DISEASE"]]}], ["After matching, all characteristics were comparable in 258 inmates and 258 non-inmates.", {"entities": []}], ["The total amount of abnormal myocardium was similar in inmates and non-inmates before and after matching.", {"entities": []}], ["Infarct size and severity were larger in inmates before ( p < 0.001) and after ( p < 0.01) matching and left ventricular ejection fraction was lower in inmates compared to non-inmates ( p < 0.01).", {"entities": []}], ["Detention is associated with larger infarct size compared to a general population of subjects referred to stress MPS also after matching for clinical variables and stress type.", {"entities": []}], ["The similar prevalence of normal MPS in the matched cohort suggests that this imaging technique might be appropriate in inmates.", {"entities": []}], ["Structural genetic variants as short tandem repeats (STRs) are not targeted in SNP-based association studies and thus, their possible association signals are missed.", {"entities": []}], ["We systematically searched for STRs in gene regions known to contribute to total cholesterol, HDL cholesterol, LDL cholesterol and triglyceride levels in two independent studies (KORA F4, n\u200a=\u200a2553 and SAPHIR, n\u200a=\u200a1648), resulting in 16 STRs that were finally evaluated.", {"entities": []}], ["In a combined dataset of both studies, the sum of STR alleles was regressed on each phenotype, adjusted for age and sex.", {"entities": []}], ["The association analyses were repeated for SNPs in a 200 kb region surrounding the respective STRs in the KORA F4 Study.", {"entities": []}], ["Three STRs were significantly associated with total cholesterol (within LDLR , the APOA1/C3/A4/A5/BUD13 gene region and ABCG5/8 ), five with HDL cholesterol (3 within CETP , one in LPL and one in APOA1/C3/A4/A5/BUD13 ), three with LDL cholesterol ( LDLR , ABCG5/8 and CETP ) and two with triglycerides ( APOA1/C3/A4/A5/BUD13 and LPL ).", {"entities": [[72, 76, "GENE"], [249, 253, "GENE"], [167, 171, "GENE"], [268, 272, "GENE"], [181, 184, "GENE"], [329, 332, "GENE"], [72, 76, "GENE"], [249, 253, "GENE"], [167, 171, "GENE"], [268, 272, "GENE"], [181, 184, "GENE"], [329, 332, "GENE"]]}], ["None of the investigated STRs, however, showed a significant association after adjusting for the lead or adjacent SNPs within that gene region.", {"entities": []}], ["The evaluated STRs were found to be well tagged by the lead SNP within the respective gene regions.", {"entities": []}], ["Therefore, the STRs reflect the association signals based on surrounding SNPs.", {"entities": []}], ["In conclusion, none of the STRs contributed additionally to the SNP-based association signals identified in GWAS on lipid traits.", {"entities": []}], ["Sepsis is a severe medical condition that ranks among the top 10 causes of death worldwide and which has permanently high incidence rates.", {"entities": []}], ["Mesenchymal stem cells (MSCs) have been found to be potent modulators of immune responses.", {"entities": []}], ["More importantly, there is evidence that MSCs have a beneficial effect on preclinical models of polymicrobial sepsis.", {"entities": []}], ["However, the changes caused by the MSCs in the effector cells of the host immune system remain unclear.", {"entities": []}], ["A mouse model of sepsis (male C57BL/6 mice) with three experimental groups was used for experiments in vivo: a control group, an untreated septic group, and a septic group treated with MSCs.", {"entities": []}], ["In vitro experiments were performed using a cell line of pulmonary macrophages (RAW 264.7) co-cultured with MSCs and stimulated with lipopolysaccharide (LPS).", {"entities": []}], ["In vivo we demonstrated that treatment with MSCs was able to reduce the expression of cyclooxygenase-2 (COX-2) and nuclear factor kappa B (NF-\u03baB), and thereby decrease the production of inflammatory cytokines.", {"entities": []}], ["In vitro experiments using a co-culture of macrophages with MSCs showed a decrease in COX-2 and NF-\u03baB, and showed that this reduction was directly related to the ability of MSCs to inhibit phosphorylation of ERK, RSK, and p38, enzymes that belong to the family of mitogen-activated protein kinases (MAPKs).", {"entities": []}], ["This study demonstrated that MSCs are able to inhibit the MAPK pathway activation, modulating the inflammatory response during sepsis.", {"entities": []}], ["This understanding that MSCs can remodel the response of host cells and improve the course of sepsis is essential for developing new treatments for this pathology.", {"entities": []}], ["To assess the effect of Michigan's smoke-free air (SFA) law on the air quality inside selected restaurants and casinos.", {"entities": []}], ["The hypothesis of the study: if the SFA law is effectively implemented in restaurants and casinos, there will be a significant reduction in the particulate matter PM 2.5 measured in the same establishments after the law is implemented.", {"entities": []}], ["Prelaw and postlaw design study.", {"entities": []}], ["78 restaurants in 14 Michigan cities from six major regions of the state, and three Detroit casinos.", {"entities": []}], ["We monitored the real-time PM 2.5 in 78 restaurants and three Detroit casinos before the SFA law, and again monitored the same restaurants and casinos after implementation of the law, which was enacted on 1 May 2010.", {"entities": []}], ["Concentration measurements of secondhand smoke (SHS) fine particles (PM 2.5 ) were compared in each restaurant in the prelaw period to measurements of PM 2.5 in the same restaurants during the postlaw period.", {"entities": []}], ["A second comparison was made for PM 2.5 levels in three Detroit casinos prelaw and postlaw; these casinos were exempted from the SFA law.", {"entities": []}], ["Prelaw data indicated that 85% of the restaurants had poor to hazardous air quality, with the average venue having \u2018unhealthy\u2019 air according to Michigan's Air Quality Index for PM 2.5 .", {"entities": []}], ["Postlaw, air quality in 93% of the restaurants improved to \u2018good\u2019.", {"entities": []}], ["The differences were statistically significant (p<0.0001).", {"entities": []}], ["By comparison, the three casinos measured had \u2018unhealthy\u2019 air both before and after the law.", {"entities": []}], ["The significant air quality improvement in the Michigan restaurants after implementation of the SFA law indicates that the law was very effective in reducing exposure to SHS.", {"entities": []}], ["Since the Detroit casinos were exempted from the law, the air quality was unchanged, and remained unhealthy in both prelaw and postlaw periods.", {"entities": []}], ["Cardiac Troponin T (cTnT) elevation during exacerbations of chronic obstructive pulmonary disease (COPD) is associated with increased mortality the first year after hospital discharge.", {"entities": [[60, 97, "DISEASE"]]}], ["The factors associated with cTnT elevation in COPD are not known.", {"entities": []}], ["From our hospital's database, all patients admitted with COPD exacerbation in 2000\u201303 were identified.", {"entities": []}], ["441 had measurement of cTnT performed.", {"entities": []}], ["Levels of cTnT \u2265 0.04 \u03bcg/l were considered elevated.", {"entities": []}], ["Clinical and historical data were retrieved from patient records, hospital and laboratory databases.", {"entities": []}], ["Odds ratios for cTnT elevation were calculated using logistic regression.", {"entities": []}], ["120 patients (27%) had elevated cTnT levels.", {"entities": []}], ["The covariates independently associated with elevated cTnT were increasing neutrophil count, creatinine concentration, heart rate and Cardiac Infarction Injury Score (CIIS), and decreasing hemoglobin concentration.", {"entities": []}], ["The adjusted odds ratios (95% confidence intervals in parentheses) for cTnT elevation were 1.52 (1.20\u20131.94) for a 5 \u00d7 10 Multiple factors are associated with cTnT elevation, probably reflecting the wide panorama of comorbid conditions typically seen in COPD.", {"entities": []}], ["The positive association between neutrophils and cTnT elevation is compatible with the concept that an exaggerated inflammatory response in COPD exacerbation may predispose for myocardial injury.", {"entities": []}], ["Ageing is associated with a decline of motor function and ability to perform daily activities.", {"entities": []}], ["Locomotive disorders are one of the major disorders resulting in adverse health condition in elderly people.", {"entities": []}], ["Concept of Locomotive syndrome (LoS) was proposed to tackle the problems and prolong healthy life expectancy of people with locomotive disorders.", {"entities": [[22, 30, "DISEASE"]]}], ["To develop intervention strategy for LoS it is mandatory to investigate impairments, functional disabilities which people with locomotive disorder experience and to examine relationships among these parameters.", {"entities": []}], ["For this purpose we have developed Geriatric Locomotive Function Scale-25 (GLFS-25).", {"entities": []}], ["Though several physical performance tests were reported for identification or monitoring the severity of LoS, there are few studies reported on characteristics of disability which people with locomotive disorders experience.", {"entities": []}], ["The aim of this study was to report the characteristics of ADL disabilities in elderly people with locomotive disorders in terms of numbers and degree of activity limitations.", {"entities": []}], ["We organized a cohort study and recruited 314 participants aged 65\u00a0years and over from five orthopedic clinics or nursing care facilities.", {"entities": []}], ["This was a cross-sectional study to use the baseline data of such cohort.", {"entities": []}], ["ADL disabilities were assessed using GLFS-25 scale arranging the GLFS-25 scores in ordinal levels using \u201cR language\u201d program.", {"entities": []}], ["Numbers and degrees of activity limitations were determined and compared among the levels.", {"entities": []}], ["Frequency of limitation in activities regarding social activity, housework, locomotion, mobility and self-care was compared among across the disability level.", {"entities": []}], ["The GLFS-25 score was mathematically categorized into 7 levels.", {"entities": []}], ["The number of activity limitations and the degrees of each activity limitation were significantly greater in high GLFS-25 levels than in low levels.", {"entities": []}], ["Difficulties in mobility appeared in less severe level, difficulties in domestic and social life appeared in moderately severe level, and difficulties in self-care appeared in advanced level.", {"entities": []}], ["High GLFS-25 score represented high degree of disability on ADLs.", {"entities": []}], ["Concordant increase of numbers of activity limitation and severity progression in activity limitation may contribute to progression of disability.", {"entities": []}], ["Activity limitation may occur in the following order: sports activity, walking, transferring, and self-care.", {"entities": []}], ["Cigarette smoke is a complex chemical mixture that causes a variety of diseases, such as lung cancer.", {"entities": [[89, 100, "DISEASE"], [94, 100, "DISEASE"]]}], ["With the electrically heated cigarette smoking system (EHCSS), temperatures are applied to the tobacco below those found in conventional cigarettes, resulting in less combustion, reduced yields of some smoke constituents, and decreased activity in some standard toxicological tests.", {"entities": []}], ["The first generation of electrically heated cigarettes (EHC) also resulted in increased formaldehyde yields; therefore, a second generation of EHC was developed with ammonium magnesium phosphate (AMP) in the cigarette paper in part to address this increase.", {"entities": []}], ["The toxicological activity of mainstream smoke from these two generations of EHC and of a conventional reference cigarette was investigated in two studies in rats: a standard 90-day inhalation toxicity study and a 35-day inhalation study focusing on lung inflammation.", {"entities": []}], ["Many of the typical smoke exposure-related changes were found to be less pronounced after exposure to smoke from the second-generation EHC with AMP than to smoke from the first-generation EHC or the conventional reference cigarette, when compared on a particulate matter or nicotine basis.", {"entities": []}], ["Differences between the EHC without AMP and the conventional reference cigarette were not as prominent.", {"entities": []}], ["Overall, AMP incorporated in the EHC cigarette paper reduced the inhalation toxicity of the EHCSS more than expected based on the observed reduction in aldehyde yields.", {"entities": []}], ["Complications can arise from spilled gallstones during cholecystectomy.", {"entities": []}], ["A surgeon should make every effort to avoid gallbladder perforation and spillage of stones during laparoscopic cholecystectomy.", {"entities": []}], ["Laparoscopic cholecystectomy is the procedure of choice for the treatment of symptomatic biliary disease.", {"entities": []}], ["There is currently no agreement on the management of spilled gallstones, which commonly occurs during laparoscopic cholecystectomy and may produce significant morbidity.", {"entities": []}], ["We present a case of spilled gallstones causing cicatrical cecal volvulus and also provide a review of pertinent literature.", {"entities": []}], ["Photocopiers emit nanoparticles with complex chemical composition.", {"entities": []}], ["Short-term exposures to modest nanoparticle concentrations triggered upper airway inflammation and oxidative stress in healthy human volunteers in a recent study.", {"entities": []}], ["To further understand the toxicological properties of copier-emitted nanoparticles, we studied in-vitro their ability to induce cytotoxicity, pro-inflammatory cytokine release, DNA damage, and apoptosis in relevant human cell lines.", {"entities": []}], ["Three cell types were used: THP-1, primary human nasal- and small airway epithelial cells.", {"entities": []}], ["Following collection in a large volume photocopy center, nanoparticles were extracted, dispersed and characterized in the cell culture medium.", {"entities": []}], ["Cells were doped at 30, 100 and 300\u00a0\u03bcg/mL administered doses for up to 24\u00a0hrs.", {"entities": []}], ["Estimated dose delivered to cells, was ~10% and 22% of the administered dose at 6 and 24\u00a0hrs, respectively.", {"entities": []}], ["Gene expression analysis of key biomarkers was performed using real time quantitative PCR (RT-qPCR) in THP-1 cells at 5\u00a0\u03bcg nanoparticles/mL for 6-hr exposure for confirmation purposes.", {"entities": []}], ["Multiple cytokines, GM-CSF, IL-1\u03b2, IL-6, IL-8, IFN\u03b3, MCP-1, TNF-\u03b1 and VEGF, were significantly elevated in THP-1 cells in a dose-dependent manner.", {"entities": []}], ["Gene expression analysis confirmed up-regulation of the TNF-\u03b1 gene in THP-1 cells, consistent with cytokine findings.", {"entities": []}], ["In both primary epithelial cells, cytokines IL-8, VEGF, EGF, IL-1\u03b1, TNF-\u03b1, IL-6 and GM-CSF were significantly elevated.", {"entities": [[56, 59, "GENE"]]}], ["Apoptosis was induced in all cell lines in a dose-dependent manner, consistent with the significant up-regulation of key apoptosis-regulating genes P53 and Casp8 in THP-1 cells.", {"entities": [[156, 161, "GENE"]]}], ["No significant DNA damage was found at any concentration with the comet assay.", {"entities": []}], ["Up-regulation of key DNA damage and repair genes, Ku70 and Rad51, were also observed in THP-1 cells, albeit not statistically significant.", {"entities": [[59, 64, "GENE"]]}], ["Significant up-regulation of the key gene HO1 for oxidative stress, implicates oxidative stress induced by nanoparticles.", {"entities": []}], ["Copier-emitted nanoparticles induced the release of pro-inflammatory cytokines, apoptosis and modest cytotoxicity but no DNA damage in all three-human cell lines.", {"entities": []}], ["Taken together with gene expression data in THP-1 cells, we conclude that these nanoparticles are directly responsible for inflammation observed in human volunteers.", {"entities": []}], ["Further toxicological evaluations of these nanoparticles, including across different toner formulations, are warranted.", {"entities": []}], ["Recent work suggests that dendritic cells (DCs) in mucosal tissues are \u201ceducated\u201d by intestinal epithelial cells (IECs) to suppress inflammation and promote immunological tolerance.", {"entities": []}], ["After attack by pathogenic microorganisms, however, \u201cnon-educated\u201d DCs are recruited from nearby areas, such as the dome of Peyer's patches (PPs) and the blood, to initiate inflammation and the ensuing immune response to the invader.", {"entities": []}], ["Differential epithelial cell (EC) responses to commensals and pathogens may control these two tolorogenic and immunogenic functions of DCs.", {"entities": []}], ["Genetic variation may underlie phenotypic variation in chronic obstructive pulmonary disease (COPD) in subjects with and without alpha 1 antitrypsin deficiency (AATD).", {"entities": [[55, 92, "DISEASE"]]}], ["Genotype specific sub-phenotypes are likely and may underlie the poor replication of previous genetic studies.", {"entities": []}], ["This study investigated subjects with AATD to determine the relationship between specific phenotypes and TNF\u03b1 polymorphisms.", {"entities": []}], ["424 unrelated subjects of the PiZZ genotype were assessed for history of chronic bronchitis, impairment of lung function and radiological presence of emphysema and bronchiectasis.", {"entities": [[164, 178, "DISEASE"], [81, 91, "DISEASE"]]}], ["A subset of subjects with 3 years consecutive lung function data was assessed for decline of lung function.", {"entities": []}], ["Four single nucleotide polymorphisms (SNPs) tagging TNF\u03b1 were genotyped using TaqMan All SNPs were in Hardy-Weinberg equilibrium.", {"entities": []}], ["A significant difference in rs361525 genotype (p = 0.01) and allele (p = 0.01) frequency was seen between subjects with and without chronic bronchitis, independent of the presence of other phenotypes.", {"entities": [[140, 150, "DISEASE"]]}], ["TNF\u03b1 plasma level showed no phenotypic or genotypic associations.", {"entities": []}], ["Variation in TNF\u03b1 is associated with chronic bronchitis in AATD.", {"entities": [[45, 55, "DISEASE"]]}], ["C-reactive protein (CRP) is a general marker for inflammation and it has been associated with prostate cancer.", {"entities": [[103, 109, "DISEASE"], [94, 109, "DISEASE"], [20, 23, "GENE"]]}], ["We hypothesized that a correlation may exist between CRP and prostate cancer in patients undergoing transrectal biopsy of the prostate because of rising prostate-specific antigen (PSA) levels.", {"entities": [[70, 76, "DISEASE"], [61, 76, "DISEASE"], [53, 56, "GENE"]]}], ["From January 2009 to March 2012, we retrospectively reviewed 710 patients who visited our urology department and were diagnosed as having a PSA value over 4.0 ng/mL.", {"entities": []}], ["Patients with acute infections, rheumatoid arthritis, gout, asthma, chronic lung disease, myocardial infarction, or apoplexy and those who had taken nonsteroidal anti-inflammatory drugs were exempted from the research because these variables could have impacted CRP.", {"entities": [[32, 52, "DISEASE"], [90, 111, "DISEASE"], [43, 52, "DISEASE"], [54, 58, "DISEASE"], [60, 66, "DISEASE"], [76, 88, "DISEASE"], [262, 265, "GENE"]]}], ["After we applied the exclusion criteria, we selected 63 patients with prostate cancer and 140 patients with benign prostatic hyperplasia (BPH).", {"entities": [[79, 85, "DISEASE"], [70, 85, "DISEASE"]]}], ["A total of 203 patients were observed: 140 patients had BPH, and 63 patients had prostate cancer.", {"entities": [[90, 96, "DISEASE"], [81, 96, "DISEASE"]]}], ["Prostate cancer patients were divided into two groups by tumor-node-metastasis classification.", {"entities": [[9, 15, "DISEASE"], [0, 15, "DISEASE"]]}], ["The patients below T2 were group A, and those above T3 were group B.", {"entities": []}], ["The natural logarithm of C-reactive protein (lnCRP) differed between the BPH group and the prostate cancer group.", {"entities": [[100, 106, "DISEASE"], [91, 106, "DISEASE"]]}], ["The lnCRP also differed between the BPH group and prostate cancer groups A and B (p<0.05).", {"entities": [[59, 65, "DISEASE"], [50, 65, "DISEASE"]]}], ["The serum CRP level of the prostate cancer group was higher than that of the BPH group.", {"entities": [[36, 42, "DISEASE"], [27, 42, "DISEASE"], [10, 13, "GENE"]]}], ["Inflammation may be correlated with prostate cancer according to the serum CRP level.", {"entities": [[45, 51, "DISEASE"], [36, 51, "DISEASE"], [75, 78, "GENE"]]}], ["To improve retention on ART, M\u00e9decins Sans Fronti\u00e8res, the Ministry of Health and patients piloted a community-based antiretroviral distribution and adherence monitoring model through Community ART Groups (CAG) in Tete, Mozambique.", {"entities": []}], ["By December 2012, almost 6000 patients on ART had formed groups of whom 95.7% were retained in care.", {"entities": []}], ["We conducted a qualitative study to evaluate the relevance, dynamic and impact of the CAG model on patients, their communities and the healthcare system.", {"entities": []}], ["Between October 2011 and May 2012, we conducted 16 focus group discussions and 24 in-depth interviews with the major stakeholders involved in the CAG model.", {"entities": []}], ["Audio-recorded data were transcribed verbatim and analysed using a grounded theory approach.", {"entities": []}], ["Six key themes emerged from the data: 1) Barriers to access HIV care, 2) CAG functioning and actors involved, 3) Benefits for CAG members, 4) Impacts of CAG beyond the group members, 5) Setbacks, and 6) Acceptance and future expectations of the CAG model.", {"entities": []}], ["The model provides cost and time savings, certainty of ART access and mutual peer support resulting in better adherence to treatment.", {"entities": []}], ["Through the active role of patients, HIV information could be conveyed to the broader community, leading to an increased uptake of services and positive transformation of the identity of people living with HIV.", {"entities": []}], ["Potential pitfalls included limited access to CAG for those most vulnerable to defaulting, some inequity to patients in individual ART care and a high dependency on counsellors.", {"entities": []}], ["The CAG model resulted in active patient involvement and empowerment, and the creation of a supportive environment improving the ART retention.", {"entities": []}], ["It also sparked a reorientation of healthcare services towards the community and strengthened community actions.", {"entities": []}], ["Successful implementation and scalability requires (a) the acceptance of patients as partners in health, (b) adequate resources, and (c) a well-functioning monitoring and management system.", {"entities": []}], ["The U.S. opioid epidemic has highlighted the need to identify patients at risk of opioid abuse and overdose.", {"entities": [[82, 94, "DISEASE"]]}], ["We initiated a novel emergency department- (ED) based interventional protocol to transition our superuser patients from the ED to an outpatient chronic pain program.", {"entities": []}], ["The objective was to evaluate the protocol\u2019s effect on superusers\u2019 annual ED visits.", {"entities": []}], ["Secondary outcomes included a quantitative evaluation of statewide opioid prescriptions for these patients, unique prescribers of controlled substances, and ancillary testing.", {"entities": []}], ["Patients were referred to the program with the following inclusion criteria: \u2265 6 visits per year to the ED; at least one visit identified by the attending physician as primarily driven by opioid-seeking behavior; and a review by a committee comprising ED administration and case management.", {"entities": []}], ["Patients were referred to a pain management clinic and informed that they would no longer receive opioid prescriptions from visits to the ED for chronic pain complaints.", {"entities": []}], ["Electronic medical record (EMR) alerts notified ED providers of the patient\u2019s referral at subsequent visits.", {"entities": []}], ["We analyzed one year of data pre- and post-referral.", {"entities": []}], ["A total of 243 patients had one year of data post-referral for analysis.", {"entities": []}], ["Median annual ED visits decreased from 14 to 4 (58% decrease, 95% CI [50 to 66]).", {"entities": []}], ["We also found statistically significant decreases for these patients\u2019 state prescription drug monitoring program (PDMP) opioid prescriptions (21 to 13), total unique controlled-substance prescribers (11 to 7), computed tomography imaging (2 to 0), radiographs (5 to 1), electrocardiograms (12 to 4), and labs run (47 to 13).", {"entities": []}], ["This program and the EMR-based alerts were successful at decreasing local ED visits, annual opioid prescriptions, and hospital resource allocation for this population of patients.", {"entities": []}], ["There is no evidence that these patients diverted their visits to neighboring EDs after being informed that they would not receive opioids at this hospital, as opioid prescriptions obtained by these patients decreased on a statewide level.", {"entities": []}], ["This implies that individual ED protocols can have significant impact on the behavior of patients.", {"entities": []}], ["There is growing evidence for nongenetic effects of maternal experience on offspring.", {"entities": []}], ["For example, previous studies have shown that female threespined stickleback fish ( Gasterosteus aculeatus ) exposed to predation risk produce offspring with altered behavior, metabolism and stress physiology.", {"entities": []}], ["Here, we investigate the effect of maternal exposure to predation risk on the embryonic transcriptome in sticklebacks.", {"entities": []}], ["Using RNA-sequencing we compared genome-wide transcription in three day post-fertilization embryos of predator-exposed and control mothers.", {"entities": []}], ["There were hundreds of differentially expressed transcripts between embryos of predator-exposed mothers and embryos of control mothers including several non-coding RNAs.", {"entities": []}], ["Gene Ontology analysis revealed biological pathways involved in metabolism, epigenetic inheritance, and neural proliferation and differentiation that differed between treatments.", {"entities": []}], ["Interestingly, predation risk is associated with an accelerated life history in many vertebrates, and several of the genes and biological pathways that were identified in this study suggest that maternal exposure to predation risk accelerates the timing of embryonic development.", {"entities": []}], ["Consistent with this hypothesis, embryos of predator-exposed mothers were larger than embryos of control mothers.", {"entities": []}], ["These findings point to some of the molecular mechanisms that might underlie maternal effects.", {"entities": []}], ["Physicians consider ease of use, satisfaction, and preferences when prescribing an inhaler device.", {"entities": []}], ["These factors may impact appropriate usage and compliance.", {"entities": []}], ["The objectives were to quantify the relative importance of inhaler attributes in patients currently using Combivent Respimat by eliciting preferences for performance and convenience attributes assessed by items in the Patient Satisfaction and Preference Questionnaire (PASAPQ).", {"entities": []}], ["Using a pharmacy database, 19,964 adults in the United States who filled \u22652 Combivent Respimat prescriptions were identified.", {"entities": []}], ["Of those, 8150 patients were randomly selected to receive invitation letters.", {"entities": []}], ["The online cross-sectional survey included the PASAPQ and best-worst scaling (BWS) questions.", {"entities": []}], ["The PASAPQ measures satisfaction with medication attributes across two domains: performance and convenience.", {"entities": []}], ["BWS questions asked participants to select the most and least important device attributes.", {"entities": []}], ["A descriptive statistics analysis of the PASAPQ and a random-parameters logit model of BWS responses were conducted.", {"entities": []}], ["The survey was completed by 503 participants.", {"entities": []}], ["Most were female (57.3%), white (88.5%), and 51\u201370\u00a0years old (67.6%).", {"entities": []}], ["Approximately 47% reported a chronic obstructive pulmonary disease diagnosis, 21.9% asthma, 8.2% other lung disease, and 23.1% more than one lung disease.", {"entities": [[29, 66, "DISEASE"], [84, 90, "DISEASE"], [103, 115, "DISEASE"], [141, 153, "DISEASE"]]}], ["PASAPQ scores indicated that the majority were satisfied or very satisfied; up to 20% reported being dissatisfied with Combivent Respimat.", {"entities": []}], ["The three most important inhaler attributes were Feeling that your medicine gets into your lungs , Inhaler works reliably , and Inhaler makes inhaling your medicine easy.", {"entities": []}], ["The most important attributes corresponded to six of seven items in the PASAPQ performance domain.", {"entities": []}], ["Most participants reported satisfaction with Combivent Respimat.", {"entities": []}], ["Performance attributes were more important than convenience attributes.", {"entities": []}], ["To preliminary investigate the effects of silodosin 8\u00a0mg once daily on obstruction urodynamic parameters and subjective symptoms in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement.", {"entities": []}], ["We performed a single-center, open-label, single-arm, post-marketing interventional clinical trial.", {"entities": []}], ["Inclusion criteria were: Caucasian subjects aged \u226550\u00a0years waiting to undergo surgery for lower urinary tract symptoms suggestive of benign prostatic enlargement, international prostate symptom total score \u2265 13, international prostate symptom-quality of life score\u2009\u2265\u20093, prostate volume \u2265 30\u00a0ml, maximum urine flow rate\u2009\u2264\u200915\u00a0mL/s, bladder outlet obstruction index >\u200940.", {"entities": []}], ["Eligible subjects received one capsule of silodosin 8\u00a0mg once daily for 8\u00a0weeks.", {"entities": []}], ["Invasive urodynamic evaluations were performed at baseline and at 8-weeks follow-up.", {"entities": []}], ["International prostate symptom questionnaire was administered at baseline, after 4-weeks and 8-weeks of treatment.", {"entities": []}], ["Overall, 34 subjects were included.", {"entities": []}], ["Mean bladder outlet obstruction index significantly decreased from 70.6 to 39.2 and bladder outlet obstruction index class improved in 16 patients (53.3%).", {"entities": []}], ["Statistically significant improvements of mean total international prostate symptom score, mean storage sub-score, mean voiding sub-score and mean quality of life sub-score were evident after 4-weeks of treatment with further improvements after 8-weeks.", {"entities": []}], ["At the end of the treatment, all patients declared that their condition improved enough to spare or delay surgery .", {"entities": []}], ["Silodosin 8\u00a0mg once daily significantly improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement waiting for surgery.", {"entities": []}], ["EudraCT n. 2015-002277-38 Date of registration: 15th December 2017.", {"entities": []}], ["Insecticide resistance in German cockroaches ( Blattella germanica (L.)) has been a barrier to effective control since its first documentation in the 1950s.", {"entities": []}], ["A necessary first step toward managing resistance is to understand insecticide susceptibility profiles in field-collected strains so that active ingredients (AIs) with lowest resistance levels can be identified.", {"entities": []}], ["As a first step in this study, diagnostic concentrations (DCs) were determined for 14 insecticide AIs based on lethal concentrations that killed 99% or 90% of the individuals from a susceptible lab strain (JWax-S).", {"entities": []}], ["Next, cockroaches were collected from two low-income multifamily housing complexes in Danville, IL, and Indianapolis, IN, and used to establish laboratory strains.", {"entities": []}], ["These strains were screened against the 14 AI-DCs in vial bioassays, and susceptibility profiles were determined by comparing percent mortalities between the field strains relative to the JWax-S strain.", {"entities": []}], ["Results revealed lowest resistance of field strains to boric acid, abamectin, dinotefuran, clothianidin, thiamethoxam, and chlorfenapyr.", {"entities": []}], ["For the AIs hydramethylnon and imidacloprid, field strains did not display survivorship different than the lab strain, but\u2009>90% mortality was never achieved.", {"entities": []}], ["Lastly, both field strains displayed resistance to indoxacarb, fipronil, acetamiprid, beta-cyfluthrin, bifenthrin, and lambda-cyhalothrin, but at varying levels.", {"entities": []}], ["These results satisfy two objectives.", {"entities": []}], ["First, baseline monitoring DCs were established for 14 insecticides presently registered for use against cockroaches, which represents a useful resource.", {"entities": []}], ["Second, our findings reveal insecticide AIs with lowest resistance levels for use in forthcoming field studies that will investigate impacts of different insecticide deployment strategies on resistance management and evolution in cockroach field populations.", {"entities": []}], ["The present study was performed in order to document costs of intensive care in a Norwegian university hospital and to perform an average cost-effectiveness study using the expected remaining life-years in survivors after 18 months.", {"entities": []}], ["Patients admitted to the general intensive care unit (ICU) at Haukeland University Hospital from 1997 to 1999 were followed up to 18 months post ICU using data from the Norwegian Peoples' registry.", {"entities": []}], ["Our ICU patients have a further mortality equal to the average population in Norway from that time.", {"entities": []}], ["By creating an age-matched and sex-matched sample of the general Norwegian population equal to survivors 18 months after ICU treatment, we could find the expected further survival time for each ICU survivor.", {"entities": []}], ["Direct and indirect ICU expenses in the study period were retrieved using a 'top-down' method.", {"entities": []}], ["Outcome assessment was performed using the total ICU expenses in the period divided by the sum of the life expectancy (years) in survivors after 18 months.", {"entities": []}], ["The total ICU costs (converted to 2001 values) were \u20ac 16,697,415, excluding the costs of radiology and the use of operating theatres, which were both impossible to retrieve.", {"entities": []}], ["A total of 1051 patients were treated, of whom 60.9% survived up to 18 months.", {"entities": []}], ["Further total life expectancies were 24,428 years.", {"entities": []}], ["The average costs of an ICU day and stay per patient were \u20ac 2601 and \u20ac 14,223, respectively, and the average cost per year of survival per patient was \u20ac 684.", {"entities": []}], ["The absolute costs were found to be higher than recent European ICU studies reporting on the cost of ICU treatment.", {"entities": []}], ["However, the price of a further life-year in survivors was lower and was comparable with other medical treatment.", {"entities": []}], ["Pay-for-performance (P4P) is one of the primary tools used to support healthcare delivery reform.", {"entities": []}], ["Substantial heterogeneity exists in the development and implementation of P4P in health care and its effects.", {"entities": []}], ["This paper summarizes evidence, obtained from studies published between January 1990 and July 2009, concerning P4P effects, as well as evidence on the impact of design choices and contextual mediators on these effects.", {"entities": []}], ["Effect domains include clinical effectiveness, access and equity, coordination and continuity, patient-centeredness, and cost-effectiveness.", {"entities": []}], ["The systematic review made use of electronic database searching, reference screening, forward citation tracking and expert consultation.", {"entities": []}], ["The following databases were searched: Cochrane Library, EconLit, Embase, Medline, PsychINFO, and Web of Science.", {"entities": []}], ["Studies that evaluate P4P effects in primary care or acute hospital care medicine were included.", {"entities": []}], ["Papers concerning other target groups or settings, having no empirical evaluation design or not complying with the P4P definition were excluded.", {"entities": []}], ["According to study design nine validated quality appraisal tools and reporting statements were applied.", {"entities": []}], ["Data were extracted and summarized into evidence tables independently by two reviewers.", {"entities": []}], ["One hundred twenty-eight evaluation studies provide a large body of evidence -to be interpreted with caution- concerning the effects of P4P on clinical effectiveness and equity of care.", {"entities": []}], ["However, less evidence on the impact on coordination, continuity, patient-centeredness and cost-effectiveness was found.", {"entities": []}], ["P4P effects can be judged to be encouraging or disappointing, depending on the primary mission of the P4P program: supporting minimal quality standards and/or boosting quality improvement.", {"entities": []}], ["Moreover, the effects of P4P interventions varied according to design choices and characteristics of the context in which it was introduced.", {"entities": []}], ["Future P4P programs should (1) select and define P4P targets on the basis of baseline room for improvement, (2) make use of process and (intermediary) outcome indicators as target measures, (3) involve stakeholders and communicate information about the programs thoroughly and directly, (4) implement a uniform P4P design across payers, (5) focus on both quality improvement and achievement, and (6) distribute incentives to the individual and/or team level.", {"entities": []}], ["P4P programs result in the full spectrum of possible effects for specific targets, from absent or negligible to strongly beneficial.", {"entities": []}], ["Based on the evidence the review has provided further indications on how effect findings are likely to relate to P4P design choices and context.", {"entities": []}], ["The provided best practice hypotheses should be tested in future research.", {"entities": []}], ["Allergic rhinitis is one of the most common health complaints worldwide.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["Complementary and alternative medical approaches have been employed to relieve allergic rhinitis symptoms and to avoid the side effects of conventional medication.", {"entities": [[79, 96, "DISEASE"], [88, 96, "DISEASE"]]}], ["Acupuncture has been widely used to treat patients with allergic rhinitis, but the available evidence of its effectiveness is insufficient.", {"entities": [[56, 73, "DISEASE"], [65, 73, "DISEASE"]]}], ["Our objective is to evaluate the effectiveness of acupuncture in patients in Korea and China with persistent allergic rhinitis compared to sham acupuncture treatment or waitlist control.", {"entities": [[109, 126, "DISEASE"], [118, 126, "DISEASE"]]}], ["This study consists of a multi-centre (two centres in Korea and two centres in China), randomised, controlled trial with three parallel arms (active acupuncture, sham acupuncture, and waitlist group).", {"entities": []}], ["The active acupuncture and sham acupuncture groups will receive real or sham acupuncture treatment, respectively, three times per week for a total of 12 sessions over four weeks.", {"entities": []}], ["Post-treatment follow-up will be performed a month later to complement these 12 acupuncture sessions.", {"entities": []}], ["Participants in the waitlist group will not receive real or sham acupuncture treatments during this period but will only be required to keep recording their symptoms in a daily diary.", {"entities": []}], ["After four weeks, the same treatment given to the active acupuncture group will be provided to the waitlist group.", {"entities": []}], ["This trial will provide evidence for the effectiveness of acupuncture as a treatment for persistent allergic rhinitis.", {"entities": [[100, 117, "DISEASE"], [109, 117, "DISEASE"]]}], ["The primary outcome between groups is a change in the self-reported total nasal symptom score (i.e., nasal obstruction, rhinorrhea, sneezing, and itching) from baseline at the fourth week.", {"entities": []}], ["Secondary outcome measures include the Rhinitis Quality of Life Questionnaire score and total non-nasal symptom score (i.e., headache, itching, pain, eye-dropping).", {"entities": [[39, 47, "DISEASE"]]}], ["The quantity of conventional relief medication used during the follow-up period is another secondary outcome measure.", {"entities": []}], ["Current Controlled Trials ISRCTN90807007", {"entities": []}], ["Official statistics tend to underestimate the incidence of occupational disease (OD) nationally and regionally in Russia.", {"entities": []}], ["The general aim was to obtain an accurate estimate of ODs in Murmansk Oblast in 1980\u20132010 and to determine the rate of specific types of ODs among cohorts of workers who had been exposed to the hazardous factors causing the disease.", {"entities": []}], ["Data were retrieved from the Murmansk Oblast ODs database for the oblast and 2 enterprises \u2013 Apatite JSC and Kolskaya MSC \u2013 which contributed to more than half of the ODs in the oblast in 1980\u20132010.", {"entities": [[118, 121, "GENE"]]}], ["The total number of ODs and 5 specific categories (musculoskeletal, respiratory, nervous diseases, hearing loss and vibration disease) were analysed.", {"entities": []}], ["The total rate of ODs among workers of main shops in both enterprises who were actually exposed to harmful factors were extremely high: the rate for Apatite JSC was 25 times higher than in Russia and 15 times higher than in Murmansk Oblast, while the rate for Kolskaya MSC was about 30 and 20 times greater than in Russia and in Murmansk Oblast, respectively; in the 2000s the difference reached 100\u2013150 times.", {"entities": [[269, 272, "GENE"]]}], ["The rise in reported ODs in both enterprises corresponded to the time when intensive medical examinations were conducted by the Kola Research Laboratory for Occupational Health (KRLOH) in Kirovsk.", {"entities": []}], ["A similar pattern was also observed for the sub-categories of musculoskeletal, respiratory, nervous diseases, hearing loss and vibration disease.", {"entities": []}], ["It is likely that the true burden of OD is even higher due to misdiagnosis, reluctance of workers concerned about job security to present for care and the lack of reliable information on working conditions needed to establish a causal link between disease and occupational exposure.", {"entities": []}], ["As with many other regions across Russia, ODs in Murmansk Oblast are grossly underestimated.", {"entities": []}], ["Serious problems exist in the Russian occupational health care system and the collection of occupational health statistics that require urgent, fundamental reform.", {"entities": []}], ["Deployments of tear gas and pepper spray have rapidly increased worldwide.", {"entities": []}], ["Large amounts of tear gas have been used in densely populated cities, including Cairo, Istanbul, Rio de Janeiro, Manama (Bahrain), and Hong Kong.", {"entities": []}], ["In the United States, tear gas was used extensively during recent riots in Ferguson, Missouri.", {"entities": []}], ["Whereas tear gas deployment systems have rapidly improved\u2014with aerial drone systems tested and requested by law enforcement\u2014epidemiological and mechanistic research have lagged behind and have received little attention.", {"entities": []}], ["Case studies and recent epidemiological studies revealed that tear gas agents can cause lung, cutaneous, and ocular injuries, with individuals affected by chronic morbidities at high risk for complications.", {"entities": []}], ["Mechanistic studies identified the ion channels TRPV1 and TRPA1 as targets of capsaicin in pepper spray, and of the tear gas agents chloroacetophenone, CS, and CR.", {"entities": [[48, 53, "GENE"], [58, 63, "GENE"], [152, 154, "GENE"]]}], ["TRPV1 and TRPA1 localize to pain\u2010sensing peripheral sensory neurons and have been linked to acute and chronic pain, cough, asthma, lung injury, dermatitis, itch, and neurodegeneration.", {"entities": [[123, 129, "DISEASE"], [144, 154, "DISEASE"], [0, 5, "GENE"], [10, 15, "GENE"]]}], ["In animal models, transient receptor potential inhibitors show promising effects as potential countermeasures against tear gas injuries.", {"entities": []}], ["On the basis of the available data, a reassessment of the health risks of tear gas exposures in the civilian population is advised, and development of new countermeasures is proposed.", {"entities": []}], ["Since, at the health system level, there is little research into the possible interrelationships among the various indicators of health, healthcare performance, non-medical determinants of health, and community and health system characteristics, we conducted this study to explore such interrelationships using the Canadian Health Indicators Framework.", {"entities": []}], ["We conducted univariate correlational analyses with health and healthcare performance as outcomes using recent Canadian data and the ten Canadian provinces and three territories as units of the analyses.", {"entities": []}], ["For health, 6 indicators were included.", {"entities": []}], ["Sixteen healthcare performance indicators, 12 non-medical determinants of health and 16 indicators of community and health system characteristics were also included as independent variables for the analysis.", {"entities": []}], ["A set of decision rules was applied to guide the choice of what was considered actual and preferred performance associations.", {"entities": []}], ["Health (28%) correlates more frequently with non-medical determinants than healthcare does (12%), in the preferred direction.", {"entities": []}], ["Better health is only correlated with better healthcare performance in 13% of the cases in the preferred direction.", {"entities": []}], ["Better health (24%) is also more frequently correlated with community and health system characteristics than healthcare is (13%), in the preferred direction.", {"entities": []}], ["Canadian health performance is a function of multiple factors, the most frequent of which may be the non-medical determinants of health and the community characteristics as against healthcare performance.", {"entities": []}], ["The contribution of healthcare to health may be limited only to relatively small groups which stand to benefit from effective healthcare, but its overall effect may be diluted in summary measures of population health.", {"entities": []}], ["Interpreting multidimensional, multi-indicator performance data in their proper context may be more complex than hitherto believed.", {"entities": []}], ["Helminth infections may modulate immune responses to unrelated pathogens and allergens; these effects may commence prenatally.", {"entities": []}], ["We addressed the hypothesis that anthelminthic treatment in pregnancy and early childhood would improve responses to immunisation and modulate disease incidence in early childhood with both beneficial and detrimental effects.", {"entities": []}], ["A randomised, double-blind, placebo-controlled trial was conducted in Entebbe, Uganda [ISRCTN32849447].", {"entities": []}], ["In three independent randomisations, 2507 pregnant women were allocated to receive single-dose albendazole or placebo, and praziquantel or placebo; 2016 of their offspring were randomised to receive quarterly single-dose albendazole or placebo from age 15 months to 5 years.", {"entities": []}], ["Primary outcomes were post-immunisation recall responses to BCG and tetanus antigens, and incidence of malaria, diarrhoea, and pneumonia; incidence of eczema was an important secondary outcome.", {"entities": [[68, 75, "DISEASE"], [127, 136, "DISEASE"], [103, 110, "DISEASE"]]}], ["Analysis was by intention-to-treat.", {"entities": []}], ["Of 2345 live births, 1622 (69%) children remained in follow-up at age 5 years.", {"entities": []}], ["68% of mothers at enrolment, and 11% of five-year-olds, had helminth infections.", {"entities": []}], ["Maternal hookworm and Schistosoma mansoni were effectively treated by albendazole and praziquantel, respectively; and childhood hookworm and Ascaris by quarterly albendazole.", {"entities": []}], ["Incidence rates of malaria, diarrhoea, pneumonia, and eczema were 34, 65, 10 and 5 per 100 py, respectively.", {"entities": [[39, 48, "DISEASE"], [19, 26, "DISEASE"]]}], ["Albendazole during pregnancy caused an increased rate of eczema in the children (HR 1.58 (95% CI 1.15\u20132.17), p\u200a=\u200a0.005).", {"entities": [[81, 83, "GENE"]]}], ["Quarterly albendazole during childhood was associated with reduced incidence of clinical malaria (HR 0.85 (95% CI 0.73\u20130.98), p\u200a=\u200a0.03).", {"entities": [[89, 96, "DISEASE"], [98, 100, "GENE"]]}], ["There were no consistent effects of the interventions on any other outcome.", {"entities": []}], ["Routine use of albendazole in pregnancy may not always be beneficial, even in tropical developing countries.", {"entities": []}], ["By contrast, regular albendazole treatment in preschool children may have an additional benefit for malaria control where helminths and malaria are co-endemic.", {"entities": [[100, 107, "DISEASE"], [136, 143, "DISEASE"]]}], ["Given the low helminth prevalence in our children, the effect of albendazole on malaria is likely to be direct.", {"entities": [[80, 87, "DISEASE"]]}], ["Current Controlled Trials ISRCTN32849447", {"entities": []}], ["Poor adherence with prescribed asthma medication is a major barrier to positive treatment outcomes.", {"entities": [[31, 37, "DISEASE"]]}], ["This study was designed to determine the effect of a once-daily administration of mometasone furoate administered via a dry powder inhaler (MF-DPI) on treatment adherence compared with a twice-daily administration.", {"entities": []}], ["This was a 12-week open-label study designed to mimic an actual clinical setting in patients \u226512 years old with mild-to-moderate persistent asthma.", {"entities": [[140, 146, "DISEASE"]]}], ["Patients were randomized to receive MF-DPI 400 \u03bcg once-daily in the evening or MF-DPI 200 \u03bcg twice-daily.", {"entities": []}], ["Adherence was assessed primarily using the number of actual administered doses reported from the device counter divided by the number of scheduled doses.", {"entities": []}], ["Self-reports were also used to determine adherence.", {"entities": []}], ["Health-related quality of life, healthcare resource utilization, and days missed from work or school were also reported.", {"entities": []}], ["1233 patients were randomized.", {"entities": []}], ["The mean adherence rates, as measured by the automatic dose counter, were significantly better ( P < 0.001) with MF-DPI 400 \u03bcg once-daily in the evening (93.3%) than with MF-DPI 200 \u03bcg twice-daily (89.5%).", {"entities": []}], ["Mean adherence rates based on self-reports were also significantly better ( P < 0.001) with MF-DPI 400 \u03bcg QD PM (97.2%) than with MF-DPI 200 \u03bcg twice-daily (95.3%).", {"entities": []}], ["Adherence rates were lower in adolescents (12-17 years old).", {"entities": []}], ["Health-related quality of life improved by 20% in patients using MF-DPI once-daily in the evening and by 14% in patients using MF-DPI twice-daily.", {"entities": []}], ["Very few (<8%) patients missed work/school.", {"entities": []}], ["Mean adherence rates were greater with a once-daily dosing regimen of MF-DPI than with a twice-daily dosing regimen.", {"entities": []}], ["This trial was completed prior to the ISMJE requirements for trial registration.", {"entities": []}], ["Airway hyperresponsiveness (AWHR), expressed as hypersensitivity ( PC 75 R L ) or hyperreactivity (slope of the histamine dose\u2010response curve), is a feature of inflammatory airway disease ( IAD ) or mild equine asthma in horses.", {"entities": [[211, 217, "DISEASE"], [67, 69, "GENE"]]}], ["Glucocorticoids are used empirically to treat IAD .", {"entities": []}], ["To determine whether dexamethasone ( DEX ) (0.05 mg/kg IM q24h) and inhaled fluticasone ( FLUT ) (3,000 \u03bcg q12h) administered by inhalation are effective in decreasing AWHR, lung inflammation, and clinical signs in horses with IAD .", {"entities": []}], ["A randomized crossover study design was used.", {"entities": []}], ["Eight horses with IAD were assigned to a treatment group with either DEX or FLUT .", {"entities": []}], ["Measured outcomes included lung mechanics during bronchoprovocative challenges, bronchoalveolar lavage fluid ( BALF ) cytology, and scoring of clinical signs during exercise.", {"entities": []}], ["Dexamethasone and FLUT abolished the increase in R L by 75% at any histamine bronchoprovocative dose in all horses after the first week of treatment.", {"entities": []}], ["However, after 2 weeks of FLUT treatment, 1 horse redeveloped hypersensitivity.", {"entities": []}], ["There was a significant decrease in the number of lymphocytes after treatment with both DEX and FLUT ( P = .039 for both) but no significant differences in other BALF cell types or total cell counts ( P > .05).", {"entities": []}], ["There was no difference in the scoring of the clinical signs during each treatment and washout period ( P > .05).", {"entities": []}], ["Both DEX and FLUT treatments significantly inhibit airway hypersensitivity and hyperreactivity in horses with IAD .", {"entities": []}], ["There are no significant effects on the clinical signs or the number of inflammatory cells (except lymphocytes) in BALF .", {"entities": []}], ["The treatments have no residual effect 3 weeks after discontinuation.", {"entities": []}], ["While several studies have documented the importance of hand washing in the university setting, the added role of environmental hygiene remains poorly understood.", {"entities": []}], ["The purpose of this study was to characterize the personal and environmental hygiene habits of college students, define the determinants of hygiene in this population, and assess the relationship between reported hygiene behaviors, environmental contamination, and health status.", {"entities": []}], ["501 undergraduate students completed a previously validated survey assessing baseline demographics, hygiene habits, determinants of hygiene, and health status.", {"entities": []}], ["Sixty survey respondents had microbiological samples taken from eight standardized surfaces in their dormitory environment.", {"entities": []}], ["Bacterial contamination was assessed using standard quantitative bacterial culture techniques.", {"entities": []}], ["Additional culturing for coagulase-positive Staphylococcus and coliforms was performed using selective agar.", {"entities": []}], ["While the vast majority of study participants (n\u200a=\u200a461, 92%) believed that hand washing was important for infection prevention, there was a large amount of variation in reported personal hygiene practices.", {"entities": []}], ["More women than men reported consistent hand washing before preparing food (p\u200a=\u200a.002) and after using the toilet (p\u200a=\u200a.001).", {"entities": []}], ["Environmental hygiene showed similar variability although 73.3% (n\u200a=\u200a367) of subjects reported dormitory cleaning at least once per month.", {"entities": []}], ["Contamination of certain surfaces was common, with at least one third of all bookshelves, desks, refrigerator handles, toilet handles, and bathroom door handles positive for >10 CFU of bacteria per 4 cm Staphylococcus was detected in three participants' rooms (5%) and coliforms were present in six students' rooms (10%).", {"entities": []}], ["Surface contamination with any bacteria did not vary by frequency of cleaning or frequency of illness (p>.05).", {"entities": []}], ["Our results suggest that surface contamination, while prevalent, is unrelated to reported hygiene or health in the university setting.", {"entities": []}], ["Further research into environmental reservoirs of infectious diseases may delineate whether surface decontamination is an effective target of hygiene interventions in this population.", {"entities": []}], ["Malnutrition, which is associated with increased medical complications in older hospitalized patients, can be attenuated by providing nutritional supplements.", {"entities": []}], ["This study evaluates the cost effectiveness of a specialized oral nutritional supplement (ONS) in malnourished older hospitalized patients.", {"entities": []}], ["We conducted an economic evaluation alongside a multicenter, randomized, controlled clinical trial (NOURISH Study).", {"entities": []}], ["The target population was malnourished older hospitalized patients in the USA.", {"entities": []}], ["We used 90-day (base case) and lifetime (sensitivity analysis) time horizons.", {"entities": []}], ["The study compared a nutrient-dense ONS, containing high protein and \u03b2-hydroxy-\u03b2-methylbutyrate to placebo.", {"entities": []}], ["Outcomes included health-care costs, measured as the product of resource use and per unit cost; quality-adjusted life-years (QALYs) (90-day time horizon); life-years (LYs) saved (lifetime time horizon); and the incremental cost-effectiveness ratio (ICER).", {"entities": []}], ["All costs were inflated to 2015 US dollars.", {"entities": []}], ["In the base-case analysis, 90-day treatment group costs averaged US$22,506 per person, compared to US$22,133 for the control group.", {"entities": []}], ["Treatment group patients gained 0.011 more QALYs than control group subjects, reflecting the treatment group\u2019s significantly greater probability of survival through 90\u00a0days\u2019 follow-up, as reported by the clinical trial.", {"entities": []}], ["Hence, the 90-day follow-up period ICER was US$33,818/QALY.", {"entities": []}], ["Assuming a lifetime time horizon, estimated treatment group life expectancy exceeded control group life expectancy by 0.71\u00a0years.", {"entities": []}], ["Hence, the lifetime ICER was US$524/LY.", {"entities": []}], ["The follow-up period for the trial was relatively short.", {"entities": []}], ["Some of the patients were lost to follow-up, thus reducing collection of health-care utilization data during the clinical trial.", {"entities": []}], ["Our findings suggest that the investigative ONS cost-effectively extends the lives of malnourished hospitalized patients.", {"entities": []}], ["We revealed in previous studies that nitration of food proteins reduces the risk of de novo sensitization in a murine food allergy model.", {"entities": [[118, 130, "DISEASE"]]}], ["In contrast, in situations with preformed specific IgE antibodies, in vitro experiments suggested an increased capacity of effector cell activation by nitrated food proteins.", {"entities": []}], ["The aim of this study was to investigate the influence of protein nitration on the effector phase of food allergy.", {"entities": [[101, 113, "DISEASE"]]}], ["BALB/c mice were immunized intraperitoneally (i.p.)", {"entities": []}], ["with the milk allergen \u03b2-lactoglobulin (BLG) or the egg allergen ovomucoid (OVM), followed by intragastric (i.g.)", {"entities": []}], ["gavages to induce a strong local inflammatory response and allergen-specific antibodies.", {"entities": []}], ["Subsequently, na\u00efve and allergic mice were intravenously (i.v.)", {"entities": []}], ["challenged with untreated, sham-nitrated or nitrated BLG or OVM.", {"entities": []}], ["Anaphylaxis was monitored by measuring core body temperature and determination of mouse mast cell protease-1 (mMCP-1) levels in blood.", {"entities": []}], ["A significant drop of body temperature accompanied with significantly elevated concentrations of the anaphylaxis marker mMCP-1 were only observed in BLG allergic animals challenged with nitrated BLG and not in OVM allergic mice challenged with nitrated OVM.", {"entities": []}], ["SDS-PAGE and circular dichroism analysis of the differentially modified allergens revealed an effect of nitration on the secondary protein structure exclusively for BLG together with enhanced protein aggregation.", {"entities": []}], ["Our data suggest that nitration affects differently the food allergens BLG and OVM.", {"entities": []}], ["In the case of BLG, structural changes favored dimerization possibly explaining the increased anaphylactic reactivity in BLG allergic animals.", {"entities": []}], ["Keratinocyte growth factor (KGF) is a paracrine-acting epithelial mitogen produced by cells of mesenchymal origin, that plays an important role in protecting and repairing epithelial tissues.", {"entities": []}], ["Pre-clinical data initially demonstrated that a recombinant truncated KGF (palifermin) could reduce gastrointestinal injury and mortality resulting from a variety of toxic exposures.", {"entities": []}], ["Furthermore, the use of palifermin in patients with hematological malignancies reduced the incidence and duration of severe oral mucositis experienced after intensive chemoradiotherapy.", {"entities": []}], ["Based upon these findings, as well as the observation that KGF receptors are expressed in many, if not all, epithelial tissues, pre-clinical studies have been conducted to determine the efficacy of palifermin in protecting different epithelial tissues from toxic injury in an attempt to model various clinical situations in which it might prove to be of benefit in limiting tissue damage.", {"entities": []}], ["In this article, we review these studies to provide the pre-clinical background for clinical trials that are described in the accompanying article and the rationale for additional clinical applications of palifermin.", {"entities": []}], ["West Nile virus (WNV) infections are predominantly asymptomatic, although almost 1% become neuroinvasive and debilitating.", {"entities": []}], ["We describe the impact of neuroinvasive and non-neuroinvasive disease on patient health-related quality of life (HRQoL).", {"entities": []}], ["Short Form 36 questionnaire data came from a Canadian WNV cohort (Loeb 2008) of 154 patients followed for up to three years.", {"entities": []}], ["We generated health utilities using the SF-6D.", {"entities": []}], ["We calculated mean utility scores throughout follow-up and examined predictors using a linear mixed-effects model.", {"entities": []}], ["We summarized HRQoL post-acute infection as: (i) long-term utility (mean of scores one year onward); (ii) area under the curve (AUC) one year onward.", {"entities": []}], ["We examined predictors using beta regression.", {"entities": []}], ["We used multiple imputation for sensitivity analysis.", {"entities": []}], ["Mean utility scores improved from 0.59 (95% CI: 0.38, 0.93) at baseline to 0.77 (0.53, 1) at six months, before plateauing for the remaining two years.", {"entities": []}], ["Mean long-term utility was 0.81 (0.78, 0.85) and mean AUC was 0.80 (0.76, 0.84).", {"entities": []}], ["Patients with neuroinvasive disease had consistently worse scores than their non-neuroinvasive counterparts, with the gap nearly closed after six months.", {"entities": []}], ["After adjusting for confounding, neuroinvasive disease was not a significant predictor of HRQoL either throughout follow-up or post-acute infection.", {"entities": []}], ["Rather, number of comorbidities and baseline utility scores were.", {"entities": []}], ["Sensitivity analysis showed similar findings.", {"entities": []}], ["Patients with WNV infection reported low HRQoL during acute illness, but improved rapidly by six months, regardless of neuroinvasive disease status.", {"entities": []}], ["This is the first study reporting health utilities for WNV infection.", {"entities": []}], ["The online version of this article (10.1186/s12955-017-0787-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Role of Th9 cells and interleukin-9 (IL-9) in human autoimmune diseases such as psoriasis and ulcerative colitis has been explored only very recently.", {"entities": [[80, 89, "DISEASE"], [94, 112, "DISEASE"]]}], ["However, their involvement in human rheumatoid arthritis (RA) is not conclusive.", {"entities": [[36, 56, "DISEASE"], [47, 56, "DISEASE"]]}], ["Pathogenesis of RA is complex and involves various T cell subsets and neutrophils.", {"entities": []}], ["Here, we aimed at understanding the impact of IL-9 on infiltrating immune cells and their eventual role in synovial inflammation in RA.", {"entities": []}], ["In vitro stimulation of T cells was performed by engagement of anti-CD3 and anti-CD28 monoclonal antibodies.", {"entities": []}], ["Flow cytometry was employed for measuring intracellular cytokine, ROR\u03b3t in T cells, evaluating apoptosis of neutrophils.", {"entities": []}], ["ELISA was used for measuring soluble cytokine, Western blot analysis and confocal microscopy were used for STAT3 phosphorylation and nuclear translocation.", {"entities": [[107, 112, "GENE"]]}], ["We demonstrated synovial enrichment of Th9 cells and their positive correlation with disease activity (DAS28-ESR) in RA.", {"entities": []}], ["Synovial IL-9 prolonged the survival of neutrophils, increased their matrix metalloprotienase-9 production and facilitated Th17 cell differentiation evidenced by induction of transcription factor ROR\u03b3t and STAT3 phosphorylation.", {"entities": [[206, 211, "GENE"]]}], ["IL-9 also augmented the function of IFN-\u03b3\u2009+\u2009and TNF-\u03b1\u2009+\u2009synovial T cells.", {"entities": []}], ["We provide evidences for critical role of IL-9 in disease pathogenesis and propose that targeting IL-9 may be an effective strategy to ameliorate synovial inflammation in RA.", {"entities": []}], ["Inhibiting IL-9 may have wider impact on the production of pathogenic cytokines involved in autoimmune diseases including RA and may offer better control over the disease.", {"entities": []}], ["The online version of this article (10.1186/s13075-017-1505-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Important knowledge about the determinants of complex human phenotypes can be obtained from the estimation of heritability, the fraction of phenotypic variation in a population that is determined by genetic factors.", {"entities": []}], ["Here, we make use of extensive phenotype data in Iceland, long-range phased genotypes, and a population-wide genealogical database to examine the heritability of 11 quantitative and 12 dichotomous phenotypes in a sample of 38,167 individuals.", {"entities": []}], ["Most previous estimates of heritability are derived from family-based approaches such as twin studies, which may be biased upwards by epistatic interactions or shared environment.", {"entities": []}], ["Our estimates of heritability, based on both closely and distantly related pairs of individuals, are significantly lower than those from previous studies.", {"entities": []}], ["We examine phenotypic correlations across a range of relationships, from siblings to first cousins, and find that the excess phenotypic correlation in these related individuals is predominantly due to shared environment as opposed to dominance or epistasis.", {"entities": []}], ["We also develop a new method to jointly estimate narrow-sense heritability and the heritability explained by genotyped SNPs.", {"entities": []}], ["Unlike existing methods, this approach permits the use of information from both closely and distantly related pairs of individuals, thereby reducing the variance of estimates of heritability explained by genotyped SNPs while preventing upward bias.", {"entities": []}], ["Our results show that common SNPs explain a larger proportion of the heritability than previously thought, with SNPs present on Illumina 300K genotyping arrays explaining more than half of the heritability for the 23 phenotypes examined in this study.", {"entities": []}], ["Much of the remaining heritability is likely to be due to rare alleles that are not captured by standard genotyping arrays.", {"entities": []}], ["Phenotype is a function of a genome and its environment.", {"entities": []}], ["Heritability is the fraction of variation in a phenotype determined by genetic factors in a population.", {"entities": []}], ["Current methods to estimate heritability rely on the phenotypic correlations of closely related individuals and are potentially upwardly biased, due to the impact of epistasis and shared environment.", {"entities": []}], ["We develop new methods to estimate heritability over both closely and distantly related individuals.", {"entities": []}], ["By examining the phenotypic correlation among different types of related individuals such as siblings, half-siblings, and first cousins, we show that shared environment is the primary determinant of inflated estimates of heritability.", {"entities": []}], ["For a large number of phenotypes, it is not known how much of the heritability is explained by SNPs included on current genotyping platforms.", {"entities": []}], ["Existing methods to estimate this component of heritability are biased in the presence of related individuals.", {"entities": []}], ["We develop a method that permits the inclusion of both closely and distantly related individuals when estimating heritability explained by genotyped SNPs and use it to make estimates for 23 medically relevant phenotypes.", {"entities": []}], ["These estimates can be used to increase our understanding of the distribution and frequency of functionally relevant variants and thereby inform the design of future studies.", {"entities": []}], ["Whilst multimorbidity is more prevalent with increasing age, approximately 30% of middle-aged adults (45\u201364 years) are also affected.", {"entities": []}], ["Several prescribing criteria have been developed to optimise medication use in older people (\u226565\u00a0years) with little focus on potentially inappropriate prescribing (PIP) in middle-aged adults.", {"entities": []}], ["We have developed a set of explicit prescribing criteria called PROMPT (PRescribing Optimally in Middle-aged People\u2019s Treatments) which may be applied to prescribing datasets to determine the prevalence of PIP in this age-group.", {"entities": []}], ["A literature search was conducted to identify published prescribing criteria for all age groups, with the Project Steering Group (convened for this study) adding further criteria for consideration, all of which were reviewed for relevance to middle-aged adults.", {"entities": []}], ["These criteria underwent a two-round Delphi process, using an expert panel consisting of general practitioners, pharmacists and clinical pharmacologists from the United Kingdom and Republic of Ireland.", {"entities": []}], ["Using web-based questionnaires, 17 panellists were asked to indicate their level of agreement with each criterion via a 5-point Likert scale (1\u2009=\u2009Strongly Disagree, 5\u2009=\u2009Strongly Agree) to assess the applicability to middle-aged adults in the absence of clinical information.", {"entities": []}], ["Criteria were accepted/rejected/revised dependent on the panel\u2019s level of agreement using the median response/interquartile range and additional comments.", {"entities": []}], ["Thirty-four criteria were rated in the first round of this exercise and consensus was achieved on 17 criteria which were accepted into the PROMPT criteria.", {"entities": []}], ["Consensus was not reached on the remaining 17, and six criteria were removed following a review of the additional comments.", {"entities": []}], ["The second round of this exercise focused on the remaining 11 criteria, some of which were revised following the first exercise.", {"entities": []}], ["Five criteria were accepted from the second round, providing a final list of 22 criteria [gastro-intestinal system (n\u2009=\u20093), cardiovascular system (n\u2009=\u20094), respiratory system (n\u2009=\u20094), central nervous system (n\u2009=\u20096), infections (n\u2009=\u20091), endocrine system (n\u2009=\u20091), musculoskeletal system (n\u2009=\u20092), duplicates (n\u2009=\u20091)].", {"entities": []}], ["PROMPT is the first set of prescribing criteria developed for use in middle-aged adults.", {"entities": []}], ["The utility of these criteria will be tested in future studies using prescribing datasets.", {"entities": []}], ["Patients with rheumatic diseases, including rheumatoid arthritis and osteoarthritis, almost universally describe pain and stiffness as important contributors to reduced health-related quality of life.", {"entities": [[44, 64, "DISEASE"], [55, 64, "DISEASE"], [69, 83, "DISEASE"]]}], ["Of the treatment options available, NSAIDs are the most widely used agents for symptomatic treatment.", {"entities": []}], ["NSAIDs are effective anti-inflammatory and analgesic drugs by virtue of their ability to inhibit biosynthesis of prostaglandins at the level of the cyclooxygenase enzyme.", {"entities": []}], ["However, many of the adverse effects of NSAIDs are also related to inhibition of prostaglandin production, making their use problematic in some patient populations.", {"entities": []}], ["For the clinician, understanding the biology of prostaglandin as it relates to gastrointestinal, renal, and cardiovascular physiology and the pharmacologic properties of specific NSAIDs is key to using these drugs safely.", {"entities": []}], ["Of particular importance is the recognition of co-morbid conditions and concomitant drugs that may increase the risk of NSAIDs in particular patients.", {"entities": []}], ["In patients with risk factors for NSAID toxicity, using the lowest dose of a drug with a short half-life only when it is needed is likely to be the safest treatment option.", {"entities": []}], ["For those patients whose symptoms cannot be managed with intermittent treatment, using protective strategies is essential.", {"entities": []}], ["Nephrotic syndrome (NS) represents a common disease in pediatric nephrology typified by a relapsing and remitting course and characterized by the presence of edema that can significantly affect the health-related quality of life in children and adolescents.", {"entities": [[10, 18, "DISEASE"]]}], ["The PROMIS pediatric measures were constructed to be publically available, efficient, precise, and valid across a variety of diseases to assess patient reports of symptoms and quality of life.", {"entities": []}], ["This study was designed to evaluate the ability of children and adolescents with NS to complete the PROMIS assessment via computer and to initiate validity assessments of the short forms and full item banks in pediatric NS.", {"entities": []}], ["Successful measurement of patient reported outcomes will contribute to our understanding of the impact of NS on children and adolescents.", {"entities": []}], ["This cross-sectional study included 151 children and adolescents 8-17\u00a0years old with NS from 16 participating institutions in North America.", {"entities": []}], ["The children completed the PROMIS pediatric depression, anxiety, social-peer relationships, pain interference, fatigue, mobility and upper extremity functioning measures using a web-based interface.", {"entities": []}], ["Responses were compared between patients experiencing active NS (n\u2009=\u200953) defined by the presence of edema and patients with inactive NS (n\u2009=\u200996) defined by the absence of edema.", {"entities": []}], ["All 151 children and adolescents were successfully able to complete the PROMIS assessment via computer.", {"entities": []}], ["As hypothesized, the children and adolescents with active NS were significantly different on 4 self-reported measures (anxiety, pain interference, fatigue, and mobility).", {"entities": []}], ["Depression, peer relationships, and upper extremity functioning were not different between children with active vs. inactive NS.", {"entities": []}], ["Multivariate analysis showed that the PROMIS instruments remained sensitive to NS disease activity after adjusting for demographic characteristics.", {"entities": []}], ["Children and adolescents with NS were able to successfully complete the PROMIS instrument using a web-based interface.", {"entities": []}], ["The computer based pediatric PROMIS measurement effectively discriminated between children and adolescents with active and inactive NS.", {"entities": []}], ["The domain scores found in this study are consistent with previous reports investigating the health-related quality of life in children and adolescents with NS.", {"entities": []}], ["This study establishes known-group validity and feasibility for PROMIS pediatric measures in children and adolescents with NS.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality and of loss of disability-adjusted life years worldwide.", {"entities": []}], ["It often is accompanied by the presence of comorbidity.", {"entities": []}], ["To systematically review the influence of COPD comorbidity on generic health-related quality of life (HRQoL).", {"entities": []}], ["A systematic review approach was used to search the databases Pubmed, Embase and Cochrane Library for studies evaluating the influence of comorbidity on HRQoL in COPD.", {"entities": []}], ["Identified studies were analyzed according to study characteristics, generic HRQoL measurement instrument, COPD severity and comorbid HRQoL impact.", {"entities": []}], ["Studies using only non-generic instruments were excluded.", {"entities": []}], ["25 studies met the selection criteria.", {"entities": []}], ["Seven studies utilized the EQ-5D, six studies each used the SF-36 or SF-12.", {"entities": []}], ["The remaining studies used one of six other instruments each.", {"entities": []}], ["Utilities were calculated by four EQ-5D studies and one 15D study.", {"entities": []}], ["Patient populations covered both early and advanced stages of COPD and ranged from populations with mostly stage 1 and 2 to studies with patients classified mainly stage 3 and 4.", {"entities": []}], ["Evidence was mainly created for cardiovascular disease, depression and anxiety as well as diabetes but also for quantitative comorbid associations.", {"entities": []}], ["Strong evidence is pointing towards the significant negative association of depression and anxiety on reduced HRQoL in COPD patients.", {"entities": []}], ["While all studies found the occurrence of specific comorbidities to decrease HRQoL in COPD patients, the orders of magnitude diverged.", {"entities": []}], ["Due to different patient populations, different measurement tools and different concomitant diseases the study heterogeneity was high.", {"entities": []}], ["Facilitating multimorbid intervention guidance, instead of applying a parsimony based single disease paradigm, should constitute an important goal for improving HRQoL of COPD patients in research and in clinical practice.", {"entities": []}], ["This study examines the surface activity and resistance to phospholipase degradation of a fully-synthetic lung surfactant containing a novel diether phosphonolipid (DEPN-8) plus a 34 amino acid peptide (Mini-B) related to native surfactant protein (SP)-B.", {"entities": []}], ["Activity studies used adsorption, pulsating bubble, and captive bubble methods to assess a range of surface behaviors, supplemented by molecular studies using Fourier transform infrared (FTIR) spectroscopy, circular dichroism (CD), and plasmon resonance.", {"entities": []}], ["Calf lung surfactant extract (CLSE) was used as a positive control.", {"entities": []}], ["DEPN-8+1.5% (by wt.)", {"entities": []}], ["Mini-B was fully resistant to degradation by phospholipase A 2 (PLA 2 ) in vitro, while CLSE was severely degraded by this enzyme.", {"entities": []}], ["Mini-B interacted with DEPN-8 at the molecular level based on FTIR spectroscopy, and had significant plasmon resonance binding affinity for DEPN-8.", {"entities": []}], ["DEPN-8+1.5% Mini-B had greatly increased adsorption compared to DEPN-8 alone, but did not fully equal the very high adsorption of CLSE.", {"entities": []}], ["In pulsating bubble studies at a low phospholipid concentration of 0.5 mg/ml, DEPN-8+1.5% Mini-B and CLSE both reached minimum surface tensions <1 mN/m after 10 min of cycling.", {"entities": []}], ["DEPN-8 (2.5 mg/ml)+1.5% Mini-B and CLSE (2.5 mg/ml) also reached minimum surface tensions <1 mN/m at 10 min of pulsation in the presence of serum albumin (3 mg/ml) on the pulsating bubble.", {"entities": []}], ["In captive bubble studies, DEPN-8+1.5% Mini-B and CLSE both generated minimum surface tensions <1 mN/m on 10 successive cycles of compression/expansion at quasi-static and dynamic rates.", {"entities": []}], ["These results show that DEPN-8 and 1.5% Mini-B form an interactive binary molecular mixture with very high surface activity and the ability to resist degradation by phospholipases in inflammatory lung injury.", {"entities": []}], ["These characteristics are promising for the development of related fully-synthetic lipid/peptide exogenous surfactants for treating diseases of surfactant deficiency or dysfunction.", {"entities": []}], ["\u03b2-glucans are fungal cell wall components that bind to the C-type lectin-like receptor dectin-1.", {"entities": []}], ["Polymorphisms of dectin-1 gene are associated with susceptibility to invasive fungal infection and medically refractory ulcerative colitis.", {"entities": [[120, 138, "DISEASE"]]}], ["The purpose of this study has been addressing the response of human macrophages to \u03b2-glucans under different conditions mimicking the composition of the inflammatory milieu in view of the wide plasticity and large range of phenotypical changes showed by these cells, and the relevant role of dectin-1 in several pathophysiological conditions.", {"entities": []}], ["Serum-differentiated macrophages stimulated with \u03b2-glucans showed a low production of TNF\u03b1 and IL-1\u03b2, a high production of IL-6 and IL-23, and a delayed induction of cyclooxygenase-2 and PGE 2 biosynthesis that resembled the responses elicited by crystals and those produced when phagosomal degradation of the phagocytic cargo increases ligand access to intracellular pattern recognition receptors.", {"entities": []}], ["Priming with a low concentration of LPS produced a rapid induction of cyclooxygenase-2 and a synergistic release of PGE 2 .", {"entities": []}], ["When the differentiation of the macrophages was carried out in the presence of M-CSF, an increased expression of dectin-1 B isoform was observed.", {"entities": []}], ["In addition, this treatment made the cells capable to release arachidonic acid in response to \u03b2-glucan.", {"entities": []}], ["These results indicate that the macrophage response to fungal \u03b2-glucans is strongly influenced by cytokines and microbial-derived factors that are usual components of the inflammatory milieu.", {"entities": []}], ["These responses can be sorted into three main patterns i) an elementary response dependent on phagosomal processing of pathogen-associated molecular patterns and/or receptor-independent, direct membrane binding linked to the immunoreceptor tyrosine-based activation motif-bearing transmembrane adaptor DNAX-activating protein 12, ii) a response primed by TLR4-dependent signals, and iii) a response dependent on M-CSF and dectin-1 B isoform expression that mainly signals through the dectin-1 B/spleen tyrosine kinase/cytosolic phospholipase A 2 route.", {"entities": []}], ["Regulation of allergy responses by intestinal epithelial cells remain poorly understood.", {"entities": []}], ["Using a model of oral allergen sensitization in the presence of cholera toxin as adjuvant and mice with cell-specific deletion of IKK\u03b2 in intestinal epithelial cells IECs (IKK\u03b2", {"entities": [[64, 71, "DISEASE"]]}], ["Cannabis smoking can create respiratory problems.", {"entities": []}], ["Vaporizers heat cannabis to release active cannabinoids, but remain cool enough to avoid the smoke and toxins associated with combustion.", {"entities": []}], ["Vaporized cannabis should create fewer respiratory symptoms than smoked cannabis.", {"entities": []}], ["We examined self-reported respiratory symptoms in participants who ranged in cigarette and cannabis use.", {"entities": []}], ["Data from a large Internet sample revealed that the use of a vaporizer predicted fewer respiratory symptoms even when age, sex, cigarette smoking, and amount of cannabis used were taken into account.", {"entities": []}], ["Age, sex, cigarettes, and amount of cannabis also had significant effects.", {"entities": []}], ["The number of cigarettes smoked and amount of cannabis used interacted to create worse respiratory problems.", {"entities": []}], ["A significant interaction revealed that the impact of a vaporizer was larger as the amount of cannabis used increased.", {"entities": []}], ["These data suggest that the safety of cannabis can increase with the use of a vaporizer.", {"entities": []}], ["Regular users of joints, blunts, pipes, and water pipes might decrease respiratory symptoms by switching to a vaporizer", {"entities": []}], ["Background: To validate the \u2018Test of Adherence to Inhalers\u2019 (TAI), a 12-item questionnaire designed to assess the adherence to inhalers in patients with COPD or asthma.", {"entities": [[161, 167, "DISEASE"]]}], ["Methods: A total of 1009 patients with asthma or COPD participated in a cross-sectional multicenter study.", {"entities": [[39, 45, "DISEASE"]]}], ["Patients with electronic adherence \u226580% were defined as adherents.", {"entities": []}], ["Construct validity, internal validity, and criterion validity were evaluated.", {"entities": []}], ["Self-reported adherence was compared with the Morisky-Green questionnaire.", {"entities": []}], ["Results: Factor analysis study demonstrated two factors, factor 1 was coincident with TAI patient domain (items 1 to 10) and factor 2 with TAI health-care professional domain (items 11 and 12).", {"entities": []}], ["The Cronbach's alpha was 0.860 and the test-retest reliability 0.883.", {"entities": []}], ["TAI scores correlated with electronic adherence (\u03c1=0.293, p =0.01).", {"entities": []}], ["According to the best cut-off for 10 items (score 50, area under the ROC curve 0.7), 569 (62.5%) patients were classified as non-adherents.", {"entities": []}], ["The non-adherence behavior pattern was: erratic 527 (57.9%), deliberate 375 (41.2%), and unwitting 242 (26.6%) patients.", {"entities": []}], ["As compared to Morisky-Green test, TAI showed better psychometric properties.", {"entities": []}], ["Conclusions: The TAI is a reliable and homogeneous questionnaire to identify easily non-adherence and to classify from a clinical perspective the barriers related to the use of inhalers in asthma and COPD.", {"entities": [[189, 195, "DISEASE"]]}], ["The intestinal parasite H. polygyrus secretes a TGF-\u03b2\u2013like molecule that induces regulatory T cells, thus suppressing anti-parasitic effector T cell responses by the host.", {"entities": []}], ["Foxp3-expressing regulatory T (T reg) cells have been implicated in parasite-driven inhibition of host immunity during chronic infection.", {"entities": []}], ["We addressed whether parasites can directly induce T reg cells.", {"entities": []}], ["Foxp3 expression was stimulated in naive Foxp3 Heligmosomoides polygyrus .", {"entities": [[0, 5, "GENE"], [41, 46, "GENE"], [0, 5, "GENE"], [41, 46, "GENE"]]}], ["In vitro, parasite-secreted proteins (termed H. polygyrus excretory-secretory antigen [HES]) induced de novo Foxp3 expression in fluorescence-sorted Foxp3 H. polygyrus \u2013infected mice.", {"entities": [[109, 114, "GENE"], [149, 154, "GENE"], [109, 114, "GENE"], [149, 154, "GENE"]]}], ["HES induced IL-17 in the presence of IL-6 but did not promote Th1 or Th2 development under any conditions.", {"entities": []}], ["Importantly, antibody to mammalian TGF-\u03b2 did not recognize HES, whereas antisera that inhibited HES did not affect TGF-\u03b2.", {"entities": []}], ["Foxp3 was also induced by secreted products of Teladorsagia circumcincta , a related nematode which is widespread in ruminant animals.", {"entities": [[0, 5, "GENE"]]}], ["We have therefore identified a novel pathway through which helminth parasites may stimulate T reg cells, which is likely to be a key part of the parasite\u2019s immunological relationship with the host.", {"entities": []}], ["Tissue-resident memory T (Trm) cells form a heterogeneous population that provides localized protection against pathogens.", {"entities": []}], ["Here, we identify CD49a as\u00a0a marker that differentiates CD8 \u2022 CD49a expression marks CD8 \u2022 IL-15 drives potent cytotoxic capacity in CD49a \u2022 IL-17 is preferentially produced by CD49a \u2022 CD49a CD49a expression marks CD8 IL-15 drives potent cytotoxic capacity in CD49a IL-17 is preferentially produced by CD49a CD49a Tissue-resident memory T (Trm) cells provide localized adaptive immunity in peripheral tissues.", {"entities": []}], ["Cheuk et\u00a0al.", {"entities": []}], ["identify cytotoxic CD49a", {"entities": []}], ["The aim of the present study was to determine the effect of an ATP-sensitive K ATP ) channel opener iptakalim (IPT) on the proliferation and apoptosis of human pulmonary artery smooth muscle cells (HPASMCs), and examine the potential value of IPT to hypoxic pulmonary hypertension (HPH) at a cellular level.", {"entities": [[268, 280, "DISEASE"], [258, 280, "DISEASE"]]}], ["HPASMCs were divided into the control, ET-1, ET-1+IPT and ET-1+IPT+glibenclamide (GLI) groups.", {"entities": []}], ["GLI was administered 30 min prior to ET-1 and IPT.", {"entities": []}], ["The 4 groups were incubated with corresponding reagents for 24 h. Cell viability was evaluated using a CCK-8 assay, cell proliferation by 5-ethynyl-2\u2032-deoxyuridine (EdU) incorporation assay, and cell apoptosis via the expression of apoptosis-related proteins, i.e., Bcl-2-associated X protein (Bax) and B-cell lymphoma 2 (Bcl-2) using western blotting.", {"entities": [[310, 318, "DISEASE"], [294, 297, "GENE"]]}], ["We incubated HPASMCs with varying concentrations of ET-1 for 24, 48 and 72 h, and found that cell survival rate was increased in a dose-dependent manner (P<0.05) rather than in a time-dependent manner (P>0.05).", {"entities": []}], ["After co-incubation of HPASMCs with varying concentrations of IPT and ET-1 for 24 h, the cell survival rate was decreased in a dose-dependent manner.", {"entities": []}], ["The cell survival rate in the IPT+ET-1 group was significantly lower than that in the ET-1 group (P<0.05).", {"entities": []}], ["The cell viability (P<0.05) and proliferation (P<0.05) in the ET-1 group were higher than those in the control group, and the expression of Bax/Bcl-2 was lower than the control group (P<0.05).", {"entities": []}], ["The cell viability (P<0.05) and proliferation (P<0.05) in the ET-1+IPT group were lower than those in the ET-1 group, and the expression of Bax/Bcl-2 was higher than that in the ET-1 group (P<0.05).", {"entities": []}], ["The cell viability (P<0.05) and proliferation (P<0.05) in the ET-1+IPT+GLI group were higher than those in the ET-1+IPT group, and the expression of Bax/Bcl-2 was lower than that in the ET-1+IPT group (P<0.05).", {"entities": []}], ["In conclusion, IPT inhibited ET-1-induced HPASMC proliferation and promoted cell apoptosis.", {"entities": []}], ["Thus, it may play an important role in the treatment of HPH.", {"entities": []}], ["Compare EoE-AP with EoE-D for clinical, endoscopy (EGD), histology and outcomes and also with FAP-N.", {"entities": []}], ["Symptoms, physical findings, EGD, histology, symptom scores, and treatments were recorded for the three groups.", {"entities": []}], ["Cluster analysis was done.", {"entities": []}], ["Dysphagia and abdominal pain were different in numbers but not statistically significant between EoE-AP and EoE-D. EGD, linear furrows, white exudates were more in the EoE-D and both combined were significant ( p < 0.05).", {"entities": []}], ["EoE-D, peak and mean eosinophils ( p \u2009\u20090.06) and eosinophilic micro abscesses ( p \u2009\u20090.001) were higher.", {"entities": []}], ["Follow-Up .", {"entities": []}], ["Based on single symptom, EoE-AP had 30% ( p \u2009\u20090.25) improvement, EoE-D 86% ( p < 0.001) and similar with composite score ( p \u2009\u20090.57 and <0.001, resp.).", {"entities": []}], ["Patients who had follow-up, EGD: 42.8% with EoE-AP and 77.8% with EoE-D, showed single symptom improvement and the eosinophil count fell from 38.5/34.6 (peak and mean) to 31.2/30.4 ( p \u2009\u20090.70) and from 43.6/40.8 to 25.2/22.8 ( p < 0.001), respectively.", {"entities": []}], ["FAP-N patients had similar symptom improvement like EoE-D.", {"entities": []}], ["Cluster Analysis .", {"entities": []}], ["EoE-AP and FAP-N were similar in clinical features and response to treatment, but EoE-D was distinctly different from EoE-AP and FAP-N.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Our study demonstrates that EoE-AP and EoE-D have different histology and outcomes.", {"entities": []}], ["In addition, EoE-AP has clinical features similar to the FAP-N group.", {"entities": []}], ["Peer support is receiving increasing attention as both an effective and cost-effective intervention method to support the self-management of chronic health conditions.", {"entities": []}], ["Given that an increasing proportion of Canadians have internet access and the increasing implementation of web-based interventions, online peer support interventions are a promising option to address the burden of chronic diseases.", {"entities": []}], ["Thus, the specific research question of this scoping review is the following: What is known from the existing literature about the key characteristics of online peer support interventions for adults with chronic conditions?", {"entities": []}], ["We will use the methodological frameworks used by Arksey and O\u2019Malley as well as Levac and colleagues for the current scoping review.", {"entities": []}], ["To be eligible for inclusion, studies must report on adults (\u226518 years of age) with one of the Public Health Agency of Canada chronic conditions or HIV/AIDS.", {"entities": []}], ["We will limit our review to peer support interventions delivered through online formats.", {"entities": []}], ["All study designs will be included.", {"entities": []}], ["Only studies published from 2012 onwards will be included to ensure relevance to the current healthcare context and feasibility.", {"entities": []}], ["Furthermore, only English language studies will be included.", {"entities": []}], ["Studies will be identified by searching a variety of databases.", {"entities": []}], ["Two reviewers will independently screen the titles and abstracts identified by the literature search for inclusion (ie, level 1 screening), the full text articles (ie, level 2 screening) and then perform data abstraction.", {"entities": []}], ["Abstracted data will include study characteristics, participant population, key characteristics of the intervention and outcomes collected.", {"entities": []}], ["This review will identify the key features of online peer support interventions and could assist in the future development of other online peer support programmes so that effective and sustainable programmes can be developed.", {"entities": []}], ["This review investigates the health of immigrants to Canada by critically examining differences in health status between immigrants and the native-born population and by tracing how the health of immigrants changes after settling in the country.", {"entities": []}], ["Fifty-one published empirical studies met the inclusion criteria for this review.", {"entities": []}], ["The analysis focuses on four inter-related questions: (1) Which health conditions show transition effects and which do not?", {"entities": []}], ["(2) Do health transitions vary by ethnicity/racialized identity?", {"entities": []}], ["(3) How are health transitions influenced by socioeconomic status?", {"entities": []}], ["and (4) How do compositional and contextual factors interact to affect the health of immigrants?", {"entities": []}], ["Theoretical and methodological challenges facing this area of research are discussed and future directions are identified.", {"entities": []}], ["This area of research has the potential to develop into a complex, nuanced, and useful account of the social determinants of health as experienced by different groups in different places.", {"entities": []}], ["Attention deficit hyperactivity disorder (ADHD) is a highly heritable neuropsychiatric condition, but it has been difficult to identify genes underlying this disorder.", {"entities": []}], ["This study aimed to explore genetics of ADHD in an ethnically homogeneous Norwegian population by means of a genome-wide association (GWA) analysis followed by examination of candidate loci.", {"entities": []}], ["Participants were recruited through Norwegian medical and birth registries as well as the general population.", {"entities": []}], ["Presence of ADHD was defined according to DSM-IV criteria.", {"entities": []}], ["Genotyping was performed using Illumina Human OmniExpress-12v1 microarrays.", {"entities": []}], ["Statistical analyses were divided into several steps: (1) genome-wide association in the form of logistic regression in PLINK and follow-up pathway analyses performed in DAPPLE and INRICH softwares, (2) SNP-heritability calculated using genome-wide complex trait analysis (GCTA) tool, (3) gene-based association tests carried out in JAG software, and (4) evaluation of previously reported genome-wide signals and candidate genes of ADHD.", {"entities": []}], ["In total, 1.358 individuals (478 cases and 880 controls) and 598.384 autosomal SNPs were subjected to GWA analysis.", {"entities": []}], ["No single polymorphism reached genome-wide significance.", {"entities": []}], ["The strongest signal was observed at rs9949006 in the ENSG00000263745 gene (OR=1.51, 95% CI 1.28\u20131.79, p=1.38E-06).", {"entities": []}], ["Pathway analyses of the top SNPs implicated genes involved in the regulation of gene expression, cell adhesion and inflammation.", {"entities": []}], ["Among previously identified ADHD candidate genes, prominent association signals were observed for SLC9A9 (rs1393072, OR=1.46, 95% CI = 1.21\u20131.77, p=9.95E-05) and TPH2 (rs17110690, OR = 1.38, 95% CI = 1.14\u20131.66, p=8.31E-04).", {"entities": [[98, 104, "GENE"], [162, 166, "GENE"]]}], ["This study confirms the complexity and heterogeneity of ADHD etiology.", {"entities": []}], ["Taken together with previous findings, our results point to a spectrum of biological mechanisms underlying the symptoms of ADHD, providing targets for further genetic exploration of this complex disorder.", {"entities": []}], ["Colorectal cancer (CRC) development is mediated by uncontrolled survival and proliferation of tumor progenitor cells.", {"entities": [[11, 17, "DISEASE"]]}], ["Using animal models to identify and study host-derived factors that underlie this process can aid interventions in preventing tumor expansion and metastasis.", {"entities": []}], ["In healthy steady states in humans and mice (e.g.", {"entities": []}], ["C57BL/6 strain), colonic Chitinase 3-like 1 (CHI3L1) gene expression is undetectable.", {"entities": [[45, 51, "GENE"]]}], ["However, this expression can be induced during intestinal inflammation and tumorigenesis where CHI3L1 plays an important role in tissue restitution and cell proliferation.", {"entities": [[95, 101, "GENE"]]}], ["Here, we show that a wild-derived mouse strain MOLF/EiJ expresses high levels of colonic epithelial CHI3L1 at the steady state due to several nucleotide polymorphisms in the proximal promoter regions of the CHI3L1 gene.", {"entities": [[100, 106, "GENE"], [207, 213, "GENE"], [100, 106, "GENE"], [207, 213, "GENE"]]}], ["Interestingly, these mice spontaneously developed polypoid nodules in the colon with signs of immune cell infiltrations at steady state.", {"entities": []}], ["The CHI3L1 positive colonic epithelial cells were highly proliferative and exhibited malignant transformation and expansion when exposed in vivo to azoxymethane, one of the well-known colonic carcinogens.", {"entities": [[4, 10, "GENE"]]}], ["To describe hospitals' organizational arrangements relevant to the abstraction of administrative data, to report on the completeness of administrative data collected and to assess associations between organizational arrangements and completeness of data submission.", {"entities": []}], ["A cross-sectional study design utilizing administrative data.", {"entities": []}], ["Randomly selected hospitals from seven European countries (The Czech Republic, France, Germany, Poland, Portugal, Spain, and Turkey).", {"entities": []}], ["Completeness of data submission for four quality indicators: mortality after acute myocardial infarction, stroke and hip fractures and complications after normal delivery.", {"entities": [[83, 104, "DISEASE"], [77, 104, "DISEASE"]]}], ["In general, hospitals were able to produce data on the four indicators required for this research study.", {"entities": []}], ["A substantial proportion had missing data on one or more data items.", {"entities": []}], ["The proportion of hospitals that was able to produce more detailed indicators of relevance for quality monitoring and improvement was low and ranged from 40.1% for thrombolysis performed on patients with acute ischemic stroke to 63.8% for hip-fracture operations performed within 48 h after admission for patients aged 65 or older.", {"entities": []}], ["National factors were strong predictors of data completeness on the studied indicators.", {"entities": []}], ["At present, hospital administrative databases do not seem to be an appropriate source of information for comparison of hospital performance across the countries of the EU.", {"entities": []}], ["However, given that this is a dynamic field, changes to administrative databases may make this possible in the near future.", {"entities": []}], ["Such changes could be accelerated by an in-depth comparative analysis of the issues of using administrative data for comparisons of hospital performances in EU countries.", {"entities": []}], ["Bronchial smooth muscle (BSM) cells from asthmatic patients maintain in vitro a distinct hyper-reactive (\u201cprimed\u201d) phenotype, characterized by increased release of pro-inflammatory factors and mediators, as well as hyperplasia and/or hypertrophy.", {"entities": []}], ["This \u201cprimed\u201d phenotype helps to understand pathogenesis of asthma, as changes in BSM function are essential for manifestation of allergic and inflammatory responses and airway wall remodelling.", {"entities": [[60, 66, "DISEASE"]]}], ["To identify signalling pathways in cultured primary BSMs of asthma patients and non-asthmatic subjects by genome wide profiling of differentially expressed mRNAs and activated intracellular signalling pathways (ISPs).", {"entities": [[60, 66, "DISEASE"]]}], ["Transcriptome profiling by cap-analysis-of-gene-expression (CAGE), which permits selection of preferentially capped mRNAs most likely to be translated into proteins, was performed in human BSM cells from asthmatic (n=8) and non-asthmatic (n=6) subjects and OncoFinder tool were then exploited for identification of ISP deregulations.", {"entities": []}], ["CAGE revealed >600 RNAs differentially expressed in asthma vs control cells (p\u22640.005), with asthma samples showing a high degree of similarity among them.", {"entities": [[52, 58, "DISEASE"], [92, 98, "DISEASE"]]}], ["Comprehensive ISP activation analysis revealed that among 269 pathways analysed, 145 (p<0.05) or 103 (p<0.01) are differentially active in asthma, with profiles that clearly characterize BSM cells of asthmatic individuals.", {"entities": [[139, 145, "DISEASE"]]}], ["Notably, we identified 7 clusters of coherently acting pathways functionally related to the disease, with ISPs down-regulated in asthma mostly targeting cell death-promoting pathways and up-regulated ones affecting cell growth and proliferation, inflammatory response, control of smooth muscle contraction and hypoxia-related signalization.", {"entities": [[129, 135, "DISEASE"]]}], ["These first-time results can now be exploited toward development of novel therapeutic strategies targeting ISP signatures linked to asthma pathophysiology.", {"entities": [[132, 138, "DISEASE"]]}], ["Characterizing how cells in three-dimensional (3D) environments or natural tissues respond to biophysical stimuli is a longstanding challenge in biology and tissue engineering.", {"entities": []}], ["We demonstrate a strategy to monitor morphological and mechanical responses of contractile fibroblasts in a 3D environment.", {"entities": []}], ["Cells responded to stretch through specific, cell-wide mechanisms involving staged retraction and reinforcement.", {"entities": []}], ["Retraction responses occurred for all orientations of stress fibers and cellular protrusions relative to the stretch direction, while reinforcement responses, including extension of cellular processes and stress fiber formation, occurred predominantly in the stretch direction.", {"entities": []}], ["A previously unreported role of F-actin clumps was observed, with clumps possibly acting as F-actin reservoirs for retraction and reinforcement responses during stretch.", {"entities": []}], ["Responses were consistent with a model of cellular sensitivity to local physical cues.", {"entities": []}], ["These findings suggest mechanisms for global actin cytoskeleton remodeling in non-muscle cells and provide insight into cellular responses important in pathologies such as fibrosis and hypertension.", {"entities": [[185, 197, "DISEASE"]]}], ["Hypersensitivity pneumonitis (HP) is a pulmonary disease with symptoms of dyspnea and cough resulting from the inhalation of an antigen to which the subject has been previously sensitized.", {"entities": [[30, 32, "GENE"]]}], ["The incidence of HP is unknown.", {"entities": [[17, 19, "GENE"]]}], ["A population-based study estimated the annual incidence of interstitial lung diseases as 30:100,000 and HP accounted for less than 2% of these cases.", {"entities": [[104, 106, "GENE"]]}], ["The diagnosis of HP can often be made or rejected with confidence, especially in areas of high or low prevalence respectively, using simple diagnostic criteria.", {"entities": [[17, 19, "GENE"]]}], ["Chest X-rays may be normal in active HP; High Resolution Computed Tomography is sensitive but not specific for the diagnosis of HP.", {"entities": [[37, 39, "GENE"], [128, 130, "GENE"], [37, 39, "GENE"], [128, 130, "GENE"]]}], ["The primary use of pulmonary function tests is to determine the physiologic abnormalities and the associated impairment.", {"entities": []}], ["Despite the pitfalls of false positive and false negatives, antigen-specific IgG antibodies analysis can be useful as supportive evidence for HP.", {"entities": [[142, 144, "GENE"]]}], ["Bronchoalveolar lavage plays an important role in the investigation of patients suspected of having HP.", {"entities": [[100, 102, "GENE"]]}], ["A normal number of lymphocytes rules out all but residual disease.", {"entities": []}], ["Surgical lung biopsy should be reserved for rare cases with puzzling clinical presentation or for verification the clinical diagnosis when the clinical course or response to therapy is unusual.", {"entities": []}], ["Being an immune reaction in the lung, the most obvious treatment of HP is avoidance of contact with the offending antigen.", {"entities": [[68, 70, "GENE"]]}], ["Systemic corticosteroids represent the only reliable pharmacologic treatment of HP but do not alter the long-term outcome.", {"entities": [[80, 82, "GENE"]]}], ["The use of inhaled steroids is anecdotal.", {"entities": []}], ["Treatment of chronic or residual disease is supportive.", {"entities": []}], ["The risk of indoor exposure to volatile organic compounds (VOCs) on allergic airway diseases in children remains unknown.", {"entities": []}], ["We examined the residential concentrations of VOCs, emitted from building materials, paints, furniture, and other lifestyle practices and the risks of multiple allergic diseases as well as the IgE-sensitization in pre-school age children in Sweden.", {"entities": []}], ["In a case-control investigation (198 case children with asthma and allergy and 202 healthy controls), air samples were collected in the room where the child slept.", {"entities": [[56, 62, "DISEASE"]]}], ["The air samples were analyzed for the levels of eight classes of VOCs.", {"entities": []}], ["A natural-log unit of summed propylene glycol and glycol ethers (PGEs) in bedroom air (equal to interquartile range, or 3.43 \u2013 15.65 \u00b5 g/m We propose a novel hypothesis that PGEs in indoor air exacerbate and/or induce the multiple allergic symptoms, asthma, rhinitis and eczema, as well as IgE sensitization respectively.", {"entities": [[258, 266, "DISEASE"], [250, 256, "DISEASE"]]}], ["Early detection enables the possibility for interventions to reduce the future burden of COPD.", {"entities": []}], ["The Danish National Board of Health recommends that individuals >35 years with tobacco/occupational exposure, and at least 1 respiratory symptom should be offered a spirometry to facilitate early detection of COPD.", {"entities": []}], ["The aim, therefore, was to provide evidence for the feasibility and impact of doing spirometry in this target population.", {"entities": []}], ["Participating general practitioners (GPs) (n = 335; 10% of the Danish GPs) recruited consecutively, subjects with >35 years exposure, no previous diagnosis of obstructive lung disease, and at least 1 of the following symptoms: cough, dyspnea, wheezing, sputum, or recurrent respiratory infection.", {"entities": [[159, 183, "DISEASE"], [171, 183, "DISEASE"]]}], ["Data on age, smoking status, pack-years, body mass index (BMI), dyspnea score (Medical Research Council, MRC), and pre-bronchodilator spirometry (FEV 1 , FEV 1 % predicted, FEV 1 /FVC) were obtained.", {"entities": [[146, 149, "GENE"], [154, 157, "GENE"], [173, 176, "GENE"], [146, 149, "GENE"], [154, 157, "GENE"], [173, 176, "GENE"], [146, 149, "GENE"], [154, 157, "GENE"], [173, 176, "GENE"]]}], ["A total of 3.095 (51% females) subjects was included: mean age 58 years, BMI 26.3, and 31.5 pack-years.", {"entities": []}], ["The majority of subjects (88%) reported MRC score 1 or 2.", {"entities": []}], ["FEV 1 /FVC-ratio \u2264 0.7 was found in 34.8% of the subjects; the prevalence of airway obstruction increased with age and decreased with increasing BMI, and was higher in men and current smokers.", {"entities": [[0, 3, "GENE"]]}], ["According to the level of FEV 1 , 79% of the subjects with airway obstruction had mild to moderate COPD.", {"entities": [[26, 29, "GENE"]]}], ["More than one-third of the recruited subjects had airway obstruction (FEV 1 / FVC < 0.7).", {"entities": [[70, 73, "GENE"]]}], ["Early detection of COPD appears to be feasible through offering spirometry to adults with tobacco/occupational exposure and at least 1 respiratory symptom.", {"entities": []}], ["Streptococcus mutans is the most significant pathogenic bacterium implicated in the formation of dental caries and, both directly and indirectly, has been associated with severe conditions such as multiple sclerosis, cerebrovascular and peripheral artery disease.", {"entities": [[197, 215, "DISEASE"], [97, 110, "DISEASE"]]}], ["Polymers able to selectively bind S .", {"entities": []}], ["mutans and/or inhibit its adhesion to oral tissue in a non-lethal manner would offer possibilities for addressing pathogenicity without selecting for populations resistant against bactericidal agents.", {"entities": []}], ["In the present work two libraries of 2-(dimethylamino)ethyl methacrylate (pDMAEMA)-based polymers were synthesized with various proportions of either N , N , N -trimethylethanaminium cationic- or sulfobetaine zwitterionic groups.", {"entities": []}], ["These copolymers where initially tested as potential macromolecular ligands for S .", {"entities": []}], ["mutans NCTC 10449, whilst Escherichia coli MG1655 was used as Gram-negative control bacteria.", {"entities": []}], ["pDMAEMA-derived materials with high proportions of zwitterionic repeating units were found to be selective for S .", {"entities": []}], ["mutans , in both isolated and S .", {"entities": []}], ["mutans \u2013 E .", {"entities": []}], ["coli mixed bacterial cultures.", {"entities": []}], ["Fully sulfobetainized pDMAEMA was subsequently found to bind/cluster preferentially Gram-positive S .", {"entities": []}], ["mutans and S .", {"entities": []}], ["aureus compared to Gram negative E .", {"entities": []}], ["coli and V .", {"entities": []}], ["A key initial stage of S .", {"entities": []}], ["mutans pathogenesis involves a lectin-mediated adhesion to the tooth surface, thus the range of potential macromolecular ligands was further expanded by investigating two glycopolymers bearing \u03b1-mannopyranoside and \u03b2-galactopyranoside pendant units.", {"entities": []}], ["Results with these polymers indicated that preferential binding to either S .", {"entities": []}], ["mutans or E .", {"entities": []}], ["coli can be obtained by modulating the glycosylation pattern of the chosen multivalent ligands without incurring unacceptable cytotoxicity in a model gastrointestinal cell line.", {"entities": []}], ["Overall, our results allowed to identify a structure\u2013property relationship for the potential antimicrobial polymers investigated, and suggest that preferential binding to Gram-positive S .", {"entities": []}], ["mutans could be achieved by fine-tuning of the recognition elements in the polymer ligands.", {"entities": []}], ["There is persuasive epidemiological and experimental evidence that dietary polyphenols have anti-inflammatory activity.", {"entities": []}], ["Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) have long been used to combat inflammation.", {"entities": []}], ["Recently, cyclooxygenase (COX) inhibitors have been developed and recommended for treatment of rheumatoid arthritis (RA) and osteoarthritis (OA).", {"entities": [[95, 115, "DISEASE"], [106, 115, "DISEASE"], [125, 139, "DISEASE"]]}], ["However, two COX inhibitors have been withdrawn from the market due to unexpected side effects.", {"entities": []}], ["Because conventional therapeutic and surgical approaches have not been able to fully control the incidence and outcome of many inflammatory diseases, there is an urgent need to find safer compounds and to develop mechanism-based approaches for the management of these diseases.", {"entities": []}], ["Polyphenols are found in many dietary plant products, including fruits, vegetables, beverages, herbs, and spices.", {"entities": []}], ["Several of these compounds have been found to inhibit the inflammation process as well as tumorigenesis in experimental animals; they can also exhibit potent biological properties.", {"entities": []}], ["In addition, epidemiological studies have indicated that populations who consume foods rich in specific polyphenols have lower incidences of inflammatory disease.", {"entities": []}], ["This paper provides an overview of the research approaches that can be used to unravel the biology and health effects of polyphenols.", {"entities": []}], ["Polyphenols have diverse biological effects, however, this review will focus on some of the pivotal molecular targets that directly affect the inflammation process.", {"entities": []}], ["Direct-to-consumer (DTC) promotion of prescription drugs can affect consumer behaviors and health outcomes, and Internet drug promotion is growing rapidly.", {"entities": []}], ["Branded drug websites often capitalize on the multimedia capabilities of the Internet by using videos to emphasize drug benefits and characteristics.", {"entities": []}], ["However, it is unknown how such videos affect consumer processing of drug information.", {"entities": []}], ["This study aimed to examine how videos on prescription drug websites, and the inclusion of risk information in those videos, influence consumer knowledge and perceptions.", {"entities": []}], ["We conducted an experimental study in which online panel participants with acid reflux (n=1070) or high blood pressure (n=1055) were randomly assigned to view 1 of the 10 fictitious prescription drug websites and complete a short questionnaire.", {"entities": []}], ["On each website, we manipulated the type of video (patient testimonial, mechanism of action animation, or none) and whether the video mentioned drug risks.", {"entities": []}], ["Participants who viewed any video were less likely to recognize drug risks presented only in the website text ( P \u2264.01).", {"entities": []}], ["Including risk information in videos increased participants\u2019 recognition of the risks presented in the videos ( P \u2264.01).", {"entities": []}], ["However, in some cases, including risk information in videos decreased participants\u2019 recognition of the risks not presented in the videos (ie, risks presented in text only; P \u2264.04).", {"entities": []}], ["Participants who viewed a video without drug risk information thought that the website placed more emphasis on benefits, compared with participants who viewed the video with drug risk information ( P \u2264.01).", {"entities": []}], ["Compared with participants who viewed a video without drug risk information, participants who viewed a video with drug risk information thought that the drug was less effective in the high blood pressure sample ( P =.03) and thought that risks were more serious in the acid reflux sample (P =.01).", {"entities": []}], ["There were no significant differences between risk and nonrisk video conditions on other perception measures ( P >.05).", {"entities": []}], ["In addition, we noted a few differences among the types of videos.", {"entities": []}], ["Including risks in branded drug website videos may increase in-video risk retention at the expense of text-only risk retention.", {"entities": []}], ["Chlamydia pneumoniae (C pn) infection causes an acute inflammation in the respiratory system that may become persistent, but little is known about the long-term respiratory effects of C pn infections.", {"entities": []}], ["Aim: To estimate the long term respiratory effects of C pn with change in forced expiratory volume in one second (FEV 1 ) and forced vital capacity (FVC) as a main outcome variable.", {"entities": [[114, 117, "GENE"]]}], ["The study comprised of 1109 subjects (500 men and 609 women, mean age 28 \u00b1 6 years) that participated in the Reykjavik Heart Study of the Young.", {"entities": []}], ["Spirometry and blood samples for measurements of IgG antibodies for C pn were done at inclusion and at the end of the follow-up period (mean follow-up time 27 \u00b1 4 years).", {"entities": []}], ["Having IgG against C pn at both examinations was significantly associated to a larger decrease in FEV 1 (6 mL/year) and FVC (7 mL/year) in women but not in men.", {"entities": [[98, 101, "GENE"]]}], ["In women the association between C pn and larger FEV 1 decline was only found in women that smoked at baseline where having C pn IgG was associated with 10 mL/year decline compared to smokers without C pn IgG.", {"entities": [[49, 52, "GENE"]]}], ["These results were still significant after adjustment for age, smoking and change in body weight.", {"entities": []}], ["Our results indicate that persistent C pn serology is related to increased decline in lung function in women but not in men.", {"entities": []}], ["This effect was, however, primarily found in smoking women.", {"entities": []}], ["This study is a further indication that the pathophysiological process leading to lung impairment may differ between men and women.", {"entities": []}], ["Approximately 13%\u201319% of new mothers report depression during the postpartum period.", {"entities": []}], ["Returning to work after childbirth is associated with depression; however, it is unclear if this finding applies to women who are at high risk for postpartum depression.", {"entities": []}], ["The purpose of this study was to examine the relationship between employment status and depression symptomatology among women at risk for postpartum depression (defined as personal or maternal history of depression).", {"entities": []}], ["This study was a post hoc analysis from a previously conducted randomized controlled trial.", {"entities": []}], ["Participants (n = 124; ages 18\u201342) were 7 months postpartum and had participated in a randomized trial examining the efficacy of an exercise intervention for the prevention of postpartum depression (study was conducted from January 2010 through November 2011).", {"entities": []}], ["Participants completed questionnaires examining demographic characteristics and psychosocial variables at 6 weeks and 7 months postpartum.", {"entities": []}], ["The Edinburgh Postnatal Depression Scale was administered at 7 months postpartum to assess depression symptomatology.", {"entities": []}], ["Sixty-eight percent of the participants reported that they were employed at 7 months postpartum.", {"entities": []}], ["Employment at 7 months postpartum was associated with lower depression symptomatology (as measured by the Edinburgh Postnatal Depression Scale) after controlling for condition assignment, marital status, and having other children.", {"entities": []}], ["Among women who worked outside of the home, there were no differences between those who worked full-time versus part-time on depression symptomatology.", {"entities": []}], ["Employment may be a protective factor for postpartum depression symptomatology; however, we cannot infer causation given this study\u2019s cross-sectional design.", {"entities": []}], ["Postpartum women at risk for depression who are contemplating employment should consider the possible protective effect of employment on depression.", {"entities": []}], ["Recent public health objectives emphasize the importance of exercise for reducing disability among people with arthritis.", {"entities": [[111, 120, "DISEASE"]]}], ["Despite the documented benefits of exercise, people with arthritis are less active than those without arthritis.", {"entities": [[57, 66, "DISEASE"], [102, 111, "DISEASE"]]}], ["The purpose of this study was to examine the factors that influence exercise participation among insufficiently active individuals with arthritis and to compare these factors with those identified by nonexercisers and regular exercisers with arthritis.", {"entities": [[136, 145, "DISEASE"], [242, 251, "DISEASE"]]}], ["Forty-six individuals with arthritis were recruited from various community-based organizations to participate in seven focus groups segmented by exercise status and education.", {"entities": [[27, 36, "DISEASE"]]}], ["Trained moderators led each discussion using a standard guide.", {"entities": []}], ["All focus group discussions were transcribed verbatim and coded.", {"entities": []}], ["Pain was the most commonly mentioned barrier to exercise and limited exercise participation for nonexercisers and insufficiently active individuals.", {"entities": []}], ["Paradoxically, insufficiently active individuals also identified exercise-related reductions in pain as a potential motivation for increasing exercise.", {"entities": []}], ["Likewise, exercise-related reductions in pain were a motivation to continue exercising for the exerciser groups.", {"entities": []}], ["Nonexercisers expressed that a reduction in pain was a possible outcome of exercise but were skeptical of its occurrence.", {"entities": []}], ["Receiving tailored advice from a health care provider was consistently identified as an exercise enabler across the groups.", {"entities": []}], ["Findings from this study indicate that potential strategies for increasing exercise participation include incorporating pain management strategies and coping skills into exercise interventions and ensuring that health care providers provide specific exercise advice to their patients with arthritis.", {"entities": [[289, 298, "DISEASE"]]}], ["This study aimed to evaluate whether a specific interleukin-1 receptor-associated kinase-4 ( IRAK4 ) gene polymorphism had any influence on the development of changes in maxillary sinus, particularly in the presence of etiological factors of dental origin.", {"entities": [[93, 98, "GENE"]]}], ["The study population included 153 Portuguese Caucasians that were selected from a database of 504 retrospectively analysed computed tomography (CT) scans.", {"entities": []}], ["A genetic test was performed, and a model was created through logistic analysis and regression coefficients.", {"entities": []}], ["The statistical methodologies included were the independent Chi test, Fisher\u2019s exact test, binary logistic regression and the receiver operating characteristic (ROC) curve.", {"entities": []}], ["The estimated prevalence of IRAK4 gene polymorphism found in a Portuguese Caucasian population was 26.8 % (CI 95\u00a0%) [20.1, 34.7 %].", {"entities": [[28, 33, "GENE"]]}], ["A model to predict the inflammatory response in the maxillary sinus in the presence etiological factors of dental origin was constructed.", {"entities": []}], ["This model had the following as variables: previously diagnosed sinusitis, sinus pressure symptoms, cortical bone loss observed on CT, positive genetic test result and radiographic examination that revealed the roots of the teeth communication with the maxillary sinus, which are interpreted as risk factors.", {"entities": [[64, 73, "DISEASE"]]}], ["The constructed model should be considered an initial clinical tool.", {"entities": []}], ["The area under the ROC curve found, AUC\u2009=\u20090.91, revealed that the model correctly predicts the outcome in 91.1\u00a0% of cases.", {"entities": []}], ["The clinical relevance of this study lies in trying to achieve a potential tool (a model) that may assist the clinician in the implementation of suitable dental treatment plans in complex cases, with probable involvement of the maxillary sinus.", {"entities": []}], ["Current musculoskeletal outcome tools are fragmented across different healthcare settings and conditions.", {"entities": []}], ["Our objectives were to develop and validate a single musculoskeletal outcome measure for use throughout the pathway and patients with different musculoskeletal conditions: the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ).", {"entities": [[176, 185, "DISEASE"]]}], ["A consensus workshop with stakeholders from across the musculoskeletal community, workshops and individual interviews with a broad mix of musculoskeletal patients identified and prioritised outcomes for MSK-HQ inclusion.", {"entities": []}], ["Initial psychometric validation was conducted in four cohorts from community physiotherapy, and secondary care orthopaedic hip, knee and shoulder clinics.", {"entities": []}], ["Stakeholders (n=29) included primary care, physiotherapy, orthopaedic and rheumatology patients (n=8); general practitioners, physiotherapists, orthopaedists, rheumatologists and pain specialists (n=7), patient and professional national body representatives (n=10), and researchers (n=4).", {"entities": []}], ["The four validation cohorts included 570 participants (n=210 physiotherapy, n=150 hip, n=150 knee, n=60 shoulder patients).", {"entities": []}], ["Outcomes included the MSK-HQ's acceptability, feasibility, comprehension, readability and responder burden.", {"entities": []}], ["The validation cohort outcomes were the MSK-HQ's completion rate, test\u2013retest reliability and convergent validity with reference standards (EQ-5D-5L, Oxford Hip, Knee, Shoulder Scores, and the Keele MSK-PROM).", {"entities": []}], ["Musculoskeletal domains prioritised were pain severity, physical function, work interference, social interference, sleep, fatigue, emotional health, physical activity, independence, understanding, confidence to self-manage and overall impact.", {"entities": []}], ["Patients reported MSK-HQ items to be \u2018highly relevant\u2019 and \u2018easy to understand\u2019.", {"entities": []}], ["Completion rates were high (94.2%), with scores normally distributed, and no floor/ceiling effects.", {"entities": []}], ["Test\u2013retest reliability was excellent, and convergent validity was strong (correlations 0.81\u20130.88).", {"entities": []}], ["A new musculoskeletal outcome measure has been developed through a coproduction process with patients to capture prioritised outcomes for use throughout the pathway and with different musculoskeletal conditions.", {"entities": []}], ["Four validation cohorts found that the MSK-HQ had high completion rates, excellent test\u2013retest reliability and strong convergent validity with reference standards.", {"entities": []}], ["Further validation studies are ongoing, including a cohort with rheumatoid/inflammatory arthritis.", {"entities": [[88, 97, "DISEASE"]]}], ["Until recently, there have been few clinical algorithms for the management of patients with COPD.", {"entities": []}], ["Current evidence-based clinical management guidelines can appear to be complex, and they lack clear step-by-step instructions.", {"entities": []}], ["For these reasons, we chose to create a simple and practical clinical algorithm for the management of patients with COPD, which would be applicable to real-world clinical practice, and which was based on clinical symptoms and spirometric parameters that would take into account the pathophysiological heterogeneity of COPD.", {"entities": []}], ["This optimized algorithm has two main fields, one for nonspecialist treatment by primary care and general physicians and the other for treatment by specialized pulmonologists.", {"entities": []}], ["Patients with COPD are treated with long-acting bronchodilators and short-acting drugs on a demand basis.", {"entities": []}], ["If the forced expiratory volume in one second (FEV 1 ) is \u226550% of predicted and symptoms are mild, treatment with a single long-acting muscarinic antagonist or long-acting beta-agonist is proposed.", {"entities": [[47, 50, "GENE"]]}], ["When FEV 1 is <50% of predicted and/or the COPD assessment test score is \u226510, the use of combined bronchodilators is advised.", {"entities": [[5, 8, "GENE"]]}], ["If there is no response to treatment after three months, referral to a pulmonary specialist is recommended for pathophysiological endotyping: 1) eosinophilic endotype with peripheral blood or sputum eosinophilia >3%; 2) neutrophilic endotype with peripheral blood neutrophilia >60% or green sputum; or 3) pauci-granulocytic endotype.", {"entities": [[199, 211, "DISEASE"]]}], ["It is hoped that this simple, optimized, step-by-step algorithm will help to individualize the treatment of COPD in real-world clinical practice.", {"entities": []}], ["This algorithm has yet to be evaluated prospectively or by comparison with other COPD management algorithms, including its effects on patient treatment outcomes.", {"entities": []}], ["However, it is hoped that this algorithm may be useful in daily clinical practice for physicians treating patients with COPD in Russia.", {"entities": []}], ["To characterize the seasonal variability of endotoxin levels, we measured endotoxin in dust from the bed, bedroom floor, and kitchen floor in 20 homes, and in air from the bedroom in 15 of the homes.", {"entities": []}], ["All homes were located in the greater Boston, Massachusetts, area and were sampled each month from April 1995 to June 1996.", {"entities": []}], ["Outdoor air was collected at two locations.", {"entities": []}], ["We found greater within-home than between-home variance for bedroom floor, kitchen floor, and airborne endotoxin.", {"entities": []}], ["However, the reverse was true for bed dust endotoxin.", {"entities": []}], ["Thus, studies using single measurements of dust endotoxin are most likely to reliably distinguish between homes if bed dust is sampled.", {"entities": []}], ["Dust endotoxin levels were not significantly associated with airborne endotoxin.", {"entities": []}], ["Airborne endotoxin was significantly (p = 0.", {"entities": []}], ["04) and positively associated with absolute humidity in a mixed-effect model adjusting for a random home effect and fixed effect of sampling month and home characteristics.", {"entities": []}], ["This finding implies that indoor humidity may be an important factor controlling endotoxin exposure.", {"entities": []}], ["We found a significant (p < 0.05) seasonal effect in kitchen floor dust (spring > fall) and bedroom airborne endotoxin (spring > winter), but not in the other indoor samples.", {"entities": []}], ["We found significant seasonal pattern in outdoor airborne endotoxin (summer > winter).", {"entities": []}], ["Current diagnostic tests cannot identify which infected individuals are at risk for progression to tuberculosis (TB).", {"entities": [[99, 111, "DISEASE"]]}], ["Our aim was to identify biomarkers which can predict the development of TB prior to clinical diagnosis.", {"entities": []}], ["In a retrospective case\u2013control study, RNA of 14 HIV-infected drug users obtained before TB diagnosis (cases) and of 15 who did not develop TB (controls) was analyzed for the expression of 141 genes by dcRT-MLPA followed by Lasso regression analysis.", {"entities": []}], ["A combined analysis of IL13 and AIRE had the highest discriminatory power to identify cases up to 8\u00a0months prior to clinical diagnosis.", {"entities": [[23, 27, "GENE"]]}], ["Cases expressing IL13 had a gene expression pattern strongly enriched for type I IFN related signaling genes, suggesting that these genes represent processes that contribute to TB pathogenesis.", {"entities": [[17, 21, "GENE"]]}], ["We here demonstrated that biomarkers, such as IL13-AIRE, can identify individuals that progress to TB within a high risk population, months prior to clinical diagnosis.", {"entities": []}], ["\u2022 A predictive signature was detected in ex vivo PBMCs of HIV-infected drug users up to 8\u00a0months prior to clinical TB diagnosis; \u2022 Combined expression of IL13 and AIRE had the highest discriminatory power to identify cases months prior to TB diagnosis.", {"entities": [[154, 158, "GENE"]]}], ["\u2022 Cases expressing IL13 had a gene expression pattern that was strongly enriched for type I IFN related signalling genes.", {"entities": [[19, 23, "GENE"]]}], ["A predictive signature was detected in ex vivo PBMCs of HIV-infected drug users up to 8\u00a0months prior to clinical TB diagnosis; Combined expression of IL13 and AIRE had the highest discriminatory power to identify cases months prior to TB diagnosis.", {"entities": [[150, 154, "GENE"]]}], ["Cases expressing IL13 had a gene expression pattern that was strongly enriched for type I IFN related signalling genes.", {"entities": [[17, 21, "GENE"]]}], ["Sheikh discusses a new study that found that the main barrier to the participation of minority ethnic people in research lies in their reduced likelihood of being invited to participate.", {"entities": []}], ["Allergic rhinitis (AR) is a common and complex disease.", {"entities": [[9, 17, "DISEASE"]]}], ["It is associated with environmental as well as genetic factors.", {"entities": []}], ["Three recent genome-wide association studies (GWAS) reported altogether 47 single nucleotide polymorphisms (SNPs) associated with AR or allergic sensitization (AS) in Europeans and North Americans.", {"entities": []}], ["Two follow up studies in Swedish and Chinese replicated 15 associations.", {"entities": []}], ["In these studies individuals were selected based on the self-reported AR, or AR/AS diagnosed using blood IgE test or skin prick test (SPT), which were performed often without restriction to specific allergens.", {"entities": []}], ["Here we performed third replication study in Lithuanians.", {"entities": []}], ["We used SPT and carefully selected set of allergens prevalent in Lithuania, as well as Illumina Core Exome chip for SNP detection.", {"entities": []}], ["We genotyped 270 SPT-positive individuals (137 Betulaceae -, 174 Poaceae -, 199 Artemisia -, 70 Helianthus -, 22 Alternaria- , 22 Cladosporium- , 140 mites-, 95 cat- and 97 dog dander-sensitive cases) and 162 SPT-negative controls.", {"entities": []}], ["We found altogether 13 known SNPs associated with AS ( p \u22640.05).", {"entities": []}], ["Three SNPs were found in Lithuanians sensitive to several allergens, and 10 SNPs were found in Lithuanians sensitive to a certain allergen.", {"entities": []}], ["For the first time, SNP rs7775228:C was associated with patient sensitivity to dog allergens (F_A=0,269, F_U=0.180, P=0.008).", {"entities": []}], ["Thus, careful assessment of AS allowed us to detect known genetic variants associated with AS/AR in relatively small cohort of Lithuanians.", {"entities": []}], ["Staphylococcus aureus is an opportunistic pathogen and variable component of the human microbiota.", {"entities": []}], ["A\u00a0characteristic of atopic eczema (AE) is colonization by S.\u00a0aureus , with exacerbations associated with an increased bacterial burden of the organism.", {"entities": []}], ["Despite this, the origins and genetic diversity of S.\u00a0aureus colonizing individual patients during AE disease flares is poorly understood.", {"entities": []}], ["To examine the microevolution of S.\u00a0aureus colonization, we deep sequenced S.\u00a0aureus populations from nine children with moderate to severe AE and 18 non-atopic children asymptomatically carrying S.\u00a0aureus nasally.", {"entities": []}], ["Colonization by clonal S.\u00a0aureus populations was observed in both AE patients and control participants, with all but one of the individuals carrying colonies belonging to a single sequence type.", {"entities": []}], ["Phylogenetic analysis showed that disease flares were associated with the clonal expansion of the S.\u00a0aureus population, occurring over a period of weeks to months.", {"entities": []}], ["There was a significant difference in the genetic backgrounds of S.\u00a0aureus colonizing AE cases versus controls (Fisher exact test, P \u00a0= 0.03).", {"entities": []}], ["Examination of intra-host genetic heterogeneity of the colonizing S.\u00a0aureus populations identified evidence of within-host selection in the AE patients, with AE variants being potentially selectively advantageous for intracellular persistence and treatment resistance.", {"entities": []}], ["Statistics is relevant to students and practitioners in medicine and health sciences and is increasingly taught as part of the medical curriculum.", {"entities": []}], ["However, it is common for students to dislike and under-perform in statistics.", {"entities": []}], ["We sought to address these issues by redesigning the way that statistics is taught.", {"entities": []}], ["The project brought together a statistician, clinician and educational experts to re-conceptualize the syllabus, and focused on developing different methods of delivery.", {"entities": []}], ["New teaching materials, including videos, animations and contextualized workbooks were designed and produced, placing greater emphasis on applying statistics and interpreting data.", {"entities": []}], ["Two cohorts of students were evaluated, one with old style and one with new style teaching.", {"entities": []}], ["Both were similar with respect to age, gender and previous level of statistics.", {"entities": []}], ["Students who were taught using the new approach could better define the key concepts of p-value and confidence interval (p < 0.001 for both).", {"entities": []}], ["They were more likely to regard statistics as integral to medical practice (p = 0.03), and to expect to use it in their medical career (p = 0.003).", {"entities": []}], ["There was no significant difference in the numbers who thought that statistics was essential to understand the literature (p = 0.28) and those who felt comfortable with the basics of statistics (p = 0.06).", {"entities": []}], ["More than half the students in both cohorts felt that they were comfortable with the basics of medical statistics.", {"entities": []}], ["Using a variety of media, and placing emphasis on interpretation can help make teaching, learning and understanding of statistics more people-centred and relevant, resulting in better outcomes for students.", {"entities": []}], ["Chronic mucus hypersecretion (CMH) is associated with an increased frequency of respiratory infections, excess lung function decline, and increased hospitalisation and mortality rates in the general population.", {"entities": []}], ["It is associated with smoking, but it is unknown why only a minority of smokers develops CMH.", {"entities": []}], ["A plausible explanation for this phenomenon is a predisposing genetic constitution.", {"entities": []}], ["Therefore, we performed a genome wide association (GWA) study of CMH in Caucasian populations.", {"entities": []}], ["GWA analysis was performed in the NELSON-study using the Illumina 610 array, followed by replication and meta-analysis in 11 additional cohorts.", {"entities": []}], ["In total 2,704 subjects with, and 7,624 subjects without CMH were included, all current or former heavy smokers (\u226520 pack-years).", {"entities": []}], ["Additional studies were performed to test the functional relevance of the most significant single nucleotide polymorphism (SNP).", {"entities": []}], ["A strong association with CMH, consistent across all cohorts, was observed with rs6577641 (p\u200a=\u200a4.25\u00d710 special AT-rich sequence-binding protein 1 locus ( SATB1 ) on chromosome 3.", {"entities": [[154, 159, "GENE"]]}], ["The risk allele (G) was associated with higher mRNA expression of SATB1 (4.3\u00d710 SATB1 mRNA expression in bronchial biopsies from COPD patients.", {"entities": [[66, 71, "GENE"], [80, 85, "GENE"], [66, 71, "GENE"], [80, 85, "GENE"]]}], ["SATB1 expression was induced during differentiation of primary human bronchial epithelial cells in culture.", {"entities": [[0, 5, "GENE"]]}], ["Our findings, that SNP rs6577641 is associated with CMH in multiple cohorts and is a cis -eQTL for SATB1 , together with our additional observation that SATB1 expression increases during epithelial differentiation provide suggestive evidence that SATB1 is a gene that affects CMH.", {"entities": [[99, 104, "GENE"], [153, 158, "GENE"], [247, 252, "GENE"], [99, 104, "GENE"], [153, 158, "GENE"], [247, 252, "GENE"], [99, 104, "GENE"], [153, 158, "GENE"], [247, 252, "GENE"]]}], ["The lymphatic system is essential for the maintenance of tissue homeostasis and immunity.", {"entities": []}], ["Its dysfunction in disease (such as lymphangioleiomyomatosis) can lead to chylous effusions, oedema or dissemination of malignant cells.", {"entities": [[36, 60, "DISEASE"]]}], ["Collagen IV has six \u03b1 chains, of which some of the non-collagenous-1 domains have endogenous anti-angiogenic properties, however, little is known about specific endogenous anti-lymphangiogenic characteristics.", {"entities": []}], ["In this study we sought to investigate the expression levels of collagen IV non-collagenous-1 domains in lung tissue of patients with and without lymphangioleiomyomatosis to explore the hypothesis that a member of the collagen IV family, specifically the non-collagenous domain-1 of \u03b15, which we named lamstatin, has anti-lymphangiogenic properties.", {"entities": [[146, 170, "DISEASE"]]}], ["Levels of lamstatin detected by immunohistochemistry were decreased in lungs of lymphangioleiomyomatosis patients.", {"entities": [[80, 104, "DISEASE"]]}], ["We produced recombinant lamstatin in an E.coli expression system and synthesized a 17-amino acid peptide from a theoretically identified, active region (CP17) and tested their effects in vitro and in vivo .", {"entities": []}], ["Recombinant lamstatin and CP17 inhibited proliferation, migration and cord formation of human microvascular lung lymphatic endothelial cells, in vitro .", {"entities": []}], ["Furthermore, lamstatin and CP17 decreased complexity and dysplasia of the tumour-associated lymphatic network in a lung adenocarcinoma xenograft mouse model.", {"entities": [[120, 134, "DISEASE"], [115, 134, "DISEASE"]]}], ["In this study we identified a novel, direct inhibitor of lymphangiogenesis, derived from collagen IV.", {"entities": []}], ["This may prove useful for exploring new avenues of treatment for lymphangioleiomyomatosis and metastasis via the lymphatic system in general.", {"entities": [[65, 89, "DISEASE"]]}], ["Current allergen-specific immunotherapy (AIT) for pollinosis requires long-term treatment with potentially severe side effects.", {"entities": []}], ["Therefore, development of an AIT that is safe and more convenient with a shorter regimen is needed.", {"entities": []}], ["This prospective, double-blind, placebo-controlled trial randomized 55 participants with Japanese cedar pollinosis (JCP) to active or placebo groups to test the safety and efficacy of short-term oral immunotherapy (OIT) with Cry j 1-galactomannan conjugate for JCP.", {"entities": []}], ["Mean symptom-medication score as the primary outcome in the active group improved 27.8% relative to the placebo group during the entire pollen season.", {"entities": []}], ["As the secondary outcomes, mean medication score in active group improved significantly, by 56.2%, compared with placebo during the entire pollen season.", {"entities": []}], ["Mean total symptom score was similar between active and placebo groups during the entire pollen season.", {"entities": []}], ["There were no severe treatment-emergent adverse events in the active and placebo groups.", {"entities": []}], ["Therefore short-term OIT with Cry j 1-galactomannan conjugate is safe, and effective for reducing the amount of medication use for JCP.", {"entities": []}], ["Peroxisome proliferator-activated receptor gamma (PPAR \u03b3), is important in the immunoregulation of the allergic response.", {"entities": []}], ["Mast cells are the most important inflammatory cells in immediate hypersensitivity and allergic diseases.", {"entities": []}], ["However, there is limited information regarding the effects of PPAR \u03b3 on mast cell maturation.", {"entities": []}], ["In the present study, mouse bone marrow-derived mast cells (BMMCs) were cultured in interleukin (IL)-3 and stem cell factor (SCF), in the presence or absence of the PPAR \u03b3 agonist, pioglitazone (PIO).", {"entities": []}], ["The expression levels of the tyrosine kinase receptor CD117 and the high affinity IgE receptor Fc\u03b5RI \u03b1, were assessed by flow cytometry, cell viability was assessed by Alamar-Blue assay and histamine release was determined by measuring the activity of \u03b2-hexosaminidase.", {"entities": []}], ["IL-3 and SCF are required for the development of mast cells in vitro .", {"entities": []}], ["PIO dose-dependently inhibited the expression of CD117 and Fc\u03b5RI \u03b1, and the maturation of BMMCs.", {"entities": []}], ["Treatment with PIO additionally inhibited the formation of granules and reduced the expression of \u03b2-hexosaminidase.", {"entities": []}], ["In addition, reverse transcription-polymerase chain reaction analysis revealed that BMMCs treated with PIO expressed a lower level of mast cell protease (MCP)-6 mRNA and PIO treatment enhanced the level of PPAR \u03b3 mRNA.", {"entities": []}], ["Furthermore, PIO induced mast cell progenitor apoptosis.", {"entities": []}], ["PPAR \u03b3 agonists may maintain mast cell homeostasis by inhibiting maturation of their precursors.", {"entities": []}], ["The inhibitory effects of PPAR \u03b3 agonists include suppression of the activation of mast cells and a decrease in mast cell function in the inflammatory response.", {"entities": []}], ["Therefore, PPAR \u03b3 agonists may serve as effective anti-inflammatory reagents in the treatment of allergic reactions.", {"entities": []}], ["Several studies suggest that dietary habits are associated with poor academic performance.", {"entities": []}], ["However, few studies have evaluated these relations after adjusting for numerous confounding factors.", {"entities": []}], ["This study evaluated the frequency of various diet items (fruit, soft drinks, fast foods, instant noodles, confections, vegetables, and milk) and the regularity of meal times (breakfast, lunch, and dinner) all at once.", {"entities": []}], ["A total of 359,264 participants aged from 12 to 18 years old were pooled from the Korea Youth Risk Behavior Web-based Survey (KYRBWS) for the 2009 to 2013 period.", {"entities": []}], ["Dietary habits over the last 7 days were surveyed, including the regularity of consuming breakfast, lunch and dinner and the frequency of eating fruits, soft drinks, fast foods, instant noodles, confections, vegetables, and milk.", {"entities": []}], ["Physical activity, obesity, region of residence, subjective assessment of health, stress level, economic level, and parental education level were collected from all of the study participants.", {"entities": [[19, 26, "DISEASE"]]}], ["School performance was classified into 5 levels.", {"entities": []}], ["The adjusted odds ratios (AORs) of dietary habits for school performance were analyzed using multinomial logistic regression analyses with complex sampling.", {"entities": []}], ["Structural equation modeling was used to analyze the effects of diet factors on school performance while considering the effects of other variables on both diet factors and school performance.", {"entities": []}], ["Frequent intakes of breakfast (AOR\u200a=\u200a2.34, 95% confidence interval [CI]\u200a=\u200a2.20\u20132.48), fruits (AOR\u200a=\u200a1.73, 95% CI\u200a=\u200a1.62\u20131.86), vegetables (AOR\u200a=\u200a1.48, 95% CI\u200a=\u200a1.37\u20131.61), and milk (AOR\u200a=\u200a1.35, 95% CI\u200a=\u200a1.28\u20131.43) were related to high levels of school performance (each with P \u200a<\u200a0.001).", {"entities": []}], ["In contrast, soft drinks (AOR\u200a=\u200a0.42, 95% CI\u200a=\u200a0.38\u20130.46), instant noodles (AOR\u200a=\u200a0.62, 95% CI\u200a=\u200a0.55\u20130.70), fast food (AOR\u200a=\u200a0.83, 95% CI\u200a=\u200a0.72\u20130.96), and confectionary (AOR\u200a=\u200a0.86, 95% CI\u200a=\u200a0.80\u20130.93) were negatively associated with school performance (each with P \u200a<\u200a0.001).", {"entities": []}], ["This study confirms previous studies of school performance and dietary habits that find a positive association with eating breakfast and consuming fruits and milk and a negative relation with soft drinks, instant noodles, fast foods, and confections.", {"entities": []}], ["In adults, overweight is associated with reduced lung function, in children evidence on this association is conflicting.", {"entities": []}], ["We examined the association of body mass index (BMI) and waist circumference (WC) at age 12, and of persistently (at ages 8 and 12\u00a0years) high BMI and large WC, with forced vital capacity (FVC) and forced expiratory volume in 1\u00a0second (FEV 1 ) at age 12.", {"entities": [[236, 239, "GENE"]]}], ["Height, weight, WC and FVC and FEV 1 were measured during a medical examination in 1288 12-year-olds participating in the PIAMA birth cohort study.", {"entities": [[31, 34, "GENE"]]}], ["1090 children also had BMI and WC measured at age 8.", {"entities": []}], ["The associations between BMI and WC and FVC, FEV 1 , and FEV 1 /FVC ratio were studied using local and linear regression analyses, separately for girls and boys.", {"entities": [[45, 48, "GENE"], [57, 60, "GENE"], [45, 48, "GENE"], [57, 60, "GENE"]]}], ["The regression models were adjusted for age, height, and pubertal development and maternal educational level.", {"entities": []}], ["High BMI and large WC (sd-score >90th percentile) were associated with higher FVC; in girls these associations were statistically significant (4.6% (95% CI: 1.5, 7.9) and 3.6% (95% CI: 0.6, 6.8) respectively in adjusted models).", {"entities": []}], ["Similar associations were observed for persistently high BMI or large WC: girls with a high BMI or large WC at both 8 and 12\u00a0years had statistically significantly higher FVC at age 12\u00a0years (BMI: 4.9% (95% CI 0.9, 9.1), WC: 5.0% (95% CI 0.7, 9.6)) than girls with normal BMI or WC at both ages.", {"entities": []}], ["No statistically significant associations were observed between (persistently) high BMI or large WC and FEV 1 .", {"entities": [[104, 107, "GENE"]]}], ["The FEV 1 /FVC ratio was statistically significantly lower in children with a high BMI or large WC than in children with a normal BMI or WC.", {"entities": [[4, 7, "GENE"]]}], ["Girls and boys with a persistently high BMI or large WC status had statistically significantly lower FEV 1 /FVC ratios.", {"entities": [[101, 104, "GENE"]]}], ["At 12\u00a0years of age, a persistently high BMI or large WC is not yet associated with lower FVC and FEV 1 , suggesting that this association, that is commonly observed in adults, develops at a later age.", {"entities": [[97, 100, "GENE"]]}], ["The online version of this article (doi:10.1186/s12890-015-0032-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Leukotrienes are pro-inflammatory mediators that are locally produced in coronary atherosclerotic plaques.", {"entities": []}], ["The response induced by cysteinyl leukotrienes (CysLT) in human coronary arteries may be altered under pathological conditions, such as atherosclerosis.", {"entities": [[136, 151, "DISEASE"]]}], ["The aim of the present study was to elucidate cysteinyl leukotriene signaling in vascular smooth muscle cells (SMCs) and the effects of inflammation on this process.", {"entities": []}], ["Immunohistochemical analysis of human carotid endarterectomy samples revealed that the CysLT 1 leukotriene receptor was expressed in areas that also stained positive for \u03b1-smooth muscle actin.", {"entities": []}], ["In human coronary artery smooth muscle cells, lipopolysaccharide significantly upregulated the CysLT 1 receptor and significantly enhanced the changes in intracellular calcium induced by leukotriene C 4 (LTC 4 ).", {"entities": []}], ["In these cells, the CysLT 1 receptor exhibited a perinuclear expression, and LTC 4 stimulation predominantly enhanced nuclear calcium increase, which was significantly inhibited by the CysLT 1 receptor antagonist MK-571.", {"entities": []}], ["Microarray analysis revealed, among a number of significantly upregulated genes after 24\u00a0h stimulation of human coronary artery smooth muscle cells with LTC 4 , a 5-fold increase in mRNA levels for plasminogen activator inhibitor (PAI)-2.", {"entities": []}], ["The LTC 4 -induced increase in PAI-2 expression was confirmed by real-time quantitative PCR and ELISA and was inhibited by the CysLT 1 receptor antagonist MK-571 and by calcium chelators.", {"entities": []}], ["In summary, pro-inflammatory stimulation of vascular SMCs upregulated a perinuclear CysLT 1 receptor expression coupled to nuclear calcium signaling and changes in gene expression, such as upregulation of PAI-2.", {"entities": []}], ["Taken together, these findings suggest a role of nuclear CysLT 1 receptor signaling in vascular SMCs inducing gene expression patterns associated with atherosclerosis.", {"entities": [[151, 166, "DISEASE"]]}], ["The online version of this article (doi:10.1007/s00109-012-0904-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The goal of this workshop is to develop a consensus within the biomaterials/bioengineering community for a research agenda focused on creating technologies that will address the current dental caries pandemic.", {"entities": [[186, 199, "DISEASE"]]}], ["The workshop will bring together expertise from academia, industry, and the NIH institutes in the areas of oral biofilm microbiology and innovative biomaterials.", {"entities": []}], ["The rationale for the workshop is that science and technology have not produced sufficient practical tools for public health practitioners and the private delivery system to address the pandemic in dental caries that exists for children and adults from families with low incomes and for numerous ethnic minority and racial groups.", {"entities": [[198, 211, "DISEASE"]]}], ["Moreover, it is unclear whether the barriers are remediable bioengineering and technical problems or fundamental science questions.", {"entities": []}], ["Nevertheless, the obligation to address the gap between scientific research and practical application is especially relevant today.", {"entities": []}], ["The U.S. and state governments bear the majority of the cost of trying to control this pandemic through Medicaid, the Public Health Service, Indian Health Service and other similar programs.", {"entities": []}], ["These costs continue to escalate as continued applications of existing technology are unlikely to markedly reduce disparities.", {"entities": []}], ["The mainstays of caries prevention, topical and systemic fluorides and pit and fissure sealants, are technologies developed in the 1950s and 1960s.", {"entities": []}], ["The aim of the study was to determine the economical impact of juvenile idiopathic arthritis (JIA) and familial Mediterranean fever (FMF) in Turkey.", {"entities": [[83, 92, "DISEASE"]]}], ["A total of 100 patients (69 F/31 M) with JIA and 100 with FMF (68 F/32 F) who were consecutively seen in the outpatient clinic of the pediatric rheumatology department at Cerrahpasa Medical School between August 2008 and January 2009 were studied.", {"entities": []}], ["Cost data were collected through a questionnaire filled out by the parents.", {"entities": []}], ["The mean age (JIA: 11\u00a0\u00b1\u00a05\u00a0years; FMF:12\u00a0\u00b1\u00a04\u00a0years) and mean disease duration (JIA:5\u00a0\u00b1\u00a03\u00a0years; FMF: 4\u00a0\u00b1\u00a03\u00a0years) of the patients were similar.", {"entities": []}], ["JIA patients were assigned to 5 subtypes (polyarticular: n \u00a0=\u00a045, oligoarticular: n \u00a0=\u00a030, systemic onset: n \u00a0=\u00a013, psoriatic: n \u00a0=\u00a06, and enthesopathy-related JIA: n \u00a0=\u00a06).", {"entities": [[139, 151, "DISEASE"]]}], ["Forty-nine percent of the patients with JIA were treated with anti-TNF drugs and 61% with DMARDs.", {"entities": []}], ["All patients with FMF were using colchicine.", {"entities": []}], ["The total annual cost of JIA (\u20ac3,994\u00a0\u00b1\u00a04,101) was considerably higher than that of FMF (\u20ac162\u00a0\u00b1\u00a077) ( P \u00a0<\u00a00.001).", {"entities": []}], ["Medication fee was the major determinant of total costs in both diseases constituting 85% in JIA and 39% in FMF.", {"entities": []}], ["Among the subtypes of JIA, total annual costs were the highest among patients with polyarticular type (\u20ac6,045\u00a0\u00b1\u00a04,078).", {"entities": []}], ["Medications especially anti-TNF drugs were the major contributor among all determinants of costs in JIA.", {"entities": []}], ["The low costs of health care system and prominent changes in the health care policies for the last 5\u00a0years in Turkey might have played role in our findings.", {"entities": []}], ["Previous studies of immunoglobulin gene sequences in patients with allergic diseases using low-throughput Sanger sequencing have limited the analytic depth for characterization of IgE repertoires.", {"entities": []}], ["We used a high-throughput, next-generation sequencing approach to characterize immunoglobulin heavy-chain gene (IGH) repertoires in patients with seasonal allergic rhinitis (AR) with the aim of better understanding the underlying disease mechanisms.", {"entities": [[155, 172, "DISEASE"], [164, 172, "DISEASE"]]}], ["IGH sequences in matched peripheral blood and nasal\u00a0biopsy specimens from nonallergic healthy control subjects (n\u00a0= 3) and patients with grass pollen\u2013related AR taken in season (n\u00a0= 3) or out of season (n\u00a0= 4) were amplified and pyrosequenced on the 454 GS FLX+ System.", {"entities": []}], ["A total of 97,610 IGH (including 8,135 IgE) sequences were analyzed.", {"entities": []}], ["Use of immunoglobulin heavy-chain variable region gene families 1 (IGHV1) and 5 (IGHV5) was higher in IgE clonotypic repertoires compared with other antibody classes independent of atopic status.", {"entities": []}], ["IgE repertoires measured inside the grass pollen season were more diverse and more mutated (particularly in the biopsy specimens) and had more evidence of antigen-driven selection compared with those taken outside of the pollen season or from healthy control subjects.", {"entities": []}], ["Clonal relatedness was observed for IgE between the blood and nasal biopsy specimens.", {"entities": []}], ["Furthermore in patients with AR, but not healthy control subjects, we found clonal relatedness between IgE and IgG classes.", {"entities": []}], ["This is the first report that exploits next-generation sequencing to determine local and peripheral blood IGH repertoires in patients with respiratory allergic disease.", {"entities": []}], ["We demonstrate that natural pollen exposure was associated with changes in IgE repertoires that were suggestive of ongoing germinal center reactions.", {"entities": []}], ["Furthermore, these changes were more often apparent in nasal biopsy specimens compared with\u00a0peripheral blood and in patients with AR compared with\u00a0healthy control subjects.", {"entities": []}], ["The ability to conduct community-level asthma surveillance is increasingly crucial for public health programming and child health advocacy.", {"entities": [[39, 45, "DISEASE"]]}], ["We explored the potential and limitations of health care use records from both public and private sources for asthma surveillance in a California county.", {"entities": [[110, 116, "DISEASE"]]}], ["We combined administrative patient record data from Kaiser Permanente of Northern California and Medi-Cal (the California Medicaid program) for Alameda County residents during 2001.", {"entities": []}], ["We assessed the resulting data set for completeness, population representation, consistency with external data, and internal indicator consistency.", {"entities": []}], ["Our resulting data set included records for 226,383 children younger than 18 years.", {"entities": []}], ["Completeness of Medicaid data was affected by managed care market share, reducing our usable data set size to 176,789, approximately equal to one of every two children in the county or one of every 3 person-months.", {"entities": []}], ["External data documenting hospitalization rates due to asthma were poorly correlated with hospitalization rates ( r = 0.2120, P = .20) but highly correlated with emergency department visits ( r = 0.8607, P <.001) in the resulting data set.", {"entities": [[55, 61, "DISEASE"]]}], ["High internal consistency of indicators suggested that the data set represented a broad spectrum of health care access and quality of care congruent with clinical aspects of the disease.", {"entities": []}], ["The utility of these data is affected by logistical and administrative factors, including the health care payment structure and the market shares of care providers.", {"entities": []}], ["These factors can be expected to similarly affect the utility of this approach in other counties.", {"entities": []}], ["Our ability to generate county-level health statistics for comparison with other locations was limited, although the data set appeared well suited for within-county geographic analysis.", {"entities": []}], ["In light of these findings, these data have the potential to expand the local health surveillance capacity of communities.", {"entities": []}], ["Interactions between bone marrow stromal cells (BMSCs) and multiple myeloma cells significantly contribute to the progression of multiple myeloma (MM).", {"entities": [[68, 75, "DISEASE"], [138, 145, "DISEASE"], [59, 75, "DISEASE"], [129, 145, "DISEASE"]]}], ["However, little is known about the molecular mechanisms that regulate these interactions.", {"entities": []}], ["Connexin-43 (Cx-43) has been implicated in the interplay between BMSCs and MM cells.", {"entities": []}], ["In this study, we hypothesized that the steroid receptor co-activator-3 (SRC3) expressed in BMSCs regulates the expression of Cx-43 to promote the proliferation and migration of myeloma cells.", {"entities": [[178, 185, "DISEASE"]]}], ["To address this, we co-cultured a human multiple myeloma cell line, RPMI-8226 transfected with either control BMSCs or sh-SRC3-BMSCs.", {"entities": [[49, 56, "DISEASE"], [40, 56, "DISEASE"]]}], ["We found that knocking down SRC3 expression in BMSCs inhibited the proliferation and migration of RPMI-8226 cells.", {"entities": []}], ["In addition, we found that co-culturing RPMI 8266 cells with BMSCs increased Cx43 expression, while knocking down SRC3 expression in BMSCs decreased Cx43 expression.", {"entities": []}], ["Moreover, our work revealed that SRC3 in BMSCs regulates Cx43 expression via the mitogen-activated protein kinase (MAPK) pathway.", {"entities": []}], ["To validate this result in vivo , we knocked down SRC3 expression in BMSCs in nude mice and found that tumor growth and cell apoptosis were significantly decreased.", {"entities": []}], ["In addition, mice treated with either RPMI 8266 cells overexpressing Cx43 or with a P38 MAPK inhibitor (SB202190) exhibited increased intratumoral leukocyte populations and promoted cell apoptosis in tumor tissue.", {"entities": []}], ["Our findings demonstrate how SRC3 and Cx43 regulation between BMSCs and myeloma cells mediate cell growth and disease progression, with potential implications for prognosis and therapeutic interventions.", {"entities": [[72, 79, "DISEASE"]]}], ["Previous studies have reported conflicting results on the association between Helicobacter pylori infection and osteoporosis.", {"entities": [[112, 124, "DISEASE"]]}], ["A few studies have discussed the influence of H .", {"entities": []}], ["pylori eradication therapy on bone mineral density.", {"entities": []}], ["We assessed the prevalence of osteoporosis among the H .", {"entities": [[30, 42, "DISEASE"]]}], ["pylori -infected population in Taiwan and the influence of early and late H .", {"entities": []}], ["pylori eradication therapy on bone mineral density.", {"entities": []}], ["Using data from Taiwan's National Health Insurance Research Database, we identified 5,447 patients who received H .", {"entities": []}], ["pylori eradication therapy from 2000 to 2010 and 21,788 controls, frequency-matched according to age, sex, and year of receiving H .", {"entities": []}], ["pylori eradication therapy.", {"entities": []}], ["Those who received H .", {"entities": []}], ["pylori eradication therapy were divided into two groups based on the time interval between the diagnosis of a peptic ulcer and commencement of eradication therapy.", {"entities": [[110, 122, "DISEASE"]]}], ["The risk of developing osteoporosis was higher in the early H .", {"entities": [[23, 35, "DISEASE"]]}], ["pylori treatment cohort (hazard ratio [HR] = 1.52, 95% confidence interval [CI] = 1.23\u20131.89) and late H .", {"entities": [[39, 41, "GENE"]]}], ["pylori treatment cohort (HR = 1.69, 95% CI = 1.39\u20132.05), compared with the risk in the control cohort.", {"entities": [[25, 27, "GENE"]]}], ["When followed for less than 5 years, both the early and late cohorts had a higher risk of developing osteoporosis (HR = 1.69, 95% CI = 1.32\u20132.16 and HR = 1.72, 95% CI = 1.38\u20132.14).", {"entities": [[101, 113, "DISEASE"], [115, 117, "GENE"], [149, 151, "GENE"], [115, 117, "GENE"], [149, 151, "GENE"]]}], ["However, when the follow-up period was over 5 years, only the late eradication group exhibited a higher incidence of osteoporosis (HR = 1.62, 95% CI = 1.06\u20132.47).", {"entities": [[117, 129, "DISEASE"], [131, 133, "GENE"]]}], ["The development of osteoporosis is complex and multi-factorial.", {"entities": [[19, 31, "DISEASE"]]}], ["Via this population-based cohort study and adjustment of possible confounding variables, we found H .", {"entities": []}], ["pylori infection may be associated with an increased risk of developing osteoporosis in Taiwan.", {"entities": [[72, 84, "DISEASE"]]}], ["Early eradication could reduce the influence of H .", {"entities": []}], ["pylori infection on osteoporosis when the follow-up period is greater than 5 years.", {"entities": [[20, 32, "DISEASE"]]}], ["Further prospective studies are necessary to discover the connection of H .", {"entities": []}], ["pylori and osteoporosis.", {"entities": [[11, 23, "DISEASE"]]}], ["Agent Orange is a phenoxy herbicide that was contaminated with 2,3,7,8-tetrachlorodibenzo- p -dioxin (TCDD).", {"entities": []}], ["We studied pregnancy outcomes among wives of male chemical workers who were highly exposed to chemicals contaminated with TCDD and among wives of nonexposed neighborhood referents.", {"entities": []}], ["For exposed pregnancies, we estimated serum TCDD concentration at the time of conception using a pharmacokinetic model.", {"entities": []}], ["The mean TCDD concentration for workers\u2019 births was 254 pg/g lipid (range, 3\u201316,340 pg/g).", {"entities": []}], ["The mean referent concentration of 6 pg/g was assigned to pregnancies fathered by workers before exposure.", {"entities": []}], ["A total of 1,117 live singleton births of 217 referent wives and 176 worker wives were included.", {"entities": []}], ["Only full-term births were included in the birth weight analysis (\u226537 weeks of gestation).", {"entities": []}], ["Mean birth weight among full-term babies was similar among referents\u2019 babies ( n = 604), preexposure workers\u2019 babies ( n = 221), and exposed workers\u2019 babies ( n = 292) (3,420, 3,347, and 3,442 g, respectively).", {"entities": []}], ["Neither continuous nor categorical TCDD concentration had an effect on birth weight for term infants after adjustment for infant sex, mother\u2019s education, parity, prenatal cigarette smoking, and gestation length.", {"entities": []}], ["An analysis to estimate potential direct exposure of the wives during periods of workers\u2019 exposure yielded a nonstatistically significant increase in infant birth weight of 130 g in the highest exposure group (TCDD concentration > 254 pg/g) compared with referents ( p = 0.09).", {"entities": []}], ["Mothers\u2019 reports of preterm delivery showed a somewhat protective association with paternal TCDD (log) concentration (odds ratio = 0.8; 95% confidence interval, 0.6\u20131.1).", {"entities": []}], ["We also include descriptive information on reported birth defects.", {"entities": []}], ["Because the estimated TCDD concentrations in this population were much higher than in other studies, the results indicate that TCDD is unlikely to increase the risk of low birth weight or preterm delivery through a paternal mechanism.", {"entities": []}], ["Reviews have repeatedly noted important methodological issues in the conduct and reporting of cluster randomized controlled trials (C-RCTs).", {"entities": []}], ["These reviews usually focus on whether the intracluster correlation was explicitly considered in the design and analysis of the C-RCT.", {"entities": []}], ["However, another important aspect requiring special attention in C-RCTs is the risk for imbalance of covariates at baseline.", {"entities": []}], ["Imbalance of important covariates at baseline decreases statistical power and precision of the results.", {"entities": []}], ["Imbalance also reduces face validity and credibility of the trial results.", {"entities": []}], ["The risk of imbalance is elevated in C-RCTs compared to trials randomizing individuals because of the difficulties in recruiting clusters and the nested nature of correlated patient-level data.", {"entities": []}], ["A variety of restricted randomization methods have been proposed as way to minimize risk of imbalance.", {"entities": []}], ["However, there is little guidance regarding how to best restrict randomization for any given C-RCT.", {"entities": []}], ["The advantages and limitations of different allocation techniques, including stratification, matching, minimization, and covariate-constrained randomization are reviewed as they pertain to C-RCTs to provide investigators with guidance for choosing the best allocation technique for their trial.", {"entities": []}], ["Cystic fibrosis (CF) is a life-shortening disease caused by mutations in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene in vivo , when removed from the lung, and in primary epithelial cultures.", {"entities": [[0, 15, "DISEASE"], [77, 92, "DISEASE"], [131, 135, "GENE"]]}], ["Lack of CFTR reduced bacterial killing.", {"entities": [[8, 12, "GENE"]]}], ["We found that ASL pH was more acidic in CF, and reducing pH inhibited the antimicrobial activity of ASL.", {"entities": [[14, 17, "GENE"], [100, 103, "GENE"], [14, 17, "GENE"], [100, 103, "GENE"]]}], ["Reducing ASL pH diminished bacterial killing in wild-type pigs, and increasing ASL pH rescued killing in CF pigs.", {"entities": [[9, 12, "GENE"], [79, 82, "GENE"], [9, 12, "GENE"], [79, 82, "GENE"]]}], ["These results directly link the initial host defense defect to loss of CFTR, an anion channel that facilitates HCO 3 3", {"entities": [[71, 75, "GENE"]]}], ["Ursolic acid (UA), a pentacyclic triterpenoid carboxylic acid, is the major component of many plants including apples, basil, cranberries, peppermint, rosemary, oregano and prunes and has been reported to possess antioxidant and anti-tumor properties.", {"entities": []}], ["These properties of UA have been attributed to its ability to suppress NF-\u03baB (nuclear factor kappa B) activation.", {"entities": []}], ["Since NF-\u03baB, in co-ordination with NF-AT (nuclear factor of activated T cells) and AP-1(activator protein-1), is known to regulate inflammatory genes, we hypothesized that UA might exhibit potent anti-inflammatory effects.", {"entities": []}], ["The anti-inflammatory effects of UA were assessed in activated T cells, B cells and macrophages.", {"entities": []}], ["Effects of UA on ERK, JNK, NF-\u03baB, AP-1 and NF-AT were studied to elucidate its mechanism of action.", {"entities": []}], ["In vivo efficacy of UA was studied using mouse model of graft-versus-host disease.", {"entities": []}], ["UA inhibited activation, proliferation and cytokine secretion in T cells, B cells and macrophages.", {"entities": []}], ["UA inhibited mitogen-induced up-regulation of activation markers and co-stimulatory molecules in T and B cells.", {"entities": []}], ["It inhibited mitogen-induced phosphorylation of ERK and JNK and suppressed the activation of immunoregulatory transcription factors NF-\u03baB, NF-AT and AP-1 in lymphocytes.", {"entities": []}], ["Treatment of cells with UA prior to allogenic transplantation significantly delayed induction of acute graft-versus-host disease in mice and also significantly reduced the serum levels of pro-inflammatory cytokines IL-6 and IFN-\u03b3.", {"entities": []}], ["UA treatment inhibited T cell activation even when added post-mitogenic stimulation demonstrating its therapeutic utility as an anti-inflammatory agent.", {"entities": []}], ["The present study describes the detailed mechanism of anti-inflammatory activity of UA.", {"entities": []}], ["Further, UA may find application in the treatment of inflammatory disorders.", {"entities": []}], ["Occupational quartz exposure continues to be a serious hazard in the construction industry.", {"entities": []}], ["Until now, evidence-based interventions aimed at reducing quartz exposure are scarce.", {"entities": []}], ["The aim of this study was to systematically develop an intervention and to describe the study to evaluate its effectiveness.", {"entities": []}], ["The intervention was developed according to the principles of the Intervention Mapping protocol, meaning that evidence from the literature was combined with information collected from stakeholders (e.g., construction workers, managers and researchers).", {"entities": []}], ["The intervention aimed to integrate technical, behavioural and organizational factors.", {"entities": []}], ["The intervention consists of two plenary meetings for all employers within the company, and individual visits at construction worksites, including specific intervention materials.", {"entities": []}], ["Additionally, a demonstration session regarding control measures was organized for all managers.", {"entities": []}], ["The effectiveness of the intervention will be evaluated in a cluster randomized controlled trial among eight construction companies, with measurements at baseline and follow-up.", {"entities": []}], ["Outcome measures are personal respirable dust and quartz exposure by means of exposure assessment, and behavioural and organizational determinants which will be assessed by means of questionnaires.", {"entities": []}], ["Additionally, a process evaluation will shed light on whether the intervention (does not) works, and, if so, the reasons for this.", {"entities": []}], ["Applying Intervention Mapping in the development of an intervention to reduce occupational quartz exposure was useful, as different stakeholders provided input for the intervention as well as the implementation strategy.", {"entities": []}], ["Therefore, the feasibility of the intervention has been enhanced, as it appeals to construction workers and managers and will not unduly interfere with the ongoing construction work.", {"entities": []}], ["NTR4586 (May 7th 2014).", {"entities": []}], ["Many patients with pneumonia and lower respiratory tract infection that could be treated as outpatients according to their clinical severity score, are in fact admitted to hospital.", {"entities": [[19, 28, "DISEASE"]]}], ["We investigated whether, with medical and social input, these patients could be discharged early and treated at home.", {"entities": []}], ["Objectives : (1) To assess the feasibility of providing an early supported discharge scheme for patients with pneumonia and lower respiratory tract infection (2) To assess the patient acceptability of a study comprising of randomisation to standard hospital care or early supported discharge scheme.", {"entities": [[110, 119, "DISEASE"]]}], ["Design : Randomised controlled trial.", {"entities": []}], ["Setting : Liverpool, UK.", {"entities": []}], ["Two University Teaching hospitals; one city-centre, 1 suburban in Liverpool, a city with high deprivation scores and unemployment rates.", {"entities": []}], ["Participants : 200 patients screened: 14 community-dwelling patients requiring an acute hospital stay for pneumonia or lower respiratory tract infection were recruited.", {"entities": [[106, 115, "DISEASE"]]}], ["Intervention : Early supported discharge scheme to provide specialist respiratory care in a patient\u2019s own home as a substitute to acute hospital care.", {"entities": []}], ["Main outcome measures : Primary - patient acceptability.", {"entities": []}], ["Secondary \u2013 safety/mortality, length of hospital stay, readmission, patient/carer (or next of kin) satisfaction, functional status and symptom improvement.", {"entities": []}], ["42 of the 200 patients screened were eligible for early supported discharge; 10 were only identified at the point of discharge, 18 declined participation and 14 were randomised to either early supported discharge or standard hospital care.", {"entities": []}], ["The total hospital length of hospital stay was 8.33 (1\u201331) days in standard hospital care and 3.4 (1\u20137) days in the early supported discharge scheme arm.", {"entities": []}], ["In the early supported discharge scheme arm patient carers reported higher satisfaction with care and there were less readmissions and hospital-acquired infections.", {"entities": []}], ["Limitations : A small study in a single city.", {"entities": []}], ["This was a feasibility study and therefore not intended to compare outcome data.", {"entities": []}], ["An early supported discharge scheme for patients with pneumonia and lower respiratory tract infection was feasible.", {"entities": [[54, 63, "DISEASE"]]}], ["Larger numbers of patients would be eligible if future work included patients with dementia and those residing in care homes.", {"entities": [[83, 91, "DISEASE"]]}], ["ISRCTN25542492 .", {"entities": []}], ["Essential oils are often used in alternative medicine as analgesic and anti-inflammatory remedies.", {"entities": []}], ["However, the specific compounds that confer the effects of essential oils and the molecular mechanisms are largely unknown.", {"entities": []}], ["TRPM8 is a thermosensitive receptor that detects cool temperatures and menthol whereas TRPA1 is a sensor of noxious cold.", {"entities": [[0, 5, "GENE"], [87, 92, "GENE"]]}], ["Ideally, an effective analgesic compound would activate TRPM8 and inhibit TRPA1.", {"entities": [[56, 61, "GENE"], [74, 79, "GENE"]]}], ["We screened essential oils and fragrance chemicals showing a high ratio of human TRPM8-activating ability versus human TRPA1-activating ability using a Ca in vivo sensory irritation tests showed that 1,8-cineole conferred an analgesic effect on sensory irritation produced by TRPA1 agonists octanol and menthol.", {"entities": [[119, 124, "GENE"], [276, 281, "GENE"]]}], ["Surprisingly, 1,4-cineole, which is structurally similar and also present in eucalyptus oil, activated both human TRPM8 and human TRPA1.", {"entities": [[114, 119, "GENE"], [130, 135, "GENE"]]}], ["1,8-cineole is a rare natural antagonist of human TRPA1 that has analgesic and anti-inflammatory effects possibly due to its inhibition of TRPA1.", {"entities": [[50, 55, "GENE"], [139, 144, "GENE"], [50, 55, "GENE"], [139, 144, "GENE"]]}], ["The anti-inflammatory effects of the selective phosphodiesterase (PDE) inhibitors cilostazol (PDE 3), RO 20-1724 (PDE 4) and sildenafil (PDE 5) were examined in a murine model of allergic asthma.", {"entities": [[179, 194, "DISEASE"], [188, 194, "DISEASE"]]}], ["These compounds were used alone and in combination to determine any potential synergism, with dexamethasone included as a positive control.", {"entities": []}], ["Control and ovalbumin sensitised Balb/C mice were administered orally with each of the possible combinations of drugs at a dose of 3 mg/Kg for 10 days.", {"entities": []}], ["When used alone, RO 20-1724 significantly reduced eosinophil influx into lungs and lowered tumour necrosis factor-\u03b1, interleukin-4 and interleukin-5 levels in the bronchoalveolar lavage fluid when compared to untreated mice.", {"entities": []}], ["Treatment with cilostazol or sildenafil did not significantly inhibit any markers of inflammation measured.", {"entities": []}], ["Combining any of these PDE inhibitors produced no additive or synergistic effects.", {"entities": []}], ["Indeed, the anti-inflammatory effects of RO 20-1724 were attenuated by co-administration of either cilostazol or sildenafil.", {"entities": []}], ["These results suggest that concurrent treatment with a PDE 3 and/or PDE 5 inhibitor will reduce the anti-inflammatory effectiveness of a PDE 4 inhibitor.", {"entities": []}], ["Evidence is increasingly accumulated about multiple roles for the \u03b22-adrenoceptor gene in asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["The results were inconsistent partly due to small sample sizes.", {"entities": []}], ["To assess the association between \u03b22-adrenoceptor gene polymorphisms and asthma risk, a meta-analysis was performed.", {"entities": [[73, 79, "DISEASE"]]}], ["We comprehensively searched the PubMed, EMBASE, BIOSIS Previews databases and extracted data from all eligible articles to estimate the association between \u03b22-adrenoceptor gene polymorphisms and asthma risk.", {"entities": [[195, 201, "DISEASE"]]}], ["The pooled odds ratio (OR) with 95% confidence intervals (CIs) were calculated.", {"entities": []}], ["Thirty-seven studies involving 6648 asthma patients and 15943 controls were included in the meta-analysis.", {"entities": [[36, 42, "DISEASE"]]}], ["Overall, significant associations were found in allelic genetic model (OR\u200a=\u200a1.06, 95% CI\u200a=\u200a1.01\u223c1.12), recessive genetic model (OR\u200a=\u200a1.11, 95% CI\u200a=\u200a1.02\u223c1.21) for Arg/Gly16.", {"entities": []}], ["Stratified by ethnicity and age, significant associations were also found in Asian population in allelic genetic model, recessive genetic model and addictive model.", {"entities": []}], ["For Gln/Glu27, no significant association was found when we combined all eligible studies.", {"entities": []}], ["Age stratification showed significant associations in adults in allelic genetic model and recessive genetic model, but no significant association was found among Asians and Caucasians in ethnicity stratification.", {"entities": []}], ["This meta-analysis implied that the \u03b22-adrenoceptor Arg/Gly16 polymorphism was likely to contribute to asthma risk in Asian population.", {"entities": [[103, 109, "DISEASE"]]}], ["Gln/Glu27 polymorphism might be a contributor to asthma susceptibility for adults.", {"entities": [[49, 55, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a treatable and preventable disease state, characterised by progressive airflow limitation that is not fully reversible.", {"entities": []}], ["Although COPD is primarily a disease of the lungs there is now an appreciation that many of the manifestations of disease are outside the lung, leading to the notion that COPD is a systemic disease.", {"entities": []}], ["Currently, diagnosis of COPD relies on largely descriptive measures to enable classification, such as symptoms and lung function.", {"entities": []}], ["Here the limitations of existing diagnostic strategies of COPD are discussed and systems biology approaches to diagnosis that build upon current molecular knowledge of the disease are described.", {"entities": []}], ["These approaches rely on new 'label-free' sensing technologies, such as high-throughput surface plasmon resonance (SPR), that we also describe.", {"entities": [[115, 118, "GENE"]]}], ["We explored the differences in the perceived HRQoL between children with asthma from Moroccan and Dutch descent and their parents.", {"entities": [[73, 79, "DISEASE"]]}], ["In total 33 children (aged 6-18 years) from Moroccan (16) and Dutch descent (17) and their parents participated.", {"entities": []}], ["All children were currently under treatment in a general hospital in the Netherlands.", {"entities": []}], ["Generic and asthma specific HRQoL were assessed (DUX-25, DISABKIDS, PAQLQ).", {"entities": [[12, 18, "DISEASE"]]}], ["Significant differences were found on the DUX-25 subscales physical, emotional and home functioning.", {"entities": []}], ["Children and parents from Dutch descent reported a lower HRQoL.", {"entities": []}], ["The findings of this study are contrary with previous research.", {"entities": []}], ["Results can be explained by the individualistic-collectivistic dimension, socially desirability, language and the feeling of miscomprehension.", {"entities": []}], ["If this explanation makes sense health care workers have to invest in a good relationship with especially immigrant children and their parents, so they will have enough confidence to talk more openly about their physical as well as their psycho-social complaints.", {"entities": []}], ["Environmental pollutants, including endocrine disruptor chemicals (EDCs), interfere on human health, leading to hormonal, immune and metabolic perturbations.", {"entities": []}], ["Bisphenol-A (BPA), a main component of polycarbonate plastics, has been receiving increased attention due to its worldwide distribution with a large exposure.", {"entities": []}], ["In humans, BPA, for its estrogenic activity, may have a role in autoimmunity, inflammatory and allergic diseases.", {"entities": []}], ["To this aim, we assessed the effect of low BPA doses on functionality of human peripheral blood mononuclear cells (PBMCs), and on in vitro differentiation of dendritic cells from monocytes (mDCs).", {"entities": []}], ["Fresh peripheral blood samples were obtained from 12 healthy adult volunteers.", {"entities": []}], ["PBMCs were left unstimulated or were activated with the mitogen phytohemagglutinin (PHA) or the anti-CD3 and anti-CD28 antibodies and incubated in presence or absence of BPA at 0.1 and 1nM concentrations.", {"entities": []}], ["The immune-modulatory effect of BPA was assessed by evaluating the cell proliferation and the levels of interferon-\u03b3 (IFN-\u03b3), interleukin-4 (IL-4), interleukin-10 (IL-10) and interleukin-13 (IL-13) secreted by PBMCs.", {"entities": []}], ["mDCs were differentiated with IL-4 and GC-CSF with or without BPA and the expression of differentiation/maturation markers (CD11c, CD1a, CD86, HLA-DR) was evaluated by flow cytometry; furthermore, a panel of 27 different cytokines, growth factors and chemokines were assayed in the mDC culture supernatants.", {"entities": [[131, 135, "GENE"], [137, 141, "GENE"]]}], ["PBMCs proliferation significantly increased upon BPA exposure compared to BPA untreated cells.", {"entities": []}], ["In addition, a significant decrease in IL-10 secretion was observed in PBMCs incubated with BPA, either in unstimulated or mitogen-stimulated cells, and at both 0.1 and 1nM BPA concentrations.", {"entities": []}], ["Similarly, IL-13 was reduced, mainly in cells activated by antiCD3/CD28.", {"entities": []}], ["By contrast, no significant changes in IFN-\u03b3 and IL-4 production were found in any condition assayed.", {"entities": []}], ["Finally, BPA at 1nM increased the density of dendritic cells expressing CD1a and concomitantly decreased the expression of HLA-DR and CD86 activation markers.", {"entities": [[72, 76, "GENE"], [134, 138, "GENE"]]}], ["In conclusion, in humans the exposure to BPA causes on PBMCs a significant modulation of proliferative capacity and cytokine production, and on mDCs alteration in differentiation and phenotype.", {"entities": []}], ["These immune cell alterations suggest that low dose chronic exposure to BPA could be involved in immune deregulation and possibly in the increased susceptibility to develop inflammatory and autoimmune diseases.", {"entities": []}], ["Multifocal motor neuropathy (MMN) is a rare immune-mediated disorder and is characterized by male predominance, the presence of serum anti-GM1 IgM antibodies in up to half of all patients, responsiveness to intravenous immunoglobulins (IVIg) and an increased frequency of HLA type HLA-DRB1*15.", {"entities": [[17, 27, "DISEASE"], [272, 275, "GENE"], [281, 284, "GENE"]]}], ["The aim of this study was to assess whether the frequency of autoimmune diseases (AID) is increased in patients with MMN and their first-degree family members, since this would indicate that MMN shares pathogenic mechanisms with other AID.", {"entities": []}], ["We conducted a case\u2013control study using questionnaires to evaluate the prevalence of AID in MMN and controls, and their first-degree relatives.", {"entities": []}], ["Questionnaires from 81 MMN patients (417 first-degree relatives) and 438 controls (2,377 first-degree relatives) were analyzed.", {"entities": []}], ["Overall prevalence of AID was higher in MMN patients (11%) than in controls (5%) (OR 2.4, 95% CI 1.1\u20135.5, p \u00a0=\u00a00.037).", {"entities": []}], ["Type 1 diabetes, Hashimoto\u2019s thyroid disease, and celiac disease were significantly more prevalent in family members of patients than controls.", {"entities": [[50, 64, "DISEASE"]]}], ["The presence of an additional AID was not associated with age at MMN onset, disease duration, titer of serum anti-GM1 IgM antibodies or HLA type HLA-DRB1*15.", {"entities": [[136, 139, "GENE"], [145, 148, "GENE"]]}], ["The higher frequency of AID in patients with MMN indicates a common autoimmune diathesis.", {"entities": []}], ["As medical students enter the role of physician, clinical outcomes not only rely on their mastery of clinical knowledge, but also on the effectiveness in which they can communicate with patients and family members.", {"entities": []}], ["While students typically have numerous opportunities to practice clinical communication with adult patients, such practice in pediatric settings is limited.", {"entities": []}], ["This study examines if simulated patient (SP) encounters strengthen third-year medical students\u2019 communication skills during the pediatrics clerkship.", {"entities": []}], ["During 2011-2013, three SP encounters (comprising 3 pediatric scenarios) were incorporated into a pediatrics clerkship at one United States medical school to give students a safe venue to practice advanced communication with observation and direct feedback.", {"entities": []}], ["Third-year medical students engaged in the scenarios and received both written and oral feedback from an evaluator observing the encounter.", {"entities": []}], ["With IRB approval, students\u2019 self-perceived confidence and abilities at performing the advanced communication skills were measured using an eightitem, Likert scale questionnaire administered pre and post the SP encounter.", {"entities": []}], ["Pre- and post-questionnaires (n=215; response rate, 96%) analyzed using a Wilcoxon-matched pairs signed-rank test demonstrated statistically significant increases in students\u2019 perception of their confidence and abilities regarding their performance (P<0.05; Bonferroni correction, P<0.006).", {"entities": []}], ["There was an increases in student confidence and self-perceived ability in: first, communicating with children and family members of young patients; second, managing confrontational situations involving parents; third, performing a thorough psychosocial history with an adolescent; and fourth, using Evidence Based Medicine to motivate parents.", {"entities": []}], ["Mast cells play a key role in asthma and recent evidence indicates that their ongoing activation in this disease is mediated, in part, via IgE in the absence of antigen.", {"entities": [[30, 36, "DISEASE"]]}], ["In this study we have examined whether IgE alone enhances human lung mast cell (HLMC) survival.", {"entities": []}], ["Purified HLMC were cultured for 4 weeks and survival assays then performed over 10 days following cytokine withdrawal in the presence or absence of human myeloma IgE.", {"entities": [[154, 161, "DISEASE"]]}], ["Quantitative real time RT-PCR was carried out to examine IL-6 mRNA expression and IL-6 protein was measured in HLMC supernatants by ELISA.", {"entities": []}], ["IgE alone promoted the survival of HLMC in a dose-dependent manner following cytokine withdrawal.", {"entities": []}], ["IgE-induced survival was eliminated with the addition of neutralising anti-IL-6 antibody but not by the addition of neutralising anti-stem cell factor.", {"entities": []}], ["IgE sensitisation initiated profound upregulation of IL-6 mRNA in HLMC, and IL-6 concentrations were also raised in the culture supernatants of IgE-exposed cells.", {"entities": []}], ["These data taken together suggest that IgE in the absence of antigen promotes HLMC survival through the autocrine production of IL-6.", {"entities": []}], ["This provides a further mechanism through which IL-6 and IgE contribute to the pathogenesis of asthma, and through which anti-IgE therapy might achieve its therapeutic effect.", {"entities": [[95, 101, "DISEASE"]]}], ["The objective of this study was to determine the effect of feeding a maternal diet supplemented with docosahexaenoic acid (DHA) during the suckling period on the development of the immune system and oral tolerance (OT) in offspring.", {"entities": []}], ["Dams were randomized to consume one of two nutritionally adequate diets throughout the suckling period: control (N = 12, 0% DHA) or DHA (N = 8, 0.9% DHA) diet.", {"entities": []}], ["At 11 days, pups from each dam were randomly assigned to a mucosal OT challenge: the placebo or the ovalbumin (OVA) treatment.", {"entities": []}], ["At three weeks, plasma immunoglobulins and splenocyte cytokine production ex vivo were measured.", {"entities": []}], ["OVA-tolerized pups had a lower Th2 (IL-13) response to OVA despite the presence of more activated T cells and memory cells (CD27+, all p < 0.05).", {"entities": []}], ["Feeding a high DHA diet improved the ability of splenocytes to respond to mitogens toward a skewed Th1 response and led to a higher IL-10 and a lower TGF-\u03b2 production after stimulation with OVA (all p < 0.05).", {"entities": []}], ["Untolerized DHA-fed pups had lower plasma concentrations of OVA-specific immunoglobulin E ( p for interaction < 0.05).", {"entities": []}], ["Overall, feeding a high DHA maternal diet improves the tolerance response in untolerized suckled pups in a direction that is thought to be beneficial for the establishment of OT.", {"entities": []}], ["The biological mechanisms involved in inflammatory response to air pollution are not clearly understood.", {"entities": []}], ["In this study we assessed the association of short-term air pollutant exposure with inflammatory markers and lung function.", {"entities": []}], ["We studied a cohort of 158 asthmatic and 50 nonasthmatic school-age children, followed an average of 22 weeks.", {"entities": []}], ["We conducted spirometric tests, measurements of fractional exhaled nitric oxide (Fe NO ), interleukin-8 (IL-8) in nasal lavage, and pH of exhaled breath condensate every 15 days during follow-up.", {"entities": []}], ["Data were analyzed using linear mixed-effects models.", {"entities": []}], ["An increase of 17.5 \u03bcg/m 2.5 levels (interquartile range) was associated with a 1.08-ppb increase in Fe NO [95% confidence interval (CI), 1.01\u20131.16] and a 1.07-pg/mL increase in IL-8 (95% CI 0.98\u20131.19) in asthmatic children and a 1.16 pg/ml increase in IL-8 (95% CI, 1.00\u20131.36) in nonasthmatic children.", {"entities": []}], ["The 5-day accumulated average of exposure to particulate matter < 2.5 \u03bcm in aerodynamic diamter (PM 2.5 ) was significantly inversely associated with forced expiratory volume in 1 sec (FEV 1 ) ( p = 0.048) and forced vital capacity (FVC) ( p = 0.012) in asthmatic children and with FVC ( p = 0.021) in nonasthmatic children.", {"entities": [[185, 188, "GENE"]]}], ["Fe NO and FEV 1 were inversely associated ( p = 0.005) in asthmatic children.", {"entities": [[10, 13, "GENE"]]}], ["Exposure to PM 2.5 resulted in acute airway inflammation and decrease in lung function in both asthmatic and nonasthmatic children.", {"entities": []}], ["Glucocorticoids (GCs) are a first-line treatment for asthma for their anti-inflammatory effects, but they also hinder the repair of airway epithelial injury.", {"entities": [[53, 59, "DISEASE"]]}], ["The anti-inflammatory protein GC-induced leucine zipper (GILZ) is reported to inhibit the activation of the mitogen-activated protein kinase (MAPK)-extracellular-signal-regulated kinase (ERK) signaling pathway, which promotes the repair of airway epithelial cells around the damaged areas.", {"entities": []}], ["We investigated whether the inhibition of airway epithelial repair imposed by the GC dexamethasone (DEX) is mediated by GILZ.", {"entities": [[82, 84, "GENE"]]}], ["We tested the effect of DEX on the expressions of GILZ mRNA and GILZ protein and the MAPK-ERK signaling pathway in human airway epithelial cells, via RT-PCR and Western blot.", {"entities": []}], ["We further evaluated the role of GILZ in mediating the effect of DEX on the MAPK-ERK signaling pathway and in airway epithelium repair by utilizing small-interfering RNAs, MTT, CFSE labeling, wound-healing and cell migration assays.", {"entities": []}], ["DEX increased GILZ mRNA and GILZ protein levels in a human airway epithelial cell line.", {"entities": []}], ["Furthermore, DEX inhibited the phosphorylation of Raf-1, Mek1/2, Erk1/2 (components of the MAPK-ERK signaling pathway), proliferation and migration.", {"entities": []}], ["However, the inhibitory effect of DEX was mitigated in cells when the GILZ gene was silenced.", {"entities": []}], ["The inhibition of epithelial injury repair by DEX is mediated in part by activation of GILZ, which suppressed activation of the MAPK-ERK signaling pathway, proliferation and migration.", {"entities": []}], ["Our study implicates the involvement of DEX in this process, and furthers our understanding of the dual role of GCs.", {"entities": []}], ["To analyze the variation in the proportion of households living below the poverty line in Brazil and the factors associated with their impoverishment.", {"entities": []}], ["Income and expenditure data from the Household Budget Survey, which was conducted in Brazil between 2002-2003 (n = 48,470 households) and 2008-2009 (n = 55,970 households) with a national sample, were analyzed.", {"entities": []}], ["Two cutoff points were used to define poverty.", {"entities": []}], ["The first cutoff is a per capita monthly income below R$100.00 in 2002-2003 and R$140.00 in 2008-2009, as recommended by the Bolsa Fam\u00edlia Program.", {"entities": []}], ["The second, which is proposed by the World Bank and is adjusted for purchasing power parity, defines poverty as per capita income below US$2.34 and US$3.54 per day in 2002-2003 and 2008-2009, respectively.", {"entities": []}], ["Logistic regression was used to identify the sociodemographic factors associated with the impoverishment of households.", {"entities": []}], ["After subtracting health expenditures, there was an increase in households living below the poverty line in Brazil.", {"entities": []}], ["Using the World Bank poverty line, the increase in 2002-2003 and 2008-2009 was 2.6 percentage points (6.8%) and 2.3 percentage points (11.6%), respectively.", {"entities": []}], ["Using the Bolsa Fam\u00edlia Program poverty line, the increase was 1.6 (11.9%) and 1.3 (17.3%) percentage points, respectively.", {"entities": []}], ["Expenditure on prescription drugs primarily contributed to the increase in poor households.", {"entities": []}], ["According to the World Bank poverty line, the factors associated with impoverishment include a worse-off financial situation, a household headed by an individual with low education, the presence of children, and the absence of older adults.", {"entities": []}], ["Using the Bolsa Fam\u00edlia Program poverty line, the factors associated with impoverishment include a worse-off financial situation and the presence of children.", {"entities": []}], ["Health expenditures play an important role in the impoverishment of segments of the Brazilian population, especially among the most disadvantaged.", {"entities": []}], ["A major challenge in traffic-related air pollution exposure studies is the lack of information regarding pollutant exposure characterization.", {"entities": []}], ["Air quality modeling can provide spatially and temporally varying exposure estimates for examining relationships between traffic-related air pollutants and adverse health outcomes.", {"entities": []}], ["A hybrid air quality modeling approach was used to estimate exposure to traffic-related air pollutants in support of the Near-Road Exposures and Effects of Urban Air Pollutants Study (NEXUS) conducted in Detroit (Michigan, USA).", {"entities": []}], ["Model-based exposure metrics, associated with local variations of emissions and meteorology, were estimated using a combination of the American Meteorological Society/Environmental Protection Agency Regulatory Model (AERMOD) and Research LINE-source dispersion model for near-surface releases (RLINE) dispersion models, local emission source information from the National Emissions Inventory, detailed road network locations and traffic activity, and meteorological data from the Detroit City Airport.", {"entities": []}], ["The regional background contribution was estimated using a combination of the Community Multi-scale Air Quality (CMAQ) and the Space-Time Ordinary Kriging (STOK) models.", {"entities": []}], ["To capture the near-road pollutant gradients, refined \u201cmini-grids\u201d of model receptors were placed around participant homes.", {"entities": []}], ["Exposure metrics for CO, NO x , PM 2.5 and its components (elemental and organic carbon) were predicted at each home location for multiple time periods including daily and rush hours.", {"entities": []}], ["The exposure metrics were evaluated for their ability to characterize the spatial and temporal variations of multiple ambient air pollutants compared to measurements across the study area.", {"entities": []}], ["A report on the European Society of Human Genetics Conference 2005, Prague, Czech Republic, 7-10 May 2005.", {"entities": []}], ["A report on the European Society of Human Genetics Conference 2005, Prague, Czech Republic, 7-10 May 2005.", {"entities": []}], ["Indices predictive of central obesity include waist circumference (WC) and waist-to-height ratio (WHtR).", {"entities": [[30, 37, "DISEASE"]]}], ["These data are lacking for Colombian adults.", {"entities": []}], ["This study aims at establishing smoothed centile charts and LMS tables for WC and WHtR; appropriate cutoffs were selected using receiver-operating characteristic analysis based on data from the representative sample.", {"entities": []}], ["We used data from the cross-sectional, national representative nutrition survey (ENSIN, 2010).", {"entities": []}], ["A total of 83\u2009220 participants (aged 20\u201364) were enroled.", {"entities": []}], ["Weight, height, body mass index (BMI), WC and WHtR were measured and percentiles calculated using the LMS method (L (curve Box-Cox), M (curve median), and S (curve coefficient of variation)).", {"entities": []}], ["Receiver operating characteristics curve analyses were used to evaluate the optimal cutoff point of WC and WHtR for overweight and obesity based on WHO definitions.", {"entities": [[131, 138, "DISEASE"]]}], ["Reference values for WC and WHtR are presented.", {"entities": []}], ["Mean WC and WHtR increased with age for both genders.", {"entities": []}], ["We found a strong positive correlation between WC and BMI ( r =0.847, P < 0.01) and WHtR and BMI ( r =0.878, P <0.01).", {"entities": []}], ["In obese men, the cutoff point value is 96.6\u2009cm for the WC.", {"entities": []}], ["In women, the cutoff point value is 91.0\u2009cm for the WC.", {"entities": []}], ["Receiver operating characteristic curve for WHtR was also obtained and the cutoff point value of 0.579 in men, and in women the cutoff point value was 0.587.", {"entities": []}], ["A high sensitivity and specificity were obtained.", {"entities": []}], ["This study presents first reference values of WC and WHtR for Colombians aged 20\u201364.", {"entities": []}], ["Through LMS tables for adults, we hope to provide quantitative tools to study obesity and its complications.", {"entities": [[78, 85, "DISEASE"]]}], ["Nonspecific interstitial pneumonia (NSIP) is characterised by interstitial infiltration of lymphocytes and varying amounts of interstitial fibrosis.", {"entities": [[25, 34, "DISEASE"]]}], ["B cells have been suggested to contribute to the pathogenesis of NSIP.", {"entities": []}], ["However, the relationship between B-lymphocyte and the clinical outcomes of NSIP was unclear.", {"entities": []}], ["In this study, 50 patients with histopathologically confirmed NSIP from Peking Union Medical College Hospital between April 2003 to December 2012 were retrospectively analyzed.", {"entities": []}], ["Using immunohistochemical analyses, CD20+ B cells were counted in the lymphoid follicles, perivascular, interstitial, and peribronchiolar regions of lung tissure.", {"entities": []}], ["The CD20+ lymphocytes were mainly present in the lymphoid follicles.", {"entities": []}], ["The number of follicular CD20+ lymphocytes was higher in the fibrosing than cellular NSIP pattern [255.08 (132.92\u2013449.71) vs. 121.33 (63.54\u2013282.88)/0.1\u2009mm", {"entities": []}], ["Hundred-thousands of fungal species are present in our environment, including normal colonizers that constitute part of the human microbiota.", {"entities": []}], ["The homeostasis of host-fungus interactions encompasses efficient fungal sensing, tolerance at mucosal surfaces, as well as antifungal defenses.", {"entities": []}], ["Decrease in host immune fitness or increase in fungal burden may favor pathologies, ranging from superficial mucocutaneous diseases to invasive life-threatening fungal infections.", {"entities": []}], ["Toll-like receptors (TLRs) are essential players in this balance, due to their ability to control both inflammatory and anti-inflammatory processes upon recognition of fungal-specific pathogen-associated molecular patterns (PAMPs).", {"entities": []}], ["Certain members of the TLR family participate to the initial recognition of fungal PAMPs on the cell surface, as well as inside phagosomes of innate immune cells.", {"entities": []}], ["Active signaling cascades in phagocytes ultimately enable fungus clearance and the release of cytokines that shape and instruct other innate immune cells and the adaptive immune system.", {"entities": []}], ["Some TLRs cooperate with other pattern recognition receptors (PRRs) (e.g., C-type lectins and Galectins), thus allowing for a tailored immune response.", {"entities": []}], ["The spatio-temporal and physiological contributions of individual TLRs in fungal infections remains ill-defined, although in humans, TLR gene polymorphisms have been linked to increased susceptibility to fungal infections.", {"entities": []}], ["This review focuses entirely on the role of TLRs that control the host susceptibility to environmental fungi (e.g., Aspergillus, Cryptoccocus , and Coccidoides ), as well as to the most frequent human fungal pathogens represented by the commensal Candida species.", {"entities": []}], ["The emerging roles of TLRs in modulating host tolerance to fungi, and the strategies that evolved in some of these fungi to evade or use TLR recognition to their advantage will also be discussed, as well as their potential suitability as targets in vaccine therapies.", {"entities": []}], ["Asthma and allergies are world-wide common chronic diseases among children and young people.", {"entities": [[0, 6, "DISEASE"]]}], ["Little information is available about the prevalence of these diseases in rural areas of Latin America.", {"entities": []}], ["This study assesses the prevalence of symptoms of asthma and allergies among children in urban and rural areas at Oropeza Province in Bolivia.", {"entities": [[50, 56, "DISEASE"]]}], ["The Spanish version of the ISAAC standardized questionnaire and the ISAAC video questionnaire were implemented to 2584 children attending the fifth elementary grade in 36 schools in Oropeza province (response 91%).", {"entities": []}], ["Lifetime, 12\u00a0months and severity prevalence were determined for asthma, rhinitis and eczema symptoms.", {"entities": [[72, 80, "DISEASE"], [64, 70, "DISEASE"]]}], ["Odds ratios (OR) with 95% confidence intervals (95% CI) were calculated adjusting for age using generalized linear mixed-effects models.", {"entities": []}], ["Median age of children was 11\u00a0years, 74.8% attended public schools, and 52.1% were female.", {"entities": []}], ["While children attending urban schools had lower prevalence of self-reported wheeze in the written questionnaire (adjusted OR 0.6; 95% CI 0.4-1.9), they were more likely than children attending rural schools to report wheeze in the video questionnaire (aOR 2.1; 95% CI 1.0-2.6).", {"entities": []}], ["They also reported more frequently severe rhinoconjunctivitis (aOR 2.8; 95% CI 1.2-6.6) and severe eczema symptoms (aOR 3.3; 95% CI 1.0-11.0).", {"entities": []}], ["Overall in accordance with the hygiene hypothesis, children living in urban areas of Bolivia seem to have a higher prevalence of symptoms of asthma and allergies compared to children living in the country side.", {"entities": [[141, 147, "DISEASE"]]}], ["In order to develop primary prevention strategies, environmental factors need to be identified in future studies.", {"entities": []}], ["Plants have served either as a natural templates for the development of new chemicals or a phytomedicine since antiquity.", {"entities": []}], ["Therefore, the present study was aimed to appraise the polarity directed antioxidant, cytotoxic, protein kinase inhibitory, antileishmanial and glucose modulatory attributes of a Himalayan medicinal plant- Quercus dilatata .", {"entities": []}], ["Total phenolic and flavonoid contents were determined colorimetrically and various polyphenols were identified by RP-HPLC analysis.", {"entities": []}], ["Brine shrimp lethality, SRB and MTT assays were employed to test cytotoxicity against Artemia salina and human cancer cell lines respectively.", {"entities": [[111, 117, "DISEASE"]]}], ["Antileishmanial activity was determined using standard MTT protocol.", {"entities": []}], ["Glucose modulation was assessed by \u03b1-amylase inhibition assay while disc diffusion assay was used to establish protein kinase inhibitory and antifungal spectrum.", {"entities": []}], ["Among 14 extracts of aerial parts, distilled water-acetone extract demonstrated maximum extract recovery (10.52% w /w), phenolic content (21.37\u00a0\u00b1\u00a00.21\u00a0\u03bcg GAE/mg dry weight (DW)), total antioxidant capacity (4.81\u00a0\u00b1\u00a00.98\u00a0\u03bcg AAE/mg DW) and reducing power potential (20.03\u00a0\u00b1\u00a02.4\u00a0\u03bcg/mg DW).", {"entities": []}], ["On the other hand, Distilled water extract proficiently extracted flavonoid content (4.78\u00a0\u00b1\u00a00.51\u00a0\u03bcg QE/mg DW).", {"entities": []}], ["RP-HPLC analysis revealed the presence of significant amounts of phenolic metabolites (0.049 to 15.336\u00a0\u03bcg/mg extract) including, pyrocatechol, gallic acid, catechin, chlorogenic acid, p-coumaric acid, ferulic acid and quercetin.", {"entities": []}], ["Highest free radical scavenging capacity was found in Methanol-Ethyl acetate extract (IC 50 8.1\u00a0\u00b1\u00a00.5\u00a0\u03bcg/ml).", {"entities": []}], ["In the brine shrimp toxicity assay, most of the tested extracts (57%) showed high cytotoxicity.", {"entities": []}], ["Among these, Chloroform-Methanol extract had highest cytotoxicity against THP-1 cell line (IC 50 3.88\u00a0\u00b1\u00a00.53\u00a0\u03bcg/ml).", {"entities": []}], ["About 50% of the extracts were found to be moderately antiproliferative against Hep G2 cell line.", {"entities": []}], ["Methanol extract exhibited considerable protein kinase inhibitory activity against Streptomyces 85E strain (28\u00a0\u00b1\u00a00.35\u00a0mm bald phenotype at 100\u00a0\u03bcg/disc; MIC\u00a0=\u00a012.5\u00a0\u03bcg/ disc) while, Chloroform extract displayed maximum antidiabetic activity (\u03b1-amylase inhibition of 21.61\u00a0\u00b1\u00a01.53% at 200\u00a0\u03bcg/ml concentration).", {"entities": []}], ["The highest antileishmanial potential was found in Ethyl acetate-Acetone extract (12.91\u00a0\u00b1\u00a00.02% at 100\u00a0\u03bcg/ml concentration), while, Q. dilatata extracts also showed a moderate antifungal activity.", {"entities": []}], ["This study proposes that multiple-solvent system is a crucial variable to elucidate pharmacological potential of Q. dilatata and the results of the present findings prospects its potential as a resource for the discovery of novel anticancer, antidiabetic, antileishmanial and antioxidant agents.", {"entities": []}], ["Since the first outbreak of a respiratory illness caused by H1N1 virus in Mexico, several reports have described the need of intensive care or extracorporeal membrane oxygenation (ECMO) assistance in young and often healthy patients.", {"entities": []}], ["Here we describe our experience in H1N1-induced ARDS using both ventilation strategy and ECMO assistance.", {"entities": []}], ["Following Italian Ministry of Health instructions, an Emergency Service was established at the Careggi Teaching Hospital (Florence, Italy) for the novel pandemic influenza.", {"entities": [[162, 171, "DISEASE"]]}], ["From Sept 09 to Jan 10, all patients admitted to our Intensive Care Unit (ICU) of the Emergency Department with ARDS due to H1N1 infection were studied.", {"entities": []}], ["All ECMO treatments were veno-venous.", {"entities": []}], ["H1N1 infection was confirmed by PCR assayed on pharyngeal swab, subglottic aspiration and bronchoalveolar lavage.", {"entities": []}], ["Lung pathology was evaluated daily by lung ultrasound (LUS) examination.", {"entities": []}], ["A total of 12 patients were studied: 7 underwent ECMO treatment, and 5 responded to protective mechanical ventilation.", {"entities": []}], ["Two patients had co-infection by Legionella Pneumophila.", {"entities": []}], ["One woman was pregnant.", {"entities": []}], ["In our series, PCR from bronchoalveolar lavage had a 100% sensitivity compared to 75% from pharyngeal swab samples.", {"entities": []}], ["The routine use of LUS limited the number of chest X-ray examinations and decreased transportation to radiology for CT-scan, increasing patient safety and avoiding the transitory disconnection from ventilator.", {"entities": []}], ["No major complications occurred during ECMO treatments.", {"entities": []}], ["In three cases, bleeding from vascular access sites due to heparin infusion required blood transfusions.", {"entities": []}], ["Overall mortality rate was 8.3%.", {"entities": []}], ["In our experience, early ECMO assistance resulted safe and feasible, considering the life threatening condition, in H1N1-induced ARDS.", {"entities": []}], ["Lung ultrasound is an effective mean for daily assessment of ARDS patients.", {"entities": []}], ["Differences in the concentrations of circulating 25-hydroxyvitamin D [25(OH)D] are associated with a wide range of health outcomes; however, most studies on genetic variants that impact 25(OH)D levels have been conducted in European populations.", {"entities": []}], ["Here we aimed to identify common genetic variants that affect vitamin D concentrations in individuals of self-reported Arab ethnicity.", {"entities": []}], ["The study included 1151 Arab subjects living in Kuwait.", {"entities": []}], ["Common variants of single-nucleotide polymorphisms and genes previously associated with vitamin D levels, such as GC, PDE3B, CYP2R1, and NADSYN1, were genotyped.", {"entities": [[114, 116, "GENE"], [118, 123, "GENE"], [125, 131, "GENE"], [137, 144, "GENE"]]}], ["Raw vitamin D level data were corrected for age, body mass index, and sex and then normalized.", {"entities": []}], ["Regression tree analyses were performed to identify the impact of genetic variants on vitamin D levels.", {"entities": []}], ["Compared with other gene variants, the GC gene variants exhibited the greatest impact on vitamin D levels in our study population, of which rs2298850 had the lowest p value (0.003).", {"entities": [[39, 41, "GENE"]]}], ["Individuals homozygous for the derived allele C had lower vitamin D levels.", {"entities": []}], ["Analyses of the interaction between the number of years for which the subjects had lived in Kuwait and genetic variation in the GC gene showed that those with the CC genotype of rs2298850 who had lived in Kuwait for\u00a0<\u00a051\u00a0years had a mean 25(OH)D level of 10\u00a0ng/ml, whereas those who were homozygous for the ancestral allele had a mean 25(OH)D level of 17\u00a0ng/ml.", {"entities": [[128, 130, "GENE"]]}], ["Furthermore, subjects who had lived in Kuwait for\u00a0>\u00a051\u00a0years had higher vitamin D levels (mean 28\u00a0ng/ml) regardless of the genotype of their GC gene.", {"entities": [[141, 143, "GENE"]]}], ["The GC gene may play a major role in determining vitamin D levels in Arab populations.", {"entities": [[4, 6, "GENE"]]}], ["The online version of this article (10.1186/s12967-018-1396-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Inducible co-stimulator (ICOS) is the third member of the CD28/cytotoxic T-lymphocyte associated antigen-4 family and is involved in the proliferation and activation of T cells.", {"entities": [[25, 29, "GENE"]]}], ["A detailed functional analysis of ICOS on peripheral blood T cells from patients with systemic lupus erythematosus (SLE) has not yet been reported.", {"entities": [[95, 114, "DISEASE"], [86, 114, "DISEASE"], [34, 38, "GENE"]]}], ["In the present study we developed a fully human anti-human ICOS mAb (JTA009) with high avidity and investigated the immunopathological roles of ICOS in SLE.", {"entities": [[59, 63, "GENE"], [144, 148, "GENE"], [59, 63, "GENE"], [144, 148, "GENE"]]}], ["JTA009 exhibited higher avidity for ICOS than a previously reported mAb, namely SA12.", {"entities": [[36, 40, "GENE"]]}], ["Using JTA009, ICOS was detected in a substantial proportion of unstimulated peripheral blood T cells from both normal control individuals and patients with SLE.", {"entities": [[14, 18, "GENE"]]}], ["Disturbances in the early establishment of the intestinal microbiota may produce important implications for the infant\u2019s health and for the risk of disease later on.", {"entities": []}], ["Different perinatal conditions may be affecting the development of the gut microbiota.", {"entities": []}], ["Some of them, such as delivery mode or feeding habits, have been extensively assessed whereas others remain to be studied, being critical to identify their impact on the microbiota and, if any, to minimize it.", {"entities": []}], ["Antibiotics are among the drugs most frequently used in early life, the use of intrapartum antimicrobial prophylaxis (IAP), present in over 30% of deliveries, being the most frequent source of exposure.", {"entities": []}], ["However, our knowledge on the effects of IAP on the microbiota establishment is still limited.", {"entities": []}], ["The aim of the present work was to evaluate the impact of IAP investigating a cohort of 40 full-term vaginally delivered infants born after an uncomplicated pregnancy, 18 of which were born from mothers receiving IAP.", {"entities": []}], ["Fecal samples were collected at 2, 10, 30, and 90\u00a0days of age.", {"entities": []}], ["We analyzed the composition of the fecal microbiota during the first 3\u00a0months of life by 16S rRNA gene sequencing and quantified fecal short chain fatty acids by gas chromatography.", {"entities": []}], ["The presence of genes for resistance to antibiotics was determined by PCR in the samples from 1-month-old infants.", {"entities": []}], ["Our results showed an altered pattern of intestinal microbiota establishment in IAP infants during the first weeks of life, with lower relative proportions of Actinobacteria and Bacteroidetes and increased of Preoteobacteria and Firmicutes .", {"entities": []}], ["A delay in the increase on the levels of acetate was observed in IAP infants.", {"entities": []}], ["The analyses of specific antibiotic resistance genes showed a higher occurrence of some \u03b2-lactamase coding genes in infants whose mothers received IAP.", {"entities": []}], ["Our results indicate an effect of IAP on the establishing early microbiota during the first months of life, which represent a key moment for the development of the microbiota-induced host homeostasis.", {"entities": []}], ["Understanding the impact of IAP in the gut microbiota development is essential for developing treatments to minimize it, favoring a proper gut microbiota development in IAP-exposed neonates.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-017-0313-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Recent advances in the measurement of health literacy allow description of a broad range of personal and social dimensions of the concept.", {"entities": []}], ["Identifying differences in patterns of health literacy between population sub-groups will increase understanding of how health literacy contributes to health inequities and inform intervention development.", {"entities": []}], ["The aim of this study was to use a multi-dimensional measurement tool to describe the health literacy of adults in urban and rural Victoria, Australia.", {"entities": []}], ["Data were collected from clients (n\u2009=\u2009813) of 8 health and community care organisations, using the Health Literacy Questionnaire (HLQ).", {"entities": []}], ["Demographic and health service data were also collected.", {"entities": []}], ["Data were analysed using descriptive statistics.", {"entities": []}], ["Effect sizes (ES) for standardised differences in means were used to describe the magnitude of difference between demographic sub-groups.", {"entities": []}], ["Mean age of respondents was 72.1 (range 19\u201399) years.", {"entities": []}], ["Females comprised 63\u00a0% of the sample, 48\u00a0% had not completed secondary education, and 96\u00a0% reported at least one existing health condition.", {"entities": []}], ["Small to large ES were seen for mean differences in HLQ scales between most demographic groups.", {"entities": []}], ["Compared with participants who spoke English at home, those not speaking English at home had much lower scores for most HLQ scales including the scales \u2018Understanding health information well enough to know what to do\u2019 (ES \u22121.09 [95\u00a0% confidence interval (CI) -1.33 to \u22120.84]), \u2018Ability to actively engage with healthcare providers\u2019 (ES \u22121.00 [95\u00a0% CI \u22121.24, \u22120.75]), and \u2018Navigating the healthcare system\u2019 (ES \u22120.72 [95\u00a0% CI \u22120.97, \u22120.48]).", {"entities": []}], ["Similar patterns and ES were seen for participants born overseas compared with those born in Australia.", {"entities": []}], ["Smaller ES were seen for sex, age group, private health insurance status, number of chronic conditions, and living alone.", {"entities": []}], ["This study has revealed some large health literacy differences across nine domains of health literacy in adults using health services in Victoria.", {"entities": []}], ["These findings provide insights into the relationship between health literacy and socioeconomic position in vulnerable groups and, given the focus of the HLQ, provide guidance for the development of equitable interventions.", {"entities": []}], ["This paper examines the relative importance of family socioeconomic status (SES) and school-based peer hierarchies for young people's psychoneuroendocrine response, represented by cortisol level.", {"entities": []}], ["Data are drawn from a study of 2824, 15-year-olds in 22 Scottish secondary schools in 2006 who provided information on family SES (parental occupation, material deprivation and family affluence) and social position in school hierarchies, together with two morning salivary cortisol samples.", {"entities": []}], ["School social position was assessed by participants placing themselves on seven \u2018ladders\u2019, from which three factors were derived, termed scholastic, peer and sports hierarchies.", {"entities": []}], ["Controlling for confounds, there was little or no variation in cortisol by any SES measure.", {"entities": []}], ["By contrast, each school hierarchy was independently associated with cortisol, but in different ways.", {"entities": []}], ["For the scholastic hierarchy, an inverse linear relationship was found for females, cortisol increasing with lower position.", {"entities": []}], ["For peer hierarchy, an opposite (direct) linear relationship occurred for males, while for females elevated cortisol was associated only with \u2018top\u2019 position.", {"entities": []}], ["For sports, elevated cortisol among males was associated with \u2018bottom\u2019 position, among females with all except the \u2018top\u2019.", {"entities": []}], ["These results are interpreted in the context of Sapolsky's (", {"entities": []}], ["Air pollution is known to contribute to respiratory and cardiovascular mortality and morbidity.", {"entities": []}], ["Oxidative stress has been suggested as one of the main mechanisms for these effects on health.", {"entities": []}], ["The aim of this study was to analyze the effects of exposure to particulate matter (PM) with aerodynamic diameters \u2264 10 \u03bcm (PM 10 ) and \u2264 2.5 \u03bcm (PM 2.5 ) and polycyclic aromatic hydrocarbons (PAHs) on urinary malondialdehyde (MDA) levels in schoolchildren.", {"entities": []}], ["The study population consisted of 120 schoolchildren.", {"entities": []}], ["The survey and measurements were conducted in four cities\u2014two in China (Ala Shan and Beijing) and two in Korea (Jeju and Seoul)\u2014between 4 and 9 June 2007.", {"entities": []}], ["We measured daily ambient levels of PM and their metal components at the selected schools during the study period.", {"entities": []}], ["We also measured urinary 1-hydroxypyrene (1-OHP) and 2-naphthol, to assess PAH exposure, and MDA, to assess oxidative stress.", {"entities": []}], ["Measurements were conducted once a day for 5 consecutive days.", {"entities": []}], ["We constructed a linear mixed model after adjusting for individual variables to estimate the effects of PM and PAH on oxidative stress.", {"entities": []}], ["We found statistically significant increases in urinary MDA levels with ambient PM concentrations from the current day to the 2 previous days ( p < 0.0001).", {"entities": []}], ["Urinary 1-OHP level also showed a positive association with urinary MDA level, which was statistically significant with or without PM in the model ( p < 0.05).", {"entities": []}], ["Outdoor PM and urinary 1-OHP were synergistically associated with urinary MDA levels.", {"entities": []}], ["Some metals bound to PM 10 (aluminum, iron, strontium, magnesium, silicon, arsenic, barium, zinc, copper, and cadmium) and PM 2.5 (magnesium, iron, strontium, arsenic, cadmium, zinc, aluminum, mercury, barium, and copper) also had significant associations with urinary MDA level.", {"entities": []}], ["Exposure to PM air pollution and PAHs was associated with oxidative stress in schoolchildren.", {"entities": []}], ["Supplemental Digital Content is available in the text This nationwide population-based retrospective cohort study was used to evaluate the association between pneumoconiosis and peripheral arterial disease (PAD).", {"entities": [[159, 173, "DISEASE"]]}], ["We identified 3374 patients with pneumoconiosis from the catastrophic illness registry who were newly diagnosed from 2000 to 2005; 13,496 patients without pneumoconiosis from Longitudinal Health Insurance Database 2000 (LHID2000) were randomly frequency matched according to sex, age, and index year and used as a nonpneumoconiosis group.", {"entities": [[33, 47, "DISEASE"], [155, 169, "DISEASE"]]}], ["Multivariate Cox proportional hazards regression was used to calculate adjusted hazard ratios (HRs) of PAD in the pneumoconiosis group compared with the nonpneumoconiosis group.", {"entities": [[114, 128, "DISEASE"]]}], ["The mean follow-up years were 7.44 years in the pneumoconiosis group and 8.17 years in the nonpneumoconiosis group.", {"entities": [[48, 62, "DISEASE"]]}], ["The incidence density rate of PAD was 1.25 times greater in the pneumoconiosis group than in the nonpneumoconiosis group (8.37 vs 6.70 per 1000 person-years).", {"entities": [[64, 78, "DISEASE"]]}], ["After adjusting for sex, age, and comorbidities, the adjusted HRs of PAD for the pneumoconiosis group were 1.30 (95% CI\u200a=\u200a1.08\u20131.57), compared with the nonpneumoconiosis group.", {"entities": [[81, 95, "DISEASE"]]}], ["The combined impacts of patients with pneumoconiosis and diabetes, hyperlipidemia, hypertension, ischemic heart disease, chronic obstructive pulmonary disease, and asthma showed a significant by joint association with PAD risk compared with patients with no pneumoconiosis and no counterpart comorbidity.", {"entities": [[83, 95, "DISEASE"], [97, 119, "DISEASE"], [106, 119, "DISEASE"], [121, 158, "DISEASE"], [164, 170, "DISEASE"], [38, 52, "DISEASE"], [258, 272, "DISEASE"]]}], ["Patients with pneumoconiosis have an independently higher risk of developing PAD.", {"entities": [[14, 28, "DISEASE"]]}], ["Physicians should include pneumoconiosis in evaluating PAD risk.", {"entities": [[26, 40, "DISEASE"]]}], ["Epidemiologic evidence supports associations between inhalation of fine and ultrafine ambient particulate matter [aerodynamic diameter \u2264 2.5 \u03bcm (PM 2.5 )] and increases in cardiovascular/respiratory morbidity and mortality.", {"entities": []}], ["Less attention has been paid to how the physical and chemical characteristics of these particles may influence their interactions with target cells.", {"entities": []}], ["Butadiene soot (BDS), produced during combustion of the high-volume petrochemical 1,3-butadiene, is rich in polynuclear aromatic hydrocarbons (PAHs), including known carcinogens.", {"entities": []}], ["We conducted experiments to characterize BDS with respect to particle size distribution, assembly, PAH composition, elemental content, and interaction with respiratory epithelial cells.", {"entities": []}], ["Freshly generated, intact BDS is primarily (> 90%) PAH-rich, metals-poor (nickel, chromium, and vanadium concentrations all < 1 ppm) PM 2.5 , composed of uniformly sized, solid spheres (30\u201350 nm) in aggregated form.", {"entities": []}], ["Cells of a human bronchial epithelial cell line (BEAS-2B) exhibit sequential fluorescent responses\u2014a relatively rapid (~ 30 min), bright but diffuse fluorescence followed by the slower (2\u20134 hr) appearance of punctate cytoplasmic fluorescence\u2014after BDS is added to medium overlying the cells.", {"entities": [[190, 192, "GENE"]]}], ["The fluorescence is associated with PAH localization in the cells.", {"entities": []}], ["The ultrafine BDS particles move down through the medium to the cell membrane.", {"entities": []}], ["Fluorescent PAHs are transferred from the particle surface to the cell membrane, cross the membrane into the cytosol, and appear to accumulate in lipid vesicles.", {"entities": []}], ["There is no evidence that BDS particles pass into the cells.", {"entities": []}], ["The results demonstrate that uptake of airborne ultrafine particles by target cells is not necessary for transfer of toxicants from the particles to the cells.", {"entities": []}], ["Echocardiographic evaluation of left ventricular (LV) structural and functional alterations in hypertension has some limitations, potentially overcome by using biomarkers.", {"entities": [[95, 107, "DISEASE"]]}], ["ST2, a prognostic biomarker for heart failure and myocardial infarction patients, was less studied in hypertension.", {"entities": [[102, 114, "DISEASE"], [50, 71, "DISEASE"]]}], ["To analyze the relationship between serum ST2 levels and diastolic dysfunction (DD) in hypertension.", {"entities": [[87, 99, "DISEASE"]]}], ["We enrolled 88 hypertensive outpatients (average age 65 years, 69.3% females) in a prospective study, stratified for presence of LV hypertrophy (LVH).", {"entities": []}], ["For each patient clinical examination, lab workup (routine and serum ST2 levels) and echocardiography were performed.", {"entities": []}], ["Hypertensive patients with LVH had higher age, pulse pressure, mean arterial pressure, and serum ST2, while having lower serum albumin than those without LVH.", {"entities": []}], ["Serum ST2 levels correlate with parameters of LV remodeling and DD.", {"entities": []}], ["We found that 5.3% of ST2 level variability was caused by a 1-unit variation of cardiovascular risk.", {"entities": []}], ["We identified cut-off values for discriminating hypertension with LVH versus that without LVH and grade 2 DD versus normal diastolic performance.", {"entities": [[48, 60, "DISEASE"]]}], ["ST2 could be used as diagnostic biomarker for cardiac remodeling and altered diastolic performance in hypertension, providing additional data to echocardiography.", {"entities": [[102, 114, "DISEASE"]]}], ["It could represent a milestone in early detection of cardiac performance alteration.", {"entities": []}], ["Musculoskeletal disorders and injuries are common causes of morbidity and loss of active, physically demanding training days in military populations.", {"entities": []}], ["We evaluated the incidence, diagnosis, and risk factors of knee disorders and injuries in male Finnish military conscripts.", {"entities": []}], ["The study population comprised 5 cohorts of 1000 men performing their military service, classified according to birth year (1969, 1974, 1979, 1984, and 1989).", {"entities": []}], ["Follow-up time for each conscript was the individual conscript\u2019s full, completed military service period.", {"entities": []}], ["Data for each man were collected from a standard pre-information questionnaire used by defense force healthcare officials and from all original medical reports of the garrison healthcare centers.", {"entities": []}], ["Background variables for risk factor analysis included the conscripts\u2019 service data, i.e., service class (A, B), length of military service, age, height, weight, body mass index (BMI), underweight, overweight, obesity, smoking habit, education, diseases, injuries, and subjective symptoms.", {"entities": [[210, 217, "DISEASE"]]}], ["Of the 4029 conscripts, 853 visited healthcare professionals for knee symptoms during their military service, and 103 of these had suffered a knee injury.", {"entities": []}], ["Independent risk factors for the incidence of knee symptoms were: older age; service class A; overweight (BMI 25.0\u201329.9\u00a0kg/m The present study highlights the frequency of knee disorders and injuries in young men during physically demanding military training.", {"entities": []}], ["One-fifth of the male conscripts visited defense force healthcare professionals due to knee symptoms during their service period.", {"entities": []}], ["Independent risk factors for the incidence of knee symptoms during military service were age at military service; military service class A; overweight; smoking habit; comprehensive school education only; and self-reported previous symptoms of the musculoskeletal system, respiratory system, or gastrointestinal system.", {"entities": []}], ["These risk factors should be considered when planning and implementing procedures to reduce knee disorders and injuries during compulsory military service.", {"entities": []}], ["PSMB5 mutations and upregulation of the \u03b25 subunit of the proteasome represent key determinants of acquired resistance to the proteasome inhibitor bortezomib (BTZ) in leukemic cells in vitro .", {"entities": [[0, 5, "GENE"]]}], ["We here undertook a multi-modality (DNA, mRNA, miRNA) array-based analysis of human CCRF-CEM leukemia cells and BTZ-resistant subclones to determine whether or not complementary mechanisms contribute to BTZ resistance.", {"entities": [[93, 101, "DISEASE"]]}], ["These studies revealed signatures of markedly reduced expression of proteolytic stress related genes in drug resistant cells over a broad range of BTZ concentrations along with a high upregulation of myristoylated alanine-rich C-kinase substrate (MARCKS) gene expression.", {"entities": [[247, 253, "GENE"]]}], ["MARCKS upregulation was confirmed on protein level and also observed in other BTZ-resistant tumor cell lines as well as in leukemia cells with acquired resistance to other proteasome inhibitors.", {"entities": [[123, 131, "DISEASE"], [0, 6, "GENE"]]}], ["Moreover, when MARCKS protein expression was demonstrated in specimens derived from therapy-refractory pediatric leukemia patients ( n = 44), higher MARCKS protein expression trended ( p = 0.073) towards a dismal response to BTZ-containing chemotherapy.", {"entities": [[113, 121, "DISEASE"], [15, 21, "GENE"], [149, 155, "GENE"], [15, 21, "GENE"], [149, 155, "GENE"]]}], ["Mechanistically, we show a BTZ concentration-dependent association of MARCKS protein levels with the emergence of ubiquitin-containing vesicles in BTZ-resistant CEM cells.", {"entities": [[70, 76, "GENE"]]}], ["These vesicles were found to be extruded and taken up in co-cultures with proteasome-proficient acceptor cells.", {"entities": []}], ["Consistent with these observations, MARCKS protein associated with ubiquitin-containing vesicles was also more prominent in clinical leukemic specimen with ex vivo BTZ resistance compared to BTZ-sensitive leukemia cells.", {"entities": [[205, 213, "DISEASE"], [36, 42, "GENE"]]}], ["Collectively, we propose a role for MARCKS in a novel mechanism of BTZ resistance via exocytosis of ubiquitinated proteins in BTZ-resistant cells leading to quenching of proteolytic stress.", {"entities": [[36, 42, "GENE"]]}], ["Superparamagnetic Iron Oxide (SPIO) complexed with cationic transfection agent is used to label various mammalian cells.", {"entities": []}], ["Labeled cells can then be utilized as an in vivo magnetic resonance imaging (MRI) probes.", {"entities": []}], ["However, certain number of in vivo administered labeled cells may be cleared from tissues by the host's macrophages.", {"entities": []}], ["For successful translation to routine clinical application of SPIO labeling method it is important that this mode of in vivo clearance of iron does not elicit any diverse immunological effects.", {"entities": []}], ["The purpose of this study was to demonstrate that SPIO agent ferumoxides-protamine sulfate (FePro) incorporation into macrophages does not alter immunological properties of these cells with regard to differentiation, chemotaxis, and ability to respond to the activation stimuli and to modulate T cell response.", {"entities": []}], ["We used THP-1 cell line as a model for studying macrophage cell type.", {"entities": []}], ["THP-1 cells were magnetically labeled with FePro, differentiated with 100 nM of phorbol ester, 12-Myristate-13-acetate (TPA) and stimulated with 100 ng/ml of LPS.", {"entities": []}], ["The results showed 1) FePro labeling had no effect on the changes in morphology and expression of cell surface proteins associated with TPA induced differentiation; 2) FePro labeled cells responded to LPS with slightly higher levels of NF\u03baB pathway activation, as shown by immunobloting; TNF-\u03b1 secretion and cell surface expression levels of CD54 and CD83 activation markers, under these conditions, were still comparable to the levels observed in non-labeled cells; 3) FePro labeling exhibited differential, chemokine dependent, effect on THP-1 chemotaxis with a decrease in cell directional migration to MCP-1; 4) FePro labeling did not affect the ability of THP-1 cells to down-regulate T cell expression of CD4 and CD8 and to induce T cell proliferation.", {"entities": [[351, 355, "GENE"], [711, 714, "GENE"]]}], ["Our study demonstrated that intracellular incorporation of FePro complexes does not alter overall immunological properties of THP-1 cells.", {"entities": []}], ["The described experiments provide the model for studying the effects of in vivo clearance of iron particles via incorporation into the host's macrophages that may follow after in vivo application of any type of magnetically labeled mammalian cells.", {"entities": []}], ["To better mimic the complex in vivo scenario, this model may be further exploited by introducing additional cellular and biological, immunologically relevant, components.", {"entities": []}], ["Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, is a highly evolved human pathogen characterized by its formidable cell wall.", {"entities": [[14, 26, "DISEASE"], [57, 69, "DISEASE"]]}], ["Many unique lipids and glycolipids from the Mtb cell wall are thought to be virulence factors that mediate host\u2013pathogen interactions.", {"entities": []}], ["An intriguing example is Sulfolipid-1 (SL-1), a sulfated glycolipid that has been implicated in Mtb pathogenesis, although no direct role for SL-1 in virulence has been established.", {"entities": []}], ["Previously, we described the biochemical activity of the sulfotransferase Stf0 that initiates SL-1 biosynthesis.", {"entities": []}], ["Here we show that a stf0 -deletion mutant exhibits augmented survival in human but not murine macrophages, suggesting that SL-1 negatively regulates the intracellular growth of Mtb in a species-specific manner.", {"entities": []}], ["Furthermore, we demonstrate that SL-1 plays a role in mediating the susceptibility of Mtb to a human cationic antimicrobial peptide in vitro , despite being dispensable for maintaining overall cell envelope integrity.", {"entities": []}], ["Thus, we hypothesize that the species-specific phenotype of the stf0 mutant is reflective of differences in antimycobacterial effector mechanisms of macrophages.", {"entities": []}], ["Macrophages exert important functions in the balance and efficiency of immune responses, and participate in innate and adaptive immunity.", {"entities": []}], ["The proinflammatory actions of macrophages are implicated in autoimmune diseases.", {"entities": []}], ["Unlike classically activated M1 macrophages, the alternatively activated cluster of differentiation (CD)163", {"entities": []}], ["The incidence of acute pancreatitis has increased sharply in many European countries and the USA in recent years.", {"entities": [[23, 35, "DISEASE"], [17, 35, "DISEASE"]]}], ["To establish trends in incidence and mortality for acute pancreatitis in Wales, UK, and to assess how incidence may be linked to factors including social deprivation, seasonal effects and alcohol consumption.", {"entities": [[57, 69, "DISEASE"], [51, 69, "DISEASE"]]}], ["Use of record linked inpatient, mortality and primary care data for 10 589 hospitalised cases of acute pancreatitis between 1999 and 2010.", {"entities": [[103, 115, "DISEASE"], [97, 115, "DISEASE"]]}], ["The incidence of acute pancreatitis was 30.0 per 100 000 population overall, mortality was 6.4% at 60 days.", {"entities": [[23, 35, "DISEASE"], [17, 35, "DISEASE"]]}], ["Incidence increased significantly from 27.6 per 100 000 in 1999 to 36.4 in 2010 (average annual increase = 2.7% per year), there was little trend in mortality (0.2% average annual reduction).", {"entities": []}], ["The largest increases in incidence were among women aged <35 years (7.9% per year) and men aged 35\u201344 (5.7%) and 45\u201354 (5.3%).", {"entities": []}], ["Incidence was 1.9 times higher among the most deprived quintile of patients compared with the most affluent (3.9 times higher for alcoholic acute pancreatitis and 1.5 for gallstone acute pancreatitis).", {"entities": [[146, 158, "DISEASE"], [187, 199, "DISEASE"], [140, 158, "DISEASE"], [181, 199, "DISEASE"]]}], ["Acute pancreatitis was increased significantly during the Christmas and New Year weeks by 48% (95% CI = 24\u201377%) for alcoholic aetiology, but not for gallstone aetiology (9%).", {"entities": [[6, 18, "DISEASE"], [0, 18, "DISEASE"]]}], ["Alcoholic admissions were increased with higher consumption of spirits and beer, but not wine.", {"entities": []}], ["The study shows an elevated rate of alcoholic acute pancreatitis during the Christmas and New Year period.", {"entities": [[52, 64, "DISEASE"], [46, 64, "DISEASE"]]}], ["Acute pancreatitis continues to rise, most rapidly for young women, while alcoholic acute pancreatitis is linked strongly with social deprivation.", {"entities": [[6, 18, "DISEASE"], [90, 102, "DISEASE"], [0, 18, "DISEASE"], [84, 102, "DISEASE"]]}], ["Recent reports have demonstrated the role of phyto-constituents in modulating inflammatory responses.", {"entities": []}], ["Mangiferin isolated from Mangifera indica is known to induce potent anti-oxidative, anti-diabetic and anti-inflammatory activity.", {"entities": []}], ["However, the molecular mechanism of its anti-inflammatory activity is not properly understood.", {"entities": []}], ["In this study we have isolated Mangiferin from the tubers of Pueraria tuberosa (PT-Mangiferin) and analysed the mechanism of its potent anti-inflammatory effects in LPS stimulated RAW 264.7 mouse macrophage cell line and in a carrageenan induced air pouch model.", {"entities": []}], ["PT-Mangiferin was non-toxic to primary cells but showed significant toxicity and apoptotic effect on cancerous cells.", {"entities": []}], ["It significantly reduced the production of pro-inflammatory mediators (COX-2, iNOS and TNF-\u03b1) in LPS stimulated RAW 264.7 cells.", {"entities": []}], ["Further, it has also reduced the generation of ROS and inhibited LPS induced NF-kB translocation in these cells.", {"entities": []}], ["Additionally, PT-Mangiferin significantly reduced inflammation in a mouse air pouch model by inhibiting the infiltration of monocytes and neutrophils and reducing the production of cytokines.", {"entities": []}], ["These effects were mediated via inactivation of NLRP3 inflammasome complex and its downstream signalling molecules.", {"entities": [[48, 53, "GENE"]]}], ["Taken together these results suggest that PT-Mangiferin is potent anti-inflammatory compound that reduces inflammation and holds promise in development of herbal based anti-inflammatory therapeutics in future.", {"entities": []}], ["The organic cation transporters OCT1, 2, and 3 (SLC22A1-3) have been implicated in the elimination of biogenic amines such as histamine.", {"entities": []}], ["Among them, OCT3 was identified as an uptake-2 transporter, responsible for clearance of histamine.", {"entities": []}], ["Because increasing evidence suggests the involvement of histamine in cerebral ischemia, we investigated the effects of targeted disruption of organic cation transporter-3 (Oct3) on the severity of ischemic brain damage.", {"entities": [[78, 86, "DISEASE"]]}], ["Transient focal ischemia for 1\u2009hour was induced by occlusion of the middle cerebral artery (MCA) of homozygous Oct3 -deficient mice and their wild-type (Wt) littermates.", {"entities": [[16, 24, "DISEASE"]]}], ["Although targeted disruption of Oct3 did not affect physiological parameters after MCA occlusion, this disruption significantly increased histamine content in the ischemic cortex and significantly reduced the infarct volume after cerebral ischemia.", {"entities": [[239, 247, "DISEASE"]]}], ["Furthermore, targeted disruption of Oct3 prevented the reduction of regulatory T-cell proportion after cerebral ischemia while this disruption did not affect Th1 and Th2 cells proportions after ischemia.", {"entities": [[112, 120, "DISEASE"], [194, 202, "DISEASE"]]}], ["Since repeated administration of L -histidine (a precursor of histamine) to Wt mice also showed the same effects, our observations suggested that OCT3 is the molecule responsible for clearance of ischemia-induced histamine in the brain and targeted disruption of Oct3 ameliorated ischemic brain damage through an increase in regulatory T cells.", {"entities": [[196, 204, "DISEASE"]]}], ["Atopy is a major risk factor for the development of asthma.", {"entities": [[52, 58, "DISEASE"]]}], ["Immune processes that lead to the development of antigen-specific IgE are essential to the development of atopy.", {"entities": []}], ["This review examines the immune processes that are candidate targets for modulation by environmental agents; environmental and lifestyle factors that have been suggested as modulators of the development of atopy; and the impact of known environmental agents on atopic processes in the airway.", {"entities": []}], ["The most important periods of immune development with regard to expression of atopy are likely during gestation and early childhood.", {"entities": []}], ["A better understanding of which environmental agents are important, as well as the period of life during which these agents may exert an important effect, is essential to devising rational environmental avoidance strategies for at-risk populations.", {"entities": []}], ["Tenascin\u2010C (TN\u2010C), an extracellular matrix glycoprotein, appears at several important steps of cardiac development in the embryo, but is sparse in the normal adult heart.", {"entities": []}], ["TN\u2010C re\u2010expresses under pathological conditions including myocarditis, and is closely associated with tissue injury and inflammation in both experimental and clinical settings.", {"entities": [[58, 69, "DISEASE"]]}], ["However, the pathophysiological role of TN\u2010C in the development of myocarditis is not clear.", {"entities": [[67, 78, "DISEASE"]]}], ["We examined how TN\u2010C affects the initiation of experimental autoimmune myocarditis, immunologically.", {"entities": [[71, 82, "DISEASE"]]}], ["A model of experimental autoimmune myocarditis was established in BALB/c mice by immunization with murine \u03b1\u2010myosin heavy chains.", {"entities": [[35, 46, "DISEASE"]]}], ["We found that TN\u2010C knockout mice were protected from severe myocarditis compared to wild\u2010type mice.", {"entities": [[60, 71, "DISEASE"]]}], ["TN\u2010C induced synthesis of proinflammatory cytokines, including interleukin (IL)\u20106, in dendritic cells via activation of a Toll\u2010like receptor 4, which led to T\u2010helper (Th)17 cell differentiation and exacerbated the myocardial inflammation.", {"entities": []}], ["In the transfer experiment, dendritic cells loaded with cardiac myosin peptide acquired the functional capacity to induce myocarditis when stimulated with TN\u2010C; however, TN\u2010C\u2010stimulated dendritic cells generated from Toll\u2010like receptor 4 knockout mice did not induce myocarditis in recipients.", {"entities": [[122, 133, "DISEASE"], [267, 278, "DISEASE"]]}], ["Our results demonstrated that TN\u2010C aggravates autoimmune myocarditis by driving the dendritic cell activation and Th17 differentiation via Toll\u2010like receptor 4.", {"entities": [[57, 68, "DISEASE"]]}], ["The blockade of Toll\u2010like receptor 4\u2010mediated signaling to inhibit the proinflammatory effects of TN\u2010C could be a promising therapeutic strategy against autoimmune myocarditis.", {"entities": [[164, 175, "DISEASE"]]}], ["Attenuated measles virus (MV) is one of the most effective and safe vaccines available, making it attractive candidate vector to prevent infectious diseases.", {"entities": [[11, 18, "DISEASE"]]}], ["Attenuated MV have acquired the ability to use the complement regulator CD46 as a major receptor to mediate virus entry and intercellular fusion.", {"entities": [[72, 76, "GENE"]]}], ["Therefore, attenuated MV strains preferentially infect and destroy a wide variety of cancer cells making them also attractive oncolytic vectors.", {"entities": [[85, 91, "DISEASE"]]}], ["The use of recombinant MV vector has to comply with various regulatory requirements, particularly relating to the assessment of potential risks for human health and the environment.", {"entities": []}], ["The present article highlights the main characteristics of MV and recombinant MV vectors used for vaccination and virotherapy and discusses these features from a biosafety point of view.", {"entities": []}], ["We assessed the role of promotoras \u2014briefly trained community health workers\u2014in depression care at community health centers.", {"entities": []}], ["The intervention focused on four contextual sources of depression in underserved, low-income communities: underemployment, inadequate housing, food insecurity, and violence.", {"entities": []}], ["A multi-method design included quantitative and ethnographic techniques to study predictors of depression and the intervention\u2019s impact.", {"entities": []}], ["After a structured training program, primary care practitioners (PCPs) and promotoras collaboratively followed a clinical algorithm in which PCPs prescribed medications and/or arranged consultations by mental health professionals and promotoras addressed the contextual sources of depression.", {"entities": []}], ["Based on an intake interview with 464 randomly recruited patients, 120 patients with depression were randomized to enhanced care plus the promotora contextual intervention, or to enhanced care alone.", {"entities": []}], ["All four contextual problems emerged as strong predictors of depression (chi square, p \u00a0<\u00a0.05); logistic regression revealed housing and food insecurity as the most important predictors (odds ratios both 2.40, p \u00a0<\u00a0.05).", {"entities": []}], ["Unexpected challenges arose in the intervention\u2019s implementation, involving infrastructure at the health centers, boundaries of the promotoras\u2019 roles, and \u201cturf\u201d issues with medical assistants.", {"entities": []}], ["In the quantitative assessment, the intervention did not lead to statistically significant improvements in depression (odds ratio 4.33, confidence interval overlapping 1).", {"entities": []}], ["Ethnographic research demonstrated a predominantly positive response to the intervention among stakeholders, including patients, promotoras , PCPs, non-professional staff workers, administrators, and community advisory board members.", {"entities": []}], ["Due to continuing unmet mental health needs, we favor further assessment of innovative roles for community health workers.", {"entities": []}], ["Spirometry testing is essential to confirm an obstructive lung disease, but studies have reported that a large proportion of patients diagnosed with COPD or asthma have no history of spirometry testing.", {"entities": [[46, 70, "DISEASE"], [157, 163, "DISEASE"], [58, 70, "DISEASE"]]}], ["Also, it has been shown that many patients are prescribed medication for obstructive lung disease without a relevant diagnosis or spirometry test registered.", {"entities": [[73, 97, "DISEASE"], [85, 97, "DISEASE"]]}], ["General practice characteristics have been reported to influence diagnosis and management of several chronic diseases.", {"entities": []}], ["However, these findings are inconsistent, and it is uncertain whether practice characteristics influence spirometry testing among patients receiving medication for obstructive lung disease.", {"entities": [[164, 188, "DISEASE"], [176, 188, "DISEASE"]]}], ["The aim of this study was therefore to examine if practice characteristics are associated with spirometry testing among patients receiving first-time prescriptions for medication targeting obstructive lung disease.", {"entities": [[189, 213, "DISEASE"], [201, 213, "DISEASE"]]}], ["A national register-based cohort study was performed.", {"entities": []}], ["All patients over 18 years receiving first-time prescriptions for medication targeting obstructive lung disease in 2008 were identified and detailed patient-specific data on sociodemographic status and spirometry tests were extracted.", {"entities": [[87, 111, "DISEASE"], [99, 111, "DISEASE"]]}], ["Information on practice characteristics like number of doctors, number of patients per doctor, training practice status, as well as age and gender of the general practitioners was linked to each medication user.", {"entities": []}], ["Partnership practices had a higher odds ratio (OR) of performing spirometry compared with single-handed practices (OR 1.24, CI 1.09-1.40).", {"entities": []}], ["We found a significant association between increasing general practitioner age and decreasing spirometry testing.", {"entities": []}], ["This tendency was most pronounced among partnership practices, where doctors over 65 years had the lowest odds of spirometry testing (OR 0.25, CI 0.10-0.61).", {"entities": []}], ["Training practice status was significantly associated with spirometry testing among single-handed practices (OR 1.40, CI 1.10-1.79).", {"entities": []}], ["Some of the variation in spirometry testing among patients receiving first-time prescriptions for medication targeting obstructive lung disease was associated with practice characteristics.", {"entities": [[119, 143, "DISEASE"], [131, 143, "DISEASE"]]}], ["This variation in performance may indicate a potential for quality improvement.", {"entities": []}], ["The objective was to assess adverse outcomes in relation to the simplified Pulmonary Embolism Severity Index (PESI) score in patients treated with rivaroxaban or standard therapy in the phase III EINSTEIN PE study and to evaluate the utility of the simplified PESI score to identify low-risk pulmonary embolism (PE) patients.", {"entities": [[75, 93, "DISEASE"], [292, 310, "DISEASE"]]}], ["A post hoc analysis of EINSTEIN PE data was performed to assess the efficacy and safety of rivaroxaban in patients with a range of simplified PESI scores.", {"entities": []}], ["Recurrent venous thromboembolism, fatal PE, all-cause mortality, and major bleeding were stratified by simplified PESI scores of 0, 1, or \u22652 and according to treatment period at 7, 14, 30, and 90\u00a0days and at the end of the full intended treatment period.", {"entities": []}], ["Simplified PESI scores could be calculated in 4,831 of the 4,832 randomized patients; of those, 53.6, 36.7, and 9.7% had PESI scores of 0, 1, and \u22652, respectively.", {"entities": []}], ["Among patients with simplified PESI scores of 0 or 1, fatal PE, all-cause mortality, and other adverse outcomes were uncommon within the first 7, 14, and 30 days.", {"entities": []}], ["Patients with simplified PESI scores of \u22652 had more frequent adverse outcomes.", {"entities": []}], ["Major bleeding was lower in the rivaroxaban group, particularly in those with simplified PESI scores of 1 or \u22652.", {"entities": []}], ["The findings support using risk stratification with the simplified PESI score to identify low-risk patients with PE.", {"entities": []}], ["Most studies investigated probiotics on food hypersensitivity, not on oral food challenge confirmed food allergy in children.", {"entities": [[100, 112, "DISEASE"]]}], ["The authors systematically reviewed the literature to investigate whether probiotic supplementation prenatally and/or postnatally could reduce the risk of atopy and food hypersensitivity in young children.", {"entities": []}], ["PubMed, Embase, the Cochrane Central Register of Controlled Trials, and 4 main Chinese literature databases (Wan Fang, VIP, China National Knowledge Infrastructure, and SinoMed) were searched for randomized controlled trials regarding the effect of probiotics on the prevention of allergy in children.", {"entities": [[119, 122, "GENE"]]}], ["The last search was conducted on July 11, 2015.", {"entities": []}], ["Seventeen trials involving 2947 infants were included.", {"entities": []}], ["The first follow-up studies were analyzed.", {"entities": []}], ["Pooled analysis indicated that probiotics administered prenatally and postnatally could reduce the risk of atopy (relative risk [RR] 0.78; 95% confidence interval [CI] 0.66\u20130.92; I I I Probiotics administered prenatally and postnatally appears to be a feasible way to prevent atopy and food hypersensitivity in young children.", {"entities": []}], ["The long-term effects of probiotics, however, remain to be defined in the follow-up of existing trials.", {"entities": []}], ["Still, studies on probiotics and confirmed food allergy, rather than surrogate measure of food hypersensitivity, are warranted.", {"entities": [[43, 55, "DISEASE"]]}], ["This study was aimed to evaluate the efficacy and tolerability of bisoprolol, in Indian patients diagnosed with stage I essential hypertension as first-line drug.", {"entities": [[130, 142, "DISEASE"], [120, 142, "DISEASE"]]}], ["This was an open-label, phase IV, multicentric prospective study.", {"entities": []}], ["239 outpatient centres across India.", {"entities": []}], ["After ethical approval, patients who were willing to sign informed consent, who are newly diagnosed with JNC VII stage I essential hypertension (systolic blood pressure 140\u2013159\u2005mm\u2002Hg or diastolic blood pressure 90\u201399\u2005mm\u2002Hg) and who are prescribed bisoprolol were enrolled in the study.", {"entities": [[131, 143, "DISEASE"], [121, 143, "DISEASE"]]}], ["Patients with significant organ disease or complications, women of childbearing age refusing reliable contraceptive method, patients with known contraindications (like symptomatic bradycardia, significant atrioventricular blockade, sick sinus syndrome) and patients with known hypersensitivity reactions to bisoprolol and unwilling patients were excluded.", {"entities": [[232, 251, "DISEASE"], [243, 251, "DISEASE"]]}], ["The primary outcome measure was percentage of patients achieving blood pressure (BP) \u2264140/90\u2005mm\u2002Hg at the end of 12\u2005weeks, while multiple secondary outcome measures were assessed.", {"entities": []}], ["Of 2418 patients screened, 2161 patients were recruited (66.64% men, mean age 51.7\u00b19.8\u2005years, smokers 19.19%) and 2131 (96.44%) patients achieved BP control.", {"entities": []}], ["There was significant reduction in systolic blood pressure (\u221225.29; SD: 13.22\u2005mm\u2002Hg), diastolic blood pressure (\u221214.14; SD: 7.67\u2005mm\u2002Hg) and heart rate (\u221212/min; SD: 6.15) compared with baseline (all p values <0.05).", {"entities": []}], ["The median dose of bisoprolol and average period required for the response were 5\u2005mg/day and 33\u2005days, respectively.", {"entities": []}], ["Bisoprolol was found to be well tolerated in the patients up to 10\u2005mg/day.", {"entities": []}], ["A total of 1.9% patients showed adverse events, which were mild to moderate in severity without any severe adverse event.", {"entities": []}], ["None required treatment withdrawal.", {"entities": []}], ["Bisoprolol is an effective and safe option to control BP.", {"entities": []}], ["Thus, it can be used as one of the first-line antihypertensive in Indian patients.", {"entities": []}], ["What is the efficacy of bisoprolol in essential hypertension patients?", {"entities": [[48, 60, "DISEASE"], [38, 60, "DISEASE"]]}], ["What is the average dose of bisoprolol required for BP control?", {"entities": []}], ["What is the tolerability of bisoprolol in essential hypertensive patients?", {"entities": []}], ["Bisoprolol is safe and effective in stage I essential hypertensive patients in India.", {"entities": []}], ["The average dose required was 5\u2005mg/day.", {"entities": []}], ["Target BP was achieved in 96.44% patients.", {"entities": []}], ["First-ever study done for bisoprolol in large Indian population.", {"entities": []}], ["Study re-affirms bisoprolol as first-line drug in the management of hypertension.", {"entities": [[68, 80, "DISEASE"]]}], ["Open-label study.", {"entities": []}], ["Short duration\u20143 months study.", {"entities": []}], ["Solena heterophylla Lour.", {"entities": []}], ["has traditionally been used in the management of diseases pertaining to gastrointestinal, respiratory and vascular system and present study was undertaken to validate its traditional uses.", {"entities": []}], ["The aqueous ethanolic extract of Solena heterophylla Lour (Sh.Cr) was tested in-vitro on isolated rabbit jejunum, tracheal and aorta preparations.", {"entities": []}], ["The responses of tissues were recorded using isotonic transducers coupled with PowerLab data acquisition system.", {"entities": []}], ["The aqueous ethanolic extract of Solena heterophylla Lour (Sh.Cr) (0.03-1.0\u00a0mg/ml) on application to spontaneous contractions in isolated rabbit jejunum preparation exerted relaxant effect through decrease in magnitude and frequency of contractions, caused relaxation of K The observed relaxant effect may be outcome of anti-muscarinic and Ca", {"entities": []}], ["The quality of a consultation provided by a physician can have a profound impact on the quality of care and patient engagement in treatment decisions.", {"entities": []}], ["When the COPD Assessment Test (CAT) was developed, one of its aims was to aid the communication between physician and patient about the impact of COPD.", {"entities": []}], ["We developed a novel study design to assess this in a primary care consultation.", {"entities": []}], ["Primary care physicians across five countries in Europe conducted videoed consultations with six standardised COPD patients (played by trained actors) which had patient-specific issues that the physician needed to identify through questioning.", {"entities": []}], ["Half the physicians saw the patients with the completed CAT, and half without.", {"entities": []}], ["Independent assessors scored the physicians on their ability to identify and address the patient-specific issues, review standard COPD aspects, their understanding of the case and their overall performance.", {"entities": []}], ["This novel study design presented many challenges which needed to be addressed to achieve an acceptable level of robustness to assess the utility of the CAT.", {"entities": []}], ["This paper discusses these challenges and the measures adopted to eliminate or minimise their impact on the study results.", {"entities": []}], ["TB and HIV co-morbidity amount to a massive burden on healthcare systems in many countries.", {"entities": []}], ["This study investigates health related quality of life among tuberculosis (TB), TB retreatment and TB-HIV co-infected public primary health care patients in three districts in South Africa.", {"entities": [[61, 73, "DISEASE"]]}], ["A cross sectional study was conducted among 4900 TB patients who were in the first month of anti-TB treatment in primary public health care clinics in three districts in South Africa.", {"entities": []}], ["Quality of life was assessed using the social functioning (SF)-12 Health Survey through face to face interviews.", {"entities": []}], ["Associations of physical health (Physical health Component Summary\u2009=\u2009PCS) and mental health (Mental health Component Summary\u2009=\u2009MCS) were identified using logistic regression analyses.", {"entities": []}], ["The overall physical and mental health scores were 42.5 and 40.7, respectively.", {"entities": []}], ["Emotional role, general health and bodily pain had the lowest sub-scale scores, while energy and fatigue and mental health had the highest domain scores.", {"entities": []}], ["Independent Kruskal\u2013Wallis tests found significant positive effects of being TB-HIV co-infected on the domains of mental health functioning, emotional role, energy and fatigue, social function and physical role, while significant negative effects were observed on general health, bodily pain and physical function.", {"entities": []}], ["In multivariable analysis higher educational, lower psychological distress, having fewer chronic conditions and being HIV negative were significantly positively associated with PCS, and low poverty, low psychological distress and being HIV positive were positively significantly associated with MCS.", {"entities": []}], ["TB and HIV weaken patients\u2019 physical functioning and impair their quality of life .", {"entities": []}], ["It is imperative that TB control programmes at public health clinics design strategies to improve the quality of health of TB and HIV co-infected patients.", {"entities": []}], ["The respiratory mucosa is a major site for pathogen invasion and, hence, a site requiring constant immune surveillance.", {"entities": []}], ["The type I, semi-invariant natural killer T (NKT) cells are enriched within the lung vasculature.", {"entities": []}], ["Despite optimal positioning, the role of NKT cells in respiratory infectious diseases remains poorly understood.", {"entities": []}], ["Hence, we assessed their function in a murine model of pulmonary tularemia\u2014because tularemia is a sepsis-like proinflammatory disease and NKT cells are known to control the cellular and humoral responses underlying sepsis.", {"entities": [[65, 74, "DISEASE"], [83, 92, "DISEASE"]]}], ["Here we show for the first time that respiratory infection with Francisella tularensis live vaccine strain resulted in rapid accumulation of NKT cells within the lung interstitium.", {"entities": []}], ["Activated NKT cells produced interferon-\u03b3 and promoted both local and systemic proinflammatory responses.", {"entities": []}], ["Consistent with these results, NKT cell-deficient mice showed reduced inflammatory cytokine and chemokine response yet they survived the infection better than their wild type counterparts.", {"entities": []}], ["Strikingly, NKT cell-deficient mice had increased lymphocytic infiltration in the lungs that organized into tertiary lymphoid structures resembling induced bronchus-associated lymphoid tissue (iBALT) at the peak of infection.", {"entities": []}], ["Thus, NKT cell activation by F .", {"entities": []}], ["tularensis infection hampers iBALT formation and promotes a systemic proinflammatory response, which exacerbates severe pulmonary tularemia-like disease in mice.", {"entities": [[130, 139, "DISEASE"]]}], ["NKT cells are innate-like lymphocytes with a demonstrated role in a wide range of diseases.", {"entities": []}], ["Often cited for their ability to rapidly produce a variety of cytokines upon activation, they have long been appreciated for their ability to \u201cjump-start\u201d the immune system and to shape the quality of both the innate and adaptive response.", {"entities": []}], ["This understanding of their function has been deduced from in vitro experiments or through the in vivo administration of highly potent, chemically synthesized lipid ligands, which may not necessarily reflect a physiologically relevant response as observed in a natural infection.", {"entities": []}], ["Using a mouse model of pulmonary tularemia, we report that intranasal infection with the live vaccine strain of F .", {"entities": [[33, 42, "DISEASE"]]}], ["tularensis rapidly activates NKT cells and promotes systemic inflammation, increased tissue damage, and a dysregulated immune response resulting in increased morbidity and mortality in infected mice.", {"entities": []}], ["Our data highlight the detrimental effects of NKT cell activation and identify a potential new target for therapies against pulmonary tularemia.", {"entities": [[134, 143, "DISEASE"]]}], ["There is a recognised need to build primary care medication adherence services which are tailored to patients' needs.", {"entities": []}], ["Continuous quality improvement of such services requires a regular working method of measuring adherence in order to monitor effectiveness.", {"entities": []}], ["Self report has been considered the method of choice for clinical use; it is cheap, relatively unobtrusive and able to distinguish between intentional and unintentional non-adherence, which have different underlying causes and therefore require different interventions.", {"entities": []}], ["A self report adherence measure used in routine clinical practice would ideally be brief, acceptable to patients, valid, reliable, have the ability to distinguish between different types of non-adherence and be able to be completed by or in conjunction with carers where necessary.", {"entities": []}], ["We systematically reviewed the literature in order to identify self report adherence measures currently available which are suitable for primary care and evaluate the extent to which they met the criteria described above.", {"entities": []}], ["We searched the databases Medline, Embase, International Pharmaceutical Abstracts, Pharmline, CINAHL, PsycINFO and HaPI to identify studies reporting the development, validation or reliability of generic adherence measures.", {"entities": []}], ["One reviewer screened all abstracts and assessed all relevant full text articles obtained and a second reviewer screened/assessed 10% to check reliability.", {"entities": []}], ["Fifty eight measures were identified.", {"entities": []}], ["While validation data were presented in support of the vast majority of self reported measures (54/58), data for a relatively small number of measures was presented for reliability (16/58) and time to complete (3/58).", {"entities": []}], ["Few were designed to have the ability to be completed by or in conjunction with carers and few were able to distinguish between different types of non-adherence, which limited their ability be used effectively in the continuous improvement of targeted adherence enhancing interventions.", {"entities": []}], ["The data available suggested that patients find it easier to estimate general adherence than to report a specific number of doses missed.", {"entities": []}], ["Visual analogue scales can be easier for patients than other types of scale but are not suitable for telephone administration.", {"entities": []}], ["There is a need for a measure which can be used in the routine continual quality monitoring of adherence services.", {"entities": []}], ["Cohort studies are of great importance in defining the mechanism responsible for the development of allergy-associated diseases, such as atopic dermatitis, allergic asthma, and allergic rhinoconjunctivitis.", {"entities": [[137, 154, "DISEASE"], [156, 171, "DISEASE"], [165, 171, "DISEASE"], [144, 154, "DISEASE"]]}], ["Although these disorders share genetic and environmental risk factors, it is still under debate whether they are linked or develop sequentially along an atopic pathway.", {"entities": []}], ["The current study was aimed to determine the pattern of allergy sensitization in the Lithuanian birth cohort \u201cAlergemol\u201d ( n = 1558) established as a part of the multicenter European birth cohort \u201cEuroPrevall\u201d.", {"entities": []}], ["Early sensitization to food allergens in the \u201cAlergemol\u201d birth cohort was analysed.", {"entities": []}], ["The analysis revealed 1.3% and 2.8% of symptomatic-sensitized subjects at 6 and 12 months of age, respectively.", {"entities": []}], ["The sensitization pattern in response to different allergens in the group of infants with food allergy symptoms was studied using allergological methods in vivo and in vitro .", {"entities": [[90, 102, "DISEASE"]]}], ["The impact of maternal and environmental risk factors on the early development of food allergy in at 6 and 12 months of age was evaluated.", {"entities": [[82, 94, "DISEASE"]]}], ["Our data showed that maternal diet, diseases, the use of antibiotics, and tobacco smoke during pregnancy had no significant impact on the early sensitization to food allergens.", {"entities": []}], ["However, infants of atopic mothers were significantly more often sensitized to egg as compared to the infants of nonatopic mothers.", {"entities": []}], ["Patients with COPD experience respiratory symptoms, impairments of daily living and recurrent exacerbations.", {"entities": []}], ["The aim of integrated disease management (IDM) is to establish a programme of different components of care (ie, self-management, exercise, nutrition) in which several healthcare providers (ie, nurses, general practitioners, physiotherapists, pulmonologists) collaborate to provide efficient and good quality of care.", {"entities": []}], ["The aim of this Cochrane systematic review was to evaluate the effectiveness of IDM on quality of life, exercise tolerance and exacerbation related outcomes.", {"entities": []}], ["Searches for all available evidence were carried out in various databases.", {"entities": []}], ["Included randomised controlled trials (RCTs) consisted of interventions with multidisciplinary (\u22652 healthcare providers) and multitreatment (\u22652 components) IDM interventions with duration of at least 3\u2005months.", {"entities": []}], ["Two reviewers independently searched, assessed and extracted data of all RCTs.", {"entities": []}], ["A total of 26 RCTs were included, involving 2997 patients from 11 different countries with a follow-up varying from 3 to 24\u2005months.", {"entities": []}], ["In all 68% of the patients were men, with a mean age of 68\u2005years and a mean forced expiratory volume in 1\u2005s (FEV 1 ) predicted value of 44.3%.", {"entities": [[109, 112, "GENE"]]}], ["Patients treated with an IDM programme improved significantly on quality of life scores and reported a clinically relevant improvement of 44\u2005m on 6\u2005min walking distance, compared to controls.", {"entities": []}], ["Furthermore, the number of patients with \u22651 respiratory related hospital admission reduced from 27 to 20 per 100 patients.", {"entities": []}], ["Duration of hospitalisation decreased significantly by nearly 4\u2005days.", {"entities": []}], ["Regular review and support for asthma self-management is promoted in guidelines.", {"entities": [[31, 37, "DISEASE"]]}], ["A randomised controlled trial suggested that unscheduled health care usage was similar when patients were offered self management support by a lay-trainer or practice nurses.", {"entities": []}], ["Following the RCT, a costing study was undertaken using the trial data to account for the cost of delivery of the service under both strategies and the resulting impact on unscheduled healthcare (measure of effectiveness) in this trial.", {"entities": []}], ["One year data (n = 418) showed that 29% (61/205) of the nurse group required unscheduled healthcare (177 events) compared with 30.5% (65/213) for lay-trainers (178 events).", {"entities": []}], ["The training costs for the lay-trainers were greater than nurses (\u00a336 versus \u00a318 respectively per patient, p<0.001), however, the consultation cost for lay-trainers were lower than nurses (\u00a36 per patient versus \u00a324, p<0.001).", {"entities": []}], ["If the cost of unscheduled healthcare are accounted for then the costs of nurses is \u00a3161, and \u00a3135 for lay-trainers (mean difference \u00a325, [95% CI = \u2212\u00a397, \u00a3149, p = 0.681]).", {"entities": []}], ["The total costs (delivery and unscheduled healthcare) were \u00a3202 per patient for nurses versus \u00a3178 for lay-trainers, (mean difference \u00a324, [95%CI = \u2212\u00a3100, \u00a3147, p = 0.707]).", {"entities": []}], ["There were no significant differences in the cost of training and healthcare delivery between nurse and lay trainers, and no significant difference in the cost of unscheduled health care use.", {"entities": []}], ["Objective Adult patients with pertussis rarely show typical symptoms, such as paroxysmal coughing, inspiratory \u201cwhoop\u201d, or post-tussive vomiting.", {"entities": [[30, 39, "DISEASE"]]}], ["While a culture is regarded as the gold standard for diagnosis, the sensitivity is very low.", {"entities": []}], ["Therefore, the diagnosis of pertussis in adults in clinical practice is mostly based on single-sample serology using an enzyme-linked immunosorbent assay (ELISA) with the pertussis toxin antigen.", {"entities": [[28, 37, "DISEASE"], [171, 180, "DISEASE"]]}], ["Various cut-off values for the anti-pertussis toxin IgG (PT-IgG) have been proposed.", {"entities": [[36, 45, "DISEASE"]]}], ["It has been reported that concentrations of PT-IgG fall below the defined cut-off about 4.5 months after infection on average, and within 1 year in most patients.", {"entities": []}], ["We investigated the distribution and time course of the PT-IgG levels.", {"entities": []}], ["Methods The data were collected from the medical records.", {"entities": []}], ["Patients The study retrospectively identified subjects who had visited Ikebukuro Otani Clinic, which is a specialized clinic for patients with cough.", {"entities": []}], ["We retrospectively reviewed 406 patients with PT-IgG measurements to investigate the age distribution of PT-IgG levels.", {"entities": []}], ["The changes in PT-IgG levels over time were assessed in the 205 patients who had more than one PT-IgG measurement.", {"entities": []}], ["Results PT-IgG levels were \u2265100 EU/mL in more than 15% of subjects.", {"entities": []}], ["The PT-IgG levels of a few subjects had diminished over a long period of time.", {"entities": []}], ["Conclusion A PT-IgG level greater than the defined cut-off value simply indicates past infection or immunization in most subjects.", {"entities": []}], ["As such, a single measurement of PT-IgG using the cut-off values might lead to overdiagnosis of pertussis.", {"entities": [[96, 105, "DISEASE"]]}], ["Further data collection and analysis are required.", {"entities": []}], ["Biomass combustion contributes to the production of ambient particulate matter (PM) in rural environments as well as urban settings, but relatively little is known about the health effects of these emissions.", {"entities": []}], ["The aim of this study was therefore to characterize airway responses in humans exposed to wood smoke PM under controlled conditions.", {"entities": []}], ["Nineteen healthy volunteers were exposed to both wood smoke, at a particulate matter (PM 2.5 ) concentration of 224 \u00b1 22 \u03bcg/m Glutathione (GSH) concentrations were enhanced in bronchoalveolar lavage (BAL) after wood smoke exposure vs. air (p = 0.025), together with an increase in upper airway symptoms.", {"entities": []}], ["Neither lung function, exhaled NO nor systemic nor airway inflammatory parameters in BAL and bronchial mucosal biopsies were significantly affected.", {"entities": []}], ["Exposure of healthy subjects to wood smoke, derived from an experimental wood pellet boiler operating under incomplete combustion conditions with PM emissions dominated by organic matter, caused an increase in mucosal symptoms and GSH in the alveolar respiratory tract lining fluids but no acute airway inflammatory responses.", {"entities": []}], ["We contend that this response reflects a mobilisation of GSH to the air-lung interface, consistent with a protective adaptation to the investigated wood smoke exposure.", {"entities": []}], ["Undiagnosed airflow limitation is common in the general population and is associated with impaired health and functional status.", {"entities": []}], ["Smoking is the most important risk factor for this condition.", {"entities": []}], ["Although primary care practitioners see most adult smokers, few currently have spirometers or regularly order spirometry tests in these patients.", {"entities": []}], ["Brief medical advice has shown to be effective in modifying smoking habits in a large number of smokers but only a small proportion remain abstinent after one year.", {"entities": []}], ["The aim of this study is to evaluate the effectiveness of regular reporting of spirometric results combined with a smoking cessation advice by a primary care physician on smoking quit rate in adult smokers.", {"entities": []}], ["Intervention study with a randomized two arms in 5 primary care centres.", {"entities": []}], ["A total of 485 smokers over the age of 18 years consulting their primary care physician will be recruited.", {"entities": []}], ["On the selection visit all participants will undergo a spirometry, peak expiratory flow rate, test of smoking dependence, test of motivation for giving up smoking and a questionnaire on socio-demographic data.", {"entities": []}], ["Thereafter an appointment will be made to give the participants brief structured advice to give up smoking combined with a detailed discussion on the results of the spirometry.", {"entities": []}], ["After this, the patients will be randomised and given appointment for follow up visits at 3, 6, 12 and 24 months.", {"entities": []}], ["Both arms will receive brief structured advice and a detailed discussion of the spirometry results at visit 0.", {"entities": []}], ["The control group will only be given brief structured advice about giving up smoking on the follow up.", {"entities": []}], ["Cessation of smoking will be tested with the carbon monoxide test.", {"entities": []}], ["Early identification of functional pulmonary abnormalities in asymptomatic patients or in those with little respiratory symptomatology may provide \"ideal educational opportunities\".", {"entities": []}], ["These opportunities may increase the success of efforts to give up smoking and may improve the opportunities of other preventive actions to minimise patient risk.", {"entities": []}], ["Comparing adult smokers in the intervention group with those in the control group, a minimum improvement expected with respect to the rates of smoking cessation would represent a large number of avoided morbimortality.", {"entities": []}], ["ClinicalTrials.gov: NCT01296295", {"entities": []}], ["Several uncontrolled studies of hyperbaric treatment in children with autism have reported clinical improvements; however, this treatment has not been evaluated to date with a controlled study.", {"entities": []}], ["We performed a multicenter, randomized, double-blind, controlled trial to assess the efficacy of hyperbaric treatment in children with autism.", {"entities": []}], ["62 children with autism recruited from 6 centers, ages 2\u20137 years (mean 4.92 \u00b1 1.21), were randomly assigned to 40 hourly treatments of either hyperbaric treatment at 1.3 atmosphere (atm) and 24% oxygen (\"treatment group\", n = 33) or slightly pressurized room air at 1.03 atm and 21% oxygen (\"control group\", n = 29).", {"entities": [[182, 185, "GENE"], [271, 274, "GENE"], [182, 185, "GENE"], [271, 274, "GENE"]]}], ["Outcome measures included Clinical Global Impression (CGI) scale, Aberrant Behavior Checklist (ABC), and Autism Treatment Evaluation Checklist (ATEC).", {"entities": []}], ["After 40 sessions, mean physician CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0008), receptive language (p < 0.0001), social interaction (p = 0.0473), and eye contact (p = 0.0102); 9/30 children (30%) in the treatment group were rated as \"very much improved\" or \"much improved\" compared to 2/26 (8%) of controls (p = 0.0471); 24/30 (80%) in the treatment group improved compared to 10/26 (38%) of controls (p = 0.0024).", {"entities": []}], ["Mean parental CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0336), receptive language (p = 0.0168), and eye contact (p = 0.0322).", {"entities": []}], ["On the ABC, significant improvements were observed in the treatment group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group.", {"entities": []}], ["In the treatment group compared to the control group, mean changes on the ABC total score and subscales were similar except a greater number of children improved in irritability (p = 0.0311).", {"entities": []}], ["On the ATEC, sensory/cognitive awareness significantly improved (p = 0.0367) in the treatment group compared to the control group.", {"entities": []}], ["Post-hoc analysis indicated that children over age 5 and children with lower initial autism severity had the most robust improvements.", {"entities": []}], ["Hyperbaric treatment was safe and well-tolerated.", {"entities": []}], ["Children with autism who received hyperbaric treatment at 1.3 atm and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.", {"entities": [[62, 65, "GENE"]]}], ["clinicaltrials.gov NCT00335790", {"entities": []}], ["5-lipoxygenase (5-LO) catalyses the transformation of arachidonic acid (AA) into leukotrienes (LTs), which are important lipid mediators of inflammation.", {"entities": []}], ["LTs have been directly implicated in inflammatory diseases like asthma, atherosclerosis and rheumatoid arthritis; therefore inhibition of LT biosynthesis is a strategy for the treatment of these chronic diseases.", {"entities": [[72, 87, "DISEASE"], [92, 112, "DISEASE"], [103, 112, "DISEASE"], [64, 70, "DISEASE"], [138, 140, "GENE"]]}], ["Analogues of caffeic acid, including the naturally-occurring caffeic acid phenethyl ester (CAPE), were synthesized and evaluated for their capacity to inhibit 5-LO and LTs biosynthesis in human polymorphonuclear leukocytes (PMNL) and whole blood.", {"entities": []}], ["Anti-free radical and anti-oxidant activities of the compounds were also measured.", {"entities": []}], ["Caffeic acid did not inhibit 5-LO activity or LT biosynthesis at concentrations up to 10 \u00b5M.", {"entities": [[46, 48, "GENE"]]}], ["CAPE inhibited 5-LO activity (IC 50 0.13 \u00b5M, 95% CI 0.08\u20130.23 \u00b5M) more effectively than the clinically-approved 5-LO inhibitor zileuton (IC 50 3.5 \u00b5M, 95% CI 2.3\u20135.4 \u00b5M).", {"entities": []}], ["CAPE was also more effective than zileuton for the inhibition of LT biosynthesis in PMNL but the compounds were equipotent in whole blood.", {"entities": [[65, 67, "GENE"]]}], ["The activity of the amide analogue of CAPE was similar to that of zileuton.", {"entities": []}], ["Inhibition of LT biosynthesis by CAPE was the result of the inhibition of 5-LO and of AA release.", {"entities": [[14, 16, "GENE"]]}], ["Caffeic acid, CAPE and its amide analog were free radical scavengers and antioxidants with IC 50 values in the low \u00b5M range; however, the phenethyl moiety of CAPE was required for effective inhibition of 5-LO and LT biosynthesis.", {"entities": [[213, 215, "GENE"]]}], ["CAPE is a potent LT biosynthesis inhibitor that blocks 5-LO activity and AA release.", {"entities": [[17, 19, "GENE"]]}], ["The CAPE structure can be used as a framework for the rational design of stable and potent inhibitors of LT biosynthesis.", {"entities": [[105, 107, "GENE"]]}], ["The lung has a limited number of patterns of reaction to inhaled particles.", {"entities": []}], ["The disease observed depends upon the location: conducting airways, terminal bronchioles and alveoli, and upon the nature of inflammation induced: acute, subacute or chronic.", {"entities": []}], ["Many different agents cause narrowing of conducting airways (asthma) and some of these cause permanent distortion or obliteration of airways as well.", {"entities": [[61, 67, "DISEASE"]]}], ["Terminal bronchioles appear to be particularly susceptible to particles which cause goblet cell metaplasia, mucous plugging and ultimately peribronchiolar fibrosis.", {"entities": []}], ["Cancer is the last outcome at the bronchial level and appears to depend upon continuous exposure to or retention of an agent in the airway and failure of the affected cells to be exfoliated which may be due to squamous metaplasia.", {"entities": []}], ["Alveoli are populated by endothelial cells, Type I or pavement epithelial cells and metabolically active cuboidal Type II cells that produce the lungs specific surfactant, dipalmytol lecithin.", {"entities": []}], ["Disturbances of surfactant lead to edema in distal lung while laryngeal edema due to anaphylaxis or fumes may produce asphyxia.", {"entities": []}], ["Physical retention of indigestible particles or retention by immune memory responses may provoke hyaline membranes, stimulate alveolar lipoproteinosis and finally fibrosis.", {"entities": []}], ["This later exuberant deposition of connective tissue has been best studied in the occupational pneumoconioses especially silicosis and asbestosis.", {"entities": [[135, 145, "DISEASE"], [121, 130, "DISEASE"]]}], ["In contrast emphysema a catabolic response, appears frequently to result from leakage or release of lysosomal proteases into the lung during processing of cigarette smoke particles.", {"entities": []}], ["The insidious and probably most important human lung disease due to particles is bronchiolar obstruction and obliteration, producing progressive impairment of air flow.", {"entities": [[48, 60, "DISEASE"]]}], ["The responsible particle is the complex combination of poorly digestive lipids and complex carbohydrates with active chemicals which we call cigarette smoke.", {"entities": []}], ["More research is needed to perfect, correct and quantify our preliminary picture of the pathogenesis of lung disease by particles, but a useful start has been made.", {"entities": [[104, 116, "DISEASE"]]}], ["This population-based cohort study aimed to investigate the demographic and psychosocial characteristics associated with fear of childbirth and the relative importance of such fear as a predictor of elective caesarean section.", {"entities": []}], ["A sample of 1789 women from the Akershus Birth Cohort in Norway provided data collected by three self-administered questionnaires at 17 and 32\u00a0weeks of pregnancy and 8\u00a0weeks postpartum.", {"entities": []}], ["Information about the participants\u2019 childbirths was obtained from the hospital records.", {"entities": []}], ["Eight percent of the women reported fear of delivery, defined as a score of \u226585 on the Wijma Delivery Expectancy Questionnaire.", {"entities": []}], ["Using multivariable logistic regression models, a previous negative overall birth experience exerted the strongest impact on fear of childbirth, followed by impaired mental health and poor social support.", {"entities": []}], ["Fear of childbirth was strongly associated with a preference for elective caesarean section (aOR 4.6, 95\u00a0% CI 2.9\u20137.3) whereas the association of fear with performance of caesarean delivery was weaker (aOR 2.4, 95\u00a0% CI 1.2\u20134.9).", {"entities": []}], ["The vast majority (87\u00a0%) of women with fear of childbirth did not, however, receive a caesarean section.", {"entities": []}], ["By contrast, a previous negative overall birth experience was highly predictive of elective caesarean section (aOR 8.1, 95\u00a0% CI 3.9\u201316.7) and few women without such experiences did request caesarean section.", {"entities": []}], ["Results suggest that women with fear of childbirth may have identifiable vulnerability characteristics, such as poor mental health and poor social support.", {"entities": []}], ["Results also emphasize the need to focus on the subjective experience of the birth to prevent fear of childbirth and elective caesarean sections on maternal request.", {"entities": []}], ["Regarding the relationship with social support, causality has to be interpreted cautiously, as social support was measured at 8\u00a0weeks postpartum only.", {"entities": []}], ["Intracellular dynamics of airway smooth muscle cells (ASMC) mediate ASMC contraction and proliferation, and thus play a key role in airway hyper-responsiveness (AHR) and remodelling in asthma.", {"entities": [[185, 191, "DISEASE"], [161, 164, "GENE"]]}], ["We evaluate the importance of store-operated entry (SOCE) in these dynamics by constructing a mathematical model of ASMC signaling based on experimental data from lung slices.", {"entities": []}], ["The model confirms that SOCE is elicited upon sufficient depletion of the sarcoplasmic reticulum (SR), while receptor-operated entry (ROCE) is inhibited in such conditions.", {"entities": []}], ["It also shows that SOCE can sustain agonist-induced oscillations in the absence of other influx.", {"entities": []}], ["SOCE up-regulation may thus contribute to AHR by increasing the oscillation frequency that in turn regulates ASMC contraction.", {"entities": [[42, 45, "GENE"]]}], ["The model also provides an explanation for the failure of the SERCA pump blocker CPA to clamp the cytosolic of ASMC in lung slices, by showing that CPA is unable to maintain the SR empty of .", {"entities": []}], ["This prediction is confirmed by experimental data from mouse lung slices, and strongly suggests that CPA only partially inhibits SERCA in ASMC.", {"entities": []}], ["There is increasing evidence that a strong primary care is a cornerstone of an efficient health care system.", {"entities": []}], ["But Switzerland is facing a shortage of primary care physicians (PCPs).", {"entities": []}], ["This pushed the Federal Council of Switzerland to introduce a multifaceted political programme to strengthen the position of primary care, including its academic role.", {"entities": []}], ["The aim of this paper is to provide a comprehensive overview of the situation of academic primary care at the five Swiss universities by the end of year 2012.", {"entities": []}], ["Although primary care teaching activities have a long tradition at the five Swiss universities with activities starting in the beginning of the 1980ies; the academic institutes of primary care were only established in recent years (2005 \u2013 2009).", {"entities": []}], ["Only one of them has an established chair.", {"entities": []}], ["Human and financial resources vary substantially.", {"entities": []}], ["At all universities a broad variety of courses and lectures are offered, including teaching in private primary care practices with 1331 PCPs involved.", {"entities": []}], ["Regarding research, differences among the institutes are tremendous, mainly caused by entirely different human resources and skills.", {"entities": []}], ["So far, the activities of the existing institutes at the Swiss Universities are mainly focused on teaching.", {"entities": []}], ["However, for a complete academic institutionalization as well as an increased acceptance and attractiveness, more research activities are needed.", {"entities": []}], ["In addition to an adequate basic funding of research positions, competitive research grants have to be created to establish a specialty-specific research culture.", {"entities": []}], ["The tribal inhabitants of the Skardu valley (Pakistan) live in an area of great endemic botanic diversity.", {"entities": []}], ["This paper presents the first quantitative ethnomedicinal spectrum of the valley and information on the uses of medicinal plant.", {"entities": []}], ["This paper aims to analyze and catalogue such knowledge based on Relative Frequency Citation (RFC) and Use Value (UV) of medicinal plants in addition to the configuration of the Pearson correlation coefficient.", {"entities": []}], ["The field study was carried out over a period of approximately 2\u00a0years (2011\u20132013) using semi-structured interviews with 71 informants (most of the informants belonged to an age between 50 and 70\u00a0years) in six remote locations in the valley.", {"entities": []}], ["Ethnomedicinal data was analyzed using frequency citation (FC), relative frequency of citation (RFC) and use value (UV) along with a Pearson correlation coefficient (PCC).", {"entities": []}], ["Demographic characteristics of participants, ethnobotanical inventory of plants and data on medicinal application and administration were recorded.", {"entities": []}], ["A total of 50 medicinal plants belonging to 25 families were reported to be used against 33 different ailments in the valley.", {"entities": []}], ["The maximum reported medicinal plant families were Asteraceae (7 report species), Lamiaceae (6) , Polygonaceae (4) and Rosaceae (4), the most dominant life form of the species includes herbs (38) followed by shrubs and subshrubs (12), the most frequent used part was leaves (41%) followed by root (26%), flower (14%), fruit (9%), seeds (8%), bulb (1%) and bark (1%), the most common preparation and administration methods were infusion (32%), decoction (26%), paste (18%), herbal juice (17%) and powder drug (7%).", {"entities": []}], ["The Pearson correlation coefficient between RFC and UV was 0.732 showing highly positive significant association.", {"entities": []}], ["In this study, we have documented considerable indigenous knowledge about the native medicinal plants in Skardu valley for treating common ailments which are ready to be further investigated phytochemically and pharmacologically which leads to natural drug discovery development.", {"entities": []}], ["The study has various socioeconomic dimensions which are associated with the local communities.", {"entities": []}], ["Little is known about how prenatal maternal stress (PNMS) influences risks of asthma in humans.", {"entities": [[78, 84, "DISEASE"]]}], ["In this small study, we sought to determine whether disaster-related PNMS would predict asthma risk in children.", {"entities": [[88, 94, "DISEASE"]]}], ["In June 1998, we assessed severity of objective hardship and subjective distress in women pregnant during the January 1998 Quebec Ice Storm.", {"entities": []}], ["Lifetime asthma symptoms, diagnoses, and corticosteroid utilization were assessed when the children were 12 years old ( N = 68).", {"entities": [[9, 15, "DISEASE"]]}], ["No effects of objective hardship or timing of the exposure were found.", {"entities": []}], ["However, we found that, in girls only, higher levels of prenatal maternal subjective distress predicted greater lifetime risk of wheezing (OR = 1.11; 90% CI = 1.01\u20131.23), doctor-diagnosed asthma (OR = 1.09; 90% CI = 1.00\u20131.19), and lifetime utilization of corticosteroids (OR = 1.12; 90% CI = 1.01\u20131.25).", {"entities": [[188, 194, "DISEASE"]]}], ["Other perinatal and current maternal life events were also associated with asthma outcomes.", {"entities": [[75, 81, "DISEASE"]]}], ["Findings suggest that stress during pregnancy opens a window for fetal programming of immune functioning.", {"entities": []}], ["A sex-based approach may be useful to examine how prenatal and postnatal environments combine to program the immune system.", {"entities": []}], ["This small study needs to be replicated with a larger, more representative sample.", {"entities": []}], ["Venomous animals have evolved with sophisticated bio-chemical strategies to arrest prey and defend themselves from natural predators.", {"entities": []}], ["In recent years, peptide toxins from venomous animals have drawn considerable attention from researchers due to their surprising chemical, biochemical, and pharmacological diversity.", {"entities": []}], ["Similar to other venomous animals, centipedes are one of the crucial venomous arthropods that have been used in traditional medicine for hundreds of years in China.", {"entities": []}], ["Despite signifying pharmacological importance, very little is known about the active components of centipede venoms.", {"entities": []}], ["More than 500 peptide sequences have been reported in centipede venomous glands by transcriptome analysis, but only a small number of peptide toxins from centipede has been functionally described.", {"entities": []}], ["Like other venomous animals such as snakes, scorpions, and spiders, the venom of centipedes could be an excellent source of peptides for developing drugs for treatments as well as bio-insecticides for agrochemical applications.", {"entities": []}], ["Although centipede venoms are yet to be adequately studied, the venom of centipedes as well as their components described to date, should be compiled to help further research.", {"entities": []}], ["Therefore, based on previous reports, this review focusses on findings and possible therapeutic applications of centipede venoms as well as their components.", {"entities": []}], ["Streptococcus pneumoniae causes a broad spectrum of illnesses ranging from mild upper respiratory tract infections to invasive pneumococcal disease (IPD).", {"entities": []}], ["Quantitative data on the burden of pneumococcal disease, important for the establishment of appropriate vaccination strategies, is currently lacking in adults.", {"entities": []}], ["This multicenter, retrospective cohort study was designed to estimate the clinical and economic burden of IPD in adults over the last decade.", {"entities": []}], ["Data were collected from patients with IPD at 10 university hospitals in South Korea.", {"entities": []}], ["We estimated the proportion of IPD among all hospitalized patients, the case fatality rate, and the direct medical costs of IPD.", {"entities": []}], ["Data were further analyzed according to age and risk groups.", {"entities": []}], ["During the study period, 970 patients with IPD were identified.", {"entities": []}], ["The mean age for all patients was 60.9 years; patients aged 50\u201364 years (33.0%) were most numerous, followed by those aged 65\u201374 years (27.4%).", {"entities": []}], ["Overall, the proportion of IPD was 0.36 cases/1000 hospitalized patients and the case fatality rate was 30.9%, which increased significantly with age ( p < 0.01).", {"entities": []}], ["The mean direct medical costs were estimated to be US $7,452 without a difference between age and risk groups.", {"entities": []}], ["On multivariate analysis, old age, advanced ECOG performance status, bacteremic pneumonia, and nosocomial infection were independent risk factors of 30-day case fatality.", {"entities": [[80, 89, "DISEASE"]]}], ["The clinical disease burden of IPD increased significantly with age and direct medical costs from IPD were substantial, regardless of age and co-morbid conditions.", {"entities": []}], ["The current age-based vaccination strategy appears to be appropriate.", {"entities": []}], ["The aim of this study was to investigate role of common pollen in Korean school-aged children with allergic rhinitis (AR) in 5 provinces (Incheon Metropolitan City-Gyeonggi Province, Chungcheongbuk-do, Gwangju Metropolitan City, Busan Metropolitan City, and Jeju Special Self-Governing Province), using a questionnaire and skin prick test, and to assess the differences among the residential regions.", {"entities": [[99, 116, "DISEASE"], [108, 116, "DISEASE"]]}], ["Among the enrolled 14,678 total children, 1,641 (22.0%) had AR.", {"entities": []}], ["The sensitization rate to pollen (38.7%) was the second highest among examined allergens and significant differences were in the sensitization rates to trees, weeds, and grasses among the 5 provinces ( P < 0.05).", {"entities": []}], ["The sensitization to trees (25.2%) was the highest common among the pollen types and significant differences also were observed in the sensitization rates to alder, birch, Japanese cedar, oak, and elm among the 5 provinces.", {"entities": []}], ["The sensitization rate to weeds (19.9%) was the second highest and significant differences were observed in the sensitization rate to Japanese hop, mugwort, and ragweed among the 5 provinces.", {"entities": []}], ["The sensitization rate to house dust mite was 86.8%, the highest among examined allergens and that to Dermatophagoides farinae exhibited regional differences ( P = 0.003) but not to D. farinae ( P = 0.584).", {"entities": []}], ["The sensitization rate to mold (13.5%) was the highest in Jeju and lowest in Busan, and a statistically significant difference was detected among the 5 provinces.", {"entities": []}], ["These results support that examined pollen allergens are strongly associated with residential region due to regional causative pollen differences among children with AR within Korea to investigate the main pollen allergens.", {"entities": []}], ["Pandemic type A (H1N1) influenza arose in early 2009, probably in Mexico and the United States, and reappeared in North America in September for seven more months.", {"entities": [[23, 32, "DISEASE"]]}], ["An amino acid substitution in the hemagglutinin (HA), D222G, has been reported in a significant proportion of patients with a severe and fatal outcome.", {"entities": []}], ["We studied the prevalence of HA222 substitutions in patients in Mexico during the second wave and its association with clinical outcome and pathogenicity in a mouse model.", {"entities": []}], ["The nucleotide sequences of hemagglutinin (HA) from viruses collected from 77 patients were determined including 50 severe and fatal cases and 27 ambulatory cases.", {"entities": []}], ["Deep sequencing was done on 5 samples from severe or fatal cases in order to determine the quasispecies proportion.", {"entities": []}], ["Weight loss and mortality due to infection with cultured influenza viruses were analyzed in a mouse model.", {"entities": [[57, 66, "DISEASE"]]}], ["Viruses from 14 out of 50 hospitalized patients (28%) had a non aspartic acid residue at the HA 222 position (nD222), while all 27 ambulatory patients had D222 (p\u2009=\u20090.0014).", {"entities": []}], ["G222 was detected as sole species or in coexistence with N222 and D222 in 12 patients with severe disease including 8 who died.", {"entities": []}], ["N222 in coexistence with D222 was detected in 1 patient who died and co-occurrence of A222 and V222, together with D222, was detected in another patient who died.", {"entities": []}], ["The patients with a nD222 residue had higher mortality (71.4%), compared to the group with only D222 (22.2%, p\u2009=\u20090.0008).", {"entities": []}], ["Four of the 14 viruses from hospitalized patients were cultured and intranasally infected into mice.", {"entities": []}], ["Two viruses with G222 were lethal while a third virus, with G222, caused only mild illness in mice similar to the fourth virus that contained D222.", {"entities": []}], ["We confirm the elevated incidence of HA222 (H1N1)pdm09 variants in severe disease and mortality.", {"entities": []}], ["Both clinical and mouse infection data support the idea that nD222 mutations contribute to increased severity of disease but additional determinants in disease outcome may be present.", {"entities": []}], ["Lightman discusses a new study that found that in a mouse model of choroidal neovascularisation (CNV), IL-10-deficient mice had decreased amounts of CNV.", {"entities": []}], ["As one of the most common cancers in men, the pathogenesis of prostate cancer has been widely researched.", {"entities": [[71, 77, "DISEASE"], [62, 77, "DISEASE"]]}], ["Aberrant activation of the erb-b2 receptor tyrosine kinase 2 (ERBB2) has been found to play a critical role in metastatic prostate cancer.", {"entities": [[131, 137, "DISEASE"], [122, 137, "DISEASE"], [62, 67, "GENE"]]}], ["In our previous study, we demonstrated that rs61552325 (Pro1140Ala) located in ERBB2 is strongly correlated to prostate cancer.", {"entities": [[120, 126, "DISEASE"], [111, 126, "DISEASE"], [79, 84, "GENE"]]}], ["Therefore, we initially studied the effect of rs61552325 on androgen-independent prostate cancer cell metastasis.", {"entities": [[90, 96, "DISEASE"], [81, 96, "DISEASE"]]}], ["Bioinformatic results demonstrated that the mutant Pro1140Ala likely decrease the stability of the ERBB2 protein and its interactions.", {"entities": [[99, 104, "GENE"]]}], ["The mean migration rate after 6 h for PC3 minor variant cells which carried the G allele was 1.28-fold higher than major variant PC3 cells that carried the C allele ( P = 0.016).", {"entities": []}], ["The mean invasion rate of DU145 putative minor variant cells was 0.40 reducer than negative control cells ( P = 5.9E-04).", {"entities": []}], ["rs61552325 major variant (C allele) and minor variant (G allele) were produced by site directed mutagenesis and transfected into DU145 and PC3 cells.", {"entities": []}], ["A wound healing assay was performed to compare migration abilities between alleles.", {"entities": []}], ["After knocking down endogenous ERBB2 and then expressing the rs61552325 minor variant, invasion abilities were evaluated with a transwell assay using DU145 and PC3 cells.", {"entities": [[31, 36, "GENE"]]}], ["Our data showed that the rs61552325 major variant decreases PC3 cell migration and its minor variant depresses DU145 cell invasion, suggesting that rs61552325 is likely an important change during prostate cancer invasion.", {"entities": [[205, 211, "DISEASE"], [196, 211, "DISEASE"]]}], ["Loquat ( Eriobotrya japonica Lindl.)", {"entities": []}], ["is a subtropical fruit tree with high medicinal value native to China.", {"entities": []}], ["Different organs of loquat have been used historically as folk medicines and this has been recorded in Chinese history for thousands of years.", {"entities": []}], ["Research shows that loquat extracts contain many antioxidants, and different extracts exhibit bioactivity capable of counteracting inflammation, diabetes, cancer, bacterial infection, aging, pain, allergy and other health issues.", {"entities": [[155, 161, "DISEASE"]]}], ["Bioactive compounds such as phenolics and terpenoids have been isolated and characterized to provide a better understanding of the chemical mechanisms underlying the biological activities of loquat extracts.", {"entities": []}], ["As the identification of compounds progresses, studies investigating the in vivo metabolism, bioavailability, and structure\u2013activity relationships, as well as potential toxicity of loquat extracts in animal or cell models are receiving more attention.", {"entities": []}], ["In addition, genetic studies and breeding of loquat germplasms for high contents of health-benefiting compounds may provide new insight for the loquat industry and research.", {"entities": []}], ["This review is focused on the main medicinal properties reported and the possible pharmaceutically active compounds identified in different loquat extracts.", {"entities": []}], ["Artesunate is an important agent for cerebral malaria and all kinds of other severe malaria because it is highly efficient, lowly toxic, and well-tolerated.", {"entities": [[37, 53, "DISEASE"], [46, 53, "DISEASE"], [84, 91, "DISEASE"]]}], ["Loads of research pointed out that it had widespread pharmacological activities such as antiparasites, antitumor, anti-inflammation, antimicrobes activities.", {"entities": []}], ["As we know, the occurrence and development of neurological disorders usually refer to intricate pathophysiologic mechanisms and multiple etiopathogenesis.", {"entities": []}], ["Recent progress has also demonstrated that drugs with single mechanism and serious side-effects are not likely the candidates for treatment of the neurological disorders.", {"entities": []}], ["Therefore, the pluripotent action of artesunate may result in it playing an important role in the prevention and treatment of these neurological disorders.", {"entities": []}], ["This review provides an overview of primary pharmacological mechanism of artesunate and its potential therapeutic effects on neurological disorders.", {"entities": []}], ["Meanwhile, we also briefly summarize the primary mechanisms of artemisinin and its derivatives.", {"entities": []}], ["We hope that, with the evidence presented in this review, the effect of artesunate in prevention and curing for neurological disorders can be further explored and studied in the foreseeable future.", {"entities": []}], ["A disintegrin and metalloprotease 10 (ADAM10) is a ubiquitously expressed transmembrane protein which is essential for embryonic development through activation of Notch proteins.", {"entities": [[38, 44, "GENE"]]}], ["ADAM10 regulates over 40 other transmembrane proteins and acts as a \u2018molecular scissor\u2019 by removing their extracellular regions.", {"entities": [[0, 6, "GENE"]]}], ["ADAM10 is also a receptor for \u03b1-toxin, a major virulence factor of Staphylococcus aureus .", {"entities": [[0, 6, "GENE"]]}], ["Owing to the importance of its substrates, ADAM10 is a potential therapeutic target for cancer, neurodegenerative diseases such as Alzheimer's and prion diseases, bacterial infection and inflammatory diseases such as heart attack, stroke and asthma.", {"entities": [[242, 248, "DISEASE"], [88, 94, "DISEASE"], [43, 49, "GENE"]]}], ["However, targetting ADAM10 is likely to result in toxic side effects.", {"entities": [[20, 26, "GENE"]]}], ["The tetraspanins are a superfamily of 33 four-transmembrane proteins in mammals which interact with and regulate specific partner proteins within membrane nanodomains.", {"entities": []}], ["Tetraspanins appear to have a cone-shaped structure with a cholesterol-binding cavity, which may enable tetraspanins to undergo cholesterol-regulated conformational change.", {"entities": []}], ["An emerging paradigm for tetraspanin function is the regulation of ADAM10 by the TspanC8 subgroup of tetraspanins, namely Tspan5, 10, 14, 15, 17 and 33.", {"entities": [[67, 73, "GENE"], [122, 128, "GENE"]]}], ["This review will describe how TspanC8s are required for ADAM10 trafficking from the endoplasmic reticulum and its enzymatic maturation.", {"entities": [[56, 62, "GENE"]]}], ["Moreover, different TspanC8s localise ADAM10 to different subcellular localisations and may cause ADAM10 to adopt distinct conformations and cleavage of distinct substrates.", {"entities": [[38, 44, "GENE"], [98, 104, "GENE"], [38, 44, "GENE"], [98, 104, "GENE"]]}], ["We propose that ADAM10 should now be regarded as six different scissor proteins depending on the interacting TspanC8.", {"entities": [[16, 22, "GENE"]]}], ["Therapeutic targetting of specific TspanC8/ADAM10 complexes could allow ADAM10 targetting in a cell type- or substrate-specific manner, to treat certain diseases while minimising toxicity.", {"entities": [[43, 49, "GENE"], [72, 78, "GENE"]]}], ["Passenger ships provide conditions suitable for the survival and growth of pest populations.", {"entities": []}], ["Arthropods and rodents can gain access directly from the ships' open spaces, can be carried in shiploads, or can be found on humans or animals as ectoparasites.", {"entities": []}], ["Vectors on board ships may contaminate stored foods, transmit illness on board, or, introduce diseases in new areas.", {"entities": []}], ["Pest species, ship areas facilitating infestations, and different risk factors related to infestations were identified in 21 ferries.", {"entities": []}], ["486 traps for insects and rodents were placed in 21 ferries.", {"entities": []}], ["Archives of Public Health Authorities were reviewed to identify complaints regarding the presence of pest species on board ferries from 1994 to 2004.", {"entities": []}], ["A detail questionnaire was used to collect data on ship characteristics and pest control practices.", {"entities": []}], ["Eighteen ferries were infested with flies (85.7%), 11 with cockroaches (52.3%), three with bedbugs, and one with fleas.", {"entities": []}], ["Other species had been found on board were ants, spiders, butterflies, beetles, and a lizard.", {"entities": []}], ["A total of 431 Blattella germanica species were captured in 28 (9.96%) traps, and 84.2% of them were nymphs.", {"entities": []}], ["One ship was highly infested.", {"entities": []}], ["Cockroach infestation was negatively associated with ferries in which Hazard Analysis Critical Control Point system was applied to ensure food safety on board (Relative Risk, RR = 0.23, p = 0.03), and positively associated with ferries in which cockroaches were observed by crew (RR = 4.09, p = 0.007), no cockroach monitoring log was kept (RR = 5.00, p = 0.02), and pesticide sprays for domestic use were applied by crew (RR = 4.00, p = 0.05).", {"entities": []}], ["Cockroach infested ships had higher age ( p = 0.03).", {"entities": []}], ["Neither rats nor mice were found on any ship, but three ferries had been infested with a rodent in the past.", {"entities": []}], ["Integrated pest control programs should include continuing monitoring for a variety of pest species in different ship locations; pest control measures should be more persistent in older ships.", {"entities": []}], ["HACCP system aids in the prevention of cockroach infestations on board.", {"entities": []}], ["Assessment of respiratory tract deposition of nanoparticles is a key link to understanding their health impacts.", {"entities": []}], ["An instrument was developed to measure respiratory tract deposition of nanoparticles in a single breath.", {"entities": []}], ["Monodisperse nanoparticles are generated, inhaled and sampled from a determined volumetric lung depth after a controlled residence time in the lung.", {"entities": []}], ["The instrument was characterized for sensitivity to inter-subject variability, particle size (22, 50, 75 and 100\u2009nm) and breath-holding time (3\u201320\u2009s) in a group of seven healthy subjects.", {"entities": []}], ["The measured particle recovery had an inter-subject variability 26\u201350 times larger than the measurement uncertainty and the results for various particle sizes and breath-holding times were in accordance with the theory for Brownian diffusion and values calculated from the Multiple-Path Particle Dosimetry model.", {"entities": []}], ["The recovery was found to be determined by residence time and particle size, while respiratory flow-rate had minor importance in the studied range 1\u201310\u2009L/s.", {"entities": []}], ["The instrument will be used to investigate deposition of nanoparticles in patients with respiratory disease.", {"entities": []}], ["The fast and precise measurement allows for both diagnostic applications, where the disease may be identified based on particle recovery, and for studies with controlled delivery of aerosol-based nanomedicine to specific regions of the lungs.", {"entities": []}], ["Social hazards as one of the dimensions of workplace discrimination are a potential social determinant of health inequalities.", {"entities": []}], ["The aim of this study was to investigate relations between self-reported health and social hazard characteristics (defined as\u2014discrimination as such, violence or threat of violence, time pressure or work overload and risk of accident) among Vietnamese and Ukrainian migrants (males and females) in Czechia by age, education level and marital status.", {"entities": []}], ["This study is based on data from a survey of 669 immigrants in Czechia in 2013.", {"entities": []}], ["Logistic regression analysis indicates that the given independent variables (given social hazards and socio-demographic characteristics), as predictors of a quality of self-reported health are more important for immigrant females than for males, irrespective of citizenship, albeit only for some of them and to differing extents.", {"entities": []}], ["We found out that being exposed to the selected social hazards in the workplace leads to worsening self-rated health, especially for females.", {"entities": []}], ["On the other hand, there was no statistically significant relationship found between poor self-rated health and discrimination as such.", {"entities": []}], ["Reality calls for more research and, consequently, better policies and practices in the field of health inequalities.", {"entities": []}], ["Using modern analytical technology, it is now possible to measure almost any chemical present in our bodies.", {"entities": []}], ["The future role of classical exposure assessment will perhaps be marginalized because biomonitoring programs can directly measure the concentration of chemicals that are present in biologic matrices.", {"entities": []}], ["Although the concentration of chemicals in the environment will continue to be measured and related to exposure parameters, the prioritization of the national environmental agenda will be dictated by biomonitoring.", {"entities": []}], ["Recent biomonitoring studies have examined the levels of > 200 chemicals.", {"entities": []}], ["Biomonitoring data, by themselves, are not informative in helping consumers understand their individual health risk.", {"entities": []}], ["A major challenge facing those who conduct biomonitoring programs is how to best communicate the information to the public.", {"entities": []}], ["In this article, we review benefits and challenges, along with select results from the National Report on Human Exposure to Environmental Chemicals .", {"entities": []}], ["We recommend that these data be carefully interpreted, with the goal of establishing baseline exposure information, rather than creating surrogates for conclusions about human health risk.", {"entities": []}], ["We report findings of a survey of 555 women 18-35 years of age living in Northern Manhattan in New York City.", {"entities": []}], ["The survey was conducted by the Columbia Center for Children's Environmental Health (CCCEH) to learn what community women knew about environmental risks to health and what they did to protect themselves and their families, to validate the findings of focus groups held with community women, and to provide information for planning the Healthy Home, Healthy Child campaign sponsored by CCCEH.", {"entities": []}], ["Survey findings showed that overall awareness of environmental risks to children's health was high, with more than 95% of respondents identifying lead, household pests, pesticides, environmental tobacco smoke, and drugs as harmful to health.", {"entities": []}], ["Similarly, more than 95% of respondents reported taking one or more protective actions to reduce these risks, suggesting that these factors significantly concern women living in Northern Manhattan.", {"entities": []}], ["The reported levels of specific protective actions to reduce these risks, however, varied greatly.", {"entities": []}], ["In each area of risk the most frequently reported actions were effective ones, but many other important protective actions were rarely mentioned, suggesting that there was room for an educational campaign to teach women new ways to protect their families.", {"entities": []}], ["Survey respondents and CCCEH scientists differed in the priorities they placed on the importance of key protective actions, confirming earlier focus group findings and suggesting the importance of incorporating community concerns into the planning of environmental campaigns.", {"entities": []}], ["Airway hyperresponsiveness (AHR), a primary characteristic of asthma, involves increased airway smooth muscle contractility in response to certain exposures.", {"entities": [[62, 68, "DISEASE"], [28, 31, "GENE"]]}], ["We sought to determine whether common genetic variants were associated with AHR severity.", {"entities": [[76, 79, "GENE"]]}], ["A genome-wide association study (GWAS) of AHR, quantified as the natural log of the dosage of methacholine causing a 20% drop in FEV 1 , was performed with 994 non-Hispanic white asthmatic subjects from three drug clinical trials: CAMP, CARE, and ACRN.", {"entities": [[42, 45, "GENE"], [129, 132, "GENE"]]}], ["Genotyping was performed on Affymetrix 6.0 arrays, and imputed data based on HapMap Phase 2, was used to measure the association of SNPs with AHR using a linear regression model.", {"entities": [[142, 145, "GENE"]]}], ["Replication of primary findings was attempted in 650 white subjects from DAG, and 3,354 white subjects from LHS.", {"entities": []}], ["Evidence that the top SNPs were eQTL of their respective genes was sought using expression data available for 419 white CAMP subjects.", {"entities": []}], ["The top primary GWAS associations were in rs848788 (P-value 7.2E-07) and rs6731443 (P-value 2.5E-06), located within the ITGB5 and AGFG1 genes, respectively.", {"entities": [[121, 126, "GENE"], [131, 136, "GENE"]]}], ["The AGFG1 result replicated at a nominally significant level in one independent population (LHS P-value 0.012), and the SNP had a nominally significant unadjusted P-value (0.0067) for being an eQTL of AGFG1 .", {"entities": [[4, 9, "GENE"], [201, 206, "GENE"], [4, 9, "GENE"], [201, 206, "GENE"]]}], ["Based on current knowledge of ITGB5 and AGFG1, our results suggest that variants within these genes may be involved in modulating AHR.", {"entities": [[30, 35, "GENE"], [40, 45, "GENE"], [130, 133, "GENE"]]}], ["Future functional studies are required to confirm that our associations represent true biologically significant findings.", {"entities": []}], ["Patients with rheumatoid arthritis (RA) suffer from co-morbidities that contribute to a shortened lifespan.", {"entities": [[14, 34, "DISEASE"], [25, 34, "DISEASE"]]}], ["Inflammation is important for the development of cardiovascular disease, but little is known on its relationship with other co-morbidities.", {"entities": []}], ["We investigated the role of inflammation for the development of new comorbidities in early RA.", {"entities": []}], ["Since 1995, all patients with early RA in Northern Sweden are included in a prospective study on co-morbidities, with a total of 950 patients being included.", {"entities": []}], ["At the time for this study, 726 had been ill for \u22655\u00a0years.", {"entities": []}], ["Data on co-morbidities, clinical and laboratory disease activity and pharmacological therapy were collected from patient records and further validated using a questionnaire at RA onset (T0) and after 5\u00a0years (T5).", {"entities": []}], ["Of the patients, 53.2\u00a0% of the patients had one or more co-morbidity at onset, the commonest being: hypertension (27.3\u00a0%), obstructive pulmonary disease (13.9\u00a0%), diabetes (8.0\u00a0%), hypothyroidism (6.3\u00a0%) and malignancy (5.0\u00a0%).", {"entities": [[100, 112, "DISEASE"], [181, 195, "DISEASE"]]}], ["After 5\u00a0years, 41.0\u00a0% had developed at least one new co-morbidity, the most common being: hypertension (15.1\u00a0%), malignancy (7.6\u00a0%), stroke/transient ischemic accident (5.1\u00a0%), myocardial infarction (4.3\u00a0%) and osteoporosis (3.7\u00a0%).", {"entities": [[90, 102, "DISEASE"], [177, 198, "DISEASE"], [211, 223, "DISEASE"]]}], ["Age at disease onset, a raised erythrocyte sedimentation rate (ESR) at inclusion, previous treatment with glucocorticoids (GC; p\u2009<\u20090.001 for all), extra-articular RA (Ex-RA; p\u2009<\u20090.01), DAS28 (area under the curve) at 24\u00a0months (p\u2009<\u20090.05), previous smoking at inclusion (p\u2009=\u20090.058) and male gender (p\u2009<\u20090.01) were associated with a new co-morbidity overall at T5.", {"entities": [[123, 125, "GENE"]]}], ["Treatment with biologics (p\u2009<\u20090.05) reduced the risk.", {"entities": []}], ["In multiple logistic regression modelling, ESR (p\u2009=\u20090.036) at inclusion was associated with a new co-morbidity after 5\u00a0years, adjusted for age, sex, smoking and GC treatment.", {"entities": [[161, 163, "GENE"]]}], ["In a similar model, Ex-RA (p\u2009<\u20090.05) was associated with a new co-morbidity at T5.", {"entities": []}], ["In a third model, adjusted for age and sex, a new pulmonary co-morbidity was associated with a smoking history at inclusion (p\u2009<\u20090.01), but not with ESR.", {"entities": []}], ["There was substantial co-morbidity among early RA patients already at disease onset, with considerable new co-morbidity being added during the first five years.", {"entities": []}], ["Measures of disease activity were associated with the occurrence of a new co-morbidity indicating that the inflammation is of importance in this context.", {"entities": []}], ["In this video Q & A, we talk to George Chrousos about stress and its impact on chronic non-communicable disorders (NCDs) and early life development.", {"entities": []}], ["Professor Chrousos also discusses the effects of psychological and economical stressors on health, and suggests ways in which we can learn to cope with stress.", {"entities": []}], ["In October 2009, the French government organized a national-wide, free of charge vaccination campaign against pandemic H1N1 influenza virus, especially targeting pregnant women, a high risk group for severe illness.", {"entities": [[124, 133, "DISEASE"]]}], ["The study objective was to evaluate pandemic flu vaccine uptake and factors associated with non-vaccination in a population of pregnant women.", {"entities": []}], ["In a prospective cohort conducted in 3 maternity hospitals in Paris, 882 pregnant women were randomly included between October 12, 2009 and February 3, 2010, with the aim to study characteristics of pandemic influenza during pregnancy.", {"entities": [[208, 217, "DISEASE"]]}], ["At inclusion, socio-demographic, medical, obstetrical factors and those associated with a higher risk of flu exposition and disease-spreading were systematically collected.", {"entities": []}], ["Pandemic flu vaccine uptake was checked until delivery.", {"entities": []}], ["555 (62.9%) women did not get vaccinated.", {"entities": []}], ["Determinants associated with non-vaccination in a multivariate logistic regression were: geographic origin (Sub-Saharan African origin, adjusted Odd Ratio aOR\u200a=\u200a5.4[2.3\u201312.7], North African origin, aOR\u200a=\u200a2.5[1.3\u20134.7] and Asian origin, aOR\u200a=\u200a2.1[1.7\u20132.6] compared to French and European origin) and socio-professional categories (farmers, craftsmen and tradesmen, aOR\u200a=\u200a2.3[2.0\u20132.6], intermediate professionals, aOR\u200a=\u200a1.3[1.0\u20131.6], employees and manual workers, aOR\u200a=\u200a2.5[1.4\u20134.4] compared to managers and intellectual professionals).", {"entities": []}], ["The probability of not receiving pandemic flu vaccine was lower among women vaccinated against seasonal flu in the previous 5 years (aOR\u200a=\u200a0.6[0.4\u20130.8]) and among those who stopped smoking before or early during pregnancy (aOR\u200a=\u200a0.6[0.4\u20130.8]).", {"entities": []}], ["Number of children less than 18 years old living at home, work in contact with children or in healthcare area, or professional contact with the public, were not associated with a higher vaccine uptake.", {"entities": []}], ["In this cohort of pregnant women, vaccine coverage against pandemic 2009 A/H1N1 flu was low, particularly in immigrant women and those having a low socio-economic status.", {"entities": []}], ["To improve its effectiveness, future vaccination campaign for pregnant women should be more specifically tailored for these populations.", {"entities": []}], ["microRNAs (miRNAs) are a class of non-coding RNAs that function as endogenous triggers of the RNA interference pathway.", {"entities": []}], ["Studies have shown that thousands of human protein-coding genes are regulated by miRNAs, indicating that miRNAs are master regulators of many important biological processes, such as cancer development.", {"entities": [[182, 188, "DISEASE"]]}], ["miRNAs frequently have deregulated expression in many types of human cancers, and play critical roles in tumorigenesis, which functions either as tumor suppressors or as oncogenes.", {"entities": []}], ["Recent studies have shown that miRNAs are highly related with cancer progression, including initiating, growth, apoptosis, invasion, and metastasis.", {"entities": [[62, 68, "DISEASE"]]}], ["Furthermore, miRNAs are shown to be responsible for the cancer-related inflammation, anti-cancer drug resistance, and regulation of cancer stem cells.", {"entities": [[56, 62, "DISEASE"], [90, 96, "DISEASE"], [132, 138, "DISEASE"]]}], ["Therefore, miRNAs have generated great interest as a novel strategy in cancer diagnosis and therapy.", {"entities": [[71, 77, "DISEASE"]]}], ["Here we review the versatile roles of miRNAs in cancers and their potential applications for diagnosis, prognosis, and treatment as biomarkers.", {"entities": []}], ["Human rhinoviruses (HRVs) are responsible for more than half of all cases of the common cold and cause billions of USD annually in medical visits and school and work absenteeism.", {"entities": [[81, 92, "DISEASE"]]}], ["An assessment was made of the cytotoxic and antiviral activities and possible mode of action of the tannin ellagic acid from the leaves of Lagerstroemia speciosa toward HeLa cells and three rhinoviruses, HRV-2, -3, and -4.", {"entities": []}], ["The antiviral property and mechanism of action of ellagic acid were evaluated using a sulforhodamine B assay and real-time reverse transcription-PCR (RT-PCR) with SYBR Green dye.", {"entities": []}], ["Results were compared with those of the currently used broad-spectrum antiviral agent, ribavirin.", {"entities": []}], ["As judged by 50% inhibitory concentration values, natural ellagic acid was 1.8, 2.3, and 2.2 times more toxic toward HRV-2 (38\u00a0\u03bcg/mL), HRV-3 (31\u00a0\u03bcg/mL), and HRV-4 (29\u00a0\u03bcg/mL) than ribavirin, respectively.", {"entities": []}], ["The inhibition rate of preincubation with 50\u00a0\u03bcg/mL ellagic acid was 17%, whereas continuous presence of ellagic acid during infection led to a significant increase in the inhibition (70%).", {"entities": []}], ["Treatment with 50\u00a0\u03bcg/mL ellagic acid considerably suppressed HRV-4 infection only when added just after the virus inoculation (0\u00a0h) (87% inhibition), but not before -1\u00a0h or after 1\u00a0h or later (<20% inhibition).", {"entities": []}], ["These findings suggest that ellagic acid does not interact with the HRV-4 particles and may directly interact with the human cells in the early stage of HRV infections to protect the cells from the virus destruction.", {"entities": []}], ["Furthermore, RT-PCR analysis revealed that 50\u00a0\u03bcg/mL ellagic acid strongly inhibited the RNA replication of HRV-4 in HeLa cells, suggesting that ellagic acid inhibits virus replication by targeting on cellular molecules, rather than virus molecules.", {"entities": []}], ["Global efforts to reduce the level of antibiotics justify further studies on L. speciosa leaf-derived materials containing ellagic acid as potential anti-HRV products or a lead molecule for the prevention or treatment of HRV infection.", {"entities": []}], ["The ubiquitin-proteasome system for protein degradation plays a major role in regulating cell function and many signaling proteins are tightly controlled by this mechanism.", {"entities": []}], ["Among these, Regulator of G Protein Signaling 2 (RGS2) is a target for rapid proteasomal degradation, however, the specific enzymes involved are not known.", {"entities": [[49, 53, "GENE"]]}], ["Using a genomic siRNA screening approach, we identified a novel E3 ligase complex containing cullin 4B (CUL4B), DNA damage binding protein 1 (DDB1) and F-box protein 44 (FBXO44) that mediates RGS2 protein degradation.", {"entities": [[104, 109, "GENE"], [142, 146, "GENE"], [170, 176, "GENE"], [192, 196, "GENE"]]}], ["While the more typical F-box partners CUL1 and Skp1 can bind FBXO44, that E3 ligase complex does not bind RGS2 and is not involved in RGS2 degradation.", {"entities": [[38, 42, "GENE"], [47, 51, "GENE"], [61, 67, "GENE"], [106, 110, "GENE"], [134, 138, "GENE"], [106, 110, "GENE"], [134, 138, "GENE"]]}], ["These observations define an unexpected DDB1/CUL4B-containing FBXO44 E3 ligase complex.", {"entities": [[62, 68, "GENE"]]}], ["Pharmacological targeting of this mechanism provides a novel therapeutic approach to hypertension, anxiety, and other diseases associated with RGS2 dysregulation.", {"entities": [[85, 97, "DISEASE"], [143, 147, "GENE"]]}], ["The HIV-TB-associated immune reconstitution inflammatory syndrome (TB-IRIS) can complicate combined treatments for HIV-1 and TB.", {"entities": [[57, 65, "DISEASE"]]}], ["Little is known about tissue damage in TB-IRIS.", {"entities": []}], ["Matrix metalloproteinases (MMPs) degrade components of the extracellular matrix and consequently may play a role in such immunopathology.", {"entities": []}], ["Here we investigated the involvement of MMPs in TB-IRIS.", {"entities": []}], ["We determined MMP transcript abundance and secreted protein in Mycobacterium tuberculosis stimulated PBMCs from 22 TB-IRIS patients and 22 non-IRIS controls.", {"entities": [[77, 89, "DISEASE"]]}], ["We also measured MMP protein levels in corresponding serum and the effect of prednisone \u2014 which reduces the duration of symptoms in IRIS patients \u2014 or placebo treatment on MMP transcript and circulating MMP protein levels.", {"entities": []}], ["PBMCs from TB-IRIS had increased MMP-1,-3,-7, and-10 transcript levels when compared with those of controls at either 6 or 24 h. Similarly, MMP-1,-3,-7, and-10 protein secretion in stimulated cultures was higher in TB-IRIS than in controls.", {"entities": []}], ["Serum MMP-7 concentration was elevated in TB-IRIS and 2 weeks of corticosteroid therapy decreased this level, although not significantly.", {"entities": []}], ["TB-IRIS is associated with a distinct pattern of MMP gene and protein activation.", {"entities": []}], ["Modulation of dysregulated MMP activity may represent a novel therapeutic approach to alleviate TB-IRIS in HIV-TB patients undergoing treatment.", {"entities": []}], ["'Protocol based care' was envisioned by policy makers as a mechanism for delivering on the service improvement agenda in England.", {"entities": []}], ["Realistic evaluation is an increasingly popular approach, but few published examples exist, particularly in implementation research.", {"entities": []}], ["To fill this gap, within this paper we describe the application of a realistic evaluation approach to the study of protocol-based care, whilst sharing findings of relevance about standardising care through the use of protocols, guidelines, and pathways.", {"entities": []}], ["Situated between positivism and relativism, realistic evaluation is concerned with the identification of underlying causal mechanisms, how they work, and under what conditions.", {"entities": []}], ["Fundamentally it focuses attention on finding out what works, for whom, how, and in what circumstances.", {"entities": []}], ["In this research, we were interested in understanding the relationships between the type and nature of particular approaches to protocol-based care (mechanisms), within different clinical settings (context), and what impacts this resulted in (outcomes).", {"entities": []}], ["An evidence review using the principles of realist synthesis resulted in a number of propositions, i.e.", {"entities": []}], [", context, mechanism, and outcome threads (CMOs).", {"entities": []}], ["These propositions were then 'tested' through multiple case studies, using multiple methods including non-participant observation, interviews, and document analysis through an iterative analysis process.", {"entities": []}], ["The initial propositions (conjectured CMOs) only partially corresponded to the findings that emerged during analysis.", {"entities": []}], ["From the iterative analysis process of scrutinising mechanisms, context, and outcomes we were able to draw out some theoretically generalisable features about what works, for whom, how, and what circumstances in relation to the use of standardised care approaches (refined CMOs).", {"entities": []}], ["As one of the first studies to apply realistic evaluation in implementation research, it was a good fit, particularly given the growing emphasis on understanding how context influences evidence-based practice.", {"entities": []}], ["The strengths and limitations of the approach are considered, including how to operationalise it and some of the challenges.", {"entities": []}], ["This approach provided a useful interpretive framework with which to make sense of the multiple factors that were simultaneously at play and being observed through various data sources, and for developing explanatory theory about using standardised care approaches in practice.", {"entities": []}], ["This study aims to examine the association between visit-to-visit glucose variability, which was measured by coefficient of variation (CV) of fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c), and risk of chronic obstructive pulmonary disease (COPD) in a large number of patients with type 2 diabetes with an average follow-up of 7.58 years.", {"entities": [[211, 248, "DISEASE"]]}], ["We conducted a retrospective cohort study on 27,257 patients with type 2 diabetes who participated in the National Diabetes Case Management Program in Taiwan.", {"entities": []}], ["Visit-to-visit variability in HbA1c and FPG at baseline and the incidence of COPD were analyzed using a modified Cox proportional hazards model considering competing risks.", {"entities": []}], ["A total of 2,346 incident cases of COPD.", {"entities": []}], ["Patients were grouped into tertiles of FPG-CV and HbA1c-CV.", {"entities": []}], ["The incidence rates in the first, second, and third tertiles were 9.87, 11.06, and 13.19, respectively, for FPG-CV and 10.2, 11.81, and 12.07, for HbA1c-CV per 1000 person-years.", {"entities": []}], ["After adjusting for age, gender, diabetes duration, treatment type, smoking, hypertension, hyperlipidemia, baseline FPG and HbA1c levels, and complications, both FPG-CV and HbA1c-CV were independently associated with COPD.", {"entities": [[77, 89, "DISEASE"]]}], ["The hazard ratios of COPD for the third terile compared with the first tertile of FPG-CV were 1.26 (95% confidence interval [CI]: 1.13\u20131.40).", {"entities": []}], ["Moreover, the hazard ratios of COPD for the third and second tertiles compared with the first tertile of HbA1c-CV were 1.13 (1.02\u20131.25) and 1.13 (1.02\u20131.26), respectively.", {"entities": []}], ["Patients with FPG-CV higher than 34.6% or HbA1c-CV higher than 8.4% exhibited an increased risk of COPD.", {"entities": []}], ["This finding confirmed the linear relationship of FPG-CV and HbA1c-CV to COPD.", {"entities": []}], ["Visit-to-visit variability in FPG and HbA1c levels are strong predictors of COPD in patients with type 2 diabetes.", {"entities": []}], ["Future studies should focus on lung dysfunction in diabetes, and adequate glucose control strategy in regular clinical practices must be established for COPD prevention.", {"entities": []}], ["Pulmonary viral infections can exacerbate or trigger the development of allergic airway diseases via multiple mechanisms depending upon the infectious agent.", {"entities": []}], ["Respiratory vaccinia virus transmission is well established, yet the effects of allergic airway disease on the host response to intra-pulmonary vaccinia virus infection remain poorly defined.", {"entities": [[12, 20, "DISEASE"], [144, 152, "DISEASE"]]}], ["As shown here BALB/c mice with preexisting airway disease infected with vaccinia virus developed more severe pulmonary inflammation, higher lung virus titers and greater weight loss compared with mice inoculated with virus alone.", {"entities": [[72, 80, "DISEASE"]]}], ["This enhanced viremia was observed despite increased pulmonary recruitment of CD8", {"entities": []}], ["There is a growing appreciation of the important role of resolution mediators in the successful termination of the inflammatory response.", {"entities": []}], ["Here, we discuss the potential importance of the lipid and peptide proresolving mediators, in particular the resolvins and chemerin-derived peptides, which mediate their effects through specific G protein-coupled receptors (GPCRs).", {"entities": []}], ["Shiitake Dermatitis is a skin eruption that resembles whiplash marks and occurs after consumption of raw shiitake mushrooms.", {"entities": [[9, 19, "DISEASE"]]}], ["It is caused by a toxic reaction to lentinan, a thermolabil polysaccharide which decomposes upon heating.", {"entities": []}], ["We report the second case of this dermatitis in Brazil.", {"entities": [[34, 44, "DISEASE"]]}], ["A 25-year-old man presented with linearly arranged erythematous, pruritic papules on the trunk and limbs, after ingestion of a salad containing raw shiitake mushrooms.", {"entities": []}], ["The eruption was self-limited, resolving within 10 days of onset.", {"entities": []}], ["The recognition of this entity gains importance due to the increased consumption of shiitake mushrooms in occidental countries.", {"entities": []}], ["Asthma is an increasing global health burden, especially in the western world.", {"entities": [[0, 6, "DISEASE"]]}], ["Public health interventions are sought to lessen its prevalence or severity, and diet and nutrition have been identified as potential factors.", {"entities": []}], ["With rapid changes in diet being one of the hallmarks of westernization, nutrition may play a key role in affecting the complex genetics and developmental pathophysiology of asthma.", {"entities": [[174, 180, "DISEASE"]]}], ["The present review investigates hypotheses about hygiene, antioxidants, lipids and other nutrients, food types and dietary patterns, breastfeeding, probiotics and intestinal microbiota, vitamin D, maternal diet, and genetics.", {"entities": []}], ["Early hypotheses analyzed population level trends and focused on major dietary factors such as antioxidants and lipids.", {"entities": []}], ["More recently, larger dietary patterns beyond individual nutrients have been investigated such as obesity, fast foods, and the Mediterranean diet.", {"entities": [[98, 105, "DISEASE"]]}], ["Despite some promising hypotheses and findings, there has been no conclusive evidence about the role of specific nutrients, food types, or dietary patterns past early childhood on asthma prevalence.", {"entities": [[180, 186, "DISEASE"]]}], ["However, diet has been linked to the development of the fetus and child.", {"entities": []}], ["Breastfeeding provides immunological protection when the infant's immune system is immature and a modest protective effect against wheeze in early childhood.", {"entities": []}], ["Moreover, maternal diet may be a significant factor in the development of the fetal airway and immune system.", {"entities": []}], ["As asthma is a complex disease of gene-environment interactions, maternal diet may play an epigenetic role in sensitizing fetal airways to respond abnormally to environmental insults.", {"entities": [[3, 9, "DISEASE"]]}], ["Recent hypotheses show promise in a biological approach in which the effects of dietary factors on individual physiology and immunology are analyzed before expansion into larger population studies.", {"entities": []}], ["Thus, collaboration is required by various groups in studying this enigma from epidemiologists to geneticists to immunologists.", {"entities": []}], ["It is now apparent that this multidisciplinary approach is required to move forward and understand the complexity of the interaction of dietary factors and asthma.", {"entities": [[156, 162, "DISEASE"]]}], ["The role of the complement system in innate immunity is well characterized.", {"entities": []}], ["However, a recent body of research implicates the complement anaphylatoxins C3a and C5a as insidious propagators of tumor growth and progression.", {"entities": []}], ["It is now recognized that certain tumors elaborate C3a and C5a and that complement, as a mediator of chronic inflammation and regulator of immune function, may in fact foster rather than defend against tumor growth.", {"entities": []}], ["A putative mechanism for this function is complement-mediated suppression of immune effector cells responsible for immunosurveillance within the tumor microenvironment.", {"entities": []}], ["This paradigm accords with models of immune dysregulation, such as autoimmunity and infectious disease, which have defined a pathophysiological role for abnormal complement signaling.", {"entities": []}], ["Several types of immune cells express the cognate receptors for the complement anaphylatoxins, C3aR and C5aR, and demonstrate functional modulation in response to complement stimulation.", {"entities": []}], ["In turn, impairment of antitumor immunity has been intimately tied to tumor progression in animal models of cancer.", {"entities": [[108, 114, "DISEASE"]]}], ["In this article, the literature was systematically reviewed to identify studies that have characterized the effects of the complement anaphylatoxins on the composition and function of immune cells within the tumor microenvironment.", {"entities": []}], ["The search identified six studies based upon models of lymphoma and ovarian, cervical, lung, breast, and mammary cancer, which collectively support the paradigm of complement as an immune regulator in the tumor microenvironment.", {"entities": [[55, 63, "DISEASE"], [113, 119, "DISEASE"]]}], ["Telecare is defined as care practiced at a distance.", {"entities": []}], ["It is an effective strategy for improving the self-health care management of home-patients with chronic diseases.", {"entities": []}], ["The purpose of this study was to explore the intent to use of telehealth patients.", {"entities": []}], ["The correlation between the self-care behaviors, the intent to use of telehealth, and the effects on physiological indicators of patients with chronic disease at home were studied.", {"entities": []}], ["A cross-sectional study design employing purposive sampling was selected.", {"entities": []}], ["The structured questionnaire \u2018Telecare Usage Intention Scale and Self-Care Behavior Scale\u2019 were used, \u2018HbA1c, glucose levels and monthly blood pressure measurements\u2019 were analyzed in this thirteen month study.", {"entities": []}], ["The self-care behaviors of the participants were positively correlated with their intent to use telehealth ( p < 0.01).", {"entities": []}], ["The results also indicated that HbA1c, glucose levels and frequency BP measurement of the participants improved significantly after using telecare ( p < 0.005).", {"entities": []}], ["The results indicated a strong intent to use telehealth and positive perception of telecare services by in-home patients with a chronic disease.", {"entities": []}], ["Telehealth improves the self-care behavior of in-home chronic disease patients and enhances medical professionals\u2019 ability to deliver quality and effective healthcare.", {"entities": []}], ["Although observational studies suggest positive vitamin D-lung function associations, randomized trials are inconsistent.", {"entities": []}], ["We examined effects of vitamin D supplementation on lung function.", {"entities": []}], ["We recruited 442 adults (50\u201384 years, 58% male) into a randomized, double-blinded, placebo-controlled trial.", {"entities": []}], ["Participants received, for 1.1 years (median; range = 0.9\u20131.5 years), either (1) vitamin D 3 200,000 IU, followed by monthly 100,000 IU doses ( n = 226); or (2) placebo monthly ( n = 216).", {"entities": []}], ["At baseline and follow-up, spirometry yielded forced expiratory volume in 1 s (FEV1; primary outcome).", {"entities": []}], ["Mean (standard deviation) 25-hydroxyvitamin D increased from 61 (24) nmol/L at baseline to 119 (45) nmol/L at follow-up in the vitamin D group, but was unchanged in the placebo group.", {"entities": []}], ["There were no significant lung function improvements (vitamin D versus placebo) in the total sample, vitamin D-deficient participants or asthma/chronic obstructive pulmonary disease (COPD) participants.", {"entities": [[144, 181, "DISEASE"], [137, 143, "DISEASE"]]}], ["However, among ever-smokers ( n = 217), the mean (95% confidence interval) FEV1 increase in the vitamin D versus placebo was 57 (4, 109) mL ( p = 0.03).", {"entities": []}], ["FEV1 increases were larger among vitamin D-deficient ever-smokers ( n = 54): 122 (8, 236) mL ( p = 0.04).", {"entities": []}], ["FEV1 improvements were largest among ever-smokers with asthma/COPD ( n = 60): 160 (53, 268) mL ( p = 0.004).", {"entities": [[55, 61, "DISEASE"]]}], ["Thus, vitamin D supplementation did not improve lung function among everyone, but benefited ever-smokers, especially those with vitamin D deficiency or asthma/COPD.", {"entities": [[152, 158, "DISEASE"]]}], ["Randomized interventional trials generally recruit highly selected patients.", {"entities": []}], ["In contrast, long-term, noninterventional studies can reflect standard of care of real-life populations.", {"entities": []}], ["DACCORD (Die ambulante Versorgung mit langwirksamen Bronchodilatatoren: COPD-Register in Deutschland [Outpatient Care With Long-Acting Bronchodilators: COPD Registry in Germany]) is an ongoing observational study, conducted in primary and secondary care in Germany, aiming to describe the impact of disease and treatments on real-life patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[349, 386, "DISEASE"]]}], ["Patients had a clinical and spirometry diagnosis of COPD, were aged \u226540 years, and were initiating or changing COPD maintenance medication.", {"entities": []}], ["The only exclusion criteria were asthma and participation in a randomized clinical trial.", {"entities": [[33, 39, "DISEASE"]]}], ["Exacerbation data were collected every 3 months.", {"entities": []}], ["COPD medication, COPD Assessment Test, and forced expiratory volume in 1 second (FEV 1 ) were recorded at the end of the 1 year period.", {"entities": [[81, 84, "GENE"]]}], ["In the 6 months prior to baseline, 26.5% of the 3,974 patients experienced \u22651 exacerbation, compared with 26.1% over the 1-year follow-up (annualized rate 0.384).", {"entities": []}], ["Importantly, only previous exacerbations and not poor lung function alone predicted an increased exacerbation risk.", {"entities": []}], ["There was a general shift to lower disease severity from baseline to 1 year, predominantly as a consequence of a lower proportion of patients considered at high risk due to exacerbations.", {"entities": []}], ["COPD Assessment Test mean change from baseline was \u22121.9, with 48.9% of patients reporting a clinically relevant improvement.", {"entities": []}], ["Overall persistence to medication was high, with 77.2% of patients still receiving the same class of medication at 1 year.", {"entities": []}], ["DACCORD suggests that in clinical practice, the large majority of COPD patients are symptomatic but seldom exacerbate and that widely used tools and treatment recommendations do not reflect this fully.", {"entities": []}], ["The prevalence of endometriosis and the need for treatment in the USA has led to the need to explore the contemporary cost burden associated with the disease.", {"entities": [[18, 31, "DISEASE"]]}], ["This retrospective cohort study compared direct and indirect healthcare costs in patients with endometriosis to a control group without endometriosis.", {"entities": [[95, 108, "DISEASE"], [136, 149, "DISEASE"]]}], ["Women aged 18\u201349\u00a0years with endometriosis (date of initial diagnosis\u00a0=\u00a0index date) were identified in the Truven Health MarketScan Overall, 113,506 endometriosis patients and 927,599 controls were included.", {"entities": [[28, 41, "DISEASE"], [148, 161, "DISEASE"]]}], ["Endometriosis patients had significantly higher HRU during both the pre- and post-index periods compared to controls ( p \u00a0<\u00a00.0001, all categories of HRU).", {"entities": [[0, 13, "DISEASE"]]}], ["Approximately two-thirds of endometriosis patients underwent an endometriosis-related surgical procedure (including laparotomy, laparoscopy, hysterectomy, oophorectomy, and other excision/ablation procedures) in the first 12\u00a0months post-index.", {"entities": [[28, 41, "DISEASE"], [64, 77, "DISEASE"]]}], ["Mean annual total adjusted direct costs per endometriosis patient during the 12-month post-index period was over three times higher than that for a non-endometriosis control [$16,573 (standard deviation (SD)\u00a0=\u00a0$21,336) vs. $4733 (SD\u00a0=\u00a0$14,833); p \u00a0<\u00a00.005].", {"entities": [[44, 57, "DISEASE"], [152, 165, "DISEASE"]]}], ["On average, incremental direct and indirect 12-month costs per endometriosis patient were $10,002 and $2132 compared to their matched controls ( p \u00a0<\u00a00.005).", {"entities": [[63, 76, "DISEASE"]]}], ["Endometriosis patients incurred significantly higher direct and indirect healthcare costs than non-endometriosis patients.", {"entities": [[0, 13, "DISEASE"], [99, 112, "DISEASE"]]}], ["AbbVie Inc.", {"entities": []}], ["The online version of this article (10.1007/s12325-018-0667-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Tissue necrosis factor-\u03b1 (TNF-\u03b1) and complement component 3 (C3) are two well-known pro-inflammatory molecules.", {"entities": [[61, 63, "GENE"]]}], ["When TNF-\u03b1 is upregulated, it contributes to changes in coagulation and causes C3 induction.", {"entities": [[79, 81, "GENE"]]}], ["They both interact with receptors on platelets and erythrocytes (RBCs).", {"entities": []}], ["Here, we look at the individual effects of C3 and TNF-\u03b1, by adding low levels of the molecules to whole blood and platelet poor plasma.", {"entities": [[43, 45, "GENE"]]}], ["We used thromboelastography, wide-field microscopy and scanning electron microscopy to study blood clot formation, as well as structural changes to RBCs and platelets.", {"entities": []}], ["Clot formation was significantly different from the na\u00efve sample for both the molecules.", {"entities": []}], ["Furthermore, TNF-\u03b1 exposure to whole blood resulted in platelet clumping and activation and we noted spontaneous plasma protein dense matted deposits.", {"entities": []}], ["C3 exposure did not cause platelet aggregation, and only slight pseudopodia formation was noted.", {"entities": [[0, 2, "GENE"]]}], ["Therefore, although C3 presence has an important function to cause TNF-\u03b1 release, it does not necessarily by itself cause platelet activation or RBC damage at these low concentrations.", {"entities": [[20, 22, "GENE"]]}], ["We conclude by suggesting that our laboratory results can be translated into clinical practice by incorporating C3 and TNF-\u03b1 measurements into broad spectrum analysis assays, like multiplex technology, as a step closer to a patient-orientated, precision medicine approach.", {"entities": [[112, 114, "GENE"]]}], ["To investigate the association between genetic variation at the matrix metalloproteinase-9 ( MMP9 ) locus and primary angle closure glaucoma (PACG) in an Australian Caucasian population.", {"entities": [[132, 140, "DISEASE"], [93, 97, "GENE"]]}], ["A total of 107 Australian patients with PACG and 288 age and sex-matched controls were included in the current study.", {"entities": []}], ["Tag single nucleotide polymorphisms (SNPs) were selected and genotyped to cover the majority of common variation within MMP9 .", {"entities": [[120, 124, "GENE"]]}], ["Allele, genotype and haplotype association analyses were conducted using PLINK.", {"entities": []}], ["Two SNPs from MMP9 , rs3918249 and rs17576 were significantly associated under the allelic model with p values of 0.006 for both SNPs.", {"entities": [[14, 18, "GENE"]]}], ["In addition, haplotype analysis revealed a protective haplotype TACGG to be significantly more frequent in controls (69%) than in PACG cases (59%), with p=0.006.", {"entities": []}], ["This study demonstrates an association between MMP9 SNPs rs3918249 and rs17576 and PACG in the Australian population, suggesting MMP9 may be involved in the pathogenesis of this blinding disease.", {"entities": [[47, 51, "GENE"], [129, 133, "GENE"], [47, 51, "GENE"], [129, 133, "GENE"]]}], ["Further replication will be helpful in confirming this finding before future clinical translation.", {"entities": []}], ["Serosal pathologies including malignant mesothelioma (MM) can show features of osseous and/or cartilaginous differentiation although the mechanism for its formation is unknown.", {"entities": [[30, 52, "DISEASE"]]}], ["Mesothelial cells have the capacity to differentiate into cells with myofibroblast, smooth muscle and endothelial cell characteristics.", {"entities": []}], ["Whether they can differentiate into other cell types is unclear.", {"entities": []}], ["This study tests the hypothesis that mesothelial cells can differentiate into cell lineages of the embryonic mesoderm including osteoblasts and adipocytes.", {"entities": []}], ["To examine this, a functional assay of bone formation and an adipogenic assay were performed in vitro with primary rat and human mesothelial cells maintained in osteogenic or adipogenic medium (AM) for 0\u201326 days.", {"entities": []}], ["Mesothelial cells expressed increasing levels of alkaline phosphatase, an early marker of the osteoblast phenotype, and formed mineralized bone-like nodules.", {"entities": []}], ["Mesothelial cells also accumulated lipid indicative of a mature adipocyte phenotype when cultured in AM.", {"entities": []}], ["All cells expressed several key osteoblast and adipocyte markers, including osteoblast-specific runt-related transcription factor 2, and demonstrated changes in mRNA expression consistent with epithelial-to-mesenchymal transition.", {"entities": []}], ["In conclusion, these studies confirm that mesothelial cells have the capacity to differentiate into osteoblast- and adipocyte-like cells, providing definitive evidence of their multipotential nature.", {"entities": []}], ["These data strongly support mesothelial cell differentiation as the potential source of different tissue types in MM tumours and other serosal pathologies, and add support for the use of mesothelial cells in regenerative therapies.", {"entities": []}], ["Previous studies localized the hedgehog (HH) signaling system to primary cilia.", {"entities": []}], ["We discovered that motile cilia on airway epithelia also contain HH signaling proteins, indicating that like primary cilia, these motile cilia have an important sensory function.", {"entities": []}], ["However, in contrast to the function of HH signaling in most primary cilia, sonic hedgehog (SHH) elicits noncanonical signaling, reducing cellular levels of cAMP.", {"entities": [[92, 95, "GENE"]]}], ["These findings suggest that airway SHH may quiet airway defenses.", {"entities": [[35, 38, "GENE"]]}], ["Involvement of SHH in lung disease and positioning of motile cilia where they sample SHH and other ligands in the airway lumen suggest that noncanonical HH signaling might modulate airway responses to the environment in health and disease.", {"entities": [[22, 34, "DISEASE"], [15, 18, "GENE"], [85, 88, "GENE"], [15, 18, "GENE"], [85, 88, "GENE"]]}], ["Differentiated airway epithelia produce sonic hedgehog (SHH), which is found in the thin layer of liquid covering the airway surface.", {"entities": [[56, 59, "GENE"]]}], ["Although previous studies showed that vertebrate HH signaling requires primary cilia, as airway epithelia mature, the cells lose primary cilia and produce hundreds of motile cilia.", {"entities": []}], ["Thus, whether airway epithelia have apical receptors for SHH has remained unknown.", {"entities": [[57, 60, "GENE"]]}], ["We discovered that motile cilia on airway epithelial cells have HH signaling proteins, including patched and smoothened.", {"entities": []}], ["These cilia also have proteins affecting cAMP-dependent signaling, including G\u03b1 i and adenylyl cyclase 5/6.", {"entities": []}], ["Apical SHH decreases intracellular levels of cAMP, which reduces ciliary beat frequency and pH in airway surface liquid.", {"entities": [[7, 10, "GENE"]]}], ["These results suggest that apical SHH may mediate noncanonical HH signaling through motile cilia to dampen respiratory defenses at the contact point between the environment and the lung, perhaps counterbalancing processes that stimulate airway defenses.", {"entities": [[34, 37, "GENE"]]}], ["A pilot study was performed to evaluate the feasibility of using trans,trans-muconic acid (MA) as a biomarker of environmental benzene exposure.", {"entities": []}], ["A secondary aim was to provide data on the extent of exposure to selected toxicants in a unique population consisting of inner-city children who were already overexposed to one urban hazard, lead.", {"entities": []}], ["Potential sources of benzene were assessed by a questionnaire.", {"entities": []}], ["Exposure biomarkers included urinary MA and cotinine and blood lead.", {"entities": []}], ["Mean MA was 176.6 +/- 341.7 ng/mg creatinine in the 79 children who participated.", {"entities": []}], ["A wide range of values was found with as many as 10.1%, depending on the comparison study, above the highest levels reported in adults not exposed by occupation.", {"entities": []}], ["Mean MA was increased in children evaluated in the afternoon compared to morning, those at or above the median for time spent playing near the street, and those studied in the first half of the investigation.", {"entities": []}], ["MA levels were not associated with blood lead or, consistently, with either questionnaire environmental tobacco smoke (ETS) data or cotinine.", {"entities": []}], ["As expected, the mean blood lead level was elevated (23.6 micrograms/dl).", {"entities": []}], ["Mean cotinine was also increased at 79.2 ng/mg creatinine.", {"entities": []}], ["We conclude that the use of MA as a biomarker for environmental benzene exposure is feasible since it was detectable in 72% of subjects with a wide range of values present.", {"entities": []}], ["In future studies, correlation of MA with personal air sampling in environmental exposure will be essential to fully interpret the significance of these findings.", {"entities": []}], ["In addition, these inner-city children comprise a high risk group for exposure to environmental toxicants including ETS, lead, and probably benzene, based on questionnaire sources and its presence in ETS.", {"entities": []}], ["New treatments need to be evaluated in real-world clinical practice to account for co-morbidities, adherence and polypharmacy.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD), \u226540\u00a0years old, with exacerbation in the previous 3\u00a0years are randomised 1:1 to once-daily fluticasone furoate 100\u00a0\u03bcg/vilanterol 25\u00a0\u03bcg in a novel dry-powder inhaler versus continuing their existing therapy.", {"entities": [[14, 51, "DISEASE"]]}], ["The primary endpoint is the mean annual rate of COPD exacerbations; an electronic medical record allows real-time collection and monitoring of endpoint and safety data.", {"entities": []}], ["The Salford Lung Study is the world\u2019s first pragmatic randomised controlled trial of a pre-licensed medication in COPD.", {"entities": []}], ["Clinicaltrials.gov identifier NCT01551758 .", {"entities": []}], ["Airway hyperresponsiveness (AHR) to direct stimuli, such as methacholine (MCh), is observed not only in asthma but other diseases.", {"entities": [[104, 110, "DISEASE"], [28, 31, "GENE"]]}], ["AHR to indirect stimuli is suggested to be more specific for asthma.", {"entities": [[61, 67, "DISEASE"], [0, 3, "GENE"]]}], ["The purpose of this study was to determine whether asthmatic airway inflammation is more closely related to AHR to hypertonic saline (HS), an indirect stimulus, than to MCh.", {"entities": [[108, 111, "GENE"]]}], ["Sixty-four consecutive adult patients with suspected asthma (45 asthma and 19 non-asthma) performed a combined bronchial challenge and sputum induction with 4.5% saline, and MCh challenge on the next day.", {"entities": [[53, 59, "DISEASE"], [64, 70, "DISEASE"], [82, 88, "DISEASE"]]}], ["Both HS-PD 15 and MCh-PC 20 were significantly lower in asthma patients than in non-asthma patients.", {"entities": [[56, 62, "DISEASE"], [84, 90, "DISEASE"]]}], ["However, the sensitivity / specificity for asthma was 48.9%/100%, respectively, in the HS test and 82.2% / 84.2%, respectively, in the MCh test.", {"entities": [[43, 49, "DISEASE"]]}], ["There was a significant relationship between HS-PD 15 and MCh-PC 20 and only 52.9% of patients with MCh-PC 20 \u22644 mg/mL showed HS-AHR, but 4 patients with HS-AHR showed MCh-PC 20 >4 mg/mL.", {"entities": []}], ["There were significant correlations between both HS-PD 15 and MCh-PC 20 and FEV 1 , or sputum eosinophils, but FEV 1 was more closely related to MCh-PC 20 (r=0.478, p <0.01) than to HS-PD 15 (r=0.278, p <0.05), and sputum eosinophils were more closely related to HS-PD 15 (r=\u22120.324, p <0.01) than to MCh-PC 20 (r=\u22120.317, p <0.05).", {"entities": [[76, 79, "GENE"], [111, 114, "GENE"], [76, 79, "GENE"], [111, 114, "GENE"]]}], ["Moreover, the IL-5 level (r=\u22120.285, p <0.05) and IFN- \u03b3 /IL-5 ratio (r=0.293, p <0.05) in sputum were significantly related to HS-PD 15 , but not to MCh-PC 20 .", {"entities": []}], ["HS-AHR may reflect allergic asthmatic airway inflammation more closely than MCh-AHR.", {"entities": []}], ["Epicardial pulmonary vein isolation has become an increasingly used therapy for medically resistant atrial fibrillation.", {"entities": []}], ["The purpose of the present study was therefore to evaluate if epicardial pulmonary vein isolation combined with ganglionated plexi ablation affects the size and mechanical function of the left atrium, and whether the effects are dependent on the extensiveness of the ablation applications.", {"entities": []}], ["A total of 42 patients underwent an echocardiographic examination prior to and 6\u00a0months after a minimal invasive epicardial pulmonary vein isolation procedure for the assessment of the effects on left atrial size and function.", {"entities": []}], ["In 27 patients, who had sinus rhythm both at baseline and follow-up, was a comparison of atrial size and function possible at these time intervals.", {"entities": []}], ["Fractional area changes were obtained from the left atrial end-systolic and end-diastolic areas in the apical four-chamber view.", {"entities": []}], ["Pulsed-Doppler was used to assess the transmitral flow velocities to evaluate mechanical function.", {"entities": []}], ["Left atrial size and function at 6-month follow-up had not changed significantly from those at baseline as indicated by left atrial maximal area (17.1\u00a0\u00b1\u00a04.6 vs. 18.7\u00a0\u00b1\u00a05.3, p \u00a0=\u00a00.118), minimal area (12.5\u00a0\u00b1\u00a03.8 vs. 13.4\u00a0\u00b1\u00a04.7, p \u00a0=\u00a00.248), fractional area change (27.4\u00a0\u00b1\u00a08.2 vs. 28.7\u00a0\u00b1\u00a010.6, p \u00a0=\u00a00.670), and E/A ratio (1.49\u00a0\u00b1\u00a00.47 vs. 1.54\u00a0\u00b1\u00a00.67, p \u00a0=\u00a00.855).", {"entities": []}], ["Radiofrequency ablation for epicardial pulmonary vein isolation combined with ganglionated plexi ablation has no major effects on atrial function or size.", {"entities": []}], ["A preserved atrial function for those maintaining sinus rhythm may have important implications for thromboembolic risk after surgery, but warrants confirmation in larger trials.", {"entities": []}], ["Short chain fatty acids (SCFAs) are produced following the fermentation of soluble fibre by gut bacteria.", {"entities": []}], ["In animal models, both dietary fibre and SCFAs have demonstrated anti-inflammatory effects via the activation of free fatty acid receptors, such as G protein-coupled receptor 41 and 43 (GPR41 and GPR43).", {"entities": []}], ["This pilot study examined the acute effect of a single dose of soluble fibre on airway inflammation\u2014including changes in gene expression of free fatty acid receptors\u2014in asthma.", {"entities": [[169, 175, "DISEASE"]]}], ["Adults with stable asthma consumed a soluble fibre meal ( n = 17) containing 3.5 g inulin and probiotics, or a control meal ( n = 12) of simple carbohydrates.", {"entities": [[19, 25, "DISEASE"]]}], ["Exhaled nitric oxide (eNO) was measured and induced sputum was collected at 0 and 4 h for differential cell counts, measurement of interleukin-8 (IL-8) protein concentration, and GPR41 and GPR43 gene expression.", {"entities": []}], ["At 4 h after meal consumption, airway inflammation biomarkers, including sputum total cell count, neutrophils, macrophages, lymphocytes, sputum IL-8, and eNO significantly decreased compared to baseline in the soluble fibre group only.", {"entities": []}], ["This corresponded with upregulated GPR41 and GPR43 sputum gene expression and improved lung function in the soluble fibre group alone.", {"entities": []}], ["Soluble fibre has acute anti-inflammatory effects in asthmatic airways.", {"entities": []}], ["Long-term effects of soluble fibre as an anti-inflammatory therapy in asthma warrants further investigation.", {"entities": [[70, 76, "DISEASE"]]}], ["Current knowledge about elder mistreatment is mainly derived from studies done in Western countries, which indicate that this problem is related to risk factors such as a shared living situation, social isolation, disease burden, and caregiver strain.", {"entities": []}], ["We know little about prevalence and risk factors for elder mistreatment and mistreatment subtypes in rural China where the elder population is the most vulnerable.", {"entities": []}], ["In 2010, we conducted a cross-sectional survey among older adults aged 60 or older in three rural communities in Macheng, a city in Hubei province, China.", {"entities": []}], ["Of 2245 people initially identified, 2039 were available for interview and this was completed in 2000.", {"entities": []}], ["A structured questionnaire was used to collect data regarding mistreatment and covariates.", {"entities": []}], ["Logistic regression analysis was used to identify factors related to elder mistreatment and subtypes of mistreatment.", {"entities": []}], ["Elder mistreatment was reported by 36.2% (95% CI: 34.1%\u201338.3%) of the participants.", {"entities": []}], ["Prevalence rates of psychological mistreatment, caregiver neglect, physical mistreatment, and financial mistreatment were 27.3% (95% CI: 25.3%\u201329.2%), 15.8% (95% CI: 14.2%\u201317.4%), 4.9% (95% CI: 3.9%\u20135.8%) and 2.0% (95% CI: 1.3%\u20132.6%), respectively.", {"entities": []}], ["The multivariate logistic regression analysis revealed that depression, being widowed/divorced/single/separated, having a physical disability, having a labor intensive job, depending solely on self-made income, and living alone were risk factors for elder mistreatment.", {"entities": []}], ["Different types of elder mistreatment were associated with different risk factors, and depression was the consistent risk factor for the three most common mistreatment subtypes.", {"entities": []}], ["Older adults in rural China self-report a higher rate of mistreatment than their counterparts in Western countries.", {"entities": []}], ["Depression is a main risk factor associated with most subtypes of mistreatment.", {"entities": []}], ["Our findings suggest that prevention and management of elder mistreatment is a challenge facing a rapidly aging Chinese population.", {"entities": []}], ["Vascular endothelial growth factor-A (VEGF-A) is intensively investigated in various medical fields.", {"entities": []}], ["However, comparing VEGF-A measurements is difficult because sample acquisition and pre-analytic procedures differ between studies.", {"entities": []}], ["We therefore investigated which variables act as confounders of VEGF-A measurements.", {"entities": []}], ["Following a standardized protocol, blood was taken at three clinical sites from six healthy participants (one male and one female participant at each center) twice one week apart.", {"entities": []}], ["The following pre-analytical parameters were varied in order to analyze their impact on VEGF-A measurements: analyzing center, anticoagulant (EDTA vs. PECT / CTAD), cannula (butterfly vs. neonatal), type of centrifuge (swing-out vs. fixed-angle), time before and after centrifugation, filling level (completely filled vs. half-filled tubes) and analyzing method (ELISA vs. multiplex bead array).", {"entities": []}], ["Additionally, intrapersonal variations over time and sex differences were explored.", {"entities": []}], ["Statistical analysis was performed using a linear regression model.", {"entities": []}], ["The following parameters were identified as statistically significant independent confounders of VEGF-A measurements: analyzing center, anticoagulant, centrifuge, analyzing method and sex of the proband.", {"entities": []}], ["The following parameters were no significant confounders in our data set: intrapersonal variation over one week, cannula, time before and after centrifugation and filling level of collection tubes.", {"entities": []}], ["VEGF-A measurement results can be affected significantly by the identified pre-analytical parameters.", {"entities": []}], ["We recommend the use of CTAD anticoagulant, a standardized type of centrifuge and one central laboratory using the same analyzing method for all samples.", {"entities": []}], ["Chronic conditions are on rise globally and in India.", {"entities": []}], ["Prevailing intra-urban inequities in access to healthcare services compounds the problems faced by urban poor.", {"entities": []}], ["This paper reports the trends in self-reported prevalence of chronic conditions and health-seeking pattern among residents of a poor urban neighborhood in south India.", {"entities": []}], ["A cross sectional survey of 1099 households (5340 individuals) was conducted using a structured questionnaire.", {"entities": []}], ["The prevalence and health-seeking pattern for chronic conditions in general and for hypertension and diabetes in particular were assessed and compared with a survey conducted in the same community three years ago.", {"entities": [[84, 96, "DISEASE"]]}], ["The predictors of prevalence and health-seeking pattern were analyzed through a multivariable logistic regression analysis.", {"entities": []}], ["The overall self-reported prevalence of chronic conditions was 12\u00a0%, with hypertension (7\u00a0%) and diabetes (5.8\u00a0%) being the common conditions.", {"entities": [[74, 86, "DISEASE"]]}], ["The self-reported prevalence of chronic conditions increased by 3.8 percentage point over a period of three years (OR: 1.5).", {"entities": []}], ["Older people, women and people living below the poverty line had greater odds of having chronic conditions across the two studies compared.", {"entities": []}], ["Majority of patients (89.3\u00a0%) sought care from private health facilities indicating a decrease by 8.7 percentage points in use of government health facility compared to the earlier study (OR: 0.5).", {"entities": []}], ["Patients seeking care from super specialty hospitals and those living below the poverty line were more likely to seek care from government health facilities.", {"entities": []}], ["There is need to strengthen health services with a preferential focus on government services to assure affordable care for chronic conditions to urban poor.", {"entities": []}], ["Although the female gametophyte in angiosperms consists of just seven cells, it has a complex biological network.", {"entities": []}], ["In this study, female gametophyte microarray data from Arabidopsis thaliana were integrated into the Arabidopsis interactome database to generate a putative interaction map of the female gametophyte development including proteome map based on biological processes and molecular functions of proteins.", {"entities": []}], ["Biological and functional groups as well as topological characteristics of the network were investigated by analyzing phytohormones, plant defense, cell death, transporters, regulatory factors, and hydrolases.", {"entities": []}], ["This approach led to the prediction of critical members and bottlenecks of the network.", {"entities": []}], ["Seventy-four and 24 upregulated genes as well as 171 and 3 downregulated genes were identified in subtracted networks based on biological processes and molecular function respectively, including novel genes such as the pathogenesis-related protein 4, ER type Ca", {"entities": []}], ["Whole genome sequencing is poised to revolutionize personalized medicine, providing the capacity to classify individuals into risk categories for a wide range of diseases.", {"entities": []}], ["Here we begin to explore how whole genome sequencing (WGS) might be incorporated alongside traditional clinical evaluation as a part of preventive medicine.", {"entities": []}], ["The present study illustrates novel approaches for integrating genotypic and clinical information for assessment of generalized health risks and to assist individuals in the promotion of wellness and maintenance of good health.", {"entities": []}], ["Whole genome sequences and longitudinal clinical profiles are described for eight middle-aged Caucasian participants (four men and four women) from the Center for Health Discovery and Well Being (CHDWB) at Emory University in Atlanta.", {"entities": []}], ["We report multivariate genotypic risk assessments derived from common variants reported by genome-wide association studies (GWAS), as well as clinical measures in the domains of immune, metabolic, cardiovascular, musculoskeletal, respiratory, and mental health.", {"entities": []}], ["Polygenic risk is assessed for each participant for over 100 diseases and reported relative to baseline population prevalence.", {"entities": []}], ["Two approaches for combining clinical and genetic profiles for the purposes of health assessment are then presented.", {"entities": []}], ["First we propose conditioning individual disease risk assessments on observed clinical status for type 2 diabetes, coronary artery disease, hypertriglyceridemia and hypertension, and obesity.", {"entities": [[165, 177, "DISEASE"], [183, 190, "DISEASE"]]}], ["An approximate 2:1 ratio of concordance between genetic prediction and observed sub-clinical disease is observed.", {"entities": []}], ["Subsequently, we show how more holistic combination of genetic, clinical and family history data can be achieved by visualizing risk in eight sub-classes of disease.", {"entities": []}], ["Having identified where their profiles are broadly concordant or discordant, an individual can focus on individual clinical results or genotypes as they develop personalized health action plans in consultation with a health partner or coach.", {"entities": []}], ["The CHDWB will facilitate longitudinal evaluation of wellness-focused medical care based on comprehensive self-knowledge of medical risks.", {"entities": []}], ["An increasing number of epidemiological and experimental studies have associated exposure to second-hand smoke (SHS) during pregnancy with adverse outcomes in newborns.", {"entities": []}], ["As we have previously shown in mice, in utero exposure to SHS at critical stages of fetal development, results in altered lung responses and increased disease susceptibility upon re-exposure to irritants (SHS or ovalbumin) in adulthood.", {"entities": []}], ["In this study, we asked whether the in utero SHS exposure alone is sufficient to alter lung structure and function in adult mice.", {"entities": []}], ["Pregnant BALB/c mice were exposed from days 6 to 19 of pregnancy to 10\u00a0mg/m n \u2009=\u200913\u201315/group) were sacrificed at 15\u00a0weeks of age.", {"entities": []}], ["We measured lung function with non-invasive and invasive methods, performed lung morphometric analysis on trichrome-stained lung tissue samples, and assessed lung gene expression via RNA sequencing and protein assays.", {"entities": []}], ["In utero SHS exposure significantly increased mean linear intercept and decreased the surface area per unit volume of the lungs in both males and females, indicating perturbation in alveolar developmental processes.", {"entities": []}], ["Tidal volume, minute volume and inspiratory capacity were significantly decreased compared with the controls only in male mice exposed in utero to SHS, suggesting that males are more sensitive than females to an SHS insult during lung development.", {"entities": []}], ["This also suggests that in our model, lung structure changes may be necessary but are not sufficient to impair lung function.", {"entities": []}], ["SERPINA1A, the mouse ortholog of human \u03b11-antitrypsin, deficiency of which is a known genetic risk factor for emphysema, was down-regulated at the protein level in the in utero SHS-exposed mice.", {"entities": []}], ["Additionally, DNMT3A protein expression was dysregulated, indicating that DNA methylation occurred in the lungs.", {"entities": [[14, 20, "GENE"]]}], ["Our results indicate that in utero SHS exposure alone alters both lung function and structure well into adulthood (15\u00a0weeks) in male mice.", {"entities": []}], ["Furthermore, lung function alterations in this model are sex-specific, with males being more susceptible to in utero SHS effects.", {"entities": []}], ["Overall, our data suggest that in utero SHS exposure alone can predispose to adult lung diseases.", {"entities": []}], ["The assessment of the work of breathing in the definitions of respiratory failure is vague and variable.", {"entities": [[62, 81, "DISEASE"]]}], ["Identify a parsimonious set of signs to describe the work of breathing in hypoxemic, acutely ill patients.", {"entities": []}], ["We examined consecutive medical ICU patients receiving oxygen with a mask, non-invasive ventilation, or T-piece.", {"entities": []}], ["A physician inspected each patient for 10 seconds, rated the level of respiratory distress, and then examined the patient for vital signs and 17 other physical signs.", {"entities": []}], ["We used the rating of distress as a surrogate for measuring the work of breathing, constructed three multivariate models to identify the one with the smallest number of signs and largest explained variance, and validated it with bootstrap analysis.", {"entities": []}], ["We performed 402 observations on 240 patients.", {"entities": []}], ["Respiratory distress was absent in 78, mild in 157, moderate in 107, and severe in 60.", {"entities": []}], ["Respiratory rate, hypoxia, heart rate, and frequency of most signs increased as distress increased.", {"entities": []}], ["Respiratory rate and hypoxia explained 43% of the variance in respiratory distress.", {"entities": []}], ["Diaphoresis, gasping, and contraction of the sternomastoid explained an additional 28%.", {"entities": []}], ["Heart rate, blood pressure, alertness, agitation, body posture, nasal flaring, audible breathing, cyanosis, tracheal tug, retractions, paradox, scalene or abdominal muscles contraction did not increase the explained variance in respiratory distress.", {"entities": []}], ["Most of the variance is respiratory distress can be explained by five signs summarized by the mnemonic DiapHRaGM ( diap horesis, h ypoxia, respiratory ra te, g asping, accessory m uscle).", {"entities": []}], ["This set of signs may allow for efficient, standardized assessments of the work of breathing of hypoxic patients.", {"entities": []}], ["Self-monitoring, by which individuals record and appraise ongoing information about the status of their body in order to improve their health, has been a key element in the personal management of conditions such as diabetes, but it is now also increasingly used in relation to health-associated behaviours.", {"entities": []}], ["The introduction of self-monitoring as an intervention to change behaviour is intended to provide feedback that can be used by individuals to both assess their status and provide ongoing support towards a goal that may be formally set or remains implicit.", {"entities": []}], ["However, little attention has been paid to how individuals actually engage in the process or act upon the information they receive.", {"entities": []}], ["This article addresses this by exploring how participants in a particular trial (\u2018Get Moving\u2019) experienced the process and nature of feedback.", {"entities": []}], ["Although the trial aimed to compare the potential efficacy of three different monitoring activities designed to encourage greater physical activity, participants did not present distinctly different accounts of each intervention and the specifics of the feedback provided.", {"entities": []}], ["Instead, their accounts took the form of much more extended and personal narratives that included other people and features of the environment.", {"entities": []}], ["We draw on these broader descriptions to problematise the notion of self-monitoring and conclude that self-monitoring is neither solely about \u2018self\u2019 nor is it exclusively about \u2018monitoring\u2019.", {"entities": []}], ["We suggest that a more expansive social and material understanding of feedback can give insight into the ways information is made active and meaningful for individuals in their everyday contexts.", {"entities": []}], ["A major complication of peritoneal dialysis is the development of peritonitis, which is associated with reduced technique and patient survival.", {"entities": [[66, 77, "DISEASE"]]}], ["The inflammatory response elicited by infection results in a fibrin and debris-rich environment within the peritoneal cavity, which may reduce the effectiveness of antimicrobial agents and predispose to recurrence or relapse of infection.", {"entities": []}], ["Strategies to enhance responses to antimicrobial agents therefore have the potential to improve patient outcomes.", {"entities": []}], ["This study presents pre-clinical data describing the compatibility of tPA and DNase in combination with antimicrobial agents used for the treatment of PD peritonitis.", {"entities": [[154, 165, "DISEASE"]]}], ["tPA and DNase were stable in standard dialysate solution and in the presence of antimicrobial agents, and were safe when given intraperitoneally in a mouse model with no evidence of local or systemic toxicity.", {"entities": []}], ["Adjunctive tPA and DNase may have a role in the management of patients presenting with PD peritonitis.", {"entities": [[90, 101, "DISEASE"]]}], ["Background: Chronic migraine is a common, highly disabling, underdiagnosed and undertreated entity of migraine.", {"entities": [[20, 28, "DISEASE"], [102, 110, "DISEASE"]]}], ["It affects 0.9%\u20132.2% of the general adult population.", {"entities": []}], ["The present paper overviews the preclinical and clinical data regarding the therapeutic effect of onabotulinumtoxinA in chronic migraineurs.", {"entities": []}], ["Methods: A literature search was conducted in the database of PubMed up to 20 May 2015 for articles related to the pathomechanism of chronic migraine, the mode of action, and the efficacy, safety and tolerability of onabotulinumtoxinA for the preventive treatment of chronic migraine.", {"entities": [[141, 149, "DISEASE"], [275, 283, "DISEASE"]]}], ["Results: The pathomechanism of chronic migraine has not been fully elucidated.", {"entities": [[39, 47, "DISEASE"]]}], ["The mode of action of onabotulinumtoxinA in the treatment of chronic migraine is suggested to be related to the inhibition of the release of calcitonin gene-related peptide and substance P in the trigeminovascular system.", {"entities": [[69, 77, "DISEASE"]]}], ["Randomized clinical trials demonstrated that long-term onabotulinumtoxinA fixed-site and fixed-dose (155\u2013195 U) intramuscular injection therapy was effective and well tolerated for the prophylactic treatment of chronic migraine.", {"entities": [[219, 227, "DISEASE"]]}], ["Conclusions: Chronic migraine is a highly devastating entity of migraine.", {"entities": [[21, 29, "DISEASE"], [64, 72, "DISEASE"]]}], ["Its exact pathomechanism is unrevealed.", {"entities": []}], ["Two-third of chronic migraineurs do not receive proper preventive medication.", {"entities": []}], ["Recent clinical studies revealed that onabotulinumtoxinA was an efficacious and safe treatment for chronic migraine.", {"entities": [[107, 115, "DISEASE"]]}], ["Questionnaires used by health services to identify children with psychosocial problems are often rather short.", {"entities": []}], ["The psychometric properties of such short questionnaires are mostly less than needed for an accurate distinction between children with and without problems.", {"entities": []}], ["We aimed to assess whether a short Computerized Adaptive Test (CAT) can overcome the weaknesses of short written questionnaires when identifying children with psychosocial problems.", {"entities": []}], ["We used a Dutch national data set obtained from parents of children invited for a routine health examination by Preventive Child Healthcare with 205 items on behavioral and emotional problems (n = 2,041, response 84%).", {"entities": []}], ["In a random subsample we determined which items met the requirements of an Item Response Theory (IRT) model to a sufficient degree.", {"entities": []}], ["Using those items, item parameters necessary for a CAT were calculated and a cut-off point was defined.", {"entities": []}], ["In the remaining subsample we determined the validity and efficiency of a Computerized Adaptive Test using simulation techniques, with current treatment status and a clinical score on the Total Problem Scale (TPS) of the Child Behavior Checklist as criteria.", {"entities": []}], ["Out of 205 items available 190 sufficiently met the criteria of the underlying IRT model.", {"entities": []}], ["For 90% of the children a score above or below cut-off point could be determined with 95% accuracy.", {"entities": []}], ["The mean number of items needed to achieve this was 12.", {"entities": []}], ["Sensitivity and specificity with the TPS as a criterion were 0.89 and 0.91, respectively.", {"entities": []}], ["An IRT-based CAT is a very promising option for the identification of psychosocial problems in children, as it can lead to an efficient, yet high-quality identification.", {"entities": []}], ["The results of our simulation study need to be replicated in a real-life administration of this CAT.", {"entities": []}], ["We recently reported that progranulin (PGRN) is a novel regulator of glucocerebrosidase and its deficiency associates with Gaucher Diseases (GD) (Jian et al., 2016a; Jian et al., 2018).", {"entities": []}], ["To isolate the relevant downstream molecules, we performed a whole genome microarray and mass spectrometry analysis, which led to the isolation of Chitinase-3-like-1 (CHI3L1) as one of the up-regulated genes in PGRN null mice.", {"entities": [[167, 173, "GENE"]]}], ["Elevated levels of CHI3L1 were confirmed by immunoblotting and immunohistochemistry.", {"entities": [[19, 25, "GENE"]]}], ["In contrast, treatment with recombinant Pcgin, a derivative of PGRN, as well as imigluerase, significantly reduced the expressions of CHI3L1 in both PGRN null GD model and the fibroblasts from GD patients.", {"entities": [[134, 140, "GENE"]]}], ["Serum levels of CHIT1, a clinical biomarker for GD, were significantly higher in GD patients than healthy controls (51.16\u00a0\u00b1\u00a02.824\u00a0ng/ml vs 35.07\u00a0\u00b1\u00a02.099\u00a0ng/ml, p \u00a0<\u00a00.001).", {"entities": [[16, 21, "GENE"]]}], ["Similar to CHIT1, serum CHI3L1 was also significantly increased in GD patients compared with healthy controls (1736\u00a0\u00b1\u00a0152.1\u00a0pg/ml vs 684.7\u00a0\u00b1\u00a068.20\u00a0pg/ml, p \u00a0<\u00a00.001).", {"entities": [[11, 16, "GENE"], [24, 30, "GENE"]]}], ["Whereas the PGRN level is significantly reduced in GD patients as compared to the healthy control (91.56\u00a0\u00b1\u00a03.986\u00a0ng/ml vs 150.6\u00a0\u00b1\u00a04.501, p\u00a0<\u00a00.001).", {"entities": []}], ["Collectively, these results indicate that CHI3L1 may be a previously unrecognized biomarker for diagnosing GD and for evaluating the therapeutic effects of new GD drug(s).", {"entities": [[42, 48, "GENE"]]}], ["\u2022 CHI3L1 is isolated as a as PGRN downstream molecule associated with Gaucher Diseases (GD).", {"entities": [[2, 8, "GENE"]]}], ["\u2022 Expression of CHI3L1 is increased in Gba1 D409V/null GD animal model.", {"entities": [[16, 22, "GENE"]]}], ["\u2022 CHI3L1 level is reduced when GD phenotypes is improved following treatments.", {"entities": [[2, 8, "GENE"]]}], ["\u2022 Serum levels of CHI3L1 is significantly elevated in GD patients compared with healthy controls.", {"entities": [[18, 24, "GENE"]]}], ["CHI3L1 is isolated as a as PGRN downstream molecule associated with Gaucher Diseases (GD).", {"entities": [[0, 6, "GENE"]]}], ["Expression of CHI3L1 is increased in Gba1 D409V/null GD animal model.", {"entities": [[14, 20, "GENE"]]}], ["CHI3L1 level is reduced when GD phenotypes is improved following treatments.", {"entities": [[0, 6, "GENE"]]}], ["Serum levels of CHI3L1 is significantly elevated in GD patients compared with healthy controls.", {"entities": [[16, 22, "GENE"]]}], ["Gaucher disease (GD), common lysosomal storage disease (LSD), is caused by mutations in GBA1 with resultant defective glucocerebrosidase (GCase) activity.", {"entities": [[29, 54, "DISEASE"]]}], ["PGRN is a novel factor of GD that directly binds to GCase and GD patients have significantly lower levels of PGRN in serum compared with healthy controls (Jian et al., 2016a).", {"entities": []}], ["Mechanistically, PGRN functions as a chaperone molecule that facilitates GCase lysosomal delivery (", {"entities": []}], ["Norwegian primary health care is maintained on the regular general practitioners (RGPs), GP\u2019s contracted to the municipalities in a list patient system, working at daytime and at out-of-hours services (OOH services).", {"entities": []}], ["Respiratory disease is most prevalent during OOH services, and in more than 50\u00a0% of the consultations, a CRP test is performed.", {"entities": [[105, 108, "GENE"]]}], ["Children in particular have a high consultation rate, and the CRP test is frequently conducted, but the contributing factors behind its frequent use are not known.", {"entities": [[62, 65, "GENE"]]}], ["This study compares the RGPs rate of CRP use at daytime and OOH in consultations with children and how this rate is influenced by characteristics of the RGPs.", {"entities": [[37, 40, "GENE"]]}], ["A cross-sectional register study was conducted based on all ( N \u2009=\u20092 552 600) electronic compensation claims from consultations with children\u2009\u2264\u20095\u00a0year during the period 2009\u20132011 from primary health care.", {"entities": []}], ["Consultation rates and CRP use were estimated and analysed using descriptive methods.", {"entities": [[23, 26, "GENE"]]}], ["Being among the 20\u00a0% of RGPs with the highest rate of CRP use at daytime or OOH was an outcome measure in regression analyses using RGP-, and RGP list characteristics as explanatory variables.", {"entities": [[54, 57, "GENE"]]}], ["One third of all RGPs work regularly in OOH services, and they use CRP 1.42 times more frequently in consultations with children in OOH services than in daytime services even when the distribution of diagnosis according to ICPC-2 chapters is similar.", {"entities": [[67, 70, "GENE"]]}], ["Not being approved specialist, have a large number at their patient-lists but relatively few children on their list and a large number of consultations with children were significantly associated with frequent use of CRP in daytime services.", {"entities": [[217, 220, "GENE"]]}], ["The predictors for frequent CRP use in OOH services were being a young doctor, having many consultations with children during OOH and a frequent use of CRP in daytime services.", {"entities": [[28, 31, "GENE"], [152, 155, "GENE"], [28, 31, "GENE"], [152, 155, "GENE"]]}], ["The increase in the frequency of CRP test use from daytime to OOH occurs in general for RGPs and for all most used diagnoses.", {"entities": [[33, 36, "GENE"]]}], ["The RGPs who use the CRP test most frequently in their daytime practice have the highest rate of CRP in OOH services.", {"entities": [[21, 24, "GENE"], [97, 100, "GENE"], [21, 24, "GENE"], [97, 100, "GENE"]]}], ["The air pollution in China is a severe problem.", {"entities": []}], ["The aim of our study was to investigate the impact of air pollutants on acute respiratory outcomes in outpatients.", {"entities": []}], ["Outpatient data from 2 December 2013 to 1 December 2014 were collected, as well as air pollutant data including ozone (O 3 ), nitrogen dioxide (NO 2 ), carbon monoxide (CO), sulfur dioxide (SO 2 ), and particulate matter (PM 2.5 and PM 10 ).", {"entities": []}], ["We screened six categories of acute respiratory outcomes and analyzed their associations with different air pollutant exposures, including upper respiratory tract infection (URTI), acute bronchitis (AB), community-acquired pneumonia (CAP), acute exacerbation of chronic obstructive pulmonary disease (AECOPD), acute exacerbation of asthma (AE-asthma), and acute exacerbation of bronchiectasis (AEBX).", {"entities": [[223, 232, "DISEASE"], [262, 299, "DISEASE"], [378, 392, "DISEASE"], [332, 338, "DISEASE"], [343, 349, "DISEASE"], [187, 197, "DISEASE"]]}], ["A case-crossover design with a bidirectional control sampling approach was used for statistical analysis.", {"entities": []}], ["A total of 57,144 patients were enrolled for analysis.", {"entities": []}], ["PM 2.5 , PM 10 , NO 2 , SO 2 , and CO exposures were positively associated with outpatient visits for URTI, AB, CAP, and AEBX.", {"entities": []}], ["PM 10 , SO 2 , and CO exposures were positively associated with outpatient visits for AECOPD.", {"entities": []}], ["Exposure to O 3 was positively associated with outpatient visits for AE-asthma, but negatively associated with outpatient visits for URTI, CAP, and AEBX.", {"entities": [[72, 78, "DISEASE"]]}], ["In conclusion, air pollutants had acute effects on outpatient visits for acute respiratory outcomes, with specific outcomes associated with specific pollutants.", {"entities": []}], ["Electroacupuncture (EA) has been applied to treat and prevent diseases for years.", {"entities": []}], ["However, molecular events happened in both the acupunctured site and the internal organs after EA stimulation have not been clarified.", {"entities": []}], ["Here we applied transcriptomic analysis to explore the gene expression signatures after EA stimulation.", {"entities": []}], ["Mice were applied EA stimulation at ST36 for 15\u00a0min and nine tissues were collected three hours later for microarray analysis.", {"entities": []}], ["We found that EA affected the expression of genes not only in the acupunctured site but also in the internal organs.", {"entities": []}], ["EA commonly affected biological networks involved in cytoskeleton and cell adhesion, and also regulated unique process networks in specific organs, such as \u03b3-aminobutyric acid-ergic neurotransmission in brain and inflammation process in lung.", {"entities": []}], ["In addition, EA affected the expression of genes related to various diseases, such as neurodegenerative diseases in brain and obstructive pulmonary diseases in lung.", {"entities": []}], ["This report applied, for the first time, a global comprehensive genome-wide approach to analyze the gene expression profiling of acupunctured site and internal organs after EA stimulation.", {"entities": []}], ["The connection between gene expression signatures, biological processes, and diseases might provide a basis for prediction and explanation on the therapeutic potentials of acupuncture in organs.", {"entities": []}], ["Phosphodiesterase (PDE) 4 participates in regulating the inflammatory response by degrading cyclic adenosine\u00a03\u2032,5\u2032-monophosphate (cAMP), a key second messenger.", {"entities": []}], ["Inhibition of PDE4 increases the intracellular cAMP level, which in turn results in a reduction in inflammatory mediators and an increase in anti-inflammatory mediators.", {"entities": []}], ["Immune-modulating effects of PDE4 inhibitors have been investigated in a number of inflammatory conditions, such as asthma, atopic dermatitis, chronic obstructive pulmonary disease, Beh\u00e7et\u2019s disease, psoriasis, and psoriatic arthritis.", {"entities": [[200, 209, "DISEASE"], [124, 141, "DISEASE"], [143, 180, "DISEASE"], [225, 234, "DISEASE"], [215, 234, "DISEASE"], [116, 122, "DISEASE"], [131, 141, "DISEASE"]]}], ["Apremilast, a selective PDE4 inhibitor, has been shown to block the production of pro-inflammatory cytokines (interferon-\u03b3, tumor necrosis factor-\u03b1, interleukin [IL]-12, IL-17, and IL-23), which are the key players in the pathogenesis of psoriasis.", {"entities": [[238, 247, "DISEASE"]]}], ["Increased intracellular cAMP levels result in a range of anti-inflammatory effects on numerous cell lines.", {"entities": []}], ["A decrease in pro-inflammatory activity has been shown to result in a reduced psoriasiform response in preclinical in\u00a0vivo models of psoriasis, and reduction of biologic activity in a pilot study in humans.", {"entities": [[133, 142, "DISEASE"]]}], ["The efficacy and safety of apremilast in the treatment of psoriasis have been demonstrated in phase\u00a0II and\u00a0III clinical trials.", {"entities": [[58, 67, "DISEASE"]]}], ["Apremilast demonstrated efficacy in reducing the severity of moderate to severe plaque psoriasis.", {"entities": [[87, 96, "DISEASE"]]}], ["Treatment with apremilast was well tolerated, with generally mild gastrointestinal complaints, which occurred early in the course of the treatment and resolved over time, and there was no requirement for laboratory test monitoring.", {"entities": []}], ["These results make apremilast an attractive therapeutic option for plaque psoriasis.", {"entities": [[74, 83, "DISEASE"]]}], ["Traumatic or serious brain injury (BI) has persistent and well documented adverse outcomes, yet 'mild' or 'moderate' BI, which often does not result in hospital treatment, accounts for half the total days of disability attributed to BI.", {"entities": []}], ["There are currently few data available from community samples on the incidence and correlates of these injuries.", {"entities": []}], ["Therefore, the study aimed to assess the 1) incidence of self-reported mild (not requiring hospital admission) and moderate (admitted to hospital)) brain injury (BI), 2) causes of injury 3) physical health scores and 4) relationship between BI and problematic alcohol or marijuana use.", {"entities": []}], ["An Australian community sequential-cohort study (cohorts aged 20-24, 40-44 and 60-64 years at wave one) used a survey methodology to assess BI and substance use at baseline and four years later.", {"entities": []}], ["Of the 7485 wave one participants, 89.7% were re-interviewed at wave two.", {"entities": []}], ["There were 56 mild (230.8/100000 person-years) and 44 moderate BI (180.5/100000 person-years) reported between waves one and two.", {"entities": []}], ["Males and those in the 20-24 year cohort had increased risk of BI.", {"entities": []}], ["Sports injury was the most frequent cause of BI (40/100) with traffic accidents being a greater proportion of moderate (27%) than mild (7%) BI.", {"entities": []}], ["Neither alcohol nor marijuana problems at wave one were predictors of BI.", {"entities": []}], ["BI was not a predictor of developing substance use problems by wave two.", {"entities": []}], ["BI were prevalent in this community sample, though the incidence declined with age.", {"entities": []}], ["Factors associated with BI in community samples differ from those reported in clinical samples (e.g.", {"entities": []}], ["typically traumatic brain injury with traffic accidents the predominate cause).", {"entities": []}], ["Further, detailed evaluation of the health consequences of these injuries is warranted.", {"entities": []}], ["Li\u00e1ng ch\u00e1 (\u201ccooling tea\u201d, \u201cherbal tea\u201d or \u201ccool tisane\u201d in Chinese) are herbal drinks widely produced in southern China and consumed by billions of people worldwide to prevent and treat internal heat as well as a range of associated health conditions.", {"entities": []}], ["Globalization and renewed interest in botanical remedies has attracted growing attention in cooling herbal drinks by industry, scientists and consumers.", {"entities": []}], ["However, there is a knowledge gap on the plant species used and commercialized for cooling herbal drinks in southern China and their associated ethnobotanical use, habitat and conservation status.", {"entities": []}], ["This is the first study to document plant species used and commercialized as li\u00e1ng ch\u00e1 in southern China\u2019s Lingnan region and associated ethnomedical function, preparation methods, habitat and conservation status.", {"entities": []}], ["Three hundred market surveys were conducted between 2010-2012 in the largest herbal drink producing region of China to record plants used for li\u00e1ng ch\u00e1 and to document knowledge on their medicinal function, habitat and conservation status.", {"entities": []}], ["Product samples and voucher specimens were collected for taxonomic identification.", {"entities": []}], ["All informants harvest and cultivate plants for preparing herbal drinks for their medicinal, cultural and economic values.", {"entities": []}], ["A total of 222 ethnotaxa corresponded to 238 botanical taxa (species, varieties or subspecies) belonging to 86 families and 209 genera were recorded as li\u00e1ng ch\u00e1 to treat health conditions in the study area.", {"entities": []}], ["Recorded remedies consisted of one or several plant species to treat conditions classified into 27 major health conditions with clearing internal heat being the most common medicinal function.", {"entities": []}], ["The habitat types of plants documented for use as li\u00e1ng ch\u00e1 include 112 wild harvested species, 51 species that are either wild harvested or cultivated, 57 cultivated species, and 2 naturalized species.", {"entities": []}], ["According to China\u2019s Red List and CITES on conservation status, one of these species is endangered, one species is critically endangered, eight species are vulnerable, one is listed in CITES II, three are listed in Regional Red Data Book and the remaining 224 species are in the least concerned conservation category.", {"entities": []}], ["The li\u00e1ng ch\u00e1 industry of southern China reflects the plant species richness and cultural diversity of the region.", {"entities": []}], ["Future research on safety and efficacy of herbal drinks as well as ecological and cultural conservation efforts are needed for the sustainable growth of China\u2019s botanical industry.", {"entities": []}], ["We analyzed age-related changes of bone mineral density (BMD) and compared with those of U.S and Japanese participants to investigate the prevalence of osteoporosis in Korea.", {"entities": [[152, 164, "DISEASE"]]}], ["The data were collected in the 2008-2011 in Korea National Health and Nutrition Examination Survey (KNHANES) IV and V to select a representative sample of civilian, noninstitutionalized South Korean population.", {"entities": []}], ["Bone mineral measurements were obtained from 8332 men and 9766 women aged 10 years and older.", {"entities": []}], ["BMD in men continued to decline from 3rd decade, however, in women, BMD remained nearly constant until the 4th decade and declined at rapid rate from the 5th decade.", {"entities": []}], ["The prevalence of osteoporosis in Korea is 7.3% in males and 38.0% in females aged 50 years and older.", {"entities": [[18, 30, "DISEASE"]]}], ["The prevalence of osteopenia in Korea is 46.5% in males and 48.7% in females, aged 50 years and older.", {"entities": []}], ["The lumbar spine and femur BMD in Korean females 20 to 49 years of ages was lower than in U.S. and Japan participants.", {"entities": []}], ["There was obvious gender, and age differences in the BMD based on the 2008-2011 KNHANES IV and V, a nationwide, cross-sectional survey conducted in a South Korean population.", {"entities": []}], ["We expect to be able to estimate reference data through ongoing KNHANES efforts in near future.", {"entities": []}], ["Asthma and pregnancy are both sources of anxiety for women.", {"entities": [[0, 6, "DISEASE"]]}], ["Although there has been a focus on physiological management of asthma and pregnancy, there has been little research on the impact that personalised support can have on asthma care during pregnancy.", {"entities": [[63, 69, "DISEASE"], [168, 174, "DISEASE"]]}], ["This systematic review and narrative synthesis of the literature set out to answer the question \u2018What are women\u2019s experiences of asthma care, its management and education, during pregnancy?\u2019 This systematic review was carried out using accepted methodology from the York Centre for Reviews and Dissemination.", {"entities": [[129, 135, "DISEASE"]]}], ["Electronic database searches were conducted using PsycInfo, CINAHL, MedLine, Google Scholar and the Cochrane Library, using the combination search terms: \u2018Asthma\u2019 AND \u2018Pregnancy\u2019 AND \u2018Care\u2019 AND (\u2018Education OR Information OR Experience\u2019).", {"entities": [[155, 161, "DISEASE"]]}], ["Hand searching of journals and searches for grey literature were also undertaken.", {"entities": []}], ["Independent quality appraisal by the three authors took place using the criteria detailed by Kmet et al.", {"entities": []}], ["(Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields, 2004).", {"entities": []}], ["All papers scoring in excess of 60% were deemed to be of adequate quality for inclusion, of which there were five: two qualitative designs and three quantitative designs.", {"entities": []}], ["The designs were too methodologically heterogeneous to permit statistical meta-analysis so narrative review and synthesis was undertaken.", {"entities": []}], ["Despite an embryonic evidence bases, it is reasonable to conclude that personalised care has beneficial outcomes for pregnant asthmatic women.", {"entities": []}], ["Larger randomised controlled trials investigating personalised care are required to build an evidence base which can establish the efficacy of such interventions.", {"entities": []}], ["As personal care products (PCPs) are used in close contact with a person, they are a major source of consumer exposure to chemical substances contained in these products.", {"entities": []}], ["The estimation of realistic consumer exposure to substances in PCPs is currently hampered by the lack of appropriate data and methods.", {"entities": []}], ["To estimate aggregate exposure of consumers to substances contained in PCPs, a person-oriented consumer exposure model has been developed (the Probabilistic Aggregate Consumer Exposure Model, PACEM).", {"entities": []}], ["The model simulates daily exposure in a population based on product use data collected from a survey among the Dutch population.", {"entities": []}], ["The model is validated by comparing diethyl phthalate (DEP) dose estimates to dose estimates based on biomonitoring data.", {"entities": []}], ["It was found that the model's estimates compared well with the estimates based on biomonitoring data.", {"entities": []}], ["This suggests that the person-oriented PACEM model is a practical tool for assessing realistic aggregate exposures to substances in PCPs.", {"entities": []}], ["In the future, PACEM will be extended with use pattern data on other product groups.", {"entities": []}], ["This will allow for assessing aggregate exposure to substances in consumer products across different product groups.", {"entities": []}], ["Obstructive sleep apnea (OSA) is a respiratory disease characterized by the collapse of the extrathoracic airway and has important social implications related to accidents and cardiovascular risk.", {"entities": []}], ["The main objective of the present study was to investigate whether the drop in expiratory flow and the volume expired in 0.2 s during the application of negative expiratory pressure (NEP) are associated with the presence and severity of OSA in a population of professional interstate bus drivers who travel medium and long distances.", {"entities": []}], ["An observational, analytic study will be carried out involving adult male subjects of an interstate bus company.", {"entities": []}], ["Those who agree to participate will undergo a detailed patient history, physical examination involving determination of blood pressure, anthropometric data, circumference measurements (hips, waist and neck), tonsils and Mallampati index.", {"entities": []}], ["Moreover, specific questionnaires addressing sleep apnea and excessive daytime sleepiness will be administered.", {"entities": []}], ["Data acquisition will be completely anonymous.", {"entities": []}], ["Following the medical examination, the participants will perform a spirometry, NEP test and standard overnight polysomnography.", {"entities": []}], ["The NEP test is performed through the administration of negative pressure at the mouth during expiration.", {"entities": []}], ["This is a practical test performed while awake and requires little cooperation from the subject.", {"entities": []}], ["In the absence of expiratory flow limitation, the increase in the pressure gradient between the alveoli and open upper airway caused by NEP results in an increase in expiratory flow.", {"entities": []}], ["Despite the abundance of scientific evidence, OSA is still underdiagnosed in the general population.", {"entities": []}], ["In addition, diagnostic procedures are expensive, and predictive criteria are still unsatisfactory.", {"entities": []}], ["Because increased upper airway collapsibility is one of the main determinants of OSA, the response to the application of NEP could be a predictor of this disorder.", {"entities": []}], ["With the enrollment of this study protocol, the expectation is to encounter predictive NEP values for different degrees of OSA in order to contribute toward an early diagnosis of this condition and reduce its impact and complications among commercial interstate bus drivers.", {"entities": []}], ["Registro Brasileiro de Ensaios Clinicos (local acronym RBEC) [Internet]: Rio de Janeiro (RJ): Instituto de Informa\u00e7ao Cientifica e Tecnologica em Saude (Brazil); 2010 - Identifier RBR-7dq5xx.", {"entities": []}], ["Cross-sectional study on efficacy of negative expiratory pressure test proposed as screening for obstructive sleep apnea syndrome among commercial interstate bus drivers; 2011 May 31 [7 pages].", {"entities": [[121, 129, "DISEASE"]]}], ["Available from http://www.ensaiosclinicos.gov.br/rg/RBR-7dq5xx/ .", {"entities": []}], ["Studies comparing the measurement properties of EQ-5D 3L (3L) and EQ-5D 5L (5L) are limited to specific patient populations with small sample sizes.", {"entities": []}], ["Using a general population sample, we compared 3L and 5L in terms of their measurement properties and association with number of chronic conditions, including multimorbidity \u2013 the concurrent occurrence of two or more chronic conditions.", {"entities": []}], ["Data were available from two consecutive cycles of a cross-sectional telephone interview survey using 3L (2010\u00a0cycle) and 5L (2012\u00a0cycle), in the general population of adults (age\u2009\u2265\u200918\u00a0years) in Alberta, Canada.", {"entities": []}], ["Measurement properties were compared by determining their feasibility, ceiling effect, and discriminatory power (Shannon indices) for 3L and 5L.", {"entities": []}], ["Linear regression models were fitted to test the associations between multimorbidity and EQ-5D index score.", {"entities": []}], ["Data were available for 4946 (2010) and 4752 (2012) survey respondents with information on HRQL.", {"entities": []}], ["Compared to 3L, 5L showed lower ceiling effect (32.3% versus 42.1%), higher absolute discriminatory power (Shannon index, mean 0.79 versus 0.52) and higher relative discriminatory power (Shannon Evenness index, mean 0.09 versus 0.06 for 3L).", {"entities": []}], ["Despite these differences, similar relationships of lower HRQL with greater multimorbidity were observed for the 3L (\u00df\u2009=\u2009\u22120.13, 95% CI \u22120.15; \u22120.11) and 5L (\u00df\u2009=\u2009\u22120.12, 95% CI \u22120.13; \u22120.11).", {"entities": []}], ["Using a general population sample, the EQ-5D 5L showed better measurement properties than the EQ-5D 3L.", {"entities": []}], ["Nonetheless, clinically important differences in HRQL associated with multimorbidity were similar in magnitude using both versions of EQ-5D.", {"entities": []}], ["Acute and chronic inflammatory lung diseases are often associated with epithelial cell injury/loss and fibroproliferative responses.", {"entities": []}], ["ResolvinD 1 (RvD1) is biosynthesized during the resolution phase of inflammatory response and exerts potent anti-inflammatory and promotes resolution of inflammatory lung diseases.", {"entities": []}], ["The aim of this study was to investigate whether RvD1 exerts protective effects on alveolar epithelial cell function/differentiation and protects against fibroproliferative stimuli.", {"entities": []}], ["Primary human alveolar type II cells were used to model the effects of RvD1 in vitro upon wound repair, proliferation, apoptosis, transdifferentiation, and epithelial\u2013mesenchymal transition (EMT).", {"entities": []}], ["Effects of RvD1 upon primary human lung fibroblast proliferation, collagen production, and myofibroblast differentiation were also examined.", {"entities": []}], ["RvD1 promoted alveolar type II (ATII) cell wound repair and proliferation.", {"entities": []}], ["RvD1 protected ATII cells against sFas-ligand/TNF- \u03b1 -induced apoptosis and inhibition on cell proliferation and viability.", {"entities": []}], ["RvD1 promoted ATII cells transdifferentiation.", {"entities": []}], ["Moreover, we demonstrate that RvD1 inhibited EMT in response to TGF- \u03b2 .", {"entities": []}], ["Furthermore RvD1 inhibited human lung fibroblast proliferation, collagen production, and myofibroblast differentiation induced by both TGF- \u03b2 and bronchoalveolar lavage fluid from acute respiratory distress syndrome (ARDS) patients.", {"entities": [[207, 215, "DISEASE"]]}], ["The effects of RvD1 were PI3-kinase dependent and mediated via the resolvin receptor.", {"entities": []}], ["RvD1 seems to promote alveolar epithelial repair by stimulating ATII cells wound repair, proliferation, reducing apoptosis, and inhibiting TGF- \u03b2 -induced EMT.", {"entities": []}], ["While RvD1 reduced fibroproliferation, collagen production, and myofibroblast differentiation.", {"entities": []}], ["Together, these results suggest a potential new therapeutic strategy for preventing and treating chronic diseases (such as idiopathic pulmonary fibrosis) as well as the fibroproliferative phase of ARDS by targeting RvD1 actions that emphasizes natural resolution signaling pathways.", {"entities": [[134, 152, "DISEASE"], [123, 152, "DISEASE"]]}], ["Benefits of triple therapy with a long-acting muscarinic antagonist (LAMA), added to inhaled corticosteroid (ICS)/long-acting \u03b2 2 -agonist (LABA), have been demonstrated.", {"entities": []}], ["Limited data assessing the efficacy of the LAMA umeclidinium (UMEC) added to ICS/LABA are available.", {"entities": []}], ["The aim of this study is to evaluate the efficacy and safety of UMEC added to ICS/LABAs in patients with moderate-to-very-severe COPD.", {"entities": []}], ["This is a multicentre, randomised, double-blind, parallel-group study.", {"entities": []}], ["Patients were symptomatic (modified Medical Research Council Dyspnoea Scale score \u2a7e2), despite receiving ICS/LABA (fluticasone propionate/salmeterol (FP/SAL, branded) 500/50\u2009mcg, budesonide/formoterol (BD/FOR, branded) 200/6\u2009mcg or 400/12\u2009mcg, or other ICS/LABAs) \u2a7e30 days before the run-in (7\u00b12 days).", {"entities": []}], ["Patients were randomised 1:1 to once-daily UMEC 62.5\u2009mcg or placebo (PBO), added to twice-daily open-label ICS/LABA for 12 weeks.", {"entities": []}], ["Primary end point was trough forced expiratory volume in 1\u2009s (FEV 1 ) at Day 85; secondary end point was weighted mean (WM) 0\u20136\u2009h FEV 1 at Day 84; other end points included COPD Assessment Test (CAT) score and Transition Dyspnoea Index (TDI) score.", {"entities": [[62, 65, "GENE"], [130, 133, "GENE"], [62, 65, "GENE"], [130, 133, "GENE"]]}], ["Adverse events (AEs) were investigated.", {"entities": []}], ["In the UMEC+ICS/LABA and PBO+ICS/LABA groups, 119 and 117 patients were randomised, respectively.", {"entities": []}], ["Patients received FP/SAL (40%), BD/FOR (43%) and other ICS/LABAs (17%).", {"entities": []}], ["UMEC+ICS/LABA resulted in significant improvements in trough FEV 1 (Day 85) and in WM 0\u20136\u2009h FEV 1 (Day 84) versus PBO+ICS/LABA (difference: 123 and 148\u2009ml, respectively, both P <0.001).", {"entities": [[61, 64, "GENE"], [92, 95, "GENE"], [61, 64, "GENE"], [92, 95, "GENE"]]}], ["Change from baseline for UMEC+ICS/LABA versus PBO+ICS/LABA was significantly different for CAT score at Day 84 (\u22121.31, P <0.05), but not for TDI score (0.40, P =0.152).", {"entities": []}], ["AE incidence was similar with UMEC+ICS/LABA (38%) and PBO+ICS/LABA (42%).", {"entities": []}], ["UMEC+ICS/LABA improved lung function and CAT score in patients with symptomatic COPD versus PBO+ICS/LABA (ClinicalTrials.gov NCT02257372).", {"entities": []}], ["Some drugs have a narrow therapeutic range and require monitoring and dose adjustments to optimize their efficacy and safety.", {"entities": []}], ["Computerized clinical decision support systems (CCDSSs) may improve the net benefit of these drugs.", {"entities": []}], ["The objective of this review was to determine if CCDSSs improve processes of care or patient outcomes for therapeutic drug monitoring and dosing.", {"entities": []}], ["We conducted a decision-maker-researcher partnership systematic review.", {"entities": []}], ["Studies from our previous review were included, and new studies were sought until January 2010 in MEDLINE, EMBASE, Evidence-Based Medicine Reviews, and Inspec databases.", {"entities": []}], ["Randomized controlled trials assessing the effect of a CCDSS on process of care or patient outcomes were selected by pairs of independent reviewers.", {"entities": []}], ["A study was considered to have a positive effect ( i.e.", {"entities": []}], [", CCDSS showed improvement) if at least 50% of the relevant study outcomes were statistically significantly positive.", {"entities": []}], ["Thirty-three randomized controlled trials were identified, assessing the effect of a CCDSS on management of vitamin K antagonists (14), insulin (6), theophylline/aminophylline (4), aminoglycosides (3), digoxin (2), lidocaine (1), or as part of a multifaceted approach (3).", {"entities": []}], ["Cluster randomization was rarely used (18%) and CCDSSs were usually stand-alone systems (76%) primarily used by physicians (85%).", {"entities": []}], ["Overall, 18 of 30 studies (60%) showed an improvement in the process of care and 4 of 19 (21%) an improvement in patient outcomes.", {"entities": []}], ["All evaluable studies assessing insulin dosing for glycaemic control showed an improvement.", {"entities": []}], ["In meta-analysis, CCDSSs for vitamin K antagonist dosing significantly improved time in therapeutic range.", {"entities": []}], ["CCDSSs have potential for improving process of care for therapeutic drug monitoring and dosing, specifically insulin and vitamin K antagonist dosing.", {"entities": []}], ["However, studies were small and generally of modest quality, and effects on patient outcomes were uncertain, with no convincing benefit in the largest studies.", {"entities": []}], ["At present, no firm recommendation for specific systems can be given.", {"entities": []}], ["More potent CCDSSs need to be developed and should be evaluated by independent researchers using cluster randomization and primarily assess patient outcomes related to drug efficacy and safety.", {"entities": []}], ["Unique phosphodihydroceramides containing phosphoethanolamine and glycerol have been previously described in Porphyromonas gingivalis .", {"entities": []}], ["Importantly, they were shown to possess pro-inflammatory properties.", {"entities": []}], ["Other common human bacteria were screened for the presence of these lipids, and they were found, amongst others, in the oral pathogen Tannerella forsythia .", {"entities": []}], ["To date, no detailed study into the lipids of this organism has been performed.", {"entities": []}], ["Lipids were extracted, separated and purified by HPTLC, and analyzed using GC-MS, ESI\u2013MS and NMR.", {"entities": []}], ["Of special interest was how T. forsythia acquires the metabolic precursors for the lipids studied here.", {"entities": []}], ["This was assayed by radioactive and stable isotope incorporation using carbon-14 and deuterium labeled myo -inositol, added to the growth medium.", {"entities": []}], ["T. forsythia synthesizes two phosphodihydroceramides (Tf GL1, Tf GL2) which are constituted by phospho- myo -inositol linked to either a 17-, 18-, or 19-carbon sphinganine, N -linked to either a branched 17:0(3-OH) or a linear 16:0(3-OH) fatty acid which, in Tf GL2, is, in turn, ester-substituted with a branched 15:0 fatty acid.", {"entities": [[54, 56, "GENE"], [62, 64, "GENE"], [259, 261, "GENE"], [54, 56, "GENE"], [62, 64, "GENE"], [259, 261, "GENE"], [54, 56, "GENE"], [62, 64, "GENE"], [259, 261, "GENE"]]}], ["T. forsythia lacks the enzymatic machinery required for myo -inositol synthesis but was found to internalize inositol from the medium for the synthesis of both Tf GL1 and Tf GL2.", {"entities": [[160, 162, "GENE"], [171, 173, "GENE"], [160, 162, "GENE"], [171, 173, "GENE"]]}], ["The study describes two novel glycolipids in T. forsythia which could be essential in this organism.", {"entities": []}], ["Their synthesis could be reliant on an external source of myo -inositol.", {"entities": []}], ["The effects of these unique lipids on the immune system and their role in bacterial virulence could be relevant in the search for new drug targets.", {"entities": []}], ["Israel has made impressive progress in improving performance on key measures of the quality of health care in the community in recent years.", {"entities": []}], ["These achievements are all the more notable given Israel's modest overall spending on health care and because they have accrued to virtually the entire population of the country.", {"entities": []}], ["Health care systems in most developed nations around the world find themselves in a similar position today with respect to health care quality.", {"entities": []}], ["Despite significantly increased improvement efforts over the past decade, routine safety processes, such as hand hygiene and medication administration, fail routinely at rates of 30% to 50%.", {"entities": []}], ["People with chronic diseases experience preventable episodes of acute illness that require hospitalization due to medication mix-ups and other failures of outpatient management.", {"entities": []}], ["Patients continue to be harmed by preventable adverse events, such as surgery on the wrong part of the body and fires in operating theaters.", {"entities": []}], ["Health care around the world is not nearly as safe as other industries, such as commercial aviation, that have mastered highly effective ways to manage serious hazards.", {"entities": []}], ["Health care organizations will have to undertake three interrelated changes to get substantially closer to the superlative safety records of other industries: leadership commitment to zero major quality failures, widespread implementation of highly effective process improvement methods, and the adoption of all facets of a culture of safety.", {"entities": []}], ["Each of these changes represents a major challenge to the way today's health care organizations plan and carry out their daily work.", {"entities": []}], ["The Israeli health system is in an enviable position to implement these changes.", {"entities": []}], ["Universal health insurance coverage, the enrolment of the entire population in a small number of health plans, and the widespread use of electronic health records provide advantages available to few other countries.", {"entities": []}], ["Achieving and sustaining levels of safety comparable to, say, commercial aviation will be a long journey for health care--one we should begin promptly.", {"entities": []}], ["This is a commentary on http://www.ijhpr.org/content/1/1/3/", {"entities": []}], ["Despite the lack of nuclei and regulated transcription, platelets actively participate in multiple physiological processes, including hemostasis and immunity.", {"entities": []}], ["discuss aspects of platelet design that optimize its functions and argue that platelets may be best conceived as automated, fully equipped surveillance vehicles.", {"entities": []}], ["Platelets participate in many important physiological processes, including hemostasis and immunity.", {"entities": []}], ["However, despite their broad participation in these evolutionarily critical roles, the anucleate platelet is uniquely mammalian.", {"entities": []}], ["In contrast with the large nucleated equivalents in lower vertebrates, we find that the design template for the evolutionary specialization of platelets shares remarkable similarities with human-engineered unmanned aerial vehicles in terms of overall autonomy, maneuverability, and expendability.", {"entities": []}], ["Here, we review evidence illustrating how platelets are uniquely suited for surveillance and the manner in which they consequently provide various types of support to other cell types.", {"entities": []}], ["Respiratory syncytial virus (RSV) is a major cause of acute respiratory infections (ARIs) in children worldwide and can cause high mortality, especially in developing countries.", {"entities": []}], ["However, information on the clinical and molecular characteristics of RSV infection in developing countries is limited.", {"entities": []}], ["From April 2010 to May 2011, 1,082 nasopharyngeal swabs were collected from children with ARI admitted to the Children's Hospital 2, Ho Chi Minh City, Vietnam.", {"entities": []}], ["Samples were screened for RSV and genotyped by reverse transcription-PCR and sequencing.", {"entities": []}], ["Demographic and clinical data was also recorded.", {"entities": []}], ["RSV was found in 23.8% (257/1,082) of samples.", {"entities": []}], ["RSV A was the dominant subgroup, accounting for 91.4% (235/257), followed by RSV B, 5.1% (13/257), and 9 cases (3.5%) were mixed infection of these subgroups.", {"entities": []}], ["The phylogenetic analysis revealed that all group A strains belonged to the GA2 genotype.", {"entities": []}], ["All group B strains belonged to the recently identified BA genotype, and further clustered into 2 recently described subgenotypes BA9 and BA10.", {"entities": []}], ["One GA2 genotype strain had a premature stop codon which shortened the G protein length.", {"entities": []}], ["RSV infection was significantly associated with younger age and higher severity score than those without.", {"entities": []}], ["Co-infection with other viruses did not affect disease severity.", {"entities": []}], ["RSV A caused more severe disease than RSV B.", {"entities": []}], ["The results from this study will not only contribute to the growing database on the molecular diversity of RSV circulating worldwide but may be also useful in clinical management and vaccine development.", {"entities": []}], ["Agriculturally fertilized soil is a dominant source of NO x pollution in California.", {"entities": []}], ["Nitrogen oxides (NO x = NO + NO 2 ) are a primary component of air pollution\u2014a leading cause of premature death in humans and biodiversity declines worldwide.", {"entities": []}], ["Although regulatory policies in California have successfully limited transportation sources of NO x pollution, several of the United States\u2019 worst\u2013air quality districts remain in rural regions of the state.", {"entities": []}], ["Site-based findings suggest that NO x emissions from California\u2019s agricultural soils could contribute to air quality issues; however, a statewide estimate is hitherto lacking.", {"entities": []}], ["We show that agricultural soils are a dominant source of NO x pollution in California, with especially high soil NO x emissions from the state\u2019s Central Valley region.", {"entities": []}], ["We base our conclusion on two independent approaches: (i) a bottom-up spatial model of soil NO x emissions and (ii) top-down airborne observations of atmospheric NO x concentrations over the San Joaquin Valley.", {"entities": []}], ["These approaches point to a large, overlooked NO x source from cropland soil, which is estimated to increase the NO x budget by 20 to 51%.", {"entities": []}], ["These estimates are consistent with previous studies of point-scale measurements of NO x emissions from the soil.", {"entities": []}], ["Our results highlight opportunities to limit NO x emissions from agriculture by investing in management practices that will bring co-benefits to the economy, ecosystems, and human health in rural areas of California.", {"entities": []}], ["In the last few years, air within homes have been indicates by various and emerging body as more serious polluted than those outdoor.", {"entities": []}], ["Prevalence of respiratory inflammation among school children aged 8 and 10 years old attending national primary schools in urban and rural area were conducted in Klang Valley.", {"entities": []}], ["Two population studies drawn from the questionnaires were used to investigate the association between indoor particulate matter (PM 2.5 & PM 10 ) in a home environment and respiratory implication through the understanding of biological responses.", {"entities": []}], ["Approximately 430 healthy school children of Standard 2 and Standard 5 were selected.", {"entities": []}], ["Indication of respiratory symptoms using adaptation questionnaire from 2.5 and PM 10 were measured using Dust Trak Aerosol Monitor.", {"entities": []}], ["The mean concentration of PM 2.5 (45.38 \u00b5g/m 10 (80.07 \u00b5g/m 2.5 and PM 10 with the level of IL-6 among school children.", {"entities": []}], ["A greater exposure to PM 2.5 and PM 10 are associated with higher expression of IL-6 level suggesting that the concentration of indoor particulate in urban density area significantly influence the health of children.", {"entities": []}], ["TNF-like 1A (TL1A) is a cytokine belonging to the TNF superfamily that promotes inflammation in autoimmune diseases.", {"entities": [[0, 3, "GENE"], [50, 53, "GENE"]]}], ["Inhibiting the interaction of TL1A with the endogenous death-domain receptor 3 (DR3) offers a therapeutic approach for treating TL1A-induced autoimmune diseases.", {"entities": []}], ["Here, we generated improved DR3 variants showing increased TL1A binding affinity and stability using a directed evolution approach.", {"entities": []}], ["Given the high cysteine content and post-translational modification of DR3, we employed yeast surface display and expression in mammalian cell lines for screening, expression and characterization of improved DR3 variants.", {"entities": []}], ["A cell-based assay performed with the human TF-1 cell line and CD4", {"entities": [[63, 66, "GENE"]]}], ["The pulmonary innate immune system is heavily implicated in the perpetual airway inflammation and impaired host defense characterizing Chronic Obstructive Pulmonary Disease (COPD).", {"entities": []}], ["The airways of patients suffering from COPD are infiltrated by various immune and inflammatory cells including macrophages, neutrophils, T lymphocytes, and dendritic cells.", {"entities": []}], ["While the role of macrophages, neutrophils and T lymphocytes is well characterized, the contribution of dendritic cells to COPD pathogenesis is still the subject of emerging research.", {"entities": []}], ["A paper by Botelho and colleagues in the current issue of Respiratory Research investigates the importance of dendritic cell recruitment in cigarette-smoke induced acute and chronic inflammation in mice.", {"entities": []}], ["Dendritic cells of the healthy lung parenchyma and airways perform an important sentinel function and regulate immune homeostasis.", {"entities": []}], ["During inflammatory responses the function and migration pattern of these cells is dramatically altered but the underlying mechanisms are incompletely understood.", {"entities": []}], ["Botelho and colleagues demonstrate here the importance of IL-1R1/IL-1\u03b1 related mechanisms including CCL20 production in cigarette-smoke induced recruitment of dendritic cells and T cell activation in the mouse lung.", {"entities": [[100, 105, "GENE"]]}], ["Pulmonary fibrosis (PF) is characterized by inflammation and fibrosis of the interstitium and destruction of alveolar histoarchitecture ultimately leading to a fatal impairment of lung function.", {"entities": []}], ["Different concepts describe either a dominant role of inflammatory pathways or a disturbed remodeling of resident cells of the lung parenchyma during fibrogenesis.", {"entities": []}], ["Further, a combination of both the mechanisms has been postulated.", {"entities": []}], ["The present review emphasizes the particular involvement of alveolar epithelial type I cells in all these processes, their contribution to innate immune/inflammatory functions and maintenance of proper alveolar barrier functions.", {"entities": []}], ["Amongst the different inflammatory and repair events the purinergic receptor P2X7, an ATP-gated cationic channel that regulates not only apoptosis, necrosis, autophagy, and NLPR3 inflammosome activation, but also the turnover of diverse tight junction (TJ) and water channel proteins, seems to be essential for the stability of alveolar barrier integrity and for the interaction with protective factors during lung injury.", {"entities": []}], ["Researchers and clinicians are seeking to develop efficacious behavioral interventions to treat overweight children; however, few studies have documented the behavioral correlates of overweight children in community samples.", {"entities": []}], ["The goal of this study was to determine the nature and prevalence of behavior problems for overweight school-aged children versus normal weight peers before and after controlling for the effect of sleep disordered breathing.", {"entities": []}], ["Hispanic and Caucasian children were invited to participate in a study of sleep through public elementary school classrooms.", {"entities": []}], ["Anthropometric evaluation and behavioral ratings were collected for 402 children aged 6\u201311 years.", {"entities": []}], ["Overweight was calculated using the Centers for Disease Control age- and gender-specific guidelines.", {"entities": []}], ["Children were classified as overweight if they were at or above the 95th percentile for their age and gender group.", {"entities": []}], ["Behavior problems were measured using the Conners' Parent Rating Scales-Revised and the Child Behavior Checklist.", {"entities": []}], ["Sleep disordered breathing was assessed using in-home overnight polysomnography.", {"entities": []}], ["Approximately 15% (59/402) of the sample was classified as overweight.", {"entities": []}], ["Simple odds ratios indicated that overweight children were more likely to have clinically relevant levels of internalizing symptoms (OR 2.23, CI 1.05\u20134.72), psychosomatic complaints (OR 2.15, CI 1.02\u20134.54), withdrawal (OR 4.69, CI 2.05\u201310.73), and social problems (3.18, 1.53\u20136.60).", {"entities": []}], ["When odds ratios were adjusted for level of sleep disordered breathing, withdrawal (OR 3.83 CI 1.59\u20139.22) and social problems (OR 2.49 CI 1.14\u20135.44) remained significantly higher for overweight subjects.", {"entities": []}], ["After controlling for the effect of sleep disordered breathing, behaviors such as withdrawal and social problems, are common in overweight children and need to be taken into account in the design of interventions and services as they may act to moderate the efficacy of behavioral treatments.", {"entities": []}], ["We established a respiratory syncytial virus (RSV)-infected model in polarized normal human nasal epithelial cells and found that the replication of RSV and the epithelial cell responses including induction of tight junctions were regulated via a protein kinase C \u03b4/hypoxia-inducible factor-1\u03b1/nuclear factor-\u03ba\u03b2 pathway.", {"entities": []}], ["The control of this pathway may be useful in therapy for RSV-induced respiratory pathogenesis.", {"entities": []}], ["Respiratory syncytial virus (RSV) is the major cause of bronchitis, asthma, and severe lower respiratory tract disease in infants and young children.", {"entities": [[87, 118, "DISEASE"], [68, 74, "DISEASE"], [56, 66, "DISEASE"]]}], ["The airway epithelium, which has a well-developed barrier regulated by tight junctions, is the first line of defense during respiratory virus infection.", {"entities": []}], ["In upper airway human nasal epithelial cells (HNECs), however, the primary site of RSV infection, the mechanisms of replication and budding of RSV, and the epithelial cell responses, including the tight junctional barrier, remain unknown.", {"entities": []}], ["To investigate the detailed mechanisms of replication and budding of RSV in HNECs and the epithelial cell responses, we established an RSV-infected model using human telomerase reverse transcriptase\u2013-transfected HNECs.", {"entities": []}], ["We first found that the expression and barrier function of tight junction molecules claudin-4 and occludin were markedly induced together with production of proinflammatory cytokines interleukin 8 and tumor necrosis factor-\u03b1 in HNECs after RSV infection, and the induction of tight junction molecules possibly contributed to budding of RSV.", {"entities": []}], ["Furthermore, the replication and budding of RSV and the epithelial cell responses in HNECs were regulated via a protein kinase C \u03b4/hypoxia-inducible factor-1\u03b1/nuclear factor-\u03baB pathway.", {"entities": []}], ["The control of this pathway in HNECs may be useful not only for prevention of replication and budding of RSV, but also in therapy for RSV-induced respiratory pathogenesis.", {"entities": []}], ["Normal childhood development and growth is affected by such factors as genetics, nutrition, and multiple familial and social factors.", {"entities": []}], ["In large urban settings, children are constantly exposed to varying amounts of assorted toxic chemicals both inside and outside the home.", {"entities": []}], ["Many of these contaminants are suspected to be associated with developmental alterations.", {"entities": []}], ["The heterogeneity of risk factors in urban populations poses a challenging situation for research.", {"entities": []}], ["Change must be made in the manner in which developmental toxicological research is undertaken.", {"entities": []}], ["Plans should be made for immediate data collection after a large-scale exposure to prevent the loss of valuable information.", {"entities": []}], ["Retrospective studies would benefit from applying rapid assessment techniques to identify high- and low-risk children.", {"entities": []}], ["In all cases, the development of research design and investigative format needs to reflect the strengths of both social factors and scientific facts.", {"entities": []}], ["Cross-disciplinary approaches, using physicians and physical and social scientists and incorporating community knowledge, are required for the evaluation of children in urban settings, with each discipline contributing to theory and methodology.", {"entities": []}], ["This article describes a chemical characterization approach for complex organic compound mixtures associated with fine atmospheric particles of diameters less than 2.5 m (PM2.5).", {"entities": []}], ["It relates molecular- and bulk-level chemical characteristics of the complex mixture to atmospheric chemistry and to emission sources.", {"entities": []}], ["Overall, the analytical approach describes the organic complex mixtures in terms of a chemical mass balance (CMB).", {"entities": []}], ["Here, the complex mixture is related to a bulk elemental measurement (total carbon) and is broken down systematically into functional groups and molecular compositions.", {"entities": []}], ["The CMB and molecular-level information can be used to understand the sources of the atmospheric fine particles through conversion of chromatographic data and by incorporation into receptor-based CMB models.", {"entities": []}], ["Once described and quantified within a mass balance framework, the chemical profiles for aerosol organic matter can be applied to existing air quality issues.", {"entities": []}], ["Examples include understanding health effects of PM2.5 and defining and controlling key sources of anthropogenic fine particles.", {"entities": []}], ["Overall, the organic aerosol compositional data provide chemical information needed for effective PM2.5 management.", {"entities": []}], ["Intimate partner violence (IPV) is a pervasive problem impacting individuals around the globe.", {"entities": []}], ["The consequences of IPV extend beyond the adults in the relationship, as children witness a significant proportion of such violence.", {"entities": []}], ["Exposure to IPV during childhood has devastating effects across multiple domains of functioning.", {"entities": []}], ["This article reviews empirical studies of the effects of exposure to IPV by developmental stage.", {"entities": []}], ["The psychological, social, physical, and cognitive consequences of witnessing IPV are examined across development; from the impact of prenatal exposure to effects in infancy and toddlerhood, the preschool years, school-aged children, and adolescence.", {"entities": []}], ["The review concludes by providing suggestions for future research based on the identified developmental variations, recommendations for developmentally-sensitive interventions for children who have witnessed IPV, and directions for policy to address the issue of violence exposure early in the lives of children.", {"entities": []}], ["We sought to determine whether patients seen in hospitals who had reduced overall emergency department (ED) length of stay (LOS) in the 2\u2005years following the introduction of the Ontario Emergency Room Wait Time Strategy were more likely to experience improvements in other measures of ED quality of care for three important conditions.", {"entities": []}], ["Retrospective medical record review using difference-in-differences analysis to compare changes in performance on quality indicators over the 3-year period between 11 Ontario hospitals where the median ED LOS had improved from fiscal year 2008 to 2010 and 13 matched sites where ED LOS was unchanged or worsened.", {"entities": []}], ["Patients with acute myocardial infarction (AMI), asthma and paediatric and adult upper limb fractures in these hospitals in 2008 and 2010 were evaluated with respect to 18 quality indicators reflecting timeliness and safety/effectiveness of care in the ED.", {"entities": [[20, 41, "DISEASE"], [14, 41, "DISEASE"], [49, 55, "DISEASE"]]}], ["In a secondary analysis, we examined shift-level ED crowding at the time of the patient visit and performance on the quality indicators.", {"entities": []}], ["Median ED LOS improved by up to 26% (63\u2005min) from 2008 to 2010 in the improved hospitals, and worsened by up to 47% (91\u2005min) in the unimproved sites.", {"entities": []}], ["We abstracted 4319 and 4498 charts from improved and unimproved hospitals, respectively.", {"entities": []}], ["Improvement in a hospital's overall median ED LOS from 2008 to 2010 was not associated with a change in any of the other ED quality indicators over the same time period.", {"entities": []}], ["In our secondary analysis, shift-level crowding was associated only with indicators that reflected timeliness of care.", {"entities": []}], ["During less crowded shifts, patients with AMI were more likely to be reperfused within target intervals (rate ratio 1.59, 95% CI 1.03 to 2.45), patients with asthma more often received timely administration of steroids (rate ratio 1.88, 95% CI 1.59 to 2.24) and beta-agonists (rate ratio 1.47, 95% CI 1.25 to 1.74), and adult (but not paediatric) patients with fracture were more likely to receive analgesia or splinting within an hour (rate ratio 1.66, 95% CI 1.22 to 2.26).", {"entities": [[158, 164, "DISEASE"]]}], ["These results suggest that a policy approach that targets only reductions in ED LOS is not associated with broader improvements in selected quality measures.", {"entities": []}], ["At the same time, there is no evidence that efforts to address crowding have a detrimental effect on quality of care.", {"entities": []}], ["The Kagera region of north western Tanzania has a rich culture of traditional medicine use and practice.", {"entities": []}], ["Traditional medicines are the mainstay of healthcare in this region and are known to support the management of many illnesses such as malaria, bacterial infections, epilepsy, gynecological problems and others.", {"entities": [[134, 141, "DISEASE"]]}], ["However, most of the plants being used have either not been documented or evaluated for safety and efficacy or both.", {"entities": []}], ["This study, the sixth of an ongoing series, reports on the medicinal plants that are used at Kikuku village, Muleba District.", {"entities": []}], ["A semi-structured questionnaire was used to collect information on the common/local names of the plants, parts of the plants used, diseases treated, methods of preparing the herbal remedies, dosage of the remedies administered, frequency and duration of treatment and toxicity of the medicines.", {"entities": []}], ["A literature review was carried out for information on the ethnomedical uses of the reported plants.", {"entities": []}], ["A total of 49 plant species belonging to 47 genera and 24 plant families were documented.", {"entities": []}], ["The family Euphorbiaceae and Asteraceae had the highest representation.", {"entities": []}], ["The plants are used for the treatment of skin conditions (10 plants; 20%), bacterial infections and wounds (14 plants; 28.6%), malaria (14 plants; 28.6%), gastrointestinal disorders (11 plants; 22.4%), gynecological problems including infertility (8 plants; 16.3%), hypertension (5 plants; 10.2%), viral infections (7 plants; 14.3%), chest problems (5 plants; 10.2%), diabetes (3 plants; 6.1%), cancer (2 plants; 4.1%), inflammatory conditions (arthritis, rheumatism), HIV and AIDS, and hernia each treated by 1 plant (3 plants in total; 6.1%).", {"entities": [[266, 278, "DISEASE"], [127, 134, "DISEASE"], [445, 454, "DISEASE"], [235, 246, "DISEASE"], [395, 401, "DISEASE"]]}], ["Information obtained from the literature indicate that 25 (51.0%) of the therapeutic claims are supported by laboratory results or have similar claims of ethnomedical use from other countries.", {"entities": []}], ["Herbal remedies comprise an important and effective component of the healthcare system in Kikuku village with plants in the families Euphorbiaceae and Asteraceae comprising an important part of plants used in the indigenous healthcare management in the village.", {"entities": []}], ["Malaria and bacterial infections dominate the list of diseases that are managed using traditional medicines.", {"entities": [[0, 7, "DISEASE"]]}], ["Physician leadership development programs typically aim to strengthen physicians\u2019 leadership competencies and improve organizational performance.", {"entities": []}], ["We conducted a systematic review of medical literature on physician leadership development programs in order to characterize the setting, educational content, teaching methods, and learning outcomes achieved.", {"entities": []}], ["Articles were identified through a search in Ovid MEDLINE from 1950 through November 2013.", {"entities": []}], ["We included articles that described programs designed to expose physicians to leadership concepts, outlined teaching methods, and reported evaluation outcomes.", {"entities": []}], ["A thematic analysis was conducted using a structured data entry form with categories for setting/target group, educational content, format, type of evaluation and outcomes.", {"entities": []}], ["We identified 45 studies that met eligibility criteria, of which 35 reported on programs exclusively targeting physicians.", {"entities": []}], ["The majority of programs focused on skills training and technical and conceptual knowledge, while fewer programs focused on personal growth and awareness.", {"entities": []}], ["Half of the studies used pre/post intervention designs, and four studies used a comparison group.", {"entities": []}], ["Positive outcomes were reported in all studies, although the majority of studies relied on learner satisfaction scores and self-assessed knowledge or behavioral change.", {"entities": []}], ["Only six studies documented favorable organizational outcomes, such as improvement in quality indicators for disease management.", {"entities": []}], ["The leadership programs examined in these studies were characterized by the use of multiple learning methods, including lectures, seminars, group work, and action learning projects in multidisciplinary teams.", {"entities": []}], ["Physician leadership development programs are associated with increased self-assessed knowledge and expertise; however, few studies have examined outcomes at a system level.", {"entities": []}], ["Our synthesis of the literature suggests important gaps, including a lack of programs that integrate non-physician and physician professionals, limited use of more interactive learning and feedback to develop greater self-awareness, and an overly narrow focus on individual-level rather than system-level outcomes.", {"entities": []}], ["Wild aquatic birds are recognized as the natural reservoir of avian influenza A viruses (AIV), but across high and low pathogenic AIV strains, scientists have yet to rigorously identify most competent hosts for the various subtypes.", {"entities": [[68, 77, "DISEASE"], [62, 77, "DISEASE"]]}], ["We examined 11,870 GenBank records to provide a baseline inventory and insight into patterns of global AIV subtype diversity and richness.", {"entities": []}], ["Further, we conducted an extensive literature review and communicated directly with scientists to accumulate data from 50 non-overlapping studies and over 250,000 birds to assess the status of historic sampling effort.", {"entities": []}], ["We then built virus subtype sample-based accumulation curves to better estimate sample size targets that capture a specific percentage of virus subtype richness at seven sampling locations.", {"entities": []}], ["Our study identifies a sampling methodology that will detect an estimated 75% of circulating virus subtypes from a targeted bird population and outlines future surveillance and research priorities that are needed to explore the influence of host and virus biodiversity on emergence and transmission.", {"entities": []}], ["Lower levels of serum bicarbonate and a higher anion gap have been associated with insulin resistance and hypertension in the general population.", {"entities": [[106, 118, "DISEASE"]]}], ["Whether these associations extend to other cardiovascular disease risk factors is unknown.", {"entities": []}], ["To clarify this, we examined the association of serum bicarbonate and anion gap with cardiorespiratory fitness in 2714 adults aged 20\u201349 years in the 1999\u20132004 National Health and Nutrition Examination Survey.", {"entities": []}], ["The mean serum bicarbonate was 24.6 mEq/L and the mean anion gap was 10.26 mEq/L, with fitness determined by submaximal exercise testing.", {"entities": []}], ["After multivariable adjustment, gender, length of fasting, soft drink consumption, systolic blood pressure, serum phosphate, and hemoglobin were independently associated with both the serum bicarbonate and the anion gap.", {"entities": []}], ["Low fitness was most prevalent among those in the lowest quartile of serum bicarbonate or highest quartile of anion gap.", {"entities": []}], ["After multivariable adjustment, a one standard deviation higher serum bicarbonate or anion gap was associated with an odds ratio for low fitness of 0.80 (95% CI 0.70\u20130.91) and 1.30 (95% CI 1.15\u20131.48), respectively.", {"entities": []}], ["The association of bicarbonate with fitness may be mediated by differences in lean body mass.", {"entities": []}], ["Thus, lower levels of serum bicarbonate and higher levels of anion gap are associated with lower cardiorespiratory fitness in adults aged 20\u201349 years in the general population.", {"entities": []}], ["Despite the disproportionate incarceration of minorities in the United States, little data exist investigating how being incarcerated contributes to persistent racial/ethnic disparities in chronic conditions.", {"entities": []}], ["We hypothesized that incarceration augments disparities in chronic disease.", {"entities": []}], ["Using data from the New York City Health and Nutrition Examination Study, a community-based survey of 1999 adults, we first estimated the association between having a history of incarceration and the prevalence of asthma, diabetes, hypertension using propensity score matching methods.", {"entities": [[232, 244, "DISEASE"], [214, 220, "DISEASE"]]}], ["Propensity scores predictive of incarceration were generated using participant demographics, socioeconomic status, smoking, excessive alcohol and illicit drug use, and intimate partner violence.", {"entities": []}], ["Among those conditions associated with incarceration, we then performed mediation analysis to explore whether incarceration mediates racial/ethnic disparities within the disease.", {"entities": []}], ["Individuals with a history of incarceration were more likely to have asthma compared to those without (13% vs. 6%, p < 0.05) and not more likely to have diabetes or hypertension, after matching on propensity scores.", {"entities": [[165, 177, "DISEASE"], [69, 75, "DISEASE"]]}], ["Statistical mediation analysis revealed that increased rates of incarceration among Blacks partially contribute to the racial disparity in asthma prevalence.", {"entities": [[139, 145, "DISEASE"]]}], ["Having been incarcerated may augment racial disparities in asthma among NYC residents.", {"entities": [[59, 65, "DISEASE"]]}], ["Eliminating health disparities should include a better understanding of the role of incarceration and criminal justice policies in contributing to these disparities.", {"entities": []}], ["Health-related quality of life (HRQOL) instruments are sometimes used without explicit understanding of which HRQOL domains are important to a given population.", {"entities": []}], ["In this study, we sought to elicit an importance hierarchy among 27 HRQOL domains (derived from the general population) via a best-worst scaling survey of the population in Singapore, and to determine whether these domains were consistently valued across gender, age, ethnicity, and presence of chronic illnesses.", {"entities": []}], ["We conducted a community-based study that sampled participants with quotas for gender, ethnicity, age, presence of chronic illness, and interview language.", {"entities": []}], ["For the best-worst scaling exercise, we constructed comparison sets according to a balanced incomplete block design resulting in 13 sets of questions, each with nine choice tasks.", {"entities": []}], ["Each task involved three HRQOL domains from which participants identified the most and least important domain.", {"entities": []}], ["We performed a standard analysis of best-worst object scaling design (Case 1) using simple summary statistics; 603 residents participated in the survey.", {"entities": []}], ["The three most important domains of health were: \u201cthe ability to take care of self without help from others\u201d (best-worst score (BWS): 636), \u201chealing and resistance to illness\u201d (BWS: 461), and \u201chaving good relationships with family, friends, and others\u201d (BWS: 373).", {"entities": []}], ["The 10 top-ranked domains included physical, mental, and social health.", {"entities": []}], ["The three least important domains were: \u201chaving a satisfying sex life\u201d (BWS: -803), \u201chaving normal physical appearance\u201d (BWS: -461), and \u201cinteracting with others (talking, shared activities, etc.", {"entities": []}], [")\u201d (BWS: -444).", {"entities": []}], ["Generally, top-ranked domains were consistently valued across gender, age, ethnicity, and presence of chronic illness.", {"entities": []}], ["We conclude that the 10 top-ranked domains reflect physical, mental, and social dimensions of well-being suggesting that the sampled population\u2019s views on health are consistent with the World Health Organization\u2019s definition of health, \u201ca state of complete physical, mental and social well-being and not merely the absence of disease or infirmity\u201d.", {"entities": []}], ["To assess the clinical efficacy of targeted arterial perfusion of verapamil and chemotherapeutic agents in the interventional therapy of lung cancer.", {"entities": [[137, 148, "DISEASE"], [142, 148, "DISEASE"]]}], ["Forty patients with advanced lung cancer underwent treatment with targeted arterial perfusion of verapamil and chemotherapeutic agents using Seldinger technique.", {"entities": [[29, 40, "DISEASE"], [34, 40, "DISEASE"]]}], ["Interventional therapy was performed once a month, and each subject received interventional treatment for 2 or more cycles.", {"entities": []}], ["The therapeutic efficacy was evaluated 2\u00a0months post-treatment.", {"entities": []}], ["Out of 40 patients with advanced lung cancer, 5 cases achieved complete remission (CR) and 29 cases achieved partial remission (PR), with a total effectiveness (CR\u00a0+\u00a0PR) rate of 85\u00a0%.", {"entities": [[33, 44, "DISEASE"], [38, 44, "DISEASE"]]}], ["Besides, 32 cases achieved significantly alleviated clinical symptoms, and 29 cases had decreased clinical tumor stage.", {"entities": []}], ["All subjects had stable karnofsky performance status score and body weight.", {"entities": []}], ["Among the 40 patients, 13 cases had leucopenia, 10 cases had gastrointestinal reactions, 3 cases presented with elevated alanine aminotransferase/aspartate aminotransferase ratio, and 3 cases had fever.", {"entities": []}], ["However, all these side effects relieved quickly.", {"entities": []}], ["No elevation of BUN/Cr ratio and allergic reactions was observed.", {"entities": []}], ["No significant changes in cardiac function and electrocardiogram were noticed after the treatment.", {"entities": []}], ["Targeted arterial perfusion of verapamil and chemotherapeutic drugs can improve the clinical symptoms of patients with advanced lung cancer and increase the efficacy of chemotherapeutic agents, thereby providing an opportunity for radiotherapy or surgical treatment for advanced lung cancer.", {"entities": [[128, 139, "DISEASE"], [279, 290, "DISEASE"], [133, 139, "DISEASE"], [284, 290, "DISEASE"]]}], ["The natural variant C491T (rs1800088) in ADRB2 gene substitutes Threonine to Isoleucine at 164", {"entities": [[41, 46, "GENE"]]}], ["Previous studies have demonstrated that long chain fatty acids influence fibroblast function at sub-lethal concentrations.", {"entities": []}], ["This study is the first to assess the effects of oleic, linoleic or palmitic acids on protein expression of fibroblasts, as determined by standard proteomic techniques.", {"entities": []}], ["The fatty acids were not cytotoxic at the concentration used in this work as assessed by membrane integrity, DNA fragmentation and the MTT assay but significantly increased cell proliferation.", {"entities": []}], ["Subsequently, a proteomic analysis was performed using two dimensional difference gel electrophoresis (2D-DIGE) and MS based identification.", {"entities": []}], ["Cells treated with 50 \u03bcM oleic, linoleic or palmitic acid for 24 h were associated with 24, 22, 16 spots differentially expressed, respectively.", {"entities": []}], ["Among the identified proteins, \u03b1-enolase and far upstream element binding protein 1 (FBP-1) are of importance due to their function in fibroblast-associated diseases.", {"entities": []}], ["However, modulation of \u03b1-enolase and FBP-1 expression by fatty acids was not validated by the Western blot technique.", {"entities": []}], ["Chronic diseases are rapidly increasing and are currently the major cause of death and disability worldwide.", {"entities": []}], ["Patients with chronic diseases experience many challenges including medicine-related problems.", {"entities": []}], ["However, there is limited information about the home management of medicines among these patients.", {"entities": []}], ["This study therefore was to determine home medication management practices and associated factors among patients with chronic diseases seeking care in a community pharmacy in Uganda.", {"entities": []}], ["A cross-sectional study was conducted in a community pharmacy in Kampala from June to July 2010.", {"entities": []}], ["A total of 207 consenting chronic disease patients or caregivers of children with chronic disease were consecutively sampled.", {"entities": []}], ["The patients were visited at home to evaluate their drug management practices and to check their medical forms for disease types and drugs prescribed.", {"entities": []}], ["An interviewer-administered questionnaire and an observation checklist were used to collect the data.", {"entities": []}], ["Overall home medication management was inappropriate for 70% (n\u2009=\u2009145) of the participants (95% CI\u2009=\u200963.3-76.2) and was associated with perceived severity of disease (not severe OR =0.40, moderately severe OR\u2009=\u20090.35), duration of disease >5 years (OR\u2009=\u20092.15), and health worker not assessing for response to treatment (OR\u2009=\u20092.53).", {"entities": []}], ["About 52% (n\u2009=\u2009107) had inappropriate storage which was associated with inadequate information about the disease (OR\u2009=\u20092.39) and distance to the health facility >5 kilometres (OR\u2009=\u20092.82).", {"entities": []}], ["Fifteen percent (n\u2009=\u200931) had no drug administration schedule and this was associated with increasing age (OR\u2009=\u20090.97), inadequate information about the disease (OR\u2009=\u20092.96), and missing last appointment for medical review (OR\u2009=\u20096.55).", {"entities": []}], ["About 9% (n\u2009=\u200918) had actual medication duplication; 1.4% (n\u2009=\u20093) had expired medicines; while 18.4% (n\u2009=\u200938) had drug hoarding associated with increasing number of prescribers (OR\u2009=\u20091.34) and duration of disease (OR\u2009=\u20092.06).", {"entities": []}], ["About 51% (n\u2009=\u2009105) had multiple prescribers associated with perceiving the disease to be non severe (OR\u2009=\u20090.27), and having more than one chronic disease (OR\u2009=\u20092.37).", {"entities": []}], ["Patients with chronic disease have poor home management of medicines.", {"entities": []}], ["In order to limit the occurrence of poor outcomes of treatment or drug toxicity, health providers need to strengthen the education of patients with chronic disease on how to handle their medicines at home.", {"entities": []}], ["Transesophageal echocardiography (TEE) is a valuable tool for evaluating hemodynamic instability in patients under general anesthesia.", {"entities": []}], ["We present the case of a 28-year-old man who presented with complaints of testicular pain concerning for testicular torsion.", {"entities": []}], ["After induction of general anesthesia for scrotal exploration and possible orchiopexy, the patient developed severe and persistent hypotension.", {"entities": []}], ["Using intraoperative TEE, the diagnosis of pericardial tamponade was made, and an emergent pericardial window was performed.", {"entities": []}], ["Governance of a country may have widespread effects on the health of its population, yet little is known about the effect of governance on child mortality in a country that is undergoing urbanization, economic development, and disease control.", {"entities": []}], ["We obtained indicators of six dimensions of governance (perceptions of voice and accountability, political stability and absence of violence, government effectiveness, regulatory quality, rule of law, and control of corruption) and national under-5 mortality rates for 149 countries between 1996 and 2010.", {"entities": []}], ["We applied a semi-parametric generalized additive mixed model to examine associations after controlling for the effects of development factors (urbanization level and economy), disease control factors (hygienic conditions and vaccination rates), health expenditures, air quality, and time.", {"entities": []}], ["Governance, development, and disease control showed clear inverse relations with the under-5 mortality rate (p<0.001).", {"entities": []}], ["Per unit increases in governance, development, and disease control factors, the child mortality rate had a 0.901-, 0.823-, and 0.922-fold decrease, respectively, at fixed levels of the other two factors.", {"entities": []}], ["In the effort to reduce the global under-5 mortality rate, addressing a country's need for better governance is as important as improvements in development and disease control.", {"entities": []}], ["Patients with rheumatoid arthritis (RA) are at increased risk of lymphoma compared with the general population.", {"entities": [[14, 34, "DISEASE"], [65, 73, "DISEASE"], [25, 34, "DISEASE"]]}], ["There are concerns that tumour necrosis factor inhibitors (TNFi) may exacerbate this risk.", {"entities": []}], ["However, since the excess risk of lymphoma in RA is related to the cumulative burden of inflammation, TNFi may conversely reduce the risk of lymphoma by decreasing the burden of inflammation.", {"entities": [[34, 42, "DISEASE"], [141, 149, "DISEASE"]]}], ["The aim of this study was to compare the risk of lymphoma in subjects with RA treated with TNFi with those treated with non-biological therapy.", {"entities": [[49, 57, "DISEASE"]]}], ["Subjects diagnosed by a rheumatologist with RA enrolled in the British Society for Rheumatology Rheumatoid Arthritis Register (BSRBR-RA), a prospective cohort study, were followed until first lymphoma, death or until 30 November 2013.", {"entities": [[96, 116, "DISEASE"], [192, 200, "DISEASE"], [107, 116, "DISEASE"]]}], ["Rates of lymphoma in the TNFi and non-biological-treated cohorts were compared using Cox regression.", {"entities": [[9, 17, "DISEASE"]]}], ["11\u2005931 TNFi-treated patients were compared with 3367 biological-naive patients.", {"entities": []}], ["84 lymphomas (88 (95% CI 70 to 109) per 100\u2005000 person-years) were reported in the TNFi cohort and 30 lymphomas (154 (95% CI 104 to 220)) in the biological-naive cohort.", {"entities": []}], ["After adjusting for differences in baseline characteristics, there was no difference in the risk of lymphoma for the TNFi versus the biological-naive group: HR 1.00 (95% CI 0.56 to 1.80).", {"entities": [[100, 108, "DISEASE"], [157, 159, "GENE"]]}], ["No risk differences were observed for individual TNFi.", {"entities": []}], ["In medium-term follow-up, there is no evidence that tumour necrosis factor inhibition influences the risk of lymphoma over the background risk in subjects with RA.", {"entities": [[109, 117, "DISEASE"]]}], ["The National Children\u2019s Study will address, among other illnesses, the environmental causes of both incident asthma and exacerbations of asthma in children.", {"entities": [[109, 115, "DISEASE"], [137, 143, "DISEASE"]]}], ["Seven of the Centers for Children\u2019s Environmental Health and Disease Prevention Research (Children\u2019s Centers), funded by the National Institute of Environmental Health Sciences and the U.S. Environmental Protection Agency, conducted studies relating to asthma.", {"entities": [[253, 259, "DISEASE"]]}], ["The design of these studies was diverse and included cohorts, longitudinal studies of older children, and intervention trials involving asthmatic children.", {"entities": []}], ["In addition to the general lessons provided regarding the conduct of clinical studies in both urban and rural populations, these studies provide important lessons regarding the successful conduct of community research addressing asthma.", {"entities": [[229, 235, "DISEASE"]]}], ["They demonstrate that it is necessary and feasible to conduct repeated evaluation of environmental exposures in the home to address environmental exposures relevant to asthma.", {"entities": [[168, 174, "DISEASE"]]}], ["The time and staff required were usually underestimated by the investigators, but through resourceful efforts, the studies were completed with a remarkably high completion rate.", {"entities": []}], ["The definition of asthma and assessment of disease severity proved to be complex and required a combination of questionnaires, pulmonary function tests, and biologic samples for markers of immune response and disease activity.", {"entities": [[18, 24, "DISEASE"]]}], ["The definition of asthma was particularly problematic in younger children, who may exhibit typical asthma symptoms sporadically with respiratory infections without developing chronic asthma.", {"entities": [[18, 24, "DISEASE"], [99, 105, "DISEASE"], [183, 189, "DISEASE"]]}], ["Medications confounded the definition of asthma disease activity, and must be repeatedly and systematically estimated.", {"entities": [[41, 47, "DISEASE"]]}], ["Despite these many challenges, the Children\u2019s Centers successfully conducted long-term studies of asthma.", {"entities": [[98, 104, "DISEASE"]]}], ["Neuregulin, previously known as ARIA, is a signaling protein involved in cell survival, synaptic plasticity, cell communication and differentiation.", {"entities": []}], ["Neuregulin has also been described as a potent inducer of acetylcholine receptor transcription in muscle and although both neuregulin and acetylcholine have been individually described to have neuroprotective roles, their relationship in the cholinergic anti-inflammatory pathway of the brain has not been examined.", {"entities": []}], ["Using three cell lines, BV-2, EOC-20 and RAW 264.7, we investigated the role that neuregulin signaling through the Erb family of tyrosine kinases may play in the anti-inflammatory process mediated by the \u03b17 nicotinic acetylcholine receptors.", {"entities": []}], ["Here we show that ErbB4 is expressed in all of our cell lines and is phosphorylated upon treatment with neuregulin.", {"entities": [[18, 23, "GENE"]]}], ["Neuregulin treatment further increases the expression of \u03b17 nicotinic acetylcholine receptors in the microglial lines tested.", {"entities": []}], ["Given the central role of \u03b17 nicotinic acetylcholine receptors in regulating system inflammation we analyzed the expression of several pro-inflammatory cytokines in our system.", {"entities": []}], ["Using ELISAs for TNF-\u03b1 and IL-6 we show that treatment with NRG can produce a nearly a 33% decrease in the levels of tumor necrosis factor-\u03b1 secreted by activated microglia and a nearly 88% decrease in IL-6.", {"entities": []}], ["Given these results we propose a neuroprotective role for neuregulin wherein it modulates the expression of TNF-\u03b1 and thus inflammation in the CNS via the upregulation of \u03b17 nicotinic acetylcholine receptor expression in microglia in vitro.", {"entities": []}], ["We suggest that the disregulation of neuregulin expression may be pivotal in neurological disorders characterized by inflammation.", {"entities": []}], ["Wild fruits are exotic or underutilized.", {"entities": []}], ["Wild fruits contain many bioactive compounds, such as anthocyanins and flavonoids.", {"entities": []}], ["Many studies have shown that wild fruits possess various bioactivities and health benefits, such as free radical scavenging, antioxidant, anti-inflammatory, antimicrobial, and anticancer activity.", {"entities": []}], ["Therefore, wild fruits have the potential to be developed into functional foods or pharmaceuticals to prevent and treat several chronic diseases.", {"entities": []}], ["In the present article, we review current knowledge about the bioactivities and health benefits of wild fruits, which is valuable for the exploitation and utilization of wild fruits.", {"entities": []}], ["Signaling through the innate immune system can promote or suppress allergic sensitization.", {"entities": []}], ["TLR9 has modulatory effects on the mucosal immune system, and we hypothesized that TLR9 would influence susceptibility to allergic sensitization to foods.", {"entities": [[0, 4, "GENE"], [83, 87, "GENE"], [0, 4, "GENE"], [83, 87, "GENE"]]}], ["We observed that TLR9\u2212/\u2212 mice were resistant to peanut-induced anaphylaxis.", {"entities": []}], ["This was associated with a significant impairment in total IgE and peanut-specific IgE and IgA, but not IgG1 or Th2 cytokine production.", {"entities": []}], ["TLR9\u2212/\u2212 mice had reduced development of Peyer\u2019s patches, but resistance to sensitization was not restricted to oral routes.", {"entities": []}], ["Rag1-deficient mice were reconstituted with TLR9+/+ or \u2212/\u2212 B cells plus CD4+ T cells.", {"entities": []}], ["TLR9\u2212/\u2212 B cells regained the ability to produce IgE in the presence of a wild-type environment.", {"entities": []}], ["Our results demonstrate that TLR9 on an unknown cell type is required for the development of IgE-producing B cells, and we conclude that TLR9 signaling indirectly shapes the immune response for optimal IgE production.", {"entities": [[29, 33, "GENE"], [137, 141, "GENE"], [29, 33, "GENE"], [137, 141, "GENE"]]}], ["Mutations in ATP-binding-cassette-member A3 ( ABCA3 ) are related to severe chronic lung disease in neonates and children, but frequency of chronic lung disease due to ABCA3 mutations in the general population is unknown.", {"entities": [[84, 96, "DISEASE"], [148, 160, "DISEASE"], [46, 51, "GENE"], [168, 173, "GENE"], [46, 51, "GENE"], [168, 173, "GENE"]]}], ["We tested the hypothesis that individuals heterozygous for ABCA3 mutations have reduced lung function and increased risk of COPD in the general population.", {"entities": [[59, 64, "GENE"]]}], ["We screened 760 individuals with extreme pulmonary phenotypes and identified three novel (H86Y, A320T, A1086D) and four previously described mutations (E292V, P766S, S1262G, R1474W) in the ABCA3 gene.", {"entities": [[189, 194, "GENE"]]}], ["We genotyped the entire Copenhagen City Heart study (n = 10,604) to assess the clinical importance of these mutations.", {"entities": []}], ["To validate our findings we genotyped an additional 54,395 individuals from the Copenhagen General Population Study.", {"entities": []}], ["In the Copenhagen City Heart Study individuals heterozygous for E292V had 5% reduced FEV 1 % predicted compared with noncarriers (t-test: p = 0.008), and an increased odds ratio for COPD of 1.9 (95% CI: 1.1-3.1).", {"entities": [[85, 88, "GENE"]]}], ["In contrast, the A1086D mutation was associated with increased FEV 1 % predicted (p = 0.03).", {"entities": [[63, 66, "GENE"]]}], ["None of the other ABCA3 mutations associated with lung function or COPD risk in the Copenhagen City Heart Study.", {"entities": [[18, 23, "GENE"]]}], ["In the larger Copenhagen General Population Study, and in the two studies combined, E292V heterozygotes did not have reduced lung function or increased risk of COPD (p = 0.11-0.98), while this was the case for the positive controls, surfactant protein-B 121ins2 heterozygotes and \u03b1 1 -antitrypsin ZZ homozygotes.", {"entities": []}], ["Our results indicate that partially reduced ABCA3 activity due to E292V is not a major risk factor for reduced lung function and COPD in the general population.", {"entities": [[44, 49, "GENE"]]}], ["This is an important finding as 1.3% in the Danish population has partially reduced ABCA3 function due to E292V.", {"entities": [[84, 89, "GENE"]]}], ["Recently the prevalence of both asthma and obesity have increased substantially in many countries.", {"entities": [[43, 50, "DISEASE"], [32, 38, "DISEASE"]]}], ["The aim of this study was to evaluate the role of retinol-binding protein (RBP) 4 in childhood asthma and its association with atopy markers, pulmonary function, and bronchial hyperresponsiveness in relation to obesity.", {"entities": [[211, 218, "DISEASE"], [95, 101, "DISEASE"]]}], ["We studied 160 children between the ages 6 to 10 yr, including 122 asthmatics and 38 controls.", {"entities": []}], ["The body mass index, pulmonary function tests, and methacholine challenge tests were measured on the same day.", {"entities": []}], ["Total eosinophil count, serum total IgE, serum eosinophil cationic protein, and serum RBP4 were measured in all subjects.", {"entities": [[86, 90, "GENE"]]}], ["There was no difference in serum RBP4 levels between the asthmatics and the control group.", {"entities": [[33, 37, "GENE"]]}], ["In all subjects or subgroups, serum RBP4 was not associated with total eosinophil count, serum total IgE, serum eosinophil cationic protein, or PC 20 .", {"entities": [[36, 40, "GENE"], [144, 146, "GENE"]]}], ["There was no relationship between serum RBP4 and pulmonary function in female asthmatics.", {"entities": [[40, 44, "GENE"]]}], ["Forced expiratory volume in 1 second/forced vital capacity (FVC) and forced expiratory flow between 25% and 75% of FVC contributed to serum RBP4 in male asthmatics.", {"entities": [[140, 144, "GENE"]]}], ["Our findings show an association between RBP4 and pulmonary function in prepubertal male asthmatics.", {"entities": [[41, 45, "GENE"]]}], ["This relationship may indirectly affect the high prevalence of childhood asthma in males.", {"entities": [[73, 79, "DISEASE"]]}], ["Herbal medication has been practised by the rural Malaysian Malays for a long time.", {"entities": []}], ["However, the long-term side-effects have never been studied.", {"entities": []}], ["In the present study, 48 species of Euphorbiaceae were screened for tumour-promoter activity by means of an in vitro assay using a human lymphoblastoid cell line harbouring the Epstein-Barr virus (EBV) genome.", {"entities": []}], ["Twenty-seven per cent (13 out of 48) of the species tested were found to be positive, and in four species, namely Breynia coronata Hk.f, Codiaeum variegatum (L) Bl, Euphorbia atoto and Exocoecaria agallocha, EBV-inducing activity was observed when the plant extracts were tested at low concentrations of between 0.2 and 1.2 micrograms ml-1 in cell culture.", {"entities": []}], ["This observation warrants attention from the regular users of these plants because regular use of plants with tumour-promoting activity could well be an aetiological factor for the promotion of tumours among rural Malaysian Malays.", {"entities": []}], ["Since the original description of X-linked agammaglobulinemia in 1952, the number of independent primary immunodeficiency diseases (PIDs) has expanded to more than 100 entities.", {"entities": [[43, 61, "DISEASE"]]}], ["By definition, a PID is a genetically determined disorder resulting in enhanced susceptibility to infectious disease.", {"entities": []}], ["Despite the heritable nature of these diseases, some PIDs are clinically manifested only after prerequisite environmental exposures but they often have associated malignant, allergic, or autoimmune manifestations.", {"entities": []}], ["PIDs must be distinguished from secondary or acquired immunodeficiencies, which are far more common.", {"entities": []}], ["In this review, we will place these immunodeficiencies in the context of both clinical and laboratory presentations as well as highlight the known genetic basis.", {"entities": []}], ["Innate immunity prevents pathogens from entering and spreading within the body.", {"entities": []}], ["This function is especially important in the gastrointestinal tract and skin, as these organs have a large surface contact area with the outside environment.", {"entities": []}], ["In the intestine, luminal commensal bacteria are necessary for adequate food digestion and play a crucial role in tolerance to benign antigens.", {"entities": []}], ["Immune system damage can create an intestinal inflammatory response, leading to chronic disease including inflammatory bowel diseases (IBD).", {"entities": []}], ["Ulcerative colitis (UC) is an IBD of unknown etiology with increasing worldwide prevalence.", {"entities": [[0, 18, "DISEASE"]]}], ["In the intestinal mucosa of UC patients, there is an imbalance in the IL-33/ST2 axis, an important modulator of the innate immune response.", {"entities": []}], ["This paper reviews the role of the IL-33/ST2 system in innate immunity of the intestinal mucosa and its importance in inflammatory bowel diseases, especially ulcerative colitis.", {"entities": [[158, 176, "DISEASE"]]}], ["Biometrical genetic studies suggest that the personality dimensions, including neuroticism, are moderately heritable (~0.4 to 0.6).", {"entities": []}], ["Quantitative analyses that aggregate the effects of many common variants have recently further informed genetic research on European samples.", {"entities": []}], ["However, there has been limited research to date on non-European populations.", {"entities": []}], ["This study examined the personality dimensions in a large sample of Han Chinese descent ( N =10\u2009064) from the China, Oxford, and VCU Experimental Research on Genetic Epidemiology study, aimed at identifying genetic risk factors for recurrent major depression among a rigorously ascertained cohort.", {"entities": []}], ["Heritability of neuroticism as measured by the Eysenck Personality Questionnaire (EPQ) was estimated to be low but statistically significant at 10% (s.e.=0.03, P =0.0001).", {"entities": []}], ["In addition to EPQ, neuroticism based on a three-factor model, data for the Big Five (BF) personality dimensions (neuroticism, openness, conscientiousness, extraversion and agreeableness) measured by the Big Five Inventory were available for controls ( n =5596).", {"entities": []}], ["Heritability estimates of the BF were not statistically significant despite high power (>0.85) to detect heritabilities of 0.10.", {"entities": []}], ["Polygenic risk scores constructed by best linear unbiased prediction weights applied to split-half samples failed to significantly predict any of the personality traits, but polygenic risk for neuroticism, calculated with LDpred and based on predictive variants previously identified from European populations ( N =171\u2009911), significantly predicted major depressive disorder case\u2013control status ( P =0.0004) after false discovery rate correction.", {"entities": [[349, 374, "DISEASE"]]}], ["The scores also significantly predicted EPQ neuroticism ( P =6.3 \u00d7 10", {"entities": []}], ["To evaluate the health consequences for children of indoor exposure to molds, an international workshop was organized with 15 scientists from eight countries.", {"entities": []}], ["The participants agreed that exposure to molds may constitute a health threat to children resulting in respiratory symptoms in both the upper and lower airways, an increased incidence of infections, and skin symptoms.", {"entities": []}], ["Allergy, either to molds or to other indoor agents, also presents a health risk.", {"entities": []}], ["At very high exposure levels to specific molds, nose bleeding, hemoptysis, and pulmonary hemorrhage have been documented.", {"entities": []}], ["Pediatricians and allergists need to obtain information about mold and dampness in the home environment when examining children with chronic respiratory symptoms, recurrent infections, or persistent fatigue and headache.", {"entities": []}], ["Measurement techniques are available to determine exposure.", {"entities": []}], ["Most important, the source of dampness must be eliminated and the indoor environment must be thoroughly cleaned of molds.", {"entities": []}], ["Normal airway epithelial barrier function is maintained by cell-cell contacts which require the translocation of adhesion proteins at the cell surface, through membrane vesicle trafficking and fusion events.", {"entities": []}], ["Myoferlin and dysferlin, members of the multiple-C2-domain Ferlin superfamily, have been implicated in membrane fusion processes through the induction of membrane curvature.", {"entities": []}], ["The objectives of this study were to examine the expression of dysferlin and myoferlin within the human airway and determine the roles of these proteins in airway epithelial homeostasis.", {"entities": []}], ["The expression of dysferlin and myoferlin were evaluated in normal human airway sections by immunohistochemistry, and primary human airway epithelial cells and fibroblasts by immuno blot.", {"entities": []}], ["Localization of dysferlin and myoferlin in epithelial cells were determined using confocal microscopy.", {"entities": []}], ["Functional outcomes analyzed included cell adhesion, protein expression, and cell detachment following dysferlin and myoferlin siRNA knock-down, using the human bronchial epithelial cell line, 16HBE.", {"entities": []}], ["Primary human airway epithelial cells express both dysferlin and myoferlin whereas fibroblasts isolated from bronchi and the parenchyma only express myoferlin.", {"entities": []}], ["Expression of dysferlin and myoferlin was further localized within the Golgi, cell cytoplasm and plasma membrane of 16HBE cells using confocal micrscopy.", {"entities": []}], ["Treatment of 16HBE cells with myoferlin siRNA, but not dysferlin siRNA, resulted in a rounded cell morphology and loss of cell adhesion.", {"entities": []}], ["This cell shedding following myoferlin knockdown was associated with decreased expression of tight junction molecule, zonula occludens-1 (ZO-1) and increased number of cells positive for apoptotic markers Annexin V and propidium iodide.", {"entities": []}], ["Cell shedding was not associated with release of the innate inflammatory cytokines IL-6 and IL-8.", {"entities": []}], ["This study demonstrates the heterogeneous expression of myoferlin within epithelial cells and fibroblasts of the respiratory airway.", {"entities": []}], ["The effect of myoferlin on the expression of ZO-1 in airway epithelial cells indicates its role in membrane fusion events that regulate cell detachment and apoptosis within the airway epithelium.", {"entities": []}], ["Early life environment is essential for lung growth and maximally attained lung function.", {"entities": []}], ["Whether early life exposures impact on lung function decline in adulthood, an indicator of lung ageing, has scarcely been studied.", {"entities": []}], ["Spirometry data from two time points (follow-up time 9\u201311 years) and information on early life exposures, health and life-style were available from 12862 persons aged 28\u201373 years participating in the European population-based cohorts SAPALDIA (n = 5705) and ECRHS (n = 7157).", {"entities": []}], ["The associations of early life exposures with lung function (FEV 1 ) decline were analysed using mixed-effects linear regression.", {"entities": [[61, 64, "GENE"]]}], ["Early life exposures were significantly associated with FEV 1 decline, with estimates almost as large as personal smoking.", {"entities": [[56, 59, "GENE"]]}], ["FEV 1 declined more rapidly among subjects born during the winter season (adjusted difference in FEV 1 /year of follow-up [95%CI] -2.04ml [-3.29;-0.80]), of older mothers, (-1.82 ml [-3.14;-0.49]) of smoking mothers (-1.82ml [-3.30;-0.34] or with younger siblings (-2.61ml [-3.85;-1.38]).", {"entities": [[0, 3, "GENE"], [97, 100, "GENE"], [0, 3, "GENE"], [97, 100, "GENE"]]}], ["Less rapid FEV 1 -decline was found in subjects who had attended daycare (3.98ml [2.78;5.18]), and indicated in subjects with pets in childhood (0.97ml [-0.16;2.09]).", {"entities": [[11, 14, "GENE"]]}], ["High maternal age and maternal smoking appeared to potentiate effects of personal smoking.", {"entities": []}], ["The effects were independent of asthma at any age.", {"entities": [[32, 38, "DISEASE"]]}], ["Early life factors predicted lung function decline decades later, suggesting that some mechanisms related lung ageing may be established early in life.", {"entities": []}], ["Early life programming of susceptibility to adult insults could be a possible pathway that should be explored further.", {"entities": []}], ["Intranasal delivery of vaccines directed against respiratory pathogens is an attractive alternative to parenteral administration.", {"entities": []}], ["However, using this delivery route for inactivated vaccines usually requires the use of potent mucosal adjuvants, and no such adjuvant has yet been approved for human use.", {"entities": []}], ["We have developed a live attenuated Bordetella pertussis vaccine, called BPZE1, and show here that it can be used to present the universal influenza virus epitope M2e to the mouse respiratory tract to prime for protective immunity against viral challenge.", {"entities": [[139, 148, "DISEASE"], [47, 56, "DISEASE"]]}], ["Three copies of M2e were genetically fused to the N-terminal domain of filamentous hemagglutinin (FHA) and produced in recombinant BPZE1 derivatives in the presence or absence of endogenous full-length FHA.", {"entities": []}], ["Only in the absence of FHA intranasal administration of the recombinant BPZE1 derivative induced antibody responses to M2e and effectively primed BALB/c mice for protection against influenza virus-induced mortality and reduced the viral load after challenge.", {"entities": [[181, 190, "DISEASE"]]}], ["Strong M2e-specific antibody responses and protection were observed after a single nasal administration with the recombinant BPZE1 derivative, followed by a single administration of M2e linked to a virus-like particle without adjuvant, whereas priming alone with the vaccine strain did not protect.", {"entities": []}], ["Using recombinant FHA-3M2e-producing BPZE1 derivatives for priming and the universal influenza M2e peptide linked to virus-like particles for boosting may constitute a promising approach for needle-free and adjuvant-free nasal vaccination against influenza.", {"entities": [[85, 94, "DISEASE"], [247, 256, "DISEASE"]]}], ["We aimed to elucidate the effects of two epigenetic inhibitors, 5-aza-2\u2019-deoxycytidine (5-aza-dC) and trichostatin A (TSA), on several key secretory mediators of diabetic retinopathy (DR) in human retinal endothelial cells (HRECs) and human retinal pigment epithelial (HRPE) cells treated with high glucose or interleukin-1\u03b2 (IL-1\u03b2).", {"entities": [[162, 182, "DISEASE"]]}], ["HRECs and HRPE cells were incubated in 30 mM D-glucose or 10 ng/ml IL-1\u03b2 with or without the presence of various concentrations of 5-aza-dC or TSA.", {"entities": []}], ["The production of pigment epithelium derived factor (PEDF), vascular endothelial cell growth factor (VEGF), intercellular cell adhesion molecule-1 (ICAM-1), IL-1\u03b2, and matrix metalloproteinase 2 (MMP2) was evaluated at the mRNA and protein levels using real-time PCR and enzyme-linked immunosorbent assay (ELISA), respectively.", {"entities": [[196, 200, "GENE"]]}], ["In the 30 mM D-glucose and the 10 ng/ml IL-1\u03b2 condition, the expression of VEGF, ICAM-1, IL-1\u03b2, and MMP2 was induced in the HRECs and the HRPE cells.", {"entities": [[100, 104, "GENE"]]}], ["PEDF was downregulated in the HRPE cells but upregulated in the HRECs.", {"entities": []}], ["However, the PEDF-to-VEGF ratio, which is thought to be critical in DR, was downregulated in both cell types.", {"entities": []}], ["5-aza-dC dose-dependently alleviated VEGF, ICAM-1, IL-1\u03b2, and MMP2 and reversed PEDF or the PEDF/VEGF ratio in both cell types.", {"entities": [[62, 66, "GENE"]]}], ["TSA had similar effects as 5-aza-dC on the target mediators.", {"entities": []}], ["However, ICAM-1 production was aggravated in the HRECs while remaining unchanged in the HRPE cells after TSA was administered.", {"entities": []}], ["Our results demonstrated that 5-aza-dC and TSA enhance the protective PEDF and the PEDF/VEGF ratio and ameliorate the adverse effects of diabetic stimuli in vitro, suggesting that these two drugs may be of potential therapeutic value in DR.", {"entities": []}], ["Despite injustice at the workplace being a potential source of sleep problems, longitudinal evidence remains scarce.", {"entities": []}], ["We examined whether changes in perceived organizational justice predicted changes in insomnia symptoms.", {"entities": []}], ["Data on 24 287 Finnish public sector employees (82% women), from three consecutive survey waves between 2000 and 2012, were treated as \u2018pseudo-trials\u2019.", {"entities": []}], ["Thus, the analysis of unfavourable changes in organizational justice included participants without insomnia symptoms in Waves 1 and 2, with high organizational justice in Wave 1 and high or low justice in Wave 2 ( N = 6307).", {"entities": []}], ["In the analyses of favourable changes in justice, participants had insomnia symptoms in Waves 1 and 2, low justice in Wave 1 and high or low justice in Wave 2 ( N = 2903).", {"entities": []}], ["In both analyses, the outcome was insomnia symptoms in Wave 3.", {"entities": []}], ["We used generalized estimating equation models to analyse the data.", {"entities": []}], ["After adjusting for social and health-related covariates in Wave 1, unfavourable changes in relational organizational justice (i.e.", {"entities": []}], ["fairness of managerial behaviours) were associated with increased odds of developing insomnia symptoms [odds ratio = 1.15; 95% confidence interval (CI) 1.02-1.30].", {"entities": []}], ["A favourable change in relational organizational justice was associated with lower odds of persistent insomnia symptoms (odds ratio = 0.83; 95% CI 0.71-0.96).", {"entities": []}], ["Changes in procedural justice (i.e.", {"entities": []}], ["the fairness of decision-making procedures) were not associated with insomnia symptoms.", {"entities": []}], ["These data suggest that changes in perceived relational justice may affect employees\u2019 sleep quality.", {"entities": []}], ["Decreases in the fairness of managerial behaviours were linked to increases in insomnia symptoms, whereas rises in fairness were associated with reduced insomnia symptoms.", {"entities": []}], ["Multipotent mesenchymal stromal cells (MSCs) represent a promising cell-based therapy for a number of inflammatory or autoimmune diseases.", {"entities": []}], ["Herein, Toll like receptor (TLR) expression by MSCs and their immune regulatory roles are investigated.", {"entities": []}], ["In this study, we investigated the influence of TLR on the immune response, proliferation, and differentiation potential of human turbinated MSC (hTMSC) cultures in vitro .", {"entities": [[141, 144, "GENE"]]}], ["After isolating hTMSCs from discarded inferior turbinate tissue, FACS analysis was used to assess the expression of TLRs such as TLR2, TLR3, TLR4, and TLR5 in hTMSCs and cell proliferation was assessed using a cell counting kit (CCK)-8.", {"entities": [[129, 133, "GENE"], [135, 139, "GENE"], [141, 145, "GENE"], [151, 155, "GENE"], [229, 232, "GENE"]]}], ["Cytokine and chemokine secretions were analyzed with multiplex immunoassays for IL-1\u03b1, IL-1\u03b2, IL-4, IL-6, IL-8, IL-10, IL-12, IP-10 (CXCL10), RANTES (CCL5), TNF-a, GM-CSF, and IFN-\u03b3.", {"entities": [[133, 139, "GENE"], [150, 154, "GENE"]]}], ["The differentiation potential of hTMSCs was evaluated in the osteogenic, chondogenic, and adipogeinc media and analyzed by histology and gene expression related to differentiation.", {"entities": []}], ["FACS analysis revealed that TLR3 and TLR4 expression consisted of a relatively high percentage of the surface proteins expressed by hTMSCs.", {"entities": [[28, 32, "GENE"], [37, 41, "GENE"]]}], ["The proliferation of hTMSCs was influenced and significantly increased by the presence of TLR4 agonists.", {"entities": [[90, 94, "GENE"]]}], ["In particular, hTMSCs produced a set of cytokines and chemokines and the expression of IL-6, IL-8, IL-12, IP-10 (CXCL10), RANTES (CCL5), TNF-\u03b1, and GM-CSF were up-regulated in response to the TLR4 agonist LPS.", {"entities": [[113, 119, "GENE"], [130, 134, "GENE"], [192, 196, "GENE"]]}], ["The osteogenic and adipogeinc differentiation potential of hTMSCs was not affected by TLR agonists.", {"entities": []}], ["We conclude that TLR4 stimulation affects TLR expression, proliferation, and the immunomodulation potential of hTMSCs.", {"entities": [[17, 21, "GENE"]]}], ["Understanding the mechanism behind TLR's influence on hTMSCs and their immunomodulating properties would be useful for providing a novel target to exploit in the improvement of stem cell-based therapeutic strategies.", {"entities": []}], ["People spend approximately one third of their life sleeping.", {"entities": []}], ["Exposure to pollutants in the sleep environment often leads to a variety of adverse health effects, such as development and exacerbation of asthma.", {"entities": [[140, 146, "DISEASE"]]}], ["Avoiding exposure to these pollutants by providing a sufficient air quality in the sleep environment might be a feasible method to alleviate these health symptoms.", {"entities": []}], ["We performed full-scale laboratory measurements using a thermal manikin positioned on an experimental bed.", {"entities": []}], ["Three ventilation settings were tested: with no filtration system operated, use of portable air cleaner and use of a temperature-controlled laminar airflow (TLA) device.", {"entities": []}], ["The first part of the experiment investigated the air-flow characteristics in the breathing zone.", {"entities": []}], ["In the second part, particle removal efficiency was estimated.", {"entities": []}], ["Measured in the breathing zone, the room air cleaner demonstrated high turbulence intensity, high velocity and turbulence diffusivity level, with a particle reduction rate of 52% compared to baseline after 30 minutes.", {"entities": []}], ["The TLA device delivered a laminar airflow to the breathing zone with a reduction rate of 99.5%.", {"entities": []}], ["During a periodical duvet lifting mimicking a subject\u2019s movement in bed, the particle concentration was significantly lower with the TLA device compared to the room air cleaner.", {"entities": []}], ["The TLA device provided a barrier which significantly reduced the introduction of airborne particles into the breathing zone.", {"entities": []}], ["Further studies should be conducted for the understanding of the transport of resuspended particles between the duvet and the laying body.", {"entities": []}], ["A variety of airborne pathogens can induce inflammatory responses in airway epithelial cells, which is a crucial component of host defence.", {"entities": []}], ["However, excessive inflammatory responses and chronic inflammation also contribute to different diseases of the respiratory system.", {"entities": []}], ["We hypothesized that the activation of protein kinase C (PKC) is one of the essential mechanisms of inflammatory response in airway epithelial cells.", {"entities": []}], ["In the present study, we stimulated human bronchial lung epithelial (BEAS-2B) cells with the phorbol ester Phorbol 12, 13-dibutyrate (PDBu), and examined gene expression profile using microarrays.", {"entities": []}], ["Microarray analysis suggests that PKC activation induced dramatic changes in gene expression related to multiple cellular functions.", {"entities": []}], ["The top two interaction networks generated from these changes were centered on NF\u03baB and TNF-\u03b1, which are two commonly known pathways for cell death and inflammation.", {"entities": []}], ["Subsequent tests confirmed the decrease in cell viability and an increase in the production of various cytokines.", {"entities": []}], ["Interestingly, each of the increased cytokines was differentially regulated at mRNA and/or protein levels by different sub-classes of PKC isozymes.", {"entities": []}], ["We conclude that pathological cell death and cytokine production in airway epithelial cells in various situations may be mediated through PKC related signaling pathways.", {"entities": []}], ["These findings suggest that PKCs can be new targets for treatment of lung diseases.", {"entities": []}], ["To determine generic utilities for Spanish chronic obstructive pulmonary disease (COPD) patients stratified by different classifications: GOLD 2007, GOLD 2013, GesEPOC 2012 and BODEx index.", {"entities": [[43, 80, "DISEASE"]]}], ["Multicentre, observational, cross-sectional study.", {"entities": []}], ["Patients were aged \u226540\u00a0years, with spirometrically confirmed COPD.", {"entities": []}], ["Utility values were derived from EQ-5D-3\u00a0L. Means, standard deviations (SD), medians and interquartile ranges (IQR) were computed based on the different classifications.", {"entities": []}], ["Differences in median utilities between groups were assessed by non-parametric tests.", {"entities": []}], ["346 patients were included, of which 85.5% were male with a mean age of 67.9 (SD\u2009=\u20099.7) years and a mean duration of COPD of 7.6 (SD\u2009=\u20095.8) years; 80.3% were ex-smokers and the mean smoking history was 54.2 (SD\u2009=\u200933.2) pack-years.", {"entities": []}], ["Median utilities (IQR) by GOLD 2007 were 0.87 (0.22) for moderate; 0.80 (0.26) for severe and 0.67 (0.42) for very-severe patients (p\u2009<\u20090.001 for all comparisons).", {"entities": []}], ["Median utilities by GOLD 2013 were group A: 1.0 (0.09); group B: 0.87 (0.13); group C: 1.0 (0.16); group D: 0.74 (0.29); comparisons were statistically significant (p\u2009<\u20090.001) except A vs C. Median utilities by GesEPOC phenotypes were 0.84 (0.33) for non exacerbator; 0.80 (0.26) for COPD-asthma overlap; 0.71 (0.62) for exacerbator with emphysema; 0.72 (0.57) for exacerbator with chronic bronchitis (p\u2009<\u20090.001).", {"entities": [[289, 295, "DISEASE"], [390, 400, "DISEASE"]]}], ["Comparisons between patients with or without exacerbations and between patients with COPD-asthma overlap and exacerbator with chronic bronchitis were statistically-significant (p\u2009<\u20090.001).", {"entities": [[90, 96, "DISEASE"], [134, 144, "DISEASE"]]}], ["Median utilities by BODEx index were: group 0\u20132: 0.89 (0.20); group 3\u20134: 0.80 (0.27); group 5\u20136: 0.67 (0.29); group 7\u20139: 0.41 (0.31).", {"entities": []}], ["All comparisons were significant (p\u2009<\u20090.001) except between groups 3\u20134 and 5\u20136.", {"entities": []}], ["Irrespective of the classification used utilities were associated to disease severity.", {"entities": []}], ["Some clinical phenotypes were associated with worse utilities, probably related to a higher frequency of exacerbations.", {"entities": []}], ["GOLD 2007 guidelines and BODEx index better discriminated patients with a worse health status than GOLD 2013 guidelines, while GOLD 2013 guidelines were better able to identify a smaller group of patients with the best health .", {"entities": []}], ["Wheezing is often treated as a crucial indicator in the diagnosis of obstructive pulmonary diseases.", {"entities": []}], ["A rapid wheezing detection system may help physicians to monitor patients over the long-term.", {"entities": []}], ["In this study, a portable wheezing detection system based on a field-programmable gate array (FPGA) is proposed.", {"entities": []}], ["This system accelerates wheezing detection, and can be used as either a single-process system, or as an integrated part of another biomedical signal detection system.", {"entities": []}], ["The system segments sound signals into 2-second units.", {"entities": []}], ["A short-time Fourier transform was used to determine the relationship between the time and frequency components of wheezing sound data.", {"entities": []}], ["A spectrogram was processed using 2D bilateral filtering, edge detection, multithreshold image segmentation, morphological image processing, and image labeling, to extract wheezing features according to computerized respiratory sound analysis (CORSA) standards.", {"entities": []}], ["These features were then used to train the support vector machine (SVM) and build the classification models.", {"entities": []}], ["The trained model was used to analyze sound data to detect wheezing.", {"entities": []}], ["The system runs on a Xilinx Virtex-6 FPGA ML605 platform.", {"entities": []}], ["The experimental results revealed that the system offered excellent wheezing recognition performance (0.912).", {"entities": []}], ["The detection process can be used with a clock frequency of 51.97 MHz, and is able to perform rapid wheezing classification.", {"entities": []}], ["Weak health systems in low- and middle-income countries are recognized as the major constraint in responding to the rising burden of chronic conditions.", {"entities": []}], ["Despite recognition by global actors for the need for research on health systems, little attention has been given to the role played by local health systems.", {"entities": []}], ["We aim to analyze a mixed local health system to identify the main challenges in delivering quality care for diabetes mellitus type 2.", {"entities": [[109, 126, "DISEASE"]]}], ["We used the health system dynamics framework to analyze a health system in KG Halli, a poor urban neighborhood in South India.", {"entities": []}], ["We conducted semi-structured interviews with healthcare providers located in and around the neighborhood who provide care to diabetes patients: three specialist and 13 non-specialist doctors, two pharmacists, and one laboratory technician.", {"entities": []}], ["Observations at the health facilities were recorded in a field diary.", {"entities": []}], ["Data were analyzed through thematic analysis.", {"entities": []}], ["There is a lack of functional referral systems and a considerable overlap in provision of outpatient care for diabetes across the different levels of healthcare services in KG Halli.", {"entities": []}], ["Inadequate use of patients\u2019 medical records and lack of standard treatment protocols affect clinical decision-making.", {"entities": []}], ["The poor regulation of the private sector, poor systemic coordination across healthcare providers and healthcare delivery platforms, widespread practice of bribery and absence of formal grievance redress platforms affect effective leadership and governance.", {"entities": []}], ["There appears to be a trust deficit among patients and healthcare providers.", {"entities": []}], ["The private sector, with a majority of healthcare providers lacking adequate training, operates to maximize profit, and healthcare for the poor is at best seen as charity.", {"entities": []}], ["Systemic impediments in local health systems hinder the delivery of quality diabetes care to the urban poor.", {"entities": []}], ["There is an urgent need to address these weaknesses in order to improve care for diabetes and other chronic conditions.", {"entities": []}], ["Influenza A virus (IAV) infections are a common cause of acute exacerbations of chronic obstructive pulmonary disease (AECOPD).", {"entities": [[80, 117, "DISEASE"]]}], ["Oxidative stress is increased in COPD, IAV-induced lung inflammation and AECOPD.", {"entities": []}], ["Therefore, we investigated whether targeting oxidative stress with the Nox2 oxidase inhibitors and ROS scavengers, apocynin and ebselen could ameliorate lung inflammation in a mouse model of AECOPD.", {"entities": []}], ["Male BALB/c mice were exposed to cigarette smoke (CS) generated from 9 cigarettes per day for 4 days.", {"entities": [[50, 52, "GENE"]]}], ["On day 5, mice were infected with 1\u2009\u00d7\u200910", {"entities": []}], ["CD5L (CD5 molecule-like) is a secreted glycoprotein that participates in host response to bacterial infection.", {"entities": [[0, 4, "GENE"], [6, 9, "GENE"]]}], ["CD5L influences the monocyte inflammatory response to the bacterial surface molecules lipopolysaccharide (LPS) and lipoteichoic acid (LTA) by inhibiting TNF secretion.", {"entities": [[0, 4, "GENE"], [134, 137, "GENE"], [153, 156, "GENE"]]}], ["Here we studied the intracellular events that lead to macrophage TNF inhibition by human CD5L.", {"entities": [[65, 68, "GENE"], [89, 93, "GENE"]]}], ["To accomplish this goal, we performed functional analyses with human monocytic THP1 macrophages, as well as with peripheral blood monocytes.", {"entities": []}], ["Inhibition of phosphatidylinositol 3-kinase (PtdIns3K) reversed the inhibitory effect of CD5L on TNF secretion.", {"entities": [[89, 93, "GENE"], [97, 100, "GENE"]]}], ["Among the various PtdIns3K isoforms, our results indicated that CD5L activates PtdIns3K (whose catalytic subunit is termed PIK3C3), a key modulator involved in autophagy.", {"entities": [[64, 68, "GENE"], [123, 129, "GENE"]]}], ["Further analysis revealed a concomitant enhancement of autophagy markers such as cellular LC3-II content, increased LC3 puncta, as well as LC3-LysoTracker Red colocalization.", {"entities": []}], ["Moreover, electron microscopy showed an increased presence of cytosolic autophagosomes in THP1 macrophages overexpressing CD5L.", {"entities": [[122, 126, "GENE"]]}], ["Besides preventing TNF secretion, CD5L also inhibited IL1B and enhanced IL10 secretion.", {"entities": [[19, 22, "GENE"], [34, 38, "GENE"], [54, 58, "GENE"], [72, 76, "GENE"]]}], ["This macrophage anti-inflammatory pattern of CD5L was reverted upon silencing of autophagy protein ATG7 by siRNA transfection.", {"entities": [[45, 49, "GENE"], [99, 103, "GENE"]]}], ["Additional siRNA experiments in THP1 macrophages indicated that the induction of autophagy mechanisms by CD5L was achieved through cell-surface scavenger receptor CD36, a multiligand receptor expressed in a wide variety of cell types.", {"entities": [[105, 109, "GENE"], [163, 167, "GENE"]]}], ["Our data represent the first evidence that CD36 is involved in autophagy and point to a significant contribution of the CD5L-CD36 axis to the induction of macrophage autophagy.", {"entities": [[43, 47, "GENE"], [125, 129, "GENE"]]}], ["The Copenhagen Hip And Groin Outcome Score (HAGOS) was developed to assess disease-specific consequences in young to middle-aged, physically active hip and/or groin patients.", {"entities": []}], ["The study aimed to determine validity and reliability of the Dutch version of the HAGOS (HAGOS-NL) for middle-aged patients with hip complaints.", {"entities": []}], ["To assess validity, 117 participants completed five questionnaires: HAGOS-NL, international Hip Outcome Tool (iHOT-12NL), Hip disability and Osteoarthritis Outcome Score (HOOS), RAND-36 Health Survey and Tegner activity scale.", {"entities": []}], ["Structural validity was determined by conducting confirmatory factor analysis.", {"entities": []}], ["Construct validity was analyzed by formulating predefined hypotheses regarding relationships between the HAGOS-NL and subscales of the iHOT-12NL, HOOS, RAND-36 and Tegner activity scale.", {"entities": []}], ["The HAGOS-NL was filled out again by 67 patients to explore test-retest reliability.", {"entities": []}], ["Reliability was assessed in terms of Cronbach\u2019s alpha, Intraclass Correlation Coefficient (ICC), Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC).", {"entities": []}], ["The Bland and Altman method was used to explore absolute agreement.", {"entities": []}], ["Factor analysis confirmed that the HAGOS-NL consists of six subscales.", {"entities": []}], ["All hypotheses were confirmed, indicating good construct validity.", {"entities": []}], ["Internal consistency was good, with Cronbach\u2019s alpha values ranging from 0.89 to 0.98.", {"entities": []}], ["Test-retest reliability was considered good, with ICC values of 0.80 and higher.", {"entities": []}], ["The SEM ranged from 6.6 to 12.3, and MDC at individual level from 18.3 to 34.1 and at group level from 2.3 to 4.4.", {"entities": []}], ["Bland and Altman analyses showed no bias.", {"entities": []}], ["The HAGOS-NL is a reliable and valid instrument for measuring pain, physical functioning and quality of life in middle-aged patients with hip complaints.", {"entities": []}], ["This review is addressed two pathophysiologic mechanisms implicated in the pathogenesis of nasal polyposis: the unique remodeling process found in nasal polyp tissue and the immune response of patients with nasal polyposis to Staphylococcus aureus .", {"entities": []}], ["These two theories converge to the same direction in different aspects, including decreased extracellular matrix production, impaired T regulation and favoring of a Th2 immune response.", {"entities": []}], ["In patients with nasal polyposis, an exaggerated immune response to Staphylococcus aureus may aggravate the airway remodeling process.", {"entities": []}], ["The human Y chromosome is almost always excluded from genome-wide investigations of copy number variants (CNVs) due to its highly repetitive structure.", {"entities": []}], ["This chromosome should not be forgotten, not only for its well-known relevance in male fertility, but also for its involvement in clinical phenotypes such as cancers, heart failure and sex specific effects on brain and behaviour.", {"entities": []}], ["We analysed Y chromosome data from Affymetrix 6.0 SNP arrays and found that the signal intensities for most of 8179 SNP/CN probes in the male specific region (MSY) discriminated between a male, background signals in a female and an isodicentric male containing a large deletion of the q-arm and a duplication of the p-arm of the Y chromosome.", {"entities": []}], ["Therefore, this SNP/CN platform is suitable for identification of gain and loss of Y chromosome sequences.", {"entities": []}], ["In a set of 1718 males, we found 25 different CNV patterns, many of which are novel.", {"entities": []}], ["We confirmed some of these variants by PCR or qPCR.", {"entities": []}], ["The total frequency of individuals with CNVs was 14.7%, including 9.5% with duplications, 4.5% with deletions and 0.7% exhibiting both.", {"entities": []}], ["Hence, a novel observation is that the frequency of duplications was more than twice the frequency of deletions.", {"entities": []}], ["Another striking result was that 10 of the 25 detected variants were significantly overrepresented in one or more haplogroups, demonstrating the importance to control for haplogroups in genome-wide investigations to avoid stratification.", {"entities": []}], ["NO-M214(xM175) individuals presented the highest percentage (95%) of CNVs.", {"entities": []}], ["If they were not counted, 12.4% of the rest included CNVs, and the difference between duplications (8.9%) and deletions (2.8%) was even larger.", {"entities": []}], ["Our results demonstrate that currently available genome-wide SNP platforms can be used to identify duplications and deletions in the human Y chromosome.", {"entities": []}], ["Future association studies of the full spectrum of Y chromosome variants will demonstrate the potential involvement of gain or loss of Y chromosome sequence in different human phenotypes.", {"entities": []}], ["Physical activity (PA) has been shown to improve the general health of patients with chronic diseases and to prevent the onset of such conditions.", {"entities": []}], ["However, the association between multimorbidity and PA has not been investigated in detail, and recent studies of this topic yield dissenting results.", {"entities": []}], ["The objective of this study was to examine whether PA levels were associated with multimorbidity, self-rated health and functional limitation.", {"entities": []}], ["This was a cross-sectional study based on data from the 2009 European Health Interview Survey for Spain.", {"entities": []}], ["The sample population included 22,190 adults over 15\u00a0years of age.", {"entities": []}], ["The independent variables were multimorbidity (measured as the number of chronic diseases), activity limitations, and self-rated health status.", {"entities": []}], ["The dependent variable was PA level, measured as a) a continuous variable in metabolic equivalents (METs) and b) a dichotomous variable based on international recommendations (</\u2265500 MET-minutes per week).", {"entities": []}], ["The associations between the dependent and independent variables were evaluated across sex and age groups (16\u201324, 25\u201344, 45\u201364, 65\u201374, >74\u00a0years), using multivariate linear and logistic regression models that were adjusted for age, educational level and employment status.", {"entities": []}], ["An inverse association was found between PA and multimorbidity among older males and young females between 16\u201324 years.", {"entities": []}], ["This negative association was also observed among males aged 25\u201344 years when analysing PA as a dichotomous variable.", {"entities": []}], ["Self-rated health status was directly related to the achievement of minimum PA levels among middle-aged and older individuals, but the opposite happened among the youngest group of females.", {"entities": []}], ["Significant associations between the existence of activity limitations and the performance of lower volumes of PA were consistently observed among subjects over 44\u00a0years.", {"entities": []}], ["There is an inverse association between multimorbidity and PA in the youngest and oldest age groups.", {"entities": []}], ["In addition, both low self-rated health status and the presence of functional limitations were related to lower PA in most of the examined population groups.", {"entities": []}], ["These features should be considered in the design and implementation of community-based approaches to promoting PA, if further corroborated in longitudinal studies.", {"entities": []}], ["A number of radiogrammetrical metacarpal indices are in use, some of which have been adapted for children.", {"entities": []}], ["The purpose of this study was to compare four known indices\u2014bone mineral density (BMD), relative cortical area, Exton-Smith index, bending breaking resistance index\u2014and the more recently defined pediatric bone index (PBI) according to the two criteria of minimum height dependence and minimum variability in children of equal bone age.", {"entities": []}], ["A total of 3,121 left-hand radiographs from 231 healthy Caucasian children ranging in age from 3\u00a0to 19\u00a0years old were analysed using BoneXpert\u00ae, a programme for automatic analysis of hand radiographs and assessment of bone age.", {"entities": []}], ["Dependence on height for chronological age or bone age and the mean relative standard deviation were lowest in the PBI for both genders pooled.", {"entities": []}], ["The differences in height dependence were statistically significant and are shown to be clinically relevant.", {"entities": []}], ["Reference data for PBI are presented.", {"entities": []}], ["PBI may be a better indicator than BMD for bone health in children; however, verification in a clinical group is needed.", {"entities": []}], ["The definition of \" clinical asthma remission\" is based on absence of symptoms and use of medication.", {"entities": [[29, 35, "DISEASE"]]}], ["However, in the majority of these subjects airway inflammation is still present when measured.", {"entities": []}], ["In the present study we investigated whether \"complete asthma remission\", additionally defined by the absence of bronchial hyperresponsiveness (BHR) and the presence of a normal lung function, is associated with the absence of airway inflammation.", {"entities": [[55, 61, "DISEASE"]]}], ["Patients with a former diagnosis of asthma and a positive histamine provocation test were re-examined to identify subjects with complete asthma remission (no asthma symptoms or medication, PC 20 histamine > 32 mg/ml, FEV 1 > 90% predicted).", {"entities": [[36, 42, "DISEASE"], [137, 143, "DISEASE"], [158, 164, "DISEASE"], [189, 191, "GENE"], [217, 220, "GENE"]]}], ["Patients with PC 20 histamine \u2264 32 mg/ml were defined as current asthmatics and were divided in two groups, i.e.", {"entities": [[14, 16, "GENE"]]}], ["asthmatics with and without BHR to adenosine 5'monophoshate (AMP).", {"entities": []}], ["Sputum induction was performed 1 week before and 1 hour after AMP provocation.", {"entities": []}], ["Sputum induction and AMP provocation were previously shown to be sensitive markers of airway inflammation.", {"entities": []}], ["Seven patients met criteria for complete asthma remission.", {"entities": [[41, 47, "DISEASE"]]}], ["Twenty-three were current asthmatics, including twelve without hyperresponsiveness to AMP.", {"entities": []}], ["Subjects with complete asthma remission showed no AMP-induced sputum eosinophilia (median (range) 0.2 (0 - 4.6)% at baseline and 0.2 (0 - 2.6)% after AMP).", {"entities": [[69, 81, "DISEASE"], [23, 29, "DISEASE"]]}], ["After AMP, current asthmatics had a significant increase in sputum eosinophils (0.5 (0 - 26.0)% at baseline and 2.6 (0 - 32.0) % after AMP), as had the subgroup of current asthmatics without hyperresponsiveness to AMP (0.2 (0 - 1.8)% at baseline and 1.3 (0 - 6.3)% after AMP).", {"entities": []}], ["Subjects with complete asthma remission, in contrast to subjects with current asthma, do not respond with eosinophilic inflammation in sputum after AMP provocations.", {"entities": [[23, 29, "DISEASE"], [78, 84, "DISEASE"]]}], ["These data lend support to the usefulness of the definition of complete asthma remission.", {"entities": [[72, 78, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a common respiratory disorder for which new diagnostic and therapeutic approaches are required.", {"entities": []}], ["Hallmarks of COPD are matrix destruction and neutrophilic airway inflammation in the lung.", {"entities": []}], ["We have previously described two tri-peptides, N-\u03b1-PGP and PGP, which are collagen fragments and neutrophil chemoattractants.", {"entities": [[51, 54, "GENE"], [59, 62, "GENE"]]}], ["In this study, we investigate if N-\u03b1-PGP and PGP are biomarkers and potential therapeutic targets for COPD.", {"entities": [[37, 40, "GENE"], [45, 48, "GENE"]]}], ["Induced sputum samples from COPD patients, healthy controls and asthmatics were examined for levels of N-\u03b1-PGP and PGP using mass spectrometry and for the ability to generate PGP de novo from collagen.", {"entities": [[107, 110, "GENE"], [115, 118, "GENE"], [175, 178, "GENE"], [107, 110, "GENE"], [115, 118, "GENE"], [175, 178, "GENE"]]}], ["Proteases important in PGP generation in the lung were identified by the use of specific inhibitors in the PGP generation assay and by instillation of proteases into mouse lungs.", {"entities": [[23, 26, "GENE"], [107, 110, "GENE"], [23, 26, "GENE"], [107, 110, "GENE"]]}], ["Serum levels of PGP were compared between COPD patients and controls.", {"entities": [[16, 19, "GENE"]]}], ["N-\u03b1-PGP was detected in most COPD sputum samples but in no asthmatics or controls.", {"entities": []}], ["PGP was detected in a few controls and in all COPD sputum samples, where it correlated with levels of myeloperoxidase.", {"entities": [[0, 3, "GENE"]]}], ["COPD sputum samples had the ability to generate N-\u03b1-PGP and PGP de novo from collagen.", {"entities": [[52, 55, "GENE"], [60, 63, "GENE"]]}], ["PGP generation by COPD sputum was blocked by inhibitors of matrix metalloproteases (MMP's) 1 and 9 and prolyl endopeptidase.", {"entities": [[0, 3, "GENE"]]}], ["MMP's 1 and 9 and prolyl endopeptidase acted synergistically to generate PGP in vivo when instilled into mouse lungs.", {"entities": [[73, 76, "GENE"]]}], ["Serum levels of PGP were also significantly higher in COPD patients than in controls N-\u03b1-PGP and PGP may represent novel diagnostic tests and biomarkers for COPD.", {"entities": [[16, 19, "GENE"], [89, 92, "GENE"], [97, 100, "GENE"], [16, 19, "GENE"], [89, 92, "GENE"], [97, 100, "GENE"]]}], ["Inhibition of this pathway may provide novel therapies for COPD directed at the chronic, neutrophilic, airway inflammation which underlies disease progression.", {"entities": []}], ["The identification of rare coding or splice site variants remains the most straightforward strategy to link genes with human phenotypes.", {"entities": []}], ["Here, we analyzed the association between 137,086 rare (minor allele frequency (MAF) <1%) coding or splice site variants and 15 hematological traits in up to 308,572 participants.", {"entities": [[80, 83, "GENE"]]}], ["We found 56 such rare coding or splice site variants at P <5x10 IL33 ) associated with reduced eosinophil count ( P = 2.4x10 P = 2.6x10 P = 4.2x10 PLG ) associated with increased platelet count ( P = 6.8x10 P = 0.018) and platelet reactivity ( P <0.03).", {"entities": [[64, 68, "GENE"], [147, 150, "GENE"]]}], ["Finally, our results indicate that searching for rare coding or splice site variants in very large sample sizes can help prioritize causal genes at many GWAS loci associated with complex human diseases and traits.", {"entities": []}], ["Genome-wide association studies (GWAS) have identified thousand of genetic associations between common DNA sequence variants ( e .", {"entities": []}], ["single nucleotide polymorphisms (SNPs)) and complex human diseases or traits.", {"entities": []}], ["In most cases, these associations highlight non-coding variants, and thus fall short of identifying causal genes.", {"entities": []}], ["The discovery of rare coding variants within these GWAS loci can greatly simplify causal gene identification.", {"entities": []}], ["Here, we tested the association between 137,086 rare coding and splice site variants (minor allele frequency (MAF) <1%) and 15 blood-cell traits in 308,572 participants.", {"entities": [[110, 113, "GENE"]]}], ["We found 56 rare coding variants associated with hematological traits, including 31 variants reported for the first time.", {"entities": []}], ["Thirty of these 31 variants are located within blood-cell trait GWAS loci, thus prioritizing candidate genes.", {"entities": []}], ["We replicated an association between a rare interleukin 33 ( IL33 ) splice site variation and eosinophil count and asthma risk, and showed that it also associates with hay fever risk.", {"entities": [[115, 121, "DISEASE"], [61, 65, "GENE"]]}], ["Finally, we found a new rare missense variant in plasminogen ( PLG ) associated with platelet count, D-dimer concentration, and platelet reactivity.", {"entities": [[63, 66, "GENE"]]}], ["In conclusion, it is possible to use the \u201crare coding variant association study\u201d strategy to pinpoint causal genes at GWAS loci, but very large sample sizes are required.", {"entities": []}], ["To examine if the gene encoding C-reactive protein ( CRP ), a biomarker of inflammation, confers risk for neovascular age-related macular degeneration (AMD) in the presence of other modifiers of inflammation, including body mass index (BMI), diabetes, smoking, and complement factor H ( CFH ) Y402 genotype.", {"entities": [[130, 150, "DISEASE"], [53, 56, "GENE"], [287, 290, "GENE"]]}], ["Additionally we examined the degree to which CRP common variation was in linkage disequilibrium (LD) within our cohort.", {"entities": [[45, 48, "GENE"]]}], ["We ascertained 244 individuals from 104 families where at least one member had neovascular AMD, and a sibling had normal maculae and was past the age of the index patient\u2019s diagnosis of neovascular AMD.", {"entities": []}], ["We employed a direct sequencing approach to analyze the 5\u2032-promoter region as well as the entire coding region and the 3\u2032-untranslated region of the CRP gene.", {"entities": [[149, 152, "GENE"]]}], ["CFH Y402 genotype data was available for all participants.", {"entities": [[0, 3, "GENE"]]}], ["Lifestyle and medical factors were obtained via administration of a standardized questionnaire.", {"entities": []}], ["The family-based association test, haplotype analysis, McNemar\u2019s test, and conditional logistic regression were used to determine significant associations and interactions.", {"entities": []}], ["Haploview was used to calculate the degree of LD ( r CRP variants identified.", {"entities": [[53, 56, "GENE"]]}], ["Six single nucleotide polymorphisms (SNPs; rs3091244 , rs1417938 , rs1800947 , rs1130864 , rs1205 , and rs3093068 ) comprised one haplotype block of which only rs1130864 and rs1417938 were in high LD ( r rs3093068 was in LD but less so with rs3093059 ( r CRP and neovascular AMD when considering disease status alone or when controlling for smoking exposure, BMI, diabetes, or CFH genotype.", {"entities": [[255, 258, "GENE"], [377, 380, "GENE"]]}], ["Significant interactions were not found between CRP genotypes and any of the risk factors studied.", {"entities": [[48, 51, "GENE"]]}], ["No novel CRP variation was identified.", {"entities": [[9, 12, "GENE"]]}], ["We provide evidence that if elevated serum/plasma levels of CRP are associated with neovascular AMD, it is likely not due to genetic variation within CRP , but likely due to variations in some other genetic as well as epidemiological factors.", {"entities": [[60, 63, "GENE"], [150, 153, "GENE"], [60, 63, "GENE"], [150, 153, "GENE"]]}], ["Objective : We have conducted a study to assess the role of environment on the burden of maternal morbidities and mortalities among women using an external exposome approach for the purpose of developing targeted public health interventions to decrease disparities.", {"entities": []}], ["Methods : We identified counties in the 48 contiguous USA where observed low birthweight (LBW) rates were higher than expected during a five-year study period.", {"entities": []}], ["The identification was conducted using a retrospective space-time analysis scan for statistically significant clusters with high or low rates by a Discrete Poisson Model.", {"entities": []}], ["Results : We observed statistically significant associations of LBW rate with a set of predictive variables.", {"entities": []}], ["However, in one of the two spatiotemporal models we discovered LBW to be associated with five predictive variables (teen birth rate, adult obesity, uninsured adults, physically unhealthy days, and percent of adults who smoke) in two counties situated in Alabama after adjusting for location changes.", {"entities": [[139, 146, "DISEASE"]]}], ["Counties with higher than expected LBW rates were similarly associated with two environmental variables (ozone and fine particulate matter).", {"entities": []}], ["Conclusions : The county-level predictive measures of LBW offer new insights into spatiotemporal patterns relative to key contributory factors.", {"entities": []}], ["An external framework provides a promising place-based approach for identifying \u201chotspots\u201d with implications for designing targeted interventions and control measures to reduce and eliminate health disparities.", {"entities": []}], ["People with depression are usually managed in primary care and antidepressants are often the first-line treatment, but only one third of patients respond fully to a single antidepressant.", {"entities": []}], ["This paper describes the protocol for a randomised controlled trial (MIR) to investigate the extent to which the addition of the antidepressant mirtazapine is effective in reducing the symptoms of depression compared with placebo in patients who are still depressed after they have been treated with a selective serotonin reuptake inhibitor (SSRI) or serotonin and noradrenaline reuptake inhibitor (SNRI) for at least 6\u00a0weeks in primary care.", {"entities": []}], ["MIR is a two-parallel group, multi-centre, pragmatic, placebo controlled, randomised trial with allocation at the level of the individual.", {"entities": []}], ["Eligible participants are those who: are aged 18\u00a0years or older; are currently taking an SSRI/SNRI antidepressant (for at least 6\u00a0weeks at an adequate dose); score \u226514 on the Beck Depression Inventory (BDI-II); have adhered to their medication; and meet ICD-10 criteria for depression (assessed using the Clinical Interview Schedule-Revised version).", {"entities": []}], ["Participants who give written, informed consent, will be randomised to receive either oral mirtazapine or matched placebo, starting at 15\u00a0mg daily for 2\u00a0weeks and increasing to 30\u00a0mg daily thereafter, for up to 12\u00a0months (to be taken in addition to their usual antidepressant).", {"entities": []}], ["Participants, their GPs, and the research team will all be blind to the allocation.", {"entities": []}], ["The primary outcome will be depression symptoms at 12\u00a0weeks post randomisation, measured as a continuous variable using the BDI-II.", {"entities": []}], ["Secondary outcomes (measured at 12, 24 and 52\u00a0weeks) include: response (reduction in depressive symptoms (BDI-II score) of at least 50\u00a0% compared to baseline); remission of depression symptoms (BDI-II <10); change in anxiety symptoms; adverse effects; quality of life; adherence to antidepressant medication; health and social care use, time off work and cost-effectiveness.", {"entities": []}], ["All outcomes will be analysed on an intention-to-treat basis.", {"entities": []}], ["A qualitative study will explore patients\u2019 views and experiences of either taking two antidepressants, or an antidepressant and a placebo; and GPs\u2019 views on prescribing a second antidepressant in this patient group.", {"entities": []}], ["The MIR trial will provide evidence on the clinical and cost-effectiveness of mirtazapine as an adjunct to SSRI/SNRI antidepressants for patients in primary care who have not responded to monotherapy.", {"entities": []}], ["EudraCT Number: 2012-000090-23 (Registered January 2012); ISRCTN06653773 (Registered September 2012)", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is frequently associated with comorbid depression and anxiety.", {"entities": []}], ["Managing COPD symptoms and exacerbations through use of appropriate and adequate pharmacotherapy in this population may result in better COPD-related outcomes.", {"entities": []}], ["This retrospective, observational study used administrative claims of patients aged 40 years and older with COPD and comorbid depression/anxiety identified from January 1, 2004 through June 30, 2008.", {"entities": []}], ["Patients were assigned to fluticasone propionate/salmeterol 250/50 mcg combination (FSC) or anticholinergics (AC) based on their first (index) prescription.", {"entities": []}], ["The risks of COPD exacerbations and healthcare utilization and costs were compared between cohorts during 1 year of follow-up.", {"entities": []}], ["The adjusted risk of a COPD-related exacerbation during the 1-year follow-up period was 30% higher in the AC cohort (n = 2923) relative to the FSC cohort (n = 1078) (odds ratio [OR]: 1.30, 95% confidence interval [CI]: 1.08\u20131.56) after controlling for baseline differences in covariates.", {"entities": []}], ["The risks of COPD-related hospitalizations and emergency department visits were 56% and 65% higher, respectively, in the AC cohort compared with the FSC cohort.", {"entities": []}], ["The average number of COPD-related hospitalizations during the follow-up period was 46% higher for the AC cohort compared with the FSC cohort (incidence rate ratio [IRR]: 1.46, 95% CI: 1.01\u20132.09, P = 0.041).", {"entities": []}], ["The savings from lower COPD-related medical costs ($692 vs $1042, P < 0.050) kept the COPD-related total costs during the follow-up period comparable to those in the AC cohort ($1659 vs $1677, P > 0.050) although the pharmacy costs were higher in the FSC cohort.", {"entities": []}], ["FSC compared with AC was associated with more favorable COPD-related outcomes and lower COPD-related utilization and medical costs among patients with COPD and comorbid anxiety/depression.", {"entities": []}], ["Autotaxin (ATX, Enpp2 ) is a secreted lysophospholipase D catalysing the production of lysophosphatidic acid, a pleiotropic growth factor-like lysophospholipid.", {"entities": [[16, 21, "GENE"]]}], ["Increased ATX expression has been detected in a number of chronic inflammatory diseases and different types of cancer, while genetic interventions have proven a role for ATX in disease pathogenesis.", {"entities": [[111, 117, "DISEASE"]]}], ["Therefore, ATX has emerged as a potential drug target and a large number of ATX inhibitors have been developed exhibiting promising therapeutic potential.", {"entities": []}], ["However, the embryonic lethality of ATX null mice and the ubiquitous expression of ATX and LPA receptors in adult life question the suitability of ATX as a drug target.", {"entities": [[91, 94, "GENE"]]}], ["Here we show that inducible, ubiquitous genetic deletion of ATX in adult mice, as well as long-term potent pharmacologic inhibition, are well tolerated, alleviating potential toxicity concerns of ATX therapeutic targeting.", {"entities": []}], ["Macrophages (M\u00d8) and mononuclear phagocytes are major targets of infection by dengue virus (DV), a mosquito-borne flavivirus that can cause haemorrhagic fever in humans.", {"entities": []}], ["To our knowledge, we show for the first time that the M\u00d8 mannose receptor (MR) binds to all four serotypes of DV and specifically to the envelope glycoprotein.", {"entities": []}], ["Glycan analysis, ELISA, and blot overlay assays demonstrate that MR binds via its carbohydrate recognition domains to mosquito and human cell\u2013produced DV antigen.", {"entities": []}], ["This binding is abrogated by deglycosylation of the DV envelope glycoprotein.", {"entities": []}], ["Surface expression of recombinant MR on NIH3T3 cells confers DV binding.", {"entities": []}], ["Furthermore, DV infection of primary human M\u00d8 can be blocked by anti-MR antibodies.", {"entities": []}], ["MR is a prototypic marker of alternatively activated M\u00d8, and pre-treatment of human monocytes or M\u00d8 with type 2 cytokines (IL-4 or IL-13) enhances their susceptibility to productive DV infection.", {"entities": []}], ["Our findings indicate a new functional role for the MR in DV infection.", {"entities": []}], ["Dengue disease and its severe manifestations are a growing public health concern, with a third to half the world's population living in dengue-endemic areas.", {"entities": [[0, 14, "DISEASE"]]}], ["In recent years there have been significant advances in understanding dengue virus (DV) interactions with target cells such as macrophages, dendritic cells, hepatocytes, and endothelial cells.", {"entities": []}], ["Interaction with and infection of these cells leads to the production of new virions as well as immune mediators, which can shape the course of the subsequent immune response.", {"entities": []}], ["The vascular leakage associated with dengue haemorrhagic fever is believed to be immune mediated.", {"entities": []}], ["Our work on the interaction of DV with human macrophages has led to two major findings; first, we have identified that the macrophage mannose receptor is important for mediating the infection of human macrophages by DV, and second, that the type 2 cytokines IL-4 and IL-13 enhance macrophage susceptibility to DV infection.", {"entities": []}], ["DV\u2013receptor interactions are of critical importance for understanding not only the mechanisms of entry, but also the biology of infection and the pathogenesis.", {"entities": []}], ["Understanding the immunopathogenesis of dengue disease is crucial to the development of both a safe dengue vaccine and therapeutic inhibitors of early DV replication.", {"entities": [[40, 54, "DISEASE"]]}], ["Adenoid cystic carcinoma (AdCC) of the head and neck is a well-recognized pathologic entity that rarely occurs in the larynx.", {"entities": [[15, 24, "DISEASE"]]}], ["Although the 5-year locoregional control rates are high, distant metastasis has a tendency to appear more than 5\u00a0years post treatment.", {"entities": []}], ["Because AdCC of the larynx is uncommon, it is difficult to standardize a treatment protocol.", {"entities": []}], ["One of the controversial points is the decision whether or not to perform an elective neck dissection on these patients.", {"entities": []}], ["Because there is contradictory information about this issue, we have critically reviewed the literature from 1912 to 2015 on all reported cases of AdCC of the larynx in order to clarify this issue.", {"entities": []}], ["During the most recent period of our review (1991\u20132015) with a more exact diagnosis of the tumor histology, 142 cases were observed of AdCC of the larynx, of which 91 patients had data pertaining to lymph node status.", {"entities": []}], ["Eleven of the 91 patients (12.1%) had nodal metastasis and, based on this low proportion of patients, routine elective neck dissection is therefore not recommended.", {"entities": []}], ["Asthma has a high prevalence in the United States, and persons with asthma may be at added risk from the adverse effects of hazardous air pollutants (HAPs).", {"entities": [[0, 6, "DISEASE"], [68, 74, "DISEASE"]]}], ["Complex mixtures (fine particulate matter and tobacco smoke) have been associated with respiratory symptoms and hospital admissions for asthma.", {"entities": [[136, 142, "DISEASE"]]}], ["The toxic ingredients of these mixtures are HAPs, but whether ambient HAP exposures can induce asthma remains unclear.", {"entities": [[95, 101, "DISEASE"]]}], ["Certain HAPs are occupational asthmagens, whereas others may act as adjuncts during sensitization.", {"entities": []}], ["HAPs may exacerbate asthma because, once sensitized, individuals can respond to remarkably low concentrations, and irritants lower the bronchoconstrictive threshold to respiratory antigens.", {"entities": [[20, 26, "DISEASE"]]}], ["Adverse responses after ambient exposures to complex mixtures often occur at concentrations below those producing effects in controlled human exposures to a single compound.", {"entities": []}], ["In addition, certain HAPs that have been associated with asthma in occupational settings may interact with criteria pollutants in ambient air to exacerbate asthma.", {"entities": [[57, 63, "DISEASE"], [156, 162, "DISEASE"]]}], ["Based on these observations and past experience with 188 HAPs, a list of 19 compounds that could have the highest impact on the induction or exacerbation of asthma was developed.", {"entities": [[157, 163, "DISEASE"]]}], ["Nine additional compounds were identified that might exacerbate asthma based on their irritancy, respirability, or ability to react with biological macromolecules.", {"entities": [[64, 70, "DISEASE"]]}], ["Although the ambient levels of these 28 compounds are largely unknown, estimated exposures from emissions inventories and limited air monitoring suggest that aldehydes (especially acrolein and formaldehyde) and metals (especially nickel and chromium compounds) may have possible health risk indices sufficient for additional attention.", {"entities": []}], ["Recommendations for research are presented regarding exposure monitoring and evaluation of biologic mechanisms controlling how these substances induce and exacerbate asthma.", {"entities": [[166, 172, "DISEASE"]]}], ["This article describes the setting-up process for nurse-led pilot clinics for the management of four chronic diseases: asthma, type 2 diabetes mellitus, epilepsy and hypertension at the primary health care level in urban and rural Cameroon.", {"entities": [[166, 178, "DISEASE"], [119, 125, "DISEASE"], [134, 151, "DISEASE"], [127, 151, "DISEASE"]]}], ["The Biyem-Assi urban and the Bafut rural health districts in Cameroon served as settings for this study.", {"entities": []}], ["International and local guidelines were identified and adapted to the country\u2019s circumstances.", {"entities": []}], ["Training and follow-up tools were developed and nurses trained by experienced physicians in the management of the four conditions.", {"entities": []}], ["Basic diagnostic and follow-up materials were provided and relevant essential drugs made available.", {"entities": []}], ["Forty six nurses attended six training courses.", {"entities": []}], ["By the second year of activity, three and four clinics were operational in the urban and the rural areas respectively.", {"entities": []}], ["By then, 925 patients had been registered in the clinics.", {"entities": []}], ["This represented a 68.5% increase from the first year.", {"entities": []}], ["While the rural clinics relied mainly on essential drugs for their prescriptions, a prescription pattern combining generic and proprietary drugs was observed in the urban clinics.", {"entities": []}], ["In the quest for cost-effective health care for NCD in sub-Saharan Africa, rethinking health workforce and service delivery has relevance.", {"entities": []}], ["Nurse-led clinics, algorithm driven service delivery stands as alternatives to overcome the shortage of trained physicians and other issues relating to access to care.", {"entities": []}], ["Since 1956, more than 100,000 Swedish soldiers have served abroad on various international missions.", {"entities": []}], ["The aim of this paper was to determine whether there was a connection between military service abroad and sleep disorders among Swedish soldiers.", {"entities": []}], ["The prevalence of sleep disturbances among 1,080 veterans from Kosovo and Afghanistan was compared with almost 27,000 Swedes from a general population sample, using propensity score matching and logistic regression.", {"entities": []}], ["The sleep disturbances studied were habitual snoring , difficulty inducing sleep (DIS), difficulty maintaining sleep (DMS), early morning awakenings (EMA), and excessive daytime sleepiness (EDS).", {"entities": []}], ["Insomnia was defined as having at least one of DIS, DMS, or EMA.", {"entities": []}], ["The covariates used in the matching and adjustments were age, gender, smoking habits, BMI, education, ever having had asthma, moist snuff, and exercise habits.", {"entities": [[118, 124, "DISEASE"]]}], ["The veterans had a significantly lower prevalence of insomnia (26.2% versus 30.4%) and EDS (22.7% versus 29.4%) compared with a matched group from the reference population, using propensity score matching.", {"entities": []}], ["Analyses with logistic regression showed that belonging to the military population was related to a lower risk of having DMS (adjusted OR (95% CI) 0.77 (0.64\u20130.91)), insomnia (OR 0.82 (0.71\u20130.95)), and EDS (OR 0.74 (0.63\u20130.86)), whereas no significant difference was found for snoring, DIS, and EMA.", {"entities": []}], ["Swedish veterans have fewer problems with insomnia and daytime sleepiness than the general Swedish population.", {"entities": []}], ["The explanation of our findings may be the selection processes involved in becoming a soldier and when sampling personnel for military assignments abroad.", {"entities": []}], ["Data on the association between influenza and tuberculosis are limited.", {"entities": [[32, 41, "DISEASE"], [46, 58, "DISEASE"]]}], ["We describe the characteristics of patients with laboratory-confirmed tuberculosis, laboratory-confirmed influenza and tuberculosis-influenza co-infection.", {"entities": [[105, 114, "DISEASE"], [132, 141, "DISEASE"], [70, 82, "DISEASE"], [119, 131, "DISEASE"]]}], ["Patients hospitalized with severe respiratory illness (acute and chronic) were enrolled prospectively in four provinces in South Africa.", {"entities": []}], ["Naso/oropharyngeal specimens were tested for influenza virus by real time reverse transcriptase polymerase chain reaction.", {"entities": [[45, 54, "DISEASE"]]}], ["Tuberculosis testing was conducted as part of clinical management.", {"entities": [[0, 12, "DISEASE"]]}], ["From June 2010 through December 2011, 8032 patients were enrolled and influenza testing was conducted on 7863 (98%).", {"entities": [[70, 79, "DISEASE"]]}], ["Influenza virus was detected in 765 (10%) patients.", {"entities": [[0, 9, "DISEASE"]]}], ["Among 2959 patients with tuberculosis and influenza results, 2227 (75%) were negative for both pathogens, 423 (14%) were positive for tuberculosis alone, 275 (9%) were positive for influenza alone and 34 (1%) had influenza and tuberculosis co-infection.", {"entities": [[42, 51, "DISEASE"], [181, 190, "DISEASE"], [213, 222, "DISEASE"], [25, 37, "DISEASE"], [134, 146, "DISEASE"], [227, 239, "DISEASE"]]}], ["On multivariable analysis amongst individuals with symptoms for \u22657\u00a0days, tuberculosis influenza co-infection was associated with increased risk of death, (adjusted relative risk ratio (aRRR) (6.1, 95% confidence interval (CI) 1.6-23.4), as compared to tuberculosis only infection.", {"entities": [[86, 95, "DISEASE"], [73, 85, "DISEASE"], [252, 264, "DISEASE"]]}], ["This association was not observed in individuals with symptoms for <7\u00a0days (aRRR.0.8, 95% CI 0.1-7.0).", {"entities": []}], ["Tuberculosis and influenza co-infection compared to tuberculosis single infection was associated with increased risk of death in individuals with symptoms \u22657\u00a0days.", {"entities": [[17, 26, "DISEASE"], [0, 12, "DISEASE"], [52, 64, "DISEASE"]]}], ["The potential public health impact of influenza vaccination among persons with laboratory-confirmed tuberculosis should be explored.", {"entities": [[38, 47, "DISEASE"], [100, 112, "DISEASE"]]}], ["Polymorphisms in the APEX nuclease (multifunctional DNA repair enzyme) 1 gene ( APEX1 ) may be involved in the carcinogenesis by affecting DNA repair.", {"entities": [[80, 85, "GENE"]]}], ["We aimed to summarize available data on the association of the APEX1 Asp148Glu (rs1130409) polymorphism with risk of multiple types of cancer via a meta-analysis.", {"entities": [[135, 141, "DISEASE"], [63, 68, "GENE"]]}], ["In total, 58 qualified articles including 22,398 cancer patients and 26,505 controls were analyzed, and the data were extracted independently by two investigators.", {"entities": [[49, 55, "DISEASE"]]}], ["Analyses of the full data set indicated a marginally significant association of the APEX1 Asp148Glu polymorphism with cancer risk under allelic (odds ratio (OR)=1.05; 95% confidence interval (95% CI): 0.99-1.11; P=0.071), dominant (OR=1.09; 95% CI: 1.01-1.17; P=0.028), and heterozygous genotypic (OR=1.08; 95% CI: 1.01-1.16; P=0.026) models, with significant heterogeneity and publication bias.", {"entities": [[118, 124, "DISEASE"], [84, 89, "GENE"]]}], ["In subgroup analyses by cancer type, with a Bonferroni corrected alpha of 0.05/6, significant association was observed for gastric cancer under both dominant (OR=1.74; 95% CI: 1.2-2.51; P=0.003) and heterozygous genotypic (OR=1.66; 95% CI: 1.2-2.31; P=0.002) models.", {"entities": [[24, 30, "DISEASE"], [131, 137, "DISEASE"]]}], ["In subgroup analysis by ethnicity, risk estimates were augmented in Caucasians, especially under dominant (OR=1.11; 95% CI: 1.0-1.24; P=0.049) and heterozygous genotypic (OR=1.11; 95% CI: 0.99-1.24; P=0.063) models.", {"entities": []}], ["By study design, there were no significant differences between population-based and hospital-based studies.", {"entities": []}], ["In subgroup analysis by sample size, risk estimates were remarkably overestimated in small studies, and no significance was reached in large studies except under the heterozygous genotypic model (OR=1.23; 95% CI: 1.06-1.43; P=0.006, significant at a Bonferroni corrected alpha of 0.05/2).", {"entities": []}], ["By quality score, the risk estimates, albeit nonsignificant, were higher in low-quality studies than in high-quality studies.", {"entities": []}], ["Further meta-regression analyses failed to identify any contributory confounders for the associated risk estimates.", {"entities": []}], ["Our findings suggest that APEX1 Asp148Glu polymorphism might be a genetic risk factor for the development of gastric cancer.", {"entities": [[117, 123, "DISEASE"], [26, 31, "GENE"]]}], ["Further investigations on large populations are warranted.", {"entities": []}], ["COPD is a leading cause of morbidity and mortality.", {"entities": []}], ["Self-management interventions are considered important in order to limit the progression of the disease.", {"entities": []}], ["Computer-tailored interventions could be an effective tool to facilitate self-management.", {"entities": []}], ["This randomized controlled trial tested the effectiveness of a web-based, computer-tailored COPD self-management intervention on physical activity and smoking behavior.", {"entities": []}], ["Participants were recruited from an online panel and through primary care practices.", {"entities": []}], ["Those at risk for or diagnosed with COPD, between 40 and 70 years of age, proficient in Dutch, with access to the Internet, and with basic computer skills (n=1,325), were randomly assigned to either the intervention group (n=662) or control group (n=663).", {"entities": []}], ["The intervention group received the web-based self-management application, while the control group received no intervention.", {"entities": []}], ["Participants were not blinded to group assignment.", {"entities": []}], ["After 6 months, the effect of the intervention was assessed for the primary outcomes, smoking cessation and physical activity, by self-reported 7-day point prevalence abstinence and the International Physical Activity Questionnaire \u2013 Short Form.", {"entities": []}], ["Of the 1,325 participants, 1,071 (80.8%) completed the 6-month follow-up questionnaire.", {"entities": []}], ["No significant treatment effect was found on either outcome.", {"entities": []}], ["The application however, was used by only 36% of the participants in the experimental group.", {"entities": []}], ["A possible explanation for the nonsignificant effect on the primary outcomes, smoking cessation and physical activity, could be the low exposure to the application as engagement with the program has been shown to be crucial for the effectiveness of computer-tailored interventions.", {"entities": []}], ["(Netherlands Trial Registry number: NTR3421.)", {"entities": []}], ["Penicillium species are among the most common fungi present in the environment and are usually considered non-pathogenic to humans.", {"entities": []}], ["However, in immunocompromised hosts they can be virulent pathogens and can cause death.", {"entities": []}], ["Penicillium digitatum is a plant pathogen that commonly causes a postharvest fungal disease of citrus called green mould; it very rarely causes systemic mycosis in humans.", {"entities": [[144, 160, "DISEASE"]]}], ["Here, we report a case of fatal pneumonia due to P. digitatum infection, as confirmed by repeated examination of cultured sputum.", {"entities": [[32, 41, "DISEASE"]]}], ["A cavity was found in the left upper lung on routine chest X-ray in a 78-year-old undernourished male who had been diagnosed at age 66 with bronchial asthma and pulmonary emphysema.", {"entities": [[161, 180, "DISEASE"], [150, 156, "DISEASE"]]}], ["No increased sputum production was present.", {"entities": []}], ["The presence of antigen-specific precipitating antibodies to Aspergillus flavus and P. digitatum was confirmed in the patient\u2019s serum and also later pleural fluid by using Ouchterlony double immunodiffusion testing with A. flavus and P. digitatum antigens.", {"entities": []}], ["The patient was treated over a period of months with itraconazole, micafungin, voriconazole, amphotericin B, and antibacterials.", {"entities": []}], ["However, the cavity enlarged, the pleural effusion increased, and the patient began producing purulent sputum.", {"entities": []}], ["He died from progressive renal failure.", {"entities": []}], ["From sputum culture only one fungus was isolated repeatedly on potato-dextrose agar in large quantities.", {"entities": []}], ["This fungus was confirmed to be P. digitatum by molecular identification.", {"entities": []}], ["Partial sequences of the beta-tubulin gene were determined by using the primers Bt2a and Bt2b for PCR amplification and sequencing and underwent a BLAST search at the National Centre for Biotechnology Information, these results confirmed that the isolated fungus was P. digitatum .", {"entities": []}], ["To our knowledge, this is the first report of pulmonary infection with P. digitatum .", {"entities": []}], ["Our patient had pulmonary emphysema and was elderly, and undernourished.", {"entities": [[16, 35, "DISEASE"]]}], ["These factors might have facilitated the infection.", {"entities": []}], ["In his case, antimycotics were ineffective in treating the lung involvement.", {"entities": []}], ["Although human infection with P. digitatum is considered rare, it appears that this organism can be very virulent and resistant to antimycotics.", {"entities": []}], ["Gumiganghwal-tang is a traditional herbal prescription that is used widely for the treatment of the common cold and inflammatory diseases in Korea and other Asian countries.", {"entities": [[100, 111, "DISEASE"]]}], ["In this study, we investigated the protective effects of a Gumiganghwal-tang aqueous extract (GGTA) against airway inflammation and pulmonary fibrosis using a mouse model of chronic asthma.", {"entities": [[132, 150, "DISEASE"], [182, 188, "DISEASE"]]}], ["Chronic asthma was modeled in BALB/c mice via sensitization/challenge with an intraperitoneal injection of 1% ovalbumin (OVA) and inhalation of nebulized 1% OVA for 4 weeks.", {"entities": [[8, 14, "DISEASE"]]}], ["GGTA (100 mg/kg or 200 mg/kg) was also administered by oral gavage once a day for 4 weeks.", {"entities": []}], ["We investigated the number of inflammatory cells, production of T-helper type 2 (Th2) cytokines, chemokine and the total transforming growth factor-\u03b21 (TGF-\u03b21) in bronchoalveolar lavage fluid (BALF); the levels of immunoglobulin E (IgE) in the plasma; the infiltration of inflammatory cells in lung tissue; and the expression of TGF-\u03b21, Smad-3, and collagen in lung tissue.", {"entities": []}], ["Our results revealed that GGTA lowered the recruitment of inflammatory cells (particularly, lymphocyte); and decreased the production of Th2 cytokines, chemokine and total TGF-\u03b21; and attenuated the levels of total and OVA-specific IgE; and decreased the infiltration of inflammatory cells.", {"entities": []}], ["Moreover, GGTA significantly reduced the expression of TGF-\u03b21 and Smad-3, and lowered collagen deposition.", {"entities": []}], ["These results indicate that GGTA reduces airway inflammation and pulmonary fibrosis by regulating Th2 cytokines production and the TGF-\u03b21/Smad-3 pathway, thus providing a potential treatment for chronic asthma.", {"entities": [[65, 83, "DISEASE"], [203, 209, "DISEASE"]]}], ["Asthma is the most common chronic childhood disease in the developed nations, and is a complex disease that has high social and economic costs.", {"entities": [[0, 6, "DISEASE"]]}], ["Studies of the genetic etiology of asthma offer a way of improving our understanding of its pathogenesis, with the goal of improving preventive strategies, diagnostic tools, and therapies.", {"entities": [[35, 41, "DISEASE"]]}], ["Considerable effort and expense have been expended in attempts to detect specific polymorphisms in genetic loci contributing to asthma susceptibility.", {"entities": [[128, 134, "DISEASE"]]}], ["Concomitantly, the technology for detecting single nucleotide polymorphisms (SNPs) has undergone rapid development, extensive catalogues of SNPs across the genome have been constructed, and SNPs have been increasingly used as a method of investigating the genetic etiology of complex human diseases.", {"entities": []}], ["This paper reviews both current and potential future contributions of SNPs to our understanding of asthma pathophysiology.", {"entities": [[99, 105, "DISEASE"]]}], ["In 2009, an outbreak of respiratory illness caused by influenza A H1N1 virus occurred worldwide.", {"entities": [[54, 63, "DISEASE"]]}], ["Some patients required Intensive Care Unit (ICU) admission.", {"entities": []}], ["The use of non-invasive ventilation (NIV) in these patients is controversial, as the aerosol dispersion may contaminate the environment and health-care co-workers.", {"entities": []}], ["Describe the respiratory profile, the mortality rate, and the benefit of using NIV in patients with confirmed diagnosis of influenza AH1N1 who were admitted in the ICU during the year 2009.", {"entities": [[123, 132, "DISEASE"]]}], ["A total of 1, 401 cases of influenza A H1N1 were confirmed in our hospital by real-time RT-PCR in 2009, and 20 patients were admitted to the ICU.", {"entities": [[27, 36, "DISEASE"]]}], ["The patients' ages ranged from 18 to 74 years (median of 42).", {"entities": []}], ["Acute Respiratory Failure (ARF) was present in 70% of patients.", {"entities": []}], ["The median Acute Physiology and Chronic Health Evaluation II score was 7 (range 7 to 25).", {"entities": []}], ["Of the 14 patients who developed ARF, 85.7% needed NIV and 14% needed invasive MV at admission.", {"entities": []}], ["Our success rate (41.6%) with NIV was higher than that described by others.", {"entities": []}], ["The hospital mortality rate was 2.1%.", {"entities": []}], ["When influenza A H1N1 arrived in Brazil, the disease was already on endemic alert in other countries.", {"entities": [[5, 14, "DISEASE"]]}], ["The population was already aware of the symptoms and the health-care system of the treatment.", {"entities": []}], ["This allowed patients to be properly and promptly treated for influenza A H1N1, while health-care workers took protective measures to avoid contamination.", {"entities": [[62, 71, "DISEASE"]]}], ["In our study we found a high success and low mortality rates with non-invasive ventilation in patients with influenza A H1N1.", {"entities": [[108, 117, "DISEASE"]]}], ["Although cigarette smoking affects all biological systems of the human body including the gastrointestinal tract, there is a lack of evidence regarding its effect on the severity of diarrhoeal disease and whether a dose\u2013response relationship exists.", {"entities": []}], ["We therefore tested for the presence of specific causative pathogens for infectious diarrhoea, assessed the independent effect of smoking on its severity and tested whether any dose\u2013response relationship existed while controlling for subjects\u2019 age, sociodemographic characteristics and presence of causative pathogens in an urban setting in Bangladesh.", {"entities": []}], ["A total of 20,757 patients aged 15\u00a0years and above with diarrhoea were enrolled into the Diarrhoeal Disease Surveillance System, managed by the International Centre for Diarrhoeal Disease Research, Bangladesh, from 1993 to 2012.", {"entities": []}], ["We collected data on individuals\u2019 current daily consumption of cigarettes and bidis (traditional hand-rolled cigarettes) and conducted an ordered logistic regression to determine the effect of smoking on diarrhoeal disease severity and whether a dose\u2013response relationship exists.", {"entities": []}], ["We identified 19\u00a0% of patients with diarrhoea as smokers, of whom 52\u00a0% smoked 1\u20139 cigarettes per day.", {"entities": []}], ["While 97\u00a0% of smokers were male, 41\u00a0% were aged 15\u201330 years of age.", {"entities": []}], ["Smokers were found to have a significantly lower severity of diarrhoeal disease (OR: 0.92, 95\u00a0% CI: 0.85\u20130.99, p\u2009=\u20090.025) after adjusting for age, wealth quintile, illiteracy and the presence of specific causative pathogens ( Vibrio cholerae and Shigella ).", {"entities": []}], ["We observed no dose\u2013response relationship between the number of cigarettes smoked per day and disease severity when adjusting for the same covariates.", {"entities": []}], ["Smokers were more frequently infected with Shigella (7 vs. 6\u00a0%, p\u2009<\u20090.001) and less often with Vibrio cholerae (22 vs. 26\u00a0%, p\u2009<\u20090.001) than their non-smoking counterparts.", {"entities": []}], ["The aetiology and severity of diarrhoeal disease differed between smokers and non-smokers in our sample.", {"entities": []}], ["However, we found no dose\u2013response relationship between disease severity and the number of cigarettes smoked per day.", {"entities": []}], ["The delivery of antipseudomonal antibiotics by inhalation to Pseudomonas aeruginosa -infected subjects with non-cystic fibrosis (CF) bronchiectasis is a logical extension of treatment strategies successfully developed in CF bronchiectasis.", {"entities": [[133, 147, "DISEASE"], [224, 238, "DISEASE"], [112, 127, "DISEASE"]]}], ["Dual release ciprofloxacin for inhalation (DRCFI) contains liposomal ciprofloxacin, formulated to optimise airway antibiotic delivery.", {"entities": []}], ["Phase II, 24-week Australian/New Zealand multicentre, randomised, double-blind, placebo-controlled trial in 42 adult bronchiectasis subjects with \u22652 pulmonary exacerbations in the prior 12\u2005months and ciprofloxacin-sensitive P aeruginosa at screening.", {"entities": [[117, 131, "DISEASE"]]}], ["Subjects received DRCFI or placebo in three treatment cycles of 28\u2005days on/28\u2005days off.", {"entities": []}], ["The primary outcome was change in sputum P aeruginosa bacterial density to the end of treatment cycle 1 (day 28), analysed by modified intention to treat (mITT).", {"entities": []}], ["Key secondary outcomes included safety and time to first pulmonary exacerbation\u2014after reaching the pulmonary exacerbation endpoint subjects discontinued study drug although remained in the study.", {"entities": []}], ["DRCFI resulted in a mean (SD) 4.2 (3.7) log 10 CFU/g reduction in P aeruginosa bacterial density at day 28 (vs \u22120.08 (3.8) with placebo, p=0.002).", {"entities": []}], ["DRCFI treatment delayed time to first pulmonary exacerbation (median 134 vs 58\u2005days, p=0.057 mITT, p=0.046 per protocol).", {"entities": []}], ["DRCFI was well tolerated with a similar incidence of systemic adverse events to the placebo group, but fewer pulmonary adverse events.", {"entities": []}], ["Once-daily inhaled DRCFI demonstrated potent antipseudomonal microbiological efficacy in adults with non-CF bronchiectasis and ciprofloxacin-sensitive P aeruginosa .", {"entities": [[108, 122, "DISEASE"]]}], ["In this modest-sized phase II study, DRCFI was also well tolerated and delayed time to first pulmonary exacerbation in the per protocol population.", {"entities": []}], ["This study assessed the long-term safety and efficacy of tiotropium Respimat, a long-acting inhaled anticholinergic bronchodilator, in asthma, added on to inhaled corticosteroids (ICS) with or without long-acting \u03b2 2 -agonist (LABA).", {"entities": [[135, 141, "DISEASE"]]}], ["285 patients with symptomatic asthma, despite treatment with ICS\u00b1LABA, were randomised 2:2:1 to once-daily tiotropium 5 \u03bcg, tiotropium 2.5 \u03bcg or placebo for 52 weeks (via the Respimat SoftMist inhaler) added on to ICS\u00b1LABA, in a double-blind, placebo-controlled, parallel-group study (NCT01340209).", {"entities": [[30, 36, "DISEASE"]]}], ["Primary objective: to describe the long-term safety profile of tiotropium.", {"entities": []}], ["Secondary end points included: trough forced expiratory volume in 1 second (FEV 1 ) response; peak expiratory flow rate (PEFR) response; seven-question Asthma Control Questionnaire (ACQ-7) score.", {"entities": [[152, 158, "DISEASE"], [76, 79, "GENE"]]}], ["At Week 52, adverse-event (AE) rates with tiotropium 5 \u03bcg, 2.5 \u03bcg and placebo were 88.6%, 86.8% and 89.5%, respectively.", {"entities": []}], ["Commonly reported AEs with tiotropium 5 \u03bcg, 2.5 \u03bcg and placebo were nasopharyngitis (48.2%, 44.7%, 42.1%), asthma (28.9%, 29.8%, 38.6%), decreased PEFR (15.8%, 7.9%, 21.1%), bronchitis (9.6%, 13.2%, 7.0%), pharyngitis (7.9%, 13.2%, 3.5%) and gastroenteritis (10.5%, 3.5%, 5.3%).", {"entities": [[68, 83, "DISEASE"], [242, 257, "DISEASE"], [107, 113, "DISEASE"], [206, 217, "DISEASE"], [174, 184, "DISEASE"]]}], ["In the tiotropium 5 \u03bcg, 2.5 \u03bcg and placebo groups, 8.8%, 5.3% and 5.3% of patients reported drug-related AEs; 3.5%, 3.5% and 15.8% reported serious AEs.", {"entities": []}], ["Asthma worsening was the only serious AE reported in more than one patient.", {"entities": [[0, 6, "DISEASE"]]}], ["At Week 52, adjusted mean trough FEV 1 and trough PEFR responses were significantly higher with tiotropium 5 \u03bcg (but not 2.5 \u03bcg) versus placebo.", {"entities": [[33, 36, "GENE"]]}], ["ACQ-7 responder rates were higher with tiotropium 5 \u03bcg and 2.5 \u03bcg versus placebo at Week 24.", {"entities": []}], ["The long-term tiotropium Respimat safety profile was comparable with that of placebo Respimat, and associated with mild to moderate, non-serious AEs in patients with symptomatic asthma despite ICS\u00b1LABA therapy.", {"entities": [[178, 184, "DISEASE"]]}], ["Compared with placebo, tiotropium 5 \u03bcg, but not 2.5 \u03bcg, significantly improved lung function and symptoms, supporting the long-term efficacy of the 5 \u03bcg dose.", {"entities": []}], ["ClinicalTrials.gov NCT01340209", {"entities": []}], ["Asthma and COPD are characterized by airway dysfunction and inflammation.", {"entities": [[0, 6, "DISEASE"]]}], ["Neutrophilic airway inflammation is a common feature of COPD and is recognized in asthma, particularly in severe disease.", {"entities": [[82, 88, "DISEASE"]]}], ["The T helper (Th) 17 cytokines IL-17A and IL-17F have been implicated in the development of neutrophilic airway inflammation, but their expression in asthma and COPD is uncertain.", {"entities": [[150, 156, "DISEASE"]]}], ["We assessed IL-17A and IL-17F expression in the bronchial submucosa from 30 subjects with asthma, 10 ex-smokers with mild to moderate COPD, and 27 nonsmoking and 14 smoking control subjects.", {"entities": [[90, 96, "DISEASE"]]}], ["Sputum IL-17 concentration was measured in 165 subjects with asthma and 27 with COPD.", {"entities": [[61, 67, "DISEASE"]]}], ["The median (interquartile range) IL-17A cells/mm P = .04).", {"entities": []}], ["In COPD, IL-17A P = .046).", {"entities": []}], ["IL-17F P = .001) but was not increased in subjects with COPD.", {"entities": []}], ["IL-17A and IL-17F were not associated with increased neutrophilic inflammation, but IL-17F was correlated with the submucosal eosinophil count ( r s = 0.5, P = .005).", {"entities": []}], ["The sputum IL-17 concentration in COPD was increased compared with asthma (2 [0-7] pg/mL vs 0 [0-2] pg/mL, P < .0001) and was correlated with post-bronchodilator FEV 1 % predicted ( r = \u22120.5, P = .008) and FEV 1 /FVC ( r = \u22120.4, P = .04).", {"entities": [[67, 73, "DISEASE"], [162, 165, "GENE"], [206, 209, "GENE"], [162, 165, "GENE"], [206, 209, "GENE"]]}], ["Our findings support a potential role for the Th17 cytokines IL-17A and IL-17F in asthma and COPD, but do not demonstrate a relationship with neutrophilic inflammation.", {"entities": [[82, 88, "DISEASE"]]}], ["Arteriovenous (AV) fistulae is an extremely rare disease of vascular malformation that involves fistulae formation between the systemic and pulmonary AV systems.", {"entities": []}], ["This case report describes a rare systemic-pulmonary AV fistulae of congenital origin, accompanied by pulmonary hypertension, as determined by aortic angiography and echocardiography.", {"entities": [[112, 124, "DISEASE"], [102, 124, "DISEASE"]]}], ["Characteristics, diagnosis, and therapeutic approaches of this rare abnormality are explored.", {"entities": []}], ["Several subtypes of APCs are found in psoriasis patients, but their involvement in disease pathogenesis is poorly understood.", {"entities": [[38, 47, "DISEASE"], [20, 24, "GENE"]]}], ["Here, we investigated the contribution of Langerhans cells (LCs) and plasmacytoid DCs (pDCs) in psoriasis.", {"entities": [[96, 105, "DISEASE"]]}], ["In human psoriatic lesions and in a psoriasis mouse model (DKO* mice), LCs are severely reduced, whereas pDCs are increased.", {"entities": [[36, 45, "DISEASE"]]}], ["Depletion of pDCs in DKO* mice prior to psoriasis induction resulted in a milder phenotype, whereas depletion during active disease had no effect.", {"entities": [[40, 49, "DISEASE"]]}], ["In contrast, while depletion of Langerin-expressing APCs before disease onset had no effect, depletion from diseased mice aggravated psoriasis symptoms.", {"entities": [[133, 142, "DISEASE"], [52, 56, "GENE"]]}], ["Disease aggravation was due to the absence of LCs, but not other Langerin-expressing APCs.", {"entities": [[85, 89, "GENE"]]}], ["LCs derived from DKO* mice produced increased IL-10 levels, suggesting an immunosuppressive function.", {"entities": []}], ["Moreover, IL-23 production was high in psoriatic mice and further increased in the absence of LCs.", {"entities": []}], ["Conversely, pDC depletion resulted in reduced IL-23 production, and therapeutic inhibition of IL-23R signaling ameliorated disease symptoms.", {"entities": [[12, 15, "GENE"]]}], ["Therefore, LCs have an anti-inflammatory role during active psoriatic disease, while pDCs exert an instigatory function during disease initiation.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder characterized by incompletely reversible airflow obstruction.", {"entities": []}], ["The complexity of the lung microbial community in COPD patients has been highlighted in recent years.", {"entities": []}], ["Evidence suggests that transplantation, medications, age, and disease severity influence microbial community membership.", {"entities": []}], ["However, the dynamics of the lung microbiome in stable COPD patients remain poorly understood.", {"entities": []}], ["In this study, we completed a longitudinal 16S ribosomal RNA survey of the lung microbiome on replicate sputum samples collected from 4 former smokers with COPD (Stage 2) within a 2-day time period.", {"entities": []}], ["Samples from each individual over the two-day period were similar based on \u03b1-diversity, principle component analysis and taxonomy at the phyla and genera level.", {"entities": []}], ["Sputum samples from COPD patients were also collected between 2\u20139 months of follow-up.", {"entities": []}], ["Data suggest an increased variability of the sputum microbiota when comparing samples collected \u2264 3 months compared to those collected \u2265 4 months; however, no statistically significant shifts in the abundance (>2-fold) of taxa between the two time points was observed.", {"entities": []}], ["Bacterial composition and the number of operational taxonomic units (OTUs) remained similar over time.", {"entities": []}], ["Results from this study suggest that the sputum microbiome is relatively stable in clinically stable COPD patients (Stage 2).", {"entities": []}], ["This study furthers our understanding of the dynamics of the lung microbiome in COPD patients.", {"entities": []}], ["NF-E2 related factor-2 (Nrf2) promotes the transcription of many cytoprotective genes and is a major drug target for prevention of cancer and other diseases.", {"entities": [[131, 137, "DISEASE"]]}], ["Indeed, the cancer-preventive activities of several well-known chemical agents were shown to depend on Nrf2 activation.", {"entities": [[12, 18, "DISEASE"]]}], ["It is well known that chemopreventive Nrf2 activators stabilize Nrf2 by blocking its ubiquitination, but previous studies have indicated that this process occurs exclusively in the cytoplasm.", {"entities": []}], ["Kelch-like ECH-associated protein 1 (Keap1) binds to Nrf2 and orchestrates Nrf2 ubiquitination, and it has been a widely-held view that inhibition of Nrf2 ubiquitination by chemopreventive agents results from the dissociation of Nrf2 from its repressor Keap1.", {"entities": [[37, 42, "GENE"], [253, 258, "GENE"], [37, 42, "GENE"], [253, 258, "GENE"]]}], ["Here, we show that while the activation of Nrf2 by prototypical chemical activators, including 5,6-dihydrocyclopenta-1,2-dithiole-3-thione (CPDT) and sulforaphane (SF), results solely from inhibition of its ubiquitination, such inhibition occurs predominantly in the nucleus.", {"entities": []}], ["Moreover, the Nrf2 activators promote Nrf2 association with Keap1, rather than disassociation, which appears to result from inhibition of Nrf2 phosphorylation at Ser40.", {"entities": [[60, 65, "GENE"]]}], ["Available evidence suggests the Nrf2 activators may block Nrf2 ubiquitination by altering Keap1 conformation via reaction with the thiols of specific Keap1 cysteines.", {"entities": [[90, 95, "GENE"], [150, 155, "GENE"], [90, 95, "GENE"], [150, 155, "GENE"]]}], ["We further show that while the inhibitory effects of CPDT and SF on Nrf2 ubiquitination depend entirely on Keap1, Nrf2 is also degraded by a Keap1-independent mechanism.", {"entities": [[107, 112, "GENE"], [141, 146, "GENE"]]}], ["These findings provide significant new insight about Nrf2 activation and suggest that exogenous chemical activators of Nrf2 enter the nucleus to exert most of their inhibitory impact on Nrf2 ubiquitination and degradation.", {"entities": []}], ["The use of animal products in healing is an ancient and widespread cross-cultural practice.", {"entities": []}], ["In northeastern Brazil, especially in the semi-arid region, animals and plants are widely used in traditional medicine and play significant roles in healing practices.", {"entities": []}], ["Zootherapies form an integral part of these cultures, and information about animals is passed from generation to generation through oral folklore.", {"entities": []}], ["Nevertheless, studies on medicinal animals are still scarce in northeastern Brazil, especially when compared to those focusing on medicinal plants.", {"entities": []}], ["This paper examines the use and commercialization of animals for medicinal purposes in Brazil's semi-arid caatinga region.", {"entities": []}], ["Data was obtained through field surveys conducted in the public markets in the city of Santa Cruz do Capibaribe, Pernambuco State, Brazil.", {"entities": []}], ["We interviewed 16 merchants (9 men and 7 women) who provided information regarding folk remedies based on animal products.", {"entities": []}], ["A total of 37 animal species (29 families), distributed among 7 taxonomic categories were found to be used to treat 51 different ailments.", {"entities": []}], ["The most frequently cited treatments focused on the respiratory system, and were mainly related to problems with asthma.", {"entities": [[113, 119, "DISEASE"]]}], ["Zootherapeutic products are prescribed as single drugs or are mixed with other ingredients.", {"entities": []}], ["Mixtures may include several to many more valuable medicinal animals added to other larger doses of more common medicinal animals and plants.", {"entities": []}], ["The uses of certain medicinal animals are associated with popular local beliefs known as 'simpatias'.", {"entities": []}], ["We identified 2 medicinal species ( Struthio camelus and Nasutitermes macrocephalus ) not previously documented for Brazil.", {"entities": []}], ["The use of animals as remedies in the area surveyed is associated with socio economic and cultural factors.", {"entities": []}], ["Some of the medicinal animal species encountered in this study are included in lists of endangered species.", {"entities": []}], ["Our results demonstrate that a large variety of animals are used in traditional medicinal practices in Brazil's semi-arid northeastern region.", {"entities": []}], ["In addition to the need for pharmacological investigations in order to confirm the efficiency of these folk medicines, the present study emphasizes the importance of establishing conservation priorities and sustainable production of the various medicinal animals used.", {"entities": []}], ["The local fauna, folk culture, and monetary value of these activities are key factors influencing the use and commercialization of animal species for therapeutic purposes.", {"entities": []}], ["Breathlessness debilitates millions of people with chronic illness.", {"entities": []}], ["Mismatch between breathlessness severity and objective disease markers is common and poorly understood.", {"entities": []}], ["Traditionally, sensory perception was conceptualised as a stimulus-response relationship, although this cannot explain how conditioned symptoms may occur in the absence of physiological signals from the lungs or airways.", {"entities": []}], ["A Bayesian model is now proposed, in which the brain generates sensations based on expectations learnt from past experiences (priors), which are then checked against incoming afferent signals.", {"entities": []}], ["In this model, psychological factors may act as moderators.", {"entities": []}], ["They may alter priors, change the relative attention towards incoming sensory information, or alter comparisons between priors and sensations, leading to more variable interpretation of an equivalent afferent input.", {"entities": []}], ["In the present study we conducted a supplementary analysis of previously published data (Hayen et al., 2017).", {"entities": []}], ["We hypothesised that individual differences in psychological traits (anxiety, depression, anxiety sensitivity) would correlate with the variability of subjective perceptions of equivalent breathlessness challenges.", {"entities": []}], ["To better understand the resulting inferential leap in the brain, we explored where these behavioural measures correlated with functional brain activity across subjects.", {"entities": []}], ["Behaviourally, anxiety sensitivity was found to positively correlate with each subject's variability of intensity and unpleasantness during mild breathlessness, and with variability of unpleasantness during strong breathlessness.", {"entities": []}], ["In the brain, anxiety sensitivity was found to negatively correlate with precuneus activity during anticipation, positively correlate with anterior insula activity during mild breathlessness, and negatively correlate with parietal sensorimotor areas during strong breathlessness.", {"entities": []}], ["Our findings suggest that anxiety sensitivity may reduce the robustness of this Bayesian sensory perception system, increasing the variability of breathlessness perception and possibly susceptibility to symptom misinterpretation.", {"entities": []}], ["These preliminary findings in healthy individuals demonstrate how differences in psychological function influence the way we experience bodily sensations, which might direct us towards better understanding of symptom mismatch in clinical populations.", {"entities": []}], ["Gastric cancer incidence demonstrates a strong etiologic association with smoking.", {"entities": [[8, 14, "DISEASE"]]}], ["Nicotine, the major component in tobacco, is a survival agonist that inhibits apoptosis induced by certain chemotherapeutic agents, but the precise mechanisms involved remain largely unknown.", {"entities": []}], ["Recently studies have indicated that \u03b15-nicotinic acetylcholine receptor (\u03b15-nAChR) is highly associated with lung cancer risk and nicotine dependence.", {"entities": [[110, 121, "DISEASE"], [131, 150, "DISEASE"], [115, 121, "DISEASE"]]}], ["Nevertheless, no information has been available about whether nicotine also affects proliferation of human gastric cancer cells through regulation of \u03b15-nAChR.", {"entities": [[115, 121, "DISEASE"]]}], ["To evaluate the hypothesis that \u03b15-nAChR may play a role in gastric cancer, we investigated its expression in gastric cancer tissues and cell lines.", {"entities": [[68, 74, "DISEASE"], [118, 124, "DISEASE"]]}], ["The expression of \u03b15-nAChR increased in gastric cancer tissue compared with para-carcinoma tissues.", {"entities": [[81, 90, "DISEASE"], [48, 54, "DISEASE"]]}], ["In view of the results, we proceeded to investigate whether nicotine inhibits cisplatin-induced apoptosis via regulating \u03b15-nAChR in gastric cancer cell.", {"entities": [[141, 147, "DISEASE"]]}], ["The results showed that nicotine significantly promoted cell proliferation in a dose and time-dependent manner through \u03b15-nAChR activation in human gastric cells.", {"entities": []}], ["Furthermore, nicotine inhibited apoptosis induced by cisplatin.", {"entities": []}], ["Silence of \u03b15-nAChR ablated the protective effects of nicotine.", {"entities": []}], ["However, when co-administrating LY294002, an inhibitor of PI3K/AKT pathway, an increased apoptosis was observed.", {"entities": []}], ["This effect correlated with the induction of Bcl-2, Bax, Survivin and Caspase-3 by nicotine in gastric cell lines.", {"entities": [[52, 55, "GENE"]]}], ["These results suggest that exposure to nicotine might negatively impact the apoptotic potential of chemotherapeutic drugs and that \u03b15-nAChR/AKT signaling plays a key role in the anti-apoptotic activity of nicotine induced by cisplatin.", {"entities": []}], ["Background: Phthalate exposure may increase the risk of asthma.", {"entities": [[56, 62, "DISEASE"]]}], ["Little is known about whether oxidative-stress related genes may alter this association.", {"entities": []}], ["First, this motivated us to investigate whether genetic polymorphisms of the oxidative-stress related genes glutathione S -transferase Mu 1 ( GSTM1 ), glutathione S -transferase pi 1 ( GSTP1 ), superoxide dismutase 2 ( SOD2 ), catalase ( CAT ), myeloperoxidase ( MPO ), and EPHX1 in children are associated with phthalate urine concentrations.", {"entities": [[142, 147, "GENE"], [185, 190, "GENE"], [219, 223, "GENE"], [263, 266, "GENE"], [274, 279, "GENE"]]}], ["Second, we addressed the question whether these genes may affect the influence of phthalates on asthma.", {"entities": [[96, 102, "DISEASE"]]}], ["Methods: In a case-control study composed of 126 asthmatic children and 327 controls, urine phthalate metabolites (monoethyl phthalate (MEP), monobutyl phthalate (MBP), monobenzyl phthalate (MBzP), and mono(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP) were measured by UPLC-MS/MS at age 3.", {"entities": [[163, 166, "GENE"]]}], ["Genetic variants were analyzed by TaqMan assay.", {"entities": []}], ["Information on asthma and environmental exposures was also collected.", {"entities": [[15, 21, "DISEASE"]]}], ["Analyses of variance and logistic regressions were performed.", {"entities": []}], ["Results: Urine MEHHP levels were associated with asthma (adjusted OR 1.33, 95% CI (1.11\u20131.60).", {"entities": [[49, 55, "DISEASE"]]}], ["Children with the GSTP1 (rs1695) AA and SOD2 (rs5746136) TT genotypes had higher MEHHP levels as compared to GG and CC types, respectively.", {"entities": [[18, 23, "GENE"], [40, 44, "GENE"]]}], ["Since only SOD2 TT genotype was significantly associated with asthma (adjusted OR (95% CI): 2.78 (1.54\u20135.02)), we estimated whether SOD2 variants modify the association of MEHHP levels and asthma.", {"entities": [[62, 68, "DISEASE"], [189, 195, "DISEASE"], [11, 15, "GENE"], [132, 136, "GENE"], [11, 15, "GENE"], [132, 136, "GENE"]]}], ["As MEHHP concentrations were dependent on GSTP1 and SOD2 , but the assessment of interaction requires independent variables, we estimated MEHHP residuals and assessed their interaction, showing that the OR for SOD2 TT was further elevated to 3.32 (1.75\u20136.32) when the residuals of MEHHP were high.", {"entities": [[42, 47, "GENE"], [52, 56, "GENE"], [210, 214, "GENE"], [52, 56, "GENE"], [210, 214, "GENE"]]}], ["Conclusions: Urine phthalate metabolite concentrations are associated with oxidative-stress related genetic variants.", {"entities": []}], ["Genetic variants of SOD2 , considered to be reflect oxidative stress metabolisms, might modify the association of phthalate exposure with asthma.", {"entities": [[138, 144, "DISEASE"], [20, 24, "GENE"]]}], ["Fms-like tyrosine kinase 3-ligand (FL) is a growth factor that may expand dendritic cell and regulatory T cell populations.", {"entities": []}], ["We hypothesised that FL-induced regulatory T cells would protect mice from experimental rapidly progressive glomerulonephritis.", {"entities": [[108, 126, "DISEASE"], [88, 126, "DISEASE"]]}], ["To determine if FL was able to enhance regulatory T cell populations, C57BL/6 mice received 10 days of daily intraperitoneal injections of either FL or phosphate buffered saline.", {"entities": []}], ["To induce accelerated autologous-phase anti-mouse glomerular basement membrane glomerulonephritis, mice were sensitized to sheep globulin 4 days prior to the induction of glomerulonephritis with sheep anti-mouse glomerular basement membrane globulin, and experiments ended 10 days later.", {"entities": [[79, 97, "DISEASE"], [171, 189, "DISEASE"]]}], ["FL was administered before, throughout and during the sensitization phase of this glomerulonephritis model.", {"entities": [[82, 100, "DISEASE"]]}], ["Renal disease and systemic immunity to the nephritogenic antigen were assessed.", {"entities": []}], ["FL increased regulatory T cell and plasmacytoid dendritic cell proportions within spleen and lymph nodes.", {"entities": []}], ["FL administration prior to glomerulonephritis did not protect mice from renal injury.", {"entities": [[27, 45, "DISEASE"]]}], ["When FL was given throughout the model, FL treated mice had reduced survival, with more interstitial neutrophils and glomerular CD11c+ cells than controls.", {"entities": []}], ["Systemic immune responses showed increased IL-17A production from splenocytes, with more CD11c+ cells, but reduced plasmacytoid dendritic cell proportions in spleen and lymph nodes, despite increased regulatory T cell proportions.", {"entities": []}], ["Under homeostatic conditions, FL expanded regulatory T cell and plasmacytoid dendritic cell populations, but FL enhanced systemic inflammatory responses and conventional dendritic cell populations when given during experimental glomerulonephritis, suggesting selective attempts to suppress pathogenic immunity by dendritic cell manipulation may be harmful.", {"entities": [[228, 246, "DISEASE"]]}], ["There is a significant treatment gap for patients with depression.", {"entities": []}], ["A third of sufferers never seek help, and the vast majority of those who do only do so after considerable delay.", {"entities": []}], ["Little is understood regarding poor help-seeking rates amongst people with depression, with existing research mainly focussed on the impact of barriers to treatment.", {"entities": []}], ["The current study explored psychological factors affecting help-seeking behaviour in clinically depressed individuals.", {"entities": []}], ["Semi-structured interviews were conducted with 20 current or previously clinically depressed participants who either had or had not sought professional help.", {"entities": []}], ["Thematic analysis was used to analyse results.", {"entities": []}], ["The onset of depressive symptoms created conflict with participants\u2019 identity and personal goals.", {"entities": []}], ["Delays in seeking help were primarily attributed to the desire to protect identity and goals from the threat of depressive symptoms.", {"entities": []}], ["Participants used avoidance strategies to reduce the perceived threat of depressive symptoms on identity.", {"entities": []}], ["These strategies interfered with help-seeking.", {"entities": []}], ["Help-seeking was only undertaken once participants reached a point of acceptance and began to make concessions in their identity and goals, at which time they reduced their use of avoidance.", {"entities": []}], ["Difficulties resolving conflict between identity and depressive symptoms may account for significant delays in seeking help for depression.", {"entities": []}], ["The results have implications for predicting health behaviour and improving treatment uptake for depression, and may inform existing help-seeking models.", {"entities": []}], ["Particulate matter (PM) induces oxidative stress in vivo , leading to adverse health effects.", {"entities": []}], ["Oxidative potential (OP) of PM is increasingly studied as a relevant metric for health impact (instead of PM mass concentration) as much of the ambient particle mass do not contribute to PM toxicity.", {"entities": []}], ["Several assays have been developed to quantify PM oxidative potential and a widely used one is the acellular dithiothreitol (DTT) assay.", {"entities": []}], ["However in such assays, particles are usually extracted with methanol or Milli-Q water which is unrepresentative of physiological conditions.", {"entities": []}], ["For this purpose, OP DTT measurements after simulated lung fluids (SLF) extraction, in order to look at the impact of simulated lung fluid constituents, were compared to Milli-Q water extraction measurements.", {"entities": []}], ["Our major finding is a significant decrease of the OP DTT when the artificial lysosomal fluid (ALF) solution was used.", {"entities": []}], ["Indeed, ligand compounds are present in the SLF solutions and some induce a decrease of the OP when compared to water extraction.", {"entities": []}], ["Our results suggest that the effect of ligands and complexation in lining fluids towards PM contaminants probably has been underestimated and should be investigated further.", {"entities": []}], ["Little is known about the effect of family structure on childhood obesity among US children.", {"entities": [[66, 73, "DISEASE"]]}], ["This study examines the effect of number of parents and number of siblings on children's body mass index and risk of obesity.", {"entities": [[117, 124, "DISEASE"]]}], ["We conducted a secondary data analysis of the Early Childhood Longitudinal Study \u2014 Kindergarten Cohort (ECLS-K), which consists of a nationally representative cohort of children who entered kindergarten during 1998-1999.", {"entities": []}], ["Our analyses included 2 cross-sectional outcomes and 1 longitudinal outcome: body mass index (BMI) calculated from measured height and weight, obesity defined as BMI in the 95th percentile or higher for age and sex, and change in BMI from kindergarten through fifth grade.", {"entities": [[143, 150, "DISEASE"]]}], ["Other things being equal, children living with single mothers were more likely to be obese by fifth grade than were children living with 2 parents (26% vs 22%, P = .05).", {"entities": []}], ["Children with siblings had lower BMI and were less likely to be obese than children without siblings.", {"entities": []}], ["We also found that living with a single mother or no siblings was associated with larger increases in BMI from kindergarten through fifth grade.", {"entities": []}], ["Children from single-mother families and, especially, children with no siblings are at higher risk for obesity than children living with 2 parents and children with siblings.", {"entities": [[103, 110, "DISEASE"]]}], ["These findings highlight the influential role that families play in childhood obesity.", {"entities": [[78, 85, "DISEASE"]]}], ["Additionally, they suggest that health care providers should consider the structure of children's families in discussions with families regarding childhood obesity.", {"entities": [[156, 163, "DISEASE"]]}], ["Treatment with 100\u2009mg/kg and 200\u2009mg/kg body weight of aqueous leaf extract (ALE) of Cardiospermum halicacabum for 30 days produced a significant dose dependent increase in the sperm counts and sperm motility in both caput and cauda regions.", {"entities": []}], ["Further, significant increase in serum testosterone level was evident at all applied doses.", {"entities": []}], ["However, no significant changes in the weight of sex organs were observed.", {"entities": []}], ["Aqueous leaf extract also increased the number of females impregnated, number of implantations, and number of viable fetuses while decreasing the total number of resorption sites in the pregnant females.", {"entities": []}], ["However, the total cholesterol level in the serum remained unchanged and there were no records on renotoxicity; nevertheless ALE exhibited a hepatoprotective effect.", {"entities": []}], ["It was concluded that aqueous leaf extract of Cardiospermum halicacabum enhanced sperm concentration, motility, and testosterone, leading to positive results in fertility.", {"entities": []}], ["Although gastrointestinal (GI), respiratory, and dermal symptoms are common, few studies have conducted concurrent and comparative prospective analyses of risk factors for these 3 morbidity outcomes.", {"entities": []}], ["We used data from a community-based randomized controlled trial among 277 South Australian families to analyze GI (diarrhea, vomiting), respiratory (sore throat, runny nose, cough) and dermal (rash, generalized itch, dermal infection) symptoms.", {"entities": [[115, 123, "DISEASE"]]}], ["Log-binomial regression analysis revealed similar risks of GI (adjusted risk ratio [RR], 1.65; 95% CI, 1.05\u20132.58) and respiratory (RR, 1.68; 95% CI, 1.31\u20132.15) symptoms among childcare/kindergarten attendees.", {"entities": []}], ["Swimming in public pools/spas in the current or previous week was associated with all 3 symptom complexes, conferring similar risk for each (RR for GI: 1.33; 95% CI, 0.99\u20131.77; respiratory: 1.20; 95% CI, 1.04\u20131.38; dermal: 1.41; 95% CI, 1.08\u20131.85).", {"entities": []}], ["Pet ownership was not associated with symptoms.", {"entities": []}], ["Household clustering of GI and respiratory symptoms was common, and clustering of respiratory symptoms correlated with number of individuals per household.", {"entities": []}], ["This simultaneous examination of risk factors for 3 health outcomes yielded new comparative data that are useful for developing prevention strategies.", {"entities": []}], ["Obesity can be linked to disease risks such as diabetes and cardiovascular disorders, but recently, the adipose tissue (AT) macrophage also emerges as actively participating in inflammation and immune function, producing pro- and anti-inflammatory factors.", {"entities": [[0, 7, "DISEASE"]]}], ["Connections between the AT and chronic lung diseases, like emphysema and asthma and a protective role of adipocyte-derived proteins against acute lung injury were suggested.", {"entities": [[73, 79, "DISEASE"]]}], ["In this study we addressed the question, whether a diet challenge increases the inflammatory response in the alveolar and the blood compartment in response to carbon nanoparticles (CNP), as a surrogate for ambient/urban particulate air pollutants.", {"entities": [[181, 184, "GENE"]]}], ["Mice were fed a high caloric carbohydrate-rich (CA) or a fat-rich (HF) diet for six weeks and were compared to mice kept on a purified low fat (LF) diet, respectively.", {"entities": []}], ["Bronchoalveolar lavage (BAL) and blood samples were taken 24 h after intratracheal CNP instillation and checked for cellular and molecular markers of inflammation.", {"entities": [[83, 86, "GENE"]]}], ["The high caloric diets resulted in distinct effects when compared with LF mice, respectively: CA resulted in increased body and fat mass without affecting blood cellular immunity.", {"entities": []}], ["Conversely, HF activated the blood system, increasing lymphocyte and neutrophil counts, and resulted in slightly increased body fat content.", {"entities": []}], ["In contrast to higher pro-inflammatory BAL Leptin in CA and HF mice, on a cellular level, both diets did not lead to an increased pro-inflammatory basal status in the alveolar compartment per se, nor did result in differences in the particle-triggered response.", {"entities": []}], ["However both diets resulted in a disturbance of the alveolar capillary barrier as indicated by enhanced BAL protein and lactate-dehydrogenase concentrations.", {"entities": []}], ["Systemically, reduced serum Adiponectin in HF mice might be related to the observed white blood cell increase.", {"entities": []}], ["The increase in BAL pro-inflammatory factors in high caloric groups and reductions in serum concentrations of anti-inflammatory factors in HF mice, clearly show diet-specific effects, pointing towards augmented systemic inflammatory conditions.", {"entities": []}], ["Our data suggest that extended feeding periods, leading to manifest obesity, are necessary to generate an increased susceptibility to particle-induced lung inflammation; although the diet-challenge already was efficient in driving pro-inflammatory systemic events.", {"entities": [[68, 75, "DISEASE"]]}], ["CCL24 is one chemotactic factor extensively studied in airway inflammation and colorectal cancer but less studied in hepatocellular carcinoma (HCC) retrospectively.", {"entities": [[117, 141, "DISEASE"], [79, 96, "DISEASE"], [132, 141, "DISEASE"], [90, 96, "DISEASE"], [0, 5, "GENE"]]}], ["So HCC tissue microarray (TMA) was used to estimate relationship between CCL24 and prognosis, cell experiments were conducted to study its influence for HCC cell biological behavior.", {"entities": [[73, 78, "GENE"]]}], ["CCL24 was injected to nude mice to monitor tumor formation and pulmonary metastasis; qRT-PCR, western blot and Immunohistochemistry were used to explore potential mechanism.", {"entities": [[0, 5, "GENE"]]}], ["CCL24 plays roles in target cells via its downstream CCR3, or it is regulated by Type 2 helper T cells (Th2 cell) factors, so immune related experiments were conducted.", {"entities": [[0, 5, "GENE"], [53, 57, "GENE"]]}], ["Meanwhile, Rho GTPase family have close relation not only with T cell priming, but with neovascularization; CCL24 contributes to neovascularization in age-related macular degeneration via CCR3, so Rho GTPase family, Th2 cell factors, Human Umbilical Vein Endothelial Cells were used to uncover their trafficking.", {"entities": [[163, 183, "DISEASE"], [108, 113, "GENE"], [188, 192, "GENE"]]}], ["Ultimate validation was confirmed by small interfering RNA.", {"entities": []}], ["Results showed CCL24 expression was higher in caner tissues than adjacent normal tissues, it could contribute to proliferation, migration, and invasion in HCCs, could accelerate pulmonary metastasis, promote HUVECs tube formation.", {"entities": [[15, 20, "GENE"], [155, 159, "GENE"]]}], ["Th2 cell factors were irrelevant with CCL24 in HCCs; and RhoB, VEGFA, and VEGFR2 correlated with CCL24 in both mRNA and protein level.", {"entities": [[38, 43, "GENE"], [97, 102, "GENE"], [47, 51, "GENE"], [57, 61, "GENE"], [63, 68, "GENE"], [38, 43, "GENE"], [97, 102, "GENE"]]}], ["Downstream RhoB-VEGFA signaling pathway was validated by siRhoB and siVEGFA inhibition.", {"entities": []}], ["In a word, CCL24 contributes to HCC malignancy via RhoB-VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis, which urges us to study further CCL24 effects on diagnosis and potential therapy for HCC.", {"entities": [[11, 16, "GENE"], [152, 157, "GENE"], [11, 16, "GENE"], [152, 157, "GENE"]]}], ["Chronic obstructive pulmonary disease (COPD) is currently the third most common cause of death in the world.", {"entities": []}], ["Patients with COPD experience airflow obstruction, weight loss, skeletal muscle dysfunction, and comorbidities.", {"entities": []}], ["Anthropometric indicators are risk factors for mortality in geriatric assessment.", {"entities": []}], ["This study examined and compared the associations of anthropometric indicators, such as low body mass index (BMI), low mid-arm circumference (MAC), and low calf circumference (CC), with the prediction of a 3-year follow-up mortality risk in patients with COPD.", {"entities": []}], ["We recruited nonhospitalized patients with COPD without acute conditions from a general hospital in Taiwan.", {"entities": []}], ["The BMI, MAC, and CC of all patients were measured, and they were followed for 3 years through telephone interviews and chart reviews.", {"entities": []}], ["The Kaplan\u2013Meier survival curves stratified by BMI, MAC, and CC were analyzed.", {"entities": []}], ["Variables univariately associated with survival were entered into a multivariate Cox regression model.", {"entities": []}], ["The Bayesian information criterion was used to compare the predictive ability of the three anthropometric indicators to predict mortality rate.", {"entities": []}], ["In total, 104 patients were included (mean \u00b1 standard deviation age, 74.2\u00b16.9 years; forced expiratory volume in 1 second [%], 58.4\u00b120.4 predicted; males, 94.2%); 22 patients (21.2%) died during the 36-month follow-up.", {"entities": []}], ["During this long-term follow-up, the three anthropometric indicators could predict mortality risk in patients with COPD (low BMI [<21 kg/m Among the three anthropometric variables examined, CC can be considered a strong predictor of mortality risk in patients with COPD.", {"entities": []}], ["Health information is increasingly being disseminated online, but there is a knowledge gap between Latinos and non-Hispanic whites, particularly those whose English language proficiency is poor, in terms both of online health information-seeking behavior and computer literacy skills.", {"entities": []}], ["This knowledge gap may also exist between US- and foreign-born Latinos.", {"entities": []}], ["The specific aim of this study was to examine Internet use, online health information-seeking behavior, and confidence in filling out online forms among Latinos, particularly as it relates to health-risk behaviors.", {"entities": []}], ["We then stratified our sample by nativity.", {"entities": []}], ["We used the adult population file of the 2011-2012 California Health Interview Survey, analyzing Internet use, online health information-seeking behavior, and confidence in filling out online forms using binary logistic regression among Latinos and whites (N=27,289), Latinos (n=9506), and Latinos who use the Internet (n=6037).", {"entities": []}], ["Foreign-born Latinos (OR 0.71, 95% CI 0.58-0.88, P =.002) have lower odds of engaging in online health information-seeking behavior, and higher odds (OR 2.90, 95% CI 2.07-4.06, P <.001) of reporting a lack of confidence in filling out online forms compared to US-born Latinos.", {"entities": []}], ["Correlates of online health information-seeking behavior and form confidence varied by nativity.", {"entities": []}], ["Latinos, particularly foreign-born individuals, are at an increased risk of being left behind as the move to increase online content delivery and care expands.", {"entities": []}], ["As online health information dissemination and online health portals become more popular, the impact of these sites on Latino gaps in coverage and care should be considered.", {"entities": []}], ["Since the global financial crisis, UK NHS spending has reduced considerably.", {"entities": [[38, 41, "GENE"]]}], ["Respiratory care is a large cost driver for Betsi Cadwaladr University Health Board, the largest health board in Wales.", {"entities": []}], ["Under the remit of \u2018prudent healthcare\u2019 championed by the Welsh Health Minister, a Programme Budgeting Marginal Analysis (PBMA) of the North Wales respiratory care pathway was conducted.", {"entities": []}], ["A PBMA panel of directors of medicines management, therapies finance, planning, public health and healthcare professionals used electronic voting to establish criteria for decision-making and vote on candidate interventions in which to disinvest and invest.", {"entities": []}], ["A sum of \u00a386.9 million was spent on respiratory care in 2012\u201313.", {"entities": []}], ["Following extensive discussion of 13 proposed candidate interventions facilitated by a chairperson, 4 candidates received recommendations to disinvest, 7 to invest and 2 to maintain current activity.", {"entities": []}], ["Marginal analysis prioritized mucolytics and high antibiotic prescribing as areas for disinvestment, and medicines waste management and pulmonary rehabilitation for investment.", {"entities": []}], ["This exercise demonstrates the potential for health boards to use evidence-based approaches to reach potentially controversial disinvestment and investment decisions.", {"entities": []}], ["Initial progress has begun with communication from the Medical Director in relation to the disinvestment in mucolytics prescribing and possible redirection of funding options being explored.", {"entities": []}], ["Over 9 million new active tuberculosis (TB) cases emerge each year from an enormous pool of 2 billion individuals latently infected with Mycobacterium tuberculosis ( M .", {"entities": [[26, 38, "DISEASE"], [151, 163, "DISEASE"]]}], ["About 3 million new TB cases per year are unaccounted for, and 1.5 million die.", {"entities": []}], ["TB, however, is generally curable if diagnosed correctly and in a timely manner.", {"entities": []}], ["The current diagnostic methods for TB, including state-of-the-art molecular tests, have failed in delivering the capacity needed in endemic countries to curtail this ongoing pandemic.", {"entities": []}], ["Efficient, cost effective and scalable diagnostic approaches are critically needed.", {"entities": []}], ["We report a multiplex TB serology panel using microbead suspension array containing a combination of 11 M .", {"entities": []}], ["antigens that demonstrated overall sensitivity of 91% in serum/plasma samples from TB patients confirmed by culture.", {"entities": []}], ["Group wise sensitivities for sputum smear positive and negative patients were 95%, and 88%, respectively.", {"entities": []}], ["Specificity of the test was 96% in untreated COPD patients and 91% in general healthy population.", {"entities": []}], ["The sensitivity of this test is superior to that of the frontline sputum smear test with a comparable specificity (30\u201370%, and 93\u201399%, respectively).", {"entities": []}], ["The multiplex serology test can be performed with scalability from 1 to 360 patients per day, and is amenable to automation for higher (1000s per day) throughput, thus enabling a scalable clinical work flow model for TB endemic countries.", {"entities": []}], ["Taken together, the above results suggest that well defined antibody profiles in blood, analyzed by an appropriate technology platform, offer a valuable approach to TB diagnostics in endemic countries.", {"entities": []}], ["Studies have explored the risk for and impact of respiratory syncytial virus (RSV) infection requiring hospitalization among healthy preterm infants born at 29\u201335 weeks of gestational age not given RSV immunoprophylaxis.", {"entities": []}], ["We performed a systematic review and qualitative synthesis of these studies.", {"entities": []}], ["Two experienced reviewers used prespecified inclusion/exclusion criteria to screen titles/abstracts and full-text studies using MEDLINE, Embase, BIOSIS and Cochrane Library (January 1, 1985, to November 6, 2014).", {"entities": []}], ["We abstracted data on risk factors for RSV hospitalization, incidence and short- and long-term outcomes of RSV hospitalization.", {"entities": []}], ["Using standard procedures, we assessed study risk of bias and graded strength of evidence (SOE).", {"entities": []}], ["We identified 4754 records and reviewed 27.", {"entities": []}], ["Important risk factors for RSV hospitalization included young age during the RSV season, having school-age siblings and day-care attendance, with odds ratios >2.5 in at least one study (high SOE).", {"entities": []}], ["Incidence rates for RSV hospitalizations ranged from 2.3% to 10% (low SOE).", {"entities": []}], ["Length of hospital stays ranged from 3.8 to 6.1 days (low SOE).", {"entities": []}], ["Recurrent wheezing rates ranged from 20.7% to 42.8% 1 to 2 years after RSV hospitalization (low SOE).", {"entities": []}], ["Young chronological age and some environmental risk factors are important clinical indicators of an increased risk of RSV hospitalization in healthy preterm infants 32 to 35 weeks of gestational age.", {"entities": []}], ["SOE was low for estimates of incidence of RSV hospitalizations, in-hospital resource use and recurrent wheezing in this population.", {"entities": []}], ["Studies were inconsistent in study characteristics, including weeks of gestational age, age during RSV season and control for confounding factors.", {"entities": []}], ["Lung cancer is a leading cause of cancer-related deaths worldwide.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"], [34, 40, "DISEASE"]]}], ["Lung cancer risk factors, including smoking and exposure to environmental carcinogens, have been linked to chronic inflammation.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"]]}], ["An integral feature of inflammation is the activation, expansion and infiltration of diverse immune cell types, including CD4 In the context of lung cancer, evidence suggests that Tregs promote metastasis and metastatic tumor foci development.", {"entities": [[144, 155, "DISEASE"], [149, 155, "DISEASE"], [122, 125, "GENE"]]}], ["Additionally, Th17 cells have been shown to be an integral component of the inflammatory milieu in the tumor microenvironment, and potentially involved in promoting distinct lung tumor phenotypes.", {"entities": []}], ["Studies have shown that the composition of Tregs and Th17 cells are altered in the tumor microenvironment, and that these two CD4 We review current knowledge on the influence of Treg and Th17 cells on lung cancer tumorigenesis, progression, metastasis and prognosis.", {"entities": [[201, 212, "DISEASE"], [206, 212, "DISEASE"], [126, 129, "GENE"]]}], ["Furthermore, we discuss the potential biological and clinical implications of the balance among Treg/Th17 cells in the context of the lung tumor microenvironment and highlight the potential prognostic function and relationship to metastasis in lung cancer.", {"entities": [[244, 255, "DISEASE"], [249, 255, "DISEASE"]]}], ["In order to find an explanation for corticosteroid resistance we assessed whether inhibition by dexamethasone (DEX) of the stimulated production of TNF-\u221d, IL-6, PGE 2 and LTB 4 by peripheral blood mononuclear cells (MNC) depends on binding to the glucocorticoid receptor (GR), and whether it is determined by the number or the affinity of the GR of these cells.", {"entities": [[171, 174, "GENE"]]}], ["GR number and affinity of MNC were determined by means of a whole cell DEX binding assay.", {"entities": []}], ["MNC were incubated with DEX and LPS or A23187 in the absence or presence of RU486, a potent steroid antagonist.", {"entities": []}], ["DEX caused a concentration dependent inhibition of TNF-\u221d, IL-6 and PGE 2 production but had no effect on LTB 4 production.", {"entities": [[105, 108, "GENE"]]}], ["RU486 significantly blocked the effect of DEX, but no correlations were found between the inhibition of mediator release and the K d or receptor number.", {"entities": []}], ["Oxygen desaturation during exercise is common in people with chronic obstructive pulmonary disease (COPD).", {"entities": [[61, 98, "DISEASE"]]}], ["The aim of the study is to determine, in people with COPD who desaturate during exercise, whether supplemental oxygen during an eight-week exercise training program is more effective than medical air (sham intervention) in improving exercise capacity and health-related quality of life both at the completion of training and at six-month follow up.", {"entities": []}], ["This is a multi-centre randomised controlled trial with concealed allocation, blinding of participants, exercise trainers and assessors, and intention-to-treat analysis.", {"entities": []}], ["110 people with chronic obstructive pulmonary disease who demonstrate oxygen desaturation lower than 90 % during the six-minute walk test will be recruited from pulmonary rehabilitation programs in seven teaching hospitals in Australia.", {"entities": [[16, 53, "DISEASE"]]}], ["People with chronic obstructive pulmonary disease on long term oxygen therapy will be excluded.", {"entities": [[12, 49, "DISEASE"]]}], ["After confirmation of eligibility and baseline assessment, participants will be randomised to receive either supplemental oxygen or medical air during an eight-week supervised treadmill and cycle exercise training program, three times per week for eight weeks, in hospital outpatient settings.", {"entities": []}], ["Primary outcome measures will be endurance walking capacity assessed by the endurance shuttle walk test and health-related quality of life assessed by the Chronic Respiratory Disease Questionnaire.", {"entities": []}], ["Secondary outcomes will include peak walking capacity measured by the incremental shuttle walk test, dyspnoea via the Dyspnoea-12 questionnaire and physical activity levels measured over seven days using an activity monitor.", {"entities": []}], ["All outcomes will be measured at baseline, completion of training and at six-month follow up.", {"entities": []}], ["Exercise training is an essential component of pulmonary rehabilitation for people with COPD.", {"entities": []}], ["This study will determine whether supplemental oxygen during exercise training is more effective than medical air in improving exercise capacity and health-related quality of life in people with COPD who desaturate during exercise.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry ACTRN12612000395831 , 5th Jan,2012", {"entities": []}], ["Placebo groups are used in randomised clinical trials (RCTs) to control for placebo effects, which can be large.", {"entities": []}], ["Participants in trials can misunderstand written information particularly regarding technical aspects of trial design such as randomisation; the adequacy of written information about placebos has not been explored.", {"entities": []}], ["We aimed to identify what participants in major RCTs in the UK are told about placebos and their effects.", {"entities": []}], ["We conducted a content analysis of 45 Participant Information Leaflets (PILs) using quantitative and qualitative methodologies.", {"entities": []}], ["PILs were obtained from trials on a major registry of current UK clinical trials (the UKCRN database).", {"entities": []}], ["Eligible leaflets were received from 44 non-commercial trials but only 1 commercial trial.", {"entities": []}], ["The main limitation is the low response rate (13.5%), but characteristics of included trials were broadly representative of all non-commercial trials on the database.", {"entities": []}], ["84% of PILs were for trials with 50\u223650 randomisation ratios yet in almost every comparison the target treatments were prioritized over the placebos.", {"entities": []}], ["Placebos were referred to significantly less frequently than target treatments (7 vs. 27 mentions, p<001) and were significantly less likely than target treatments to be described as triggering either beneficial effects (1 vs. 45, p<001) or adverse effects (4 vs. 39, p<001).", {"entities": []}], ["8 PILs (18%) explicitly stated that the placebo treatment was either undesirable or ineffective.", {"entities": []}], ["PILs from recent high quality clinical trials emphasise the benefits and adverse effects of the target treatment, while largely ignoring the possible effects of the placebo.", {"entities": []}], ["Thus they provide incomplete and at times inaccurate information about placebos.", {"entities": []}], ["Trial participants should be more fully informed about the health changes that they might experience from a placebo.", {"entities": []}], ["To do otherwise jeopardises informed consent and is inconsistent with not only the science of placebos but also the fundamental rationale underpinning placebo controlled trials.", {"entities": []}], ["Asthma is a heterogeneous disease characterized by symptoms of chronic inflammation and airway structural and functional changes.", {"entities": [[0, 6, "DISEASE"]]}], ["It affects about 300 million people worldwide and causes 250 000 deaths annually, but its symptoms can be greatly relieved by regular use of inhaled glucocorticoids (GCs).", {"entities": []}], ["GCs exert their function through interacting with glucocorticoid receptors (GRs).", {"entities": []}], ["Diosgenin is a naturally occurring steroidal saponin abundantly present in many medicinal plants, including Dioscorea nipponica , which shares a similar steroidal structure with GC.", {"entities": [[178, 180, "GENE"]]}], ["In this study, ovalbumin (OVA)-induced asthmatic mice and primary tracheal epithelial cells (TECs) were used as research models.", {"entities": []}], ["ELISAs were applied to measure the secretion of TNF-\u03b1, IL-1\u03b2, and IL-6, while quantitative PCR and western blotting were applied to evaluate expression of GRs SLPI, TTP, GILZ, MKP-1, and NF-\u03baB.", {"entities": [[159, 163, "GENE"]]}], ["Our data demonstrated that diosgenin suppressed the secretion of TNF-\u03b1, IL-1\u03b2, and IL-6 by enhancing the expression of GRs, SLPI, GILZ, and MKP-1, and inhibiting the expression of HSP70.", {"entities": [[124, 128, "GENE"]]}], ["These data provide some evidence on the molecular mechanism of diosgenin, which might facilitate its clinical applications.", {"entities": []}], ["The indications for rigid bronchoscopy for interventional pulmonology have increased and include stent placements and transbronchial cryobiopsy procedures.", {"entities": []}], ["The shared airway between anesthesiologist and pulmonologist and the open airway system, requiring specific ventilation techniques such as jet ventilation, need a good understanding of the procedure to reduce potentially harmful complications.", {"entities": []}], ["Appropriate adjustment of the ventilator settings including pause pressure and peak inspiratory pressure reduces the risk of barotrauma.", {"entities": []}], ["High frequency jet ventilation allows adequate oxygenation and carbon dioxide removal even in cases of tracheal stenosis up to frequencies of around 150\u2009min", {"entities": [[103, 120, "DISEASE"]]}], ["Epigenetics is defined as mitotically heritable changes in gene expression that do not directly alter the DNA sequence.", {"entities": []}], ["By implication, such epigenetic changes are non-genetically determined, although they can be affected by inherited genetic variation.", {"entities": []}], ["Extensive evidence indicates that autoimmune diseases including type 1 diabetes are determined by the interaction of genetic and non-genetic factors.", {"entities": []}], ["Much is known of the genetic causes of these diseases, but the non-genetic effects are less clear-cut.", {"entities": []}], ["Further, it remains unclear how they interact to cause the destructive autoimmune process.", {"entities": []}], ["This review identifies the key issues in the genetic/non-genetic interaction, examining the most recent evidence of the role of non-genetic effects in the disease process, including the impact of epigenetic effects on key pathways.", {"entities": []}], ["Recent research indicates that these pathways likely involve immune effector cells both of the innate and adaptive immune response.", {"entities": []}], ["Specifically, there is evidence of cell type-specific enrichment in altered DNA methylation, changes which were temporally stable and enriched at gene regulatory elements.", {"entities": []}], ["Epigenomics remains in its infancy, and we anticipate further studies will define how the interaction of genetic and non-genetic effects induces tissue-specific destruction and enhances our ability to predict, and possibly even modify that process.", {"entities": []}], ["Irreversible airway obstruction (IAO) is a subtype of asthma and relates to poorer prognosis in some asthma patients.", {"entities": [[54, 60, "DISEASE"], [101, 107, "DISEASE"]]}], ["However, the prevalence and risk factors for IAO are unknown.", {"entities": []}], ["A systematic review regarding controlled clinical studies (cohort, case-control studies) on IAO asthma in adult and/or children affected by asthma/early wheeze was performed.", {"entities": [[96, 102, "DISEASE"], [140, 146, "DISEASE"]]}], ["Eighteen papers were identified in this study.", {"entities": []}], ["It was reported that the incidence of IAO at random effects or fixed effects in severe asthma and nonsevere asthma was 0.54 (95% CI: 0.45\u20130.62) and 0.16 (95% CI: 0.12\u20130.20), respectively.", {"entities": [[87, 93, "DISEASE"], [108, 114, "DISEASE"]]}], ["In IAO asthma, the pooled odds ratio (OR) related to smoking exposure was 2.22 (95% CI: 1.82\u20132.73), the OR for male, smoking, and fractional exhaled nitric oxide (FENO) was 2.22 (95% CI: 1.82\u20132.7), 1.79 (95% CI: 1.46\u20132.19), and 2.16 (95% CI: 1.05\u20134.43), respectively, suggesting these factors increase the risk of IAO.", {"entities": [[7, 13, "DISEASE"]]}], ["However, a decreased OR in IAO asthma was observed due to rhinitis (OR = 0.31, 95% CI: 0.24\u20130.40), atopy (OR = 0.584, 95% CI: 0.466\u20130.732), and atopic dermatitis (OR = 0.60, 95% CI: 0.42\u20130.85), indicating these factors are associated with reduced risk of IAO.", {"entities": [[144, 161, "DISEASE"], [58, 66, "DISEASE"], [31, 37, "DISEASE"], [151, 161, "DISEASE"]]}], ["IAO in asthma is associated with gender, smoking, FENO, rhinitis, atopy, and atopic dermatitis.", {"entities": [[77, 94, "DISEASE"], [56, 64, "DISEASE"], [7, 13, "DISEASE"], [84, 94, "DISEASE"]]}], ["The aim of the study was to compare visualisation of the surgically relevant anatomical structures via low- and standard-dose multidetector CT protocol in patients with chronic rhinosinusitis (CRS) and higher risk for perioperative complications (i.e.", {"entities": []}], ["presence of bronchial asthma, history of sinus surgery and advanced nasal polyposis).", {"entities": [[22, 28, "DISEASE"]]}], ["135 adult CRS patients were divided randomly into standard-dose (120\u00a0kVp, 100\u00a0mAs) or low-dose CT groups (120\u00a0kVp, 45\u00a0mAs).", {"entities": []}], ["The detectability of the vital anatomical structures (anterior ethmoid artery, optic nerve, cribriform plate and lamina papyracea) was scored using a five-point scale (from excellent to unacceptable) by a radiologist and sinus surgeon.", {"entities": []}], ["Polyp sizes were quantified endoscopically according to the Lildholdt\u2019s scale (LS).", {"entities": []}], ["Olfactory function was tested with the \u201cSniffin\u2019 Sticks\u201d test.", {"entities": []}], ["On the low-dose CT images, detectability ranged from 2.42 (better than poor) for cribriform plate among anosmic cases to 4.11 (better than good) for lamina papyracea in cases without nasal polyps.", {"entities": []}], ["Identification of lamina papyracea on low-dose scans was significantly worse in each group and the same was the case with cribriform plates in patients with advanced polyposis and anosmia.", {"entities": []}], ["Cribriform plates were the most poorly identified (between poor and average) among all the structures on low-dose images.", {"entities": []}], ["Identification of anterior ethmoid artery (AEA) with reduced dose was insignificantly worse than with standard-dose examination.", {"entities": []}], ["The AEA was scored as an average-defined structure and was the second weakest visualised.", {"entities": []}], ["In conclusion, preoperatively, low-dose protocols may not sufficiently visualise the surgically relevant anatomical structures in patients with CRS and bronchial asthma, advanced nasal polyps (LS\u00a0>\u00a02) and history of sinus surgery.", {"entities": [[162, 168, "DISEASE"]]}], ["Low mAs value enables comparable detectability of sinonasal landmarks with standard-dose protocols in patients without analysed risk factors.", {"entities": []}], ["In the context of planned surgery, the current preferences of the tube should be carefully evaluated for different patient constitutions to minimise the risk of complications.", {"entities": []}], ["Trichotillomania is considered a behavioral disorder and is characterized by the recurring habit of pulling one's hair, resulting in secondary alopecia.", {"entities": [[0, 16, "DISEASE"], [143, 151, "DISEASE"]]}], ["It affects 1% of the adult population, and 2 to 4.4% of psychiatric patients meet the diagnostic criteria.", {"entities": []}], ["It can occur at any age and is more prevalent in adolescents and females.", {"entities": []}], ["Its occurrence in childhood is not uncommon and tends to have a more favorable clinical course.", {"entities": []}], ["The scalp, eyebrows and eyelashes are the most commonly affected sites.", {"entities": []}], ["Glutamate modulating agents, such as N-acetylcysteine, have been shown to be a promising treatment.", {"entities": []}], ["N-acetylcysteine acts by reducing oxidative stress and normalizing glutaminergic transmission.", {"entities": []}], ["In this paper, we report a case of trichotillomania with an excellent response to N-acetylcysteine.", {"entities": [[35, 51, "DISEASE"]]}], ["Dendritic Cells (DC) represent a key lung immune cell population, which play a critical role in the antigen presenting process and initiation of the adaptive immune response.", {"entities": []}], ["The study of DCs has largely benefited from the joint development of fluorescence microscopy and knock-in technology, leading to several mouse strains with constitutively labeled DC subsets.", {"entities": []}], ["However, in the lung most transgenic mice do express fluorescent protein not only in DCs, but also in closely related cell lineages such as monocytes and macrophages.", {"entities": []}], ["As an example, in the lungs of CX 3 CR1", {"entities": [[36, 39, "GENE"]]}], ["The aim of the present study was to compare, during the pollen season, serum levels of total IgE and soluble CD23 (sCD23) from patients with allergic bronchial asthma, with those from healthy subjects.", {"entities": [[160, 166, "DISEASE"]]}], ["Significantly higher levels of total IgE and sCD23 were found in patients with asthma compared to the control group.", {"entities": [[79, 85, "DISEASE"]]}], ["Both in normal controls and in asthmatic patients, a significant correlation was shown between the levels of these two molecules.", {"entities": []}], ["In asthmatic patients, significant correlations were found for both total IgE and sCD23, with lung function measured as bronchial responsiveness to inhaled methacholine.", {"entities": []}], ["These results suggest that in asthmatic patients, in addition to the study of total serum IgE levels, the assessment of sCD23 serum levels may be helpful in the evaluation of disease activity.", {"entities": []}], ["Toll-like receptor (TLR) agonists reportedly have potent antiviral and antitumor activities and may be a new kind of adjuvant for enhancing immune efficacy.", {"entities": []}], ["Resiquimod (R848) is an imidazoquinoline compound with potent antiviral activity and functions through the TLR7/TLR8 MyD88-dependent signaling pathway.", {"entities": []}], ["Polyinosinic-polycytidylic acid [poly(I:C)] is a synthetic analog of double-stranded RNA that induces the production of pro-inflammatory cytokines by the activation of NF-\u03baB\u00a0through TLR3.", {"entities": [[182, 186, "GENE"]]}], ["This study investigated the potential of R848 and poly(I:C) as an adjuvant 146S foot-and-mouth disease virus (FMDV) vaccine formulated with aluminum hydroxide (Al(OH) 3 ).", {"entities": [[89, 102, "DISEASE"]]}], ["Antibody titers to FMDV and CD8 3 \u2009+\u2009R848\u2009+\u2009poly(I:C) compared with mice immunized to FMDV\u2009+\u2009ISA206.", {"entities": []}], ["IFN-\u03b3 secretion substantially increased compared with IL-4 secretion by splenic T cells stimulated with FMDV antigens in vitro, suggesting that R848, poly(I:C), and with Al(OH) 3 together biased the immune response toward a Th1-type direction.", {"entities": []}], ["These results indicated that the R848 and poly(I:C) together with Al(OH) 3 enhanced humoral and cellular immune responses to immunization with 146S\u00a0FMDV antigens.", {"entities": []}], ["Thus, this new vaccine formulation can be used for FMDV prevention.", {"entities": []}], ["Currently available long-acting inhaled bronchodilators (tiotropium, salmeterol, formoterol) have demonstrated beneficial effects on exacerbations in placebo-controlled trials.", {"entities": []}], ["However, there have been no direct comparisons of these drugs with exacerbations as the primary outcome and consequently COPD treatment guidelines do not indicate a preference for either bronchodilator.", {"entities": []}], ["Therefore, an international, randomized, double-blind, double-dummy, parallel-group clinical trial has been designed to investigate the comparative efficacy of 2 long-acting bronchodilators tiotropium 18 \u03bcg daily and salmeterol 50 \u03bcg bid on exacerbations.", {"entities": []}], ["The trial will include at least 6800 randomized patients with diagnosis of COPD, \u2265 10 pack-year history of smoking, post-bronchodilator FEV 1 \u2264 70% predicted, and a history of exacerbations in the previous year.", {"entities": [[136, 139, "GENE"]]}], ["The primary endpoint is time to first COPD exacerbation.", {"entities": []}], ["Secondary endpoints include number of exacerbations and time to premature discontinuation of trial medication.", {"entities": []}], ["The trial has been designed to address several of the challenges in studying exacerbations in a controlled trial by a symptom and event-based definition of exacerbations, frequent follow-up contacts, selection of time to first event as the primary endpoint and using exposure adjusted analysis when examining number of events.", {"entities": []}], ["Other challenges in designing exacerbation trials such as differential discontinuation and follow-up of discontinued patients are discussed.", {"entities": []}], ["Inhaled budesonide is a novel approach to prevent acute mountain sickness (AMS).", {"entities": []}], ["However, its mechanism is not completely understood.", {"entities": []}], ["We aimed to investigate the effects of budesonide and dexamethasone on renin\u2013angiotensin\u2013aldosterone system in AMS prevention.", {"entities": []}], ["Data were obtained from a randomised controlled trial including 138 participants.", {"entities": []}], ["The participants were randomly assigned to receive budesonide, dexamethasone or placebo as prophylaxis before they travelled to 3450 m altitude from 400 m by car.", {"entities": []}], ["Their plasma concentrations of renin, angiotensin-converting enzyme (ACE) and aldosterone were measured at both altitudes.", {"entities": []}], ["All parameters were comparable among the three groups at 400 m. After high-altitude exposure of 3450, renin in all groups increased significantly; the ACE, aldosterone concentrations, as well as the aldosterone/renin ratio, rose markedly in the dexamethasone and placebo groups but not in the budesonide group.", {"entities": []}], ["Moreover, the aldosterone/renin ratio correlated closely with ACE concentration.", {"entities": []}], ["Upon acute high-altitude exposure, budesonide, but not dexamethasone, blunted the response of aldosterone to renin elevation by suppressing angiotensin converting enzyme.", {"entities": []}], ["The relationship of domestic endotoxin exposure to allergy and asthma has been widely investigated.", {"entities": [[63, 69, "DISEASE"]]}], ["However, few studies have evaluated predictors of household endotoxin, and none have done so for multiple locations within homes and on a national scale.", {"entities": []}], ["We assayed 2,552 house dust samples in a nationwide study to understand the predictors of household endotoxin in bedroom floors, family room floors, beds, kitchen floors, and family room sofas.", {"entities": []}], ["Reservoir house dust from five locations within homes was assayed for endotoxin and demographic and housing information was assessed through questionnaire and onsite evaluation of 2,456 residents of 831 homes selected to represent national demographics.", {"entities": []}], ["We performed repeated-measures analysis of variance (rANOVA) for 37 candidate variables to identify independent predictors of endotoxin.", {"entities": []}], ["Meteorologic data were obtained for each primary sampling unit and tested as predictors of indoor endotoxin to determine if wetter or warmer microclimates were associated with higher endotoxin levels.", {"entities": []}], ["Weighted geometric mean endotoxin concentration ranged from 18.7 to 80.5 endotoxin units (EU)/mg for the five sampling locations, and endotoxin load ranged from 4,160 to 19,500 EU/m Increased endotoxin in household reservoir dust is principally associated with poverty, people, pets, household cleanliness, and geography.", {"entities": []}], ["During the pandemic outbreak of the 2009 swine influenza (A(H1N1)pdm09), 32 fatal cases occurred in Norway and 19 of these were included in this study.", {"entities": [[41, 56, "DISEASE"], [47, 56, "DISEASE"]]}], ["We characterised pulmonary changes in these fatal Norwegian cases.", {"entities": []}], ["Upon hospitalisation, detailed clinical information and specimens from the upper and lower respiratory pathways were collected.", {"entities": []}], ["At post\u2010mortem, lung tissue was collected, formalin\u2010fixed and paraffin\u2010embedded.", {"entities": []}], ["Immunohistochemical and light microscopic examination was performed to visualise the local expression of the A(H1N1)pdm09 virus.", {"entities": []}], ["Reverse transcription\u2010polymerase chain reaction ( RT \u2010 PCR ) and pyrosequencing of the non\u2010fixed specimens allowed the identification of mutations in the influenza virus surface glycoprotein (haemagglutinin gene) particularly at position 222.", {"entities": [[154, 163, "DISEASE"]]}], ["The overall course of illness lasted from 2 to 40\u00a0days (median 9\u00a0days).", {"entities": []}], ["Diffused alveolar damage ( DAD ) was evident in 11 cases, 4 of which had no apparent underlying illness.", {"entities": []}], ["Obesity was prominent in 12 cases, where three individuals were classified as otherwise healthy.", {"entities": []}], ["The HA D222G mutation was detected in six cases, 3 of which had no underlying illness.", {"entities": []}], ["Immunohistochemistry showed the A(H1N1)pdm09 virus to be prominent at the site of inflammation both in close proximity to and inside alveolar structures in the lung tissue.", {"entities": []}], ["In addition to a possible role for the HA D222G mutation, our findings indicate that host factors and underlying conditions in the infected individuals are fundamental for disease outcome in many cases.", {"entities": []}], ["This study increases our understanding of determinants for the clinical outcome of pandemic influenza, which could guide future treatment.", {"entities": [[92, 101, "DISEASE"]]}], ["Evidence suggests that air pollution exposure adversely affects pregnancy outcomes.", {"entities": []}], ["Few studies have examined individual-level intraurban exposure contrasts.", {"entities": []}], ["We evaluated the impacts of air pollution on small for gestational age (SGA) birth weight, low full-term birth weight (LBW), and preterm birth using spatiotemporal exposure metrics.", {"entities": []}], ["With linked administrative data, we identified 70,249 singleton births (1999\u20132002) with complete covariate data (sex, ethnicity, parity, birth month and year, income, education) and maternal residential history in Vancouver, British Columbia, Canada.", {"entities": []}], ["We estimated residential exposures by month of pregnancy using nearest and inverse-distance weighting (IDW) of study area monitors [carbon monoxide, nitrogen dioxide, nitric oxide, ozone, sulfur dioxide, and particulate matter < 2.5 (PM 2.5 ) or < 10 (PM 10 ) \u03bcm in aerodynamic diameter], temporally adjusted land use regression (LUR) models (NO, NO 2 , PM 2.5 , black carbon), and proximity to major roads.", {"entities": []}], ["Using logistic regression, we estimated the risk of mean (entire pregnancy, first and last month of pregnancy, first and last 3 months) air pollution concentrations on SGA (< 10th percentile), term LBW (< 2,500 g), and preterm birth.", {"entities": []}], ["Residence within 50 m of highways was associated with a 26% increase in SGA [95% confidence interval (CI), 1.07\u20131.49] and an 11% (95% CI, 1.01\u20131.23) increase in LBW.", {"entities": []}], ["Exposure to all air pollutants except O 3 was associated with SGA, with similar odds ratios (ORs) for LUR and monitoring estimates (e.g., LUR: OR = 1.02; 95% CI, 1.00\u20131.04; IDW: OR = 1.05; 95% CI, 1.03\u20131.08 per 10-\u03bcg/m 2.5 for births < 37 weeks gestation (and for other pollutants at < 30 weeks).", {"entities": []}], ["No consistent patterns suggested exposure windows of greater relevance.", {"entities": []}], ["Associations between traffic-related air pollution and birth outcomes were observed in a population-based cohort with relatively low ambient air pollution exposure.", {"entities": []}], ["This study investigated the effects of Coleus Forskohlii (CF) on body composition, and determined the safety and efficacy of supplementation.", {"entities": []}], ["In a double blind and randomized manner, 23 females supplemented their diet with ForsLean\u2122 (250 mg of 10% CF extract, (n = 7) or a placebo [P] (n = 12) two times per day for 12-wks.", {"entities": []}], ["Body composition (DEXA), body weight, and psychometric instruments were obtained at 0, 4, 8 & 12 weeks of supplementation.", {"entities": []}], ["Fasting blood samples and dietary records (4-d) were obtained at 0 and 12-wks.", {"entities": []}], ["Side effects were recorded on a weekly basis.", {"entities": []}], ["Data were analyzed by repeated measures ANOVA and are presented as mean changes from baseline for the CF and placebo groups, respectively.", {"entities": []}], ["No significant differences were observed in caloric or macronutrient intake.", {"entities": []}], ["CF tended to mitigate gains in body mass (-0.7 \u00b1 1.8, 1.0 \u00b1 2.5 kg, p = 0.10) and scanned mass (-0.2 \u00b1 1.3, 1.7 \u00b1 2.9 kg, p = 0.08) with no significant differences in fat mass (-0.2 \u00b1 0.7, 1.1 \u00b1 2.3 kg, p = 0.16), fat free mass (-0.1 \u00b1 1.3, 0.6 \u00b1 1.2 kg, p = 0.21), or body fat (-0.2 \u00b1 1.0, 0.4 \u00b1 1.4%, p = 0.40).", {"entities": []}], ["Subjects in the CF group tended to report less fatigue (p = 0.07), hunger (p = 0.02), and fullness (p = 0.04).", {"entities": []}], ["No clinically significant interactions were seen in metabolic markers, blood lipids, muscle and liver enzymes, electrolytes, red cells, white cells, hormones (insulin, TSH, T3, and T4), heart rate, blood pressure, or weekly reports of side effects.", {"entities": []}], ["Results suggest that CF does not appear to promote weight loss but may help mitigate weight gain in overweight females with apparently no clinically significant side effects.", {"entities": []}], ["Exposure to organic dust causes detrimental airway inflammation.", {"entities": []}], ["Current preventative and therapeutic measures do not adequately treat resulting disease, necessitating novel therapeutic interventions.", {"entities": []}], ["Recently identified mediators derived from polyunsaturated fatty acids exhibit anti-inflammatory and pro-resolving actions.", {"entities": []}], ["We tested the potential of one of these mediators, maresin-1 (MaR1), in reducing organic dust-associated airway inflammation.", {"entities": []}], ["As bronchial epithelial cells (BECs) are pivotal in initiating organic dust-induced inflammation, we investigated the in vitro effects of MaR1 on a human BEC cell line (BEAS-2B).", {"entities": []}], ["Cells were pretreated for 1\u00a0hour with 0\u2013200 nM MaR1, followed by 1\u201324\u00a0hour treatment with 5% hog confinement facility-derived organic dust extract (HDE).", {"entities": []}], ["Alternatively, a mouse lung slice model was utilized in supportive cytokine studies.", {"entities": []}], ["Supernatants were harvested and cytokine levels determined via enzyme-linked immunosorbent assays.", {"entities": []}], ["Epithelial cell protein kinase C (PKC) isoforms \u03b1 and \u03f5, and PKA activities were assessed via radioactivity assays, and NF\u03baB and MAPK-related signaling mechanisms were investigated using luciferase vector reporters.", {"entities": []}], ["MaR1 dose-dependently reduced IL-6 and IL-8 production following HDE treatment of BECs.", {"entities": []}], ["MaR1 also reduced HDE-stimulated cytokine release including TNF-\u03b1 in a mouse lung slice model when given before or following HDE treatment.", {"entities": []}], ["Previous studies have established that HDE sequentially activates epithelial PKC\u03b1 and PKC\u03f5 at 1 and 6\u00a0hours, respectively that regulated TNF-\u03b1, IL-6, and IL-8 release.", {"entities": []}], ["MaR1 pretreatment abrogated these HDE-induced PKC activities.", {"entities": []}], ["Furthermore, HDE treatment over a 24-hour period revealed temporal increases in NF\u03baB, AP-1, SP-1, and SRE DNA binding activities, using luciferase reporter assays.", {"entities": []}], ["MaR1 pretreatment did not alter the activation of NF\u03baB, AP-1, or SP-1, but did reduce the activation of DNA binding at SRE.", {"entities": []}], ["These observations indicate a role for MaR1 in attenuating the pro-inflammatory responses of BECs to organic dust extract, through a mechanism that does not appear to rely on reduced NF\u03baB, AP-1, or SP-1-related signaling, but may be mediated partly through SRE-related signaling.", {"entities": []}], ["These data offer insights for a novel mechanistic action of MaR1 in bronchial epithelial cells, and support future in vivo studies to test MaR1\u2019s utility in reducing the deleterious inflammatory effects of environmental dust exposures.", {"entities": []}], ["Community-acquired pneumonia (CAP) is the most frequent infection-related cause of death.", {"entities": [[19, 28, "DISEASE"]]}], ["The reference standard to diagnose CAP is a new infiltrate on chest radiograph in the presence of recently acquired respiratory signs and symptoms.", {"entities": []}], ["This study aims to evaluate the diagnostic and prognostic accuracy of clinical signs and symptoms and laboratory biomarkers for CAP.", {"entities": []}], ["545 patients with suspected lower respiratory tract infection, admitted to the emergency department of a university hospital were included in a pre-planned post-hoc analysis of two controlled intervention trials.", {"entities": []}], ["Baseline assessment included history, clinical examination, radiography and measurements of procalcitonin (PCT), highly sensitive C-reactive protein (hsCRP) and leukocyte count.", {"entities": []}], ["Of the 545 patients, 373 had CAP, 132 other respiratory tract infections, and 40 other final diagnoses.", {"entities": []}], ["The AUC of a clinical model including standard clinical signs and symptoms (i.e.", {"entities": []}], ["fever, cough, sputum production, abnormal chest auscultation and dyspnea) to diagnose CAP was 0.79 [95% CI, 0.75\u20130.83].", {"entities": []}], ["This AUC was significantly improved by including PCT and hsCRP (0.92 [0.89\u20130.94]; p < 0.001).", {"entities": []}], ["PCT had a higher diagnostic accuracy (AUC, 0.88 [0.84\u20130.93]) in differentiating CAP from other diagnoses, as compared to hsCRP (AUC, 0.76 [0.69\u20130.83]; p < 0.001) and total leukocyte count (AUC, 0.69 [0.62\u20130.77]; p < 0.001).", {"entities": []}], ["To predict bacteremia, PCT had a higher AUC (0.85 [0.80\u20130.91]) as compared to hsCRP (p = 0.01), leukocyte count (p = 0.002) and elevated body temperature (p < 0.001).", {"entities": []}], ["PCT, in contrast to hsCRP and leukocyte count, increased with increasing severity of CAP, as assessed by the pneumonia severity index (p < 0.001).", {"entities": [[109, 118, "DISEASE"]]}], ["PCT, and to a lesser degree hsCRP, improve the accuracy of currently recommended approaches for the diagnosis of CAP, thereby complementing clinical signs and symptoms.", {"entities": []}], ["PCT is useful in the severity assessment of CAP.", {"entities": []}], ["Vaccination against infectious diseases has been one of the major breakthroughs in human medical history, saving the lives of millions of people each year.", {"entities": []}], ["More recently, prophylactic vaccination against non-infectious diseases such as cancer, Alzheimer\u2019s disease, diabetes, and type I allergy is being investigated.", {"entities": [[80, 86, "DISEASE"]]}], ["Particularly in case of IgE-driven allergic disorders, which afflict almost a quarter of the population in highly developed countries, preventative measures would represent a major improvement for patients\u2019 health as well as an economic relief for public health services.", {"entities": []}], ["As an alternative to allergen-specific immunotherapy, prophylactic vaccination against type I allergic diseases could slow down or even stop the progress of the allergy pandemic.", {"entities": []}], ["Allergen-encoding gene-based vaccines, i.e., plasmid DNA and mRNA vaccines, provide the advantage of purity over crude allergen extracts, which involve the risk of de novo sensitizations.", {"entities": []}], ["Furthermore, these formulations have been demonstrated to induce T helper 1 as well as T regulatory immune responses\u2014a pre-requisite for prophylactic intervention against allergies.", {"entities": []}], ["However, prophylactic vaccines against environmental allergens strikingly differ from conventional vaccines against infectious diseases or therapeutic approaches concerning the underlying immunological mechanisms.", {"entities": []}], ["The production of reactive species is an inevitable by-product of metabolism and thus, life itself.", {"entities": []}], ["Since reactive species are able to damage cellular structures, especially proteins, as the most abundant macromolecule of mammalian cells, systems are necessary which regulate and preserve a functional cellular protein pool, in a process termed \u201cproteostasis\u201d.", {"entities": []}], ["Not only the mammalian protein pool is subject of a constant turnover, organelles are also degraded and rebuild.", {"entities": []}], ["The most important systems for these removal processes are the \u201cubiquitin-proteasomal system\u201d (UPS), the central proteolytic machinery of mammalian cells, mainly responsible for proteostasis, as well as the \u201cautophagy-lysosomal system\u201d, which mediates the turnover of organelles and large aggregates.", {"entities": []}], ["Many age-related pathologies and the aging process itself are accompanied by a dysregulation of UPS, autophagy and the cross-talk between both systems.", {"entities": []}], ["This review will describe the sources and effects of oxidative stress, preservation of cellular protein- and organelle-homeostasis and the effects of aging on proteostasis in mammalian cells.", {"entities": []}], ["Many interventions to reduce allergen levels in the home are recommended to asthma and allergy patients.", {"entities": [[76, 82, "DISEASE"]]}], ["One that is readily available and can be highly effective is the use of high performing filters in forced air ventilation systems.", {"entities": []}], ["We conducted a modeling analysis of the effectiveness of filter-based interventions in the home to reduce airborne asthma and allergy triggers.", {"entities": [[115, 121, "DISEASE"]]}], ["This work used \u201ceach pass removal efficiency\u201d applied to health-relevant size fractions of particles to assess filter performance.", {"entities": []}], ["We assessed effectiveness for key allergy and asthma triggers based on applicable particle sizes for cat allergen, indoor and outdoor sources of particles <2.5\u2009\u00b5m in diameter (PM 2.5 ), and airborne influenza and rhinovirus.", {"entities": [[199, 208, "DISEASE"], [46, 52, "DISEASE"]]}], ["Our analysis finds that higher performing filters can have significant impacts on indoor particle pollutant levels.", {"entities": []}], ["Filters with removal efficiencies of >70% for cat dander particles, fine particulate matter (PM 2.5 ) and respiratory virus can lower concentrations of those asthma triggers and allergens in indoor air of the home by >50%.", {"entities": [[158, 164, "DISEASE"]]}], ["Very high removal efficiency filters, such as those rated a 16 on the nationally recognized Minimum Efficiency Removal Value (MERV) rating system, tend to be only marginally more effective than MERV12 or 13 rated filters.", {"entities": []}], ["The results of this analysis indicate that use of a MERV12 or higher performing air filter in home ventilation systems can effectively reduce indoor levels of these common asthma and allergy triggers.", {"entities": [[172, 178, "DISEASE"]]}], ["These reductions in airborne allergens in turn may help reduce allergy and asthma symptoms, especially if employed in conjunction with other environmental management measures recommended for allergy and asthma patients.", {"entities": [[75, 81, "DISEASE"], [203, 209, "DISEASE"]]}], ["All natural Leishmania infections start in the skin; however, little is known of the contribution made by the sand fly vector to the earliest events in mammalian infection, especially in inflamed skin that can rapidly kill invading parasites.", {"entities": []}], ["During transmission sand flies regurgitate a proteophosphoglycan gel synthesized by the parasites inside the fly midgut, termed promastigote secretory gel (PSG).", {"entities": []}], ["Regurgitated PSG can exacerbate cutaneous leishmaniasis.", {"entities": [[42, 55, "DISEASE"], [32, 55, "DISEASE"]]}], ["Here, we show that the amount of Leishmania mexicana PSG regurgitated by Lutzomyia longipalpis sand flies is proportional to the size of its original midgut infection and the number of parasites transmitted.", {"entities": []}], ["Furthermore, PSG could exacerbate cutaneous L. mexicana infection for a wide range of doses (10\u201310,000 parasites) and enhance infection by as early as 48 hours in inflamed dermal air pouches.", {"entities": []}], ["This early exacerbation was attributed to two fundamental properties of PSG: Firstly, PSG powerfully recruited macrophages to the dermal site of infection within 24 hours.", {"entities": []}], ["Secondly, PSG enhanced alternative activation and arginase activity of host macrophages, thereby increasing L-arginine catabolism and the synthesis of polyamines essential for intracellular parasite growth.", {"entities": []}], ["The increase in arginase activity promoted the intracellular growth of L. mexicana within classically activated macrophages, and inhibition of macrophage arginase completely ablated the early exacerbatory properties of PSG in vitro and in vivo .", {"entities": []}], ["Thus, PSG is an essential component of the infectious sand fly bite for the early establishment of Leishmania in skin, which should be considered when designing and screening therapies against leishmaniasis.", {"entities": [[193, 206, "DISEASE"]]}], ["Parasites are known to manipulate their arthropod vectors for increased transmission, yet little is known about the manipulator-molecules involved.", {"entities": []}], ["The protozoan parasite Leishmania secrete a proteophosphoglycan-rich gel (termed promastigote secretory gel, PSG) to block the sand fly midgut to force the regurgitation of parasites and gel into the skin.", {"entities": []}], ["Here we show that the amount of PSG and dose of Leishmania transmitted by individual sand flies strongly correlate with the size of the original midgut infection.", {"entities": []}], ["Regurgitated PSG exacerbated both low and high dose mouse infections, resulting from the gel's ability to augment the recruitment of its principal host cell, the macrophage, to the site of injury and induce the upregulation of macrophage arginase activity.", {"entities": []}], ["The infecting parasites take advantage of the increased arginase-mediated L-arginine catabolism and the increased pool of polyamines available within these macrophages for their early nutrition and growth.", {"entities": []}], ["This resulted in enhanced survival and growth of Leishmania in macrophages.", {"entities": []}], ["Since arginase plays a crucial role in orchestrating wound repair in skin, it would appear that through the generation of PSG, Leishmania has evolved to exploit the wound response to the bite of the sand fly for its early survival.", {"entities": []}], ["COPD is a worsening condition that leads to a pathologic degeneration of the respiratory system.", {"entities": []}], ["It represents one of the most important causes of mortality and morbidity in the world, and it is characterized by the presence of associated comorbidity.", {"entities": []}], ["This article analyzes gastroesophageal reflux disease (GERD) and low back pain (LBP) in patients with COPD and tries to produce anatomo-clinical considerations on the reasons of the presence of these comorbidities.", {"entities": [[22, 53, "DISEASE"], [80, 83, "GENE"]]}], ["The considerations of the authors are based on the anatomic functions and characteristics of the respiratory diaphragm that are not always considered, from which elements useful to comprehend the symptomatic status of the patient can be deduced, finally improving the therapeutic approach.", {"entities": []}], ["The information contained in the article can be of help to the clinician and for physiotherapy, and to all health professionals who gravitate around the patient\u2019s care, improving the approach to the diaphragm muscle.", {"entities": []}], ["The elderly comprise the fastest-expanding age group globally, with the greatest increase occurring in developing countries.", {"entities": []}], ["Disease and deteriorating health are implicitly assumed to be associated with ageing, as chronic medical illnesses mostly present with increasing age.", {"entities": []}], ["To describe the morbidity pattern of elderly patients presenting at the General Outpatients Clinic of the University College Hospital, Ibadan, Nigeria.", {"entities": []}], ["This was a cross-sectional descriptive study of 500 elderly respondents who presented at the clinic between September 2004 and April 2005.", {"entities": []}], ["They were interviewed according to the format of the electronic, second revision of the International Classification of Primary Care (ICPC-2-E) questionnaire.", {"entities": []}], ["Main outcome measurements were the prevalence of various morbidities, self-reported health status and socio-demographic characteristics.", {"entities": []}], ["Body mass index (BMI) was used to assess respondents\u2019 nutritional status.", {"entities": []}], ["Respondents were found to under-report their actual health problems.", {"entities": []}], ["The mean \u00b1 s.d of self-reported health problems was 1.7 \u00b1 0.9 (range 1\u20136), while the mean \u00b1 s.d of diagnosed morbidities was 2.7 \u00b1 1.4 (range 1\u20138).", {"entities": []}], ["The most prevalent morbidities were hypertension (40.0%), cataracts (39.4%) and osteoarthritis (26.8%).", {"entities": [[36, 48, "DISEASE"], [80, 94, "DISEASE"]]}], ["The prevalence of anaemia was 8.0% (females = 11.2%; males = 2.6%), and it was significantly associated with gender ( p = 0.001).", {"entities": []}], ["Nutritional status indicated a high prevalence of overweight and obesity (51.8%), which was significantly higher amongst the female respondents than the males ( p = 0.001).", {"entities": [[65, 72, "DISEASE"]]}], ["The prevalence of chronic medical illnesses was high amongst the elderly in this setting.", {"entities": []}], ["In addition, the elderly under-reported their actual health problems.", {"entities": []}], ["The high prevalence of overweight and obesity amongst the elderly in this setting calls for public health action that advocates lifestyle changes to manage the health of the elderly.", {"entities": [[38, 45, "DISEASE"]]}], ["This study was conducted to determine the effect of ethanolic extract of the dried stems of Tinospora crispa in a male rat model of hepatic fibrosis caused by the hepatotoxin, thioacetamide.", {"entities": []}], ["The extract was gavaged daily to the rats, at doses of 100 and 200 mg/kg along with thioacetamide at a dose of 200 mg/kg twice weekly.", {"entities": []}], ["To assess the effectivity of extract, against thioacetamide, the activity of aminotransferases (alanine aminotransferase, aspartate aminotransferase), alkaline phosphatase (AP); and bilirubin were measured, together with morphological and histopathological indices in the liver of healthy and thioacetamide-treated rats.", {"entities": []}], ["A significant increase in the activity of liver enzymes, bilirubin and G-glutamyl transferase and gross and histopathological changes were determined.", {"entities": []}], ["Although previous in vitro study established that this extract had strong antioxidant activity, this in vivo study establishes that this extract contains hepatotoxins whose identity may be quite different from those compounds with antioxidant properties.", {"entities": []}], ["The study confirms that complete reliance on data obtained using in vitro methodologies may lead to erroneous conclusions pertaining to the safety of phytopharmaceuticals.", {"entities": []}], ["Knowledge about predictors of health-related quality of life for multimorbid patients with type 2 diabetes mellitus in primary care could help to improve quality and patient-centeredness of care in this specific group of patients.", {"entities": [[98, 115, "DISEASE"], [91, 115, "DISEASE"]]}], ["Thus, the aim of this study was to investigate the impact of several patient characteristics on health-related quality of life of multimorbid patients with type 2 diabetes mellitus in a community setting.", {"entities": [[163, 180, "DISEASE"], [156, 180, "DISEASE"]]}], ["A cross-sectional study with 32 primary care practice teams in Mannheim, Germany, and randomly selected multimorbid patients with type 2 diabetes mellitus (N = 495) was conducted.", {"entities": [[137, 154, "DISEASE"], [130, 154, "DISEASE"]]}], ["In order to analyze associations of various patient characteristics with health-related quality of life (EQ-5D index) a multilevel analysis was applied.", {"entities": []}], ["After excluding patients with missing data, the cohort consisted of 404 eligible patients.", {"entities": []}], ["The final multilevel model highlighted six out of 14 explanatory patient variables which were significantly associated with health-related quality of life: female gender (r = -0.0494; p = .0261), school education of nine years or less (r = -0.0609; p = .0006), (physical) mobility restrictions (r = -0.1074; p = .0003), presence of chronic pain (r = -0.0916; p = .0004), diabetes-related distress (r = -0.0133; p < .0001), and BMI (r = -0.0047; p = .0045).", {"entities": []}], ["The findings of this study suggest that increased diabetes-related distress, chronic pain, restrictions in (physical) mobility, female gender, as well as lower education and, increased BMI have a noteworthy impact on health-related quality of life in multimorbid patients with type 2 diabetes mellitus seen in primary care practices in a community setting.", {"entities": [[284, 301, "DISEASE"], [277, 301, "DISEASE"]]}], ["The highlighted aspects should gain much more attention when treating multimorbid patients with type 2 diabetes mellitus.", {"entities": [[103, 120, "DISEASE"], [96, 120, "DISEASE"]]}], ["\u2022 History of seven fungal species used as models for studying development and pathogenicity.", {"entities": []}], ["\u2022 Outline of central stages of their life cycle and their infection processes.", {"entities": []}], ["\u2022 Molecular toolkits used to study different aspects of pathogenicity.", {"entities": []}], ["\u2022 Insight gained from genome sequencing projects.", {"entities": []}], ["\u2022 Current research trends and future challenges.", {"entities": []}], ["History of seven fungal species used as models for studying development and pathogenicity.", {"entities": []}], ["Outline of central stages of their life cycle and their infection processes.", {"entities": []}], ["Molecular toolkits used to study different aspects of pathogenicity.", {"entities": []}], ["Insight gained from genome sequencing projects.", {"entities": []}], ["Current research trends and future challenges.", {"entities": []}], ["Fungi have the capacity to cause devastating diseases of both plants and animals, causing significant harvest losses that threaten food security and human mycoses with high mortality rates.", {"entities": []}], ["As a consequence, there is a critical need to promote development of new antifungal drugs, which requires a comprehensive molecular knowledge of fungal pathogenesis.", {"entities": []}], ["In this review, we critically evaluate current knowledge of seven fungal organisms used as major research models for fungal pathogenesis.", {"entities": []}], ["These include pathogens of both animals and plants; Ashbya gossypii , Aspergillus fumigatus , Candida albicans , Fusarium oxysporum , Magnaporthe oryzae , Ustilago maydis and Zymoseptoria tritici .", {"entities": []}], ["We present key insights into the virulence mechanisms deployed by each species and a comparative overview of key insights obtained from genomic analysis.", {"entities": []}], ["We then consider current trends and future challenges associated with the study of fungal pathogenicity.", {"entities": []}], ["ACE2 is a novel homologue of angiotensin converting enzyme (ACE).", {"entities": [[0, 4, "GENE"]]}], ["ACE2 is highly expressed in human heart and animal data suggest that ACE2 is an essential regulator of cardiac function in vivo .", {"entities": [[0, 4, "GENE"], [69, 73, "GENE"], [0, 4, "GENE"], [69, 73, "GENE"]]}], ["Since overactivity of the renin-angiotensin system contributes to the progression of heart failure, this investigation assessed changes in gene expression of ACE2, ACE, AT 1 receptor and renin in the human failing heart.", {"entities": [[158, 162, "GENE"]]}], ["The sensitive technique of quantitative reverse transcriptase polymerase chain reaction was used to determine the level of mRNA expression of ACE and ACE2 in human ventricular myocardium from donors with non-diseased hearts (n = 9), idiopathic dilated cardiomyopathy (IDC, n = 11) and ischemic cardiomyopathy (ICM, n = 12).", {"entities": [[252, 266, "DISEASE"], [294, 308, "DISEASE"], [244, 266, "DISEASE"], [150, 154, "GENE"]]}], ["Following logarithmic transformation of the data, a one-way analysis of variance was performed for each target gene followed by a Dunnett's test to compare the two disease groups IDC and ICM versus control.", {"entities": []}], ["As anticipated, ACE mRNA was found to be significantly increased in the failing heart with a 3.1 and 2.4-fold up-regulation found in IDC and ICM relative to non-diseased myocardium.", {"entities": []}], ["Expression of ACE2 mRNA was also significantly up-regulated in IDC (2.4-fold increase) and ICM (1.8-fold increase) versus non-diseased myocardium.", {"entities": [[14, 18, "GENE"]]}], ["No change in angiotensin AT 1 receptor mRNA expression was found in failing myocardium and renin mRNA was not detected.", {"entities": []}], ["These data suggest that ACE2 is up-regulated in human IDC and ICM and are consistent with the hypothesis that differential regulation of this enzyme may have important functional consequences in heart failure.", {"entities": [[24, 28, "GENE"]]}], ["This strengthens the hypothesis that ACE2 may be a relevant target for the treatment of heart failure and will hopefully spur further studies to clarify the functional effects in human myocardium of ACE2 derived peptides.", {"entities": [[37, 41, "GENE"], [199, 203, "GENE"], [37, 41, "GENE"], [199, 203, "GENE"]]}], ["Human papillomaviruses (HPVs) are a very complex group of pathogenic viruses, with more than 80 types, causing human infection.", {"entities": []}], ["Given the prevalence of HPV infection and its relationship with the development of cervical and many other cancers, HPV vaccine development has been a major public health initiative worldwide in the last decade.", {"entities": []}], ["The aim of the presented study was to identify HPV DNA by MY-PCR in 4,150 school children and adolescents, aged 10\u201318\u00a0years in the Wielkopolska region, Poland.", {"entities": []}], ["All individuals were asked to fill in extensive questionnaires; further normal, oral squamous cells were collected from each pupil.", {"entities": []}], ["Cellular DNA was isolated and used as a MY-PCR template to estimate the incidence of HPV-active infection.", {"entities": []}], ["Forty five subjects (1.08% of the sample) were carriers of oropharyngeal HPVs.", {"entities": []}], ["HPV status and variables of interest, such as age, gender, socioeconomical status, and risk factors (smoking and sexual intercourse history, alcohol consumption) were not correlated.", {"entities": []}], ["The presence of HPVs in the oral cavity was cumulated in several schools of the region.", {"entities": []}], ["DNA sequencing of MY-PCR products revealed only four HPV genotypes.", {"entities": []}], ["The most frequent genotype was HPV11 (38/45 HPV-positive cases), while other more rare genotypes were HPV6 (3/45), HPV12 (3/45), and HPV57 (1/45).", {"entities": []}], ["Conclusion : Our findings presented herein, reveal a relatively low prevalance of oropharyngeal HPVs in Polish adolescents and fill an important gap in the knowledge of oral HPV infections of children above 10\u00a0years and adolescents.", {"entities": []}], ["In a mouse model of viral induced atopic disease, expression of Fc\u03b5RI on dendritic cells is critical.", {"entities": []}], ["While adult human conventional (cDC) and plasmacytoid (pDC) dendritic cells have been shown to express Fc\u03b5RI, it is not known if this receptor is expressed in childhood and how its expression is governed by IgE.", {"entities": [[55, 58, "GENE"]]}], ["Following informed consent of subjects (n\u200a=\u200a27, aged 12\u2013188 months), peripheral blood was stained for surface expression of CD19, ILT7, CD1c, IgE, Fc\u03b5RI and analyzed by flow cytometry (cDC: CD19 Independent of sensitization status, Fc\u03b5RI expression was noted on cDC and pDC as early as 12 months of age.", {"entities": [[124, 128, "GENE"], [190, 194, "GENE"], [136, 140, "GENE"], [124, 128, "GENE"], [190, 194, "GENE"], [270, 273, "GENE"]]}], ["Serum IgE level correlated with expression of Fc\u03b5RI on cDC, but not pDC.", {"entities": [[68, 71, "GENE"]]}], ["Based on the concentration of IgE, a complex relationship was found between surface bound IgE and expression of Fc\u03b5RI on cDC.", {"entities": []}], ["pDC exhibited a linear relationship of Fc\u03b5RI expression and bound IgE that was consistent through all IgE concentrations.", {"entities": [[0, 3, "GENE"]]}], ["In children, Fc\u03b5RI expression on cDC and pDC is modulated differently by serum and cell bound IgE.", {"entities": [[41, 44, "GENE"]]}], ["IgE governance of Fc\u03b5RI expression on cDC depends upon a complex relationship.", {"entities": []}], ["Further studies are needed to determine the functional roles of Fc\u03b5RI on cDC and pDC.", {"entities": [[81, 84, "GENE"]]}], ["The G-protein coupled receptor (GPCR) superfamily is currently the largest class of therapeutic targets.", {"entities": []}], ["In silico prediction of interactions between GPCRs and small molecules in the transmembrane ligand-binding site is therefore a crucial step in the drug discovery process, which remains a daunting task due to the difficulty to characterize the 3D structure of most GPCRs, and to the limited amount of known ligands for some members of the superfamily.", {"entities": []}], ["Chemogenomics, which attempts to characterize interactions between all members of a target class and all small molecules simultaneously, has recently been proposed as an interesting alternative to traditional docking or ligand-based virtual screening strategies.", {"entities": []}], ["We show that interaction prediction in the chemogenomics framework outperforms state-of-the-art individual ligand-based methods in accuracy both for receptor with known ligands and without known ligands.", {"entities": []}], ["This is done with no knowledge of the receptor 3D structure.", {"entities": []}], ["In particular we are able to predict ligands of orphan GPCRs with an estimated accuracy of 78.1%.", {"entities": []}], ["We propose new methods for in silico chemogenomics and validate them on the virtual screening of GPCRs.", {"entities": []}], ["The methods represent an extension of a recently proposed machine learning strategy, based on support vector machines (SVM), which provides a flexible framework to incorporate various information sources on the biological space of targets and on the chemical space of small molecules.", {"entities": []}], ["We investigate the use of 2D and 3D descriptors for small molecules, and test a variety of descriptors for GPCRs.", {"entities": []}], ["We show that incorporating information about the known hierarchical classification of the target family and about key residues in their inferred binding pockets significantly improves the prediction accuracy of our model.", {"entities": []}], ["Few studies have evaluated the associations between respiratory parameters and pain in chronic obstructive pulmonary disease (COPD).", {"entities": [[87, 124, "DISEASE"]]}], ["The purpose of this study is to evaluate the differences in respiratory parameters between COPD patients who did and did not have pain.", {"entities": []}], ["In this cross-sectional study respiratory parameters were measured by spirometry and the St Georges Respiratory Questionnaire.", {"entities": []}], ["Patients responded to a single question that asked if they were generally bothered by pain.", {"entities": []}], ["Of the 100 patients, 45% reported that they were generally bothered by pain.", {"entities": []}], ["Patients who had pain reported a higher number of comorbidities ( P < 0.001) and higher breathlessness scores ( P = 0.003).", {"entities": []}], ["Physical dimensions of breathlessness were significantly associated with pain ( P \u2264 0.03).", {"entities": []}], ["The results of logistic regression analysis determined that a higher number of comorbidities (OR = 0.28; P = 0.026) and higher breathlessness scores (OR = 1.03; P = 0.003) made significant unique contributions to the prediction of pain group membership.", {"entities": []}], ["Comorbidity and breathlessness were risk factors for pain and the physical dimensions of breathlessness were associated with pain.", {"entities": []}], ["Fibrotic remodeling of airway and lung parenchymal compartments is attributed to pulmonary dysfunction with an involvement of reactive oxygen species (ROS) in chronic lung diseases such as idiopathic pulmonary fibrosis and asthma.", {"entities": [[200, 218, "DISEASE"], [223, 229, "DISEASE"], [189, 218, "DISEASE"]]}], ["The in vitro study elucidated inhibitory effects of astragalin, kaempferol-3-O-glucoside from leaves of persimmon and green tea seeds, on oxidative stress-induced airway fibrosis.", {"entities": []}], ["The in vivo study explored the demoting effects of astragalin on epithelial to mesenchymal transition in BALB/c mice sensitized with ovalbumin (OVA).", {"entities": []}], ["The exposure of 20 \u03bcM H 2 O 2 for 72 h accelerated E-cadherin loss and vimentin induction in airway epithelial BEAS-2B cells, which was reversed by non-toxic astragalin at 1\u201320 \u03bcM.", {"entities": []}], ["Astragalin allayed the airway tissue levels of ROS and vimentin enhanced by OVA challenge.", {"entities": []}], ["Collagen type 1 production increased in H 2 O 2 \u2013exposed epithelial cells and collagen fiber deposition was observed in OVA-challenged mouse airways.", {"entities": []}], ["This study further investigated that the oxidative stress-triggered autophagic regulation was responsible for inducing airway fibrosis.", {"entities": []}], ["H 2 O 2 highly enhanced the expression induction of the autophagy-related beclin-1 and light chains 3A/B (LC3A/B) within 4 h and astragalin blocked such induction by H 2 O 2 .", {"entities": []}], ["This compound deterred the ROS-promoted autophagosome formation in BEAS-2B cells.", {"entities": []}], ["Consistently, in OVA-sensitized mice the expression of beclin-1 and LC3A/B was highly induced, and oral administration of astragalin suppressed the autophagosome formation with inhibiting the induction of these proteins in OVA-challenged airway subepithelium.", {"entities": []}], ["Induction of autophagy by spermidine influenced the epithelial induction of E-cadherin and vimentin that was blocked by treating astragalin.", {"entities": []}], ["These results demonstrate that astragalin can be effective in allaying ROS-promoted bronchial fibrosis through inhibiting autophagosome formation in airways.", {"entities": []}], ["Children presenting for the first time with inflammatory bowel disease (IBD) offer a unique opportunity to study aetiological agents before the confounders of treatment.", {"entities": [[44, 70, "DISEASE"]]}], ["Microaerophilic bacteria can exploit the ecological niche of the intestinal epithelium; Helicobacter and Campylobacter are previously implicated in IBD pathogenesis.", {"entities": []}], ["We set out to study these and other microaerophilic bacteria in de-novo paediatric IBD.", {"entities": []}], ["100 children undergoing colonoscopy were recruited including 44 treatment na\u00efve de-novo IBD patients and 42 with normal colons.", {"entities": []}], ["Colonic biopsies were subjected to microaerophilic culture with Gram-negative isolates then identified by sequencing.", {"entities": []}], ["Biopsies were also PCR screened for the specific microaerophilic bacterial groups: Helicobacteraceae, Campylobacteraceae and Sutterella wadsworthensis.", {"entities": []}], ["129 Gram-negative microaerophilic bacterial isolates were identified from 10 genera.", {"entities": []}], ["The most frequently cultured was S. wadsworthensis (32 distinct isolates).", {"entities": []}], ["Unusual Campylobacter were isolated from 8 subjects (including 3 C. concisus , 1 C. curvus , 1 C. lari , 1 C. rectus , 3 C. showae ).", {"entities": []}], ["No Helicobacter were cultured.", {"entities": []}], ["When comparing IBD vs. normal colon control by PCR the prevalence figures were not significantly different ( Helicobacter 11% vs. 12%, p\u200a=\u200a1.00; Campylobacter 75% vs. 76%, p\u200a=\u200a1.00; S. wadsworthensis 82% vs. 71%, p\u200a=\u200a0.312).", {"entities": []}], ["This study offers a comprehensive overview of the microaerophilic microbiota of the paediatric colon including at IBD onset.", {"entities": []}], ["Campylobacter appear to be surprisingly common, are not more strongly associated with IBD and can be isolated from around 8% of paediatric colonic biopsies.", {"entities": []}], ["S. wadsworthensis appears to be a common commensal.", {"entities": []}], ["Helicobacter species are relatively rare in the paediatric colon.", {"entities": []}], ["This study is publically registered on the United Kingdom Clinical Research Network Portfolio (9633).", {"entities": []}], ["From airborne particulatesto pesticide-laden fruit, children probably encounter more pollutants than adults.", {"entities": []}], ["Because their bodies are rapidly developing, children may react more strongly to these toxins, too.", {"entities": []}], ["The NIEHS hopes to learn more about how several hazardous agents specifically affect kids.", {"entities": []}], ["Together, the NIEHS and the EPA are spending $10 million to establish up to six Centers for Children's Environmental Health and Disease Prevention Research.", {"entities": []}], ["The CDC, a third partner,will later help apply center research to public health.", {"entities": []}], ["Human phospholipase A 2 ( h PLA 2 ) of the IIA group (HGIIA) catalyzes the hydrolysis of membrane phospholipids, producing arachidonic acid and originating potent inflammatory mediators.", {"entities": []}], ["Therefore, molecules that can inhibit this enzyme are a source of potential anti-inflammatory drugs, with different action mechanisms of known anti-inflammatory agents.", {"entities": []}], ["For the study and development of new anti-inflammatory drugs with this action mechanism, snake venom PLA 2 ( sv PLA 2 ) can be employed, since the sv PLA 2 has high similarity with the human PLA 2 HGIIA.", {"entities": []}], ["Despite the high similarity between these secretory PLA 2 s , it is still not clear if these toxins can really be employed as an experimental model to predict the interactions that occur with the human PLA 2 HGIIA and its inhibitors.", {"entities": []}], ["Thus, the present study aims to compare and evaluate, by means of theoretical calculations, docking and molecular dynamics simulations, as well as experimental studies, the interactions of human PLA 2 HGIIA and two sv PLA 2 s , Bothrops toxin II and Crotoxin B (BthTX-II and CB, respectively).", {"entities": []}], ["Our theoretical findings corroborate experimental data and point out that the human PLA 2 HGIIA and sv PLA 2 BthTX-II lead to similar interactions with the studied compounds.", {"entities": []}], ["From our results, the sv PLA 2 BthTX-II can be used as an experimental model for the development of anti-inflammatory drugs for therapy in humans.", {"entities": []}], ["Idiopathic pulmonary fibrosis, the most common form of idiopathic interstitial pneumonia, is characterized by progressive, irreversible scarring of the lung parenchyma.", {"entities": [[55, 88, "DISEASE"], [79, 88, "DISEASE"], [11, 29, "DISEASE"], [0, 29, "DISEASE"]]}], ["Idiopathic pulmonary fibrosis has a poor prognosis, and there are no medical therapies available that have been shown to improve survival.", {"entities": [[11, 29, "DISEASE"], [0, 29, "DISEASE"]]}], ["It is usually sporadic, but there is evidence of familial clustering of pulmonary fibrosis, suggesting a genetic basis for this disease.", {"entities": [[72, 90, "DISEASE"]]}], ["More recently, studies have confirmed that specific genetic variants are associated with both familial and sporadic forms of pulmonary fibrosis.", {"entities": [[125, 143, "DISEASE"]]}], ["Although there are common and rare genetic variants that have been associated with the risk of developing pulmonary fibrosis, the genotyping of patients is not a generally accepted strategy.", {"entities": [[106, 124, "DISEASE"]]}], ["Better understanding of the interplay between genetic risk and environmental exposure is likely needed to inform both treatment and disease prevention.", {"entities": []}], ["Several identified disease-associated genetic variants have implications for disease progression and survival, but systematic studies of known genetic variants and their influence on therapeutic efficacy are lacking.", {"entities": []}], ["Future investigations should focus on understanding phenotypic differences between patients carrying different risk alleles, and clinical studies should be designed to control for the influence of different genetic risk variants on patient outcomes.", {"entities": []}], ["Inherited genetic factors play a significant role in the risk of developing pulmonary fibrosis.", {"entities": [[76, 94, "DISEASE"]]}], ["Future studies will be needed to characterize patient phenotypes and to understand how these genetic factors will influence clinical decision-making for both diagnosis and treatment of idiopathic pulmonary fibrosis.", {"entities": [[196, 214, "DISEASE"], [185, 214, "DISEASE"]]}], ["Introduction: Doxycycline is highly effective, inexpensive with a broad therapeutic spectrum and exceptional bioavailability.", {"entities": []}], ["However these benefits have been overshadowed by its classification alongside the tetracyclines \u2013 class D drugs, contraindicated in pregnancy and in children under 8 years of age.", {"entities": []}], ["Doxycycline-treatable diseases are emerging as leading causes of undifferentiated febrile illness in Southeast Asia.", {"entities": []}], ["For example scrub typhus and murine typhus have an unusually severe impact on pregnancy outcomes, and current mortality rates for scrub typhus reach 12-13% in India and Thailand.", {"entities": [[12, 24, "DISEASE"], [130, 142, "DISEASE"], [18, 24, "DISEASE"], [36, 42, "DISEASE"], [136, 142, "DISEASE"]]}], ["The emerging evidence for these important doxycycline-treatable diseases prompted us to revisit doxycycline usage in pregnancy and childhood.", {"entities": []}], ["Areas Covered: A systematic review of the available literature on doxycycline use in pregnant women and children revealed a safety profile of doxycycline that differed significantly from that of tetracycline; no correlation between the use of doxycycline and teratogenic effects during pregnancy or dental staining in children was found.", {"entities": []}], ["Expert Opinion: The change of the US FDA pregnancy classification scheme to an evidence-based approach will enable adequate evaluation of doxycycline in common tropical illnesses and in vulnerable populations in clinical treatment trials, dosage-optimization pharmacokinetic studies and for the empirical treatment of undifferentiated febrile illnesses, especially in pregnant women and children.", {"entities": []}], ["The aim of this study was to examine the relationship between types and amount of social activity and health-related quality of life according to gender and age group.", {"entities": []}], ["This study used data from the Community Health Survey (CHS), which was collected in 2011 and consisted of 229,226 participants aged 19 or older.", {"entities": []}], ["A linear mixed effects model was used to evaluate the factors influencing health-related quality of life among individuals tracked in the CHS and, in particular, to analyze the associations between the amount and types of social activities participated in and the EuroQol EQ-5D assessment.", {"entities": []}], ["We found that the average quality of life increased according to the amount of social activities individuals participated in (zero\u2009=\u200989.30, one\u2009=\u200993.28, two\u2009=\u200995.25, three\u2009=\u200996.27, four\u2009=\u200996.85).", {"entities": []}], ["When people participated in one social activity, social activity was more strongly associated with EQ-5D in the elderly age group (males: 19\u201334 years\u2009=\u20090.195, 35\u201349 years\u2009=\u20090.642, 50\u201364 years\u2009=\u20091.716, \u226565\u00a0years\u2009=\u20094.408; females: 19\u201334 years\u2009=\u20090.170, 35\u201349 years\u2009=\u20090.502, 50\u201364 years\u2009=\u20091.411, \u226565\u00a0years\u2009=\u20094.180).", {"entities": []}], ["More participation was positively associated with higher EQ-5D (one\u2009=\u20091.939, two\u2009=\u20092.377, three\u2009=\u20092.439, four\u2009=\u20092.515, p for trend\u2009<\u20090.0001).", {"entities": []}], ["In females, those who participated in relationship organizations had a higher EQ-5D than those who participated in other types of social activities (Females \u226565 age group; Relationship\u2009=\u20094.373, Leisure\u2009=\u20092.620, Religion\u2009=\u20091.842, Charity\u2009=\u20091.544).", {"entities": []}], ["There was a positive association between the increase in the number of social activities and increase in health-related quality of life, especially when evaluated in terms of type of social activities and health-related quality of life according to gender and age group.", {"entities": []}], ["The purpose of the present study was to analyze the relationship between the levels of air pollutants and respiratory function/physical efficiency of pre-adolescent children living in the Upper Silesian Industrial Region.", {"entities": []}], ["Spirometric evaluations and physical exercise test were performed in 103 children aged 14-16.", {"entities": []}], ["Standard spirometry was used to analyze: vital capacity (VC), forced vital capacity (FVC), forced expiratory volume in 1 second (FEV 1 ), and maximal voluntary volume (MVV).", {"entities": [[129, 132, "GENE"]]}], ["From 1994 through 2008, air pollutants were regularly monitored, and compared with reference ranges.", {"entities": []}], ["Differences were noted in the average annual pollutant (SO 2 , NO 2 , PM 10 , CO) concentrations during the observation period.", {"entities": []}], ["Exposure to air pollution was associated with reduced respiratory function and may lead to a decline in physical efficiency in pre-adolescent children.", {"entities": []}], ["The pollution-related reduction of lung function in childhood might be related, at least partially, to long-term exposure to particulate air pollutants, and especially in those children who spend more time practicing outdoor sports.", {"entities": []}], ["The increasing age of coronary artery disease (CAD) patients and the occurrence of sarcopenia in the elderly population accompanied by 'fear of moving' and hospitalization in these patients often results in a substantial loss of skeletal muscle mass and muscle strength.", {"entities": []}], ["Cardiac rehabilitation can improve exercise tolerance and muscle strength in CAD patients but less data describe eventual morphological muscular changes possibly by more difficult access to imaging techniques.", {"entities": []}], ["Therefore the aim of this study is to assess and quantify the reliability and validity of an easy applicable method, the ultrasound (US) technique, to measure the diameter of rectus femoris muscle in comparison to the muscle dimensions measured with CT scans.", {"entities": []}], ["45 older CAD patients without cardiac event during the last 9 months were included in this study.", {"entities": []}], ["25 patients were tested twice with ultrasound with a two day interval to assess test-retest reliability and 20 patients were tested twice (once with US and once with CT) on the same day to assess the validity of the US technique compared to CT as the gold standard.", {"entities": []}], ["Isometric and isokinetic muscle testing was performed to test potential zero-order correlations between muscle diameter, muscle volume and muscle force.", {"entities": []}], ["An intraclass correlation coefficient (ICC) of 0.97 ((95%CL: 0.92 - 0.99) was found for the test-retest reliability of US and the ICC computed between US and CT was 0.92 (95%CL: 0.81 - 0.97).", {"entities": []}], ["The absolute difference between both techniques was 0.01 \u00b1 0.12 cm (p = 0.66) resulting in a typical percentage error of 4.4%.", {"entities": []}], ["Significant zero-order correlations were found between local muscle volume and muscle diameter assessed with CT (r = 0.67, p = 0.001) and assessed with US (r = 0.49, p < 0.05).", {"entities": []}], ["Muscle strength parameters were also significantly correlated with muscle diameter assessed with both techniques (range r = 0.45-r = 0.61, p < 0.05).", {"entities": []}], ["Ultrasound imaging can be used as a valid and reliable measurement tool to assess the rectus femoris muscle diameter in older CAD patients.", {"entities": []}], ["Selective cyclooxygenase-2 (COX-2) inhibitors are analgesic, antipyretic, and anti-inflammatory drugs.", {"entities": []}], ["They have been found to inhibit the development of glioma in laboratory investigations.", {"entities": []}], ["Whether these drugs reduce the risk of glioma incidence in humans is unknown.", {"entities": []}], ["We conducted a matched case-control analysis using the U.K.-based Clinical Practice Research Datalink (CPRD).", {"entities": []}], ["We identified 2,469 cases matched to 24,690 controls on age, sex, calendar time, general practice, and number of years of active history in the CPRD prior to the index date.", {"entities": []}], ["We conducted conditional logistic regression analyses to determine relative risks, estimated as odds ratios (ORs) with 95% confidence intervals (CIs) of glioma in relation to use of selective COX-2 inhibitors, adjusted for several confounding variables.", {"entities": []}], ["Use of selective COX-2 inhibitors was unrelated to risk of glioma (adjusted OR for 1\u20139 versus 0 prescriptions = 1.02; 95% CI = 0.92\u20131.13, 10\u201329 versus 0 prescriptions = 1.01; 95% CI = 0.80\u20131.28, \u226530 versus 0 prescriptions = 1.16; 95% CI = 0.86\u20131.55).", {"entities": []}], ["Trends for increasing numbers of prescriptions for other non-steroidal anti-inflammatory drugs (NSAIDs), and non-NSAID analgesics were also not associated with glioma risk.", {"entities": []}], ["Further epidemiologic studies are needed to confirm the null relation of use of selective COX-2 inhibitors to glioma risk and to explain the discrepancy between laboratory investigations and our observational study.", {"entities": []}], ["Impact: Use of selective COX-2 inhibitors is unrelated to glioma risk.", {"entities": []}], ["Reduced lung function in patients with chronic obstructive pulmonary disease (COPD) is likely due to both environmental and genetic factors.", {"entities": [[39, 76, "DISEASE"]]}], ["We report here a targeted high-throughput DNA sequencing approach to identify new and previously known genetic variants in a set of candidate genes for COPD.", {"entities": []}], ["Exons in 22 genes implicated in lung development as well as 61 genes and 10 genomic regions previously associated with COPD were sequenced using individual DNA samples from 68 cases with moderate or severe COPD and 66 controls matched for age, gender and smoking.", {"entities": []}], ["Cases and controls were selected from the Obstructive Lung Disease in Northern Sweden (OLIN) studies.", {"entities": []}], ["In total, 37 genetic variants showed association with COPD ( p \u2009<\u20090.05, uncorrected).", {"entities": []}], ["Several variants previously discovered to be associated with COPD from genetic genome-wide analysis studies were replicated using our sample.", {"entities": []}], ["Two high-risk variants were followed-up for functional characterization in a large eQTL mapping study of 1,111 human lung specimens.", {"entities": []}], ["The C allele of a synonymous variant, rs8040868, predicting a p.(S45=) in the gene for cholinergic receptor nicotinic alpha 3 ( CHRNA3 ) was associated with COPD ( p \u2009=\u20098.8 x 10 p \u2009=\u20090.003 and OR\u2009=\u20091.4, 95\u00a0% CI 1.1-1.7) when analysing all available cases and controls in OLIN ( n \u2009=\u20091,534).", {"entities": [[128, 134, "GENE"]]}], ["The rs8040868 variant is in linkage disequilibrium with rs16969968 previously associated with COPD and altered expression of the CHRNA5 gene.", {"entities": [[129, 135, "GENE"]]}], ["A follow-up analysis for detection of expression quantitative trait loci revealed that rs8040868-C was found to be significantly associated with a decreased expression of the nearby gene cholinergic receptor, nicotinic, alpha 5 ( CHRNA5 ) in lung tissue.", {"entities": [[230, 236, "GENE"]]}], ["Our data replicate previous result suggesting CHRNA5 as a candidate gene for COPD and rs8040868 as a risk variant for the development of COPD in the Swedish population.", {"entities": [[46, 52, "GENE"]]}], ["The online version of this article (doi:10.1186/s12890-016-0309-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Transcatheter aortic valve implantation is an alternative to open heart surgery in high risk patients with severe aortic stenosis.", {"entities": []}], ["High mortality and complications related to cardiopulmonary bypass for conventional open heart surgery can be avoided with this new less invasive technique.", {"entities": []}], ["In case of concomitant severe arterial disease, the transapical approach is recommended rather than transfemoral access.", {"entities": []}], ["An 80-yr-old man with symptomatic aortic stenosis and who had very high surgical risk factors such as diabetes mellitus, hypertension, a history of stroke, bronchial asthma including poor pulmonary function and hepatocellular carcinoma was treated with a transapical aortic valve replacement.", {"entities": [[121, 133, "DISEASE"], [211, 235, "DISEASE"], [226, 235, "DISEASE"], [166, 172, "DISEASE"], [102, 119, "DISEASE"]]}], ["The expected mortality in this patient was 25.4% by Euroscore if we performed the conventional aortic valve surgery.", {"entities": []}], ["The patient was discharged and was well at the 45 follow-up days.", {"entities": []}], ["We report the first case of successful transcatheter transapical aortic valve implantation which is available recently in Korea.", {"entities": []}], ["Triptans have been safely and effectively used in the management of migraine for more than fifteen years, and it seems reasonable to wonder what would be the economic impact of moving a specific triptan to OTC availability.", {"entities": [[68, 76, "DISEASE"], [206, 209, "GENE"]]}], ["The objective of this study was then to examine the economic impact of payer policies of a triptan Rx-to-OTC switch in six EU countries (France, UK, Spain, Italy, Germany and Poland).", {"entities": []}], ["A decision model was used to model the budgetary impact of a triptan Rx-to-OTC switch from the third-party payer (TPP) and the societal perspectives, using a one-year timeframe.", {"entities": []}], ["From the TPP perspective, it is estimated that the current overall direct spending on the management of migraine attacks across the 6 EU Member States is \u20ac582 million annually, and that the savings would reach \u20ac75 million (13% of the overall direct economic burden of migraine).", {"entities": [[104, 112, "DISEASE"], [268, 276, "DISEASE"]]}], ["From the societal perspective, \u20ac86 million annually would be added.", {"entities": []}], ["Given evidence of effectiveness and safety, and given the potential savings, a triptan Rx-to-OTC switch is a reasonable public policy decision.", {"entities": []}], ["Invasive Staphylococcus aureus infection is increasingly recognised as an important cause of serious sepsis across the developing world, with mortality rates higher than those in the developed world.", {"entities": []}], ["The factors determining mortality in developing countries have not been identified.", {"entities": []}], ["A prospective, observational study of invasive S. aureus disease was conducted at a provincial hospital in northeast Thailand over a 1-year period.", {"entities": []}], ["All-cause and S. aureus -attributable mortality rates were determined, and the relationship was assessed between death and patient characteristics, clinical presentations, antibiotic therapy and resistance, drainage of pus and carriage of genes encoding Panton-Valentine Leukocidin (PVL).", {"entities": []}], ["A total of 270 patients with invasive S. aureus infection were recruited.", {"entities": []}], ["The range of clinical manifestations was broad and comparable to that described in developed countries.", {"entities": []}], ["All-cause and S. aureus -attributable mortality rates were 26% and 20%, respectively.", {"entities": []}], ["Early antibiotic therapy and drainage of pus were associated with a survival advantage (both p<0.001) on univariate analysis.", {"entities": []}], ["Patients infected by a PVL gene-positive isolate (122/248 tested, 49%) had a strong survival advantage compared with patients infected by a PVL gene-negative isolate (all-cause mortality 11% versus 39% respectively, p<0.001).", {"entities": []}], ["Multiple logistic regression analysis using all variables significant on univariate analysis revealed that age, underlying cardiac disease and respiratory infection were risk factors for all-cause and S. aureus- attributable mortality, while one or more abscesses as the presenting clinical feature and procedures for infectious source control were associated with survival.", {"entities": []}], ["Drainage of pus and timely antibiotic therapy are key to the successful management of S. aureus infection in the developing world.", {"entities": []}], ["Defining the presence of genes encoding PVL provides no practical bedside information and draws attention away from identifying verified clinical risk factors and those interventions that save lives.", {"entities": []}], ["Obesity is the cause of other chronic diseases, psychological problems, obesity shortens the lifespan and puts strain on health systems.", {"entities": [[0, 7, "DISEASE"], [72, 79, "DISEASE"]]}], ["The risk associated with childhood obesity in particular, which will accelerate the development of adult morbidity and mortality, has been identified as an emerging public health problem.", {"entities": [[35, 42, "DISEASE"]]}], ["To estimate the length of stay and associated hospital costs for obesity related illnesses a cost of illness study was set up.", {"entities": [[65, 72, "DISEASE"]]}], ["All discharges from all acute hospitals in the Republic of Ireland from 1997 to 2004 with a principal or secondary diagnostic code for obesity for all children from 6 to 18 years of age and for adults were collected.", {"entities": [[135, 142, "DISEASE"]]}], ["A discharge frequency was calculated by dividing obesity related discharges by the total number of diagnoses (principal and secondary) for each year.", {"entities": [[49, 56, "DISEASE"]]}], ["The hospital costs related to obesity was calculated based on the total number of days care.", {"entities": [[30, 37, "DISEASE"]]}], ["The discharge frequency of obesity related conditions increased from 1.14 in 1997 to 1.49 in 2004 for adults and from 0.81 to 1.37 for children.", {"entities": [[27, 34, "DISEASE"]]}], ["The relative length of stay (number of days in care for obesity related conditions per 1000 days of hospital care given) increased from 1.47 in 1997 to 4.16 in 2004 for children and from 3.68 in 1997 to 6.74 in 2004 for adults.", {"entities": [[56, 63, "DISEASE"]]}], ["Based on the 2001 figures for cost per inpatient bed day, the annual hospital cost was calculated to be 4.4 Euromillion in 1997, increasing to 13.3 Euromillion in 2004.", {"entities": []}], ["At a 20% variable hospital cost the cost ranges from 0.9 Euromillion in 1997 to 2.7 Euromillion in 2004; a 200% increase.", {"entities": []}], ["The annual increase in the proportion of hospital discharges related to obesity is alarming.", {"entities": [[72, 79, "DISEASE"]]}], ["This increase is related to a significant increase in economic costs.", {"entities": []}], ["This paper emphasises the need for action at an early stage of life.", {"entities": []}], ["Health promotion and primary prevention of obesity should be high on the political agenda.", {"entities": [[43, 50, "DISEASE"]]}], ["Bronchodilators represent the hallmark of symptomatic treatment of Chronic Obstructive Pulmonary Disease (COPD).", {"entities": []}], ["There are four categories of bronchodilators: anticholinergics, methylxanthines, short-acting \u03b2 2 -agonists, and long-acting \u03b2 2 -agonists such as formoterol.", {"entities": []}], ["Significant research has been performed to investigate the efficacy, safety and tolerability of formoterol in the therapeutic field of COPD.", {"entities": []}], ["Formoterol exhibits a rapid onset of bronchodilation similar to that observed with salbutamol, yet its long bronchodilatory duration is comparable to salmeterol.", {"entities": []}], ["In addition, formoterol presents with a clear superiority in lung function improvement compared with either ipratropium bromide or oral theophylline, while its efficacy improves when administered in combination with ipratropium.", {"entities": []}], ["Formoterol has been shown to better reduce dynamic hyperinflation, which is responsible for exercise intolerance and dyspnea in COPD patients, compared with other bronchodilators, whereas it exerts synergistic effect with tiotropium.", {"entities": []}], ["Moreover, formoterol reduces exacerbations, increases days free of use of rescue medication and improves patients\u2019 quality of life and disease symptoms.", {"entities": []}], ["Formoterol has a favorable safety profile and is better tolerated than theophylline.", {"entities": []}], ["Collectively, data extracted from multicenter clinical trials support formoterol as a valid therapeutic option in the treatment of COPD.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease with pulmonary and extra-pulmonary manifestations.", {"entities": []}], ["Although COPD is a complex disease, diagnosis and staging are still based on simple spirometry measurements.", {"entities": []}], ["Different COPD phenotypes exist based on clinical, physiological, immunological and radiological observations.", {"entities": []}], ["Cigarette smoking is the most important risk factor for COPD, but only 15\u201320% of smokers develop the disease, suggesting a genetic predisposition.", {"entities": []}], ["Unfortunately, little is known about the pathogenesis of COPD, and even less on the very first steps that are associated with an aberrant response to smoke exposure.", {"entities": []}], ["This study aims to investigate the underlying local and systemic inflammation of different clinical COPD phenotypes, and acute effects of cigarette smoke exposure in individuals susceptible and non-susceptible for the development of COPD.", {"entities": []}], ["Furthermore, we will investigate mechanisms associated with corticosteroid insensitivity.", {"entities": []}], ["Our study will provide valuable information regarding the pathogenetic mechanisms underlying the natural course of COPD.", {"entities": []}], ["This cross-sectional study will include young and old individuals susceptible or non-susceptible to develop COPD.", {"entities": []}], ["At a young age (18\u201340\u2005years) 60 \u2018party smokers\u2019 will be included who are called susceptible or non-susceptible based on COPD prevalence in smoking family members.", {"entities": []}], ["In addition, 30 healthy smokers (age 40\u201375\u2005years) and 110 COPD patients will be included.", {"entities": []}], ["Measurements will include questionnaires, pulmonary function, low-dose CT scanning of the lung, body composition, 6\u2005min walking distance and biomarkers in peripheral blood, sputum, urine, exhaled breath condensate, epithelial lining fluid, bronchial brushes and biopsies.", {"entities": []}], ["Non-biased approaches such as proteomics will be performed in blood and epithelial lining fluid.", {"entities": []}], ["This multicentre study was approved by the medical ethical committees of UMC Groningen and Utrecht, the Netherlands.", {"entities": []}], ["The study findings will be presented at conferences and will be reported in peer-reviewed journals.", {"entities": []}], ["ClinicalTrials.gov, NCT00807469 (study 1) and NCT00850863 (study 2).", {"entities": []}], ["Sarcoidosis is a granulomatous inflammatory disease, possibly of infectious aetiology.", {"entities": [[0, 11, "DISEASE"]]}], ["We aimed to investigate whether the degree of functional polarization of alveolar macrophages (AMs), or Toll-like receptor (TLR) expression, is associated with sarcoidosis or with distinct clinical manifestations of this disease.", {"entities": [[160, 171, "DISEASE"]]}], ["Total BAL cells (cultured four or 24 h in medium, or stimulated 24 h with LPS) from 14 patients and six healthy subjects, sorted AMs from 22 patients (L\u00f6fgren's syndrome n = 11) and 11 healthy subjects, and sorted CD4+ T cells from 26 patients (L\u00f6fgren's syndrome n = 13) and seven healthy subjects, were included.", {"entities": [[161, 169, "DISEASE"], [255, 263, "DISEASE"]]}], ["Using real-time PCR, the relative gene expression of IL-10, IL-12p35, IL-12p40, IL-23p19, CCR2, CCR7, iNOS, CXCL10, CXCL11, CXCL16, CCL18, CCL20, CD80, and CD86, and innate immune receptors TLR2, TLR4, and TLR9, was quantified in sorted AMs, and for selected genes in total BAL cells, while IL-17A was quantified in T cells.", {"entities": [[90, 94, "GENE"], [96, 100, "GENE"], [108, 114, "GENE"], [116, 122, "GENE"], [124, 130, "GENE"], [132, 137, "GENE"], [139, 144, "GENE"], [146, 150, "GENE"], [156, 160, "GENE"], [190, 194, "GENE"], [196, 200, "GENE"], [206, 210, "GENE"]]}], ["We did not find evidence of a difference with regard to alveolar macrophage M1/M2 polarization between sarcoidosis patients and healthy controls.", {"entities": [[103, 114, "DISEASE"]]}], ["TLR2 gene expression was significantly lower in sorted AMs from patients, particular in L\u00f6fgren's patients.", {"entities": [[0, 4, "GENE"]]}], ["CCL18 gene expression in AMs was significantly higher in patients compared to controls.", {"entities": [[0, 5, "GENE"]]}], ["Additionally, the IL-17A expression was lower in L\u00f6fgren's patients' CD4+ T cells.", {"entities": []}], ["Overall, there was no evidence for alveolar macrophage polarization in sarcoidosis.", {"entities": [[71, 82, "DISEASE"]]}], ["However, there was a reduced TLR2 mRNA expression in patients with L\u00f6fgren's syndrome, which may be of relevance for macrophage interactions with a postulated sarcoidosis pathogen, and for the characteristics of the ensuing T cell response.", {"entities": [[77, 85, "DISEASE"], [159, 170, "DISEASE"], [29, 33, "GENE"]]}], ["In this study we investigated the potential impact of climate change in Portugal on heat-related mortality, air pollution\u2013related health effects, and selected vectorborne diseases.", {"entities": []}], ["The assessment used climate scenarios from two regional climate models for a range of future time periods.", {"entities": []}], ["The annual heat-related death rates in Lisbon may increase from between 5.4 and 6 per 100,000 in 1980\u20131998 to between 8.5 and 12.1 by the 2020s and to a maximum of 29.5 by the 2050s, if no adaptations occur.", {"entities": []}], ["The projected warmer and more variable weather may result in better dispersion of nitrogen dioxide levels in winter, whereas the higher temperatures may reduce air quality during the warmer months by increasing tropospheric ozone levels.", {"entities": []}], ["We estimated the future risk of zoonoses using ecologic scenarios to describe future changes in vectors and parasites.", {"entities": []}], ["Malaria and schistosomiasis, which are currently not endemic in Portugal, are more sensitive to the introduction of infected vectors than to temperature changes.", {"entities": [[12, 27, "DISEASE"]]}], ["Higher temperatures may increase the transmission risk of zoonoses that are currently endemic to Portugal, such as leishmaniasis, Lyme disease, and Mediterranean spotted fever.", {"entities": [[115, 128, "DISEASE"], [162, 175, "DISEASE"]]}], ["Recent epidemiological studies have found that the prevalence of high blood pressure (BP) has significantly increased among children and adolescents.", {"entities": []}], ["The aim of this study was to examine the associations between short sleep duration and prehypertension and hypertension in Lithuanian children and adolescents aged 12 to 15\u00a0years.", {"entities": [[107, 119, "DISEASE"]]}], ["A cross-sectional study was conducted from November 2010 to April 2012.", {"entities": []}], ["The participants with high BP (\u226590th percentile) were screened on two separate occasions.", {"entities": []}], ["Self-reported sleep duration was evaluated using questionnaires.", {"entities": []}], ["Data on 6,940 subjects aged 12\u201315\u00a0years were analyzed.", {"entities": []}], ["Adjusted odds ratios (aORs) with 95% confidence intervals for the associations were estimated using multivariate logistic regression models.", {"entities": []}], ["Short sleep duration was defined as <8\u00a0hours per day (h/day).", {"entities": []}], ["The prevalence of prehypertension and hypertension in the current sample was 12.6% and 22.5%, respectively.", {"entities": [[38, 50, "DISEASE"]]}], ["The percentages of the subjects with sleep durations of <7 (h/day), 7\u2013\u2009<\u20098\u00a0h/day, and \u22658\u00a0h/day were 8.7%, 21.0%, and 70.3%, respectively.", {"entities": []}], ["After adjusting for age, sex, body mass index, physical activity, and smoking, significant associations were found between short sleep duration and high BP, including prehypertension (7\u2013\u2009<\u20098\u00a0h/day: aOR\u2009=\u20091.77; 95% CI, 1.48\u20132.12; <7\u00a0h/day: aOR\u2009=\u20092.18; 95% CI, 1.70\u20132.79) and hypertension (7\u2013\u2009<\u20098\u00a0h/day: aOR\u2009=\u20091.99; 95% CI, 1.72\u20132.31; <7\u00a0h/day: aOR\u2009=\u20092.28; 95% CI, 1.85\u20132.80) (all P values <0.001), compared to participants who were sleeping longer (\u22658\u00a0h/day).", {"entities": [[274, 286, "DISEASE"]]}], ["Prehypertension and hypertension were associated with short sleep duration among Lithuanian children and adolescents aged 12 to 15\u00a0years.", {"entities": [[20, 32, "DISEASE"]]}], ["Dyspnea is among the most common reasons for emergency department (ED) visits by patients with cardiopulmonary disease who are commonly asked to recall the symptoms that prompted them to come to the ED.", {"entities": []}], ["The reliability of recalled dyspnea has not been systematically investigated in ED patients.", {"entities": []}], ["Patients with chronic or acute cardiopulmonary conditions who came to the ED with dyspnea ( N \u2009=\u2009154) completed the Multidimensional Dyspnea Profile (MDP) several times during the visit and in a follow-up visit 4 to 6\u2009weeks later ( n \u2009=\u200968).", {"entities": []}], ["The MDP has 12 items with numerical ratings of intensity, unpleasantness, sensory qualities, and emotions associated with how breathing felt when participants decided to come to the ED (recall MDP) or at the time of administration (\u201cnow\u201d MDP).", {"entities": []}], ["The recall MDP was administered twice in the ED and once during the follow-up visit.", {"entities": []}], ["Principal components analysis (PCA) with varimax rotation was used to assess domain structure of the recall MDP.", {"entities": []}], ["Internal consistency reliability was assessed with Cronbach\u2019s alpha.", {"entities": []}], ["Test\u2013retest reliability was assessed with intraclass correlation coefficients (ICCs) for absolute agreement for individual items and domains.", {"entities": []}], ["PCA of the recall MDP was consistent with two domains (Immediate Perception, 7 items, Cronbach\u2019s alpha\u2009=\u2009.89 to .94; Emotional Response, 5 items; Cronbach\u2019s alpha\u2009=\u2009.81 to .85).", {"entities": []}], ["Test\u2013retest ICCs for the recall MDP during the ED visit ranged from .70 to .87 for individual items and were .93 and .94 for the Immediate Perception and Emotional Response domains.", {"entities": []}], ["ICCs were much lower for the interval between the ED visit and follow-up, both for individual items (.28 to .66) and for the Immediate Perception and Emotional Response domains (.72 and .78, respectively).", {"entities": []}], ["During an ED visit, recall MDP ratings of dyspnea at the time participants decided to seek care in the ED are reliable and sufficiently stable, both for individual items and the two domains, that a time lag between arrival and questionnaire administration does not critically affect recall of perceptual and emotional characteristics immediately prior to the visit.", {"entities": []}], ["However, test\u2013retest reliability of recall over a 4- to 6-week interval is poor for individual items and significantly attenuated for the two domains.", {"entities": []}], ["Parasympathetic signaling has been inferred to regulate epithelial branching as well as organ regeneration and tumor development.", {"entities": []}], ["However, the relative contribution of local nerve contact versus secreted signals remains unclear.", {"entities": []}], ["Here, we show a conserved (vertebrates to invertebrates) requirement for intact local nerves in airway branching, persisting even when cholinergic neurotransmission is blocked.", {"entities": []}], ["In the vertebrate lung, deleting enhanced green fluorescent protein (eGFP)-labeled intrinsic neurons using a two-photon laser leaves adjacent cells intact, but abolishes branching.", {"entities": []}], ["Branching is unaffected by similar laser power delivered to the immediately adjacent non-neural mesodermal tissue, by blocking cholinergic receptors or by blocking synaptic transmission with botulinum toxin A.", {"entities": []}], ["Because adjacent vasculature and epithelial proliferation also contribute to branching in the vertebrate lung, the direct dependence on nerves for airway branching was tested by deleting neurons in Drosophila embryos.", {"entities": []}], ["A specific deletion of neurons in the Drosophila embryo by driving cell-autonomous RicinA under the pan-neuronal elav enhancer perturbed Drosophila airway development.", {"entities": []}], ["This system confirmed that even in the absence of a vasculature or epithelial proliferation, airway branching is still disrupted by neural lesioning.", {"entities": []}], ["Together, this shows that airway morphogenesis requires local innervation in vertebrates and invertebrates, yet neurotransmission is dispensable.", {"entities": []}], ["The need for innervation persists in the fly, wherein adjacent vasculature and epithelial proliferation are absent.", {"entities": []}], ["Our novel, targeted laser ablation technique permitted the local function of parasympathetic innervation to be distinguished from neurotransmission.", {"entities": []}], ["The online version of this article (doi:10.1186/s12915-014-0092-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aryl hydrocarbon receptor (AHR) binds to environmental toxicants including synthetic halogenated aromatic hydrocarbons and is involved in a diverse array of biological processes.", {"entities": [[31, 34, "GENE"]]}], ["Recently, the AHR was shown to control host immunity by affecting the balance between inflammatory T cells that produce IL-17 (Th17) and IL-22 versus regulatory T cells (Treg) involved in tolerance.", {"entities": [[14, 17, "GENE"]]}], ["While environmental AHR ligands can mediate this effect, endogenous ligands are likely to be more relevant in host immune responses.", {"entities": [[20, 23, "GENE"]]}], ["We investigated downstream metabolites of tryptophan as potential AHR ligands because (1) tryptophan metabolites have been implicated in regulating the balance between Th17 and Treg cells and (2) many of the AHR ligands identified thus far are derivatives of tryptophan.", {"entities": [[66, 69, "GENE"], [208, 211, "GENE"], [66, 69, "GENE"], [208, 211, "GENE"]]}], ["We characterized the ability of tryptophan metabolites to bind and activate the AHR and to increase IL-22 production in human T cells.", {"entities": [[80, 83, "GENE"]]}], ["We report that the tryptophan metabolite, cinnabarinic acid (CA), is an AHR ligand that stimulates the differentiation of human and mouse T cells producing IL-22.", {"entities": [[72, 75, "GENE"]]}], ["We compare the IL-22-stimulating activity of CA to that of other tryptophan metabolites and define stimulation conditions that lead to CA production from immune cells.", {"entities": []}], ["Our findings link tryptophan metabolism to AHR activation and define a novel endogenous AHR agonist with potentially broad biological functions.", {"entities": [[43, 46, "GENE"], [88, 91, "GENE"], [43, 46, "GENE"], [88, 91, "GENE"]]}], ["Economic evaluation is a tool used to inform decision makers on the efficiency of comparative healthcare interventions and inform resource allocation decisions.", {"entities": []}], ["There is a growing need for the use of economic evaluations to assess the value of interventions for children with neurodevelopmental disorders (NDDs), a population that has increasing demands for healthcare services.", {"entities": []}], ["Unfortunately, few evaluations have been conducted to date, perhaps stemming from challenges in applying existing economic evaluation methodologies in this heterogeneous population.", {"entities": []}], ["Opportunities exist to innovate methods to address key challenges in conducting economic evaluations of interventions for children with NDDs.", {"entities": []}], ["In this paper, we discuss important considerations and highlight areas for future work.", {"entities": []}], ["This includes the paucity of appropriate instruments for measuring outcomes meaningful to children with NDDs and their families, difficulties in the measurement of costs due to service utilization in a wide variety of sectors, complexities in the measurement of caregiver and family effects and considerations in estimating long-term productivity costs.", {"entities": []}], ["Innovation and application of evaluation approaches in these areas will help inform decisions around whether the resources currently spent on interventions for children with NDDs represent good value for money, or whether greater benefits for children could be generated by spending money in other ways.", {"entities": []}], ["We focus on the role of CD8 DMR97-IRB-259", {"entities": []}], ["In vitro study of the deposition of drug particles is commonly used during development of formulations for pulmonary delivery.", {"entities": []}], ["The assay is demanding, complex, and depends on: properties of the drug and carrier particles, including size, surface characteristics, and shape; interactions between the drug and carrier particles and assay conditions, including flow rate, type of inhaler, and impactor.", {"entities": []}], ["The aerodynamic properties of an aerosol are measured in vitro using impactors and in most cases are presented as the fine particle fraction, which is a mass percentage of drug particles with an aerodynamic diameter below 5 \u03bcm.", {"entities": []}], ["In the present study, a model in the form of a mathematical equation was developed for prediction of the fine particle fraction.", {"entities": []}], ["The feature selection was performed using the R-environment package \u201cfscaret\u201d.", {"entities": []}], ["The input vector was reduced from a total of 135 independent variables to 28.", {"entities": []}], ["During the modeling stage, techniques like artificial neural networks, genetic programming, rule-based systems, and fuzzy logic systems were used.", {"entities": []}], ["The 10-fold cross-validation technique was used to assess the generalization ability of the models created.", {"entities": []}], ["The model obtained had good predictive ability, which was confirmed by a root-mean-square error and normalized root-mean-square error of 4.9 and 11%, respectively.", {"entities": []}], ["Moreover, validation of the model using external experimental data was performed, and resulted in a root-mean-square error and normalized root-mean-square error of 3.8 and 8.6%, respectively.", {"entities": []}], ["Small for gestational age (SGA) infants are at increased risk of morbidity and mortality.", {"entities": []}], ["We sought to identify risk factors associated with SGA and examined the potential for reducing the proportion of infants with SGA at a population level.", {"entities": []}], ["Birth and hospital records were linked for births occurring in 2007\u20132010 in New South Wales, Australia.", {"entities": []}], ["The analysis was stratified into three groups: preterm births, term births to non-diabetic mothers and term births to diabetic mothers.", {"entities": []}], ["Logistic regression was used to examine the association between SGA and a range of socio-demographic and behavioural factors and health conditions, with generalised estimating equations to account for correlation among births to the same mother.", {"entities": []}], ["Model-based population attributable fractions (PAFs) were calculated for risk factors that were considered causative and potentially modifiable.", {"entities": []}], ["Of 28,126 SGA infants, the largest group was term infants of non-diabetic mothers (88.5%), followed by term infants of diabetic mothers (6.3%) and preterm infants (5.3%).", {"entities": []}], ["The highest PAFs were for smoking: 12.4% for preterm SGA and 10.3% for term SGA infants of non-diabetic mothers.", {"entities": []}], ["Other risk factors for SGA that were considered modifiable included: illicit drug dependency or abuse in pregnancy in all three groups, and pregnancy hypertension and late commencement of antenatal care in term infants of non-diabetic mothers, but PAFs were less than 3%.", {"entities": [[150, 162, "DISEASE"]]}], ["There are opportunities for modest reduction of the prevalence of SGA through reduction in smoking in pregnancy, and possibly earlier commencement of antenatal care and improved management of high-risk pregnancies.", {"entities": []}], ["Alpha 1- antitrypsin (\u03b11AT) a 54\u00a0kDa glycoprotein is a protease inhibitor.", {"entities": []}], ["In the absence of \u03b11AT, elastase released by lung macrophages, was not inhibited and lead to elastin breakdown and pulmonary problems such as emphysema or COPD.", {"entities": []}], ["\u03b11AT has three site of N-glycosylation and a characteristic reactive central loop (RCL).", {"entities": []}], ["As small-scale medicines are preferred for pulmonary drug delivery, in this study \u03b11ATs (1, 2, 3, 4 and 5) were engineered and shortened from the N-terminal region.", {"entities": []}], ["In order to investigate the effect of different mutations and the deletion of 46 amino acids theoretical studies were performed.", {"entities": []}], ["Homology modeling was performed to generate the 3D structure of \u03b11ATs.", {"entities": []}], ["The 10\u00a0ns Molecular Dynamic (MD) simulations were carried out to refine the models.", {"entities": []}], ["Results from MD and protein docking showed that \u03b11AT2 has the highest binding affinity for neutrophil elastase, provided the basis for the experimental phase in which sequences from the five \u03b11AT constructs were inserted into the expression vector pGAPZ\u03b1 and expressed in the yeast Pichia pastoris .", {"entities": []}], ["Although, the \u03b11AT2 construct has the highest inhibitory activity even more that the native construct (\u03b11AT5), results indicated the presence of protease inhibitory function of all the proteins' construct against elastase.", {"entities": []}], ["A fixed-dose inhaled corticosteroid/long-acting \u03b2 2 -agonist (ICS/LABA) combination of extrafine beclometasone dipropionate and formoterol fumarate (BDP/FF) has been recently approved for use in chronic obstructive pulmonary disease (COPD).", {"entities": [[195, 232, "DISEASE"]]}], ["Small airway inflammation and remodelling are cardinal features of COPD; therefore, the ability of this extrafine formulation to reach the small, as well as the large, airways is likely to be therapeutically important by enabling treatment of inflammatory processes in the whole bronchial tree.", {"entities": []}], ["The clinical development of extrafine BDP/FF has demonstrated significant benefits over extrafine FF in terms of lung function improvement and reduction of the exacerbation rate, thus supporting the beneficial effect of an ICS combined to a LABA in COPD patients.", {"entities": []}], ["Head-to-head comparison studies versus other ICS/LABA combinations have shown that the extrafine formulation enables the clinical benefits to be achieved with a lower dose of ICS.", {"entities": []}], ["Extrafine BDP/FF showed lung function and dyspnoea improvements comparable to other ICS/LABAs, and a significantly faster onset of action was observed when compared with a salmeterol-containing fixed-dose combination.", {"entities": []}], ["This review summarises the clinical evidence supporting the efficacy of extrafine BDP/FF in COPD and confirming that extrafine BDP/FF achieves the type of health benefit expected from such a targeted ICS/LABA combination in COPD.", {"entities": []}], ["The association between ambient air pollution and adverse health effects, such as emergency room visits, hospitalizations, and mortality from respiratory and cardiovascular diseases, has been studied extensively in many countries, including Canada.", {"entities": []}], ["Recently, studies conducted in China, the Czech Republic, and the United States have related ambient air pollution to adverse pregnancy outcomes.", {"entities": []}], ["In this study, we examined association between preterm birth, low birth weight, and intrauterine growth retardation (IUGR) among singleton live births and ambient concentrations of sulfur dioxide (SO2), nitrogen dioxide (NO2), carbon monoxide (CO), and ozone in Vancouver, Canada, for 1985-1998.", {"entities": []}], ["Multiple logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for such effects.", {"entities": []}], ["Low birth weight was associated with exposure to SO2 during the first month of pregnancy (OR = 1.11, 95% CI, 1.01-1.22, for a 5.0 ppb increase).", {"entities": []}], ["Preterm birth was associated with exposure to SO2 (OR = 1.09, 95% CI, 1.01-1.19, for a 5.0 ppb increase) and to CO (OR = 1.08, 95% CI, 1.01-1.15, for a 1.0 ppm increase) during the last month of pregnancy.", {"entities": []}], ["IUGR was associated with exposure to SO2 (OR = 1.07, 95% CI, 1.01-1.13, for a 5.0 ppb increase), to NO2 (OR = 1.05, 95% CI, 1.01-1.10, for a 10.0 ppb increase), and to CO (OR = 1.06, 95% CI, 1.01-1.10, for a 1.0 ppm increase) during the first month of pregnancy.", {"entities": []}], ["In conclusion, relatively low concentrations of gaseous air pollutants are associated with adverse effects on birth outcomes in populations experiencing diverse air pollution profiles.", {"entities": []}], ["As part of its single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited the manufacturer of rituximab (Roche Products) to submit evidence of the clinical and cost effectiveness of rituximab in combination with corticosteroids for treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).", {"entities": [[353, 363, "DISEASE"]]}], ["The School of Health and Related Research Technology Appraisal Group at the University of Sheffield was commissioned to act as the independent Evidence Review Group (ERG).", {"entities": []}], ["The ERG produced a critical review of the evidence for the clinical and cost effectiveness of the technology, based upon the manufacturer\u2019s submission to NICE.", {"entities": []}], ["The evidence was derived mainly from a double-blind, phase\u00a0III, placebo-controlled trial of rituximab in patients with new or relapsed \u2018severe\u2019 AAV, which compared a rituximab treatment regimen with an oral cyclophosphamide treatment regimen.", {"entities": []}], ["Intravenous cyclophosphamide is also commonly used but was not included in the pivotal trial.", {"entities": []}], ["The evidence showed that rituximab is noninferior to oral cyclophosphamide in terms of induction of remission in adults with AAV and de\u00a0novo disease, and is superior to oral cyclophosphamide in terms of remission in adults who have relapsed once on cyclophosphamide.", {"entities": []}], ["The ERG concluded that the results of the manufacturer\u2019s economic evaluation could not be considered robust, because of errors and because the full range of relevant treatment sequences were not modelled.", {"entities": []}], ["The ERG amended the manufacturer\u2019s model and demonstrated that rituximab was likely to represent a cost-effective addition to the treatment sequence if given after cyclophosphamide treatment.", {"entities": []}], ["The functional study of different mutations on vitamin D receptor (VDR) gene causing hereditary vitamin D-resistant rickets (HVDRR) remains limited.", {"entities": [[116, 123, "DISEASE"], [67, 70, "GENE"]]}], ["This study was to determine the VDR mutation and the mechanisms of this mutation-causing phenotype in a family with HVDRR and alopecia.", {"entities": [[126, 134, "DISEASE"], [32, 35, "GENE"]]}], ["Phenotype was analyzed, and in vitro functional studies were performed.", {"entities": []}], ["The proband and his affected sister exhibited typical HVDRR with alopecia, and their biochemical and radiographic abnormalities but not alopecia responded to supraphysiological doses of active vitamin D 3 .", {"entities": [[65, 73, "DISEASE"], [136, 144, "DISEASE"]]}], ["A novel homozygous missense R343H mutation in the exon 9 of VDR residing in the retinoid X receptor (RXR)-binding domain was identified.", {"entities": [[60, 63, "GENE"]]}], ["The expression level and C-terminal conformation of R343H mutant are not different from the wild-type VDR.", {"entities": [[102, 105, "GENE"]]}], ["This mutant had no effect on the nuclear localization of VDR, VDR-RXR heterodimerization, but it impaired CYP24A1 promoter activity in the presence of 1,25 (OH) 2 vitamin D 3 , at least in part, mediated through specific nuclear receptor coactivator.", {"entities": [[57, 60, "GENE"], [62, 65, "GENE"], [106, 113, "GENE"]]}], ["Simulation models revealed the vanished interaction between guanidinium group of R343 and carboxyl group of E269.", {"entities": []}], ["Without affecting the expression, conformation, nuclear location of VDR or heteridimerization with RXR, VDR-R343H impairs the transactivation activity of VDR on downstream transcription, accounting for HVDRR features with alopecia.", {"entities": [[222, 230, "DISEASE"], [68, 71, "GENE"], [104, 107, "GENE"], [154, 157, "GENE"], [68, 71, "GENE"], [104, 107, "GENE"], [154, 157, "GENE"]]}], ["Coronary heart disease (CHD) is the leading cause of mortality in African Americans.", {"entities": [[9, 22, "DISEASE"], [0, 22, "DISEASE"]]}], ["To identify common genetic polymorphisms associated with CHD and its risk factors (LDL- and HDL-cholesterol (LDL-C and HDL-C), hypertension, smoking, and type-2 diabetes) in individuals of African ancestry, we performed a genome-wide association study (GWAS) in 8,090 African Americans from five population-based cohorts.", {"entities": [[127, 139, "DISEASE"]]}], ["We replicated 17 loci previously associated with CHD or its risk factors in Caucasians.", {"entities": []}], ["For five of these regions (CHD: CDKN2A/CDKN2B ; HDL-C: FADS1-3 , PLTP , LPL , and ABCA1 ), we could leverage the distinct linkage disequilibrium (LD) patterns in African Americans to identify DNA polymorphisms more strongly associated with the phenotypes than the previously reported index SNPs found in Caucasian populations.", {"entities": [[65, 69, "GENE"], [72, 75, "GENE"], [82, 87, "GENE"]]}], ["We also developed a new approach for association testing in admixed populations that uses allelic and local ancestry variation.", {"entities": []}], ["Using this method, we discovered several loci that would have been missed using the basic allelic and global ancestry information only.", {"entities": []}], ["Our conclusions suggest that no major loci uniquely explain the high prevalence of CHD in African Americans.", {"entities": []}], ["Our project has developed resources and methods that address both admixture- and SNP-association to maximize power for genetic discovery in even larger African-American consortia.", {"entities": []}], ["To date, most large-scale genome-wide association studies (GWAS) carried out to identify risk factors for complex human diseases and traits have focused on population of European ancestry.", {"entities": []}], ["It is currently unknown whether the same loci associated with complex diseases and traits in Caucasians will replicate in population of African ancestry.", {"entities": []}], ["Here, we conducted a large GWAS to identify common DNA polymorphisms associated with coronary heart disease (CHD) and its risk factors (type-2 diabetes, hypertension, smoking status, and LDL- and HDL-cholesterol) in 8,090 African Americans as part of the NHLBI Candidate gene Association Resource (CARe) Project.", {"entities": [[153, 165, "DISEASE"], [94, 107, "DISEASE"], [85, 107, "DISEASE"]]}], ["We replicated 17 associations previously reported in Caucasians, suggesting that the same loci carry common DNA sequence variants associated with CHD and its risk factors in Caucasians and African Americans.", {"entities": []}], ["At five of these 17 loci, we used the different patterns of linkage disequilibrium between populations of European and African ancestry to identify DNA sequence variants more strongly associated with phenotypes than the index SNPs found in Caucasians, suggesting smaller genomic intervals to search for causal alleles.", {"entities": []}], ["We also used the CARe data to develop new statistical methods to perform association studies in admixed populations.", {"entities": []}], ["The CARe Project data represent an extraordinary resource to expand our understanding of the genetics of complex diseases and traits in non-European-derived populations.", {"entities": []}], ["Human rhinoviruses (HRVs) are a highly prevalent cause of acute respiratory infection in children.", {"entities": []}], ["They are classified into at least three species, HRV-A, HRV-B and HRV-C, which are characterized by sequencing the 5\u2032 untranslated region (UTR) or the VP4/VP2 region of the genome.", {"entities": []}], ["Given the increased interest for novel HRV strain identification and their worldwide distribution, we have carried out clinical and molecular diagnosis of HRV strains in a 2-year study of children with acute respiratory infection visiting one district hospital in Shanghai.", {"entities": []}], ["We cloned and sequenced a 924-nt fragment that covered part of the 5\u2032UTR and the VP4/VP2 capsid genes.", {"entities": []}], ["Sixty-four HRV-infected outpatients were diagnosed amongst 827 children with acute low respiratory tract infection.", {"entities": []}], ["Two samples were co-infected with HRV-A and HRV-B or HRV-C. By comparative analysis of the VP4/VP2 sequences of the 66 HRVs, we showed a high diversity of strains in HRV-A and HRV-B species, and a prevalence of 51.5% of strains that belonged to the recently identified HRV-C species.", {"entities": []}], ["When analyzing a fragment of the 5\u2032 UTR, we characterized at least two subspecies of HRV-C: HRV-Cc, which clustered differently from HRV-A and HRV-B, and HRV-Ca, which resulted from previous recombination in this region with sequences related to HRV-A.", {"entities": []}], ["The full-length sequence of one strain of each HRV-Ca and HRV-Cc subspecies was obtained for comparative analysis.", {"entities": []}], ["We confirmed the close relationship of their structural proteins but showed apparent additional recombination events in the 2A gene and 3\u2032UTR of the HRV-Ca strain.", {"entities": []}], ["Double or triple infections with HRV-C and respiratory syncytial virus and/or bocavirus were diagnosed in 33.3% of the HRV-infected patients, but no correlation with severity of clinical outcome was observed.", {"entities": []}], ["Our study showed a high diversity of HRV strains that cause bronchitis and pneumonia in children.", {"entities": [[75, 84, "DISEASE"], [60, 70, "DISEASE"]]}], ["A predominance of HRV-C over HRV-A and HRV-B was observed, and two subspecies of HRV-C were identified, the diversity of which seemed to be related to recombination with former HRV-A strains.", {"entities": []}], ["None of the HRV-C strains appeared to have a higher clinical impact than HRV-A or HRV-B on respiratory compromise.", {"entities": []}], ["Flavones are a class of natural plant secondary metabolites that have anti-inflammatory and anti-bacterial effects.", {"entities": []}], ["Some flavones also activate the T2R14 bitter taste receptor, which is expressed in motile cilia of the sinonasal epithelium and activates innate immune nitric oxide (NO) production.", {"entities": []}], ["Flavones may thus be potential therapeutics for respiratory infections.", {"entities": []}], ["Our objective was to examine the anti-microbial effects of flavones on the common sinonasal pathogens Candida albicans , Staphylococcus aureus , and Pseudomonas aeruginosa , evaluating both planktonic and biofilm growth.", {"entities": []}], ["Flavones had only very low-level antibacterial activity alone.", {"entities": []}], ["They did not reduce biofilm formation, but did reduce production of the important P .", {"entities": []}], ["aeruginosa inflammatory mediator and ciliotoxin pyocyanin.", {"entities": []}], ["However, flavones exhibited synergy against P .", {"entities": []}], ["aeruginosa in the presence of antibiotics or recombinant human lysozyme.", {"entities": []}], ["They also enhanced the efficacy of antimicrobials secreted by cultured and primary human airway cells grown at air-liquid interface.", {"entities": []}], ["This suggests that flavones may have anti-gram-negative potential as topical therapeutics when combined with antibiotics or in the context of innate antimicrobials secreted by the respiratory or other epithelia.", {"entities": []}], ["This may have an additive effect when combined with T2R14-activated NO production.", {"entities": []}], ["Additional studies are necessary to understand which flavone compounds or mixtures are the most efficacious.", {"entities": []}], ["The dermatitis caused by contact with the larva of Megalopyge opercularis is produced by a poison introduced by the hollow, specialized set\u00e6 of its cuticular tubercles.", {"entities": [[4, 14, "DISEASE"]]}], ["It is not produced by the ornamental hairs, or by the tissue juices of the animal.", {"entities": []}], ["The poison appears to be of the nature of a venom, combined with protein vehicles, and may be itself a protein.", {"entities": []}], ["It is rendered inert by boiling, or by heating to 55\u00b0C.", {"entities": []}], ["for a considerable period of time.", {"entities": []}], ["It is apparently stored in sacs at the base of the set\u00e6, but whether secreted there, or by hypodermal glands, remains to be determined.", {"entities": [[27, 31, "GENE"]]}], ["It diminishes in virulence after the larva has spun its cocoon, and is no longer active after the caterpillar is dead.", {"entities": []}], ["The poisonous spines cause localized necrosis of the human epidermis, followed by the formation of small vesicles.", {"entities": []}], ["The cellular reaction to the poison is chiefly lymphocytic.", {"entities": []}], ["In this prospective study we wanted to determine whether perceived stress over time among students in the Preparatory Year of King Saud University (KSU) predisposes them to cardiometabolic abnormalities.", {"entities": []}], ["A total of 110 apparently healthy Saudi students (35 men and 75 women enrolled during the 2010\u22122011 academic year) were included.", {"entities": []}], ["Perceived stress was determined at baseline and 1 year later.", {"entities": []}], ["Anthropometrics were obtained and morning fasting serum glucose, lipid profile and cortisol were measured at both times.", {"entities": []}], ["Perceived stress was noted among 48.2% of subjects at baseline and was not significantly different after follow-up, with 45.4% scoring high.", {"entities": []}], ["In men, the prevalence of perceived stress was 48.6% at baseline (13 out of 35) and 37.1% at follow-up (13 out of 35), while in women it was 48% at baseline and 49.3% at follow-up.", {"entities": []}], ["Interestingly, significant improvements in the blood pressure and lipid profiles, with the exception of HDL-cholesterol, were observed in both men and women, while fasting glucose also improved in women.", {"entities": []}], ["Serum cortisol was inversely associated to fasting glucose, and total- and LDL-cholesterol ( p -values 0.007, 0.04 and 0.04, respectively).", {"entities": []}], ["These data are opposite to findings in students entering Western universities, in whom increasing stress and a deteriorating cardiometabolic profile have been repeatedly noted.", {"entities": []}], ["Perceived stress and morning cortisol levels among students of the Preparatory Year in KSU remained constant for both genders over time, yet an improved cardiometabolic profile was observed, suggesting good adaptation among our pre-college students in their first year of university life.", {"entities": []}], ["Some factors are known to influence the academic performance of children with Sickle Cell Anaemia (SCA).", {"entities": []}], ["Information on their effects in these children is limited in Nigeria.", {"entities": []}], ["The factors which influence academic performance of children with SCA in Enugu, Nigeria are determined in this study.", {"entities": []}], ["Consecutive children with SCA aged 5\u201311\u00a0years were recruited at the weekly sickle cell clinic of the University of Nigeria Teaching Hospital (UNTH) Enugu, Nigeria.", {"entities": []}], ["Their age- and sex- matched normal classmates were recruited as controls.", {"entities": []}], ["The total number of days of school absence for 2009/2010 academic session was obtained for each pair of pupils from the class attendance register.", {"entities": []}], ["Academic performance was assessed using the average of the overall scores in the three term examinations of same session.", {"entities": []}], ["Intelligence ability was determined with Draw-A-Person Quotient (DAPQ) using the Draw-A-Person Test while socio-economic status was determined using the occupational status and educational attainment of each parent.", {"entities": []}], ["Academic performance of children with SCA showed statistically significant association with their socio-economic status ( \u03c7 2\u2009=\u20099.626, p\u2009=\u20090.047), and significant correlation with DAPQ (r\u2009=\u20090.394, p\u2009=\u20090.000) and age (r\u2009=\u2009-0.412, p\u2009=\u20090.000).", {"entities": []}], ["However, no significant relationship existed between academic performance and school absence in children with SCA (r\u2009=\u2009-0.080, p\u2009=\u20090.453).", {"entities": []}], ["Academic performance of children with SCA is influenced by their intelligence ability, age and socio-economic status but not negatively affected by their increased school absenteeism.", {"entities": []}], ["The \u201cWatch Me Grow\u201d (WMG) study examines the current developmental surveillance system in South West Sydney.", {"entities": []}], ["This paper describes the establishment of the study birth cohort, including the recruitment processes, representativeness, follow-up and participants\u2019 baseline risk for future developmental risk.", {"entities": []}], ["Newborn infants and their parents were recruited from two public hospital postnatal wards and through child health nurses during the years 2011\u20132013.", {"entities": []}], ["Data was obtained through a detailed participant questionnaire and linked with the participant\u2019s electronic medical record (EMR).", {"entities": []}], ["Representativeness was determined by Chi-square analyses of the available clinical, psychosocial and sociodemographic EMR data, comparing the WMG participants to eligible non-participants.", {"entities": []}], ["Reasons for non-participation were also elicited.", {"entities": []}], ["Participant characteristics were examined in six, 12, and 18-month follow-ups.", {"entities": []}], ["The number of infants recruited totalled 2,025, with 50\u00a0% of those approached agreeing to participate.", {"entities": []}], ["Reasons for parents not participating included: lack of interest, being too busy, having plans to relocate, language barriers, participation in other research projects, and privacy concerns.", {"entities": []}], ["The WMG cohort was broadly representative of the culturally diverse and socially disadvantaged local population from which it was sampled.", {"entities": []}], ["Of the original 2025 participants enrolled at birth, participants with PEDS outcome data available at follow-up were: 792 (39\u00a0%) at six months, 649 (32\u00a0%) at 12\u00a0months, and 565 (28\u00a0%) at 18\u00a0months.", {"entities": []}], ["Participants with greater psychosocial risk were less likely to have follow-up outcome data.", {"entities": []}], ["Almost 40\u00a0% of infants in the baseline cohort were exposed to at least two risk factors known to be associated with developmental risk.", {"entities": []}], ["The WMG study birth cohort is a valuable resource for health services due to the inclusion of participants from vulnerable populations, despite there being challenges in being able to actively follow-up this population.", {"entities": []}], ["The role of the antioxidant N-acetylcysteine (NAC) in the treatment of chronic obstructive pulmonary disease (COPD) has not been clarified as yet.", {"entities": [[71, 108, "DISEASE"]]}], ["In early studies, we found that the proportion of smokers with COPD having extremely slow/slow microsomal epoxide hydrolase (EPHX1) enzyme activity is significantly higher than that in healthy smokers.", {"entities": [[125, 130, "GENE"]]}], ["The purpose of this study was to evaluate whether different EPHX1 enzyme activity is related to differential therapeutic effects of treatment with NAC in COPD.", {"entities": [[60, 65, "GENE"]]}], ["A total of 219 patients with COPD were randomly allocated to an extremely slow/slow EPHX1 enzyme activity group (n=157) or a fast/normal EPHX1 enzyme activity group (n=62) according to their EPHX1 enzyme activity.", {"entities": [[84, 89, "GENE"], [137, 142, "GENE"], [191, 196, "GENE"], [84, 89, "GENE"], [137, 142, "GENE"], [191, 196, "GENE"], [84, 89, "GENE"], [137, 142, "GENE"], [191, 196, "GENE"]]}], ["Both groups were treated with NAC 600 mg twice daily for one year.", {"entities": []}], ["The main study parameters, including forced expiratory volume in one second (FEV 1 ), St George\u2019s Respiratory Questionnaire (SGRQ), and yearly exacerbation rate, were measured at baseline and at 6-month intervals for one year.", {"entities": [[77, 80, "GENE"]]}], ["Both FEV 1 and SGRQ symptom scores were improved after treatment with NAC in the slow activity group when compared with the fast activity group.", {"entities": [[5, 8, "GENE"]]}], ["Further, changes in FEV 1 and SGRQ symptom score in patients with mild-to-moderate COPD were more significant than those in patients with severe-to-very severe COPD.", {"entities": [[20, 23, "GENE"]]}], ["The yearly exacerbation rates were reduced in both groups, but the reduction in the slow activity group was significantly lower than in the fast activity group.", {"entities": []}], ["NAC treatment in COPD patients with extremely slow/slow EPHX1 enzyme activity improves FEV 1 and the SGRQ symptom score, especially in those with mild-to-moderate COPD, and polymorphism in the EPHX1 gene may have a significant role in differential responses to treatment with NAC in patients with COPD.", {"entities": [[56, 61, "GENE"], [193, 198, "GENE"], [87, 90, "GENE"], [56, 61, "GENE"], [193, 198, "GENE"]]}], ["Nerve growth factor (NGF) is a neurotrophin crucial for the development and survival of neurons.", {"entities": [[21, 24, "GENE"]]}], ["It also acts on cells of the immune system which express the NGF receptors TrkA and p75 We used cell culture, flow cytometry, confocal microscopy and ELISA assays to investigate the expression of NGF receptors by NK cells and their secretion of NGF.", {"entities": [[61, 64, "GENE"], [196, 199, "GENE"], [245, 248, "GENE"], [61, 64, "GENE"], [196, 199, "GENE"], [245, 248, "GENE"], [61, 64, "GENE"], [196, 199, "GENE"], [245, 248, "GENE"]]}], ["We show that resting NK cells express TrkA and that the expression is different on NK cell subpopulations defined by the relative presence of CD27 and CD11b.", {"entities": [[142, 146, "GENE"]]}], ["Expression of TrkA is dramatically increased in IL-2-activated NK cells.", {"entities": []}], ["The p75 We demonstrate for the first time that mouse NK cells express the NGF receptor TrkA and that this expression is dynamically regulated.", {"entities": [[74, 77, "GENE"]]}], ["Homozygosity has long been associated with rare, often devastating, Mendelian disorders g ) and educational attainment (nominal p<1 \u00d7 10", {"entities": []}], ["Several reports link cigarette smoking with leukemia.", {"entities": [[44, 52, "DISEASE"]]}], ["However, the effects of cigarette smoke extract (CSE) on bone marrow hematopoiesis remain unknown.", {"entities": []}], ["The objective of this study was to elucidate the direct effects of cigarette smoke on human bone marrow hematopoiesis and characterize the inflammatory process known to result from cigarette smoking.", {"entities": []}], ["Bone marrow mononuclear cells (BMCs) from healthy individuals when exposed to CSE had significantly diminished CFU-E, BFU-E and CFU-GM.", {"entities": []}], ["We found increased nuclear translocation of the NF-\u03baB p65 subunit and, independently, enhanced activation of AKT and ERK1/2.", {"entities": []}], ["Exposure of BMCs to CSE induced IL-8 and TGF-\u03b21 production, which was dependent on NF-\u03baB and ERK1/2, but not on AKT.", {"entities": []}], ["CSE treatment had no effect on the release of TNF-\u03b1, IL-10, or VEGF.", {"entities": []}], ["Finally, CSE also had a significant induction of TLR2, TLR3 and TLR4, out of which, the up-regulation of TLR2 and TLR3 was found to be dependent on ERK1/2 and NF-\u03baB activation, but not AKT.", {"entities": [[49, 53, "GENE"], [105, 109, "GENE"], [55, 59, "GENE"], [114, 118, "GENE"], [64, 68, "GENE"], [49, 53, "GENE"], [105, 109, "GENE"], [55, 59, "GENE"], [114, 118, "GENE"]]}], ["These results indicate that CSE profoundly inhibits the growth of erythroid and granulocyte-macrophage progenitors in the bone marrow.", {"entities": []}], ["Further, CSE modulates NF-\u03baB- and ERK1/2-dependent responses, suggesting that cigarette smoking may impair bone marrow hematopoiesis in vivo as well as induce inflammation, two processes that proceed malignant transformation.", {"entities": []}], ["Urticarial rash observed in cryopyrin-associated periodic syndrome (CAPS) caused by nucleotide-binding oligomerization domain\u2013leucine-rich repeats containing pyrin domain 3 (NLRP3) mutations is effectively suppressed by anti\u2013interleukin (IL)-1 treatment, suggesting a pathophysiological role of IL-1\u03b2 in the skin.", {"entities": [[58, 66, "DISEASE"], [68, 72, "GENE"], [174, 179, "GENE"]]}], ["However, the cellular mechanisms regulating IL-1\u03b2 production in the skin of CAPS patients remain unclear.", {"entities": [[76, 80, "GENE"]]}], ["We identified mast cells (MCs) as the main cell population responsible for IL-1\u03b2 production in the skin of CAPS patients.", {"entities": [[107, 111, "GENE"]]}], ["Unlike normal MCs that required stimulation with proinflammatory stimuli for IL-1\u03b2 production, resident MCs from CAPS patients constitutively produced IL-1\u03b2.", {"entities": [[113, 117, "GENE"]]}], ["Primary MCs expressed inflammasome components and secreted IL-1\u03b2 via NLRP3 and apoptosis-associated speck-like protein containing a caspase recruitment domain when stimulated with microbial stimuli known to activate caspase-1.", {"entities": [[69, 74, "GENE"]]}], ["Furthermore, MCs expressing disease-associated but not wild-type NLRP3 secreted IL-1\u03b2 and induced neutrophil migration and vascular leakage, the histological hallmarks of urticarial rash, when transplanted into mouse skin.", {"entities": [[65, 70, "GENE"]]}], ["Our findings implicate MCs as IL-1\u03b2 producers in the skin and mediators of histamine-independent urticaria through the NLRP3 inflammasome.", {"entities": [[97, 106, "DISEASE"], [119, 124, "GENE"]]}], ["Glucocorticoid (GC)-induced osteonecrosis (ON) is an important complication of medical therapy.", {"entities": [[28, 41, "DISEASE"], [16, 18, "GENE"]]}], ["The exact pathomechanisms of ON has not been clearly elucidated.", {"entities": []}], ["There is a need for a reproducible animal model that better approximates the clinical scenario.", {"entities": []}], ["To determine the genetic susceptibility of rats to develop GC-induced femoral head ON, we evaluated 5 different inbred strains of rats (Spontaneous Hypertensive Rat, Wistar Kyoto, Wistar Furth, SASCO Fisher and Lewis).", {"entities": []}], ["Prednisone pellets (dosage of 1.82-2.56 mg/kg/day) were implanted subcutaneously for 90.", {"entities": []}], ["After 90 days, the femurs were resected and examined histologically and radiographically.", {"entities": []}], ["Pathological and histological examination was performed.", {"entities": []}], ["Hematoxylin and eosin (H & E) staining was used to delineate the femoral head osteonecrosis lesions as well as abnormalities of articular cartilage and growth plate.", {"entities": [[78, 91, "DISEASE"]]}], ["The greatest differences in H & E staining were seen in the Wistar Kyoto and Wistar Furth groups.", {"entities": []}], ["In these groups 4 out of 5 and 3 out of 5, respectively, steroid-induced rats revealed growth plate disruption with acellular areas.", {"entities": []}], ["The TUNEL apoptosis staining assay for apoptosis revealed that 4 out of 5 of Wistar Kyoto rats, 5 out of 5 of Wistar Furth, 2 out of 4 of surviving Lewis and 2 out of 2 of the surviving spontaneous hypertensive rats had apoptotic osteocytes in trabeculae, whereas none of the Fisher rats showed apoptotic osteocytes.", {"entities": []}], ["We postulate that Wistar Kyoto, Wistar Furth and spontaneous hypertensive rats may be strains of rats more susceptible to develop ON of the femoral head while Fisher rats were the most resistant.", {"entities": []}], ["Gamma-interferon-inducible lysosomal thiol reductase (GILT) is known to reduce disulfide bonds present in proteins internalized by antigen presenting cells, facilitating optimal processing and presentation of peptides on Major Histocompatibility Complex class II molecules, as well as the subsequent activation of CD4-positive T lymphocytes.", {"entities": []}], ["Here, we show that GILT is required for class II-restricted processing and presentation of immunodominant epitopes from the major house dust mite allergen Der p 1.", {"entities": []}], ["In the absence of GILT, CD4-positive T cell responses to Der p 1 are significantly reduced, resulting in mitigated allergic airway inflammation in response to Der p 1 and house dust mite extracts in a murine model of asthma.", {"entities": [[217, 223, "DISEASE"]]}], ["In the PLATelet inhibition and patient Outcomes (PLATO) study of patients with acute coronary syndromes, ticagrelor reduced mortality compared to clopidogrel but the mechanisms for this mortality reduction remain uncertain.", {"entities": []}], ["We analysed adverse events (AEs) consistent with either pulmonary infection or sepsis, and subsequent mortality, in 18,421 PLATO patients treated with ticagrelor or clopidogrel.", {"entities": []}], ["AEs occurring within 7 days of last dose of study medication were defined as \u201con-treatment\u201d.", {"entities": []}], ["Serial measurements of blood leukocyte counts, C-reactive protein and interleukin-6 were performed.", {"entities": []}], ["Fewer on-treatment pulmonary AEs occurred in the ticagrelor compared to the clopidogrel group (275 vs. 331 respectively; p = 0.019), with fewer deaths following these AEs (33 vs. 71; p < 0.001), particularly in those who remained on study medication three days after AE onset (10 vs. 43; p < 0.001).", {"entities": []}], ["There were fewer deaths attributed to sepsis in the ticagrelor group (7 vs. 23; p = 0.003).", {"entities": []}], ["Leukocyte counts were lower in the clopidogrel group during treatment ( p < 0.0001 at 1, 3 and 6 months) but not at 1 month post-discontinuation.", {"entities": []}], ["C-reactive protein increased more at discharge in the ticagrelor group (28.0 \u00b1 38.0 vs. 26.1 \u00b1 36.6 mg/l; p < 0.001) and interleukin-6 remained higher during the first month of treatment with ticagrelor.", {"entities": []}], ["We conclude that the mortality risk following pulmonary AEs and sepsis in acute coronary syndrome patients appears to be lower during ticagrelor compared to clopidogrel therapy.", {"entities": [[89, 97, "DISEASE"]]}], ["Further work should assess whether ticagrelor and clopidogrel have differential effects on immune signalling.", {"entities": []}], ["Exposure to coarse, fine, and ultrafine particles is associated with adverse population health impacts.", {"entities": []}], ["We investigated whether size-fractionated particles collected repeatedly in the vicinity of industrial (steel mills and associated coking operations, wastewater treatment), high traffic, and residential areas display systematic differences in biological potency.", {"entities": []}], ["Particulate matter (PM <0.1 , PM 0.1\u20130.5 , PM 0.5\u20132.5 , PM 2.5\u201310 , PM >10 ) samples collected at sites within Windsor, Ontario, were screened for biological potency in human A549 lung epithelial and murine J774A.1 macrophage-like cells using cytotoxicity bioassays (cellular ATP, resazurin reduction, lactate dehydrogenase (LDH) release), cytokine production, and transcript profiles.", {"entities": []}], ["Potency was determined from the slope of each dose-effect relationship.", {"entities": []}], ["Cytotoxic potency varied across size fractions and within a fraction across sites and sampling periods, suggesting that particle composition, in addition to size and mass, affected particle toxicity.", {"entities": []}], ["While ATP and LDH profiles showed some similarity, resazurin reduction (a measure of metabolic activity) exhibited a unique pattern of response, indicating that the cytotoxicity assays were sensitive to distinct particle characteristics.", {"entities": []}], ["Chemical speciation varied in relation to prevailing winds, consistent with enrichment of source emissions (e.g.", {"entities": []}], ["higher metal and polycyclic aromatic hydrocarbon content downwind of the industrial site).", {"entities": []}], ["Notwithstanding this variability, site-dependent differences in particle toxicity were evident, including greater potency of coarse fractions at the industrial site and of ultrafine particles at the traffic site ( Site \u00d7 Size interactions, p \u2009<\u20090.05).", {"entities": []}], ["Regression of potency against particle constituents revealed correlations between resazurin reduction, induction of metal-responsive genes, and metal content, which were particularly strong for the coarse fraction, and between cytokine release and endotoxin, suggesting that these factors were important drivers of biological effects that explain, at least in part, the contrasting potencies of particles compared on an equivalent mass basis.", {"entities": []}], ["The data show that 1) particle potency and composition can exhibit significant temporal variation in relation to source contributions; 2) sources may differentially impact the potency of specific size fractions; and 3) particle constituents, notably metals and endotoxin, may elicit distinct biological responses.", {"entities": []}], ["Together, the data are consistent with the notion that sources and composition, in addition to size and mass concentration, are relevant to particle toxicity.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-015-0099-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma is characterized by chronic airway inflammation, leading to structura1 changes in the airway, collectively termed airway remodeling.", {"entities": [[0, 6, "DISEASE"]]}], ["Airway remodeling is thought to contribute to airway hyper responsiveness and irreversible airflow limitation.", {"entities": []}], ["The combination of Herba Epimedii (HE) and Fructus Ligustri Lucidi (FLL) decoction and the systemic administration of glucocorticoids (GC) had a synergistic inhibitory action on airway inflammation in the asthmatic model rats.", {"entities": [[135, 137, "GENE"]]}], ["However, the effects of the combination on airway remodeling have not been studied and compared.", {"entities": []}], ["In the present study, we investigated the effects of the co-administration of combined extracts of HE and FLL with inhaled GC (budesonide) on airway remodeling in the rat asthmatic model induced by ovalbumin (OVA).", {"entities": [[123, 125, "GENE"]]}], ["Male Sprague-Dawley rats were sensitized to intraperitoneal OVA followed by repetitive OVA challenge for 7\u00a0weeks.", {"entities": []}], ["Treatments included extracts of HE and FLL (Extracts for short, 100\u00a0mg/kg by gastric perfusion), budesonide (1\u00a0mg budesonide suspension in 50\u00a0ml sterile physiological saline, 3 rats in an ultrasonic nebulizer by nebulized inhabation with a flow of 1.6\u00a0ml/min for 30\u00a0min), and co-administration of extracts of HE and FLL with budesonide (Co-administration for short) for 4\u00a0weeks.", {"entities": []}], ["Lung histomorphometry and bronchoalveolar lavage fluid (BALF) cell count were assessed 24\u00a0h after the final OVA challenge.", {"entities": []}], ["Levels of interleukin (IL)-4, IL-5 and IgE were measured by ELISA.", {"entities": []}], ["Expressions of Collagen I and Collagen III were tested by immunohistology.", {"entities": []}], ["Expressions of transforming growth factor (TGF) -\u03b21, TGF-\u03b22 and Smads mRNA were measured by quantitative real-time PCR.", {"entities": []}], ["Extracts, budesonide and Co-administration significantly reduced allergen-induced increases in the serum levels of IL-4, IL-5 and IgE, the number of eosinophils in BALF, goblet cell hyperplasia, Collagen III integral optical density (IOD) and the mRNA expression of TGF-\u03b22 and Smad2.", {"entities": [[277, 282, "GENE"]]}], ["Extracts and Co-administration could depress the IOD level of Collagen I and the positive area of Collagen I and Collagen III.", {"entities": []}], ["Budesonide and Co-administration significantly alleviated the thickening of airway wall.", {"entities": []}], ["Only Co-administration significantly decreased collagen deposition according to the morphometry of Masson\u2019s-stained lung sections, the thickening of airway smooth muscle layer, the number of lymphocytes in BALF and the mRNA expression of TGF-\u03b21 and Smad3, and this was associated with a significant increase in levels of Smad7 mRNA.", {"entities": [[249, 254, "GENE"], [321, 326, "GENE"]]}], ["The findings suggested that the combination of budesonide and the herbal extracts had a better synergistic effect on airway remodeling in OVA-reduced asthma rats than the single use of budesonide.", {"entities": [[150, 156, "DISEASE"]]}], ["Asthma-related health resource use and costs may be influenced by increasing asthma prevalence, changes to asthma management guidelines, and new medications over the last decade.", {"entities": [[0, 6, "DISEASE"], [77, 83, "DISEASE"], [107, 113, "DISEASE"]]}], ["The objective of this work was to analyze direct asthma-related medical costs, and trends in total and per-patient costs of hospitalizations, physician visits, and medications.", {"entities": [[49, 55, "DISEASE"]]}], ["A cohort of asthma patients from British Columbia (BC), Canada, was created.", {"entities": [[12, 18, "DISEASE"]]}], ["Asthma patients were identified using a validated case definition.", {"entities": [[0, 6, "DISEASE"]]}], ["Costs for hospitalizations, physician visits, and medications were calculated from billing records (in 2008 Canadian dollars).", {"entities": []}], ["Trends in total and per-patient costs over the study period were analyzed using Generalized Linear Models.", {"entities": []}], ["398,235 patients satisfied the asthma case definition (mid-point prevalence 8.0%).", {"entities": [[31, 37, "DISEASE"]]}], ["Patients consumed $315.9 million (M) in direct asthma-related health resources between 2002 and 2007.", {"entities": [[47, 53, "DISEASE"]]}], ["Hospitalizations, physician visits, and medication costs accounted for 16.0%, 15.7% and 68.2% of total costs, respectively.", {"entities": []}], ["Cost of asthma increased from $49.4 M in 2002 to $54.7 M in 2007.", {"entities": [[8, 14, "DISEASE"]]}], ["Total annual costs attributable to hospitalizations and physician visits decreased (\u221239.8% and \u221225.5%, respectively; p<0.001), while medication costs increased (+38.7%; p<0.001).", {"entities": []}], ["This population-based analysis shows that the total direct cost of asthma in BC has increased since 2002, mainly due to a rise in asthma prevalence and cost of medication.", {"entities": [[67, 73, "DISEASE"], [130, 136, "DISEASE"]]}], ["Combination therapy with inhaled corticosteroids/long-acting beta-agonists has become a significant component of the cost of asthma.", {"entities": [[125, 131, "DISEASE"]]}], ["Although billing records capture only a fraction of the true burden of asthma, the simultaneous increase in medication costs and reductions in hospitalization and physician visit costs provides valuable insight for policy makers into the shifts in asthma-related resource use.", {"entities": [[71, 77, "DISEASE"], [248, 254, "DISEASE"]]}], ["Tracheostomy is a common airway procedure for life support.", {"entities": []}], ["The fracture of the tracheostomy tube is a rare complication.", {"entities": []}], ["We report a case of a 14-year-old boy whose fractured stainless steel tracheostomy tube dislodged into the tracheobronchial tree.", {"entities": []}], ["We include a literature review and proposed recommendations for tracheostomy care.", {"entities": []}], ["A 14-year-old Thai boy who had a stainless steel tracheostomy tube presented with a complaint of intermittent cough for 2 months.", {"entities": []}], ["During tracheostomy tube cleaning, his parents found that the inner tube was missing.", {"entities": []}], ["A chest X-ray revealed a metallic density foreign body in his right main bronchus.", {"entities": []}], ["He underwent bronchoscopic removal of the inner tracheostomy tube and was discharged without further complications.", {"entities": []}], ["A fractured tracheostomy tube is a rare complication.", {"entities": []}], ["Appropriate cleaning and scheduled replacement of the tracheostomy tube may prevent this complication.", {"entities": []}], ["The purpose of this study was to investigate the association between body mass index (BMI) and the prevalence of wheeze using nation-wide cross-sectional study in Korean children.", {"entities": []}], ["Total 50,200 children from 427 elementary schools were randomly selected according to residential areas (metropolitan, provincial, rural, and industrial areas) by the cluster sampling method.", {"entities": []}], ["The International Study of Asthma and Allergies in Childhood (ISAAC) questionnaires were used to measure the prevalence of wheeze.", {"entities": [[27, 33, "DISEASE"]]}], ["Among 31,026 respondents, 25,322 were analyzed.", {"entities": []}], ["BMI was classified into quartiles based on BMI-for-age percentile.", {"entities": []}], ["In all residential areas, pets at home and visible mold or moisture were associated with an increased prevalence of wheeze in both genders.", {"entities": []}], ["However, other living environment factors were not consistently associated among residential areas and gender.", {"entities": []}], ["Among girls, lowest BMI was negatively associated with prevalence of wheeze and highest BMI was positively associated in all residential areas.", {"entities": []}], ["In multilevel logistic regression analysis, environmental tobacco smoking exposure, pets at home, visible mold or moisture, and being in the lowest and highest BMI quartile were significantly associated with the prevalence of wheeze in both genders.", {"entities": []}], ["BMI has become an important risk factor for asthma symptoms among Korean children.", {"entities": [[44, 50, "DISEASE"]]}], ["Increasing number of eQTL (Expression Quantitative Trait Loci) datasets facilitate genetics and systems biology research.", {"entities": []}], ["Meta-analysis tools are in need to jointly analyze datasets of same or similar issue types to improve statistical power especially in trans-eQTL mapping.", {"entities": []}], ["Meta-analysis framework is also necessary for ChrX eQTL discovery.", {"entities": []}], ["We developed a novel tool, meta-eqtl , for fast eQTL meta-analysis of arbitrary sample size and arbitrary number of datasets.", {"entities": []}], ["Further, this tool accommodates versatile modeling, eg.", {"entities": []}], ["non-parametric model and mixed effect models.", {"entities": []}], ["In addition, meta-eqtl readily handles calculation of chrX eQTLs.", {"entities": []}], ["We demonstrated and validated meta-eqtl as fast and comprehensive tool to meta-analyze multiple datasets and ChrX eQTL discovery.", {"entities": []}], ["Meta-eqtl is a set of command line utilities written in R, with some computationally intensive parts written in C. The software runs on Linux platforms and is designed to intelligently adapt to high performance computing (HPC) cluster.", {"entities": []}], ["We applied the novel tool to liver and adipose tissue data, and revealed eSNPs underlying diabetes GWAS loci.", {"entities": []}], ["Expression of surfactant protein (SP)-B, which assures the structural stability of the pulmonary surfactant film, is influenced by various stimuli, including glucocorticoids; however, the role that cell-cell contact plays in SP-B transcription remains unknown.", {"entities": []}], ["The aim of the current study was to investigate the impact of cell-cell contact on SP-B mRNA and mature SP-B expression in the lung epithelial cell line H441.", {"entities": []}], ["Different quantities of H441 cells per growth area were either left untreated or incubated with dexamethasone.", {"entities": []}], ["The expression of SP-B, SP-B transcription factors, and tight junction proteins were determined by qPCR and immunoblotting.", {"entities": []}], ["The influence of cell density on SP-B mRNA stability was investigated using the transcription inhibitor actinomycin D. SP-B mRNA and mature SP-B expression levels were significantly elevated in untreated and dexamethasone-treated H441 cells with increasing cell density.", {"entities": []}], ["High cell density as a sole stimulus was found to barely have an impact on SP-B transcription factor and tight junction mRNA levels, while its stimulatory ability on SP-B mRNA expression could be mimicked using SP-B-negative cells.", {"entities": []}], ["SP-B mRNA stability was significantly increased in high-density cells, but not by dexamethasone alone.", {"entities": []}], ["SP-B expression in H441 cells is dependent on cell-cell contact, which increases mRNA stability and thereby potentiates the glucocorticoid-mediated induction of transcription.", {"entities": []}], ["Loss of cell integrity might contribute to reduced SP-B secretion in damaged lung cells via downregulation of SP-B transcription.", {"entities": []}], ["Cell density-mediated effects should thus receive greater attention in future cell culture-based research.", {"entities": []}], ["Atopic dermatitis (AD) is a chronic, relapsing eczematous inflammatory skin disease.", {"entities": [[71, 83, "DISEASE"], [7, 17, "DISEASE"]]}], ["Mutations in the filaggrin gene ( FLG ) are major predisposing factors for AD.", {"entities": [[34, 37, "GENE"]]}], ["Ethnic differences exist between Asian and European populations in the frequency and spectrum of FLG mutations.", {"entities": [[97, 100, "GENE"]]}], ["Moreover, a distinct set of FLG mutations has been reported in Asian populations.", {"entities": [[28, 31, "GENE"]]}], ["The aim of this study was to examine the spectrum of FLG mutations in Koreans with AD.", {"entities": [[53, 56, "GENE"]]}], ["We also investigated the association of FLG mutations and clinical features of AD and compared the Korean FLG landscape with that of other East Asian countries.", {"entities": [[40, 43, "GENE"], [106, 109, "GENE"], [40, 43, "GENE"], [106, 109, "GENE"]]}], ["Seventy Korean patients with AD were enrolled in this study.", {"entities": []}], ["Fourteen FLG mutations previously detected in Korean, Japanese, and Chinese patients were screened by genotyping.", {"entities": [[9, 12, "GENE"]]}], ["Four FLG null mutations (3321delA, K4022X, S3296X, and S2889X) were identified in eleven patients (15.7%).", {"entities": [[5, 8, "GENE"]]}], ["The most commonly detected mutations in Korean patients with AD were 3321delA (n=6, 9.1%) and K4022X (n=3, 4.5%).", {"entities": []}], ["FLG mutations were significantly associated with elevated IgE (\u2265200 KIU/L and/or MAST-CLA >3+, p =0.005), palmar hyperlinearity ( p <0.001), and a family history of allergic disease ( p =0.021).", {"entities": [[0, 3, "GENE"]]}], ["This study expanded our understanding of the landscape of FLG mutations in Koreans and revealed an association between FLG mutations and AD phenotype.", {"entities": [[58, 61, "GENE"], [119, 122, "GENE"], [58, 61, "GENE"], [119, 122, "GENE"]]}], ["CD14, a receptor for lipopolysaccharides (LPS), is found in both a membrane-bound form (mCD14) and a soluble form (sCD14).", {"entities": [[0, 4, "GENE"]]}], ["It is suggested that sCD14 is mainly released from blood monocytes by serine protease-mediated shedding.", {"entities": []}], ["Because \u03b1 1 -antitrypsin (AAT), an inhibitor of serine proteases, has been shown to regulate CD14 expression in human monocytes in vitro , we sought to investigate plasma levels of sCD14 and monocyte expression of mCD14 in subjects at age 30 years with normal MM and deficient PiZZ and PiSZ genotypes of AAT.", {"entities": [[93, 97, "GENE"]]}], ["Plasma levels of AAT and sCD14 were measured in 75 PiZZ and 34 PiSZ individuals with normal lung function identified from the Swedish neonatal AAT deficiency screening, and in 95 age matched PiMM controls.", {"entities": []}], ["The mCD14 expression in monocytes from 9 PiZZ, 6 PiSZ and 11 PiMM subjects was analysed by FACS and Quantitative Real Time Reverse Transcription PCA.", {"entities": []}], ["As expected, plasma AAT concentrations were PiMM>PiSZ>PiZZ (p < 0.001).", {"entities": []}], ["Plasma sCD14 levels were higher in PiZZ than in PiMM subjects (p < 0.01).", {"entities": []}], ["The expression level of mCD14 was higher (1.89-fold) in monocytes isolated from PiZZ subjects compared to PiMM controls (p = 0.00189).", {"entities": []}], ["This study is the first to show higher levels of plasma sCD14 and monocyte mCD14 expression in young, clinically healthy PiZZ AAT subjects.", {"entities": []}], ["A new quinolone, zabofloxacin, has now been developed; hence, a non-inferiority trial is needed to compare this new compound with another widely used quinolone to examine its efficacy and safety for the treatment of chronic obstructive pulmonary disease (COPD) exacerbations.", {"entities": [[216, 253, "DISEASE"]]}], ["This was a prospective, multicenter, double-blind, double-dummy, randomized, controlled, parallel-group, Phase III, non-inferiority clinical trial designed to compare oral zabofloxacin (367 mg once daily for 5 days) with moxifloxacin (400 mg once daily for 7 days) for the treatment of patients with COPD exacerbation.", {"entities": []}], ["In all, 345 COPD patients with a moderate COPD exacerbation were enrolled in the study via the outpatient clinics at 31 university hospitals.", {"entities": []}], ["Clinical per protocol analysis revealed that the clinical cure rate for zabofloxacin was 86.7% and that for moxifloxacin was 86.3% (the rate difference, 0.4%; 95% confidence interval, \u22127.7%\u20138.6%).", {"entities": []}], ["Intention-to-treat analysis revealed clinical cure rates of 77.1% and 77.3% (difference, \u22120.2%; 95% confidence interval, \u22129.0%\u20138.8%), respectively.", {"entities": []}], ["These results confirm that zabofloxacin is not inferior to moxifloxacin.", {"entities": []}], ["The favorable microbiological response rate for zabofloxacin was 67.4% and that for moxifloxacin was 79.5% ( P =0.22).", {"entities": []}], ["Patients in the zabofloxacin group showed better patient-oriented outcomes, as measured by EXAcerbations of Chronic Pulmonary Disease Tool-Patient-Reported Outcome and the COPD assessment test scores, than patients in the moxifloxacin group.", {"entities": []}], ["Adverse drug reactions related to zabofloxacin occurred in 9.7% of cases and those related to moxifloxacin occurred in 9.6% of cases ( P =0.97).", {"entities": []}], ["The dropout rate due to adverse events was 0% (0/175) in the zabofloxacin group and 1.8% (3/167) in the moxifloxacin group ( P =0.12).", {"entities": []}], ["Oral zabofloxacin (367 mg once daily for 5 days) was not inferior to oral moxifloxacin (400 mg once daily for 7 days) for the treatment of patients with COPD exacerbation.", {"entities": []}], ["Radiation-induced organizing pneumonia (RIOP) is an inflammatory lung disease that is occasionally observed after irradiation to the breast.", {"entities": [[29, 38, "DISEASE"], [65, 77, "DISEASE"]]}], ["It is a type of secondary organizing pneumonia that is characterized by infiltrates outside the irradiated volume that are sometimes migratory.", {"entities": [[37, 46, "DISEASE"]]}], ["Corticosteroids work acutely, but relapse of pneumonia is often experienced.", {"entities": [[45, 54, "DISEASE"]]}], ["Management of RIOP should simply be symptom-oriented, and the use of corticosteroids should be limited to severe symptoms from the perspective not only of cost-effectiveness but also of cancer treatment.", {"entities": [[186, 192, "DISEASE"]]}], ["Once steroid therapy is started, it takes a long time to stop it due to frequent relapses.", {"entities": []}], ["We review RIOP from the perspective of its diagnosis, epidemiology, molecular pathogenesis, and patient management.", {"entities": []}], ["Our previous meta-analysis found that South Asians and Blacks in the UK were at a substantially increased risk of hospital admission from asthma.", {"entities": [[138, 144, "DISEASE"]]}], ["These estimates were, however, derived from pooling data from a limited number of now dated studies, confined to only three very broad ethnic groups (i.e.", {"entities": []}], ["Whites, South Asians and Blacks) and failed to take account of possible sex-related differences in outcomes within these ethnic groups.", {"entities": []}], ["We undertook the first study investigating ethnic variations in asthma outcomes across an entire population.", {"entities": [[64, 70, "DISEASE"]]}], ["This retrospective 9-year cohort study linked Scotland\u2019s hospitalisation/death records on asthma to the 2001 census (providing ethnic group).", {"entities": [[90, 96, "DISEASE"]]}], ["We calculated age, country of birth and Scottish Index of Multiple Deprivation adjusted incident rate ratios (IRRs) for hospitalisation or death by sex for the period May 2001\u20132010.", {"entities": []}], ["We calculated hazard ratios (HRs) for asthma readmission and subsequent asthma death.", {"entities": [[38, 44, "DISEASE"], [72, 78, "DISEASE"]]}], ["We were able to link data on 4.62 million people (91.8\u00a0% of the Scottish population), yielding over 38 million patient-years of data, 1,845 asthma deaths, 113,795 first asthma admissions, and 107,710 readmissions (40,075 of which were for asthma).", {"entities": [[140, 146, "DISEASE"], [169, 175, "DISEASE"], [239, 245, "DISEASE"]]}], ["There were substantial ethnic variations in the rate of hospitalisation/death in both males and females.", {"entities": []}], ["When compared to the reference Scottish White population, the highest age-adjusted rates were in Pakistani males (IRR\u2009=\u20091.59; 95\u00a0% CI, 1.30\u20131.94) and females (IRR\u2009=\u20091.50; 95\u00a0% CI, 1.06\u20132.11) and Indian males (IRR\u2009=\u20091.34; 95\u00a0% CI, 1.16\u20131.54), and the lowest were seen in Chinese males (IRR\u2009=\u20090.62; 95\u00a0% CI, 0.41\u20130.94) and females (IRR\u2009=\u20090.49; 95\u00a0% CI, 0.39\u20130.61).", {"entities": []}], ["There are very substantial ethnic variations in hospital admission/deaths from asthma in Scotland, with Pakistanis having the worst and Chinese having the best outcomes.", {"entities": [[79, 85, "DISEASE"]]}], ["Cultural factors, including self-management and health seeking behaviours, and variations in the quality of primary care provision are the most likely explanations for these differences and these now need to be formally investigated.", {"entities": []}], ["Asthma is a serious global health problem and its prevalence is increasing, especially among children.", {"entities": [[0, 6, "DISEASE"]]}], ["It represents a significant social and economic burden, and it can severely affect the health-related quality of life (HRQL) of patients.", {"entities": []}], ["Among the numerous questionnaires aiming at evaluating asthma HRQL in children, the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) has proved to have good measurement properties.", {"entities": [[55, 61, "DISEASE"], [94, 100, "DISEASE"]]}], ["The present study was aimed at investigating the possible role of the Italian, self-administered version of the PAQLQ in the routine clinical evaluation of children affected by bronchial asthma.", {"entities": [[187, 193, "DISEASE"]]}], ["52 Italian children and adolescents (40 males and 12 females), aged 6 to 17 years, affected by allergic asthma, were enrolled.", {"entities": [[95, 110, "DISEASE"], [104, 110, "DISEASE"]]}], ["Each patient was evaluated twice, and at each visit asthma control and severity were assessed, spirometry was performed and the patients completed the self-administered version of the PAQLQ.", {"entities": [[52, 58, "DISEASE"]]}], ["The questionnaire was well-accepted and understood by the children.", {"entities": []}], ["Children showed an overall good quality of life, with mild impairment in the activity and emotional function domains.", {"entities": []}], ["The PAQLQ showed an overall good correlation with the clinical and functional indexes that are normally evaluated in follow-up visits of asthmatic patients.", {"entities": []}], ["The PAQLQ appeared to be strongly related to asthma control, both at the first (p < 0.01) and second (p < 0.001) time of the study.", {"entities": [[45, 51, "DISEASE"]]}], ["The PAQLQ was also seen to decrease with increasing asthma severity.", {"entities": [[52, 58, "DISEASE"]]}], ["The results suggest a better compliance of the children towards completion of the questionnaire at t 1 .", {"entities": []}], ["Finally, the PAQLQ does not appear to discriminate HRQL in patients with good lung function.", {"entities": []}], ["The Italian version of the PAQLQ is a quick-to-administer aid to clinical activity and can add valuable information to symptom reports, objective measurements and clinical assessment of asthma control and severity in daily clinical practice.", {"entities": [[186, 192, "DISEASE"]]}], ["Re-administration at each follow-up visit allows HRQL to be monitored over time.", {"entities": []}], ["Childhood obesity is associated with serious physiological and psychological consequences including type 2 diabetes, higher rates of depression and low self-esteem.", {"entities": [[10, 17, "DISEASE"]]}], ["With the population of overweight and obese youth increasing, appropriate interventions are needed that speak to the issue of readiness to change and motivation to maintain adherence to healthy behavior changes.", {"entities": []}], ["Motivational Interviewing (MI) is a method of therapy found to resolve ambivalence, enhance intrinsic motivation and promote confidence in a person's ability to make behavior changes.", {"entities": []}], ["While MI has shown promise in the adult obesity literature as effecting positive lifestyle change, little is known about the effectiveness of MI with overweight and obese youth.", {"entities": [[40, 47, "DISEASE"]]}], ["This study aims to: 1) demonstrate that MI is an effective intervention for increasing a person's self-efficacy; 2) demonstrate that exposure to MI will facilitate healthy behavior changes; 3) explore psychological changes related to participation in MI and 4) compare physiological and anthropometric outcomes before and after intervention.", {"entities": []}], ["The current investigation is a prospective study conducted with ongoing participants who regularly attend an outpatient pediatric care center for weight-loss.", {"entities": []}], ["Overweight youth (BMI > 85 Results from this study are expected to enhance our understanding of the efficacy of MI with children and adolescents who are overweight or obese.", {"entities": []}], ["Current Controlled Trials # NCT00326404 .", {"entities": []}], ["Adrenal crisis (AC) occurs in various clinical conditions but previous epidemiological studies in AC are limited to chronic adrenal insufficiency (AI) and sepsis.", {"entities": []}], ["The aim of this study was to investigate characteristics of AC patients, including predisposing diseases and to describe candidate risk factors for AC such as comorbidities and glucocorticoid (GC) therapy.", {"entities": [[193, 195, "GENE"]]}], ["We conducted a retrospective cohort study using a claims database on 7.4 million patients from 145 acute care hospitals between January 1, 2003 and April 30, 2014.", {"entities": []}], ["We identified AC patients who met the following criteria: 1) disease name with ICD-10 corresponded with AI; 2) therapeutic GC administration (hydrocortisone equivalent dose \u2265100 mg/day); 3) admission; and 4) age \u226518 years.", {"entities": [[123, 125, "GENE"]]}], ["We identified 504 patients with AC (median age, 71 years; interquartile range, 59 to 80; 50.6% male).", {"entities": []}], ["As predisposing conditions, primary AI and central AI accounted for 23 (4.6%) and 136 patients (27.0%), respectively.", {"entities": []}], ["In the remaining AC patients (68.5%), comorbidities such as cancer, autoimmune diseases, and renal failure were frequent.", {"entities": [[60, 66, "DISEASE"]]}], ["The most frequent indication for hospitalization was AC (16.3%), followed by pituitary disease (14.7%), cancer (14.7%), AI-related clinical symptoms (11.5%), and infection (11.1%).", {"entities": [[104, 110, "DISEASE"]]}], ["Admission under oral GC treatment was reported in 104 patients (20.6%).", {"entities": [[21, 23, "GENE"]]}], ["Twenty-six patients were admitted within 14 days after GC cessation (5.2%).", {"entities": [[55, 57, "GENE"]]}], ["These findings present an overview of patients with AC in general practice settings, clarifying that predisposing factors for AC were complicated and that patients other than those with chronic AI were older and had more comorbid conditions than those with primary and central AI.", {"entities": []}], ["The online version of this article (10.1186/s12902-017-0208-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To further understand the role of neuro-immunological interactions in the pathogenesis of rheumatoid arthritis (RA), we studied the influence of sympathetic neurotransmitters on cytokine production of T cells in patients with RA.", {"entities": [[90, 110, "DISEASE"], [101, 110, "DISEASE"]]}], ["T cells were isolated from peripheral blood of RA patients or healthy donors (HDs), and stimulated via CD3 and CD28.", {"entities": [[111, 115, "GENE"]]}], ["Co-incubation was carried out with epinephrine or norepinephrine in concentrations ranging from 10", {"entities": []}], ["Categorization is designed to enhance resource description by organizing content description so as to enable the reader to grasp quickly and easily what are the main topics discussed in it.", {"entities": []}], ["The objective of this work is to propose a categorization algorithm to classify a set of scientific articles indexed with the MeSH thesaurus, and in particular those of the MEDLINE bibliographic database.", {"entities": []}], ["In a large bibliographic database such as MEDLINE, finding materials of particular interest to a specialty group, or relevant to a particular audience, can be difficult.", {"entities": []}], ["The categorization refines the retrieval of indexed material.", {"entities": []}], ["In the CISMeF terminology, metaterms can be considered as super-concepts.", {"entities": []}], ["They were primarily conceived to improve recall in the CISMeF quality-controlled health gateway.", {"entities": []}], ["The MEDLINE categorization algorithm (MCA) is based on semantic links existing between MeSH terms and metaterms on the one hand and between MeSH subheadings and metaterms on the other hand.", {"entities": []}], ["These links are used to automatically infer a list of metaterms from any MeSH term/subheading indexing.", {"entities": []}], ["Medical librarians manually select the semantic links.", {"entities": []}], ["The MEDLINE categorization algorithm lists the medical specialties relevant to a MEDLINE file by decreasing order of their importance.", {"entities": []}], ["The MEDLINE categorization algorithm is available on a Web site.", {"entities": []}], ["It can run on any MEDLINE file in a batch mode.", {"entities": []}], ["As an example, the top 3 medical specialties for the set of 60 articles published in BioMed Central Medical Informatics & Decision Making, which are currently indexed in MEDLINE are: information science , organization and administration and medical informatics .", {"entities": []}], ["We have presented a MEDLINE categorization algorithm in order to classify the medical specialties addressed in any MEDLINE file in the form of a ranked list of relevant specialties.", {"entities": []}], ["The categorization method introduced in this paper is based on the manual indexing of resources with MeSH (terms/subheadings) pairs by NLM indexers.", {"entities": []}], ["This algorithm may be used as a new bibliometric tool.", {"entities": []}], ["Botanical dietary supplements are increasingly popular for women\u2019s health, particularly for older women.", {"entities": []}], ["The specific botanicals women take vary as a function of age.", {"entities": []}], ["Younger women will use botanicals for urinary tract infections, especially Vaccinium macrocarpon (cranberry), where there is evidence for efficacy.", {"entities": []}], ["Botanical dietary supplements for premenstrual syndrome (PMS) are less commonly used, and rigorous clinical trials have not been done.", {"entities": [[47, 55, "DISEASE"]]}], ["Some examples include Vitex agnus-castus (chasteberry), Angelica sinensis (dong quai), Viburnum opulus/prunifolium (cramp bark and black haw), and Zingiber officinale (ginger).", {"entities": []}], ["Pregnant women have also used ginger for relief from nausea.", {"entities": []}], ["Natural galactagogues for lactating women include Trigonella foenum-graecum (fenugreek) and Silybum marianum (milk thistle); however, rigorous safety and efficacy studies are lacking.", {"entities": []}], ["Older women suffering menopausal symptoms are increasingly likely to use botanicals, especially since the Women\u2019s Health Initiative showed an increased risk for breast cancer associated with traditional hormone therapy.", {"entities": [[161, 174, "DISEASE"], [168, 174, "DISEASE"]]}], ["Serotonergic mechanisms similar to antidepressants have been proposed for Actaea/Cimicifuga racemosa (black cohosh) and Valeriana officinalis (valerian).", {"entities": []}], ["Plant extracts with estrogenic activities for menopausal symptom relief include Glycine max (soy), Trifolium pratense (red clover), Pueraria lobata (kudzu), Humulus lupulus (hops), Glycyrrhiza species (licorice), Rheum rhaponticum (rhubarb), Vitex agnus-castus (chasteberry), Linum usitatissimum (flaxseed), Epimedium species (herba Epimedii, horny goat weed), and Medicago sativa (alfalfa).", {"entities": [[88, 91, "GENE"]]}], ["Some of the estrogenic botanicals have also been shown to have protective effects against osteoporosis.", {"entities": [[90, 102, "DISEASE"]]}], ["Several of these botanicals could have additional breast cancer preventive effects linked to hormonal, chemical, inflammatory, and/or epigenetic pathways.", {"entities": [[50, 63, "DISEASE"], [57, 63, "DISEASE"]]}], ["Finally, although botanicals are perceived as natural safe remedies, it is important for women and their healthcare providers to realize that they have not been rigorously tested for potential toxic effects and/or drug/botanical interactions.", {"entities": []}], ["Understanding the mechanism of action of these supplements used for women\u2019s health will ultimately lead to standardized botanical products with higher efficacy, safety, and chemopreventive properties.", {"entities": []}], ["A 54-year-old woman was admitted for cough, sputum, and an abnormal chest X-ray shadow.", {"entities": []}], ["Bronchoscopy showed mucoid impaction of the bronchi (MIB).", {"entities": []}], ["Histopathologic evidence of mucous plugs was consistent with one component of allergic bronchopulmonary mycosis.", {"entities": []}], ["Schizophyllum commune (S. commune) was identified.", {"entities": []}], ["Two attempts at removal of the mucous plugs were unsuccessful.", {"entities": []}], ["Itraconazole was then administered, and the mucous plugs disappeared.", {"entities": []}], ["There are few reports of MIB due to S. commune ; we herein report a case of MIB due to S. commune infection.", {"entities": []}], ["Exposure to particulate matter (PM) has been associated with an increase in many inflammatory markers, including interleukin 6 ( IL6 ).", {"entities": [[129, 132, "GENE"]]}], ["Air pollution exposure has also been suggested to induce an imbalance in the autonomic nervous system (ANS), such as a decrease in heart rate variability (HRV).", {"entities": []}], ["In this study we aimed to investigate the modifying effect of polymorphisms in a major proinflammatory marker gene, interleukin 6 ( IL6 ), on the relationship between long-term exposure to traffic-related PM 10 (TPM 10 ) and HRV.", {"entities": [[132, 135, "GENE"]]}], ["For this cross-sectional study we analysed 1552 participants of the SAPALDIA cohort aged 50 years and older.", {"entities": []}], ["Included were persons with valid genotype data, who underwent ambulatory 24-hr electrocardiogram monitoring, and reported on medical history and lifestyle.", {"entities": []}], ["Main effects of annual average TPM 10 and IL6 gene variants (rs1800795; rs2069827; rs2069840; rs10242595) on HRV indices and their interaction with average annual exposure to TPM 10 were tested, applying a multivariable mixed linear model.", {"entities": [[42, 45, "GENE"]]}], ["No overall association of TPM 10 on HRV was found.", {"entities": []}], ["Carriers of two proinflammatory G-alleles of the functional IL6 -174 G/C (rs1800795) polymorphism exhibited lower HRV.", {"entities": [[60, 63, "GENE"]]}], ["An inverse association between a 1 \u00b5g/m 10 and HRV was restricted to GG genotypes at this locus with a standard deviation of normal-to-normal intervals (SDNN) (GG-carriers: \u22121.8%; 95% confidence interval \u22123.5 to 0.01; p interaction(additive) \u200a=\u200a0.028); and low frequency power (LF) (GG-carriers: \u22125.7%; 95%CI: \u221210.4 to \u22120.8; p interaction(dominant) \u200a=\u200a0.049).", {"entities": []}], ["Our results are consistent with the hypothesis that traffic-related air pollution decreases heart rate variability through inflammatory mechanisms.", {"entities": []}], ["Obesity and its association with co-morbidities in Africa are on the rise.", {"entities": [[0, 7, "DISEASE"]]}], ["This systematic review examines evidence of obesity and its association with co-morbidities within the African continent.", {"entities": [[44, 51, "DISEASE"]]}], ["Comparative studies conducted in Africa on adults 17 years and older with mean body mass index (BMI) \u2265 28 kg/m", {"entities": []}], ["Tobacco use is the most important preventable risk factor for premature death.", {"entities": []}], ["The World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC), the first international public health treaty, came into force in 2005.", {"entities": []}], ["This paper reviews the present status of tobacco control policies in Korea according to the WHO FCTC recommendations.", {"entities": []}], ["In Korea, cigarette use is high among adult males (48.2% in 2010), and cigarette prices are the lowest among the Organization for Economic Cooperation and Development countries with no tax increases since 2004.", {"entities": []}], ["Smoke-free policies have shown incremental progress since 1995, but smoking is still permitted in many indoor public places.", {"entities": []}], ["More than 30% of non-smoking adults and adolescents are exposed to second-hand smoke.", {"entities": []}], ["Public education on the harmful effects of tobacco is currently insufficient and the current policies have not been adequately evaluated.", {"entities": []}], ["There is no comprehensive ban on tobacco advertising, promotion, or sponsorship in Korea.", {"entities": []}], ["Cigarette packages have text health warnings on only 30% of the main packaging area, and misleading terms such as \"mild\" and \"light\" are permitted.", {"entities": []}], ["There are nationwide smoking cessation clinics and a Quitline service, but cessation services are not covered by public insurance schemes and there are no national treatment guidelines.", {"entities": []}], ["The sale of tobacco to minors is prohibited by law, but is poorly enforced.", {"entities": []}], ["The socioeconomic inequality of smoking prevalence has widened, although the government considers inequality reduction to be a national goal.", {"entities": []}], ["The tobacco control policies in Korea have faltered recently and priority should be given to the development of comprehensive tobacco control policies.", {"entities": []}], ["Previous studies suggest that earlier cigarette smoking initiation in adolescence predicts greater cigarette consumption later in adolescence or adulthood.", {"entities": []}], ["Results from these studies have been used to inform interventions for adolescent smoking.", {"entities": []}], ["However, previous studies suffer from several important methodological limitations.", {"entities": []}], ["The objective of the present study was to address these limitations by longitudinally and prospectively examining whether and how age of initiation of smoking among adolescents predicts cigarette consumption by age 16 or 17.", {"entities": []}], ["Participants completed an in-class survey every 6\u00a0months for 2\u20133 school years.", {"entities": []}], ["Participants included 395 adolescents (Mean age = 14\u00a0years at baseline; 53.2% female) from two public high schools in Northern California (Schools A and B) who completed self-report measures of smoking initiation, number of friends who smoke, and number of whole cigarettes smoked by the final survey time point.", {"entities": []}], ["Adolescents who were older when they first smoked one whole cigarette were 5.3 to 14.6 times more likely in School A and 2.9 to 4.3 times more likely in School B to have smoked a greater number of cigarettes by age 16 or 17.", {"entities": []}], ["Results suggested that earlier smoking initiation may not lead to heavier cigarette consumption later in time, as has been previously shown.", {"entities": []}], ["There may be a period of heightened vulnerability in mid- or late adolescence where smoking experimentation is more likely to lead to greater cigarette consumption.", {"entities": []}], ["Targeting prevention efforts to adolescents aged 14 to 17\u00a0years may further reduce smoking initiation among youth, thus limiting subsequent smoking-related morbidity and mortality in adulthood.", {"entities": []}], ["Reminder/recall systems are effective ways to improve immunization rates, but their feasibility in primary health care (PHC) settings in Nigeria has not been adequately evaluated.", {"entities": []}], ["In this study we describe the acceptability and adaptability of immunization reminder/recall system in an urban setting in southwest Nigeria.", {"entities": []}], ["This is a descriptive report of a cluster randomized controlled trial.", {"entities": []}], ["Four local government areas (LGAs) were randomly assigned into a cellphone reminder/recall intervention group or a usual care control group.", {"entities": []}], ["Within each LGA, PHC centers were purposively selected to participate in the study.", {"entities": []}], ["In each PHC center, mothers and their infants aged 0\u20133\u00a0months were enrolled into the two groups during the infants\u2019 first immunization visit.", {"entities": []}], ["Mothers (or other contact persons) in the intervention group received cellphone calls reminding them to take their child for scheduled immunizations.", {"entities": []}], ["Follow-up of all the children lasted till the final scheduled immunization visit for each child.", {"entities": []}], ["The intervention lasted for 13\u00a0months.", {"entities": []}], ["A total of 595 mothers/infants pairs (295 in the intervention group and 300 in the control group) participated in the study.", {"entities": []}], ["Almost all mothers ( n \u00a0=\u00a0590, 99.2%) had access to their own cellphone or had access to a cellphone belonging to a significant other.", {"entities": []}], ["Ninety-eight percent ( n \u00a0=\u00a0584) of all mothers were willing to receive immunization reminder/recall phone calls.", {"entities": []}], ["Eighty-seven percent ( n \u00a0=\u00a02023) of all calls ( n \u00a0=\u00a02324) for the reminder/recall intervention went through to the recipients and of these calls, 1948 (96.3%) were received.", {"entities": []}], ["The mean cost of each call in US Dollars was about 5 cents.", {"entities": []}], ["Immunization compliance rate (the receipt of required number of doses of routine vaccines at the appropriate age at recommended interval) was 79.2% among the children in intervention group and 46.4% in the control group ( p \u00a0<\u00a00.001).", {"entities": []}], ["Results demonstrate that cellphone reminder/recall interventions to improve routine childhood immunization are feasible in PHC settings in limited-resource settings with wide cellphone coverage, such as urban areas in Nigeria.", {"entities": []}], ["Further research to test the potential for scale up in a variety of settings is recommended.", {"entities": []}], ["PACTR201702002043415 ; Date of registration: 17 February 2017.", {"entities": []}], ["(Retrospectively registered).", {"entities": []}], ["Neoadjuvant androgen deprivation therapy (ADT) has been suggested to confer several clinical benefits in patients with prostate cancer (PCa) undergoing transperineal prostate brachytherapy (TPPB).", {"entities": [[128, 134, "DISEASE"], [119, 134, "DISEASE"]]}], ["Unlike gonadotropin-releasing hormone (GnRH) receptor agonists, a GnRH antagonist such as degarelix can achieve castrate levels of testosterone without testosterone flare.", {"entities": []}], ["However, normalization of serum testosterone levels following completion of neoadjuvant ADT in either form of treatment has never been compared in clinical trials.", {"entities": []}], ["This is a single-center, open-label, randomized controlled study that will compare the efficacy and safety of degarelix with those of existing GnRH agonists combined with The present study will provide additional insight regarding the benefit and potency of degarelix and will examine its potential as a new option for administration in neoadjuvant ADT.", {"entities": []}], ["Identification number: UMIN000015519 .", {"entities": []}], ["Registration date: October 24, 2014.", {"entities": []}], ["Different molecular therapies like the EGFR-inhibiting antibody cetuximab have come into clinical practice.", {"entities": []}], ["Cetuximab is EMEA-approved for metastatic colorectal cancer and advanced squamous-cell head and neck cancer.", {"entities": [[42, 59, "DISEASE"], [53, 59, "DISEASE"], [101, 107, "DISEASE"]]}], ["Administration is said to be safe and well tolerated with common, usually mild dermatologic side effects.", {"entities": []}], ["We present the case of a patient with fatal complications after oesophagectomy and neoadjuvant chemotherapy including cetuximab for squamous-cell esophageal cancer.", {"entities": [[146, 163, "DISEASE"], [157, 163, "DISEASE"]]}], ["A transthoracic en-bloc oesophagectomy was performed.", {"entities": []}], ["Few days later the patient died due to gas exchange dysfunction and circulation instability after a previously unseen combination of drain-erosion of the stomach with subsequent pleurisy and air leak of the left main bronchus.", {"entities": [[178, 186, "DISEASE"]]}], ["So far we have never observed this fatal combination of drain erosion of the stomach with fibrinous pleurisy and unmanageable progressive tracheal defect before.", {"entities": [[100, 108, "DISEASE"]]}], ["The role of cetuximab in the multifactorial aetiology of damages of stomach and trachea after oesophagectomy remains unclear since we are not able to link the complication directly to cetuximab or definitely exclude it as a sole surgical complication.", {"entities": []}], ["Clinicians should be aware of the possibility of fatal side effects and careful recording of all complications is necessary in ongoing and planned studies to obtain more evidence about safety and tolerance of targeted therapies.", {"entities": []}], ["We describe three cases of J-wave syndrome in which ventricular fibrillation (VF) was probably induced by corticosteroid therapy.", {"entities": [[34, 42, "DISEASE"]]}], ["The patients involved were being treated with prednisolone for concomitant bronchial asthma.", {"entities": [[85, 91, "DISEASE"]]}], ["One of the three patients had only one episode of VF during her long follow-up period (14 years).", {"entities": []}], ["Two patients had hypokalemia during their VF episodes.", {"entities": [[17, 28, "DISEASE"]]}], ["Corticosteroids have been shown to induce various types of arrhythmia and to modify cardiac potassium channels.", {"entities": []}], ["We discuss the possible association between corticosteroid therapy and VF in J-wave syndrome based on the cases we have encountered.", {"entities": [[84, 92, "DISEASE"]]}], ["The toll-like receptor (TLR) system constitutes a pylogenetically ancient, evolutionary conserved, archetypal pattern recognition system, which underpins pathogen recognition by and activation of the immune system.", {"entities": []}], ["Toll-like receptor agonists have long been used as immunoadjuvants in anti cancer immunotherapy.", {"entities": [[75, 81, "DISEASE"]]}], ["However, TLRs are increasingly implicated in human disease pathogenesis and an expanding body of both clinical and experimental evidence suggests that the neoplastic process may subvert TLR signalling pathways to advance cancer progression.", {"entities": [[221, 227, "DISEASE"]]}], ["Recent discoveries in the TLR system open a multitude of potential therapeutic avenues.", {"entities": []}], ["Extrapolation of such TLR system manipulations to a clinical oncological setting demands care to prevent potentially deleterious activation of TLR-mediated survival pathways.", {"entities": []}], ["Thus, the TLR system is a double-edge sword, which needs to be carefully wielded in the setting of neoplastic disease.", {"entities": []}], ["YKL-40 is also called chitinase-3-like-1 (CHI3L1) protein and may be a marker for asthma.", {"entities": [[82, 88, "DISEASE"], [42, 48, "GENE"]]}], ["The aims of the present study were to investigate whether serum YKL-40 levels are stable or decreased in patients with asthma after appropriate treatment and to evaluate the correlation of YKL-40 levels with lung function and asthma control test (ACT) results.", {"entities": [[119, 125, "DISEASE"], [226, 232, "DISEASE"]]}], ["A total of 103 asthmatic patients (mean age 33.1\u2009\u00b1\u20090.9\u00a0years) with diagnosed asthma were enrolled in our study.", {"entities": [[77, 83, "DISEASE"]]}], ["All patients underwent a detailed clinical examination and completed the ACT questionnaire, serum YKL-40 measurement, and spirometry before (visit 1) and 8\u00a0weeks after initiation of treatment (visit 2).", {"entities": []}], ["At the follow-up, the median serum YKL-40 level was significantly decreased compared to the levels at visit 1 (75.2 [55.8-86.8] ng/ml versus 54.5 [46.4-58.4] ng/ml, p \u2009<\u20090.001).", {"entities": []}], ["The serum YKL-40 level was negatively correlated with %FEV 1 ( r \u2009=\u2009-0.37, p \u2009<\u20090.001) and ACT score ( r \u2009=\u2009-0.26, p \u2009=\u20090.007) at visit 1.", {"entities": [[55, 58, "GENE"]]}], ["The change in serum YKL-40 levels between the visits was significantly correlated with changes in FEV 1 ( r \u2009=\u2009-0.28, p \u2009=\u20090.006) and ACT score ( r \u2009=\u2009-0.22, p \u2009=\u20090.037).", {"entities": [[98, 101, "GENE"]]}], ["Patients with elevated YKL-40 levels had significantly greater corticosteroid use than patients with lower levels.", {"entities": []}], ["YKL-40 was reduced in the serum of asthmatic patients after appropriate treatment, and the levels correlated with improvements in %FEV 1 and ACT.", {"entities": [[131, 134, "GENE"]]}], ["High levels of serum YKL-40 may be refractory to current asthma treatments.", {"entities": [[57, 63, "DISEASE"]]}], ["ChiCTR-OCC-13003316 The online version of this article (doi:10.1186/1471-2466-15-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Frequently eHealth applications are not used as intended and they have high attrition rates; therefore, a better understanding of patients\u2019 need for support is warranted.", {"entities": []}], ["Specifically, more research is needed to identify which system components target different patient groups and under what conditions.", {"entities": []}], ["To explore user characteristics associated with the use of different system components of a Web-based illness management support system for cancer patients (WebChoice).", {"entities": [[140, 146, "DISEASE"]]}], ["For this secondary post hoc analysis of a large randomized controlled trial (RCT), in which WebChoice was tested among 325 breast cancer and prostate cancer patients who were followed with repeated measures for 1 year, usage patterns of 162 cancer patients in the intervention arm with access to WebChoice were extracted from the user log.", {"entities": [[123, 136, "DISEASE"], [130, 136, "DISEASE"], [150, 156, "DISEASE"], [241, 247, "DISEASE"], [141, 156, "DISEASE"]]}], ["Logistic regression was performed to identify patterns of associations between system use and patient characteristics.", {"entities": []}], ["Latent class analyses (LCA) were performed to identify associations among the use of different system components and levels of social support, symptom distress, depression, self-efficacy, and health-related quality of life.", {"entities": []}], ["Approximately two-thirds (103/162, 63.6%) of the patients logged on to WebChoice more than once, and were defined as users.", {"entities": []}], ["A high level of computer experience (odds ratio [OR] 3.77, 95% CI 1.20-11.91) and not having other illnesses in addition to cancer (OR 2.10, 95% CI 1.02-4.34) increased the overall probability of using WebChoice.", {"entities": [[124, 130, "DISEASE"]]}], ["LCA showed that both men with prostate cancer and women with breast cancer who had low scores on social support accompanied with high levels of symptom distress and high levels of depression were more likely to use the e-message component.", {"entities": [[61, 74, "DISEASE"], [39, 45, "DISEASE"], [68, 74, "DISEASE"], [30, 45, "DISEASE"]]}], ["For men with prostate cancer, these variables were also associated with high use of the self-management advice component.", {"entities": [[22, 28, "DISEASE"], [13, 28, "DISEASE"]]}], ["We found important differences between men with prostate cancer and women with breast cancer when associations between WebChoice use and each user characteristic were analyzed separately.", {"entities": [[79, 92, "DISEASE"], [57, 63, "DISEASE"], [86, 92, "DISEASE"], [48, 63, "DISEASE"]]}], ["High use of all components was associated with low levels of social support among women with breast cancer, but not among men with prostate cancer.", {"entities": [[93, 106, "DISEASE"], [100, 106, "DISEASE"], [140, 146, "DISEASE"], [131, 146, "DISEASE"]]}], ["High use of e-messages, advice, and the discussion forum were associated with high levels of depression among women with breast cancer, but not among men with prostate cancer.", {"entities": [[121, 134, "DISEASE"], [128, 134, "DISEASE"], [168, 174, "DISEASE"], [159, 174, "DISEASE"]]}], ["For men with prostate cancer (but not women with breast cancer), high use of symptom assessments, advice, and the discussion forum were associated with high levels of symptom distress.", {"entities": [[49, 62, "DISEASE"], [22, 28, "DISEASE"], [56, 62, "DISEASE"], [13, 28, "DISEASE"]]}], ["However, it is unclear whether these findings can be attributed to differences related to diagnosis, gender, or both.", {"entities": []}], ["This study provides evidence that different user characteristics are associated with different use patterns.", {"entities": []}], ["Such information is crucial to target Web-based support systems to different patient groups.", {"entities": []}], ["LCA is a useful technique to identify subgroups of users.", {"entities": []}], ["In our study, e-messages and self-management advice were highly used components for patients who had low levels of social support and high illness burden, suggesting that patients with these characteristics may find such tools particularly useful.", {"entities": []}], ["ClinicalTrials.gov NCT00710658; http://clinicaltrials.gov/ct2/show/NCT00710658 (Archived by WebCite at http://www.webcitation.org/6EmEWZiwz)", {"entities": []}], ["Epidemiological data suggest that the consumption of polyphenol-rich foods reduces the incidence of cancer, coronary heart disease, and inflammation.", {"entities": [[117, 130, "DISEASE"], [108, 130, "DISEASE"], [100, 106, "DISEASE"]]}], ["Chlorogenic acid (CGA), an ester of caffeic and quinic acids, is one of the most abundant polyphenol compounds in human diet with proven biological effectiveness both in vitro and in vivo.", {"entities": [[18, 21, "GENE"]]}], ["The aim of the study is to investigate the possible anti-inflammatory effect of CGA in the gastrointestinal (GI) tract and its mechanism of action.", {"entities": [[80, 83, "GENE"]]}], ["We used a well-established model of colitis, induced by intracolonic (i.c.)", {"entities": []}], ["administration of trinitrobenzenesulfonic acid (TNBS) in mice.", {"entities": []}], ["The anti-inflammatory effect of CGA in the colon was evaluated based on the clinical and macroscopic and microscopic parameters.", {"entities": [[32, 35, "GENE"]]}], ["To investigate the mechanism of protective action of CGA, myeloperoxidase (MPO), H 2 O 2 , and NF-\u03baB levels were assessed in the colon tissue.", {"entities": [[53, 56, "GENE"], [75, 78, "GENE"]]}], ["CGA administered i.c.", {"entities": [[0, 3, "GENE"]]}], ["at the dose of 20\u00a0mg/kg (two times daily) protected against TNBS-induced colitis more effectively than the same dose administered orally (p.o.", {"entities": []}], ["), as evidenced by significantly lower macroscopic and ulcer scores.", {"entities": []}], ["Furthermore, CGA (20\u00a0mg/kg, i.c.)", {"entities": [[13, 16, "GENE"]]}], ["reduced neutrophil infiltration, as demonstrated by decreased MPO activity.", {"entities": [[62, 65, "GENE"]]}], ["Moreover, CGA suppressed activation of NF-\u03baB, as evidenced by lower levels of phospho-NF-\u03baB/NF-\u03baB ratio in the tissue.", {"entities": [[10, 13, "GENE"]]}], ["CGA did not affect the oxidative stress pathways.", {"entities": [[0, 3, "GENE"]]}], ["CGA exhibits anti-inflammatory properties through reduction of neutrophil infiltration and inhibition of NF-\u03baB-dependent pathways.", {"entities": [[0, 3, "GENE"]]}], ["Our results suggest that CGA may have the potential to become a valuable supplement in the treatment of GI diseases.", {"entities": [[25, 28, "GENE"]]}], ["Asthma is a chronic inflammatory airway disease characterized by reversible obstruction, inflammation and hyperresponsiveness to different stimulus.", {"entities": [[0, 6, "DISEASE"]]}], ["Aerobic and breathing exercises have been demonstrated to benefit asthmatic patients; however, there is no evidence comparing the effectiveness of these treatments.", {"entities": []}], ["This is a prospective, comparative, blinded, and randomized clinical trial with 2 groups that will receive distinct interventions.", {"entities": []}], ["Forty-eight asthmatic adults with optimized medical treatment will be randomly divided into either aerobic (AG) or breathing exercises (BG).", {"entities": []}], ["Patients will perform breathing or aerobic exercise twice a week for 3\u00a0months, totalizing 24 sessions of 40\u00a0minutes each.", {"entities": []}], ["Before intervention, both groups will complete an educational program consisting of 2 educational classes.", {"entities": []}], ["Before and after interventions, the following parameters will be quantified: clinical control (main outcome), health related quality of life, levels of anxiety and depression, daily living physical activity and maximal exercise capacity (secondary outcome).", {"entities": []}], ["Hyperventilation syndrome symptoms, autonomic nervous imbalance, thoracoabdominal kinematics, inflammatory cells in the sputum, fraction of exhaled nitric oxide (FE NO ) and systemic inflammatory cytokines will also be evaluated as possible mechanisms to explain the benefits of both interventions.", {"entities": [[17, 25, "DISEASE"]]}], ["Although the benefits of breathing and aerobic exercises have been extensively studied, the comparison between both has never been investigated.", {"entities": []}], ["Furthermore, the findings of our results will allow us to understand its application and suitability to patients that will have more benefits for every intervention optimizing its effect.", {"entities": []}], ["Clinicaltrials.gov; Identifier: NCT02065258 .", {"entities": []}], ["Eosinophilic esophagitis (EoE) has been defined as \u201casthma of the esophagus\u201d for the large number of similarities between the two diseases.", {"entities": [[13, 24, "DISEASE"], [52, 58, "DISEASE"], [0, 24, "DISEASE"]]}], ["Omalizumab is an anti-Immunoglobulin E (IgE) antibody currently approved only in allergic IgE-mediated severe persistent uncontrolled asthma and in chronic spontaneous urticaria unresponsive to antihistamines, but it has been tried in other diseases, too.", {"entities": [[168, 177, "DISEASE"], [134, 140, "DISEASE"]]}], ["We present herein the case of a 13-year-old boy, affected from preschool age by severe chronic allergic asthma poorly controlled despite a generous long-term therapy, and, since he was 8\u00a0years old, by eosinophilic esophagitis, responsive to courses of strict elimination diet and semi-elemental diet, even if very burdensome for his quality of life.", {"entities": [[214, 225, "DISEASE"], [95, 110, "DISEASE"], [104, 110, "DISEASE"], [201, 225, "DISEASE"]]}], ["At the age of 11.5\u00a0years, for inadequate asthma control, he started to receive therapy with omalizumab.", {"entities": [[41, 47, "DISEASE"]]}], ["After the first month and for the entire duration (18\u00a0months) of omalizumab treatment, asthma was well controlled, long-term conventional therapy was gradually withdrawn and lung- function improved.", {"entities": [[87, 93, "DISEASE"]]}], ["Concerning EoE, after an initial clinical but not histological remission during the first few months of treatment with omalizumab, the patient experienced an exacerbation of gastrointestinal symptoms.", {"entities": []}], ["Therefore, he started treatment with topical steroids which was effective to improve gastrointestinal symptoms.", {"entities": []}], ["However, EoE is still steroid-dependent.", {"entities": []}], ["Currently, he continues both treatments: omalizumab for asthma and topical steroid for EoE.", {"entities": [[56, 62, "DISEASE"]]}], ["This case report confirms that omalizumab is an effective treatment in patients with severe persistent, uncontrolled asthma.", {"entities": [[117, 123, "DISEASE"]]}], ["On the other hand, in our patient it did not produce persistent improvement neither on symptoms nor on biopsy findings of EoE.", {"entities": []}], ["The outcome of this case might indicate different pathogenic mechanism(s) of the two diseases.", {"entities": []}], ["Objectives .", {"entities": []}], ["Shoulder surgery can produce severe postoperative pain and movement limitations.", {"entities": []}], ["Evidence has shown that regional nerve block is an effective management for postoperative shoulder pain.", {"entities": []}], ["The purpose of this study was to investigate the postoperative analgesic effect of intravenous patient-controlled analgesia (PCA) combined with interscalene nerve block in comparison to PCA alone after shoulder surgery.", {"entities": []}], ["In this study, 103 patients receiving PCA combined with interscalene nerve block (PCAIB) and 48 patients receiving PCA alone after shoulder surgery were included.", {"entities": []}], ["Patients' characteristics, preoperative shoulder score and range of motion, surgical and anesthetic condition in addition to visual analog scale (VAS) pain score, postoperative PCA consumption, and adverse outcomes were evaluated.", {"entities": []}], ["The results showed that PCA combined with interscalene nerve block (PCAIB) group required less volume of analgesics than PCA alone group in 24 hours (57.76 \u00b1 23.29\u2009mL versus 87.29 \u00b1 33.73\u2009mL, p < 0.001) and 48 hours (114.86 \u00b1 40.97\u2009mL versus 183.63 \u00b1 44.83\u2009mL, p < 0.001) postoperatively.", {"entities": []}], ["The incidence of dizziness in PCAIB group was significantly lower than PCA group (resp., 1.9% and 14.6%, p = 0.005).", {"entities": []}], ["VAS, nausea, and vomiting were less in group PCAIB, but in the absence of significant statistical correlation.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Interscalene nerve block is effective postoperatively in reducing the demand for PCA analgesics and decreasing opioids-induced adverse events following shoulder surgery.", {"entities": []}], ["Numerous genome-wide screens for polymorphisms that influence gene expression have provided key insights into the genetic control of transcription.", {"entities": []}], ["Despite this work, the relevance of specific polymorphisms to in vivo expression and splicing remains unclear.", {"entities": []}], ["We carried out the first genome-wide screen, to our knowledge, for SNPs that associate with alternative splicing and gene expression in human primary cells, evaluating 93 autopsy-collected cortical brain tissue samples with no defined neuropsychiatric condition and 80 peripheral blood mononucleated cell samples collected from living healthy donors.", {"entities": []}], ["We identified 23 high confidence associations with total expression and 80 with alternative splicing as reflected by expression levels of specific exons.", {"entities": []}], ["Fewer than 50% of the implicated SNPs however show effects in both tissue types, reflecting strong evidence for distinct genetic control of splicing and expression in the two tissue types.", {"entities": []}], ["The data generated here also suggest the possibility that splicing effects may be responsible for up to 13 out of 84 reported genome-wide significant associations with human traits.", {"entities": []}], ["These results emphasize the importance of establishing a database of polymorphisms affecting splicing and expression in primary tissue types and suggest that splicing effects may be of more phenotypic significance than overall gene expression changes.", {"entities": []}], ["Although humans have a relatively small complement of genes, the proteins encoded by those genes and their biologic function are far more complex.", {"entities": []}], ["The increased complexity is achieved in part through processes that create different messages from the same gene sequence (alternative splicing) and that regulate the expression of those messages in a tissue-specific fashion.", {"entities": []}], ["These processes expand the functional capacity of the human genome, but also can create predisposition to disease when these processes go awry.", {"entities": []}], ["In this study, we investigated how single nucleotide polymorphisms influence both overall gene expression and alternative splicing in two important cell types (brain and blood) highly relevant to human disease.", {"entities": []}], ["Extensive and tissue-specific regulation of gene expression and alternative splicing were observed in the two tissue types, and some of these polymorphisms were shown to be connected to other polymorphsims that have been recently implicated in human diseases through genome-wide association studies.", {"entities": []}], ["Most of these connections appeared to relate to alternative splicing as opposed to overall expression changes, suggesting that changes in splicing patterns may be more consequential for disease than those affecting only expression.", {"entities": []}], ["These data emphasize the importance of comprehensive studies into genetic regulation of gene expression in all human tissue types in order to help understand how genetic variation influences risk of common diseases.", {"entities": []}], ["We investigated tissue-specific genetic control of gene expression and alternative splicing in primary human cells, and we describe here the implications for understanding how genetic variation influences human disease.", {"entities": []}], ["Understanding the effectiveness of complex, face\u2010to\u2010face health behaviour change interventions requires high\u2010quality measures to assess fidelity of delivery and engagement.", {"entities": []}], ["This systematic review aimed to (1) identify the types of measures used to monitor fidelity of delivery of, and engagement with, complex, face\u2010to\u2010face health behaviour change interventions and (2) describe the reporting of psychometric and implementation qualities.", {"entities": []}], ["Electronic databases were searched, systematic reviews and reference lists were hand\u2010searched, and 21 experts were contacted to identify articles.", {"entities": []}], ["Studies that quantitatively measured fidelity of delivery of, and/or engagement with, a complex, face\u2010to\u2010face health behaviour change intervention for adults were included.", {"entities": []}], ["Data on interventions, measures, and psychometric and implementation qualities were extracted and synthesized using narrative analysis.", {"entities": []}], ["Sixty\u2010six studies were included: 24 measured both fidelity of delivery and engagement, 20 measured fidelity of delivery, and 22 measured engagement.", {"entities": []}], ["Measures of fidelity of delivery included observation ( n \u00a0=\u00a017; 38.6%), self\u2010report ( n \u00a0=\u00a015; 34%), quantitatively rated qualitative interviews ( n \u00a0=\u00a01; 2.3%), or multiple measures ( n \u00a0=\u00a011; 25%).", {"entities": []}], ["Measures of engagement included self\u2010report ( n \u00a0=\u00a018; 39.1%), intervention records ( n \u00a0=\u00a011; 24%), or multiple measures ( n \u00a0=\u00a017; 37%).", {"entities": []}], ["Fifty\u2010one studies (77%) reported at least one psychometric or implementation quality; 49 studies (74.2%) reported at least one psychometric quality, and 17 studies (25.8%) reported at least one implementation quality.", {"entities": []}], ["Fewer than half of the reviewed studies measured both fidelity of delivery of, and engagement with complex, face\u2010to\u2010face health behaviour change interventions.", {"entities": []}], ["More studies reported psychometric qualities than implementation qualities.", {"entities": []}], ["Interpretation of intervention outcomes from fidelity of delivery and engagement measurements may be limited due to a lack of reporting of psychometric and implementation qualities.", {"entities": []}], ["Statement of contribution What is already known on this subject?", {"entities": []}], ["Evidence of fidelity and engagement is needed to understand effectiveness of complex interventions Evidence of fidelity and engagement are rarely reported High\u2010quality measures are needed to measure fidelity and engagement What does this study add?", {"entities": []}], ["Evidence that indicators of quality of measures are reported in some studies Evidence that psychometric qualities are reported more frequently than implementation qualities A recommendation for intervention evaluations to report indicators of quality of fidelity and engagement measures What is already known on this subject?", {"entities": []}], ["Evidence of fidelity and engagement is needed to understand effectiveness of complex interventions Evidence of fidelity and engagement are rarely reported High\u2010quality measures are needed to measure fidelity and engagement Evidence of fidelity and engagement is needed to understand effectiveness of complex interventions Evidence of fidelity and engagement are rarely reported High\u2010quality measures are needed to measure fidelity and engagement What does this study add?", {"entities": []}], ["Evidence that indicators of quality of measures are reported in some studies Evidence that psychometric qualities are reported more frequently than implementation qualities A recommendation for intervention evaluations to report indicators of quality of fidelity and engagement measures Evidence that indicators of quality of measures are reported in some studies Evidence that psychometric qualities are reported more frequently than implementation qualities A recommendation for intervention evaluations to report indicators of quality of fidelity and engagement measures", {"entities": []}], ["Experimental models of pneumonia with penicillin non-susceptible Streptococcus pneumoniae (PNSSP) are hard to reproduce because the majority of strains with clinical relevance (like serotypes 6B, 9 V and 19 F) have low murine virulence.", {"entities": [[23, 32, "DISEASE"]]}], ["By optimization of culture and inoculum conditions of PNSSP (using porcine mucin), our aim was to develop a suitable, reliable and reproducible pneumonia mouse model for anti-infective pharmacology research.", {"entities": [[144, 153, "DISEASE"]]}], ["Seven PNSSP strains, including serotypes 6B, 9 V, 14 and 19 F were included.", {"entities": []}], ["Strain INS-E611 displayed the highest murine virulence and was chosen to validate the lung model.", {"entities": []}], ["Nose-instilled pneumococci grew between 2.1 and 2.5 log 10 CFU/g of lung in 24 hours when an optimized culture of bacterial cells was used, but animals were all alive and recovered of infection after 36 h. In contrast, inoculum supplementation with mucin led to 100% mortality related to a successful lung infection confirmed by histopathology.", {"entities": []}], ["These findings were reproduced with all seven PNSSP strains in neutropenic mice.", {"entities": []}], ["Immunocompetent animals cleared all strains spontaneously.", {"entities": []}], ["This pneumonia model produces a progressive and uniformly fatal lung infection with diverse serotypes of PNSSP independently of their intrinsic murine virulence.", {"entities": [[5, 14, "DISEASE"]]}], ["The gut microbiota (GM) is a complex, evolutionarily molded ecological system, which contributes to a variety of physiological functions.", {"entities": []}], ["The GM is highly dynamic, being sensitive to environmental stimuli, and its composition changes over the host\u2019s entire lifespan.", {"entities": []}], ["However, the basic question of how much these changes may be ascribed to variables such as population, diet, genetics and gender, and/or to the aging process per se is still largely unanswered.", {"entities": []}], ["We argue that comparison among studies on centenarians\u2014the best model of healthy aging and longevity\u2014recruited from different geographical areas/populations (different genetics and dietary habits) can help to disentangle the contribution of aging and non-aging-related variables to GM remodeling with age.", {"entities": []}], ["The current review focuses on the role of population, gender and host genetics as possible drivers of GM modification along the human aging process.", {"entities": []}], ["The feedback impact of age-associated GM variation on the GM\u2013brain axis and GM metabolomics is also discussed.", {"entities": []}], ["We likewise address the role of GM in neurodegenerative diseases such as Parkinson\u2019s and Alzheimer\u2019s, and its possible therapeutic use, taking advantage of the fact that centenarians are characterized by an extreme (healthy) phenotype versus patients suffering from age-related pathologies.", {"entities": []}], ["Finally, it is argued that longitudinal studies combining metagenomics sequencing and in-depth phylogenetic analysis with a comprehensive phenotypic characterization of centenarians and patients using up-to-date omics (metabolomics, transcriptomics and meta-transcriptomics) are urgently needed.", {"entities": []}], ["A study reported an increased risk of asthma in children whose mothers were exposed to magnetic field (MF) levels above 0.2 \u03bcT during pregnancy.", {"entities": [[38, 44, "DISEASE"]]}], ["We re-examined this association using data from mothers and children in the Danish National Birth Cohort (DNBC).", {"entities": []}], ["This study included 92,676 singleton-born children and their mothers from the DNBC.", {"entities": []}], ["MF exposure from power lines was estimated for all residences where the mothers lived during pregnancy and for all children from birth until the end of follow up.", {"entities": []}], ["Exposure was categorized into 0 \u03bcT, 0.1 \u03bcT, and \u2265 0.2 \u03bcT for analysis.", {"entities": []}], ["Definitive and possible asthma cases were identified using data from three independent data sources: 1) mothers\u2019 reports, 2) a national hospitalization register, 3) a national prescription drug register.", {"entities": [[24, 30, "DISEASE"]]}], ["We calculated hazard ratios (HR) and 95% confidence intervals (CI) for the association between the highest level of exposure during pregnancy and asthma in children, adjusting for several potential confounding factors.", {"entities": [[146, 152, "DISEASE"], [29, 31, "GENE"]]}], ["We also examined the sensitivity of the risk estimates to changes in exposure and outcome definitions.", {"entities": []}], ["No differences or trends in the risk of asthma development were detected between children with different levels of MF exposure regardless of the asthma case definition or outcome data source.", {"entities": [[40, 46, "DISEASE"], [145, 151, "DISEASE"]]}], ["For definitive cases, the HR (95% CI) for those with any exposure was 0.72 (0.27\u20131.92), and it was 0.41 (0.06\u20132.92) for those exposed to \u2265 0.2 \u03bcT.", {"entities": [[26, 28, "GENE"]]}], ["Adjustments for confounding and variations in the exposure definition did not appreciably alter the results.", {"entities": []}], ["We did not find evidence that residential exposure to MF during pregnancy or early childhood increased the risk of childhood asthma.", {"entities": [[125, 131, "DISEASE"]]}], ["This interpretation is in line with the lack of an established biological mechanism directly linking MF exposure to asthma, but high exposure was very rare in this cohort.", {"entities": [[116, 122, "DISEASE"]]}], ["The current mainstay of therapy for chronic obstructive pulmonary disease (COPD) is long-acting bronchodilators.", {"entities": [[36, 73, "DISEASE"]]}], ["To date, the effect of indacaterol, a \u03b22-agonist, on activities of daily living in COPD patients is not well understood.", {"entities": []}], ["The aim of this study was to evaluate the efficacy of indacaterol with regard to activities of daily living in patients with COPD.", {"entities": []}], ["In this nonrandomized open-label study, 23 patients with COPD were instructed to carry an accelerometer for 4 weeks without indacaterol therapy and then for another period of 4 weeks while receiving indacaterol therapy.", {"entities": []}], ["The number of steps, duration of moderate or greater physical activity, and energy expenditure were significantly increased after treatment with indacaterol compared with baseline data in all patients with COPD; the metabolic equivalent of task was also significantly enhanced after treatment with indacaterol.", {"entities": []}], ["This study provides early evidence that indacaterol improves daily physical activity in patients with COPD.", {"entities": []}], ["Rapid qualitative and quantitative analysis of solid samples (e.g., pharmaceutical preparations) by using a small and low-resolution mass spectrometer without MS/MS function is still a challenge in ambient pressure ionization mass spectrometric analysis.", {"entities": []}], ["Herein, a practically efficient method termed microwave-enhanced in-source decay (MEISD) using microwave plasma torch desorption ionization coupled with time-of-flight mass spectrometry (MPTDI-TOF MS) was developed for fast analysis of pharmaceutical tablets using a miniature TOF mass spectrometer without tandem mass function.", {"entities": []}], ["The intensity of ISD fragmentation was evaluated under different microwave power values.", {"entities": []}], ["Several factors, including desorption distance and time that might affect the signal intensity and fragmentation, were systematically investigated.", {"entities": []}], ["It was observed that both the protonated molecular ions and major fragment ions from the active ingredients in tablets could be found in the full-scan mass spectra in positive ion mode, which were comparable to those obtained by a commercial LTQ-XL ion trap mass spectrometer.", {"entities": []}], ["The structures of the ingredients could be elucidated in detail using the MEISD method, which promotes our understanding of the desorption/ionization processes in microwave plasma torch (MPT).", {"entities": []}], ["Quantitative analysis of 10 tablets was achieved by full-scan MPTDI-TOF MS with low limit of detection (LOD, 0.763 mg/g), acceptable relative standard deviation (RSD < 7.33%, n =10), and 10 s for each tablet, showing promising applications in high throughput screening of counterfeit drugs.", {"entities": []}], ["Graphical Abstract \u115f \u115f The online version of this article (doi:10.1007/s13361-017-1708-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The local and systemic renin angiotensin system (RAS) influences the skeletal system micro-structure and metabolism.", {"entities": []}], ["Studies suggested angiotensin 1-7 (Ang(1-7)) as the beneficial RAS molecule via Mas receptor activation.", {"entities": [[35, 38, "GENE"]]}], ["This study examines the function of Ang(1-7) in bone micro-architecture and metabolism in an ovariectomized (OVX) rodent model of osteoporosis.", {"entities": [[130, 142, "DISEASE"], [36, 39, "GENE"]]}], ["OVX rats showed structural and bone metabolic degeneration in parallel with suppressed expressions of the angiotensin converting enzyme-2 (ACE-2)/Ang(1-7)/Mas components.", {"entities": []}], ["The infusion of Ang(1-7) markedly alleviated the altered bone metabolism and significantly enhanced both trabecular (metaphyseal) and cortical (metaphyseal-diaphyseal) morphometry.", {"entities": [[16, 19, "GENE"]]}], ["Urinary and bones minerals were also improved in OVX rats by Ang(1-7).", {"entities": [[61, 64, "GENE"]]}], ["The infusion of the heptapeptide enhanced ACE-2/Mas receptor expressions, while down-regulated AngII, ACE, and AngII type-1 receptor (AT1R) in OVX animals.", {"entities": []}], ["Moreover, Ang(1-7) markedly improved osteoprotegerin (OPG) and lowered receptor activator NF-\u03baB ligand (RANKL) expressions.", {"entities": [[10, 13, "GENE"]]}], ["The defensive properties of Ang(1-7) on bone metabolism, structure and minerals were considerably eradicated after blockage of Mas receptor with A-779.", {"entities": [[28, 31, "GENE"]]}], ["Ang(1-7)-induced up-regulated ACE-2/Ang(1-7)/Mas cascade and OPG expressions were abolished and the expressions of ACE/AngII/AT1R and RANKL were provoked by A-779.", {"entities": [[0, 3, "GENE"], [36, 39, "GENE"]]}], ["These findings shows for the first time the novel valuable therapeutic role of Ang(1-7) on bone health and metabolism through the ACE-2/Mas cascade.", {"entities": [[79, 82, "GENE"]]}], ["The release of reactive oxygen species (ROS) and the generation of oxidative stress are considered critical factors for the pathogenesis of diabetes mellitus (DM), a disorder that is growing in prevalence and results in significant economic loss.", {"entities": [[140, 157, "DISEASE"]]}], ["New therapeutic directions that address the detrimental effects of oxidative stress may be especially warranted to develop effective care for the millions of individuals that currently suffer from DM.", {"entities": []}], ["The mechanistic target of rapamycin (mTOR), silent mating type information regulation 2 homolog 1 ( S. cerevisiae ) (SIRT1), and Wnt1 inducible signaling pathway protein 1 (WISP1) are especially justified to be considered treatment targets for DM since these pathways can address the complex relationship between stem cells, trophic factors, impaired glucose tolerance, programmed cell death pathways of apoptosis and autophagy, tissue remodeling, cellular energy homeostasis, and vascular biology that greatly impact the biology and disease progression of DM.", {"entities": [[37, 41, "GENE"], [117, 122, "GENE"], [129, 133, "GENE"], [173, 178, "GENE"]]}], ["The translation and development of these pathways into viable therapies will require detailed understanding of their proliferative nature to maximize clinical efficacy and limit adverse effects that have the potential to lead to unintended consequences.", {"entities": []}], ["Patients infected with influenza A (H1N1)pdm09 virus requiring admission to the ICU remain an important source of mortality during the influenza season.", {"entities": [[23, 32, "DISEASE"], [135, 144, "DISEASE"]]}], ["The objective of the study was to assess the impact of a delay in diagnosis of community-acquired influenza A (H1N1)pdm09 virus infection on clinical outcome in critically ill patients admitted to the ICU.", {"entities": [[98, 107, "DISEASE"]]}], ["A prospective multicenter observational cohort study was based on data from the GETGAG/SEMICYUC registry (2009\u20132015) collected by 148 Spanish ICUs.", {"entities": []}], ["All patients admitted to the ICU in which diagnosis of influenza A (H1N1)pdm09 virus infection had been established within the first week of hospitalization were included.", {"entities": [[55, 64, "DISEASE"]]}], ["Patients were classified into two groups according to the time at which the diagnosis was made: early (within the first 2 days of hospital admission) and late (between the 3rd and 7th day of hospital admission).", {"entities": []}], ["Factors associated with a delay in diagnosis were assessed by logistic regression analysis.", {"entities": []}], ["In 2059 ICU patients diagnosed with influenza A (H1N1)pdm09 virus infection within the first 7 days of hospitalization, the diagnosis was established early in 1314 (63.8 %) patients and late in the remaining 745 (36.2 %).", {"entities": [[36, 45, "DISEASE"]]}], ["Independent variables related to a late diagnosis were: age (odds ratio (OR)\u2009=\u20091.02, 95 % confidence interval (CI) 1.01\u20131.03, P \u2009<\u20090.001); first seasonal period (2009\u20132012) (OR\u2009=\u20092.08, 95 % CI 1.64\u20132.63, P \u2009<\u20090.001); days of hospital stay before ICU admission (OR\u2009=\u20091.26, 95 % CI 1.17\u20131.35, P \u2009<\u20090.001); mechanical ventilation (OR\u2009=\u20091.58, 95 % CI 1.17\u20132.13, P \u2009=\u20090.002); and continuous venovenous hemofiltration (OR\u2009=\u20091.54, 95 % CI 1.08\u20132.18, P \u2009=\u20090.016).", {"entities": []}], ["The intra-ICU mortality was significantly higher among patients with late diagnosis as compared with early diagnosis (26.9 % vs 17.1 %, P \u2009<\u20090.001).", {"entities": []}], ["Diagnostic delay was one independent risk factor for mortality (OR\u2009=\u20091.36, 95 % CI 1.03\u20131.81, P \u2009<\u20090.001).", {"entities": []}], ["Late diagnosis of community-acquired influenza A (H1N1)pdm09 virus infection is associated with a delay in ICU admission, greater possibilities of respiratory and renal failure, and higher mortality rate.", {"entities": [[37, 46, "DISEASE"]]}], ["Delay in diagnosis of flu is an independent variable related to death.", {"entities": []}], ["Many politicians and business leaders are advocating high deductible health insurance plans linked with health savings accounts\u2014so-called consumer-directed healthcare.", {"entities": []}], ["These policies penalize the sick, discourage needed care (especially primary and preventive care), and direct tax subsidies towards the wealthiest Americans.", {"entities": []}], ["They offer little hope of slowing the growth of health care costs and add further bureaucratic costs and complexity to our health care financing system.", {"entities": []}], ["In renal cystic diseases, sustained enlargement of fluid-filled cysts is associated with severe interstitial fibrosis and progressive loss of functioning nephrons.", {"entities": []}], ["Periostin, a matricellular protein, is highly overexpressed in cyst-lining epithelial cells of autosomal dominant polycystic disease kidneys (ADPKD) compared to normal tubule cells.", {"entities": []}], ["Periostin accumulates in situ within the matrix subjacent to ADPKD cysts, binds to \u03b1 V \u03b2 3 - and \u03b1 V \u03b2 5 -integrins and stimulates the integrin-linked kinase to promote cell proliferation.", {"entities": []}], ["We knocked out periostin ( Postn ) in pcy/pcy mice, an orthologous model of nephronophthisis type 3, to determine whether periostin loss reduces PKD progression in a slowly progressive model of renal cystic disease.", {"entities": [[76, 92, "DISEASE"], [27, 32, "GENE"]]}], ["At 20 weeks of age, pcy/pcy: Postn\u2212/\u2212 mice had a 34% reduction in kidney weight/body weight, a reduction in cyst number and total cystic area, a 69% reduction in phosphorylated S6, a downstream component of the mTOR pathway, and fewer proliferating cells in the kidneys compared to pcy/pcy: Postn+/+ mice.", {"entities": [[211, 215, "GENE"]]}], ["The pcy/pcy Postn knockout mice also had less interstitial fibrosis with improved renal function at 20 weeks and significantly longer survival (51.4 compared to 38.0 weeks).", {"entities": [[12, 17, "GENE"]]}], ["Thus, periostin adversely modifies the progression of renal cystic disease by promoting cyst epithelial cell proliferation, cyst enlargement and interstitial fibrosis, all contributing to the decline in renal function and premature death.", {"entities": []}], ["The human nasal epithelium is the first line of defense during respiratory virus infection.", {"entities": []}], ["Respiratory syncytial virus (RSV) is the major cause of bronchitis, asthma and severe lower respiratory tract disease in infants and young children.", {"entities": [[86, 117, "DISEASE"], [68, 74, "DISEASE"], [56, 66, "DISEASE"]]}], ["We previously reported in human nasal epithelial cells (HNECs), the replication and budding of RSV and the epithelial responses, including release of proinflammatory cytokines and enhancement of the tight junctions, are in part regulated via an NF-\u03baB pathway.", {"entities": []}], ["In this study, we investigated the effects of the NF-\u03baB in HNECs infected with RSV.", {"entities": []}], ["Curcumin prevented the replication and budding of RSV and the epithelial responses to it without cytotoxicity.", {"entities": []}], ["Furthermore, the upregulation of the epithelial barrier function caused by infection with RSV was enhanced by curcumin.", {"entities": []}], ["Curcumin also has wide pharmacokinetic effects as an inhibitor of NF-\u03baB, eIF-2\u03b1 dephosphorylation, proteasome and COX2.", {"entities": []}], ["RSV-infected HNECs were treated with the eIF-2\u03b1 dephosphorylation blocker salubrinal and the proteasome inhibitor MG132, and inhibitors of COX1 and COX2.", {"entities": []}], ["Treatment with salubrinal, MG132 and COX2 inhibitor, like curcumin, prevented the replication of RSV and the epithelial responses, and treatment with salubrinal and MG132 enhanced the upregulation of tight junction molecules induced by infection with RSV.", {"entities": []}], ["These results suggest that curcumin can prevent the replication of RSV and the epithelial responses to it without cytotoxicity and may act as therapy for severe lower respiratory tract disease in infants and young children caused by RSV infection.", {"entities": [[161, 192, "DISEASE"]]}], ["Walking, more specifically gait, is an essential component of daily living.", {"entities": []}], ["Walking is a very different activity for individuals with a Body Mass Index (BMI) of 40 or more (Class III obesity) compared with those who are overweight or obese with a BMI between 26\u201335.", {"entities": [[107, 114, "DISEASE"]]}], ["Yet all obesity weight classes receive the same physical activity guidelines and recommendations.", {"entities": [[8, 15, "DISEASE"]]}], ["This observational study examined the components of function and disability in a group with Class III obesity and a group that is overweight or has Class I obesity.", {"entities": [[102, 109, "DISEASE"], [156, 163, "DISEASE"]]}], ["Significant differences were found between the groups in the areas of gait, body size, health condition, and activity capacity and participation.", {"entities": []}], ["The Timed Up and Go test, gait velocity, hip circumference, and stance width appear to be most predictive of activity capacity as observed during gait assessment.", {"entities": []}], ["The findings indicate that Class III-related gait is pathologic and not a normal adaptation.", {"entities": []}], ["An ongoing issue related to global urbanization is the association of air pollution with increased incidences of morbidity and mortality.", {"entities": []}], ["However, no in-depth study has investigated this issue focusing on peritoneal dialysis (PD) patients.", {"entities": []}], ["Therefore, this study assessed the effects of traffic-related air pollutants and other important mortality-associated factors on 2-year mortality in PD patients.", {"entities": []}], ["A total of 160 PD patients were recruited in this 2-year retrospective observational study.", {"entities": []}], ["Differences in air quality were analyzed with respect to the patients\u2019 living areas.", {"entities": []}], ["The PD patients were categorized into 2 groups according to high (n\u200a=\u200a65) and low (n\u200a=\u200a95) nitrogen dioxide (NO 2 ) exposure.", {"entities": []}], ["Demographic, hematological, nutritional, inflammatory, biochemical, air pollutants, and dialysis-related data were analyzed.", {"entities": []}], ["Univariate and multivariate Cox regression analyses were used for 2-year mortality analysis.", {"entities": []}], ["A total of 160 PD patients (38 men and 122 women) were enrolled.", {"entities": []}], ["Fourteen patients (8.8%) died within 2 years; among them, the causes of death were infection (n\u200a=\u200a10), malignancy (n\u200a=\u200a1), and cardiovascular events (n\u200a=\u200a3).", {"entities": []}], ["Among the 10 patients who died from infection, 5, 4, and 1 died from pneumonia, PD-related peritonitis, and sepsis of unknown origin, respectively.", {"entities": [[69, 78, "DISEASE"], [91, 102, "DISEASE"]]}], ["All patients who died from pneumonia were living in high environmental NO 2 exposure areas.", {"entities": [[27, 36, "DISEASE"]]}], ["Multivariate Cox regression analysis showed that age (hazard ratio [HR] 1.073, 95% confidence interval [CI] [1.013\u20131.137]; P \u200a=\u200a0.017), white blood cell count (HR 1.41, 95% CI [1.116\u20131.781]; P \u200a=\u200a0.004), log normalized protein nitrogen appearance (HR 0.0001, 95% CI [0\u20130.073]; P \u200a=\u200a0.005), high cardiothoracic ratio (HR 14.28, 95% CI [1.778\u2013114.706]; P \u200a=\u200a0.012), and high environmental NO 2 exposure (HR 3.776, 95% CI [1.143\u201312.47]; P \u200a=\u200a0.029) were significantly associated with 2-year mortality.", {"entities": [[68, 70, "GENE"], [160, 162, "GENE"], [248, 250, "GENE"], [317, 319, "GENE"], [402, 404, "GENE"], [68, 70, "GENE"], [160, 162, "GENE"], [248, 250, "GENE"], [317, 319, "GENE"], [402, 404, "GENE"], [68, 70, "GENE"], [160, 162, "GENE"], [248, 250, "GENE"], [317, 319, "GENE"], [402, 404, "GENE"], [68, 70, "GENE"], [160, 162, "GENE"], [248, 250, "GENE"], [317, 319, "GENE"], [402, 404, "GENE"], [68, 70, "GENE"], [160, 162, "GENE"], [248, 250, "GENE"], [317, 319, "GENE"], [402, 404, "GENE"]]}], ["PD patients with high environmental NO 2 exposure had a higher 2-year mortality rate than those with low exposure.", {"entities": []}], ["Therefore, air pollution may be associated with 2-year mortality in such patients.", {"entities": []}], ["Subthalamic nucleus deep brain stimulation (STN-DBS) is an effective treatment for the motor and non-motor signs of Parkinson\u2019s disease (PD), however, psychological disorders and social maladjustment have been reported in about one third of patients after STN-DBS.", {"entities": []}], ["We propose here a perioperative psychoeducation programme to limit such social and familial disruption.", {"entities": []}], ["Nineteen PD patients and carers were included in a randomised single blind study.", {"entities": []}], ["Social adjustment scale (SAS) scores from patients and carers that received the psychoeducation programme ( n = 9) were compared, both 1 and 2 years after surgery, with patients and carers with usual care ( n = 10).", {"entities": []}], ["Depression, anxiety, cognitive status, apathy, coping, parkinsonian disability, quality-of-life, carers\u2019 anxiety and burden were also analysed.", {"entities": []}], ["Seventeen patients completed the study, 2 were excluded from the final analysis because of adverse events.", {"entities": []}], ["At 1 year, 2/7 patients with psychoeducation and 8/10 with usual care had an aggravation in at least one domain of the SAS (p = .058).", {"entities": []}], ["At 2 years, only 1 patient with psychoeducation suffered persistent aggravated social adjustment as compared to 8 patients with usual care (p = .015).", {"entities": []}], ["At 1 year, anxiety, depression and instrumental coping ratings improved more in the psychoeducation than in the usual care group (p = .038, p = .050 and p = .050, respectively).", {"entities": []}], ["No significant differences were found between groups for quality of life, cognitive status, apathy or motor disability.", {"entities": []}], ["Our results suggest that a perioperative psychoeducation programme prevents social maladjustment in PD patients following STN-DBS and improves anxiety and depression compared to usual care.", {"entities": []}], ["These preliminary data need to be confirmed in larger studies.", {"entities": []}], ["Mercury exists naturally and as a man-made contaminant.", {"entities": []}], ["The release of processed mercury can lead to a progressive increase in the amount of atmospheric mercury, which enters the atmospheric-soil-water distribution cycles where it can remain in circulation for years.", {"entities": []}], ["Mercury poisoning is the result of exposure to mercury or mercury compounds resulting in various toxic effects depend on its chemical form and route of exposure.", {"entities": []}], ["The major route of human exposure to methylmercury (MeHg) is largely through eating contaminated fish, seafood, and wildlife which have been exposed to mercury through ingestion of contaminated lower organisms.", {"entities": []}], ["MeHg toxicity is associated with nervous system damage in adults and impaired neurological development in infants and children.", {"entities": []}], ["Ingested mercury may undergo bioaccumulation leading to progressive increases in body burdens.", {"entities": []}], ["This review addresses the systemic pathophysiology of individual organ systems associated with mercury poisoning.", {"entities": []}], ["Mercury has profound cellular, cardiovascular, hematological, pulmonary, renal, immunological, neurological, endocrine, reproductive, and embryonic toxicological effects.", {"entities": []}], ["To determine whether genetic variation within genes related to the Toll-like receptor, inflammasome and interferon-\u03b3 pathways contributes to the differences in treatment response to tumour necrosis factor inhibitors (anti-TNF) in patients with rheumatoid arthritis (RA).", {"entities": [[244, 264, "DISEASE"], [255, 264, "DISEASE"]]}], ["In a retrospective case-case study, we assessed 23 functional single nucleotide polymorphisms (SNPs) in 15 genes.", {"entities": []}], ["We included 538 anti-TNF na\u00efve Danish RA patients from the nationwide DANBIO database.", {"entities": []}], ["Multivariable logistic regression analyses were performed to detect associations (p-value<0.05) between genotypes and European League Against Rheumatism (EULAR) treatment responses.", {"entities": []}], ["False Discovery Rate corrections for multiple testing (q-value) and stratified analyses were performed to investigate association with individual therapies and IgM-rheumatoid factor (RF) status.", {"entities": []}], ["Six of twenty successfully genotyped polymorphisms were nominally associated with EULAR treatment response.", {"entities": []}], ["Three of these were in weak to moderate linkage disequilibrium with polymorphisms previously reported associated with anti-TNF treatment response.", {"entities": []}], ["TLR5 (rs5744174) variant allele carriers (odds ratio(OR) = 1.7(1.1\u20132.5),p = 0.010,q = 0.46) and TLR1 (rs4833095) homozygous variant carriers (OR = 2.8(1.1\u20137.4),p = 0.037,q = 0.46) had higher odds for a positive treatment response.", {"entities": [[0, 4, "GENE"], [96, 100, "GENE"]]}], ["NLRP3 (rs10754558) variant allele carriers (odds ratio(OR) = 0.6(0.4\u20131.0),p = 0.045,q = 0.46) were more likely to have a negative treatment response.", {"entities": [[0, 5, "GENE"]]}], ["The association in TLR5 (rs5744174) remained significant after correction for multiple comparisons among patients negative for RF (OR = 6.2(2.4\u201316.3),p = 0.0002,q = 0.024).", {"entities": [[19, 23, "GENE"]]}], ["No other association withstood correction for multiple testing.", {"entities": []}], ["Post hoc analyses showed that change in Patient Global score on a visual analogue scale (VAS) and change in pain VAS were the main factors responsible for the association.", {"entities": []}], ["We reproduced previously reported associations between genetic variation in the TLR10/1/6 gene cluster, TLR5 , and NLRP3 loci and response to anti-TNF treatment in RA.", {"entities": [[104, 108, "GENE"], [115, 120, "GENE"]]}], ["Changes in VAS pain and patient global scores were the main contributors to the association found for TLR5 .", {"entities": [[102, 106, "GENE"]]}], ["Furthermore, we identified other candidate genes that require replication in independent cohorts.", {"entities": []}], ["Arsenic has been linked to disrupted immune function and greater infection susceptibility in highly exposed populations.", {"entities": []}], ["Well arsenic levels above the U.S. EPA limit occur in our U.S. study area and are of particular concern for pregnant women and infants.", {"entities": []}], ["We investigated whether in utero arsenic exposure affects the risk of infections and respiratory symptoms over the first year of life.", {"entities": []}], ["We prospectively obtained information on infant infections and symptoms, including their duration and treatment (n = 412) at 4, 8, and 12 months using a parental telephone survey.", {"entities": []}], ["Using generalized estimating equation models adjusted for potential confounders, we evaluated the association between maternal pregnancy urinary arsenic and infant infections and symptoms over the first year.", {"entities": []}], ["Each doubling of maternal urinary arsenic was related to increases in the total number of infections requiring prescription medication in the first year [relative risk (RR) = 1.1; 95% CI: 1.0, 1.2].", {"entities": []}], ["Urinary arsenic was related specifically to respiratory symptoms (difficulty breathing, wheezing, and cough) lasting \u2265 2 days or requiring prescription medication (RR = 1.1; 95% CI: 1.0, 1.2; and RR = 1.2; 95% CI: 1.0, 1.5, respectively), and wheezing lasting \u2265 2 days, resulting in a doctor visit or prescription medication treatment (RR = 1.3; 95% CI: 1.0, 1.7; RR = 1.3; 95% CI: 1.0, 1.8, and RR = 1.5; 95% CI: 1.0, 2.2, respectively).", {"entities": []}], ["Associations also were observed with diarrhea (RR = 1.4; 95% CI: 1.1, 1.9) and fever resulting in a doctor visit (RR = 1.2; 95% CI: 1.0, 1.5).", {"entities": [[37, 45, "DISEASE"]]}], ["In utero arsenic exposure was associated with a higher risk of infection during the first year of life in our study population, particularly infections requiring medical treatment, and with diarrhea and respiratory symptoms.", {"entities": [[190, 198, "DISEASE"]]}], ["Farzan SF, Li Z, Korrick SA, Spiegelman D, Enelow R, Nadeau K, Baker E, Karagas MR. 2016.", {"entities": []}], ["Infant infections and respiratory symptoms in relation to in utero arsenic exposure in a U.S. cohort.", {"entities": []}], ["Environ Health Perspect 124:840\u2013847;\u2002http://dx.doi.org/10.1289/ehp.1409282", {"entities": []}], ["CD23 is a differentiation/activation antigen expressed by a variety of hematopoietic and epithelial cells.", {"entities": []}], ["It can also be detected in soluble forms in biological fluids.", {"entities": []}], ["Initially known as the low-affinity receptor for immunoglobulin E (Fc\u03b5RII), CD23 displays various other physiologic ligands such as CD21, CD11b/c, CD47-vitronectin, and mannose-containing proteins.", {"entities": []}], ["CD23 mediates numerous immune responses by enhancing IgE-specific antigen presentation, regulating IgE synthesis, influencing cell differentiation and growth of both B- and T-cells.", {"entities": []}], ["CD23-crosslinking promotes the secretion of pro-inflammatory mediators from human monocytes/macrophages, eosinophils and epithelial cells.", {"entities": []}], ["Increased CD23 expression is found in patients during allergic reactions and rheumatoid arthritis while its physiopathologic role in these diseases remains to be clarified.", {"entities": [[77, 97, "DISEASE"], [88, 97, "DISEASE"]]}], ["We previously generated heptapeptidic countrestructures of human CD23.", {"entities": []}], ["Based on in vitro studies on healthy and arthritic patients' cells, we showed that CD23-specific peptide addition to human macrophages greatly diminished the transcription of genes encoding inflammatory cytokines.", {"entities": []}], ["This was also confirmed by significant reduction of mediator levels in cell supernatants.", {"entities": []}], ["We also show that CD23 peptide decreased IgE-mediated activation of both human and rat CD23 In vivo studies in rat model of arthritis showed that CD23-blocking peptide ameliorates clinical scores and prevent bone destruction in a dose dependent manner.", {"entities": [[124, 133, "DISEASE"]]}], ["Ex-vivo analysis of rat macrophages further confirmed the inhibitory effect of peptides on their activation.", {"entities": []}], ["Taken together our results support the role of CD23 activation and subsequent inflammatory response in arthritis.", {"entities": [[103, 112, "DISEASE"]]}], ["CD23-blocking peptide (p30A) prevents the activation of monocytes/macrophages without cell toxicity.", {"entities": []}], ["Thus, targeting CD23 by antagonistic peptide decreases inflammatory markers and may have clinical value in the treatment of human arthritis and allergic reactions involving CD23.", {"entities": [[130, 139, "DISEASE"]]}], ["Pathogen-activated and damage-associated molecular patterns activate the inflammasome in macrophages.", {"entities": []}], ["We report that mouse macrophages release IL-1\u03b2 while co-incubated with pro-B (Ba/F3) cells dying, as a result of IL-3 withdrawal, by apoptosis with autophagy, but not when they are co-incubated with living, apoptotic, necrotic or necrostatin-1 treated cells.", {"entities": []}], ["NALP3-deficient macrophages display reduced IL-1\u03b2 secretion, which is also inhibited in macrophages deficient in caspase-1 or pre-treated with its inhibitor.", {"entities": []}], ["This finding demonstrates that the inflammasome is activated during phagocytosis of dying autophagic cells.", {"entities": []}], ["We show that activation of NALP3 depends on phagocytosis of dying cells, ATP release through pannexin-1 channels of dying autophagic cells, P 2 X 7 purinergic receptor activation, and on consequent potassium efflux.", {"entities": []}], ["Dying autophagic Ba/F3 cells injected intraperitoneally in mice recruit neutrophils and thereby induce acute inflammation.", {"entities": []}], ["These findings demonstrate that NALP3 performs key upstream functions in inflammasome activation in mouse macrophages engulfing dying autophagic cells, and that these functions lead to pro-inflammatory responses.", {"entities": []}], ["There are over 100 genes that have been reported to be associated with asthma or related phenotypes.", {"entities": [[71, 77, "DISEASE"]]}], ["In 2006\u20132007 alone there were 53 novel candidate gene associations reported in the literature.", {"entities": []}], ["Replication of genetic associations and demonstration of a functional mechanism for the associated variants are needed to confirm an asthma susceptibility gene.", {"entities": [[133, 139, "DISEASE"]]}], ["For most of the candidate genes there is little functional information.", {"entities": []}], ["In a previous review by Hoffjan et al .", {"entities": []}], ["published in 2003, functional information was reported for 40 polymorphisms and here we list another 22 genes which have such data.", {"entities": []}], ["Some important genes such as filaggrin, interleukin-13, interleukin-17 and the cysteinyl leukotriene receptor-1 which not only were replicated by independent association studies but also have functional data are reviewed in this article.", {"entities": []}], ["Children\u2019s psychological and physiological health can be summarized as the child\u2019s thinking, feeling, behaving, eating, growing, and moving.", {"entities": []}], ["Children\u2019s psychological and physiological health conditions are influenced by today\u2019s life challenges: Thus, stress exposure and lack of physical activity represent important health challenges in older children.", {"entities": []}], ["However, corresponding evidence for young children is scarce.", {"entities": []}], ["The aim of Swiss Preschoolers\u2019 Health Study (SPLASHY) is to examine the role of stress and physical activity on children\u2019s psychological and physiological health, particularly on cognitive functioning, psychological well-being, adiposity and motor skills in children at an early stage of childhood.", {"entities": []}], ["We will also assess the role of child and environmental characteristics and aim to define sensitive time points.", {"entities": []}], ["In a total of 84 child care centers, children at preschool age (2\u20136\u00a0years) are recruited and are assessed immediately and one year later.", {"entities": []}], ["Assessments include direct measurements of the children in the child care centers and at home as well as assessments of children\u2019s behavior and environmental factors through informants (parents and child care educators).", {"entities": []}], ["SPLASHY is one of the first studies in early childhood aiming to investigate the influence of stress and physical activity on children\u2019s psychological and physiological health in a community-based longitudinal design.", {"entities": []}], ["Current Controlled Trials ISRCTN41045021 (date of registration: 21.03.14)", {"entities": []}], ["The concept of lung sounds conveying information regarding lung physiology has been used extensively in clinical practice, particularly with physical auscultation using a stethoscope.", {"entities": []}], ["Advances in computer technology have facilitated the construction of dynamic visual images derived from recorded lung sounds.", {"entities": []}], ["Arguably, the most significant progress in this field was the development of the commercially available vibration response imaging (VRI) (Deep Breeze Ltd, Or-Akiva, Israel).", {"entities": []}], ["This device provides a non-invasive, dynamic image of both lungs constructed from sounds detected from the lungs using surface sensors.", {"entities": []}], ["In the literature, VRI has been utilized in a multitude of clinical and research settings.", {"entities": []}], ["This systematic review aims to address three study questions relating to whether VRI can be used as an evaluative device, whether the images generated can be characterized, and which tools and measures have been used to assess these images.", {"entities": []}], ["This systematic review will involve implementing search strategies in five online journal databases in order to extract articles relating to the application of VRI.", {"entities": []}], ["Appropriate articles will be identified against a set of pre-determined eligibility criteria and assessed for methodological quality using a standardized scale.", {"entities": []}], ["Included articles will have data extracted by the reviewers using a standardized evidence table.", {"entities": []}], ["A narrative synthesis based on a standardized framework will be conducted, clustering evidence into three main groups; one for each of the study questions.", {"entities": []}], ["A meta-analysis will be conducted if two or more research articles meet pre-determined criteria that allow quantitative synthesis to take place.", {"entities": []}], ["This systematic review aims to provide a complete overview of the scope of VRI in the clinical and research settings, as well as to discuss methods to interpret the data obtained from VRI.", {"entities": []}], ["The systematic review intends to help clinicians to make informed decisions on the clinical applicability of the device, to allow researchers to identify further potential avenues of investigation, and to provide methods for the evaluation and interpretation of dynamic and static images.", {"entities": []}], ["The publication and registration of this review with PROSPERO provides transparency and accountability, and facilitates the appraisal of the proposed systematic review against the original design.", {"entities": []}], ["PROSPERO registration number: CRD42013003751", {"entities": []}], ["Schools can play an important role in the prevention of obesity, e.g.", {"entities": [[56, 63, "DISEASE"]]}], ["by providing an environment that stimulates healthy eating habits and by developing a food policy to provide such an environment.", {"entities": []}], ["The effectiveness of a school food policy is affected by the content of the policy, its implementation and its support by parents, teachers and principals.", {"entities": []}], ["The aim of this study is to detect opportunities to improve the school food policy and/or implementation at Dutch primary schools.", {"entities": []}], ["Therefore, this study explores the school food policy and investigates schools\u2019 (teachers and principals) and parents\u2019 opinion on the school food policy.", {"entities": []}], ["Data on the schools\u2019 perspective of the food policy was collected from principals and teachers by means of semi-structured interviews.", {"entities": []}], ["In total 74 principals and 72 teachers from 83 Dutch primary schools were interviewed.", {"entities": []}], ["Data on parental perceptions about the school food policy were based on a cross-sectional survey among 1,429 parents from the same schools.", {"entities": []}], ["Most principals (87.1%) reported that their school had a written food policy; however in most cases the rules were not clearly defined.", {"entities": []}], ["Most of the principals (87.8%) believed that their school paid sufficient attention to nutrition and health.", {"entities": []}], ["Teachers and principals felt that parents were primarily responsible to encourage healthy eating habits among children, while 49.8% of the parents believed that it is also a responsibility of the school to foster healthy eating habits among children.", {"entities": []}], ["Most parents reported that they appreciated the school food policy and comply with the food rules.", {"entities": []}], ["Parents\u2019 opinion on the enforcement of the school food policy varied: 28.1% believed that the school should enforce the policy more strongly, 32.1% was satisfied, and 39.8% had no opinion on this topic.", {"entities": []}], ["Dutch primary schools could play a more important role in fostering healthy eating habits among children.", {"entities": []}], ["The school food policy could be improved by clearly formulating food rules, simplifying supervision of the food rules, and defining how to enforce the food rules.", {"entities": []}], ["In addition, the school food policy will only influence children\u2019s dietary behaviour if both the school and the parents support the policy.", {"entities": []}], ["Cigarette smoking enhances oxidative stress and airway inflammation in asthma, the mechanisms of which are largely unknown.", {"entities": [[71, 77, "DISEASE"]]}], ["Myeloid-derived regulatory cells (MDRC) are free radical producing immature myeloid cells with immunoregulatory properties which have recently been demonstrated as critical regulators of allergic airway inflammation.", {"entities": []}], ["NO (nitric oxide)-producing immunosuppressive MDRC suppress T cell proliferation and airway-hyper responsiveness (AHR), while the O 2 2 in vivo and exacerbated AHR in C57BL/6 mice, mice deficient in Type I IFNR and MyD88, both with reduced numbers of endogenous MDRC.", {"entities": [[114, 117, "GENE"], [160, 163, "GENE"], [114, 117, "GENE"], [160, 163, "GENE"], [215, 220, "GENE"]]}], ["Thus, CS exposure modulates MDRC function and contributes to asthma exacerbation and identifies MDRC as potential targets for asthma therapy.", {"entities": [[61, 67, "DISEASE"], [126, 132, "DISEASE"], [6, 8, "GENE"]]}], ["Autism spectrum disorders (ASD) are complex conditions whose pathogenesis may be attributed to gene\u2013environment interactions.", {"entities": []}], ["There are no definitive mechanisms explaining how environmental triggers can lead to ASD although the involvement of inflammation and immunity has been suggested.", {"entities": []}], ["Inappropriate antigen trafficking through an impaired intestinal barrier, followed by passage of these antigens or immune-activated complexes through a permissive blood\u2013brain barrier (BBB), can be part of the chain of events leading to these disorders.", {"entities": []}], ["Our goal was to investigate whether an altered BBB and gut permeability is part of the pathophysiology of ASD.", {"entities": []}], ["Postmortem cerebral cortex and cerebellum tissues from ASD, schizophrenia (SCZ), and healthy subjects (HC) and duodenal biopsies from ASD and HC were analyzed for gene and protein expression profiles.", {"entities": [[60, 73, "DISEASE"]]}], ["Tight junctions and other key molecules associated with the neurovascular unit integrity and function and neuroinflammation were investigated.", {"entities": []}], ["Claudin ( CLDN )-5 and -12 were increased in the ASD cortex and cerebellum.", {"entities": []}], ["CLDN-3 , tricellulin , and MMP-9 were higher in the ASD cortex.", {"entities": []}], ["IL-8 , tPA , and IBA-1 were downregulated in SCZ cortex; IL-1b was increased in the SCZ cerebellum.", {"entities": []}], ["Differences between SCZ and ASD were observed for most of the genes analyzed in both brain areas.", {"entities": []}], ["CLDN-5 protein was increased in ASD cortex and cerebellum, while CLDN-12 appeared reduced in both ASD and SCZ cortexes.", {"entities": []}], ["In the intestine, 75% of the ASD samples analyzed had reduced expression of barrier-forming TJ components ( CLDN-1 , OCLN , TRIC ), whereas 66% had increased pore-forming CLDNs ( CLDN-2 , -10 , -15 ) compared to controls.", {"entities": [[117, 121, "GENE"]]}], ["In the ASD brain, there is an altered expression of genes associated with BBB integrity coupled with increased neuroinflammation and possibly impaired gut barrier integrity.", {"entities": []}], ["While these findings seem to be specific for ASD, the possibility of more distinct SCZ subgroups should be explored with additional studies.", {"entities": []}]]